Citrus Sinensis ID: 040242

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660--
Protein Sequence
METFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSEDDSDPSS
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHccccccccEEEcccccccEEEEEcEEEccccEEEEccccccEEEEEEccccEEccccccccccccccccEEEEEEEEEEEEEEccccccccccEEEEEcccccccccccccccccccccccccccccEEEEEEEcccccccccccccEEEEEcccccccccccccccccccccccccccEEEEcccccEEEEEEEEcccEEEEEEEEEcccccccccEEEEEccccccccccEEEEEEccccccEEEEEEEEEEEcccccccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHEEEccccccccHHHHHcccccEEcHHHHHHHHHcccccccccccccEEEEEEEccccccEEEEEEEcccccccHHHHHHHHHHHHcccccccccEEEEEEcccEEEEEEEEcccccccHHcccccccccccccHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccEEEcccccccccccccEEEccccccccccEEcccccccccccccccccccccccccHHHHHHHccccccccccccccccccHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHcccccEEEEcccccccEEEccEEEEccccEEEEEcccccccccEccccccEEccccccccccccccccEEEEEEEEEEEEEcccccccccEEEEEEEcccccccccHHHHcEEEEcccccccccEEEEEEEEccccccccccccccEEEEEccccccccccccEEccccccccccEEEEEEEccccEEEEEEcccccEEEEEEEcccccccccccEEEEEEccHHHccccEEEEEEcccccEccEEEEEEEEEccccccccccHHcccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccEEEEEEEccccHccHHHHHHHHHHHHHHHHHHHHHHHHHHcccccEEEEEEccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHcccEEcccccHHHEEEEccccEEEccccccEEcccccEcccccccEcHHHccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccEEEHHHHHHHHHcccHHHHcccccccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
METFSLLLHLLLLGFAhaetnsfiYNGFIQanlsldgtafvrkdgilavsndqgrilghafypsplrfkqlskyninnntishtaltfstnfvfsivpkypqlgghgLAFVLMsrkqppsclanqylglpndtsnakfSTRILAVEFDAvqnlelqdindnhvgIDISSLIsnisepaayyfskgsninddnisvVLKSGDPIQAWIDYNSQEMLINvtisplgipkphrplisypidLATVLDEYMYVGFSASTGLLTAFHNVhgwsfkiggtareldvtmlpfharpkskqvvhkKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYsatkgfreknlvgsggfgkvyrgvipstGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVydyvpngsldkllfdndqqKKKILNWDQRYKILIGVAQALLYLHEecdqrvvhrdvkpsnvlidadlnpklgdfglaraydhninpqtthivgtlgylapeltrtgkattstdvfgFGTLMLEVAcgrrpiepqrTAMELVLVDWVRELHsqgqitraidptldyfdpqEAELVLTLGllccdphpdfrpstRRVVQFLLRdaslpqapldihhefpraipefseddsdpss
Flexible Loop (DISEMBL)
METFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYsatkgfreknlvgsggfgKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAipefseddsdpss
Low Complexity Region (SEG)
METFSlllhllllGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITlasailvifviiaailvlrrirNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIpefseddsdpss
Disordered region (IsUnstruct)
***FSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI********************
Disordered Region (DISOPRED)
*ETFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKY*******SHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHAR*****VVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN*****KEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI*****AMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF****************
Disordered Region (DISEMBL)
METFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPE**********
Disordered Region (DISPRO)
METFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQL***********HTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAP***********************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METFSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSEDDSDPSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	662	2.2.26 [Sep-21-2011]
Q9M345	677	L-type lectin-domain cont	yes	no	0.909	0.889	0.486	1e-164
Q9M2S4	684	L-type lectin-domain cont	no	no	0.901	0.872	0.474	1e-164
O80939	675	L-type lectin-domain cont	no	no	0.918	0.900	0.488	1e-159
O81292	674	L-type lectin-domain cont	no	no	0.922	0.906	0.475	1e-157
Q9SZD5	669	L-type lectin-domain cont	no	no	0.913	0.904	0.456	1e-156
O81291	669	L-type lectin-domain cont	no	no	0.906	0.896	0.469	1e-152
O04534	666	Putative L-type lectin-do	no	no	0.895	0.890	0.435	1e-145
Q9FIF1	674	Probable L-type lectin-do	no	no	0.912	0.896	0.444	1e-143
Q9M020	688	Lectin-domain containing	no	no	0.906	0.872	0.424	1e-142
Q9SR87	693	Probable L-type lectin-do	no	no	0.915	0.874	0.436	1e-141

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  579 bits (1493), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 305/627 (48%), Positives = 419/627 (66%), Gaps = 25/627 (3%)

Query: 22  SFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNN 79
           +F YNGF     ++SL G A V  +G+L ++N   +  GHAF    +RFK     N++  
Sbjct: 26  NFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDSQNGNVS-- 83

Query: 80  TISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFS 139
                  +FST FVF+I  + P L GHG+AFV+      P  L +QY+GL N ++N   +
Sbjct: 84  -------SFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDT 136

Query: 140 TRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
             I AVEFD +Q+ E  D NDNHVGID++ L S     A Y      + +D   ++ L S
Sbjct: 137 NHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGY-----RDDHDKFQNLSLIS 191

Query: 200 GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLT 259
              IQ WIDY+++   I+VT++P    KP +PL+SY  DL+++L E MYVGFS++TG + 
Sbjct: 192 RKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVL 251

Query: 260 AFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAA 319
           + H + GWSF++ G A  L ++ LP   R + +++   + + +G+ L S  L+  +I  A
Sbjct: 252 SEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRI--SEFYKIGMPLISLSLIFSIIFLA 309

Query: 320 ILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPST 379
             ++RR +  ++ L+DWE E+G  RFR+ ELY ATKGF+EK+L+GSGGFG+VYRG++P+T
Sbjct: 310 FYIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTT 369

Query: 380 GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 439
            LEVA+KRV+H+S+QGMKEFVAEI S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGSL
Sbjct: 370 KLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSL 429

Query: 440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP 499
           DK L++N +     L+W QR  I+ GVA  L YLHEE +Q V+HRDVK SNVL+DAD N 
Sbjct: 430 DKYLYNNPET---TLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNG 486

Query: 500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR 559
           +LGDFGLAR YDH  +PQTTH+VGTLGYLAPE +RTG+ATT+TDV+ FG  +LEV  GRR
Sbjct: 487 RLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRR 546

Query: 560 PIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTLDY--FDPQEAELVLTLGLLCCDPHP 616
           PIE    + +  +LV+WV  L  +G I  A DP L    +D +E E+VL LGLLC    P
Sbjct: 547 PIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDP 606

Query: 617 DFRPSTRRVVQFLLRDASLPQ-APLDI 642
             RPS R+V+Q+L  D +LP+  PLD+
Sbjct: 607 RARPSMRQVLQYLRGDMALPELTPLDL 633

Required during pollen development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  578 bits (1489), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 293/618 (47%), Positives = 415/618 (67%), Gaps = 21/618 (3%)

Query: 23  FIYNGFIQA--NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
           F + GF +A  NL+L+G A +   G + ++ +  R++GHAFY  P+RFK +    +N   
Sbjct: 26  FSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPI---GVNR-- 80

Query: 81  ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
               AL+FST+F  ++VP++  LGGHGLAF +         L +QYLGL N +S   FS+
Sbjct: 81  ----ALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLN-SSRVNFSS 135

Query: 141 RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSG 200
              AVEFD V++LE +DINDNHVGIDI+S+ S+IS PA Y+ +     N     + L  G
Sbjct: 136 HFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLA-----NSTKKELFLDGG 190

Query: 201 DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTA 260
             IQAWIDY+S +  ++V +SP    KP   L+SY +DL++VL + MYVGFSASTGLL +
Sbjct: 191 RVIQAWIDYDSNKKRLDVKLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLAS 249

Query: 261 FHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIFVIIAAI 320
            H + GW+F + G A  L +  LP       K+   ++   +G++L  ++L+  V++AA 
Sbjct: 250 SHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAAS 309

Query: 321 LVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTG 380
           L + R    +D +E+WE+++G  RF Y EL  AT GF +K L+GSGGFGKVY+G +P + 
Sbjct: 310 LFVVRKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSD 369

Query: 381 LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD 440
             VA+KR++H SRQG++EF++E++S+G LRHRNLVQL GWCR++D+LLLVYD++PNGSLD
Sbjct: 370 EFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLD 429

Query: 441 KLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK 500
             LF  D+  + IL W QR+KI+ GVA  LLYLHE  +Q V+HRD+K +NVL+D+++N +
Sbjct: 430 MYLF--DENPEVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGR 487

Query: 501 LGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +GDFGLA+ Y+H  +P  T +VGT GYLAPELT++GK TTSTDV+ FG ++LEVACGRRP
Sbjct: 488 VGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRP 547

Query: 561 IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLCCDPHPDFR 619
           IE      ELV+VDWV      G I   +D  L+  FD +E  +V+ LGLLC +  P+ R
Sbjct: 548 IETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVR 607

Query: 620 PSTRRVVQFLLRDASLPQ 637
           P+ R+VV +L +    P+
Sbjct: 608 PTMRQVVMYLEKQFPSPE 625

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  563 bits (1451), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 309/632 (48%), Positives = 417/632 (65%), Gaps = 24/632 (3%)

Query: 16  AHAETNSFIYN-GF-IQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSK 73
           + +++ +F YN GF    +LS+ G   V  +G+L ++N   +  GHAFY  P+RFK    
Sbjct: 20  SSSQSLNFAYNNGFNPPTDLSIQGITTVTPNGLLKLTNTTVQKTGHAFYTKPIRFK---- 75

Query: 74  YNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT 133
            +  N T+S    +FST+FVF+I  +   L GHG+AFV+      P    +QY+GL N  
Sbjct: 76  -DSPNGTVS----SFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLA 130

Query: 134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
           +N   +  + AVE D + + E  D NDNHVGIDI+SL S  S PA Y+  KG   N    
Sbjct: 131 NNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKN---- 186

Query: 194 SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA 253
            + L S  P+Q W+DY+ +   I+VT++P    KP RPL++   DL++VL + MYVGFS+
Sbjct: 187 -LTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSS 245

Query: 254 STGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVI 313
           +TG + + H + GWSF +   A  L ++ LP   R + K++   + + +G+ L S  L+ 
Sbjct: 246 ATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRI--SEFYKIGMPLISLFLIF 303

Query: 314 FVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYR 373
             I     ++RR R   + LE+WE E+G  RFR+ +LY ATKGF+EK L+G+GGFG VY+
Sbjct: 304 SFIFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYK 363

Query: 374 GVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY 433
           GV+P T LE+A+KRV+H SRQGMKEFVAEI S+GR+ HRNLV L G+CR++ ELLLVYDY
Sbjct: 364 GVMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDY 423

Query: 434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI 493
           +PNGSLDK L++  +     LNW QR K+++GVA  L YLHEE +Q V+HRDVK SNVL+
Sbjct: 424 MPNGSLDKYLYNTPEV---TLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLL 480

Query: 494 DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE 553
           D +LN +LGDFGLAR YDH  +PQTTH+VGTLGYLAPE TRTG+AT +TDVF FG  +LE
Sbjct: 481 DGELNGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLE 540

Query: 554 VACGRRPIE-PQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLC 611
           VACGRRPIE  Q T    +LVDWV  L ++G I  A DP +    D +E E+VL LGLLC
Sbjct: 541 VACGRRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLC 600

Query: 612 CDPHPDFRPSTRRVVQFLLRDASLPQ-APLDI 642
               P  RPS R+V+ +L  DA LP+ +PLD+
Sbjct: 601 SHSDPRARPSMRQVLHYLRGDAKLPELSPLDL 632

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  556 bits (1433), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 303/637 (47%), Positives = 415/637 (65%), Gaps = 26/637 (4%)

Query: 16  AHAETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSK 73
           + +++ +F YN F +   N+S+ G A V  +GIL +++      GHAFY  P+RFK    
Sbjct: 22  SSSQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFK---- 77

Query: 74  YNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT 133
            +  N+T+S    +FST FV  I    P + GHG+AF +       S +A+QYLGL + T
Sbjct: 78  -DSPNDTVS----SFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSST 132

Query: 134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
           +N   +  ILAVEFD + N E  D NDNHVGI+I+SL S  S    Y+      IN  N 
Sbjct: 133 NNGNDTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYW----DEINQFN- 187

Query: 194 SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA 253
           ++ L S   +Q W+DY+ +   I+VT++P G  KP + L+S   DL++V  + MY+GFSA
Sbjct: 188 NLTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSA 247

Query: 254 STGLLTAFHNVHGWSFKIGG-TARELDVTMLPFHAR--PKSKQVVHKKGFAV-GITLASA 309
           +TG + + H V GWSF + G TA  L ++ +P   R  P S Q  +K    +  + L   
Sbjct: 248 ATGYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPV 307

Query: 310 ILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFG 369
           + V+ +I     ++RR R   +  EDWE E+G  R R+ +LY ATKGF++K+L+GSGGFG
Sbjct: 308 LFVVSLIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFG 367

Query: 370 KVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL 429
           +VYRGV+P+T  E+A+KRV++ SRQG+KEFVAEI S+GR+ HRNLV L G+CR++DELLL
Sbjct: 368 RVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLL 427

Query: 430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPS 489
           VYDY+PNGSLDK L+D  +     L+W QR+ ++IGVA  L YLHEE +Q V+HRD+K S
Sbjct: 428 VYDYMPNGSLDKYLYDCPEVT---LDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKAS 484

Query: 490 NVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGT 549
           NVL+DA+ N +LGDFGLAR  DH  +PQTT +VGT GYLAP+  RTG+ATT+TDVF FG 
Sbjct: 485 NVLLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGV 544

Query: 550 LMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTL 607
           L+LEVACGRRPIE +  + E ++LVD V     +G I  A DP L   +D +E E VL L
Sbjct: 545 LLLEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKL 604

Query: 608 GLLCCDPHPDFRPSTRRVVQFLLRDASLPQ-APLDIH 643
           GLLC    P  RP+ R+V+Q+L  DA+LP  +PLD  
Sbjct: 605 GLLCSHSDPQVRPTMRQVLQYLRGDATLPDLSPLDFR 641

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  553 bits (1424), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 290/635 (45%), Positives = 411/635 (64%), Gaps = 30/635 (4%)

Query: 14  GFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSK 73
             + +E   F +NG++  N    G A     G++ ++N      GH FY SP+RFK    
Sbjct: 19  ALSQSEEGEFGFNGYLYDN---SGIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFK---- 71

Query: 74  YNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT 133
            N  N T+S    +FST FVF+IV     L GHGLAFV+   K  P   ++QYLGL N T
Sbjct: 72  -NSPNGTVS----SFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLT 126

Query: 134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
           +N   S  I+AVEFD  QN E  D+++NHVGIDI+SL S  +  A YY       +DD  
Sbjct: 127 NNGDPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYY------EDDDGT 180

Query: 194 --SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
             ++ L +  PIQAWI+Y+S    +NVTI P+ +PKP  PL+S   DL+  L + MYVGF
Sbjct: 181 FKNIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGF 240

Query: 252 SASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAIL 311
           +++TG L + H + GW+FK+ GTA  +D++ LP   R  S+    KK  A+ ++L S  +
Sbjct: 241 TSATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPR-DSRSTSVKKILAISLSLTSLAI 299

Query: 312 VIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKV 371
           ++F+ I+ +L L+R +   ++LEDWEV++G  RF Y +LY ATKGFR   L+G GGFGKV
Sbjct: 300 LVFLTISYMLFLKR-KKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKV 358

Query: 372 YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY 431
           Y+G + ++ +++A+K+V+H+SRQGM+EFVAEI ++GRLRH NLV+L G+CR++ EL LVY
Sbjct: 359 YKGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVY 418

Query: 432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV 491
           D +P GSLDK L+    Q ++ L+W QR+KI+  VA  L YLH +  Q ++HRD+KP+NV
Sbjct: 419 DCMPKGSLDKFLY---HQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANV 475

Query: 492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLM 551
           L+D  +N KLGDFGLA+  +H  +PQT+++ GT GY++PEL+RTGKA+TS+DVF FG LM
Sbjct: 476 LLDDSMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILM 535

Query: 552 LEVACGRRPIEPQRTA-MELVLVDWVRELHSQGQITRAIDPTL---DYFDPQEAELVLTL 607
           LE+ CGRRP+ P+ ++  E+VL DWV +   +  I + +D  +   D +  ++  LVL L
Sbjct: 536 LEITCGRRPVLPRASSPSEMVLTDWVLDCW-EDDILQVVDERVKQDDKYLEEQVALVLKL 594

Query: 608 GLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
           GL C  P    RPS   V+QFL   A LP    DI
Sbjct: 595 GLFCSHPVAAVRPSMSSVIQFLDGVAQLPNNLFDI 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  540 bits (1392), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 296/630 (46%), Positives = 410/630 (65%), Gaps = 30/630 (4%)

Query: 23  FIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
           F YNGF     ++S+ G A +  +G+L ++N   +  GHAFY  P+RFK     +  N T
Sbjct: 28  FTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIRFK-----DSPNGT 82

Query: 81  ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
           +S    +FST FVF+I  + P    HG+AFV+    + P     QYLGL N T+N     
Sbjct: 83  VS----SFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVRN 136

Query: 141 RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSG 200
            + AVE D + N+E  D N+NHVGIDI+SL S  S PA Y+     + ND   ++ L S 
Sbjct: 137 HVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYW-----DENDQFHNLTLISS 191

Query: 201 DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTA 260
             +Q W+D++    LI+VT++P G  KP +PL+S   DL++VL + M+VGFS++TG + +
Sbjct: 192 KRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVS 251

Query: 261 FHNVHGWSFKIGGTARELDVTMLP----FHARPKSKQVVHKKGFAVGITLASAILVIFVI 316
              V GWSF + G A+ L ++ LP    +  +P      +K    V +     I  + +I
Sbjct: 252 EIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKN--WVPLISLLLIPFLLII 309

Query: 317 IAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVI 376
                +++R R   + +EDWE E+G  R R+ +LY ATKGF++KN++GSGGFG VY+G++
Sbjct: 310 FLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIM 369

Query: 377 PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 436
           P T  E+A+KRV++ SRQG+KEFVAEI S+G++ HRNLV L G+CR++DELLLVYDY+PN
Sbjct: 370 PKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPN 429

Query: 437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
           GSLDK L+++ +     L+W QR+K++ GVA AL YLHEE +Q V+HRDVK SNVL+DA+
Sbjct: 430 GSLDKYLYNSPEVT---LDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAE 486

Query: 497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC 556
           LN +LGDFGLA+  DH  +PQTT +VGT GYLAP+  RTG+ATT+TDVF FG L+LEVAC
Sbjct: 487 LNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVAC 546

Query: 557 GRRPIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDP 614
           GRRPIE    + E +VLVDWV     +  I  A DP L   +D +E E+VL LGLLC   
Sbjct: 547 GRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHS 606

Query: 615 HPDFRPSTRRVVQFLLRDASLPQ-APLDIH 643
            P  RP+ R+V+Q+L  DA LP  +PLD+ 
Sbjct: 607 DPLARPTMRQVLQYLRGDAMLPDLSPLDLR 636

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  517 bits (1331), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 268/615 (43%), Positives = 394/615 (64%), Gaps = 22/615 (3%)

Query: 31  ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST 90
            N+   G+A++  +G++ ++N   +  G  FY   LRFK         N+++ T  +FST
Sbjct: 32  GNMYTSGSAYINNNGLIRLTNSTPQTTGQVFYNDQLRFK---------NSVNGTVSSFST 82

Query: 91  NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAV 150
            FVFSI       GG+G+AFV+   +         YLGL N ++       I+AVE D  
Sbjct: 83  TFVFSIEFHNGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDPKNHIVAVELDTK 142

Query: 151 QNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYN 210
            + + +D + NHVGIDI++L+S+    A YY   G+       S++L SG P+Q WI+Y+
Sbjct: 143 VDQQFEDKDANHVGIDINTLVSDTVALAGYYMDNGTFR-----SLLLNSGQPMQIWIEYD 197

Query: 211 SQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFK 270
           S++  INVT+ PL +PKP  PL+S   DL+  L E MYVGF+++TG LTA H + GW+FK
Sbjct: 198 SKQKQINVTLHPLYVPKPKIPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFK 257

Query: 271 IGGTARELDVTMLPFHARPKSKQVVHKKG-FAVGITLASAILVIFVIIAAILVLRRIRNG 329
           + GT  ++D + LP   R     +    G   + +T++  I++I + ++  L L+R +  
Sbjct: 258 MNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSLSLWLFLKR-KKL 316

Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
            ++LEDWEV++G  RF + +L+ ATKGF++  ++G GGFGKVY+G +P + +E+A+K V+
Sbjct: 317 LEVLEDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVS 376

Query: 390 HNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ 449
           H+SRQGM+EF+AEI ++GRLRH NLV+L G+CR + EL LVYD +  GSLDK L+    Q
Sbjct: 377 HDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLY---HQ 433

Query: 450 KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA 509
           +   L+W QR+KI+  VA  L YLH++  Q ++HRD+KP+N+L+DA++N KLGDFGLA+ 
Sbjct: 434 QTGNLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKL 493

Query: 510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            DH  +PQT+H+ GTLGY++PEL+RTGKA+T +DVF FG +MLE+ACGR+PI P+ +  E
Sbjct: 494 CDHGTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQRE 553

Query: 570 LVLVDWVRELHSQGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           +VL DWV E      I + +D  +  +Y + Q A LVL LGL C  P    RP+   V+Q
Sbjct: 554 MVLTDWVLECWENEDIMQVLDHKIGQEYVEEQ-AALVLKLGLFCSHPVAAIRPNMSSVIQ 612

Query: 628 FLLRDASLPQAPLDI 642
            L   A LP   LDI
Sbjct: 613 LLDSVAQLPHNLLDI 627

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FIF1|LRK21_ARATH Probable L-type lectin-domain containing receptor kinase II.1 OS=Arabidopsis thaliana GN=LECRK21 PE=2 SV=1

 Score =  508 bits (1307), Expect = e-143,   Method: Compositional matrix adjust.
 Identities = 285/641 (44%), Positives = 396/641 (61%), Gaps = 37/641 (5%)

Query: 8   LHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLR 67
           +H+  L FA  E + F+Y  F  A+L LDG A     G L ++N+     GHAFY  P++
Sbjct: 16  IHVTFLVFAQ-EGDHFVYYDFRNADLELDGMANTNH-GPLHLTNNTNTGTGHAFYNIPIK 73

Query: 68  FKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPS-CLANQY 126
           F   S  + + +T    A          I P      GHG+AFV+   K   S   AN  
Sbjct: 74  FTASSLSSFSFSTEFVFA----------IFPLQKSTYGHGMAFVVSPTKDLRSNGSANSN 123

Query: 127 LGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGS 186
           LG+ N  ++ K +T I AVE D  QN E  D   N VGIDI+S++S  S  A+Y+ ++  
Sbjct: 124 LGIFNRANDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADASYFNAR-- 181

Query: 187 NINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRP-----------LISY 235
                NIS+ L SG  I  WIDY+  E ++NVT++P+  PKP  P           L+S 
Sbjct: 182 --KGKNISLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSR 239

Query: 236 PIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVV 295
            I+L+ +  E MYVGFS STG + +   + GWSFK GG A  LD++ L  +  P  K+  
Sbjct: 240 SINLSEIFTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLS-NPPPSPKRFP 298

Query: 296 HKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATK 355
            K+   +G T+++   + F+ +  I+ L + +   ++LE WE EY   R+ +  LY ATK
Sbjct: 299 LKE--VLGATIST---IAFLTLGGIVYLYKKKKYAEVLEQWEKEYSPQRYSFRILYKATK 353

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
           GFRE  L+G+GGFGKVY+G++PS G ++A+KRV H++ QGMK++VAEI SMGRLRH+NLV
Sbjct: 354 GFRENQLLGAGGFGKVYKGILPS-GTQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLV 412

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L G+CR++ ELLLVYDY+PNGSLD  LF   + K K L W QR  I+ GVA ALLYLHE
Sbjct: 413 HLLGYCRRKGELLLVYDYMPNGSLDDYLFH--KNKLKDLTWSQRVNIIKGVASALLYLHE 470

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           E +Q V+HRD+K SN+L+DADLN KLGDFGLAR +D  +N + T +VGT+GY+APELT  
Sbjct: 471 EWEQVVLHRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAM 530

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY 595
           G  TT TDV+ FG  +LEV CGRRP++P     +++LV WV     +  +T  +D  L  
Sbjct: 531 GVTTTCTDVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLID 590

Query: 596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP 636
           F  +EA+L+L LG+LC   +P+ RPS R+++Q+L  + S+P
Sbjct: 591 FKVEEAKLLLKLGMLCSQINPENRPSMRQILQYLEGNVSVP 631

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M020|LRK63_ARATH Lectin-domain containing receptor kinase VI.3 OS=Arabidopsis thaliana GN=LECRK63 PE=2 SV=1

 Score =  506 bits (1302), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 267/629 (42%), Positives = 396/629 (62%), Gaps = 29/629 (4%)

Query: 23  FIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
           FI+ GF   Q+N+   G A ++ DG+L +++    + G +FY  P+R  +      N ++
Sbjct: 26  FIFRGFSGNQSNIVTTGAATIKLDGLLRLTDRNSNVTGTSFYHKPVRLLE-----TNTSS 80

Query: 81  ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
            + T  +FST+FVF I+P     GG G  F L          + QYLGL N  ++   + 
Sbjct: 81  TNSTIRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPDRTGAESAQYLGLLNKANDGNSTN 140

Query: 141 RILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
            + AVEFD VQ   +  D   NH+G++ +SL S++ EP  YY ++  N  +D     L+S
Sbjct: 141 HVFAVEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQEPVVYYDNEDPNRKED---FPLQS 197

Query: 200 GDPIQAWIDYNSQEMLINVTISPLGI-PKPHRPLISYPI-DLATVLDEYMYVGFSASTGL 257
           GDPI+A +DY+     +N+T+ P  +  +P RPLIS P+  L+ ++ E MYVGF+A+TG 
Sbjct: 198 GDPIRAILDYDGPTQTLNLTVYPANLKSRPVRPLISRPVPKLSQIVQEEMYVGFTAATGR 257

Query: 258 -LTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGI-TLASAILVIFV 315
             ++ H V GWSF  GG     D   L    RP       K+G+   +  L  A+  + V
Sbjct: 258 DQSSAHYVMGWSFSSGGDLLTEDTLDLLELPRPP-PNTAKKRGYNSQVLALIVALSGVTV 316

Query: 316 IIAAILVL-----RRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGK 370
           I+ A+L       +R++ G+ +LEDWE+ +   R RY +LY+AT GF+E  +VG+GGFG 
Sbjct: 317 ILLALLFFFVMYKKRLQQGE-VLEDWEINH-PHRLRYKDLYAATDGFKENRIVGTGGFGT 374

Query: 371 VYRGVIPS-TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL 429
           V+RG + S +  ++A+K++  NS QG++EF+AEI S+GRLRH+NLV L GWC+++++LLL
Sbjct: 375 VFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKNLVNLQGWCKQKNDLLL 434

Query: 430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPS 489
           +YDY+PNGSLD LL+   +Q   +L+W+ R+KI  G+A  LLYLHEE ++ V+HRD+KPS
Sbjct: 435 IYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLYLHEEWEKVVIHRDIKPS 494

Query: 490 NVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGT 549
           NVLI+ D+NP+LGDFGLAR Y+      TT +VGT+GY+APEL R GK+++++DVF FG 
Sbjct: 495 NVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPELARNGKSSSASDVFAFGV 554

Query: 550 LMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVLTLG 608
           L+LE+  GRRP +    +    L DWV ELH++G+I  A+DP L + +D  EA L L +G
Sbjct: 555 LLLEIVSGRRPTD----SGTFFLADWVMELHARGEILHAVDPRLGFGYDGVEARLALVVG 610

Query: 609 LLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
           LLCC   P  RPS R V+++L  D  +P+
Sbjct: 611 LLCCHQRPTSRPSMRTVLRYLNGDDDVPE 639

Involved in negative regulation of abscisic acid response in seed germination.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SR87|LRK61_ARATH Probable L-type lectin-domain containing receptor kinase VI.1 OS=Arabidopsis thaliana GN=LECRK61 PE=2 SV=1

 Score =  504 bits (1297), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 277/634 (43%), Positives = 395/634 (62%), Gaps = 28/634 (4%)

Query: 15  FAHAETNSFIYNGFI--QANLSLDGTAFVRKDG-ILAVSNDQGRILGHAFYPSPLRFKQL 71
            A A T  F + GF   Q ++  +G + ++ D  +L ++N +  + G AFY  P+R ++L
Sbjct: 28  LAEATTAKFTFIGFKENQTDIQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLREL 87

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
           +      N+      +FST+FVF I+P  P  GG G  F L      P   + QYLGL N
Sbjct: 88  T------NSSDIKVCSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLN 141

Query: 132 DTSNAKFSTRILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
            T+N   S  + AVEFD VQ   +  D   NH+G++ ++L SN+ EP  YY     +  D
Sbjct: 142 RTNNGNPSNHVFAVEFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYY-----DTED 196

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIP-KPHRPLISYPI-DLATVLDEYMY 248
                 L+SG+PI+  IDY+     +NVTI P  +  KP +PLIS  + +L+ ++ + MY
Sbjct: 197 RKEDFQLESGEPIRVLIDYDGSSETLNVTIYPTRLEFKPKKPLISRRVSELSEIVKDEMY 256

Query: 249 VGFSASTGL-LTAFHNVHGWSFKIGG---TARELDVTMLPFHARPKSKQVVHKKGFAVGI 304
           VGF+A+TG   ++ H V GWSF   G    A  L+++ LP   R  +K+  + +   + +
Sbjct: 257 VGFTAATGKDQSSAHYVMGWSFSSCGENPMADWLEISRLPPPPRLSNKKGYNSQVIVLIV 316

Query: 305 TLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVG 364
            L+   LV+ V++   ++ +R    +D LEDWE++Y   RFRY +LY ATK F+E  ++G
Sbjct: 317 ALSIVTLVLLVLLFIFVMYKRRIQEEDTLEDWEIDY-PHRFRYRDLYLATKKFKESEIIG 375

Query: 365 SGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ 424
           +GGFG VYRG + S+G  +A+K++  NS QG++EF+AEI S+GRL H+NLV L GWC+ +
Sbjct: 376 TGGFGIVYRGNLSSSG-PIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHK 434

Query: 425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHR 484
           +ELLL+YDY+PNGSLD LL+   ++   +L WD R++I+ G+A  LLYLHEE +Q VVHR
Sbjct: 435 NELLLIYDYIPNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIVVHR 494

Query: 485 DVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDV 544
           DVKPSNVLID D+N KLGDFGLAR Y+     QTT IVGTLGY+APELTR GK +T++DV
Sbjct: 495 DVKPSNVLIDEDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTASDV 554

Query: 545 FGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAEL 603
           F FG L+LE+ CG +P      A    L DWV E H+ G I   +D  L   F+ +EA+L
Sbjct: 555 FAFGVLLLEIVCGNKPT----NAENFFLADWVMEFHTNGGILCVVDQNLGSSFNGREAKL 610

Query: 604 VLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
            L +GLLCC   P FRPS R V+++L  + ++PQ
Sbjct: 611 ALVVGLLCCHQKPKFRPSMRMVLRYLNGEENVPQ 644

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	662
147860501	625	hypothetical protein VITISV_016437 [Viti	0.922	0.977	0.688	0.0
356528060	666	PREDICTED: L-type lectin-domain containi	0.975	0.969	0.654	0.0
356567976	674	PREDICTED: L-type lectin-domain containi	0.919	0.903	0.515	0.0
255559006	667	kinase, putative [Ricinus communis] gi|2	0.935	0.928	0.522	0.0
255558978	662	kinase, putative [Ricinus communis] gi|2	0.932	0.932	0.509	1e-180
359481749	1258	PREDICTED: L-type lectin-domain containi	0.903	0.475	0.520	1e-179
356523179	673	PREDICTED: L-type lectin-domain containi	0.889	0.875	0.514	1e-179
449439978	683	PREDICTED: L-type lectin-domain containi	0.904	0.877	0.503	1e-178
224106407	675	predicted protein [Populus trichocarpa]	0.942	0.924	0.503	1e-177
255584540	683	kinase, putative [Ricinus communis] gi|2	0.900	0.872	0.515	1e-177

>gi|147860501|emb|CAN83975.1| hypothetical protein VITISV_016437 [Vitis vinifera]

 Score =  889 bits (2297), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 445/646 (68%), Positives = 523/646 (80%), Gaps = 35/646 (5%)

Query: 14  GFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSK 73
           GF  ++T SF+YNGF++A+LSLDG + +R +GIL+++ND  R++GHAFYPSP+ FK+   
Sbjct: 14  GFVSSDT-SFVYNGFLKADLSLDGASQLRSNGILSLTNDSVRLIGHAFYPSPIHFKRSKD 72

Query: 74  YNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT 133
           +           +TFSTNFVFS+ PKYP LGGHGLAFVL+S K P  CL NQYLGLPN T
Sbjct: 73  HR-------SWVVTFSTNFVFSMAPKYPGLGGHGLAFVLLSTKAPMGCLPNQYLGLPNVT 125

Query: 134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
           SNA FSTR+LAVEFDAVQNLEL DINDNHVGIDISSLISN+S+PAAYYF+     N+ N 
Sbjct: 126 SNADFSTRVLAVEFDAVQNLELMDINDNHVGIDISSLISNVSKPAAYYFT-----NNSNN 180

Query: 194 SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA 253
           S+  KSGDPIQAWI+YNSQE L+NVTISPLGIPK  RPLIS+PIDL+ VL+EYM++GFSA
Sbjct: 181 SIAFKSGDPIQAWIEYNSQEQLMNVTISPLGIPKSFRPLISFPIDLSMVLNEYMHIGFSA 240

Query: 254 STGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVI 313
           STGLLTA HNVHGWSF+IGG A +LD   LP     +S++V+H++G  +GI LASA LVI
Sbjct: 241 STGLLTAAHNVHGWSFRIGGRAADLDPLRLP-SPVTRSRKVLHQRGLTLGIILASATLVI 299

Query: 314 FVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYR 373
            VI     V+ RIRN ++ILE+WEVEYGA RF+YS+L+SAT+GFREKNL+GSGGFG+VY+
Sbjct: 300 LVISGTAHVVHRIRNKEEILEEWEVEYGAHRFKYSDLFSATRGFREKNLIGSGGFGRVYK 359

Query: 374 GVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY 433
           G+IP TGLEVAIKRVAH+SRQGMKEFVAEI SMGRLRHRNLVQLHGWCR+QDEL+LVYDY
Sbjct: 360 GIIPRTGLEVAIKRVAHDSRQGMKEFVAEIISMGRLRHRNLVQLHGWCRRQDELILVYDY 419

Query: 434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI 493
           VPNGSLDK+LFD DQQKKKIL W+QRYKILIGV+QALLYLHEECDQRVVHRDVKPSNVLI
Sbjct: 420 VPNGSLDKILFD-DQQKKKILTWEQRYKILIGVSQALLYLHEECDQRVVHRDVKPSNVLI 478

Query: 494 DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE 553
           DA+LN +LGDFGLAR Y H  NP+TTHIVGTLGYLAPELTR GKATTS DV+ +G LMLE
Sbjct: 479 DAELNARLGDFGLARMYKHGNNPETTHIVGTLGYLAPELTRIGKATTSIDVYAYGVLMLE 538

Query: 554 VACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCD 613
           VA GRRPIEPQR A ELVL+DW                    ++P EA+LVL+LGLLC  
Sbjct: 539 VATGRRPIEPQRNAQELVLMDW--------------------YNPDEAKLVLSLGLLCSH 578

Query: 614 PHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSEDDSD 659
           PHPD+RP  RRV+Q+LL+D  LP+ P D+H E P  + EFS+   D
Sbjct: 579 PHPDYRPDIRRVIQYLLKDVCLPELPPDVHLEVPGTMIEFSDTYPD 624

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528060|ref|XP_003532623.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  888 bits (2295), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/663 (65%), Positives = 519/663 (78%), Gaps = 17/663 (2%)

Query: 1   METFSLLLHLL--LLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILG 58
           M  F +LL +L  LL F  ++ N F+  GF QA L +DG ++VR +GIL + ND  +ILG
Sbjct: 3   MHAFGILLGVLYSLLSFVSSDIN-FVKYGFKQAGLKMDGASYVRPNGILTLINDSPKILG 61

Query: 59  HAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQP 118
           HAFYPSPL FK     +I          TFST FVFSIVPKYP+LG  G AFVL+S  +P
Sbjct: 62  HAFYPSPLPFKSSKNKSI--------VATFSTTFVFSIVPKYPELGAQGFAFVLISTNKP 113

Query: 119 PSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPA 178
             CL NQYLGLPN TS+ +FSTR LA+EFD +QNL+L D+NDNHVGIDISSLISNIS P 
Sbjct: 114 KGCLMNQYLGLPNVTSSLEFSTRFLAIEFDGIQNLDLHDMNDNHVGIDISSLISNISRPV 173

Query: 179 AYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPID 238
           AYY S  S     NIS  LKSG PIQAW+DYN  EML+NVT+SP G+PKP+ PLIS+PID
Sbjct: 174 AYYLSDHSK----NISFSLKSGKPIQAWVDYNEGEMLMNVTVSPFGMPKPYFPLISFPID 229

Query: 239 LATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPF--HARPKSKQVVH 296
           L+ VL++YMY GFSAS GLL A HN+HGW FKIG   +ELD + +P    +   S +VVH
Sbjct: 230 LSLVLNDYMYAGFSASNGLLVAEHNIHGWGFKIGEAGQELDKSAVPLIGSSTSTSSKVVH 289

Query: 297 KKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKG 356
           KK FAVGITL SA L I  +I A  VLRR+RNGD+ILEDWE+E+ + +F+YSEL+SAT  
Sbjct: 290 KKDFAVGITLTSATLFILTVIGAFHVLRRLRNGDEILEDWELEFASHKFKYSELHSATGK 349

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F + NL+G GGFGKVYRGVI STGLEVA+KRVA +SRQG++EFV+EITSM +L+HRNLVQ
Sbjct: 350 FGDSNLIGYGGFGKVYRGVIASTGLEVAVKRVAPDSRQGIREFVSEITSMAQLKHRNLVQ 409

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LHGWCRK+DELL+VY+YVPNGSLDKLLF+N+ QKKK+L WDQRY I+ GVAQ LLYLHEE
Sbjct: 410 LHGWCRKKDELLIVYNYVPNGSLDKLLFENEHQKKKLLTWDQRYTIITGVAQGLLYLHEE 469

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
           C+ +VVHRDVKPSNVLID DL PKLGDFGLAR Y+H INPQTT++VGTLGY+APELT+TG
Sbjct: 470 CELQVVHRDVKPSNVLIDEDLQPKLGDFGLARTYEHGINPQTTNVVGTLGYMAPELTKTG 529

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF 596
           KA TSTDV+G+G L+LEVACGR+PIEPQ+   ELVLVDWVRELH QG+I+RAIDP+LD +
Sbjct: 530 KARTSTDVYGYGILILEVACGRKPIEPQKNPEELVLVDWVRELHHQGKISRAIDPSLDEY 589

Query: 597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSED 656
           D  EA LVL+LGL C  P+PD+RPS RR+VQFLL + SLP  P DIH E P AI +   +
Sbjct: 590 DKDEARLVLSLGLFCAHPNPDYRPSMRRIVQFLLGETSLPPLPPDIHCEDPTAIRKCPNN 649

Query: 657 DSD 659
            +D
Sbjct: 650 FAD 652

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567976|ref|XP_003552190.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  648 bits (1672), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/648 (51%), Positives = 445/648 (68%), Gaps = 39/648 (6%)

Query: 6   LLLHLLLLGFAHAETNSFIYNGFIQ---ANLSLDGTAFVRKDGILAVSNDQGRILGHAFY 62
           L L +LLL     + +  +Y GF     +NL+++G A +  +GIL ++ND  R++GHAFY
Sbjct: 8   LSLTVLLLIPVSCQVDQLLYAGFKDVGASNLTMNGVAKIEHNGILKLTNDSSRLMGHAFY 67

Query: 63  PSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCL 122
           PSP + K         N+ S   L+FS++F  +IVP+YP+LGGHGLAF + + K     L
Sbjct: 68  PSPFQLK---------NSTSGKVLSFSSSFALAIVPEYPKLGGHGLAFTIATSKDL-KAL 117

Query: 123 ANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYF 182
            +QYLGL N + N   S  I AVEFD VQ+ E  DINDNHVGIDI+S+ SN S       
Sbjct: 118 PSQYLGLLNSSDNGNISNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNASA------ 171

Query: 183 SKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV 242
                 N   + + LKSG PI AW+DY+SQ  LI+V +SP    KP  PL+++ +DL+ V
Sbjct: 172 ------NVSLVGLTLKSGKPILAWVDYDSQLNLISVALSP-NSSKPKTPLLTFNVDLSPV 224

Query: 243 LDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAV 302
             + MYVGFSASTGLL + H + GWSFKI G A  LD++ LP   +PK KQ        +
Sbjct: 225 FHDIMYVGFSASTGLLASSHYILGWSFKINGPAPPLDLSSLPQLPQPKKKQT----SLII 280

Query: 303 GITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNL 362
           G++++  ++V+  I   I   R+I+N D ++E WE+E G  R+ Y EL  AT+GF++K L
Sbjct: 281 GVSVSVFVIVLLAISIGIYFYRKIKNAD-VIEAWELEIGPHRYSYQELKKATRGFKDKEL 339

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G GGFG+VY+G +P++ ++VA+KRV+H S+QG++EFV+EI S+GRLRHRNLVQL GWCR
Sbjct: 340 LGQGGFGRVYKGTLPNSKIQVAVKRVSHESKQGLREFVSEIASIGRLRHRNLVQLLGWCR 399

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++ +LLLVYD++ NGSLDK LFD   + K ILNW+ R+KI+ GVA ALLYLHE  +Q V+
Sbjct: 400 RRGDLLLVYDFMANGSLDKYLFD---EPKIILNWEHRFKIIKGVASALLYLHEGYEQVVI 456

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRDVK SNVL+D +LN +LGDFGLAR Y+H  NP TT +VGTLGYLAPEL RTGKATTS+
Sbjct: 457 HRDVKASNVLLDFELNGRLGDFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSS 516

Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEA 601
           DVF FG L+LEVACGRRPIEP+    ELVLVDWV E + QG+I   +DP L+ YFD +E 
Sbjct: 517 DVFAFGALLLEVACGRRPIEPKALPEELVLVDWVWEKYKQGRILDLVDPKLNVYFDEKEV 576

Query: 602 ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ---APLDI-HHE 645
            +VL LGL+C +  P  RPS R+VV++L  +  +P+    P DI HHE
Sbjct: 577 IVVLKLGLMCSNDVPVTRPSMRQVVRYLDGEVEVPEDLKKPGDISHHE 624

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255559006|ref|XP_002520526.1| kinase, putative [Ricinus communis] gi|223540368|gb|EEF41939.1| kinase, putative [Ricinus communis]

 Score =  644 bits (1662), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 334/639 (52%), Positives = 445/639 (69%), Gaps = 20/639 (3%)

Query: 4   FSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYP 63
           F+L +H   L FA  E + FIYNGF  ANLSL+G A +  +G+L ++N   + +GHAF+P
Sbjct: 12  FTLFVHSKPLAFAQ-EADQFIYNGFNGANLSLNGAANIHPNGLLELTNTSHQQIGHAFFP 70

Query: 64  SPLRFKQLSKYNINNNTISHTAL-TFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCL 122
            PL F      +++NN  S T+L +FSTNFVF++VP+ P L GHGLAF +    +    +
Sbjct: 71  FPLHFNS----SLSNN--SRTSLVSFSTNFVFAMVPESPGLDGHGLAFAISPSLEFKGAI 124

Query: 123 ANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYF 182
           A QYLGL N T+    S  +LA+E D V+N E  DI+ NHVG+D+++L S  S  A+Y+ 
Sbjct: 125 ATQYLGLFNSTTIGLSSNHLLAIELDTVKNPEFGDIDGNHVGVDVNNLTSIQSVSASYF- 183

Query: 183 SKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV 242
              S   + N S+ L SG P+Q WIDY+  E L+NVT++P+   KP +PL+S  IDL+ +
Sbjct: 184 ---SETEEKNKSLELTSGRPMQMWIDYDEMEKLLNVTLAPIERMKPEKPLLSTNIDLSAL 240

Query: 243 LDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAV 302
           L E MYVGFSASTG +++ H + GWSF   G A+ LD + LP  + P+ ++   K    +
Sbjct: 241 LLESMYVGFSASTGSVSSNHYILGWSFNRSGQAQSLDPSKLP--SLPQERKSRGKLAMKI 298

Query: 303 GITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNL 362
            + L   I+++  I A I ++R+    ++I EDWE +YG  RF Y +LY ATKGF++K L
Sbjct: 299 MLPLVIVIVLLMTISATIYIMRK--RYEEIREDWEQQYGPQRFSYKDLYKATKGFKDKEL 356

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G GGFGKVYRG +PS+ +EVA+K+V+H+SRQGMKEFVAEI SMGRLRHRNLVQL G+CR
Sbjct: 357 LGCGGFGKVYRGTLPSSNVEVAVKKVSHDSRQGMKEFVAEIASMGRLRHRNLVQLLGYCR 416

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++ EL LVYD++PNGSLDK LF N+   K  ++W +RY+I+ GVA AL YLHEE +Q V+
Sbjct: 417 RKGELFLVYDHMPNGSLDKFLFSNE---KPNIDWVRRYQIIKGVASALYYLHEEWEQVVL 473

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRDVK SNVL+DADLN +LGDFGLA+ YDH   PQTTH+VGTLGYLAPELT TGKATTS+
Sbjct: 474 HRDVKASNVLLDADLNGRLGDFGLAKLYDHGSTPQTTHVVGTLGYLAPELTTTGKATTSS 533

Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEA 601
           DVF FG  MLEVACGR+P++ +R   E++LVDWV E   +G I   IDP L D +  +E 
Sbjct: 534 DVFAFGIFMLEVACGRKPVKSERPPEEVILVDWVLECWERGNILGTIDPRLEDSYVAEET 593

Query: 602 ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPL 640
           ELVL LGLL     P  RP+ R+V+Q+L  +A+LPQ  L
Sbjct: 594 ELVLKLGLLSTQRIPTARPTIRQVMQYLDGNATLPQISL 632

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255558978|ref|XP_002520512.1| kinase, putative [Ricinus communis] gi|223540354|gb|EEF41925.1| kinase, putative [Ricinus communis]

 Score =  637 bits (1642), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 324/636 (50%), Positives = 432/636 (67%), Gaps = 19/636 (2%)

Query: 4   FSLLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYP 63
            +L + L LL  A  E N FIYNGF  ANLSL G A +  +G+L ++N   +++G AF+P
Sbjct: 8   LTLFVSLKLLASAQ-EINQFIYNGFQGANLSLSGIATIHPNGLLELTNTSYQMIGRAFFP 66

Query: 64  SPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLA 123
            P RF   S  N        +AL+FSTNFVF++VP+ P  GGHG+AF +   K     +A
Sbjct: 67  LPFRFNTSSSNNF------QSALSFSTNFVFAMVPELPTHGGHGIAFAISPSKLCVGSMA 120

Query: 124 NQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFS 183
            QYLGL N T++   S  + AVE D+ ++ +L+D+N NHVGIDI+SL SN S P  YY  
Sbjct: 121 TQYLGLLNSTTDGLSSNHLFAVELDSAKSPDLEDMNANHVGIDINSLKSNESAPVTYYLD 180

Query: 184 KGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVL 243
           K       N ++ L SGDP+Q WIDY  +E L+NVT++P+G+ KP RPL+S  ++L+ VL
Sbjct: 181 K----EGRNQTLELNSGDPMQVWIDYKEEEKLLNVTVAPIGVSKPSRPLLSKSLNLSQVL 236

Query: 244 DEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLP-FHARPKSKQVVHKKGFAV 302
            E MYVGFSA+TG +++ H + GWSF   G ++ LD + LP   +  KS+++  +    +
Sbjct: 237 LESMYVGFSAATGSVSSRHYILGWSFNKSGESQTLDPSKLPSLPSLAKSRKLNLRLIILL 296

Query: 303 GITLASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNL 362
            +TL   I+V  V+    + +RR R  ++I EDWE  YG  RF Y  LY AT+ FR+K+L
Sbjct: 297 AVTLTVTIIVTAVL--GTMFIRRKRY-EEIREDWEKAYGPQRFSYEVLYKATRDFRDKDL 353

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+GGFGKVYRG++ S   +VA+K+++HNS QGMKEF+AEI SMGRLRHRNLVQL G+CR
Sbjct: 354 LGAGGFGKVYRGILSSCNTQVAVKKISHNSAQGMKEFIAEIASMGRLRHRNLVQLLGYCR 413

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++ ELLLVY+Y+PNGSLDK LF   + K   LNWDQR++I+ GVA  LLYLH + +Q V+
Sbjct: 414 RKGELLLVYEYMPNGSLDKFLFSKKEAK---LNWDQRHRIIRGVASGLLYLHHDWEQVVL 470

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRDVK SNVL+DA+ N +LGDFGLA+ YDH  NPQTT +VGT+GYLAPEL +TGK TTS+
Sbjct: 471 HRDVKASNVLLDANFNARLGDFGLAKFYDHGTNPQTTCVVGTVGYLAPELIKTGKPTTSS 530

Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEA 601
           DVF FG  MLE+ACGR+P EP+    E +L DWV E   +G I  + DP L+  +  QE 
Sbjct: 531 DVFAFGNFMLEIACGRKPFEPKCLPEETILADWVLECWKRGDILSSSDPRLEGNYVVQEM 590

Query: 602 ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
           ELVL LGLLC    P  RP  R+VV +L  + SLP+
Sbjct: 591 ELVLKLGLLCAHSTPAARPDMRQVVNYLDHNVSLPE 626

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera]

 Score =  636 bits (1640), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 324/623 (52%), Positives = 432/623 (69%), Gaps = 25/623 (4%)

Query: 18   AETNSFIYNGF-IQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNI 76
             E  SF YNGF   ANLSLDG A    +G+L ++N   +  GHAFY  P+RFK       
Sbjct: 609  GEDVSFTYNGFQTAANLSLDGLAQFTPNGLLILTNRTKQETGHAFYSHPMRFK------- 661

Query: 77   NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA 136
              N+ +  A +FST FVF+I P+YP L GHG+AFV+   +  P  L +Q+LGL +D +N 
Sbjct: 662  --NSSNAPAFSFSTTFVFAIHPQYPTLSGHGIAFVIAPTRGLPGALPSQHLGLFSDANNG 719

Query: 137  KFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVV 196
              +  I+AVE D +QN EL DINDNHVGIDI+ L S+ + PA Y+ SK    N D  ++ 
Sbjct: 720  NSTNHIVAVELDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASK----NGDFKNLS 775

Query: 197  LKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTG 256
            L SG P+Q W+DYN+ E  I+V ++P+ + KP  PL+S P DL+ +L+  MYVGFS+STG
Sbjct: 776  LISGRPMQVWVDYNALEKQIDVRLAPVSVDKPDIPLLSLPRDLSLILNNTMYVGFSSSTG 835

Query: 257  LLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAV-GITLASAILVIFV 315
             +   H + GWSFK+ G A+ L ++ LP   R   ++   K  F   G+ +   + ++ V
Sbjct: 836  SVLTSHYLLGWSFKMNGQAQPLAISQLPKLPRIGGQK---KSAFLTSGLPVICVVSILAV 892

Query: 316  IIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGV 375
            +  A+ ++RR +   + LEDWE++YG  RF+Y +LY ATKGF++K L+GSGGFG+VYRGV
Sbjct: 893  MSGAVYLIRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRGV 952

Query: 376  IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP 435
            +P++ LE+A+K+++H SRQGMKEFVAEI S+GRLRHRN+V L G+CR++ ELLLVYDY+P
Sbjct: 953  LPTSKLEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYMP 1012

Query: 436  NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA 495
            NGSLDK L+D   Q K  LNW+QR+++L GVA  L YLH E +Q VVHRDVK SNVL+D 
Sbjct: 1013 NGSLDKYLYD---QPKVTLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDG 1069

Query: 496  DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            +LN +LGDFGLAR YDH  +PQTTH+VGTLGYLAPE TRTGKATT TDV+ FG  +LEVA
Sbjct: 1070 ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVA 1129

Query: 556  CGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVLTLGLLCCDP 614
            CGRRPI P     +L+LVDWV    ++G+I +A DP L   ++ +E ELVL LGL+C   
Sbjct: 1130 CGRRPIAPME---DLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHS 1186

Query: 615  HPDFRPSTRRVVQFLLRDASLPQ 637
             P+ RPS  +VVQ+L R   LP+
Sbjct: 1187 EPNARPSMPQVVQYLERTVPLPE 1209

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356523179|ref|XP_003530219.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Glycine max]

 Score =  634 bits (1635), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 321/624 (51%), Positives = 435/624 (69%), Gaps = 35/624 (5%)

Query: 18  AETNSFIYNGFIQ---ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKY 74
            + +  +Y+GF     +NL+++G   + ++GIL ++N+  R +GHAFYPSP + K     
Sbjct: 20  CQVDQVLYSGFKDVGASNLTMNGVTTIERNGILKLTNESSRSIGHAFYPSPFQLK----- 74

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               N+ S  AL+FS++F F+IVP+YP+LGGHGLAF + + K     L NQYLGL N + 
Sbjct: 75  ----NSTSGKALSFSSSFAFAIVPEYPKLGGHGLAFTIATSKDL-KALPNQYLGLLNSSD 129

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
           N  FS  I AVEFD VQ+ E  DINDNHVGIDI+S+ SN S             N   + 
Sbjct: 130 NGNFSNHIFAVEFDTVQDFEFGDINDNHVGIDINSMQSNTSA------------NVSLVG 177

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
           + LKSG PI AW+DY+S+  LI+V +SP    KP  PL+++ +DL+ V  + MYVGFSAS
Sbjct: 178 LTLKSGKPILAWVDYDSRLNLISVALSP-NSSKPKTPLLTFNVDLSPVFHDTMYVGFSAS 236

Query: 255 TGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAILVIF 314
           TGLL + H + GWSFKI G A  LD++ LP   +PK KQ        +G++++  ++V+ 
Sbjct: 237 TGLLASSHYILGWSFKINGPAPPLDLSSLPQLPKPKKKQT----SLIIGVSVSVVVIVLL 292

Query: 315 VIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRG 374
            I   I   R+I+N D ++E WE+E G  R+ Y EL  AT+GF++K L+G GGFG+VY+G
Sbjct: 293 AISIGIYFYRKIKNAD-VIEAWELEIGPHRYSYQELKKATRGFKDKELLGQGGFGRVYKG 351

Query: 375 VIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV 434
            +P++ ++VA+KRV+H S+QG++EFV+EI S+GRLRHRNLVQL GWCR+Q +LLLVYD++
Sbjct: 352 TLPNSKIQVAVKRVSHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRQGDLLLVYDFM 411

Query: 435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID 494
            NGSLDK LFD   + K ILNW+ R+KI+ GVA AL+YLHE  +Q V+HRDVK SNVL+D
Sbjct: 412 ANGSLDKYLFD---EPKIILNWEHRFKIIKGVASALMYLHEGYEQVVIHRDVKASNVLLD 468

Query: 495 ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            +LN +LGDFGLAR Y+H  NP TT +VGTLGYLAPEL RTGKATTS+DVF FG L+LEV
Sbjct: 469 FELNGRLGDFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVFAFGALLLEV 528

Query: 555 ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLCCD 613
            CGRRPIEP+    E+VLVDWV E + QG+I   +DP L+ +FD +E  +VL LGL+C +
Sbjct: 529 VCGRRPIEPKALPEEMVLVDWVWEKYKQGRILDVVDPKLNGHFDEKEVMVVLKLGLMCSN 588

Query: 614 PHPDFRPSTRRVVQFLLRDASLPQ 637
             P  RPS R+VV++L  +  +P+
Sbjct: 589 DVPAARPSMRQVVRYLDGEVEVPE 612

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439978|ref|XP_004137762.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus] gi|449524894|ref|XP_004169456.1| PREDICTED: L-type lectin-domain containing receptor kinase S.4-like [Cucumis sativus]

 Score =  633 bits (1632), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 316/628 (50%), Positives = 431/628 (68%), Gaps = 29/628 (4%)

Query: 16  AHAETNSFIYNGF-----IQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQ 70
           A A +    ++GF     + ANL+L   A + ++GIL ++ND  R+ GHAFY SP+RFK 
Sbjct: 17  APAASQQLYFSGFQDDAAVAANLTLTDIAKIEQNGILKLTNDTSRLQGHAFYSSPVRFK- 75

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                   N+      +FST FV ++VP+YP LGGHGLAF +   K     L +QYLGL 
Sbjct: 76  --------NSSDGKVFSFSTAFVIAVVPEYPTLGGHGLAFTIAPSKNL-RGLPSQYLGLL 126

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           N      F+  + AVEFD VQ+ E  DINDNHVGI+++ +ISN+S  A+Y+   G    +
Sbjct: 127 NAKDVGNFTNHLFAVEFDTVQDFEFADINDNHVGINLNHMISNVSTTASYFVDDGPTKQN 186

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
               + LKSG PIQAW+DY+S    + V +SP    KP +P++S+ +DL+ +LDE+MYVG
Sbjct: 187 ----LTLKSGRPIQAWVDYDSSVNSLTVALSPSST-KPKKPILSFNVDLSPILDEFMYVG 241

Query: 251 FSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITLASAI 310
           FSASTGLL + H V GWSF + G AR LD++ LP    PK K       F +GI++A+ +
Sbjct: 242 FSASTGLLASSHYVLGWSFSMNGQARSLDLSSLPSVPGPKKKHTA----FTIGISVAAVL 297

Query: 311 LVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGK 370
           +VI  I  A+L++ +I+N D I+E WE E G  R+ Y EL  ATK FR+K L+G GGFGK
Sbjct: 298 IVIIAICVAVLIIWKIKNAD-IIEAWEHEIGPHRYSYKELKKATKRFRDKELLGRGGFGK 356

Query: 371 VYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV 430
           VY+G +P++ ++VA+KR++H S+QG++EFV+EI S+GRLRHRNLVQL GWCR++ +LLLV
Sbjct: 357 VYKGTLPNSKIQVAVKRISHESKQGLREFVSEIASIGRLRHRNLVQLLGWCRRRGDLLLV 416

Query: 431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN 490
           YD++ NGSLD  +FD+       L+W QR+ I+ GVA  LLYLHE  +Q V+HRDVK SN
Sbjct: 417 YDFMANGSLDNYIFDDPDVN---LSWQQRFGIIKGVASGLLYLHEGYEQVVIHRDVKASN 473

Query: 491 VLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTL 550
           VL+D+++N KLGDFGLAR Y+H  NP TT +VGTLGYLAPEL RTGKATTS+DV+ FG L
Sbjct: 474 VLLDSEMNGKLGDFGLARLYEHGANPSTTRVVGTLGYLAPELPRTGKATTSSDVYAFGAL 533

Query: 551 MLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVLTLGL 609
           +LEVACGRRPI+P+ ++ ELVLVDWV E + +G++   +DP L   F+  EA ++L LGL
Sbjct: 534 LLEVACGRRPIDPKSSSEELVLVDWVWENYREGKLLDVMDPKLKGDFNVVEAMMILKLGL 593

Query: 610 LCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
            C +     RPS R+VV+FL  +  +P+
Sbjct: 594 FCSNDSAAARPSMRQVVRFLEGEMGVPE 621

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224106407|ref|XP_002314156.1| predicted protein [Populus trichocarpa] gi|222850564|gb|EEE88111.1| predicted protein [Populus trichocarpa]

 Score =  629 bits (1623), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 328/651 (50%), Positives = 445/651 (68%), Gaps = 27/651 (4%)

Query: 6   LLLHLLLLGFAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSP 65
           L + L LL  A  E N FIY+GF  ANL L   A +  +G+L ++N     +G AF P P
Sbjct: 14  LFVSLKLLALAQEE-NHFIYHGFTGANLLLSEIAKIHPNGLLELTNTSKPQIGRAFLPFP 72

Query: 66  LRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQ 125
            +F      ++ NN+ S   L+FST F F++VP+ P  GG G+AF +         +A Q
Sbjct: 73  FQFNT----SLFNNSRS---LSFSTQFAFAMVPELPTHGGQGMAFTISPSVDFTGAVAAQ 125

Query: 126 YLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKG 185
           Y G+ N T++   S  +LAVE D VQ+ +L+DIN++HVGID++SLIS  S P  Y+    
Sbjct: 126 YFGILNSTTDGLPSNHLLAVELDTVQSQDLKDINESHVGIDLNSLISIESAPVTYF---- 181

Query: 186 SNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDE 245
           S+  ++N S+ L SG  +  WIDY+  E L+NVT++P+   KP  PL+S P+DL++V+ +
Sbjct: 182 SDEENENKSLTLISGHVMHVWIDYDEVEKLLNVTVAPITRTKPTLPLLSKPLDLSSVMLD 241

Query: 246 YMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGIT 305
            MYVGFSASTG + + H + GWSF  GG A+ LDV+ LP  + P  ++   K    + + 
Sbjct: 242 SMYVGFSASTGAVASSHYILGWSFNRGGQAQSLDVSKLP--SLPPQRKSRKKPYLIILVP 299

Query: 306 LASAILVIFVIIAAILVLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGS 365
             +AI+++  I  A  ++RR +  +++ EDWE EYG  RF Y +LY AT GF ++ L+GS
Sbjct: 300 TITAIILLVAISGAASIIRR-KKYEELREDWEQEYGPQRFSYKDLYKATTGFTDRKLLGS 358

Query: 366 GGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD 425
           GGFGKVYRGV+PS+ ++VAIK+V+H+S+QG K+FVAEI SMGRLRHRNLVQL G+CR++ 
Sbjct: 359 GGFGKVYRGVLPSSNMQVAIKKVSHDSKQGTKQFVAEIASMGRLRHRNLVQLLGYCRRKG 418

Query: 426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRD 485
           ELLLVYDY+PNGSLDKLLF ND      LNW QRY++L GVA ALLYLHEE +Q V+HRD
Sbjct: 419 ELLLVYDYMPNGSLDKLLFRNDTPS---LNWVQRYQVLRGVASALLYLHEEWEQVVLHRD 475

Query: 486 VKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVF 545
           VK SN+L+D D N +LGDFGLA+ YD   NPQTT +VGT+GY+APE+TRTG+ATTS+DVF
Sbjct: 476 VKASNILLDDDFNGRLGDFGLAKFYDRGANPQTTCVVGTVGYIAPEVTRTGRATTSSDVF 535

Query: 546 GFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELV 604
            FGT MLE+ACGR+P+EP+++A +++LVDWV +    G I R  DP L+  +  +E ELV
Sbjct: 536 AFGTFMLEMACGRKPLEPEQSAEKMILVDWVLDSWKIGDILRTGDPRLEGNYVVEEMELV 595

Query: 605 LTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLD--------IHHEFP 647
           L LGLLCC   P  RPS R++ Q+L  +ASLP+ PLD        + HE P
Sbjct: 596 LKLGLLCCFSTPHARPSMRQIGQYLDGNASLPEIPLDGASIGLMPVSHEEP 646

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255584540|ref|XP_002532997.1| kinase, putative [Ricinus communis] gi|223527226|gb|EEF29389.1| kinase, putative [Ricinus communis]

 Score =  628 bits (1619), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 323/626 (51%), Positives = 433/626 (69%), Gaps = 30/626 (4%)

Query: 18  AETNSFIYNGFIQA---NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKY 74
            + N   Y GF      N+SL G A ++K+GI+ ++N+  R++G AFY SP +FK     
Sbjct: 20  CQLNELYYPGFKHVDTVNISLTGVAEIQKNGIIRLTNETSRLMGQAFYASPFQFK----- 74

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               N+ +  A +FST+F  +I P+Y +LGGHGLAF + + K     L +QYLGL N + 
Sbjct: 75  ----NSSNGKAFSFSTSFALAIFPEYKKLGGHGLAFTISASKDLKG-LPSQYLGLLNASD 129

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
              F+  +LAVEFD VQ+ E  DINDNHVGIDI++L SN S  AAYY +  S   D N  
Sbjct: 130 LGNFTNHLLAVEFDTVQDFEFGDINDNHVGIDINNLKSNASAAAAYYINDTSK-QDLN-- 186

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
             LK+G PIQ WIDY+S + L+NVTISP    KP  P++S+PIDL+ + +EYMYVGFSAS
Sbjct: 187 --LKTGKPIQVWIDYDSIQNLLNVTISPTS-EKPRLPILSFPIDLSQIFEEYMYVGFSAS 243

Query: 255 TGLLTAFHNVHGWSFKIGGTARELDVTMLPFHAR-PKSKQVVHKKGFAVGITLASAILVI 313
           TGLL + H + GWSFK+ G AR LD++ LP   R PK+K      G  + + + S  L I
Sbjct: 244 TGLLASSHYILGWSFKMDGQARALDLSSLPSLPRGPKTKHT----GLTIAVIVPSVFLAI 299

Query: 314 FVIIAAIL-VLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVY 372
             +  AI  V+R+IRN D ++EDWE+E G  R+ Y EL  ATKGF  K L+G GGFG+VY
Sbjct: 300 IALSLAIFYVIRKIRNAD-VIEDWELEIGPHRYSYQELKKATKGFSGKELLGQGGFGQVY 358

Query: 373 RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD 432
           +G++P + ++VA+KR+++ S QG++EFV+EI S+GRLRHRNLVQL GWCR++D+ LLVYD
Sbjct: 359 KGILPDSKVQVAVKRISNESNQGLREFVSEIASVGRLRHRNLVQLLGWCRRRDDFLLVYD 418

Query: 433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL 492
           Y+ NGSLD  LFD   + K ILNW+QR+KI+  VA  LLYLHE  +Q V+HRDVK SNVL
Sbjct: 419 YMANGSLDNFLFD---EPKIILNWEQRFKIIKDVASGLLYLHEGYEQVVIHRDVKASNVL 475

Query: 493 IDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLML 552
           +D++L  +LGDFGLAR Y+H  NP TT +VGTLGYLAPE+ RTGKAT  +DV+ FG L+L
Sbjct: 476 LDSELTGRLGDFGLARLYEHGSNPGTTRVVGTLGYLAPEMPRTGKATACSDVYAFGALLL 535

Query: 553 EVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLC 611
           EVACGRRPIEP+ +  E+VLVDWV E+  QG++   +D  L+  ++  E  +VLTLGL+C
Sbjct: 536 EVACGRRPIEPKASPEEMVLVDWVWEMFKQGRVLDVVDSRLNGEYNEGEMMMVLTLGLMC 595

Query: 612 CDPHPDFRPSTRRVVQFLLRDASLPQ 637
            +  P  RPS R+VV++L  +  +P+
Sbjct: 596 SNNAPMARPSMRQVVKYLDGEVGMPE 621

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	662
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.901	0.872	0.462	2.8e-146
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.909	0.889	0.475	4e-145
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.916	0.900	0.470	6.3e-140
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.904	0.895	0.464	4e-138
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.829	0.813	0.496	2.8e-137
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.886	0.877	0.454	1.1e-135
TAIR|locus:2168509	674	AT5G59260 [Arabidopsis thalian	0.901	0.885	0.447	3.9e-131
TAIR|locus:2097613	693	AT3G08870 [Arabidopsis thalian	0.913	0.873	0.431	2.8e-130
TAIR|locus:2149795	688	LECRKA4.2 "lectin receptor kin	0.909	0.875	0.415	3.5e-130
TAIR|locus:2149810	691	LECRKA4.3 "lectin receptor kin	0.906	0.868	0.409	2.6e-125

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 1429 (508.1 bits), Expect = 2.8e-146, P = 2.8e-146
 Identities = 286/618 (46%), Positives = 402/618 (65%)

Query:    23 FIYNGFIQA--NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
             F + GF +A  NL+L+G A +   G + ++ +  R++GHAFY  P+RFK +    +N   
Sbjct:    26 FSFIGFKKASPNLTLNGVAEIAPTGAIRLTTETQRVIGHAFYSLPIRFKPIG---VNR-- 80

Query:    81 ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
                 AL+FST+F  ++VP++  LGGHGLAF +         L +QYLGL N +S   FS+
Sbjct:    81 ----ALSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLN-SSRVNFSS 135

Query:   141 RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSG 200
                AVEFD V++LE +DINDNHVGIDI+S+ S+IS PA Y+ +     N     + L  G
Sbjct:   136 HFFAVEFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLA-----NSTKKELFLDGG 190

Query:   201 DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTA 260
               IQAWIDY+S +  ++V +SP    KP   L+SY +DL++VL + MYVGFSASTGLL +
Sbjct:   191 RVIQAWIDYDSNKKRLDVKLSPFS-EKPKLSLLSYDVDLSSVLGDEMYVGFSASTGLLAS 249

Query:   261 FHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITXXXXXXXXXXXXXXX 320
              H + GW+F + G A  L +  LP       K+   ++   +G++               
Sbjct:   250 SHYILGWNFNMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAAS 309

Query:   321 XXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTG 380
                      +D +E+WE+++G  RF Y EL  AT GF +K L+GSGGFGKVY+G +P + 
Sbjct:   310 LFVVRKVKDEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSD 369

Query:   381 LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD 440
               VA+KR++H SRQG++EF++E++S+G LRHRNLVQL GWCR++D+LLLVYD++PNGSLD
Sbjct:   370 EFVAVKRISHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLD 429

Query:   441 KLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK 500
               LFD + +   IL W QR+KI+ GVA  LLYLHE  +Q V+HRD+K +NVL+D+++N +
Sbjct:   430 MYLFDENPEV--ILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGR 487

Query:   501 LGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +GDFGLA+ Y+H  +P  T +VGT GYLAPELT++GK TTSTDV+ FG ++LEVACGRRP
Sbjct:   488 VGDFGLAKLYEHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRP 547

Query:   561 IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLCCDPHPDFR 619
             IE      ELV+VDWV      G I   +D  L+  FD +E  +V+ LGLLC +  P+ R
Sbjct:   548 IETSALPEELVMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVR 607

Query:   620 PSTRRVVQFLLRDASLPQ 637
             P+ R+VV +L +    P+
Sbjct:   608 PTMRQVVMYLEKQFPSPE 625

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 1418 (504.2 bits), Expect = 4.0e-145, P = 4.0e-145
 Identities = 298/627 (47%), Positives = 408/627 (65%)

Query:    22 SFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNN 79
             +F YNGF     ++SL G A V  +G+L ++N   +  GHAF    +RFK     N+++ 
Sbjct:    26 NFTYNGFHPPLTDISLQGLATVTPNGLLKLTNTSVQKTGHAFCTERIRFKDSQNGNVSS- 84

Query:    80 TISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFS 139
                     FST FVF+I  + P L GHG+AFV+      P  L +QY+GL N ++N   +
Sbjct:    85 --------FSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDT 136

Query:   140 TRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
               I AVEFD +Q+ E  D NDNHVGID++ L S     A Y   +  +    N+S++  S
Sbjct:   137 NHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGY---RDDHDKFQNLSLI--S 191

Query:   200 GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLT 259
                IQ WIDY+++   I+VT++P    KP +PL+SY  DL+++L E MYVGFS++TG + 
Sbjct:   192 RKRIQVWIDYDNRSHRIDVTVAPFDSDKPRKPLVSYVRDLSSILLEDMYVGFSSATGSVL 251

Query:   260 AFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITXXXXXXXXXXXXXX 319
             + H + GWSF++ G A  L ++ LP   R + +++   + + +G+               
Sbjct:   252 SEHFLVGWSFRLNGEAPMLSLSKLPKLPRFEPRRI--SEFYKIGMPLISLSLIFSIIFLA 309

Query:   320 XXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPST 379
                       ++ L+DWE E+G  RFR+ ELY ATKGF+EK+L+GSGGFG+VYRG++P+T
Sbjct:   310 FYIVRRKKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTT 369

Query:   380 GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 439
              LEVA+KRV+H+S+QGMKEFVAEI S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGSL
Sbjct:   370 KLEVAVKRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSL 429

Query:   440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP 499
             DK L++N +     L+W QR  I+ GVA  L YLHEE +Q V+HRDVK SNVL+DAD N 
Sbjct:   430 DKYLYNNPETT---LDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNG 486

Query:   500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR 559
             +LGDFGLAR YDH  +PQTTH+VGTLGYLAPE +RTG+ATT+TDV+ FG  +LEV  GRR
Sbjct:   487 RLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRR 546

Query:   560 PIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTLDY--FDPQEAELVLTLGLLCCDPHP 616
             PIE    + +  +LV+WV  L  +G I  A DP L    +D +E E+VL LGLLC    P
Sbjct:   547 PIEFHSASDDTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDP 606

Query:   617 DFRPSTRRVVQFLLRDASLPQ-APLDI 642
               RPS R+V+Q+L  D +LP+  PLD+
Sbjct:   607 RARPSMRQVLQYLRGDMALPELTPLDL 633

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1369 (487.0 bits), Expect = 6.3e-140, P = 6.3e-140
 Identities = 298/633 (47%), Positives = 401/633 (63%)

Query:    18 AETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYN 75
             +++ +F YN F +   N+S+ G A V  +GIL +++      GHAFY  P+RFK      
Sbjct:    24 SQSLNFTYNSFHRPPTNISIQGIATVTSNGILKLTDKTVISTGHAFYTEPIRFKDSP--- 80

Query:    76 INNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSN 135
               N+T+S    +FST FV  I    P + GHG+AF +       S +A+QYLGL + T+N
Sbjct:    81 --NDTVS----SFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGLFSSTNN 134

Query:   136 AKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISV 195
                +  ILAVEFD + N E  D NDNHVGI+I+SL S  S    Y+      IN  N ++
Sbjct:   135 GNDTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYW----DEINQFN-NL 189

Query:   196 VLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST 255
              L S   +Q W+DY+ +   I+VT++P G  KP + L+S   DL++V  + MY+GFSA+T
Sbjct:   190 TLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKALVSVVRDLSSVFLQDMYLGFSAAT 249

Query:   256 GLLTAFHNVHGWSFKIGG-TARELDVTMLPFHAR--PKSKQVVHKKGFAV-GITXXXXXX 311
             G + + H V GWSF + G TA  L ++ +P   R  P S Q  +K    +  +       
Sbjct:   250 GYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLF 309

Query:   312 XXXXXXXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKV 371
                                +  EDWE E+G  R R+ +LY ATKGF++K+L+GSGGFG+V
Sbjct:   310 VVSLIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRV 369

Query:   372 YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY 431
             YRGV+P+T  E+A+KRV++ SRQG+KEFVAEI S+GR+ HRNLV L G+CR++DELLLVY
Sbjct:   370 YRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVY 429

Query:   432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV 491
             DY+PNGSLDK L+D  +     L+W QR+ ++IGVA  L YLHEE +Q V+HRD+K SNV
Sbjct:   430 DYMPNGSLDKYLYDCPEVT---LDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNV 486

Query:   492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLM 551
             L+DA+ N +LGDFGLAR  DH  +PQTT +VGT GYLAP+  RTG+ATT+TDVF FG L+
Sbjct:   487 LLDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLL 546

Query:   552 LEVACGRRPIEPQRTAMELVL-VDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGL 609
             LEVACGRRPIE +  + E VL VD V     +G I  A DP L   +D +E E VL LGL
Sbjct:   547 LEVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGL 606

Query:   610 LCCDPHPDFRPSTRRVVQFLLRDASLPQ-APLD 641
             LC    P  RP+ R+V+Q+L  DA+LP  +PLD
Sbjct:   607 LCSHSDPQVRPTMRQVLQYLRGDATLPDLSPLD 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1352 (481.0 bits), Expect = 4.0e-138, P = 4.0e-138
 Identities = 292/629 (46%), Positives = 402/629 (63%)

Query:    23 FIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
             F YNGF     ++S+ G A +  +G+L ++N   +  GHAFY  P+RFK        N T
Sbjct:    28 FTYNGFRPPPTDISILGIATITPNGLLKLTNTTMQSTGHAFYTKPIRFKDSP-----NGT 82

Query:    81 ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
             +S    +FST FVF+I  + P    HG+AFV+    + P     QYLGL N T+N     
Sbjct:    83 VS----SFSTTFVFAIHSQIPI--AHGMAFVIAPNPRLPFGSPLQYLGLFNVTNNGNVRN 136

Query:   141 RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSG 200
              + AVE D + N+E  D N+NHVGIDI+SL S  S PA Y+     + ND   ++ L S 
Sbjct:   137 HVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYW-----DENDQFHNLTLISS 191

Query:   201 DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTA 260
               +Q W+D++    LI+VT++P G  KP +PL+S   DL++VL + M+VGFS++TG + +
Sbjct:   192 KRMQVWVDFDGPTHLIDVTMAPFGEVKPRKPLVSIVRDLSSVLLQDMFVGFSSATGNIVS 251

Query:   261 FHNVHGWSFKIGGTARELDVTMLP----FHARPKSKQVVHKKGFAVGITXXXXXXXXXXX 316
                V GWSF + G A+ L ++ LP    +  +P      +K    + I+           
Sbjct:   252 EIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPL-ISLLLIPFLLIIF 310

Query:   317 XXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVI 376
                          +++ EDWE E+G  R R+ +LY ATKGF++KN++GSGGFG VY+G++
Sbjct:   311 LVRFIMKRRRKFAEEV-EDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIM 369

Query:   377 PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN 436
             P T  E+A+KRV++ SRQG+KEFVAEI S+G++ HRNLV L G+CR++DELLLVYDY+PN
Sbjct:   370 PKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPN 429

Query:   437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
             GSLDK L+++ +     L+W QR+K++ GVA AL YLHEE +Q V+HRDVK SNVL+DA+
Sbjct:   430 GSLDKYLYNSPEVT---LDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAE 486

Query:   497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC 556
             LN +LGDFGLA+  DH  +PQTT +VGT GYLAP+  RTG+ATT+TDVF FG L+LEVAC
Sbjct:   487 LNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVAC 546

Query:   557 GRRPIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDP 614
             GRRPIE    + E +VLVDWV     +  I  A DP L   +D +E E+VL LGLLC   
Sbjct:   547 GRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHS 606

Query:   615 HPDFRPSTRRVVQFLLRDASLPQ-APLDI 642
              P  RP+ R+V+Q+L  DA LP  +PLD+
Sbjct:   607 DPLARPTMRQVLQYLRGDAMLPDLSPLDL 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
 Identities = 279/562 (49%), Positives = 369/562 (65%)

Query:    84 TALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRIL 143
             T  +FST+FVF+I  +   L GHG+AFV+      P    +QY+GL N  +N   +  + 
Sbjct:    81 TVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGLFNLANNGNETNHVF 140

Query:   144 AVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPI 203
             AVE D + + E  D NDNHVGIDI+SL S  S PA Y+  KG   N     + L S  P+
Sbjct:   141 AVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKN-----LTLISRKPM 195

Query:   204 QAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHN 263
             Q W+DY+ +   I+VT++P    KP RPL++   DL++VL + MYVGFS++TG + + H 
Sbjct:   196 QVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAVRDLSSVLLQDMYVGFSSATGSVLSEHY 255

Query:   264 VHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAVGITXXXXXXXXXXXXXXXXXX 323
             + GWSF +   A  L ++ LP   R + K++   + + +G+                   
Sbjct:   256 ILGWSFGLNEKAPPLALSRLPKLPRFEPKRI--SEFYKIGMPLISLFLIFSFIFLVCYIV 313

Query:   324 XXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEV 383
                    + LE+WE E+G  RFR+ +LY ATKGF+EK L+G+GGFG VY+GV+P T LE+
Sbjct:   314 RRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEI 373

Query:   384 AIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL 443
             A+KRV+H SRQGMKEFVAEI S+GR+ HRNLV L G+CR++ ELLLVYDY+PNGSLDK L
Sbjct:   374 AVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYL 433

Query:   444 FDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
             ++  +     LNW QR K+++GVA  L YLHEE +Q V+HRDVK SNVL+D +LN +LGD
Sbjct:   434 YNTPEVT---LNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGD 490

Query:   504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE- 562
             FGLAR YDH  +PQTTH+VGTLGYLAPE TRTG+AT +TDVF FG  +LEVACGRRPIE 
Sbjct:   491 FGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEF 550

Query:   563 PQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPS 621
              Q T    +LVDWV  L ++G I  A DP +    D +E E+VL LGLLC    P  RPS
Sbjct:   551 QQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPS 610

Query:   622 TRRVVQFLLRDASLPQ-APLDI 642
              R+V+ +L  DA LP+ +PLD+
Sbjct:   611 MRQVLHYLRGDAKLPELSPLDL 632

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 1329 (472.9 bits), Expect = 1.1e-135, P = 1.1e-135
 Identities = 277/610 (45%), Positives = 383/610 (62%)

Query:    37 GTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSI 96
             G A     G++ ++N      GH FY SP+RFK     N  N T+S    +FST FVF+I
Sbjct:    39 GIAITNSKGLMKLTNSSEFSYGHVFYNSPVRFK-----NSPNGTVS----SFSTTFVFAI 89

Query:    97 VPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQ 156
             V     L GHGLAFV+   K  P   ++QYLGL N T+N   S  I+AVEFD  QN E  
Sbjct:    90 VSNVNALDGHGLAFVISPTKGLPYSSSSQYLGLFNLTNNGDPSNHIVAVEFDTFQNQEFD 149

Query:   157 DINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLI 216
             D+++NHVGIDI+SL S  +  A YY          NI ++ +   PIQAWI+Y+S    +
Sbjct:   150 DMDNNHVGIDINSLSSEKASTAGYYEDDDGTFK--NIRLINQK--PIQAWIEYDSSRRQL 205

Query:   217 NVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTAR 276
             NVTI P+ +PKP  PL+S   DL+  L + MYVGF+++TG L + H + GW+FK+ GTA 
Sbjct:   206 NVTIHPIHLPKPKIPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTAS 265

Query:   277 ELDVTMLPFHARPKSKQVVHKKGFAVGITXXXXXXXXXXXXXXXXXXXXXXNGDDILEDW 336
              +D++ LP   R  S+    KK  A+ ++                        + +LEDW
Sbjct:   266 NIDISRLPKLPRD-SRSTSVKKILAISLSLTSLAILVFLTISYMLFLKRKKLME-VLEDW 323

Query:   337 EVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM 396
             EV++G  RF Y +LY ATKGFR   L+G GGFGKVY+G + ++ +++A+K+V+H+SRQGM
Sbjct:   324 EVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQGM 383

Query:   397 KEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNW 456
             +EFVAEI ++GRLRH NLV+L G+CR++ EL LVYD +P GSLDK L+   +Q    L+W
Sbjct:   384 REFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQS---LDW 440

Query:   457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP 516
              QR+KI+  VA  L YLH +  Q ++HRD+KP+NVL+D  +N KLGDFGLA+  +H  +P
Sbjct:   441 SQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDP 500

Query:   517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA-MELVLVDW 575
             QT+++ GT GY++PEL+RTGKA+TS+DVF FG LMLE+ CGRRP+ P+ ++  E+VL DW
Sbjct:   501 QTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSEMVLTDW 560

Query:   576 VRELHSQGQITRAIDPTL---DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
             V +   +  I + +D  +   D +  ++  LVL LGL C  P    RPS   V+QFL   
Sbjct:   561 VLDCW-EDDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGV 619

Query:   633 ASLPQAPLDI 642
             A LP    DI
Sbjct:   620 AQLPNNLFDI 629

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2168509 AT5G59260 [Arabidopsis thaliana (taxid:3702)]

 Score = 1286 (457.8 bits), Expect = 3.9e-131, P = 3.9e-131
 Identities = 284/634 (44%), Positives = 385/634 (60%)

Query:    15 FAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKY 74
             FA  E + F+Y  F  A+L LDG A     G L ++N+     GHAFY  P++F      
Sbjct:    23 FAQ-EGDHFVYYDFRNADLELDGMANTNH-GPLHLTNNTNTGTGHAFYNIPIKF------ 74

Query:    75 NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSC-LANQYLGLPNDT 133
                    S ++ +FST FVF+I P      GHG+AFV+   K   S   AN  LG+ N  
Sbjct:    75 ----TASSLSSFSFSTEFVFAIFPLQKSTYGHGMAFVVSPTKDLRSNGSANSNLGIFNRA 130

Query:   134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
             ++ K +T I AVE D  QN E  D   N VGIDI+S++S  S  A+Y+ ++       NI
Sbjct:   131 NDNKTATHIFAVELDTNQNSESFDKGGNDVGIDINSIVSVESADASYFNARKGK----NI 186

Query:   194 SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRP-----------LISYPIDLATV 242
             S+ L SG  I  WIDY+  E ++NVT++P+  PKP  P           L+S  I+L+ +
Sbjct:   187 SLPLASGKSILVWIDYDGIEKVLNVTLAPVQTPKPDSPYFSSFIKPKVPLLSRSINLSEI 246

Query:   243 LDEYMYVGFSASTGLLTAFHNVHGWSFKIGGTARELDVTMLPFHARPKSKQVVHKKGFAV 302
               E MYVGFS STG + +   + GWSFK GG A  LD++ L  +  P  K+   K+   +
Sbjct:   247 FTETMYVGFSGSTGSIKSNQYILGWSFKQGGKAESLDISRLS-NPPPSPKRFPLKE--VL 303

Query:   303 GITXXXXXXXXXXXXXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNL 362
             G T                         ++LE WE EY   R+ +  LY ATKGFRE  L
Sbjct:   304 GATISTIAFLTLGGIVYLYKKKKYA---EVLEQWEKEYSPQRYSFRILYKATKGFRENQL 360

Query:   363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
             +G+GGFGKVY+G++PS G ++A+KRV H++ QGMK++VAEI SMGRLRH+NLV L G+CR
Sbjct:   361 LGAGGFGKVYKGILPS-GTQIAVKRVYHDAEQGMKQYVAEIASMGRLRHKNLVHLLGYCR 419

Query:   423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             ++ ELLLVYDY+PNGSLD  LF  +  K K L W QR  I+ GVA ALLYLHEE +Q V+
Sbjct:   420 RKGELLLVYDYMPNGSLDDYLFHKN--KLKDLTWSQRVNIIKGVASALLYLHEEWEQVVL 477

Query:   483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
             HRD+K SN+L+DADLN KLGDFGLAR +D  +N + T +VGT+GY+APELT  G  TT T
Sbjct:   478 HRDIKASNILLDADLNGKLGDFGLARFHDRGVNLEATRVVGTIGYMAPELTAMGVTTTCT 537

Query:   543 DVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAE 602
             DV+ FG  +LEV CGRRP++P     +++LV WV     +  +T  +D  L  F  +EA+
Sbjct:   538 DVYAFGAFILEVVCGRRPVDPDAPREQVILVKWVASCGKRDALTDTVDSKLIDFKVEEAK 597

Query:   603 LVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP 636
             L+L LG+LC   +P+ RPS R+++Q+L  + S+P
Sbjct:   598 LLLKLGMLCSQINPENRPSMRQILQYLEGNVSVP 631

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)]

 Score = 1278 (454.9 bits), Expect = 2.8e-130, P = 2.8e-130
 Identities = 273/633 (43%), Positives = 385/633 (60%)

Query:    16 AHAETNSFIYNGFI--QANLSLDGTAFVRKDG-ILAVSNDQGRILGHAFYPSPLRFKQLS 72
             A A T  F + GF   Q ++  +G + ++ D  +L ++N +  + G AFY  P+R ++L+
Sbjct:    29 AEATTAKFTFIGFKENQTDIQTEGASTIQHDNDLLRLTNRKQNVTGTAFYRKPIRLRELT 88

Query:    73 KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPND 132
                 N++ I     +FST+FVF I+P  P  GG G  F L      P   + QYLGL N 
Sbjct:    89 ----NSSDIK--VCSFSTSFVFVILPSSPGNGGFGFTFTLSPTPNRPGAESAQYLGLLNR 142

Query:   133 TSNAKFSTRILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
             T+N   S  + AVEFD VQ   +  D   NH+G++ ++L SN+ EP  YY     +  D 
Sbjct:   143 TNNGNPSNHVFAVEFDTVQGFKDGADRRGNHIGLNFNNLSSNVQEPLIYY-----DTEDR 197

Query:   192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIP-KPHRPLISYPI-DLATVLDEYMYV 249
                  L+SG+PI+  IDY+     +NVTI P  +  KP +PLIS  + +L+ ++ + MYV
Sbjct:   198 KEDFQLESGEPIRVLIDYDGSSETLNVTIYPTRLEFKPKKPLISRRVSELSEIVKDEMYV 257

Query:   250 GFSASTGL-LTAFHNVHGWSFKIGGT---ARELDVTMLPFHARPKSKQVVHKKGFAVGIT 305
             GF+A+TG   ++ H V GWSF   G    A  L+++ LP   R  +K+  + +   + + 
Sbjct:   258 GFTAATGKDQSSAHYVMGWSFSSCGENPMADWLEISRLPPPPRLSNKKGYNSQVIVLIVA 317

Query:   306 XXXXXXXXXXXXXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGS 365
                                     +D LEDWE++Y   RFRY +LY ATK F+E  ++G+
Sbjct:   318 LSIVTLVLLVLLFIFVMYKRRIQEEDTLEDWEIDYPH-RFRYRDLYLATKKFKESEIIGT 376

Query:   366 GGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD 425
             GGFG VYRG + S+G  +A+K++  NS QG++EF+AEI S+GRL H+NLV L GWC+ ++
Sbjct:   377 GGFGIVYRGNLSSSG-PIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHKN 435

Query:   426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRD 485
             ELLL+YDY+PNGSLD LL+   ++   +L WD R++I+ G+A  LLYLHEE +Q VVHRD
Sbjct:   436 ELLLIYDYIPNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIVVHRD 495

Query:   486 VKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVF 545
             VKPSNVLID D+N KLGDFGLAR Y+     QTT IVGTLGY+APELTR GK +T++DVF
Sbjct:   496 VKPSNVLIDEDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTASDVF 555

Query:   546 GFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELV 604
              FG L+LE+ CG +P      A    L DWV E H+ G I   +D  L   F+ +EA+L 
Sbjct:   556 AFGVLLLEIVCGNKPTN----AENFFLADWVMEFHTNGGILCVVDQNLGSSFNGREAKLA 611

Query:   605 LTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
             L +GLLCC   P FRPS R V+++L  + ++PQ
Sbjct:   612 LVVGLLCCHQKPKFRPSMRMVLRYLNGEENVPQ 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2149795 LECRKA4.2 "lectin receptor kinase a4.1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1277 (454.6 bits), Expect = 3.5e-130, P = 3.5e-130
 Identities = 264/635 (41%), Positives = 387/635 (60%)

Query:    23 FIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNT 80
             FI+ GF   Q+N+   G A ++ DG+L +++    + G +FY  P+R  +      N ++
Sbjct:    26 FIFRGFSGNQSNIVTTGAATIKLDGLLRLTDRNSNVTGTSFYHKPVRLLET-----NTSS 80

Query:    81 ISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFST 140
              + T  +FST+FVF I+P     GG G  F L          + QYLGL N  ++   + 
Sbjct:    81 TNSTIRSFSTSFVFVIIPTSSSNGGFGFTFTLSPTPDRTGAESAQYLGLLNKANDGNSTN 140

Query:   141 RILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
              + AVEFD VQ   +  D   NH+G++ +SL S++ EP  YY ++  N  +D     L+S
Sbjct:   141 HVFAVEFDTVQGFKDGADRTGNHIGLNFNSLTSDVQEPVVYYDNEDPNRKED---FPLQS 197

Query:   200 GDPIQAWIDYNSQEMLINVTISPLGIP-KPHRPLISYPID-LATVLDEYMYVGFSASTGL 257
             GDPI+A +DY+     +N+T+ P  +  +P RPLIS P+  L+ ++ E MYVGF+A+TG 
Sbjct:   198 GDPIRAILDYDGPTQTLNLTVYPANLKSRPVRPLISRPVPKLSQIVQEEMYVGFTAATGR 257

Query:   258 -LTAFHNVHGWSFKIGG---TARELDVTMLPFHARPKSKQVVHKKGF-----AVGITXXX 308
               ++ H V GWSF  GG   T   LD+  LP   RP       K+G+     A+ +    
Sbjct:   258 DQSSAHYVMGWSFSSGGDLLTEDTLDLLELP---RPPPN-TAKKRGYNSQVLALIVALSG 313

Query:   309 XXXXXXXXXXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGF 368
                                   ++LEDWE+ +   R RY +LY+AT GF+E  +VG+GGF
Sbjct:   314 VTVILLALLFFFVMYKKRLQQGEVLEDWEINHPH-RLRYKDLYAATDGFKENRIVGTGGF 372

Query:   369 GKVYRGVIPSTGLE-VAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL 427
             G V+RG + S   + +A+K++  NS QG++EF+AEI S+GRLRH+NLV L GWC+++++L
Sbjct:   373 GTVFRGNLSSPSSDQIAVKKITPNSMQGVREFIAEIESLGRLRHKNLVNLQGWCKQKNDL 432

Query:   428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK 487
             LL+YDY+PNGSLD LL+   +Q   +L+W+ R+KI  G+A  LLYLHEE ++ V+HRD+K
Sbjct:   433 LLIYDYIPNGSLDSLLYSRPRQSGVVLSWNARFKIAKGIASGLLYLHEEWEKVVIHRDIK 492

Query:   488 PSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGF 547
             PSNVLI+ D+NP+LGDFGLAR Y+      TT +VGT+GY+APEL R GK+++++DVF F
Sbjct:   493 PSNVLIEDDMNPRLGDFGLARLYERGSQSNTTVVVGTIGYMAPELARNGKSSSASDVFAF 552

Query:   548 GTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVLT 606
             G L+LE+  GRRP +    +    L DWV ELH++G+I  A+DP L + +D  EA L L 
Sbjct:   553 GVLLLEIVSGRRPTD----SGTFFLADWVMELHARGEILHAVDPRLGFGYDGVEARLALV 608

Query:   607 LGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLD 641
             +GLLCC   P  RPS R V+++L  D  +P+   D
Sbjct:   609 VGLLCCHQRPTSRPSMRTVLRYLNGDDDVPEIDND 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA

TAIR|locus:2149810 LECRKA4.3 "lectin receptor kinase a4.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1231 (438.4 bits), Expect = 2.6e-125, P = 2.6e-125
 Identities = 259/632 (40%), Positives = 386/632 (61%)

Query:    20 TNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNIN 77
             T  FI++GF   Q+ + + G + +  +G+L +++    ++G AFY  P+R        ++
Sbjct:    27 TTEFIFHGFKGNQSEIHMQGDSTITSNGLLRLTDRNSDVVGTAFYHKPVRL-------LD 79

Query:    78 NNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAK 137
             +N+ + T  +FST+F+F I       GG G  F L            QY+GL N+ ++  
Sbjct:    80 SNSTNTTVRSFSTSFIFIIPSSSTSNGGFGFTFTLSPTPNRTDADPEQYMGLLNERNDGN 139

Query:   138 FSTRILAVEFDAVQNLELQDIN--DNHVGIDISSLISNISEPAAYYFSKGSNINDDNISV 195
              S  + AVEFD VQ  +    N   NH+G++ +SL S++ EP AY+    +N +      
Sbjct:   140 SSNHVFAVEFDTVQGFK-DGTNRIGNHIGLNFNSLSSDVQEPVAYF----NNNDSQKEEF 194

Query:   196 VLKSGDPIQAWIDYNSQEMLINVTISP--LGIPKPHRPLISYPID-LATVLDEYMYVGFS 252
              L SG+PIQ ++DY+     +N+T+ P  LG  KP  PLIS  +  L+ ++ + M+VGF+
Sbjct:   195 QLVSGEPIQVFLDYHGPTKTLNLTVYPTRLGY-KPRIPLISREVPKLSDIVVDEMFVGFT 253

Query:   253 ASTGL--LTAFHNVHGWSFKIGGT---ARELDVTMLPFHARPKSKQVVHK-KGFAVGITX 306
             A+TG    ++ H V GWSF  GG    A  LD++ LP     K+K+  +  K  A+ +  
Sbjct:   254 AATGRHGQSSAHYVMGWSFASGGEHPLAAMLDISQLPPPPPNKAKKRGYNGKVIALIVAL 313

Query:   307 XXXXXXXXXXXXXXXXXXXXXNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSG 366
                                    ++ILEDWE+++   RFRY +LY AT+GF+E  +VG+G
Sbjct:   314 STVISIMLVLLFLFMMYKKRMQQEEILEDWEIDHPH-RFRYRDLYKATEGFKENRVVGTG 372

Query:   367 GFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE 426
             GFG VYRG I S+  ++A+K++  NS QG++EFVAEI S+GRLRH+NLV L GWC+ +++
Sbjct:   373 GFGIVYRGNIRSSSDQIAVKKITPNSMQGVREFVAEIESLGRLRHKNLVNLQGWCKHRND 432

Query:   427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV 486
             LLL+YDY+PNGSLD LL+   ++   +L+W+ R++I  G+A  LLYLHEE +Q V+HRDV
Sbjct:   433 LLLIYDYIPNGSLDSLLYSKPRRSGAVLSWNARFQIAKGIASGLLYLHEEWEQIVIHRDV 492

Query:   487 KPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFG 546
             KPSNVLID+D+NP+LGDFGLAR Y+      TT +VGT+GY+APEL R G +++++DVF 
Sbjct:   493 KPSNVLIDSDMNPRLGDFGLARLYERGSQSCTTVVVGTIGYMAPELARNGNSSSASDVFA 552

Query:   547 FGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVL 605
             FG L+LE+  GR+P +    +    + DWV EL + G+I  AIDP L   +D  EA L L
Sbjct:   553 FGVLLLEIVSGRKPTD----SGTFFIADWVMELQASGEILSAIDPRLGSGYDEGEARLAL 608

Query:   606 TLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
              +GLLCC   P+ RP  R V+++L RD  +P+
Sbjct:   609 AVGLLCCHHKPESRPLMRMVLRYLNRDEDVPE 640

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9M345	LRK42_ARATH	2, ., 7, ., 1, 1, ., 1	0.4864	0.9093	0.8892	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.914
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00031525001 SubName- Full=Chromosome chr12 scaffold_57, whole genome shotgun sequence; (647 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	662
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	3e-95
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	2e-87
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	8e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-46
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-44
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	7e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-36
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-33
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-30
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-29
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	6e-29
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	8e-29
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-28
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-28
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-27
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-27
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	8e-27
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	9e-27
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	3e-26
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-25
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-25
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-24
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-24
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-24
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-24
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-24
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-24
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-24
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd01951	223	cd01951, lectin_L-type, legume lectins	2e-23
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-23
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-23
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-23
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-23
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	7e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	8e-23
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-22
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	4e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	8e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-21
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-21
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-21
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-21
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-21
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-20
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	4e-20
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-20
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-20
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	5e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-20
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	7e-20
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-20
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-19
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-19
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-19
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-19
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-19
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-19
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-18
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-18
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	2e-18
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-18
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-18
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-18
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-18
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-18
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	7e-18
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	9e-18
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	9e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-17
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	3e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	5e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	9e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-16
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-16
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-16
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	7e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	8e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	9e-16
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	9e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	9e-16
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-15
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-15
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-15
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	7e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	9e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-14
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-14
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-14
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-14
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	3e-14
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-14
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-14
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-14
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	7e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-14
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	8e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	9e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-13
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-13
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-13
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-13
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-13
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-13
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	5e-13
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	8e-13
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-12
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-12
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-12
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	2e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-12
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-12
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-12
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-12
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-12
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	2e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-11
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-11
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-11
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	8e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	9e-11
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-10
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-10
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	3e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-10
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	4e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	6e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	8e-10
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	8e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	4e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-09
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-09
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-08
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	5e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	9e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-07
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-07
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	5e-07
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	1e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	5e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-06
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	0.001
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	0.002
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.002
pfam01636	238	pfam01636, APH, Phosphotransferase enzyme family	0.004

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  292 bits (751), Expect = 3e-95
 Identities = 112/256 (43%), Positives = 149/256 (58%), Gaps = 25/256 (9%)

Query: 22  SFIYNGF--IQANLSLDGTAFVRKDGILAVSND--QGRILGHAFYPSPLRFKQLSKYNIN 77
           SF +NGF   Q+NL+L G A +  +G L ++ND      +G A Y  P+R          
Sbjct: 2   SFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLW-------- 53

Query: 78  NNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAK 137
            ++ +    +FST+F FSI P  P LGG GLAF L      P   +  YLGL N ++N  
Sbjct: 54  -DSTTGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGN 112

Query: 138 FSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVL 197
            S  I+AVEFD  QN E  D +DNHVGID++SL   +S  A Y+         D+    L
Sbjct: 113 SSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSL---VSVKAGYW---------DDDGGKL 160

Query: 198 KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL 257
           KSG P+QAWIDY+S    ++VT++  G+ KP +PL+SYP+DL+ VL E +YVGFSASTGL
Sbjct: 161 KSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTGL 220

Query: 258 LTAFHNVHGWSFKIGG 273
           LT  H +  WSF   G
Sbjct: 221 LTELHYILSWSFSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  272 bits (698), Expect = 2e-87
 Identities = 105/254 (41%), Positives = 139/254 (54%), Gaps = 25/254 (9%)

Query: 19  ETNSFIYNGFI-QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNIN 77
            T SF YNGF   +NL+L G A V  +G+L ++N      G A Y  P+R          
Sbjct: 1   STVSFNYNGFSNVSNLTLQGDATVLPNGLLQLTNVTNNSAGRALYSKPIRLW-------- 52

Query: 78  NNTISHTALTFSTNFVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA 136
            ++ +    +FST+FVF+I        GG GLAF L      P   +  YLGL N ++N 
Sbjct: 53  -DSSTGKVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNG 111

Query: 137 KFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVV 196
             S  I+AVEFD   N E  DI+DNHVGID++S+IS  SE A+             + + 
Sbjct: 112 NSSNHIVAVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESAS------------FVPLD 159

Query: 197 LKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTG 256
           L SG PIQ WIDY+     ++VT++     KP RPL+S  +DL+TVL E++YVGFSASTG
Sbjct: 160 LNSGKPIQVWIDYDGSSKRLSVTLAY--PNKPKRPLLSASVDLSTVLPEWVYVGFSASTG 217

Query: 257 LLTAFHNVHGWSFK 270
             T  H V  WSF 
Sbjct: 218 GATESHYVLSWSFS 231

Length = 231

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (453), Expect = 5e-52
 Identities = 68/194 (35%), Positives = 108/194 (55%), Gaps = 11/194 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           +G GGFG VY      TG +VAIK +   +S   ++E + EI  + +L H N+V+L+G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             ++ L LV +Y   GSL  LL    ++ +  L+ D+  +IL+ + + L YLH      +
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHS---NGI 113

Query: 482 VHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           +HRD+KP N+L+D+D    KL DFGL++    +       IVGT  Y+APE L   G  +
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 540 TSTDVFGFGTLMLE 553
             +D++  G ++ E
Sbjct: 173 EKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  179 bits (456), Expect = 8e-52
 Identities = 77/277 (27%), Positives = 125/277 (45%), Gaps = 27/277 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVAEITSMGRLRHRNL 414
           +     +GSG FG VY+     TG  VA+K +       +  +    EI  + RL H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +D L LV +Y   G L   L      +   L+ D+  KI + + + L YLH
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLS-----RGGPLSEDEAKKIALQILRGLEYLH 115

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 ++HRD+KP N+L+D +   K+ DFGLA+    + +   T  VGT  Y+APE+  
Sbjct: 116 S---NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKS-SSSLTTFVGTPWYMAPEVLL 171

Query: 535 TGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
            G       DV+  G ++ E+  G+ P   +    +L L+             R + P L
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR------------RILGPPL 219

Query: 594 DYFDPQEAELVLTLGLL---CCDPHPDFRPSTRRVVQ 627
           ++ +P+ +        L   C +  P  RP+   ++Q
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (437), Expect = 4e-49
 Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 23/272 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +     +G G FGKVY      TG  VAIK +     ++  +  + EI  + +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L+     +D+L LV +Y   G L  LL     +K+  L+ D+    L  +  AL YLH 
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLL-----KKRGRLSEDEARFYLRQILSALEYLH- 114

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              + +VHRD+KP N+L+D D + KL DFGLAR  D     + T  VGT  Y+APE+   
Sbjct: 115 --SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLG 170

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY 595
                + D++  G ++ E+  G+ P       +EL            G+      P    
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL--------FKKIGKPKPPFPPPEWD 222

Query: 596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             P+  +L+    LL  D  P+ R +    +Q
Sbjct: 223 ISPEAKDLI--RKLLVKD--PEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (414), Expect = 7e-46
 Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 40/278 (14%)

Query: 364 GSGGFGKVYRGV----IPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FG+VY+G          +EVA+K +  + S Q ++EF+ E   M +L H N+V+L 
Sbjct: 8   GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLL 67

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C +++ L +V +Y+  G L   L    ++ +  L+        + +A+ + YL     
Sbjct: 68  GVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLE---S 120

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGY--LAPELTRT 535
           +  +HRD+   N L+  +L  K+ DFGL+R  YD +   +     G L    +APE  + 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRG---GKLPIRWMAPESLKE 177

Query: 536 GKATTSTDVFGFGTLMLEVA-CGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
           GK T+ +DV+ FG L+ E+   G +P   +  +           V E    G        
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----------VLEYLKNGYRLPQPPN 227

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                 P E   +  L L C    P+ RP+   +V+ L
Sbjct: 228 C-----PPE---LYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  161 bits (411), Expect = 2e-45
 Identities = 75/279 (26%), Positives = 132/279 (47%), Gaps = 41/279 (14%)

Query: 364 GSGGFGKVYRGV----IPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FG+VY+G          +EVA+K +  + S Q ++EF+ E   M +L H N+V+L 
Sbjct: 8   GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLL 67

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C +++ L++V +Y+P G L   L  N   + K L+        + +A+ + YL     
Sbjct: 68  GVCTEEEPLMIVMEYMPGGDLLDYLRKN---RPKELSLSDLLSFALQIARGMEYLE---S 121

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYLAPELTRTGK 537
           +  +HRD+   N L+  +L  K+ DFGL+R  YD +        +  + ++APE  + GK
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWMAPESLKEGK 180

Query: 538 ATTSTDVFGFGTLMLEVA-CGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
            T+ +DV+ FG L+ E+   G  P   +          +++++++               
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE------VLEYLKK--------------- 219

Query: 594 DYFDPQEA---ELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            Y  P+       +  L L C    P+ RP+   +V+ L
Sbjct: 220 GYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (401), Expect = 7e-44
 Identities = 79/283 (27%), Positives = 134/283 (47%), Gaps = 36/283 (12%)

Query: 361 NLVGSGGFGKVYRGV---IPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
             +G G FG+VY+G          EVA+K +  + S +  K+F+ E   M +L H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLL----FDNDQQKKKILNWDQRYKILIGVAQALLY 472
           L G C +++ L LV +Y+  G L   L          +K  L+        I +A+ + Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG-----Y 527
           L     ++ VHRD+   N L+  DL  K+ DFGL+R    +   +      T G     +
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           +APE  + G  T+ +DV+ FG L+ E+   G  P  P  +  E  +++++R+ +   +  
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-PGLSNEE--VLEYLRKGYRLPK-- 228

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
               P  +Y   +  EL+L+    C    P+ RP+   +V+ L
Sbjct: 229 ----P--EYCPDELYELMLS----CWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  157 bits (400), Expect = 7e-44
 Identities = 81/277 (29%), Positives = 129/277 (46%), Gaps = 37/277 (13%)

Query: 364 GSGGFGKVYRGVI----PSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FG+VY+G +      T  +VA+K +    S +  +EF+ E + M +L H N+V+L 
Sbjct: 8   GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLL 67

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C + + L +V +Y+P G L   L    ++  + L      ++ + +A+ + YL     
Sbjct: 68  GVCTQGEPLYIVTEYMPGGDLLDFL----RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APELT 533
           +  VHRD+   N L+  +L  K+ DFGL+R     I     +     G L     APE  
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPESL 176

Query: 534 RTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
           + GK T+ +DV+ FG L+ E+   G +P  P  +  E      V EL   G       P 
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEE------VLELLEDGYRL----PR 225

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            +   P E   +  L L C    P+ RP+   +V+ L
Sbjct: 226 PEN-CPDE---LYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  151 bits (385), Expect = 1e-41
 Identities = 65/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
            L+G G FG VY  +   TG  +A+K   ++ +S + ++    EI  +  L+H N+V+ +
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 419 GWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWD--QRY--KILIGVAQALLY 472
           G  R +++  L +  +YV  GSL  LL     +K   L     ++Y  +IL    + L Y
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQIL----EGLAY 116

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPE 531
           LH      +VHRD+K +N+L+D+D   KL DFG A+          T  + GT  ++APE
Sbjct: 117 LHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           + R  +   + D++  G  ++E+A G+ P
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  136 bits (344), Expect = 3e-36
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 9/204 (4%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F     +G GGFG+VY+     TG EVAIK +   S++  ++ + EI  + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            +G   K+DEL +V ++   GSL  LL    +   + L   Q   +   + + L YLH  
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHS- 116

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               ++HRD+K +N+L+ +D   KL DFGL+     +       +VGT  ++APE+    
Sbjct: 117 --NGIIHRDIKAANILLTSDGEVKLIDFGLSA--QLSDTKARNTMVGTPYWMAPEVINGK 172

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D++  G   +E+A G+ P
Sbjct: 173 PYDYKADIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (327), Expect = 1e-33
 Identities = 53/206 (25%), Positives = 103/206 (50%), Gaps = 7/206 (3%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFV-AEITSMGRLRHRNL 414
           +     +G G FGKVY     S G    +K +   N  +  +E    E+  + +L H N+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++ +    ++ +L +V +Y   G L + +    +++ K    +Q     + +  AL YLH
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQLCLALKYLH 120

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               ++++HRD+KP N+ + ++   KLGDFG+++     ++   T +VGT  YL+PEL +
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQ 176

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
                  +D++  G ++ E+   + P
Sbjct: 177 NKPYNYKSDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 8e-33
 Identities = 66/208 (31%), Positives = 107/208 (51%), Gaps = 21/208 (10%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
            +L+G G FG VY+G+   TG  VAIK++       + +K  + EI  +  L+H N+V+ 
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLY 472
            G     D L ++ +Y  NGSL +++     F        +      Y++L    Q L Y
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV------YQVL----QGLAY 114

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LHE   Q V+HRD+K +N+L   D   KL DFG+A   +       + +VGT  ++APE+
Sbjct: 115 LHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEV 170

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                A+T++D++  G  ++E+  G  P
Sbjct: 171 IEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  127 bits (320), Expect = 3e-30
 Identities = 95/355 (26%), Positives = 165/355 (46%), Gaps = 37/355 (10%)

Query: 289 PKSKQVVHKKGFAVGITLASAILVIFVIIAAILVLRRIRNGDDIL----ED--WEVEYGA 342
           P  K+V     +   IT      ++  ++A   V  R RN  ++     ED  WE+++  
Sbjct: 617 PPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFD 676

Query: 343 CRFRYS----ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMK 397
            +   S    ++ S+ K   E+N++  G  G  Y+G     G++  +K +   NS     
Sbjct: 677 SKVSKSITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSS- 732

Query: 398 EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD 457
               EI  MG+L+H N+V+L G CR +    L+++Y+   +L ++L +        L+W+
Sbjct: 733 ----EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN--------LSWE 780

Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ 517
           +R KI IG+A+AL +LH  C   VV  ++ P  ++ID    P L    L       +   
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL-RLSLPGL----LCTD 835

Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR 577
           T   + +  Y+APE   T   T  +D++GFG +++E+  G+ P + +       +V+W R
Sbjct: 836 TKCFISS-AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWAR 893

Query: 578 ELHSQGQITRAIDPTLDY---FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
             +S   +   IDP++      +  E   V+ L L C    P  RP    V++ L
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 6e-30
 Identities = 80/303 (26%), Positives = 130/303 (42%), Gaps = 25/303 (8%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRH- 411
            +R    +G G FG+VY          VA+K +A    +  + ++ F+ EI  +  L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N+V+L+ + + +  L LV +YV  GSL+ LL      +K  L+  +   IL  +  AL 
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALE 115

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLN-PKLGDFGLARAYDHN-----INPQTTHIVGTL 525
           YLH    + ++HRD+KP N+L+D D    KL DFGLA+          I    +  VGT 
Sbjct: 116 YLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172

Query: 526 GYLAPEL---TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ 582
           GY+APE+        A++S+D++  G  + E+  G  P E +             ++  +
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE---KNSSATSQTLKIILE 229

Query: 583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV-QFLLRDASLPQAPLD 641
                   P         ++    L        P  R S+   +   LL    L ++ L 
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289

Query: 642 IHH 644
              
Sbjct: 290 DLL 292

Length = 384

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (294), Expect = 2e-29
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
              +G G FG V  G     G +VA+K +  +S    + F+AE + M  LRH NLVQL G
Sbjct: 11  GATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              + + L +V +Y+  GSL   L     + + ++   Q+    + V + + YL E   +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEE---K 121

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGK 537
             VHRD+   NVL+  DL  K+ DFGLA+              G L   + APE  R  K
Sbjct: 122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKE------ASQGQDSGKLPVKWTAPEALREKK 175

Query: 538 ATTSTDVFGFGTLMLEV-ACGRRP 560
            +T +DV+ FG L+ E+ + GR P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  116 bits (293), Expect = 3e-29
 Identities = 69/207 (33%), Positives = 112/207 (54%), Gaps = 15/207 (7%)

Query: 361 NLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQ 416
            ++G G FG+V RG +   G   ++VAIK +   S    + +F+ E + MG+  H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L G   K   ++++ +Y+ NGSLDK L +ND +        Q   +L G+A  + YL E 
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK----FTVGQLVGMLRGIASGMKYLSEM 125

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG--TLGYLAPELTR 534
                VHRD+   N+L++++L  K+ DFGL+R    +     T   G   + + APE   
Sbjct: 126 N---YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATYTTKGGKIPIRWTAPEAIA 181

Query: 535 TGKATTSTDVFGFGTLMLEV-ACGRRP 560
             K T+++DV+ FG +M EV + G RP
Sbjct: 182 YRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  115 bits (291), Expect = 6e-29
 Identities = 58/211 (27%), Positives = 107/211 (50%), Gaps = 11/211 (5%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           G G  G VY+     TG   A+K++  +   +  K+ + E+ ++       +V+ +G   
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           K+ E+ +V +Y+  GSL  LL     +K   +       I   + + L YLH    + ++
Sbjct: 70  KEGEISIVLEYMDGGSLADLL-----KKVGKIPEPVLAYIARQILKGLDYLHT--KRHII 122

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+KPSN+LI++    K+ DFG+++  ++ ++   T  VGT+ Y++PE  +    + + 
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSYAA 181

Query: 543 DVFGFGTLMLEVACGRRPIEPQRTA--MELV 571
           D++  G  +LE A G+ P  P       EL+
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQPSFFELM 212

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  116 bits (292), Expect = 8e-29
 Identities = 70/225 (31%), Positives = 109/225 (48%), Gaps = 40/225 (17%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGR-------LRHRNL 414
           +G G +G+VY+     TG  VA+K++   N ++G       IT++ R       LRH N+
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMENEKEGF-----PITAI-REIKLLQKLRHPNI 60

Query: 415 VQLHGWC--RKQDELLLVYDYVP---NGSLDKLLFD-NDQQKKKILNWDQRYKILIGVAQ 468
           V+L      + +  + +V++Y+     G LD       + Q K  +      ++L G+  
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYM-----KQLLEGLQ- 114

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
              YLH      ++HRD+K SN+LI+ D   KL DFGLAR Y    +   T+ V TL Y 
Sbjct: 115 ---YLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR 168

Query: 529 APEL----TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            PEL    TR G      D++  G ++ E+  G +PI    T +E
Sbjct: 169 PPELLLGATRYG---PEVDMWSVGCILAELFLG-KPIFQGSTELE 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 1e-28
 Identities = 67/208 (32%), Positives = 110/208 (52%), Gaps = 18/208 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH-NSRQGM-KEFVAEITSMGRLRHRNL 414
           + +   +G G +G VY+     TG  VA+K++   N  +G+    + EI+ +  L+H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI-LNWDQR--YKILIGVAQALL 471
           V+L      + +L LV++Y     L K L   D++   +  N  +   Y++L G+A    
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYL---DKRPGPLSPNLIKSIMYQLLRGLA---- 112

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           Y H     R++HRD+KP N+LI+ D   KL DFGLARA+   +   T  +V TL Y APE
Sbjct: 113 YCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPE 168

Query: 532 -LTRTGKATTSTDVFGFGTLMLEVACGR 558
            L  +   +T+ D++  G +  E+  G+
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  114 bits (288), Expect = 2e-28
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 29/275 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           +     +G G FG V +    S G  +  K + + +   M E      V+E+  +  L+H
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKH 58

Query: 412 RNLVQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
            N+V+ +     R    L +V +Y   G L +L+    ++++K +  +  ++IL  +  A
Sbjct: 59  PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI-QKCKKERKYIEEEFIWRILTQLLLA 117

Query: 470 LLYLH--EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           L   H   +    V+HRD+KP+N+ +DA+ N KLGDFGLA+   H+ +   T+ VGT  Y
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-VGTPYY 176

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           ++PE          +D++  G L+ E+     P    R  ++L             +I  
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-ARNQLQL-----------ASKIKE 224

Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
                + Y    E   V+       +  PD RPST
Sbjct: 225 GKFRRIPYRYSSELNEVIK---SMLNVDPDKRPST 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  113 bits (286), Expect = 2e-28
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFV-AEITSMGRLRHRNLVQLHG 419
           +G G FGKV       TG   A+K  +     ++   E    E   + R+ H  +V+LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59

Query: 420 WCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLYLHEE 476
               Q E  L LV +Y P G L   L      K+   + ++R +     +  AL YLH  
Sbjct: 60  -YAFQTEEKLYLVLEYAPGGELFSHL-----SKEGRFS-EERARFYAAEIVLALEYLHS- 111

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               +++RD+KP N+L+DAD + KL DFGLA+        +T    GT  YLAPE+    
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE-GSRTNTFCGTPEYLAPEVLLGK 168

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
               + D +  G L+ E+  G+ P
Sbjct: 169 GYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  112 bits (281), Expect = 1e-27
 Identities = 68/212 (32%), Positives = 121/212 (57%), Gaps = 19/212 (8%)

Query: 358 REKNLVGSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRN 413
           ++K ++G+G FG+V+RG++   G   + VAIK +    + +  ++F++E + MG+  H N
Sbjct: 9   KQK-VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHN 67

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L G   K    +++ +Y+ NG+LDK L D+D +        Q   +L G+A  + YL
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSY----QLVGMLRGIAAGMKYL 123

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG----TLGYLA 529
               D   VHRD+   N+L++++L  K+ DFGL+R  +   +P+ T+        + + A
Sbjct: 124 ---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED--DPEGTYTTSGGKIPIRWTA 178

Query: 530 PELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           PE     K T+++DV+ FG +M EV + G RP
Sbjct: 179 PEAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (282), Expect = 1e-27
 Identities = 79/289 (27%), Positives = 130/289 (44%), Gaps = 41/289 (14%)

Query: 357 FREKNL-----VGSGGFGKVYRGVIP----STGLEVAIKRVAHNS-RQGMKEFVAEITSM 406
           F +++L     +G G FGKV          +TG +VA+K + H+   Q   +F  EI  +
Sbjct: 1   FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEIL 60

Query: 407 GRLRHRNLVQLHGWCRKQ--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
             L H N+V+  G C K     L L+ +Y+P+GSL   L    Q+ +  +N  +      
Sbjct: 61  RTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL----QRHRDQINLKRLLLFSS 116

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA------YDHNINPQT 518
            + + + YL     QR +HRD+   N+L++++   K+ DFGLA+       Y +   P  
Sbjct: 117 QICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGE 173

Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVR 577
           + I     + APE  RT K ++++DV+ FG  + E+   G     P    + ++ +    
Sbjct: 174 SPIF----WYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA--- 226

Query: 578 ELHSQGQITRAID-----PTLDYFDPQEAELVLTLGLLCCDPHPDFRPS 621
               Q  +TR ++       L        E V  L  LC +  P  RPS
Sbjct: 227 --QGQMIVTRLLELLKEGERLPRPPSCPDE-VYDLMKLCWEAEPQDRPS 272

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  111 bits (280), Expect = 2e-27
 Identities = 69/214 (32%), Positives = 113/214 (52%), Gaps = 28/214 (13%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           N +G G FGKVY  V   TG  +A+K  R+  N  + +KE   E+  +  L+H NLV+ +
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIGVAQALLYLHEE 476
           G    ++++ +  +Y   G+L++LL       + ++   + Y  ++L G+A    YLH  
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVI---RVYTLQLLEGLA----YLHS- 117

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT-------HIVGTLGYLA 529
               +VHRD+KP+N+ +D +   KLGDFG A      +   TT        + GT  Y+A
Sbjct: 118 --HGIVHRDIKPANIFLDHNGVIKLGDFGCAVK----LKNNTTTMGEEVQSLAGTPAYMA 171

Query: 530 PELTRTGKAT---TSTDVFGFGTLMLEVACGRRP 560
           PE+   GK      + D++  G ++LE+A G+RP
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  110 bits (277), Expect = 8e-27
 Identities = 65/228 (28%), Positives = 108/228 (47%), Gaps = 43/228 (18%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE----FVA-EITSMGRL-RHRNLV 415
           ++G G F  V       T  E AIK +  + RQ +KE    +V  E   + RL  H  ++
Sbjct: 8   IIGEGSFSTVVLAKEKETNKEYAIKIL--DKRQLIKEKKVKYVKIEKEVLTRLNGHPGII 65

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ-RYKILIGVAQ---ALL 471
           +L+   + ++ L  V +Y PNG L + +     +K   L+    R+      A+   AL 
Sbjct: 66  KLYYTFQDEENLYFVLEYAPNGELLQYI-----RKYGSLDEKCTRFYA----AEILLALE 116

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-------------- 517
           YLH    + ++HRD+KP N+L+D D++ K+ DFG A+  D N +P+              
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 518 -----TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
                    VGT  Y++PEL     A  S+D++  G ++ ++  G+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  109 bits (274), Expect = 9e-27
 Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 32/210 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F  +  +GSG FG+V+ G+     + VAIK +  +     ++F  E+ ++ RLRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEGLW-KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
           L   C   + + ++ + +  GSL   L   + Q             LI     VA+ + Y
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQ-------VLPVASLIDMACQVAEGMAY 119

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR--------AYDHNINPQTTHIVGT 524
           L E   Q  +HRD+   N+L+  DL  K+ DFGLAR        + D  I  + T     
Sbjct: 120 LEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWT----- 171

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               APE    G  +T +DV+ FG L+ E+
Sbjct: 172 ----APEAASHGTFSTKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  108 bits (272), Expect = 2e-26
 Identities = 68/209 (32%), Positives = 116/209 (55%), Gaps = 18/209 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLE---VAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           ++G+G FG+V RG +   G     VAIK  +  +  +Q  ++F++E + MG+  H N++ 
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L G   K   ++++ +++ NG+LD  L  ND Q   I    Q   +L G+A  + YL E 
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYLSE- 124

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI-NPQTTHIVG---TLGYLAPEL 532
                VHRD+   N+L++++L  K+ DFGL+R  + +  +P  T  +G    + + APE 
Sbjct: 125 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K T+++DV+ +G +M EV + G RP
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  107 bits (270), Expect = 2e-26
 Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 38/286 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           F   N +G G FG V++ V  +     A+K++  +  +R+  +E + E   + +L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++ +     + +L +V +Y  NG L KLL     Q+ + L  DQ ++  I +   L +LH
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILLGLAHLH 118

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               ++++HRD+K  N+ +DA  N K+GD G+A+    N N   T IVGT  YL+PEL  
Sbjct: 119 S---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCE 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI----- 589
                  +DV+  G ++ E   G+ P +                  +QG +   I     
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDAN----------------NQGALILKIIRGVF 218

Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL 635
            P    +  Q A+L+      C       RP T +    LLR+ SL
Sbjct: 219 PPVSQMYSQQLAQLI----DQCLTKDYRQRPDTFQ----LLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (273), Expect = 3e-26
 Identities = 69/213 (32%), Positives = 104/213 (48%), Gaps = 15/213 (7%)

Query: 348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
            ELY       EK  +G G  G+VY+    +TG EVAIK++    +Q  +  + EI  M 
Sbjct: 18  RELYK----NLEK--IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMK 70

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
             +H N+V  +      DEL +V +Y+  GSL  ++     Q    +N  Q   +   V 
Sbjct: 71  DCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVL 126

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           Q L YLH    Q V+HRD+K  N+L+  D + KL DFG A A       +   +VGT  +
Sbjct: 127 QGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYW 182

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +APE+ +        D++  G + +E+A G  P
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  108 bits (273), Expect = 3e-26
 Identities = 82/280 (29%), Positives = 122/280 (43%), Gaps = 43/280 (15%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG--MKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G  G V++     TG  VA+K+VA    +G    + + EI ++   +H  +V+L   
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDND-----QQKKKILNWDQRYKILIGVAQALLYLHE 475
                  +LV +Y+P   L ++L D +      Q K  +       +L GVA    Y+H 
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMR-----MLLKGVA----YMHA 117

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL--- 532
                ++HRD+KP+N+LI AD   K+ DFGLAR +        +H V T  Y APEL   
Sbjct: 118 N---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-LVLV----------DW--VREL 579
            R  K     D++  G +  E+  G  P+ P    +E L +V           W  +  L
Sbjct: 175 AR--KYDPGVDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL 231

Query: 580 HSQGQIT-RAIDPTL--DYF-DPQEAELVLTLGLLCCDPH 615
               +IT     P    + F D     L L  GLL  DP 
Sbjct: 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPS 271

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  107 bits (268), Expect = 7e-26
 Identities = 68/209 (32%), Positives = 109/209 (52%), Gaps = 16/209 (7%)

Query: 358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHR 412
           R+  L+GSG FG VY G+    G   A+K V         ++ +K+   EI  + +L+H 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+VQ  G  R++D L +  + VP GSL KLL       + ++    R +IL+G+     Y
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR-QILLGLE----Y 117

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE- 531
           LH   D+  VHRD+K +N+L+D +   KL DFG+A+              G+  ++APE 
Sbjct: 118 LH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEV 172

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           + + G    + D++  G  +LE+A G+ P
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-25
 Identities = 88/279 (31%), Positives = 134/279 (48%), Gaps = 45/279 (16%)

Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQG-MKE--FVAEITSMGRLRHRNLV 415
           +GSG FG V    +RG I     +VAIK +    R+G M E  F+ E   M +L H NLV
Sbjct: 12  LGSGQFGVVHLGKWRGKI-----DVAIKMI----REGAMSEDDFIEEAKVMMKLSHPNLV 62

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           QL+G C KQ  + +V +Y+ NG L   L    +++K  L  +    +   V +A+ YL  
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYL----RERKGKLGTEWLLDMCSDVCEAMEYLES 118

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPEL 532
                 +HRD+   N L+  D   K+ DFGLAR   + ++ Q T   GT   + +  PE+
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLAR---YVLDDQYTSSQGTKFPVKWAPPEV 172

Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
               + ++ +DV+ FG LM EV + G+ P E + +  E+V      E  S G   R   P
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVV------ESVSAG--YRLYRP 223

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL 630
            L          V T+   C    P+ RP+ ++++  L 
Sbjct: 224 KL------APTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  104 bits (262), Expect = 4e-25
 Identities = 59/215 (27%), Positives = 105/215 (48%), Gaps = 14/215 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F     +G G +G VY+ +   TG  VAIK V       ++E + EI+ + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            +G   K  +L +V +Y   GS+  ++    +   K L  ++   IL    + L YLH  
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIM----KITNKTLTEEEIAAILYQTLKGLEYLH-- 116

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
              + +HRD+K  N+L++ +   KL DFG++      +  + T ++GT  ++APE+ +  
Sbjct: 117 -SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174

Query: 537 KATTSTDVFGFGTLMLEVACGRRP---IEPQRTAM 568
                 D++  G   +E+A G+ P   I P R A+
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYSDIHPMR-AI 208

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  103 bits (259), Expect = 1e-24
 Identities = 68/207 (32%), Positives = 113/207 (54%), Gaps = 16/207 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           ++G+G FG+V  G +   G   + VAIK  +  +  +Q  ++F++E + MG+  H N++ 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL   
Sbjct: 70  LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVI----QLVGMLRGIASGMKYL--- 122

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG--YLAPELTR 534
            D   VHRD+   N+L++++L  K+ DFGL+R  + +     T   G +   + APE   
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182

Query: 535 TGKATTSTDVFGFGTLMLEV-ACGRRP 560
             K T+++DV+ +G +M EV + G RP
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 1e-24
 Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 9/199 (4%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G+  +T   VA+K +   +    K+F+AE   M +LRH  L+QL+  C 
Sbjct: 14  LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V + +  GSL + L     +  K+    Q   +   VA  + YL     Q  +
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKL---PQLIDMAAQVASGMAYLEA---QNYI 125

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+   NVL+  +   K+ DFGLAR    +I          + + APE     + +  +
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKS 185

Query: 543 DVFGFGTLMLE-VACGRRP 560
           DV+ FG L+ E V  GR P
Sbjct: 186 DVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  103 bits (258), Expect = 1e-24
 Identities = 73/285 (25%), Positives = 136/285 (47%), Gaps = 36/285 (12%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFVAEITSMG 407
              F+ +  +G G F  VY+ +    G  VA+K+V         +RQ   + + EI  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           +L H N+++      + +EL +V +    G L +++  + +++K+++     +K  + + 
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTIWKYFVQLC 116

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT---HIVGT 524
            AL ++H    +R++HRD+KP+NV I A    KLGD GL R +    + +TT    +VGT
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGT 169

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
             Y++PE          +D++  G L+ E+A  + P        ++ L    +      +
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCK------K 219

Query: 585 ITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           I +   P L  D++  +  +LV      C +P P+ RP    V+Q
Sbjct: 220 IEKCDYPPLPADHYSEELRDLV----SRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  102 bits (257), Expect = 2e-24
 Identities = 71/219 (32%), Positives = 116/219 (52%), Gaps = 36/219 (16%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G +  VY+G   +TG  VA+K +  ++ +G     + EI+ M  L+H N+V+LH   
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR-----------YKILIGVAQAL 470
             +++L+LV++Y+          D D +K    +  +            Y++L G+A   
Sbjct: 68  HTENKLMLVFEYM----------DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA--- 114

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + HE    RV+HRD+KP N+LI+     KL DFGLARA+   +N  +  +V TL Y AP
Sbjct: 115 -FCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAP 169

Query: 531 EL---TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
           ++   +RT   +TS D++  G +M E+  G RP+ P   
Sbjct: 170 DVLLGSRT--YSTSIDIWSVGCIMAEMITG-RPLFPGTN 205

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 3e-24
 Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +VG G +G V +    +TG  VAIK  + + +     K  + E+  + +LRH N+V L  
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             R++  L LV++YV    L+ L     +     L  D     +  + QA+ Y H     
Sbjct: 68  AFRRKGRLYLVFEYVERTLLELL-----EASPGGLPPDAVRSYIWQLLQAIAYCHS---H 119

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL----TRT 535
            ++HRD+KP N+L+      KL DFG ARA         T  V T  Y APEL    T  
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNY 179

Query: 536 GKATTSTDVFGFGTLMLEVACGR 558
           GK     DV+  G +M E+  G 
Sbjct: 180 GKP---VDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  102 bits (256), Expect = 3e-24
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 20/215 (9%)

Query: 363 VGSGGFGKVYRG----VIPSTGLE-VAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FGKV+ G    + P    E VA+K +    S    K+F  E   +   +H N+V+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDND---------QQKKKILNWDQRYKILIGVA 467
            +G C + D  ++V++Y+ +G L+K L  +                L   Q  +I + +A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             ++YL     Q  VHRD+   N L+  DL  K+GDFG++R  Y  +      H +  + 
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  101 bits (254), Expect = 4e-24
 Identities = 63/206 (30%), Positives = 95/206 (46%), Gaps = 18/206 (8%)

Query: 363 VGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLH 418
           +G G FG V +GV        +EVA+K +       G KEF+ E + M +L H  +V+L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDN-DQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           G C K + L+LV +  P G L K L    +     +            VA  + YL    
Sbjct: 63  GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLES-- 113

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA--YDHNINPQTTHIVGTLGYLAPELTRT 535
            +  VHRD+   NVL+      K+ DFG++RA     +    TT     L + APE    
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172

Query: 536 GKATTSTDVFGFGTLMLEV-ACGRRP 560
           GK ++ +DV+ +G  + E  + G +P
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 67/220 (30%), Positives = 114/220 (51%), Gaps = 37/220 (16%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFV----AEITSMGRLRH 411
           L+G G +G+VY  +  +TG  +A+K+V      A       K+ V    +EI ++  L H
Sbjct: 8   LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGV 466
            N+VQ  G+   ++ L +  +YVP GS+   L     F+ +Q  +         ++L G+
Sbjct: 68  LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFE-EQLVRFFTE-----QVLEGL 121

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR----AYDHNINPQTTHIV 522
           A    YLH    + ++HRD+K  N+L+DAD   K+ DFG+++     YD   N Q   + 
Sbjct: 122 A----YLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD---NDQNMSMQ 171

Query: 523 GTLGYLAPELTRTGKATTS--TDVFGFGTLMLEVACGRRP 560
           G++ ++APE+  +     S   D++  G ++LE+  GRRP
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 9e-24
 Identities = 65/204 (31%), Positives = 101/204 (49%), Gaps = 13/204 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G +G VY+     TG  VAIK++            A  EI  +  L H N+++L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
            R + +L LV++++ +  L KL+ D     ++ L        L  + Q L + H      
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HG 118

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           ++HRD+KP N+LI+ +   KL DFGLAR++   + P  TH V T  Y APE L      +
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY-THYVVTRWYRAPELLLGDKGYS 177

Query: 540 TSTDVFGFGTLMLEVACGRRPIEP 563
           T  D++  G +  E+   RRP+ P
Sbjct: 178 TPVDIWSVGCIFAELL-SRRPLFP 200

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (251), Expect = 1e-23
 Identities = 57/201 (28%), Positives = 103/201 (51%), Gaps = 10/201 (4%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLRHRNLVQLHGWCR 422
           G+G  G V + +   TG  +A+K +     + + K+ + E+  + +     +V  +G   
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
              ++ +  +Y+  GSLDK+L    ++ +  +      KI + V + L YLHE    +++
Sbjct: 70  NNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE--KHKII 123

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRDVKPSN+L+++    KL DFG++      +N      VGT  Y+APE  +    +  +
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGNDYSVKS 180

Query: 543 DVFGFGTLMLEVACGRRPIEP 563
           D++  G  ++E+A GR P  P
Sbjct: 181 DIWSLGLSLIELATGRFPYPP 201

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 98.7 bits (246), Expect = 2e-23
 Identities = 64/255 (25%), Positives = 101/255 (39%), Gaps = 40/255 (15%)

Query: 21  NSFIYNGFI---QANLSLDGTAFV-RKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNI 76
            S  ++ F    Q+N  L+G+A +    G+L ++ D G   G A+Y +P+        ++
Sbjct: 1   TSLNFSNFSNNNQSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPI--------DL 52

Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPS--CLANQYLGLPNDTS 134
           + +        F+T F F +       G  G+AFVL +              LG      
Sbjct: 53  SKD--------FTTTFKFYL-GTKGTNGADGIAFVLQNDPAGALGGGGGGGGLG------ 97

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
                   +AVEFD  +N +  D N NH+ ID++          A   S GS    +   
Sbjct: 98  -YGGIGNSVAVEFDTYKNDDNNDPNGNHISIDVN----GNGNNTALATSLGSASLPNG-- 150

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
                G+     I Y+     + V +            I+ P+DL  +     Y GF+AS
Sbjct: 151 --TGLGNEHTVRITYDPTTNTLTVYLD--NGSTLTSLDITIPVDLIQLGPTKAYFGFTAS 206

Query: 255 TGLLTAFHNVHGWSF 269
           TG LT  H++  WSF
Sbjct: 207 TGGLTNLHDILNWSF 221

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =   99 bits (249), Expect = 2e-23
 Identities = 73/228 (32%), Positives = 107/228 (46%), Gaps = 36/228 (15%)

Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           E+ ++G G +G VY     ST + +AIK +     + ++    EI     L+HRN+VQ  
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLL-------FDNDQQ----KKKILNWDQRYKILIGVA 467
           G   +     +  + VP GSL  LL        DN+Q      K+IL             
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL------------- 118

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLG 526
           + L YLH   D ++VHRD+K  NVL++      K+ DFG ++     INP T    GTL 
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQ 174

Query: 527 YLAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRPI----EPQRTAM 568
           Y+APE+   G        D++  G  ++E+A G+ P     EPQ  AM
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAM 221

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  100 bits (250), Expect = 3e-23
 Identities = 77/238 (32%), Positives = 118/238 (49%), Gaps = 27/238 (11%)

Query: 341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-E 398
           G CR        +   F + N +G G +G VYR    ++G  VA+K+V   N R G+   
Sbjct: 1   GRCR--------SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS 52

Query: 399 FVAEITSMGRLRHRNLVQLH----GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
            + EIT +  LRH N+V+L     G  +  D + LV +Y     L  LL DN        
Sbjct: 53  SLREITLLLNLRHPNIVELKEVVVG--KHLDSIFLVMEYCEQ-DLASLL-DNMPTP---F 105

Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           +  Q   +++ + + L YLHE     ++HRD+K SN+L+      K+ DFGLAR Y    
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162

Query: 515 NPQTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
            P T  +V TL Y APE L      TT+ D++  G ++ E+    +P+ P ++ +E +
Sbjct: 163 KPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAH-KPLLPGKSEIEQL 218

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =   99 bits (250), Expect = 4e-23
 Identities = 65/212 (30%), Positives = 103/212 (48%), Gaps = 22/212 (10%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVA--EITSMGRLRHRNLV 415
             +G G +  VY+     TG  VAIK++    R+  K+   F A  EI  +  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK-ILIGVAQALLYLH 474
            L      +  + LV++++    L+K++ D     K I+      K  ++   + L YLH
Sbjct: 66  GLLDVFGHKSNINLVFEFME-TDLEKVIKD-----KSIVLTPADIKSYMLMTLRGLEYLH 119

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTLGYLAPEL 532
                 ++HRD+KP+N+LI +D   KL DFGLAR++    +P    TH V T  Y APEL
Sbjct: 120 ---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG---SPNRKMTHQVVTRWYRAPEL 173

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
               +      D++  G +  E+   R P  P
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAEL-LLRVPFLP 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 98.5 bits (246), Expect = 6e-23
 Identities = 63/201 (31%), Positives = 101/201 (50%), Gaps = 15/201 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MK--EFVAEITSMGRLRHRNLVQLHGW 420
           G+G FG+V+ G    T  +VA+K +    + G M    F+ E   M +LRH  LVQL+  
Sbjct: 15  GAGQFGEVWMGTWNGT-TKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAV 69

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
           C +++ + +V +Y+  GSL   L   + +K   L   Q   +   +A+ + YL     + 
Sbjct: 70  CSEEEPIYIVTEYMSKGSLLDFLKSGEGKK---LRLPQLVDMAAQIAEGMAYLES---RN 123

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
            +HRD+   N+L+  +L  K+ DFGLAR  + +           + + APE    G+ T 
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTI 183

Query: 541 STDVFGFGTLMLE-VACGRRP 560
            +DV+ FG L+ E V  GR P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 98.1 bits (244), Expect = 7e-23
 Identities = 64/216 (29%), Positives = 111/216 (51%), Gaps = 23/216 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM---KEFVAEITSMGRLRHRNLVQLHG 419
           +GSG FG V+ G       +VAIK +    R+G    ++F+ E   M +L H  LVQL+G
Sbjct: 12  IGSGQFGLVWLGYWLEKR-KVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYG 66

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++  + LV++++ +G L   L    + ++   + +    + + V + + YL      
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTG 536
            V+HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    
Sbjct: 121 -VIHRDLAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 537 KATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELV 571
           K ++ +DV+ FG LM EV + G+ P E  R+  E+V
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 98.6 bits (246), Expect = 8e-23
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 27/224 (12%)

Query: 357 FREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRH 411
             +  ++GSG FG VY+GV IP      + VAIK +   +  +  KE + E   M  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++V+L G C    ++ L+   +P G L   + ++      + +LNW  +      +A+ 
Sbjct: 69  PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKG 121

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG--- 526
           + YL E   +R+VHRD+   NVL+    + K+ DFGLA+  D              G   
Sbjct: 122 MSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD----VDEKEYHAEGGKVP 174

Query: 527 --YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTA 567
             ++A E       T  +DV+ +G  + E+   G +P E     
Sbjct: 175 IKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 1e-22
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 29/212 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-------EFVA--EITSMGRL-RHR 412
           +G G FG VY      TG  VAIK+        MK       E +   E+ S+ +L  H 
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLRKLNEHP 58

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L    R+ DEL  V++Y+  G+L +L+     +K K  +      I+  + Q L +
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLYQLM---KDRKGKPFSESVIRSIIYQILQGLAH 114

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE- 531
           +H+       HRD+KP N+L+      K+ DFGLAR    +  P T + V T  Y APE 
Sbjct: 115 IHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDY-VSTRWYRAPEI 169

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           L R+   ++  D++  G +M E+    RP+ P
Sbjct: 170 LLRSTSYSSPVDIWALGCIMAELYTL-RPLFP 200

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 13/210 (6%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRHR 412
            F    ++G G FGKV       T    A+K   +     +  ++  + E   +  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            LV L    + ++ + LV D +  G L   L      +K   + +Q    +  +  AL Y
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWICEIVLALEY 115

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH    + ++HRD+KP N+L+D   +  + DF +A     +    TT   GT GY+APE+
Sbjct: 116 LHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL--TTSTSGTPGYMAPEV 170

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
                 + + D +  G    E   G+RP  
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYR 200

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.5 bits (243), Expect = 2e-22
 Identities = 58/221 (26%), Positives = 99/221 (44%), Gaps = 22/221 (9%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRN 413
           +   E + +G G  G V +  + +TG+  A+K +    +    K+ + E+      +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 414 LVQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIG 465
           +V+ +G         + +  +Y   GSLD +        KK+     R       KI   
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIY-------KKVKKRGGRIGEKVLGKIAES 113

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           V + L YLH    ++++HRD+KPSN+L+      KL DFG++      +N       GT 
Sbjct: 114 VLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL---VNSLAGTFTGTS 167

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
            Y+APE  +    + ++DV+  G  +LEVA  R P  P+  
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE 208

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 44/235 (18%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF-VAEITSMGRLR---H 411
           + E   +G G +G VY+    +TG  VA+K+V    S +G+    + EI  + +L    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 412 RNLVQL----HGWCRKQD-ELLLVYDYVPNGSLDKLLFDNDQQ------------KKKIL 454
            N+V+L    HG    ++ +L LV+++V          D D               + I 
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV----------DQDLATYLSKCPKPGLPPETIK 110

Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
             D   ++L GV     +LH     R+VHRD+KP N+L+ +D   K+ DFGLAR Y   +
Sbjct: 111 --DLMRQLLRGVD----FLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161

Query: 515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
               T +V TL Y APE+       T  D++  G +  E+   RRP+    +  +
Sbjct: 162 --ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEAD 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 363 VGSGGFGKVYRGVI--PSTGLE---VAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FGKVY+G +  P+  L    VAIK +  N   +  +EF  E   M  L+H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DNDQQKKKILNWDQRYKILIG 465
           L G C K+    ++++Y+ +G L + L              D+  K  L+      I I 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGT 524
           +A  + YL        VHRD+   N L+   L  K+ DFGL+R  Y  +     +  +  
Sbjct: 133 IAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + ++ PE    GK TT +D++ FG ++ E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 14/215 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +GSG +G VY+    +TG  VAIK +        +    EI+ +   RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
             G   ++D+L +V +Y   GSL  +     Q  +  L+  Q   +     + L YLHE 
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIY----QVTRGPLSELQIAYVCRETLKGLAYLHE- 119

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT--- 533
                +HRD+K +N+L+  D + KL DFG++      I  + + I GT  ++APE+    
Sbjct: 120 --TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP---IEPQR 565
           R G      D++  G   +E+A  + P   + P R
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 96.2 bits (240), Expect = 6e-22
 Identities = 70/212 (33%), Positives = 108/212 (50%), Gaps = 22/212 (10%)

Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-----EITSMGRLRHRN 413
           EK  +G G +G VY+     TG  VA+K++   +     E V      EI+ +  L H N
Sbjct: 5   EK--IGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPN 59

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V+L      +++L LV++++ +  L K +   D      L+       L  + Q + Y 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFL-DLDLKKYM---DSSPLTGLDPPLIKSYLYQLLQGIAYC 115

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIVGTLGYLAPEL 532
           H     RV+HRD+KP N+LID +   KL DFGLARA+   +  +T TH V TL Y APE+
Sbjct: 116 HS---HRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 170

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
               +  +T  D++  G +  E+   RRP+ P
Sbjct: 171 LLGSRQYSTPVDIWSIGCIFAEM-VNRRPLFP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 95.4 bits (238), Expect = 8e-22
 Identities = 70/273 (25%), Positives = 117/273 (42%), Gaps = 35/273 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F     +G G FG+VY+ +   T   VAIK +    +   +++   EI  + + R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y   GS   LL      K   L+      IL  V   L YLHE
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLL------KPGKLDETYIAFILREVLLGLEYLHE 116

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              +  +HRD+K +N+L+  + + KL DFG++      ++ + T  VGT  ++APE+ + 
Sbjct: 117 ---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT-FVGTPFWMAPEVIKQ 172

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
                  D++  G   +E+A G  P   + P R                   I +   P+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL---------------IPKNNPPS 217

Query: 593 L--DYFDPQEAELVLTLGLLCCDPHPDFRPSTR 623
           L  + F     + V     LC +  P  RPS +
Sbjct: 218 LEGNKFSKPFKDFV----SLCLNKDPKERPSAK 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.9 bits (236), Expect = 1e-21
 Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 55/289 (19%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +G+G F   Y+     TG  +A+K+V      +    + ++    EI  M RL H +++
Sbjct: 7   QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           ++ G   +     L  +++  GS+  LL      K+ ++           + + L YLH 
Sbjct: 67  RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVII-----NYTEQLLRGLSYLH- 120

Query: 476 ECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTT-------HIVGTL 525
             + +++HRDVK +N+LID+    L  ++ DFG A      +  + T        ++GT+
Sbjct: 121 --ENQIIHRDVKGANLLIDSTGQRL--RIADFGAAA----RLAAKGTGAGEFQGQLLGTI 172

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG-- 583
            ++APE+ R  +   S DV+  G +++E+A  + P              W  E HS    
Sbjct: 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP--------------WNAEKHSNHLA 218

Query: 584 ---QITRAIDP--TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
              +I  A       ++  P   ++ L     C +  P+ RP +R +++
Sbjct: 219 LIFKIASATTAPSIPEHLSPGLRDVTLR----CLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 70/206 (33%), Positives = 112/206 (54%), Gaps = 19/206 (9%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF-VAEITSMGRLRHRNLVQLHGW 420
           +G G +G VY+G    TG  VA+K++   +  +G+    + EI+ +  L+H N+V L   
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67

Query: 421 CRKQDELLLVYDYVPNGSLD-KLLFDN---DQQKKKILNWDQRYKILIGVAQALLYLHEE 476
             ++  L L+++++   S+D K   D+    Q     L     Y+IL    Q +L+ H  
Sbjct: 68  LMQESRLYLIFEFL---SMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHS- 119

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRT 535
             +RV+HRD+KP N+LID     KL DFGLARA+   +    TH V TL Y APE L  +
Sbjct: 120 --RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY-THEVVTLWYRAPEVLLGS 176

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPI 561
            + +T  D++  GT+  E+A  ++P+
Sbjct: 177 PRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 94.0 bits (234), Expect = 2e-21
 Identities = 60/207 (28%), Positives = 93/207 (44%), Gaps = 18/207 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWC 421
           +G G    VY  +      +VAIKR+     Q  + E   E+ +M +  H N+V+ +   
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSF 68

Query: 422 RKQDELLLVYDYVPNGSLDKLL---FDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              DEL LV  Y+  GSL  ++   +      + I+       +L  V + L YLH    
Sbjct: 69  VVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIA-----TVLKEVLKGLEYLH---S 120

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFG----LARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +HRD+K  N+L+  D + K+ DFG    LA   D     + T  VGT  ++APE+  
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKT-FVGTPCWMAPEVME 179

Query: 535 TGKATTS-TDVFGFGTLMLEVACGRRP 560
                    D++ FG   +E+A G  P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.8 bits (233), Expect = 3e-21
 Identities = 68/224 (30%), Positives = 115/224 (51%), Gaps = 23/224 (10%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---------RQGMKEFVAEITSMGRLRHR 412
           L+GSG FG VY G+  S+G  +A+K+V   S         R  +     EI  +  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+VQ  G     D L +  +YVP GS+  LL +N    ++ L  +   +IL G    L Y
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFEETLVRNFVRQILKG----LNY 121

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI-----NPQTTHIVGTLGY 527
           LH   ++ ++HRD+K +N+L+D     K+ DFG+++  + N      N     + G++ +
Sbjct: 122 LH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           +APE+ +    T   D++  G L++E+  G+ P  P  T ++ +
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF-PDCTQLQAI 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 74/268 (27%), Positives = 120/268 (44%), Gaps = 41/268 (15%)

Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           +G+G FG V    +RG       +VAIK +   S     EF+ E   M +L H  LVQL+
Sbjct: 12  LGTGQFGVVKYGKWRG-----QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLY 65

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C KQ  + +V +Y+ NG L   L    ++  K     Q  ++   V + + YL     
Sbjct: 66  GVCTKQRPIYIVTEYMSNGCLLNYL----REHGKRFQPSQLLEMCKDVCEGMAYLES--- 118

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRT 535
           ++ +HRD+   N L+D     K+ DFGL+R   + ++ + T  VG+   + +  PE+   
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLY 175

Query: 536 GKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
            K ++ +DV+ FG LM EV + G+ P                 E  +  +    +   L 
Sbjct: 176 SKFSSKSDVWAFGVLMWEVYSLGKMPY----------------ERFNNSETVEKVSQGLR 219

Query: 595 YFDPQEA-ELVLTLGLLCCDPHPDFRPS 621
            + P  A E V  +   C     + RP+
Sbjct: 220 LYRPHLASEKVYAIMYSCWHEKAEERPT 247

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 93.3 bits (232), Expect = 5e-21
 Identities = 57/202 (28%), Positives = 103/202 (50%), Gaps = 13/202 (6%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           G G FGKVY+     TGL  A K +   S + +++F+ EI  +   +H N+V L+     
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY 73

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
           +++L ++ ++   G+LD ++ + +    + L   Q   +   + +AL +LH     +V+H
Sbjct: 74  ENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIH 126

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL--TRTGKAT-- 539
           RD+K  N+L+  D + KL DFG++      +  + T I GT  ++APE+    T K    
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI-GTPYWMAPEVVACETFKDNPY 185

Query: 540 -TSTDVFGFGTLMLEVACGRRP 560
               D++  G  ++E+A    P
Sbjct: 186 DYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 92.1 bits (229), Expect = 8e-21
 Identities = 76/280 (27%), Positives = 122/280 (43%), Gaps = 36/280 (12%)

Query: 362 LVGSGGFGKVYRGVIPSTG---LEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
            +G G FG V RG   ++G   + VA+K +  +     M +F+ E   M  L H NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 418 HGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           +G       L++V +  P GSL D+L     +               + +A  + YL   
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRL----RKDALGHFLISTLCDYAVQIANGMRYLES- 115

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTR 534
             +R +HRD+   N+L+ +D   K+GDFGL RA   N +      H+     + APE  R
Sbjct: 116 --KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 535 TGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQG-QITRAIDPT 592
           T   + ++DV+ FG  + E+   G  P              W       G QI + ID  
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP--------------WA---GLSGSQILKKIDKE 216

Query: 593 LDYFDPQEA--ELVLTLGLLCCDPHPDFRPSTRRVVQFLL 630
            +  +  EA  + +  + L C   +P  RP+   + +FL 
Sbjct: 217 GERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 21/224 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRH---R 412
           ++   L+G G +G VYRG    TG  VA+K +  ++    + +   E+  + +LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI--GVAQAL 470
           N+ + +G   K   L ++ +Y   GS+  L+     +   I    ++Y  +I   V  AL
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPI---AEKYISVIIREVLVAL 114

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            Y+H+     V+HRD+K +N+L+    N KL DFG+A   + N + ++T  VGT  ++AP
Sbjct: 115 KYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAP 170

Query: 531 ELTRTGKA-TTSTDVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           E+   GK   T  D++  G  + E+A G  P        AM L+
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 59/217 (27%), Positives = 112/217 (51%), Gaps = 10/217 (4%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
            F+    +G G +G VY+    S     A+K V     S++  ++ V EI  +  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           ++         ++L +V +Y P G L K +    ++K+K++   + ++I I + + L  L
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAI-SKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           HE   Q+++HRD+K +N+L+ A+   K+GD G+++    N+       +GT  Y+APE+ 
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM---AKTQIGTPHYMAPEVW 173

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
           +    +  +D++  G L+ E+A    P E  R+  +L
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDL 209

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 91.7 bits (228), Expect = 2e-20
 Identities = 65/202 (32%), Positives = 98/202 (48%), Gaps = 18/202 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHG 419
           LVG G +G V +     TG  VAIK+   +    M + +A  EI  + +LRH NLV L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             R++  L LV+++V +  LD L     ++    L+  +  K L  + + + + H     
Sbjct: 68  VFRRKKRLYLVFEFVDHTVLDDL-----EKYPNGLDESRVRKYLFQILRGIEFCH---SH 119

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL----TRT 535
            ++HRD+KP N+L+      KL DFG AR          T  V T  Y APEL    T+ 
Sbjct: 120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYTDYVATRWYRAPELLVGDTKY 178

Query: 536 GKATTSTDVFGFGTLMLEVACG 557
           G+A    D++  G L+ E+  G
Sbjct: 179 GRA---VDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.0 bits (226), Expect = 2e-20
 Identities = 70/219 (31%), Positives = 109/219 (49%), Gaps = 31/219 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVA---EITSMGRLRH 411
           +R   L+G G FG+VY      TG E+A+K+V    +S +  KE  A   EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 412 RNLVQLHGWCRKQDELLLVY-DYVPNGSL-DKL-----LFDNDQQKKKILNWDQRYKILI 464
             +VQ +G C + DE L ++ +Y+P GS+ D+L     L +   +K          +IL 
Sbjct: 64  ERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYT-------RQILE 115

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI--- 521
           GV     YLH      +VHRD+K +N+L D+  N KLGDFG ++     I    T +   
Sbjct: 116 GVE----YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMKSV 167

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            GT  +++PE+          DV+  G  ++E+   + P
Sbjct: 168 TGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.1 bits (226), Expect = 3e-20
 Identities = 77/288 (26%), Positives = 124/288 (43%), Gaps = 42/288 (14%)

Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y      TG  VA+K +     +Q    +  EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 418 HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C +Q    L L+ +YVP GSL   L  +     ++L + Q+      + + + YLH 
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAYLHS 125

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPELT 533
              Q  +HRD+   NVL+D D   K+GDFGLA+A    H            + + A E  
Sbjct: 126 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP-IEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
           +  K + ++DV+ FG  + E+         P +   E++          QGQ+T      
Sbjct: 183 KENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-------KQGQMTVV--RL 233

Query: 593 LDYFD-----------PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           ++  +           PQE  +++     C +    FRP+ R ++  L
Sbjct: 234 IELLERGMRLPCPKNCPQEVYILMK---NCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 90.5 bits (225), Expect = 4e-20
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 17/206 (8%)

Query: 363 VGSGGFGKVYRGVI-----PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +G G FG VY G+            VAIK V    + R+ + EF+ E + M      ++V
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLF----DNDQQKK-KILNWDQRYKILIGVAQAL 470
           +L G        L+V + +  G L   L     + +           +  ++   +A  +
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLA 529
            YL     ++ VHRD+   N ++  DL  K+GDFG+ R  Y+ +   +    +  + ++A
Sbjct: 133 AYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVA 555
           PE  + G  TT +DV+ FG ++ E+A
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMA 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 91.0 bits (226), Expect = 4e-20
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 26/211 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF-VAEITSMGRLRHRNLVQLHGW 420
           +G G +G V++     T   VA+KRV   +  +G+    + EI  +  L+H+N+V+L+  
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY-------KILIGVAQALLYL 473
                +L LV++Y             DQ  KK  +              +  + + L + 
Sbjct: 68  LHSDKKLTLVFEYC------------DQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFC 115

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H      V+HRD+KP N+LI+ +   KL DFGLARA+   +   +  +V TL Y  P++ 
Sbjct: 116 HS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171

Query: 534 RTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
              K  +TS D++  G +  E+A   RP+ P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 90.1 bits (223), Expect = 5e-20
 Identities = 72/275 (26%), Positives = 131/275 (47%), Gaps = 26/275 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA---HNSRQGMKEFVAEITSMGRLRHRN 413
           FR +  +G G F +VYR      G+ VA+K+V        +   + + EI  + +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++ +    + +EL +V +    G L +++  + +++K+++     +K  + +  AL ++
Sbjct: 64  VIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H    +RV+HRD+KP+NV I A    KLGD GL R +        + +VGT  Y++PE  
Sbjct: 123 HS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 178

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID-PT 592
                   +D++  G L+ E+A  + P    +             L+S  +     D P 
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----------NLYSLCKKIEQCDYPP 227

Query: 593 L--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRV 625
           L  D++  +  +LV     +C +P P+ RP    V
Sbjct: 228 LPSDHYSEELRQLV----NMCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 5e-20
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 14/197 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLHGW 420
            +G G FG VY+GV+     EVA+K         +K  F+ E   + +  H N+V+L G 
Sbjct: 2   KIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
           C ++  + +V + VP GSL   L    ++KK  L   +  ++ +  A  + YL  +    
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFL----RKKKNRLTVKKLLQMSLDAAAGMEYLESKN--- 113

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI---NPQTTHIVGTLGYLAPELTRTGK 537
            +HRD+   N L+  +   K+ DFG++R  +  I   +     I   + + APE    G+
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI--PIKWTAPEALNYGR 171

Query: 538 ATTSTDVFGFGTLMLEV 554
            T+ +DV+ +G L+ E 
Sbjct: 172 YTSESDVWSYGILLWET 188

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 91.4 bits (228), Expect = 5e-20
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 28/218 (12%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQL 417
              +GSG +G V   V   TG +VAIK++++  +     K  + EI  +  LRH N++ L
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 418 HGWCR-----KQDELLLVYDYVPNGSLDKLLFDN----DQQKKKILNWDQRYKILIGVAQ 468
               R       +++ +V + +    L K++       D   +  L     Y+IL G   
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFL-----YQILRG--- 115

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTLG 526
            L YLH      V+HRD+KPSN+L++++ + K+ DFGLAR  D + + +   T  V T  
Sbjct: 116 -LKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 527 YLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
           Y APEL  +    T + D++  G +  E+   R+P+ P
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKPLFP 208

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.2 bits (221), Expect = 7e-20
 Identities = 74/272 (27%), Positives = 129/272 (47%), Gaps = 33/272 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG V +G    TG +VA+K +  +     + F+ E   M +L H+NLV+L G   
Sbjct: 14  IGEGEFGAVLQG--EYTGQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
               L +V + +  G+L   L     + + +++  Q  +  + VA+ + YL     +++V
Sbjct: 70  HNG-LYIVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLV 122

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+   N+L+  D   K+ DFGLAR     ++     +  T    APE  +  K ++ +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178

Query: 543 DVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEA 601
           DV+ +G L+ EV + GR P  P+ +  E      V+E   +G     ++P      P+  
Sbjct: 179 DVWSYGVLLWEVFSYGRAPY-PKMSLKE------VKECVEKGY---RMEP------PEGC 222

Query: 602 E-LVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
              V  L   C +  P  RPS  ++ + L ++
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKLEKE 254

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 91.0 bits (226), Expect = 9e-20
 Identities = 64/209 (30%), Positives = 105/209 (50%), Gaps = 25/209 (11%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHG 419
           N +GSG  G VY+ +   TG   A+K +  N    ++  +  EI  +  + H N+V+ H 
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                 E+ ++ +++  GSL+     ++Q        D   +IL G+A    YLH    +
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-----DVARQILSGIA----YLHR---R 187

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT---- 535
            +VHRD+KPSN+LI++  N K+ DFG++R     ++P  +  VGT+ Y++PE   T    
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGTIAYMSPERINTDLNH 246

Query: 536 ----GKATTSTDVFGFGTLMLEVACGRRP 560
               G A    D++  G  +LE   GR P
Sbjct: 247 GAYDGYA---GDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 80/285 (28%), Positives = 127/285 (44%), Gaps = 34/285 (11%)

Query: 361 NLVGSGGFGKVYRGVI-----PSTG-LEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRN 413
           N +GSG FG+VY G       P +G + VA+K +   +  Q  KEF+ E   M    H N
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK--ILNWDQRYKILIGVAQALL 471
           +V+L G C   +   ++ + +  G L   L D   ++    +L   +   I + VA+  +
Sbjct: 61  IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 472 YLHEECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL 525
           YL        +HRD+   N L+     DAD   K+GDFGLAR  Y  +   +    +  +
Sbjct: 121 YLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
            ++APE    GK TT +DV+ FG LM E+   G++P  P     E  ++  V      G+
Sbjct: 178 RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY-PALNNQE--VLQHVTA---GGR 231

Query: 585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + +  +     +          L   C    P  RP+  R+ + L
Sbjct: 232 LQKPENCPDKIYQ---------LMTNCWAQDPSERPTFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 89.7 bits (223), Expect = 1e-19
 Identities = 68/249 (27%), Positives = 108/249 (43%), Gaps = 56/249 (22%)

Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRL 409
           S  + +     +G G FG+VY+     TG  VA+K++  HN + G     + EI  + +L
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF-------DND--------------Q 448
           +H N+V L         + +  +        +          D+D               
Sbjct: 65  KHPNVVPL---------IDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTES 115

Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
           Q K  +      ++L G+     YLHE     ++HRD+K +N+LID     K+ DFGLAR
Sbjct: 116 QIKCYM-----LQLLEGIN----YLHE---NHILHRDIKAANILIDNQGILKIADFGLAR 163

Query: 509 AYDHNI-NPQT---------THIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACG 557
            YD    NP+          T++V T  Y  PEL    +  TT+ D++G G +  E+   
Sbjct: 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMF-T 222

Query: 558 RRPIEPQRT 566
           RRPI   ++
Sbjct: 223 RRPILQGKS 231

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 123

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 184 IKSDVWAFGVLLWEIA 199

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 89.1 bits (221), Expect = 2e-19
 Identities = 67/210 (31%), Positives = 111/210 (52%), Gaps = 12/210 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEF-VAEITSMGRLRHRNL 414
           F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L + H
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSY--LFQLLQGLAFCH 117

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+  
Sbjct: 118 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEILL 173

Query: 535 TGK-ATTSTDVFGFGTLMLEVACGRRPIEP 563
             K  +T+ D++  G +  E+   RR + P
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMVT-RRALFP 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 88.5 bits (219), Expect = 3e-19
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 21/219 (9%)

Query: 360 KNLVGSGGFGKVYRG----VIPSTG-LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K  +G G FGKV+      + P+   + VA+K +   +    K+F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDK----------LLFDND-QQKKKILNWDQRYKIL 463
           V+ +G C   D L++V++Y+ +G L+K          +L D   +Q K  L   Q   I 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIV 522
             +A  ++YL     Q  VHRD+   N L+ A+L  K+GDFG++R  Y  +      H +
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
             + ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 12/207 (5%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRN 413
           K +     +G G  G VY  +  +TG EVAIK++ +  +Q  KE +  EI  M   +H N
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPN 77

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V         DEL +V +Y+  GSL  ++ +    + +I        +     QAL +L
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIA------AVCRECLQALEFL 131

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H     +V+HRD+K  N+L+  D + KL DFG         + ++T +VGT  ++APE+ 
Sbjct: 132 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVV 187

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
                    D++  G + +E+  G  P
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 87.6 bits (217), Expect = 3e-19
 Identities = 60/206 (29%), Positives = 109/206 (52%), Gaps = 17/206 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLE-VAIKRV-AHNS--RQGMKE-------FVAEITSMG-RL 409
            +GSG FG VY+    + G   +A+K +  HN    +  +E        V+E+T +  +L
Sbjct: 7   HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           RH N+V+ +    + D L +V D +    L +  F++ ++KK+    ++ + I + +  A
Sbjct: 67  RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH-FNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L YLH+E  +R+VHRD+ P+N+++  D    + DFGLA+        + T +VGT+ Y  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVA 555
           PE+ +        DV+ FG ++ ++ 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 64/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G +G V++     TG  VAIK+   +    + + +A  EI  + +L+H NLV L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
            R++ +L LV++Y  +  L++L     ++  + +      KI+    QA+ + H+     
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNEL-----EKNPRGVPEHLIKKIIWQTLQAVNFCHK---HN 120

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGTLGYLAPEL----T 533
            +HRDVKP N+LI      KL DFG AR     +       T  V T  Y APEL    T
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARI----LTGPGDDYTDYVATRWYRAPELLVGDT 176

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
           + G      DV+  G +  E+  G +P+ P ++
Sbjct: 177 QYG---PPVDVWAIGCVFAELLTG-QPLWPGKS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 87.8 bits (217), Expect = 5e-19
 Identities = 64/231 (27%), Positives = 108/231 (46%), Gaps = 15/231 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V       TG +VA+K++    +Q  +    E+  M    H N+V ++    
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L       D      +N +Q   + + V +AL YLH   +Q V+
Sbjct: 90  VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLSVLRALSYLH---NQGVI 140

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+ +D   KL DFG        + P+   +VGT  ++APE+       T  
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV---LVDWVRELHSQGQITRA 588
           D++  G +++E+  G  P   EP   AM  +   L   V++ H    + R 
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 9e-19
 Identities = 73/275 (26%), Positives = 126/275 (45%), Gaps = 39/275 (14%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKE--FVAEITSMGRLRHRNLVQLHG 419
           +GSG FG V+ G   +  ++VAIK +     +G M E  F+ E   M +L H  LVQL+G
Sbjct: 12  LGSGQFGVVHLGKWRAQ-IKVAIKAI----NEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C +Q  L +V +++ NG L   L    +Q++  L+ D    +   V + + YL      
Sbjct: 67  VCTQQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLER---N 119

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTG 536
             +HRD+   N L+ +    K+ DFG+ R   + ++ + T   G    + +  PE+    
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTR---YVLDDEYTSSSGAKFPVKWSPPEVFNFS 176

Query: 537 KATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY 595
           K ++ +DV+ FG LM EV   G+ P E +                S  ++   I      
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKK----------------SNYEVVEMISRGFRL 220

Query: 596 FDPQEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + P+ A + V  +   C    P+ RP+   +++ +
Sbjct: 221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 86.2 bits (213), Expect = 9e-19
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 20/202 (9%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG-WC 421
           +G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G   
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNF 123

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGKAT 539
           VHRD+   NVL+  D   K+ DFGL +         +T   G L   + APE  R  K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 177

Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           T +DV+ FG L+ E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 86.2 bits (213), Expect = 2e-18
 Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 12/211 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L       D      +N +Q   + + V +AL  LH    Q V+
Sbjct: 88  VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIAAVCLAVLKALSVLHA---QGVI 138

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 14  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 70

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 124

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 185 DVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 86.0 bits (213), Expect = 2e-18
 Identities = 68/211 (32%), Positives = 109/211 (51%), Gaps = 25/211 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF-VAEITSMGRLRHRNLVQLHGW 420
           +G G +G VY+     T   +A+K++      +G+    + EI+ +  ++H N+V+L   
Sbjct: 10  IGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDV 69

Query: 421 CRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
              +  L LV++Y+ +  L K +     F  + +  K       Y+IL G+A    Y H 
Sbjct: 70  VHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPRLIKTY----LYQILRGIA----YCHS 120

Query: 476 ECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQT-THIVGTLGYLAPELT 533
               RV+HRD+KP N+LID   N  KL DFGLARA+   I  +T TH V TL Y APE+ 
Sbjct: 121 ---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEIL 175

Query: 534 RTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
              +  +T  D++  G +  E+   ++P+ P
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMV-NQKPLFP 205

Length = 294

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 55/183 (30%), Positives = 84/183 (45%), Gaps = 25/183 (13%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGW 420
           ++G G +GKVY+     TG  VAIK +        +E   E   + +   H N+   +G 
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 421 CRK------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK------ILIGVAQ 468
             K       D+L LV +    GS+  L+       K +    +R K      IL    +
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGSVTDLV-------KGLRKKGKRLKEEWIAYILRETLR 124

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L YLHE    +V+HRD+K  N+L+  +   KL DFG++   D  +  + T I GT  ++
Sbjct: 125 GLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWM 180

Query: 529 APE 531
           APE
Sbjct: 181 APE 183

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 85.0 bits (211), Expect = 3e-18
 Identities = 61/217 (28%), Positives = 97/217 (44%), Gaps = 26/217 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFV-AEITSMGRLRHRNLVQLHG 419
           +G GGFG+V    + S     A+K V   H    G +E + +E   +    H  +V+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 420 WCRKQDELLLVYDYVPNGSL-----DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
             + +  + ++ +Y   G L     D+ LFD    +            +  V  A  YLH
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARF----------YIACVVLAFEYLH 110

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPELT 533
               + +++RD+KP N+L+D++   KL DFG A+      + Q T    GT  Y+APE+ 
Sbjct: 111 N---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLK---SGQKTWTFCGTPEYVAPEII 164

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI-EPQRTAME 569
                  S D +  G L+ E+  GR P  E     ME
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME 201

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 75/277 (27%), Positives = 125/277 (45%), Gaps = 24/277 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA---HNSRQGMKEFVAEITSMGRLRHRN 413
           F+ +  +G G F +VYR         VA+K+V        +  ++ V EI  + +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR--YKILIGVAQALL 471
           +++      + +EL +V +    G L +++    +QK+ I    +R  +K  + +  A+ 
Sbjct: 64  VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI---PERTVWKYFVQLCSAVE 120

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           ++H    +RV+HRD+KP+NV I A    KLGD GL R +        + +VGT  Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
                     +D++  G L+ E+A  + P    +  M L  +          Q      P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLFSL-----CQKIEQCDYPPLP 229

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF 628
           T  Y     +E +  L  +C  P PD RP    V Q 
Sbjct: 230 TEHY-----SEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 40/263 (15%)

Query: 360 KNLVGSGGFGKVYRG----VIPSTG-LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K  +G G FGKV+      + P    + VA+K +   S    K+F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN--------DQQKKKILNWDQRYKILIGV 466
           V+ +G C + D L++V++Y+ +G L+K L  +        +  +   L   Q   I   +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL 525
           A  ++YL     Q  VHRD+   N L+  +L  K+GDFG++R  Y  +      H +  +
Sbjct: 130 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLE-----------------VAC---GR---RPIE 562
            ++ PE     K TT +DV+  G ++ E                 + C   GR   RP  
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRT 246

Query: 563 PQRTAMELVLVDWVRELHSQGQI 585
             +   +L+L  W RE H +  I
Sbjct: 247 CPKEVYDLMLGCWQREPHMRLNI 269

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 84.7 bits (209), Expect = 5e-18
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 12/209 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +  VY+G    T   VA+K +     +G     + E++ +  L+H N+V LH   
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             +  L LV++Y     LDK L          +N       L  + + L Y H    ++V
Sbjct: 74  HTEKSLTLVFEY-----LDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR---RKV 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKATT 540
           +HRD+KP N+LI+     KL DFGLARA        +  +V TL Y  P+ L  +   +T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYST 184

Query: 541 STDVFGFGTLMLEVACGRRPIEPQRTAME 569
             D++G G +  E++ G RP+ P  T  E
Sbjct: 185 QIDMWGVGCIFYEMSTG-RPLFPGSTVEE 212

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 75/275 (27%), Positives = 130/275 (47%), Gaps = 36/275 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     TG   A K +   S + +++++ EI  +    H  +V+L G   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
              +L ++ ++ P G++D ++ + D+     L   Q   I   + +AL YLH     +++
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHS---MKII 132

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--LTRTGKATT 540
           HRD+K  NVL+  D + KL DFG++      +  + + I GT  ++APE  +  T K T 
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-GTPYWMAPEVVMCETMKDTP 191

Query: 541 ---STDVFGFGTLMLEVACGRRPIEP---QRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                D++  G  ++E+A     IEP   +   M ++L           +I ++  PTL 
Sbjct: 192 YDYKADIWSLGITLIEMA----QIEPPHHELNPMRVLL-----------KIAKSEPPTLS 236

Query: 595 YFDPQEAEL--VLTLGLLCCDPHPDFRPSTRRVVQ 627
                  E    L   L   D HP+ RPS  ++++
Sbjct: 237 QPSKWSMEFRDFLKTAL---DKHPETRPSAAQLLE 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 26/211 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA---EITSMGRLRHRNLVQLHG 419
           +G G FGK+Y     S      IK +   ++  +KE  A   E+  + +++H N+V    
Sbjct: 8   IGEGSFGKIYLAKAKSDSEHCVIKEIDL-TKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 420 WCRKQDELLLVYDYVPNGSLDK-------LLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
             ++   L +V +Y   G L K       +LF  DQ    IL+W       + ++  L +
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ----ILSW------FVQISLGLKH 116

Query: 473 LHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +H   D++++HRD+K  N+ +  + +  KLGDFG+AR  + ++    T  VGT  YL+PE
Sbjct: 117 IH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPE 172

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           + +       TD++  G ++ E+   + P E
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 83.8 bits (207), Expect = 7e-18
 Identities = 62/206 (30%), Positives = 106/206 (51%), Gaps = 16/206 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           ++G+G FG++ RG +       L VAI  + A  S +  + F+AE  ++G+  H N+V+L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            G   + + +++V +Y+ NG+LD  L  ++ Q    L   Q   +L G+A  + YL E  
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFLRKHEGQ----LVAGQLMGMLPGLASGMKYLSE-- 125

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL--APELTRT 535
               VH+ +    VL+++DL  K+  F   R  +       T + G    L  APE  + 
Sbjct: 126 -MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQY 182

Query: 536 GKATTSTDVFGFGTLMLEV-ACGRRP 560
              ++++DV+ FG +M EV + G RP
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 9/193 (4%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGW 420
           L+G G FG+V++G +      VA+K    +  Q +K +F++E   + +  H N+V+L G 
Sbjct: 2   LLGKGNFGEVFKGTLKDK-TPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
           C ++  + +V + VP G     L    ++KK  L   Q  K  +  A  + YL     + 
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFL----RKKKDELKTKQLVKFALDAAAGMAYLES---KN 113

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
            +HRD+   N L+  +   K+ DFG++R  D  I   +      + + APE    G+ ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 541 STDVFGFGTLMLE 553
            +DV+ +G L+ E
Sbjct: 174 ESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 83.6 bits (206), Expect = 8e-18
 Identities = 76/283 (26%), Positives = 134/283 (47%), Gaps = 34/283 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +   L+  Q   IL  + + L YLH 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHS 119

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+      KL DFG+A +  D  I  +    VGT  ++APE+ +
Sbjct: 120 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIK 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G  P   +   M+++ +           I +   PTL+
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPP-HSELHPMKVLFL-----------IPKNNPPTLE 222

Query: 595 --YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDA 633
             Y  P + E V      C +  P FRP+ + ++  +F++R A
Sbjct: 223 GNYSKPLK-EFVEA----CLNKEPSFRPTAKELLKHKFIVRFA 260

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.7 bits (208), Expect = 9e-18
 Identities = 61/209 (29%), Positives = 94/209 (44%), Gaps = 31/209 (14%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHG 419
           +G+G FG+V       +G   A+K ++      +K+    + E   +  +RH  LV L+G
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68

Query: 420 WCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQ---ALL 471
             +    L LV +YVP G L   L     F     +                AQ   AL 
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-------------FYAAQVVLALE 115

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           YLH      +V+RD+KP N+L+D+D   K+ DFG A+     +  +T  + GT  YLAPE
Sbjct: 116 YLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAK----RVKGRTYTLCGTPEYLAPE 168

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +  +     + D +  G L+ E+  G  P
Sbjct: 169 IILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 83.6 bits (207), Expect = 9e-18
 Identities = 58/199 (29%), Positives = 96/199 (48%), Gaps = 12/199 (6%)

Query: 360 KNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLV 415
              +G G FG VY+GV  S     + VA+K   + +   ++E F+ E   M +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G    ++ + +V +  P G L   L    Q  K  L+          ++ AL YL  
Sbjct: 71  KLIGVI-TENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLE- 124

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              +R VHRD+   NVL+ +    KLGDFGL+R  +     + +     + ++APE    
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 536 GKATTSTDVFGFGTLMLEV 554
            + T+++DV+ FG  M E+
Sbjct: 183 RRFTSASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 9e-18
 Identities = 68/232 (29%), Positives = 110/232 (47%), Gaps = 34/232 (14%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKE-----FVAEITSMG 407
           TKG     ++G G +G VY G+  + G  +A+K+V    S     E        E+  + 
Sbjct: 3   TKG----EVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIG 465
            L+H N+VQ  G C   + + +  ++VP GS+  +L       + +     +Y  +IL G
Sbjct: 58  SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVF---CKYTKQILDG 114

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-------DHNINPQT 518
           VA    YLH  C   VVHRD+K +NV++  +   KL DFG AR          H+   ++
Sbjct: 115 VA----YLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS 167

Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAM 568
            H  GT  ++APE+         +D++  G  + E+A G+ P+    +  AM
Sbjct: 168 MH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM 217

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 83.4 bits (206), Expect = 1e-17
 Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 23/216 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHG 419
           +G+G FG+V+ G       +VAIK    + +QG      F+AE   M +L+H  LV+L+ 
Sbjct: 14  LGAGQFGEVWMGYYNGH-TKVAIK----SLKQGSMSPEAFLAEANLMKQLQHPRLVRLYA 68

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL---IGVAQALLYLHEE 476
              ++  + ++ +Y+ NGSL   L   +  K  I       K++     +A+ + ++   
Sbjct: 69  VVTQE-PIYIITEYMENGSLVDFLKTPEGIKLTI------NKLIDMAAQIAEGMAFIER- 120

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             +  +HRD++ +N+L+   L  K+ DFGLAR  + N           + + APE    G
Sbjct: 121 --KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 178

Query: 537 KATTSTDVFGFGTLMLE-VACGRRPIEPQRTAMELV 571
             T  +DV+ FG L+ E V  GR P  P  T  E++
Sbjct: 179 TFTIKSDVWSFGILLTEIVTYGRIPY-PGMTNPEVI 213

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 66/199 (33%), Positives = 99/199 (49%), Gaps = 15/199 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGWC 421
           G G +  VY+G    TG  VA+K +     +G   F A  E + +  L+H N+V LH   
Sbjct: 14  GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIVTLHDII 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             +  L LV++Y+     D  L          L+       L  + + L Y H    +RV
Sbjct: 73  HTKKTLTLVFEYL-----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH---QRRV 124

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIVGTLGYLAPE-LTRTGKAT 539
           +HRD+KP N+LI      KL DFGLARA   ++  +T ++ V TL Y  P+ L  + + +
Sbjct: 125 LHRDLKPQNLLISERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 540 TSTDVFGFGTLMLEVACGR 558
           TS D++G G +  E+A GR
Sbjct: 183 TSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 75/282 (26%), Positives = 129/282 (45%), Gaps = 36/282 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+VY+G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL     ++  I        IL  + + L YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHS 119

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   R +HRD+K +NVL+    + KL DFG+A +  D  I   T   VGT  ++APE+ +
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
                   D++  G   +E+A G  P   + P R    L L+        +GQ ++   P
Sbjct: 175 QSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIPKNSPPTLEGQYSK---P 228

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLR 631
             ++ +             C +  P FRP+ + +++  F+ R
Sbjct: 229 FKEFVEA------------CLNKDPRFRPTAKELLKHKFITR 258

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 12/206 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +  V++G    T   VA+K +     +G     + E++ +  L+H N+V LH   
Sbjct: 14  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIV 73

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
                L LV++Y     LDK L         I++       L  + + L Y H    ++V
Sbjct: 74  HTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR---RKV 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKATT 540
           +HRD+KP N+LI+     KL DFGLARA        +  +V TL Y  P+ L  + + +T
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYST 184

Query: 541 STDVFGFGTLMLEVACGRRPIEPQRT 566
             D++G G +  E+A G RP+ P  T
Sbjct: 185 QIDMWGVGCIFFEMASG-RPLFPGST 209

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 12/200 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G       +VA+K +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 14  LGNGQFGEVWMGTWNGN-TKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYA-VV 70

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNW-DQRYKILIGVAQALLYLHEECDQRV 481
            ++ + +V +Y+  GSL   L D + +  K+ N  D   ++  G+A    Y+        
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA----YIER---MNY 123

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
           +HRD++ +N+L+   L  K+ DFGLAR  + N           + + APE    G+ T  
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 542 TDVFGFGTLMLE-VACGRRP 560
           +DV+ FG L+ E V  GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 77/285 (27%), Positives = 123/285 (43%), Gaps = 38/285 (13%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF---VAEITSMGRLRHR 412
             RE   +G G FG VY      T   VAIK+++++ +Q  +++   + E+  + +LRH 
Sbjct: 19  DLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHP 75

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N ++  G   ++    LV +Y    + D L     +  KK L   +   I  G  Q L Y
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDIL-----EVHKKPLQEVEIAAICHGALQGLAY 130

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH       +HRD+K  N+L+      KL DFG A      ++P  +  VGT  ++APE+
Sbjct: 131 LHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS-FVGTPYWMAPEV 182

Query: 533 TRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
                 G+     DV+  G   +E+A  R+P      AM  +             I +  
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELA-ERKPPLFNMNAMSALY-----------HIAQND 230

Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRD 632
            PTL   D  +          C    P  RPS+  +++  F+LR+
Sbjct: 231 SPTLSSNDWSDY--FRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFV-AEITSMGRLRHRNLVQLHG 419
           +  G +G+V+     STG   AIK +  A   R+   + V  E   + + +   +V+L+ 
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60

Query: 420 WCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
             + +  L LV +Y+P G L  LL      D D  +  I       +I++    AL YLH
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYI------AEIVL----ALEYLH 110

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-------YDHNINPQTTHIVGTLGY 527
                 ++HRD+KP N+LID++ + KL DFGL++          ++   +   IVGT  Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +APE+      + + D +  G ++ E   G  P
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 82.0 bits (202), Expect = 3e-17
 Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 30/214 (14%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEV--AIKRVA-HNSRQGMKEFVAEITSMGRL-RHRNLVQ 416
           +++G G FG+V +  I   GL +  AIKR+  + S+   ++F  E+  + +L  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILIG 465
           L G C  +  L L  +Y P+G+L   L           F         L+  Q       
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           VA+ + YL +   ++ +HRD+   N+L+  +   K+ DFGL+R        Q  ++  T+
Sbjct: 121 VARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVKKTM 170

Query: 526 G-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
           G     ++A E       TT++DV+ +G L+ E+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.2 bits (205), Expect = 3e-17
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 121

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 122 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 176

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPP-DAKELELM 213

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 82.3 bits (204), Expect = 3e-17
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 34/208 (16%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF----VAEITSMGRLRHRNLV 415
           N +  G +G VYR     TG  VA+K++     ++G   F    + EI  + +L+H N+V
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIV 67

Query: 416 QLH----GWCRKQDELLLVYDYVPNGSLDKLLFDNDQ-----QKKKILNWDQRYKILIGV 466
            +     G     D++ +V +YV +  L  L+    Q     + K ++      ++L GV
Sbjct: 68  TVKEVVVG--SNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM-----LQLLSGV 119

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
           A    +LH   D  ++HRD+K SN+L++     K+ DFGLAR Y   + P  T +V TL 
Sbjct: 120 A----HLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP-YTQLVVTLW 171

Query: 527 YLAPE-LTRTGKATTSTDVFGFGTLMLE 553
           Y APE L    + +T+ D++  G +  E
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAE 199

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 75/268 (27%), Positives = 124/268 (46%), Gaps = 35/268 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           FR+  ++G GGFG+V    + +TG   A K++       R+G    + E   + ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
           +V L      +D L LV   +  G L   ++   +       +++   +     +   L 
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEA-----GFEEGRAVFYAAEICCGLE 116

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAP 530
            LH+E   R+V+RD+KP N+L+D   + ++ D GLA    H    QT    VGT+GY+AP
Sbjct: 117 DLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAP 170

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM--ELV--LVDWVRELHSQGQIT 586
           E+ +  + T S D +  G L+ E+  G+ P + ++  +  E V  LV  V+E +S+    
Sbjct: 171 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEK--- 227

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDP 614
                    F P    L     LLC DP
Sbjct: 228 ---------FSPDARSLCKM--LLCKDP 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.7 bits (202), Expect = 5e-17
 Identities = 64/223 (28%), Positives = 110/223 (49%), Gaps = 44/223 (19%)

Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 1   FEERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILK 60

Query: 408 RLRHRNLVQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L LV +Y+P GSL   L              Q+++  + 
Sbjct: 61  SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL--------------QKHRERLD 106

Query: 466 VAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
             + LLY  + C        +R VHRD+   N+L++++   K+GDFGL +     + PQ 
Sbjct: 107 HRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK-----VLPQD 161

Query: 519 T--HIVGTLG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + V   G     + APE     K + ++DV+ FG ++ E+
Sbjct: 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 30/215 (13%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEV--AIKRVA-HNSRQGMKEFVAEITSMGRL-RHRNLV 415
           ++++G G FG+V R +I   GL++  AIK +    S    ++F  E+  + +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILI 464
            L G C  +  L +  +Y P G+L   L           F  +      L   Q  +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
            VA  + YL    +++ +HRD+   NVL+  +L  K+ DFGL+R        +  ++  T
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-------EEVYVKKT 176

Query: 525 LG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
           +G     ++A E       TT +DV+ FG L+ E+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 81.6 bits (201), Expect = 6e-17
 Identities = 54/198 (27%), Positives = 98/198 (49%), Gaps = 10/198 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V       +G +VA+K +    +Q  +    E+  M   +H+N+V+++    
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             +EL ++ +++  G+L  ++       +  LN +Q   +   V QAL YLH    Q V+
Sbjct: 89  VGEELWVLMEFLQGGALTDIV------SQTRLNEEQIATVCESVLQALCYLHS---QGVI 139

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG       ++ P+   +VGT  ++APE+       T  
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEV 198

Query: 543 DVFGFGTLMLEVACGRRP 560
           D++  G +++E+  G  P
Sbjct: 199 DIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 81.9 bits (203), Expect = 7e-17
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 27/219 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLR-HRNLVQLHG 419
           +G G +G V++ +   T   VA+K++  A  +    +    EI  +  L  H N+V+L  
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLN 74

Query: 420 WCRKQD--ELLLVYDYVPNGSLDKLLFDNDQQ---KKKILNWDQRYKILIGVAQALLYLH 474
             + ++  ++ LV++Y+          + D     +  IL    +  I+  + +AL Y+H
Sbjct: 75  VIKAENDKDIYLVFEYM----------ETDLHAVIRANILEDVHKRYIMYQLLKALKYIH 124

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA----YDHNINPQTTHIVGTLGYLAP 530
                 V+HRD+KPSN+L+++D   KL DFGLAR+     ++  NP  T  V T  Y AP
Sbjct: 125 S---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP 181

Query: 531 E-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
           E L  + + T   D++  G ++ E+  G +P+ P  + +
Sbjct: 182 EILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTL 219

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 81.2 bits (200), Expect = 9e-17
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGL--EVAIKRVA-HNSRQGMKEFVAEITSMGRL-RHRNLV 415
           ++++G G FG+V +  I   GL  + AIKR+  + S+   ++F  E+  + +L  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL---LY 472
            L G C  +  L L  +Y P+G+L   L     +K ++L  D  + I    A  L     
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFL-----RKSRVLETDPAFAIANSTASTLSSQQL 126

Query: 473 LHEECD----------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           LH   D          ++ +HRD+   N+L+  +   K+ DFGL+R        Q  ++ 
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVK 179

Query: 523 GTLG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
            T+G     ++A E       TT++DV+ +G L+ E+
Sbjct: 180 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 33/272 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQL-HG 419
           VG G +G+V      + G +  IK++   + SR+  K    E   + +L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           W  +   L +V  +   G L   L    +QK K+L  +Q  +  + +A AL YLHE+   
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKL---KEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
            ++HRD+K  NV +      K+GD G+AR  ++  +  +T ++GT  Y++PEL       
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYN 180

Query: 540 TSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID----PTLDY 595
             +DV+  G  + E+A  +                  ++++S   + R I+    P    
Sbjct: 181 YKSDVWALGCCVYEMATLKHAFN-------------AKDMNS--LVYRIIEGKLPPMPKD 225

Query: 596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           + P+  EL+ T  +L     P+ RPS + +++
Sbjct: 226 YSPELGELIAT--MLS--KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 70/263 (26%), Positives = 123/263 (46%), Gaps = 20/263 (7%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLRHRNLVQLHGWC 421
           +G+G  G V +     TG  +A K V   ++  + K+ + E+  M   R   +V  +G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             ++ + +  +++  GSLD++      +K   +  +   KI + V + L YL+     R+
Sbjct: 73  LNENNICMCMEFMDCGSLDRIY-----KKGGPIPVEILGKIAVAVVEGLTYLYNV--HRI 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
           +HRD+KPSN+L+++    KL DFG++      IN      VGT  Y++PE  + GK T  
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGEL---INSIADTFVGTSTYMSPERIQGGKYTVK 182

Query: 542 TDVFGFGTLMLEVACGRRPIE--PQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD-P 598
           +DV+  G  ++E+A G+ P          +   +  +  L    QI +   P L   D P
Sbjct: 183 SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ---QIVQEPPPRLPSSDFP 239

Query: 599 QEAELVLTLGLLCCDPHPDFRPS 621
           ++    +   LL     P  RP+
Sbjct: 240 EDLRDFVDACLL---KDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 80.6 bits (199), Expect = 1e-16
 Identities = 61/217 (28%), Positives = 98/217 (45%), Gaps = 25/217 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G GGFG+V    + +TG   A K++       R+G +  + E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR----YKILIGVAQ---ALLY 472
               +D+L LV   +  G L          K  I N  +      + +   AQ    L +
Sbjct: 61  AFETKDDLCLVMTLMNGGDL----------KYHIYNVGEPGFPEARAIFYAAQIICGLEH 110

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH+    R+V+RD+KP NVL+D   N ++ D GL  A +     +     GT GY+APE+
Sbjct: 111 LHQR---RIVYRDLKPENVLLDDHGNVRISDLGL--AVELKGGKKIKGRAGTPGYMAPEV 165

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            +      S D F  G  + E+  GR P   ++  +E
Sbjct: 166 LQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 59/208 (28%), Positives = 106/208 (50%), Gaps = 11/208 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F +   +G+G  G V + +   +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  + IL      KI I V + L YL E
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG-----KISIAVLRGLTYLRE 117

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 118 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 172

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEP 563
              T  +D++  G  ++E+A GR PI P
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPIPP 200

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 81.6 bits (201), Expect = 1e-16
 Identities = 56/202 (27%), Positives = 105/202 (51%), Gaps = 11/202 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G+G  G V +     +GL +A K +    +  ++ + + E+  +       +V  +G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
               E+ +  +++  GSLD++L +  +  ++IL      K+ I V + L YL E+   ++
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREK--HQI 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
           +HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  +    +  
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTHYSVQ 182

Query: 542 TDVFGFGTLMLEVACGRRPIEP 563
           +D++  G  ++E+A GR PI P
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 68/279 (24%), Positives = 126/279 (45%), Gaps = 36/279 (12%)

Query: 363 VGSGGFGKVYRGVIPSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +G G F K+++G+    G        EV +K +  + R   + F    + M +L H++LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G C   DE ++V +YV  GSLD  L    ++ K ++N   + ++   +A AL +L  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYL----KKNKNLINISWKLEVAKQLAWALHFLE- 117

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH---IVGTLGYLAPEL 532
             D+ + H +V   NVL+  + + K G+    +  D  I+        ++  + ++ PE 
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACG-RRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
               +  + + D + FGT + E+  G  +P+    +  +L   +   +L +         
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPA--------- 226

Query: 591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                  P+  EL   +   C D  PDFRPS R +++ L
Sbjct: 227 -------PKWTELANLIN-QCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V      STG +VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L       D      +N +Q   + + V +AL +LH    Q V+
Sbjct: 87  VGDELWVVMEFLEGGAL------TDIVTHTRMNEEQIATVCLAVLKALSFLHA---QGVI 137

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+ +D   KL DFG        + P+   +VGT  ++APE+       T  
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPEVISRLPYGTEV 196

Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAM 568
           D++  G +++E+  G  P   EP   AM
Sbjct: 197 DIWSLGIMVIEMVDGEPPYFNEPPLQAM 224

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 80.5 bits (199), Expect = 2e-16
 Identities = 65/216 (30%), Positives = 100/216 (46%), Gaps = 29/216 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G FG+V++     T   VA+K+V   + +      A  EI  +  L+H N+V L   
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 421 CRK--------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           CR         +    LV+++  +  L  LL      K       +  K++  +   L Y
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLL----SNKNVKFTLSEIKKVMKMLLNGLYY 134

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGTLGYLA 529
           +H     +++HRD+K +N+LI  D   KL DFGLARA+  + N +    T+ V TL Y  
Sbjct: 135 IHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 530 PEL----TRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           PEL       G      D++G G +M E+   R PI
Sbjct: 192 PELLLGERDYGPP---IDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 15/210 (7%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLE-----VAIKRVAHNSRQGMK-EFVAEITSMGRL 409
             +E   +G G FG+V+         E     V +K +     + ++ EF  E+    +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN----DQQKKKILNWDQRYKILIG 465
            H+N+V+L G CR+ +   ++ +Y   G L + L       ++ K   L+  Q+  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGT 524
           +A  + +L    + R VHRD+   N L+ +    K+    L++  Y+         ++  
Sbjct: 126 IALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           L +LAPE  +    +T +DV+ FG LM EV
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 66/222 (29%), Positives = 109/222 (49%), Gaps = 33/222 (14%)

Query: 345 FRYSELYSATKGFREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHNS-RQGMKEF 399
            + +EL       R+  L+GSG FG V++G+ IP   S  + VAIK +   S RQ  +E 
Sbjct: 4   LKETEL-------RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEI 56

Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK------KI 453
              + +MG L H  +V+L G C     L LV    P GSL     D+ +Q +      ++
Sbjct: 57  TDHMLAMGSLDHAYIVRLLGIC-PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRL 111

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDH 512
           LNW       + +A+ + YL E    R+VHR++   N+L+ +D   ++ DFG+A   Y  
Sbjct: 112 LNW------CVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162

Query: 513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           +     +     + ++A E    G+ T  +DV+ +G  + E+
Sbjct: 163 DKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEM 204

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 28/219 (12%)

Query: 363 VGSGGFGKVY----RGVIP-STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV+      ++P    + VA+K +   S    ++F  E   +  L+H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 418 HGWCRKQDELLLVYDYVPNGSLD----------KLLFDNDQQKKKILNWDQRYKILIGVA 467
           +G C +   LL+V++Y+ +G L+          K+L   +      L   Q   I   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---- 523
             ++YL        VHRD+   N L+   L  K+GDFG++R    +I     + VG    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTM 185

Query: 524 -TLGYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
             + ++ PE     K TT +D++ FG ++ E+   G++P
Sbjct: 186 LPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 27/218 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVA---EITSMGRLRH 411
           +R   L+G G FG+VY      TG E+A+K+V  +  S++  KE  A   EI  +  LRH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 412 RNLVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKK---ILNWDQRY--KILI 464
             +VQ +G  R  +E  L +  +Y+P GS+       DQ K       N  +RY  +IL 
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSI------KDQLKAYGALTENVTRRYTRQILQ 117

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIV 522
           GV+    YLH      +VHRD+K +N+L D+  N KLGDFG ++         T    + 
Sbjct: 118 GVS----YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           GT  +++PE+          DV+     ++E+   + P
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 14/210 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +  V++G    T   VA+K +     +G     + E++ +  L+H N+V LH   
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI-LIGVAQALLYLHEECDQR 480
             +  L LV++Y+ +    K   DN      + N     KI +  + + L Y H+   ++
Sbjct: 73  HTERCLTLVFEYLDSDL--KQYLDNCGNLMSMHN----VKIFMFQLLRGLSYCHK---RK 123

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           ++HRD+KP N+LI+     KL DFGLARA        +  +V TL Y  P+ L  + + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182

Query: 540 TSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
           T  D++G G ++ E+A G RP+ P  T  E
Sbjct: 183 TPIDMWGVGCILYEMATG-RPMFPGSTVKE 211

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 53/195 (27%), Positives = 100/195 (51%), Gaps = 14/195 (7%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   +   ++ F+ E   M  L+H  LV+L+    
Sbjct: 14  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALLYLHEECDQ 479
           K++ + ++ +Y+  GSL   L  ++  K    K++++  +      +A+ + Y+     +
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---K 122

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD++ +NVL+   L  K+ DFGLAR  + N           + + APE    G  T
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 540 TSTDVFGFGTLMLEV 554
             +DV+ FG L+ E+
Sbjct: 183 IKSDVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 21/210 (10%)

Query: 363 VGSGGFGKVYRGV-IPSTGLEVAIKRV-AHNSRQGMK----EFVAEITSMGRLRHRNLVQ 416
           +G G +GKV++   + + G  VA+KRV      +GM       VA +  +    H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 417 LHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
           L   C      ++ +L LV+++V       L    +         D  +++L    + L 
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL----RGLD 124

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y  +     T +V TL Y APE
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 179

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +       T  D++  G +  E+   R+P+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF-RRKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 17/213 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVA---EITSMGRLRH 411
           +R   L+G G FG+VY      TG E+A+K+V  +  S +  KE  A   EI  +  L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 412 RNLVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
             +VQ +G  R   E  L +  +++P GS+   L       + +     R +IL GV   
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR-QILEGV--- 119

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTLGY 527
             YLH      +VHRD+K +N+L D+  N KLGDFG ++         T    + GT  +
Sbjct: 120 -SYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYW 175

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           ++PE+          D++  G  ++E+   + P
Sbjct: 176 MSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 78.2 bits (192), Expect = 6e-16
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 19/214 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVA---EITSMGRLRH 411
           +R   L+G G FG+VY      TG E+A K+V  +  S +  KE  A   EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 412 RNLVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKK-KILNWDQRYKILIGVAQ 468
             +VQ +G  R + E  L +  +Y+P GS+       DQ K    L      K    + +
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSV------KDQLKAYGALTESVTRKYTRQILE 117

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTLG 526
            + YLH      +VHRD+K +N+L D+  N KLGDFG ++         T    + GT  
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +++PE+          DV+  G  ++E+   + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 67/273 (24%), Positives = 121/273 (44%), Gaps = 28/273 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +    +  Q   +L  + + L YLH 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHS 119

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+    + KL DFG+A +  D  I   T   VGT  ++APE+ +
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G  P         L L+         G+ ++     +D
Sbjct: 175 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFID 234

Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
                           C +  P FRP+ + +++
Sbjct: 235 ---------------ACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 78.7 bits (194), Expect = 7e-16
 Identities = 69/221 (31%), Positives = 107/221 (48%), Gaps = 36/221 (16%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLRHRNLVQLH 418
             +G G +G+VY+     TG  VA+K+V   N ++G     + EI  + +L HRN+V L 
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 419 GWCR-KQDEL---------LLVYDYVPN---GSLDKLLFD-NDQQKKKILNWDQRYKILI 464
                KQD L          LV++Y+ +   G L+  L   ++   K  +      ++L 
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMK-----QLLE 127

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
           G+     Y H    +  +HRD+K SN+L++     KL DFGLAR Y+   +   T+ V T
Sbjct: 128 GLN----YCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVIT 180

Query: 525 LGYLAPEL----TRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           L Y  PEL     R G A    DV+  G ++ E+   ++PI
Sbjct: 181 LWYRPPELLLGEERYGPA---IDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 78.2 bits (193), Expect = 8e-16
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 30/217 (13%)

Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRH-RNLVQ 416
           +   +G G FG V + +   +G  +A+KR+ +    +  K  + ++  + R      +V+
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 417 LHG--------W-CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
            +G        W C    EL+ +       SLDK      +  K ++  +   KI +   
Sbjct: 68  FYGALFREGDCWICM---ELMDI-------SLDKFYKYVYEVLKSVIPEEILGKIAVATV 117

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           +AL YL EE   +++HRDVKPSN+L+D + N KL DFG++     +I    T   G   Y
Sbjct: 118 KALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI--AKTRDAGCRPY 173

Query: 528 LAPEL----TRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +APE      R G    S DV+  G  + EVA G+ P
Sbjct: 174 MAPERIDPSARDGYDVRS-DVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 23/201 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G FGK         G +  IK +  +  S +  +E   E+  +  ++H N+VQ    
Sbjct: 8   IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67

Query: 421 CRKQDELLLVYDYVPNGSLDK-------LLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
             +   L +V DY   G L K       +LF  DQ    IL+W       + +  AL ++
Sbjct: 68  FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ----ILDW------FVQICLALKHV 117

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H   D++++HRD+K  N+ +  D   KLGDFG+AR  +  +    T I GT  YL+PE+ 
Sbjct: 118 H---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEIC 173

Query: 534 RTGKATTSTDVFGFGTLMLEV 554
                   +D++  G ++ E+
Sbjct: 174 ENRPYNNKSDIWALGCVLYEM 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 77.7 bits (191), Expect = 9e-16
 Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 21/210 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLE----VAIKRVA-HNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G   FGK+Y+G +   G++    VAIK +   N+ Q   EF  E + M  L H N+V L
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLF------------DNDQQKKKILNWDQRYKILIG 465
            G   ++  + ++++Y+  G L + L             D D   K  L+      I I 
Sbjct: 73  LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQ 132

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGT 524
           +A  + YL        VH+D+   N+LI   L+ K+ D GL+R  Y  +        +  
Sbjct: 133 IAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLP 189

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + ++ PE    GK ++ +D++ FG ++ E+
Sbjct: 190 IRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 78.6 bits (194), Expect = 9e-16
 Identities = 66/240 (27%), Positives = 103/240 (42%), Gaps = 46/240 (19%)

Query: 352 SATKGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--------SRQGMKE---- 398
           S ++ + +K   +G G +GKV +     TG  VAIK+V            RQ +      
Sbjct: 5   SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64

Query: 399 FVA--EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN----DQQKKK 452
           F    E+  M  ++H N++ L     + D + LV D +    L K++       + Q K 
Sbjct: 65  FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKC 123

Query: 453 ILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-- 510
           IL      +IL G+      LH+      +HRD+ P+N+ I++    K+ DFGLAR Y  
Sbjct: 124 IL-----LQILNGLNV----LHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGY 171

Query: 511 -------DHNINPQT----THIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGR 558
                    +   Q     T  V TL Y APEL     K   + D++  G +  E+  G+
Sbjct: 172 PPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 15/205 (7%)

Query: 363 VGSGGFGK--VYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           +G G FG+  +YR         V  K V     S +  ++ + EI  +  L+H N++  +
Sbjct: 8   LGKGAFGEATLYRRT--EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 419 GWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
                 + LL+  +Y   G+L DK++    +QK ++   +     L  +  A+ Y+H+  
Sbjct: 66  NHFMDDNTLLIEMEYANGGTLYDKIV----RQKGQLFEEEMVLWYLFQIVSAVSYIHKA- 120

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
              ++HRD+K  N+ +      KLGDFG+++      +   T +VGT  Y++PEL +  K
Sbjct: 121 --GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGVK 177

Query: 538 ATTSTDVFGFGTLMLEVACGRRPIE 562
               +D++  G ++ E+   +R  +
Sbjct: 178 YNFKSDIWALGCVLYELLTLKRTFD 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 58/206 (28%), Positives = 103/206 (50%), Gaps = 17/206 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     TG+  A K +   S + +++++ EI  +    H N+V+L     
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ L ++ ++   G++D ++     + ++ L   Q   +     +AL YLHE    +++
Sbjct: 73  YENNLWILIEFCAGGAVDAVML----ELERPLTEPQIRVVCKQTLEALNYLHE---NKII 125

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--LTRTGKATT 540
           HRD+K  N+L   D + KL DFG++      I  + + I GT  ++APE  +  T K   
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 184

Query: 541 ---STDVFGFGTLMLEVACGRRPIEP 563
                DV+  G  ++E+A     IEP
Sbjct: 185 YDYKADVWSLGITLIEMA----QIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 63/218 (28%), Positives = 106/218 (48%), Gaps = 23/218 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           FR+  ++G GGFG+V    + +TG   A KR+       R+G    + E   + ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ---QKKKILNWDQRYKILIGVAQAL 470
           +V L      +D L LV   +  G L   +++      ++++ L +    +IL G    L
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA--EILCG----L 115

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLGY 527
             LH E     V+RD+KP N+L+D   + ++ D GLA        P+   I   VGT+GY
Sbjct: 116 EDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKI-----PEGESIRGRVGTVGY 167

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
           +APE+    + T S D +G G L+ E+  G+ P   ++
Sbjct: 168 MAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 78.3 bits (193), Expect = 1e-15
 Identities = 71/218 (32%), Positives = 98/218 (44%), Gaps = 18/218 (8%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN- 413
           K F  K+LVG G FG+V      +TG   A+K V   S    +E V+       +   + 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMK-VMKKSVLLAQETVSFFEEERDILSISN 59

Query: 414 ---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              + QL    + +D L LV +Y P G L  LL   + Q  +  +  Q Y     +A+ +
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDE--DMAQFY-----LAELV 112

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           L +H       VHRD+KP NVLID   + KL DFG A     N    +   VGT  Y+AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172

Query: 531 ELTRT----GKAT--TSTDVFGFGTLMLEVACGRRPIE 562
           E+  T    GK T     D +  G +  E+  GR P  
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 66/221 (29%), Positives = 108/221 (48%), Gaps = 39/221 (17%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G V       T  +VAIK++  A ++R   K  + EI  +  L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 421 ----CRKQ-DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR----------YKILIG 465
                R+  +++ +VY+          L D D  +  I+   Q           Y++L G
Sbjct: 73  MPPPHREAFNDVYIVYE----------LMDTDLHQ--IIRSSQTLSDDHCQYFLYQLLRG 120

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
               L Y+H      V+HRD+KPSN+L++A+ + K+ DFGLAR      +  T ++V T 
Sbjct: 121 ----LKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TR 172

Query: 526 GYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
            Y APE L    + TT+ DV+  G +  E+  GR+P+ P +
Sbjct: 173 WYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGK 212

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 17/201 (8%)

Query: 366 GGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHR-NLVQLHGWC 421
           G FG VY     STG   AIK +  +   ++  +    AE   M        + +L+   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
           + +D L LV +Y+  G    L+     +    L  D   + +  V   +  LH    + +
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLI-----KTLGGLPEDWAKQYIAEVVLGVEDLH---QRGI 118

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
           +HRD+KP N+LID   + KL DFGL+R      N +    VGT  YLAPE          
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLSRNGL--ENKK---FVGTPDYLAPETILGVGDDKM 173

Query: 542 TDVFGFGTLMLEVACGRRPIE 562
           +D +  G ++ E   G  P  
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 78.1 bits (193), Expect = 1e-15
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 40/224 (17%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSG +G V   +   +G +VAIK++ H        K  + E+  +   +H N++ +   
Sbjct: 13  IGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI 72

Query: 421 CRKQDELL----LVYDYVPNGSLDKLLFDNDQQKKKILNWDQR----------YKILIGV 466
            R          +V D          L ++D     I++ DQ           Y++L G 
Sbjct: 73  LRPPGADFKDVYVVMD----------LMESDLHH--IIHSDQPLTEEHIRYFLYQLLRG- 119

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VG 523
              L Y+H      V+HRD+KPSN+L++ D   ++GDFG+AR    +       +   V 
Sbjct: 120 ---LKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173

Query: 524 TLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
           T  Y APEL  +  + TT+ D++  G +  E+  GRR + P + 
Sbjct: 174 TRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM-LGRRQLFPGKN 216

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 77.9 bits (192), Expect = 2e-15
 Identities = 62/209 (29%), Positives = 99/209 (47%), Gaps = 13/209 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSM-GRLRHRNLVQLH 418
           +G G FGKV      + G   A+K +   +   ++  K  +AE   +   ++H  LV LH
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              +  D+L  V DYV  G L    F + Q+++       R+     +A AL YLH    
Sbjct: 63  YSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARF-YAAEIASALGYLHS--- 114

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
             +++RD+KP N+L+D+  +  L DFGL +      +  T+   GT  YLAPE+ R    
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPY 173

Query: 539 TTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
             + D +  G ++ E+  G  P   + TA
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLPPFYSRDTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 77.5 bits (190), Expect = 2e-15
 Identities = 64/235 (27%), Positives = 111/235 (47%), Gaps = 14/235 (5%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K +     +G G  G V+  +  +TG EVAIK++    +   +  + EI  M  L++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V         DEL +V +Y+  GSL  ++ +    + +I        +     QAL +LH
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIA------AVCRECLQALEFLH 132

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                +V+HRD+K  NVL+  D + KL DFG         + ++T +VGT  ++APE+  
Sbjct: 133 A---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVT 188

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPI---EPQRTAMELVLVDWVRELHSQGQIT 586
                   D++  G + +E+  G  P     P R A+ L+  +   EL +  +++
Sbjct: 189 RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLS 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 80.3 bits (198), Expect = 2e-15
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 21/202 (10%)

Query: 379 TGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHGWCRKQDELLL-VYDYV 434
           TG EVAIK +  ++ +   +   F  E     RL H N+V L         LL  V++YV
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61

Query: 435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID 494
           P  +L ++L          L   +  ++++ V  AL   H   +Q +VHRD+KP N+++ 
Sbjct: 62  PGRTLREVL-----AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVS 113

Query: 495 A-DLNP--KLGDFGL------ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVF 545
              + P  K+ DFG+       R  D     +TT ++GT  Y APE  R    T ++D++
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173

Query: 546 GFGTLMLEVACGRRPIEPQRTA 567
            +G + LE   G+R ++    A
Sbjct: 174 AWGLIFLECLTGQRVVQGASVA 195

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 63/222 (28%), Positives = 109/222 (49%), Gaps = 28/222 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLRHRNLV 415
           ++  + +G G +G V       TG++VAIK+++    Q   +  + EI  + R +H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 416 QLHGWCRKQD-----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ----RYKILIGV 466
            +    R        ++ +V + +    L KL+      K + L+ D      Y+IL   
Sbjct: 67  GILDIIRPPSFESFNDVYIVQELMET-DLYKLI------KTQHLSNDHIQYFLYQIL--- 116

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD--HNINPQTTHIVGT 524
            + L Y+H      V+HRD+KPSN+L++ + + K+ DFGLAR  D  H+     T  V T
Sbjct: 117 -RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172

Query: 525 LGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQR 565
             Y APE+    K  T + D++  G ++ E+    RP+ P +
Sbjct: 173 RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPLFPGK 213

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 72/274 (26%), Positives = 132/274 (48%), Gaps = 32/274 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+     +   +VA+K +   S   ++ F+AE   M  L+H  LV+LH    
Sbjct: 14  LGAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 423 KQDELLLVYDYVPNGSLDKLLFD---NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           K+  + ++ +++  GSL   L     + Q   K++++  +      +A+ + ++ +   +
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ---R 121

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD++ +N+L+ A L  K+ DFGLAR  + N           + + APE    G  T
Sbjct: 122 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 181

Query: 540 TSTDVFGFGTLMLE-VACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
             +DV+ FG L++E V  GR P  P  +  E+     +R L    ++ R  +       P
Sbjct: 182 IKSDVWSFGILLMEIVTYGRIPY-PGMSNPEV-----IRALERGYRMPRPENC------P 229

Query: 599 QEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
           +E   ++   + C    P+ RP T   +Q +L D
Sbjct: 230 EELYNIM---MRCWKNRPEERP-TFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 2e-15
 Identities = 63/227 (27%), Positives = 107/227 (47%), Gaps = 14/227 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAIK++    +   +  + EI  M   ++ N+V       
Sbjct: 27  IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL       D   +  ++  Q   +     QAL +LH     +V+
Sbjct: 87  VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALDFLHS---NQVI 137

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  N+L+  D + KL DFG         + ++T +VGT  ++APE+          
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 196

Query: 543 DVFGFGTLMLEVACGRRPI---EPQRTAMELVLVDWVRELHSQGQIT 586
           D++  G + +E+  G  P     P R A+ L+  +   EL +  +++
Sbjct: 197 DIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIATNGTPELQNPERLS 242

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 19/208 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAE--ITSMGRLRHRNLVQ 416
           ++G G FGKV    +  T    A+K +          ++  + E  + ++   +H  L Q
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH   + +D L  V +YV  G L   +F   +  +      + Y   I     L +LHE 
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAEI--VLGLQFLHE- 114

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYLAPELTR 534
             + +++RD+K  NVL+D++ + K+ DFG+ +     I     T+   GT  Y+APE+  
Sbjct: 115 --RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPDYIAPEILS 169

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIE 562
                 + D +  G L+ E+  G+ P E
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 10/199 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T  +VAIK +   +    + F+ E   M +LRH  LV L+    
Sbjct: 14  LGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYA-VV 70

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +++  GSL   L + D    K L   Q   +   +A  + Y+        +
Sbjct: 71  SEEPIYIVTEFMGKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYI 124

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 543 DVFGFGTLMLE-VACGRRP 560
           DV+ FG L+ E V  GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 63/230 (27%), Positives = 107/230 (46%), Gaps = 20/230 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL       D   +  ++  Q   +     QAL +LH     +V+
Sbjct: 88  VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVI 138

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGTLGYLAPELTRTGKAT 539
           HRD+K  N+L+  D + KL DFG        I P+    + +VGT  ++APE+       
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCA----QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194

Query: 540 TSTDVFGFGTLMLEVACGRRPI---EPQRTAMELVLVDWVRELHSQGQIT 586
              D++  G + +E+  G  P     P R A+ L+  +   EL +  +++
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPELQNPEKLS 243

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 4e-15
 Identities = 76/281 (27%), Positives = 118/281 (41%), Gaps = 30/281 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVA---IKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           +G+G FGKV  G     G+  A   +K + A  +      F+ E+     L H N++Q  
Sbjct: 3   IGNGWFGKVLLGEA-HRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C +    LLV ++ P G L   L  N     ++   D   ++   VA  LL+LH+   
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ--- 118

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLA--RAYDHNINPQTTHIVGTLGYLAPELT--- 533
              +H D+   N  + ADL+ K+GD+GLA  +  +     +  H V  L +LAPEL    
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEIR 177

Query: 534 ----RTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
                    T  ++++  G  M E+     +P  P  +  + VL   VRE     Q  + 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQ-VLKQVVRE-----QDIKL 230

Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
             P LD         V+      C   P+ RP+   V + L
Sbjct: 231 PKPQLDLKYSDRWYEVMQF----CWLDPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 64/222 (28%), Positives = 101/222 (45%), Gaps = 32/222 (14%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEI-TSMGRLRHRNLVQLHGWC 421
           G G +G V +     TG  +A+KR+    + Q  K  + ++  SM  +     V  +G  
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++ ++ +  + V + SLDK  +     K   +  D   KI + + +AL YLH +    V
Sbjct: 70  FREGDVWICME-VMDTSLDKF-YKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SV 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFG--------LARAYDHNINPQTTHIVGTLGYLAPELT 533
           +HRDVKPSNVLI+ +   KL DFG        +A+  D    P          Y+APE  
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------YMAPE-- 173

Query: 534 RTGKATTS------TDVFGFGTLMLEVACGRRPIEPQRTAME 569
           R             +DV+  G  M+E+A GR P +  +T  +
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 69/265 (26%), Positives = 117/265 (44%), Gaps = 32/265 (12%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE----FVAEITSMGRLRHRNLVQL 417
           +VG G FG V+     +    V IK++     Q  K+       E   +  L H N+++ 
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQI--PVEQMTKDERLAAQNECQVLKLLSHPNIIEY 64

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +    +   L++V +Y P G+L + +    ++   +L+ D    IL    Q LL LH   
Sbjct: 65  YENFLEDKALMIVMEYAPGGTLAEYI---QKRCNSLLDEDT---ILHFFVQILLALHHVH 118

Query: 478 DQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            + ++HRD+K  N+L+D      K+GDFG+++         T  +VGT  Y++PEL    
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPELCEGK 176

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA-IDPTLDY 595
                +D++  G ++ E+A  +R  E       LVL           +I      P  D 
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLP-ALVL-----------KIMSGTFAPISDR 224

Query: 596 FDPQEAELVLTLGLLCCDPHPDFRP 620
           + P   +L+L++  L     P  RP
Sbjct: 225 YSPDLRQLILSMLNL----DPSKRP 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 20/217 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLV 415
           F    +VG+G +G+VY+G    TG   AIK V   +    +E   EI  + +   HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 416 QLHGWCRKQ------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
             +G   K+      D+L LV ++   GS+  L+      K   L  D    I   + + 
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV---KNTKGNALKEDWIAYICREILRG 133

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L +LH     +V+HRD+K  NVL+  +   KL DFG++   D  +  + T I GT  ++A
Sbjct: 134 LAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 189

Query: 530 PELTRTGKATTST-----DVFGFGTLMLEVACGRRPI 561
           PE+    +   +T     D++  G   +E+A G  P+
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 5e-15
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG---MKEFVAEITSMGRLRH 411
           K F +   +G G FG VY          VAIK+++++ +Q     ++ + E+  + +LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N +Q  G   ++    LV +Y    + D L     +  KK L   +   +  G  Q L 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLA 129

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           YLH      ++HRDVK  N+L+      KLGDFG A     +I       VGT  ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPE 181

Query: 532 LTRT---GKATTSTDVFGFGTLMLEVACGRRPI 561
           +      G+     DV+  G   +E+A  + P+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 75.3 bits (185), Expect = 5e-15
 Identities = 55/201 (27%), Positives = 95/201 (47%), Gaps = 8/201 (3%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G GGFG+V    + +TG   A K++       R+G +  + E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             + + +L LV   +  G L   +++ D++           +     AQ +  L     +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGF----PEPRACFYTAQIISGLEHLHQR 116

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           R+++RD+KP NVL+D D N ++ D GLA       + +T    GT G++APEL +  +  
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELLQGEEYD 175

Query: 540 TSTDVFGFGTLMLEVACGRRP 560
            S D F  G  + E+   R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 75.4 bits (185), Expect = 7e-15
 Identities = 75/314 (23%), Positives = 132/314 (42%), Gaps = 68/314 (21%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLE----------------VAIKRV-AHNSRQGMKEF 399
            +EK  +G G FG+V+  +  + GL                 VA+K + A  ++    +F
Sbjct: 9   LKEK--LGEGQFGEVH--LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64

Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK-------K 452
           + EI  M RL++ N+++L G C   D L ++ +Y+ NG L++ L   + +          
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124

Query: 453 ILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD 511
            ++      + + +A  + YL        VHRD+   N L+      K+ DFG++R  Y 
Sbjct: 125 SVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV--ACGRRPIEPQRTAME 569
            +        V  + ++A E    GK TT++DV+ FG  + E+   C  +P         
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYS------- 234

Query: 570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF----------- 618
            +L D            + I+ T ++F  Q  ++ L+   LC  P P F           
Sbjct: 235 -LLSD-----------EQVIENTGEFFRNQGRQIYLSQTPLC--PSPVFKLMMRCWSRDI 280

Query: 619 --RPSTRRVVQFLL 630
             RP+  ++  FL 
Sbjct: 281 KDRPTFNKIHHFLR 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 63/231 (27%), Positives = 108/231 (46%), Gaps = 31/231 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           FR   ++G GGFG+V    + +TG   A K++       R+G    + E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      +D L LV   +  G L   +++          +D++        +A+ Y 
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP-----GFDEQ--------RAIFYA 108

Query: 474 HEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VG 523
            E C        +R+V+RD+KP N+L+D   + ++ D GLA        P+   +   VG
Sbjct: 109 AELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI-----PEGETVRGRVG 163

Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
           T+GY+APE+    K T S D +G G L+ E+  G+ P   ++  ++   VD
Sbjct: 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 75.1 bits (185), Expect = 9e-15
 Identities = 55/213 (25%), Positives = 98/213 (46%), Gaps = 24/213 (11%)

Query: 362 LVGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNL 414
            +G G FG+V +        P+    VA+K +  + + + + + V+E+  M  + +H+N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKI----LIG-- 465
           + L G C ++  L +V +Y  +G+L   L       +             +    L+   
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 466 --VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             VA+ + +L     ++ +HRD+   NVL+  D   K+ DFGLAR   H+I+       G
Sbjct: 139 YQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDI-HHIDYYRKTTNG 194

Query: 524 TLGY--LAPELTRTGKATTSTDVFGFGTLMLEV 554
            L    +APE       T  +DV+ FG L+ E+
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 227

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 75.4 bits (185), Expect = 1e-14
 Identities = 71/245 (28%), Positives = 112/245 (45%), Gaps = 15/245 (6%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHRNLVQL 417
           L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH  L  L
Sbjct: 2   LLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++ + D+       +  AL YLH E 
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSE- 114

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
            + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+     
Sbjct: 115 -KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDND 172

Query: 538 ATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRAIDPTLDY 595
              + D +G G +M E+ CGR P   Q      EL+L++ +R   +     +++   L  
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLK 232

Query: 596 FDPQE 600
            DP++
Sbjct: 233 KDPKQ 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 76/266 (28%), Positives = 111/266 (41%), Gaps = 46/266 (17%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKEFVAEITSMGRLR 410
           L+G G FGKV      +TG   A+K            VAH         + E   +   R
Sbjct: 2   LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLQNTR 53

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H  L  L    +  D L  V +Y   G L   L      ++++ + D+       +  AL
Sbjct: 54  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSAL 108

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH      VV+RD+K  N+++D D + K+ DFGL +    +         GT  YLAP
Sbjct: 109 GYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAP 164

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRA 588
           E+        + D +G G +M E+ CGR P   Q      EL+L++ +R         R 
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR-------FPRT 217

Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDP 614
           + P        EA+ +L  GLL  DP
Sbjct: 218 LSP--------EAKSLLA-GLLKKDP 234

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 58/204 (28%), Positives = 95/204 (46%), Gaps = 20/204 (9%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      T   VA+K+++++ +Q     ++ + E+  + +L+H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              K+    LV +Y    + D L     +  KK L   +   I  G  Q L YLH     
Sbjct: 89  CYLKEHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAITHGALQGLAYLHSHN-- 141

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT---G 536
            ++HRD+K  N+L+      KL DFG A     + +      VGT  ++APE+      G
Sbjct: 142 -MIHRDIKAGNILLTEPGQVKLADFGSA-----SKSSPANSFVGTPYWMAPEVILAMDEG 195

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
           +     DV+  G   +E+A  R+P
Sbjct: 196 QYDGKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 14/209 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +G VY+ +   TG+ +A+K +     +    + + E+  + +     +V  +G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             +  + +  +Y+  GSLDKL         + +  D   +I   V + L +L EE    +
Sbjct: 69  FIEGAVYMCMEYMDAGSLDKLY--AGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNI 124

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA--- 538
           +HRDVKP+NVL++ +   KL DFG++     ++    T+I G   Y+APE  ++G     
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL--AKTNI-GCQSYMAPERIKSGGPNQN 181

Query: 539 ---TTSTDVFGFGTLMLEVACGRRPIEPQ 564
              T  +DV+  G  +LE+A GR P  P+
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPE 210

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 14/204 (6%)

Query: 363 VGSGGFGKVYRGV--IPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +GSG FG V +GV  +    ++VAIK + + + + ++ E + E   M +L +  +V++ G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C + + L+LV +    G L+K L      KK  +      +++  V+  + YL     +
Sbjct: 63  VC-EAEALMLVMEMASGGPLNKFL----SGKKDEITVSNVVELMHQVSMGMKYLEG---K 114

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELTRTGK 537
             VHRD+   NVL+      K+ DFGL++A   + +       G   L + APE     K
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 538 ATTSTDVFGFGTLMLEV-ACGRRP 560
            ++ +DV+ +G  M E  + G++P
Sbjct: 175 FSSRSDVWSYGITMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 75.0 bits (184), Expect = 1e-14
 Identities = 75/260 (28%), Positives = 114/260 (43%), Gaps = 34/260 (13%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
           L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L 
Sbjct: 2   LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              +  D L  V +Y   G L   L      ++++   ++       +  AL YLH    
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS--- 113

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTRTG 536
           + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  YLAPE+    
Sbjct: 114 RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDN 170

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRAIDPTLD 594
               + D +G G +M E+ CGR P   Q      EL+L++ +R         R + P   
Sbjct: 171 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR-------FPRTLSP--- 220

Query: 595 YFDPQEAELVLTLGLLCCDP 614
                EA+ +L  GLL  DP
Sbjct: 221 -----EAKSLLA-GLLKKDP 234

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 60/201 (29%), Positives = 103/201 (51%), Gaps = 16/201 (7%)

Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y     +TG +VA+K +   S    + +   EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 418 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C +   + + L+ +++P+GSL + L  N   K KI N  Q+ K  + + + + YL  
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYLPRN---KNKI-NLKQQLKYAVQICKGMDYLGS 127

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH--IVGTLGYLAPELT 533
              ++ VHRD+   NVL++++   K+GDFGL +A + +    T    +   + + APE  
Sbjct: 128 ---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 534 RTGKATTSTDVFGFGTLMLEV 554
              K   ++DV+ FG  + E+
Sbjct: 185 IQSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 74.6 bits (183), Expect = 2e-14
 Identities = 59/214 (27%), Positives = 106/214 (49%), Gaps = 26/214 (12%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V R          P   + VA+K +  N + + + + ++E+  M  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C ++  L ++ +Y   G+L + L           FD  +  ++ L++      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              VA+ + YL     +R +HRD+   NVL+  D   K+ DFGLAR   H+I+   +T++
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTSN 195

Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 74.2 bits (182), Expect = 2e-14
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 20/209 (9%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLR---HRNLVQL 417
           +G G +G VY+   P +G  VA+K V    +  G+    V E+  + RL    H N+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 418 HGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
              C      ++ ++ LV+++V +  L   L   D+     L  +    ++    + L +
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH  C   +VHRD+KP N+L+ +    KL DFGLAR Y   +    T +V TL Y APE+
Sbjct: 124 LHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEV 178

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPI 561
                  T  D++  G +  E+   R+P+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 74.4 bits (183), Expect = 2e-14
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 21/204 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHG 419
           VG GG+G+V+      TG  VA+KR+  +    + E    + E   +   +   LV+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             +  + L L  +YVP G    LL +       +L+ D     +  + +A+  LHE    
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHE---L 120

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARA---YDHNINPQTTHIVGTLGYLAPELTRTG 536
             +HRD+KP N LIDA  + KL DFGL++    Y ++       +VG+  Y+APE+ R  
Sbjct: 121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS-------VVGSPDYMAPEVLRGK 173

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
               + D +  G ++ E  CG  P
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPP 197

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 20/217 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLV 415
           F    LVG+G +G+VY+G    TG   AIK V   +    +E   EI  + +   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 416 QLHGWCRKQ------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
             +G   K+      D+L LV ++   GS+  L+      K   L  +    I   + + 
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRG 123

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L +LH+    +V+HRD+K  NVL+  +   KL DFG++   D  +  + T I GT  ++A
Sbjct: 124 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMA 179

Query: 530 PELTRTGKATTST-----DVFGFGTLMLEVACGRRPI 561
           PE+    +   +T     D++  G   +E+A G  P+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 16/205 (7%)

Query: 363 VGSGGFGKVYRGVIPSTGLE--VAIKRVAH-NSRQGMK-EFVAEITSMGRLRHRNLVQLH 418
           +GSG FG V +G+      E  VA+K + + N+   +K E + E   M +L +  +V++ 
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C + +  +LV +    G L+K L  N    +K +      +++  V+  + YL E   
Sbjct: 63  GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT-----ELVHQVSMGMKYLEE--- 113

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPELTRTG 536
              VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE     
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 537 KATTSTDVFGFGTLMLEV-ACGRRP 560
           K ++ +DV+ FG LM E  + G++P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 73.9 bits (181), Expect = 3e-14
 Identities = 68/227 (29%), Positives = 114/227 (50%), Gaps = 33/227 (14%)

Query: 362 LVGSGGFGKVYRGV-IP---STGLEVAIKRVAHNSRQGMK---EFVAEITSMGRLRHRNL 414
           ++GSG FG VY+G+ +P   +  + VAIK +  N   G K   EF+ E   M  + H +L
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPHL 71

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLY 472
           V+L G C     + LV   +P+G L   + ++      + +LNW       + +A+ ++Y
Sbjct: 72  VRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMY 124

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-----DHNINPQTTHIVGTLGY 527
           L E   +R+VHRD+   NVL+ +  + K+ DFGLAR       ++N +     I     +
Sbjct: 125 LEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI----KW 177

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIE--PQRTAMELV 571
           +A E     K T  +DV+ +G  + E+   G +P +  P R   +L+
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.1 bits (182), Expect = 3e-14
 Identities = 63/222 (28%), Positives = 112/222 (50%), Gaps = 24/222 (10%)

Query: 362 LVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-----LRHRNL 414
           ++G G FGKV+  R +      ++   +V   +   +++ V   T M R     + H  +
Sbjct: 3   VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR--TKMERDILAEVNHPFI 60

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI-LIGVAQALLYL 473
           V+LH   + + +L L+ D++  G L   L       K+++  ++  K  L  +A AL +L
Sbjct: 61  VKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHL 114

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAPEL 532
           H      +++RD+KP N+L+D + + KL DFGL++ + DH    +     GT+ Y+APE+
Sbjct: 115 H---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPEV 169

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVL 572
                 T S D + FG LM E+  G  P + +  +  M ++L
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 41/280 (14%)

Query: 361 NLVGSGGFGKVYRG-VIPSTGLEV--AIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +I S G ++  A+K +      + +++F+ E   M    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 417 LHGWCRKQDEL-LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALL 471
           L G C   +   L+V  Y+ +G L    F   +     +      K LIG    VA+ + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL--RNFIRSETHNPTV------KDLIGFGLQVAKGME 112

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYL 528
           YL     ++ VHRD+   N ++D     K+ DFGLAR  YD        H    L   ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV--LVDWVRELHSQGQIT 586
           A E  +T K TT +DV+ FG L+ E+     P  P   + ++   L+   R L  +    
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPE---- 225

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
                    + P     V+   L C  P P+ RP+   +V
Sbjct: 226 ---------YCPDPLYEVM---LSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H  LV LH   + +  L  V ++V  G L   +F   +Q+K      + Y   I +A  L
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLA--L 109

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYL 528
            +LHE   + +++RD+K  NVL+DA+ + KL D+G+ +     I P   T+   GT  Y+
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYI 163

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           APE+ R      S D +  G LM E+  GR P +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 73.8 bits (181), Expect = 3e-14
 Identities = 78/271 (28%), Positives = 122/271 (45%), Gaps = 43/271 (15%)

Query: 362 LVGSGGFGKVY--RGVI-PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHRN--- 413
           ++G+G +GKV+  R V    TG   A+K V   +    K    E T   R  L H     
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 414 -LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALL 471
            LV LH   + + +L L+ DYV  G +   L+  D         +   +   G +  AL 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS------EDEVRFYSGEIILALE 119

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +LH+     +V+RD+K  N+L+D++ +  L DFGL++ +      +T    GT+ Y+APE
Sbjct: 120 HLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176

Query: 532 LTRT----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           + R     GKA    D +  G L+ E+  G  P   +             E ++Q +++R
Sbjct: 177 IIRGKGGHGKA---VDWWSLGILIFELLTGASPFTLE------------GERNTQSEVSR 221

Query: 588 AI---DPTLDYFDPQEAELVLTLGLLCCDPH 615
            I   DP    F   EA+ +L   LL  DP 
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLH-KLLRKDPK 251

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 73.8 bits (181), Expect = 4e-14
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--------- 413
           +G G FG+VY+     T    A+K ++       KE VA+      +  RN         
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 414 ---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQA 469
              +V L    +   +L LV DY+  G L    F + Q++ +    + R K  I  +  A
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFS--EDRAKFYIAELVLA 108

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L +LH+     +V+RD+KP N+L+DA  +  L DFGL++A +   N  T    GT  YLA
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLA 164

Query: 530 PELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
           PE+    K  T   D +  G L+ E+ CG  P   + T
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT 202

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 61/224 (27%), Positives = 105/224 (46%), Gaps = 23/224 (10%)

Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVI--PSTGLE---VAIKRVAHNSRQGMKE-FVAE 402
           E+  +T  F E+  +G   FGKVY+G +   + G +   VAIK +   +   ++E F  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 403 ITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DNDQQKK 451
                RL+H N+V L G   K+  L +++ Y  +  L + L            D+D+  K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AY 510
             L       I+  +A  + +L       VVH+D+   NVL+   LN K+ D GL R  Y
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175

Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
             +      + +  + +++PE    GK +  +D++ +G ++ EV
Sbjct: 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 23/210 (10%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-------RQGMKEFVAEITSMGRLRHRNL 414
           ++G G FGKV    +  T    AIK +  +           M E    I ++   +H  L
Sbjct: 2   VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPFL 58

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
             LH   + +D L  V +YV  G L   +F   + +K      + Y     V  AL++LH
Sbjct: 59  TALHCCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAA--EVTLALMFLH 113

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYLAPEL 532
                 V++RD+K  N+L+DA+ + KL DFG+ +     I     TT   GT  Y+APE+
Sbjct: 114 R---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIAPEI 167

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
            +  +   S D +  G LM E+  G+ P E
Sbjct: 168 LQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 11/215 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEF-VAEITSMGRLRHRNL 414
           F    +VG G +G V +     T   VAIK+   +   + +KE  + E+  +  L+  N+
Sbjct: 3   FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L    R++ +L LV++YV    L+ L        +++ N     K+   + Q +  +H
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLELL--------EEMPNGVPPEKVRSYIYQLIKAIH 114

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 +VHRD+KP N+LI  +   KL DFG AR      N   T  V T  Y +PEL  
Sbjct: 115 WCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLL 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
                 + D++  G ++ E++ G +P+ P  + ++
Sbjct: 175 GAPYGKAVDMWSVGCILGELSDG-QPLFPGESEID 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 73.2 bits (179), Expect = 5e-14
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM---KEFVAEITSMGRLRH 411
           K F +   +G G FG VY      T   VAIK+++++ +Q     ++ + E+  + R++H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N ++  G   ++    LV +Y    + D L     +  KK L   +   I  G  Q L 
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAITHGALQGLA 139

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           YLH      ++HRD+K  N+L+      KL DFG A     +I       VGT  ++APE
Sbjct: 140 YLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSA-----SIASPANSFVGTPYWMAPE 191

Query: 532 LTRT---GKATTSTDVFGFGTLMLEVACGRRPI 561
           +      G+     DV+  G   +E+A  + P+
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 6e-14
 Identities = 62/221 (28%), Positives = 103/221 (46%), Gaps = 14/221 (6%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
           L+G G FGKV      ++G   A+K +      ++  +   + E   +   RH  L  L 
Sbjct: 2   LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              + +D L  V +YV  G L   L      ++++ + D+       +  AL YLH    
Sbjct: 62  YSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTRFYGAEIVSALDYLHS--- 113

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
            ++V+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+      
Sbjct: 114 GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAPEVLEDNDY 172

Query: 539 TTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
             + D +G G +M E+ CGR P   Q      EL+L++ ++
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIK 213

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 68/263 (25%), Positives = 105/263 (39%), Gaps = 64/263 (24%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV----AHNSRQGM-----KEFVAEITSMGRLRHR 412
           ++G G FG+V+      TG   A+K +         Q       ++ +A+  S       
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW----- 62

Query: 413 NLVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKIL--NWDQRYKILIGVAQ 468
            +V+L+     QDE  L LV +Y+P G L  LL      +K +      + Y     +A+
Sbjct: 63  -IVKLY--YSFQDEEHLYLVMEYMPGGDLMNLLI-----RKDVFPEETARFY-----IAE 109

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY------------DHNIN- 515
            +L L        +HRD+KP N+LIDAD + KL DFGL +               HN+  
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLF 169

Query: 516 -----------PQTTH----IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
                       Q        VGT  Y+APE+ R        D +  G ++ E+  G  P
Sbjct: 170 RDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Query: 561 I---EPQRTAMELVLVDWVRELH 580
                 Q T  +  +++W   L 
Sbjct: 230 FYSDTLQETYNK--IINWKESLR 250

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.8 bits (178), Expect = 7e-14
 Identities = 52/151 (34%), Positives = 78/151 (51%), Gaps = 13/151 (8%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV LH   +    L LV +YV  G L   +F   +Q+K      + Y   I +A  L +L
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIA--LNFL 112

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYLAPE 531
           HE   + +++RD+K  NVL+DAD + KL D+G+ +     + P   T+   GT  Y+APE
Sbjct: 113 HE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPE 166

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           + R  +   S D +  G LM E+  GR P +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 74/284 (26%), Positives = 118/284 (41%), Gaps = 47/284 (16%)

Query: 364 GSGGFGKVYRGV--------IPSTGLEVAIKR-VAHNSRQGMKEFVAEITSMGRLRHRNL 414
           G G F  +Y+GV        I   G EV++   V  +  +    F    + M +L H++L
Sbjct: 4   GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHL 63

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L+G C + DE ++V +YV  G LD  L     ++K  ++   +  +   +A AL YL 
Sbjct: 64  VKLYGVCVR-DENIMVEEYVKFGPLDVFL----HREKNNVSLHWKLDVAKQLASALHYLE 118

Query: 475 EECDQRVVHRDVKPSNVL-IDADLNP------KLGDFGLARAYDHNINPQTTHIVGTLGY 527
              D+++VH +V   N+L     LN       KL D G+               V  + +
Sbjct: 119 ---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER-----VERIPW 170

Query: 528 LAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI 585
           +APE  R G+A  T + D + FGT +LE+              E  L         +   
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLSTLSSSEKERFYQ 220

Query: 586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            +   P  D    + A L+      C    P  RPS R +++ L
Sbjct: 221 DQHRLPMPDC--AELANLINQ----CWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 72.2 bits (177), Expect = 7e-14
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           FR   ++G GGFG+V    + +TG   A K++       R+G    + E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      +D L LV   +  G L   +++          +D+  + +   A+    L
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNP-----GFDEE-RAVFYAAEITCGL 115

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLGYLAP 530
            +   +R+V+RD+KP N+L+D   + ++ D GLA        P+   I   VGT+GY+AP
Sbjct: 116 EDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEI-----PEGETIRGRVGTVGYMAP 170

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+ +  + T S D +G G L+ E+  G+ P
Sbjct: 171 EVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 72.7 bits (179), Expect = 8e-14
 Identities = 54/191 (28%), Positives = 86/191 (45%), Gaps = 33/191 (17%)

Query: 363 VGSGGFGKVYRGV--IPSTGLEVAIKRVAHNSRQGM---KEFVAEITSMGRLRHRNLVQL 417
           +G G +G+VY+        G E AIK+   +  Q     +    EI  +  L+H N+V L
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 418 HGWC--RKQDELLLVYDYVPNGSLDKLLFDNDQQK--------KKILNWDQRYKILIGVA 467
                      + L++DY  +     + F    ++        K +L     ++IL GV 
Sbjct: 68  VEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLL-----WQILNGVH 122

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLARAYDHNINPQTT--HI 521
               YLH      V+HRD+KP+N+L+  +       K+GD GLAR ++  + P      +
Sbjct: 123 ----YLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 522 VGTLGYLAPEL 532
           V T+ Y APEL
Sbjct: 176 VVTIWYRAPEL 186

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 8e-14
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 21/220 (9%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G +  VY+G+    G  VA+K ++  + +G+  F A  E + +  L+H N+V LH  
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHDI 71

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR---YKILIGVAQALLYLHEEC 477
              ++ L  V++Y+       ++    Q    +  ++ R   +++L G+A    Y+H   
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMI----QHPGGLHPYNVRLFMFQLLRGLA----YIHG-- 121

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIVGTLGYLAPE-LTRT 535
            Q ++HRD+KP N+LI      KL DFGLARA   +I  QT +  V TL Y  P+ L   
Sbjct: 122 -QHILHRDLKPQNLLISYLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW 575
              +++ D++G G + +E+  G+          E +   W
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.4 bits (177), Expect = 9e-14
 Identities = 56/214 (26%), Positives = 102/214 (47%), Gaps = 26/214 (12%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D  +   + + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              VA+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198

Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 72.1 bits (177), Expect = 9e-14
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 27/215 (12%)

Query: 357 FREKNLV-----GSGGFGKVYR----GVIPS-TGLEVAIKRVAHNSRQGMKE-FVAEITS 405
           F   NL      G+G FGKV      G+  S   ++VA+K +   +    +E  ++E+  
Sbjct: 32  FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKI 91

Query: 406 MGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
           M  L  H N+V L G C     +L++ +Y   G L   L      ++  L  +       
Sbjct: 92  MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK---RESFLTLEDLLSFSY 148

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG- 523
            VA+ + +L     +  +HRD+   NVL+      K+ DFGLAR   ++ N    ++V  
Sbjct: 149 QVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----YVVKG 201

Query: 524 ----TLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
                + ++APE       T  +DV+ +G L+ E+
Sbjct: 202 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 72.3 bits (177), Expect = 1e-13
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 15/211 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSRQGMKEFVAEITSMGR-LRHRNLVQ 416
           ++G G FGKV        G    ++V  K++  N ++  K  +AE   + + ++H  LV 
Sbjct: 2   VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKE-QKHIMAERNVLLKNVKHPFLVG 60

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH   +  ++L  V D+V  G L    F + Q+++       R+     +A AL YLH  
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYA-AEIASALGYLHS- 114

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               +V+RD+KP N+L+D+  +  L DFGL +      +  TT   GT  YLAPE+ R  
Sbjct: 115 --INIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
               + D +  G ++ E+  G  P   +  A
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 18/226 (7%)

Query: 361 NLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNL 414
             +G G FG+VY G+       +  L+VA+K +  + S Q   +F+ E   M +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKILIGVAQALLY 472
           V+L G   ++    ++ + +  G L   L +N    ++   L           VA+   Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 473 LHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
           L E      +HRD+   N L+         K+ DFG+AR  Y  +   +    +  + ++
Sbjct: 132 LEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188

Query: 529 APELTRTGKATTSTDVFGFGTLMLEV-ACGRRPI--EPQRTAMELV 571
            PE    G  T+ TDV+ FG L+ E+ + G  P      +  ME V
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFV 234

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 56/197 (28%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +  VY+G     G  VA+K +     +G     + E + +  L+H N+V LH   
Sbjct: 13  LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             ++ L LV++YV       +      +    L+ +     L  + + L Y+H+   + +
Sbjct: 73  HTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYIHQ---RYI 124

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKATT 540
           +HRD+KP N+LI      KL DFGLARA     +  +  +V TL Y  P+ L  + + +T
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDVLLGSTEYST 183

Query: 541 STDVFGFGTLMLEVACG 557
             D++G G + +E+  G
Sbjct: 184 CLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 71.2 bits (174), Expect = 2e-13
 Identities = 79/294 (26%), Positives = 131/294 (44%), Gaps = 42/294 (14%)

Query: 357 FREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRH 411
            ++  ++GSG FG VY+G+ IP   +  + VAIK +  N S +  KE + E   M  +  
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
             + +L G C     + LV   +P G L   + +N  +   + +LNW       + +A+ 
Sbjct: 69  PYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKG 121

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL E    R+VHRD+   NVL+ +  + K+ DFGLAR  D  I+    H  G    + 
Sbjct: 122 MSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIK 176

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIE--PQRTAMELVLVDWVRELHSQG 583
           ++A E     + T  +DV+ +G  + E+   G +P +  P R   +L        L    
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL--------LEKGE 228

Query: 584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ 637
           ++ +    T+D         V  + + C     + RP  R +V    R A  P 
Sbjct: 229 RLPQPPICTID---------VYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 71.6 bits (175), Expect = 2e-13
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H  LV LH   + +  L  V +YV  G L   +F   +Q+K      + Y   I +A  L
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--L 109

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYL 528
            YLHE   + +++RD+K  NVL+D++ + KL D+G+ +     + P   T+   GT  Y+
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYI 163

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           APE+ R      S D +  G LM E+  GR P +
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.5 bits (175), Expect = 2e-13
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGR-LRHRNLVQL 417
           ++G G FGKV      S G   A+K +   +   ++     +AE   + + L+H  LV L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +  ++L  V DYV  G L    F + Q+++  L    R+     VA A+ YLH   
Sbjct: 62  HYSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARF-YAAEVASAIGYLHS-- 114

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ--TTHIVGTLGYLAPELTRT 535
              +++RD+KP N+L+D+  +  L DFGL +     + P+  T+   GT  YLAPE+ R 
Sbjct: 115 -LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEVLRK 170

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
                + D +  G ++ E+  G  P
Sbjct: 171 EPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 56/184 (30%), Positives = 82/184 (44%), Gaps = 36/184 (19%)

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTT 519
           K+ + + +AL YL E+    V+HRDVKPSN+L+DA  N KL DFG++ R  D       T
Sbjct: 118 KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 520 HIVGTLGYLAPEL----TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW 575
              G   Y+APE         K     DV+  G  ++E+A G+ P +  +T  E+     
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV----- 227

Query: 576 VRELHSQGQITRAID---PTLDY---FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ-- 627
                    +T+ +    P+L     F P     V     LC       RP  R ++Q  
Sbjct: 228 ---------LTKILQEEPPSLPPNEGFSPDFCSFV----DLCLTKDHRKRPKYRELLQHP 274

Query: 628 FLLR 631
           F+ R
Sbjct: 275 FIRR 278

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 70.0 bits (171), Expect = 3e-13
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 16/206 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +VG G FG+       ++  + A+K +     +       KE V     + +++H N+V 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKMKHPNIVA 62

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                     L +V +Y   G L + +     Q+ K+   D   +  + +   + ++H  
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKI---KLQRGKLFPEDTILQWFVQMCLGVQHIH-- 117

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            ++RV+HRD+K  N+ +  +   KLGDFG AR          T+ VGT  Y+ PE+    
Sbjct: 118 -EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENM 175

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIE 562
                +D++  G ++ E+   + P +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 71.2 bits (174), Expect = 3e-13
 Identities = 59/214 (27%), Positives = 104/214 (48%), Gaps = 26/214 (12%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+  + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           FD  +  ++ L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              VA+ + YL     Q+ +HRD+   NVL+  D   K+ DFGLAR   HNI+   +TT+
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195

Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG L+ E+
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 70.7 bits (173), Expect = 4e-13
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-------RQGMKEFVAEITSMGRLRHRNL 414
           ++G G FGKV    +  +G   A+K +  +           M E    I S+ R  H  L
Sbjct: 2   VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 58

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
            QL+   +  D L  V ++V  G L   +F    QK +  +  +       +  AL++LH
Sbjct: 59  TQLYCCFQTPDRLFFVMEFVNGGDL---MFH--IQKSRRFDEARARFYAAEITSALMFLH 113

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              D+ +++RD+K  NVL+D + + KL DFG+ +    N    T+   GT  Y+APE+ +
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFCGTPDYIAPEILQ 169

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
                 S D +  G L+ E+ CG  P E +
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 71.8 bits (176), Expect = 4e-13
 Identities = 46/160 (28%), Positives = 77/160 (48%), Gaps = 16/160 (10%)

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLG 526
           Q LL +H    + ++HRD+K +N+L+ ++   KLGDFG ++ Y   ++        GT  
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY 210

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           Y+APE+ R    +   D+F  G L+ E+   +RP + +   ME V+            + 
Sbjct: 211 YVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE--NMEEVM---------HKTLA 259

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
              DP      P+  E+V    LL  DP    RPS+ +++
Sbjct: 260 GRYDPLPPSISPEMQEIVTA--LLSSDPKR--RPSSSKLL 295

Length = 496

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 70.2 bits (172), Expect = 5e-13
 Identities = 71/226 (31%), Positives = 106/226 (46%), Gaps = 33/226 (14%)

Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--------- 401
           +  T  + +   VG G FG V       TG  VAIK++       MK F           
Sbjct: 6   FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYR 58

Query: 402 EITSMGRLRHRNLVQLHG-WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY 460
           E+  +  LRH N++ L   +    +++  V + +    L +LL     +K+ I  +   Y
Sbjct: 59  ELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQYF--LY 115

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH 520
           +IL G    L Y+H      VVHRD+KPSN+LI+ + + K+ DFGLAR  D    PQ T 
Sbjct: 116 QILRG----LKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQD----PQMTG 164

Query: 521 IVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
            V T  Y APE+  T  K     D++  G +  E+  G +P+ P +
Sbjct: 165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPLFPGK 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 70.0 bits (171), Expect = 5e-13
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 17/212 (8%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGR-LRHRNLVQL 417
           ++G G FGKV      +     A+K +   +   ++  K  ++E   + + ++H  LV L
Sbjct: 2   VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +  D+L  V DY+  G L    F + Q+++  L    R+     +A AL YLH   
Sbjct: 62  HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARF-YAAEIASALGYLHS-- 114

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ--TTHIVGTLGYLAPELTRT 535
              +V+RD+KP N+L+D+  +  L DFGL +    NI     T+   GT  YLAPE+   
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHK 170

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
                + D +  G ++ E+  G  P   + TA
Sbjct: 171 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 202

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 69.0 bits (169), Expect = 8e-13
 Identities = 51/220 (23%), Positives = 102/220 (46%), Gaps = 21/220 (9%)

Query: 350 LYSATKGFREKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVA-HNSRQGMKEFVAEIT 404
           +  +       +L+  G FG+++ G++    P    EV +K V  H S   +   + E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 405 SMGRLRHRNLVQLHGWC-RKQDELLLVYDYVPNGSLDKLLFD---NDQQKKKILNWDQRY 460
            +  L H+N++ +   C    +   ++Y Y+  G+L   L      +    + L+  Q  
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH 520
            + I +A  + YLH+   + V+H+D+   N +ID +L  K+ D  L+R    ++ P   H
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSR----DLFPMDYH 173

Query: 521 IVGT-----LGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            +G      + ++A E     + ++++DV+ FG L+ E+ 
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 20/215 (9%)

Query: 357 FREKNLVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHR 412
           F    ++G+G +GKV+  R V      ++   +V   +    K    E T   R  L H 
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 413 N----LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VA 467
                LV LH   +   +L L+ DY+  G L    F +  Q+++    +Q  +I  G + 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGEL----FTHLSQRERFK--EQEVQIYSGEIV 115

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
            AL +LH+     +++RD+K  N+L+D++ +  L DFGL++ +  +   +     GT+ Y
Sbjct: 116 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEY 172

Query: 528 LAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRP 560
           +AP++ R G      + D +  G LM E+  G  P
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 69.2 bits (169), Expect = 8e-13
 Identities = 64/233 (27%), Positives = 108/233 (46%), Gaps = 33/233 (14%)

Query: 363 VGSGGFGKVYRGVIPS-TGL----EVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQ 416
           +G G FGKV +       G      VA+K +  N+    +++ ++E   + ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLL------------FDNDQQKKKILNWDQR---YK 461
           L+G C +   LLL+ +Y   GSL   L             D ++    + N D+R     
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 462 ILIGVA----QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINP 516
            LI  A    + + YL E    ++VHRD+   NVL+      K+ DFGL+R  Y+ +   
Sbjct: 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE-VACGRRP---IEPQR 565
           + +     + ++A E       TT +DV+ FG L+ E V  G  P   I P+R
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 31/218 (14%)

Query: 363 VGSGGFGKVYR----GVIPSTG-LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+V++    G++P      VA+K +    S     +F  E   M    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDND-----------------QQKKKILNWDQR 459
           L G C     + L+++Y+  G L++ L                           L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR---AYDHNINP 516
             I   VA  + YL E   ++ VHRD+   N L+  ++  K+ DFGL+R   + D+    
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           +   I   + ++ PE     + TT +DV+ +G ++ E+
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 1e-12
 Identities = 57/203 (28%), Positives = 100/203 (49%), Gaps = 9/203 (4%)

Query: 373 RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD 432
           RG  P    +V  K V  N  +      +E+  +    H  +V+     +  D+LLL+ +
Sbjct: 88  RGSDPKE--KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145

Query: 433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL 492
           Y   G L+K +    Q+ K+ L + Q Y++ +   Q +L L E   ++++HRD+K +N+ 
Sbjct: 146 YGSGGDLNKQI---KQRLKEHLPF-QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201

Query: 493 IDADLNPKLGDFGLARAYDHNINPQT-THIVGTLGYLAPELTRTGKATTSTDVFGFGTLM 551
           +      KLGDFG ++ Y  +++    +   GT  YLAPEL    + +   D++  G ++
Sbjct: 202 LMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVIL 261

Query: 552 LEVACGRRPIE--PQRTAMELVL 572
            E+    RP +   QR  M+ VL
Sbjct: 262 YELLTLHRPFKGPSQREIMQQVL 284

Length = 478

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 62/224 (27%), Positives = 111/224 (49%), Gaps = 23/224 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRN 413
           ++ + ++G G +G V   +   TG +VAIK++ ++  + + +    + EI  +  LRH +
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 414 LVQ-----LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           +V+     L    R+  ++ +V++ +    L +++  ND      L  +     L  + +
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDD-----LTPEHHQFFLYQLLR 114

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTLG 526
           AL Y+H      V HRD+KP N+L +AD   K+ DFGLAR   ++       T  V T  
Sbjct: 115 ALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 527 YLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
           Y APEL  +   K T + D++  G +  EV  G +P+ P +  +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPLFPGKNVV 214

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 54/213 (25%), Positives = 103/213 (48%), Gaps = 24/213 (11%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++  Q  ++ L++      
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 69.1 bits (169), Expect = 1e-12
 Identities = 56/212 (26%), Positives = 91/212 (42%), Gaps = 25/212 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRN 413
           F     +G+G FG+V       TG   AIK +       MK+      E + +  L H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQ 468
           +V +    + ++ +  + ++V  G L   L     F ND  K               +  
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE----------LVL 129

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           A  YLH   D  +++RD+KP N+L+D   + K+ DFG A+     +  +T  + GT  YL
Sbjct: 130 AFEYLHS-KD--IIYRDLKPENLLLDNKGHVKVTDFGFAK----KVPDRTFTLCGTPEYL 182

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           APE+ ++     + D +  G L+ E   G  P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 68.2 bits (166), Expect = 2e-12
 Identities = 53/196 (27%), Positives = 91/196 (46%), Gaps = 12/196 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG +G VY+    +TG   AIK +     +       EI  M   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++D+L +  ++   GSL  +        +  + +  R  +     Q L YLH +     +
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHSKGK---M 128

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT---RTGKAT 539
           HRD+K +N+L+  + + KL DFG++      I  + + I GT  ++APE+    R G   
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYN 187

Query: 540 TSTDVFGFGTLMLEVA 555
              D++  G   +E+A
Sbjct: 188 QLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 68.0 bits (166), Expect = 2e-12
 Identities = 55/178 (30%), Positives = 89/178 (50%), Gaps = 15/178 (8%)

Query: 363 VGSGGFGKVYRGVIPS--TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G+G FGKV  G + S  T  +V +K +  + S Q   +F+ E      L+H NL+Q  G
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR--YKILIGVAQALLYLHEEC 477
            C +    LLV ++ P G L   L     +K +++  D     ++   +A  LL+LH+  
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYL--RSCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLAR---AYDHNINPQTTHIVGTLGYLAPEL 532
               +H D+   N L+ ADL  K+GD+GL+      D+ + P    +   L ++APEL
Sbjct: 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPEL 173

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 62/238 (26%), Positives = 107/238 (44%), Gaps = 39/238 (16%)

Query: 357 FREKNLVGSGGFGKVYRGVIPST----------------GLEVAIKRV-AHNSRQGMKEF 399
           F+EK  +G G FG+V+   + +                  L VA+K +    ++    +F
Sbjct: 9   FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66

Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ- 458
           + E+  + RL+  N+++L G C  +D L ++ +Y+ NG L++ L  +    K+    D  
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 459 ---------RYKILIGVA----QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG 505
                     Y  L+ VA      + YL        VHRD+   N L+  +L  K+ DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183

Query: 506 LAR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV--ACGRRP 560
           ++R  Y  +        V  + ++A E    GK TT++DV+ FG  + E+   C  +P
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 67.2 bits (164), Expect = 3e-12
 Identities = 51/204 (25%), Positives = 99/204 (48%), Gaps = 16/204 (7%)

Query: 358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           + + ++G G  G VY+     T   +A+K +  + + +  K+ ++E+  + +     ++ 
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            +G    ++ + +  +++  GSLD       +  + +L      +I + V + L YL   
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLG-----RIAVAVVKGLTYL--- 111

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
              +++HRDVKPSN+L++     KL DFG++      +N      VGT  Y+APE     
Sbjct: 112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGE 168

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
           +    +DV+  G   +E+A GR P
Sbjct: 169 QYGIHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 67/274 (24%), Positives = 115/274 (41%), Gaps = 31/274 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+ G + +    VA+K         +K +F+ E   + +  H N+V+L G C
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  + +V + V  G     L    + +   L   +  +++   A  + YL  +     
Sbjct: 63  TQKQPIYIVMELVQGGDFLTFL----RTEGPRLKVKELIQMVENAAAGMEYLESKH---C 115

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT-LGYLAPELTRTGKATT 540
           +HRD+   N L+      K+ DFG++R  +  +   T  +    + + APE    G+ ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 541 STDVFGFGTLMLEV-ACGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF 596
            +DV+ FG L+ E  + G  P   +  Q+T          RE   QG   R   P     
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQT----------REAIEQG--VRLPCPE---- 219

Query: 597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL 630
                + V  L   C +  P  RPS   V Q L 
Sbjct: 220 --LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 66.9 bits (163), Expect = 4e-12
 Identities = 56/230 (24%), Positives = 105/230 (45%), Gaps = 31/230 (13%)

Query: 357 FREKNLVGSGGFGKVY----------------RGVIPSTGLEVAIKRVAHNSRQGMK-EF 399
           F+EK  +G G FG+V+                  V  +  + VA+K +  ++ +  + +F
Sbjct: 9   FKEK--LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66

Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF------DNDQQKKKI 453
           + EI  M RL+  N+++L   C   D L ++ +Y+ NG L++ L         ++     
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDH 512
           +++     +   +A  + YL        VHRD+   N L+  +   K+ DFG++R  Y  
Sbjct: 127 ISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSG 183

Query: 513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA--CGRRP 560
           +        V  + +++ E    GK TT++DV+ FG  + E+   C  +P
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 68.1 bits (166), Expect = 4e-12
 Identities = 65/236 (27%), Positives = 111/236 (47%), Gaps = 29/236 (12%)

Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH 411
           S  K ++  N++G+G FG VY  +   T  +VAIK+V  + +   +E +     M  L H
Sbjct: 63  SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLNH 118

Query: 412 RNLVQLHGW----CRKQDE----LLLVYDYVPNG--SLDKLLFDNDQQKKKILNWDQRYK 461
            N++ L  +    C K++E    L +V +++P       K    N+      L     Y+
Sbjct: 119 INIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNI--NPQT 518
           +     +AL Y+H    + + HRD+KP N+LID + +  KL DFG A+    N+    ++
Sbjct: 179 L----CRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK----NLLAGQRS 227

Query: 519 THIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              + +  Y APEL       TT  D++  G ++ E+  G      Q +  +LV +
Sbjct: 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.9 bits (166), Expect = 5e-12
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 20/219 (9%)

Query: 322 VLRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGL 381
            LR+ +N D+ L  +E    A +    +L    + F    ++G G FG+V      S+  
Sbjct: 14  ALRKNKNIDNFLSRYEKA--AEKIT--KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQ 69

Query: 382 EVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE--LLLVYDYVPN 436
             A+K ++      R     F  E   M       +VQLH     QD+  L +V +Y+P 
Sbjct: 70  VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH--YAFQDDKYLYMVMEYMPG 127

Query: 437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
           G L  L+ + D  +K    W + Y     V  AL  +H       +HRDVKP N+L+D  
Sbjct: 128 GDLVNLMSNYDIPEK----WARFY--TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKS 178

Query: 497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
            + KL DFG     D N   +    VGT  Y++PE+ ++
Sbjct: 179 GHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 67.3 bits (165), Expect = 5e-12
 Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 35/217 (16%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNL 414
           ++  + VGSG +G+V       TG +VAIK+++    S    K    E+  +  + H N+
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKL--------LFDNDQQ---KKKILNWDQRYKIL 463
           +           LL V  + P  SL+          L   D     K + L+ D   + L
Sbjct: 77  I----------GLLDV--FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLS-DDHIQFL 123

Query: 464 I-GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           +  + + L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V
Sbjct: 124 VYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD----EMTGYV 176

Query: 523 GTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGR 558
            T  Y APE +        + D++  G +M E+  G+
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 66.6 bits (162), Expect = 5e-12
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHR 412
           +G G FG VY G+        P T   VAIK V  N    M+E   F+ E + M      
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPET--RVAIKTV--NEAASMRERIEFLNEASVMKEFNCH 69

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKILNWDQRYKILI---GVA 467
           ++V+L G   +    L++ + +  G L   L     + +   +       K++     +A
Sbjct: 70  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + 
Sbjct: 130 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVA 555
           +++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 215

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.5 bits (162), Expect = 5e-12
 Identities = 53/204 (25%), Positives = 93/204 (45%), Gaps = 17/204 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G GGFG+V    + +TG   A K++       + G K  + E   + ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQ---QKKKILNWDQRYKILIGVAQALLYLHEE 476
               +  L LV   +  G L   +++  +   + ++++++  +      +   +L+LH  
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQ------ITCGILHLHS- 113

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               +V+RD+KP NVL+D   N +L D GLA           T   GT GY+APE+ +  
Sbjct: 114 --MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD--GKTITQRAGTNGYMAPEILKEE 169

Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
             +   D F  G  + E+  GR P
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.7 bits (163), Expect = 7e-12
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 37/219 (16%)

Query: 363 VGSGGFGKV--YRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLR-HRNLVQL 417
           +G G +G V   R    S    VAIK++    + +   K  + E+  +   R H+N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 418 HGWCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQR----------YKILIGV 466
           +       ++ +V+    N   L + L + D  +  I+   Q           Y+IL G 
Sbjct: 68  Y-------DMDIVFPGNFNELYLYEELMEADLHQ--IIRSGQPLTDAHFQSFIYQILCG- 117

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VG 523
              L Y+H      V+HRD+KP N+L++AD   K+ DFGLAR +  N       +   V 
Sbjct: 118 ---LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171

Query: 524 TLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPI 561
           T  Y APE+  + ++ T + DV+  G ++ E+  GR+P+
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 55/211 (26%), Positives = 101/211 (47%), Gaps = 16/211 (7%)

Query: 363 VGSGGFGKVYRGVIPSTG--LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           +G G FG V  G +      L+VA+K  ++A  +R  M++F++E   M    H N+++L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 419 GWCRKQDEL------LLVYDYVPNGSLDK-LLFDNDQQKKKILNWDQRYKILIGVAQALL 471
           G C +  E       +++  ++ +G L   LL+       + L      K +  +A  + 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYLAP 530
           YL     +  +HRD+   N +++ ++N  + DFGL++  Y+ +   Q       + ++A 
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           E       TT +DV+ FG  M E+A  G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 67/255 (26%), Positives = 113/255 (44%), Gaps = 37/255 (14%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           ++G GGFG+VY      TG   A+K      R  MK+   E  ++      +LV   G C
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ--GETLALNERIMLSLVST-GDC 56

Query: 422 ----------RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
                        D+L  + D +  G L   L  +    +K    + R+       + +L
Sbjct: 57  PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK----EMRFY----ATEIIL 108

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
            L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +     P  +  VGT GY+APE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS--VGTHGYMAPE 165

Query: 532 LTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           + + G A  +S D F  G ++ ++  G  P    +T          ++ H   ++T  ++
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----------KDKHEIDRMTLTVN 215

Query: 591 PTL-DYFDPQEAELV 604
             L D F P+   L+
Sbjct: 216 VELPDSFSPELKSLL 230

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 2e-11
 Identities = 63/225 (28%), Positives = 110/225 (48%), Gaps = 24/225 (10%)

Query: 360 KNLVGSGGFGKVYRGVIPSTG--------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRH 411
             ++G GG+GKV++ V   TG        ++V  K     +++      AE   +  ++H
Sbjct: 1   LKVLGKGGYGKVFQ-VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH 59

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
             +V L    +   +L L+ +Y+  G L   L     +++ I   D     L  ++ AL 
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-----EREGIFMEDTACFYLSEISLALE 114

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAP 530
           +LH+   Q +++RD+KP N+L+DA  + KL DFGL +  +       TH   GT+ Y+AP
Sbjct: 115 HLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAP 169

Query: 531 E-LTRTGKATTSTDVFGFGTLMLEVACGRRPI--EPQRTAMELVL 572
           E L R+G    + D +  G LM ++  G  P   E ++  ++ +L
Sbjct: 170 EILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 61/218 (27%), Positives = 90/218 (41%), Gaps = 32/218 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA---EITSM------- 406
           FR   ++G G FGKV       TG   AIK +        K  +    E+ S+       
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALK-------KGDIIARDEVESLMCEKRIF 53

Query: 407 ---GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
                 RH  LV L    + +D +  V +Y   G L  +    D   +       R    
Sbjct: 54  ETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDL-MMHIHTDVFSEP------RAVFY 106

Query: 464 IG-VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
              V   L YLHE    ++V+RD+K  N+L+D +   K+ DFGL +        +T+   
Sbjct: 107 AACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFC 162

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           GT  +LAPE+      T + D +G G L+ E+  G  P
Sbjct: 163 GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/207 (24%), Positives = 98/207 (47%), Gaps = 16/207 (7%)

Query: 362 LVGSGGFGKVYRGVIP---STGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           ++G G FG V  G +     + L+VA+K  ++  ++   ++EF++E   M    H N+++
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65

Query: 417 LHGWCRKQDEL------LLVYDYVPNGSLDK-LLFDNDQQKKKILNWDQRYKILIGVAQA 469
           L G C +   L      +++  ++ +G L   LL+       + L      K ++ +A  
Sbjct: 66  LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYL 528
           + YL    ++  +HRD+   N ++  D+   + DFGL++  Y  +   Q       + ++
Sbjct: 126 MEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVA 555
           A E       T+ +DV+ FG  M E+A
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIA 209

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 66.3 bits (161), Expect = 2e-11
 Identities = 46/173 (26%), Positives = 84/173 (48%), Gaps = 13/173 (7%)

Query: 386 KRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV---YDYVPNGSLDKL 442
           KRV   SR  + +   EI ++GRL H N++++    R +    ++   YD+     L   
Sbjct: 198 KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSF 252

Query: 443 LFDND-QQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL 501
           ++D     K + L    R  I+  +  A+ Y+H   D++++HRD+K  N+ ++ D    L
Sbjct: 253 MYDEAFDWKDRPLLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVL 308

Query: 502 GDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           GDFG A  ++          VGT+   +PE+         TD++  G ++L++
Sbjct: 309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Length = 501

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 3e-11
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)

Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 77

Query: 414 LVQL---HGWCRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 78  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 131

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 132 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 184

Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 185 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 65.4 bits (159), Expect = 3e-11
 Identities = 71/300 (23%), Positives = 115/300 (38%), Gaps = 70/300 (23%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FG+V       T    A+K +      +R  +    AE   +    +  +V+L+ 
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             + +D L  V DY+P G +  LL   +   + +     R+ I    A+  L +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL----ARFYI----AELTLAIESVHKM 120

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNIN--PQTTHI-------------- 521
             +HRD+KP N+LID D + KL DFGL   +   HN     + +HI              
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDV 180

Query: 522 ----------------------------VGTLGYLAPELTRTGKATTSTDVFGFGTLMLE 553
                                       VGT  Y+APE+      T   D +  G ++ E
Sbjct: 181 SNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240

Query: 554 VACGRRP-IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
           +  G+ P + P  T  +L +++W   LH   Q+            P+  +L+     LCC
Sbjct: 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK---------LSPEAVDLI---TKLCC 288

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 65.0 bits (158), Expect = 3e-11
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 33/216 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNL 414
           +R+   VGSG +G V   +   TG +VAIK++     S    K    E+  +  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKL--------LFDNDQ---QKKKILNWDQRYKIL 463
           + L            +  + P+ SLD+             D     K + L+ D+   ++
Sbjct: 77  IGL------------LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             + + L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D     + T  V 
Sbjct: 125 YQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVV 177

Query: 524 TLGYLAPELTRTGKATTST-DVFGFGTLMLEVACGR 558
           T  Y APE+       T T D++  G +M E+  G+
Sbjct: 178 TRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 56/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK--EFV-AEITSMGRLRHRN 413
                 VG+G FG+V+      +    A+K +A      +K  + V  E   +  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L      Q  L ++ +YVP G L    F   +   +  N    +     +  AL YL
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGEL----FSYLRNSGRFSNSTGLF-YASEIVCALEYL 117

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H    + +V+RD+KP N+L+D + + KL DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 118 HS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVI 170

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
           ++     + D +  G L+ E+  G  P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 65.0 bits (158), Expect = 4e-11
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 38/254 (14%)

Query: 323 LRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREK-------NLVGSGGFGKVYRGV 375
           LR+ +N D+ L            RY ++    +  + K        ++G G FG+V    
Sbjct: 15  LRKNKNIDNFLN-----------RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVR 63

Query: 376 IPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE--LLLV 430
             S+    A+K ++      R     F  E   M       +VQL  +C  QD+  L +V
Sbjct: 64  HKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMV 121

Query: 431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN 490
            +Y+P G L  L+ + D  +K    W + Y      A+ +L L       ++HRDVKP N
Sbjct: 122 MEYMPGGDLVNLMSNYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDN 172

Query: 491 VLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT----GKATTSTDVFG 546
           +L+D   + KL DFG     D     +    VGT  Y++PE+ ++    G      D + 
Sbjct: 173 MLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232

Query: 547 FGTLMLEVACGRRP 560
            G  + E+  G  P
Sbjct: 233 VGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 5e-11
 Identities = 62/247 (25%), Positives = 102/247 (41%), Gaps = 69/247 (27%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V+L+   + +D L  V DY+P G +  LL      +  I   D     +  +  A+  +
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RLGIFEEDLARFYIAELTCAIESV 117

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL---------ARAYDHNINPQ------- 517
           H+      +HRD+KP N+LID D + KL DFGL         ++ Y    + +       
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPS 174

Query: 518 -------------------------TTH-IVGTLGYLAPE-LTRTGKATTSTDVFGFGTL 550
                                      H +VGT  Y+APE L RTG  T   D +  G +
Sbjct: 175 EEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVI 233

Query: 551 MLEVACGRRP-IEPQRTAMELVLVDWVRELH--SQGQITRAIDPTLDYFDPQEAELVLTL 607
           + E+  G+ P +       +L +++W   LH  SQ +++R           + ++L+L  
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSR-----------EASDLILR- 281

Query: 608 GLLCCDP 614
             LCC  
Sbjct: 282 --LCCGA 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 6e-11
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 30/208 (14%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLY 472
           LV LH   +   +L L+ DYV  G L   L+  +         +   ++ I  +  AL +
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT------ESEVRVYIAEIVLALDH 120

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH+     +++RD+K  N+L+D++ +  L DFGL++ +      +     GT+ Y+APE+
Sbjct: 121 LHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEV 177

Query: 533 TRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI- 589
            R G      + D +  G L  E+  G  P            VD   E +SQ +I+R I 
Sbjct: 178 IRGGSGGHDKAVDWWSLGVLTFELLTGASPFT----------VD--GEQNSQSEISRRIL 225

Query: 590 ---DPTLDYFDPQEAELVLTLGLLCCDP 614
               P       +  + +    LL  DP
Sbjct: 226 KSKPPFPKTMSAEARDFIQK--LLEKDP 251

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.1 bits (153), Expect = 7e-11
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 31/217 (14%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWC 421
           +G G +GKVY+      G   A+K +        +E  AE   +  L  H N+V+ +G  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 422 RKQD-----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK------ILIGVAQAL 470
            K D     +L LV +    GS+ +L+       K +L   QR        IL G    L
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELV-------KGLLICGQRLDEAMISYILYGALLGL 141

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL-ARAYDHNINPQTTHIVGTLGYLA 529
            +LH   + R++HRDVK +N+L+  +   KL DFG+ A+     +   T+  VGT  ++A
Sbjct: 142 QHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMA 196

Query: 530 PELTRTGKATTST-----DVFGFGTLMLEVACGRRPI 561
           PE+    +    +     DV+  G   +E+  G  P+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 45/153 (29%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
           L QLH   +  D L  V +YV  G L   ++   Q  K    + + + +     +A  L 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGK----FKEPHAVFYAAEIAIGLF 115

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLA 529
           +LH    + +++RD+K  NV++DA+ + K+ DFG+ +    NI    T     GT  Y+A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK---ENIFGGKTTRTFCGTPDYIA 169

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           PE+        S D + FG L+ E+  G+ P +
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 63.1 bits (153), Expect = 9e-11
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 23/215 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+    G    + VAIK +    S +  KE + E   M  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 69  PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL E   +R+VHRD+   NVL+    + K+ DFGLA+      + +  H  G    + 
Sbjct: 122 MNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIK 176

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 37/214 (17%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G +GKVY+    +TG  VA+K+    +R  M E     T+   LR  +L+Q+     
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKK----TRLEMDEEGIPPTA---LREISLLQMLSESI 61

Query: 423 KQDELLLVYDYVPNGSLDKLLF------DNDQQKKKILNWDQR-------------YKIL 463
               LL V ++V   +    L+      D+D +K    N                 Y++L
Sbjct: 62  YIVRLLDV-EHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIV 522
            GVA    + H+     V+HRD+KP N+L+D      K+ D GL RA+   +   T  IV
Sbjct: 121 KGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173

Query: 523 GTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVA 555
            TL Y APE L  +   +T  D++  G +  E++
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 63.3 bits (154), Expect = 1e-10
 Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 43/240 (17%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV- 415
           + +   +G G  G V+  V       VA+K++     Q +K  + EI  + RL H N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 416 ----------QLHGWCRKQDELLLVY---DYVPNGSLDKLLFDNDQQKKKILNWDQR--- 459
                      L        EL  VY   +Y+    L  +L     ++  +     R   
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVL-----EQGPLSEEHARLFM 120

Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNINPQT 518
           Y++L G    L Y+H      V+HRD+KP+NV I+  DL  K+GDFGLAR  D    P  
Sbjct: 121 YQLLRG----LKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD----PHY 169

Query: 519 THI------VGTLGYLAPELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           +H       + T  Y +P L       T + D++  G +  E+  G +P+      +E +
Sbjct: 170 SHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KPLFAGAHELEQM 228

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 63.5 bits (154), Expect = 1e-10
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 21/215 (9%)

Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K +++   +GSG  G V        G+ VA+K+++    ++   K    E+  +  
Sbjct: 17  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76

Query: 409 LRHRNLVQLHGWCRKQ------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q       ++ LV + +       +  + D ++   L     Y++
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL----LYQM 132

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    N     T  V
Sbjct: 133 LCGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYV 183

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 27/207 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITS------------MGRL 409
           +G G FG VY        L    K VA    + +KE  V E+              + +L
Sbjct: 8   LGKGSFGTVY--------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL 59

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
            H  +V+ H    ++D   ++ +Y     LD  L +  +   K L+ +Q  +  I +   
Sbjct: 60  DHPAIVKFHASFLERDAFCIITEYCEGRDLDCKL-EELKHTGKTLSENQVCEWFIQLLLG 118

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           + Y+H+   +R++HRD+K  N+ +  +L  K+GDFG++R    + +  TT   GT  Y++
Sbjct: 119 VHYMHQ---RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT-FTGTPYYMS 173

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVAC 556
           PE  +     + +D++  G ++ E+ C
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 12/201 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK--RVAH-NSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FGKV +     T    A+K  R AH  SR  +   +AE T + ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
             +  ++L LV  ++  G L    F + Q++ +      R+      A+ L  L      
Sbjct: 61  SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYT----AELLCALENLHKF 112

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
            V++RD+KP N+L+D   +  L DFGL +    + + +T    GT  YLAPEL      T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYT 171

Query: 540 TSTDVFGFGTLMLEVACGRRP 560
            + D +  G L+ E+  G  P
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 2e-10
 Identities = 60/236 (25%), Positives = 96/236 (40%), Gaps = 39/236 (16%)

Query: 357 FREKNLVGSGGFGKVY----RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR 412
           F++  L+G G  G+V+    +G      L+V  K+     R  +K  + E   +  L H 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIK-RNKVKRVLTEQEILATLDHP 61

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  L+   + +  L LV DY P G L +LL    +Q  K L+ +        V  AL Y
Sbjct: 62  FLPTLYASFQTETYLCLVMDYCPGGELFRLL---QRQPGKCLSEEVARFYAAEVLLALEY 118

Query: 473 LHEECDQRVVHRDVKPSNVLI---------DADLNPKLGDFGLARAY-------DHNINP 516
           LH      +V+RD+KP N+L+         D DL+ +        +          ++N 
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175

Query: 517 QTTHI------------VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +              VGT  Y+APE+       ++ D +  G L+ E+  G  P
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 62.3 bits (151), Expect = 2e-10
 Identities = 61/224 (27%), Positives = 96/224 (42%), Gaps = 39/224 (17%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-----LRH 411
           F    ++G G FG            EVA+ ++ H  R    + + +   + R      R 
Sbjct: 3   FEIIKVIGRGAFG------------EVAVVKMKHTERIYAMKILNKWEMLKRAETACFRE 50

Query: 412 RNLVQLHGWCRK--------QDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
              V ++G C+         QDE  L LV DY   G L  LL   + +  + +    R+ 
Sbjct: 51  ERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM---ARFY 107

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI 521
           I    A+ +L +H       VHRD+KP NVL+D + + +L DFG     + +   Q++  
Sbjct: 108 I----AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVA 163

Query: 522 VGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRP 560
           VGT  Y++PE+ +      GK     D +  G  M E+  G  P
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 35/100 (35%), Positives = 55/100 (55%), Gaps = 8/100 (8%)

Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT 519
           Y+IL G    L YLH      ++HRD+KP N+L++++   K+ DFGLAR  + + +   T
Sbjct: 110 YQILRG----LKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT 162

Query: 520 HIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGR 558
             V T  Y APE L  +   T++ D++  G +  E+   R
Sbjct: 163 QEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 30/203 (14%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLR-HRNLVQLHGW 420
           G G F +V +     TG   AIK +     + +++     EI ++ RL  H N+++L   
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLI-- 64

Query: 421 CRKQDELLLVYDYVPNGSL-------DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
                E+L  +D    G L       D  L++  + +K+ L   +    +  + ++L ++
Sbjct: 65  -----EVL--FD-RKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM 116

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYLAPE- 531
           H      + HRD+KP N+LI  D+  KL DFG  R  Y     P  T  + T  Y APE 
Sbjct: 117 HR---NGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPEC 169

Query: 532 LTRTGKATTSTDVFGFGTLMLEV 554
           L   G      D++  G +  E+
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 42/215 (19%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-----EITSMGRLRHRNLVQ 416
            VGSG +G V   +   TG +VAIK++   SR    E  A     E+T +  ++H N++ 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKL---SRPFQSEIFAKRAYRELTLLKHMQHENVI- 77

Query: 417 LHGWCRKQ---------DELLLVYDYVPNGSLDKLL---FDNDQQKKKILNWDQRYKILI 464
             G               +  LV  Y+    L K++      D+ +  +      Y++L 
Sbjct: 78  --GLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLV------YQMLC 128

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
           G    L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D     + T  V T
Sbjct: 129 G----LKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVT 177

Query: 525 LGYLAPELTRTGKATTST-DVFGFGTLMLEVACGR 558
             Y APE+         T D++  G +M E+  G+
Sbjct: 178 RWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 43/153 (28%), Positives = 74/153 (48%), Gaps = 17/153 (11%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
           L QLH   +  D L  V +YV  G L         Q +++  + + + +     +A  L 
Sbjct: 63  LTQLHSCFQTMDRLYFVMEYVNGGDLM-------YQIQQVGRFKEPHAVFYAAEIAIGLF 115

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLA 529
           +LH    + +++RD+K  NV++D++ + K+ DFG+ +    N+     T    GT  Y+A
Sbjct: 116 FLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIA 169

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           PE+        S D + FG L+ E+  G+ P E
Sbjct: 170 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 25/213 (11%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR------LRHRNLV 415
           ++G G FGKV+   +  T    AIK +  +    M + V E T + +        H  L 
Sbjct: 2   MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDV-ECTMVEKRVLSLAWEHPFLT 59

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIGVAQALLYL 473
            L+   + ++ L  V +Y+  G L   +F      K  L     Y  +I+ G    L +L
Sbjct: 60  HLYCTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICG----LQFL 112

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLAPE 531
           H    + +V+RD+K  N+L+D D + K+ DFG+ +    N+  + +T    GT  Y+APE
Sbjct: 113 HS---KGIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPE 166

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           +    K  TS D + FG L+ E+  G+ P    
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 67/250 (26%), Positives = 109/250 (43%), Gaps = 37/250 (14%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           ++G GGFG+VY      TG   A+K      R  MK+   E  ++      +LV   G C
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ--GETLALNERIMLSLVST-GDC 56

Query: 422 ----------RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
                        D+L  + D +  G L   L     Q       + R+      A+ +L
Sbjct: 57  PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFY----AAEIIL 108

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
            L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +     P  +  VGT GY+APE
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHAS--VGTHGYMAPE 165

Query: 532 LTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           + + G A  +S D F  G ++ ++  G  P    +T          ++ H   ++T  + 
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----------KDKHEIDRMTLTMA 215

Query: 591 PTL-DYFDPQ 599
             L D F P+
Sbjct: 216 VELPDSFSPE 225

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 60.8 bits (147), Expect = 4e-10
 Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 19/207 (9%)

Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNL 414
           +G G FG VY G           T   VA+K V  + S +   EF+ E + M      ++
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAET--RVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQA 469
           V+L G   K    L+V + + +G L   L        +   +      +  ++   +A  
Sbjct: 72  VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
           + YL+    ++ VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + ++
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVA 555
           APE  + G  TTS+D++ FG ++ E+ 
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEIT 215

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 12/196 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           VGSG +G VY+     TG   A+K +             EI  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            +++L +  +Y   GSL  +        +  + +  R  +     Q L YLH +     +
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK---M 128

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT---RTGKAT 539
           HRD+K +N+L+  + + KL DFG+A      I  + + I GT  ++APE+    + G   
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187

Query: 540 TSTDVFGFGTLMLEVA 555
              D++  G   +E+A
Sbjct: 188 QLCDIWAVGITAIELA 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.4 bits (149), Expect = 6e-10
 Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 4/98 (4%)

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVG 523
            + +AL YLH    + ++HRDVK  N+ +D   N  LGDFG A +   H   PQ     G
Sbjct: 193 RLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSG 249

Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           TL   +PEL         TD++  G ++ E++     +
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 54/206 (26%), Positives = 93/206 (45%), Gaps = 15/206 (7%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN----LVQL 417
           ++G G FGKV       T    AIK +  +      +    +     L  ++    L QL
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +  D L  V +YV  G L   ++   Q  K      Q       ++  L +LH   
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK--FKEPQAVFYAAEISVGLFFLHR-- 119

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPELTRTG 536
            + +++RD+K  NV++D++ + K+ DFG+ +  +H ++  TT    GT  Y+APE+    
Sbjct: 120 -RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQ 176

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIE 562
               S D + +G L+ E+  G+ P +
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.1 bits (146), Expect = 8e-10
 Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 23/195 (11%)

Query: 383 VAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK 441
           VA+K +  + S    ++F+ E+  + RL   N+ +L G C     L ++ +Y+ NG L++
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 442 LLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-----------RVVHRDVKPSN 490
            L     QK                   LLY+     Q             VHRD+   N
Sbjct: 109 FL-----QKHVAETSGLACNSKSLSFSTLLYM---ATQIASGMRYLESLNFVHRDLATRN 160

Query: 491 VLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGT 549
            L+  +   K+ DFG++R  Y  +           + ++A E    GK TT +DV+ FG 
Sbjct: 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220

Query: 550 LMLEVA--CGRRPIE 562
            + E+   C  +P E
Sbjct: 221 TLWEILTLCREQPYE 235

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 60.2 bits (146), Expect = 8e-10
 Identities = 60/215 (27%), Positives = 98/215 (45%), Gaps = 37/215 (17%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV-----AEITSMGR------LR 410
           ++G G FGKV    +  T    AIK +        K+ V      E T + R        
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALK-------KDVVLEDDDVECTMVERRVLALAWE 54

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVA 467
           H  L  L    + ++ L  V +Y+  G L   +F + Q   +      R+   +I+ G  
Sbjct: 55  HPFLTHLFCTFQTKEHLFFVMEYLNGGDL---MF-HIQSSGRFDEARARFYAAEIICG-- 108

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTL 525
             L +LH+   + +++RD+K  NVL+D D + K+ DFG+ +    N+N +       GT 
Sbjct: 109 --LQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTP 160

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            Y+APE+ +  K   S D + FG L+ E+  G+ P
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 22/205 (10%)

Query: 363 VGSGGFGKVYRGVIPSTGLE-VAIKRVAHNS--RQGMKEFV-AEITSMGRLRHRNLVQLH 418
           +G+G FG+V      +     VAIKR   +   +Q   + V +E   +  + H   V L+
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG---VAQALLYLHE 475
           G  + +  L LV ++V  G     L  N           +R+   +G    AQ +L    
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRN-----------KRFPNDVGCFYAAQIVLIFEY 146

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
                +V+RD+KP N+L+D D   K+ DFG A+  D     +T  + GT  Y+APE+   
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLN 202

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
                + D +  G  + E+  G  P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 59.8 bits (145), Expect = 4e-09
 Identities = 55/217 (25%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV----AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           L+G GG G+VY    P     VA+K++    + N     K F+ E      L H  +V +
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLL-KKRFLREAKIAADLIHPGIVPV 67

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQK--KKILNWDQRYK----ILIGVAQALL 471
           +  C   D +     Y+   +L  LL    Q++   K L           I   +   + 
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIE 127

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA----------YDHNINPQTTH- 520
           Y+H    + V+HRD+KP N+L+       + D+G A             D +        
Sbjct: 128 YVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSS 184

Query: 521 ------IVGTLGYLAPELTRTGKATTSTDVFGFGTLM 551
                 IVGT  Y+APE      A+ STD++  G ++
Sbjct: 185 MTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV-----AEITSMGR----LRHR 412
           ++G G FGKV    +   G   A+K +        K+ V      E T + +    L   
Sbjct: 2   VLGKGSFGKVLLAELKGKGEYFAVKALK-------KDVVLIDDDVECTMVEKRVLALAWE 54

Query: 413 N--LVQLHGWCRKQDELLLVYDYVPNGSL-----DKLLFDNDQQKKKILNWDQRYKILIG 465
           N  L  L+   + ++ L  V +++  G L     DK  FD              Y+    
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD-------------LYRATFY 101

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
            A+ +  L     + +++RD+K  NV++D D + K+ DFG+ +      N  +T   GT 
Sbjct: 102 AAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTP 160

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            Y+APE+ +  K T S D + FG L+ E+  G+ P
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 5e-09
 Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 34/252 (13%)

Query: 323 LRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREK-------NLVGSGGFGKVYRGV 375
           LR+ +N D+ L            RY +  +  +  R K        ++G G FG+V    
Sbjct: 15  LRKNKNIDNFLN-----------RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVR 63

Query: 376 IPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD 432
             ST    A+K ++      R     F  E   M       +VQL    +    L +V +
Sbjct: 64  HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVME 123

Query: 433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL 492
           Y+P G L  L+ + D  +K    W + Y      A+ +L L        +HRDVKP N+L
Sbjct: 124 YMPGGDLVNLMSNYDVPEK----WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNML 174

Query: 493 IDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFG 548
           +D   + KL DFG     +     +    VGT  Y++PE+ ++    G      D +  G
Sbjct: 175 LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234

Query: 549 TLMLEVACGRRP 560
             + E+  G  P
Sbjct: 235 VFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 5e-09
 Identities = 62/242 (25%), Positives = 110/242 (45%), Gaps = 42/242 (17%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRHRNLVQ- 416
           +G+G FG+V+      T      K +++   +G+KE      V E+  M  L+H+N+V+ 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISY---RGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 417 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ---ALLY 472
           +  +  K ++ L ++ ++   G L +    N Q+  K+    + + I+    Q   AL Y
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSR----NIQKCYKMFGKIEEHAIVDITRQLLHALAY 133

Query: 473 LHEECD----QRVVHRDVKPSNVLIDA-------------DLN----PKLGDFGLARAYD 511
            H   D    +RV+HRD+KP N+ +               +LN     K+GDFGL++  +
Sbjct: 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--N 191

Query: 512 HNINPQTTHIVGTLGYLAPELT--RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
             I       VGT  Y +PEL    T      +D++  G ++ E+  G+ P        +
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQ 251

Query: 570 LV 571
           L+
Sbjct: 252 LI 253

Length = 1021

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 2e-08
 Identities = 44/163 (26%), Positives = 72/163 (44%), Gaps = 16/163 (9%)

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKILNWDQRYKILIGVAQA 469
           R +  LH   + ++ L LV DY   G L  LL  F++     ++     R+ +    A+ 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED-----RLPEDMARFYL----AEM 111

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           +L +        VHRD+KP NVL+D + + +L DFG       +   Q+   VGT  Y++
Sbjct: 112 VLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYIS 171

Query: 530 PELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
           PE+ +      G+     D +  G  M E+  G  P   +   
Sbjct: 172 PEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 214

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 2e-08
 Identities = 73/304 (24%), Positives = 116/304 (38%), Gaps = 73/304 (24%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRN 413
           F +   +G G FG+V       T    A+K +       R  +    AE   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V+L+   + +D L  V DY+P G +  LL      +  I   D     +  +  A+  +
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLI-----RMGIFPEDLARFYIAELTCAVESV 117

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY------------DH--------- 512
           H+      +HRD+KP N+LID D + KL DFGL   +            DH         
Sbjct: 118 HK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174

Query: 513 -------------NINPQTTH------------IVGTLGYLAPE-LTRTGKATTSTDVFG 546
                         + P                +VGT  Y+APE L RTG  T   D + 
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS 233

Query: 547 FGTLMLEVACGRRPI---EPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAEL 603
            G ++ E+  G+ P     P  T M+  +++W   LH          P      P+ ++L
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMK--VINWQTSLHI---------PPQAKLSPEASDL 282

Query: 604 VLTL 607
           ++ L
Sbjct: 283 IIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 40/216 (18%)

Query: 363 VGSGGFGKVYRGVI--------PSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGR-LR 410
           +G G   ++Y G++             E  IK   +V   S + +     E  SM R + 
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H+++V L+G C +  E ++V ++V  G LD  +     +K  +L    ++K+   +A AL
Sbjct: 63  HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFM----HRKSDVLTTPWKFKVAKQLASAL 118

Query: 471 LYLHEECDQRVVHRDVKPSNVL-----IDADLNP--KLGDFGLARAYDHNINPQTT---- 519
            YL    D+ +VH +V   N+L     ID +  P  KL D G+         P T     
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI---------PITVLSRQ 166

Query: 520 HIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
             V  + ++APE     K  + + D + FGT + E+
Sbjct: 167 ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 14/153 (9%)

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           + N ++L+         +L+ DY+ +G L  LL     +K+  L+  +  KI+  + +AL
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL-----KKEGKLSEAEVKKIIRQLVEAL 122

Query: 471 LYLHEECDQRVVHRDVKPSNVLID-ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
             LH+     ++H D+K  NVL D A     L D+GL +     I   + +  GTL Y +
Sbjct: 123 NDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK----IIGTPSCY-DGTLDYFS 174

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  +      S D +  G L  E+  G+ P +
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFK 207

Length = 267

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 55.7 bits (134), Expect = 5e-08
 Identities = 47/151 (31%), Positives = 71/151 (47%), Gaps = 21/151 (13%)

Query: 366 GGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFV-AEITSMGRLRHRNLVQLHGWCR 422
           G FGKVY G   +     A+K  + A    + M   V AE  ++   +   +V L+   +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 423 KQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
             + + LV +Y+  G +  LL     FD +   K I            VA AL YLH   
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISE----------VALALDYLHR-- 122

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
              ++HRD+KP N+LI  + + KL DFGL++
Sbjct: 123 -HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.3 bits (130), Expect = 9e-08
 Identities = 56/216 (25%), Positives = 95/216 (43%), Gaps = 21/216 (9%)

Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79

Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL----LYQM 135

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 186

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
            T  Y APE+        + D++  G +M E+  G 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 69/256 (26%), Positives = 100/256 (39%), Gaps = 67/256 (26%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN-LVQLHG- 419
           ++G G FG+V       TG   A+K++   S    KE VA + +      R+ L +    
Sbjct: 8   VIGRGAFGEVRLVQKKDTGHIYAMKKL-RKSEMLEKEQVAHVRA-----ERDILAEADNP 61

Query: 420 WCRK-----QDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ-RYKILIGVAQALL 471
           W  K     QDE  L L+ +Y+P G +  LL      KK     ++ R+ I    A+ +L
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLLM-----KKDTFTEEETRFYI----AETIL 112

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL------------ARAYDHNINPQTT 519
            +        +HRD+KP N+L+DA  + KL DFGL             R   H +     
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172

Query: 520 HI-------------------------VGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLE 553
                                      VGT  Y+APE   +TG      D +  G +M E
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYE 231

Query: 554 VACGRRPI---EPQRT 566
           +  G  P     PQ T
Sbjct: 232 MLVGYPPFCSDNPQET 247

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 29/216 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLR-HRNLVQLHG 419
           +G G +GKV++ +    G + A+K +   H+  +   E  AE   +  L  H N+V+ +G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSDHPNVVKFYG 82

Query: 420 WCRKQD-----ELLLVYDYVPNGSLDKL----LFDNDQQKKKILNWDQRYKILIGVAQAL 470
              K+D     +L LV +    GS+  L    L   ++ ++ I+ +     IL      L
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----ILHEALMGL 137

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            +LH     + +HRDVK +N+L+  +   KL DFG++         + T  VGT  ++AP
Sbjct: 138 QHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPFWMAP 193

Query: 531 ELTRTGKATTST-----DVFGFGTLMLEVACGRRPI 561
           E+    +   ST     DV+  G   +E+  G  P+
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 52.6 bits (126), Expect = 2e-07
 Identities = 51/213 (23%), Positives = 96/213 (45%), Gaps = 17/213 (7%)

Query: 362 LVGSGGFGKVYRGVIPS---TGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           ++G G FG V    + S   +  +VA+K  +    S   ++EF+ E   M    H N+++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 417 LHGWC---RKQDEL---LLVYDYVPNGSLDKLLFDNDQQKKKI-LNWDQRYKILIGVAQA 469
           L G     R +  L   +++  ++ +G L   L  +   ++   L      + +I +A  
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYL 528
           + YL     +  +HRD+   N +++ ++   + DFGL++  Y  +   Q       + +L
Sbjct: 126 MEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL 182

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           A E       TT +DV+ FG  M E+   G+ P
Sbjct: 183 ALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V          +VA+K+++    S    +    E+  +  ++H N
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHEN 75

Query: 414 LVQL------HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           ++ L             +E+ LV + +    L+ ++      K + L+ +    ++  + 
Sbjct: 76  VIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIV------KCQKLSDEHVQFLIYQLL 128

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           + L Y+H      ++HRD+KPSNV ++ D   ++ DFGLAR  D     + T  V T  Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADD----EMTGYVATRWY 181

Query: 528 LAPELTRTGKATTST-DVFGFGTLMLEVACGR 558
            APE+         T D++  G +M E+  G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.2 bits (127), Expect = 2e-07
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 21/212 (9%)

Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 128

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 129 LCGIK----HLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 179

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            T  Y APE+        + D++  G +M E+
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 67/255 (26%), Positives = 97/255 (38%), Gaps = 58/255 (22%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F    ++G G FG+V       TG   A+K +   +    KE VA I    R     LV+
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMK-ILRKADMLEKEQVAHI----RAERDILVE 57

Query: 417 LHG-WCRK-----QDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
             G W  K     QD+  L L+ +++P G +  LL   D   ++     Q Y     +A+
Sbjct: 58  ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEA---TQFY-----IAE 109

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL---------------------- 506
            +L +        +HRD+KP N+L+DA  + KL DFGL                      
Sbjct: 110 TVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPS 169

Query: 507 ------------ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
                       A  +  N        VGT  Y+APE+          D +  G +M E+
Sbjct: 170 DFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 555 ACGRRPI---EPQRT 566
             G  P     PQ T
Sbjct: 230 LIGYPPFCSETPQET 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.0 bits (124), Expect = 4e-07
 Identities = 44/152 (28%), Positives = 69/152 (45%), Gaps = 12/152 (7%)

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +  LH   + ++ L LV DY   G L  LL   + +    L  D     L  +  A+  +
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR----LPEDMARFYLAEMVIAIDSV 118

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H+      VHRD+KP N+L+D + + +L DFG       +   Q++  VGT  Y++PE+ 
Sbjct: 119 HQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 534 RT-----GKATTSTDVFGFGTLMLEVACGRRP 560
           +      GK     D +  G  M E+  G  P
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 52.2 bits (125), Expect = 4e-07
 Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 7/102 (6%)

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           L  DQ   I   + + L YLH    QR++HRDVK  N+ I+      +GD G A+     
Sbjct: 154 LPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF---P 207

Query: 514 IN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           +  P    + GT+   APE+    K  +  D++  G ++ E+
Sbjct: 208 VVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.4 bits (123), Expect = 5e-07
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 8/174 (4%)

Query: 363 VGSGGFGKVYRGVI--PSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G+G FGKV    I   +    V +K + A+ S +   EF+ +      L+H N++Q  G
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C +    LLV++Y   G L K     +Q  ++        ++   +A  + ++H+    
Sbjct: 63  QCVEAIPYLLVFEYCELGDL-KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---H 118

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYLAPEL 532
             +H D+   N  + +DL  K+GD+G+  + Y  +           L +LAPEL
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPEL 172

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 43/208 (20%)

Query: 381 LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD 440
           L V +K +  + R     F    + M ++ H +L  +HG C +  E ++V ++V +G LD
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 441 KLLFDNDQQKKKILNWDQRYKILIG--VAQALLYLHEECDQRVVHRDVKPSNVL-----I 493
             L      +K+       +KI +   +A AL YL    D+ +VH +V   N+L     +
Sbjct: 105 VCL------RKEKGRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGL 155

Query: 494 DADLNP--KLGDFG-----LARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVF 545
               +P  KL D G     L+R             V  + ++APE    G + +T+ D +
Sbjct: 156 AEGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKW 205

Query: 546 GFGTLMLEVAC--------GRRPIEPQR 565
            FGT +LE+ C         R P E +R
Sbjct: 206 SFGTTLLEI-CFDGEVPLKERTPSEKER 232

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 14/167 (8%)

Query: 393 RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK 452
           R G      E   +  + H +++QL G         L+   +P    D   +   ++   
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIA 180

Query: 453 ILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH 512
           I +      I   V +A+ YLHE    R++HRD+K  N+ I+   +  LGDFG A  +  
Sbjct: 181 ICDI---LAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG-AACFPV 233

Query: 513 NINPQTTH-IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
           +IN    +   GT+   APEL        + D++  G ++ E+A   
Sbjct: 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 65/255 (25%), Positives = 98/255 (38%), Gaps = 58/255 (22%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F    ++G G FG+V       TG   A+K +   +    KE V  I    R     LV+
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMK-ILRKADMLEKEQVGHI----RAERDILVE 57

Query: 417 LHG-WCRK-----QDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
               W  K     QD+  L L+ +++P G +  LL   D   ++     Q Y     +A+
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEE---TQFY-----IAE 109

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA------------RAYDHNINP 516
            +L +        +HRD+KP N+L+D+  + KL DFGL             R  +H++  
Sbjct: 110 TVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPS 169

Query: 517 QTT----------------------HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
             T                        VGT  Y+APE+          D +  G +M E+
Sbjct: 170 DFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEM 229

Query: 555 ACGRRPI---EPQRT 566
             G  P     PQ T
Sbjct: 230 LIGYPPFCSETPQET 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 48.6 bits (116), Expect = 5e-06
 Identities = 29/78 (37%), Positives = 42/78 (53%), Gaps = 17/78 (21%)

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA---------YDHNINPQT- 518
           AL YLH   +  +VHRD+KP N+LI +  + KL DFGL++          Y+ +I   T 
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 519 ----THIVGTLGYLAPEL 532
                 + GT  Y+APE+
Sbjct: 170 EFLDKQVCGTPEYIAPEV 187

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 48.6 bits (116), Expect = 7e-06
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 9/99 (9%)

Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT 519
           Y++L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR      +   T
Sbjct: 125 YQMLCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMT 175

Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
             V T  Y APE+        + D++  G +M E+  G 
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 52/221 (23%), Positives = 92/221 (41%), Gaps = 49/221 (22%)

Query: 363 VGSGGFGKVYRG--------------VIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR 408
           VG G +G VY+                I  TG+ ++  R              EI  +  
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACR--------------EIALLRE 54

Query: 409 LRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGV 466
           L+H N++ L          ++ L++DY  +     + F    +  K     +  ++  G+
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK-----KPVQLPRGM 109

Query: 467 AQALLY-----LHEECDQRVVHRDVKPSNVLIDADLNP-----KLGDFGLARAYDHNINP 516
            ++LLY     +H      V+HRD+KP+N+L+  +  P     K+ D G AR ++  + P
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKP 168

Query: 517 --QTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
                 +V T  Y APEL    +  T + D++  G +  E+
Sbjct: 169 LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 54/211 (25%), Positives = 91/211 (43%), Gaps = 29/211 (13%)

Query: 363 VGSGGFGKVYRGVIPSTG--LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG- 419
           VG G +G VY+          E A+K++             EI  +  L+H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIALQKV 66

Query: 420 -WCRKQDELLLVYDYVPNGSLDKLLFDN-DQQKKKILNWDQR------YKILIGVAQALL 471
                  ++ L++DY  +     + F    +  KK +   +       Y+IL G+     
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH---- 122

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNP-----KLGDFGLARAYDHNINP--QTTHIVGT 524
           YLH      V+HRD+KP+N+L+  +  P     K+ D G AR ++  + P      +V T
Sbjct: 123 YLHANW---VLHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 525 LGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
             Y APEL    +  T + D++  G +  E+
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 5e-05
 Identities = 34/95 (35%), Positives = 48/95 (50%), Gaps = 8/95 (8%)

Query: 466 VAQALL----YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTH 520
           VA+ LL    Y+H E    ++HRD+K  NVL++   +  LGDFG A  A      P    
Sbjct: 265 VARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321

Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
           I GT+   APE+      T S D++  G ++ E A
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 44.6 bits (106), Expect = 1e-04
 Identities = 48/220 (21%), Positives = 83/220 (37%), Gaps = 27/220 (12%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV---AEITSMGRLRHRNLVQLHGW 420
                  + +     T   VA+K++  +S    ++      EI +  +L+H N++     
Sbjct: 11  EDLMIVHLAKHK--PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTS 67

Query: 421 CRKQDELLLVYDYVPNGSLDKLL---FDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
                EL +V   +  GS + LL   F     +  I        IL  V  AL Y+H + 
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAF------ILKDVLNALDYIHSK- 120

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ------TTHIVGTLGYLAPE 531
               +HR VK S++L+  D    L     + +   +   Q          V  L +L+PE
Sbjct: 121 --GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178

Query: 532 LTRTGKA--TTSTDVFGFGTLMLEVACGRRPI-EPQRTAM 568
           + +         +D++  G    E+A G  P  +   T M
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM 218

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 35/127 (27%), Positives = 58/127 (45%), Gaps = 11/127 (8%)

Query: 431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN 490
           Y    +  +  LL D+  +    L+          VA+ + +L     +  VHRD+   N
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL---LSFTYQVARGMEFL---ASKNCVHRDLAARN 267

Query: 491 VLIDADLNPKLGDFGLARAYDHNIN---PQTTHIVGTLGYLAPELTRTGKATTSTDVFGF 547
           VL+      K+ DFGLAR   H+ N     +T +   + ++APE       TT +DV+ +
Sbjct: 268 VLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFL--PVKWMAPESIFDNLYTTLSDVWSY 325

Query: 548 GTLMLEV 554
           G L+ E+
Sbjct: 326 GILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 44.2 bits (104), Expect = 2e-04
 Identities = 35/102 (34%), Positives = 51/102 (50%), Gaps = 12/102 (11%)

Query: 460 YKILIG----VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN-- 513
           Y  L+G    VA  + +L     +  VHRD+   NVLI      K+ DFGLAR    +  
Sbjct: 238 YMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294

Query: 514 -INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            I+  +T +   L ++APE       TT +DV+ FG L+ E+
Sbjct: 295 YISKGSTFL--PLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 31/101 (30%), Positives = 51/101 (50%), Gaps = 13/101 (12%)

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG-- 523
           VAQ + +L     +  +HRDV   NVL+      K+ DFGLAR    +I   + ++V   
Sbjct: 221 VAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR----DIMNDSNYVVKGN 273

Query: 524 ---TLGYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               + ++APE       T  +DV+ +G L+ E+ + G+ P
Sbjct: 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 44.1 bits (104), Expect = 2e-04
 Identities = 30/125 (24%), Positives = 40/125 (32%), Gaps = 46/125 (36%)

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAY---------------DHNINPQTTH------ 520
           +HRD+KP N+LID   + KL DFGL+  +                 N N           
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 521 -------------------------IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
                                     VGT  Y+APE+          D +  G +M E  
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECL 242

Query: 556 CGRRP 560
            G  P
Sbjct: 243 IGWPP 247

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 41.6 bits (97), Expect = 0.001
 Identities = 28/92 (30%), Positives = 46/92 (50%), Gaps = 8/92 (8%)

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           VA+ + +L     ++ +HRD+   N+L+  +   K+ DFGLAR  D   +P         
Sbjct: 188 VAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDAR 242

Query: 525 --LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
             L ++APE       T  +DV+ FG L+ E+
Sbjct: 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 29/92 (31%), Positives = 47/92 (51%), Gaps = 8/92 (8%)

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           VA+ + +L     ++ +HRD+   N+L+  +   K+ DFGLAR  D   +P         
Sbjct: 183 VARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSAR 237

Query: 525 --LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
             L ++APE       TT +DV+ FG L+ E+
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 0.002
 Identities = 38/120 (31%), Positives = 54/120 (45%), Gaps = 16/120 (13%)

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI 521
           IL G  + L YLH+      +HR++K S++LI  D    L   GL+  Y    N Q   +
Sbjct: 106 ILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160

Query: 522 V--------GTLGYLAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQ-RTAMEL 570
           V          L +L+PEL R         +D++  G    E+A GR P +   RT M L
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 28/118 (23%), Positives = 45/118 (38%), Gaps = 11/118 (9%)

Query: 401 AEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY 460
           AE  ++     R L +LH      + L L         L + L    ++       D+  
Sbjct: 89  AERGALLEALARLLARLHSV--PPEALPLARRLRRRLKLLRQLAAALRRLVAAELLDRLA 146

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG---DFGLA----RAYD 511
           ++   +  ALL L       +VH D+ P N+L+D     ++    DF  A     AYD
Sbjct: 147 ELWERLLAALLALLPALPLVLVHGDLHPGNLLVDPG--GRVTGVIDFEDAGLGDPAYD 202

This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	662
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.98
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.98
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.97
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.97
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.96
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.94
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.94
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.94
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.93
PLN00181	793	protein SPA1-RELATED; Provisional	99.92
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.91
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.91
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.84
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.81
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.8
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.79
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.78
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.77
PRK12274	218	serine/threonine protein kinase; Provisional	99.76
PRK10345	210	hypothetical protein; Provisional	99.74
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	99.74
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.69
smart00090	237	RIO RIO-like kinase.	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.67
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.67
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.67
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.67
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.66
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.57
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	99.55
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.54
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.51
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.44
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.4
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.38
KOG3839	351	consensus Lectin VIP36, involved in the transport	99.36
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.23
KOG1243	690	consensus Protein kinase [General function predict	99.19
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.19
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	99.1
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.07
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.06
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.05
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.03
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
KOG3087	229	consensus Serine/threonine protein kinase [General	98.91
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	98.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.79
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.75
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.74
COG4248	637	Uncharacterized protein with protein kinase and he	98.66
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.5
PRK09902	216	hypothetical protein; Provisional	98.44
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.42
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.38
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.32
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.15
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.0
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.97
PF01636	239	APH: Phosphotransferase enzyme family This family	97.95
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.88
PLN02876	822	acyl-CoA dehydrogenase	97.86
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.86
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.84
PRK10593	297	hypothetical protein; Provisional	97.54
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.54
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.54
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.41
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.39
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.37
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.32
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.3
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.06
PRK05231	319	homoserine kinase; Provisional	97.02
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.78
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.68
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	96.66
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.34
PLN02236	344	choline kinase	96.25
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.08
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.03
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.02
KOG1093	725	consensus Predicted protein kinase (contains TBC a	95.78
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.69
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.59
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.26
PRK12396	409	5-methylribose kinase; Reviewed	95.18

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-57  Score=478.59  Aligned_cols=290  Identities=44%  Similarity=0.793  Sum_probs=256.1

Q ss_pred             CccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeee
Q 040242          341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       341 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      ....|+|+|+..||++|...++||+|+||.||+|.+. +|..||||++.....+..++|.+|+.++.+++|||||+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            4667999999999999999999999999999999995 458999998877654325669999999999999999999999


Q ss_pred             EeccC-eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          421 CRKQD-ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       421 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      |.+.+ +.+||||||++|+|+++|+.....   .|+|.+|++|+.++|+||+|||+.+.++|+||||||+|||||+++++
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence            99999 599999999999999999876421   89999999999999999999999998899999999999999999999


Q ss_pred             EEeeccccccccC-CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDH-NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||+++.... ........ .||.+|+|||+...+..++|+|||||||+|+||+||+.+.+......+..+.+|++.
T Consensus       217 KlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~  295 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP  295 (361)
T ss_pred             EccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence            9999999976544 22111111 799999999999999999999999999999999999999887655555669999999


Q ss_pred             HhhcCccccccCCCCC--CCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 040242          579 LHSQGQITRAIDPTLD--YFDP-QEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL  635 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~--~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  635 (662)
                      .+.++++.+.+|+.+.  .+.. ++..++..++.+|++.+|.+||+|.||+++|+.....
T Consensus       296 ~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  296 LLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            9999999999999983  4554 6888899999999999999999999999999655433

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=5.6e-55  Score=436.64  Aligned_cols=231  Identities=46%  Similarity=0.766  Sum_probs=208.7

Q ss_pred             eeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC--CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEE
Q 040242           21 NSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ--GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSI   96 (662)
Q Consensus        21 ~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~--~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i   96 (662)
                      ++|+|++|..  .+|+|+|+|.+.+++.|+||++.  .+++|||+|++||+||         +..++.++||+|+|+|+|
T Consensus         1 ~~f~f~~f~~~~~~l~l~G~A~~~~~~~i~LT~~~~~~~~~G~v~y~~pi~l~---------~~~~~~~~sFst~F~F~i   71 (236)
T cd06899           1 LSFNFNGFSSDQSNLTLQGDATISSNGALQLTNDTSPASSVGRALYSKPVRLW---------DSTTGKVASFSTSFSFSI   71 (236)
T ss_pred             CceecCCCCCCCCCEEEecceEcCCCCeEEecCCCCCCcceEEEEeCCCEEee---------cCCCCCceeEEEEEEEEE
Confidence            4799999986  79999999999768999999998  8999999999999999         666778888999999999


Q ss_pred             ecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccc
Q 040242           97 VPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISE  176 (662)
Q Consensus        97 ~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~  176 (662)
                      .+.+...+||||||+|+|....+.+..|++|||++..+.+++.+++|||||||++|.+++||++||||||+|++.|..+.
T Consensus        72 ~~~~~~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHigIdvn~~~S~~~~  151 (236)
T cd06899          72 TPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLVSVKAG  151 (236)
T ss_pred             EcCCCCCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeecccCcccCCCCCCeEEEEcCCcccceee
Confidence            98776789999999999987666678999999999887777889999999999999988899999999999999887766


Q ss_pred             cccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccCC
Q 040242          177 PAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTG  256 (662)
Q Consensus       177 ~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG  256 (662)
                      .+..            ..+.+.+|+.++|||+|++.+++|+|++...+..+|..|++++.+||+.+|+++|||||||+||
T Consensus       152 ~~~~------------~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFSasTG  219 (236)
T cd06899         152 YWDD------------DGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKKPLLSYPVDLSKVLPEEVYVGFSASTG  219 (236)
T ss_pred             cccc------------ccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcCCEEEEeccHHHhCCCceEEEEEeEcC
Confidence            5531            1234789999999999999999999999987777888999999999999999999999999999


Q ss_pred             cccceeEEecceeeec
Q 040242          257 LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       257 ~~~~~~~i~sW~f~~~  272 (662)
                      ...|.|+|++|+|++.
T Consensus       220 ~~~~~h~i~sWsF~s~  235 (236)
T cd06899         220 LLTELHYILSWSFSSN  235 (236)
T ss_pred             CCcceEEEEEEEEEcC
Confidence            9999999999999864

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=1.5e-53  Score=427.67  Aligned_cols=232  Identities=37%  Similarity=0.622  Sum_probs=203.8

Q ss_pred             ceeEEeCCC-CCCCeeEecceeeeCCCeEEecCCCC-CeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEe
Q 040242           20 TNSFIYNGF-IQANLSLDGTAFVRKDGILAVSNDQG-RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIV   97 (662)
Q Consensus        20 ~~~f~~~~f-~~~~~~l~G~a~~~~~~~~~Lt~~~~-~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~   97 (662)
                      +++|+|+.| +..+++|+|+|.+..+|.|+||++.. +++|||||++||+||         +..++.++||+|+|+|+|.
T Consensus         1 ~~~F~~~~F~~~~~~~l~G~A~~~~~~~l~LT~~~~~~~~G~~~y~~pi~l~---------d~~~~~~~sF~t~F~f~i~   71 (236)
T PF00139_consen    1 SVSFSFPSFSNSSNLTLNGDASISSNGSLQLTPDSTNNQAGRAWYNNPIQLW---------DSTTGNVASFSTSFSFSIT   71 (236)
T ss_dssp             EEEEEESSBTTGTTEEEEETEEEETTSEEESSTBETSSEEEEEEESSEEESB---------ETTTTEBEEEEEEEEEEEE
T ss_pred             CceEEcCCCCCCCceEEEeeEEeccCCeEEcCCCCCCCcEEEEEECCcEEEe---------CCCCcceeeeeeEEEEEEe
Confidence            478999999 56899999999996689999999988 999999999999999         6667777889999999996


Q ss_pred             cC--CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccc
Q 040242           98 PK--YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNIS  175 (662)
Q Consensus        98 ~~--~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~  175 (662)
                      ..  ....+||||||||+|....+.++.|++||+++..+.+.+.+++|||||||++|++++||++||||||+|++.|..+
T Consensus        72 ~~~~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEFDT~~N~~~~d~~~nHIgI~~n~~~s~~~  151 (236)
T PF00139_consen   72 NGPGSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEFDTYKNPEYNDPDDNHIGIDVNSVVSNKT  151 (236)
T ss_dssp             ESSSSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEEETSTCGGGTTTSSSEEEEEESSSSESEE
T ss_pred             ccCCCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEEeeeecccccccCCCEEEEECCCCccccc
Confidence            43  4577899999999999866777899999999988777778999999999999999999999999999999999888


Q ss_pred             ccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccC
Q 040242          176 EPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST  255 (662)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast  255 (662)
                      .+++++         ......+.+|+.++|||+||+.+++|+|++.... .+|..|++++.+||+.+|+++|||||||||
T Consensus       152 ~~~~~~---------~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~~~l~~~vdL~~~l~~~v~vGFsasT  221 (236)
T PF00139_consen  152 ASAGYY---------SSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSSPVLSVNVDLSAVLPEQVYVGFSAST  221 (236)
T ss_dssp             EE-------------EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEEEEEEEE--HHHHSCSEEEEEEEEEE
T ss_pred             cccccc---------ccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcceeEEEEEchHHhcCCCcEEEEEeec
Confidence            766644         2245678999999999999999999999999874 688889999999999999999999999999


Q ss_pred             CcccceeEEecceee
Q 040242          256 GLLTAFHNVHGWSFK  270 (662)
Q Consensus       256 G~~~~~~~i~sW~f~  270 (662)
                      |...|.|.|++|+|+
T Consensus       222 G~~~~~h~I~sW~F~  236 (236)
T PF00139_consen  222 GGSYQTHDILSWSFS  236 (236)
T ss_dssp             SSSSEEEEEEEEEEE
T ss_pred             CCCcceEEEEEEEeC
Confidence            999999999999995

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=387.31  Aligned_cols=250  Identities=32%  Similarity=0.538  Sum_probs=207.3

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcE-EEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccC-eeeEEEecc
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLE-VAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-ELLLVYDYV  434 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~-vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~~  434 (662)
                      ..+.||+|+||+||+|.+.  |+. ||||++.....  ...++|.+|+.+|.+++|||||+++|+|.+.. .+++|||||
T Consensus        45 ~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            3456999999999999994  555 99999976532  22679999999999999999999999999887 799999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC-EEeCCcCCCceEeCCCC-CeEEeeccccccccC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR-VVHRDVKPSNVLIDADL-NPKLGDFGLARAYDH  512 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~  512 (662)
                      ++|+|.++|+..   ....+++..+++++.|||+||.|||+   .+ ||||||||+||||+.++ ++||+|||+++....
T Consensus       123 ~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  123 PGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             CCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            999999999875   25779999999999999999999999   56 99999999999999997 999999999987654


Q ss_pred             CCCCcceecccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          513 NINPQTTHIVGTLGYLAPELTR--TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      .. ...+...||+.|||||++.  ...++.|+||||||++||||+||+.||..... .+..  ..+.        .....
T Consensus       197 ~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~--~~v~--------~~~~R  264 (362)
T KOG0192|consen  197 SK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVA--SAVV--------VGGLR  264 (362)
T ss_pred             cc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHH--HHHH--------hcCCC
Confidence            32 2333368999999999999  56899999999999999999999999987654 1111  1111        01111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      |   ..+......+..|+.+||+.||.+||++.+|+..|+.
T Consensus       265 p---~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~  302 (362)
T KOG0192|consen  265 P---PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLES  302 (362)
T ss_pred             C---CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHH
Confidence            2   2233366778888899999999999999999999974

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-45  Score=364.64  Aligned_cols=255  Identities=27%  Similarity=0.395  Sum_probs=214.4

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK  423 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~  423 (662)
                      ++.+||..       .+.||+|..|+|||+.++.+++.+|+|.+... .....+++.+|++++++.+|||||+++|+|..
T Consensus        76 i~~~dle~-------~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~  148 (364)
T KOG0581|consen   76 ISLSDLER-------LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS  148 (364)
T ss_pred             cCHHHhhh-------hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence            45555543       67899999999999999999999999999655 44556889999999999999999999999999


Q ss_pred             cC-eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          424 QD-ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       424 ~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ++ +..++||||.+|+|++++...     +.+++...-+|+.++++||.|||++  .+||||||||+|||++..|.+|||
T Consensus       149 ~~~~isI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  149 NGEEISICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             CCceEEeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEec
Confidence            99 599999999999999999543     4588999999999999999999964  899999999999999999999999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc--hhhHHHHHHHHHHh
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT--AMELVLVDWVRELH  580 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~  580 (662)
                      |||.++.+-+.   .....+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....+  .....+..++    
T Consensus       222 DFGVS~~lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I----  294 (364)
T KOG0581|consen  222 DFGVSGILVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI----  294 (364)
T ss_pred             cccccHHhhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH----
Confidence            99999876544   33457899999999999999999999999999999999999999986421  1222222222    


Q ss_pred             hcCccccccCCCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQGQITRAIDPTLDYFDP-QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~~~~~~~id~~l~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                              ++..-...+. ....++..++..||+.||.+||++.|++++
T Consensus       295 --------v~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  295 --------VDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             --------hcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                    2211122223 367788999999999999999999999974

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-44  Score=378.88  Aligned_cols=253  Identities=26%  Similarity=0.440  Sum_probs=216.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .+|...+.||+|||+.||++++..+|+.||+|++.+.   .....+...+||++.++|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5688899999999999999999899999999999774   3445677899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |+|++++|..++++     ++.+++.+.+.+..||+.||.|||+   .+|+|||||..|+||++++++||+|||||...+
T Consensus        98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence            99999999999952     5789999999999999999999999   899999999999999999999999999999887


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .+... ....+|||.|+|||++.....+..+||||+||+||-|++|++||+...-.          +.+..-+..+..- 
T Consensus       170 ~~~Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk----------ety~~Ik~~~Y~~-  237 (592)
T KOG0575|consen  170 YDGER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK----------ETYNKIKLNEYSM-  237 (592)
T ss_pred             Ccccc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH----------HHHHHHHhcCccc-
Confidence            65433 34469999999999999888999999999999999999999999865322          2222111122221 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  632 (662)
                           +........+|+.++|++||.+|||+++|+.  ++.+.
T Consensus       238 -----P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  238 -----PSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             -----ccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence                 2234455778899999999999999999997  45333

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=378.87  Aligned_cols=251  Identities=29%  Similarity=0.436  Sum_probs=213.0

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      ...+.||+|.||.||.|.+. ....||+|.+... ....+.|.+|+++|++|+|+|||+++|+|..++.++||||||+.|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G  286 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG  286 (468)
T ss_pred             HHHHHhcCCccceEEEEEEc-CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence            34678999999999999994 3458999999765 334578999999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|.++|....   ...+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||||+....+....
T Consensus       287 sLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  287 SLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             cHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            9999997633   5678999999999999999999999   899999999999999999999999999999666554444


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC-CC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DY  595 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~~  595 (662)
                      .....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+.                .+.++... -.
T Consensus       361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev----------------~~~le~GyRlp  424 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV----------------LELLERGYRLP  424 (468)
T ss_pred             cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH----------------HHHHhccCcCC
Confidence            444456789999999999999999999999999999999 8888876543221                12222222 23


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+..++..+.+|+..||+.+|++|||++.+...|+..
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            4567888999999999999999999999988888653

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-43  Score=354.66  Aligned_cols=201  Identities=28%  Similarity=0.519  Sum_probs=182.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .+|...+.||+|.|++||+|+++.++..||||.+.+.  .....+....|+.+|++++|||||++++++..++.++||||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME   89 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME   89 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence            5677788899999999999999999999999999776  56666778999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC------CCeEEeeccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD------LNPKLGDFGL  506 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~------~~~kL~DfGl  506 (662)
                      ||.+|+|.++|+..     ..+++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+
T Consensus        90 yC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf  161 (429)
T KOG0595|consen   90 YCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF  161 (429)
T ss_pred             eCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence            99999999999643     469999999999999999999999   999999999999999875      4589999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQR  565 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~  565 (662)
                      |+.+...  ......+|++.|||||++...+|+.|+|+||+|+||||+++|+.||+...
T Consensus       162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            9987643  33445789999999999999999999999999999999999999998543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-44  Score=342.97  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=214.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeee-EeccCe-eeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGW-CRKQDE-LLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~-~~~~~~-~~lV  430 (662)
                      .+|++.++||+|.||+|||+....+|..+|.|.++-.  .....+++..|+.+|++|+|||||+++++ +.++.+ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            3477889999999999999999999999999998754  45566789999999999999999999994 344444 8999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||..|+|..++...... +..++++..|+++.|++.||..+|+.+.. -|+||||||.||+|+.+|.+||+||||++.
T Consensus        99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~  177 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF  177 (375)
T ss_pred             HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence            9999999999999765432 56799999999999999999999985532 499999999999999999999999999998


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      +.... ......+|||.||+||.+....++.||||||+||++|||+.-+.||.+..-   ..|    .+...+++     
T Consensus       178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~L----~~KI~qgd-----  244 (375)
T KOG0591|consen  178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LSL----CKKIEQGD-----  244 (375)
T ss_pred             hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HHH----HHHHHcCC-----
Confidence            87643 233447899999999999999999999999999999999999999987621   111    12222221     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      -|.+.  +.-....+..|+..|+..||+.||+...+++.+.++
T Consensus       245 ~~~~p--~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  245 YPPLP--DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             CCCCc--HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            11121  245678899999999999999999976666665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.1e-43  Score=353.52  Aligned_cols=253  Identities=27%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-------hHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-------GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      +.|...+.||+|+||.|-+|+.+.+|+.||||++.+....       ......+|+++|++|+|||||++++++...+..
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~  251 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS  251 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence            4466789999999999999999999999999999765211       122356999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeec
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDF  504 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~Df  504 (662)
                      |+|||||+||.|.+.+..+     +.+.+..-.-+++|++.|+.|||+   .+|+||||||+|||+..+   ..+||+||
T Consensus       252 YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  252 YMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             EEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEeccc
Confidence            9999999999999998654     346666677899999999999999   999999999999999776   67999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCC--C-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGK--A-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      |+|+..++.  ......+||+.|.|||++.++.  + ..+.|+||+||+||-+++|.+||........  +    .++..
T Consensus       324 GlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQIL  395 (475)
T ss_pred             chhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHHHh
Confidence            999987643  3445579999999999997653  3 3488999999999999999999985543211  1    11111


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .|+..  +.   ........++.+.|+.+||..||++||++.|++++
T Consensus       396 ~G~y~--f~---p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 KGRYA--FG---PLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cCccc--cc---ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            12110  00   12234567788999999999999999999999975

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=4e-42  Score=377.48  Aligned_cols=260  Identities=28%  Similarity=0.431  Sum_probs=216.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +....+.||+|.||+||+|+..+     ....||||.++..... ..++|.+|++++..++|||||+|+|.|.+++.+++
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            34456789999999999998742     3367999999887555 78899999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccc---------cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeE
Q 040242          430 VYDYVPNGSLDKLLFDNDQQK---------KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                      |+|||..|+|.++|.......         ..+|+..+.+.||.|||.||.||-+   ..+|||||..+|+||.++..||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VK  643 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVK  643 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEE
Confidence            999999999999997543211         2348999999999999999999999   8999999999999999999999


Q ss_pred             Eeeccccccc-cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHH
Q 040242          501 LGDFGLARAY-DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       501 L~DfGla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      |+||||++.. ..+.........-+.+||+||.+..+++|.+||||||||+|||+++ |+.|+.+....+..   +.   
T Consensus       644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI---e~---  717 (774)
T KOG1026|consen  644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI---EC---  717 (774)
T ss_pred             ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH---HH---
Confidence            9999999853 2222222223345789999999999999999999999999999998 99999876554322   22   


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                       ..+|+        +-..++.++.++..|++.||+.+|.+||+++||-..|..-.
T Consensus       718 -i~~g~--------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  718 -IRAGQ--------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             -HHcCC--------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence             22333        23456788899999999999999999999999999997543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-42  Score=371.67  Aligned_cols=270  Identities=28%  Similarity=0.472  Sum_probs=225.6

Q ss_pred             cchHHHHHhccC---------CcccceeeeeCceEEEEEEeCCCC---cEEEEEEeecc-chhhHHHHHHHHHHhhcccc
Q 040242          345 FRYSELYSATKG---------FREKNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRH  411 (662)
Q Consensus       345 ~~~~el~~at~~---------f~~~~~LG~G~~g~Vy~~~~~~~g---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H  411 (662)
                      ++|+|-..|-..         ..+.++||.|.||.||+|.++..|   ..||||.++.. .+....+|+.|+.+|.+..|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            567765555443         345789999999999999997655   56999999876 45567899999999999999


Q ss_pred             ccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       412 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      |||++|.|...+.+..++|.|||+||+|+.+|..+.    ..+++-++.-++++||.||+||.+   .++|||||.++||
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNI  762 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNI  762 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhhe
Confidence            999999999999999999999999999999997763    459999999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCCCcceeccc--CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchh
Q 040242          492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVG--TLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAM  568 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  568 (662)
                      |++.+..+|++||||+|.++++.....+..-|  +.+|.|||.+...++|.++||||||++|||.++ |.+||......+
T Consensus       763 LVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd  842 (996)
T KOG0196|consen  763 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD  842 (996)
T ss_pred             eeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH
Confidence            99999999999999999887665333332222  579999999999999999999999999999887 999997544322


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ  637 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  637 (662)
                      .                .+.++... -.-+++++..|.+|++.||+.|..+||++.+|+.+|.+...-|.
T Consensus       843 V----------------IkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  843 V----------------IKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             H----------------HHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            1                12222222 12356788899999999999999999999999999987654443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.4e-41  Score=329.31  Aligned_cols=264  Identities=27%  Similarity=0.360  Sum_probs=211.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +.|+...++|+|+||.|||++.+.+|+.||||++....  ....+-.++|+++|++++|+|+|.+++.|..++.++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            34677889999999999999999999999999996543  3334556899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||+..-|+++= ..    ...++.....+++.|+++|+.|+|+   ++++||||||+|||++.++.+||||||.|+.+..
T Consensus        82 ~~dhTvL~eLe-~~----p~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDHTVLHELE-RY----PNGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecchHHHHHHH-hc----cCCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            99775555543 32    3457888899999999999999999   8999999999999999999999999999998875


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH--------HHHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV--------RELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~  583 (662)
                      . ....+..+.|..|.|||.+-+ .+|....|||+.||++.||++|.+-|.+..+.++..++...        .+.+...
T Consensus       154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N  232 (396)
T KOG0593|consen  154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN  232 (396)
T ss_pred             C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence            3 345566788999999998877 68999999999999999999999999887776665543321        1222222


Q ss_pred             ccc-cccCCCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          584 QIT-RAIDPTL------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       584 ~~~-~~id~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ... ...-|..      ....+.....+++++..|++.||++|++-+|++.
T Consensus       233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            111 1111211      1112233456889999999999999999999885

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-41  Score=338.28  Aligned_cols=243  Identities=26%  Similarity=0.368  Sum_probs=203.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .++|+..++||+|+||+||.++.+++++.+|+|++++..   ....+...+|..+|.+++||.||+++-.++..+.+|||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            467999999999999999999999999999999997752   33456789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +||+.||.|..+|.+     ...+++....-.+..|+.||.|||+   .+|+||||||+|||||++|.++|+||||++..
T Consensus       104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            999999999999954     3458888888889999999999999   99999999999999999999999999999964


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... ...+...+||+.|||||++.+..++..+|.||+|+++|||++|.+||......      .+...... ++      
T Consensus       176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~~~~~I~~-~k------  241 (357)
T KOG0598|consen  176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------KMYDKILK-GK------  241 (357)
T ss_pred             ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------HHHHHHhc-Cc------
Confidence            433 23344479999999999999999999999999999999999999999876432      12211111 11      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                        +...+.-......+++.+.+..||++|-
T Consensus       242 --~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  242 --LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence              1222222445567788899999999995

>cd01951 lectin_L-type legume lectins

Probab=100.00  E-value=6.4e-40  Score=327.11  Aligned_cols=205  Identities=29%  Similarity=0.422  Sum_probs=172.3

Q ss_pred             CCCeeEecceeeeC-CCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCce
Q 040242           30 QANLSLDGTAFVRK-DGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGL  108 (662)
Q Consensus        30 ~~~~~l~G~a~~~~-~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGl  108 (662)
                      ..+++++|+|.+.+ ++.|+||++..+++||+||++||++|                ++|+|+|+|+|.+.. ..+||||
T Consensus        13 ~~~~~~~G~A~~~~~~~~l~Lt~~~~~~~G~~~~~~~i~~~----------------~~F~~~F~f~i~~~~-~~~gdG~   75 (223)
T cd01951          13 QSNWQLNGSATLTTDSGVLRLTPDTGNQAGSAWYKTPIDLS----------------KDFTTTFKFYLGTKG-TNGADGI   75 (223)
T ss_pred             hhhcEEcccEEecCCCCEEEECCCCCCcEEEEEECCcEecc----------------CCEEEEEEEEEeCCC-CCCCCcE
Confidence            35899999999975 78999999999999999999999998                469999999998864 5689999


Q ss_pred             eEEEccCCCCCCCCcc--cccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccc--cccccccccC
Q 040242          109 AFVLMSRKQPPSCLAN--QYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNI--SEPAAYYFSK  184 (662)
Q Consensus       109 aF~l~~~~~~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~--~~~~~~~~~~  184 (662)
                      ||+|+|....+.+.+|  ++||+       ...++.+|||||||+|.+++||+.+|||||+|+..+..  ..+.++.   
T Consensus        76 aF~l~~~~~~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~higi~~n~~~~~~~~~~~~~~~---  145 (223)
T cd01951          76 AFVLQNDPAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSA---  145 (223)
T ss_pred             EEEEecCCCCccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEEEEEcCCCCCCccccccccee---
Confidence            9999998755555555  78887       34567899999999999888999999999999997642  1111211   


Q ss_pred             CCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEE
Q 040242          185 GSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNV  264 (662)
Q Consensus       185 ~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i  264 (662)
                             ..+....+|+.++|||+|++.+++|+|++.....  |..+.++.++||+..++++||||||||||...+.|+|
T Consensus       146 -------~~~~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~~~l~~~~~l~~~~~~~~yvGFTAsTG~~~~~h~V  216 (223)
T cd01951         146 -------SLPNGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDI  216 (223)
T ss_pred             -------eCCCccCCCCEEEEEEEEeCCCCEEEEEECCCCc--cccccEEEeeeecccCCCcEEEEEEcccCCCcceeEE
Confidence                   0111222399999999999999999999986554  6678999999999999999999999999999999999


Q ss_pred             ecceee
Q 040242          265 HGWSFK  270 (662)
Q Consensus       265 ~sW~f~  270 (662)
                      ++|+|+
T Consensus       217 ~~wsf~  222 (223)
T cd01951         217 LNWSFT  222 (223)
T ss_pred             EEEEec
Confidence            999996

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-40  Score=344.95  Aligned_cols=279  Identities=25%  Similarity=0.357  Sum_probs=221.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  430 (662)
                      +.|+..++||+|.||.||||++..+|+.||+|++..+.  .....-..+||.+|++|.||||++|.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            34666789999999999999999999999999997764  33345557999999999999999999988776  689999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +|||++ +|.-++...    .-.++..++..+++|+++||.|+|+   .+|+|||||.+|||||.+|.+||+|||||+.+
T Consensus       197 FeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y  268 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFY  268 (560)
T ss_pred             Eecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeec
Confidence            999965 788877543    3568999999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH-----hhcCc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL-----HSQGQ  584 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-----~~~~~  584 (662)
                      ........+..+-|..|.|||.+.+. .|+.+.|+||.||||.||++|++.+.+..+.++...+--+..-     |...+
T Consensus       269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k  348 (560)
T KOG0600|consen  269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK  348 (560)
T ss_pred             cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence            87766667777889999999988764 6999999999999999999999999987766655433222211     11111


Q ss_pred             cc--cccCCCCCCCC-------HHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCCCCCCCCCC
Q 040242          585 IT--RAIDPTLDYFD-------PQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPLDIH  643 (662)
Q Consensus       585 ~~--~~id~~l~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~~~~  643 (662)
                      +.  ..+.+. ..+.       .......++|+..+|..||++|.|+.++++  ++ ...|+|..|...+
T Consensus       349 LP~~~~~kp~-~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF-~t~p~~~~p~~Lp  416 (560)
T KOG0600|consen  349 LPHATIFKPQ-QPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF-TTEPLPCDPSSLP  416 (560)
T ss_pred             CCcccccCCC-CcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc-ccCCCCCCcccCC
Confidence            11  111111 1111       122345788899999999999999999996  34 5666666666644

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-41  Score=342.04  Aligned_cols=257  Identities=26%  Similarity=0.435  Sum_probs=207.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC--eeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--ELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV~E  432 (662)
                      .++...+.||+|.||+||++...++|...|||.+........+.+.+|+.+|++++|||||+++|.....+  .++++||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            34566789999999999999998889999999987764444677899999999999999999999854444  6999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~  511 (662)
                      |+++|+|.+++.+..   . .|++....+...||++||.|||+   ++|+||||||+||||+. ++.+||+|||+++...
T Consensus        97 y~~~GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             ccCCCcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999996653   2 69999999999999999999998   99999999999999999 7999999999999776


Q ss_pred             C--CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 H--NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .  ..........||+.|||||++..+ ...+++||||+||++.||+||++||......     .+++-.....     .
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~-----~~~~~~ig~~-----~  239 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEE-----AEALLLIGRE-----D  239 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcch-----HHHHHHHhcc-----C
Confidence            4  222234457899999999999854 3446999999999999999999999864111     1111111111     1


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .-|   .++........+++.+|+..+|.+|||+.+++++.--
T Consensus       240 ~~P---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  240 SLP---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             CCC---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            112   3344466677888999999999999999999997543

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-41  Score=352.35  Aligned_cols=263  Identities=25%  Similarity=0.424  Sum_probs=211.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ..+.+...+.||+|+||+||+|.+.+   .||||.+...  ..+..+.|++|+..+++-||.||+-+.|||.+... .+|
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIi  465 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AII  465 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eee
Confidence            33455667899999999999999954   4999999765  45577899999999999999999999999988877 999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +.+|+|-+|..+||..    +..++..+.+.|++|||+|+.|||.   ++|||||||+.||+|.++++|||+||||+...
T Consensus       466 TqwCeGsSLY~hlHv~----etkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk  538 (678)
T KOG0193|consen  466 TQWCEGSSLYTHLHVQ----ETKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVK  538 (678)
T ss_pred             ehhccCchhhhhccch----hhhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeee
Confidence            9999999999999876    4668999999999999999999999   99999999999999999999999999999754


Q ss_pred             cCC-CCCcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          511 DHN-INPQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       511 ~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ..- .........|...|||||++..   ..+++.+||||||+|+|||+||..||.. ...++..   |     .-|+  
T Consensus       539 ~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi---f-----mVGr--  607 (678)
T KOG0193|consen  539 TRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII---F-----MVGR--  607 (678)
T ss_pred             eeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE---E-----Eecc--
Confidence            321 1222333457889999998864   3689999999999999999999999983 3322221   1     0011  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC-CCC
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS-LPQ  637 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~-~p~  637 (662)
                      ..+-+.+........+.+.+|...||..++++||.+.+|+..|+...+ +|.
T Consensus       608 G~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pk  659 (678)
T KOG0193|consen  608 GYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPK  659 (678)
T ss_pred             cccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccc
Confidence            111233323344567778888899999999999999999998877655 443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=7.2e-40  Score=314.20  Aligned_cols=284  Identities=24%  Similarity=0.341  Sum_probs=226.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .+|...++||+|.||.||+|++..+|+.||||+++.....  .....++|++.|++++|+||+.+++++-..+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677789999999999999999999999999999765322  23467899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      || ..+|+..+++.    ...|+-.++..++.++++||+|||+   +.|+||||||.|+|++++|.+||+|||+++.+..
T Consensus        82 fm-~tdLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             ec-cccHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            99 56999999766    5678889999999999999999999   8999999999999999999999999999999886


Q ss_pred             CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc---------
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ---------  582 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---------  582 (662)
                      ...... ..+-|..|.|||.+.+. .|+...|+||.|||+.||+.|.+-|.+..+.++...+-.+-.....         
T Consensus       154 p~~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~l  232 (318)
T KOG0659|consen  154 PNRIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSL  232 (318)
T ss_pred             CCcccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccc
Confidence            544333 34779999999988664 6899999999999999999998888776665554432211111000         


Q ss_pred             ---CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-hcCCCCCCCCCCCCCCCC
Q 040242          583 ---GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL-LRDASLPQAPLDIHHEFP  647 (662)
Q Consensus       583 ---~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L-~~~~~~p~~p~~~~~~~~  647 (662)
                         .++.+.=.+.+...-.......++|+..++..||.+|+++.|++++= -+..|.|.+|.+.+.+..
T Consensus       233 pdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p~~  301 (318)
T KOG0659|consen  233 PDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIPST  301 (318)
T ss_pred             ccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCCcc
Confidence               01111111222223334455669999999999999999999999863 344888888888665554

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.9e-39  Score=389.90  Aligned_cols=268  Identities=28%  Similarity=0.554  Sum_probs=221.2

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ  424 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~  424 (662)
                      ++++++.   ..|...++||+|+||.||+|+...++..||||++.......    ..|++.+++++||||++++++|...
T Consensus       683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~  755 (968)
T PLN00113        683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSE  755 (968)
T ss_pred             hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcC
Confidence            4444444   45778889999999999999998889999999986543221    3468889999999999999999999


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      +..++||||+++|+|.++++        .++|.++.+++.|+|+||+|||+.+.++|+||||||+||+++.++.+++. +
T Consensus       756 ~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~  826 (968)
T PLN00113        756 KGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-L  826 (968)
T ss_pred             CCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-e
Confidence            99999999999999999983        38999999999999999999997666899999999999999999988876 6


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |........     ....++..|+|||++.+..++.++|||||||++|||+||+.|+..... ....+.+|++..+....
T Consensus       827 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~  900 (968)
T PLN00113        827 SLPGLLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCH  900 (968)
T ss_pred             ccccccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccc
Confidence            655433211     223678999999999999999999999999999999999999864322 23346678877766666


Q ss_pred             cccccCCCCC---CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          585 ITRAIDPTLD---YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       585 ~~~~id~~l~---~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      ....+|+.+.   ..+..+..++.+++.+||+.+|++||+|+||++.|++...
T Consensus       901 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        901 LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             hhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            6667777762   3455677788999999999999999999999999987644

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-40  Score=347.79  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC-
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD-  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~-  425 (662)
                      .++|+..++||+|+||.||+|...     ..+..||||++.... ....+.+.+|+.++.++ +||||++++++|...+ 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            367888999999999999999752     345679999987543 33456789999999999 8999999999887644 


Q ss_pred             eeeEEEeccCCCCcchhccccccc--------------------------------------------------------
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ--------------------------------------------------------  449 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------  449 (662)
                      ..++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            689999999999999998643210                                                        


Q ss_pred             -ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcc
Q 040242          450 -KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGY  527 (662)
Q Consensus       450 -~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y  527 (662)
                       ....+++.++..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++....... .......++..|
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence             02358889999999999999999999   8999999999999999999999999999986533221 112223467889


Q ss_pred             cCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHH
Q 040242          528 LAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLT  606 (662)
Q Consensus       528 ~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~  606 (662)
                      +|||.+.+..++.++|||||||++|||++ |+.||........  +    ......+..     ..   .+......+.+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~----~~~~~~~~~-----~~---~~~~~~~~l~~  308 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F----CQRLKDGTR-----MR---APENATPEIYR  308 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H----HHHHhcCCC-----CC---CCCCCCHHHHH
Confidence            99999988889999999999999999997 9999975432211  1    111111111     11   11233456889


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          607 LGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       607 l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      |+.+||+.||.+||++.|+++.|+..
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.4e-41  Score=343.48  Aligned_cols=264  Identities=26%  Similarity=0.381  Sum_probs=213.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-hHHHHHHHHHHhhccc-cccceeeeeeEeccC-eeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLR-HRNLVQLHGWCRKQD-ELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~-~~~lV~  431 (662)
                      ++|...++||.|.||+||+|+....|..||||++++.-.. ....=++|++.|++|+ ||||++|.+.+.+.+ .+++||
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVf   89 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVF   89 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeH
Confidence            5677789999999999999999999999999999765322 1223378999999998 999999999998888 999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||| ..+|.+++++.    +..+++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+|||+||-..
T Consensus        90 E~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~  161 (538)
T KOG0661|consen   90 EFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVR  161 (538)
T ss_pred             Hhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccc
Confidence            999 56999999765    5789999999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCCcceecccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH-----HhhcC-c
Q 040242          512 HNINPQTTHIVGTLGYLAPELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE-----LHSQG-Q  584 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~~~-~  584 (662)
                      .  .+..+..+.|..|.|||++ ..+.|+.+.|+|++|||++|+.+-++-|.+..+.++..-+--+-.     -+.++ .
T Consensus       162 S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  162 S--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             c--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHH
Confidence            3  3566778899999999976 567899999999999999999999999988766555432111110     01110 1


Q ss_pred             c--------ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 I--------TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~--------~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +        .+.....+...-+.......+|+.+|+.+||.+|||+.|++++
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            1        1111122222223366778999999999999999999999985

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-39  Score=335.53  Aligned_cols=262  Identities=27%  Similarity=0.436  Sum_probs=212.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ...+.++||+|-||.|.+++.. .+..||||.++... ....++|..|+++|.+++||||++++|.|..++.+++|+|||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeve-g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm  617 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVE-GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM  617 (807)
T ss_pred             heehhhhhcCcccceeEEEEec-CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence            4555788999999999999994 46899999998764 445689999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC-C
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-N  513 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~-~  513 (662)
                      ++|+|.++|..+..   ..+.-....+|+.|||.||+||.+   .+++||||.++|+|++.++++||+|||+++.+-. +
T Consensus       618 EnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  618 ENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             hcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            99999999977642   224556677899999999999999   8999999999999999999999999999994432 2


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHH--cCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ell--tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ........+-+.+|||||.+..+++|.++|||+||+++||++  |...||.....+   ..++-..+.++.+.....   
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e---~vven~~~~~~~~~~~~~---  765 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE---QVVENAGEFFRDQGRQVV---  765 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH---HHHHhhhhhcCCCCccee---
Confidence            223333455678999999999999999999999999999985  577888754322   222333333333221111   


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        ...+.-++..+.++++.||..+-.+||+++++..+|...
T Consensus       766 --l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 --LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             --ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence              223455677888999999999999999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-40  Score=336.38  Aligned_cols=268  Identities=26%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhh--ccccccceeeeeeEeccC----eee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG--RLRHRNLVQLHGWCRKQD----ELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~--~l~H~niv~l~~~~~~~~----~~~  428 (662)
                      ...+..++||+|+||.||||++  .++.||||++....   .+.|.+|-.+.+  .++|+||++++++-....    +++
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             CchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            4455578899999999999999  56899999996544   456667766655  468999999999887665    899


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC------CCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC------DQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ||+||.++|+|.++|.      ...++|....+|+..+++||+|||++.      +++|+|||||++||||..|+++.|+
T Consensus       285 LVt~fh~kGsL~dyL~------~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIa  358 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLK------ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIA  358 (534)
T ss_pred             EEeeeccCCcHHHHHH------hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEee
Confidence            9999999999999995      457999999999999999999999864      5679999999999999999999999


Q ss_pred             eccccccccCCCCC-cceecccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCc-ccchhhHHH--
Q 040242          503 DFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGK------ATTSTDVFGFGTLMLEVACGRRPIEP-QRTAMELVL--  572 (662)
Q Consensus       503 DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~-~~~~~~~~l--  572 (662)
                      |||||..+...... ..-..+||.+|||||++.+..      .-.+.||||+|.|||||++.....+. ..++.+..+  
T Consensus       359 DFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~  438 (534)
T KOG3653|consen  359 DFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEA  438 (534)
T ss_pred             ccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhH
Confidence            99999988765433 223378999999999997642      22468999999999999986654431 111111111  


Q ss_pred             -------HHHHHHHhhcCccccccCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 040242          573 -------VDWVRELHSQGQITRAIDPTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ  637 (662)
Q Consensus       573 -------~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  637 (662)
                             .+-++....    .+...|.+.  ......+..+.+.+..||+.||+.|-|+.=|.+++....-+.+
T Consensus       439 evG~hPt~e~mq~~VV----~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  439 EVGNHPTLEEMQELVV----RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HhcCCCCHHHHHHHHH----hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                   112222221    122233331  1122567788999999999999999999999988877655544

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.4e-39  Score=334.95  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .|+..+.||+|+||+||++....+++.||+|.+....   ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            3677899999999999999998899999999986542   2334567899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|..++....   ...+++..++.++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++.....
T Consensus        81 ~~~~g~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            999999998885432   3468999999999999999999999   8999999999999999999999999999987543


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ..  ......||..|+|||++.+..++.++|||||||++|||++|+.||..........  . +.....         ..
T Consensus       155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~-~~~~~~---------~~  220 (285)
T cd05631         155 GE--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--E-VDRRVK---------ED  220 (285)
T ss_pred             CC--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--H-HHHHhh---------cc
Confidence            22  2233568999999999998899999999999999999999999998654321111  0 000000         00


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                      ...+.......+..|+.+||+.||.+||+     +++++++
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            11222334567888999999999999997     7888864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-39  Score=340.32  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=207.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc----ch-hhHHHHHHHHHHhhccc-cccceeeeeeEeccCe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN----SR-QGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDE  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~----~~-~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~  426 (662)
                      ..++|...+.||+|.||+|++|....++..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            446788999999999999999999999999999977553    11 23445668999999999 9999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeecc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFG  505 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfG  505 (662)
                      +++||||+.+|+|.+++.+     ...+.+.+...++.|++.|++|+|+   .+|+||||||+|||++.+ +++||+|||
T Consensus        95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            9999999999999999965     3567888999999999999999999   899999999999999999 999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCC-CC-cchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGK-AT-TSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ++.... .........+||+.|+|||++.+.. ++ .++||||+||+||.|++|+.||+......   +       +.. 
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l-------~~k-  234 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---L-------YRK-  234 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---H-------HHH-
Confidence            999874 2223444568999999999998866 64 78999999999999999999999743211   1       111 


Q ss_pred             ccccccCCCCCCCCHHH-HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQE-AELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~-~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           +...--.++... ...+..|+.+|+..||.+|+++.+|+.+
T Consensus       235 -----i~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  235 -----IRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -----HhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                 111111112222 6778899999999999999999999953

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=6.5e-39  Score=329.26  Aligned_cols=255  Identities=26%  Similarity=0.407  Sum_probs=205.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|.+.   ..+..||+|.+.... ......|.+|+..+.+++||||+++++++..++..++|
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   84 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV   84 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence            56888999999999999999874   346789999987653 33456789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...    ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+|++|||.+...
T Consensus        85 ~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~  157 (266)
T cd05064          85 TEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQED  157 (266)
T ss_pred             EEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence            9999999999999643    2468999999999999999999999   89999999999999999999999999987653


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ............++..|+|||.+.+..++.++|||||||++||+++ |+.||.......   +...+    .++.     
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~-----  225 (266)
T cd05064         158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAV----EDGF-----  225 (266)
T ss_pred             cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCC-----
Confidence            3221111112345678999999988899999999999999999775 999997543221   11111    1111     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .   ...+...+..+.+++.+||+.+|.+||++.+|.+.|.+
T Consensus       226 ~---~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 R---LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             C---CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            0   01123345678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-39  Score=326.48  Aligned_cols=260  Identities=27%  Similarity=0.379  Sum_probs=209.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +.|+..+.||.|..++||+|.....++.||||++..+. ....+.+.+|+..++.++||||++++..|..+..+|+||.|
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf  105 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF  105 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence            56888999999999999999998889999999997653 33368889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      |.+||+.++++..-   ...+++..+..|++++++||.|||+   ++.||||||+.||||+.+|.+||+|||.+-.+-..
T Consensus       106 Ma~GS~ldIik~~~---~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  106 MAGGSLLDIIKTYY---PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             hcCCcHHHHHHHHc---cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            99999999997654   4458899999999999999999999   89999999999999999999999999977655443


Q ss_pred             CCCcc---eecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          514 INPQT---THIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       514 ~~~~~---~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..+..   ...+||+.|||||++..  ..|+.|+||||||+...||.+|..||....+- +..+.    .+  ++.....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm-kvLl~----tL--qn~pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM-KVLLL----TL--QNDPPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH-HHHHH----Hh--cCCCCCc
Confidence            32222   34689999999999643  35899999999999999999999999865432 11111    10  1111100


Q ss_pred             cCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          589 IDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       589 id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .-..+ .+........+.+++..||+.||++|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            00011 1222334457889999999999999999999987

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=368.64  Aligned_cols=260  Identities=28%  Similarity=0.455  Sum_probs=214.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-----cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-----LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++.+..+.||+|.||.||+|...+..     ..||||.+.+. +.+...+|+.|..+|++++|||||+++|.|......+
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34455788999999999999985432     34999999776 5666789999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhccccccc--ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      +++|||++|+|..+|.+.+..  +...|+....+.++.|||+|+.||++   +++|||||.++|+||++...+||+||||
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGl  848 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGL  848 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccch
Confidence            999999999999999876332  24669999999999999999999999   8999999999999999999999999999


Q ss_pred             cccc-cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAY-DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+.+ ..+.........-+..|||||.+..+.++.|+|||||||+|||++| |..||......+.  +..|+.    .| 
T Consensus       849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v--~~~~~~----gg-  921 (1025)
T KOG1095|consen  849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV--LLDVLE----GG-  921 (1025)
T ss_pred             hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--HHHHHh----CC-
Confidence            9943 3332222222344579999999999999999999999999999999 8889986654321  222221    22 


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                             +| ..+..+++.+.+|+..||+.+|++||++..+++.+...
T Consensus       922 -------RL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  922 -------RL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             -------cc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence                   22 23456788899999999999999999999999987644

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.7e-40  Score=340.98  Aligned_cols=273  Identities=26%  Similarity=0.389  Sum_probs=223.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|...+.||+|.||.||||+.+.+.+.||+|.+.+.  .+...+.+.+|++++++++||||+.++++++...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4677888999999999999999999999999999765  34456789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+.+ +|..+|.+     ...|++++...++.++..||.|||+   .+|+|||+||+||||+.++.+|+||||+|+.+..
T Consensus        82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9966 99999954     4569999999999999999999999   8999999999999999999999999999998876


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      + ....+.+.||+.|||||...++.++..+|.||+||++||+++|++||....      +.+.++....        ||.
T Consensus       153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~~I~~--------d~v  217 (808)
T KOG0597|consen  153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVKSILK--------DPV  217 (808)
T ss_pred             C-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHHHHhc--------CCC
Confidence            4 345566789999999999999999999999999999999999999997432      2222222221        222


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCC---CCCCCCCCCCCCCCCCCCCC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDA---SLPQAPLDIHHEFPRAIPEF  653 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~---~~p~~p~~~~~~~~~~~~~~  653 (662)
                      .  .+......+..+..-.+..||.+|-+-.+++++  .++..   ..|..|.....-....||+.
T Consensus       218 ~--~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~  281 (808)
T KOG0597|consen  218 K--PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEY  281 (808)
T ss_pred             C--CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHH
Confidence            1  223555667788889999999999999999974  45443   33444444433344444533

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-39  Score=337.83  Aligned_cols=253  Identities=25%  Similarity=0.384  Sum_probs=211.2

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  428 (662)
                      ..++|...+.||+|+|++|++|+.+.+++.+|||++.+.   .+...+-...|-..|.+| .||.|++|+-.+.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            346788899999999999999999999999999999665   222334567788889999 8999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +|+||++||+|.++|+.     ...+++...+..+.+|+.||.|||+   .+||||||||+|||||.|+++||+|||.|+
T Consensus       151 FvLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK  222 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAK  222 (604)
T ss_pred             EEEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccc
Confidence            99999999999999954     3568888899999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCC----------c--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH
Q 040242          509 AYDHNINP----------Q--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       509 ~~~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  576 (662)
                      .+......          .  ....+||..|.+||++..+..++.+|+|+|||+||+|+.|++||.+..+-   .+.+-+
T Consensus       223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney---liFqkI  299 (604)
T KOG0592|consen  223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY---LIFQKI  299 (604)
T ss_pred             cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH---HHHHHH
Confidence            87542111          1  13478999999999999999999999999999999999999999876432   111111


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .          .++   -.+++..++.+.+|+.+.|..||.+|++..+|-++.
T Consensus       300 ~----------~l~---y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  300 Q----------ALD---YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             H----------Hhc---ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence            1          111   123444557788899999999999999999988753

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-40  Score=342.09  Aligned_cols=240  Identities=24%  Similarity=0.427  Sum_probs=202.7

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      +.+-||+|+.|.||+|++  .++.||||+++...       ..+|+.|++|+|+||+.+.|+|.....+|||||||+.|-
T Consensus       128 ELeWlGSGaQGAVF~Grl--~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  128 ELEWLGSGAQGAVFLGRL--HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhhccCcccceeeeec--cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeecccccc
Confidence            367899999999999999  46889999884432       257899999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcc
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT  518 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~  518 (662)
                      |...|+..     ..+.-.....+.++||.||+|||.   +.|||||||+-||||..+..+||+|||.++.....  ...
T Consensus       199 L~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk  268 (904)
T KOG4721|consen  199 LYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK  268 (904)
T ss_pred             HHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence            99999654     456777889999999999999999   89999999999999999999999999999865443  334


Q ss_pred             eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC-CCCC
Q 040242          519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFD  597 (662)
Q Consensus       519 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~  597 (662)
                      ...+||..|||||++.....++|.||||||||||||+||..||..-+....      +|         .+-...| -..+
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------Iw---------GVGsNsL~LpvP  333 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IW---------GVGSNSLHLPVP  333 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EE---------eccCCcccccCc
Confidence            457899999999999999999999999999999999999999975433210      11         1111222 2345


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..+++-+.-|+++||+..|..||++++|+.+|.--
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            56777788889999999999999999999999643

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2e-38  Score=329.05  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=207.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||.||++++..+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999998889999999987542  3345678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++++.|..+...     ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            9998877655421     3458899999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH---------HHHHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW---------VRELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~~  583 (662)
                      ..........|++.|+|||++.+..++.++|||||||++|||++|+.||..............         ........
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07848         153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP  232 (287)
T ss_pred             cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence            333333445789999999999888899999999999999999999999976543222111111         11111111


Q ss_pred             ccccccCCCCC-------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLD-------YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~-------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .......+...       .+.......+.+++.+||+.||++|||++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            11111111110       0111234568999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=339.98  Aligned_cols=251  Identities=26%  Similarity=0.379  Sum_probs=213.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ..|...++||+|..|.||.+....++..||||++........+-+++|+.+|+..+|+|||++++.+..++++++|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            34666788999999999999999999999999998776666677899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+.+.      ...+++.++..|+.++++||+|||.   ++|+|||||.+||||+.++++||+|||++..+....
T Consensus       353 ~ggsLTDvVt------~~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~  423 (550)
T KOG0578|consen  353 EGGSLTDVVT------KTRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ  423 (550)
T ss_pred             CCCchhhhhh------cccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeecccccc
Confidence            9999999984      3458999999999999999999999   999999999999999999999999999998876554


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . .....+||+.|||||+.....|.+|.||||||++++||+-|.+||-...+.-...++            ...--|.+.
T Consensus       424 ~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------------a~ng~P~lk  490 (550)
T KOG0578|consen  424 S-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ATNGTPKLK  490 (550)
T ss_pred             C-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------------hhcCCCCcC
Confidence            3 444568999999999999999999999999999999999999999864332111111            111123331


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ........+.++..+||+.|+++||++.|+|++
T Consensus       491 -~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  491 -NPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             -CccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence             233455678889999999999999999999984

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.5e-38  Score=331.49  Aligned_cols=266  Identities=24%  Similarity=0.381  Sum_probs=205.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC----------------CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS----------------TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQL  417 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~----------------~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l  417 (662)
                      ++|...++||+|+||.||++.+..                .+..||+|.+... ......+|.+|+.++.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            467888999999999999998632                3447999998764 33445689999999999999999999


Q ss_pred             eeeEeccCeeeEEEeccCCCCcchhcccccc--------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEe
Q 040242          418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ--------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH  483 (662)
Q Consensus       418 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  483 (662)
                      ++++...+..++||||+++|+|.+++.....              .....++|.++++++.||+.||.|||+   .+|+|
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH  161 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVH  161 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccc
Confidence            9999999999999999999999998854321              112457899999999999999999999   89999


Q ss_pred             CCcCCCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCC
Q 040242          484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC--GRRP  560 (662)
Q Consensus       484 ~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p  560 (662)
                      |||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++  +..|
T Consensus       162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p  241 (304)
T cd05096         162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP  241 (304)
T ss_pred             cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence            99999999999999999999999986543221 11223345789999999988889999999999999999987  5566


Q ss_pred             CCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          561 IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       561 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      |......   .....+...+........     ...++..+..+.+|+.+||+.+|.+||++.+|.+.|+.
T Consensus       242 ~~~~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         242 YGELTDE---QVIENAGEFFRDQGRQVY-----LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             CCcCCHH---HHHHHHHHHhhhcccccc-----ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            6643221   122223222221110000     11122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.4e-38  Score=328.27  Aligned_cols=246  Identities=17%  Similarity=0.270  Sum_probs=199.4

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh---hHHHHHHHHHHhhccccccceeeeeeEec----cCeeeEEEe
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELLLVYD  432 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV~E  432 (662)
                      ...||+|+++.||+|.+  +|+.||||++......   ..+.|.+|+.++++++||||+++++++.+    ....++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            46899999999999998  6889999999765322   25778899999999999999999999876    346899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++...     ..++|...++++.+++.||.|||+.  .+++||||||+||++++++.+||+|||+++....
T Consensus       103 y~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~  175 (283)
T PHA02988        103 YCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS  175 (283)
T ss_pred             eCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcc
Confidence            99999999999543     4688999999999999999999973  4788999999999999999999999999986543


Q ss_pred             CCCCcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..    ....|+..|+|||.+.+  ..++.++|||||||++|||++|+.||.......   +...+   ...+     ..
T Consensus       176 ~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i---~~~~-----~~  240 (283)
T PHA02988        176 PP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLI---INKN-----NS  240 (283)
T ss_pred             cc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHH---HhcC-----CC
Confidence            21    22457899999999876  678999999999999999999999998553221   11111   1110     01


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.   .+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       241 ~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        241 LK---LPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CC---CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11   1223456788999999999999999999999999764

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-38  Score=337.01  Aligned_cols=253  Identities=26%  Similarity=0.369  Sum_probs=207.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|....+++.||||++....   ....+.+..|+.++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46888999999999999999998889999999997642   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.+...++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            99999999999953     3458899999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~~~~~~id  590 (662)
                      .    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... +..|       ....  -.
T Consensus       153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-------~~~~--~~  219 (333)
T cd05600         153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW-------KETL--QR  219 (333)
T ss_pred             c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc-------cccc--cC
Confidence            3    2234578999999999998899999999999999999999999997654322111 1111       0000  01


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +............+.+++.+||..+|.+||++.+++++
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            11111112345667889999999999999999999976

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.8e-38  Score=325.21  Aligned_cols=255  Identities=25%  Similarity=0.385  Sum_probs=208.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .+|...+.||+|++|.||+|.....+..|++|.+.... ...+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            34777889999999999999998889999999987543 34567899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++..++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        85 ~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          85 TYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             CCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            9999999986442   3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |..|+.......      .... ...+     ..+  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~~~~-~~~~-----~~~--  224 (263)
T cd05052         159 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYEL-LEKG-----YRM--  224 (263)
T ss_pred             eeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH-HHCC-----CCC--
Confidence            222222334678999999988899999999999999999998 889987543211      1111 1111     111  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       225 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         225 -ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             1122344678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-39  Score=344.62  Aligned_cols=259  Identities=27%  Similarity=0.369  Sum_probs=210.6

Q ss_pred             cccceeeeeCceEEEEEEeCCCCc---E-EEEEEeec---cchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGL---E-VAIKRVAH---NSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~---~-vavK~~~~---~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ...++||+|.||.||+|.+...+.   . ||||....   ..+...++|.+|++++++++|||||+++|++.....+++|
T Consensus       160 ~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~iv  239 (474)
T KOG0194|consen  160 ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLV  239 (474)
T ss_pred             cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEE
Confidence            345899999999999999965422   3 89999875   3477789999999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||+|+||+|+++|...    ...++..+++.++.+.|+||+|||+   .+++||||-++|+|++.+..+||+||||++.-
T Consensus       240 mEl~~gGsL~~~L~k~----~~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~  312 (474)
T KOG0194|consen  240 MELCNGGSLDDYLKKN----KKSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAG  312 (474)
T ss_pred             EEecCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCC
Confidence            9999999999999655    2369999999999999999999999   89999999999999999999999999998864


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHH-HHHhhcCccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWV-RELHSQGQITRA  588 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~-~~~~~~~~~~~~  588 (662)
                      .. .........-+..|+|||.+..+.+++++|||||||++||+++ |..||.+....   .+..++ ...++       
T Consensus       313 ~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~kI~~~~~r-------  381 (474)
T KOG0194|consen  313 SQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKAKIVKNGYR-------  381 (474)
T ss_pred             cc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHHHHHhcCcc-------
Confidence            31 1111112235689999999999999999999999999999999 88898765432   222222 11111       


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAP  639 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p  639 (662)
                           ...+...+..+..++.+||..+|++||+|.+|.+.|+........+
T Consensus       382 -----~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  382 -----MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             -----CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                 1122355666777888999999999999999999998765555543

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-38  Score=327.91  Aligned_cols=259  Identities=28%  Similarity=0.459  Sum_probs=209.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-----cEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-----~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||.||+|.....+     ..|++|.+.... .....+|.+|+..+.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            45778899999999999999986544     679999986543 344567899999999999999999999999989999


Q ss_pred             EEEeccCCCCcchhcccccccc-----------cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQK-----------KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL  497 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  497 (662)
                      ++|||+++++|.+++.......           ...+++.+++.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            9999999999999996542111           1568899999999999999999999   8999999999999999999


Q ss_pred             CeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHH
Q 040242          498 NPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDW  575 (662)
Q Consensus       498 ~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  575 (662)
                      .+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||......   .+...
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~---~~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ---EVIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999986533221 12233456789999999988889999999999999999998 99998754332   11111


Q ss_pred             HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          576 VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      +.    .+.        ....+...+..+.+|+.+||+.||.+||++.||+++|++
T Consensus       239 i~----~~~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 IR----SRQ--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH----cCC--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            11    111        112233456778899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-39  Score=333.06  Aligned_cols=246  Identities=24%  Similarity=0.282  Sum_probs=203.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||++....+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999998889999999986542   234566889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.....++.|++.||+|||+   .+++||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            99999999999853     3458889999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....|++.|+|||.+.+..++.++|||||||++|||++|+.||.......   +...+    ..+.      .
T Consensus       153 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i----~~~~------~  215 (291)
T cd05612         153 DR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKI----LAGK------L  215 (291)
T ss_pred             CC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCC------c
Confidence            32    223468999999999988889999999999999999999999997653221   11111    1111      0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                         .++......+.+++.+||+.||.+||+     +++++++
T Consensus       216 ---~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         216 ---EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ---CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence               112223456788999999999999995     8888765

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.9e-39  Score=327.94  Aligned_cols=250  Identities=35%  Similarity=0.577  Sum_probs=195.9

Q ss_pred             ccceeeeeCceEEEEEEeC----CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~----~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ..+.||.|.||.||+|.+.    ..+..|+||.+... ..+..++|.+|++.+++++||||++++|+|...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3578999999999999996    34678999999654 344578999999999999999999999999988889999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|+|.++|....   ...+++.+++.++.||++||.|||+   .+++|++|+++||+++.++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999997652   4568999999999999999999999   89999999999999999999999999999876322


Q ss_pred             CC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          514 IN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       514 ~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .. ...........|+|||.+....++.++||||||+++|||++ |+.|+......   .   ..... .++..      
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~---~~~~~-~~~~~------  223 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---E---IIEKL-KQGQR------  223 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---H---HHHHH-HTTEE------
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc---c---ccccc-ccccc------
Confidence            11 11222356789999999988889999999999999999999 67888655321   1   11111 11111      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                        ...+......+..++.+||+.+|.+||+++++++.|
T Consensus       224 --~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence              111223456688999999999999999999999986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-38  Score=337.22  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=200.0

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      +.||+|+||.||+++...+|+.||+|++....   ......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334467889999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|.+++..     ...+++.+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~  151 (323)
T cd05571          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GAT  151 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCc
Confidence            99998853     3468899999999999999999999   89999999999999999999999999998753221 122


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +...+.    .+      +.   .++
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~~----~~------~~---~~p  215 (323)
T cd05571         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL----ME------EI---RFP  215 (323)
T ss_pred             ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHHH----cC------CC---CCC
Confidence            334579999999999998889999999999999999999999997543211   111110    11      11   112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ......+.+++.+||+.||++||     ++.+++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            23455678899999999999999     79998863

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.5e-38  Score=341.33  Aligned_cols=261  Identities=23%  Similarity=0.361  Sum_probs=205.6

Q ss_pred             cCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ++|+..+.||+|+||.||+|..     ..++..||||++.... ....+.+.+|+.++..+ +||||++++++|...+..
T Consensus        35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~  114 (375)
T cd05104          35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT  114 (375)
T ss_pred             HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence            4688899999999999999974     2456689999986542 33456788999999999 899999999999999999


Q ss_pred             eEEEeccCCCCcchhccccccc----------------------------------------------------------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQ----------------------------------------------------------  449 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~----------------------------------------------------------  449 (662)
                      ++||||+++|+|.+++......                                                          
T Consensus       115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (375)
T cd05104         115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY  194 (375)
T ss_pred             eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence            9999999999999998643210                                                          


Q ss_pred             ------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          450 ------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       450 ------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                                  ....++|..+++++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.........
T Consensus       195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  271 (375)
T cd05104         195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV  271 (375)
T ss_pred             cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence                        01258899999999999999999999   899999999999999999999999999998664432211


Q ss_pred             -ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          518 -TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       518 -~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                       .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......  .+..++..    +.     .+.   
T Consensus       272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~~----~~-----~~~---  337 (375)
T cd05104         272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIKE----GY-----RML---  337 (375)
T ss_pred             ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHHh----Cc-----cCC---
Confidence             122345678999999998899999999999999999998 888886543221  12222211    11     000   


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+......+.+|+.+||+.||++||++.||++.|++.
T Consensus       338 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0111235688999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-37  Score=330.56  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=207.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||+++...++..+|+|.+.... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (331)
T cd06649           5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (331)
T ss_pred             ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence            67888999999999999999999899999999987653 34456799999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...     ..+++..+..++.|++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  157 (331)
T cd06649          85 MDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (331)
T ss_pred             CCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence            9999999998542     4588999999999999999999982  46999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc--c------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ--I------  585 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~--~------  585 (662)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......   +...+......+.  .      
T Consensus       158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  231 (331)
T cd06649         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISP  231 (331)
T ss_pred             ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCc
Confidence               2233468999999999998889999999999999999999999996543211   1111110000000  0      


Q ss_pred             -------------------------cc-ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          586 -------------------------TR-AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       586 -------------------------~~-~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                                               .+ .+.... ..........+.+++.+||+.||++|||++|++++-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                                     00 000000 000112345688999999999999999999999863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-38  Score=337.09  Aligned_cols=246  Identities=23%  Similarity=0.295  Sum_probs=203.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|....+++.||+|++....   ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999999899999999997542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...     ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        98 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         98 EFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             cCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            999999999998542     457888889999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   ..    +....+..      
T Consensus       170 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~----~~i~~~~~------  232 (329)
T PTZ00263        170 DR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY----EKILAGRL------  232 (329)
T ss_pred             CC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH----HHHhcCCc------
Confidence            32    223578999999999998889999999999999999999999997543211   11    11111110      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||+     +++++++
T Consensus       233 ~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 K---FPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             C---CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            1   11123355778999999999999997     6888754

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=3.6e-38  Score=333.36  Aligned_cols=243  Identities=26%  Similarity=0.348  Sum_probs=198.8

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      +.||+|+||.||++....+|..||+|++....   ......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334566788999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|..++..     ...+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  151 (323)
T cd05595          81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-AT  151 (323)
T ss_pred             cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cc
Confidence            99988843     3458899999999999999999999   899999999999999999999999999987532221 12


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   .   ... ...      ..   .+
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~---~---~~~-~~~------~~---~p  215 (323)
T cd05595         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF---E---LIL-MEE------IR---FP  215 (323)
T ss_pred             cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH---H---HHh-cCC------CC---CC
Confidence            23356899999999999889999999999999999999999999754322111   0   000 000      11   12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ......+.+++.+||+.||++||     ++.+++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            23345678899999999999998     89988763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5e-38  Score=320.45  Aligned_cols=252  Identities=26%  Similarity=0.409  Sum_probs=203.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||++... .+..+|+|.+.... ...++|.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            45777889999999999999885 45689999886442 33467899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++...    ...++|..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          82 ENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            999999998643    2358999999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......   .....+.+    +.  ....   
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~----~~--~~~~---  222 (256)
T cd05114         155 YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISR----GF--RLYR---  222 (256)
T ss_pred             eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHC----CC--CCCC---
Confidence            222222345678999999988889999999999999999999 89998754321   11112111    11  0011   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                         +......+.+++.+||+.+|++||++.++++.|.
T Consensus       223 ---~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         223 ---PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             ---CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence               1123356889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=4.4e-38  Score=333.35  Aligned_cols=243  Identities=26%  Similarity=0.349  Sum_probs=199.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      ++||+|+||.||++....++..||+|++....   ......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334567889999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|..++..     ...+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ...
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~  151 (328)
T cd05593          81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AAT  151 (328)
T ss_pred             CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccc
Confidence            99988853     3458899999999999999999999   89999999999999999999999999998753322 112


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ..... ..      +..   ++
T Consensus       152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~-~~------~~~---~p  215 (328)
T cd05593         152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELIL-ME------DIK---FP  215 (328)
T ss_pred             cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhc-cC------Ccc---CC
Confidence            2335799999999999888899999999999999999999999975432211      11100 00      111   12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ......+.+++.+||+.||++||     ++.+++++
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            23345678899999999999997     89999875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=5.3e-38  Score=328.02  Aligned_cols=253  Identities=26%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ..++|+..++||+|+||.||+++-+.+|..+|+|++.+..   ..+.+..++|-.+|....+|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999999999999999998763   4455678899999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||++||++..+|..     ...|+.......+.+++.|+..||+   .++|||||||+|+|||..|.+||+||||+.-
T Consensus       219 iMEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             EEEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999954     4678999999999999999999999   9999999999999999999999999999953


Q ss_pred             ccC---------------C-------CCC-----c-------------------ceecccCCcccCcccccCCCCCcchh
Q 040242          510 YDH---------------N-------INP-----Q-------------------TTHIVGTLGYLAPELTRTGKATTSTD  543 (662)
Q Consensus       510 ~~~---------------~-------~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~t~ksD  543 (662)
                      +..               .       ...     .                   ....+|||.|+|||++.+..++..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            311               0       000     0                   01246999999999999999999999


Q ss_pred             HHHHHHHHHHHHcCCCCCCcccchhh-HHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-
Q 040242          544 VFGFGTLMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-  621 (662)
Q Consensus       544 V~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-  621 (662)
                      .||+|||+|||+.|.+||....+... ..+..|...+..         |.    ......+..+||.+|+. ||.+|-- 
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f---------P~----~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF---------PE----EVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC---------CC----cCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            99999999999999999987655432 234444322110         11    11122567788888998 9999976 


Q ss_pred             --HHHHHH
Q 040242          622 --TRRVVQ  627 (662)
Q Consensus       622 --~~eVl~  627 (662)
                        +.||-+
T Consensus       437 ~G~~EIK~  444 (550)
T KOG0605|consen  437 KGAEEIKK  444 (550)
T ss_pred             ccHHHHhc
Confidence              444443

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-38  Score=306.04  Aligned_cols=237  Identities=24%  Similarity=0.346  Sum_probs=200.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .+|+..+.||.|+||.|.+.+.+.+|..+|+|++.+...   .+.+...+|..+|+.+.||+++++++.|.+.+.+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            457788999999999999999999999999999987643   33456789999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||++||.|..+|++.     ..++.+..+-.+.||+.||.|||+   ..|++|||||+|||||.+|.+||+|||.|+...
T Consensus       124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999543     468889999999999999999999   899999999999999999999999999999764


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .    .+...+||+.|+|||.+..+.+..++|.|+|||++|||++|.+||....+..   +.+            +++..
T Consensus       196 ~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~---iY~------------KI~~~  256 (355)
T KOG0616|consen  196 G----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ---IYE------------KILEG  256 (355)
T ss_pred             C----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH---HHH------------HHHhC
Confidence            3    3667899999999999999999999999999999999999999998765421   110            11111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFR  619 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~R  619 (662)
                      .+ .++.-....+.+|+...++.|-.+|
T Consensus       257 ~v-~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  257 KV-KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cc-cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            11 1233334456677778888888888

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-38  Score=338.23  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=212.2

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      |+..+-||+|+-|.|-.|++..+|+.+|||++.+..   ......+.+|+-+|+.+.|||++++++.++.+.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            555788999999999999999999999999997652   22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|.|.++|..     ++.|+..+..+.++||+.|+.|+|.   .+|+||||||+|+|||..+++||+|||+|.+--.+
T Consensus        94 v~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   94 VPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             cCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            999999999954     4679999999999999999999999   89999999999999999999999999999875433


Q ss_pred             CCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                        ......+|.++|.|||++.+..| ..++||||+|||||.|+||+.||+++.-   ..|..-|+             ..
T Consensus       166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi---r~LLlKV~-------------~G  227 (786)
T KOG0588|consen  166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI---RVLLLKVQ-------------RG  227 (786)
T ss_pred             --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH---HHHHHHHH-------------cC
Confidence              33445699999999999998775 6799999999999999999999995432   11111111             11


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQA  638 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~  638 (662)
                      .-+.+.....+.+.|+.+|+..||++|-|++||+++  |.+-..+|..
T Consensus       228 ~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~  275 (786)
T KOG0588|consen  228 VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS  275 (786)
T ss_pred             cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence            112334556678889999999999999999999996  4554444443

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.2e-38  Score=321.14  Aligned_cols=254  Identities=23%  Similarity=0.409  Sum_probs=206.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..++||+|++|.||+|... ++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            56888999999999999999974 56779999886543 33578899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++.+++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          84 AKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999996542   3568899999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||++..+.++.++|||||||++|||++ |+.||.......   ...++..    +.    ..+..
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~----~~~~~  226 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR----GY----RMPRM  226 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----CC----CCCCC
Confidence            222223345778999999988889999999999999999998 999987543221   1112111    10    00111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          ......+.+++.+|++.+|++||+++++.+.|+.
T Consensus       227 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 ----ENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             ----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                1234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.6e-38  Score=325.76  Aligned_cols=265  Identities=24%  Similarity=0.343  Sum_probs=202.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..++||+|+||.||+|....++..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999998899999999986543 22345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.+++...    ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            97 5898888543    3457889999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH-----HHhhc----C
Q 040242          514 INPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR-----ELHSQ----G  583 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~-----~~~~~----~  583 (662)
                      .. ......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||................     ..+..    .
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07871         157 TK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE  235 (288)
T ss_pred             Cc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence            21 2233467899999998765 468999999999999999999999997654332221110000     00000    0


Q ss_pred             ccccccCCCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLD-----YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .......+...     ...........+++.+||+.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00111111110     0011223557899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-37  Score=332.71  Aligned_cols=248  Identities=25%  Similarity=0.381  Sum_probs=196.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +|+..++||+|+||+||+|++..+++.||||++.... ....+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            3455788999999999999998889999999986543 334567899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|....         .+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus       155 ~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        155 DGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            999987543         24566778899999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          515 NPQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      . ......||..|+|||++..     ...+.++|||||||++|||++|+.||..........+...+.    .     ..
T Consensus       223 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~----~-----~~  292 (353)
T PLN00034        223 D-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC----M-----SQ  292 (353)
T ss_pred             c-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----c-----cC
Confidence            2 1233578999999998743     234568999999999999999999997433221111111000    0     00


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .   ..........+.+|+.+||+.||++||++.|++++
T Consensus       293 ~---~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 P---PEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C---CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   11122345568899999999999999999999986

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-38  Score=333.96  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=202.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-cEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-LEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|.+...+ ..||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            56888999999999999999875544 689999986542   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...     ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~  181 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV  181 (340)
T ss_pred             EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence            9999999999998543     458899999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..    .....+.      
T Consensus       182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~----~~i~~~~------  244 (340)
T PTZ00426        182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---IY----QKILEGI------  244 (340)
T ss_pred             CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---HH----HHHhcCC------
Confidence            432    234578999999999988889999999999999999999999998653321   11    1111111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                         ..++......+.+++.+|++.||.+|+     ++++++++
T Consensus       245 ---~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 ---IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence               011222334577899999999999995     89988875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-38  Score=339.65  Aligned_cols=261  Identities=24%  Similarity=0.394  Sum_probs=204.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ++|+..+.||+|+||.||+|+...     ++..||||++.... ......+.+|+.+++.+ +|+||++++++|...+..
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~  117 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV  117 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence            468889999999999999998633     33579999997543 33456788999999999 899999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccc-----------------------------------------------------------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQ-----------------------------------------------------------  448 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  448 (662)
                      ++||||+++|+|.+++.....                                                           
T Consensus       118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (374)
T cd05106         118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS  197 (374)
T ss_pred             EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence            999999999999998854211                                                           


Q ss_pred             ------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC-cceec
Q 040242          449 ------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTHI  521 (662)
Q Consensus       449 ------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~  521 (662)
                            .....+++.+.++++.||++||.|||+   .+|+||||||+|||+++++.+||+|||+++........ .....
T Consensus       198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                  011347889999999999999999999   89999999999999999999999999999865433211 11123


Q ss_pred             ccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHH
Q 040242          522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQE  600 (662)
Q Consensus       522 ~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~  600 (662)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||........  ..    .....+     ..+..   +...
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~-----~~~~~---~~~~  340 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG-----YQMSR---PDFA  340 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc-----cCccC---CCCC
Confidence            35678999999988889999999999999999997 9999975432211  10    111111     01111   1112


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          601 AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       601 ~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ...+.+++.+||+.||.+||++.+|++.|++.
T Consensus       341 ~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         341 PPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            45688899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.9e-38  Score=321.19  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=211.8

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +..+|+..++||.|++|.||+|.... +..+++|.+.........++..|+.++++++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34568889999999999999999976 88999999987766567789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++....   ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            999999999997543   3568999999999999999999999   8999999999999999999999999999987644


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... .....++..|+|||.+....++.++||||||+++++|++ |+.||.......   ....+..    +     .. 
T Consensus       157 ~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~----~-----~~-  222 (261)
T cd05148         157 DVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQITA----G-----YR-  222 (261)
T ss_pred             cccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHHh----C-----Cc-
Confidence            3221 123345778999999988889999999999999999998 899987543211   1111111    0     00 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ...+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         223 --MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence              11122345668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=318.91  Aligned_cols=255  Identities=28%  Similarity=0.415  Sum_probs=206.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|++|.||+|... .+..||+|.+.... ...+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            356888999999999999999984 45789999986543 3356789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.++..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.....
T Consensus        83 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  156 (261)
T cd05068          83 MKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKED  156 (261)
T ss_pred             ccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence            99999999996542   3468999999999999999999999   89999999999999999999999999999876533


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ..........+..|+|||++.+..++.++||||||+++|||++ |+.||.......   +...+    ....     .  
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~-----~--  222 (261)
T cd05068         157 IYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQV----DQGY-----R--  222 (261)
T ss_pred             cccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC-----C--
Confidence            2222222233468999999988889999999999999999999 999987543211   11111    1110     0  


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ..........+.+++.+|++.+|.+||++.++++.|+.
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             01122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-37  Score=346.24  Aligned_cols=253  Identities=22%  Similarity=0.330  Sum_probs=206.6

Q ss_pred             CCcccceeeeeCceEEEEEEeCCC-CcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPST-GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~-g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .|...+.||+|++|.||+|....+ +..||+|.+..........+..|+.+++.++||||+++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            378889999999999999998766 7789999876665555667889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.++|.+... ....+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus       148 ~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        148 SGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            99999998864321 13468889999999999999999999   899999999999999999999999999998765432


Q ss_pred             CC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .. ......||++|+|||++.+..++.++|||||||++|||++|+.||.......      .+.... .+.    .++  
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~-~~~----~~~--  290 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVL-YGK----YDP--  290 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHH-hCC----CCC--
Confidence            21 2334569999999999998899999999999999999999999997543211      111111 111    111  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                        .+......+.+++.+||+.+|++||++.++++
T Consensus       291 --~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 --FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              11223456888999999999999999999875

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1e-37  Score=324.25  Aligned_cols=263  Identities=27%  Similarity=0.378  Sum_probs=196.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-CCcEEEEEEeeccc--hhhHHHHHHHHHHhhcc---ccccceeeeeeEec-----
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHNS--RQGMKEFVAEITSMGRL---RHRNLVQLHGWCRK-----  423 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~~-----  423 (662)
                      ++|+..+.||+|+||.||+|.... ++..||+|++....  ......+.+|+.+++++   +||||++++++|..     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            368889999999999999999854 46889999886542  22234556677666655   69999999999852     


Q ss_pred             cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      ....++||||++ ++|.+++....   ...+++.++..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence            346899999995 68999886442   3458999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHHHHHhhc
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVRELHSQ  582 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~  582 (662)
                      ||+++.....  .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......... +.+... ....
T Consensus       154 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~-~~~~  230 (290)
T cd07862         154 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG-LPGE  230 (290)
T ss_pred             ccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhC-CCCh
Confidence            9999876443  22334568999999999988889999999999999999999999998654322111 111100 0000


Q ss_pred             Ccc-------ccccCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          583 GQI-------TRAIDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       583 ~~~-------~~~id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ...       .....+..    ....+.....+.+++.+||+.||++|||+.|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000       00011000    0111223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=323.49  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=205.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +|+..++||+|+||+||++....+++.||+|++....   ......+.+|+.++++++|+||+++++++..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999998889999999996542   2234567889999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++....   ...+++..+..++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999999998885432   3468999999999999999999999   8999999999999999999999999999987543


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ..  ......|+..|+|||.+.+..++.++||||+||++|||++|+.||.........   +.+...         +...
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~---------~~~~  220 (285)
T cd05605         155 GE--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERR---------VKED  220 (285)
T ss_pred             CC--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHH---------hhhc
Confidence            22  122346899999999998888999999999999999999999999754322111   011111         1111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ...+.......+.+|+.+||+.||.+||     ++.+++++
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            1122334556688999999999999999     88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=318.05  Aligned_cols=256  Identities=30%  Similarity=0.463  Sum_probs=207.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|.+...   ...||||.+.... .....+|.+|+..+++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv   83 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII   83 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence            5688899999999999999998543   4579999986543 34456789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++.+++.++.|++.||.|||+   .+|+||||||+||++++++.++|+|||+++..
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          84 TEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            9999999999999654    2468999999999999999999999   89999999999999999999999999999977


Q ss_pred             cCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          511 DHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       511 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ...... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......   .+.+.+.    .+.    
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~~----  225 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ---DVIKAVE----DGY----  225 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH---HHHHHHH----cCC----
Confidence            522211 1112345678999999988889999999999999999998 99998644321   1112211    110    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..+    ........+.+++.+|++.+|++||++.+|+++|++.
T Consensus       226 ~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         226 RLP----PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCC----CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            001    1123456688999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-37  Score=328.11  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=204.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .+|+..+.||+|+||.||+|++..++.    .||+|.+.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            468889999999999999999765554    48999986543 34567889999999999999999999999764 5789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+++|+|.+++...    ...+++..++.++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          86 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEcccccccc
Confidence            99999999999999654    3458899999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCCcc-eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINPQT-THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ......... ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......   +..    ....+.   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~---  228 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGE---  228 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCC---
Confidence            654322211 12234678999999998899999999999999999998 999987543211   111    111111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                          .+ ..+......+.+++.+||+.+|.+||++.+++..|.....
T Consensus       229 ----~~-~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         229 ----RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             ----CC-CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                00 0111233567889999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.3e-37  Score=333.89  Aligned_cols=259  Identities=21%  Similarity=0.190  Sum_probs=199.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||++.+..+++.||+|....      ..+.+|+.++++++||||+++++++..+...++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            579999999999999999999999999999997532      34678999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                       .++|..++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       166 -~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        166 -KTDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             -CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence             4788888743     2458899999999999999999999   899999999999999999999999999997543322


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh-----hHHHHHHHHH-----------
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-----ELVLVDWVRE-----------  578 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-----~~~l~~~~~~-----------  578 (662)
                      ........||+.|+|||++.+..++.++|||||||++|||++|+.|+.......     ...+...+..           
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            223334579999999999988889999999999999999999998875322110     0001000000           


Q ss_pred             -------HhhcCccccccCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 -------LHSQGQITRAIDPTLDY---FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 -------~~~~~~~~~~id~~l~~---~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                             .+..........+....   ........+..|+.+||+.||.+|||++|++++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                   00000000000000000   001234568899999999999999999999974

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.7e-38  Score=336.15  Aligned_cols=256  Identities=23%  Similarity=0.266  Sum_probs=204.5

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ...++|+..+.||+|+||.||+++...++..||+|++....   ....+.+..|+.+++.++||||+++++++...+..+
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            34568999999999999999999999899999999996532   233455788999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++|+|.+++..      ..++......++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       120 lv~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             EEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEecccee
Confidence            99999999999999843      247778888899999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTG----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ..............||+.|+|||.+.+.    .++.++|||||||++|||++|+.||........      .........
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~  264 (370)
T cd05596         191 KMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHKN  264 (370)
T ss_pred             eccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCC
Confidence            7654332223345799999999988643    478899999999999999999999986543211      111111000


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  628 (662)
                        .   .... ........+.+++.+||+.+|.+  ||++.+++++
T Consensus       265 --~---~~~~-~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 --S---LTFP-DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --c---CCCC-CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              0   0010 01123466788899999999988  9999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-38  Score=330.52  Aligned_cols=241  Identities=25%  Similarity=0.301  Sum_probs=196.9

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|+||.||++....+++.||+|++...   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999888999999998653   234456788999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++...     ..+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  151 (312)
T cd05585          81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN  151 (312)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence            9998542     458899999999999999999999   899999999999999999999999999998543221 2233


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||......      ........ +.      .   .++..
T Consensus       152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~-~~------~---~~~~~  215 (312)
T cd05585         152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQ-EP------L---RFPDG  215 (312)
T ss_pred             cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHc-CC------C---CCCCc
Confidence            457899999999999888999999999999999999999999754321      11111111 00      1   11223


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPS---TRRVVQF  628 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt---~~eVl~~  628 (662)
                      ....+.+++.+||+.||.+||+   +.|++++
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            3456788899999999999975   5666653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.7e-37  Score=315.64  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      +.||+|+||.||+|.+..+++.||+|.+... .......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999999888999999988654 344456799999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcc-
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-  518 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-  518 (662)
                      .+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++........... 
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9998543    3458899999999999999999999   8999999999999999999999999999886543211111 


Q ss_pred             eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       519 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....+..|+|||.+.++.++.++|||||||++|||++ |..|+........       .......     ..   ...+
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~-----~~---~~~~  218 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQG-----VR---LPCP  218 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcC-----CC---CCCc
Confidence            11123467999999988889999999999999999998 8888864332111       1111110     00   1112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ......+.+++.+|++.+|++||++.+|++.|.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            233567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.9e-37  Score=314.22  Aligned_cols=251  Identities=27%  Similarity=0.425  Sum_probs=208.1

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||++....++..|++|.+...  .......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            467788999999999999999889999999998653  344567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999996542   3568999999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ... .....|++.|+|||+..+..++.++|||||||+++||++|+.||......   .....+    ..+        ..
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~----~~~--------~~  218 (256)
T cd08529         155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKI----IRG--------VF  218 (256)
T ss_pred             cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHH----HcC--------CC
Confidence            222 22346789999999999888999999999999999999999999755421   111111    111        11


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..........+.+++.+||+.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            11122345678899999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.8e-37  Score=329.67  Aligned_cols=261  Identities=25%  Similarity=0.375  Sum_probs=198.7

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC-----eee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----ELL  428 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~  428 (662)
                      +|+..++||+|+||.||+|+...++..||||++...  ......++.+|+.++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            477889999999999999999889999999998643  2233457889999999999999999999885432     479


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+. ++|.+++..     ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            9999995 688888843     2458999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC--CcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh----
Q 040242          509 AYDHNIN--PQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH----  580 (662)
Q Consensus       509 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----  580 (662)
                      .......  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||..........   .+....    
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~---~~~~~~~~~~  228 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD---LITDLLGTPS  228 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHHHhCCCC
Confidence            6533211  12234578999999998865  578999999999999999999999997543221111   110000    


Q ss_pred             -------hcCc---cccccCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 -------SQGQ---ITRAIDPT----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 -------~~~~---~~~~id~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                             ....   ....+.+.    +....+.....+.+++.+||+.||++||+++|++++
T Consensus       229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                   0000   00000000    000011223557899999999999999999999974

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.8e-38  Score=333.54  Aligned_cols=253  Identities=25%  Similarity=0.365  Sum_probs=206.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||+||+|....+++.||||++....   ......+..|+.++..++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46888999999999999999998889999999997642   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...     ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999998543     468899999999999999999999   899999999999999999999999999998665


Q ss_pred             CCC----------------------------CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 040242          512 HNI----------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP  563 (662)
Q Consensus       512 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  563 (662)
                      ...                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            432                            1122335689999999999998999999999999999999999999986


Q ss_pred             ccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 040242          564 QRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-TRRVVQF  628 (662)
Q Consensus       564 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~~  628 (662)
                      .......      ......   .+.+  .+.. .......+..++.+|++ +|.+||+ +.+++++
T Consensus       233 ~~~~~~~------~~i~~~---~~~~--~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         233 DTLQETY------NKIINW---KESL--RFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             CCHHHHH------HHHhcc---CCcc--cCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            5422111      111000   0000  0100 11135667788889997 9999999 9999985

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.6e-38  Score=333.48  Aligned_cols=254  Identities=28%  Similarity=0.328  Sum_probs=205.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||++....+++.||+|++....   .+..+.+.+|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999999899999999997643   234566889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...    ...+++.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            999999999999543    2468999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTR------TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ...........||+.|+|||++.      ...++.++|||||||++|||++|+.||........      ..........
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~  227 (330)
T cd05601         154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF  227 (330)
T ss_pred             CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc
Confidence            44333333457899999999886      45678899999999999999999999975433211      1111111110


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...  +    ........+..|+..|++ +|.+||++.+++++
T Consensus       228 ~~~--~----~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 LKF--P----EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCC--C----CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            000  0    011234557788889998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.2e-37  Score=319.70  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=208.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|...+.||+|+||.||+|....     ++..||||.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            457788999999999999998743     3578999998765443 5678999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhccccc---------ccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          429 LVYDYVPNGSLDKLLFDND---------QQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      +||||+++++|.+++....         ......+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeE
Confidence            9999999999999996542         1123568999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       500 kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |+.||.......   ..+.+.
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~~  238 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECIT  238 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH
Confidence            9999999976433211 11223345788999999999999999999999999999998 999987543321   111111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          .+.        ....+......+.+++++||+.||++||++.||++.|++
T Consensus       239 ----~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         239 ----QGR--------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----cCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                111        111122345678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=325.12  Aligned_cols=250  Identities=28%  Similarity=0.459  Sum_probs=210.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ..|+..+.||+|.||.||||.+..+++.||+|++..+ .+...++..+|+.+|.+++++||.++++.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            4566778999999999999999999999999999765 345567888999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      |.+|++.+.|...     ..+++....-+++++..||.|||.   .+.+|||||+.|||+..+|.+||+|||++......
T Consensus        93 ~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             hcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999543     334677777789999999999999   89999999999999999999999999999877655


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .... ...+||+.|||||+++...|+.|+||||||++.+||++|.+|+..-.+.-...            -+.+...|.+
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------------lIpk~~PP~L  231 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------------LIPKSAPPRL  231 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------------eccCCCCCcc
Confidence            4333 55789999999999998899999999999999999999999987554311100            0112223333


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         +......+.+++..||+.||+.||++.+++++
T Consensus       232 ---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 ---DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ---ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence               22566778899999999999999999999973

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.9e-37  Score=318.77  Aligned_cols=261  Identities=23%  Similarity=0.400  Sum_probs=205.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      ++++|+..+.||+|++|.||+|....     .+..||+|++.... .....+|.+|+.++++++|+||+++++++.....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~   83 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP   83 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45779999999999999999998642     34679999986432 3345678999999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhccccccc-----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ-----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      .++||||+++++|.+++......     ....+++..++.++.|+++||.|||+   .+++||||||+||++++++.++|
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEEE
Confidence            99999999999999998643211     12346888999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ..+.+   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~---  234 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV---  234 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---
Confidence            999998765432211 1112345778999999988889999999999999999999 688886543221   11111   


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ..+.        ....+......+.+++.+|++.+|++||++.|+++.|++
T Consensus       235 -~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         235 -MEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -HcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence             1111        111122344578899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.9e-37  Score=321.35  Aligned_cols=263  Identities=27%  Similarity=0.429  Sum_probs=211.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...+.||+|+||.||+++..     .++..+++|.+........+.+.+|+..+++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            35777889999999999999853     2445699999877766666789999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          430 VYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      ||||+++++|.+++.....           .....++|..++.++.|++.||+|||+   .+++||||||+||+++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            9999999999999965321           112458999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  576 (662)
                      +||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   ..+. 
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~-  237 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIEC-  237 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-
Confidence            99999999976543221 11223456788999999988889999999999999999998 999986543321   1111 


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL  635 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  635 (662)
                         ...+...        ......+..+.+++.+||+.+|.+||++++|+++|+.....
T Consensus       238 ---~~~~~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         238 ---ITQGRVL--------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ---HhCCCCC--------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence               1111111        11122456688999999999999999999999999887443

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.9e-37  Score=322.30  Aligned_cols=263  Identities=23%  Similarity=0.350  Sum_probs=200.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|+..+.||+|+||.||+|....+++.||||++..... .....+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4679999999999999999999988899999999865432 223467889999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++ ++|.+++...    ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          84 YVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            995 6787777543    3458888999999999999999999   8999999999999999999999999999875433


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---c----
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---Q----  584 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~----  584 (662)
                      .. .......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||........ . .+.+.......   .    
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-Q-LERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-H-HHHHHHHhCCCChhhccch
Confidence            21 12233468899999998765 4578899999999999999999999986433211 1 11111110000   0    


Q ss_pred             -cccccCCC-CCCCCH----------HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          585 -ITRAIDPT-LDYFDP----------QEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       585 -~~~~id~~-l~~~~~----------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                       .....++. .....+          .....+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence             00000000 000000          11245778999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.8e-37  Score=345.47  Aligned_cols=261  Identities=24%  Similarity=0.369  Sum_probs=209.6

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC-
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-  425 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-  425 (662)
                      +.....++|...+.||+|+||+||++....+++.||||++...  .......+.+|+..+..++|+|+++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3344557899999999999999999999889999999998654  3445567889999999999999999988765432 


Q ss_pred             -------eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          426 -------ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       426 -------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                             .+++||||+++|+|.+++..... ....+++.....++.|++.||.|||+   .+|+||||||+|||++.++.
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCC
Confidence                   36899999999999999865321 13568899999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      +||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +.+.
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence            99999999987654322 1223457999999999999889999999999999999999999999754321      1111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .... +.    .+    ..+......+..++.+||+.||.+||++.+++++
T Consensus       256 ~~~~-~~----~~----~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLA-GR----YD----PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhc-CC----CC----CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111 11    11    1223345668899999999999999999999874

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-37  Score=327.48  Aligned_cols=246  Identities=25%  Similarity=0.358  Sum_probs=196.8

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHH---hhccccccceeeeeeEeccCeeeEE
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITS---MGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~---l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      |+..+.||+|+||.||++....+++.||||++....   ....+.+..|+.+   +++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            566889999999999999998899999999997542   2233456666554   4677899999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|..++.      ...+++.+...++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~------~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIH------TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            99999999998874      2458999999999999999999999   89999999999999999999999999998753


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... ........|++.|+|||.+.+..++.++|||||||++|||++|+.||........      ...... +.      
T Consensus       152 ~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~-~~------  217 (324)
T cd05589         152 MGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVN-DE------  217 (324)
T ss_pred             CCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CC------
Confidence            222 1223345789999999999988899999999999999999999999976533211      111111 10      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ..   ++......+.+++.+||+.||.+||     ++.+++++
T Consensus       218 ~~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 VR---YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CC---CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            11   1222345678899999999999999     57777664

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.8e-37  Score=325.52  Aligned_cols=260  Identities=23%  Similarity=0.338  Sum_probs=204.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||++.+..++..+|+|.+... .......+.+|++++++++|+||++++++|..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH   84 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEec
Confidence            6788999999999999999999888999999988765 334456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..     ...+++.....++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||++......
T Consensus        85 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~  157 (333)
T cd06650          85 MDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  157 (333)
T ss_pred             CCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence            999999999854     24578889999999999999999972  47999999999999999999999999999765332


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR------  587 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~------  587 (662)
                         ......|+..|+|||.+.+..++.++|||||||++|||++|+.||..........   .+ .....+....      
T Consensus       158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~-~~~~~~~~~~~~~~~~  230 (333)
T cd06650         158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL---MF-GCPVEGDPAESETSPR  230 (333)
T ss_pred             ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH---Hh-cCcccCCccccccCcc
Confidence               1223468999999999988889999999999999999999999997543211110   00 0000000000      


Q ss_pred             -----------------------ccC----CCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          588 -----------------------AID----PTLDYF-DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       588 -----------------------~id----~~l~~~-~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                             ..+    ...... .......+.+|+.+||+.||++||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                   000    000000 01133567899999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.7e-37  Score=306.29  Aligned_cols=273  Identities=26%  Similarity=0.341  Sum_probs=212.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-h-HHHHHHHHHHhhccccccceeeeeeEec--cCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-G-MKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-~-~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV  430 (662)
                      +.|+..+.|++|.||.||+|+++.+++.||+|+++.+.+. + --.-++||.+|.+++|||||.+.....-  .+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4578889999999999999999999999999999765422 1 1234799999999999999999887653  4579999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||||+. +|..+|...    ...+...+..-+..|+++|++|||.   ..|+|||||++|+|++..|.+||+||||||.+
T Consensus       156 Me~~Eh-DLksl~d~m----~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~y  227 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM----KQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREY  227 (419)
T ss_pred             HHHHHh-hHHHHHHhc----cCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhh
Confidence            999965 888888765    3567888888999999999999999   89999999999999999999999999999999


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      +.... ..+..+-|..|.|||.+.+. .++...|+||+|||+.||+++++.|.+..+.++...+-.+.     |.-.+.+
T Consensus       228 gsp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~ll-----GtPte~i  301 (419)
T KOG0663|consen  228 GSPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLL-----GTPSEAI  301 (419)
T ss_pred             cCCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHh-----CCCcccc
Confidence            87644 34556779999999988764 58999999999999999999999998776655544221111     1111111


Q ss_pred             CCCC--------------------CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHHH-hcCCCCCCCCCC
Q 040242          590 DPTL--------------------DYFDPQ-EAELVLTLGLLCCDPHPDFRPSTRRVVQFL-LRDASLPQAPLD  641 (662)
Q Consensus       590 d~~l--------------------~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L-~~~~~~p~~p~~  641 (662)
                      -|.+                    ..+... ..+.-.+|....+..||.+|-|++|.+++= =.+.|.|..|-.
T Consensus       302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~  375 (419)
T KOG0663|consen  302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSM  375 (419)
T ss_pred             CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhh
Confidence            1111                    011111 235567888899999999999999999852 344455444433

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=332.49  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=215.1

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ....++||-|.||.||.|+++.-...||||.++.+. ...++|+.|..+|+.++|||+|+|+|.|..+...|||+|||..
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~y  347 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCY  347 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccC
Confidence            445789999999999999999888899999997654 4568999999999999999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.++|.+..   +..++--..+.++.||+.||.||..   +++|||||..+|+|+.++-.+|++||||++++..+...
T Consensus       348 GNLLdYLRecn---r~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  348 GNLLDYLRECN---RSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccHHHHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            99999998765   5567777789999999999999999   89999999999999999999999999999998765444


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                      .......+..|.|||.+....++.|+|||+|||+|||+.| |..||.+-+...       +-.+++++-       + .+
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq-------VY~LLEkgy-------R-M~  486 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-------VYGLLEKGY-------R-MD  486 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH-------HHHHHhccc-------c-cc
Confidence            3334455789999999999999999999999999999998 888988654321       122222211       1 23


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      -+..++..+.+|++.||+++|.+||++.|+-+.++
T Consensus       487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence            45678889999999999999999999999887665

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=331.85  Aligned_cols=253  Identities=22%  Similarity=0.317  Sum_probs=201.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+++...+++.||||++....   ......+.+|+.++.+++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46888999999999999999998899999999997542   334456788999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...     ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++..+.
T Consensus        81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            999999999998543     458999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCC-------------------------------------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHH
Q 040242          512 HNINP-------------------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV  554 (662)
Q Consensus       512 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el  554 (662)
                      .....                                     ......||+.|+|||++....++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            21100                                     01124689999999999888899999999999999999


Q ss_pred             HcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 040242          555 ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS---TRRVVQF  628 (662)
Q Consensus       555 ltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~eVl~~  628 (662)
                      ++|+.||........   ...+   .....  ....+.    .......+.+++.+|+. +|.+|++   +.|++++
T Consensus       233 ~~G~~Pf~~~~~~~~---~~~i---~~~~~--~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         233 LVGYPPFCSDNPQET---YRKI---INWKE--TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             hcCCCCCCCCCHHHH---HHHH---HcCCC--ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            999999976543211   1111   00000  000011    01123456677788886 9999998   9998874

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-37  Score=313.29  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=205.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-----hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-----RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|++|.||++....++..|++|.+....     ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57888999999999999999998889999999986532     2234578899999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |+||+++++|.+++..     ...+++.....++.|++.||.|||+   .+++||||+|+||++++++.++|+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            9999999999998853     2457888999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCCcc--eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINPQT--THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .........  ....++..|+|||.+.+..++.++||||||+++|||++|+.||.........   ....   .     .
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~~---~-----~  222 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKIA---T-----Q  222 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHHh---c-----c
Confidence            543221111  2345788999999999888999999999999999999999998754322111   0100   0     0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         +.....+......+.+++.+||..+|.+||++.+++++
T Consensus       223 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 ---PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ---CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence               01112233345668889999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.9e-37  Score=323.66  Aligned_cols=242  Identities=23%  Similarity=0.338  Sum_probs=193.5

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhc-cccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGR-LRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|....+++.||+|++....   ....+.+..|..++.. .+||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999997642   2334455667777665 4899999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++...     ..+++.+...++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~  151 (316)
T cd05592          81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G  151 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence            9999988543     358889999999999999999999   899999999999999999999999999998643322 2


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +   .......       .+   .+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~~~-------~~---~~  215 (316)
T cd05592         152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L---FDSILND-------RP---HF  215 (316)
T ss_pred             ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHcC-------CC---CC
Confidence            2334578999999999998889999999999999999999999997653211   1   1111100       11   11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTR-RVVQ  627 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl~  627 (662)
                      +......+.+++.+||+.+|.+||++. ++++
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            222345677889999999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=3.3e-37  Score=332.51  Aligned_cols=264  Identities=24%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC-----eee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----ELL  428 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~  428 (662)
                      +|+..+.||+|+||.||++....+++.||||++...  .....+++.+|+.+++.++|+||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            477889999999999999999889999999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +|+||+. ++|.+++..     ...+++..+..++.||+.||.|||+   .+++||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence            9999996 577777743     3468999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH------------
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW------------  575 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~------------  575 (662)
                      ..............++..|+|||.+.+. .++.++||||+||++|||++|+.||..............            
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~  231 (372)
T cd07853         152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS  231 (372)
T ss_pred             ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            7654333333345678999999988764 478999999999999999999999976543322111100            


Q ss_pred             ----HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 ----VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ----~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ...............+.+........+.+.+|+.+||+.||.+|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         232 ACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                00000000000000000011122235668899999999999999999999975

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.5e-37  Score=320.05  Aligned_cols=249  Identities=23%  Similarity=0.359  Sum_probs=199.6

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|+||+||++....+++.||+|++....   ....+.+..|+.++++++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999998899999999986542   22345678899999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      ..++..... ....+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........ ...
T Consensus        81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~  155 (280)
T cd05608          81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK  155 (280)
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence            988754321 24568999999999999999999999   8999999999999999999999999999986544322 223


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.||.........  ......         ..... ..++..
T Consensus       156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~---------~~~~~-~~~~~~  223 (280)
T cd05608         156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQR---------ILNDS-VTYPDK  223 (280)
T ss_pred             ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHh---------hcccC-CCCccc
Confidence            357899999999999999999999999999999999999999754322110  000110         01111 112233


Q ss_pred             HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ....+.+++.+||+.||++||     ++++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            456688999999999999999     77788764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=318.41  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=209.9

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--------------hHHHHHHHHHHhhccccccceee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--------------GMKEFVAEITSMGRLRHRNLVQL  417 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--------------~~~~f~~Ei~~l~~l~H~niv~l  417 (662)
                      ...++|+..+.||+|.||.|-+|+...+++.||||++.+....              ..++..+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            3447899999999999999999999999999999999664211              13578999999999999999999


Q ss_pred             eeeEecc--CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC
Q 040242          418 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA  495 (662)
Q Consensus       418 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  495 (662)
                      +++..+.  +.+|||+|||..|.+...=-.     ...|+..+.++++.++..||.|||.   ++||||||||+|+||++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcC
Confidence            9998764  479999999999888665321     2239999999999999999999999   99999999999999999


Q ss_pred             CCCeEEeeccccccccCCCC----CcceecccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCcccch
Q 040242          496 DLNPKLGDFGLARAYDHNIN----PQTTHIVGTLGYLAPELTRTGK----ATTSTDVFGFGTLMLEVACGRRPIEPQRTA  567 (662)
Q Consensus       496 ~~~~kL~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  567 (662)
                      ++++||+|||.+..+.....    ......+||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+....
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            99999999999987643321    2233468999999999887643    466889999999999999999999865321


Q ss_pred             hhHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          568 MELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       568 ~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                                +++     .+++...| -...+++.+.+.+|++++|+.||++|.+..+|..+.....+
T Consensus       326 ----------~l~-----~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  326 ----------ELF-----DKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----------HHH-----HHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                      111     12333344 22233567889999999999999999999999998754433

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=3.4e-37  Score=314.64  Aligned_cols=252  Identities=29%  Similarity=0.409  Sum_probs=202.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...+.||+|++|.||+|... ++..+|+|.+.... ....+|.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            35677889999999999999884 35569999886543 23467899999999999999999999999988999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          82 SNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            999999998643    2368999999999999999999999   899999999999999999999999999988654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   ..+.+    .++.     .+. 
T Consensus       155 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-----~~~-  221 (256)
T cd05113         155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQGL-----RLY-  221 (256)
T ss_pred             eeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hcCC-----CCC-
Confidence            222222345678999999988889999999999999999998 999987543221   11111    1111     001 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                        ........+.+++.+||+.+|.+||++.++++.|+
T Consensus       222 --~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         222 --RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             --CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence              11123467889999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5.6e-37  Score=331.74  Aligned_cols=252  Identities=24%  Similarity=0.347  Sum_probs=198.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .|+..+.||+|+||+||+|+...++..||||++....   ....+.+.+|+.++++++|+||+++++++...+..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5778899999999999999999999999999997642   3345678999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++...     ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            99999999998543     457888889999999999999999   8999999999999999999999999999764321


Q ss_pred             CCC----------------------------------------------CcceecccCCcccCcccccCCCCCcchhHHH
Q 040242          513 NIN----------------------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFG  546 (662)
Q Consensus       513 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S  546 (662)
                      ...                                              .......||+.|+|||.+.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            000                                              0012246999999999998888999999999


Q ss_pred             HHHHHHHHHcCCCCCCcccchhhH-HHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH--ccCCCCCCCCCHH
Q 040242          547 FGTLMLEVACGRRPIEPQRTAMEL-VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLL--CCDPHPDFRPSTR  623 (662)
Q Consensus       547 ~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~--Cl~~dP~~RPt~~  623 (662)
                      |||++|||++|+.||......... ....|      ...   ..-+....++    ..+.+++.+  |+..+|..||++.
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~~i~~~------~~~---~~~~~~~~~s----~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQLKVINW------ENT---LHIPPQVKLS----PEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHHHHHcc------ccc---cCCCCCCCCC----HHHHHHHHHHccCcccccCCCCHH
Confidence            999999999999999765432111 11100      000   0001111223    334455544  6677788899999


Q ss_pred             HHHHH
Q 040242          624 RVVQF  628 (662)
Q Consensus       624 eVl~~  628 (662)
                      +++++
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99985

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.7e-37  Score=314.41  Aligned_cols=261  Identities=26%  Similarity=0.429  Sum_probs=210.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|+...++..||||.+...   .......+.+|+.++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            4688899999999999999999889999999987542   3344567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..... +...+++.++..++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            99999999998854321 13458889999999999999999999   899999999999999999999999999988764


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .   .+.... .     ....+
T Consensus       158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~---~~~~~~-~-----~~~~~  226 (267)
T cd08228         158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-F---SLCQKI-E-----QCDYP  226 (267)
T ss_pred             chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-H---HHHHHH-h-----cCCCC
Confidence            3321 1223467889999999988888999999999999999999999986443211 1   111111 1     11111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+  ........+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 ~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         227 PL--PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC--ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11  1223456788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.1e-37  Score=334.53  Aligned_cols=263  Identities=25%  Similarity=0.367  Sum_probs=207.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCC-----CcEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPST-----GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~-----g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~  426 (662)
                      .++|...++||+|+||.||+|.....     +..||||++.... ....+.+.+|+.+++++. ||||++++++|...+.
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~  115 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP  115 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence            35788889999999999999986432     3469999997543 334567899999999996 9999999999999999


Q ss_pred             eeEEEeccCCCCcchhccccccc---------------------------------------------------------
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ---------------------------------------------------------  449 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------------  449 (662)
                      .++|||||++|+|.++|+.....                                                         
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (400)
T cd05105         116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK  195 (400)
T ss_pred             eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence            99999999999999988643210                                                         


Q ss_pred             ----------------------------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC
Q 040242          450 ----------------------------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA  495 (662)
Q Consensus       450 ----------------------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  495 (662)
                                                        ....+++.+++.++.|+++||.|||+   .+++||||||+|||++.
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~  272 (400)
T cd05105         196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeC
Confidence                                              01248889999999999999999999   89999999999999999


Q ss_pred             CCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHH
Q 040242          496 DLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLV  573 (662)
Q Consensus       496 ~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~  573 (662)
                      ++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........  +.
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~~  350 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--FY  350 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--HH
Confidence            99999999999986543221 12223456788999999988889999999999999999997 8899875422111  11


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ..+    ..+.     ..   ..+......+.+++.+||+.+|++||++.+|.++|++..
T Consensus       351 ~~~----~~~~-----~~---~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 NKI----KSGY-----RM---AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHH----hcCC-----CC---CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            111    1110     01   112234567889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-37  Score=319.67  Aligned_cols=261  Identities=26%  Similarity=0.443  Sum_probs=208.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...+.||+|+||+||++...     .++..+|+|.+........+.+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   84 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            46788899999999999999852     3456799999977666667789999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc--------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          430 VYDYVPNGSLDKLLFDNDQ--------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      ||||+++++|.+++.....        .+...+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEEe
Confidence            9999999999999864321        123459999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||+++....... .......++..|+|||.+.+..++.++|||||||+++||++ |..||.......   ....+   
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~~i---  235 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIECI---  235 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence            99999986543211 11122345778999999988889999999999999999998 888886543221   11111   


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                       ..+...     ..   .......+.+++.+||+.+|.+||++.+|++.|+...
T Consensus       236 -~~~~~~-----~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 -TQGRVL-----QR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             -HcCCcC-----CC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence             111111     11   1123356889999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=342.43  Aligned_cols=262  Identities=25%  Similarity=0.347  Sum_probs=212.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeE-ec------cCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWC-RK------QDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~-~~------~~~  426 (662)
                      .+.++.++|.+|||+.||.+.+...|..+|+|++-...+...+.+.+|+.+|++|+ |+|||.+++.. ..      .-+
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            34566889999999999999998777999999998888888999999999999997 99999999932 11      137


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .+|.||||++|+|-++|....   ...|++.++++|+.++++|+++||. +..+|||||||-+||||..++..||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccc
Confidence            899999999999999997554   3449999999999999999999998 457799999999999999999999999998


Q ss_pred             cccccCCCC-Cc-------ceecccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH
Q 040242          507 ARAYDHNIN-PQ-------TTHIVGTLGYLAPELT---RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW  575 (662)
Q Consensus       507 a~~~~~~~~-~~-------~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  575 (662)
                      +.-.-.... ..       .-...-|+.|.|||++   .+...++|+|||+|||+||-|+....||+....         
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~---------  263 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK---------  263 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc---------
Confidence            864322211 00       0112458999999976   456789999999999999999999999986532         


Q ss_pred             HHHHhhcCccccccCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc----CCCCCCCC
Q 040242          576 VRELHSQGQITRAIDPTLDY-FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR----DASLPQAP  639 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~~l~~-~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~----~~~~p~~p  639 (662)
                                ..+++..... -.+.+...+..||+.||++||.+||++.+|++.+..    .-++++.+
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                      2333433311 125788899999999999999999999999987743    34444444

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.1e-37  Score=318.86  Aligned_cols=254  Identities=24%  Similarity=0.336  Sum_probs=201.5

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|+||.||++....+|+.||+|++....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999998899999999986532   12234556799999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++....   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~  152 (277)
T cd05607          81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT  152 (277)
T ss_pred             HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence            98886442   3458899999999999999999999   899999999999999999999999999998664332  223


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...|+..|+|||++.+..++.++||||+||++|||++|+.||........  ..+..+....     ..+..    ....
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~-----~~~~~----~~~~  221 (277)
T cd05607         153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLE-----DEVKF----EHQN  221 (277)
T ss_pred             ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhc-----ccccc----cccc
Confidence            35689999999999888899999999999999999999999975432111  1111111111     01110    0112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL  635 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  635 (662)
                      ....+.+|+.+||+.||++||+++|+++.+..+.-+
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f  257 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFF  257 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhh
Confidence            345678999999999999999998877666655444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.4e-37  Score=320.38  Aligned_cols=263  Identities=24%  Similarity=0.373  Sum_probs=204.1

Q ss_pred             cCCcccceeeeeCceEEEEEEe----CCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc--Ceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~----~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  428 (662)
                      ++|+..+.||+|+||.||++..    ..++..||+|++........+.+.+|++++++++||||+++++++...  ...+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678889999999999999984    346789999999877777778899999999999999999999987543  4689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...    ...+++..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++
T Consensus        84 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccc
Confidence            999999999999998543    3458999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCc--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh---------HHHHHHHH
Q 040242          509 AYDHNINPQ--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME---------LVLVDWVR  577 (662)
Q Consensus       509 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~~  577 (662)
                      .........  .....++..|+|||++.+..++.++|||||||++|||++|..++........         ......+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            764432211  1112334569999999888899999999999999999998876543211000         00000000


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +....+        ............+.+++.+||+.+|++|||+.||++.|+..
T Consensus       237 ~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNN--------GRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcC--------CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            100000        00111223446788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.8e-38  Score=330.64  Aligned_cols=244  Identities=27%  Similarity=0.354  Sum_probs=198.6

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      +.||+|+||.||++....++..||+|.+....   ......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999998899999999997642   334567788999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|..++..     ...+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            99988843     34589999999999999999999962  689999999999999999999999999987533221 12


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........   ..+.    ..      ...   ++
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~---~~i~----~~------~~~---~p  216 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF---ELIL----ME------EIR---FP  216 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH---HHHh----cC------CCC---CC
Confidence            23356899999999999889999999999999999999999999754332111   1110    00      011   12


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ......+.+++.+||+.||++|+     ++.+++++
T Consensus       217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            22345678899999999999996     89999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.3e-37  Score=318.11  Aligned_cols=257  Identities=27%  Similarity=0.415  Sum_probs=203.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|+||.||+|.+..++.    .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            457778999999999999999876665    47788875443 334567888999999999999999999885 455789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+++|+|.+++...    ...++|..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.
T Consensus        86 i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~  158 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADL  158 (279)
T ss_pred             EEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence            99999999999999654    3468999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......++..|+|||.+.++.++.++|||||||++|||++ |+.||.......   +.+++    ..+... 
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~-  230 (279)
T cd05111         159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDLL----EKGERL-  230 (279)
T ss_pred             ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH----HCCCcC-
Confidence            5433221 2233456789999999988899999999999999999998 999987543221   11111    111111 


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                       ..+.      .....+..++.+|+..+|++||++.|+++.|.....
T Consensus       231 -~~~~------~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         231 -AQPQ------ICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             1111      123456778899999999999999999999977543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.2e-37  Score=330.97  Aligned_cols=259  Identities=22%  Similarity=0.261  Sum_probs=203.7

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccC
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD  425 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~  425 (662)
                      ++....++|+..+.||+|+||.||++....+++.+|+|.+.+..   ....+.+.+|+.+++.++||||+++++++..++
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34445678999999999999999999998899999999986532   223456788999999999999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||+++|+|.+++..      ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecc
Confidence            99999999999999999843      247888899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTG----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      ++...............||+.|+|||.+.+.    .++.++||||+||++|||++|+.||........      ......
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~  261 (370)
T cd05621         188 TCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMD  261 (370)
T ss_pred             cceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHh
Confidence            9987654322223345799999999988653    378899999999999999999999975532211      111111


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  628 (662)
                      ...   .+  .. .........+.+++..|+..++.+  ||++.|++++
T Consensus       262 ~~~---~~--~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         262 HKN---SL--NF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCc---cc--CC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            100   00  01 011123455677788888765544  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.8e-37  Score=318.01  Aligned_cols=260  Identities=23%  Similarity=0.380  Sum_probs=206.5

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      ++++|...+.||+|++|.||+|.+..     .+..|++|.+.... ......|..|+.++++++|+||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678889999999999999999976     66789999886543 3445679999999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccc--cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC---CeEE
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQ--QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL---NPKL  501 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL  501 (662)
                      .++||||+++++|.+++.....  .....++|.+++.++.||+.||+|||+   .+++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999965431  112368999999999999999999999   8999999999999998764   5999


Q ss_pred             eeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||........   .+.+   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~~~---  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---MEFV---  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---
Confidence            999999876322111 1112234568999999988899999999999999999997 9999875433211   1111   


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .....         ...+...+..+.+++.+|++.+|++||++.+|+++|.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGGR---------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11100         1112233567889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-38  Score=298.63  Aligned_cols=250  Identities=27%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .++|++.+.||+|.||.||.|..+.++-.||+|++.+.+   .+...++.+|+++-+.|+||||+++++|+.+....||+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367899999999999999999999999999999997753   33456899999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +||.++|+|...|.+..   ...++.......+.|+|.||.|+|.   ++|+||||||+|+|++..+..||+|||.+...
T Consensus       101 lEya~~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEecCCchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            99999999999996543   4557788888999999999999999   99999999999999999999999999988764


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      .   .......+||..|++||+..+...+...|+|++|++.||++.|.+||+.....+   ....+.       -.+..+
T Consensus       175 p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e---tYkrI~-------k~~~~~  241 (281)
T KOG0580|consen  175 P---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE---TYKRIR-------KVDLKF  241 (281)
T ss_pred             C---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH---HHHHHH-------HccccC
Confidence            4   223445689999999999999999999999999999999999999998654221   111111       122222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      |      ........+++.+|+..+|.+|.+..||+++
T Consensus       242 p------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  242 P------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             C------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            2      3345567788999999999999999999976

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=9e-37  Score=313.37  Aligned_cols=259  Identities=27%  Similarity=0.393  Sum_probs=207.9

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      |++.+++++.....||+|+||.||+|.+..++..|++|.+........+.+.+|+.++++++|+||+++++++..++..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            34556777777889999999999999998888999999998776667778999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccc--cHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeecc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKIL--NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFG  505 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG  505 (662)
                      +|+||+++++|.+++...    ...+  ++..+..++.|+++||.|||+   .+|+||||||+||+++. ++.++|+|||
T Consensus        82 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg  154 (268)
T cd06624          82 IFMEQVPGGSLSALLRSK----WGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFG  154 (268)
T ss_pred             EEEecCCCCCHHHHHHHh----cccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecch
Confidence            999999999999999643    1234  788888999999999999999   89999999999999986 6789999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ++....... .......++..|+|||++....  ++.++||||||+++|||++|+.|+.........   .|.....   
T Consensus       155 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~---  227 (268)
T cd06624         155 TSKRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMF---  227 (268)
T ss_pred             hheecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhh---
Confidence            987654322 2222345789999999986543  788999999999999999999998643321111   1110000   


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ...   ...+......+..++.+||+.+|++||++.|++++
T Consensus       228 ----~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         228 ----KIH---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ----ccC---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                011   12233345668889999999999999999999864

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=6.2e-37  Score=314.27  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=204.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||+|+...+++.||+|++..........+.+|+.++++++||||+++++++..++..++||||+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~   88 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC   88 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence            46888999999999999999998889999999997665555567889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++..     ...+++.++..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06646          89 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI  160 (267)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence            99999998853     3458899999999999999999999   899999999999999999999999999998664322


Q ss_pred             CCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          515 NPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+..........  .+     ...   ....+
T Consensus       161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~-----~~~---~~~~~  229 (267)
T cd06646         161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LM-----SKS---NFQPP  229 (267)
T ss_pred             c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--ee-----ecC---CCCCC
Confidence            1 122346889999999874   3457889999999999999999999986432211100  00     000   00111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .... .......+.+++.+||+.+|++||++++++++|
T Consensus       230 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         230 KLKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCcc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            1111 112346788999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=7.6e-37  Score=311.68  Aligned_cols=254  Identities=31%  Similarity=0.505  Sum_probs=204.7

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhH--HHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM--KEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~--~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |+..+.||+|+||+||++....+++.+|+|++........  .....|+..+++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678899999999999999999999999999987644332  23456999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++.     +...+++..++.++.|+++||.+||+   .+++|+||||+||++++++.++|+|||.+.... ..
T Consensus        81 ~~~~L~~~l~-----~~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~  151 (260)
T PF00069_consen   81 PGGSLQDYLQ-----KNKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLS-EN  151 (260)
T ss_dssp             TTEBHHHHHH-----HHSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEEST-ST
T ss_pred             cccccccccc-----cccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc-cc
Confidence            9999999996     24678999999999999999999999   899999999999999999999999999998642 22


Q ss_pred             CCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+. +...+.++||||+|+++++|++|+.|+..................    .....   . 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~---~-  223 (260)
T PF00069_consen  152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR----PLPSS---S-  223 (260)
T ss_dssp             TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT----HHHHH---T-
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc----ccccc---c-
Confidence            23344567899999999998 788999999999999999999999999865222222111111100    00000   0 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .........+.+++.+||+.||++||++.+++++
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0000112788999999999999999999999863

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-36  Score=327.17  Aligned_cols=203  Identities=25%  Similarity=0.384  Sum_probs=177.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||++....+++.||||++....   ......+..|+.++.+++|+||+++++.+.....+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46888999999999999999998889999999997642   233456788999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            99999999999854     3468899999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCC----------------------------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC
Q 040242          512 HNIN----------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG  557 (662)
Q Consensus       512 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG  557 (662)
                      ....                                  .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            2110                                  001234799999999999888899999999999999999999


Q ss_pred             CCCCCccc
Q 040242          558 RRPIEPQR  565 (662)
Q Consensus       558 ~~p~~~~~  565 (662)
                      +.||....
T Consensus       233 ~~Pf~~~~  240 (363)
T cd05628         233 YPPFCSET  240 (363)
T ss_pred             CCCCCCCC
Confidence            99997544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.8e-37  Score=327.74  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=201.0

Q ss_pred             CCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      +|+..+.||+|+||.||+++..   .++..||+|++.+..    ....+.+..|+.++.++ +|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4778899999999999998863   467899999986532    23345678899999999 599999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++|+|.+++..     ...+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence            999999999999999853     3458899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      +..............||+.|+|||.+.+. .++.++|||||||++|||++|+.||..........   .+.....     
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~-----  224 (332)
T cd05614         153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRIL-----  224 (332)
T ss_pred             ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHh-----
Confidence            87644433334456799999999998765 47889999999999999999999997432211111   1111111     


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                       ..++.+   +......+.+++.+||+.||++||     ++++++++
T Consensus       225 -~~~~~~---~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 -KCDPPF---PSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             -cCCCCC---CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence             112222   222345677889999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-37  Score=313.75  Aligned_cols=251  Identities=29%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +|+..+.||+|++|.||++.+. .+..+|+|.+..... ...+|.+|++++++++|+||+++++++...+..++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            4677889999999999999985 466799998864332 34578899999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++...    ...+++..++.++.|+++||+|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        83 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~  155 (256)
T cd05059          83 NGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY  155 (256)
T ss_pred             CCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence            99999998644    2368999999999999999999999   8999999999999999999999999999986543221


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      .......++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ....+.    .+     ....  
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~----~~-----~~~~--  221 (256)
T cd05059         156 TSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVS----AG-----YRLY--  221 (256)
T ss_pred             cccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHH----cC-----CcCC--
Confidence            11112234568999999988889999999999999999999 788887543221   111111    11     1111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                       .+...+..+.+++.+||+.+|++||++.|+++.|.
T Consensus       222 -~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~  256 (256)
T cd05059         222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQLT  256 (256)
T ss_pred             -CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence             11234567889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.5e-37  Score=317.70  Aligned_cols=259  Identities=24%  Similarity=0.393  Sum_probs=204.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeC----CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~----~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|+||.||+|...    ..+..|++|.+... ..+....+.+|+.++++++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            45777899999999999999852    34578999999643 34445778999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC
Q 040242          430 VYDYVPNGSLDKLLFDNDQ------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL  497 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  497 (662)
                      ||||+++++|.+++.....            .....+++.+.+.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            9999999999999853211            112458899999999999999999999   8999999999999999999


Q ss_pred             CeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHH
Q 040242          498 NPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDW  575 (662)
Q Consensus       498 ~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~  575 (662)
                      .+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......   .+.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence            999999999986533221 11222345678999999988889999999999999999998 88898654321   11111


Q ss_pred             HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          576 VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      +    ......        ..+......+..++.+|++.+|.+||++.+|.++|..
T Consensus       239 ~----~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 V----RKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1    111110        1122334567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=6.8e-37  Score=314.17  Aligned_cols=256  Identities=29%  Similarity=0.493  Sum_probs=206.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc---EEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL---EVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|++|.||+|..+.++.   .+++|.+... .....+++..|++++++++|+|++++++++...+..++|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII   84 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence            567888999999999999999865544   7999998655 334456789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          85 TEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceec
Confidence            9999999999998543    3468999999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCCCcce--ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINPQTT--HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .........  ....+..|+|||++....++.++|||||||++|||++ |+.||......      ++.... ..+.   
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i-~~~~---  227 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAI-NDGF---  227 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHH-hcCC---
Confidence            543222111  1223457999999988889999999999999999997 99999654321      111111 1110   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       ..+.    .......+.+++.+|++.+|++||++.+|++.|++.
T Consensus       228 -~~~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 -RLPA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -CCCC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             0111    112345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.7e-37  Score=325.62  Aligned_cols=250  Identities=24%  Similarity=0.314  Sum_probs=198.3

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||++....+++.||+|++...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999989999999999764   233445678888888776 899999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++..     ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~  151 (329)
T cd05618          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GD  151 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CC
Confidence            999888743     3458999999999999999999999   89999999999999999999999999998753222 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch--hhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA--MELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||......  .......++.+......         .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---------~  222 (329)
T cd05618         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---------I  222 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC---------C
Confidence            223457899999999999889999999999999999999999999632111  11111223322222111         1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPS------TRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~eVl~~  628 (662)
                      ..+......+..++.+||+.||++||+      +.+++++
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            122234456788999999999999998      5677654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.6e-37  Score=326.31  Aligned_cols=243  Identities=23%  Similarity=0.374  Sum_probs=196.4

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||+||+++...+++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999997542   23456677888888876 699999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++...     ..+++..+..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++...... .
T Consensus        81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~  151 (320)
T cd05590          81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-K  151 (320)
T ss_pred             chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-C
Confidence            9999988533     458899999999999999999999   899999999999999999999999999987543221 2


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +..   .. ..+.      .   ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~---~i-~~~~------~---~~  215 (320)
T cd05590         152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AI-LNDE------V---VY  215 (320)
T ss_pred             cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHH---HH-hcCC------C---CC
Confidence            2234578999999999998889999999999999999999999997654221   111   11 1111      0   11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPST------RRVVQF  628 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~------~eVl~~  628 (662)
                      +......+.+++.+||+.||.+||++      ++++++
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            11234567889999999999999998      666653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.8e-37  Score=325.62  Aligned_cols=247  Identities=23%  Similarity=0.332  Sum_probs=198.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcccc-ccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~  431 (662)
                      +|+..+.||+|+||.||+|+...+++.||||++....   ....+.+..|..++..++| ++|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4778899999999999999998889999999997642   3345677889999999976 45888999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            99999999998853     2457889999999999999999999   899999999999999999999999999987532


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .. ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......   +...+.    ..      ..
T Consensus       153 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~----~~------~~  218 (324)
T cd05587         153 FG-GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSIM----EH------NV  218 (324)
T ss_pred             CC-CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----cC------CC
Confidence            21 122334578999999999998889999999999999999999999997554221   111111    10      01


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPST-----RRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~  627 (662)
                         .++......+.+++.+||+.||.+||+.     .++.+
T Consensus       219 ---~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         219 ---SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence               1122234567889999999999999976     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-38  Score=314.36  Aligned_cols=249  Identities=25%  Similarity=0.425  Sum_probs=212.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .+|++.+.||+|.||+|-++.....|+.||||.+++.   .++..-.+.+||++|+.|+||||++++..|+.++.+.+||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4577788999999999999999889999999998765   4455567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||..+|.|.+++.+     +..|++.+...++.||..|+.|+|.   ++++|||||.+|||||.|+++||+||||+.++.
T Consensus       133 EYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  133 EYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            99999999999954     4679999999999999999999999   899999999999999999999999999999887


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...  .....+|++-|.+||++++..| .+..|-||+||+||.|+.|..||++.+-.   .+   +++ ...|.      
T Consensus       205 ~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk---~l---vrQ-Is~Ga------  269 (668)
T KOG0611|consen  205 DKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK---RL---VRQ-ISRGA------  269 (668)
T ss_pred             ccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH---HH---HHH-hhccc------
Confidence            543  3445799999999999998876 67899999999999999999999976421   11   222 11121      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                          ...++.+....-|++|||-.||++|-|+.+|..+..
T Consensus       270 ----YrEP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  270 ----YREPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             ----ccCCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence                112234445678999999999999999999999873

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.1e-37  Score=325.37  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=199.5

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||++....+++.||+|++....   ....+.+..|..++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999999899999999997642   33445678899999888 799999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++..     ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++..... ..
T Consensus        81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~  151 (329)
T cd05588          81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GD  151 (329)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccC-CC
Confidence            999988843     3468999999999999999999999   89999999999999999999999999998743221 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh--hHHHHHHHHHHhhcCccccccCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM--ELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~--~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....++..+.......      .  
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~--  223 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------R--  223 (329)
T ss_pred             ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------C--
Confidence            2234578999999999998889999999999999999999999996322111  11122233332222111      1  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPS------TRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt------~~eVl~~  628 (662)
                       .+......+.+++.+||+.||.+||+      +++++++
T Consensus       224 -~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         224 -IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence             12223456788999999999999997      7788754

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=9e-37  Score=312.94  Aligned_cols=261  Identities=27%  Similarity=0.454  Sum_probs=210.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|++|.||++....++..++||.+...   ......++.+|+.+++.++|+||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4677889999999999999999888999999988653   2334568899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..... ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999864321 24568999999999999999999999   899999999999999999999999999988664


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++|..||........ .   +...      +.....+
T Consensus       158 ~~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~---~~~~------~~~~~~~  226 (267)
T cd08229         158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-S---LCKK------IEQCDYP  226 (267)
T ss_pred             cCCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-H---Hhhh------hhcCCCC
Confidence            4322 12234688999999999888899999999999999999999999865432211 1   1111      0111111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+  ........+.+++.+||+.+|++||||.+|++.+++.
T Consensus       227 ~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         227 PL--PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CC--CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            11  1123456788999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6e-37  Score=313.27  Aligned_cols=253  Identities=27%  Similarity=0.432  Sum_probs=203.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||+|... .+..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            46778899999999999999885 566799999865433 3467899999999999999999999885 45689999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++.+++.++.|++.||.|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          83 SKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999996542   3458999999999999999999999   899999999999999999999999999998765433


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||......   ...+.+.    .+     ..   
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~----~~-----~~---  221 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE----RG-----YR---  221 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH----cC-----CC---
Confidence            222222345678999999988889999999999999999999 88888654322   1111111    11     00   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ...+......+.+++.+|++.+|++|||+.++.+.|+.
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11122345668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4.6e-37  Score=326.69  Aligned_cols=262  Identities=24%  Similarity=0.360  Sum_probs=204.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEecc-Ce
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ-DE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~-~~  426 (662)
                      ++|+..+.||+|+||.||+|...+     +++.||+|++.... ....+.+..|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~   86 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP   86 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence            468889999999999999997533     34789999986542 33456788999999999 899999999988654 56


Q ss_pred             eeEEEeccCCCCcchhccccccc--------------------------------------------------------c
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ--------------------------------------------------------K  450 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~--------------------------------------------------------~  450 (662)
                      ++++|||+++++|.+++......                                                        .
T Consensus        87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (337)
T cd05054          87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY  166 (337)
T ss_pred             EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence            88999999999999988532110                                                        0


Q ss_pred             cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcccC
Q 040242          451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLA  529 (662)
Q Consensus       451 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~a  529 (662)
                      ...++|..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..... .......++..|+|
T Consensus       167 ~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         167 KEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence            2368999999999999999999999   8999999999999999999999999999987543221 11223456778999


Q ss_pred             cccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 040242          530 PELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG  608 (662)
Q Consensus       530 PE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~  608 (662)
                      ||++.+..++.++|||||||++|||++ |+.||......+  .+.    .....+..     +   ..+......+.+++
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~----~~~~~~~~-----~---~~~~~~~~~~~~l~  309 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFC----RRLKEGTR-----M---RAPEYATPEIYSIM  309 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHH----HHHhccCC-----C---CCCccCCHHHHHHH
Confidence            999999999999999999999999998 999987533211  111    11111110     0   11122345688999


Q ss_pred             HHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          609 LLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       609 ~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      .+||+.+|++||++.||+++|+...
T Consensus       310 ~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         310 LDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHccCChhhCcCHHHHHHHHHHHH
Confidence            9999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2.1e-36  Score=309.82  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=211.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|++|.||+|....+|..||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5788899999999999999999888999999988642   2334568899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..... ....+++.+++.++.++++||.|||+   .+++||||+|+||+++.++.++|+|||+++...
T Consensus        82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999864321 13558999999999999999999999   899999999999999999999999999988654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......    +.+.... ...+.     .+
T Consensus       158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-~~~~~-----~~  226 (267)
T cd08224         158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKK-IEKCD-----YP  226 (267)
T ss_pred             CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhh-hhcCC-----CC
Confidence            4322 223346888999999998888999999999999999999999998644321    1111111 11111     01


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..  ........+.+++.+||+.+|++||++.+|++.|...
T Consensus       227 ~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         227 PL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11  1124456788999999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6.6e-37  Score=329.71  Aligned_cols=264  Identities=22%  Similarity=0.244  Sum_probs=207.4

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeE
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWC  421 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~  421 (662)
                      -.+.++....++|+..+.||+|+||.||++....+++.+|+|++....   ....+.+.+|+.+++.++||||+++++++
T Consensus        33 ~~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~  112 (371)
T cd05622          33 NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF  112 (371)
T ss_pred             hHHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            345566667789999999999999999999999999999999986532   23345678899999999999999999999


Q ss_pred             eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       422 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      ...+..++||||+++|+|.+++..      ..++...+..++.||+.||.|||+   .+|+||||||+|||++.++.+||
T Consensus       113 ~~~~~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL  183 (371)
T cd05622         113 QDDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL  183 (371)
T ss_pred             EcCCEEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999843      347788888999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCCcceecccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          502 GDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       502 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      +|||+++..............||+.|+|||++...    .++.++|||||||++|||++|+.||........      ..
T Consensus       184 ~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~  257 (371)
T cd05622         184 ADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YS  257 (371)
T ss_pred             EeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HH
Confidence            99999987654332233345799999999998653    378899999999999999999999986432211      11


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQFL  629 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~L  629 (662)
                      ..........     .. ........+..++.+|+..++.+  ||++.+++++.
T Consensus       258 ~i~~~~~~~~-----~~-~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         258 KIMNHKNSLT-----FP-DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHcCCCccc-----CC-CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            1111100000     00 11133455778888999854443  78999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.2e-36  Score=317.72  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=207.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||+|+...++..|++|.+........+.+.+|+.++++++|+||+++++++......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888899999999999999998889999999997765555678899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++..      ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus       100 ~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~  170 (296)
T cd06654         100 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (296)
T ss_pred             CCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence            99999999842      347889999999999999999999   899999999999999999999999999988654322


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . ......+++.|+|||.+.+..++.++|||||||++|||++|+.||.........  ..+.    ..+      .+.+ 
T Consensus       171 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~----~~~------~~~~-  236 (296)
T cd06654         171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----TNG------TPEL-  236 (296)
T ss_pred             c-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh----cCC------CCCC-
Confidence            1 122346889999999998888899999999999999999999999754332111  1000    000      0111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+......+.+++.+||..+|++||++.+++++
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            1122344668889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.2e-37  Score=325.15  Aligned_cols=243  Identities=26%  Similarity=0.373  Sum_probs=196.2

Q ss_pred             ceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          361 NLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++||+|+||.||+++..   ..++.||||.+....    ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            67999999999999863   467899999997532    22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..     ...+.+.....++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            999999998853     3457788888999999999999999   89999999999999999999999999998754322


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      ..... .+.      .  
T Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~-~~~------~--  217 (323)
T cd05584         154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKIL-KGK------L--  217 (323)
T ss_pred             C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHH-cCC------C--
Confidence            1 122335789999999999888899999999999999999999999976543211      11111 111      0  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                       ..+......+.+++.+||+.+|++||     ++.+++++
T Consensus       218 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         218 -NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence             11222345678999999999999999     78888764

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-37  Score=309.43  Aligned_cols=279  Identities=25%  Similarity=0.357  Sum_probs=216.2

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEee--ccchhhHHHHHHHHHHhhccccccceeeeeeEec-----c
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-----Q  424 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~--~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-----~  424 (662)
                      .....|...+.||+|.||.|+++.++.+|+.||||++.  -......++.++|+++|+.++|+||+.+.+....     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            34456666789999999999999999999999999997  3455567888999999999999999999998755     3


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      +..|+|+|+| ..+|...++.+     ..|+......++.|+++||.|+|+   .+|+||||||+|++++.+..+||+||
T Consensus        99 ~DvYiV~elM-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF  169 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF  169 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence            4789999999 77999999543     348889999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCC-CCCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH---
Q 040242          505 GLARAYDHN-INPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL---  579 (662)
Q Consensus       505 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---  579 (662)
                      |||+..... .....+..+.|..|.|||.+. ...++.+.||||.|||+.||++|++-|.+.+...+..+..-+-..   
T Consensus       170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~  249 (359)
T KOG0660|consen  170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE  249 (359)
T ss_pred             cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence            999987643 122346678899999999764 567999999999999999999999999877665554432221110   


Q ss_pred             -----hhcCccccccC--CCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCC
Q 040242          580 -----HSQGQITRAID--PTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAP  639 (662)
Q Consensus       580 -----~~~~~~~~~id--~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p  639 (662)
                           ....+....+.  |..     ...-+......++|..+||..||.+|+|++|.+++  |+.-..+.+-|
T Consensus       250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence                 01000111110  111     01111334567888999999999999999999984  55554444444

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.2e-37  Score=325.81  Aligned_cols=243  Identities=26%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|+...+++.||||++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999998889999999997642   33445677888888866 799999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++...     ..+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~  151 (321)
T cd05591          81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-V  151 (321)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-c
Confidence            9999888533     458899999999999999999999   899999999999999999999999999987543221 2


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .... +.   .   .   .
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~---~i~~-~~---~---~---~  215 (321)
T cd05591         152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFE---SILH-DD---V---L---Y  215 (321)
T ss_pred             cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHH---HHHc-CC---C---C---C
Confidence            2234568999999999988889999999999999999999999998654321   111   1111 11   0   0   1


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRP-------STRRVVQF  628 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RP-------t~~eVl~~  628 (662)
                      +......+.+++.+||+.||++||       ++.+++++
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            112335677889999999999999       88888864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-37  Score=312.70  Aligned_cols=265  Identities=24%  Similarity=0.377  Sum_probs=204.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHh--hccccccceeeeeeEeccC----eee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSM--GRLRHRNLVQLHGWCRKQD----ELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l--~~l~H~niv~l~~~~~~~~----~~~  428 (662)
                      ++....+.||+|+||.||+|.+  .|+.||||++....+.   .+.+|.++.  ..|||+||+.+++.-..+.    +++
T Consensus       211 rqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  211 RQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             heeEEEEEecCccccceeeccc--cCCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEE
Confidence            5677789999999999999999  4788999999665443   444555555  4569999999999876554    789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhc-----CCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE-----CDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      ||.+|.++|||.++|.      +..++-...++++..+|.||++||.+     .++.|.|||||++|||+..++.+.|+|
T Consensus       286 LvTdYHe~GSL~DyL~------r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLN------RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EeeecccCCcHHHHHh------hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            9999999999999994      45788999999999999999999975     357799999999999999999999999


Q ss_pred             ccccccccCCCC---CcceecccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHcC----------CCCCCcc
Q 040242          504 FGLARAYDHNIN---PQTTHIVGTLGYLAPELTRTG------KATTSTDVFGFGTLMLEVACG----------RRPIEPQ  564 (662)
Q Consensus       504 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p~~~~  564 (662)
                      +|||-......+   ......+||.+|||||++...      +.-..+||||||.|+||+...          +.||.+-
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            999988765532   234456899999999998543      223468999999999999762          2355432


Q ss_pred             cchhhHHHHHHHHHHhhcCccccccCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          565 RTAMELVLVDWVRELHSQGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       565 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                      .+.+...  +-+++    ---.+.+.|.+  ...+.+....+.+|++.||..+|..|-|+-.|-+.|.+....+
T Consensus       440 Vp~DPs~--eeMrk----VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~~  507 (513)
T KOG2052|consen  440 VPSDPSF--EEMRK----VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNSD  507 (513)
T ss_pred             CCCCCCH--HHHhc----ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcCh
Confidence            2211111  01111    11223344444  2345577888999999999999999999999999998776543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.4e-37  Score=323.29  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=195.0

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||+||+|....+++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999998889999999997642   23345567788888764 899999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++..     ...+++.+...++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  151 (316)
T cd05619          81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DA  151 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CC
Confidence            999999853     2458899999999999999999999   89999999999999999999999999998753222 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+.    ..      .+..   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i~----~~------~~~~---  215 (316)
T cd05619         152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSIR----MD------NPCY---  215 (316)
T ss_pred             ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hC------CCCC---
Confidence            2334578999999999988889999999999999999999999997653221   111111    00      1111   


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTR-RVVQ  627 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl~  627 (662)
                      +......+.+++.+||+.||++||++. ++.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            112345577889999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.1e-37  Score=317.71  Aligned_cols=259  Identities=24%  Similarity=0.388  Sum_probs=204.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +|+..+.||+|+||.||+|+...     ....+++|.+.... .....++.+|+.+++.++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            36778899999999999998742     23568899886543 3345678999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc-------------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCc
Q 040242          430 VYDYVPNGSLDKLLFDNDQ-------------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN  490 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  490 (662)
                      ++||+++++|.+++.....                   .....+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            9999999999999864211                   112458899999999999999999998   899999999999


Q ss_pred             eEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchh
Q 040242          491 VLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAM  568 (662)
Q Consensus       491 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  568 (662)
                      |++++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||++++||++ |+.||...... 
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-  236 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-  236 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH-
Confidence            99999999999999999865332211 1222345678999999988889999999999999999998 99998654322 


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .+.+++    ..+.     ...   .+......+..++.+|++.+|.+||++.++++.|++.
T Consensus       237 --~~~~~~----~~~~-----~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         237 --RLFNLL----KTGY-----RME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHHHHH----hCCC-----CCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              111111    1110     011   1122345688999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.3e-36  Score=308.71  Aligned_cols=247  Identities=25%  Similarity=0.425  Sum_probs=199.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ++||+|+||.||+|... ++..+|+|.+.... ......+.+|+.++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            46999999999999974 67889999987653 33345789999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++...    ...+++..++.++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||++............
T Consensus        80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            9998543    3458899999999999999999998   89999999999999999999999999999765433222222


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP  598 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  598 (662)
                      ...++..|+|||++.++.++.++||||||+++|||++ |..||.......   ....+    ..+.     ..   ....
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~~~~----~~~~-----~~---~~~~  217 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AREQV----EKGY-----RM---SCPQ  217 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----HcCC-----CC---CCCC
Confidence            2344678999999998889999999999999999998 999987543221   11111    1111     00   1122


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          599 QEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       599 ~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .....+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            34567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1e-36  Score=312.28  Aligned_cols=253  Identities=28%  Similarity=0.428  Sum_probs=203.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..++||+|++|.||+|.+..+ ..||+|++.... ...++|.+|+.++++++|+||+++++.+.. ...++||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~   82 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   82 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence            5688899999999999999998654 569999987532 234678999999999999999999998754 5689999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++....   ...+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          83 SKGSLLDFLKGEM---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCcHHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            9999999996432   3468999999999999999999999   899999999999999999999999999998765443


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||+..+..++.++|||||||++|||++ |+.||........   .   .. ...+.     .   
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~---~~-~~~~~-----~---  221 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---DQ-VERGY-----R---  221 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H---HH-HhcCC-----C---
Confidence            222223456778999999988889999999999999999999 7888865432211   0   11 11110     0   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ..........+.+++.+|++.+|++||++.+++++|+.
T Consensus       222 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         222 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            11123455678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=4.3e-37  Score=325.09  Aligned_cols=238  Identities=27%  Similarity=0.357  Sum_probs=191.0

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHH-HhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEIT-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||+||+|....+|+.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999899999999997542   223345555554 56789999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++..     ...+++.....++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~  151 (323)
T cd05575          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SK  151 (323)
T ss_pred             CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CC
Confidence            999998853     3458889999999999999999999   89999999999999999999999999998753222 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ....... +        .+ ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~-~--------~~-~~  215 (323)
T cd05575         152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILN-K--------PL-RL  215 (323)
T ss_pred             ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHc-C--------CC-CC
Confidence            2334578999999999998889999999999999999999999997543211      1111111 0        01 11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                      .......+.+++.+||+.||.+||+++
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            122355678899999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5e-37  Score=323.61  Aligned_cols=241  Identities=22%  Similarity=0.328  Sum_probs=193.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|+...+|..||+|.+....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999899999999997642   23345567788777754 899999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++..     ...+++.+...++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus        81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  151 (316)
T cd05620          81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DN  151 (316)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CC
Confidence            999998853     2457889999999999999999999   89999999999999999999999999998743221 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.+.+    ...      .+.+   
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~----~~~------~~~~---  215 (316)
T cd05620         152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESI----RVD------TPHY---  215 (316)
T ss_pred             ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH----HhC------CCCC---
Confidence            233457899999999999889999999999999999999999999754322   111111    100      1111   


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTR-RVV  626 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl  626 (662)
                      +......+.+++.+||+.||++||++. ++.
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            112345577899999999999999984 665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-36  Score=311.44  Aligned_cols=256  Identities=24%  Similarity=0.369  Sum_probs=201.1

Q ss_pred             cccceeeeeCceEEEEEEeCCCCc--EEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------Cee
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGL--EVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------DEL  427 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~--~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~~~  427 (662)
                      ...++||+|+||.||+|++...+.  .+|+|.+...  .....+.+..|+.++++++|+||++++++|...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            456889999999999999876664  6899988654  344567889999999999999999999988532      246


Q ss_pred             eEEEeccCCCCcchhcccccc-cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQ-QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      +++|||+++|+|.+++..... .+...+++.....++.|++.||+|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCc
Confidence            899999999999998743321 123568999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++........ ......+++.|+|||...+..++.++|||||||++|||++ |+.||......   .+.+    ....+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~~~  231 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD----YLRQGN  231 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH----HHHcCC
Confidence            9876543211 1122345778999999998889999999999999999999 78888654321   1111    111111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ..        .........+.+++.+||+.+|++||++.++++.|+.
T Consensus       232 ~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         232 RL--------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            11        1112334568899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=314.11  Aligned_cols=259  Identities=25%  Similarity=0.401  Sum_probs=207.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC-----CcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST-----GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~-----g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|...+.||+|+||.||+|.....     +..||+|.+.... ......+.+|+.++..++|+||+++++++......+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   85 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL   85 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence            5678889999999999999998543     3789999986553 344567889999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhccccccc-----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQ-----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      +||||+++++|.+++......     ....++|..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        86 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          86 VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             EEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEECC
Confidence            999999999999999654321     12357899999999999999999998   8999999999999999999999999


Q ss_pred             ccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhh
Q 040242          504 FGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       504 fGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      ||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||.......   +..++.    
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~----  235 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI----  235 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh----
Confidence            999986543321 12223456789999999988889999999999999999998 888987543221   111111    


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .+.        ....+......+.+++.+||+.+|++|||+.++++.|+.
T Consensus       236 ~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         236 DGG--------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             cCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence            111        111122235678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-37  Score=329.36  Aligned_cols=244  Identities=24%  Similarity=0.357  Sum_probs=205.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  428 (662)
                      .-++|...++||+|.||+|+++..+.+++.+|||.+++.   .....+....|.+++... +||.|++++.++..+++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            346799999999999999999999999999999999886   345566777888887777 5999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+.||++..+.+      ...++.....-++..|+.||+|||+   ++||+||||.+|||||.+|.+||+||||++
T Consensus       446 fvmey~~Ggdm~~~~~------~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHIH------TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEecCCCcEEEEEe------cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999655553      3568888889999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ---. ....+...+||+.|||||++.+..|+...|.|+|||+||||+.|..||.+.++++...   -+.          .
T Consensus       517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fd---sI~----------~  582 (694)
T KOG0694|consen  517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFD---SIV----------N  582 (694)
T ss_pred             ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHh----------c
Confidence            5322 2335667899999999999999999999999999999999999999999765542211   000          0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST  622 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  622 (662)
                      .|+   .|+.....+.+.|+++++..+|++|--+
T Consensus       583 d~~---~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEV---RYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCC---CCCCcccHHHHHHHHHHhccCcccccCC
Confidence            111   2444566777888899999999999876

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.3e-37  Score=314.07  Aligned_cols=255  Identities=26%  Similarity=0.398  Sum_probs=203.0

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEecc------
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ------  424 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~------  424 (662)
                      .+++.|+..+.||+|+||.||+|....+++.||+|++.... .....+..|+.++.++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            46678888999999999999999998899999999986543 3345788999999998 799999999998653      


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ...++||||+++++|.+++....   ...+++..+..++.|++.||+|||+   .+++|+||||+||++++++.+||+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Df  155 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDF  155 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccC
Confidence            45899999999999999986532   3468999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      |++....... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||..........     .  
T Consensus       156 g~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~--  227 (272)
T cd06637         156 GVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L--  227 (272)
T ss_pred             CCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H--
Confidence            9998654322 2223356899999999885     3357889999999999999999999996543221111     0  


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....     ..+.+  ........+.+++.+||..+|.+||++.+++++
T Consensus       228 ~~~~-----~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         228 IPRN-----PAPRL--KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             HhcC-----CCCCC--CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            0000     01111  111234567899999999999999999999863

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.3e-37  Score=323.82  Aligned_cols=247  Identities=23%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +|+..+.||+|+||.||+|+...++..||||.+....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778899999999999999998889999999997642   22344567788888777 5899999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            99999999988843     2458899999999999999999999   899999999999999999999999999997543


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+.    ...       
T Consensus       153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~----~~~-------  217 (323)
T cd05616         153 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIM----EHN-------  217 (323)
T ss_pred             CCC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHH----hCC-------
Confidence            221 1223457899999999999989999999999999999999999999765322   1111111    111       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPST-----RRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~  627 (662)
                        ..++......+..++.+|++.+|.+|++.     .++.+
T Consensus       218 --~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         218 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             --CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence              01122344567889999999999999984     66654

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-36  Score=311.15  Aligned_cols=258  Identities=22%  Similarity=0.392  Sum_probs=204.2

Q ss_pred             CcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCe-----
Q 040242          357 FREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE-----  426 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~-----  426 (662)
                      |+..+.||+|+||.||+|....+   +..||+|++...  ......++.+|+..++.++|+||+++++++...+.     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            45678999999999999998543   378999998754  23445689999999999999999999999876554     


Q ss_pred             -eeEEEeccCCCCcchhccccccc-ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          427 -LLLVYDYVPNGSLDKLLFDNDQQ-KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       427 -~~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                       .++++||+++|+|..++...... ....+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999998654221 23468999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          505 GLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       505 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      |+++........ ......++..|+|||.+....++.++|||||||++|||++ |..||......   .+.+++..    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~~~~~----  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYDYLRH----  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHc----
Confidence            999866433221 1122335678999999988889999999999999999999 88888654322   11222211    


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.        ....+......+.+++.+||+.||++||++.||++.|+..
T Consensus       231 ~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         231 GN--------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             CC--------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            11        1111223456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.3e-38  Score=327.27  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=214.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCe-eeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE-LLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~-~~lV~  431 (662)
                      ++|...+++|+|+||.++....+.++..+++|.+...  .....+...+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            4677889999999999999999889999999988654  33344567899999999999999999999999988 99999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      +||+||+|.+.|...+   ...++.+.+++++.|++.|+.|||+   ..|+|||||+.||+++.+..+||+|||+++.+.
T Consensus        84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            9999999999997653   4678899999999999999999998   899999999999999999999999999999987


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .....+.||+.|+.||.+.+.+|..|+|||||||++|||++-+++|...+..   .|+.   +      +.+..  
T Consensus       158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~---k------i~~~~--  222 (426)
T KOG0589|consen  158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELIL---K------INRGL--  222 (426)
T ss_pred             Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHH---H------Hhhcc--
Confidence            654 2334578999999999999999999999999999999999999999876432   1111   1      11111  


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ....+..+...+..++..|++.+|+.||++.+++.+
T Consensus       223 -~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  223 -YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             123345566778889999999999999999999974

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-36  Score=317.96  Aligned_cols=258  Identities=28%  Similarity=0.434  Sum_probs=203.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc--EEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL--EVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|....++.  .+++|.+... .....+.|..|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            468889999999999999999876654  4788888643 334456789999999999 799999999999999999999


Q ss_pred             EeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          431 YDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      +||+++++|.+++......           ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            9999999999999643210           12358899999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||++.......  .......+..|+|||+.....++.++|||||||++|||++ |+.||.......      ....
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~  230 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK  230 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence            999999987432211  1111223567999999988889999999999999999997 999997543221      1111


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      . ..+     ..+   ..+......+.+|+.+||+.+|.+||++.++++.|+..
T Consensus       231 ~-~~~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  275 (297)
T cd05089         231 L-PQG-----YRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRM  275 (297)
T ss_pred             H-hcC-----CCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1 111     111   11222345688999999999999999999999987644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.5e-36  Score=318.74  Aligned_cols=265  Identities=25%  Similarity=0.347  Sum_probs=201.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|...+.||+|+||+||+|....++..||+|++.... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999998889999999987543 22344678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++ +|.+++...    ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        86 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            964 888877543    3457889999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH--------HHHhhcC-
Q 040242          514 INPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV--------RELHSQG-  583 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~-  583 (662)
                      .. ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+........        |...... 
T Consensus       158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07872         158 TK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND  236 (309)
T ss_pred             cc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence            21 1223467899999998764 46789999999999999999999999765433222111110        0000000 


Q ss_pred             ccccccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....-.+..     ..........+.+++.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence            0000000000     00111234567889999999999999999999973

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.1e-36  Score=311.18  Aligned_cols=253  Identities=26%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..++||+|+||.||+|... +++.||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++|||+
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM   82 (260)
T ss_pred             HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence            56788899999999999999974 578899999875433 3467899999999999999999999874 45789999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++.+++.++.|++.||+|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05067          83 ENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence            9999999986543   3468999999999999999999998   899999999999999999999999999998765332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||++....++.++||||||+++|||++ |+.||.......   ....+    ..+.     ... 
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~-----~~~-  223 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNL----ERGY-----RMP-  223 (260)
T ss_pred             cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHH----HcCC-----CCC-
Confidence            222223346778999999988889999999999999999999 999997543221   11111    1110     011 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ........+.+++.+|++.+|++||+++++++.|+.
T Consensus       224 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 --RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence              112234568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-36  Score=315.54  Aligned_cols=258  Identities=25%  Similarity=0.370  Sum_probs=204.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +|+..+.||+|+||.||+|....     .+..||+|++..... ...+.+..|+.++++++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            35667889999999999998743     247899999976543 334678899999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          430 VYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      ++||+++++|.+++.....           .....+++..++.++.|+++||.|||+   .+++||||||+||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            9999999999999853210           112458899999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  576 (662)
                      +||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..|+......   .+.+.+
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~i  239 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVIEMI  239 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH
Confidence            99999999886543221 11223345789999999988889999999999999999998 88888654321   111111


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          ..+        .....+......+..++..|++.+|.+||++.+|++.|+.
T Consensus       240 ----~~~--------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 ----RNR--------QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ----HcC--------CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                111        1112233455668899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7e-37  Score=322.75  Aligned_cols=243  Identities=22%  Similarity=0.339  Sum_probs=197.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||+||++....++..||||++....   ......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998889999999997642   23445677888888887 799999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++...     ..+++.+...++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++..... ..
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~  151 (318)
T cd05570          81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GV  151 (318)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcC-CC
Confidence            9999888432     358999999999999999999999   89999999999999999999999999998753222 11


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......|++.|+|||++.+..++.++|||||||++|||++|+.||.......   +.   ... ....      .   .+
T Consensus       152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~---~~i-~~~~------~---~~  215 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LF---QSI-LEDE------V---RY  215 (318)
T ss_pred             cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HH---HHH-HcCC------C---CC
Confidence            2233568999999999998899999999999999999999999997543211   11   111 1110      1   11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPST-----RRVVQF  628 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~~  628 (662)
                      +......+.+++.+||+.||.+||++     .+++++
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            22234567899999999999999999     888764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.9e-36  Score=315.59  Aligned_cols=266  Identities=23%  Similarity=0.354  Sum_probs=208.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC----------------cEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG----------------LEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQL  417 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g----------------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l  417 (662)
                      ++|+..+.||+|+||.||++.....+                ..||+|.+.... ....+++.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            57888999999999999999875433                458999987653 3456788999999999999999999


Q ss_pred             eeeEeccCeeeEEEeccCCCCcchhcccccccc------cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQK------KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       418 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      ++++..++..+++|||+++++|.+++.......      ...+++..++.++.|+++||.|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~Ni  161 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhce
Confidence            999999999999999999999999996543111      2368999999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCcccchh
Q 040242          492 LIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC--GRRPIEPQRTAM  568 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  568 (662)
                      +++.++.++|+|||+++....... .......++..|+|||++..+.++.++|||||||++|||++  |..|+...... 
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~-  240 (296)
T cd05051         162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ-  240 (296)
T ss_pred             eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence            999999999999999986543221 12233456789999999988889999999999999999998  66777543221 


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        .....+...+........     ...+...+..+.+++.+|++.||.+||++.||++.|++
T Consensus       241 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         241 --QVIENAGHFFRDDGRQIY-----LPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             --HHHHHHHhcccccccccc-----CCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence              122222222211111111     11122334678999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-36  Score=315.33  Aligned_cols=265  Identities=26%  Similarity=0.385  Sum_probs=202.3

Q ss_pred             cccceeeeeCceEEEEEEe----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEE
Q 040242          358 REKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLV  430 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  430 (662)
                      +..+.||+|+||+||++..    ..++..||+|.+.... ......|.+|+.++++++||||+++++++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (283)
T cd05080           7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI   86 (283)
T ss_pred             eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence            7789999999999987653    3467889999987643 33456788999999999999999999988654  358999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++..      ..+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++..
T Consensus        87 ~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          87 MEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             ecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            999999999999843      348999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          511 DHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       511 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......  ......++..|+|||.+.....+.++||||||+++|||++|+.|+........ ....+.........+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence            543221  11122456779999999888899999999999999999999999864332111 000000000000111111


Q ss_pred             cCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          589 IDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       589 id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ++... ...+...+..+.+++.+||+.+|++||++++|+++|+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            11111 112334456788999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=8.8e-37  Score=329.64  Aligned_cols=252  Identities=25%  Similarity=0.328  Sum_probs=197.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +|+..+.||+|+||.||+++...+++.||||++....   ......+.+|+.++++++|+||+++++.+..++.+++|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            6888999999999999999999899999999986542   2334568899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++...     ..++......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          82 YIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            99999999998543     457888888999999999999999   8999999999999999999999999999753310


Q ss_pred             CC------------------------------------------CCcceecccCCcccCcccccCCCCCcchhHHHHHHH
Q 040242          513 NI------------------------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTL  550 (662)
Q Consensus       513 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvv  550 (662)
                      ..                                          ........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            00                                          000113469999999999998889999999999999


Q ss_pred             HHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC---CHHHHHH
Q 040242          551 MLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP---STRRVVQ  627 (662)
Q Consensus       551 l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP---t~~eVl~  627 (662)
                      +|||++|+.||..........      ..... . .....+....    ....+.+++.+|+ .+|.+|+   ++.++++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~------~i~~~-~-~~~~~~~~~~----~s~~~~~li~~l~-~~p~~R~~~~t~~ell~  300 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQL------KVINW-E-TTLHIPSQAK----LSREASDLILRLC-CGAEDRLGKNGADEIKA  300 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHH------HHhcc-C-ccccCCCCCC----CCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence            999999999998654322111      10000 0 0000111111    2334455566665 4999999   8999997


Q ss_pred             H
Q 040242          628 F  628 (662)
Q Consensus       628 ~  628 (662)
                      +
T Consensus       301 h  301 (376)
T cd05598         301 H  301 (376)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.2e-37  Score=318.80  Aligned_cols=262  Identities=25%  Similarity=0.376  Sum_probs=208.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCC-----CcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPST-----GLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~-----g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ..++|+..+.||+|++|.||++.....     ...+|+|.+... ..+...++.+|+.++.++ +|+||+++++++..++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            346688889999999999999987533     367999998754 334456788999999999 8999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..+++|||+++|+|.+++.....           .....+++..++.++.|++.||.|||+   .+|+||||||+||+++
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~~  166 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLVT  166 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEEc
Confidence            99999999999999999864310           123568999999999999999999998   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..|+........   
T Consensus       167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---  243 (293)
T cd05053         167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL---  243 (293)
T ss_pred             CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH---
Confidence            9999999999999876543211 1122335678999999988889999999999999999998 8888875432211   


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..    ....+.        ....+......+.+|+.+|++.+|.+|||+.|+++.|+..
T Consensus       244 ~~----~~~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         244 FK----LLKEGY--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HH----HHHcCC--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            11    111111        0112223456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-36  Score=314.08  Aligned_cols=266  Identities=24%  Similarity=0.373  Sum_probs=204.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC--------------CcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST--------------GLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHG  419 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~--------------g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~  419 (662)
                      ++|+..+.||+|+||.||++.....              ...||+|.+... .......|.+|++++++++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788889999999999999987432              235899998764 3344567999999999999999999999


Q ss_pred             eEeccCeeeEEEeccCCCCcchhccccccc-------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceE
Q 040242          420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQ-------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       420 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  492 (662)
                      ++...+..++||||+++++|.+++......       ....+++..++.++.|++.||+|||+   .+++||||||+||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil  161 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNCL  161 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhEE
Confidence            999999999999999999999998543210       11347899999999999999999999   89999999999999


Q ss_pred             eCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCcccchhh
Q 040242          493 IDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC--GRRPIEPQRTAME  569 (662)
Q Consensus       493 l~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~~  569 (662)
                      ++.++.+||+|||++........ .......++..|+|||.+..+.++.++|||||||+++||++  |..||....... 
T Consensus       162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~-  240 (295)
T cd05097         162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ-  240 (295)
T ss_pred             EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH-
Confidence            99999999999999976533221 11222345778999999988889999999999999999998  556766433211 


Q ss_pred             HHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       570 ~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ....+.+.+.......     ....+...+..+.+|+.+|++.+|++||+|.+|++.|..
T Consensus       241 --~~~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 --VIENTGEFFRNQGRQI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             --HHHHHHHhhhhccccc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence              1111111111110000     011122234679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=4.9e-36  Score=321.78  Aligned_cols=263  Identities=23%  Similarity=0.279  Sum_probs=200.5

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC-----
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----  425 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----  425 (662)
                      ..++|+..+.||+|+||.||++....+|..||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347899999999999999999999888999999998653  3344567889999999999999999999986543     


Q ss_pred             -eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 -ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                       ..++||||+++ +|.+.+       ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~-------~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVI-------HMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHH-------hccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence             47999999964 566665       2347888899999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH------------H
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV------------L  572 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~------------l  572 (662)
                      |+++.....  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||...+......            +
T Consensus       168 g~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            999864332  22233578999999999998899999999999999999999999997553221100            0


Q ss_pred             ----HHHHHHHhhcCcc------cccc----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          573 ----VDWVRELHSQGQI------TRAI----DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       573 ----~~~~~~~~~~~~~------~~~i----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ...+.........      .+..    .+............+.+|+.+||+.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0000100000000      0000    000001111234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2e-36  Score=313.19  Aligned_cols=259  Identities=24%  Similarity=0.397  Sum_probs=206.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...++||+|+||.||++...     .++..+++|.+..........+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            45677889999999999999742     3466899999887766677889999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhccccccc----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          430 VYDYVPNGSLDKLLFDNDQQ----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      +|||+++++|.+++......          ....+++..++.++.|++.||+|||+   .+++||||||+||++++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            99999999999998654210          11358999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       500 kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.........   ..+ 
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~~~-  237 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---ECI-  237 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---HHH-
Confidence            9999999976543211 11122345678999999988889999999999999999998 89998654322111   111 


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         ..+.     ..   ..+...+..+.+++.+||+.||.+||++.+|++.|+.
T Consensus       238 ---~~~~-----~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         238 ---TQGR-----EL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             ---HcCc-----cC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence               1111     00   1112234568899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.8e-37  Score=325.00  Aligned_cols=244  Identities=26%  Similarity=0.337  Sum_probs=193.8

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHH-HhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEIT-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||+||+++...+|+.||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999998899999999997542   233445566654 56779999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++..     ...+++.+...++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~  151 (325)
T cd05604          81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SD  151 (325)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CC
Confidence            999988843     3468899999999999999999999   89999999999999999999999999998753222 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +   ...... .        .+ ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~---~~~~~~-~--------~~-~~  215 (325)
T cd05604         152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---M---YDNILH-K--------PL-VL  215 (325)
T ss_pred             CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---H---HHHHHc-C--------Cc-cC
Confidence            2334578999999999998889999999999999999999999997643221   1   111111 1        01 01


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .+.....+.+++.+|++.+|.+||++++.++.+
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i  248 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDFLEI  248 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHH
Confidence            112345577889999999999999886444433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.6e-36  Score=307.21  Aligned_cols=251  Identities=25%  Similarity=0.405  Sum_probs=207.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||+|....++..+++|.+.....  .+++.+|++++++++|+||+++++++...+..++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578889999999999999999988889999999876533  678999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          81 GAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            999999998543    3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . ......++..|+|||++.+..++.++||||||+++|||++|+.|+..........         .   ......+. .
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~---------~---~~~~~~~~-~  219 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF---------M---IPNKPPPT-L  219 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh---------h---hccCCCCC-C
Confidence            1 2233457889999999988889999999999999999999999997543321110         0   00000111 1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+......+.+++.+|++.+|++||++.||+++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            1222344668899999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=3.7e-36  Score=311.00  Aligned_cols=251  Identities=23%  Similarity=0.349  Sum_probs=201.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..++||+|++|.||+|++..++..||+|.+... .....+++.+|++++.+++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577789999999999999999889999999998655 334456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|..+.         .+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            9999997543         36778888999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH-HHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL-VLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~-~l~~~~~~~~~~~~~~~~id~~  592 (662)
                         ......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....+... ...     ...+.
T Consensus       149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~-----~~~~~  219 (279)
T cd06619         149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-IVD-----EDPPV  219 (279)
T ss_pred             ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-Hhc-----cCCCC
Confidence               222346899999999998888999999999999999999999999643221110 00011110 000     01111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.  .......+.+++.+|++.+|++||+++|++++
T Consensus       220 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         220 LP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             CC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11  11234567889999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-36  Score=308.19  Aligned_cols=249  Identities=31%  Similarity=0.452  Sum_probs=205.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||+|..  .|+.||+|.+..... ..+++.+|+.++++++|+||+++++++......++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            5678889999999999999998  478899999976654 5678999999999999999999999999888999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++..+..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          83 AKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             CCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999986442   2368999999999999999999999   899999999999999999999999999998763322


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .    ....+..|+|||.+..+.++.++||||||++++||++ |+.||......   .+...+.    .+.     ..  
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~----~~~-----~~--  218 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVE----KGY-----RM--  218 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHh----cCC-----CC--
Confidence            1    2334678999999988889999999999999999997 99998754321   1111111    110     00  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ..+...+..+.+++.+||..+|++||++.+++++|.+
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             1122335678899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=8.6e-37  Score=322.51  Aligned_cols=238  Identities=26%  Similarity=0.350  Sum_probs=190.1

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHH-HhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEIT-SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|+...+++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999998899999999997542   222344555654 67889999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|..++..     ...++..+...++.||++||.|||+   .+|+||||||+||+++.++.+||+|||+++..... ..
T Consensus        81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~  151 (321)
T cd05603          81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EE  151 (321)
T ss_pred             CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CC
Confidence            999888743     3457888888999999999999999   89999999999999999999999999998753222 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......   .+.+.+   . ..        .+ ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i---~-~~--------~~-~~  215 (321)
T cd05603         152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNI---L-HK--------PL-QL  215 (321)
T ss_pred             ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHH---h-cC--------CC-CC
Confidence            233457899999999998888999999999999999999999999765321   111111   0 00        11 12


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                      +......+.+++.+||+.+|.+||+..
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            223445688999999999999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2e-36  Score=309.00  Aligned_cols=246  Identities=27%  Similarity=0.385  Sum_probs=197.1

Q ss_pred             eeeeeCceEEEEEEe--CCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          362 LVGSGGFGKVYRGVI--PSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~--~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      .||+|+||.||+|.+  ..++..+|+|++....  ....+++..|+.++++++|+||+++++++. .+..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            589999999999965  3567889999986543  344678999999999999999999999885 45678999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +|.+++..     ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999843     2458899999999999999999999   899999999999999999999999999998765432211


Q ss_pred             --ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          518 --TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       518 --~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                        .....++..|+|||.+....++.++|||||||++|||++ |+.||......   .+.+.+    ..+..     +   
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i----~~~~~-----~---  217 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMI----ESGER-----M---  217 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH----HCCCC-----C---
Confidence              112234578999999988888999999999999999998 99999754322   111111    11110     1   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ..+......+.+++.+||+.||++||++.+|++.|++
T Consensus       218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            1122344668899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.6e-36  Score=313.29  Aligned_cols=252  Identities=24%  Similarity=0.374  Sum_probs=202.1

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      |+..+.||+|+||+||++....+++.||+|.+....   ......+.+|+.++++++|+|++++.+++..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            666789999999999999998899999999986542   22335578899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999998886432   3469999999999999999999999   89999999999999999999999999999765432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||..........  .+.... ...      .   
T Consensus       156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~-~~~------~---  221 (285)
T cd05632         156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRV-LET------E---  221 (285)
T ss_pred             C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhh-hcc------c---
Confidence            1  2233468999999999988889999999999999999999999997543321111  111111 100      0   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                      ..+.......+.+|+..|++.||++||+     +.+++++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            1112233456788999999999999999     5566653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=3.7e-36  Score=307.52  Aligned_cols=253  Identities=28%  Similarity=0.437  Sum_probs=202.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...+.||+|++|.||++.+... ..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            4577788999999999999998544 569999886543 23467889999999999999999999885 45688999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...++|..+..++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          83 GKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999996542   3458999999999999999999999   899999999999999999999999999998764432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||...+..++.++||||||+++|||++ |+.||.......   ...++..    +     ..+  
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~-----~~~--  222 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVER----G-----YRM--  222 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C-----CCC--
Confidence            222222346778999999988889999999999999999999 888987543221   1111111    1     001  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ......+..+.+++.+||+.+|++||++.+|+++|+.
T Consensus       223 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         223 -PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             -CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence             1122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-37  Score=329.75  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=198.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||++....+++.||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999999999999999986542   334567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...     ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.
T Consensus        81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            999999999998542     457888899999999999999999   899999999999999999999999999996432


Q ss_pred             CCCCC----------------------------------------------cceecccCCcccCcccccCCCCCcchhHH
Q 040242          512 HNINP----------------------------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVF  545 (662)
Q Consensus       512 ~~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~  545 (662)
                      .....                                              ......||+.|+|||++.+..++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            11000                                              00124699999999999888899999999


Q ss_pred             HHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC---CCCH
Q 040242          546 GFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF---RPST  622 (662)
Q Consensus       546 S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~---RPt~  622 (662)
                      ||||++|||++|+.||.........      .......   +.+  .+.. .......+.+++.+|+. +|.+   ||++
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~---~~~--~~p~-~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSHETY------RKIINWR---ETL--YFPD-DIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHHHHH------HHHHccC---Ccc--CCCC-CCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            9999999999999999754432111      1110000   000  0000 01123457788888997 6665   4699


Q ss_pred             HHHHHH
Q 040242          623 RRVVQF  628 (662)
Q Consensus       623 ~eVl~~  628 (662)
                      .|++++
T Consensus       300 ~~~l~h  305 (377)
T cd05629         300 HEIKSH  305 (377)
T ss_pred             HHHhcC
Confidence            999986

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=294.20  Aligned_cols=264  Identities=25%  Similarity=0.318  Sum_probs=214.8

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC-----ee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----EL  427 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~  427 (662)
                      ..++|.+.++||+|||+.||.++...++..+|+|++.....+..+..++|++..++++|||++++++++..+.     +.
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            3478999999999999999999988899999999998888888889999999999999999999999986554     48


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ||+++|...|+|.+.+..... +...+++.+.+.|+.++.+||++||+. .+++.||||||.|||+.+++.++|.|||.+
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~  176 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA  176 (302)
T ss_pred             EEEeehhccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence            999999999999999965532 245799999999999999999999983 245999999999999999999999999998


Q ss_pred             ccccCCCCCc--------ceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH
Q 040242          508 RAYDHNINPQ--------TTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       508 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  576 (662)
                      ....-.....        .....-|..|.|||.+.   +...++++|||||||+||+|+.|..||+.....         
T Consensus       177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~---------  247 (302)
T KOG2345|consen  177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ---------  247 (302)
T ss_pred             cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence            8654322111        11234588999999875   345789999999999999999999999743211         


Q ss_pred             HHHhhcCcccc-ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          577 RELHSQGQITR-AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       577 ~~~~~~~~~~~-~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                           .+.+.- ...+.+ ........+.+.+++.+|++.||.+||++.+++..+...
T Consensus       248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                 111221 223333 122233778899999999999999999999999988654

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.2e-36  Score=327.24  Aligned_cols=252  Identities=25%  Similarity=0.338  Sum_probs=195.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .|+..++||+|+||+||+|+...+++.||+|++....   ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5788999999999999999999899999999997642   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++|+|.+++.+.     ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+..
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            99999999998543     357888888999999999999999   8999999999999999999999999999753311


Q ss_pred             CC----------------------------------------------CCcceecccCCcccCcccccCCCCCcchhHHH
Q 040242          513 NI----------------------------------------------NPQTTHIVGTLGYLAPELTRTGKATTSTDVFG  546 (662)
Q Consensus       513 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S  546 (662)
                      ..                                              ........||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            00                                              00011246899999999998888999999999


Q ss_pred             HHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HH
Q 040242          547 FGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS---TR  623 (662)
Q Consensus       547 ~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~  623 (662)
                      |||++|||++|+.||..........      ......  ...-.+......    ..+.+++.+|+ .+|.+|++   +.
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~------~i~~~~--~~~~~p~~~~~s----~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQM------KVINWQ--TSLHIPPQAKLS----PEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHH------HHHccC--CCcCCCCcccCC----HHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            9999999999999998654321110      000000  000011111222    33444454554 49999997   88


Q ss_pred             HHHHH
Q 040242          624 RVVQF  628 (662)
Q Consensus       624 eVl~~  628 (662)
                      +++++
T Consensus       301 ei~~h  305 (382)
T cd05625         301 EIKAH  305 (382)
T ss_pred             HHhcC
Confidence            88764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=318.71  Aligned_cols=256  Identities=24%  Similarity=0.282  Sum_probs=199.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+++...+++.||+|++.+.   .....+.+.+|+.++..++|+||+++++++..++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999999888999999999753   2233456889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...    ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            999999999999542    3458889999999999999999999   899999999999999999999999999997665


Q ss_pred             CCCCCcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ...........||+.|+|||++..     ..++.++|||||||++|||++|+.||.......      ............
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~  227 (331)
T cd05597         154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHF  227 (331)
T ss_pred             CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence            433333333568999999999863     457889999999999999999999997543211      111111111101


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccC--CCCCCCCCHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCD--PHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~--~dP~~RPt~~eVl~~  628 (662)
                      . +.+...    .....+.+++.+|+.  .++..||++++++++
T Consensus       228 ~-~~~~~~----~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         228 Q-FPPDVT----DVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c-CCCccC----CCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            1 111111    133445666666554  444458999999986

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.1e-36  Score=312.66  Aligned_cols=259  Identities=27%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..++||+|+||+||+|.+..++.    .||+|.+... .....+++.+|+.++..++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l   85 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL   85 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence            568888999999999999999766665    4899998654 33445678999999999999999999999975 45789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+++|+|.+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        86 ~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          86 VTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceee
Confidence            99999999999998653    3458999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......++..|+|||...+..++.++|||||||++|||++ |..||......   .+..++.    .+..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~--  229 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGER--  229 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCc--
Confidence            6533211 1112234678999999988889999999999999999998 88998654322   1222221    1110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                       .     .........+.+++.+||+.||++||++.++++.|......|
T Consensus       230 -~-----~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         230 -L-----PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             -C-----CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence             0     111223456889999999999999999999999997765554

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-36  Score=307.08  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=209.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||++....++..+++|.+........+.+.+|+.++++++||||+++++++...+..+++|||+
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~   82 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC   82 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence            57888999999999999999998888999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++.++..++.|++.||.|||+   .+++|+||+|+||+++.++.+||+|||++.......
T Consensus        83 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          83 GGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            999999988543    2468899999999999999999999   899999999999999999999999999998655432


Q ss_pred             CCcceecccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG---KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . ......++..|+|||.+...   .++.++|||||||++|||++|+.|+..........  ..     ..    ....+
T Consensus       156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~--~~-----~~----~~~~~  223 (262)
T cd06613         156 A-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF--LI-----SK----SNFPP  223 (262)
T ss_pred             h-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HH-----Hh----ccCCC
Confidence            1 22234678899999998776   78899999999999999999999997544321111  00     00    00111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ............+.+++.+||+.+|.+||++.+|+.+
T Consensus       224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1111223445678999999999999999999999853

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2.7e-36  Score=307.33  Aligned_cols=251  Identities=21%  Similarity=0.340  Sum_probs=205.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +|+..+.||+|+||.||++....++..+|+|.+... .....+.+..|+.++++++|+||+++++.+..++..++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            467789999999999999999889999999998653 3345567889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++...+.++.|++.||.|||+   .+++|+||||+||++++++.++|+|||+++......
T Consensus        81 ~~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            9999999885432   3457889999999999999999999   899999999999999999999999999998664322


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       .......|+..|+|||++.+..++.++||||||+++|+|++|+.||........      .... ..+..        .
T Consensus       155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~-~~~~~--------~  218 (255)
T cd08219         155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKV-CQGSY--------K  218 (255)
T ss_pred             -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHH-hcCCC--------C
Confidence             122335688999999999888899999999999999999999999975432111      1111 11111        1


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+......+.+++.+||+.||++||++.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            1122234567889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-36  Score=318.93  Aligned_cols=257  Identities=28%  Similarity=0.458  Sum_probs=202.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc--EEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL--EVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|.+..++.  .+++|++... .....+++.+|+.++.++ +|+||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            567888999999999999999876665  4577777543 344556888999999999 899999999999999999999


Q ss_pred             EeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          431 YDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      |||+++++|.+++.....           .....+++.+++.++.|++.||+|||+   .+++||||||+|||++.++.+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~  163 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  163 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcE
Confidence            999999999999965421           112468999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||+++.....  .......++..|+|||.+.+..++.++|||||||++|||+| |..||.......   ..+   .
T Consensus       164 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---~  235 (303)
T cd05088         164 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE---K  235 (303)
T ss_pred             EeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHH---H
Confidence            99999998743221  11112234678999999988888999999999999999998 999986543221   111   1


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      . ..+     .  .. ..+......+.+|+.+|++.+|++||++.++++.|..
T Consensus       236 ~-~~~-----~--~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         236 L-PQG-----Y--RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             H-hcC-----C--cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1 100     0  00 1111234567899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.3e-36  Score=315.30  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             cCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ++|...+.||+|+||.||++..     ...+..||||++.... ....+.+.+|+.+++++ +|+||+++++++...+..
T Consensus        35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~  114 (302)
T cd05055          35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI  114 (302)
T ss_pred             HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence            5688899999999999999975     2345689999987543 33456789999999999 799999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++|+|.+++....   ...+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus       115 ~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         115 LVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             EEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999996432   2348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +........ ......++..|+|||.+.++.++.++||||+||++|||++ |+.||........  +...+    ..+. 
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~----~~~~-  261 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI----KEGY-  261 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----HcCC-
Confidence            865433211 1122345778999999988889999999999999999998 9999875432211  11111    1111 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          .+   .........+.+++.+|++.+|++||++.|+++.|++
T Consensus       262 ----~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         262 ----RM---AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ----cC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                00   0111234568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-36  Score=309.14  Aligned_cols=254  Identities=28%  Similarity=0.473  Sum_probs=206.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...++||+|++|.||+|... ++..|+||.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus         6 ~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   83 (261)
T cd05034           6 ESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM   83 (261)
T ss_pred             hheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence            57888999999999999999985 56789999987543 33567899999999999999999999999889999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        84 ~~~~L~~~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          84 SKGSLLDFLKSGE---GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             CCCCHHHHHhccc---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999996543   3468999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++||||||++++||++ |+.||.......   ..+.+..    +     ...  
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~----~-----~~~--  223 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVER----G-----YRM--  223 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C-----CCC--
Confidence            222222334678999999988889999999999999999998 999986543221   1111110    0     000  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       ..+...+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 -PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence             1111235678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1e-36  Score=321.54  Aligned_cols=239  Identities=25%  Similarity=0.337  Sum_probs=193.6

Q ss_pred             ceeeeeCceEEEEEEe---CCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~---~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +.||+|+||.||++..   ..+|+.||+|++.....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   35688999999976432  234567789999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +|+|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+||+++.++.+||+|||+++...... 
T Consensus        82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  152 (318)
T cd05582          82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-  152 (318)
T ss_pred             CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence            9999998843     3458999999999999999999999   899999999999999999999999999998654321 


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                      .......|++.|+|||.+.+..++.++|||||||++|||++|+.||.......   ..   ..... ..         ..
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~---~~i~~-~~---------~~  216 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TM---TMILK-AK---------LG  216 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HH---HHHHc-CC---------CC
Confidence            22334578999999999988888999999999999999999999997543221   11   11111 10         01


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRR  624 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  624 (662)
                      .+......+.+++.+||+.||++||++.+
T Consensus       217 ~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         217 MPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            12223456788999999999999999433

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.8e-36  Score=314.55  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=202.5

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      |+..++||+|+||.||++....+++.||||.+....   ......+..|+.++++++|+|++++++.+..++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            667889999999999999999999999999986542   22345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999885432   3458899999999999999999999   89999999999999999999999999998765432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh-HHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .  ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........ .........          ... 
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~----------~~~-  222 (285)
T cd05630         156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----------VQE-  222 (285)
T ss_pred             c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh----------hhh-
Confidence            2  11234689999999999988899999999999999999999999975432111 111100000          000 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQ  627 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  627 (662)
                        .+.......+.+|+.+||+.||++||+     +.|+++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              111223455788999999999999999     888887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-36  Score=310.99  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=204.7

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCc---EEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGL---EVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .|+..+.||+|+||.||+|....++.   .||||.+... ......+|..|+.++++++||||+++++++..++..++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            46778999999999999999876554   6999998764 3445678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...    ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          85 EFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             ecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccc
Confidence            999999999998654    3458999999999999999999999   899999999999999999999999999988654


Q ss_pred             CCCCCc-cee-cc--cCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          512 HNINPQ-TTH-IV--GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       512 ~~~~~~-~~~-~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ...... ... ..  .+..|+|||++....++.++|||||||++|||++ |..||......   ....++...       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~-------  227 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQD-------  227 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcC-------
Confidence            432211 111 11  2457999999988899999999999999999886 99998754322   122222110       


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .  .+ ....+.+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       228 --~--~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 --Y--RL-PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             --C--cC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0  00 01123345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-36  Score=320.44  Aligned_cols=250  Identities=23%  Similarity=0.301  Sum_probs=198.4

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||+||++....+++.||+|++....   ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999899999999997642   23456688899999888 699999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|..++..     ...+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~  151 (327)
T cd05617          81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GD  151 (327)
T ss_pred             CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CC
Confidence            999988743     2458999999999999999999999   89999999999999999999999999998753221 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||............+++.+......        . ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--------~-~~  222 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--------I-RI  222 (327)
T ss_pred             ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--------C-CC
Confidence            22345789999999999988999999999999999999999999964322111111222222221110        0 11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPS------TRRVVQF  628 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt------~~eVl~~  628 (662)
                      +......+.+++.+||+.||.+||+      +.+++++
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            2223455778999999999999998      4577653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.2e-36  Score=314.49  Aligned_cols=261  Identities=25%  Similarity=0.390  Sum_probs=211.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||.|++|.||+|....+++.|++|.+........+.+.+|+.+++.++|+|++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888999999999999999998899999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|..++.      ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~------~~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~  169 (296)
T cd06655          99 AGGSLTDVVT------ETCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ  169 (296)
T ss_pred             CCCcHHHHHH------hcCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence            9999999884      2358999999999999999999999   899999999999999999999999999988654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . ......++..|+|||.+.+..++.++|||||||++|||++|+.||..........   .+.   . ..     .+.+ 
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~~---~-~~-----~~~~-  235 (296)
T cd06655         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LIA---T-NG-----TPEL-  235 (296)
T ss_pred             c-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH---h-cC-----Cccc-
Confidence            1 2223468899999999988889999999999999999999999997654322111   010   0 00     0111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQA  638 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~  638 (662)
                      ..+......+.+++.+||..+|++||++.+++++  +....+...+
T Consensus       236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~~~~  281 (296)
T cd06655         236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSL  281 (296)
T ss_pred             CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccccccC
Confidence            1122234567789999999999999999999973  4444444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.3e-36  Score=313.58  Aligned_cols=260  Identities=26%  Similarity=0.383  Sum_probs=211.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|++|.||+++...++..||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67888999999999999999998889999999997765555677889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++.+      ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~  169 (297)
T cd06656          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (297)
T ss_pred             CCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence            99999999842      347889999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||..........         .   ....-.+.+ 
T Consensus       170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~---------~---~~~~~~~~~-  235 (297)
T cd06656         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---------L---IATNGTPEL-  235 (297)
T ss_pred             c-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee---------e---eccCCCCCC-
Confidence            1 2223468899999999988889999999999999999999999997543221100         0   000000111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCCCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQ  637 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~  637 (662)
                      ..+......+.+++.+||+.+|++||++.++++  .+....+.+.
T Consensus       236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~  280 (297)
T cd06656         236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLSS  280 (297)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccccc
Confidence            112234456788999999999999999999998  4444444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.4e-36  Score=310.14  Aligned_cols=255  Identities=27%  Similarity=0.459  Sum_probs=204.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC---cEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g---~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .+|+..+.||+|+||.||+|....++   ..+|+|.+.... ....+.+.+|+.++.+++||||+++++++..++..++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            46788899999999999999885433   379999986543 33456889999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++...
T Consensus        84 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          84 TEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            9999999999999643    2458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcce--ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINPQTT--HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .........  ...++..|+|||.+.+..++.++||||||+++||+++ |+.||.......   ...++.    ++.   
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~---  226 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGY---  226 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCC---
Confidence            543221111  1223568999999988889999999999999999886 999987543221   111211    110   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ...   .....+..+.+++.+|++.+|.+||+|.++++.|.+
T Consensus       227 --~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 --RLP---APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --cCC---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              000   112234567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.9e-36  Score=312.36  Aligned_cols=262  Identities=24%  Similarity=0.396  Sum_probs=205.8

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      .+++|+..++||+|+||.||+|..+.     .+..||+|.+.... ......+.+|+..+++++|+||+++++++.....
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP   83 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            45778899999999999999997642     34579999886543 2334568899999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccc-----cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQ-----QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      .++||||+++|+|.+++.....     .....+++..+..++.|++.||.|||+   ++++||||||+||+++.++.+||
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999964321     112446778889999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ..+.+   
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~---  234 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV---  234 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---
Confidence            999999865432211 1122345678999999988889999999999999999998 788886543221   11111   


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      . .+        .....+......+.+++.+|++.+|++||++.++++.|.+.
T Consensus       235 ~-~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 M-DG--------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             H-cC--------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            1 11        11111223346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.8e-36  Score=313.23  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      .++|+..+.||+|+||.||++....     ++..||+|.+.... ....+++.+|+.++++++||||++++++|...+..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            3678889999999999999998743     56789999987643 34456799999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccc-----------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQ-----------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN  490 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  490 (662)
                      ++||||+++|+|.+++.....                 .....+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhh
Confidence            999999999999999964321                 112357899999999999999999999   899999999999


Q ss_pred             eEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchh
Q 040242          491 VLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAM  568 (662)
Q Consensus       491 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~  568 (662)
                      |+++.++.++|+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||.......
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~  240 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE  240 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999998765332211 1122234678999999988889999999999999999998 888886443221


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                            +... ...++.        ...+......+.+++.+|++.+|++||++.|+++.|++
T Consensus       241 ------~~~~-~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         241 ------VIYY-VRDGNV--------LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ------HHHH-HhcCCC--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence                  1111 111111        11122345678899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.1e-36  Score=334.46  Aligned_cols=286  Identities=22%  Similarity=0.309  Sum_probs=207.5

Q ss_pred             HHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc------ccceeeeeeEec
Q 040242          350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH------RNLVQLHGWCRK  423 (662)
Q Consensus       350 l~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H------~niv~l~~~~~~  423 (662)
                      +...+++|++.++||+|+||+||+|.+...++.||||++.... ...+++..|+.++++++|      .+++++++++..
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3445688999999999999999999998889999999996532 223345566666666654      458889998876


Q ss_pred             c-CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-----
Q 040242          424 Q-DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-----  497 (662)
Q Consensus       424 ~-~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----  497 (662)
                      . ...++|||++ +++|.+++..     ...+++..+..++.||+.||.|||+.  .+|+||||||+|||++.++     
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~  274 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDP  274 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCccccc
Confidence            5 4789999998 7888888853     24689999999999999999999972  4899999999999998765     


Q ss_pred             -----------CeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          498 -----------NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       498 -----------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                                 .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       275 ~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~  350 (467)
T PTZ00284        275 VTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN  350 (467)
T ss_pred             ccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence                       499999998764322    23346799999999999998999999999999999999999999986544


Q ss_pred             hhhHHHHH---------HHHH--------Hhhc-CccccccCCCC-----C---CCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          567 AMELVLVD---------WVRE--------LHSQ-GQITRAIDPTL-----D---YFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       567 ~~~~~l~~---------~~~~--------~~~~-~~~~~~id~~l-----~---~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                      .....+..         |...        .+.. +.+....++..     .   .........+.+|+.+||+.||.+||
T Consensus       351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~  430 (467)
T PTZ00284        351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL  430 (467)
T ss_pred             HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence            32222111         1100        0000 00000111100     0   00011235578999999999999999


Q ss_pred             CHHHHHHH--Hhc----CCCCCCCCCCCCCCCCC
Q 040242          621 STRRVVQF--LLR----DASLPQAPLDIHHEFPR  648 (662)
Q Consensus       621 t~~eVl~~--L~~----~~~~p~~p~~~~~~~~~  648 (662)
                      |++|++++  +.+    +...|..|..++...+.
T Consensus       431 ta~e~L~Hp~~~~~~~~~~~~~~~~~~~~~~~~~  464 (467)
T PTZ00284        431 NARQMTTHPYVLKYYPECRQHPNYPDNRSMLRPT  464 (467)
T ss_pred             CHHHHhcCccccccCCccccCCCCCCccccCCCC
Confidence            99999983  433    44567776665554443

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-36  Score=307.48  Aligned_cols=247  Identities=25%  Similarity=0.385  Sum_probs=196.8

Q ss_pred             eeeeeCceEEEEEEeC--CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          362 LVGSGGFGKVYRGVIP--STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~--~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .||+|+||.||+|.+.  ..+..||+|.+.... ....+.+.+|+.++++++|+||++++++|. .+..++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            3899999999999874  345679999986653 334567899999999999999999999885 457899999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc-
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-  517 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~-  517 (662)
                      |.+++...    ...+++..+++++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++......... 
T Consensus        81 L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          81 LNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            99998543    3468999999999999999999999   899999999999999999999999999998654432211 


Q ss_pred             -ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          518 -TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       518 -~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                       .....++..|+|||.+....++.++|||||||++|||++ |+.||.......   ....+    ..+..        ..
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~--------~~  218 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFI----EQGKR--------LD  218 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----HCCCC--------CC
Confidence             111233578999999988889999999999999999996 999997543321   11111    11110        11


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .+......+.+++.+||..+|++||++.+|.+.|+.
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            223345678889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.5e-36  Score=322.38  Aligned_cols=263  Identities=23%  Similarity=0.268  Sum_probs=201.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------  424 (662)
                      ..++|+..+.||+|+||.||++.....++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999888999999998654  233456788999999999999999999988543      


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ...++||||++ ++|.+.+       ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        95 ~~~~lv~e~~~-~~l~~~~-------~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          95 QDVYLVMELMD-ANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             ceeEEEhhhhc-ccHHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeC
Confidence            35799999995 4676666       2347888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH------------
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL------------  572 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l------------  572 (662)
                      |+++......  ......||..|+|||.+.+..++.++|||||||++|||++|+.||..........-            
T Consensus       164 g~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         164 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            9998654321  22335689999999999888899999999999999999999999976542211100            


Q ss_pred             ----HHHHHHHhhcC-ccccccCC-----CC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          573 ----VDWVRELHSQG-QITRAIDP-----TL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       573 ----~~~~~~~~~~~-~~~~~id~-----~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ...+....... .......+     .+    ..........+.+++.+||+.||++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                00001100000 00000000     00    11112234567899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.8e-36  Score=305.00  Aligned_cols=251  Identities=24%  Similarity=0.381  Sum_probs=205.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEec-cCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E  432 (662)
                      +|+..+.||+|++|.||++....+++.||+|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788899999999999999998889999999986542  3445678899999999999999999998764 446899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++....   ...+++.++..++.+++.||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            999999999996532   3468999999999999999999999   8999999999999999999999999999987644


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ... ......+++.|+|||.+.+..++.++||||||++++||++|+.||.......      ..... ..+.        
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~-~~~~--------  218 (257)
T cd08223         155 QCD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRI-IEGK--------  218 (257)
T ss_pred             cCC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHH-HhcC--------
Confidence            322 2233468899999999998889999999999999999999999987543211      11111 1111        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +...+......+.+++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            111223445678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.5e-36  Score=310.69  Aligned_cols=252  Identities=25%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      |+..+.||+|+||.||+|....++..+++|.+........+.+.+|+++++.++|||++++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            45678899999999999999888999999999776666678899999999999999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|..++...    ...+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....... .
T Consensus        87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~  158 (282)
T cd06643          87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  158 (282)
T ss_pred             CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-c
Confidence            9999987543    3468999999999999999999999   899999999999999999999999999987654321 1


Q ss_pred             cceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          517 QTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ......++..|+|||++.     ...++.++|||||||++|||++|+.||.......  .......     .     ..+
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~-----~-----~~~  226 (282)
T cd06643         159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK-----S-----EPP  226 (282)
T ss_pred             ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhh-----c-----CCC
Confidence            223346889999999873     3457789999999999999999999987543211  1111110     0     011


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .+ ..+......+.+++.+||+.+|.+||++.+++++-
T Consensus       227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         227 TL-AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             CC-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence            11 11122345678899999999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=4.7e-36  Score=314.95  Aligned_cols=260  Identities=25%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||++....++..+|+|.+... ......++.+|++++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3688899999999999999999888999999998754 333456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...     ..+++..+..++.|+++||.|||+.  .+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999543     4578899999999999999999972  58999999999999999999999999998765332


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc--------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI--------  585 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~--------  585 (662)
                         ......++..|+|||.+.+..++.++|||||||++|||++|+.||.......   +..+..........        
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCccccc
Confidence               1223468899999999988889999999999999999999999986443211   11111100000000        


Q ss_pred             -------------------ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          586 -------------------TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       586 -------------------~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                                         .....+.+.  .......+.+++.+||+.+|++||++.+|+++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVNEPPPKLP--SGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhcCCCccCc--CcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                               000001110  011344688999999999999999999999863

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.2e-36  Score=320.75  Aligned_cols=256  Identities=23%  Similarity=0.277  Sum_probs=200.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+++...+++.||+|.+.+..   ......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999998899999999986532   233455788999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...    ...+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            999999999999643    2458888999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ...........||+.|+|||++.+     +.++.++|||||||++|||++|+.||........      ......... .
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~-~  226 (331)
T cd05624         154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEE-R  226 (331)
T ss_pred             CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCC-c
Confidence            433223333579999999998865     4678899999999999999999999975432211      111111100 0


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  628 (662)
                      -.+.+..    ....+.+.+++.+|++.++++  |+++++++++
T Consensus       227 ~~~p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 FQFPSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ccCCCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            0011111    123456777788888765544  5688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.6e-36  Score=327.21  Aligned_cols=261  Identities=24%  Similarity=0.368  Sum_probs=205.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~  427 (662)
                      ++|...+.||+|+||.||+|.+.     ..++.||||++.... ....+.+..|+.++.++. ||||++++++|...+..
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~  116 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI  116 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence            45777899999999999999863     245689999997653 233457889999999997 99999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccc-----------------------------------------------------------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQ-----------------------------------------------------------  448 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~-----------------------------------------------------------  448 (662)
                      ++||||+++|+|.++++....                                                           
T Consensus       117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (401)
T cd05107         117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK  196 (401)
T ss_pred             EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence            999999999999999965321                                                           


Q ss_pred             ----------------------------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          449 ----------------------------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       449 ----------------------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                                                        .....++|..++.++.|++.||.|||+   .+++||||||+|||++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~  273 (401)
T cd05107         197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEe
Confidence                                              011347888899999999999999998   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      +++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||........  +
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~--~  351 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ--F  351 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH--H
Confidence            999999999999986543221 11223456789999999988889999999999999999998 8889865432211  1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                          ......+.     .+.   .+......+.+|+.+||+.+|.+||++++|++.|++.
T Consensus       352 ----~~~~~~~~-----~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         352 ----YNAIKRGY-----RMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ----HHHHHcCC-----CCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                11111110     001   1122346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.3e-36  Score=321.71  Aligned_cols=247  Identities=26%  Similarity=0.328  Sum_probs=194.1

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHH-HHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEI-TSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei-~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||+||+++...++..||+|++....   ......+..|. .+++.++|+||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999998889999999997542   22233444454 456788999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++...     ..++......++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..... ..
T Consensus        81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~  151 (325)
T cd05602          81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NG  151 (325)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccC-CC
Confidence            9999988542     346778888899999999999999   89999999999999999999999999999754322 12


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+   .. .        .+ ..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~~-~--------~~-~~  215 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI---LN-K--------PL-QL  215 (325)
T ss_pred             CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHH---Hh-C--------Cc-CC
Confidence            2334579999999999998899999999999999999999999997543221   11111   11 0        00 11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .......+.+++.+|++.+|.+||++.+.+..+.++
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~  251 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH  251 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence            123345678889999999999999987555444443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-37  Score=325.63  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=210.2

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      .-+||+|.||+||.|++..+...+|||.+.....+..+-+..||...++|+|+|||+++|.|.+++..-+.||.+|||+|
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            34799999999999999999999999999887777777889999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccc--cHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-CCCCeEEeeccccccccCCCCC
Q 040242          440 DKLLFDNDQQKKKIL--NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      .++|...    -.+|  ++...-...+||++||.|||+   +.|||||||-+|||++ -.|.+||+|||.++.+. +.++
T Consensus       660 SsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA-ginP  731 (1226)
T KOG4279|consen  660 SSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA-GINP  731 (1226)
T ss_pred             HHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhc-cCCc
Confidence            9999654    3455  566667788999999999999   8999999999999996 57889999999998765 3567


Q ss_pred             cceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      .+...-||..|||||++..+  .|..++|||||||.+.||.||++||..-.... ..       ++.-|  .-.+.   .
T Consensus       732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq-AA-------MFkVG--myKvH---P  798 (1226)
T KOG4279|consen  732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ-AA-------MFKVG--MYKVH---P  798 (1226)
T ss_pred             cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh-Hh-------hhhhc--ceecC---C
Confidence            77778899999999999776  48899999999999999999999997433211 00       00001  01112   3


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRD  632 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  632 (662)
                      ..+.+...+...++++|+.+||..||++.++++  +|.-.
T Consensus       799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            346677888899999999999999999999997  56433

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.2e-36  Score=310.89  Aligned_cols=253  Identities=25%  Similarity=0.414  Sum_probs=205.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +.|+..+.||+|+||.||+|....++..+++|.+........+.+..|+.++++++|+||+++++++..++..++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56788899999999999999998889999999998777777788999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|..++.+.    ...+++..+..++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        92 ~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~  164 (292)
T cd06644          92 PGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL  164 (292)
T ss_pred             CCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc
Confidence            999998887543    3458999999999999999999998   899999999999999999999999999987643321


Q ss_pred             CCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          515 NPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                       .......++..|+|||++.     ...++.++|||||||++|||++|+.|+.......  ...    ...      +..
T Consensus       165 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~----~~~------~~~  231 (292)
T cd06644         165 -QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL----KIA------KSE  231 (292)
T ss_pred             -cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHH----HHh------cCC
Confidence             1223346788999999884     3446789999999999999999999987543211  111    110      011


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.+ ..+......+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         232 PPTL-SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CccC-CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111 1122334567889999999999999999999874

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.3e-36  Score=304.70  Aligned_cols=252  Identities=21%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||.|+||.||.+....++..+++|.+...  .....+++.+|+.++++++|+||+++++++...+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            477889999999999999999889999999998654  345567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.++..++.|++++|.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999986542   3468999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .. ......+++.|+|||.+.+...+.++||||||+++|||++|+.||.......      ..... ..+..        
T Consensus       155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~--------  218 (256)
T cd08221         155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNY--------  218 (256)
T ss_pred             cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCC--------
Confidence            32 2233568999999999988888999999999999999999999997543221      11111 11111        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      ..........+.+++.+||+.+|++||++.++++++
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            111223455688899999999999999999999763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-36  Score=319.73  Aligned_cols=242  Identities=23%  Similarity=0.314  Sum_probs=195.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +|+..+.||+|+||+||++....+++.||+|++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            3677899999999999999998899999999997642   233456788888888885 577888999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            99999999998843     2458999999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+.   . ..      .
T Consensus       153 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~---~-~~------~  218 (323)
T cd05615         153 VDG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIM---E-HN------V  218 (323)
T ss_pred             CCC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHH---h-CC------C
Confidence            221 1223356899999999998888999999999999999999999999765321   1111111   1 11      0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPST  622 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~  622 (662)
                         .++......+.+++.+||+.+|.+|++.
T Consensus       219 ---~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 ---SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               1122234567889999999999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.1e-36  Score=319.15  Aligned_cols=261  Identities=25%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-------CCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      .+|+..+.||+|+||.||++....       .+..||+|.+... .....+++.+|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   91 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence            357888999999999999998632       2236899988754 334467899999999999 7999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..+++|||+++|+|.+++.....           .....++|.+++.++.|+++||.|||+   .+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill~  168 (334)
T cd05100          92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLVT  168 (334)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEc
Confidence            99999999999999999865321           113458999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......    
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~----  244 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE----  244 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH----
Confidence            9999999999999865432211 1122234568999999988889999999999999999998 888886543211    


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                        +..... .+.        ....+......+.+++.+|++.+|.+||++.|+++.|.+..
T Consensus       245 --~~~~~~-~~~--------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 --LFKLLK-EGH--------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             --HHHHHH-cCC--------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence              111111 110        01112233456889999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-36  Score=305.59  Aligned_cols=251  Identities=23%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|+||.+|++....++..|++|++...  .....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            477889999999999999999888999999998653  234456889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.+++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            99999999886432   2357899999999999999999999   89999999999999999999999999999866443


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .. ......|++.|+|||.+.+...+.++|||||||+++||++|+.|+.......      .+.... .+.        .
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~--------~  218 (256)
T cd08218         155 VE-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGS--------Y  218 (256)
T ss_pred             hh-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCC--------C
Confidence            21 1223467889999999988889999999999999999999999987543221      111111 111        1


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...+......+.+++.+||+.+|.+||+|.+|+++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            11122345668899999999999999999999974

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.5e-36  Score=308.72  Aligned_cols=254  Identities=24%  Similarity=0.369  Sum_probs=204.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||+|....+++.||+|.+..........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~   88 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC   88 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence            46777889999999999999998889999999997765555667889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++..     ...+++.+.+.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06645          89 GGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI  160 (267)
T ss_pred             CCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc
Confidence            99999999853     3458899999999999999999999   899999999999999999999999999987654322


Q ss_pred             CCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          515 NPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                       .......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+..........      . ......   ..+
T Consensus       161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~-~~~~~~---~~~  229 (267)
T cd06645         161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------L-MTKSNF---QPP  229 (267)
T ss_pred             -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------h-hhccCC---CCC
Confidence             1223356899999999874   4557889999999999999999999986543221111      0 000110   011


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .... .......+.+++.+|++.+|++||++.+|+++
T Consensus       230 ~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         230 KLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            1110 01123457889999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3e-36  Score=331.47  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=196.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc--------
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--------  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--------  424 (662)
                      ..++|+..++||+|+||.||+|....+++.||||++.....    ...+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ----YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            34679999999999999999999988899999998855422    234699999999999999999876432        


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEee
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGD  503 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~D  503 (662)
                      ..+++||||++ ++|.+++..... ....+++.....++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeec
Confidence            24679999997 477776643211 14568999999999999999999999   8999999999999999765 699999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      ||+++.+....  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........  ..+. ....
T Consensus       215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~~-~~~~  289 (440)
T PTZ00036        215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RIIQ-VLGT  289 (440)
T ss_pred             cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHH-HhCC
Confidence            99998764332  2223568999999998765 468999999999999999999999997654332211  1111 0000


Q ss_pred             ----------CccccccCCC-----C-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 ----------GQITRAIDPT-----L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ----------~~~~~~id~~-----l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                ....+..-+.     + ..++......+.+|+.+||+.||.+|||+.|++++
T Consensus       290 p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        290 PTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                      0000000011     1 11122234678899999999999999999999964

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.7e-36  Score=312.97  Aligned_cols=266  Identities=24%  Similarity=0.379  Sum_probs=204.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeC----------------CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP----------------STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQL  417 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~----------------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l  417 (662)
                      ++|+..++||+|+||.||++...                .++..||+|.+... ......+|.+|+.++++++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            56888999999999999998542                23456999999754 33445789999999999999999999


Q ss_pred             eeeEeccCeeeEEEeccCCCCcchhccccccc------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       418 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      ++++...+..++||||+++++|.+++......      ....+++.+.+.++.|++.||.|||+   .+++||||||+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~Ni  161 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNC  161 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChheE
Confidence            99999999999999999999999998654311      12358889999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc--CCCCCCcccchh
Q 040242          492 LIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC--GRRPIEPQRTAM  568 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt--G~~p~~~~~~~~  568 (662)
                      +++.++.++|+|||+++.+...... ......++..|++||....+.++.++|||||||++|||++  |..||.......
T Consensus       162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~  241 (296)
T cd05095         162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ  241 (296)
T ss_pred             EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence            9999999999999999865432211 1222344678999998888889999999999999999998  667876443221


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         ........+..... ....+.    +..+...+.+++.+||+.||.+||++.+|++.|++
T Consensus       242 ---~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 ---VIENTGEFFRDQGR-QVYLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             ---HHHHHHHHHhhccc-cccCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence               11111111111110 011111    12234678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.4e-36  Score=305.63  Aligned_cols=248  Identities=28%  Similarity=0.447  Sum_probs=199.5

Q ss_pred             ceeeeeCceEEEEEEeCCCC---cEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g---~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|+....+   ..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999875544   7899999876543 34567899999999999999999999876 4568999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|.+++...     ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999543     368999999999999999999998   89999999999999999999999999999876543322


Q ss_pred             cc--eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          517 QT--THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       517 ~~--~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ..  ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......   .+..++.+    +..        
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~--------  216 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GER--------  216 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CCc--------
Confidence            11  11223568999999988889999999999999999998 99998754321   22222221    110        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ...+...+..+.+++.+||..+|++||++.++++.|++.
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            011223346788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4e-36  Score=309.11  Aligned_cols=252  Identities=28%  Similarity=0.450  Sum_probs=198.3

Q ss_pred             ceeeeeCceEEEEEEeCCCCc--EEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGL--EVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||.||+|.+.+++.  .+++|.+... .....+.+..|++++.++ +||||++++++|...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999977665  4688888653 344556789999999999 799999999999999999999999999


Q ss_pred             CCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          437 GSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       437 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      |+|.+++.....           .....+++.+++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            999999865321           112358899999999999999999998   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++......  ........+..|+|||++....++.++|||||||++|||++ |+.||.......      ..... ..+.
T Consensus       158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~~~~-~~~~  228 (270)
T cd05047         158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYEKL-PQGY  228 (270)
T ss_pred             Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HHHHH-hCCC
Confidence            98643221  11111234567999999988889999999999999999997 999986543211      11111 1110


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                             .. .........+.+++.+|++.+|.+||++.++++.|.+.
T Consensus       229 -------~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 -------RL-EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             -------CC-CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                   00 11122345678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.3e-36  Score=311.60  Aligned_cols=264  Identities=27%  Similarity=0.362  Sum_probs=196.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhcc---ccccceeeeeeEecc-----C
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRL---RHRNLVQLHGWCRKQ-----D  425 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~~~-----~  425 (662)
                      +|+..+.||+|+||+||+|....+++.||+|.+....  ......+.+|+.+++++   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999999899999999986532  12223455676666655   799999999988642     3


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||++ ++|.+++....   ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence            5799999997 58888885432   3458999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHHH----HHh
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVR----ELH  580 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~----~~~  580 (662)
                      +++......  ......|+..|+|||.+.+..++.++||||+||++|||++|++||.......... +..+..    ..+
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07863         154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW  231 (288)
T ss_pred             ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence            998764322  2233568899999999988889999999999999999999999997543322111 111100    000


Q ss_pred             hc-Ccc-ccccCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQ-GQI-TRAIDPT----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~-~~~-~~~id~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .. ... .....+.    +....+...+.+.+++.+||+.||++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            00 000 0001110    011122345667899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2e-36  Score=313.71  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=203.4

Q ss_pred             cCCcccceeeeeCceEEEEEEe----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc--Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  427 (662)
                      +-|+..+.||+|+||.||++..    ..++..||+|.+.... ......+.+|+.++++++||||+++.+++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3467789999999999999974    3467889999987553 34456789999999999999999999998775  568


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++...    ...++|.+++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccc
Confidence            9999999999999998543    2358999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch---------hhHHHHHHH
Q 040242          508 RAYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA---------MELVLVDWV  576 (662)
Q Consensus       508 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~  576 (662)
                      +........  ......++..|+|||.+.+..++.++|||||||++|||++++.|.......         .+.....++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV  236 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH
Confidence            876543221  112345677899999998888999999999999999999987765321110         000111111


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       .....+..        ..........+.+|+.+||+.+|++||++.++++.|+.
T Consensus       237 -~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         237 -RVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             -HHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence             11111110        11122345678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.1e-36  Score=311.04  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=203.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566788999999999999998888999999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++..      ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.......
T Consensus        85 ~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06642          85 GGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc
Confidence            99999998842      358899999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       .......++..|+|||++.+..++.++|||||||++|||++|+.|+........   ..+    ..     +...+.  
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~~-----~~~~~~--  220 (277)
T cd06642         156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----IP-----KNSPPT--  220 (277)
T ss_pred             -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----hh-----cCCCCC--
Confidence             122234678899999999888899999999999999999999999864432111   000    00     111111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ........+.+++.+|++.+|++||+|.+|+++
T Consensus       221 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         221 -LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence             222345668899999999999999999999985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=8.4e-36  Score=306.46  Aligned_cols=256  Identities=26%  Similarity=0.393  Sum_probs=194.3

Q ss_pred             ceeeeeCceEEEEEEeCC--CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPS--TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      +.||+|+||.||+|....  ++..+++|.+.... ......+.+|+.++++++||||+++++++......++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998643  34679999886643 334457889999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-C
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-P  516 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~  516 (662)
                      +|.+++..........+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++....... .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999965432223456778888999999999999999   8999999999999999999999999999875433211 1


Q ss_pred             cceecccCCcccCcccccCC-------CCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          517 QTTHIVGTLGYLAPELTRTG-------KATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.||..........   ..    ..+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---YT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---HH----hhcccCCC
Confidence            12234577889999988532       35789999999999999996 999997543322111   10    01111122


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .++.+.   ....+.+.+++..|+ .+|++||++.||++.|+
T Consensus       231 ~~~~~~---~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLK---LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccC---CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222221   122344677888998 68999999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-36  Score=307.81  Aligned_cols=250  Identities=25%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||.|++|.||+|....++..||+|.+.... ......+.+|+.++++++|+|++++++++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35778899999999999999998889999999987653 34456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..      ..+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            999999999853      268999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      . .......++..|+|||++.+..++.++|||||||++|||++|+.||........      ... ..     ....+.+
T Consensus       152 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~-~~-----~~~~~~~  218 (274)
T cd06609         152 M-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFL-IP-----KNNPPSL  218 (274)
T ss_pred             c-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHH-hh-----hcCCCCC
Confidence            2 222334678899999999888899999999999999999999999975432110      111 00     1111222


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...  .....+.+++.+||+.+|++||++++++++
T Consensus       219 ~~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         219 EGN--KFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             ccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111  144567889999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-36  Score=303.75  Aligned_cols=252  Identities=29%  Similarity=0.475  Sum_probs=205.5

Q ss_pred             ceeeeeCceEEEEEEeCCC---CcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||.||+|.....   +..|++|.+...... ..+.+.+|++.+++++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999765   889999999765433 367889999999999999999999999999999999999999


Q ss_pred             CCcchhccccccc----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          437 GSLDKLLFDNDQQ----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       437 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ++|.+++......    ....+++.+++.++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999654211    02568999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          513 NIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       513 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... .......++..|+|||.+....++.++||||+|++++||++ |+.||......   .+.+.+    ..+       
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~----~~~-------  223 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYL----RKG-------  223 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----HcC-------
Confidence            321 12233457889999999988889999999999999999999 68998765321   111111    111       


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                       .....+......+.+++.+|++.+|++||++.|++++|+
T Consensus       224 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             011112233567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.2e-36  Score=319.68  Aligned_cols=256  Identities=23%  Similarity=0.263  Sum_probs=198.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||.||+++...+++.+|+|.+.+..   ......+..|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999998889999999986532   223445788999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++.+.    ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            999999999999643    3458899999999999999999999   899999999999999999999999999997654


Q ss_pred             CCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ...........||+.|+|||++.     ...++.++|||||||++|||++|+.||.......      .......... .
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~-~  226 (332)
T cd05623         154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKE-R  226 (332)
T ss_pred             cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCc-c
Confidence            33222333457999999999885     3467889999999999999999999997543221      1111111100 0


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDP--HPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~--dP~~RPt~~eVl~~  628 (662)
                      ..+...    .......+.+++.+|+..  ++..||++.|++++
T Consensus       227 ~~~p~~----~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 FQFPAQ----VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ccCCCc----cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            001111    112344566677777754  44447899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6e-36  Score=305.99  Aligned_cols=253  Identities=25%  Similarity=0.437  Sum_probs=204.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||++... .+..+++|.+.... ...+.+.+|+.++++++|+||+++.+.+.. ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~   82 (260)
T cd05073           6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM   82 (260)
T ss_pred             cceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence            56888999999999999999874 45679999886543 345678999999999999999999999887 7789999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          83 AKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             CCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            9999999996532   3468899999999999999999998   899999999999999999999999999998665432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||++..+.++.++|||||||++||+++ |+.||......   .+..++    ..+...    +  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~----~--  223 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRM----P--  223 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCC----C--
Confidence            222223345678999999988889999999999999999999 89998754322   111111    111100    1  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ........+.+++.+|++.+|++||++.++.+.|+.
T Consensus       224 --~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 --RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             --CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence              112334568899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.9e-36  Score=305.41  Aligned_cols=241  Identities=24%  Similarity=0.395  Sum_probs=191.3

Q ss_pred             ceeeeeCceEEEEEEeCCC------------CcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          361 NLVGSGGFGKVYRGVIPST------------GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~------------g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      +.||+|+||.||+|+....            ...|++|.+..........|.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            4689999999999986322            2358999887665556678899999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC-------eEE
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN-------PKL  501 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-------~kL  501 (662)
                      +||||+++++|..++...    ...+++..++.++.||++||.|||+   .+|+||||||+|||++.++.       +++
T Consensus        81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEe
Confidence            999999999999988543    3458999999999999999999999   89999999999999987664       899


Q ss_pred             eeccccccccCCCCCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHH-cCCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||++......     ....++..|+|||.+. +..++.++|||||||++|||+ +|+.|+..........       .
T Consensus       154 ~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-------~  221 (262)
T cd05077         154 SDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-------F  221 (262)
T ss_pred             CCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-------H
Confidence            999998754322     2245788999999886 456889999999999999998 5888876432211110       0


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      . .+..      ..   .......+.+|+.+||+.||.+||++.+|++.|+
T Consensus       222 ~-~~~~------~~---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         222 Y-EGQC------ML---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             H-hcCc------cC---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0 1100      01   1112356789999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=5.6e-36  Score=321.92  Aligned_cols=263  Identities=22%  Similarity=0.277  Sum_probs=201.2

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------  424 (662)
                      ..++|+..+.||+|+||.||+++....++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999999888999999998653  234456788999999999999999999987543      


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ...++||||++ ++|.+.+       ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHH-------HhcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence            35799999996 4777766       2347888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH---------HH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV---------DW  575 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~  575 (662)
                      |+++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.||..........-.         ++
T Consensus       171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  248 (364)
T cd07875         171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF  248 (364)
T ss_pred             CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9998654322  223356899999999999889999999999999999999999999765432211100         00


Q ss_pred             H-------HHHhhcC-ccc----cccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 V-------RELHSQG-QIT----RAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ~-------~~~~~~~-~~~----~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .       ....... ...    +.+.+..     ..........+.+++.+|++.||.+|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            0       0000000 000    0000000     01111234567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.2e-36  Score=313.41  Aligned_cols=262  Identities=25%  Similarity=0.352  Sum_probs=201.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|...+.||+|+||.||+|....++..||+|.+.... ......+.+|+.++++++|+||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999998889999999986543 23345678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.+++...    ...+++.....++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        86 ~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            96 6888888543    3457899999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh------------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH------------  580 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~------------  580 (662)
                      .. ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||..........   .+....            
T Consensus       158 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         158 TK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH---FIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHcCCCChhhchhhh
Confidence            21 12223568899999987653 57889999999999999999999997654322211   111110            


Q ss_pred             hcCccccccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQGQITRAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~~~~~~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........-.+..     ..........+.+|+.+|++.||.+|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000000110     00111234567889999999999999999999973

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.1e-36  Score=310.68  Aligned_cols=266  Identities=23%  Similarity=0.312  Sum_probs=208.4

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEe-
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCR-  422 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~-  422 (662)
                      +.++.+..++++|+..+.||+|+||.||++....+++.+|+|.+.... ....++.+|+.+++++ +|+||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            455677788899999999999999999999998889999999886532 2235678899999999 6999999999884 


Q ss_pred             ----ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          423 ----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       423 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                          .++..++||||+++++|.+++..... ....+++..+..++.|+++||.|||+   .+++||||||+||+++.++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~  162 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCC
Confidence                34568999999999999998754321 13568899999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      +||+|||+++...... .......|+..|+|||++..     ..++.++||||+||++|||++|+.|+.........  .
T Consensus       163 ~kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F  239 (286)
T ss_pred             EEEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h
Confidence            9999999998664322 22233468999999998753     34788999999999999999999998754321110  0


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      ..          .....+.+. .+......+..++.+||+.+|++||++.|+++++
T Consensus       240 ~~----------~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 KI----------PRNPPPTLH-QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hc----------cccCCCccc-CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00          000111110 1111234688899999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.8e-36  Score=305.58  Aligned_cols=252  Identities=27%  Similarity=0.448  Sum_probs=202.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .+|+..+.||+|++|.||++.+. .+..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            45777899999999999999885 467899998865432 3457899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++..++.++.|++.+|.|||+   .+++|+||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          82 EHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            999999998543    3458899999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++.+|+|||.+.++.++.++||||||+++|||++ |+.||......   .   .+... .++  .....+. 
T Consensus       155 ~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~---~~~~~-~~~--~~~~~~~-  224 (256)
T cd05112         155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---E---VVETI-NAG--FRLYKPR-  224 (256)
T ss_pred             ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---H---HHHHH-hCC--CCCCCCC-
Confidence            211222335678999999988889999999999999999998 89998754321   1   11111 111  0111121 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                           .....+.+|+.+||+.+|++||++.+|+++|.
T Consensus       225 -----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         225 -----LASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 13467889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-36  Score=309.80  Aligned_cols=254  Identities=25%  Similarity=0.400  Sum_probs=207.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||.|++|.||++....++..+|+|.+........+.|..|++++++++|+||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            45688899999999999999999888999999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...    ...+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          84 CDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             cCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            9999999998543    3468999999999999999999999   89999999999999999999999999988765432


Q ss_pred             CCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          514 INPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      . .......++..|+|||.+.     ...++.++||||||+++|||++|+.||.......  .+..+     ..+     
T Consensus       157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~-----~~~-----  223 (280)
T cd06611         157 L-QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKI-----LKS-----  223 (280)
T ss_pred             c-cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHH-----hcC-----
Confidence            2 2223356899999999874     3346789999999999999999999997543221  11111     011     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+.+ ..+......+.+++.+||+.+|++||++.+|+++
T Consensus       224 ~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 EPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            01111 1122334567889999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=6.8e-36  Score=342.27  Aligned_cols=261  Identities=23%  Similarity=0.299  Sum_probs=205.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||.||+|.+..+++.||+|++...   .....++|.+|++++++++||||+++++++..++..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5788899999999999999999888999999998653   2334567999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccc------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          432 DYVPNGSLDKLLFDNDQ------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ||+++++|.+++.....      .....+++..+++++.||++||+|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            99999999999864211      112346788889999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCC-----------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh
Q 040242          506 LARAYDHNIN-----------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM  568 (662)
Q Consensus       506 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  568 (662)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||+||+.||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986621110                 01122469999999999998899999999999999999999999997533211


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-STRRVVQFLLR  631 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~  631 (662)
                      . ..    .     ..   ..++.-.......+..+.+++.+|++.||++|| +++++++.|+.
T Consensus       239 i-~~----~-----~~---i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 I-SY----R-----DV---ILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             h-hh----h-----hh---ccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0 00    0     00   011110000123345678899999999999996 56666666654

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.9e-36  Score=308.86  Aligned_cols=240  Identities=25%  Similarity=0.365  Sum_probs=189.9

Q ss_pred             eeeeeCceEEEEEEeCC------------------------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceee
Q 040242          362 LVGSGGFGKVYRGVIPS------------------------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL  417 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~~------------------------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l  417 (662)
                      .||+|+||.||+|....                        ....|++|.+..........|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999998532                        124589999876655556788999999999999999999


Q ss_pred             eeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC
Q 040242          418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL  497 (662)
Q Consensus       418 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  497 (662)
                      +++|......++||||+++|+|..++...    ...+++..++.++.|+++||+|||+   .+|+||||||+||+++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccC
Confidence            99999999999999999999999998543    3468899999999999999999998   8999999999999997654


Q ss_pred             -------CeEEeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHH-cCCCCCCcccchh
Q 040242          498 -------NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAM  568 (662)
Q Consensus       498 -------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~ell-tG~~p~~~~~~~~  568 (662)
                             .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence                   3799999988643221     12356788999998865 56899999999999999995 6899987543321


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ..   .+..    ..       ..+   +......+.+++.+||+.+|++||++.+|++.|.
T Consensus       230 ~~---~~~~----~~-------~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KE---RFYE----KK-------HRL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH---HHHH----hc-------cCC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11   1111    00       011   0111235788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=8.8e-36  Score=308.92  Aligned_cols=257  Identities=25%  Similarity=0.382  Sum_probs=207.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|++|+||++....++..||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            45777899999999999999998889999999886543 34467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..     ...+++.....++.+++.+|.|||+.  .+++||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~  157 (284)
T cd06620          85 MDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS  157 (284)
T ss_pred             CCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence            999999998843     24589999999999999999999973  57999999999999999999999999998754322


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch-----hhHHHHHHHHHHhhcCccccc
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA-----MELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .   .....|+..|+|||++.++.++.++|||||||++|||++|+.||......     ....+.+++.......     
T Consensus       158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  229 (284)
T cd06620         158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP-----  229 (284)
T ss_pred             c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence            1   22346899999999998888999999999999999999999999754331     1111222322221110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       .+.+.  .......+.+++.+|++.||++||++.|++++.
T Consensus       230 -~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         230 -PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             -CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence             11111  112445688999999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=5.9e-36  Score=309.93  Aligned_cols=264  Identities=28%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+|+...++..||+|++....  ....+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4777899999999999999998889999999986542  22346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.+++.....  ...+++.++..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            96 688888754321  3568999999999999999999999   89999999999999999999999999999865433


Q ss_pred             CCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH-------hhc---
Q 040242          514 INPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL-------HSQ---  582 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------~~~---  582 (662)
                      .. ......+++.|+|||.+.+. .++.++|||||||+++||+||+.||..........  ......       +..   
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  231 (285)
T cd07861         155 VR-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVTS  231 (285)
T ss_pred             cc-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcchh
Confidence            21 12233568899999987654 47889999999999999999999997553321111  000000       000   


Q ss_pred             -Ccccccc----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 -GQITRAI----DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 -~~~~~~i----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .......    ...+..........+.+++.+||+.||++|||+.+|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence             0000000    000111111234567789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.5e-36  Score=313.69  Aligned_cols=262  Identities=24%  Similarity=0.384  Sum_probs=206.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-------CCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-------STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      .+|...+.||+|+||.||+++..       ..+..||+|.+... .....+++.+|+.+++.+ +||||+++++++...+
T Consensus        15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   94 (304)
T cd05101          15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG   94 (304)
T ss_pred             HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCC
Confidence            56778899999999999999752       23457999988654 234557889999999999 8999999999999999


Q ss_pred             eeeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..++||||+++|+|.+++......           ....++|.+++.++.|+++||.|||+   .+++||||||+||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nili~  171 (304)
T cd05101          95 PLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVLVT  171 (304)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEEEc
Confidence            999999999999999999754211           12458899999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+......     
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-----  246 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE-----  246 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-----
Confidence            9999999999999876543221 1222345678999999988889999999999999999998 77887643221     


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                       ++.... ..+..        ...+......+.+++.+||+.+|++||++.||++.|.+...
T Consensus       247 -~~~~~~-~~~~~--------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         247 -ELFKLL-KEGHR--------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             -HHHHHH-HcCCc--------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence             111111 11110        01122345668889999999999999999999999977543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-35  Score=304.21  Aligned_cols=250  Identities=25%  Similarity=0.403  Sum_probs=193.6

Q ss_pred             ceeeeeCceEEEEEEeCC---CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEe-ccCeeeEEEeccC
Q 040242          361 NLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCR-KQDELLLVYDYVP  435 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~~~  435 (662)
                      +.||+|+||.||+|++..   .+..||+|++... .....+.+..|+.+++.++||||++++++|. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998743   3457999998543 3445678899999999999999999999876 4556899999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            99999999643    2346778889999999999999999   8999999999999999999999999999986533211


Q ss_pred             ---CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          516 ---PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR-RPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       516 ---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                         .......++..|+|||.+.+..++.++|||||||++|||++|+ .|+......   .+...+.    .+.     .+
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~----~~~-----~~  221 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLL----QGR-----RL  221 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHh----cCC-----CC
Confidence               1112234577899999998888999999999999999999964 555433211   1111111    110     01


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .   .+...+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       222 ~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         222 L---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             C---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1   1112345688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=4e-36  Score=315.29  Aligned_cols=260  Identities=24%  Similarity=0.373  Sum_probs=204.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-------CCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++|...+.||+|+||.||++....       ....+|+|.+... ......++..|+.++.++ +|+||++++++|...+
T Consensus        18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   97 (307)
T cd05098          18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   97 (307)
T ss_pred             HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence            568889999999999999998643       2346999999754 234456788999999999 7999999999999999


Q ss_pred             eeeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..++||||+++|+|.+++......           ....++|.++++++.|++.||+|||+   .+++||||||+||+++
T Consensus        98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  174 (307)
T cd05098          98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  174 (307)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEEc
Confidence            999999999999999999654210           12358999999999999999999998   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---~  251 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L  251 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---H
Confidence            9999999999998865432111 1111234568999999988889999999999999999998 888886543211   1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         ... ...+..        ...+......+.+++.+|++.+|++||+|.+|++.|...
T Consensus       252 ---~~~-~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         252 ---FKL-LKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---HHH-HHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               111 111110        111223456788899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.7e-36  Score=304.79  Aligned_cols=248  Identities=30%  Similarity=0.424  Sum_probs=199.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe-ccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR-KQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|++|.||++..  .|..|++|.+....  ..+.+.+|+.++++++|+|++++++++. .++..+++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            4677889999999999999987  47789999986543  3467899999999999999999999764 45678999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          82 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            99999999986542   3458899999999999999999999   89999999999999999999999999998854332


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .    ....++..|+|||++....++.++|||||||++|||++ |+.||......   .+..++..    +.     .+ 
T Consensus       156 ~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~----~~-----~~-  218 (256)
T cd05082         156 Q----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK----GY-----KM-  218 (256)
T ss_pred             C----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc----CC-----CC-
Confidence            1    22344678999999988889999999999999999997 99998643221   11111111    10     01 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ......+..+.+++.+|++.+|++||++.++++.|..
T Consensus       219 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         219 --DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              1122345678889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-36  Score=309.94  Aligned_cols=254  Identities=25%  Similarity=0.425  Sum_probs=204.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +|+..+.||+|+||.||++....++..||+|.+... ......++.+|+.++++++|+||+++++++...+..++||||+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM   81 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence            577789999999999999999888999999988654 3344578899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|..++.....  ...+++..+..++.|+++||.|||+.  .+++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  157 (286)
T cd06622          82 DAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL  157 (286)
T ss_pred             CCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence            99999998854321  24689999999999999999999963  589999999999999999999999999997653321


Q ss_pred             CCcceecccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGK------ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                         .....++..|+|||.+.+..      ++.++|||||||++|||++|+.||.........   .-+.         ..
T Consensus       158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~---------~~  222 (286)
T cd06622         158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLS---------AI  222 (286)
T ss_pred             ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHH---------HH
Confidence               22245788999999885543      478999999999999999999999754321111   0000         11


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+......+......+.+++.+|++.+|++||++.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         223 VDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             hhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1111112233456778899999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.3e-36  Score=305.42  Aligned_cols=250  Identities=25%  Similarity=0.439  Sum_probs=202.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch---------hhHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---------QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---------~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      +|.....||+|++|.||+|....++..+|+|.+.....         ...+.+..|+.++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36677899999999999999988889999998865321         223568899999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+++++|.+++..     ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||+
T Consensus        81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence            9999999999999999943     2458889999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCC-----cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          507 ARAYDHNINP-----QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       507 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      ++........     ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.........      ...  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~--  224 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI------FKI--  224 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH------HHH--
Confidence            9876532111     112235788999999998888999999999999999999999999754321110      000  


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          .....+.   .+......+..++.+||+.+|.+||++.+|+++
T Consensus       225 ----~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         225 ----GENASPE---IPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----hccCCCc---CCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                0111112   222345677889999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.4e-35  Score=306.37  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=206.1

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++|+||+++++++......++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999998889999999987543 455678899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++..      ..+++.+...++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06640          85 GGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence            99999998843      347888999999999999999999   899999999999999999999999999998664432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       .......++..|+|||.+.+..++.++|||||||++|||++|+.|+..........       ....     ..   ..
T Consensus       156 -~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~-----~~---~~  219 (277)
T cd06640         156 -IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPK-----NN---PP  219 (277)
T ss_pred             -cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhc-----CC---CC
Confidence             12233467889999999988889999999999999999999999987543221110       0000     00   12


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .........+.+++.+||+.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            2334566778899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.4e-36  Score=303.58  Aligned_cols=249  Identities=28%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             ceeeeeCceEEEEEEeCC-CC--cEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPS-TG--LEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~-~g--~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|++|.||+|.+.. .+  ..||+|.+..... ...+.+..|+..+++++|+||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999854 33  3699999987655 667789999999999999999999999988 889999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|.+++.+..   ...++|...+.++.|+++||+|||+   .+++|+||||+||+++.++.+||+|||+++........
T Consensus        80 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDA---LGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhcc---cccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            99999996542   1468999999999999999999999   89999999999999999999999999999876543221


Q ss_pred             --cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          517 --QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       517 --~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                        ......++..|+|||++.+..++.++|||||||++|||++ |+.||.......   +...+..   ..       ...
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~-------~~~  220 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EG-------ERL  220 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cC-------CcC
Confidence              1112456789999999988889999999999999999998 999986443221   1111110   00       011


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                       ..+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       221 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 -ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             -CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence             112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-36  Score=311.37  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=205.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC----CCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEec--cCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS----TGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~----~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~  427 (662)
                      +.|+..+.||+|+||.||++....    ++..+|||.+...... ..++|.+|++.+++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            346677899999999999998743    3788999999766443 56789999999999999999999999987  5578


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++...    ...+++..++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus        84 ~lv~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH----RDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC----ccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence            9999999999999999654    2359999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh---------HHHHHHH
Q 040242          508 RAYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME---------LVLVDWV  576 (662)
Q Consensus       508 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~  576 (662)
                      .........  ......++..|++||.+.+..++.++||||||++++||++|+.|+........         .....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL  236 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence            876533221  11123455679999999888899999999999999999999999764322110         0011111


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      . ....+.       . ...+......+.+++.+||+.+|++||+|.||+++|++.
T Consensus       237 ~-~~~~~~-------~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 E-LLKEGE-------R-LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             H-HHHcCC-------c-CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1 111100       0 011223346788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.8e-37  Score=307.30  Aligned_cols=263  Identities=27%  Similarity=0.335  Sum_probs=201.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC-----eeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----ELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~l  429 (662)
                      -.|...+++|.|+||.||+|+...+++.||||+.-.+.+..    -.|+++|+++.|||||+++-++....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k----nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK----NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC----cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            34666899999999999999999899999999986554322    36899999999999999998885432     3578


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeeccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLAR  508 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~  508 (662)
                      ||||||. +|.+.++.... .+..++.-.+.-...||.+||.|||+   .+|+||||||+|+|+|.+ +.+||||||.|+
T Consensus       100 VleymP~-tL~~~~r~~~~-~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTR-ANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHhchH-HHHHHHHHHhh-cCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            9999965 88888864211 13456667777889999999999999   899999999999999987 899999999999


Q ss_pred             cccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc-----
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ-----  582 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~-----  582 (662)
                      ....+...  ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.....+..++--+-.....     
T Consensus       175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            88765433  23345889999998765 46999999999999999999999999886655554432222111111     


Q ss_pred             --CccccccCCCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 --GQITRAIDPTLD------YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 --~~~~~~id~~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .+..+...|.+.      -.......+.++++.+++..+|.+|.++.|++.+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence              111122223331      1334456778899999999999999999999974

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.7e-35  Score=303.71  Aligned_cols=251  Identities=26%  Similarity=0.420  Sum_probs=198.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEecc--Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  427 (662)
                      .+|+..+.||+|+||.||++....++..|++|++...     ..+..+.+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688899999999999999999888999999988643     223456788999999999999999999988653  568


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++++||+++++|.+++...     ..+++...+.++.|+++||.|||+   .+++||||+|+||+++.++.+||+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence            8999999999999998532     347899999999999999999998   89999999999999999999999999999


Q ss_pred             ccccCCC--CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNI--NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +......  ........++..|+|||.+.+..++.++|||||||++|||++|+.||........      +....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~-----  222 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIA-----  222 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHh-----
Confidence            8654321  1112234578999999999888899999999999999999999999975432211      11110     


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....+.+   +....+.+..++ .||..+|++||+++||+++
T Consensus       223 ~~~~~~~~---~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         223 TQPTNPQL---PSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             cCCCCCCC---chhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            01112222   222334455555 6888999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-35  Score=318.64  Aligned_cols=194  Identities=23%  Similarity=0.309  Sum_probs=168.0

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ...+|+..+.||+|+||.||+|....++..||+|.....      ....|+.++++++|+||+++++++...+..++|+|
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  137 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP  137 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence            446799999999999999999999888899999975433      23568999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+ .++|.+++...    ...+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       138 ~~-~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        138 HY-SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             cc-CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            99 56888887543    3568999999999999999999999   8999999999999999999999999999975332


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      .  .......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence            1  22234568999999999998899999999999999999998666553

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-35  Score=308.21  Aligned_cols=262  Identities=25%  Similarity=0.325  Sum_probs=206.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+|.+..+|..|++|++....  ....+.+.+|+.++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4777899999999999999998889999999987653  33456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      + +++|.+++...    ...+++.+++.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDE----ERPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 99999998644    2568999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---------  583 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---------  583 (662)
                      .........++..|+|||.+.+. .++.++||||+||+++||++|+.||........   ..++.......         
T Consensus       153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhcc
Confidence            32223345789999999988654 468999999999999999999877765432211   11111111100         


Q ss_pred             ---ccccccCCC-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 ---QITRAIDPT-----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ---~~~~~id~~-----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         +......+.     +....++....+.+++.+|++.+|.+||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               000000000     011112334778999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.8e-36  Score=305.85  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=191.8

Q ss_pred             eeeeeCceEEEEEEeCC--CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          362 LVGSGGFGKVYRGVIPS--TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .||+|+||.||+|....  ....+++|.+.... ......|.+|+..++.++|+||++++++|......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            58999999999997532  34578899876543 3445678999999999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-Cc
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQ  517 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~  517 (662)
                      |.+++...........++.....++.||+.||+|||+   .+|+||||||+||+++.++.+||+|||+++....... ..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976543223446788889999999999999999   8999999999999999999999999999875432211 11


Q ss_pred             ceecccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          518 TTHIVGTLGYLAPELTRT-------GKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .....++..|+|||++..       ...+.++|||||||++|||++ |..||.......  .+.    .....+ .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~----~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK----QVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH----HHhhcc-CccCC
Confidence            122345778999998642       356889999999999999999 778886543221  111    111111 11111


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ++.+   .......+..++..|+ .||++||++++|++.|.
T Consensus       232 ~~~~---~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL---DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc---cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2222   2234455666777888 59999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3.3e-36  Score=307.63  Aligned_cols=241  Identities=27%  Similarity=0.433  Sum_probs=192.3

Q ss_pred             ceeeeeCceEEEEEEeCCCCc-------EEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          361 NLVGSGGFGKVYRGVIPSTGL-------EVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~-------~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +.||+|+||.||+|.....+.       .|++|.+........+.+.+|+.+++.++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            469999999999998855443       4888988766556667889999999999999999999999998999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC--------eEEeecc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN--------PKLGDFG  505 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~kL~DfG  505 (662)
                      +++|+|.+++...    ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.++.        ++++|||
T Consensus        81 ~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecccc
Confidence            9999999999654    2368899999999999999999999   89999999999999988765        5899999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCC-CCCCcccchhhHHHHHHHHHHhhcC
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGR-RPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ++.....     .....++..|+|||++.+. .++.++|||||||++|||++|. .|+..........       .... 
T Consensus       154 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------~~~~-  220 (258)
T cd05078         154 ISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------FYED-  220 (258)
T ss_pred             cccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-------HHHc-
Confidence            8875432     1224578899999998764 5789999999999999999995 5554332221111       0110 


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                            ...   .+......+.+++.+||+.+|++||+++++++.|+
T Consensus       221 ------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ------RHQ---LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ------ccc---CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  011   11122356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.8e-36  Score=317.78  Aligned_cols=261  Identities=23%  Similarity=0.365  Sum_probs=201.4

Q ss_pred             cCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEecc-Ce
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ-DE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~-~~  426 (662)
                      ++|+..+.||+|+||.||+|..     ..+++.||||++.... ......+.+|+.++.++ +|+||++++++|... ..
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~   86 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   86 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence            5788899999999999999984     2356789999997543 33456788999999999 689999999988654 46


Q ss_pred             eeEEEeccCCCCcchhccccccc---------------------------------------------------------
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ---------------------------------------------------------  449 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~---------------------------------------------------------  449 (662)
                      .++||||+++|+|.+++......                                                         
T Consensus        87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T cd05103          87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA  166 (343)
T ss_pred             eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence            79999999999999998642100                                                         


Q ss_pred             -----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-Ccceeccc
Q 040242          450 -----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVG  523 (662)
Q Consensus       450 -----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~g  523 (662)
                           ....++|.++..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++....... .......+
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                 01347889999999999999999999   8999999999999999999999999999986532211 11122345


Q ss_pred             CCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHH
Q 040242          524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAE  602 (662)
Q Consensus       524 t~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~  602 (662)
                      +..|+|||.+.+..++.++||||||+++|||++ |..|+........  +.    .....+..     ....   .....
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~-----~~~~---~~~~~  309 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTR-----MRAP---DYTTP  309 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCC-----CCCC---CCCCH
Confidence            678999999988889999999999999999997 8889865432211  11    11111111     0111   11234


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          603 LVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       603 ~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+.+++..||+.+|++||++.||+++|+..
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            578899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-35  Score=302.12  Aligned_cols=249  Identities=28%  Similarity=0.438  Sum_probs=203.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-----hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-----RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-----~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      +|+..+.||+|++|.||+|....++..|++|.+....     .+..+.+.+|+.++++++|+||+++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            4667889999999999999998789999999986543     33567889999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...     ..+++..++.++.|+++||.|||+   .+++|+||+|+||+++.++.+||+|||++...
T Consensus        81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999998532     358899999999999999999999   89999999999999999999999999998865


Q ss_pred             cCCCCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ....  ......++..|++||.+.... ++.++|+|||||++|+|++|+.||.......      .........      
T Consensus       153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~------  218 (258)
T cd06632         153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSK------  218 (258)
T ss_pred             cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcc------
Confidence            4332  223456889999999987766 8999999999999999999999997543211      111110000      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .....+......+.+++++||+.+|.+||++.+++++
T Consensus       219 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         219 --ELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             --cCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence              1111222345667889999999999999999999863

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.2e-35  Score=305.38  Aligned_cols=255  Identities=26%  Similarity=0.396  Sum_probs=203.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...+.||+|+||.||+|.....   ...|+||...... ....+.+.+|+.++++++||||+++++++.. +..++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            4577789999999999999987543   3468999887654 4556789999999999999999999999875 557899


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          85 MELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeec
Confidence            9999999999999543    2358999999999999999999998   89999999999999999999999999999866


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ............++..|+|||.+....++.++||||||+++|||++ |..||........   ..++.    .+...   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~----~~~~~---  227 (270)
T cd05056         158 EDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE----NGERL---  227 (270)
T ss_pred             ccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH----cCCcC---
Confidence            5432222222334578999999988889999999999999999986 9999975543211   11111    11100   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .   .....+..+.+++.+|+..+|++||++.++++.|...
T Consensus       228 --~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         228 --P---MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             --C---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              1   1123345788899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1e-35  Score=309.42  Aligned_cols=265  Identities=25%  Similarity=0.315  Sum_probs=209.1

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEec
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK  423 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~  423 (662)
                      +.+.++..++++|+..+.||+|+||.||++....+++.+|+|++.... ....++.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            556777788999999999999999999999998899999999986542 2245677899999998 89999999999865


Q ss_pred             c-----CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          424 Q-----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       424 ~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      .     +..++||||+++++|.+++..... ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCC
Confidence            4     358999999999999998864321 13568999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      +||+|||++........ ......|+..|+|||.+...     .++.++|||||||++|||++|+.||........  +.
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~  243 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LF  243 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HH
Confidence            99999999886543221 12234688999999987543     368899999999999999999999975432211  11


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.     .+.     .+.+. ........+..++.+|++.+|++||++.|++++
T Consensus       244 ~~~-----~~~-----~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         244 KIP-----RNP-----PPTLL-HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHh-----cCC-----CCCCC-cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111     011     01111 112234568899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=3.6e-36  Score=322.98  Aligned_cols=253  Identities=23%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||++....+++.||||++....   ......+..|+.++.+++|+||+++++++...+..++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999998899999999997542   334567888999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...     ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999998543     458899999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCC----------------------------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC
Q 040242          512 HNIN----------------------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG  557 (662)
Q Consensus       512 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG  557 (662)
                      ....                                  .......||+.|+|||++.+..++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            2100                                  001234699999999999988999999999999999999999


Q ss_pred             CCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 040242          558 RRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS---TRRVVQF  628 (662)
Q Consensus       558 ~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt---~~eVl~~  628 (662)
                      +.||.........      ...... ...-.+.+. ..    ....+.+++.+|+ .+|.+|++   +.|++++
T Consensus       233 ~~Pf~~~~~~~~~------~~i~~~-~~~~~~p~~-~~----~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         233 YPPFCSETPQETY------RKVMNW-KETLVFPPE-VP----ISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCCCHHHHH------HHHHcC-CCceecCCC-CC----CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            9999765432111      111100 000001111 11    2334555666665 49999985   6777764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-35  Score=308.51  Aligned_cols=262  Identities=25%  Similarity=0.350  Sum_probs=202.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-----hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-----GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      +|+..+.||+|++|.||+|....+++.|+||++......     ....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999999888999999999765322     345677899999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+ +++|.+++...    ...+++..++.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 99999999543    2368999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH-------hh-
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL-------HS-  581 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------~~-  581 (662)
                      ..... ......++..|+|||.+.+ ..++.++|||||||+++||++|..||..........  ......       +. 
T Consensus       153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  229 (298)
T cd07841         153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG--KIFEALGTPTEENWPG  229 (298)
T ss_pred             cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH--HHHHHcCCCchhhhhh
Confidence            54321 2223356788999998854 457899999999999999999987776543321111  000000       00 


Q ss_pred             cCcccccc------CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 QGQITRAI------DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~i------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........      ...+..........+.+++.+||+.+|++||++.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000      011111122345678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-35  Score=307.65  Aligned_cols=261  Identities=22%  Similarity=0.352  Sum_probs=206.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCC----CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec-cCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPS----TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~  427 (662)
                      .++|+..++||+|+||.||+|....    .+..|++|++... .....+.+.+|+.++++++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999864    2578999988654 33446778999999999999999999999876 4678


Q ss_pred             eEEEeccCCCCcchhccccccc---ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQ---KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ++++||+++++|.+++......   ....+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCC
Confidence            9999999999999998654321   12568999999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          505 GLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       505 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      |+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......   .+..++..    
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~----  234 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLKD----  234 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHHc----
Confidence            999865432211 1112345678999999988889999999999999999999 99999754321   12222211    


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.       .+. .....+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       235 ~~-------~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         235 GY-------RLA-QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             CC-------CCC-CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            10       010 1112345688999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=301.21  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=199.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ++||+|++|.||++.+.. ++.|++|.+..... ...+.+.+|++++++++|+||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999976 89999999876533 3567899999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcc-
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-  518 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-  518 (662)
                      .+++...    ...+++..++.++.+++++|.|||+   .+++||||||+||+++.++.+||+|||++........... 
T Consensus        80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            9998543    2357899999999999999999999   8999999999999999999999999999986543221111 


Q ss_pred             eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCC
Q 040242          519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFD  597 (662)
Q Consensus       519 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~  597 (662)
                      .....+..|+|||.+.++.++.++|||||||++|||++ |..||.......   ....+.    .+.       .+ ..+
T Consensus       153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~~----~~~-------~~-~~~  217 (251)
T cd05041         153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERIE----SGY-------RM-PAP  217 (251)
T ss_pred             ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHHh----cCC-------CC-CCC
Confidence            11234567999999988889999999999999999999 888886543221   111111    100       00 112


Q ss_pred             HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          598 PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       598 ~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ......+.+++.+|++.+|++||++.|+++.|.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-35  Score=303.04  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=207.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec--cCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~  431 (662)
                      +|+..+.||.|++|.||++....++..+|+|++...  .....+++..|+.++++++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477789999999999999999888999999998653  33445678899999999999999999998754  34689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC--CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC--DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||+++++|.+++..... ....+++.+++.++.|+++||.|||..+  ..+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            99999999999965321 2456899999999999999999999322  28999999999999999999999999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ...... ......+++.|+|||.+....++.++||||||+++++|++|+.||......   .+.+.+.    .+      
T Consensus       160 ~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~~----~~------  225 (265)
T cd08217         160 LGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKIK----EG------  225 (265)
T ss_pred             ccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHHh----cC------
Confidence            654332 122346899999999998888999999999999999999999999865421   1111111    11      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .....+......+.+++.+|++.+|++||++.+|+++
T Consensus       226 --~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         226 --KFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              1122333455778899999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.8e-36  Score=301.86  Aligned_cols=268  Identities=24%  Similarity=0.315  Sum_probs=206.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--hHHHHHHHHHHhhcccccc-ceeeeeeEeccC------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRN-LVQLHGWCRKQD------  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--~~~~f~~Ei~~l~~l~H~n-iv~l~~~~~~~~------  425 (662)
                      ..|...++||+|.||+||+|+.+.+|+.||+|++....++  ......+|+.++++++|+| ||++.+++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            3456677899999999999999999999999999776442  3345689999999999999 999999998877      


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      .+++|+||+ .-+|..++....... ..++...+..++.||++||.|||+   ++|+||||||+|||++++|.+||+|||
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccc
Confidence            789999999 669999996654211 356668899999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      +|+.+.-... ..+..++|..|.|||++.+. .++...||||+|||+.||++++..|.+..+..+...+-.+.....+..
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~  244 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD  244 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence            9997764432 24456789999999988766 689999999999999999999999987765433322111111111110


Q ss_pred             ccc---ccCC--CC------CCCCHH---HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITR---AIDP--TL------DYFDPQ---EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~---~id~--~l------~~~~~~---~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .-.   .-+-  ..      ......   ......+++.+|++.+|.+|.+++.++++
T Consensus       245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            000   0010  01      011111   11367889999999999999999999985

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-35  Score=306.55  Aligned_cols=257  Identities=25%  Similarity=0.383  Sum_probs=205.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .+|+..+.||+|+||.||+|..+.+|.    .+|+|.+.... .....++.+|+..+++++|+||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            457778999999999999999866554    58999886653 3455788999999999999999999999987 78899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++...    ...+++..++.++.|++.||+|||+   .+++||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCccccc
Confidence            99999999999999654    3458999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCcc-eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINPQT-THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ......... ....++..|+|||.+....++.++||||||+++||+++ |+.||.......   +...+    ..+..  
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~--  229 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLL----EKGER--  229 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----hCCCC--
Confidence            653322111 11223568999999988889999999999999999998 999987543221   11111    11110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                            ...+......+.+++.+||..+|.+||++.++++.|.....
T Consensus       230 ------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 ------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             ------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                  01111233467888999999999999999999999987533

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.5e-35  Score=305.37  Aligned_cols=260  Identities=23%  Similarity=0.362  Sum_probs=206.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||.||+|..+.     ....|++|.+...... ..+++.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            568888999999999999999743     3467999988665443 5678999999999999999999999999989999


Q ss_pred             EEEeccCCCCcchhcccccccc----cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQK----KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      +||||+++++|.+++.......    ...+++..++.++.|+++||+|||+   .+++||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            9999999999999996543110    1268999999999999999999998   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      |+++..............++..|+|||.+.+...+.++||||||+++|||++ |..||......   ......    ..+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~~~~~----~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EVLNRL----QAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HHHHHH----HcC
Confidence            9987543322222333456788999999988888999999999999999999 77888643221   111111    111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ....       ......+..+.+++.+||+.+|++||++.|+++.|.+
T Consensus       235 ~~~~-------~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 KLEL-------PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             CcCC-------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            1110       1112344678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=309.28  Aligned_cols=252  Identities=26%  Similarity=0.345  Sum_probs=203.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|++|.||++....++..||+|.+.....   ...+.+..|++++++++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            368888999999999999999988899999999976532   34567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++....   ...+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999986432   3568999999999999999999999   899999999999999999999999999987653


Q ss_pred             CCCCC----------------------------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 040242          512 HNINP----------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP  563 (662)
Q Consensus       512 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  563 (662)
                      .....                            ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            32110                            11123678899999999888899999999999999999999999975


Q ss_pred             ccchhhHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 040242          564 QRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPS----TRRVVQ  627 (662)
Q Consensus       564 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt----~~eVl~  627 (662)
                      ......  +.    .         ...... ..........+.+++.+|++.+|++||+    +.|+++
T Consensus       235 ~~~~~~--~~----~---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         235 SNRDET--FS----N---------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CchHHH--HH----H---------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            433211  10    0         011111 0011125677899999999999999999    555554

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.4e-35  Score=310.41  Aligned_cols=260  Identities=25%  Similarity=0.396  Sum_probs=204.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-------CCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-------STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      .+|...+.||+|+||.||++...       .....+|+|.+... ......++..|+.+++++ +||||++++++|...+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            56778899999999999999753       23457999998754 334456789999999999 6999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..+++|||+++|+|.+++.....           .....++|.++.+++.|++.||.|||+   .+++||||||+||+++
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill~  168 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVT  168 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEEc
Confidence            99999999999999999965321           112458999999999999999999998   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |..||.......   +
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~  245 (314)
T cd05099         169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE---L  245 (314)
T ss_pred             CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999986543211 11112234567999999988889999999999999999999 888886543211   1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ...+    ..+..        ...+......+.+++.+|++.+|++||++.++++.|.+.
T Consensus       246 ~~~~----~~~~~--------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         246 FKLL----REGHR--------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHH----HcCCC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            1111    11110        011223345677899999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2e-35  Score=300.72  Aligned_cols=250  Identities=23%  Similarity=0.378  Sum_probs=204.6

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||++....++..+|+|++...  .....+.+.+|+.++++++|||++++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            477889999999999999999889999999998654  234467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccccccC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYDH  512 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~  512 (662)
                      +++++|.+++....   ...+++..+..++.+++++|.|||+   .+++|+||+|+||+++++. .+||+|||++.....
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999996532   3458999999999999999999999   8999999999999998654 589999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ..  ......++..|+|||.+.+...+.++||||||+++|+|++|+.||.......   ....+   .. +.        
T Consensus       155 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~~-~~--------  217 (256)
T cd08220         155 KS--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---MS-GT--------  217 (256)
T ss_pred             Cc--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---Hh-cC--------
Confidence            32  2223467899999999988889999999999999999999999997543321   11111   10 00        


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...........+..++.+||+.+|++||+++|++++
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            111122245568899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-35  Score=302.75  Aligned_cols=239  Identities=27%  Similarity=0.452  Sum_probs=191.9

Q ss_pred             ceeeeeCceEEEEEEeCCCC----------cEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          361 NLVGSGGFGKVYRGVIPSTG----------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g----------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      +.||+|+||.||+|.+...+          ..+++|.+...... ...|.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999997655          35888887655433 6788999999999999999999999988 778999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-------CeEEee
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-------NPKLGD  503 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-------~~kL~D  503 (662)
                      |||+++|+|.+++....    ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++       .+||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCC
Confidence            99999999999996542    268899999999999999999998   8999999999999999888       799999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHh
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      ||++.....     .....++..|+|||++...  .++.++|||||||++|||++ |..|+.........   .+.    
T Consensus       152 fg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~----  219 (259)
T cd05037         152 PGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFY----  219 (259)
T ss_pred             CCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHH----
Confidence            999986543     2223567789999998776  78999999999999999999 56777544321111   111    


Q ss_pred             hcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          581 SQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       581 ~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ....       ...   ......+.+++.+||..+|++||++.+|++.|.
T Consensus       220 ~~~~-------~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QDQH-------RLP---MPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hcCC-------CCC---CCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            0000       010   011167889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=307.99  Aligned_cols=266  Identities=27%  Similarity=0.369  Sum_probs=206.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|++|.||+|.+..+++.|++|++...  .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688899999999999999999888999999988653  23345778999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++++.|..++..     ...+++.+++.++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            9998777766532     3458899999999999999999999   8999999999999999999999999999987665


Q ss_pred             CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH--------Hhh-c
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE--------LHS-Q  582 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~--------~~~-~  582 (662)
                      ..........++..|+|||++.+. .++.++||||||+++|||++|+.||.................        .+. .
T Consensus       153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07833         153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN  232 (288)
T ss_pred             CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence            433233345678899999999887 789999999999999999999999875433221111100000        000 0


Q ss_pred             Ccc-----ccccCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 GQI-----TRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~~~-----~~~id~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...     .+..++..  ..++......+.+++++||+.+|++||++++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence            000     00000000  01122236778999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.6e-35  Score=301.43  Aligned_cols=252  Identities=27%  Similarity=0.499  Sum_probs=203.7

Q ss_pred             CcccceeeeeCceEEEEEEeCCCC----cEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g----~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      |+..+.||.|+||.||++.....+    ..||+|.+...... ..+.+..|+..+.+++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            345688999999999999997655    88999999765433 5678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++....   ...+++.+++.++.|++.||+|||+   .+++|+||||+||+++.++.++|+|||+++...
T Consensus        81 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNR---PKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhh---hccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            9999999999996542   2228999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...........++..|+|||.+....++.++||||+|++++||++ |+.||......   .+...+.    .+..     
T Consensus       155 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~----~~~~-----  222 (258)
T smart00219      155 DDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYLK----KGYR-----  222 (258)
T ss_pred             cccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHh----cCCC-----
Confidence            442222212346789999999988889999999999999999998 77887653221   1111111    1110     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                         ..........+.+++.+|+..+|++|||+.|+++.|
T Consensus       223 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 ---LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ---CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence               011122456688899999999999999999999865

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.5e-35  Score=306.89  Aligned_cols=265  Identities=27%  Similarity=0.338  Sum_probs=203.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|++|.||+|++..+++.||+|++....  ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999998889999999986542  2234567899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++++.|..++..     ...+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            9999988887643     2358999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH-HHHH----H---HHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL-VDWV----R---ELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~----~---~~~~~~  583 (662)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.... ....    .   ..+...
T Consensus       153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07847         153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN  231 (286)
T ss_pred             Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence            321 2223457889999998865 4578999999999999999999999975543222111 0000    0   000000


Q ss_pred             ccc-cccCCCCC-CC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QIT-RAIDPTLD-YF-----DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~-~~id~~l~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ... ....+... ..     .......+.+++.+||+.+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            000 00001110 00     11234668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=9.1e-36  Score=305.81  Aligned_cols=252  Identities=29%  Similarity=0.461  Sum_probs=200.0

Q ss_pred             ceeeeeCceEEEEEEeCCCC------cEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          361 NLVGSGGFGKVYRGVIPSTG------LEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +.||+|+||.||+|+.....      ..+++|.+.... .....++.+|+.++++++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            46999999999999985433      679999886543 34467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhccccccc--ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-----CeEEeeccc
Q 040242          434 VPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-----NPKLGDFGL  506 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~DfGl  506 (662)
                      +++++|.+++......  ....+++.+++.++.|++.||.|||+   .+++|+||||+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999654321  13458899999999999999999998   8999999999999999887     899999999


Q ss_pred             cccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......   .....+.    .+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~~----~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHVT----AGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHHh----cCC
Confidence            976533211 11122345688999999998999999999999999999998 99998644321   1111111    000


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                             . .......+..+.+++.+||..+|++||++.+|++.|.
T Consensus       231 -------~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------R-LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------c-cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   0 1112234567889999999999999999999999986

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.8e-35  Score=301.39  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=208.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||.|++|+||+|....++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999998889999999986542 33567889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++.....  ...+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999965321  2468999999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCC---cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          514 INP---QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       514 ~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ...   ......|+..|+|||++... .++.++|+|||||++|||++|+.||.......  .+.....          ..
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~~----------~~  223 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTLQ----------ND  223 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHhc----------CC
Confidence            222   12334688999999998776 78999999999999999999999997543221  1111111          11


Q ss_pred             CCCCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYF--DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.+...  .......+.+++.+|++.||++||++.+++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            1122111  12445678899999999999999999999874

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.4e-35  Score=302.81  Aligned_cols=256  Identities=25%  Similarity=0.429  Sum_probs=203.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCC-CCcEEEEEEeecc----------chhhHHHHHHHHHHhhc-cccccceeeeeeEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHN----------SRQGMKEFVAEITSMGR-LRHRNLVQLHGWCRK  423 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~-l~H~niv~l~~~~~~  423 (662)
                      +|+..+.||+|+||.||+|.... .+..+|+|.+...          ......++..|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47778899999999999999976 6788999987532          22334567889988875 799999999999999


Q ss_pred             cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      ++..+++|||+++++|.+++..... ....+++..++.++.|++.||.|||+.  .+++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999998854221 135688999999999999999999962  6799999999999999999999999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ||++.......  ......|+..|+|||.+.++.++.++||||||+++|||++|+.||........      .... .++
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~-~~~  228 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKI-VEA  228 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHH-hhc
Confidence            99998765432  33345688999999999988899999999999999999999999865432211      1111 111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ..    .+..   .......+.+++.+||+.||++||++.||..+++
T Consensus       229 ~~----~~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         229 VY----EPLP---EGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             cC----CcCC---cccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11    0111   1123456888999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.1e-35  Score=300.64  Aligned_cols=252  Identities=29%  Similarity=0.497  Sum_probs=204.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+|....++..|++|.+.....  ...+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47788999999999999999988899999999876544  3677899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...     ..+++..+..++.+++.||.|||+   .+++|+||+|+||++++++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999998542     347889999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcc---eecccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          514 INPQT---THIVGTLGYLAPELTRTGK---ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       514 ~~~~~---~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .....   ....++..|+|||++....   .+.++||||||++++||++|+.||..........  ..+.         .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~--~~~~---------~  221 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM--FHVG---------A  221 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH--HHHh---------c
Confidence            22211   1346788999999988766   8899999999999999999999997543221110  0000         0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ...+.+.. .......+.+++.+||+.+|.+||++.++++
T Consensus       222 ~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 GHKPPIPD-SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCCCCc-ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111211 1122556778999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.7e-36  Score=291.19  Aligned_cols=252  Identities=24%  Similarity=0.365  Sum_probs=207.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      +.|...+.||.|..+.|-++..+.+|...|+|++....        .+-.+.-..|+.+|+++ -||+|+++.+.++.+.
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            45777889999999999999999999999999985431        22244567899999998 6999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++|+|.|+.|.|.++|..     .-.++++...+|++|+.+|+.|||.   ..|+||||||+|||++++.++||+|||
T Consensus        97 F~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFG  168 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFG  168 (411)
T ss_pred             hhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccc
Confidence            99999999999999999943     4579999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      .++.+..+.  .....+||++|+|||.+..      ..|+...|+|++||++|.|+.|.+||........       -.+
T Consensus       169 Fa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM-------LR~  239 (411)
T KOG0599|consen  169 FACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM-------LRM  239 (411)
T ss_pred             eeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH-------HHH
Confidence            999877653  4556799999999998753      3578899999999999999999999986543211       111


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+|+. +.-.    ..-.+......+|+.+||+.||.+|-|.+|++.+
T Consensus       240 ImeGky-qF~s----peWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  240 IMEGKY-QFRS----PEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             HHhccc-ccCC----cchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            122221 1111    1123445667899999999999999999999973

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.6e-35  Score=310.21  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=202.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|+||.||+|.+..++.    .||+|.+.... .....++.+|+.++++++||||++++++|... ..++
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            457778999999999999999866665    47889886543 23345788999999999999999999999754 4679


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+++|+|.+++...    ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccc
Confidence            99999999999998643    3458899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......++..|+|||.+.+..++.++|||||||++|||++ |+.||......   ...+++.    .+.   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~---  228 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDLLE----KGE---  228 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH----CCC---
Confidence            6533221 1222345678999999988889999999999999999997 88998654321   1222221    111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                          .+ .........+..++..||..+|++||++.++++.|....
T Consensus       229 ----~~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~  269 (303)
T cd05110         229 ----RL-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMA  269 (303)
T ss_pred             ----CC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                01 001123356788999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.8e-35  Score=339.99  Aligned_cols=258  Identities=22%  Similarity=0.352  Sum_probs=202.3

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec--cCee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDEL  427 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~  427 (662)
                      ...++|.+.+.||+|+||+||++.+..++..||+|.+...  .......|..|+.++.+|+||||+++++++..  ...+
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l   89 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL   89 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence            3456899999999999999999999989999999998653  33445678999999999999999999998754  3568


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC----CCCEEeCCcCCCceEeCCC-------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC----DQRVVHRDVKPSNVLIDAD-------  496 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivH~Dlkp~NIll~~~-------  496 (662)
                      ++||||+++|+|.++|..... ....+++..++.|+.||+.||.|||+..    ..+|+||||||+||||+.+       
T Consensus        90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            999999999999999964321 1346999999999999999999999842    1459999999999999643       


Q ss_pred             ----------CCeEEeeccccccccCCCCCcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          497 ----------LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       497 ----------~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                                ..+||+|||++.......  ......||+.|+|||++.+  ..++.++|||||||+||||++|+.||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                      348999999998654321  2234578999999998854  45889999999999999999999999754


Q ss_pred             cchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          565 RTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       565 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .....     .+... ..+       +.+.  .......+.+|+..||+.+|.+||++.|+++
T Consensus       247 ~~~~q-----li~~l-k~~-------p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        247 NNFSQ-----LISEL-KRG-------PDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcHHH-----HHHHH-hcC-------CCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            33211     11111 111       1110  0122456888999999999999999999995

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-35  Score=306.28  Aligned_cols=262  Identities=27%  Similarity=0.396  Sum_probs=208.1

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEec
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK  423 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~  423 (662)
                      .++.++..+.+.|+..+.||+|+||.||+|....+++.+|+|.+.... ....++..|+.++.++ +|+||+++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            466777778899999999999999999999998889999999986553 3345688899999998 69999999999853


Q ss_pred             ------cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC
Q 040242          424 ------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL  497 (662)
Q Consensus       424 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~  497 (662)
                            ....+++|||+++|+|.+++....   ...+++..+..++.|+++||.|||+   .+++|+||+|+||++++++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~  158 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA  158 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence                  457899999999999999986432   3457888899999999999999999   8999999999999999999


Q ss_pred             CeEEeeccccccccCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH
Q 040242          498 NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL  572 (662)
Q Consensus       498 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  572 (662)
                      .++|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||.......... 
T Consensus       159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~-  236 (282)
T cd06636         159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF-  236 (282)
T ss_pred             CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-
Confidence            999999999886543221 223356889999999875     3457889999999999999999999996543221111 


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           .      ......+.+  ........+.+++.+||+.||.+||++.|++++
T Consensus       237 -----~------~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         237 -----L------IPRNPPPKL--KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             -----h------HhhCCCCCC--cccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                 0      001111111  112244578899999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-35  Score=308.57  Aligned_cols=247  Identities=24%  Similarity=0.391  Sum_probs=202.6

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      ....||+|+||.||++....++..||||++........+.+.+|+..+++++|+||+++++.+...+..++||||+++++
T Consensus        26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~  105 (292)
T cd06658          26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA  105 (292)
T ss_pred             hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence            34679999999999999988899999999977666666788999999999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcc
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT  518 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~  518 (662)
                      |.+++..      ..+++.++..++.||+.||.|||+   .+++||||||+||++++++.++|+|||++....... ...
T Consensus       106 L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         106 LTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence            9998842      347899999999999999999999   899999999999999999999999999987654322 222


Q ss_pred             eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCH
Q 040242          519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP  598 (662)
Q Consensus       519 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  598 (662)
                      ....|+..|+|||.+.+..++.++||||||+++|||++|+.||..........   -+         ...+.+.+.. ..
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~---~~---------~~~~~~~~~~-~~  242 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR---RI---------RDNLPPRVKD-SH  242 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---------HhcCCCcccc-cc
Confidence            33568899999999988889999999999999999999999997543221110   01         1111222211 11


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          599 QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       599 ~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....+..++.+|++.||.+||++++++++
T Consensus       243 ~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         243 KVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            234467788899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.8e-35  Score=300.05  Aligned_cols=251  Identities=24%  Similarity=0.384  Sum_probs=199.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEecc--Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  427 (662)
                      ++|+..++||+|+||.||+|....++..||||.+...     .....+.+.+|+.++++++|+||+++++++...  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4688899999999999999999888999999988542     123456788999999999999999999988664  467


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      +++|||+++++|.+++...     ..+++...++++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence            8999999999999998532     347888899999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +.......  .......++..|+|||.+.+..++.++|||||||++|||++|+.||.........      ....     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~-----  222 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIA-----  222 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH------HHHh-----
Confidence            86543211  1122345889999999998888999999999999999999999999754322111      0100     


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         ..+.....+......+..++.+|+. +|++||++++|+++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         223 ---TQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---cCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               0111112234455667788888984 99999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-35  Score=324.23  Aligned_cols=261  Identities=21%  Similarity=0.221  Sum_probs=198.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ..+|...+.||+|+||.||++.+...++.||||....      ..+.+|+.++++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            3578889999999999999999998899999996432      3456899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      + .++|..++...    ...++|.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       242 ~-~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        242 Y-RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             c-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            9 57888887543    3469999999999999999999999   89999999999999999999999999999865433


Q ss_pred             CCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch-----hhHHHHHHHHHHhhc-Cccc
Q 040242          514 INP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA-----MELVLVDWVRELHSQ-GQIT  586 (662)
Q Consensus       514 ~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-----~~~~l~~~~~~~~~~-~~~~  586 (662)
                      ... ......||..|+|||++.+..++.++|||||||+||||++|..|+......     ....+...+...-.. ....
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            211 222356999999999999889999999999999999999988765422110     111111111111000 0000


Q ss_pred             cc----------------cCCCC-C-CC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          587 RA----------------IDPTL-D-YF--DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~----------------id~~l-~-~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..                ..+.. . ..  .......+.+|+.+||+.||.+|||+.|++++
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00                00000 0 00  00122357789999999999999999999975

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.7e-36  Score=308.45  Aligned_cols=265  Identities=29%  Similarity=0.408  Sum_probs=203.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..++||+|++|.||+|.+..+++.||+|++....  ....+.+.+|++++++++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            46788899999999999999998889999999886542  2235678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|..+...     ...++|.++..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            9999999887643     2348999999999999999999999   8999999999999999999999999999987644


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHHH-------HHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVR-------ELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~-------~~~~~~  583 (662)
                      .. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.......... +..+..       ..+...
T Consensus       153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            32 22233457899999998865 347889999999999999999999987543221111 111100       000000


Q ss_pred             ccc-cccCCCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QIT-RAIDPTLD------YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~-~~id~~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ... ....+...      ...+.....+.+++.+||+.+|++||++.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence            000 00011110      0112335678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3e-35  Score=311.52  Aligned_cols=262  Identities=21%  Similarity=0.263  Sum_probs=196.6

Q ss_pred             ccceeeee--CceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          359 EKNLVGSG--GFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       359 ~~~~LG~G--~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ..++||+|  +|++||++....+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35789999  78999999999999999999996542  333456778999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++....   ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.++++||+.........
T Consensus        82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            9999999985432   3458999999999999999999999   899999999999999999999999998654332111


Q ss_pred             C------CcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh-----
Q 040242          515 N------PQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS-----  581 (662)
Q Consensus       515 ~------~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~-----  581 (662)
                      .      .......++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  ...........     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~  233 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHHhcCCccccccc
Confidence            0      01112346778999999875  358899999999999999999999997532211  11000000000     


Q ss_pred             ---------cCccccccCCCC------------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 ---------QGQITRAIDPTL------------------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ---------~~~~~~~id~~l------------------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                               ........+...                  ..........+.+++.+||+.||++|||+.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                     000000000000                  01122334578899999999999999999999973

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.6e-35  Score=306.67  Aligned_cols=263  Identities=27%  Similarity=0.371  Sum_probs=201.1

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+|+...++..||||++....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788899999999999999998889999999886542  22345788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +. ++|.+++....   ...+++.++..++.|+++||+|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            95 68888886543   3568999999999999999999999   89999999999999999999999999998865433


Q ss_pred             CCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc----------
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ----------  582 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~----------  582 (662)
                      .. ......++..|+|||.+.+.. ++.++|||||||++|||+||+.||........  +.......-..          
T Consensus       154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07860         154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTS  230 (284)
T ss_pred             cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhH
Confidence            21 122335688999999876544 68899999999999999999999975432211  11111100000          


Q ss_pred             -----CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 -----GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 -----~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ....+.....+....+.....+.+++.+|++.||++||++++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         231 LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                 0000000001101111223456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.7e-35  Score=306.84  Aligned_cols=256  Identities=23%  Similarity=0.277  Sum_probs=203.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||++.....++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            36888999999999999999999889999999987653   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...     ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus        81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            999999999999542     458899999999999999999999   899999999999999999999999999987421


Q ss_pred             CCCC--------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          512 HNIN--------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       512 ~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ....              .......++..|+|||.+.+..++.++|||||||++|||++|+.||.......      +..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~  226 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFG  226 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence            1100              01112357889999999988889999999999999999999999997543221      111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .... +   ....+..   .......+.+++.+||+.+|++||++.++.+.|+.
T Consensus       227 ~~~~-~---~~~~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         227 QVIS-D---DIEWPEG---DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHHh-c---ccCCCCc---cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            1110 0   0011111   11244567899999999999999997666665554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.3e-35  Score=302.30  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=201.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch----------hhHHHHHHHHHHhhccccccceeeeeeEeccC
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR----------QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD  425 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~----------~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~  425 (662)
                      +|...+.||+|++|.||+|....+++.||+|.+.....          ...+.+..|+.++++++|+|++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            35667899999999999999988899999998854211          12346788999999999999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||+++++|.+++...     ..+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence            999999999999999998543     458899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCC-cceecccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          506 LARAYDHNINP-QTTHIVGTLGYLAPELTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       506 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      +++........ ......++..|+|||.+....  ++.++||||||+++|||++|+.|+........      ..+....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~  227 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGNK  227 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhcc
Confidence            99865432211 123346889999999887654  78999999999999999999999864332111      1111111


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .....+.+   .........+.+++.+|++.+|++||++.+|+++
T Consensus       228 -~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         228 -RSAPPIPP---DVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -ccCCcCCc---cccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence             11111111   1222345678889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.3e-35  Score=310.82  Aligned_cols=199  Identities=25%  Similarity=0.403  Sum_probs=161.9

Q ss_pred             cceeeeeCceEEEEEEeC--CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec--cCeeeEEEeccC
Q 040242          360 KNLVGSGGFGKVYRGVIP--STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVP  435 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~--~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~  435 (662)
                      .++||+|+||+||+|+..  .++..||+|.+....  ....+.+|+.++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999975  356889999986542  23456789999999999999999998854  456899999995


Q ss_pred             CCCcchhcccccc----cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe----CCCCCeEEeecccc
Q 040242          436 NGSLDKLLFDNDQ----QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLA  507 (662)
Q Consensus       436 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla  507 (662)
                       ++|.+++.....    .+...+++.....++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             588877753221    112358899999999999999999999   899999999999999    45678999999999


Q ss_pred             ccccCCCCC--cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          508 RAYDHNINP--QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       508 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                      +........  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876543221  22345789999999988764 5889999999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=4.7e-35  Score=299.96  Aligned_cols=250  Identities=24%  Similarity=0.427  Sum_probs=200.6

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc------hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +|...+.||+|+||+||+|.. .++..+|+|.+....      ....+.+.+|+.++++++|+||++++++|...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            467788999999999999987 468899999886432      2334568899999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++.+.     ..+++..+..++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++..
T Consensus        80 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  151 (265)
T cd06631          80 FMEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARR  151 (265)
T ss_pred             EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHh
Confidence            99999999999999532     357899999999999999999998   8999999999999999999999999999886


Q ss_pred             ccCCC-----CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          510 YDHNI-----NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       510 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      .....     ........++..|+|||.+.+..++.++|||||||++|||++|+.||..........   ...   .   
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~---~~~---~---  222 (265)
T cd06631         152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIG---A---  222 (265)
T ss_pred             hhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH---Hhh---h---
Confidence            53211     111223468899999999988889999999999999999999999997543221110   000   0   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                       .....+.+   +......+..++++||+.+|++||++.++++
T Consensus       223 -~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         223 -HRGLMPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             -ccCCCCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence             00111122   2234566788999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-35  Score=300.65  Aligned_cols=248  Identities=27%  Similarity=0.451  Sum_probs=199.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||++..  +++.||+|.+....  ....+.+|+.++++++|||++++++++..+ ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578889999999999999976  67789999986543  345788999999999999999999998664 479999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++....   ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~  154 (254)
T cd05083          81 SKGNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV  154 (254)
T ss_pred             CCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC
Confidence            9999999996542   3458899999999999999999998   899999999999999999999999999987643221


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                          .....+..|+|||.+.++.++.++|||||||++|||++ |+.||.......   +..    ....+.   ..+   
T Consensus       155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~---~~~---  217 (254)
T cd05083         155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE----CVEKGY---RME---  217 (254)
T ss_pred             ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhCCC---CCC---
Confidence                12234578999999988889999999999999999997 999987543221   111    111111   011   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .....+..+.+++.+||+.+|++||++.++++.|+++
T Consensus       218 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  254 (254)
T cd05083         218 --PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEKE  254 (254)
T ss_pred             --CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHccC
Confidence              1123346678999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-35  Score=311.42  Aligned_cols=251  Identities=25%  Similarity=0.326  Sum_probs=212.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh---hHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~l  429 (662)
                      ...|+..+.||+|.||.||+++.+.+|+.+|+|.+.+....   ....+.+|+.+|+++. |||||++.+.++....+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            35677789999999999999999999999999999776432   3468899999999998 9999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC----CCeEEeecc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD----LNPKLGDFG  505 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfG  505 (662)
                      |||++.||.|.+.+...      .++......++.|++.++.|||+   .+|+||||||+|+|+...    +.+|++|||
T Consensus       114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            99999999999999543      28899999999999999999999   999999999999999643    479999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ++.....  .......+||+.|+|||++....++.++||||+||++|.|++|..||..........       ....++.
T Consensus       185 la~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~  255 (382)
T KOG0032|consen  185 LAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF  255 (382)
T ss_pred             CceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC
Confidence            9998776  345566899999999999998999999999999999999999999998765432211       1111221


Q ss_pred             ccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            .. ...-......+.+++..|+..||.+|+|+.+++++
T Consensus       256 ------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                  11 22333456778889999999999999999999994

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.5e-35  Score=304.63  Aligned_cols=263  Identities=25%  Similarity=0.386  Sum_probs=212.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...+.||+|+||.||++....++..|++|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            57888899999999999999988888999999987655555677899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++.+      ..+++.++..++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        99 ~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          99 AGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            99999999843      347889999999999999999999   899999999999999999999999999887654332


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      . ......+++.|+|||.+..+.++.++|||||||++||+++|+.||..........      .....+      .+.. 
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~------~~~~~~------~~~~-  235 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNG------TPEL-  235 (293)
T ss_pred             c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee------ehhcCC------CCCC-
Confidence            2 2223468889999999988889999999999999999999999997543321110      000000      0111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPL  640 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~  640 (662)
                      .........+.+++.+||+.+|++||++.+++++  +....++...|+
T Consensus       236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            1122345568889999999999999999999985  455555544443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2e-35  Score=308.58  Aligned_cols=247  Identities=24%  Similarity=0.381  Sum_probs=201.8

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      ....||+|+||.||++....++..||+|++........+.+.+|+.++..++||||+++++++..++..++||||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            34579999999999999988899999999976555556778899999999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcc
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT  518 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~  518 (662)
                      |..++.      ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... ...
T Consensus       105 L~~~~~------~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  174 (297)
T cd06659         105 LTDIVS------QTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR  174 (297)
T ss_pred             HHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence            999873      2458899999999999999999999   899999999999999999999999999987654332 122


Q ss_pred             eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCH
Q 040242          519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP  598 (662)
Q Consensus       519 ~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~  598 (662)
                      ....|+..|+|||++.+..++.++|||||||+++||++|+.||.........   ..+.    ..     ..+.. ....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~----~~-----~~~~~-~~~~  241 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLR----DS-----PPPKL-KNAH  241 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHh----cc-----CCCCc-cccC
Confidence            3356889999999998888999999999999999999999999754332111   1111    00     00111 1111


Q ss_pred             HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          599 QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       599 ~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....+.+++.+|++.+|.+||++.+++++
T Consensus       242 ~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         242 KISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            234557889999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.1e-35  Score=301.90  Aligned_cols=261  Identities=23%  Similarity=0.355  Sum_probs=205.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~  431 (662)
                      ++|...+.||.|++|.||++.+..++..+|+|.+.... .....++.+|++++++++||||++++++|...  +..++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788899999999999999998889999999987543 34457789999999999999999999988654  3689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..... ....+++.....++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999998754321 24568889999999999999999999   899999999999999999999999999987543


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc--hhhHHHHHHHHHHhhcCcccccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT--AMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~--~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ...   .....++..|+|||.+.+..++.++|||||||++|||++|+.||.....  .....+..|+...    . ...+
T Consensus       157 ~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~-~~~~  228 (287)
T cd06621         157 NSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM----P-NPEL  228 (287)
T ss_pred             ccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC----C-chhh
Confidence            322   1234578899999999888899999999999999999999999975532  1112222222210    0 0011


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .... .........+.+++.+||+.+|++|||+.||+++
T Consensus       229 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         229 KDEP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             ccCC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            1111 1112245678899999999999999999999983

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.6e-35  Score=299.09  Aligned_cols=254  Identities=24%  Similarity=0.410  Sum_probs=205.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc------hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +|+..+.||+|++|.||++....++..||+|.+....      ....+.+..|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4777899999999999999998899999999986532      2245788999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLAR  508 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~  508 (662)
                      ||||+++++|.+++.+     ...+++..+..++.|++.||.|||+   .+++|+||+|+||+++.++ .+||+|||++.
T Consensus        81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            9999999999999853     3468899999999999999999999   8999999999999998776 59999999998


Q ss_pred             cccCCCCC---cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          509 AYDHNINP---QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       509 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ........   ......++..|+|||.+.+..++.++||||+|+++++|++|+.||..........   .......    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~----  225 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIAS----  225 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHhc----
Confidence            76543211   1223467899999999988888999999999999999999999997443221111   1111000    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ..   .....+......+.+++.+|++.+|++||++.+++++
T Consensus       226 -~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         226 -AT---TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             -cC---CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence             00   0122334456778899999999999999999999853

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=4e-35  Score=305.02  Aligned_cols=265  Identities=23%  Similarity=0.327  Sum_probs=200.6

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++++|...+.||+|+||.||+|....++..|++|++..... .....+.+|+.++++++|+||+++.+++..++..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            56889999999999999999999988899999999865432 22346788999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+. ++|.+++...    ...+++.++..++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9995 6777766433    2457888889999999999999999   899999999999999999999999999998643


Q ss_pred             CCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--------
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--------  582 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--------  582 (662)
                      .... ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||.......+.....|  .....        
T Consensus       155 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~--~~~~~~~~~~~~~  231 (291)
T cd07870         155 IPSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW--TVLGVPTEDTWPG  231 (291)
T ss_pred             CCCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH--HHcCCCChhhhhh
Confidence            3211 12233578999999988654 578899999999999999999999975543222111111  10000        


Q ss_pred             ----Ccccccc-----CCCCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 ----GQITRAI-----DPTLDYF--DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ----~~~~~~i-----d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          .+.....     .+.+...  .......+.+++.+|+..||.+|||+.|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence                0000000     0000000  00124567789999999999999999998853

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-36  Score=317.08  Aligned_cols=241  Identities=26%  Similarity=0.338  Sum_probs=188.8

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc---ccccceeeeeeEeccCeeeEEEeccCC
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL---RHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ||+|+||+||+|+...++..||||++....   ......+..|..++.+.   +||||+++++++......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999998899999999996542   22234455677776665   699999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++..     ...+++.....++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~  151 (330)
T cd05586          81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-K  151 (330)
T ss_pred             ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-C
Confidence            999988853     3458899999999999999999999   899999999999999999999999999987543221 2


Q ss_pred             cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                      ......||..|+|||.+.+. .++.++|||||||++|||++|+.||.......      .... ...+.      ..+. 
T Consensus       152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~-i~~~~------~~~~-  217 (330)
T cd05586         152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRN-IAFGK------VRFP-  217 (330)
T ss_pred             CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHH-HHcCC------CCCC-
Confidence            22345789999999988654 47899999999999999999999997543211      1111 11111      1111 


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRP----STRRVVQ  627 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RP----t~~eVl~  627 (662)
                       .......+.+++.+||+.||.+||    ++.++++
T Consensus       218 -~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 -KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             112345567889999999999998    4666655

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-35  Score=314.60  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=198.8

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEecc-----
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----  424 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----  424 (662)
                      ...++|+..+.||+|+||.||+|....++..||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            34578899999999999999999998889999999986542  23345678999999999999999999987543     


Q ss_pred             -CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          425 -DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       425 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                       ...++++|++ +++|.+++.      ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~D  161 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK------CQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILD  161 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcC
Confidence             3578999998 889988873      2358999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      ||+++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........  ..+. .....
T Consensus       162 fg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~-~~~~~  234 (343)
T cd07878         162 FGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL--KRIM-EVVGT  234 (343)
T ss_pred             CccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHH-HHhCC
Confidence            9999865432    233468999999998876 46889999999999999999999999754322111  1110 00000


Q ss_pred             -----------CccccccCCCCCCCC--------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 -----------GQITRAIDPTLDYFD--------PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 -----------~~~~~~id~~l~~~~--------~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                 ......+ ..+...+        ......+.+|+.+|++.||.+|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         235 PSPEVLKKISSEHARKYI-QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCHHHHHhcchhhHHHHh-hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0000000 0000000        1122346789999999999999999999975

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.4e-35  Score=300.24  Aligned_cols=251  Identities=23%  Similarity=0.406  Sum_probs=204.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||++....+|..+|+|.+....  ....+.+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999999889999999986542  23446788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC-eEEeeccccccccC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN-PKLGDFGLARAYDH  512 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~DfGla~~~~~  512 (662)
                      +++++|.+++....   ...+++..+..++.|+++||.|||+   .+++|+||||+||++++++. +||+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            99999999986432   3457999999999999999999999   89999999999999998864 69999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ... ......|++.|+|||...+..++.++||||||++++||++|+.|+......      +++.+... +        .
T Consensus       155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~--------~  218 (257)
T cd08225         155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-G--------Y  218 (257)
T ss_pred             Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-c--------c
Confidence            322 222346889999999998888999999999999999999999998754321      12222111 1        1


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...........+.+++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            111122334568899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.3e-35  Score=309.35  Aligned_cols=199  Identities=25%  Similarity=0.402  Sum_probs=161.6

Q ss_pred             cceeeeeCceEEEEEEeCC--CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec--cCeeeEEEeccC
Q 040242          360 KNLVGSGGFGKVYRGVIPS--TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVP  435 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~  435 (662)
                      .++||+|+||+||+|+...  ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4689999999999999753  55789999986543  23457789999999999999999998854  457899999996


Q ss_pred             CCCcchhcccccc----cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe----CCCCCeEEeecccc
Q 040242          436 NGSLDKLLFDNDQ----QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLA  507 (662)
Q Consensus       436 ~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla  507 (662)
                       ++|.+++.....    .....+++..+..++.|++.||.|||+   .+|+||||||+||++    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             577777643211    113458899999999999999999999   899999999999999    56678999999999


Q ss_pred             ccccCCCCC--cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          508 RAYDHNINP--QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       508 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                      +........  ......||+.|+|||.+.+ ..++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221  2234568999999998876 45789999999999999999999999743

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-35  Score=304.96  Aligned_cols=262  Identities=25%  Similarity=0.344  Sum_probs=199.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+|....+|..||+|++....  ......+.+|+.++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777899999999999999999899999999986542  22235678899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.+++...    ...+++...+.++.||++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            96 5787777543    3458999999999999999999999   89999999999999999999999999999866443


Q ss_pred             CCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC------ccc
Q 040242          514 INPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG------QIT  586 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~  586 (662)
                      .. ......++..|+|||.+.+. .++.++|||||||++|||++|+.|+.........  ...+.......      .+.
T Consensus       153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHH--HHHHHHHhCCCChHHhHHhh
Confidence            22 12234578899999988664 4689999999999999999999986543322111  01111100000      000


Q ss_pred             cccC----CCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          587 RAID----PTL------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~id----~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +..+    +..      ....+.....+.+++.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            0000    000      01112234667889999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.3e-35  Score=305.26  Aligned_cols=249  Identities=29%  Similarity=0.409  Sum_probs=201.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .+.|+..+.||+|++|+||+|....+++.||+|++...   ..+..+++.+|++++++++||||++++++|...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            35688889999999999999999888999999998643   233446788999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||++ |+|.+++...    ...+++..+..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++...
T Consensus        94 ~e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          94 MEYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             HHhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            99996 6777766433    3458999999999999999999999   89999999999999999999999999998765


Q ss_pred             cCCCCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ...     ....++..|+|||.+.   ...++.++||||||+++|||++|+.|+..........      .. ...    
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~-~~~----  229 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HI-AQN----  229 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HH-hcC----
Confidence            332     2246788999999874   4568899999999999999999999987543221110      00 000    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       ..+.+  ........+.+++.+||+.+|++||++.+|+++.
T Consensus       230 -~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         230 -DSPTL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             -CCCCC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence             01111  1223456789999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=301.82  Aligned_cols=258  Identities=27%  Similarity=0.378  Sum_probs=204.8

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC-----
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD-----  425 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~-----  425 (662)
                      .++++|+..+.||+|++|.||+|....++..+++|++..... ..+++.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            467899999999999999999999988889999999876543 346789999999999 6999999999997644     


Q ss_pred             -eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 -ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                       ..++||||+++++|.+++..... ....+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~  157 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDF  157 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCC
Confidence             48999999999999999854321 13568999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      |++....... .......++..|+|||.+..     ..++.++|||||||+++||++|+.||.......  .+...    
T Consensus       158 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~----  230 (275)
T cd06608         158 GVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR--ALFKI----  230 (275)
T ss_pred             ccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH--HHHHh----
Confidence            9987654322 22233568899999998753     346789999999999999999999997432211  11110    


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            .....+.+ .........+.+++.+||..||++|||+.+++++
T Consensus       231 ------~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         231 ------PRNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             ------hccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                  00111111 1122345678899999999999999999999863

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.2e-34  Score=296.04  Aligned_cols=254  Identities=24%  Similarity=0.400  Sum_probs=210.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|++|.||++....+++.|+||++..... ...+.+.+|+..+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            367888999999999999999988899999999876643 4567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...     ..+++..++.++.|+++||.|||+.  .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999543     5689999999999999999999973  68999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+..........+..++.            ....
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~------------~~~~  220 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC------------DGPP  220 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh------------cCCC
Confidence            322 223467899999999998889999999999999999999999997654211122222221            1111


Q ss_pred             CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQ-EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...+.. ....+..++.+|++.+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111222 45678899999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6e-35  Score=303.04  Aligned_cols=250  Identities=23%  Similarity=0.360  Sum_probs=204.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      .|...+.||+|++|.||++....++..+++|++........+.+.+|+.++++++|+||+++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            35556899999999999999988899999999876655566778999999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++..      ..+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++........
T Consensus       100 ~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648         100 GGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            9999999853      348899999999999999999999   8999999999999999999999999998876543321


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                       ......|+..|+|||.+.+..++.++|||||||++|||++|+.||.......      ...... ..     ..+.+. 
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~-~~-----~~~~~~-  236 (285)
T cd06648         171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIR-DN-----LPPKLK-  236 (285)
T ss_pred             -ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHH-hc-----CCCCCc-
Confidence             2233468899999999988889999999999999999999999987543211      111111 11     111111 


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........+.+++.+||+.+|++||++.+++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            112244678999999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-35  Score=302.46  Aligned_cols=261  Identities=26%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEEEe
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLVYD  432 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~E  432 (662)
                      |+..+.||+|++|.||+|....++..+|+|++....  ......+.+|+.++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            566789999999999999998889999999997653  33456788999999999999999999999888  78999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++ ++|.+++...    ...+++.+++.++.|+++||+|||+   .+++|+||+|+||++++++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            997 4888888543    2468999999999999999999999   8999999999999999999999999999987765


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc---Cc---c
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ---GQ---I  585 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~---~  585 (662)
                      ..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||..........   .+......   ..   .
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGV  229 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcccc
Confidence            43323334467889999997654 457899999999999999999999997654322111   11110000   00   0


Q ss_pred             -----cc------ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 -----TR------AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 -----~~------~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           .+      .....+ ..+...+...+.+++.+||+.+|++||++++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                 00      000000 00111125678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-35  Score=317.73  Aligned_cols=259  Identities=23%  Similarity=0.258  Sum_probs=198.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC--CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS--TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .+|...+.||+|+||.||++...+  .+..||+|.+...     +...+|+.++++++||||+++++++......++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            468889999999999999997643  4578999988543     234679999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ++. ++|.+++..     ...+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       167 ~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~  237 (392)
T PHA03207        167 KYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDA  237 (392)
T ss_pred             hcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence            995 688888732     3568999999999999999999999   8999999999999999999999999999986654


Q ss_pred             CCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh-HHHHHHHHHHhhcCc------
Q 040242          513 NIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQ------  584 (662)
Q Consensus       513 ~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~------  584 (662)
                      ... .......||+.|+|||++....++.++|||||||++|||++|+.||........ ..+..-++ ......      
T Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~  316 (392)
T PHA03207        238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQN  316 (392)
T ss_pred             ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCc
Confidence            322 222345799999999999988899999999999999999999999975432211 11111111 000000      


Q ss_pred             -----------cccccCCCC--CC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 -----------ITRAIDPTL--DY--FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 -----------~~~~id~~l--~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                 ......+..  ..  ........+..++.+||+.||++||++.|++.+
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                       000000000  00  001223457788999999999999999999986

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3.4e-35  Score=300.72  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +|+..+.||+|++|.||++.+..+++.+++|++.... ....+++.+|++++++++||||+++++++...+..++++||+
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   81 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM   81 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence            5777889999999999999998889999999987653 345577899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++.....++.|+++||.|||+.  .+++|+||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          82 DGGSLDKILKEV----QGRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             CCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            999999998643    25688899999999999999999983  689999999999999999999999999987654321


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ..   ...++..|+|||.+.+..++.++||||||+++++|++|+.|+........ ...+.+......      ..+.+.
T Consensus       156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~  225 (265)
T cd06605         156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE------PPPRLP  225 (265)
T ss_pred             hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC------CCCCCC
Confidence            11   15688899999999888999999999999999999999999975422111 111122111111      011111


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .......+.+++.+||..+|++||++.+++++
T Consensus       226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence              11145668899999999999999999999864

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=9.2e-35  Score=300.18  Aligned_cols=247  Identities=25%  Similarity=0.412  Sum_probs=202.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      |+..+.||+|+||.||+|....++..||+|.+.... ....+.+.+|+..+++++|+||+++++++..+...++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            566788999999999999998889999999886542 3445678899999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++..      ..+++.....++.|++.+|.|||+   .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        86 ~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-  155 (277)
T cd06641          86 GGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  155 (277)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-
Confidence            9999999842      358899999999999999999999   899999999999999999999999999987654321 


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                      .......++..|+|||.+.+..++.++|||||||++|||++|..|+.......      +.... ..+.        ...
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~~--------~~~  220 (277)
T cd06641         156 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKNN--------PPT  220 (277)
T ss_pred             hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcCC--------CCC
Confidence            12223467889999999988889999999999999999999999987543211      11111 0110        111


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........+.+++.+|++.+|.+||++.+++++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            222345667889999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5.3e-35  Score=304.12  Aligned_cols=245  Identities=26%  Similarity=0.324  Sum_probs=202.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|++|.||++....+++.||+|.+....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            36888899999999999999998889999999986542   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...     ..+++..+..++.|+++||.|||+   .+++|+||+|+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            999999999998543     468899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....+++.|+|||.+.+...+.++||||||+++|||++|+.||......   ...    +....+.      .
T Consensus       153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~----~~~~~~~------~  215 (290)
T cd05580         153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIY----EKILEGK------V  215 (290)
T ss_pred             CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHH----HHHhcCC------c
Confidence            43    23346889999999998888899999999999999999999999754421   111    1111111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  627 (662)
                      .   .+......+.+++.+||+.+|.+||     +++|+++
T Consensus       216 ~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 R---FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             c---CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            1   1222356778899999999999999     6666664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.9e-35  Score=302.11  Aligned_cols=254  Identities=26%  Similarity=0.366  Sum_probs=197.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHH-hhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITS-MGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||.||+++...+|+.||+|++.... .....++..|+.. ++.++||||+++++++..++..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            36888899999999999999998899999999987642 2333456666665 566789999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++ |+|.+++..... ....+++..++.++.|++.||.|||+.  .+++||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            995 788888754322 135689999999999999999999982  2899999999999999999999999999986543


Q ss_pred             CCCCcceecccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..  ......++..|+|||.+.+    ..++.++|+|||||++|||++|+.||.......+ .+    ....      +.
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~----~~~~------~~  223 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-QL----KQVV------EE  223 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-HH----HHHH------hc
Confidence            21  1223467889999998754    3468899999999999999999999964322111 11    1110      11


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ..+.+.  .......+.+++.+||..+|++||++.++++
T Consensus       224 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLP--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCC--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111111  1123456889999999999999999999997

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-35  Score=302.94  Aligned_cols=262  Identities=28%  Similarity=0.374  Sum_probs=201.4

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |+..+.||.|++|.||+|....+|..|++|++....  ....+.+.+|+.++++++|+|++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            566789999999999999998899999999987543  223457889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                       +++|.+++....   ...+++..++.++.|+++||.|||+   .+++||||+|+||+++.++.++|+|||+++......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 -DLDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             -CcCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence             578999885442   2468999999999999999999999   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC----------
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG----------  583 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~----------  583 (662)
                      . ......++..|+|||++.+. .++.++||||||+++|||++|+.||........  +...........          
T Consensus       154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd07835         154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSL  230 (283)
T ss_pred             c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhc
Confidence            1 11223568899999987654 568899999999999999999999975433211  111111100000          


Q ss_pred             -c----cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 -Q----ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 -~----~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .    ......+............+.+++.+|++.+|++||+++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence             0    00000011111122334668899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=299.39  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=202.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccc---cccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .|+..+.||+|+||.||+|.+..++..|++|.+... .....+++.+|+.++++++   |||++++++++..+...++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            467788999999999999999888999999998654 3344567889999999987   999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..      ..+++...+.++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            99999999998842      368899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... .......|+..|+|||.+.++ .++.++|||||||++|+|++|+.||........      ...      ......
T Consensus       153 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~------~~~~~~  219 (277)
T cd06917         153 QNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML------IPKSKP  219 (277)
T ss_pred             CCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc------cccCCC
Confidence            443 222334688999999988654 468899999999999999999999975432111      100      001111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.+..  ......+.+++.+||+.||++||++.+++++
T Consensus       220 ~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         220 PRLED--NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             CCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            22211  1144568889999999999999999999873

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=6.1e-35  Score=306.97  Aligned_cols=269  Identities=22%  Similarity=0.322  Sum_probs=200.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCC--CCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEecc--Ceee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS--TGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELL  428 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  428 (662)
                      +|+..+.||+|++|.||+|+...  .+..||+|.+....   ....+.+.+|+.++++++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47778899999999999999987  78999999997633   33446678899999999999999999999888  7899


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC----CCCeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA----DLNPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kL~Df  504 (662)
                      +||||+++ +|.+++..........++....+.++.|++.||.|||+   .+++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 67666644332223468899999999999999999999   89999999999999999    899999999


Q ss_pred             cccccccCCCC--CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchh-------hHHHHH
Q 040242          505 GLARAYDHNIN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-------ELVLVD  574 (662)
Q Consensus       505 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~  574 (662)
                      |++........  .......++..|+|||.+.+. .++.++|||||||+++||++|+.||.......       ...+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987654322  122234678899999987654 57899999999999999999999997543321       001111


Q ss_pred             HHHHHh-----------hcCccccccCC-CCCCCC---------H--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 WVRELH-----------SQGQITRAIDP-TLDYFD---------P--QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 ~~~~~~-----------~~~~~~~~id~-~l~~~~---------~--~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+..+-           .........+. ....++         .  .....+.+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            111000           00000000000 000011         0  234568899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-35  Score=303.16  Aligned_cols=263  Identities=25%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|++|.||+|....+++.||+|.+..... .....+.+|++++++++|+||+++++++..++..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            578889999999999999999988899999999865432 2234567899999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.+++...    ...+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            97 4899888644    2368899999999999999999999   89999999999999999999999999998754322


Q ss_pred             CCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc---Ccc----
Q 040242          514 INPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ---GQI----  585 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~---~~~----  585 (662)
                      ... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......+..  .-+......   ...    
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL--HKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH--HHHHHhcCCCChhhhhhhh
Confidence            111 122346789999998865 457899999999999999999999996543211110  001110000   000    


Q ss_pred             -----cc----cc-CCCCCCC--CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 -----TR----AI-DPTLDYF--DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 -----~~----~i-d~~l~~~--~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ..    .. ...+...  .......+.+++.+||+.+|++||++.|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                 00    00 0000000  00112567789999999999999999998863

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.6e-35  Score=301.79  Aligned_cols=250  Identities=24%  Similarity=0.326  Sum_probs=197.1

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|+||+||++....+|+.||+|.+....   ......+..|++++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986542   22345678899999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++....   ...+++.+++.++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++.......  ...
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~  152 (277)
T cd05577          81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK  152 (277)
T ss_pred             HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence            99986542   2468999999999999999999999   899999999999999999999999999988654321  222


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...++..|+|||.+.+..++.++|||||||++++|++|+.||..........   .+..    .     ........+..
T Consensus       153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~----~-----~~~~~~~~~~~  220 (277)
T cd05577         153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKR----R-----TLEMAVEYPDK  220 (277)
T ss_pred             cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHh----c-----cccccccCCcc
Confidence            3467889999999988889999999999999999999999997543311100   0000    0     00011112223


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHH-HHHHHhcC
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRR-VVQFLLRD  632 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~e-Vl~~L~~~  632 (662)
                      ....+.+++.+||+.+|.+||+.++ .++.|..+
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            4566889999999999999995444 34434333

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-36  Score=317.29  Aligned_cols=261  Identities=29%  Similarity=0.403  Sum_probs=214.2

Q ss_pred             cccceeeeeCceEEEEEEeCCC-C--cEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          358 REKNLVGSGGFGKVYRGVIPST-G--LEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~-g--~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ...++||+|.||.|++|.+..- |  ..||||++...... ...+|++|+.+|-+|+|+|+++|+|.... ....+|+|.
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL  191 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL  191 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence            3467899999999999999642 2  45999999877544 67899999999999999999999999987 778999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++.|+|.+.|++.   .+..|-.......+.|||.||.||..   +++|||||..+|+||-....+||+||||.+.+..+
T Consensus       192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999773   26778888999999999999999999   89999999999999999999999999999988765


Q ss_pred             CCCcce--ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          514 INPQTT--HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       514 ~~~~~~--~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ......  ...-...|+|||.+...+++.++|||+|||++|||++ |..||.+-...                .+++.+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhcc
Confidence            443211  1234678999999999999999999999999999999 77888754322                1233344


Q ss_pred             CCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH-HHHhcCCCCCCCCCC
Q 040242          591 PTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV-QFLLRDASLPQAPLD  641 (662)
Q Consensus       591 ~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl-~~L~~~~~~p~~p~~  641 (662)
                      ..- -..+..+.+.++++++.||..+|++|||+..+. +.+..++...++-..
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~eaqp~~a~~~  382 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAEAQPAVARET  382 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHhcCCceeeee
Confidence            222 334567889999999999999999999999998 445555554444333

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-34  Score=291.83  Aligned_cols=251  Identities=28%  Similarity=0.451  Sum_probs=207.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      .|+..+.||+|++|.||++....++..+++|++........+.+.+|+..+++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36678899999999999999988899999999977665567789999999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++...    ...+++..+..++.|++++|.|||+   .+++|+||+|+||++++++.++|+|||.+........
T Consensus        81 ~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  153 (253)
T cd05122          81 GGSLKDLLKST----NQTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA  153 (253)
T ss_pred             CCcHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence            99999998543    2468999999999999999999999   8999999999999999999999999999987654322


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                        .....++..|++||.+.....+.++||||||+++++|++|+.|+..........   ...    ...     -+.+. 
T Consensus       154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~~-----~~~~~-  218 (253)
T cd05122         154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---KIA----TNG-----PPGLR-  218 (253)
T ss_pred             --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHH----hcC-----CCCcC-
Confidence              334568899999999988889999999999999999999999987543211111   000    000     01110 


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........+.+++.+|++.||++||++.+++++
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            111124668899999999999999999999864

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=2.5e-34  Score=295.54  Aligned_cols=255  Identities=22%  Similarity=0.349  Sum_probs=190.8

Q ss_pred             ceeeeeCceEEEEEEeCCC--CcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          361 NLVGSGGFGKVYRGVIPST--GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~--g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      +.||+|+||.||+|.....  ...+++|.+.... ....+.|.+|+.+++.++||||++++++|......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3599999999999976432  2356677766543 345678999999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC-CC
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI-NP  516 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~-~~  516 (662)
                      +|.+++.+.... ...+++.....++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999654221 2346777788999999999999999   899999999999999999999999999986432211 11


Q ss_pred             cceecccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          517 QTTHIVGTLGYLAPELTRT-------GKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......++..|+|||++..       ...+.++|||||||++|||++ |..||.......      ....... +.....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~  229 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVIK-DQQVKL  229 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHHh-hccccc
Confidence            1223467889999998743       245789999999999999997 566775433211      1111111 122233


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .++.+..   .....+.+++..|| .+|++||++++|++.|.
T Consensus       230 ~~~~~~~---~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         230 FKPQLEL---PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCCccCC---CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            3444421   13345667888899 67999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-35  Score=315.41  Aligned_cols=261  Identities=22%  Similarity=0.303  Sum_probs=207.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-c-----ccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-H-----RNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H-----~niv~l~~~~~~~~~~~l  429 (662)
                      +|.+.+.||+|.||.|-+|.+..+++.||||+++... .-..+-..|+.+|..|+ |     -|+|++++++...+++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            7888999999999999999999999999999997653 34566688999999997 4     589999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC--CeEEeecccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL--NPKLGDFGLA  507 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfGla  507 (662)
                      |+|.+ .-||.++|+.+.   ...++......++.||+.||..||+   .+|||+||||+||||.+-.  .+||+|||.+
T Consensus       266 VfELL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eehhh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccc
Confidence            99999 679999998765   5669999999999999999999998   9999999999999997544  5999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH-----Hhh-
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE-----LHS-  581 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~~~-  581 (662)
                      +......    .....+..|.|||++.+.+++.+.||||||||+.||++|.+.|.+..+.++...+.-+..     +++ 
T Consensus       339 c~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8754432    245678899999999999999999999999999999999888877665544432111100     000 


Q ss_pred             ---------c-C---------c-----------------cccccCC-CC---C-CCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          582 ---------Q-G---------Q-----------------ITRAIDP-TL---D-YFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       582 ---------~-~---------~-----------------~~~~id~-~l---~-~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                               . .         .                 ..+..-| ..   . .........+++++++|++.||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                     0 0         0                 0000011 00   0 11124456789999999999999999


Q ss_pred             CHHHHHHH
Q 040242          621 STRRVVQF  628 (662)
Q Consensus       621 t~~eVl~~  628 (662)
                      |..|.+++
T Consensus       495 tp~qal~H  502 (586)
T KOG0667|consen  495 TPAQALNH  502 (586)
T ss_pred             CHHHHhcC
Confidence            99999985

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.4e-34  Score=297.73  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=201.1

Q ss_pred             CcccceeeeeCceEEEEEEeCC---CCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC------
Q 040242          357 FREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------  425 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~------  425 (662)
                      |...+.||+|+||.||+|.+..   ++..||||++...  .....+++.+|+.++++++||||+++++++...+      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            4567889999999999998643   4688999998654  3345677899999999999999999999886532      


Q ss_pred             eeeEEEeccCCCCcchhccccccc-ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ-KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ..++++||+++|+|..++...... ....+++...+.++.|++.||+|||+   .+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            247899999999999887543211 12358899999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          505 GLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       505 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      |+++....... .......+++.|++||.+....++.++|||||||++|||++ |+.||......   .+..++..    
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~~----  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLIK----  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHHc----
Confidence            99986543221 11222345678999999988889999999999999999999 88888654321   12222211    


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.       .+ .........+.+++.+|++.+|++||++.++++.|++.
T Consensus       231 ~~-------~~-~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         231 GN-------RL-KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             CC-------cC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10       00 01123446788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.4e-34  Score=303.22  Aligned_cols=256  Identities=27%  Similarity=0.409  Sum_probs=204.2

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      |+..+.||+|+||.||+++...++..||+|++...   .....+++..|+.++++++|+|++++++++......++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            66678899999999999999888999999998643   233456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ |+|.+++...    ...++|.++..++.|++.||.|||+   .+++||||+|+||+++.++.+||+|||++......
T Consensus       107 ~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         107 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            96 5777776433    3458999999999999999999999   89999999999999999999999999998754332


Q ss_pred             CCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          514 INPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                           ....++..|+|||++.   .+..+.++|||||||++|||++|+.||........  +..+..    .+      .
T Consensus       179 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~----~~------~  241 (317)
T cd06635         179 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ----NE------S  241 (317)
T ss_pred             -----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHh----cc------C
Confidence                 2346788999999873   45688999999999999999999999875432111  111111    00      0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAP  639 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p  639 (662)
                      +..  ........+.+++.+|++.+|.+||++.+|++++......+..+
T Consensus       242 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~  288 (317)
T cd06635         242 PTL--QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV  288 (317)
T ss_pred             CCC--CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence            111  12234456889999999999999999999999776554444443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=9.3e-35  Score=300.77  Aligned_cols=263  Identities=29%  Similarity=0.442  Sum_probs=202.7

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +|+..+.||.|++|.||+|+...+|..||||++..... .....+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            47888999999999999999988899999999876532 23456788999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++ +|.+++.....  ...+++.++..++.|+++||.|||+   .+++||||||+||++++++.++|+|||++.......
T Consensus        81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            74 88888754321  3468999999999999999999998   899999999999999999999999999998654332


Q ss_pred             CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHH-------HHHhhcCcc
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWV-------RELHSQGQI  585 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~-------~~~~~~~~~  585 (662)
                      . ......++..|++||.+.+. .++.++|||||||++|||++|+.||.......... .....       ++.+..   
T Consensus       155 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  230 (284)
T cd07836         155 N-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ---  230 (284)
T ss_pred             c-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc---
Confidence            2 12234568899999987654 56889999999999999999999997654322111 00000       000000   


Q ss_pred             ccccCCCC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTL--------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ........        ....+.....+.+++.+|++.||.+||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00000111        11112234567899999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-37  Score=290.10  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=204.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++.|+..+.||+|.|+.||++....+|+.+|+|.+...  .....+++.+|+.+.+.|+||||++|.....+.+..++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            35677788999999999999999999999999987443  3446778899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~  508 (662)
                      |+|.|+.|..-+..     +...++...-..+.||+++|.|+|.   ++|+|||+||+|++|-..   --+||+|||++.
T Consensus        90 e~m~G~dl~~eIV~-----R~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   90 DLVTGGELFEDIVA-----REFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ecccchHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence            99999999776632     3456777788899999999999999   899999999999999543   349999999999


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ...  ........+|||+|||||++...+++..+|||+.||+||-|+.|+.||.+....   .+.    +....+..  -
T Consensus       162 ~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---rly----e~I~~g~y--d  230 (355)
T KOG0033|consen  162 EVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY----EQIKAGAY--D  230 (355)
T ss_pred             EeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---HHH----HHHhcccc--C
Confidence            876  234455578999999999999999999999999999999999999999874332   111    11111110  1


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +++.   +-....+....|+++||..||.+|.|+.|.+++
T Consensus       231 ~~~~---~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  231 YPSP---EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             CCCc---ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence            1111   122344566788899999999999999988753

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-35  Score=309.57  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Cee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~  427 (662)
                      +++|+..+.||+|++|.||+|....+|..||+|++... .......+..|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            47899999999999999999999889999999998643 233456788999999999999999999987544     357


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++|+||++ ++|.+++.      ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~------~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          84 YIVQELME-TDLYKLIK------TQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEehhcc-cCHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccce
Confidence            99999996 57777763      3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC--cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC-
Q 040242          508 RAYDHNINP--QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG-  583 (662)
Q Consensus       508 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  583 (662)
                      +........  ......|+..|+|||.+.+ ..++.++||||+||++|||++|+.||.........   .++...+... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~---~~~~~~~~~~~  230 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQL---NLILGVLGTPS  230 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCC
Confidence            865432211  1123468899999998654 46889999999999999999999999754322111   1111111100 


Q ss_pred             --ccccccC-------------CCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 --QITRAID-------------PTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 --~~~~~id-------------~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ......+             +...  ...+.....+.+++.+||+.+|.+||++.|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000             0000  0011234568899999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.6e-34  Score=300.71  Aligned_cols=265  Identities=24%  Similarity=0.306  Sum_probs=201.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  430 (662)
                      ++|+..+.||+|++|.||+|....+++.+++|.+.....  .....+.+|+.++.+++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            468888999999999999999988899999999965432  2234577899999999999999999998877  789999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||++ ++|.+++...    ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++...
T Consensus        85 ~e~~~-~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVE-HDLKSLMETM----KQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcC-cCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            99996 5898888543    2368999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHH-------HHHHhh
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDW-------VRELHS  581 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~~  581 (662)
                      ..... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||.......... +...       .|..+.
T Consensus       157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (293)
T cd07843         157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS  235 (293)
T ss_pred             cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence            54321 22234578899999988654 46889999999999999999999997543321111 0000       010000


Q ss_pred             c------CccccccCCCC-CCCCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 Q------GQITRAIDPTL-DYFDPQ-EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~------~~~~~~id~~l-~~~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .      ..........+ ..++.. ..+.+.+++.+||+.+|++||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            0      00001111111 111111 35668899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=9.1e-35  Score=301.73  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|...+.||+|+||.||++....++..||+|++.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4555778999999999999999899999999986543 344567889999999996 99999999999998899999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ ++|.++...........+++.....++.++++||.|||+.  .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            85 4655543211111135689999999999999999999973  58999999999999999999999999999765432


Q ss_pred             CCCcceecccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTG---KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      .  ......|+..|+|||.+.+.   .++.++|||||||++|||++|+.||......     .+-+.+.      .....
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~~~~~------~~~~~  228 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQLTQV------VKGDP  228 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHHHhhh------cCCCC
Confidence            2  11223578899999998765   6889999999999999999999998754311     1111111      11111


Q ss_pred             CCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.+ ..........+.+++.+|++.+|++||++.+|+++
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            222 11223355678899999999999999999999974

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.3e-34  Score=291.12  Aligned_cols=252  Identities=28%  Similarity=0.414  Sum_probs=208.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLVY  431 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~  431 (662)
                      +|+..+.||+|++|.||+|....++..|++|++....  ....+.+.+|+..+++++|+||+++++++...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999998889999999987654  25567889999999999999999999999988  8899999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...     ..+++.+++.++.|++++|.|||+   .+++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999998543     378999999999999999999999   899999999999999999999999999998766


Q ss_pred             CCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..... ......++..|+|||.+.....+.++||||||+++++|++|+.||.........     +.....        .
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~--------~  219 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA-----LYKIGS--------S  219 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH-----HHhccc--------c
Confidence            54321 123356889999999998888999999999999999999999999765421111     111000        0


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ......+......+.+++.+|++.+|++||++.+++++
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            11122233346778999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-34  Score=299.05  Aligned_cols=255  Identities=28%  Similarity=0.410  Sum_probs=208.5

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ..++.|+..+.||+|++|.||++.+..++..+++|++..... ..+.+.+|++.+++++|+|++++++++...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456778888999999999999999987889999999976544 5677899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...    ...+++.+++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~~~~L~~~l~~~----~~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          95 EYMDGGSLTDIITQN----FVRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             eccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            999999999999643    1379999999999999999999999   899999999999999999999999999887654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......++..|++||.+.+..++.++|||||||++|+|++|+.|+.........  ..+     .....     +
T Consensus       168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~~~-----~~~~~-----~  234 (286)
T cd06614         168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--FLI-----TTKGI-----P  234 (286)
T ss_pred             cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--HHH-----HhcCC-----C
Confidence            3221 222345788999999998888999999999999999999999998754332111  100     00000     0


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+ .........+..++.+|++.+|.+||++.+|+++
T Consensus       235 ~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         235 PL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             CC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11 1111234668899999999999999999999963

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=309.08  Aligned_cols=251  Identities=27%  Similarity=0.439  Sum_probs=211.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCC----CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPS----TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~----~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .....++||.|-||.||+|+...    ....||||..+.+ .....+.|+.|..++++++||||++++|.|.+. ..++|
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv  468 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV  468 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence            34446789999999999998742    2346899998774 455578899999999999999999999999764 68999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||.++-|.|..+|..+    +..|+.......+.||..||.|||+   ...|||||..+|||+...-.+||+||||++.+
T Consensus       469 mEL~~~GELr~yLq~n----k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  469 MELAPLGELREYLQQN----KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             EecccchhHHHHHHhc----cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            9999999999999765    5678899999999999999999999   89999999999999999999999999999998


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      +.+.....+...-+..|||||.++-.+++.++|||-|||++||++. |..||.+-...+                ....+
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------VI~~i  605 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------VIGHI  605 (974)
T ss_pred             cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------eEEEe
Confidence            8765555555566789999999999999999999999999999987 999998654321                11112


Q ss_pred             CCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          590 DPT-LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       590 d~~-l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ... -...++.++..|..|+.+||..+|.+||.+.|+...|.
T Consensus       606 EnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  606 ENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             cCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence            111 12356678888999999999999999999999887664

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-34  Score=301.54  Aligned_cols=266  Identities=23%  Similarity=0.313  Sum_probs=199.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCe-----
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDE-----  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~-----  426 (662)
                      ++|+..+.||+|+||.||+|.+..+++.||+|.+....  ......+.+|+.++++++ |+||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999998899999999886542  223457888999999995 6999999999877665     


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeecc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFG  505 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfG  505 (662)
                      .++||||+++ +|.+++..........+++..++.++.||++||.|||+   .+++||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 88888865432223468999999999999999999999   89999999999999998 8899999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      +++.+..... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||.........  ..... ......
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~-~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFK-LLGTPT  232 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHH-HhCCCC
Confidence            9986543221 1222356889999998765 45789999999999999999999999754332211  11110 000000


Q ss_pred             --cc-cc------c-CCC-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 --IT-RA------I-DPT-----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 --~~-~~------i-d~~-----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .. ..      . -+.     +....+.....+.+++.+||+.||.+||++.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence              00 00      0 000     001112345668899999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.1e-35  Score=297.42  Aligned_cols=248  Identities=23%  Similarity=0.333  Sum_probs=204.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +|+..++||.|+||.||++....++..||+|.+....   ....+.+.+|++++++++||||+++++++......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788899999999999999998889999999997542   2456789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++...     ..+++.+...++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999998432     468899999999999999999999   8999999999999999999999999999887644


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ..  ......|+..|+|||.+.+...+.++|+||||+++|+|++|+.||........    ++.......         .
T Consensus       153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~---------~  217 (258)
T cd05578         153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET---------A  217 (258)
T ss_pred             Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc---------c
Confidence            32  22335688899999999888899999999999999999999999986543211    111111110         1


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPST--RRVV  626 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~--~eVl  626 (662)
                      ....+......+.+++.+||+.||.+||++  +|++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            111222344778899999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.5e-34  Score=302.15  Aligned_cols=265  Identities=25%  Similarity=0.317  Sum_probs=201.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccC-----
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----  425 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----  425 (662)
                      +.++|+..+.||+|++|.||+|....+++.||+|++....  ......+.+|++++++++||||+++++++....     
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~   84 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF   84 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence            4578899999999999999999998889999999997543  223456788999999999999999999987654     


Q ss_pred             -----eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeE
Q 040242          426 -----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       426 -----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                           ..++|+||+++ +|...+...    ...+++.+++.++.|++.||+|||+   .+|+|+||||+||++++++.+|
T Consensus        85 ~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          85 KKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             cccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEE
Confidence                 78999999975 676766433    3468999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          501 LGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       501 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      |+|||++...............++..|+|||.+.+ ...+.++|||||||+++||++|+.||..........  . +.+.
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~--~-~~~~  233 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE--L-ISRL  233 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHH
Confidence            99999998765443222223356788999998754 357889999999999999999999997543322111  1 1111


Q ss_pred             hhcC---c--------cccccCC------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQG---Q--------ITRAIDP------TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~---~--------~~~~id~------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....   .        .....++      .........+..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1000   0        0000010      0000011235678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-34  Score=292.90  Aligned_cols=266  Identities=26%  Similarity=0.334  Sum_probs=218.1

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .|+..+.||+|.-|+||++.+.+++..+|+|++.+..   +....+...|-++|+.+.||.+..|++.++.++..||+||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            3556788999999999999999988999999997764   3445567789999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||+||+|..++++..   ...++.....-.+..++.||.|||.   .|||.|||||+||||.++|.+-|+||.|+.....
T Consensus       158 yCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             cCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            999999999997665   5678999999999999999999999   9999999999999999999999999998754311


Q ss_pred             ---------------------------------C-CC---------------------CcceecccCCcccCcccccCCC
Q 040242          513 ---------------------------------N-IN---------------------PQTTHIVGTLGYLAPELTRTGK  537 (662)
Q Consensus       513 ---------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~  537 (662)
                                                       . ..                     ......+||-.|+|||++.+..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 00                     0112357999999999999999


Q ss_pred             CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC--CCCCHHHHHHHHHHHHHccCCC
Q 040242          538 ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPH  615 (662)
Q Consensus       538 ~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l--~~~~~~~~~~l~~l~~~Cl~~d  615 (662)
                      .+.+.|.|+|||+||||+.|+.||.+.......               ..++-..+  .+. +.....+.+||++.|..|
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl---------------~NIv~~~l~Fp~~-~~vs~~akDLIr~LLvKd  375 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL---------------RNIVGQPLKFPEE-PEVSSAAKDLIRKLLVKD  375 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH---------------HHHhcCCCcCCCC-CcchhHHHHHHHHHhccC
Confidence            999999999999999999999999987654322               22222222  222 255677889999999999


Q ss_pred             CCCCCC----HHHHHHH---------HhcCCCCCCCCCCCC
Q 040242          616 PDFRPS----TRRVVQF---------LLRDASLPQAPLDIH  643 (662)
Q Consensus       616 P~~RPt----~~eVl~~---------L~~~~~~p~~p~~~~  643 (662)
                      |++|--    +.||-++         |.+...+|..|....
T Consensus       376 P~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~~d  416 (459)
T KOG0610|consen  376 PSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIPKPVD  416 (459)
T ss_pred             hhhhhccccchHHhhcCccccCCChhheeccCCCcCCCccc
Confidence            999998    8888763         455666677666544

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-34  Score=300.80  Aligned_cols=266  Identities=25%  Similarity=0.328  Sum_probs=198.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccC-------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-------  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-------  425 (662)
                      ++|+..+.||+|++|.||+|....++..||||++....  ......+.+|+.++++++||||++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            56888999999999999999998899999999986542  222345678999999999999999999987654       


Q ss_pred             -eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 -ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                       ..++||||+. ++|.+++...    ...+++.+.+.++.|+++||+|||+   .+++|+||||+||+++.++.+||+||
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df  163 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF  163 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence             3599999995 5787777432    3468999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCC---cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh
Q 040242          505 GLARAYDHNINP---QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       505 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      |++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............+....
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~  243 (310)
T cd07865         164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI  243 (310)
T ss_pred             CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999876443221   11234578899999987654 36889999999999999999999997654332222222211100


Q ss_pred             hcC-----ccccccCC-CC-CCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQG-----QITRAIDP-TL-DYF---------DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~~-----~~~~~id~-~l-~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...     ......+. .+ ...         .......+.+++.+||+.||.+||++.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000     00000000 00 000         00123456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.4e-34  Score=300.86  Aligned_cols=278  Identities=27%  Similarity=0.353  Sum_probs=204.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l  429 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||+|++.....  .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4678899999999999999999988999999999865422  2233567899999999999999999998654  46899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||++ ++|.+++...    ...+++.++..++.|+++||+|||+   .+++||||||+||+++.++.+||+|||++..
T Consensus        86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence            999996 5888887543    3568999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHH-------HHHHh
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDW-------VRELH  580 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~-------~~~~~  580 (662)
                      ...... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.......... +.++       .+...
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF  236 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence            654321 2222345788999998865 457899999999999999999999997554322111 1110       00000


Q ss_pred             hcCcccccc--CCC-CCCC---CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH-hcCCCCCCCCC
Q 040242          581 SQGQITRAI--DPT-LDYF---DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL-LRDASLPQAPL  640 (662)
Q Consensus       581 ~~~~~~~~i--d~~-l~~~---~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L-~~~~~~p~~p~  640 (662)
                      .........  ... ....   .......+.+++.+|++.||++||++.+++++- -+..++|..|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~  303 (309)
T cd07845         237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPE  303 (309)
T ss_pred             hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCC
Confidence            000000000  000 0000   011245677899999999999999999999753 23345554433

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.7e-34  Score=296.85  Aligned_cols=258  Identities=22%  Similarity=0.260  Sum_probs=196.7

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccceeeeeeEecc--CeeeEEEe
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQ--DELLLVYD  432 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E  432 (662)
                      |+..+.||+|+||.||+|....++..||+|++.... .........|+.++.++. |+|++++++++...  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            456788999999999999998889999999986542 222234467888898885 99999999999887  88999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++ ++|.+++...    ...++|.+++.++.|++.||.|||+   .+++||||+|+||+++. +.+||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            996 5887777443    3468999999999999999999999   89999999999999999 9999999999987643


Q ss_pred             CCCCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh-----------
Q 040242          513 NINPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH-----------  580 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-----------  580 (662)
                      ...  .....++..|+|||.+. ++.++.++|||||||++|||++|+.||......+   ...+.....           
T Consensus       152 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         152 KPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             CCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhh
Confidence            321  12345788999999764 4567889999999999999999999997543321   111111111           


Q ss_pred             hcCccccccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQGQITRAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~~~~~~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..........+..     ..........+.+++.+||+.+|++||++.+++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            1111111111110     01112346789999999999999999999999874

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.8e-34  Score=292.03  Aligned_cols=251  Identities=25%  Similarity=0.413  Sum_probs=207.8

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||+++...++..+++|++...  ......++..|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999999888999999998754  234456788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++.+.. .....+++..++.++.|+++||.|||+   .+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            99999999986532 123568999999999999999999999   89999999999999999999999999999876554


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                         ......++..|++||.+.+..++.++|+||+|+++|||++|+.||.......   +...+    ..        ...
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~----~~--------~~~  218 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKV----QR--------GKY  218 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----hc--------CCC
Confidence               1222457889999999988889999999999999999999999997554221   11111    11        111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..........+..++.+|++.+|++||++.+++++
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            22233456678999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.1e-34  Score=290.54  Aligned_cols=253  Identities=23%  Similarity=0.412  Sum_probs=208.7

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||++....++..+++|++.....  ...+++..|++.+++++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            47778999999999999999988899999999976532  5567789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..... ....+++.++..++.++++||.|||+   .+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999865421 13678999999999999999999999   89999999999999999999999999999876554


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      . .......|++.|+|||......++.++||||+|+++++|++|+.|+.......      ...... ..        ..
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~--------~~  220 (258)
T cd08215         157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KG--------QY  220 (258)
T ss_pred             c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cC--------CC
Confidence            2 12233468889999999988889999999999999999999999987553211      111111 11        11


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...+......+.+++.+||..+|++||++.+++++
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11222345678889999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=297.21  Aligned_cols=260  Identities=27%  Similarity=0.362  Sum_probs=203.3

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |+..+.||+|++|.||++....+++.+++|++.....  .....+..|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            4567889999999999999988899999999865532  34567889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++ +|.+++...    ...+++.+++.++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||.+.......
T Consensus        81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            65 888887543    2468999999999999999999999   899999999999999999999999999998765543


Q ss_pred             CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC------cccc
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG------QITR  587 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~------~~~~  587 (662)
                       .......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+....   +.+.....      ...+
T Consensus       153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK---IFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHcCCCchHhcccchh
Confidence             122234578899999988766 789999999999999999999999976543222111   00000000      0000


Q ss_pred             -----------ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          588 -----------AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       588 -----------~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                 ..+.............+.+++.+||+.||.+||++++++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                       00000011122346778999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.6e-34  Score=299.41  Aligned_cols=266  Identities=25%  Similarity=0.348  Sum_probs=198.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|++|.||+|....+++.||+|++....  ....+.+.+|++++++++|+||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999998889999999986542  2334678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~  511 (662)
                      |++ ++|.+++....   ...+++.....++.||+.||+|||+   .+++|+||+|+||+++. ++.+||+|||++....
T Consensus        82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            995 57877774332   2345778888999999999999999   89999999999999985 5579999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHHHHHHHhhcC-----c
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVRELHSQG-----Q  584 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~~~~~~~~~~-----~  584 (662)
                      .... ......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.......... ...+........     .
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        155 IPVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCcc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            3221 12234568899999988653 57899999999999999999999997543322111 000000000000     0


Q ss_pred             c---ccc----cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 I---TRA----IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~---~~~----id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +   ...    ....+....+.....+.+++.+|++.+|++||++.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0   000    0000011122334567889999999999999999999973

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-34  Score=306.66  Aligned_cols=273  Identities=24%  Similarity=0.322  Sum_probs=202.3

Q ss_pred             hHHHHHhc----cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeee
Q 040242          347 YSELYSAT----KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       347 ~~el~~at----~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      .+|+..++    ++|...+.||+|++|.||+|+...+|+.||||++...  .......+.+|+.++++++|+||++++++
T Consensus         3 ~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~   82 (342)
T cd07879           3 REEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV   82 (342)
T ss_pred             hhhhhhhhhccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhhe
Confidence            34455443    7899999999999999999999888999999998653  22334568899999999999999999999


Q ss_pred             EeccC------eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          421 CRKQD------ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       421 ~~~~~------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      +....      ..++|+||+. .+|..++       ...+++..+..++.|++.||.|||+   .+++||||||+||+++
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~  151 (342)
T cd07879          83 FTSAVSGDEFQDFYLVMPYMQ-TDLQKIM-------GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVN  151 (342)
T ss_pred             ecccccCCCCceEEEEecccc-cCHHHHH-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEC
Confidence            86543      4699999995 4666654       3358899999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      .++.+||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||............
T Consensus       152 ~~~~~kL~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~  227 (342)
T cd07879         152 EDCELKILDFGLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQI  227 (342)
T ss_pred             CCCCEEEeeCCCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            9999999999998865332    223457889999998866 46889999999999999999999999865422111100


Q ss_pred             HHH--------HHHhhcCccccccC--CC-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCC
Q 040242          574 DWV--------RELHSQGQITRAID--PT-----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDAS  634 (662)
Q Consensus       574 ~~~--------~~~~~~~~~~~~id--~~-----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~  634 (662)
                      ...        ............+.  +.     +....+.....+.+++.+||+.||.+||++.+++++  +++..+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         228 LKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000        00000000000000  00     000011234567899999999999999999999965  665544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=308.77  Aligned_cols=246  Identities=28%  Similarity=0.414  Sum_probs=207.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .|...+-||.|+||.||.+.+..+.+.||||++...   +.+.+.+++.|+..|.+++|||.+.+.||+......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            356677899999999999999999999999999654   34556789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      || -|+-.++|.-.    +++|...++..|+.+.+.||+|||+   .+.||||||+.||||++.|.|||+|||.+.....
T Consensus       107 YC-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP  178 (948)
T ss_pred             HH-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc
Confidence            99 77888888544    5788999999999999999999999   8999999999999999999999999999987544


Q ss_pred             CCCCcceecccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          513 NINPQTTHIVGTLGYLAPELT---RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .     ...+|||.|||||++   ..+.|+-|.||||+|++..||.-.++|+.......-  |..          +.+.-
T Consensus       179 A-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA--LYH----------IAQNe  241 (948)
T KOG0577|consen  179 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH----------IAQNE  241 (948)
T ss_pred             h-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH--HHH----------HHhcC
Confidence            3     346899999999976   357899999999999999999999999875432111  110          12222


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .|.|.  ..+....+..++..||+.-|.+|||..+++++
T Consensus       242 sPtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  242 SPTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             CCCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            34443  44667788899999999999999999999874

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.6e-34  Score=297.57  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=201.3

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ..+||+|++|.||++....++..||||++..........+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            46799999999999999889999999998766555667799999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++..      ..+++.....++.|++.+|+|||+   .+++|+||+|+||++++++.++|+|||++....... ....
T Consensus       105 ~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~  174 (292)
T cd06657         105 TDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRK  174 (292)
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-cccc
Confidence            998742      347899999999999999999999   899999999999999999999999999987654322 1223


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...++..|+|||.+.+..++.++||||+|+++|||++|+.||.........   ..+..         .+.+.+.. ...
T Consensus       175 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~---------~~~~~~~~-~~~  241 (292)
T cd06657         175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRD---------NLPPKLKN-LHK  241 (292)
T ss_pred             ccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---------hCCcccCC-ccc
Confidence            346889999999998888899999999999999999999998754322111   11111         11111111 112


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....+..++.+||+.+|.+||++.+++++
T Consensus       242 ~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         242 VSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            34457788999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.1e-34  Score=304.81  Aligned_cols=263  Identities=24%  Similarity=0.294  Sum_probs=201.5

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC-----
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----  425 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----  425 (662)
                      ..++|+..+.||+|+||.||++....++..||+|++...  ......++.+|+.++++++|+||+++++++....     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            447899999999999999999999889999999998643  2334567788999999999999999999886442     


Q ss_pred             -eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 -ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 -~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                       ..++||||+. ++|.+.+.       ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQ-------MDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccC
Confidence             5799999995 58888773       238888999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-H--------HHH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-L--------VDW  575 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~~~  575 (662)
                      |+++......  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+...... +        .++
T Consensus       163 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  240 (353)
T cd07850         163 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEF  240 (353)
T ss_pred             ccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence            9998764432  1223457899999999988889999999999999999999999997543221110 0        000


Q ss_pred             -------HHHHhhcCc------cccccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 -------VRELHSQGQ------ITRAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 -------~~~~~~~~~------~~~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                             +........      ..+.....+     ..........+.+++.+||+.||++||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   000000000      001111111     01122345668899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-34  Score=288.57  Aligned_cols=248  Identities=28%  Similarity=0.484  Sum_probs=205.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|+..+.||+|++|.||++.....+..|++|.+.....  ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            46778999999999999999988889999999976643  4567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...     ..+++..+..++.|++.+|.|||+   .+++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999998532     468999999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ... .....++..|+|||...+..++.++|||++|+++++|++|+.|+........    .|  .. ...     ..+. 
T Consensus       153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~----~~--~~-~~~-----~~~~-  218 (254)
T cd06627         153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA----LF--RI-VQD-----DHPP-  218 (254)
T ss_pred             ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH----HH--HH-hcc-----CCCC-
Confidence            321 2334678999999999887889999999999999999999999875432110    01  10 000     0111 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                        .+......+..++.+||+.+|++||++.+++.
T Consensus       219 --~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         219 --LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence              12233566789999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=289.63  Aligned_cols=251  Identities=24%  Similarity=0.374  Sum_probs=201.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEecc--Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  427 (662)
                      .+|+..+.||+|++|.||+|.+..++..|++|.+...     ..+..+.+.+|++++++++|+||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4688899999999999999999888999999987532     234456889999999999999999999998654  468


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++++||+++++|.+++..     ...+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence            899999999999999853     2347888999999999999999998   89999999999999999999999999999


Q ss_pred             ccccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +.......  .......++..|+|||.+.+..++.++|||||||+++||++|+.||........  ..    +...    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~----~~~~----  223 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IF----KIAT----  223 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HH----HHHc----
Confidence            86543211  112234688999999999888899999999999999999999999975432211  11    1000    


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ....   ...+....+.+.+++.+|+. +|.+||+..+++.+
T Consensus       224 -~~~~---~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         224 -QPTK---PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -CCCC---CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             0011   22334455678889999999 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-35  Score=316.19  Aligned_cols=257  Identities=29%  Similarity=0.425  Sum_probs=212.0

Q ss_pred             cccceeeeeCceEEEEEEeCCCC----cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ...++||+|+||+||||.+...|    .+||+|++... ..+...++++|+.+|.+++||||++|+|+|.... +.||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            34689999999999999985444    46899988665 4556789999999999999999999999997765 889999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||+.|+|.++++.+    +..+.-+..+.|..|||+||.|||+   +.++||||-++||||.+-..+||.|||+++....
T Consensus       778 ~mP~G~LlDyvr~h----r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH----RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             hcccchHHHHHHHh----hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999776    5668888999999999999999998   8999999999999999999999999999998876


Q ss_pred             CCCCcc-eecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          513 NINPQT-THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       513 ~~~~~~-~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      +..... ....-.+.|||-|.+....++.++|||||||.+||++| |..|+++....+.       ...++.|.      
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~ge------  917 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKGE------  917 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhccc------
Confidence            543322 22334678999999999999999999999999999999 9999987654322       22222222      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ  637 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  637 (662)
                       +| ..++-....+..++.+||..|+..||+++++...+.+-+.-|+
T Consensus       918 -RL-sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq  962 (1177)
T KOG1025|consen  918 -RL-SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ  962 (1177)
T ss_pred             -cC-CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence             12 3355667778999999999999999999999988765544433

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.1e-33  Score=300.87  Aligned_cols=264  Identities=25%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhcc-ccccceeeeeeEecc--Ceee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ--DELL  428 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~--~~~~  428 (662)
                      .++|+..+.||+|+||.||+|.+..++..+|+|++...  .......+..|+.+++++ +|+||++++++|...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788889999999999999999888999999988542  233445677899999999 999999999998654  3689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||++ ++|..++..      ..++|..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.
T Consensus        86 lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~  155 (337)
T cd07852          86 LVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR  155 (337)
T ss_pred             EEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence            9999996 588888742      267899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC----CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH-------
Q 040242          509 AYDHNIN----PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV-------  576 (662)
Q Consensus       509 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------  576 (662)
                      .......    .......|+..|+|||.+.+ ...+.++||||||+++|||++|+.||...............       
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~  235 (337)
T cd07852         156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE  235 (337)
T ss_pred             ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            6644322    22233568899999998754 45788999999999999999999999754432221110000       


Q ss_pred             -----HHHhhcCccccccC----CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 -----RELHSQGQITRAID----PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 -----~~~~~~~~~~~~id----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ..... ..+.+.+.    ..+..........+.+++.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFA-ATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhH-HHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                 00000 00011110    00111111245678899999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.6e-34  Score=290.98  Aligned_cols=243  Identities=23%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||.|++|.||+++...++..+++|++....   ....+.+.+|+.++++++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999998889999999986542   23456789999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++.+.     ..+++.++..++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~  150 (262)
T cd05572          81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW  150 (262)
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence            9999543     348899999999999999999999   899999999999999999999999999998765432  223


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...++..|++||.+....++.++|+||||+++|||++|..||........    +....... +       .....++..
T Consensus       151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~-~-------~~~~~~~~~  218 (262)
T cd05572         151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILK-G-------NGKLEFPNY  218 (262)
T ss_pred             cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhc-c-------CCCCCCCcc
Confidence            34678999999999888899999999999999999999999976542111    11111110 0       011112222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPS-----TRRVVQ  627 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  627 (662)
                      ....+..++.+||+.+|++||+     +.|+++
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            3567899999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.2e-34  Score=294.08  Aligned_cols=243  Identities=22%  Similarity=0.322  Sum_probs=190.2

Q ss_pred             eeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHh---hccccccceeeeeeEeccCeeeEEEeccC
Q 040242          362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSM---GRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l---~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +||+|+||.||++....+++.+|+|.+....   ......+.+|..++   ...+|+|++++++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998889999999886542   12223344454433   33479999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++..     ...+++.....++.|++.||.|||+   .+++||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-  151 (279)
T cd05633          81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (279)
T ss_pred             CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence            9999998853     3458999999999999999999999   899999999999999999999999999987654322 


Q ss_pred             CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                        .....|+..|+|||.+.. ..++.++||||+||+++||++|+.||..........+    ....      ......  
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~------~~~~~~--  217 (279)
T cd05633         152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMT------LTVNVE--  217 (279)
T ss_pred             --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHh------hcCCcC--
Confidence              123468999999998864 4578999999999999999999999975433221111    1110      011111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                       .+......+.+++.+||+.||++||     ++.|++++
T Consensus       218 -~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         218 -LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             2233456788899999999999999     59999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-33  Score=291.88  Aligned_cols=261  Identities=28%  Similarity=0.357  Sum_probs=197.6

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhcc---ccccceeeeeeEeccCe-----
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRL---RHRNLVQLHGWCRKQDE-----  426 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~~~~~-----  426 (662)
                      |+..+.||+|++|.||+|+...++..||+|++....  ......+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567789999999999999998889999999996432  22234566777766655   69999999999988776     


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .+++|||++ ++|.+++....   ...+++.+++.++.|+++||.|||+   .+++|+||+|+||+++.++.+||+|||+
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence            999999996 58888885432   2358999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc-
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI-  585 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~-  585 (662)
                      +..+.....  .....++..|+|||.+.+..++.++|||||||++|||++|+.||........  +..+.......... 
T Consensus       154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  229 (287)
T cd07838         154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDKIFDVIGLPSEEE  229 (287)
T ss_pred             ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHHHHHHcCCCChHh
Confidence            987654322  1233578899999999888899999999999999999999999875433211  11111110000000 


Q ss_pred             --------ccccCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 --------TRAIDPT----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 --------~~~id~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                              .......    ...........+.+++.+||+.||++||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                    0000000    011112344667899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.9e-34  Score=303.60  Aligned_cols=265  Identities=24%  Similarity=0.340  Sum_probs=201.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Ce
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  426 (662)
                      .++|...+.||+|+||+||++....++..||||++...  .......+..|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            46788999999999999999999889999999998653  233455678899999999999999999988654     24


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+. ++|.+++..     ...+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            799999995 788888753     2458899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH--------
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR--------  577 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------  577 (662)
                      ++...... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||.............-+.        
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            98764432 12223457889999998764 468899999999999999999999997543222111110000        


Q ss_pred             HHhhcCccc-------cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          578 ELHSQGQIT-------RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       578 ~~~~~~~~~-------~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .........       ...++......+.....+.+++++||+.+|++||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000000       000111111112345668899999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.5e-34  Score=291.64  Aligned_cols=246  Identities=25%  Similarity=0.389  Sum_probs=197.9

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|++|.||+++...+++.+++|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988899999999866533   4566789999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC----
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN----  515 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~----  515 (662)
                      .+++...     ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.++|+|||++........    
T Consensus        81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9998542     368999999999999999999999   8999999999999999999999999999886543311    


Q ss_pred             ---CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          516 ---PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       516 ---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                         .......++..|++||.......+.++||||||++++||++|+.||........      ...... +.    ....
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~----~~~~  221 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILN-GK----IEWP  221 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-CC----cCCC
Confidence               122334678899999999888899999999999999999999999975542211      111110 11    0000


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                       ..  ......+..++.+|++.+|++||++.+|.+.|+
T Consensus       222 -~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 -ED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -cc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             00  012567789999999999999999966555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1e-33  Score=295.36  Aligned_cols=253  Identities=26%  Similarity=0.415  Sum_probs=196.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|++|.||+|....++..||||++.... .....++..|+.++.+.. |+||++++++|......+++||
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e   94 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME   94 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence            55778899999999999999998889999999997543 334456777887777765 9999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |++ ++|.+++...    ...+++..+..++.|+++||+|||+.  .+++||||+|+||++++++.+||+|||++..+..
T Consensus        95 ~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          95 LMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             ccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            984 5777766432    34689999999999999999999972  5899999999999999999999999999886543


Q ss_pred             CCCCcceecccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGK----ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ...  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.||.......+ .    ........     
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~----~~~~~~~~-----  235 (296)
T cd06618         168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-V----LTKILQEE-----  235 (296)
T ss_pred             CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-H----HHHHhcCC-----
Confidence            221  12235788999999986543    78899999999999999999999965322111 1    11111110     


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .+... ........+.+++.+||+.||.+||++.+++++
T Consensus       236 -~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 -PPSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             -CCCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence             01111 011234568899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.1e-36  Score=290.48  Aligned_cols=248  Identities=24%  Similarity=0.405  Sum_probs=209.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      |.+..+||+|+||.|||+.++..|..+|||.+..++  ..+++..|+.++++.+.|++|+++|.+.....+++|||||-.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA  112 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA  112 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence            666889999999999999999999999999986653  457889999999999999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |++.+++.-.    +++|++.++-.+++..++||+|||.   ..-+|||||+.||||+.+|.+||+|||.+..+.... .
T Consensus       113 GSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A  184 (502)
T KOG0574|consen  113 GSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A  184 (502)
T ss_pred             CcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence            9999999543    6889999999999999999999999   678999999999999999999999999998654322 2


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC-CC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DY  595 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~~  595 (662)
                      ....+.||+.|||||++..-.|..++||||+|+...||.-|++||.+-.+---.              ..-.-.|.- -.
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPPTF~  250 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPPTFK  250 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCCCCC
Confidence            334578999999999998888999999999999999999999999754321000              000011111 12


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .++.....+.++++.||-.+|++|-|+-+++++
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            345667889999999999999999999999885

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-34  Score=318.62  Aligned_cols=270  Identities=20%  Similarity=0.287  Sum_probs=190.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCC-cEEEEE------------------EeeccchhhHHHHHHHHHHhhccccccc
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTG-LEVAIK------------------RVAHNSRQGMKEFVAEITSMGRLRHRNL  414 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g-~~vavK------------------~~~~~~~~~~~~f~~Ei~~l~~l~H~ni  414 (662)
                      .++|+..+.||+|+||+||++..+... ...+.|                  .+. ........+.+|+.++++++|+||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            367999999999999999998764322 111211                  111 122334568899999999999999


Q ss_pred             eeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       415 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      +++++++...+..++|+|++ .++|.+++..............+...++.||+.||.|||+   .+|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence            99999999999999999999 5677777654322112223455677899999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC-CCcccchhhHHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP-IEPQRTAMELVLV  573 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~  573 (662)
                      .++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.+ +..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987765433333446799999999999988999999999999999999998754 4322211111111


Q ss_pred             HHHHHHhh-cC-------ccccccCCC-C----CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          574 DWVRELHS-QG-------QITRAIDPT-L----DYF-----DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       574 ~~~~~~~~-~~-------~~~~~id~~-l----~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.+...-. ..       ++.+.++.. +    ...     .......+.+++.+||+.||.+||++.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11110000 00       000000000 0    000     00112346677889999999999999999974

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-33  Score=292.47  Aligned_cols=263  Identities=27%  Similarity=0.381  Sum_probs=200.0

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |+..+.||+|++|+||+|....+++.|+||++..... .......+|+..+.+++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5667899999999999999988889999999865422 22334567899999999 999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                       +|+|.+++....   ...+++.++..++.|++++|.|||+   .+++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             889998885442   3468999999999999999999999   899999999999999999999999999998654322


Q ss_pred             CCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HH---------HHHHHHhhcC
Q 040242          515 NPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LV---------DWVRELHSQG  583 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~---------~~~~~~~~~~  583 (662)
                        ......++..|+|||.+. ...++.++||||||++++||++|+.||.......... ..         .|........
T Consensus       154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence              222346788999999774 4457899999999999999999999987554322211 00         1111110011


Q ss_pred             ccccccCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPT----LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~----l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....+...    +..........+..++++||+.+|++||+++|++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            111111100    011111124678899999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.4e-34  Score=300.63  Aligned_cols=265  Identities=26%  Similarity=0.355  Sum_probs=206.6

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccC-----eee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-----ELL  428 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~  428 (662)
                      +|+..+.||+|++|.||+|+...++..||+|++....  ....+.+.+|+.++++++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998889999999987643  445577899999999999999999999987775     789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||++ ++|.+++...     ..+++..++.++.|+++||.|||+   .+++||||||+||+++.++.++|+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            9999997 5888888533     368999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC--CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh----
Q 040242          509 AYDHNIN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS----  581 (662)
Q Consensus       509 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~----  581 (662)
                      .......  .......++..|+|||.+.+. .++.++||||||+++++|++|+.||...........   +.....    
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~~~~~~~  228 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEVLGTPSE  228 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHhcCCCCh
Confidence            7655421  122334678899999999877 789999999999999999999999976543221111   110000    


Q ss_pred             -------cCccccccC---C----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 040242          582 -------QGQITRAID---P----TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRD  632 (662)
Q Consensus       582 -------~~~~~~~id---~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  632 (662)
                             .......+.   .    .+..........+.+++.+||+.+|.+||++.+++++  +.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence                   000000000   0    0011112245668899999999999999999999985  5544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.4e-34  Score=298.34  Aligned_cols=267  Identities=25%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEecc-------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-------  424 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-------  424 (662)
                      .++|+..++||+|++|.||+|....++..++||++.....  .....+.+|++++++++|+||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999988899999999865422  2234567899999999999999999987543       


Q ss_pred             -CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          425 -DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       425 -~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                       ...++|+||+. ++|...+...    ...+++.++..++.|+++||.|||+   .+++|+||||+||++++++.+||+|
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence             34699999996 4676666433    3468999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCC----------cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH
Q 040242          504 FGLARAYDHNINP----------QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL  572 (662)
Q Consensus       504 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l  572 (662)
                      ||+++........          ......+++.|+|||.+.+. .++.++|||||||++|||++|+.||...........
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~  238 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL  238 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999865433211          11234568889999987654 578999999999999999999999975543322111


Q ss_pred             HHHHHHHhhc------Cccccc--------cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          573 VDWVRELHSQ------GQITRA--------IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       573 ~~~~~~~~~~------~~~~~~--------id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..........      ..+...        ..+.+..........+.+++.+|++.||.+|||+.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         239 IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1110000000      000000        0111100011223567899999999999999999999853

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-34  Score=294.55  Aligned_cols=249  Identities=24%  Similarity=0.345  Sum_probs=211.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .-|...+.||+|.|..|-++++.-+|.+||||++.+..  .-....+.+|++.|+.++|||||+|++.......+|||.|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            34666788999999999999998899999999997753  3334578899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe-CCCCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI-DADLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DfGla~~~~  511 (662)
                      .=.+|+|.++|..+    ...+++....+.+.||..|+.|+|+   ..+|||||||+||.+ ..-|-+||.|||++..+.
T Consensus        98 LGD~GDl~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             ecCCchHHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            99999999999776    4668899999999999999999999   899999999999976 456889999999999887


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      .+.  ..+..+|...|-|||++.+..| .++.||||+|||||.|+||+.||+.....+...               .++|
T Consensus       171 PG~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImD  233 (864)
T KOG4717|consen  171 PGK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMD  233 (864)
T ss_pred             Ccc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhc
Confidence            653  4455689999999999988776 467899999999999999999998665543322               2222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      -. ...+.....++.+|+..||..||.+|-+.+||+..
T Consensus       234 CK-YtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  234 CK-YTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             cc-ccCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            22 23455677888999999999999999999999864

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.9e-34  Score=294.27  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...+.||+|++|.||++....++..|++|++...   .....+.+..|+.++++++ |+||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688889999999999999999889999999998653   2334567889999999998 99999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...     ..+++..++.++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            9999999999998543     369999999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCC-------------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH
Q 040242          511 DHNIN-------------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV  571 (662)
Q Consensus       511 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  571 (662)
                      .....                   .......++..|+|||......++.++||||||++++++++|+.||.......  .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~  230 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--T  230 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH--H
Confidence            54321                   12223457899999999988889999999999999999999999998554211  1


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST----RRVVQ  627 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~----~eVl~  627 (662)
                       ...+.             ......+......+.+++.+||+.+|.+||++    +++++
T Consensus       231 -~~~~~-------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 -FQKIL-------------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -HHHHH-------------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence             11111             00011222335678899999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3e-33  Score=287.56  Aligned_cols=249  Identities=23%  Similarity=0.274  Sum_probs=194.1

Q ss_pred             HHHHhccCCccccee--eeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          349 ELYSATKGFREKNLV--GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       349 el~~at~~f~~~~~L--G~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++....++|+..+.+  |+|+||.||++..+.++..+|+|.+........     |+.....+ +|+|++++++++...+
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~   82 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK   82 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence            344445666666666  999999999999988999999999865422211     22222222 6999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeec
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDF  504 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Df  504 (662)
                      ..++||||+++++|.+++...     ..+++.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|+||
T Consensus        83 ~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         83 GHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             eeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            999999999999999998543     368999999999999999999999   8999999999999999998 9999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+++.....     ....++..|+|||++.+..++.++||||||+++|||++|+.||...... ......+....     
T Consensus       155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----  223 (267)
T PHA03390        155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-----  223 (267)
T ss_pred             ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-----
Confidence            998865432     1235789999999998888999999999999999999999999743322 12222222211     


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-TRRVVQ  627 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~  627 (662)
                           .... .........+.+++.+||+.+|.+||+ ++++++
T Consensus       224 -----~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 -----QKKL-PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -----cccC-CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence                 0111 111234566888999999999999996 688875

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.6e-33  Score=296.87  Aligned_cols=260  Identities=22%  Similarity=0.287  Sum_probs=195.1

Q ss_pred             ceeeee--CceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSG--GFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G--~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ..||+|  +||+||++++..+|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            356666  8999999999889999999998653  233457788999999999999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|.+++....   ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.++++||+.+.........
T Consensus        84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99999986542   2458899999999999999999998   89999999999999999999999999865433221111


Q ss_pred             c------ceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH---------
Q 040242          517 Q------TTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL---------  579 (662)
Q Consensus       517 ~------~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~---------  579 (662)
                      .      .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........  ........         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~  235 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITT  235 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccc
Confidence            0      0112345679999998663  478999999999999999999999975432211  11100000         


Q ss_pred             --------------hhc---------CccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 --------------HSQ---------GQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 --------------~~~---------~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                    ...         +......+..+ ..........+.+|+++||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         236 FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                          000         00000011111 11123456678999999999999999999999874

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2e-33  Score=295.11  Aligned_cols=248  Identities=29%  Similarity=0.415  Sum_probs=198.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +.|+..+.||+|++|.||+|+...++..+++|.+...   .....+++.+|+++++.++|+|++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466678899999999999999888999999998642   3344567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+. |+|.+++...    ...+++.++..++.|++.||.|||+   .+++||||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  166 (308)
T cd06634          95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (308)
T ss_pred             EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence            9996 6887776433    3458899999999999999999999   899999999999999999999999999987654


Q ss_pred             CCCCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..     ....++..|+|||.+.   ....+.++|||||||++|||++|+.|+.........  ..+.     .+.    
T Consensus       167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~-----~~~----  230 (308)
T cd06634         167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL--YHIA-----QNE----  230 (308)
T ss_pred             Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH--HHHh-----hcC----
Confidence            32     2345788999999874   356788999999999999999999998654322111  1111     110    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       .+..  ........+..++.+||+.+|.+||++.+++++.
T Consensus       231 -~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         231 -SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             -CCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence             0111  1223456688999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.1e-34  Score=303.03  Aligned_cols=266  Identities=24%  Similarity=0.373  Sum_probs=201.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEec----cCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~  427 (662)
                      ..+|+..+.||+|++|.||+|....++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367888999999999999999998899999999987542  2345677889999999999999999998753    3468


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+. ++|.+++...     ..+++.....++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence            99999995 6898888532     348999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC---cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH-------
Q 040242          508 RAYDHNINP---QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV-------  576 (662)
Q Consensus       508 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-------  576 (662)
                      .........   ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.............-.       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~  234 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE  234 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence            865432211   1123468899999998765 46889999999999999999999999754432211100000       


Q ss_pred             -HHHhhcCccccc---cCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 -RELHSQGQITRA---IDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 -~~~~~~~~~~~~---id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .+........+.   .....    ....+.....+.+++.+||+.+|++||++.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             000000000000   00000    11112345778999999999999999999999985

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=287.32  Aligned_cols=244  Identities=25%  Similarity=0.274  Sum_probs=190.8

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHH-hhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITS-MGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|++|.||+|....+++.||+|.+....   ......+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999998889999999986543   2223344555544 4455899999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      ++|.+++...     ..+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||+++....    
T Consensus        82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----  149 (260)
T cd05611          82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----  149 (260)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence            9999998532     458899999999999999999999   8999999999999999999999999999875433    


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                       .....++..|+|||.+.+..++.++||||||+++|||++|..||........  .     .....+...  ..+   ..
T Consensus       150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~-----~~~~~~~~~--~~~---~~  216 (260)
T cd05611         150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV--F-----DNILSRRIN--WPE---EV  216 (260)
T ss_pred             -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH--H-----HHHHhcccC--CCC---cc
Confidence             2234578899999999888889999999999999999999999975432211  0     111111100  001   11


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .......+.+++.+||+.+|++||++.++.+.|
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence            123456688999999999999999776555543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.7e-33  Score=292.32  Aligned_cols=256  Identities=22%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             CCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      +|+..+.||+|++|.||++...   .++..||||.+....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            3677889999999999999863   356889999986532    23345688999999999 599999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++..     ...+++.....++.|++++|.|||+   .+++||||+|+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence            999999999999999853     2458889999999999999999999   89999999999999999999999999998


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +..............|+..|+|||.+.+..  .+.++||||||+++|||++|+.||.......  ...+........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~---  227 (288)
T cd05583         153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKS---  227 (288)
T ss_pred             cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHcc---
Confidence            875543322233346889999999987655  7889999999999999999999986432111  011111111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          .+.   .+......+.+++.+||+.+|++|||+.+|.+.|+-
T Consensus       228 ----~~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 ----KPP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             ----CCC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence                111   122234557788999999999999999888776654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=5.2e-33  Score=292.57  Aligned_cols=245  Identities=27%  Similarity=0.422  Sum_probs=195.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      |...+.||+|++|+||+|+...++..|++|++...   .......+.+|+.++++++|+|++++++++......++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            44567799999999999999888999999998653   233446788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +. ++|.+++...    ...+++.++..++.|++.+|.|||+   .+++|+||+|+||+++.++.+||+|||++..... 
T Consensus       103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-  173 (313)
T cd06633         103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-  173 (313)
T ss_pred             CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC-
Confidence            95 6777777433    3458999999999999999999999   8999999999999999999999999998864322 


Q ss_pred             CCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          514 INPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                          .....|+..|+|||++.   .+.++.++|||||||++|||++|+.|+.........      ..... ..     .
T Consensus       174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~-~~-----~  237 (313)
T cd06633         174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-ND-----S  237 (313)
T ss_pred             ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHh-cC-----C
Confidence                12346888999999874   456888999999999999999999998754322111      11100 00     1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +..  ........+..++.+||+.+|.+||++.+++++
T Consensus       238 ~~~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 PTL--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             CCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111  111233457889999999999999999999975

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.3e-33  Score=291.68  Aligned_cols=252  Identities=22%  Similarity=0.340  Sum_probs=197.6

Q ss_pred             CCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          356 GFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      +|+..+.||+|+||.||++...   .+|..||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4677899999999999999874   368899999986532    22346678899999999 599999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++..     ...+++.....++.|+++||.|||+   .+++||||+|+||+++.++.+||+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence            999999999999999853     3457888999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +..............|+..|+|||.+...  ..+.++||||||+++|+|++|+.|+.......  ...++.......   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~---  227 (290)
T cd05613         153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---  227 (290)
T ss_pred             eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc---
Confidence            87654332333345688999999988653  46789999999999999999999986432211  111111111110   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQ  627 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  627 (662)
                          .+   .++......+..++.+|++.+|++||     +..+++.
T Consensus       228 ----~~---~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ----EP---PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CC---CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                11   12223456678999999999999997     5666655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=307.16  Aligned_cols=249  Identities=23%  Similarity=0.413  Sum_probs=197.1

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeec----cchhhHHHHHHHHHHhhccccccceeeeeeEeccC--eeeEEEec
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH----NSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--ELLLVYDY  433 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~----~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV~E~  433 (662)
                      ..+||+|.|-+||||.+..+|..||=-.++.    ......+.|..|+.+|+.|+||||++++.++.+..  ..-+|+|.
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL  124 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL  124 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence            4679999999999999988998887432221    23455688999999999999999999999887655  48899999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeeccccccccC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDH  512 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~~~~  512 (662)
                      |..|+|..|+++.     ..++.+...+|++||++||.|||+. .++|||||||..||+|+.+ |.|||+|+|||.....
T Consensus       125 ~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  125 FTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            9999999999665     3477889999999999999999985 5899999999999999765 8899999999998754


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .   ....+.|||.|||||+.. ..|.+..||||||++++||+|+..||..=....+..  .-|    ..|..-..+   
T Consensus       199 s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY--KKV----~SGiKP~sl---  265 (632)
T KOG0584|consen  199 S---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY--KKV----TSGIKPAAL---  265 (632)
T ss_pred             c---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH--HHH----HcCCCHHHh---
Confidence            3   233478999999999887 678999999999999999999999996322221111  111    112111111   


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRD  632 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  632 (662)
                          ..-...++.++|.+|+.. .++|||+.|+++  +|..+
T Consensus       266 ----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  266 ----SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ----hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence                112234578899999999 999999999997  56543

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-34  Score=300.92  Aligned_cols=250  Identities=24%  Similarity=0.370  Sum_probs=199.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeec--cchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~--~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +.|++.++||+||.+.||++... +...+|+|++..  ...+...-|.+|+..|.+|+ |.+|++|++|-..++.+|+||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s-~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNS-DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecC-CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            46888999999999999999884 455678776643  35566788999999999995 999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||= .-+|..+|.+..   .....| .+..+..||+.++.++|+   .+|||.||||.|+|+= .|.+||+|||+|..+.
T Consensus       440 E~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            986 678999996553   333445 677889999999999999   8999999999999884 5789999999999887


Q ss_pred             CCCC-CcceecccCCcccCcccccCC-----------CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          512 HNIN-PQTTHIVGTLGYLAPELTRTG-----------KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       512 ~~~~-~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      .+.. ......+||+.||+||.+...           +.++++||||+|||||+|+.|+.||.....       .|    
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~----  579 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI----  579 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH----
Confidence            6533 344567999999999987422           257899999999999999999999974321       11    


Q ss_pred             hhcCccccccCCCC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQGQITRAIDPTL-DYFDP-QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~~~~~~id~~l-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         .++....||.- .+++. .....+++++..||..||.+||+..|++++
T Consensus       580 ---aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 ---AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               13344556643 12221 122238999999999999999999999985

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=8.9e-33  Score=288.19  Aligned_cols=256  Identities=18%  Similarity=0.248  Sum_probs=187.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeeccchhh-----------HHHHHHHHHHhhccccccceeeeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQG-----------MKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~~~~~-----------~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      ++|+..++||+|+||+||+|....+   +..+++|.........           ......+...+..+.|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            6789999999999999999998766   5667777643322111           0122334455667789999999998


Q ss_pred             EeccC----eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          421 CRKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       421 ~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      +....    ..++++|++. .++.+.+..     ....++..+..++.|+++||.|||+   .+|+||||||+|||++.+
T Consensus        92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~  162 (294)
T PHA02882         92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGN  162 (294)
T ss_pred             eeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCC
Confidence            76544    3467788773 456555532     1235678889999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccCCCC------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH
Q 040242          497 LNPKLGDFGLARAYDHNIN------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL  570 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  570 (662)
                      +.++|+|||+++.+.....      .......||+.|+|||...+..++.++|||||||+++||++|+.||.........
T Consensus       163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~  242 (294)
T PHA02882        163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL  242 (294)
T ss_pred             CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence            9999999999987643211      1122346999999999999889999999999999999999999999865322211


Q ss_pred             H---HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          571 V---LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       571 ~---l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .   ..++..... .        +.+.  .......+.+++..|++.+|++||++.++.+.|.
T Consensus       243 ~~~~~~~~~~~~~-~--------~~~~--~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        243 IHAAKCDFIKRLH-E--------GKIK--IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHHhHHHHHHHhh-h--------hhhc--cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1   111211111 1        1110  1122466889999999999999999999998763

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-33  Score=299.25  Aligned_cols=270  Identities=23%  Similarity=0.321  Sum_probs=203.9

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      ....++...+++|+..+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.++++++|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~   86 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT   86 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence            345667788899999999999999999999998889999999986532  233466888999999999999999999885


Q ss_pred             cc------CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          423 KQ------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       423 ~~------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      ..      ...+++++++ +++|.+++..      ..+++..+..++.|+++||+|||+   .+++||||||+||+++++
T Consensus        87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~  156 (345)
T cd07877          87 PARSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED  156 (345)
T ss_pred             ecccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCC
Confidence            43      3468888887 8899888742      358899999999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH-HH
Q 040242          497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL-VD  574 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~  574 (662)
                      +.+||+|||+++.....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||........... ..
T Consensus       157 ~~~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (345)
T cd07877         157 CELKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  232 (345)
T ss_pred             CCEEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998864332    223467889999998765 4678899999999999999999999965433211110 00


Q ss_pred             H-------HHHHhhcC---ccccccCC----CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 W-------VRELHSQG---QITRAIDP----TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 ~-------~~~~~~~~---~~~~~id~----~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .       +.......   ...+.+..    ............+.+++.+|++.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0       00000000   00000000    0000011224567899999999999999999999975

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.2e-33  Score=294.53  Aligned_cols=265  Identities=26%  Similarity=0.354  Sum_probs=202.9

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec-cC
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QD  425 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~  425 (662)
                      ++...+++|+..+.||+|+||.||++....++..||+|++...  .....+.+..|+.++++++||||+++++++.. ..
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4556788999999999999999999999889999999988543  22345678899999999999999999998865 55


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++++||+ +++|.+++..      ..+++.....++.|+++||.|||+   .+++||||+|+||+++.++.+||+|||
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccc
Confidence            789999999 6689888742      347788888999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHH--------H
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVD--------W  575 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------~  575 (662)
                      ++......    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.+        |
T Consensus       154 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  229 (328)
T cd07856         154 LARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV  229 (328)
T ss_pred             cccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            98854332    122456889999998765 568999999999999999999999997544321111 111        1


Q ss_pred             HHHHhhcCccccccCC-CC-CCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 VRELHSQGQITRAIDP-TL-DYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~-~l-~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....... ...+.+.. .. ...+     ......+.+++.+|++.+|++||++.+++.+
T Consensus       230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            1110000 00010000 00 0011     1234678899999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=292.73  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=206.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +.|..-++||+||||.||-++...+|+.+|.|++.+.   .+++....++|-.+|.+++.+.||.+--.++.++.++||+
T Consensus       185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL  264 (591)
T KOG0986|consen  185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL  264 (591)
T ss_pred             cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence            5688889999999999999999999999999998654   3444556789999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ..|.||+|.-+|.+..   ...+++...+-.+.+|+.||.+||.   ..||.|||||+|||||+.|+++|+|+|||..+.
T Consensus       265 tlMNGGDLkfHiyn~g---~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  265 TLMNGGDLKFHIYNHG---NPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EeecCCceeEEeeccC---CCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            9999999999998775   4678999999999999999999999   899999999999999999999999999999776


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ...  .....+||.+|||||+++++.|+...|.||+||+||||+.|+.||..........-   +.+         .+-.
T Consensus       339 ~g~--~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE---vdr---------r~~~  404 (591)
T KOG0986|consen  339 EGK--PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE---VDR---------RTLE  404 (591)
T ss_pred             CCC--ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH---HHH---------HHhc
Confidence            542  22334899999999999999999999999999999999999999986543211100   000         0000


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                      .-..++....++...|.+..|+.||.+|---+
T Consensus       405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             chhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            11234455666777788889999999997543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3e-33  Score=297.14  Aligned_cols=263  Identities=26%  Similarity=0.301  Sum_probs=199.1

Q ss_pred             cCCcc-cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh--------------HHHHHHHHHHhhccccccceeeee
Q 040242          355 KGFRE-KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG--------------MKEFVAEITSMGRLRHRNLVQLHG  419 (662)
Q Consensus       355 ~~f~~-~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~--------------~~~f~~Ei~~l~~l~H~niv~l~~  419 (662)
                      ++|.. .+.||+|+||+||+|.+...++.||||++.......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            45543 577999999999999998889999999986542211              125778999999999999999999


Q ss_pred             eEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       420 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      ++...+..++||||++ ++|.+++..     ...+++.....++.|++.||.|||+   .+++|+||+|+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCE
Confidence            9999999999999996 689888843     3458899999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCC-------------CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 040242          500 KLGDFGLARAYDHNI-------------NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQR  565 (662)
Q Consensus       500 kL~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~  565 (662)
                      ||+|||+++......             ........++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999998665111             1111223467899999988754 46889999999999999999999997654


Q ss_pred             chhhHHHHHHHHHHhhcCc---ccc------------ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          566 TAMELVLVDWVRELHSQGQ---ITR------------AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       566 ~~~~~~l~~~~~~~~~~~~---~~~------------~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      .....   ..+........   ..+            ...+............+.+++.+||+.+|++||++.|++.+-
T Consensus       239 ~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        239 EIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             HHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence            32211   11111111000   000            000111111122346688999999999999999999999753

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=303.67  Aligned_cols=251  Identities=23%  Similarity=0.391  Sum_probs=207.7

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.+..-||.|+||.||+++.+.++-..|-|.+...+.+..++|+-||++|....||+||+|++.|+..+.++++.|||.|
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G  113 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG  113 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence            44566799999999999999888888889999988889999999999999999999999999999999999999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |-.+.++..-    ...|...++.-++.|++.||.|||+   +.|||||||+.|||++-+|.++|+|||.+-..... ..
T Consensus       114 GAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~q  185 (1187)
T KOG0579|consen  114 GAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQ  185 (1187)
T ss_pred             chHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hh
Confidence            9999988544    4679999999999999999999999   89999999999999999999999999987643221 22


Q ss_pred             cceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          517 QTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ......||+.|||||+..     ...|..++||||||+.|.||..+.+|-....+  ...+...          . .-+|
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp--MRVllKi----------a-KSeP  252 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKI----------A-KSEP  252 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch--HHHHHHH----------h-hcCC
Confidence            334578999999999764     45788999999999999999999998654322  1111111          1 1122


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .--..+......+.++..+||..||..||++.+++++
T Consensus       253 PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  253 PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2222344556678888889999999999999999875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.1e-33  Score=291.84  Aligned_cols=258  Identities=22%  Similarity=0.276  Sum_probs=191.7

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      +.+|.|++  ||.++...+++.||||++...  .....+.+..|+.++++++|+||+++++++...+..+++|||+++++
T Consensus         8 ~~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~   85 (314)
T cd08216           8 KCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS   85 (314)
T ss_pred             HhhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence            33444444  455555458899999998764  34556789999999999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC---
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN---  515 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~---  515 (662)
                      |.+++....   ...+++.....++.|+++||+|||+   .+|+||||||+||+++.++.+||+|||.+........   
T Consensus        86 l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          86 CEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             HHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            999996542   3458888999999999999999999   8999999999999999999999999998875532211   


Q ss_pred             ---CcceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh----h-----
Q 040242          516 ---PQTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH----S-----  581 (662)
Q Consensus       516 ---~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~----~-----  581 (662)
                         .......++..|+|||.+...  .++.++|||||||++|||++|+.||.......  .+.+......    .     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~  237 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYP  237 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchh
Confidence               111234567889999998653  57889999999999999999999997543221  1111111000    0     


Q ss_pred             --cCcccc----ccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 --QGQITR----AIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 --~~~~~~----~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .....+    ..++..     ..........+.+++.+||+.||++||++++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         238 LYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence              000000    001110     11223345678899999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-33  Score=289.37  Aligned_cols=263  Identities=26%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |+..+.||+|++|.||+|+...+++.+++|.+....  ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999998889999999997653  334567889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      + ++|.+++...    ...+++..++.++.|++.||.|||+   .+++||||+|+||++++++.+||+|||+++......
T Consensus        81 ~-~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKR----PGPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            7 5899998643    2468999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHH-------HHHHHhhcCcc
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVD-------WVRELHSQGQI  585 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~-------~~~~~~~~~~~  585 (662)
                      . ......++..|+|||.+.+. .++.++|||||||+++||++|+.||.......... +..       ..+.....-..
T Consensus       153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence            2 22233457789999988766 78999999999999999999999997644321110 000       00000000000


Q ss_pred             ccccCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTL-----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....-+..     ....+.....+.+++.+||+.+|++||++++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            00000010     01111225678999999999999999999999863

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=6.9e-33  Score=286.52  Aligned_cols=243  Identities=23%  Similarity=0.333  Sum_probs=189.8

Q ss_pred             eeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHH---HhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEIT---SMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~---~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +||+|+||.||++....+++.||+|.+....   ......+..|..   .++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999998889999999986542   122223444443   3444579999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++..     ...+++.++..++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....... 
T Consensus        81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-  151 (278)
T cd05606          81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-  151 (278)
T ss_pred             CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence            9999988843     3468999999999999999999999   899999999999999999999999999987654321 


Q ss_pred             CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                        .....|+..|+|||.+.++ .++.++||||+||++|||++|+.||...........    ...      ....++.+ 
T Consensus       152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~----~~~------~~~~~~~~-  218 (278)
T cd05606         152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRM------TLTMAVEL-  218 (278)
T ss_pred             --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH----HHH------hhccCCCC-
Confidence              1234689999999998754 588999999999999999999999975432211111    000      00111112 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                        +......+.+++.+|+..+|.+||     ++.+++++
T Consensus       219 --~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         219 --PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             --CCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence              222356788899999999999999     99999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-33  Score=285.74  Aligned_cols=252  Identities=21%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      +|...+.||+|+||.||++.....+..+++|.++..     ......++..|+.++++++||||+++++++...+..++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477789999999999999998766666666665432     122334567899999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++..... ....+++.+++.++.|+++||.|||+   .+++|+||+|+||+++. +.+||+|||++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence            999999999998864321 24568999999999999999999999   89999999999999975 56999999998865


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.|+......      .......         .
T Consensus       156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~---------~  219 (260)
T cd08222         156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV---------E  219 (260)
T ss_pred             CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH---------c
Confidence            43221 222345788999999988888899999999999999999999998643221      1111110         1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ......+......+.+++.+||+.+|++||++.|++++
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            11112233455678899999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.2e-32  Score=292.27  Aligned_cols=263  Identities=23%  Similarity=0.311  Sum_probs=195.0

Q ss_pred             CCcccceeeeeCceEEEEEEeCCC--CcEEEEEEeecc--chhhHHHHHHHHHHhhcc-ccccceeeeeeEecc----Ce
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPST--GLEVAIKRVAHN--SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ----DE  426 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~--g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~----~~  426 (662)
                      +|+..+.||+|+||.||++.....  +..||+|++...  .....+.+.+|+.++.++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477789999999999999999877  889999998653  223356788999999999 599999999976433    35


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++++||+. ++|.+++..     ...+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence            788899985 689888843     3458899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCC---cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH-H--------
Q 040242          507 ARAYDHNINP---QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL-V--------  573 (662)
Q Consensus       507 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~--------  573 (662)
                      ++........   ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||........... .        
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9866533221   1233468999999998765 4678999999999999999999999875432211100 0        


Q ss_pred             HHHHHHhhcC------ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          574 DWVRELHSQG------QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       574 ~~~~~~~~~~------~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ++....-...      .....-...+....+.....+..++.+|++.||.+||++.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000000      00000000111111123456889999999999999999999986

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-33  Score=298.69  Aligned_cols=262  Identities=23%  Similarity=0.350  Sum_probs=197.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc----------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ----------  424 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~----------  424 (662)
                      .+|...+.||.|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++++...          
T Consensus         5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (342)
T cd07854           5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS   84 (342)
T ss_pred             cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence            6788899999999999999999889999999999776666677889999999999999999999876543          


Q ss_pred             ----CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCe
Q 040242          425 ----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNP  499 (662)
Q Consensus       425 ----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~  499 (662)
                          ...++||||++ ++|.+++.      ...+++.....++.||++||.|||+   .+++||||||+||+++. ++.+
T Consensus        85 ~~~~~~~~lv~e~~~-~~L~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          85 LTELNSVYIVQEYME-TDLANVLE------QGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             ccccceEEEEeeccc-ccHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceE
Confidence                35789999996 58888773      2358899999999999999999999   89999999999999974 5678


Q ss_pred             EEeeccccccccCCCCC--cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINP--QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  576 (662)
                      ||+|||+++........  ......++..|+|||.+.. ..++.++|||||||++|||++|+.||...........  ..
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~--~~  232 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL--IL  232 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HH
Confidence            99999999865432111  1122357889999997654 4578899999999999999999999975543221110  00


Q ss_pred             HHHhh-----cCccc----ccc-----CCC--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 RELHS-----QGQIT----RAI-----DPT--LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 ~~~~~-----~~~~~----~~i-----d~~--l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .....     .....    +..     .+.  ...........+.+++.+||+.||.+||++.+++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            00000     00000    000     000  000111234567889999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=7e-34  Score=273.40  Aligned_cols=250  Identities=25%  Similarity=0.383  Sum_probs=201.1

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEeccC
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +....||.|..|.|++...+.+|...|||.+... ..+..++++..+.++.+-+ +|+||+.+||+..+...++.||.| 
T Consensus        95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-  173 (391)
T KOG0983|consen   95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-  173 (391)
T ss_pred             hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-
Confidence            3466799999999999999999999999999765 5666778888888777664 999999999999999999999999 


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      ...++.+|..-    ..++++.-.=++...+..||.||.+.  ++|+|||+||+|||+|+.|++||||||++..+-..  
T Consensus       174 s~C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--  245 (391)
T KOG0983|consen  174 STCAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--  245 (391)
T ss_pred             HHHHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceeecc--
Confidence            55777777544    45677777778889999999999985  89999999999999999999999999999765432  


Q ss_pred             CcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      ...+..+|-+.|||||.+.-   .+|.-++||||||+.|+||.||+.||..-..+-+. +.          ++.+...|.
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~-lt----------kvln~ePP~  314 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV-LT----------KVLNEEPPL  314 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH-HH----------HHHhcCCCC
Confidence            23445689999999998854   35788999999999999999999999865433211 11          112222244


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      |.. .......+++++..||+.|+.+||...+++++
T Consensus       315 L~~-~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  315 LPG-HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCc-ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            421 22356778889999999999999999999874

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.1e-34  Score=277.79  Aligned_cols=288  Identities=25%  Similarity=0.359  Sum_probs=214.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC----cEEEEEEeeccch--hhHHHHHHHHHHhhccccccceeeeeeEec-cCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g----~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~  427 (662)
                      ..|+....||+|.||.||+|+...++    ..+|+|+++.+..  .......+|+.++++++||||+.|...+.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            45778899999999999999765443    2689999865522  223456789999999999999999998877 7789


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC----CCeEEee
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD----LNPKLGD  503 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~----~~~kL~D  503 (662)
                      ++++||.+. +|..+++-++..+...++-.....|++||+.|+.|||+   +-|+||||||.|||+..+    |++||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999965 88888887766666789999999999999999999999   789999999999999888    8999999


Q ss_pred             ccccccccCCCCC--cceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchh------hHHHHH
Q 040242          504 FGLARAYDHNINP--QTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAM------ELVLVD  574 (662)
Q Consensus       504 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------~~~l~~  574 (662)
                      +|+++.+.....+  ....++-|..|.|||.+.+. .+|++.|||+.|||+.||+|-++-|.+.+...      +..-.+
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            9999999876544  33456789999999988765 58999999999999999999988886543211      111112


Q ss_pred             HHHHHhhcCccccccCCCC---------------CCCCH-----------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 WVRELHSQGQITRAIDPTL---------------DYFDP-----------QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 ~~~~~~~~~~~~~~id~~l---------------~~~~~-----------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.+.+...  .+..=|.+               ..++.           .......+|..++|..||.+|-|+++.+++
T Consensus       260 rIf~vLG~P--t~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  260 RIFEVLGTP--TDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHcCCC--ccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            222211100  00000000               00000           011226778889999999999999999986


Q ss_pred             H-hcCCCCCCCCCCCCCCCCC
Q 040242          629 L-LRDASLPQAPLDIHHEFPR  648 (662)
Q Consensus       629 L-~~~~~~p~~p~~~~~~~~~  648 (662)
                      . =.+.++|+.|.++...+..
T Consensus       338 ~yF~~d~lpp~pt~~~vnf~~  358 (438)
T KOG0666|consen  338 PYFTEDPLPPLPTSDNVNFEG  358 (438)
T ss_pred             cccccCCCCCCcccceeeccc
Confidence            5 3456677666665543333

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-32  Score=292.80  Aligned_cols=262  Identities=25%  Similarity=0.373  Sum_probs=199.3

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC----
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----  425 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----  425 (662)
                      ...++|+..+.||+|++|.||++....++..||||++...  .......+.+|+.++++++|+||+++++++....    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467899999999999999999999889999999998543  2333456889999999999999999999887554    


Q ss_pred             --eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          426 --ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       426 --~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                        ..++||||+ +++|.+++..      ..+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEee
Confidence              458999999 7899888742      358899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-H--------H
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-L--------V  573 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l--------~  573 (662)
                      ||++......    .....+++.|+|||.+.+ ..++.++||||+||++++|++|+.||.......... .        .
T Consensus       162 fg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         162 FGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            9999865432    223457889999998865 458899999999999999999999997543221100 0        0


Q ss_pred             HHHHHHhhcC------ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          574 DWVRELHSQG------QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       574 ~~~~~~~~~~------~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      +|........      .+.......+..........+.+++.+|++.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0100000000      00000000011111223445789999999999999999999995

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-33  Score=315.51  Aligned_cols=261  Identities=25%  Similarity=0.409  Sum_probs=208.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-------CCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++....+.||+|.||.|++|....       ....||||.++... ....+.+..|+++++.+ +|+||+.++|+|..++
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            444556699999999999998631       14579999997653 35567899999999998 6999999999999999


Q ss_pred             eeeEEEeccCCCCcchhccccc---------cccc--ccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDND---------QQKK--KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..++|+||++.|+|.++|+..+         ....  ..|+..+.+.++.|||.|++||++   .+++||||.++|||+.
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLIT  452 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEec
Confidence            9999999999999999998765         1111  249999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCCcceecc--cCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINPQTTHIV--GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELV  571 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  571 (662)
                      ++..+||+|||+++...+..........  -+..|||||.+....++.|+||||||++||||++ |..||.+-...  ..
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~--~~  530 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT--EE  530 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH--HH
Confidence            9999999999999965443322212122  2567999999999999999999999999999999 88888752211  12


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.+++++    |..        ...+..+..++..+++.||+.+|++||++.++++.|+.+
T Consensus       531 l~~~l~~----G~r--------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  531 LLEFLKE----GNR--------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHhc----CCC--------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            2233332    211        122334567788999999999999999999999999884

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.8e-33  Score=314.98  Aligned_cols=255  Identities=26%  Similarity=0.423  Sum_probs=194.0

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec-------
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-------  423 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-------  423 (662)
                      +-..+|++.++||+||||.|||++.+-+|+.+|||++... +........+|+..+++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3446799999999999999999999999999999999765 44456678999999999999999998843210       


Q ss_pred             --------------------------------------------------------------------------------
Q 040242          424 --------------------------------------------------------------------------------  423 (662)
Q Consensus       424 --------------------------------------------------------------------------------  423 (662)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------c--------CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHH
Q 040242          424 ------------------------Q--------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL  471 (662)
Q Consensus       424 ------------------------~--------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~  471 (662)
                                              +        ..+|+-||||+...|++++.++....    .-...|+++.+|++||.
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHHH
Confidence                                    0        12478899999888888886543210    34667899999999999


Q ss_pred             HhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc---C--------------CCCCcceecccCCcccCccccc
Q 040242          472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD---H--------------NINPQTTHIVGTLGYLAPELTR  534 (662)
Q Consensus       472 yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~---~--------------~~~~~~~~~~gt~~y~aPE~~~  534 (662)
                      |+|+   .+||||||||.||+|+++..+||+|||++....   .              ......+..+||.-|+|||.+.
T Consensus       712 YIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~  788 (1351)
T KOG1035|consen  712 YIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS  788 (1351)
T ss_pred             HHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence            9999   899999999999999999999999999998721   0              0112345578999999999986


Q ss_pred             CC---CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHc
Q 040242          535 TG---KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLC  611 (662)
Q Consensus       535 ~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~C  611 (662)
                      +.   .++.|.|+||+|+||+||+.   ||....+...      +-..++.+.+...     .++...+...-.++++++
T Consensus       789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~------iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~L  854 (1351)
T KOG1035|consen  789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERAS------ILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWL  854 (1351)
T ss_pred             ccccccccchhhhHHHHHHHHHHhc---cCCchHHHHH------HHHhcccCCCCCC-----cccccccchHHHHHHHHH
Confidence            54   49999999999999999985   4553322110      1111122222111     222344455567889999


Q ss_pred             cCCCCCCCCCHHHHHH
Q 040242          612 CDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       612 l~~dP~~RPt~~eVl~  627 (662)
                      ++.||.+|||+.|+++
T Consensus       855 l~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  855 LSHDPSKRPTATELLN  870 (1351)
T ss_pred             hcCCCccCCCHHHHhh
Confidence            9999999999999874

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-33  Score=302.48  Aligned_cols=257  Identities=30%  Similarity=0.399  Sum_probs=198.2

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccC------eeeE
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------ELLL  429 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~------~~~l  429 (662)
                      +...+.||+|+||.||+|+.+.+|+.||||.+.... ....+....|++++++++|+|||++++.-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            344678999999999999999999999999987643 334556789999999999999999999865543      6799


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC--CCC--CeEEeecc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID--ADL--NPKLGDFG  505 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DfG  505 (662)
                      |||||++|+|+..|.+.+.  ...|+..+.+.++.++..||.|||+   ++|+||||||.||++-  +++  .-||+|||
T Consensus        95 vmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG  169 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG  169 (732)
T ss_pred             EEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence            9999999999999977654  5679999999999999999999998   8999999999999983  333  38999999


Q ss_pred             ccccccCCCCCcceecccCCcccCccccc-CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTR-TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--  582 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  582 (662)
                      .|+-.+.+.  .....+||..|++||... .+.++...|.|||||++||.+||..||..........-..|.-..-..  
T Consensus       170 ~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  170 AARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             ccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            999877653  556689999999999998 488999999999999999999999999865443211111221110000  


Q ss_pred             ----------Cccccc-cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          583 ----------GQITRA-IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       583 ----------~~~~~~-id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                                |.+... .-|.-..........+.+....+|..+|++|-
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                      000000 00111223345566677777778888888887

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=298.59  Aligned_cols=262  Identities=23%  Similarity=0.350  Sum_probs=200.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCe----
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE----  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~----  426 (662)
                      ..++|+..+.||+|++|.||+|....++..||||++...  .....+.+.+|+.++++++|+|++++++++...+.    
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            457899999999999999999999888999999998653  23344667889999999999999999998766554    


Q ss_pred             --eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          427 --LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       427 --~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                        .++|+||+ +++|.+++..      ..+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+||+||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence              89999999 6799988843      358999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH-HHH--------
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVD--------  574 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~-l~~--------  574 (662)
                      |++......    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.+        
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  238 (343)
T cd07851         163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEE  238 (343)
T ss_pred             ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHH
Confidence            999865432    223467889999998765 367889999999999999999999997544321111 000        


Q ss_pred             HHHHHhhc--CccccccC----CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 WVRELHSQ--GQITRAID----PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 ~~~~~~~~--~~~~~~id----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.......  ......+.    +............+.+++.+||+.+|++|||+.+|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            00000000  00000000    00000111235678899999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-33  Score=295.25  Aligned_cols=250  Identities=24%  Similarity=0.321  Sum_probs=206.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ...|.+...||+|.|+.|.+|++..++..||||.+.+..  ......+.+|+.+|..|+|||||+++.+.+....+|+||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            456888999999999999999999999999999997753  333455899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+.+|.+.++|..+.     .+.......++.|+.+|++|||+   +.|+|||||++||||+.+.++||+|||++..+.
T Consensus       135 eya~~ge~~~yl~~~g-----r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  135 EYASGGELFDYLVKHG-----RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EeccCchhHHHHHhcc-----cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999997653     34457778899999999999999   899999999999999999999999999999887


Q ss_pred             CCCCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..  ......+|++.|.|||++.+.+ ..+++|+||+|++||-|++|..||++..-.+-           ++    .++-
T Consensus       207 ~~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L-----------r~----rvl~  269 (596)
T KOG0586|consen  207 YG--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL-----------RP----RVLR  269 (596)
T ss_pred             cc--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc-----------cc----hhee
Confidence            43  3445578999999999998765 47899999999999999999999986532100           00    0111


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      ..+ ..+.-....+.+++++++-.+|.+|+++.++.+.-
T Consensus       270 gk~-rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  270 GKY-RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eee-cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            111 11222334466788889999999999999999854

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-34  Score=324.64  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      -+-+++....||.|.||.||-|....+|...|||.+...  .....+...+|+.++..|+|||+|+++|.-.+.++.+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            345677788999999999999999999999999987654  334456778999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||||++|+|.+.+...+     .+++........|++.|+.|||+   .+||||||||.||+|+.+|.+|++|||.|...
T Consensus      1313 MEyC~~GsLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHhccCcHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999995442     24444455678899999999999   89999999999999999999999999999987


Q ss_pred             cCCCC---CcceecccCCcccCcccccCC---CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          511 DHNIN---PQTTHIVGTLGYLAPELTRTG---KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       511 ~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      .....   .......||+.|||||++.+.   ....++||||+|||++||+||++||...+..       |.-..+-   
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~V--- 1454 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYHV--- 1454 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhHH---
Confidence            65531   122346799999999998653   3566899999999999999999999765442       3211111   


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                          .-.....++......-.+++..||+.||.+|.++.|++++=
T Consensus      1455 ----~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1455 ----AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             ----hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                01111223334556667888999999999999999888753

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-32  Score=278.94  Aligned_cols=237  Identities=27%  Similarity=0.365  Sum_probs=195.1

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      ||+|++|.||++....+++.+++|.+.....   .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988899999999876532   2456789999999999999999999999999999999999999999


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcce
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT  519 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~  519 (662)
                      .+++...     ..+++.....++.|+++||.|||+   .+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~  151 (250)
T cd05123          81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTN  151 (250)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-Cccc
Confidence            9998543     358999999999999999999999   899999999999999999999999999998764432 1233


Q ss_pred             ecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       520 ~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ...++..|++||...+...+.++|+||||+++|||++|+.||......   .+...+   ..         ..+ ..+..
T Consensus       152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~---~~---------~~~-~~~~~  215 (250)
T cd05123         152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKI---LK---------DPL-RFPEF  215 (250)
T ss_pred             CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---hc---------CCC-CCCCC
Confidence            456788999999998888899999999999999999999999754321   111111   10         011 11222


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRR  624 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~e  624 (662)
                      ....+.+++.+||..||++||++.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCccc
Confidence            3566788999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=3.7e-33  Score=273.82  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...++||+|.||+|-+++-+.+++.+|+|+++++   .+.....-+.|-++|+..+||.+..|.-.+...+.+|+||
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM  247 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM  247 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence            5788899999999999999999999999999999876   3444556678899999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||..||.|.-+|.+     ...++.....-.-..|..||.|||+   .+||.||||.+|+|||.+|.+||+||||++---
T Consensus       248 eyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  248 EYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            99999999999954     3457777777778899999999999   899999999999999999999999999998422


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . ....+...+||+.|+|||++....+....|.|.+||++|||+||+.||...+...-..+   +.  ..        | 
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL---Il--~e--------d-  384 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL---IL--ME--------D-  384 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH---HH--hh--------h-
Confidence            1 22344567999999999999999999999999999999999999999986643211111   10  00        0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  627 (662)
                        -.++.....+...|..-.|..||.+|.     .+.||.+
T Consensus       385 --~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~  423 (516)
T KOG0690|consen  385 --LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMR  423 (516)
T ss_pred             --ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHh
Confidence              012223333445566678899999996     3666664

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=269.62  Aligned_cols=264  Identities=22%  Similarity=0.328  Sum_probs=207.1

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEec
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRK  423 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~  423 (662)
                      -++.|+++-|     .+.||+|+|+.|--++...+|.++|||++.+.......+..+|++++.+.+ |+||++|++|+++
T Consensus        73 g~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd  147 (463)
T KOG0607|consen   73 GKFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED  147 (463)
T ss_pred             chHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence            3577888887     478999999999999999999999999999988788889999999999985 9999999999999


Q ss_pred             cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eE
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PK  500 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~k  500 (662)
                      +...|||||-|.||+|..+|.+     +.-+++.+..++.++||.||.+||.   ++|.||||||+|||-.....   +|
T Consensus       148 d~~FYLVfEKm~GGplLshI~~-----~~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK  219 (463)
T KOG0607|consen  148 DTRFYLVFEKMRGGPLLSHIQK-----RKHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK  219 (463)
T ss_pred             cceEEEEEecccCchHHHHHHH-----hhhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence            9999999999999999999854     4568889999999999999999999   99999999999999865543   89


Q ss_pred             EeeccccccccC--CC----CCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh-
Q 040242          501 LGDFGLARAYDH--NI----NPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-  568 (662)
Q Consensus       501 L~DfGla~~~~~--~~----~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-  568 (662)
                      ||||.|..-...  +.    .+.....+|+..|||||+..     ...|..++|.||+|||||-|++|.+||.+.-..+ 
T Consensus       220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC  299 (463)
T KOG0607|consen  220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC  299 (463)
T ss_pred             eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence            999988764322  21    22334467899999999763     2357889999999999999999999997542210 


Q ss_pred             ----hHHHHHHHHHHhhcCccccccCCCCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          569 ----ELVLVDWVRELHSQGQITRAIDPTLDYFDP----QEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       569 ----~~~l~~~~~~~~~~~~~~~~id~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                          ...-.....      ++.+.|-...-+++.    ....+..+++...+..++.+|-++.++++
T Consensus       300 GWdrGe~Cr~CQ~------~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  300 GWDRGEVCRVCQN------KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CccCCCccHHHHH------HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                000001111      112222222222332    23455677888888999999999999886

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.98  E-value=4.1e-34  Score=274.16  Aligned_cols=253  Identities=26%  Similarity=0.363  Sum_probs=199.3

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhc-cccccceeeeeeEeccCeeeEEEeccCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGR-LRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~-l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ....||.|.||+|+|-.++..|+..|||+++... ....++++.|.....+ -++||||+++|.+..++..++.||.| .
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence            3567999999999999999999999999998764 3566788889876555 47999999999999999999999999 6


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      -||+.+-..-..-+...+++.-.=.|......||.||.++  ..|||||+||+||||+..|.+||||||++..+....  
T Consensus       147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--  222 (361)
T KOG1006|consen  147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--  222 (361)
T ss_pred             hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH--
Confidence            6877765433223356688887788888899999999986  899999999999999999999999999998665432  


Q ss_pred             cceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ..+.-+|-..|||||.+...  .+.-+|||||+|++|+|+.||+.|+..-...     .+-+.+       .-.-||.+-
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~-------Vv~gdpp~l  290 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQ-------VVIGDPPIL  290 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHH-------HHcCCCCee
Confidence            22334688899999988543  3788999999999999999999999854321     111111       112233332


Q ss_pred             CCC---HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFD---PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~---~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+   .+....+..++..|+..|.+.||...++.++
T Consensus       291 ~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  291 LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            222   3356778899999999999999999998763

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=2e-31  Score=306.77  Aligned_cols=146  Identities=29%  Similarity=0.430  Sum_probs=132.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|.+.++||+|+||+||+|.+..+++.||||++....   ......+..|+.++..++|+||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57888999999999999999998889999999986542   333467889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      ||+++++|.+++...     ..+++...+.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999998532     357888899999999999999999   899999999999999999999999999886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.97  E-value=1.1e-31  Score=270.94  Aligned_cols=220  Identities=20%  Similarity=0.195  Sum_probs=178.2

Q ss_pred             eCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCcchhccc
Q 040242          366 GGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD  445 (662)
Q Consensus       366 G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  445 (662)
                      |.+|.||++.++.+++.+|+|++....     .+..|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            789999999999999999999996643     233455555566799999999999999999999999999999999853


Q ss_pred             ccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCC
Q 040242          446 NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL  525 (662)
Q Consensus       446 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~  525 (662)
                      .     ..+++.....++.|+++||.|||+   .+++||||||+||+++.++.++++|||++.......    ....++.
T Consensus        79 ~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~  146 (237)
T cd05576          79 F-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVEN  146 (237)
T ss_pred             h-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCc
Confidence            2     358999999999999999999999   899999999999999999999999999887654321    2234567


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 040242          526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVL  605 (662)
Q Consensus       526 ~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~  605 (662)
                      .|+|||......++.++||||+|+++|||++|+.|+.......                 .....   ...+......+.
T Consensus       147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~---~~~~~~~~~~~~  206 (237)
T cd05576         147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTT---LNIPEWVSEEAR  206 (237)
T ss_pred             cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccc---cCCcccCCHHHH
Confidence            8999999988888999999999999999999998865321100                 00000   011223345678


Q ss_pred             HHHHHccCCCCCCCCCH
Q 040242          606 TLGLLCCDPHPDFRPST  622 (662)
Q Consensus       606 ~l~~~Cl~~dP~~RPt~  622 (662)
                      .++.+|++.||++||++
T Consensus       207 ~li~~~l~~dp~~R~~~  223 (237)
T cd05576         207 SLLQQLLQFNPTERLGA  223 (237)
T ss_pred             HHHHHHccCCHHHhcCC
Confidence            89999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=4.4e-31  Score=264.94  Aligned_cols=239  Identities=31%  Similarity=0.420  Sum_probs=195.7

Q ss_pred             CceEEEEEEeCCCCcEEEEEEeeccchhh-HHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCcchhccc
Q 040242          367 GFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD  445 (662)
Q Consensus       367 ~~g~Vy~~~~~~~g~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  445 (662)
                      +||.||+|+...+++.+++|++....... .+.+.+|++.+++++|+|++++++++......+++|||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998889999999997765544 68899999999999999999999999999999999999999999999854


Q ss_pred             ccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCC
Q 040242          446 NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL  525 (662)
Q Consensus       446 ~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~  525 (662)
                      ..     .+++..++.++.++++++.|||+   .+++|+||+|+||+++.++.++|+|||.+.......  ......++.
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~  150 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTP  150 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCc
Confidence            32     28899999999999999999999   899999999999999999999999999998765432  233456788


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 040242          526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVL  605 (662)
Q Consensus       526 ~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~  605 (662)
                      .|++||.......+.++|||+||+++++|++|..|+......  ....++..    .+.      .............+.
T Consensus       151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~----~~~------~~~~~~~~~~~~~~~  218 (244)
T smart00220      151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIG----KPK------PPFPPPEWKISPEAK  218 (244)
T ss_pred             CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHh----ccC------CCCccccccCCHHHH
Confidence            999999998888899999999999999999999998753221  11111111    100      000011111446788


Q ss_pred             HHHHHccCCCCCCCCCHHHHHH
Q 040242          606 TLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       606 ~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      +++.+|+..+|++||++.++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhh
Confidence            8999999999999999999987

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.97  E-value=2.8e-32  Score=265.57  Aligned_cols=268  Identities=23%  Similarity=0.297  Sum_probs=207.0

Q ss_pred             hccCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEec----cCe
Q 040242          353 ATKGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK----QDE  426 (662)
Q Consensus       353 at~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~----~~~  426 (662)
                      .|++|++. ++||-|-.|.|-.+..+.+++++|+|++....     ...+|++..-.. .|||||++++.++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45566553 68999999999999999999999999985542     235677765554 69999999998854    346


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEee
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGD  503 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~D  503 (662)
                      +++|||.|+||.|...+.+..   ...+++++.-.|++||+.|+.|||+   .+|.||||||+|+|...   |-.+||+|
T Consensus       134 LLiVmE~meGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecc
Confidence            899999999999999997654   5678999999999999999999999   89999999999999965   45599999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ||+|+.....  ......+-|+.|.|||++...++...+|+||+||++|-|+||.+||.......   +.-=++.....|
T Consensus       208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~g  282 (400)
T KOG0604|consen  208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTG  282 (400)
T ss_pred             cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhcc
Confidence            9999976543  23334577999999999999999999999999999999999999997443210   000011111111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCCC
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPLD  641 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~~  641 (662)
                      .   .--|  ...-.+..+...++++..|..+|.+|.|+.+++.+  +.+..-+|.-|+.
T Consensus       283 q---y~FP--~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl~  337 (400)
T KOG0604|consen  283 Q---YEFP--EPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPLS  337 (400)
T ss_pred             C---ccCC--ChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCch
Confidence            0   0000  11123456778899999999999999999999985  5667777777776

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=269.11  Aligned_cols=266  Identities=23%  Similarity=0.302  Sum_probs=210.1

Q ss_pred             hHHHHHhccCCcccceeeeeCceEEEEEEeCCCC-----cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeee
Q 040242          347 YSELYSATKGFREKNLVGSGGFGKVYRGVIPSTG-----LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       347 ~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      ..||.....+++...++.+|.||.||+|.+.+..     +.|-||.++.. +.-+...++.|...+..+.|||+.++.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            4456556677888889999999999999875433     34667766544 34456678999999999999999999999


Q ss_pred             Eecc-CeeeEEEeccCCCCcchhcccccc---cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          421 CRKQ-DELLLVYDYVPNGSLDKLLFDNDQ---QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       421 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      +.+. ...+++|.++.-|+|..+|...+.   .....++-.+...++.|++.|+.|||.   .++||.||..+|+++|+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence            8765 468999999999999999973321   123567778899999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccC-CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHH
Q 040242          497 LNPKLGDFGLARAYDH-NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVD  574 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  574 (662)
                      .++||+|=.++|.+-. +...-...-..+..||+||.+....++.++|||||||+||||+| |+.|+..-++.+..   .
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---~  509 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---H  509 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---H
Confidence            9999999999985432 22222222345689999999999999999999999999999998 99998766554322   2


Q ss_pred             HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       575 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ++..    |.       ++ ..+..+++++..++..||...|++||+++|++.-|.
T Consensus       510 ylkd----Gy-------Rl-aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLs  553 (563)
T KOG1024|consen  510 YLKD----GY-------RL-AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLS  553 (563)
T ss_pred             HHhc----cc-------ee-cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHH
Confidence            2221    11       11 224467889999999999999999999999998775

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.6e-31  Score=295.54  Aligned_cols=266  Identities=20%  Similarity=0.237  Sum_probs=173.7

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCC----CcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeee------Ee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPST----GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW------CR  422 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~----g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~------~~  422 (662)
                      ..++|+..++||+|+||.||+|++..+    +..||||++......  +....|  .+.+..+.++..++..      +.
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            567899999999999999999999888    899999988643221  111111  1122222222222111      34


Q ss_pred             ccCeeeEEEeccCCCCcchhccccccc---------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC
Q 040242          423 KQDELLLVYDYVPNGSLDKLLFDNDQQ---------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK  487 (662)
Q Consensus       423 ~~~~~~lV~E~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  487 (662)
                      .....++||||+++++|.+++......               .........+..++.|+++||.|||+   .+|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence            566899999999999999998643210               00111233456799999999999999   899999999


Q ss_pred             CCceEeCC-CCCeEEeeccccccccCCCCCcceecccCCcccCcccccCC----------------------CCCcchhH
Q 040242          488 PSNVLIDA-DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG----------------------KATTSTDV  544 (662)
Q Consensus       488 p~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksDV  544 (662)
                      |+|||++. ++.+||+|||+++..............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57899999999987654444444456789999999965321                      23456799


Q ss_pred             HHHHHHHHHHHcCCCCCCcccchh-------hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCC
Q 040242          545 FGFGTLMLEVACGRRPIEPQRTAM-------ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPD  617 (662)
Q Consensus       545 ~S~Gvvl~elltG~~p~~~~~~~~-------~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~  617 (662)
                      |||||+||||+++..+........       ...+..|.......  ....+..... ..........+|+.+||+.||+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR--ASPDLRRGFE-VLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc--cchhhhhhhh-hccccchHHHHHHHHHccCCcc
Confidence            999999999999776654221100       00111221111000  0000000000 0001122345799999999999


Q ss_pred             CCCCHHHHHHH
Q 040242          618 FRPSTRRVVQF  628 (662)
Q Consensus       618 ~RPt~~eVl~~  628 (662)
                      +|||+.|++++
T Consensus       440 kR~ta~e~L~H  450 (566)
T PLN03225        440 QRISAKAALAH  450 (566)
T ss_pred             cCCCHHHHhCC
Confidence            99999999985

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=3.8e-32  Score=273.43  Aligned_cols=263  Identities=22%  Similarity=0.315  Sum_probs=209.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-c-c----cceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-H-R----NLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H-~----niv~l~~~~~~~~~~  427 (662)
                      +++|.+...+|+|.||.|-.+.+...+..||||+++...+ -.+.-+-|++++.++. + |    -+|++.+|+...++.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi  166 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI  166 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence            6889999999999999999999988899999999865433 2344578999999993 2 2    278899999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC------------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA------------  495 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------------  495 (662)
                      ++|+|.+ |-|+.++|..+.   ..+++..++..++.|+++++++||+   .+++|.||||+|||+.+            
T Consensus       167 Civfell-G~S~~dFlk~N~---y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  167 CIVFELL-GLSTFDFLKENN---YIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             EEEEecc-ChhHHHHhccCC---ccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999 789999997664   5678999999999999999999999   89999999999999831            


Q ss_pred             --------CCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch
Q 040242          496 --------DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA  567 (662)
Q Consensus       496 --------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  567 (662)
                              +..+||.|||.|+.-...    ....+.|..|.|||++.+-.++.++||||+||||.|+.+|...|...+..
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    345899999999864432    24567899999999999999999999999999999999999999876655


Q ss_pred             hhHHHHHHHHHHh--------------hcCccc-----------cccCCC--C---CCCCHHHHHHHHHHHHHccCCCCC
Q 040242          568 MELVLVDWVRELH--------------SQGQIT-----------RAIDPT--L---DYFDPQEAELVLTLGLLCCDPHPD  617 (662)
Q Consensus       568 ~~~~l~~~~~~~~--------------~~~~~~-----------~~id~~--l---~~~~~~~~~~l~~l~~~Cl~~dP~  617 (662)
                      +...+.+.+-+..              ..+++.           ...++.  +   ......+...|.+|+++||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            5444333322111              111110           111111  1   112345667799999999999999


Q ss_pred             CCCCHHHHHHH
Q 040242          618 FRPSTRRVVQF  628 (662)
Q Consensus       618 ~RPt~~eVl~~  628 (662)
                      +|+|++|++++
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999974

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=243.53  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=198.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +|...++||+|.||+||||+...+++.||+|+++.+.  +......++|+.+++.++|+|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            3556788999999999999999999999999987653  33345678999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      | .-+|..+...-    ...++......++.|+++||.++|+   .++.||||||+|++++.+|+.|++|||+++.++-.
T Consensus        83 c-dqdlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 C-DQDLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             h-hHHHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            9 55777776433    4668888899999999999999999   89999999999999999999999999999988765


Q ss_pred             CCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCC-CCcccchhhHHHHHHHHHHhhcCc---cccc
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRP-IEPQRTAMELVLVDWVRELHSQGQ---ITRA  588 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~---~~~~  588 (662)
                      .... ...+-|..|.+|.++.+.+ ++...|+||-||++.|+....+| |.+.+..++..-+-|+-....+..   +.+.
T Consensus       155 vrcy-saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~l  233 (292)
T KOG0662|consen  155 VRCY-SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKL  233 (292)
T ss_pred             eEee-eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccC
Confidence            4332 2335689999999887754 78889999999999999985444 555444444333333322222211   1122


Q ss_pred             cCCCC-CCCCH---------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTL-DYFDP---------QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l-~~~~~---------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      -|-.. ..++.         .....=.++..+.+.-+|.+|.++++.+++
T Consensus       234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22211 11211         111222455666777799999999888764

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=299.69  Aligned_cols=219  Identities=30%  Similarity=0.355  Sum_probs=191.4

Q ss_pred             ccCccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccce
Q 040242          339 EYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLV  415 (662)
Q Consensus       339 ~~~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv  415 (662)
                      .+.+..-...++.-..++|.+.++||+|+||.|...+.+.+++.+|+|++.+..   .....-|..|-.+|..-+.+-|+
T Consensus        59 ~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv  138 (1317)
T KOG0612|consen   59 RYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIV  138 (1317)
T ss_pred             HhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHH
Confidence            334444456677777889999999999999999999999999999999997742   33445688899999999999999


Q ss_pred             eeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC
Q 040242          416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA  495 (662)
Q Consensus       416 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  495 (662)
                      +++-.|.+++++|+|||||+||+|-.+|...     ..++.+-....+..|.-||..||+   .|+|||||||+|||||.
T Consensus       139 ~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~  210 (1317)
T KOG0612|consen  139 QLHYAFQDERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDK  210 (1317)
T ss_pred             HHHHHhcCccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecc
Confidence            9999999999999999999999999999543     257777777888899999999999   89999999999999999


Q ss_pred             CCCeEEeeccccccccCCCCCcceecccCCcccCccccc----C-CCCCcchhHHHHHHHHHHHHcCCCCCCccc
Q 040242          496 DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR----T-GKATTSTDVFGFGTLMLEVACGRRPIEPQR  565 (662)
Q Consensus       496 ~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~  565 (662)
                      .|.+||+|||.+-.+..+..-.....+|||.|++||++.    + +.|.+.+|.||+||++|||+.|..||....
T Consensus       211 ~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  211 SGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             cCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            999999999999888876655666679999999999884    2 578999999999999999999999998543

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=4.6e-32  Score=280.33  Aligned_cols=245  Identities=25%  Similarity=0.351  Sum_probs=195.8

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      .++||+|.||+||-|+.+.+|+.||||++.+.  ......+..+|+.+|++++||.||.+--.|+..+..++|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            57899999999999999999999999999664  3444578899999999999999999999999999999999999544


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeeccccccccCCC
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~~~~~  514 (662)
                      -|+-+| ..+   +..|+...-..++.||+.||.|||.   ++|+|+||||+||||...   ..+||||||.|+.+++..
T Consensus       649 MLEMIL-SsE---kgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  649 MLEMIL-SSE---KGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             HHHHHH-Hhh---cccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            454444 332   5678888888899999999999999   999999999999999654   459999999999987653


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      .  ...++||+.|+|||++..+.+...-|+||.|||+|--++|..||..+++..+..     +       -...+-|.- 
T Consensus       722 F--RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-----Q-------NAaFMyPp~-  786 (888)
T KOG4236|consen  722 F--RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-----Q-------NAAFMYPPN-  786 (888)
T ss_pred             h--hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-----h-------ccccccCCC-
Confidence            3  334689999999999999999999999999999999999999998654432211     0       011111111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                       --.+.....++|+...|+..-++|-+..+.+.
T Consensus       787 -PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  787 -PWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             -chhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence             11234455667777788888888887766554

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=2.9e-30  Score=283.54  Aligned_cols=264  Identities=20%  Similarity=0.275  Sum_probs=184.3

Q ss_pred             hccCCcccceeeeeCceEEEEEEeC----------------CCCcEEEEEEeeccchhhHHHH--------------HHH
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIP----------------STGLEVAIKRVAHNSRQGMKEF--------------VAE  402 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~----------------~~g~~vavK~~~~~~~~~~~~f--------------~~E  402 (662)
                      ..++|++.++||+|+||.||+|.+.                ..++.||||++........++|              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                2346799999876543333333              346


Q ss_pred             HHHhhccccccc-----eeeeeeEec--------cCeeeEEEeccCCCCcchhccccccc-------------------c
Q 040242          403 ITSMGRLRHRNL-----VQLHGWCRK--------QDELLLVYDYVPNGSLDKLLFDNDQQ-------------------K  450 (662)
Q Consensus       403 i~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~~~-------------------~  450 (662)
                      +.++.+++|.++     ++++++|..        ++..+|||||+++++|.++|+.....                   .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            777777776654     677887753        35689999999999999998743110                   1


Q ss_pred             cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCc
Q 040242          451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP  530 (662)
Q Consensus       451 ~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aP  530 (662)
                      ...++|..+..++.|++++|.|||+   .+|+||||||+||+++.++.+||+|||+++..............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            1345788899999999999999999   8999999999999999999999999999976544322222223457899999


Q ss_pred             ccccCCCC----------------------CcchhHHHHHHHHHHHHcCCC-CCCcccchh------hHHHHHHHHHHhh
Q 040242          531 ELTRTGKA----------------------TTSTDVFGFGTLMLEVACGRR-PIEPQRTAM------ELVLVDWVRELHS  581 (662)
Q Consensus       531 E~~~~~~~----------------------t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~------~~~l~~~~~~~~~  581 (662)
                      |.+.....                      ..+.||||+||+++||++|.. |+.......      ...+..|.  .+.
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r--~~~  457 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR--MYK  457 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH--hhc
Confidence            98753321                      234799999999999999875 664321110      01111221  111


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCC---CCCCCHHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHP---DFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP---~~RPt~~eVl~~  628 (662)
                      ...    .+-..   .........+|+.+|+..+|   .+|+|+.|+++|
T Consensus       458 ~~~----~~~~~---~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        458 GQK----YDFSL---LDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             ccC----CCccc---ccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            111    11111   11234556777788888765   789999999975

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-30  Score=279.24  Aligned_cols=241  Identities=23%  Similarity=0.303  Sum_probs=195.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +..|.....+|.|+|+.|-++....+++..+||++.+...    +-.+|+.++.+. .||||+++.+.+....+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            5677778889999999999999999999999999976622    223566555555 79999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe-CCCCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI-DADLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~~~~kL~DfGla~~~~  511 (662)
                      .+.++-|.+.+...+      ..-.++..|+.+|+.++.|||+   ++++||||||+|||+ ++.++++|+|||.++...
T Consensus       397 ~l~g~ell~ri~~~~------~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP------EFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hccccHHHHHHHhcc------hhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999988877774332      2226777899999999999999   899999999999999 688999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    ....+-|..|.|||++....+++++|+||||++||+|++|+.||......  ..+    ......         
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei----~~~i~~---------  528 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI----HTRIQM---------  528 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH----HHhhcC---------
Confidence            44    22235688999999999999999999999999999999999999865433  111    111111         


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ..+.....+...+|+.+||+.||.+||+|.++..+
T Consensus       529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             --CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence              11224455667788899999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.9e-31  Score=265.34  Aligned_cols=241  Identities=24%  Similarity=0.318  Sum_probs=193.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .+|....+||+|+||+|.+|..+++.+.+|||+++++.   ....+--..|-++|... +-|.++++..++...+.+|+|
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV  428 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV  428 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence            46888999999999999999999999999999997762   22222334566666655 678999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+.||+|--++.+     -..+.+....-.+..||-||-+||+   ++|+.||||..|||||.+|.+||+|||+++--
T Consensus       429 MEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn  500 (683)
T KOG0696|consen  429 MEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  500 (683)
T ss_pred             EEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence            999999999888843     3456677788889999999999999   99999999999999999999999999999832


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      -- ....+...+||+.|+|||++....|....|.|||||+||||+.|++||++.++.+   +..-+.            +
T Consensus       501 i~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---lF~aI~------------e  564 (683)
T KOG0696|consen  501 IF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQAIM------------E  564 (683)
T ss_pred             cc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH------------H
Confidence            11 1223445799999999999999999999999999999999999999999765432   111111            1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                      . --.|+.....+...+....+...|.+|.
T Consensus       565 h-nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  565 H-NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             c-cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1 1234555666677777788888888885

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=263.93  Aligned_cols=256  Identities=25%  Similarity=0.372  Sum_probs=197.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hh-----hHHHHHHHHHHhhccccccceeeeeeEec-cCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQ-----GMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~-----~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~  426 (662)
                      ++|-..++||+|||+.|||+.+....+.||||+-..+.  +.     -.+...+|..+.+.|.||.||++++|+.- .+.
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds  542 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS  542 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence            45777889999999999999998889999999764432  11     12446789999999999999999999864 557


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC---CCCCeEEee
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGD  503 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~D  503 (662)
                      .|-|.|||+|.+|+-+|+.+     ..+++++...|+.||..||.||.+. ..+|||-||||.||||-   .-|.+||+|
T Consensus       543 FCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITD  616 (775)
T KOG1151|consen  543 FCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITD  616 (775)
T ss_pred             ceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeee
Confidence            89999999999999999654     5688999999999999999999974 58899999999999994   457799999


Q ss_pred             ccccccccCCCCC------cceecccCCcccCcccccCC----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          504 FGLARAYDHNINP------QTTHIVGTLGYLAPELTRTG----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       504 fGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      |||++.++.+...      -+...+||..|++||++.-+    +.+.|.||||.|||+|..+.|+.||......  ..  
T Consensus       617 FGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd--  692 (775)
T KOG1151|consen  617 FGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD--  692 (775)
T ss_pred             cchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH--
Confidence            9999998764322      22346899999999987533    5788999999999999999999999865321  11  


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV  626 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl  626 (662)
                           .+....+..+-.-... ..+....+...++++||+..-+.|-...++.
T Consensus       693 -----ILqeNTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  693 -----ILQENTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             -----HHhhhchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence                 1122222222222211 0122344567888999999988887666554

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2e-31  Score=253.73  Aligned_cols=266  Identities=27%  Similarity=0.404  Sum_probs=201.7

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hh-hHHHHHHHHHHhhccccccceeeeeeEecc--------C
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--------D  425 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--------~  425 (662)
                      .|....+||+|.||.||+|+.+.+|+.||+|++..+. ++ --...++|+.+|..|+|+|++.+++.|...        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~   97 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA   97 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence            3555678999999999999999999999998764422 22 233458899999999999999999998543        2


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||++|+. +|.-+|.+.    ...++..++.++++++..||.|+|.   ..|+|||+|+.|+|++.++.+||+|||
T Consensus        98 t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFG  169 (376)
T KOG0669|consen   98 TFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFG  169 (376)
T ss_pred             eeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccc
Confidence            47999999965 788777543    3568888999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCC---CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh-
Q 040242          506 LARAYDHNIN---PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH-  580 (662)
Q Consensus       506 la~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~-  580 (662)
                      +++.+....+   +..+..+-|..|.+||.+.+ ..++++.|||.-|||+.||+|+.+-+.+..+..+..++.-+..-+ 
T Consensus       170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t  249 (376)
T KOG0669|consen  170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT  249 (376)
T ss_pred             cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence            9987764432   33445567999999997765 568999999999999999999998887665544444433222111 


Q ss_pred             -------hcCccccccCCC-C--CCCC--HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          581 -------SQGQITRAIDPT-L--DYFD--PQ------EAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       581 -------~~~~~~~~id~~-l--~~~~--~~------~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                             .+-.+.+.+... +  +.+.  ++      .....++|+.+++..||.+|+.+.+++.+-
T Consensus       250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence                   111222222111 1  0000  11      123567889999999999999999999754

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.4e-30  Score=278.68  Aligned_cols=262  Identities=26%  Similarity=0.369  Sum_probs=213.7

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEec
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK  423 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~  423 (662)
                      ..++.+...+.-|++.+.||.|.+|.||+++.+.+++.+|+|+....... .++...|.++++.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34455556678899999999999999999999999999999998765433 35667889999888 69999999999864


Q ss_pred             -----cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          424 -----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       424 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                           +++++||||||.+||..++++.-.   ...+.|..+..|+..++.||.+||.   ..++|||||-.||||+.++.
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~  161 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAE  161 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCc
Confidence                 358999999999999999997654   5679999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      +||.|||++....... .......||+.|||||++...     .++..+|+||+|++..||.-|.+|+-+..+.      
T Consensus       162 VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------  234 (953)
T KOG0587|consen  162 VKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------  234 (953)
T ss_pred             EEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------
Confidence            9999999998766543 233446899999999998643     3667899999999999999999998754331      


Q ss_pred             HHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          574 DWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         +.++.     -.-.|.. -..+....+++.+++..||..|-.+||++.+++++
T Consensus       235 ---raLF~-----IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  235 ---RALFL-----IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             ---hhhcc-----CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence               11110     0112333 22355678889999999999999999999998864

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.96  E-value=3.1e-30  Score=281.25  Aligned_cols=246  Identities=28%  Similarity=0.411  Sum_probs=188.1

Q ss_pred             CcccceeeeeCceE-EEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEecc
Q 040242          357 FREKNLVGSGGFGK-VYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       357 f~~~~~LG~G~~g~-Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      |...+++|.|..|+ ||+|..  .|+.||||++-....   .-..+|+..|+.- +|||||++++.-.+....|+..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            55567899999886 799999  688999999854432   2346799988887 6999999999988899999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---C--CCeEEeecccccc
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---D--LNPKLGDFGLARA  509 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~--~~~kL~DfGla~~  509 (662)
                       ..+|++++.... .......--..+.+..|+++||++||+   .+||||||||+||||+.   +  .+++|+|||+++.
T Consensus       586 -~~sL~dlie~~~-~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  586 -ACSLQDLIESSG-LDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             -hhhHHHHHhccc-cchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence             679999997641 111111113457789999999999999   89999999999999976   2  5699999999998


Q ss_pred             ccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          510 YDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG-RRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       510 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ...+...  ......||.||+|||.+....-+.+.||||+||++|+.++| ..||...-....              ++.
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------------NIl  726 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------------NIL  726 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------------hhh
Confidence            8765432  23456899999999999988888899999999999999996 889975432211              111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .-. ..+....+....+..+|+.+|++++|..||++.+|+.
T Consensus       727 ~~~-~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  727 TGN-YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             cCc-cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence            100 1110011111116778999999999999999999985

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2e-30  Score=249.18  Aligned_cols=263  Identities=24%  Similarity=0.359  Sum_probs=204.2

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc-----CeeeEE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DELLLV  430 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~~lV  430 (662)
                      +..+.||-|.||.||...++.+|+.||.|++...  .-...+.+.+|+++|...+|.|++..++...-.     .++|++
T Consensus        56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~  135 (449)
T KOG0664|consen   56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL  135 (449)
T ss_pred             CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence            3467899999999999999999999999998654  233457899999999999999999988876543     367899


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +|.| ..+|.+++..     ...|+-+...-+..||++||+|||+   .+|.||||||.|+|++.|..+||||||+++..
T Consensus       136 TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  136 TELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence            9999 6688888854     3567888888899999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH--------HHhh
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR--------ELHS  581 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~  581 (662)
                      +.+.....+..+-|..|.|||++.+. .++.+.||||.|||+.||+..+..|....+..+..++.-+-        +.-.
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            76666666666779999999999875 58899999999999999999999998776655554322110        0011


Q ss_pred             cCccccccC--------CCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          582 QGQITRAID--------PTLDY--FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       582 ~~~~~~~id--------~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      +|.....+.        +.+..  -+.....+...+..+++..||+.|-+..+.+.++
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            121111111        12211  1112233445666678999999999999998876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=7e-28  Score=235.48  Aligned_cols=212  Identities=33%  Similarity=0.579  Sum_probs=185.4

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCcch
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK  441 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  441 (662)
                      ||+|.+|.||++....+++.+++|++...... ..+.+.+|+..+++++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999777899999999766443 45678999999999999999999999999999999999999999999


Q ss_pred             hcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeeccccccccCCCCCccee
Q 040242          442 LLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNINPQTTH  520 (662)
Q Consensus       442 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~  520 (662)
                      ++....    ..+++..++.++.+++++|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ....
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~  152 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKT  152 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhc
Confidence            985431    358899999999999999999999   89999999999999999 89999999999987654321 1233


Q ss_pred             cccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHH
Q 040242          521 IVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQ  599 (662)
Q Consensus       521 ~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~  599 (662)
                      ..+...|++||..... ..+.+.|+|++|+++++|                                             
T Consensus       153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------  187 (215)
T cd00180         153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------  187 (215)
T ss_pred             ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence            4578899999998877 788999999999999999                                             


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                        ..+.+++.+|++.+|++||++.++++.+
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3477889999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=1.2e-28  Score=259.87  Aligned_cols=204  Identities=27%  Similarity=0.407  Sum_probs=174.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      -|...+.||-|+||+|.++...++...+|+|.+++..   +......++|-.+|.....+-||+|+-.|.+++.+|+|||
T Consensus       630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd  709 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD  709 (1034)
T ss_pred             ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence            4777889999999999999998888899999997764   3344567889999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc-
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~-  511 (662)
                      |++||++-.+|.+.     ..+.+...+..+..+.+|+.+.|.   .++|||||||+|||||.+|.+||+|||||.-+. 
T Consensus       710 YIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW  781 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  781 (1034)
T ss_pred             ccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeecccccccee
Confidence            99999999988543     457777777788899999999999   899999999999999999999999999996431 


Q ss_pred             --------CCCCC--------------------------------cceecccCCcccCcccccCCCCCcchhHHHHHHHH
Q 040242          512 --------HNINP--------------------------------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLM  551 (662)
Q Consensus       512 --------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl  551 (662)
                              ++...                                .....+||+.|+|||++....++..+|.||.||||
T Consensus       782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil  861 (1034)
T KOG0608|consen  782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL  861 (1034)
T ss_pred             ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence                    10000                                00124699999999999998999999999999999


Q ss_pred             HHHHcCCCCCCcccch
Q 040242          552 LEVACGRRPIEPQRTA  567 (662)
Q Consensus       552 ~elltG~~p~~~~~~~  567 (662)
                      |||+.|+.||....+.
T Consensus       862 ~em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  862 YEMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHHhhCCCCccCCCCC
Confidence            9999999999866543

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-29  Score=231.04  Aligned_cols=201  Identities=29%  Similarity=0.392  Sum_probs=169.3

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      ...||+|++|.|-+-++..+|...|+|++... ..+..++.+.|+.+..+- .+|.+|.++|........++.||.| .-
T Consensus        51 i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~t  129 (282)
T KOG0984|consen   51 IEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DT  129 (282)
T ss_pred             hhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hh
Confidence            56799999999999999999999999999764 445567788899876654 7999999999999999999999999 66


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      ||+.+-.+.- .+...+++.-+=+|+..+..||.|||+.  ..++|||+||+|||++.+|++||||||++..+.+..  .
T Consensus       130 Sldkfy~~v~-~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi--A  204 (282)
T KOG0984|consen  130 SLDKFYRKVL-KKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI--A  204 (282)
T ss_pred             hHHHHHHHHH-hcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhh--H
Confidence            8887654322 2256788888899999999999999996  889999999999999999999999999998765432  2


Q ss_pred             ceecccCCcccCcccccC----CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          518 TTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      .+...|-..|||||.+..    ..|+-|+||||+|+.+.||.+++.||+....
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            233467889999998743    3688999999999999999999999985543

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.2e-28  Score=242.86  Aligned_cols=248  Identities=24%  Similarity=0.319  Sum_probs=192.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...++||+|+|.+|-.+.++.+.+.+|+|+++++   ..+.+.=...|-.+..+. +||.+|.+..++..+..+++|
T Consensus       250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv  329 (593)
T KOG0695|consen  250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV  329 (593)
T ss_pred             ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence            5788899999999999999999999999999998764   222333344555555555 799999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      .||+++|+|--++.+     ...|+++........|.-||.|||+   .+|+.||||..|||+|.+|.+||+|+|+++--
T Consensus       330 ieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  330 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            999999999777633     3468888888889999999999999   99999999999999999999999999999843


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc-chhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQR-TAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      -.. ...+...+||+.|+|||++.+..+....|.|++||+++||+.|+.||+--. ...+..-.+++.+..-+..     
T Consensus       402 l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekq-----  475 (593)
T KOG0695|consen  402 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ-----  475 (593)
T ss_pred             CCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc-----
Confidence            222 234456799999999999999999999999999999999999999997211 1111222334333322211     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                         + ..+.....+...+...-|..||.+|.
T Consensus       476 ---i-riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  476 ---I-RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             ---c-cccceeehhhHHHHHHhhcCCcHHhc
Confidence               1 11222333445566677888888875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-29  Score=259.71  Aligned_cols=249  Identities=23%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +++....||-||||.|=+.........+|+|++++.   .....+....|-.+|.+.+.|.||+++--+.+.+..|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            344566799999999999988655555788877654   34445677899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      -|-||.|...|.+     +..++......++..+.+|+.|||.   ++||.|||||+|++|+.+|-+||.|||.|+.+..
T Consensus       501 aClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~  572 (732)
T KOG0614|consen  501 ACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS  572 (732)
T ss_pred             hhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence            9999999999954     4567777788889999999999999   9999999999999999999999999999998876


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      +  ..+-..+||+.|.|||++.++....+.|.|++|+++|||++|++||...++.....++            +.-+|. 
T Consensus       573 g--~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~-  637 (732)
T KOG0614|consen  573 G--RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDK-  637 (732)
T ss_pred             C--CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhh-
Confidence            4  4556689999999999999988999999999999999999999999987654333221            111111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                       ..++....+...+|+++.+..+|.+|.-     +.+|-++
T Consensus       638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence             1344455666788899999999999976     6676664

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=7.7e-27  Score=231.95  Aligned_cols=200  Identities=33%  Similarity=0.502  Sum_probs=174.6

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-hHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      |...+.||+|++|.||++....+++.+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45678899999999999999877899999999876544 66788999999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +++|.+++....    ..+++.....++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~  153 (225)
T smart00221       81 GGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA  153 (225)
T ss_pred             CCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc
Confidence            999999986432    117899999999999999999999   7999999999999999999999999999987755421


Q ss_pred             CcceecccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 040242          516 PQTTHIVGTLGYLAPELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEP  563 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  563 (662)
                      .......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus       154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            122334678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=4.2e-28  Score=251.23  Aligned_cols=286  Identities=22%  Similarity=0.285  Sum_probs=223.3

Q ss_pred             CccchhhhccCccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc
Q 040242          331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR  410 (662)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~  410 (662)
                      .+...|....|..++.+-|+..  .+|......|+|-|++|.+|.+...|..||||++..+... .+.=+.|+++|++|+
T Consensus       410 ~L~DNWdDaEGYYrv~igE~LD--~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~  486 (752)
T KOG0670|consen  410 GLQDNWDDAEGYYRVRIGELLD--SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLN  486 (752)
T ss_pred             ccccCcccccceEEEehhhhhc--ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhh
Confidence            3456788777888888888875  6799999999999999999999888999999999776432 233478999999995


Q ss_pred             ------cccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeC
Q 040242          411 ------HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHR  484 (662)
Q Consensus       411 ------H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  484 (662)
                            -.|+++++..|...+++|||+|-+ .-+|.+.|+....  ...|........+.|+.-||..|..   .+|+|.
T Consensus       487 ~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHa  560 (752)
T KOG0670|consen  487 DADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHA  560 (752)
T ss_pred             ccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeec
Confidence                  367899999999999999999988 6799999976542  5678899999999999999999999   899999


Q ss_pred             CcCCCceEeCCCC-CeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCc
Q 040242          485 DVKPSNVLIDADL-NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP  563 (662)
Q Consensus       485 Dlkp~NIll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~  563 (662)
                      ||||.|||+++.- .+||||||.|.....+   ..+...-+..|.|||++.+..|....|+||.||+||||.||+..|.+
T Consensus       561 DIKPDNiLVNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  561 DIKPDNILVNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             ccCccceEeccCcceeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            9999999998765 4899999999876554   23334556789999999999999999999999999999999999986


Q ss_pred             ccchhhHHHHHHHH-----HHhhcCc---------------------------cccccCC------------CCCCCCHH
Q 040242          564 QRTAMELVLVDWVR-----ELHSQGQ---------------------------ITRAIDP------------TLDYFDPQ  599 (662)
Q Consensus       564 ~~~~~~~~l~~~~~-----~~~~~~~---------------------------~~~~id~------------~l~~~~~~  599 (662)
                      ...-...-+..-+.     .++..+.                           ++..+.|            .+......
T Consensus       638 ~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~  717 (752)
T KOG0670|consen  638 RTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPK  717 (752)
T ss_pred             CCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHH
Confidence            54432222211111     1111111                           1111112            11222334


Q ss_pred             HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          600 EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       600 ~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....+..|...|+..||++|-|..+.+++
T Consensus       718 ~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  718 IVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence            45667889999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.9e-26  Score=238.13  Aligned_cols=144  Identities=24%  Similarity=0.333  Sum_probs=118.9

Q ss_pred             ccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-----c---cc
Q 040242          342 ACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-----H---RN  413 (662)
Q Consensus       342 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H---~n  413 (662)
                      .+...+-|... ..+|...++||.|.|++||++.+..+.+.||+|+.+... .-.+.-+.||++|++++     |   ..
T Consensus        66 YHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~  143 (590)
T KOG1290|consen   66 YHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKC  143 (590)
T ss_pred             Cceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCce
Confidence            33334444432 367899999999999999999999999999999986542 22345688999999984     3   46


Q ss_pred             ceeeeeeEecc----CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCC
Q 040242          414 LVQLHGWCRKQ----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPS  489 (662)
Q Consensus       414 iv~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  489 (662)
                      ||+|++.|...    .++++|+|+. |-+|..+|....   ...++.....+|++||+.||.|||.+  .+|||-||||+
T Consensus       144 VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPE  217 (590)
T KOG1290|consen  144 VVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPE  217 (590)
T ss_pred             eeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcc
Confidence            99999998654    4899999999 889999997664   56789999999999999999999997  58999999999


Q ss_pred             ceEe
Q 040242          490 NVLI  493 (662)
Q Consensus       490 NIll  493 (662)
                      |||+
T Consensus       218 NvLl  221 (590)
T KOG1290|consen  218 NVLL  221 (590)
T ss_pred             eeee
Confidence            9998

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.94  E-value=2.5e-27  Score=222.92  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccC--eeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQD--ELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~--~~~lV  430 (662)
                      .++|++.+++|+|.++.||.|....++++++||.++...   .+.+.+|+++|..|+ ||||+++++...+..  ...||
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467888999999999999999988889999999996543   456788999999997 999999999886654  67899


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeecccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARA  509 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla~~  509 (662)
                      +||+.+.+...+-        ..|+...+...+.+++.||.|+|+   .||.|||+||.|+++|.. ..++|+|+|||..
T Consensus       114 FE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             hhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhh
Confidence            9999888876654        567788888899999999999999   899999999999999865 4599999999998


Q ss_pred             ccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCccc-chhhHH----------HHHHHH
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQR-TAMELV----------LVDWVR  577 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~-~~~~~~----------l~~~~~  577 (662)
                      +......  .-.+.+..|.-||.+-.. .+...-|+|||||+|..|+..+.||.... ..++..          +..++.
T Consensus       183 YHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~  260 (338)
T KOG0668|consen  183 YHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLN  260 (338)
T ss_pred             cCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHH
Confidence            8765322  223456778899987654 46778899999999999999999997443 222222          112221


Q ss_pred             HHhhcCccccccCCCCCC----------------CCHH-HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          578 ELHSQGQITRAIDPTLDY----------------FDPQ-EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~----------------~~~~-~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..      .-.+||....                .+.. ...+.++++.+.|..|.++|||++|.+.+
T Consensus       261 KY------~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  261 KY------QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HH------ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            11      1112222210                0011 13567788889999999999999998863

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.94  E-value=2.1e-27  Score=234.11  Aligned_cols=261  Identities=23%  Similarity=0.293  Sum_probs=199.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------C
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------D  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~  425 (662)
                      ..+|...+.+|.|.- .|..+.+.-.+++||+|++...  .....+.-.+|...+..++|+|+++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            356777888999988 7888888778999999988543  233456678899999999999999999998543      3


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      +.|+|||+| ..+|...+.       ..++-.....|..|+++|++|||+   .+|+||||||+||++..+..+||.|||
T Consensus        95 e~y~v~e~m-~~nl~~vi~-------~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg  163 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL-------MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFG  163 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH-------HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccch
Confidence            679999999 779998884       446777888999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH---------HHH
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV---------DWV  576 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~~  576 (662)
                      +++.....  -..+..+.|..|.|||++-+..+.+..||||.||++.||++|+.-|.+.+..++....         .+.
T Consensus       164 ~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  164 LARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             hhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHH
Confidence            99975443  3455678899999999988877999999999999999999999988754432221100         001


Q ss_pred             HHHhhcC-------------ccccccCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 RELHSQG-------------QITRAIDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 ~~~~~~~-------------~~~~~id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .++...+             ...+.+...+    .+.+.-....+..++.+||-.||++|-+.++++++
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            1111100             0111111111    11122344567788999999999999999999986

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-27  Score=251.44  Aligned_cols=253  Identities=25%  Similarity=0.369  Sum_probs=205.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .+|...+.+|+|.||.|||++++..++..|+|.++.......+-..+|+-+++..+|+||+.++|-+...+.++++||||
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEyc   94 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYC   94 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEec
Confidence            56777899999999999999999999999999998887777777788999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      .+|+|.+.-+-     ..+|+..++-.+++...+||+|||+   .+-+|||||-.||++++.+.+|++|||.+-.+....
T Consensus        95 gggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati  166 (829)
T KOG0576|consen   95 GGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI  166 (829)
T ss_pred             CCCcccceeee-----cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh
Confidence            99999997643     5679999999999999999999999   788999999999999999999999999887665432


Q ss_pred             CCcceecccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          515 NPQTTHIVGTLGYLAPELT---RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . ......||+.|||||+.   ..+.+.+++|||++|+...|+---.+|.....+.  ..+.     +..    ....+|
T Consensus       167 ~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm--r~l~-----LmT----kS~~qp  234 (829)
T KOG0576|consen  167 A-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM--RALF-----LMT----KSGFQP  234 (829)
T ss_pred             h-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH--HHHH-----Hhh----ccCCCC
Confidence            2 33346899999999976   4567899999999999999998877776543221  1110     000    112222


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .-..-.....+.+-.+++.|+..+|.+||+++..++
T Consensus       235 p~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  235 PTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            221222344566778888999999999999887664

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-26  Score=242.98  Aligned_cols=197  Identities=25%  Similarity=0.357  Sum_probs=169.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--------hHHHHHHHHHHhhccc---cccceeeeeeEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--------GMKEFVAEITSMGRLR---HRNLVQLHGWCRK  423 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--------~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~  423 (662)
                      .+|...+.+|+|+||.|+.|.++.+...|+||.+.+..--        ..-..-.||.+|..++   |+||+++++++++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            3578889999999999999999999999999998665211        1113457999999997   9999999999999


Q ss_pred             cCeeeEEEecc-CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          424 QDELLLVYDYV-PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       424 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ++.+||+||-. ++-+|.+++..     +..+++.+...|++|++.|+++||+   ++|+|||||-+||.++.+|.+||+
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kli  712 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLI  712 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEe
Confidence            99999999975 45678888854     4568899999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCC
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      |||.+.....+   .....+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       713 dfgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  713 DFGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99999876543   3345689999999999988765 566899999999999999988875

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.8e-26  Score=219.32  Aligned_cols=252  Identities=23%  Similarity=0.313  Sum_probs=188.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeee-eEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHG-WCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~-~~~~~~~~~lV~E  432 (662)
                      +.|.+.+.||+|.||.+-++.++.+...+++|.+.... ...++|.+|...=-.| .|.||+.-++ .++..+.+++++|
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE  102 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE  102 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence            56788999999999999999999999999999987653 3457899998765555 5899998776 4667778999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe-CCC-CCeEEeeccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI-DAD-LNPKLGDFGLARAY  510 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-~~~-~~~kL~DfGla~~~  510 (662)
                      |+|.|+|.+-+..      ..+.+....+++.|+++||.|||+   .++||||||.+|||+ +.+ .++||||||+.+..
T Consensus       103 ~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~  173 (378)
T KOG1345|consen  103 FAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKV  173 (378)
T ss_pred             cCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccccccc
Confidence            9999999998853      346677778899999999999999   899999999999999 333 46999999999865


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +....    ...-+..|.+||.....     ...+.+|||.||++++..+||+.|+......++.   -|-+..|..++.
T Consensus       174 g~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  174 GTTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKRKN  246 (378)
T ss_pred             Cceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcccC
Confidence            43211    12235678999976432     3577899999999999999999999843322221   233444444433


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .     .+...-.-..++++++.++-+.++|.+|=...++.++
T Consensus       247 ~-----~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  247 P-----ALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             c-----cCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence            2     2211112234567778888999999999555555443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.92  E-value=5.7e-26  Score=267.70  Aligned_cols=196  Identities=18%  Similarity=0.280  Sum_probs=141.1

Q ss_pred             cccc-ccceeeeeeE-------eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC
Q 040242          408 RLRH-RNLVQLHGWC-------RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ  479 (662)
Q Consensus       408 ~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  479 (662)
                      +++| +||.+++++|       ...+..++++||+ +++|.++|...    ...+++.+++.++.||++||.|||+   .
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~   99 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS---Q   99 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---C
Confidence            4556 6888888887       3334578889988 67999999643    3458999999999999999999999   8


Q ss_pred             CEEeCCcCCCceEeCC-------------------CCCeEEeeccccccccCCCC---------------CcceecccCC
Q 040242          480 RVVHRDVKPSNVLIDA-------------------DLNPKLGDFGLARAYDHNIN---------------PQTTHIVGTL  525 (662)
Q Consensus       480 ~ivH~Dlkp~NIll~~-------------------~~~~kL~DfGla~~~~~~~~---------------~~~~~~~gt~  525 (662)
                      +|+||||||+||||+.                   ++.+||+|||+++.......               .......||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            9999999999999954                   44566666776654221000               0011235788


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 040242          526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVL  605 (662)
Q Consensus       526 ~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~  605 (662)
                      .|+|||++.+..++.++|||||||+||||++|..|+.....    .+..+...         .+.+..    ........
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~---------~~~~~~----~~~~~~~~  242 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR---------VLPPQI----LLNWPKEA  242 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh---------hcChhh----hhcCHHHH
Confidence            99999999988999999999999999999999887653211    11111000         111111    11123345


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHH
Q 040242          606 TLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       606 ~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .++.+||+++|.+||+|.||+++
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhc
Confidence            77889999999999999999974

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.91  E-value=6.6e-25  Score=224.30  Aligned_cols=263  Identities=25%  Similarity=0.404  Sum_probs=196.3

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC---CCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~  428 (662)
                      ..+.|...++||+|.|++||++.+..   ..+.||+|.+...+.  .....+|+++|..+. +.||+++.++...++...
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            44678889999999999999999876   678899999866533  345789999999995 999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeecccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLA  507 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla  507 (662)
                      +|+||++.....++.        ..++..++...+..+..||.++|+   .+|+||||||+|+|.+.. +.-.|.||||+
T Consensus       112 ivlp~~~H~~f~~l~--------~~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLY--------RSLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             EEecccCccCHHHHH--------hcCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhH
Confidence            999999999988887        346678888899999999999999   999999999999999754 56899999999


Q ss_pred             ccccCCC-------------C------------------------------CcceecccCCcccCcccccC-CCCCcchh
Q 040242          508 RAYDHNI-------------N------------------------------PQTTHIVGTLGYLAPELTRT-GKATTSTD  543 (662)
Q Consensus       508 ~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~t~ksD  543 (662)
                      ...+...             .                              ......+||+||.|||++.. ..-+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            7221100             0                              00112469999999998754 45788999


Q ss_pred             HHHHHHHHHHHHcCCCCCCcccchhhH-----HHHHH--HHH-HhhcCc--ccc---------------ccC-CCC----
Q 040242          544 VFGFGTLMLEVACGRRPIEPQRTAMEL-----VLVDW--VRE-LHSQGQ--ITR---------------AID-PTL----  593 (662)
Q Consensus       544 V~S~Gvvl~elltG~~p~~~~~~~~~~-----~l~~~--~~~-~~~~~~--~~~---------------~id-~~l----  593 (662)
                      |||.|||++-+++++.||.........     .+..|  +++ ....|.  +.+               .++ ..+    
T Consensus       261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~  340 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR  340 (418)
T ss_pred             eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence            999999999999999999643322111     01001  111 011122  111               010 000    


Q ss_pred             ------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 ------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            .......+..++++..+|++.||.+|-|+++.+++
T Consensus       341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence                  01111223478899999999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.91  E-value=7.8e-24  Score=203.13  Aligned_cols=166  Identities=20%  Similarity=0.177  Sum_probs=125.4

Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++...    ...++|.+++.++.|+++||.|||+   .+      ||+||+++.++.+|+  ||+++......  
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence            6888888543    3469999999999999999999999   44      999999999999999  99998754422  


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                          ..||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+..+.....       ..++.....
T Consensus        64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-------~~~~~~~~~  131 (176)
T smart00750       64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-------ADDPRDRSN  131 (176)
T ss_pred             ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-------cCCcccccc
Confidence                258899999999999999999999999999999999999996543211 11111211110       011111111


Q ss_pred             CHHHHH--HHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          597 DPQEAE--LVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       597 ~~~~~~--~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ......  .+.+++.+||+.+|.+||++.|+++++..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            122222  68999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.3e-22  Score=214.34  Aligned_cols=168  Identities=20%  Similarity=0.204  Sum_probs=131.3

Q ss_pred             HHhccCCcccceeeeeCceEEEEEEeCC-CCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEecc
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ  424 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~  424 (662)
                      .....+|...+.||+|+||+||+|.+.. ++..||||++...     .....+.|.+|+++|++++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            3445789999999999999999998865 6777899987533     122356789999999999999998533322   


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCc-CCCceEeCCCCCeEEee
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV-KPSNVLIDADLNPKLGD  503 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~D  503 (662)
                      +..++||||+++++|....  .    ..      ...++.+++++|.|||+   .+|+|||| ||+|||++.++.+||+|
T Consensus        91 ~~~~LVmE~~~G~~L~~~~--~----~~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 GKDGLVRGWTEGVPLHLAR--P----HG------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             CCcEEEEEccCCCCHHHhC--c----cc------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence            4579999999999996321  0    01      13578899999999999   89999999 99999999999999999


Q ss_pred             ccccccccCCCCC-------cceecccCCcccCcccccCC
Q 040242          504 FGLARAYDHNINP-------QTTHIVGTLGYLAPELTRTG  536 (662)
Q Consensus       504 fGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  536 (662)
                      ||+++.+......       ..+...+++.|+|||++...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999977543211       11345788899999988543

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.88  E-value=5.5e-21  Score=189.80  Aligned_cols=195  Identities=21%  Similarity=0.232  Sum_probs=135.5

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++..++.|++||+.|+++.                 +|+|+|+|+|.+.. ..+||||||
T Consensus        20 ~~w~~~G~a~~~-~~~i~LT~~~~~~~G~~~~~~pi~~~-----------------~F~~~f~F~i~~~~-~~~gdG~af   80 (218)
T cd07308          20 GNWTVGGSTVIT-KNYIRLTPDVPSQSGSLWSRVPIPAK-----------------DFEIEVEFSIHGGS-GLGGDGFAF   80 (218)
T ss_pred             CCeEEcCCeEEe-CCEEEeCCCCCCCEeEEEeCCCccCC-----------------CEEEEEEEEEeCCC-CCCCCEEEE
Confidence            589999999987 88999999999999999999999975                 49999999998763 568999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND  190 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~  190 (662)
                      +++|...    ..|+.+|..+       ..+-+||||||+.|.   +....+|.+-+|.-......    ..|.....-.
T Consensus        81 ~~~~~~~----~~g~~~G~~~-------~~~Glai~fdt~~n~---~~~~p~i~~~~Ndg~~~~~~----~~d~~~~~~~  142 (218)
T cd07308          81 WYTEEPG----SDGPLFGGPD-------KFKGLAIFFDTYDND---GKGFPSISVFLNDGTKSYDY----ETDGEKLELA  142 (218)
T ss_pred             EEECCCC----CCCcccccCC-------CCCEEEEEEEcCCCC---CCCCCeEEEEEeCCCceecc----cCCCcccccc
Confidence            9999653    2445555532       234599999999985   33445665544432211000    0000000000


Q ss_pred             CCcceeec-CCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeeccccc-ccccceEEeeeccCCcccceeEEecce
Q 040242          191 DNISVVLK-SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLAT-VLDEYMYVGFSASTGLLTAFHNVHGWS  268 (662)
Q Consensus       191 ~~~~~~l~-~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~-~l~~~~~vGFsastG~~~~~~~i~sW~  268 (662)
                      . ..+... ++.+++++|.|+  .+.|.|.+....   +....  ..+++.. .+|+..|+||||+||...+.|+|++|.
T Consensus       143 ~-c~~~~~~~~~~~~~~I~y~--~~~l~v~i~~~~---~~~~~--~c~~~~~~~l~~~~y~G~sA~tg~~~d~~dIls~~  214 (218)
T cd07308         143 S-CSLKFRNSNAPTTLRISYL--NNTLKVDITYSE---GNNWK--ECFTVEDVILPSQGYFGFSAQTGDLSDNHDILSVH  214 (218)
T ss_pred             c-eeEecccCCCCeEEEEEEE--CCEEEEEEeCCC---CCCcc--EEEEcCCcccCCCCEEEEEeccCCCcCcEEEEEEE
Confidence            0 112222 268999999999  678899886432   11122  3334444 468899999999999999999999998


Q ss_pred             ee
Q 040242          269 FK  270 (662)
Q Consensus       269 f~  270 (662)
                      +.
T Consensus       215 ~~  216 (218)
T cd07308         215 TY  216 (218)
T ss_pred             ee
Confidence            74

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=2e-21  Score=205.17  Aligned_cols=275  Identities=21%  Similarity=0.211  Sum_probs=200.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCC-cEEEEEEeeccchhhHHHHHHHHHHhhcccc----ccceeeeeeE-eccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTG-LEVAIKRVAHNSRQGMKEFVAEITSMGRLRH----RNLVQLHGWC-RKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H----~niv~l~~~~-~~~~~~~l  429 (662)
                      +|...++||+|+||.||++.....+ ..+|+|............+..|..++..+..    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7899999999999999999986654 5788888766533333367778888888863    6888888888 47778899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-----CCeEEeec
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-----LNPKLGDF  504 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-----~~~kL~Df  504 (662)
                      ||+.+ |.+|.++.....   ...++..+.++|+.|++.+|.+||+   .+++||||||.|+++...     ..+.|.||
T Consensus        99 VM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             EEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99998 999999875543   4668899999999999999999999   899999999999999865     45999999


Q ss_pred             cccc--cccCCCC----Cc---ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH
Q 040242          505 GLAR--AYDHNIN----PQ---TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW  575 (662)
Q Consensus       505 Gla~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  575 (662)
                      |+++  .+.....    ..   .....||..|++++...+...+++.|+||++.++.|+..|..|+...........   
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---  248 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---  248 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---
Confidence            9999  4322111    11   2235699999999999999999999999999999999999999965443222110   


Q ss_pred             HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCCCCCC
Q 040242          576 VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPR  648 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~~~~~~~~~  648 (662)
                      +.+...    .....+ .   ....+..+.++...+-..+...+|....+...|.............+..|..
T Consensus       249 ~~~~~~----~~~~~~-~---~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~~  313 (322)
T KOG1164|consen  249 FEKDPR----KLLTDR-F---GDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWEV  313 (322)
T ss_pred             HHHHhh----hhcccc-c---cCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCcccc
Confidence            000000    000010 1   1122344455555566689999999999998876554433444444444443

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=6.2e-23  Score=197.68  Aligned_cols=244  Identities=18%  Similarity=0.322  Sum_probs=188.2

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      ..+|.+...|+.|+|++.+  ..+++|++...  .....++|..|.-.|+-..||||+.++|.|.....+.++..||+.|
T Consensus       195 ~tkl~e~hsgelwrgrwqg--ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQG--NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccccccC--cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            4568889999999999954  45667766443  3444578999999999999999999999999999999999999999


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe--eccccccccCCCC
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG--DFGLARAYDHNIN  515 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~--DfGla~~~~~~~~  515 (662)
                      +|...|++..   .-..+-.+..+++.++|+|++|||+- ++-|.---|.++.+++|++.+++|+  |--++.       
T Consensus       273 slynvlhe~t---~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-------  341 (448)
T KOG0195|consen  273 SLYNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------  341 (448)
T ss_pred             HHHHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee-------
Confidence            9999998764   45678889999999999999999984 2345555799999999999998885  211111       


Q ss_pred             CcceecccCCcccCcccccCCCC---CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~---t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                       +.....-.+.||+||.++.++.   -..+|+|||+++||||.|...||..-.+.+-.               .+..-..
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeg  405 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEG  405 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcc
Confidence             0111123678999999976643   35789999999999999999999755432111               0111112


Q ss_pred             C-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          593 L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       593 l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      + ...++.....+.+|+.-|+..||.+||.+..|+-.|++-
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            2 344666777888999999999999999999999988763

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=4.7e-20  Score=191.94  Aligned_cols=259  Identities=29%  Similarity=0.426  Sum_probs=198.3

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh---hHHHHHHHHHHhhccccc-cceeeeeeEeccCeeeEEEe
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHR-NLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~---~~~~f~~Ei~~l~~l~H~-niv~l~~~~~~~~~~~lV~E  432 (662)
                      |...+.||.|+|+.||++...   ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            566788999999999999995   67999998765332   467899999999999988 79999999977777899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~  511 (662)
                      ++.+++|.+++......  ..+.......+..|++.++.|+|+   .+++|||+||+||+++... .++++|||+++...
T Consensus        79 ~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~  153 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLP  153 (384)
T ss_pred             cCCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecC
Confidence            99999999776433210  368888999999999999999999   7899999999999999998 69999999998655


Q ss_pred             CCCCC-----cceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccch-hhHHHHHHHHHHhhc
Q 040242          512 HNINP-----QTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTA-MELVLVDWVRELHSQ  582 (662)
Q Consensus       512 ~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~-~~~~l~~~~~~~~~~  582 (662)
                      .....     ......|+..|+|||.+..   .......|+|++|++++++++|..|+...... ........+......
T Consensus       154 ~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (384)
T COG0515         154 DPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP  233 (384)
T ss_pred             CCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc
Confidence            43322     2355689999999999987   57889999999999999999999997654321 011111111111100


Q ss_pred             CccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 GQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ...... ..........+..++..|+..+|..|.++.+....
T Consensus       234 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 -----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             -----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence                 001111 11112334567888889999999999999988764

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.1e-21  Score=220.26  Aligned_cols=254  Identities=20%  Similarity=0.243  Sum_probs=191.7

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEee----c-cch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA----H-NSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~----~-~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ...+++|.|.+|.|+........+..+.|.+.    . ... .....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            34688999999988887776555555555432    1 111 12223677888888899999999888888777777779


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++ +|..++...     ..+.-.++..+++|+..|+.|||+   .++.|||+|++|++++.++.+||+|||.+..+.
T Consensus       401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence            99999 999998532     357788889999999999999999   899999999999999999999999999998776


Q ss_pred             CCCC---CcceecccCCcccCcccccCCCCCc-chhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          512 HNIN---PQTTHIVGTLGYLAPELTRTGKATT-STDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       512 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....   .......|+..|+|||.+...++.+ ..||||.|+++..|++|+.||..........       .........
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-------~~~~~~~~~  544 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-------KTNNYSDQR  544 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-------hhhcccccc
Confidence            5443   3445578999999999999888866 4799999999999999999997554432221       000011111


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .+...........+.+...++.++|+.+|.+|-|+++|++
T Consensus       545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            1111112223345666788899999999999999999986

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=3.3e-20  Score=199.34  Aligned_cols=214  Identities=25%  Similarity=0.410  Sum_probs=166.1

Q ss_pred             hhccccccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCE-EeC
Q 040242          406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV-VHR  484 (662)
Q Consensus       406 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i-vH~  484 (662)
                      |+.+.|.|+.+++|.|......+.|.+||+.|+|.+.+...    ...++|.....++++|+.||.|||.   .+| .|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence            46789999999999999999999999999999999999764    4669999999999999999999999   444 999


Q ss_pred             CcCCCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCC-------CCCcchhHHHHHHHHHHHHc
Q 040242          485 DVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTG-------KATTSTDVFGFGTLMLEVAC  556 (662)
Q Consensus       485 Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDV~S~Gvvl~ellt  556 (662)
                      .++++|+++|....+||+|||+......... .......-..-|.|||.+...       ..+.+.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            9999999999999999999999987643111 111112345689999988653       15778999999999999999


Q ss_pred             CCCCCCcccchh-hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          557 GRRPIEPQRTAM-ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       557 G~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+.||....... ...+..++..     .....+.|.+.... +....+..++..||..+|.+||++.+|-..++..
T Consensus       154 r~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            999998533221 1223333332     12333444443222 4445789999999999999999999999887654

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.81  E-value=1.9e-19  Score=182.40  Aligned_cols=234  Identities=22%  Similarity=0.293  Sum_probs=157.9

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccc----------cccceeeeeeEe-
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLR----------HRNLVQLHGWCR-  422 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~----------H~niv~l~~~~~-  422 (662)
                      +...+.||.|+++.||.+.+..+|+.+|||.+...   .....+++.+|.-.+..+.          |-.++-.++... 
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            44578899999999999999999999999987543   3345677777776665532          223332222221 


Q ss_pred             --------cc---C-----eeeEEEeccCCCCcchhccc---ccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEe
Q 040242          423 --------KQ---D-----ELLLVYDYVPNGSLDKLLFD---NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH  483 (662)
Q Consensus       423 --------~~---~-----~~~lV~E~~~~gsL~~~l~~---~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  483 (662)
                              ..   .     ..+++|+-+ -++|.+++.-   ... ....+....++.+..|+.+.+++||+   .+++|
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~-~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH  168 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQ-THSPLAFAARLSLTVQMIRLVANLHS---YGLVH  168 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTT-TSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhccc-ccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence                    11   1     237788888 6788887642   111 13456677888899999999999999   89999


Q ss_pred             CCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccC--------CCCCcchhHHHHHHHHHHHH
Q 040242          484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT--------GKATTSTDVFGFGTLMLEVA  555 (662)
Q Consensus       484 ~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~ell  555 (662)
                      +||+|+|++++++|.+.|+||+.....+.....    ...+..|.+||....        -.++.+.|.|++|+++|.|+
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999877765432111    234578999997643        24788999999999999999


Q ss_pred             cCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040242          556 CGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFR  619 (662)
Q Consensus       556 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R  619 (662)
                      ||+.||.........                   +.....+. +.++.+..|+..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~-------------------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADP-------------------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTS-------------------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccc-------------------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999855332111                   00334556 788899999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.80  E-value=2.1e-19  Score=174.51  Aligned_cols=140  Identities=19%  Similarity=0.192  Sum_probs=108.4

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--h-------HHH-----------------HHHHHHHhhcccccc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--G-------MKE-----------------FVAEITSMGRLRHRN  413 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--~-------~~~-----------------f~~Ei~~l~~l~H~n  413 (662)
                      ...||+|++|.||+|... +|+.||||+++.....  .       ...                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999996 8999999999654211  0       112                 234999999998887


Q ss_pred             ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHh-HhcCCCCEEeCCcCCCceE
Q 040242          414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL-HEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       414 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIl  492 (662)
                      +.....+..  ...++||||+++++|...+..     ...+++.+...++.|++.+|.|| |+   .+|+||||||+|||
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIl  150 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLL  150 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEE
Confidence            644333222  223899999998877654321     24578889999999999999999 56   79999999999999


Q ss_pred             eCCCCCeEEeecccccccc
Q 040242          493 IDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       493 l~~~~~~kL~DfGla~~~~  511 (662)
                      ++ ++.++|+|||++...+
T Consensus       151 i~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         151 YH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             EE-CCcEEEEEccccccCC
Confidence            98 4789999999998543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.80  E-value=7.8e-20  Score=179.99  Aligned_cols=170  Identities=12%  Similarity=0.155  Sum_probs=131.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh---HHH------HHHHHHHhhccccccceeeeeeEecc
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG---MKE------FVAEITSMGRLRHRNLVQLHGWCRKQ  424 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~---~~~------f~~Ei~~l~~l~H~niv~l~~~~~~~  424 (662)
                      .++|+..++||.|+||.||....  ++..+|||.+.......   ...      +.+|+..+.+++|++|..+..++...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            57899999999999999999765  46689999996543222   122      67999999999999999998885533


Q ss_pred             --------CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          425 --------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       425 --------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                              +..++||||++|.+|.++..         ++.    ....+++++|..||+   .+++|||+||+||+++.+
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCC
Confidence                    35799999999999988741         111    245689999999999   899999999999999998


Q ss_pred             CCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHH
Q 040242          497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA  555 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ell  555 (662)
                      + ++|+|||............             .+.....+..++|+|+||+.+..+.
T Consensus       172 g-i~liDfg~~~~~~e~~a~d-------------~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRKAKD-------------RIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             C-EEEEECCCcccccchhhHH-------------HHHHHhHhcccccccceeEeehHHH
Confidence            8 9999999887653221110             1233334557899999999886653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=4e-20  Score=207.23  Aligned_cols=248  Identities=23%  Similarity=0.251  Sum_probs=180.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHH--hhccccccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITS--MGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~--l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++...+.||+++|=+|.+|++. +|. |+||++-+.. .-..+.|.++++-  ...++|||.+++.-+-..++..|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5666889999999999999994 565 9999986654 3334444444433  455689999999988888888899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc--
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--  510 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~--  510 (662)
                      |. .-+|.+.|.     .+..|..-+..-|+.|++.||..+|.   .+|+|||||.+|||++.-.-+.|+||.--+..  
T Consensus       102 yv-khnLyDRlS-----TRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL  172 (1431)
T KOG1240|consen  102 YV-KHNLYDRLS-----TRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL  172 (1431)
T ss_pred             HH-hhhhhhhhc-----cchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence            99 458998883     25678888888899999999999999   99999999999999999999999999866532  


Q ss_pred             cCCCCCcce----ecccCCcccCcccccCC-----------CCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHH
Q 040242          511 DHNINPQTT----HIVGTLGYLAPELTRTG-----------KATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVD  574 (662)
Q Consensus       511 ~~~~~~~~~----~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  574 (662)
                      .++.-...+    ......+|+|||.+...           ..+++.||||+||++.||++ |++||....      |..
T Consensus       173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~a  246 (1431)
T KOG1240|consen  173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLA  246 (1431)
T ss_pred             CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHh
Confidence            221111111    12234689999977431           26789999999999999999 677776321      111


Q ss_pred             HHHHHhhcCccccccCCC--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          575 WVRELHSQGQITRAIDPT--LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       575 ~~~~~~~~~~~~~~id~~--l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      +     +.+.   ..|+.  +...   +...+..+++.|++.||++|-++++.++.-.+
T Consensus       247 Y-----r~~~---~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  247 Y-----RSGN---ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             H-----hccC---ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence            1     1111   11111  0111   11257889999999999999999999986443

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.79  E-value=3.2e-19  Score=169.74  Aligned_cols=203  Identities=23%  Similarity=0.347  Sum_probs=169.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc-ccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ..|...++||+|+||.+|.|....+|+.||||.-.....  ..++.-|.++.+.|++ ..|..+.-+..++..-.+|||.
T Consensus        15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            568889999999999999999999999999998755433  2466778888888875 6677777788888888999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~~  510 (662)
                      . |.+|+++..-.    ...++..+.+.++-|++.-++|+|.   .+++||||||+|+|..-+   ..+.++||||++.+
T Consensus        93 L-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   93 L-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             c-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhh
Confidence            9 99999998544    4568889999999999999999999   899999999999998644   45899999999987


Q ss_pred             cCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch
Q 040242          511 DHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA  567 (662)
Q Consensus       511 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  567 (662)
                      ......      ......||.+|.+=....+.+-+...|+-|+|.+|..+--|..||.+-...
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            543221      223457999998877776667788999999999999999999999876543

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=99.79  E-value=5.8e-18  Score=169.09  Aligned_cols=200  Identities=16%  Similarity=0.135  Sum_probs=129.2

Q ss_pred             CCCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCcee
Q 040242           30 QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLA  109 (662)
Q Consensus        30 ~~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGla  109 (662)
                      ..++.+.|+|.+. ++.|+||++.+++.|++||+.|+++-                 +|+|+|+|+|.+.+...+|||||
T Consensus        19 i~~w~~~G~a~v~-~~~IrLTp~~~~~~G~~w~~~p~~~~-----------------~F~~~f~F~I~~~~~~~~GdGlA   80 (248)
T cd06901          19 MPLWDFLGSTMVT-SQYIRLTPDHQSKQGSIWNRVPCYLR-----------------DWEMHVHFKVHGSGKNLFGDGFA   80 (248)
T ss_pred             CCCEEEcceEEEc-CCeEEECCCCCCCEEEEeccCCccCC-----------------CEEEEEEEEEeCCCCCCCCCEEE
Confidence            4689999999987 67999999998899999999999976                 49999999999876667899999


Q ss_pred             EEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCC-CCCCCCeeEEecCCCcccccccccccccCCCCC
Q 040242          110 FVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLEL-QDINDNHVGIDISSLISNISEPAAYYFSKGSNI  188 (662)
Q Consensus       110 F~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~  188 (662)
                      |+++....    ..|..+|-.+.-       .=+||-|||+.|.+- .....+-|.+-+|.-    +..+....|.+...
T Consensus        81 fw~t~~~~----~~G~~fG~~~~f-------~Gl~I~~Dt~~n~~~~~~~~~P~i~~~~NDG----t~~yd~~~Dg~~~~  145 (248)
T cd06901          81 IWYTKERM----QPGPVFGSKDNF-------HGLAIFFDTYSNQNGEHEHVHPYISAMVNNG----SLSYDHDRDGTHTE  145 (248)
T ss_pred             EEEEcCCC----ccCcccccCCCC-------ceEEEEEECCCCCCCcccCCCceEEEEEcCC----CeeecccCCCchhh
Confidence            99998642    334445543321       118999999998531 001122232222221    11111111111111


Q ss_pred             CCCCcceee-cCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeeccccc-ccccceEEeeeccCCcccceeEEec
Q 040242          189 NDDNISVVL-KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLAT-VLDEYMYVGFSASTGLLTAFHNVHG  266 (662)
Q Consensus       189 ~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~-~l~~~~~vGFsastG~~~~~~~i~s  266 (662)
                      -..+. ... ..+...+++|.|...  .+.|.++..+...     .....+... .||...|+||||+||.+.+.|+|++
T Consensus       146 ~~~C~-~~~rn~~~~t~~rI~Y~~~--~l~v~vd~~~~~~-----w~~Cf~~~~v~LP~~~yfGiSA~Tg~~sd~hdIls  217 (248)
T cd06901         146 LAGCS-APFRNKDHDTFVAIRYSKG--RLTVMTDIDGKNE-----WKECFDVTGVRLPTGYYFGASAATGDLSDNHDIIS  217 (248)
T ss_pred             cCcee-eeccCCCCCeEEEEEEECC--eEEEEEecCCCCc-----eeeeEEeCCeecCCCCEEEEEecCCCCCCcEEEEE
Confidence            11111 122 345667899999964  4666665322111     112233333 3577799999999999999999998


Q ss_pred             ceee
Q 040242          267 WSFK  270 (662)
Q Consensus       267 W~f~  270 (662)
                      -.+.
T Consensus       218 v~~~  221 (248)
T cd06901         218 MKLY  221 (248)
T ss_pred             EEEe
Confidence            6654

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.78  E-value=7.7e-19  Score=174.33  Aligned_cols=199  Identities=22%  Similarity=0.294  Sum_probs=169.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEecc
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .|...++||+|.||.++.|+..-+++.||||.-...+  ...++..|....+.| ..++|.+.+-+..++.+-.||+|..
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL  106 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL  106 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence            4778899999999999999999999999999765443  235677788888777 4799999988888888889999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-----CeEEeecccccc
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-----NPKLGDFGLARA  509 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-----~~kL~DfGla~~  509 (662)
                       |.||+++..-+    ...++.++...+|+|++.-++|+|+   +.+|.|||||+|+||..-+     .+.|.|||+|+.
T Consensus       107 -GPSLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  107 -GPSLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             -CcCHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence             99999987533    4568899999999999999999999   8999999999999996543     389999999998


Q ss_pred             ccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          510 YDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       510 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                      +......      ......||.+||+=....+.+-+...|.-|+|-+++..+-|..||.+-
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGL  239 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL  239 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccc
Confidence            7654322      233457999999999888889999999999999999999999999754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.77  E-value=3.8e-18  Score=166.08  Aligned_cols=141  Identities=21%  Similarity=0.220  Sum_probs=111.1

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--------------------------hHHHHHHHHHHhhcccccc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--------------------------GMKEFVAEITSMGRLRHRN  413 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--------------------------~~~~f~~Ei~~l~~l~H~n  413 (662)
                      ...||+|++|.||+|.+. +|+.||||++......                          ....+..|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999986 8999999998764211                          0122357899999999998


Q ss_pred             ceeeeeeEeccCeeeEEEeccCCCCcchh-cccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceE
Q 040242          414 LVQLHGWCRKQDELLLVYDYVPNGSLDKL-LFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       414 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  492 (662)
                      +.....+...  ..++||||++++++... +.      ...++..+...++.|++.++.+||+.  .+|+||||||+||+
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~------~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIl  150 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK------DVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNIL  150 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh------hccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEE
Confidence            7554443332  24899999988865443 32      23467788899999999999999984  69999999999999


Q ss_pred             eCCCCCeEEeeccccccccC
Q 040242          493 IDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       493 l~~~~~~kL~DfGla~~~~~  512 (662)
                      ++ ++.++|+|||++...++
T Consensus       151 l~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         151 YH-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             EE-CCCEEEEEcccceecCC
Confidence            99 88999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=8.3e-18  Score=162.21  Aligned_cols=186  Identities=17%  Similarity=0.104  Sum_probs=139.5

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh----HHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEe
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG----MKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~----~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .....|++|+||+||.+..  .+.+++.+.+.....-.    ...|.+|+++|++|. |+++.+++++    +..+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3467899999999997665  56788878776554311    225789999999995 5889999887    34699999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCc-CCCceEeCCCCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV-KPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl-kp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |++|.+|...+..      .      ...++.|++++|.++|+   .+|+|||| ||.|||++.++.++|+|||++....
T Consensus        79 yI~G~~L~~~~~~------~------~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~  143 (218)
T PRK12274         79 YLAGAAMYQRPPR------G------DLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN  143 (218)
T ss_pred             eecCccHHhhhhh------h------hHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence            9999998654311      1      13467899999999999   89999999 7999999999999999999998654


Q ss_pred             CCCCC----c--------ceecccCCcccCcccccCC-CCC-cchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          512 HNINP----Q--------TTHIVGTLGYLAPELTRTG-KAT-TSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       512 ~~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~t-~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                      .....    .        ......++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+...+
T Consensus       144 ~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        144 PRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             CcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence            43210    0        0112357788888744321 233 5679999999999999999887544

>PRK10345 hypothetical protein; Provisional

Probab=99.74  E-value=1.9e-17  Score=162.47  Aligned_cols=136  Identities=24%  Similarity=0.302  Sum_probs=107.8

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-----ccccceeeeeeEeccC---e-ee
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-----RHRNLVQLHGWCRKQD---E-LL  428 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-----~H~niv~l~~~~~~~~---~-~~  428 (662)
                      ...++||+|++|.||.  ++.++.. +||++........+++.+|+.+++++     .||||++++|+++.+.   . ..
T Consensus         5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            4468899999999996  6666665 69988765455567899999999999     5799999999998874   3 34


Q ss_pred             EEEec--cCCCCcchhcccccccccccccHHHHHHHHHHHHHHH-HHhHhcCCCCEEeCCcCCCceEeCC----CCCeEE
Q 040242          429 LVYDY--VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL-LYLHEECDQRVVHRDVKPSNVLIDA----DLNPKL  501 (662)
Q Consensus       429 lV~E~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivH~Dlkp~NIll~~----~~~~kL  501 (662)
                      +|+||  +++++|.+++.+.      .+++.  ..++.+++.++ .|||+   .+|+||||||+|||++.    +..++|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEE
Confidence            78999  6689999999432      24444  35577788777 99999   89999999999999974    347999


Q ss_pred             eecccc
Q 040242          502 GDFGLA  507 (662)
Q Consensus       502 ~DfGla  507 (662)
                      +|++.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995433

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.74  E-value=2.7e-16  Score=155.13  Aligned_cols=199  Identities=17%  Similarity=0.180  Sum_probs=135.7

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++.+++.|.+|.+.|++.-                 +|+.+|+|+|.... ..+||||||
T Consensus        22 ~~W~~~G~t~~~-~~~IrLTp~~~~~~G~iw~~~~~~~~-----------------~w~ie~~Fri~g~~-~~~gdG~a~   82 (225)
T cd06902          22 PFWSHGGDAIAS-LEQVRLTPSLRSKKGSVWTKNPFSFE-----------------NWEVEVTFRVTGRG-RIGADGLAI   82 (225)
T ss_pred             CceEecccEEec-CCEEEECCCCCCCEEEEeeCCCcCCC-----------------CEEEEEEEEEecCC-CCCCCEEEE
Confidence            589999999886 78999999999999999999999844                 49999999998764 357899999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND  190 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~  190 (662)
                      +++....    ..|+.+|..+.-       .=+||.|||+.|.+  ..+...|-+-+|.-.    .......|.....-.
T Consensus        83 W~t~~~~----~~G~~~G~~~~f-------~Gl~I~~Dt~~n~~--~~~~p~i~~~~NDGt----~~yd~~~D~~~~~~~  145 (225)
T cd06902          83 WYTKERG----EEGPVFGSSDKW-------NGVGIFFDSFDNDG--KKNNPAILVVGNDGT----KSYDHQNDGLTQALG  145 (225)
T ss_pred             EEECCCC----CCCCccCCCCcc-------cEEEEEEECCCCCC--CCCCcEEEEEECCCC----eeccccCCCcccccc
Confidence            9997642    245566664332       12899999998853  233456655444321    111111111111111


Q ss_pred             CCcceee-cCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccc-cccceEEeeeccCCcccceeEEecce
Q 040242          191 DNISVVL-KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV-LDEYMYVGFSASTGLLTAFHNVHGWS  268 (662)
Q Consensus       191 ~~~~~~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~-l~~~~~vGFsastG~~~~~~~i~sW~  268 (662)
                      .+. ... +...+.+++|.|..  ..|.|.++...  .+........+++..+ ||...|+||||+||.+.+.|+|++|.
T Consensus       146 ~C~-~~~rn~~~p~~~rI~Y~~--~~l~V~~d~~~--~~~~~~~~~Cf~~~~v~LP~~~yfGiSA~Tg~l~d~hDIls~~  220 (225)
T cd06902         146 SCL-RDFRNKPYPVRAKITYYQ--NVLTVSINNGF--TPNKDDYELCTRVENMVLPPNGYFGVSAATGGLADDHDVLSFL  220 (225)
T ss_pred             eEE-EeccCCCCCeEEEEEEEC--CeEEEEEeCCc--CCCCCcccEEEecCCeeCCCCCEEEEEecCCCCCCcEeEEEEE
Confidence            111 122 23578999999997  46888886322  2222223445555553 68889999999999999999999999


Q ss_pred             ee
Q 040242          269 FK  270 (662)
Q Consensus       269 f~  270 (662)
                      +.
T Consensus       221 ~~  222 (225)
T cd06902         221 TF  222 (225)
T ss_pred             Ee
Confidence            86

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.8e-16  Score=181.82  Aligned_cols=195  Identities=22%  Similarity=0.261  Sum_probs=156.2

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc---cccceeeeeeEeccCeeeE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~l  429 (662)
                      ..+.|.+.+.||+|+||+||+|...+ |+.||+|+-.......   |.--.+++.||+   -+-|+++..++.-.+..+|
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l  771 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL  771 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence            34678889999999999999999965 9999999876654332   222223333443   2445556666666778899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-------CCCeEEe
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-------DLNPKLG  502 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------~~~~kL~  502 (662)
                      |+||.+.|+|.+++..     .+.++|...+.++.|++..+..||.   .+|||+||||+|+||..       +.-++|+
T Consensus       772 v~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  772 VSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             eeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEE
Confidence            9999999999999962     5679999999999999999999999   89999999999999942       3459999


Q ss_pred             eccccccccCCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 040242          503 DFGLARAYDHNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR  559 (662)
Q Consensus       503 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~  559 (662)
                      |||.+..+.--. .......++|-++-.+|+..+..++.+.|.|.++.+++-|+.|+.
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            999887543221 124455688999999999999999999999999999999999975

>smart00090 RIO RIO-like kinase

Probab=99.69  E-value=2.3e-16  Score=158.44  Aligned_cols=143  Identities=16%  Similarity=0.209  Sum_probs=111.1

Q ss_pred             CCcccceeeeeCceEEEEEE-eCCCCcEEEEEEeeccchh------------------------hHHHHHHHHHHhhccc
Q 040242          356 GFREKNLVGSGGFGKVYRGV-IPSTGLEVAIKRVAHNSRQ------------------------GMKEFVAEITSMGRLR  410 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~-~~~~g~~vavK~~~~~~~~------------------------~~~~f~~Ei~~l~~l~  410 (662)
                      .|.+.+.||+|++|.||+|. ...+|+.||||++......                        ....+..|+..+.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47778999999999999999 5568999999998653210                        1123568999999997


Q ss_pred             ccc--ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC-EEeCCcC
Q 040242          411 HRN--LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR-VVHRDVK  487 (662)
Q Consensus       411 H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivH~Dlk  487 (662)
                      +..  +.+++++    ...++||||+++++|...+..     ...+...+...++.|++.+|.+||+   .+ ++|||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dik  176 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLS  176 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCC
Confidence            633  3344443    235899999999888776522     1234455667899999999999999   78 9999999


Q ss_pred             CCceEeCCCCCeEEeecccccccc
Q 040242          488 PSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       488 p~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |+||+++ ++.++|+|||++....
T Consensus       177 p~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      177 EYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhhEEEE-CCCEEEEEChhhhccC
Confidence            9999999 8899999999988544

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.67  E-value=3e-16  Score=155.24  Aligned_cols=134  Identities=21%  Similarity=0.323  Sum_probs=113.6

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--------hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--------QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +.||+|++|.||+|..  .|..+++|+......        .....+.+|+.++..++|+++.....++...+..+++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5799999999999988  567899997653221        123467889999999999999888888777788899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |+++++|.+++...        .+ .+..++.+++.+|.+||+   .+++|+|++|.||+++ ++.++|+|||++..
T Consensus        80 ~~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999988432        12 788999999999999999   8999999999999999 78899999998875

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.67  E-value=4.8e-16  Score=175.27  Aligned_cols=139  Identities=21%  Similarity=0.279  Sum_probs=113.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--------chhhHHHHHHHHHHhhccccccceeeeeeEecc
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--------SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--------~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~  424 (662)
                      ....|...++||+|+||+||+|.+...  .+++|+....        .....+.+.+|++++.+++|++++....++...
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            345556789999999999999988443  3444432211        112235688999999999999999888888777


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ...++||||+++++|.+++.             .+..++.+++++|.|||+   .+++||||||+||++ .++.++|+||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF  471 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF  471 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence            78899999999999998873             356789999999999999   899999999999999 6789999999


Q ss_pred             cccccc
Q 040242          505 GLARAY  510 (662)
Q Consensus       505 Gla~~~  510 (662)
                      |+++..
T Consensus       472 Gla~~~  477 (535)
T PRK09605        472 GLGKYS  477 (535)
T ss_pred             cccccC
Confidence            999863

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.67  E-value=2.3e-16  Score=160.09  Aligned_cols=196  Identities=21%  Similarity=0.289  Sum_probs=138.4

Q ss_pred             ccccceeeeeeEec---------------------------cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHH
Q 040242          410 RHRNLVQLHGWCRK---------------------------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI  462 (662)
Q Consensus       410 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  462 (662)
                      +|||||++.+++.+                           ...+|+||..+ .-+|..++-.      ...+...+.-+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~------~~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT------RHRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc------CCCchHHHHHH
Confidence            59999998876532                           23578999988 4589888853      33556667788


Q ss_pred             HHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC--CCC--CeEEeeccccccccCC-----CCCcceecccCCcccCcccc
Q 040242          463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLID--ADL--NPKLGDFGLARAYDHN-----INPQTTHIVGTLGYLAPELT  533 (662)
Q Consensus       463 ~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~--~~kL~DfGla~~~~~~-----~~~~~~~~~gt~~y~aPE~~  533 (662)
                      +.|+++|+.|||+   ++|.|||+|++|||+.  +|.  .+.|+|||++-.-+..     ........-|...-||||+.
T Consensus       347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            9999999999999   8999999999999983  343  3788999988654331     11122234577889999987


Q ss_pred             cCCC------CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHH
Q 040242          534 RTGK------ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTL  607 (662)
Q Consensus       534 ~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l  607 (662)
                      ....      -..|+|.|+.|.+.||++....||....+. ......     |     .+   ..+...+...+..+.+|
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Y-----qe---~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----Y-----QE---SQLPALPSRVPPVARQL  489 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----h-----hh---hhCCCCcccCChHHHHH
Confidence            5421      246899999999999999999999863221 111111     1     11   12223344455667888


Q ss_pred             HHHccCCCCCCCCCHHHHHHHH
Q 040242          608 GLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       608 ~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      +...|++||++||+..-....|
T Consensus       490 V~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHH
Confidence            8899999999999976555544

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.67  E-value=1.6e-17  Score=175.33  Aligned_cols=123  Identities=28%  Similarity=0.470  Sum_probs=109.1

Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      .+++.|++|...+|.++|.+.+.  ....+|.....++.|++.|+.|      ++.+|+|+||.||+...+..+||+|||
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg  401 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG  401 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence            57999999999999999976543  4557788899999999999999      478999999999999999999999999


Q ss_pred             ccccccCCC-----CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc
Q 040242          506 LARAYDHNI-----NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC  556 (662)
Q Consensus       506 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt  556 (662)
                      +........     ....+...||..||+||.+.+..++.|+|||+||++|+||+.
T Consensus       402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            998776654     234566789999999999999999999999999999999987

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.67  E-value=6.6e-16  Score=151.35  Aligned_cols=145  Identities=19%  Similarity=0.233  Sum_probs=112.5

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch----------------------hhHHHHHHHHHHh
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR----------------------QGMKEFVAEITSM  406 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l  406 (662)
                      ++...-.-|...+.||+|++|.||++... +|+.||||++.....                      .....+..|+.++
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            44444444777899999999999999984 789999998754320                      0112367788899


Q ss_pred             hcccccc--ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeC
Q 040242          407 GRLRHRN--LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHR  484 (662)
Q Consensus       407 ~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~  484 (662)
                      ..+.|++  +.+.++.    ...++||||+++++|..+...           .....++.++++++.++|+   .+++||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~  149 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHG  149 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcC
Confidence            9998874  4445443    345899999999999876521           2345688999999999999   899999


Q ss_pred             CcCCCceEeCCCCCeEEeeccccccccC
Q 040242          485 DVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       485 Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||||+||++++++.++|+|||++.....
T Consensus       150 Dl~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         150 DLSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCCcccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.66  E-value=1.6e-17  Score=178.56  Aligned_cols=226  Identities=23%  Similarity=0.276  Sum_probs=171.0

Q ss_pred             eeeeeCceEEEEEEe---CCCCcEEEEEEeeccchhh--HHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEeccC
Q 040242          362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG--MKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~---~~~g~~vavK~~~~~~~~~--~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      .+|+|.||.|++..-   .+.|..+|+|.+.+.....  ......|..++..++ ||.+|++.-.++.+...+++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999885432   3456778888876542111  114456777888886 9999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      +|.|...+...     ..............++-++.++|+   .+++|||+|++||+++.+|.+++.|||+.+..-....
T Consensus        81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99999988554     234444455566778899999999   8999999999999999999999999999986433211


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                           .+||..|||||+.+  ......|.||||++++||+||-.||...    .      +.....         .. -.
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~----~------~~~Il~---------~~-~~  205 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD----T------MKRILK---------AE-LE  205 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH----H------HHHHhh---------hc-cC
Confidence                 18999999999998  4577899999999999999999999861    0      000000         00 12


Q ss_pred             CCHHHHHHHHHHHHHccCCCCCCCCCH
Q 040242          596 FDPQEAELVLTLGLLCCDPHPDFRPST  622 (662)
Q Consensus       596 ~~~~~~~~l~~l~~~Cl~~dP~~RPt~  622 (662)
                      .+.+....+..++..+...+|..|--.
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            344555666777778888888888654

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=6.6e-16  Score=151.35  Aligned_cols=130  Identities=24%  Similarity=0.351  Sum_probs=107.5

Q ss_pred             eeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       362 ~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .||+|++|.||+|..  .+..|++|......        ....+++.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999996  56789999864321        11235678899999999998876666666666778999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      +++++|.+++....      .      .++.+++.+|.+||+   .+++|+|++|.||+++ ++.+++.|||+++.
T Consensus        79 ~~g~~l~~~~~~~~------~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN------D------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH------H------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998874321      0      789999999999999   8999999999999999 88999999998875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=99.58  E-value=9.2e-14  Score=135.95  Aligned_cols=188  Identities=16%  Similarity=0.163  Sum_probs=124.6

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++ +++.|.+|-+.|+++.         +       +|+.+|+|+|.... ..+||||||
T Consensus        21 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~iWs~~pl~~~---------~-------~w~ie~~Fri~G~~-~~~gdGla~   81 (215)
T cd06903          21 PNWQTSGNPKLE-SGRIILTPP-GNQRGSLWLKKPLSLK---------D-------EWTIEWTFRSTGPE-GRSGGGLNF   81 (215)
T ss_pred             CCeEEcCcEEee-CCeEEECCC-CCceEeEeeCCcCCCC---------C-------CEEEEEEEEecccC-CcCCCEEEE
Confidence            589999999987 789999999 9999999999999876         1       39999999998764 368999999


Q ss_pred             EEccCCCCCCCCcc-cccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCC
Q 040242          111 VLMSRKQPPSCLAN-QYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN  189 (662)
Q Consensus       111 ~l~~~~~~~~~~~g-~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~  189 (662)
                      .++......   .| ..+|-.+.-   +    =+||.|||+.|.   .   ..|-+-+|.    .+.......| +...-
T Consensus        82 W~t~~~~~~---~g~~~fG~~~~f---~----Gl~I~~Dt~~n~---~---p~i~~~~ND----Gt~~yd~~~d-~~~~~  140 (215)
T cd06903          82 WLVKDGNAD---VGTSSIYGPSKF---D----GLQLLIDNNGGS---G---GSLRGFLND----GSKDYKNEDV-DSLAF  140 (215)
T ss_pred             EEECCCccc---CCccccCCCCCC---c----EEEEEEECCCCC---C---ceEEEEECC----CCeeccccCC-ccccc
Confidence            999764211   12 233332221   1    179999999873   1   233332222    1122221122 11111


Q ss_pred             CCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccc-cc-cceEEeeeccCCcccceeEEecc
Q 040242          190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV-LD-EYMYVGFSASTGLLTAFHNVHGW  267 (662)
Q Consensus       190 ~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~-l~-~~~~vGFsastG~~~~~~~i~sW  267 (662)
                      ..+.---.+.+.+.+++|.|......|.|.++.       +.+    .+...+ || .-.|+||||+||...+.|+|++-
T Consensus       141 g~C~~~~rn~~~p~~iri~Y~~~~~~l~v~vd~-------~~C----f~~~~v~lP~~~y~fGiSAaTg~~~d~hdIl~~  209 (215)
T cd06903         141 GSCLFAYQDSGVPSTIRLSYDALNSLFKVQVDN-------RLC----FQTDKVQLPQGGYRFGITAANADNPESFEILKL  209 (215)
T ss_pred             ceeeEeccCCCCCEEEEEEEECCCCEEEEEECC-------CEE----EecCCeecCCCCCEEEEEEcCCCCCCcEEEEEE
Confidence            111111124577899999999877899999852       122    333332 45 55689999999999999999985


Q ss_pred             ee
Q 040242          268 SF  269 (662)
Q Consensus       268 ~f  269 (662)
                      .+
T Consensus       210 ~~  211 (215)
T cd06903         210 KV  211 (215)
T ss_pred             EE
Confidence            43

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=2.3e-14  Score=132.72  Aligned_cols=135  Identities=17%  Similarity=0.177  Sum_probs=114.4

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc--ccceeeeeeEeccCeeeEEEeccCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH--RNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.+.||+|.++.||++...  +..+++|.......  ...+..|+..+..++|  .++.+++.+....+..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            3577999999999999984  36899999866543  4678899999999987  5899999988888889999999988


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      +.+..+            +......++.+++++|.+||.....+++|+|++|+||++++.+.+++.|||+++.
T Consensus        78 ~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            877654            3456677899999999999985445799999999999999989999999998874

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.57  E-value=2.6e-15  Score=169.08  Aligned_cols=211  Identities=24%  Similarity=0.265  Sum_probs=144.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .+|+..++|-.|+||.||...++.+.+++|+| +.++.--     ++-  ++.....|.+|                   
T Consensus        83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv-------------------  135 (1205)
T KOG0606|consen   83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV-------------------  135 (1205)
T ss_pred             cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee-------------------
Confidence            56888999999999999999998888889984 4332111     000  22233333333                   


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                        |+-...++..     +.++-        +++.+++|||+   .+|+|||+||+|.+++.-|.+|++|||+.+......
T Consensus       136 --gDc~tllk~~-----g~lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~  197 (1205)
T KOG0606|consen  136 --GDCATLLKNI-----GPLPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL  197 (1205)
T ss_pred             --chhhhhcccC-----CCCcc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence              3333333221     22322        22789999999   899999999999999999999999999987542211


Q ss_pred             C--------------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh
Q 040242          515 N--------------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       515 ~--------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      .              -....++||+.|.|||++....|....|.|++|+|+||.+-|+.||.+..+++-..  ..+... 
T Consensus       198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg--~visd~-  274 (1205)
T KOG0606|consen  198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG--QVISDD-  274 (1205)
T ss_pred             cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh--hhhhhh-
Confidence            0              01234689999999999988889999999999999999999999998765432111  111100 


Q ss_pred             hcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          581 SQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       581 ~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                        ...        .+-+.....+...++.+.|+.+|..|--..
T Consensus       275 --i~w--------pE~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  275 --IEW--------PEEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             --ccc--------cccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence              000        111233445577788889999999996433

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=99.55  E-value=8.1e-14  Score=138.75  Aligned_cols=198  Identities=20%  Similarity=0.252  Sum_probs=122.3

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++.+++.|.+|.+.|++.-                 +|+.+|+|+|.......+||||||
T Consensus        22 ~~W~~~G~t~i~-~~~IrLTp~~~~~~G~iws~~~~~~~-----------------~w~i~~~Fri~g~~~~~~g~G~a~   83 (229)
T PF03388_consen   22 PNWDIGGSTVIT-DNFIRLTPDRQSQSGSIWSRKPIPFD-----------------NWEIEFTFRISGQEKGLGGDGMAF   83 (229)
T ss_dssp             TTEEEEET-EEE-SSEEEEE-SSTTEEEEEEESS-BEES-----------------EEEEEEEEEEESS-SSS-S-EEEE
T ss_pred             CCEEECCeEEec-CCEEEECCCcccCEEEEEEcCCCCcc-----------------CEEEEEEEEEeccccCcCCCeEEE
Confidence            489999999887 88999999999999999999999975                 499999999998855678999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCC-CCCCCeeEEecCCCcccccccccccccCCCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQ-DINDNHVGIDISSLISNISEPAAYYFSKGSNIN  189 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~  189 (662)
                      .++....    ..|..+|..+.-       .=+||=||||.|.+-. ......|.+-+|.    .+..+....|.....-
T Consensus        84 W~t~~~~----~~G~~fG~~~~f-------~Gl~i~idt~~N~~~~~~~~~p~i~~~~ND----Gt~~~~~~~dg~~~~~  148 (229)
T PF03388_consen   84 WYTKDPG----SDGPVFGGPDKF-------DGLGIFIDTYDNDEGGHKRGFPYISAMLND----GTKSYDHDNDGKDQSL  148 (229)
T ss_dssp             EEESSSS----SSCSBTTB-SS--------EEEEEEEEES-TTCTTCTSTSSEEEEEEEE----SSS---GGGTTTTT-S
T ss_pred             EEEcCcc----ccccccCCCccc-------ceEEEEEEcccCCCcccccccceEEEEecC----CCccccccccCccccc
Confidence            9987652    255666653321       1189999999986321 1233455554443    2232222222111111


Q ss_pred             CCCcceeec-CCCcEEEEEEEeCCCcEEEEEEccC--CCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEEec
Q 040242          190 DDNISVVLK-SGDPIQAWIDYNSQEMLINVTISPL--GIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHG  266 (662)
Q Consensus       190 ~~~~~~~l~-~g~~~~~~I~Y~~~~~~l~V~~~~~--~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~s  266 (662)
                      ..+ ...+. .+.+.+++|.|...  .+.|.+...  .....-..++...   .-.||+..|+||||+||...+.|+|++
T Consensus       149 ~~C-~~~~rn~~~p~~~ri~Y~~~--~l~v~id~~~~~~~~~~~~Cf~~~---~v~LP~~~yfGvSA~Tg~~~d~hdi~s  222 (229)
T PF03388_consen  149 GSC-SADYRNSDVPTRIRISYSKN--TLTVSIDSNYLKNQDDWELCFTTD---GVDLPEGYYFGVSAATGELSDNHDILS  222 (229)
T ss_dssp             EEE-E---BTESSEEEEEEEEETT--EEEEEEETSCCSECCTTEEEEEES---TEEGGSSBEEEEEEEESSSGGEEEEEE
T ss_pred             ccc-eeccCcCCCCEEEEEEEECC--eEEEEEecccccCCcCCcEEEEcC---CeecCCCCEEEEEecCCCCCCcEEEEE
Confidence            111 11222 35678999999964  567776521  1011112233321   113678889999999999999999987


Q ss_pred             c
Q 040242          267 W  267 (662)
Q Consensus       267 W  267 (662)
                      -
T Consensus       223 ~  223 (229)
T PF03388_consen  223 V  223 (229)
T ss_dssp             E
T ss_pred             E
Confidence            3

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.54  E-value=4.2e-14  Score=137.04  Aligned_cols=138  Identities=20%  Similarity=0.223  Sum_probs=98.2

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh--hHHH----------------------HHHHHHHhhcccccc--
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKE----------------------FVAEITSMGRLRHRN--  413 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~--~~~~----------------------f~~Ei~~l~~l~H~n--  413 (662)
                      .+.||+|+||+||+|... +++.||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 7889999998654211  1111                      134555555554433  


Q ss_pred             ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe
Q 040242          414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI  493 (662)
Q Consensus       414 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  493 (662)
                      +.+.+++    ...++||||++++.+........     ... .+...++.+++.++.++|..  .+++|+||||+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh-----hhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEE
Confidence            3444443    24589999999965432211110     011 56778999999999999984  689999999999999


Q ss_pred             CCCCCeEEeecccccccc
Q 040242          494 DADLNPKLGDFGLARAYD  511 (662)
Q Consensus       494 ~~~~~~kL~DfGla~~~~  511 (662)
                      + ++.++|+|||.+....
T Consensus       149 ~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         149 D-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             E-CCcEEEEECccccccc
Confidence            9 8999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.51  E-value=1e-13  Score=139.63  Aligned_cols=135  Identities=19%  Similarity=0.213  Sum_probs=105.8

Q ss_pred             cceee-eeCceEEEEEEeCCCCcEEEEEEeeccc-------------hhhHHHHHHHHHHhhccccccc--eeeeeeEec
Q 040242          360 KNLVG-SGGFGKVYRGVIPSTGLEVAIKRVAHNS-------------RQGMKEFVAEITSMGRLRHRNL--VQLHGWCRK  423 (662)
Q Consensus       360 ~~~LG-~G~~g~Vy~~~~~~~g~~vavK~~~~~~-------------~~~~~~f~~Ei~~l~~l~H~ni--v~l~~~~~~  423 (662)
                      ...|| .||.|+||+...  .+..++||++....             ......+.+|+.++.+|+|+++  .+.++++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45788 899999999988  36789999885421             1223567889999999998885  677776544


Q ss_pred             cC----eeeEEEeccCC-CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          424 QD----ELLLVYDYVPN-GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       424 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      ..    ..++|||++++ .+|.+++...      .++..    .+.+++++|.+||+   .+|+||||||.|||++.++.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~  180 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGK  180 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCC
Confidence            32    23599999997 6898887432      23332    35689999999999   89999999999999999999


Q ss_pred             eEEeecccccc
Q 040242          499 PKLGDFGLARA  509 (662)
Q Consensus       499 ~kL~DfGla~~  509 (662)
                      ++|+|||.+..
T Consensus       181 v~LIDfg~~~~  191 (239)
T PRK01723        181 FWLIDFDRGEL  191 (239)
T ss_pred             EEEEECCCccc
Confidence            99999998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.44  E-value=1.4e-14  Score=163.18  Aligned_cols=255  Identities=22%  Similarity=0.252  Sum_probs=187.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-CCcEEEEEEeeccc--hhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV  430 (662)
                      ..|...+.||+|.++.|-...... ....+|+|.+....  ....+....|..+-..+. |+|++++++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            456677889999999998887743 34557777775543  223334445777777776 99999999999999999999


Q ss_pred             EeccCCCCcchhcc-cccccccccccHHHHHHHHHHHHHHHHHhH-hcCCCCEEeCCcCCCceEeCCCC-CeEEeecccc
Q 040242          431 YDYVPNGSLDKLLF-DNDQQKKKILNWDQRYKILIGVAQALLYLH-EECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLA  507 (662)
Q Consensus       431 ~E~~~~gsL~~~l~-~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla  507 (662)
                      .||..++++.+-+. ..    ....+....-..+.|+..++.|+| .   .++.|+||||+|.+++..+ ..+++|||++
T Consensus       100 ~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~A  172 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLA  172 (601)
T ss_pred             cCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhh
Confidence            99999999999883 32    223445556678899999999999 6   8999999999999999999 9999999999


Q ss_pred             ccccC--CCCCcceeccc-CCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          508 RAYDH--NINPQTTHIVG-TLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       508 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ..+..  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+......... ...|....    
T Consensus       173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~----  247 (601)
T KOG0590|consen  173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK----  247 (601)
T ss_pred             ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc----
Confidence            98766  22333344578 9999999988774 5577889999999999999999998755433211 11111110    


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                            +..-............++..+|+..+|..|.+.+++..
T Consensus       248 ------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 ------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ------cccccCccccCChhhhhcccccccCCchhccccccccc
Confidence                  00001111123344567777888899999999888764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.40  E-value=3e-13  Score=134.76  Aligned_cols=203  Identities=22%  Similarity=0.350  Sum_probs=141.1

Q ss_pred             HHhhccccccceeeeeeEecc-----CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCC
Q 040242          404 TSMGRLRHRNLVQLHGWCRKQ-----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD  478 (662)
Q Consensus       404 ~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  478 (662)
                      ..|-++-|.|||+++.|+.+.     .+..++.|||+.|+|..+|++.... ...+......+++.||..||.|||+ |.
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs-~~  196 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHS-CD  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence            345556799999999987544     3578999999999999999765432 4557777788999999999999998 67


Q ss_pred             CCEEeCCcCCCceEeCCCCCeEEeeccccccccCC----CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHH
Q 040242          479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN----INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV  554 (662)
Q Consensus       479 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~el  554 (662)
                      ++|+|+++..+-|++..++-+||+--. .......    ....+....+-++|.+||+=.....+-.+|||+||+..+||
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            999999999999999999888885311 1111110    11112223457899999987777778899999999999999


Q ss_pred             HcCCCCCCcccch--hhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          555 ACGRRPIEPQRTA--MELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       555 ltG~~p~~~~~~~--~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                      ..+..--......  .+....          +....+...+          -..++.+|++..|..||+|++.+.+.
T Consensus       276 ailEiq~tnseS~~~~ee~ia----------~~i~~len~l----------qr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  276 AILEIQSTNSESKVEVEENIA----------NVIIGLENGL----------QRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             HHheeccCCCcceeehhhhhh----------hheeeccCcc----------ccCcCcccccCCCCCCcchhhhhcCc
Confidence            8876532211110  000000          0001111111          12455689999999999999988753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.38  E-value=1.7e-12  Score=141.91  Aligned_cols=142  Identities=18%  Similarity=0.233  Sum_probs=100.9

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhH----------------------------------------HHH
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM----------------------------------------KEF  399 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~f  399 (662)
                      .+.||.|++|.||+|+++ +|+.||||+.+.......                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            468999999999999985 689999999865421110                                        024


Q ss_pred             HHHHHHhhccc----cccceeeeeeE-eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHH-HHHHh
Q 040242          400 VAEITSMGRLR----HRNLVQLHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ-ALLYL  473 (662)
Q Consensus       400 ~~Ei~~l~~l~----H~niv~l~~~~-~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~L~yL  473 (662)
                      ..|...+.+++    |.+-+.+-..+ ......+|||||++|++|.++.....    ...   .+..++..+++ .+..+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~---~~~~ia~~~~~~~l~ql  273 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGL---DRKALAENLARSFLNQV  273 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCC---CHHHHHHHHHHHHHHHH
Confidence            55666555553    32323332222 23345799999999999998764221    111   34556776666 46788


Q ss_pred             HhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       474 H~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |.   .+++|+|++|.||+++.++++++.|||++..+..
T Consensus       274 ~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       274 LR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             Hh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            87   8999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=99.36  E-value=1.1e-11  Score=123.43  Aligned_cols=198  Identities=21%  Similarity=0.238  Sum_probs=140.9

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|++.+. ..-++||.+.+++.|.++=.+||-..                 .|...+.|.|..+.....|||||+
T Consensus        72 ~~W~~~Gstvv~-~~~irLT~d~qsk~GAv~n~~Pv~s~-----------------~wev~v~fkv~~~s~~lfgdG~Ai  133 (351)
T KOG3839|consen   72 PNWNLSGSTVVT-SNYIRLTPDEQSKSGAVWNRQPVFSR-----------------DWEVLVHFKVHGQSKNLFGDGMAI  133 (351)
T ss_pred             cCccccccEEEE-eeeeeccccccccccccccCCCcccc-----------------ceeEEEEEEEecCCCcccccceEE
Confidence            489999999887 67799999999999999999999866                 399999999999988999999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND  190 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~  190 (662)
                      ..+-.+..    +|..+|-++.-       +.+||=.|||.|.+   -...||---+..++++  -+++|+.++++..++
T Consensus       134 w~t~Er~q----~GPvFG~~dkF-------~GL~vfidtY~n~~---g~~~~v~P~isvmv~~--gs~sYD~~~Dg~~te  197 (351)
T KOG3839|consen  134 WYTKERAQ----PGPVFGSKDKF-------TGLAVFIDTYGNHN---GPHEHVFPYISVMVNI--GSLSYDHSKDGTHTE  197 (351)
T ss_pred             Eeeccccc----CCCCCCCcccc-------eeEEEEEeccCCcC---CCcccceeeEEEEecc--CCcccccCCCCCccc
Confidence            99987632    66777775542       23899999999853   1234442222222222  344566666543322


Q ss_pred             CCc-ceeecCCC-cEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccc-cccceEEeeeccCCcccceeEEecc
Q 040242          191 DNI-SVVLKSGD-PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV-LDEYMYVGFSASTGLLTAFHNVHGW  267 (662)
Q Consensus       191 ~~~-~~~l~~g~-~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~-l~~~~~vGFsastG~~~~~~~i~sW  267 (662)
                      -.. ...+++.. .-..-|.|+.  +.|++.++..+   |  -.+...++|..+ +|.--|+|+||+||.+...|.|.+-
T Consensus       198 l~gc~a~~rn~~~dt~~~iry~~--~~l~~~~dl~~---~--~~~~~c~~~n~v~lp~g~~fg~SasTGdlSd~HdivS~  270 (351)
T KOG3839|consen  198 LAGCTANFRNLPHDTLVVIRYEK--KTLSISIDLEG---P--NEWIDCFSLNNVELPLGYFFGVSASTGDLSDSHDIVSL  270 (351)
T ss_pred             cccceeeeccCCCcceeEEEecC--CceEEEEecCC---C--ceeeeeeeecceecccceEEeeeeccCccchhhHHHHh
Confidence            221 11223322 3447899997  67777766433   1  246677888876 6888999999999999999999885


Q ss_pred             ee
Q 040242          268 SF  269 (662)
Q Consensus       268 ~f  269 (662)
                      .+
T Consensus       271 kl  272 (351)
T KOG3839|consen  271 KL  272 (351)
T ss_pred             hh
Confidence            44

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2.2e-12  Score=139.28  Aligned_cols=248  Identities=23%  Similarity=0.295  Sum_probs=182.8

Q ss_pred             CCcccceeee--eCceEEEEEEe--CCCCcEEEEEEeecc--chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeee
Q 040242          356 GFREKNLVGS--GGFGKVYRGVI--PSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       356 ~f~~~~~LG~--G~~g~Vy~~~~--~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  428 (662)
                      .|...+.+|.  |.+|.+|.+..  ...+..+|+|+-+..  .......=.+|+....++ .|+|.++....++..+..+
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556788999  99999999998  788899999984433  222223335677666777 4999999888899999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHH----HHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEee
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ----ALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGD  503 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~D  503 (662)
                      +-.|++ +.+|..+.+..    ...++....+....+..+    ||.++|.   ..++|-|+||.||+...+ ...+++|
T Consensus       195 iqtE~~-~~sl~~~~~~~----~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTP----CNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeeccc-cchhHHhhhcc----cccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCC
Confidence            999999 57888877544    344666777777888888    9999999   899999999999999999 8899999


Q ss_pred             ccccccccCCCCC----cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          504 FGLARAYDHNINP----QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       504 fGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      ||+...+......    ......|...|++||..+ +.++...|+|++|.+.+|..++..+.......      .|  ..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W--~~  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW--SQ  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--cc
Confidence            9999988765321    112236788999999886 56788999999999999999988765433111      11  11


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .+++-+.       .++-..-...+......+++.+|..|++.+.+..
T Consensus       338 ~r~~~ip-------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYIP-------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccCc-------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            1111100       1111122233444778899999999999888765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.23  E-value=1.1e-11  Score=137.12  Aligned_cols=146  Identities=16%  Similarity=0.215  Sum_probs=94.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh----------------------------------HH---
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG----------------------------------MK---  397 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~----------------------------------~~---  397 (662)
                      ..|+. +.||+|++|.||+|+++++|+.||||+.+....+.                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35666 78999999999999998779999999997552111                                  11   


Q ss_pred             ---HHHHHHHHhhccc----cccceeeeeeEe-ccCeeeEEEeccCCCCcchhc--ccccccccccccHHHHHHHHHHHH
Q 040242          398 ---EFVAEITSMGRLR----HRNLVQLHGWCR-KQDELLLVYDYVPNGSLDKLL--FDNDQQKKKILNWDQRYKILIGVA  467 (662)
Q Consensus       398 ---~f~~Ei~~l~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l--~~~~~~~~~~l~~~~~~~i~~~ia  467 (662)
                         +|..|+..+.+++    +.+.+.+-..+. ...+.+|||||++|+.|.++-  .... .....+.......++.|+ 
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g-~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG-TDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC-CCHHHHHHHHHHHHHHHH-
Confidence               2344554444442    333333222222 234568999999999998742  1111 001122222222233333 


Q ss_pred             HHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEeeccccccccC
Q 040242          468 QALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGDFGLARAYDH  512 (662)
Q Consensus       468 ~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~DfGla~~~~~  512 (662)
                            ..   .+++|+|+||.||+++.++    .+++.|||++..++.
T Consensus       277 ------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 ------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             ------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                  23   7999999999999999988    899999999987654

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.19  E-value=4e-10  Score=123.09  Aligned_cols=171  Identities=20%  Similarity=0.258  Sum_probs=128.8

Q ss_pred             EEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccc
Q 040242          373 RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK  452 (662)
Q Consensus       373 ~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~  452 (662)
                      .|..+.++.+|.|+.+............+-++.|+.+|||||++++...+..+..|||+|-+.  .|..++.+       
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------  100 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------  100 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------
Confidence            466667888999998877666444556777899999999999999999999999999999873  56666632       


Q ss_pred             cccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCccc
Q 040242          453 ILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL  532 (662)
Q Consensus       453 ~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~  532 (662)
                       +......-.+.||+.||.+||+.  .+++|++|.-..|++++.|..||++|.++.....-.. ......--..|..|+.
T Consensus       101 -l~~~~v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~  176 (690)
T KOG1243|consen  101 -LGKEEVCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEE  176 (690)
T ss_pred             -hHHHHHHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhh
Confidence             22344555788999999999975  7899999999999999999999999998875433211 1111112234566665


Q ss_pred             ccCCCCCcchhHHHHHHHHHHHHcCC
Q 040242          533 TRTGKATTSTDVFGFGTLMLEVACGR  558 (662)
Q Consensus       533 ~~~~~~t~ksDV~S~Gvvl~elltG~  558 (662)
                      +....  -..|.|.|||+++|++.|.
T Consensus       177 ~~~s~--~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  177 IDPSE--WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             cCccc--cchhhhhHHHHHHHHhCcc
Confidence            43222  3469999999999999993

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.19  E-value=8.4e-11  Score=111.80  Aligned_cols=131  Identities=18%  Similarity=0.148  Sum_probs=96.6

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccccee-eeeeEeccCeeeEEEeccCCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ-LHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~-l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .+.|+.|.++.||++...  +..+++|....... ....+..|+.++..+.+.++++ ++.+.  ....++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCc
Confidence            457899999999999873  67899998765432 1234578999999887666554 44433  234589999999988


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC--CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC--DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      +....          .   ....++.+++++|..||+..  ...++|+|++|.||+++ ++.+++.||+.+..
T Consensus        78 l~~~~----------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED----------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc----------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            86531          0   11235678999999999832  12369999999999999 66899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=99.10  E-value=3.1e-09  Score=107.45  Aligned_cols=195  Identities=18%  Similarity=0.216  Sum_probs=128.9

Q ss_pred             CeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeEE
Q 040242           32 NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFV  111 (662)
Q Consensus        32 ~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~  111 (662)
                      -+..-|||.. +.-.|+|+++..++.|.+|-+..+.+-                 -|..+-+|+|+..+ ..++||||+.
T Consensus        55 FW~~~GdAIa-s~eqvRlaPSmrsrkGavWtka~~~fe-----------------~weVev~~rVtGrG-RiGAdGlaiW  115 (497)
T KOG3838|consen   55 FWSHHGDAIA-SSEQVRLAPSMRSRKGAVWTKASVPFE-----------------NWEVEVQFRVTGRG-RIGADGLAIW  115 (497)
T ss_pred             eeeecCcccc-cccceeeccccccccCceeecccCCcc-----------------cceEEEEEEecccc-cccCCceEEE
Confidence            4788899854 467899999999999999888777764                 28899999999874 6789999999


Q ss_pred             EccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCCC
Q 040242          112 LMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD  191 (662)
Q Consensus       112 l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~  191 (662)
                      -+....    .-|..+|=.+.= +      =+++-||.|.|.  +--|..-|.+-.|.-    +.+...-.|...-+=.+
T Consensus       116 Yt~~~G----~~GpVfGg~d~W-n------GigiffDSfdnD--~qknnP~Is~~lndG----t~~ydh~~DGasQ~Lss  178 (497)
T KOG3838|consen  116 YTRGRG----HVGPVFGGLDSW-N------GIGIFFDSFDND--GQKNNPAISVLLNDG----TIPYDHPGDGASQGLSS  178 (497)
T ss_pred             EecCCC----cccccccccccc-c------ceEEEeeccccc--CCcCCccEEEEecCC----cccccCCCccHHHHHHH
Confidence            986542    233333332111 1      179999999985  334555666655432    22222111211100001


Q ss_pred             CcceeecC-CCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccc-cccceEEeeeccCCcccceeEEecce
Q 040242          192 NISVVLKS-GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV-LDEYMYVGFSASTGLLTAFHNVHGWS  268 (662)
Q Consensus       192 ~~~~~l~~-g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~-l~~~~~vGFsastG~~~~~~~i~sW~  268 (662)
                      + --+..| --+.+|+|+|-  .++|+|.+...-.+.   +-....++...+ ||..-|+|.||+||.+..-|+|++..
T Consensus       179 C-qrDFRNkPyPvRarItY~--~nvLtv~innGmtp~---d~yE~C~rve~~~lp~nGyFGvSAATGgLADDHDVl~Fl  251 (497)
T KOG3838|consen  179 C-QRDFRNKPYPVRARITYY--GNVLTVMINNGMTPS---DDYEFCVRVENLLLPPNGYFGVSAATGGLADDHDVLSFL  251 (497)
T ss_pred             h-hHHhccCCCCceEEEEEe--ccEEEEEEcCCCCCC---CCcceeEeccceeccCCCeeeeeecccccccccceeeeE
Confidence            0 012222 24678999997  578999997543322   234456666765 48899999999999999999999854

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.07  E-value=3e-09  Score=112.72  Aligned_cols=172  Identities=19%  Similarity=0.306  Sum_probs=134.3

Q ss_pred             ceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec----cCeeeEEEeccCC-CCcchh
Q 040242          368 FGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELLLVYDYVPN-GSLDKL  442 (662)
Q Consensus       368 ~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV~E~~~~-gsL~~~  442 (662)
                      ..+.||+....+|..|++||++....+.......-+++++++.|.|+|++.+.+..    +..+++||+|.|+ ++|.++
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            36889999999999999999965544444444566889999999999999998763    3478999999987 567665


Q ss_pred             cccccc----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          443 LFDNDQ----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       443 l~~~~~----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      -.....          .....+++..+|.++.|++.||.++|+   .|...+-|.+++|+++.+.+++|+.+|.......
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            543221          123457888999999999999999999   8999999999999999999999998887776544


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP  560 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p  560 (662)
                      +..               |-+.   --.+-|.=.||.+++.|.||...
T Consensus       446 d~~---------------~~le---~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPT---------------EPLE---SQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCC---------------cchh---HHhhhhHHHHHHHHHHHhhcccc
Confidence            320               1111   12467999999999999999654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.06  E-value=1.3e-10  Score=125.64  Aligned_cols=248  Identities=21%  Similarity=0.222  Sum_probs=176.4

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeC-CCCcEEEEEEeeccchhhHHH--HHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIP-STGLEVAIKRVAHNSRQGMKE--FVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~~g~~vavK~~~~~~~~~~~~--f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      .-+.+|.....||.|.|+.|++.... .++..+++|.+.+.......+  -+.|+.+...+ .|.++++....+...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34467888999999999999987765 567889999886653322222  14455555555 588888887777777788


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeeccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGL  506 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGl  506 (662)
                      ++=-|||+++++...+.     ....++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..+++|||+
T Consensus       342 ~ip~e~~~~~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cCchhhhcCcchhhhhH-----HHHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhcccccc
Confidence            89999999999877661     14567888899999999999999998   899999999999999886 8899999998


Q ss_pred             cccccCCCCCcceecccCCccc--CcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYL--APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      +..+.-.   ... ....-+++  +|+......+..+.|+|+||.-+.|.+++..--....        .|.       .
T Consensus       414 ~t~~~~~---~~~-~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~-------~  474 (524)
T KOG0601|consen  414 WTRLAFS---SGV-FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL-------T  474 (524)
T ss_pred             cccccee---ccc-ccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce-------e
Confidence            8742211   111 12223333  5556666778899999999999999999875433211        110       0


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      +....-+.+    ......+..+...+..+++..||.+.+...+..
T Consensus       475 i~~~~~p~~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  475 IRSGDTPNL----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             eecccccCC----CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence            011111121    122255677777899999999999988776544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.05  E-value=1.5e-09  Score=107.70  Aligned_cols=143  Identities=18%  Similarity=0.206  Sum_probs=109.3

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccc--cceeeeeeEeccC---eeeEEEec
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHR--NLVQLHGWCRKQD---ELLLVYDY  433 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~--niv~l~~~~~~~~---~~~lV~E~  433 (662)
                      .+.|+.|..+.+|++... +|..+++|....... ....++..|+++++.+++.  ++.+++.++....   ..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            357899999999999884 367899998765432 1345778999999999764  4567788776643   56899999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC------------------------------------
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC------------------------------------  477 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  477 (662)
                      +++.+|.+.+..      ..++..++..++.++++.|..||+..                                    
T Consensus        82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            999998886621      23566677778888888888887421                                    


Q ss_pred             -----------------CCCEEeCCcCCCceEeCC--CCCeEEeecccccc
Q 040242          478 -----------------DQRVVHRDVKPSNVLIDA--DLNPKLGDFGLARA  509 (662)
Q Consensus       478 -----------------~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~  509 (662)
                                       ...++|+|+++.||+++.  ++.+.|.||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             256899999999999998  56689999987764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.03  E-value=4.6e-09  Score=101.56  Aligned_cols=138  Identities=19%  Similarity=0.144  Sum_probs=97.8

Q ss_pred             ceeeeeCceEEEEEEeCC------CCcEEEEEEeeccc------------h----------hhHHHHH----HHHHHhhc
Q 040242          361 NLVGSGGFGKVYRGVIPS------TGLEVAIKRVAHNS------------R----------QGMKEFV----AEITSMGR  408 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~------~g~~vavK~~~~~~------------~----------~~~~~f~----~Ei~~l~~  408 (662)
                      ..||.|--+.||.|....      .+..+|||..+...            .          ...+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998743      35789999874321            0          0122233    78999988


Q ss_pred             ccc--ccceeeeeeEeccCeeeEEEeccCCCCcch-hcccccccccccccHHHHHHHHHHHHHHHHHh-HhcCCCCEEeC
Q 040242          409 LRH--RNLVQLHGWCRKQDELLLVYDYVPNGSLDK-LLFDNDQQKKKILNWDQRYKILIGVAQALLYL-HEECDQRVVHR  484 (662)
Q Consensus       409 l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~  484 (662)
                      +..  -++.+++++    ..-+|||||+.+..+.. .|.      ...++..+...+..+++.+|..| |+   .+++|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk------d~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK------DAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh------ccccCHHHHHHHHHHHHHHHHHHHHh---CCeecC
Confidence            854  344555554    45689999997654422 221      12244455667789999999999 77   799999


Q ss_pred             CcCCCceEeCCCCCeEEeeccccccccC
Q 040242          485 DVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       485 Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++.||+++ ++.+.|+|||.+...++
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999997 46899999998876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=7.1e-09  Score=97.02  Aligned_cols=131  Identities=21%  Similarity=0.308  Sum_probs=101.5

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEE-eecc-------chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKR-VAHN-------SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~-~~~~-------~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ..+++|+-+.+|.+.+  -|..+++|. +.+.       .+-......+|+.++.+++--.|--.+-+..+.....++||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            3578999999999977  344566663 2221       11223457889999999876666666666677778899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |+++..|.+.+...            +..++..+-.-+.-||.   .+|+|+||.++||++..+. +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999888432            35577778888889999   8999999999999998765 99999999985

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.91  E-value=1.3e-08  Score=94.85  Aligned_cols=144  Identities=18%  Similarity=0.264  Sum_probs=106.1

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEE-eecc-------chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKR-VAHN-------SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~-~~~~-------~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ...+|-+|+-+.|+++.+  .|+...||. +.+.       ..-..+..++|++.+.+++--.|.-..-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            567899999999999998  567777773 2221       122346778999999998765665555555566666899


Q ss_pred             EeccCC-CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEeeccc
Q 040242          431 YDYVPN-GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLGDFGL  506 (662)
Q Consensus       431 ~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGl  506 (662)
                      |||+++ .++.+++.....   ..........++..|-+.+.-||.   ..|+|+||..+||+|..++.   +.+.|||+
T Consensus        89 ME~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgl  162 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGL  162 (229)
T ss_pred             EEeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecc
Confidence            999976 478888754321   112222236788899999999999   89999999999999976654   58999999


Q ss_pred             cccc
Q 040242          507 ARAY  510 (662)
Q Consensus       507 a~~~  510 (662)
                      +...
T Consensus       163 s~~s  166 (229)
T KOG3087|consen  163 SSVS  166 (229)
T ss_pred             hhcc
Confidence            8753

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=98.79  E-value=5.8e-07  Score=86.89  Aligned_cols=202  Identities=16%  Similarity=0.153  Sum_probs=114.5

Q ss_pred             CCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeEEEccCCC-CCCCC
Q 040242           44 DGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQ-PPSCL  122 (662)
Q Consensus        44 ~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~-~~~~~  122 (662)
                      +|.||||+...+++|-+.|.++++--+        +       -...+|.+..-.. ...++||+||||+-... +..+.
T Consensus        31 ~g~LRLT~~~~nqata~~~~~~FPs~~--------n-------~v~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~   94 (255)
T cd06900          31 NNRLRLTDASGNQATAVTLQRLFPSAG--------N-------YVEVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGA   94 (255)
T ss_pred             cCeEEeccCccCcceeEEEeeeeccCC--------C-------eEEEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCC
Confidence            689999999999999999999988441        1       1677888777654 46689999999984332 23567


Q ss_pred             cccccCCCCCC-CCCCCCCcEEEEEeeccCCCC-CCCCCCCeeEEecCCCc---ccc-cccccccccCCCCCCCCCccee
Q 040242          123 ANQYLGLPNDT-SNAKFSTRILAVEFDAVQNLE-LQDINDNHVGIDISSLI---SNI-SEPAAYYFSKGSNINDDNISVV  196 (662)
Q Consensus       123 ~g~~lGl~~~~-~~~~~~~~~vaVEFDt~~n~~-~~d~~~~Hvgid~ns~~---s~~-~~~~~~~~~~~~~~~~~~~~~~  196 (662)
                      .||.||+--+. .........++|-||-|-|.. -.+....-.|.--+++.   |.. ...+.|... +.  .. ...++
T Consensus        95 fGGsLGYa~~~~~~~GfaGGwLGiGlDEyGNFsn~~eg~~~~~g~r~~sV~vRGsg~g~~gY~yl~g-t~--~~-~~~id  170 (255)
T cd06900          95 FGGSLGYAQRNDGVPGFAGGWLGIGLDEYGNFSNPNEGRNGFSGRRPQSVTVRGSGSGYTGYKYITG-TG--VL-PPGID  170 (255)
T ss_pred             cCcccccccccCCCCccccceEEEEEeccccccCCCCCccCCcccccceEEEECCCCCCcCceEecc-cC--CC-Ccccc
Confidence            88999997654 233456678999999987731 01211111122222211   111 122222111 11  00 00111


Q ss_pred             ecC----CCcEEEEEEEeCC---CcEEEEEEccCCCCCCCCCeeeeecc---cc--cccccceEEeeeccCCcccceeEE
Q 040242          197 LKS----GDPIQAWIDYNSQ---EMLINVTISPLGIPKPHRPLISYPID---LA--TVLDEYMYVGFSASTGLLTAFHNV  264 (662)
Q Consensus       197 l~~----g~~~~~~I~Y~~~---~~~l~V~~~~~~~~~~~~~~ls~~vd---L~--~~l~~~~~vGFsastG~~~~~~~i  264 (662)
                      ..+    ...++=+|.-|+.   ...|+|.-+-.+... .. .+-..+|   ..  ..+|+..+++|++|||..+-.|.|
T Consensus       171 ~~~~~~~~~~hrY~i~Ids~~~~~~~vsV~R~~~~gg~-~~-~~I~~~d~~~~~~q~avP~~f~lS~TgSTGgstN~HEI  248 (255)
T cd06900         171 NNSTSTPAPGHRYRITIDSTNGDNAWLSVERDIGNGGA-YF-VVILTFDALAEQNQDAIPENFYLSFTGSTGGSTNTHEI  248 (255)
T ss_pred             cCCCCCCCCceEEEEEEecCCCCceEEEEEEEccCCce-eE-EeecceeeccccCCCCCCccEEEEEEecCCCcccceee
Confidence            111    1223444444433   234556554222111 11 1222222   22  457999999999999999999999


Q ss_pred             ecc
Q 040242          265 HGW  267 (662)
Q Consensus       265 ~sW  267 (662)
                      ...
T Consensus       249 dnf  251 (255)
T cd06900         249 DNF  251 (255)
T ss_pred             cce
Confidence            763

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.79  E-value=2.4e-09  Score=121.75  Aligned_cols=250  Identities=20%  Similarity=0.217  Sum_probs=161.8

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ..+.|.+.+-+.+|.++.++.+.-...|...+.|.......   ...+....+-.++-..+||-++...--+-.....+|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            34566667788888899988877666665455554322211   111111222222222334555544333344567899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      +++|..+++|...|+...     .++.......+..+..+++|||.   ..+.|+|++|.|++...++..+++|||+...
T Consensus       882 ~~~~~~~~~~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG-----CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             hhHHhccCCchhhhhcCC-----CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccc
Confidence            999999999999987653     23333334445567789999998   6689999999999999999999999984432


Q ss_pred             ccC---------------------CCC---------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 040242          510 YDH---------------------NIN---------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR  559 (662)
Q Consensus       510 ~~~---------------------~~~---------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~  559 (662)
                      ...                     ...         .......||+.|.+||.+.+......+|.|+.|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            210                     000         11233568999999999999999999999999999999999999


Q ss_pred             CCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          560 PIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       560 p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                      ||.........            +++....-+. ..-..+.......++...+..+|.+|-.|.
T Consensus      1034 p~na~tpq~~f------------~ni~~~~~~~-p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIF------------ENILNRDIPW-PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhh------------hccccCCCCC-CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99865432110            0111111111 112223344566777778889999997766

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.75  E-value=1.1e-07  Score=96.97  Aligned_cols=141  Identities=15%  Similarity=0.108  Sum_probs=100.2

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-hHH----------HHHHHHHHhhccccccc--eeeeeeEec----
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMK----------EFVAEITSMGRLRHRNL--VQLHGWCRK----  423 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-~~~----------~f~~Ei~~l~~l~H~ni--v~l~~~~~~----  423 (662)
                      +.+-.-....|++...  +|+.+.||+....... ..+          .+.+|...+.++...+|  .+++++.+.    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            4444444445777766  5778999987443211 111          37789998888854443  344555543    


Q ss_pred             -cCeeeEEEeccCCC-CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC------
Q 040242          424 -QDELLLVYDYVPNG-SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA------  495 (662)
Q Consensus       424 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------  495 (662)
                       ....+||+|++++. +|.+++.+..   ....+...+..++.+++..+.-||.   .+|+|+|++++|||++.      
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~  179 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGRE  179 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCC
Confidence             23578999999886 7988874321   1234456677899999999999999   89999999999999975      


Q ss_pred             -CCCeEEeecccccc
Q 040242          496 -DLNPKLGDFGLARA  509 (662)
Q Consensus       496 -~~~~kL~DfGla~~  509 (662)
                       +..+.|+||+.++.
T Consensus       180 ~~~~~~LIDl~r~~~  194 (268)
T PRK15123        180 EDLKLSVIDLHRAQI  194 (268)
T ss_pred             CCceEEEEECCcccc
Confidence             46799999998863

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.74  E-value=9.8e-08  Score=91.97  Aligned_cols=126  Identities=23%  Similarity=0.324  Sum_probs=82.5

Q ss_pred             EEEEEEeCCCCcEEEEEEeeccc--------------h------------hhHHHHHHHHHHhhcccccc--ceeeeeeE
Q 040242          370 KVYRGVIPSTGLEVAIKRVAHNS--------------R------------QGMKEFVAEITSMGRLRHRN--LVQLHGWC  421 (662)
Q Consensus       370 ~Vy~~~~~~~g~~vavK~~~~~~--------------~------------~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~  421 (662)
                      .||.|... +|..+|||......              +            .......+|.+.|.++..-+  +.+++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999984 67899999874421              0            01234678999999997653  45555442


Q ss_pred             eccCeeeEEEeccC--CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHh-HhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          422 RKQDELLLVYDYVP--NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL-HEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       422 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                          .-.|||||++  +..+..+.       ...++......++.+++..+..+ |.   .+++|+||.+.||+++++ .
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~-------~~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~  144 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLK-------DVDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-K  144 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHH-------HCGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-C
T ss_pred             ----CCEEEEEecCCCccchhhHH-------hccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-e
Confidence                3479999998  55554443       12222455667888888866664 56   899999999999999988 9


Q ss_pred             eEEeecccccccc
Q 040242          499 PKLGDFGLARAYD  511 (662)
Q Consensus       499 ~kL~DfGla~~~~  511 (662)
                      +.|+|||.+....
T Consensus       145 ~~iIDf~qav~~~  157 (188)
T PF01163_consen  145 VYIIDFGQAVDSS  157 (188)
T ss_dssp             EEE--GTTEEETT
T ss_pred             EEEEecCcceecC
Confidence            9999999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.66  E-value=7.2e-07  Score=92.76  Aligned_cols=257  Identities=19%  Similarity=0.166  Sum_probs=159.3

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeE------ec-cCeeeEE
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWC------RK-QDELLLV  430 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~------~~-~~~~~lV  430 (662)
                      ..+.||+|+.+.+|-.-..  + ..+-|+++........+...|   |... .||-+..=+.|=      -. ....-+.
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCccccCCccceeeecchh--h-chhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            3577999999999954331  1 234577776654433333333   3333 455444323331      11 2236788


Q ss_pred             EeccCCCCcchhcccc--cccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          431 YDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      |..+++..=-..+.+.  +........|...++++..+|.+.+.||.   .+.+-+|++++|+|+++++.+.|.|=..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEccccee
Confidence            8888765322223222  22224568999999999999999999999   899999999999999999999998844333


Q ss_pred             cccCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcC-CCCCCcccchh--hHHHHHHHHHHh
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACG-RRPIEPQRTAM--ELVLVDWVRELH  580 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~--~~~l~~~~~~~~  580 (662)
                      ...+  .......+|...|.+||.-.     +..-+...|-|.+|+++++++.| +.||.+-....  ...+..-    .
T Consensus       166 i~~n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~----I  239 (637)
T COG4248         166 INAN--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETD----I  239 (637)
T ss_pred             eccC--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhh----h
Confidence            2221  22333357889999999654     34567889999999999999986 89996432110  0000000    0


Q ss_pred             hcCccccccCCCC------CCCCH-HHHHHHHHHHHHccCC--CCCCCCCHHHHHHHHh
Q 040242          581 SQGQITRAIDPTL------DYFDP-QEAELVLTLGLLCCDP--HPDFRPSTRRVVQFLL  630 (662)
Q Consensus       581 ~~~~~~~~id~~l------~~~~~-~~~~~l~~l~~~Cl~~--dP~~RPt~~eVl~~L~  630 (662)
                      ..+.....-+.+.      ...+- -....+..|..+|+..  ++.-||+++-++..|.
T Consensus       240 a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~  298 (637)
T COG4248         240 AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALD  298 (637)
T ss_pred             hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHH
Confidence            1122222222111      11221 2234567777788865  3678999998887663

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.50  E-value=4.2e-08  Score=107.95  Aligned_cols=150  Identities=19%  Similarity=0.286  Sum_probs=104.6

Q ss_pred             HHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC-------c-ceecccCCcccCcccccC
Q 040242          464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-------Q-TTHIVGTLGYLAPELTRT  535 (662)
Q Consensus       464 ~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~-------~-~~~~~gt~~y~aPE~~~~  535 (662)
                      .+++.||.|+|..  .++||++|.|++|.++.++..||+.|+.+.........       . ..-......|.|||++..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            4456999999985  89999999999999999999999999987654432110       0 011234578999999998


Q ss_pred             CCCCcchhHHHHHHHHHHHHcCCCC-CCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCC
Q 040242          536 GKATTSTDVFGFGTLMLEVACGRRP-IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP  614 (662)
Q Consensus       536 ~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~  614 (662)
                      ...+.++|+||+||++|.+..|..+ +............            ....+.....+....+.++.+=+.+++..
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~------------~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS------------RNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh------------hcccccccccccccCcHHHHHHHHHHhcC
Confidence            8889999999999999999954444 4332221111100            11122222233445556666667789999


Q ss_pred             CCCCCCCHHHHHH
Q 040242          615 HPDFRPSTRRVVQ  627 (662)
Q Consensus       615 dP~~RPt~~eVl~  627 (662)
                      ++..||++.++..
T Consensus       252 ~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  252 DSAVRPTLDLLLS  264 (700)
T ss_pred             CcccCcchhhhhc
Confidence            9999998887765

>PRK09902 hypothetical protein; Provisional

Probab=98.44  E-value=2.3e-06  Score=83.09  Aligned_cols=137  Identities=17%  Similarity=0.170  Sum_probs=102.8

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccc------hhhHHHHHHHHHHhhcccccc--ceeeeeeEe-cc----CeeeE
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS------RQGMKEFVAEITSMGRLRHRN--LVQLHGWCR-KQ----DELLL  429 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~~-~~----~~~~l  429 (662)
                      -|+||-+.|++-..  .|..+-+|+-...-      +.....|.+|+..|.+|...+  +.+++ ++. ..    ..-+|
T Consensus        26 ~~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            46789999999877  45578899875211      235678999999999986433  44444 332 21    24689


Q ss_pred             EEeccCC-CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC--eEEeeccc
Q 040242          430 VYDYVPN-GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN--PKLGDFGL  506 (662)
Q Consensus       430 V~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfGl  506 (662)
                      |+|-+++ -+|.+++.+..   ....+..++..++.+++..+.-||+   .++.|+|+.+.||+++.++.  ++++||.-
T Consensus       103 VTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk  176 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEK  176 (216)
T ss_pred             EEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhc
Confidence            9998754 67888885432   2345667788999999999999999   89999999999999986667  99999976


Q ss_pred             cc
Q 040242          507 AR  508 (662)
Q Consensus       507 a~  508 (662)
                      ++
T Consensus       177 ~r  178 (216)
T PRK09902        177 SR  178 (216)
T ss_pred             cc
Confidence            65

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.42  E-value=9.2e-07  Score=97.73  Aligned_cols=141  Identities=21%  Similarity=0.294  Sum_probs=93.2

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhH----------------------------------------HHHH
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM----------------------------------------KEFV  400 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~----------------------------------------~~f~  400 (662)
                      +.|+.++-|.||+|+++ +|+.||||+.+.+-.+..                                        -++.
T Consensus       131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            68999999999999995 599999999876532211                                        0144


Q ss_pred             HHHHHhhccc-----cccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHH-HHHhH
Q 040242          401 AEITSMGRLR-----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA-LLYLH  474 (662)
Q Consensus       401 ~Ei~~l~~l~-----H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-L~yLH  474 (662)
                      .|...+.+++     .+++.=-.=|.+......|+|||++|-.+.+...-.    ...++   +..++..++++ +..+-
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~----~~g~d---~k~ia~~~~~~f~~q~~  282 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK----SAGID---RKELAELLVRAFLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH----hcCCC---HHHHHHHHHHHHHHHHH
Confidence            4555555542     233222222333345678999999999999985322    12233   22233333332 12222


Q ss_pred             hcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       475 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      .   .+++|.|.+|.||+++.++++.+.|||+...++.
T Consensus       283 ~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 R---DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             h---cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            2   6899999999999999999999999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.38  E-value=3.1e-06  Score=84.10  Aligned_cols=134  Identities=20%  Similarity=0.248  Sum_probs=92.7

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch----------------------hhHHHHHHHHHHhhccccc--c
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR----------------------QGMKEFVAEITSMGRLRHR--N  413 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~----------------------~~~~~f~~Ei~~l~~l~H~--n  413 (662)
                      .+.++||-|--+.||.|..+ .|.++|||.-+....                      .......+|.+.|.+|.-.  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            34688999999999999996 688999995432210                      0123356788888888655  5


Q ss_pred             ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe
Q 040242          414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI  493 (662)
Q Consensus       414 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  493 (662)
                      +.+.+++-    .-.+||||+++-.|...--          +-...-.++..|++-+.-+-.   .+|+|+|+++-||++
T Consensus       173 VP~P~~~n----RHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV  235 (304)
T COG0478         173 VPKPIAWN----RHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV  235 (304)
T ss_pred             CCCccccc----cceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence            55566543    4589999998877765431          112222334444444443334   799999999999999


Q ss_pred             CCCCCeEEeecccccc
Q 040242          494 DADLNPKLGDFGLARA  509 (662)
Q Consensus       494 ~~~~~~kL~DfGla~~  509 (662)
                      +++|.+.++||--+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999965543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.32  E-value=3.7e-06  Score=82.84  Aligned_cols=106  Identities=25%  Similarity=0.346  Sum_probs=83.3

Q ss_pred             HHHHHHHHHHhhcccccc--ceeeeeeEeccC----eeeEEEeccCCC-CcchhcccccccccccccHHHHHHHHHHHHH
Q 040242          396 MKEFVAEITSMGRLRHRN--LVQLHGWCRKQD----ELLLVYDYVPNG-SLDKLLFDNDQQKKKILNWDQRYKILIGVAQ  468 (662)
Q Consensus       396 ~~~f~~Ei~~l~~l~H~n--iv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  468 (662)
                      .....+|...+.+|+...  ..+.+++.+...    ..++|+|++++. +|.+++....     .++...+..++.++++
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            345778888888875433  455666665533    458999999884 7999885421     1555667889999999


Q ss_pred             HHHHhHhcCCCCEEeCCcCCCceEeCCCC---CeEEeecccccc
Q 040242          469 ALLYLHEECDQRVVHRDVKPSNVLIDADL---NPKLGDFGLARA  509 (662)
Q Consensus       469 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~  509 (662)
                      .+.-||+   .+|+|+|+++.|||++.+.   .+.++||+-++.
T Consensus       130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999   8999999999999999887   799999997774

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=1.8e-05  Score=77.28  Aligned_cols=137  Identities=15%  Similarity=0.200  Sum_probs=93.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHH---------HHHHHHHhhccccc---cceeeeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---------FVAEITSMGRLRHR---NLVQLHGWC  421 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~---------f~~Ei~~l~~l~H~---niv~l~~~~  421 (662)
                      .++|...+++-......|.+...  +|..+++|..........+.         ..+++..+.+++..   ..+.++.+.
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            46777778888777777777776  67889999886654333222         23344445555432   233333333


Q ss_pred             ec-----cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          422 RK-----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       422 ~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      +.     ....+++|||++|..|.++..         ++.    .++..+.+++.-||+   .|+.|+|.+|.|++++.+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC
Confidence            22     235679999999998877641         111    245667788999999   899999999999999865


Q ss_pred             CCeEEeecccccc
Q 040242          497 LNPKLGDFGLARA  509 (662)
Q Consensus       497 ~~~kL~DfGla~~  509 (662)
                      + +++.||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            4 99999986653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.15  E-value=2.3e-05  Score=78.29  Aligned_cols=141  Identities=14%  Similarity=0.177  Sum_probs=84.9

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc--eeeeeeEeccCeeeEEEeccCCCC
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL--VQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .+||+|..+.||+.    .+..+++|......  ......+|.++++.+..-.+  .+.++++...+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            57899999999983    24457788876533  23445789999988865444  567788777777889999998863


Q ss_pred             -cchhcccccc----------------cc--cccccHHHHHH-HHH----------HHHH-HHHHhHhc-CCCCEEeCCc
Q 040242          439 -LDKLLFDNDQ----------------QK--KKILNWDQRYK-ILI----------GVAQ-ALLYLHEE-CDQRVVHRDV  486 (662)
Q Consensus       439 -L~~~l~~~~~----------------~~--~~~l~~~~~~~-i~~----------~ia~-~L~yLH~~-~~~~ivH~Dl  486 (662)
                       +...+.....                ..  ........+.. +..          .+.+ ...+|... ....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             3222211000                00  00001111000 000          0011 12222211 1245799999


Q ss_pred             CCCceEeCCCCCeEEeeccccc
Q 040242          487 KPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       487 kp~NIll~~~~~~kL~DfGla~  508 (662)
                      .|.||++++++ +.|.||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999998776

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.00  E-value=0.00013  Score=72.17  Aligned_cols=154  Identities=20%  Similarity=0.202  Sum_probs=96.1

Q ss_pred             cchHHHHHhccCCcccceee---eeCceEEEEEEeCCCCcEEEEEEeeccchhhHH---------H--------------
Q 040242          345 FRYSELYSATKGFREKNLVG---SGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK---------E--------------  398 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG---~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~---------~--------------  398 (662)
                      .+++.+.....+..+..+.|   .|.-+.||+|.. .++..+|||++........+         .              
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            45566666666666665555   566678999987 56889999998654221110         0              


Q ss_pred             -HHHHHHHhhccc--cccceeeeeeEeccCeeeEEEeccCCCC-cchhcccccccccccccHHHHHHHHHHHHHHHHHhH
Q 040242          399 -FVAEITSMGRLR--HRNLVQLHGWCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH  474 (662)
Q Consensus       399 -f~~Ei~~l~~l~--H~niv~l~~~~~~~~~~~lV~E~~~~gs-L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH  474 (662)
                       ...|+..|.++.  +-.+.+-+++.    +-.|||||+.... -.-.|.      ...+...+...+..++++.+.-|-
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~  183 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLY  183 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHH
Confidence             234555555553  22222333322    2379999995531 111221      122222245566667777777666


Q ss_pred             hcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       475 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ..  .++||+||+.-|||+. ++.+.|+|+|-+....+
T Consensus       184 ~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         184 KE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             Hh--cCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            53  7899999999999999 88999999997775543

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.97  E-value=2.7e-05  Score=86.01  Aligned_cols=144  Identities=22%  Similarity=0.307  Sum_probs=93.7

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh-------------------------------------HHHHHHH
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-------------------------------------MKEFVAE  402 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~-------------------------------------~~~f~~E  402 (662)
                      .+.||.-+.|.||+|+++. |+.||||+-+..-+..                                     .-+|..|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999965 9999999876643211                                     0125566


Q ss_pred             HHHhhcc----cccccee---eee-eEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhH
Q 040242          403 ITSMGRL----RHRNLVQ---LHG-WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH  474 (662)
Q Consensus       403 i~~l~~l----~H~niv~---l~~-~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH  474 (662)
                      .+...+.    +|-++..   +=. |........|+||||+|..+.+.-.-.    ...++-.   .++..+.++  |++
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~----~~gi~~~---~i~~~l~~~--~~~  315 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAID----KRGISPH---DILNKLVEA--YLE  315 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHH----HcCCCHH---HHHHHHHHH--HHH
Confidence            6555444    3444111   111 122334679999999999998874322    2234433   333333332  333


Q ss_pred             hcCCCCEEeCCcCCCceEeCC----CCCeEEeeccccccccCC
Q 040242          475 EECDQRVVHRDVKPSNVLIDA----DLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       475 ~~~~~~ivH~Dlkp~NIll~~----~~~~kL~DfGla~~~~~~  513 (662)
                      +....|++|+|-+|.||+++.    ++.+.+-|||+.....+.
T Consensus       316 qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  316 QIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             HHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence            333368999999999999984    677999999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.95  E-value=8e-05  Score=74.14  Aligned_cols=144  Identities=18%  Similarity=0.176  Sum_probs=84.1

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeeeEec---cCeeeEEEecc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGWCRK---QDELLLVYDYV  434 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~~~---~~~~~lV~E~~  434 (662)
                      .+.|+.|..+.||+....+  ..+++|.....  .....+..|..+++.+....  +.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4678999999999999843  48999987655  44566778888888886443  4566664432   23568999999


Q ss_pred             CCCCcch----------------hcc---cccccccccccHHH---------HHHH------------HHHHHH-HHHHh
Q 040242          435 PNGSLDK----------------LLF---DNDQQKKKILNWDQ---------RYKI------------LIGVAQ-ALLYL  473 (662)
Q Consensus       435 ~~gsL~~----------------~l~---~~~~~~~~~l~~~~---------~~~i------------~~~ia~-~L~yL  473 (662)
                      ++..+..                .+.   .... ......+..         ....            ...+.+ .+..+
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPP-PFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQEL  156 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHT-TCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccc-cccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHH
Confidence            9988877                110   1100 000001000         0000            111222 33333


Q ss_pred             Hhc----CCCCEEeCCcCCCceEeC-CCCCeEEeeccccc
Q 040242          474 HEE----CDQRVVHRDVKPSNVLID-ADLNPKLGDFGLAR  508 (662)
Q Consensus       474 H~~----~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~  508 (662)
                      ++.    ....++|+|+.|.||+++ +++.+.|.||+.+.
T Consensus       157 ~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  157 EALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            321    346799999999999999 55666799998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.88  E-value=5.6e-05  Score=73.12  Aligned_cols=104  Identities=25%  Similarity=0.213  Sum_probs=82.8

Q ss_pred             HHHHHhhcccc-ccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC
Q 040242          401 AEITSMGRLRH-RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ  479 (662)
Q Consensus       401 ~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  479 (662)
                      .|.-+++.+++ +++.+++|+|-    .++|.||...+++...-..  ..+-..-+|..|.+|+.++++.+.+|++....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            57888888876 69999999993    3679999987766532100  00123468999999999999999999987666


Q ss_pred             CEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       480 ~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      .+.-+|++++|+-+++++++|+.|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6899999999999999999999999877644

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=97.86  E-value=0.00016  Score=86.14  Aligned_cols=81  Identities=11%  Similarity=0.205  Sum_probs=58.5

Q ss_pred             cceeeeeCceEEEEEEeCCCC--cEEEEEEeeccc-hhhHHHHHHHHHHhhccc-cccc--eeeeeeEecc---CeeeEE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTG--LEVAIKRVAHNS-RQGMKEFVAEITSMGRLR-HRNL--VQLHGWCRKQ---DELLLV  430 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g--~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV  430 (662)
                      .+.++.|.+..+|+......+  ..+++|+..... ......+.+|+++++.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998774332  467778764432 122356789999999995 6665  7788888664   467999


Q ss_pred             EeccCCCCcc
Q 040242          431 YDYVPNGSLD  440 (662)
Q Consensus       431 ~E~~~~gsL~  440 (662)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999887653

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.86  E-value=2.7e-06  Score=92.94  Aligned_cols=182  Identities=20%  Similarity=0.153  Sum_probs=131.4

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc-ceeeeeeEeccCeeeEEEeccCCC-
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN-LVQLHGWCRKQDELLLVYDYVPNG-  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E~~~~g-  437 (662)
                      -+-++++.++++||.+...+...+ ++.+...     ....-++++|.+++||| .++.++-+..+...+++++++..+ 
T Consensus       247 fh~fvK~altknpKkRptaeklL~-h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r  320 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR  320 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhhee-ceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence            455789999999998775443333 5555333     33456889999999999 777777777777889999999887 


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ  517 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~  517 (662)
                      +-.......    ...+...+...+...-++++++||+   ..=+|+|    ||+..+ ...|..||+....+....  .
T Consensus       321 s~~~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~--~  386 (829)
T KOG0576|consen  321 SSALEMTVS----EIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM--K  386 (829)
T ss_pred             cccccCChh----hHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc--c
Confidence            322222111    2234444555667777889999998   3347888    776655 678999999888766543  2


Q ss_pred             ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 040242          518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI  561 (662)
Q Consensus       518 ~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~  561 (662)
                      .....+++.++|||......+..+.|+|+.|+--.++.-|-.|-
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             cccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            33457899999999999999999999999998766776666654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.84  E-value=0.00015  Score=73.28  Aligned_cols=140  Identities=18%  Similarity=0.130  Sum_probs=83.9

Q ss_pred             eeeeCc-eEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEeccCCCCcc
Q 040242          363 VGSGGF-GKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSLD  440 (662)
Q Consensus       363 LG~G~~-g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~  440 (662)
                      |-.|.. ..||+....  +..+.||+.....   ..+...|+.+++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC--CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444444 789998763  4678888875543   335667888888874 333556777777666789999999998887


Q ss_pred             hhcc-------------------ccccccccccc--HHHHHHHHH--------------------HHHHHHHHhHh----
Q 040242          441 KLLF-------------------DNDQQKKKILN--WDQRYKILI--------------------GVAQALLYLHE----  475 (662)
Q Consensus       441 ~~l~-------------------~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~L~yLH~----  475 (662)
                      ....                   .-... .....  +..+.....                    .+.+.+..|-.    
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVA-DCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcc-cCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            5421                   10000 00000  000000000                    01111222211    


Q ss_pred             cCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       476 ~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      .....++|+|+.|.|||++++..+.|.||+.+.
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            112569999999999999998778899998665

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK10593 hypothetical protein; Provisional

Probab=97.54  E-value=0.0011  Score=69.07  Aligned_cols=77  Identities=8%  Similarity=-0.004  Sum_probs=56.0

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc---ccceeeeeeEec---cCeeeEEEe
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH---RNLVQLHGWCRK---QDELLLVYD  432 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~niv~l~~~~~~---~~~~~lV~E  432 (662)
                      ..+.||.|..+.||+.... ++ .+.+|..+..  .....|..|...|+.|.-   -.+.+++++|..   .+..++|||
T Consensus        18 ~~~~i~~G~~~~vy~~~~~-~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         18 RVECISEQPYAALWALYDS-QG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             eeeecCCccceeEEEEEcC-CC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3567999999999998763 33 4667764331  123477889999988853   357788888754   366899999


Q ss_pred             ccCCCCc
Q 040242          433 YVPNGSL  439 (662)
Q Consensus       433 ~~~~gsL  439 (662)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998876

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.54  E-value=0.00062  Score=79.78  Aligned_cols=199  Identities=18%  Similarity=0.174  Sum_probs=134.2

Q ss_pred             HHHHHHHHHhhccccccceeeeeeEeccCe----eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHH
Q 040242          397 KEFVAEITSMGRLRHRNLVQLHGWCRKQDE----LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY  472 (662)
Q Consensus       397 ~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~----~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y  472 (662)
                      ....-|++.+.++.|+|++.++.|..+...    ..+..|+++..++...+..     ...++....+.+..++.+||.|
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~-----v~~i~~~~~r~~~~~~~~GL~~  301 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS-----VGSIPLETLRILHQKLLEGLAY  301 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh-----ccccCHHHHHHHHHHHhhhHHH
Confidence            344567788899999999999999866542    3455678888888887743     3457788888899999999999


Q ss_pred             hHhcCCCCEEeCCcCCC---ceEeCCCCCeEEe--eccccccccCCCCCcceecccCCcccCcccccCCCCC--cchhHH
Q 040242          473 LHEECDQRVVHRDVKPS---NVLIDADLNPKLG--DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT--TSTDVF  545 (662)
Q Consensus       473 LH~~~~~~ivH~Dlkp~---NIll~~~~~~kL~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t--~ksDV~  545 (662)
                      +|+   ....|.-+..+   +.-.+.++.+.++  ||+..+.+........  ..-+..+.+||......+.  ...|+|
T Consensus       302 ~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  302 LHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             HHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHH
Confidence            999   44445444444   4444556667776  8887776554322211  2234567788877655444  447999


Q ss_pred             HHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHH
Q 040242          546 GFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRV  625 (662)
Q Consensus       546 S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eV  625 (662)
                      .+|..+..+..|..+-.......                  ..++.       .....+.....+|+..++++|+...++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~~------------------~~l~~-------~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVPV------------------SLLDV-------LSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccchh------------------hhhcc-------ccchhhhhhhhhhcchhhhhccchhhh
Confidence            99999999999876543221110                  00000       011145566678999999999999999


Q ss_pred             HHHHh
Q 040242          626 VQFLL  630 (662)
Q Consensus       626 l~~L~  630 (662)
                      +.+.-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            98653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.54  E-value=0.00061  Score=68.51  Aligned_cols=75  Identities=16%  Similarity=0.139  Sum_probs=46.4

Q ss_pred             ceeeeeCce-EEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccc---cceeeeeeEecc---CeeeEEEec
Q 040242          361 NLVGSGGFG-KVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR---NLVQLHGWCRKQ---DELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g-~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---niv~l~~~~~~~---~~~~lV~E~  433 (662)
                      +.|+.||.. .||+.     +..+++|.....  ....++..|.+.+..+...   -+.++++.+...   ...+++||+
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777776 48874     234677765442  2344678899888877532   233344444332   235889999


Q ss_pred             cCCCCcchh
Q 040242          434 VPNGSLDKL  442 (662)
Q Consensus       434 ~~~gsL~~~  442 (662)
                      ++|.++.+.
T Consensus        76 i~G~~l~~~   84 (235)
T cd05155          76 LEGETATAA   84 (235)
T ss_pred             ecCCCCCcc
Confidence            999888644

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.41  E-value=0.0017  Score=62.92  Aligned_cols=125  Identities=29%  Similarity=0.423  Sum_probs=89.5

Q ss_pred             cCCcccceeeeeCc-eEEEEEEeCCCCcEEEEEEeec---cc--------h----------hhHHHHHHHHHHhhccc--
Q 040242          355 KGFREKNLVGSGGF-GKVYRGVIPSTGLEVAIKRVAH---NS--------R----------QGMKEFVAEITSMGRLR--  410 (662)
Q Consensus       355 ~~f~~~~~LG~G~~-g~Vy~~~~~~~g~~vavK~~~~---~~--------~----------~~~~~f~~Ei~~l~~l~--  410 (662)
                      ..++..+.||.|.- |.|||.+.  +|..+|+|.+..   ..        .          .....|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            66778899999999 99999999  678999999322   00        0          11235888988888875  


Q ss_pred             -cccc--eeeeeeEeccC------------------eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHH
Q 040242          411 -HRNL--VQLHGWCRKQD------------------ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA  469 (662)
Q Consensus       411 -H~ni--v~l~~~~~~~~------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~  469 (662)
                       +.++  |+++||..-..                  ...||.||++...              .+    ..+-+.+|.+-
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------------~~----~~~~~~~~~~d  176 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------------PL----QIRDIPQMLRD  176 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------------cc----chhHHHHHHHH
Confidence             4566  99999873220                  2356777765433              11    12234567777


Q ss_pred             HHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       470 L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      |..+|.   .+|+-+|+++.|..     .-||+|||.+
T Consensus       177 l~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  177 LKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            888999   89999999999986     4589999854

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.39  E-value=0.0049  Score=66.51  Aligned_cols=77  Identities=12%  Similarity=0.126  Sum_probs=52.6

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----c--hhhHHHHHHHHHHhhccc---cccceeeeeeEeccCeeeE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----S--RQGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~--~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~l  429 (662)
                      .+.||.|.+..||+....+.++.|+||.-...     .  ....+.+..|.+.|..+.   ..++.+++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            45799999999999999643358999974321     1  123456677877777763   234666666633  55789


Q ss_pred             EEeccCCCC
Q 040242          430 VYDYVPNGS  438 (662)
Q Consensus       430 V~E~~~~gs  438 (662)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.38  E-value=0.0012  Score=67.39  Aligned_cols=139  Identities=13%  Similarity=0.061  Sum_probs=78.6

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEeccCCCCcch
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVPNGSLDK  441 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~gsL~~  441 (662)
                      +..|-...+|+...  ++..+++|..........-...+|..+++.+....++ +++..+.    -.+||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            45677788998874  5667888876543322111346788888888654443 3344332    368999999877753


Q ss_pred             h-----------------cccccccccccccHHHHH-HHH---------HHHHHHHHHhHhc-----CCCCEEeCCcCCC
Q 040242          442 L-----------------LFDNDQQKKKILNWDQRY-KIL---------IGVAQALLYLHEE-----CDQRVVHRDVKPS  489 (662)
Q Consensus       442 ~-----------------l~~~~~~~~~~l~~~~~~-~i~---------~~ia~~L~yLH~~-----~~~~ivH~Dlkp~  489 (662)
                      .                 ||..... ...++...+. ...         ..+.+.+..+-..     ....++|+|+.|.
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~-~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRF-GYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCC-CCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            2                 1111100 1111211111 100         0111112222111     1246899999999


Q ss_pred             ceEeCCCCCeEEeecccccc
Q 040242          490 NVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       490 NIll~~~~~~kL~DfGla~~  509 (662)
                      ||++++++ +.|.||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999987764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.37  E-value=0.0019  Score=64.80  Aligned_cols=76  Identities=14%  Similarity=0.141  Sum_probs=48.5

Q ss_pred             cceeeeeCceEEEEEEeCC-CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEeccCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      .+.|..|-...+|+..... .+..+++|......... -.-..|+.++..+...+++ ++++.+.    -.++|||++|.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~-~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELI-IDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccce-ecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            3567778888999987642 25678899775432221 1224688888888544444 3443332    24799999998


Q ss_pred             Ccc
Q 040242          438 SLD  440 (662)
Q Consensus       438 sL~  440 (662)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            774

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.32  E-value=0.0019  Score=62.91  Aligned_cols=129  Identities=21%  Similarity=0.348  Sum_probs=88.9

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc----------------hhhHHHHHHHHHHhhccc------ccccee
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS----------------RQGMKEFVAEITSMGRLR------HRNLVQ  416 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~----------------~~~~~~f~~Ei~~l~~l~------H~niv~  416 (662)
                      ....||+|+.=.||.-  + .....+||+.....                ....+++.+|+....++.      +.+|.+
T Consensus         5 ~~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3568999999999963  3 24457889886655                223456777776666555      889999


Q ss_pred             eeeeEeccCeeeEEEeccCC--C----CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCc
Q 040242          417 LHGWCRKQDELLLVYDYVPN--G----SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN  490 (662)
Q Consensus       417 l~~~~~~~~~~~lV~E~~~~--g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  490 (662)
                      ++|+.+.+.-+-+|+|.+.+  |    +|.+++.+      ..++. .   +...+-+-..||-+   ..|+.+|++|+|
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~------~~~~~-~---~~~~L~~f~~~l~~---~~Iv~~dl~~~N  148 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE------GGLTE-E---LRQALDEFKRYLLD---HHIVIRDLNPHN  148 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc------CCccH-H---HHHHHHHHHHHHHH---cCCeecCCCccc
Confidence            99999999889999997643  3    45556532      23443 2   33333344566666   789999999999


Q ss_pred             eEeCCCC----CeEEee
Q 040242          491 VLIDADL----NPKLGD  503 (662)
Q Consensus       491 Ill~~~~----~~kL~D  503 (662)
                      |++....    .+.|.|
T Consensus       149 Iv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLID  165 (199)
T ss_pred             EEEEecCCCceEEEEEe
Confidence            9996432    466666

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.30  E-value=0.0016  Score=61.14  Aligned_cols=128  Identities=20%  Similarity=0.227  Sum_probs=86.8

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccccee-eeeeEeccCeeeEEEeccCCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ-LHGWCRKQDELLLVYDYVPNG  437 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~-l~~~~~~~~~~~lV~E~~~~g  437 (662)
                      ..+.|++|..|.||+|.+  .|..+|+|+-..++.  ...+..|+++|..+.-.++.+ ++.|..    -++.|||..|.
T Consensus        26 v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          26 VEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhcccccEEEEeec--cCceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            357799999999999999  456899998765543  357788999999988776654 444332    24559999888


Q ss_pred             CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC-CCceEeCCCCCeEEeecccccc
Q 040242          438 SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK-PSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       438 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk-p~NIll~~~~~~kL~DfGla~~  509 (662)
                      .|.++-...        +-+    -...+++.---|-.   .+|-|+.|. |...+|-.+..+.|+||.-|..
T Consensus        98 ~L~~~~~~~--------~rk----~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG--------DRK----HLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc--------cHH----HHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            887765211        112    23334444223333   788888886 4444444455999999998873

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.06  E-value=0.0055  Score=63.75  Aligned_cols=145  Identities=15%  Similarity=0.103  Sum_probs=86.0

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeee------EeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGW------CRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~  431 (662)
                      .+.|..|....+|+....  +..+++|+....   ...+...|+.++..+.+.+  +.+++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            556777877899998763  346888987642   2344566777777775433  3444332      12344678999


Q ss_pred             eccCCCCcchh----c----------cccccc------ccccccHHHHHH----------HHHHHHHHHHHhHh----cC
Q 040242          432 DYVPNGSLDKL----L----------FDNDQQ------KKKILNWDQRYK----------ILIGVAQALLYLHE----EC  477 (662)
Q Consensus       432 E~~~~gsL~~~----l----------~~~~~~------~~~~l~~~~~~~----------i~~~ia~~L~yLH~----~~  477 (662)
                      +|++|..+...    .          |.....      ......|.....          ....+..++.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99999876531    0          100000      001123322210          11123344455443    12


Q ss_pred             CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       478 ~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ..+++|+|+.|.||+++++..+.|.||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999987778999987763

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK05231 homoserine kinase; Provisional

Probab=97.02  E-value=0.0099  Score=62.63  Aligned_cols=145  Identities=15%  Similarity=0.135  Sum_probs=76.7

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeee------eEeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHG------WCRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~------~~~~~~~~~lV~  431 (662)
                      .+.|..|....+|+.... +| .+++|++.....   +....|+..+..|...+  +.+.+.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~-~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTT-QG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeC-CC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            355677777899998763 34 688898752222   22333444444443212  222222      122345679999


Q ss_pred             eccCCCCcchh--------------ccccccc------ccccccH-HHHHHH------------H-HHHHHHHHHhHhc-
Q 040242          432 DYVPNGSLDKL--------------LFDNDQQ------KKKILNW-DQRYKI------------L-IGVAQALLYLHEE-  476 (662)
Q Consensus       432 E~~~~gsL~~~--------------l~~~~~~------~~~~l~~-~~~~~i------------~-~~ia~~L~yLH~~-  476 (662)
                      ||++|..+...              +|.....      ....+.| .....-            . ..+...+..+.+. 
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            99998765321              0110000      0001112 211111            1 1111122333211 


Q ss_pred             ---CCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          477 ---CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       477 ---~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                         ...+++|+|+.+.||+++.+...-|.||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence               246899999999999999765568999997763

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.78  E-value=0.012  Score=61.65  Aligned_cols=145  Identities=17%  Similarity=0.192  Sum_probs=81.8

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeeeE------eccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGWC------RKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~------~~~~~~~lV~  431 (662)
                      .+.++.|-...+|+... .+| .+++|+......  ..+...|++++..|....  +.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEe-CCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            45677777789998876 334 577887754311  223445666666664322  33333321      2245678999


Q ss_pred             eccCCCCcchh--------------ccccccc----cc---ccccHHHHHH------------HHHHHHHHHHHhHh---
Q 040242          432 DYVPNGSLDKL--------------LFDNDQQ----KK---KILNWDQRYK------------ILIGVAQALLYLHE---  475 (662)
Q Consensus       432 E~~~~gsL~~~--------------l~~~~~~----~~---~~l~~~~~~~------------i~~~ia~~L~yLH~---  475 (662)
                      ||++|..+...              +|.....    ..   ..-.|.....            ....+.+.+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            99998765321              1110000    00   0112221110            01123334555542   


Q ss_pred             -cCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          476 -ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       476 -~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                       ....+++|+|+++.||+++.++...|.||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             234789999999999999998777899999775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.68  E-value=0.023  Score=58.58  Aligned_cols=31  Identities=35%  Similarity=0.562  Sum_probs=25.7

Q ss_pred             CCEEeCCcCCCceEeCCCCC-eEEeecccccc
Q 040242          479 QRVVHRDVKPSNVLIDADLN-PKLGDFGLARA  509 (662)
Q Consensus       479 ~~ivH~Dlkp~NIll~~~~~-~kL~DfGla~~  509 (662)
                      ..++|+|+++.||+++++++ .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 45999997764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=96.66  E-value=0.016  Score=60.51  Aligned_cols=144  Identities=21%  Similarity=0.239  Sum_probs=83.5

Q ss_pred             ceeeeeCceEEEEEEeCC------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEec
Q 040242          361 NLVGSGGFGKVYRGVIPS------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~  433 (662)
                      +.|..|-...+|+.....      .++.+++|....... ...+...|.+++..+....+. ++++++. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            456666677899887643      257899998765432 223446788888777544444 4455543 2   358999


Q ss_pred             cCCCCcchh-c----------------ccccccc------cccccHHHHHH--------------------------HHH
Q 040242          434 VPNGSLDKL-L----------------FDNDQQK------KKILNWDQRYK--------------------------ILI  464 (662)
Q Consensus       434 ~~~gsL~~~-l----------------~~~~~~~------~~~l~~~~~~~--------------------------i~~  464 (662)
                      ++|..+... +                |......      ....-|..+..                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            998877542 1                1111000      00011111111                          111


Q ss_pred             HHHHHHHHhHh------cCCCCEEeCCcCCCceEeCCC----CCeEEeecccccc
Q 040242          465 GVAQALLYLHE------ECDQRVVHRDVKPSNVLIDAD----LNPKLGDFGLARA  509 (662)
Q Consensus       465 ~ia~~L~yLH~------~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~  509 (662)
                      .+...+..|..      .....++|+|+.+.||+++++    +.++++||..+..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22223334432      234679999999999999985    8899999987763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.34  E-value=0.043  Score=56.78  Aligned_cols=75  Identities=19%  Similarity=0.328  Sum_probs=47.9

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc---cccceeeeeeEeccCeeeEEEecc
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +..+.++.|....+|+..  .++..+.||.-..   .....|..|..-|+.|.   --.+.+++++....+..+||+||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            335678888899999977  4677899998762   23346778888777773   455778899888877889999999


Q ss_pred             CCC
Q 040242          435 PNG  437 (662)
Q Consensus       435 ~~g  437 (662)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            877

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=96.25  E-value=0.043  Score=58.51  Aligned_cols=144  Identities=17%  Similarity=0.231  Sum_probs=82.7

Q ss_pred             ceeeeeCceEEEEEEeCC----CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEeccC
Q 040242          361 NLVGSGGFGKVYRGVIPS----TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~----~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +.|-.|-.-.+|+.....    .++.|++|............ .+|..++..+...++. ++++.+. ++   .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~-~g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFP-NG---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEEC-Cc---eEEEeeC
Confidence            345456677889887532    23678999886654332222 5788888888655555 3555543 32   5899998


Q ss_pred             CCCcchh-----------------ccccccc-ccccccHHHHHHHHHH-----------------HHHHHHHhHh-----
Q 040242          436 NGSLDKL-----------------LFDNDQQ-KKKILNWDQRYKILIG-----------------VAQALLYLHE-----  475 (662)
Q Consensus       436 ~gsL~~~-----------------l~~~~~~-~~~~l~~~~~~~i~~~-----------------ia~~L~yLH~-----  475 (662)
                      +.+|...                 +|+.... ......|.+..++..+                 +...+..|.+     
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            8777532                 1111100 0111223332222211                 1111222221     


Q ss_pred             cCCCCEEeCCcCCCceEeCC-CCCeEEeecccccc
Q 040242          476 ECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARA  509 (662)
Q Consensus       476 ~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~  509 (662)
                      .....++|+|+++.|||+++ ++.+++.||..+..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            12356899999999999986 46799999988874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.08  E-value=0.00091  Score=80.05  Aligned_cols=163  Identities=13%  Similarity=0.007  Sum_probs=113.3

Q ss_pred             HHHHHHHHhhccccccceeeeeeEe--ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHh
Q 040242          398 EFVAEITSMGRLRHRNLVQLHGWCR--KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE  475 (662)
Q Consensus       398 ~f~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  475 (662)
                      ..+.|...+++..|+++.....-..  +..+.+..++|+..|.+.+.|-..... ...++..-....-++......-.|.
T Consensus      1275 mll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1275 MLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             hhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhcccc-CCcchhchHHHHHHHHHhccchhhh
Confidence            3455555666678888776544332  233568999999999999998655321 2333333333333332444444444


Q ss_pred             cC--CCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHH
Q 040242          476 EC--DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE  553 (662)
Q Consensus       476 ~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~e  553 (662)
                      ..  ..-.+|+++|+-|.++..+.++|++++|+.+...+. ....+...+++.|+.|+..+.-+++.++|+|..|+-+|+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            32  244799999999999999999999999999943332 223334567888999999888888989999999999999


Q ss_pred             HHcCCCCCC
Q 040242          554 VACGRRPIE  562 (662)
Q Consensus       554 lltG~~p~~  562 (662)
                      +..|..++.
T Consensus      1433 rs~~n~~fi 1441 (2724)
T KOG1826|consen 1433 RSDGNAYFI 1441 (2724)
T ss_pred             HhcccHHHH
Confidence            988877654

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.03  E-value=0.071  Score=55.68  Aligned_cols=131  Identities=18%  Similarity=0.208  Sum_probs=79.0

Q ss_pred             ceEEEEEEeCCCCcEEEEEEee-ccchhhHHHHHHHHHHhhcccc--ccceeeeeeEeccC--eeeEEEeccCCCCcchh
Q 040242          368 FGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVAEITSMGRLRH--RNLVQLHGWCRKQD--ELLLVYDYVPNGSLDKL  442 (662)
Q Consensus       368 ~g~Vy~~~~~~~g~~vavK~~~-~~~~~~~~~f~~Ei~~l~~l~H--~niv~l~~~~~~~~--~~~lV~E~~~~gsL~~~  442 (662)
                      .-.+|....  .++++++++-. ...........+|+..|+.+.-  --+-..+++|..+.  ..+.||+|++|..+...
T Consensus        38 sn~t~~~~~--~~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~  115 (321)
T COG3173          38 SNDTFRLGD--TGQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSA  115 (321)
T ss_pred             ccceEEEec--CCceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCc
Confidence            334555444  26677777221 1222333444567777777632  23345677776665  77999999988655544


Q ss_pred             cccccccccccccHHHHHHHH-HHHHHHHHHhH-----------------------------------------------
Q 040242          443 LFDNDQQKKKILNWDQRYKIL-IGVAQALLYLH-----------------------------------------------  474 (662)
Q Consensus       443 l~~~~~~~~~~l~~~~~~~i~-~~ia~~L~yLH-----------------------------------------------  474 (662)
                      +.....      .    .+.+ ..+++.|.-||                                               
T Consensus       116 ~~~~~~------~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~  185 (321)
T COG3173         116 LPPESL------G----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIK  185 (321)
T ss_pred             CCcccc------h----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHH
Confidence            422110      0    0111 24444444444                                               


Q ss_pred             ---hcC-----CCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          475 ---EEC-----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       475 ---~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                         +..     ...++|+|+++.|++++.+.-+=+.||+++..-
T Consensus       186 Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         186 WLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence               221     356999999999999999988999999998853

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.02  E-value=0.0078  Score=61.77  Aligned_cols=137  Identities=18%  Similarity=0.148  Sum_probs=88.7

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---------h--------h-----hHHHHHHHHHHhhccc-ccc
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---------R--------Q-----GMKEFVAEITSMGRLR-HRN  413 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---------~--------~-----~~~~f~~Ei~~l~~l~-H~n  413 (662)
                      +...++||-|.-+.+|.+.+ ..|.+.++|.-....         +        .     ..-....|...|+.|. |-.
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56689999999999999998 468888888432110         0        0     0112345666777764 222


Q ss_pred             -ceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceE
Q 040242          414 -LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       414 -iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  492 (662)
                       +.+.++++    ..++|||++.+-.|...-+-        .+..+++.-+.+   -+.-|-.   .++||+|..--||+
T Consensus       173 pVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v--------~d~~~ly~~lm~---~Iv~la~---~GlIHgDFNEFNim  234 (465)
T KOG2268|consen  173 PVPKPIDHN----RHCVVMELVDGYPLRQVRHV--------EDPPTLYDDLMG---LIVRLAN---HGLIHGDFNEFNIM  234 (465)
T ss_pred             CCCCccccc----ceeeHHHhhcccceeeeeec--------CChHHHHHHHHH---HHHHHHH---cCceecccchheeE
Confidence             33344443    45899999988888765421        222333332222   2333334   89999999999999


Q ss_pred             eCCCCCeEEeeccccccccC
Q 040242          493 IDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       493 l~~~~~~kL~DfGla~~~~~  512 (662)
                      ++++..++++||--+....+
T Consensus       235 v~dd~~i~vIDFPQmvS~sh  254 (465)
T KOG2268|consen  235 VKDDDKIVVIDFPQMVSTSH  254 (465)
T ss_pred             EecCCCEEEeechHhhccCC
Confidence            99999999999975554433

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=95.78  E-value=0.0085  Score=64.93  Aligned_cols=157  Identities=21%  Similarity=0.302  Sum_probs=90.0

Q ss_pred             HHHHHHHHHhhccccccceeeeeeEeccC-eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHh
Q 040242          397 KEFVAEITSMGRLRHRNLVQLHGWCRKQD-ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE  475 (662)
Q Consensus       397 ~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  475 (662)
                      .+.+....+++.+.|+|+.+.+.+..... ...+|+|++ +-||++.+....      +..          .+++  -  
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~------l~~----------~s~~--~--   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN------LKD----------ESLL--A--   85 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc------cch----------hhhc--c--
Confidence            45567788899999999999988776543 478899999 889999885432      110          0111  0  


Q ss_pred             cCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHH
Q 040242          476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA  555 (662)
Q Consensus       476 ~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ell  555 (662)
                         +++.|-     |++       +++| -++..                 |  |-     ...+|+|||++|.++.|+.
T Consensus        86 ---~~~~~~-----~~~-------~~td-~~~t~-----------------~--~~-----~~~pKsdVwsl~~i~~el~  125 (725)
T KOG1093|consen   86 ---HGVLHL-----NII-------YITD-HFLTK-----------------Y--PS-----PIGPKSDVWSLGFIILELY  125 (725)
T ss_pred             ---ccccee-----hhh-------hccc-ccccc-----------------C--CC-----CCCcchhhhhHHHHHHHHH
Confidence               233332     222       2233 01100                 0  10     0114999999999999999


Q ss_pred             cCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040242          556 CGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRR  624 (662)
Q Consensus       556 tG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  624 (662)
                      -|..-+......      +.+.....    ....|..+      ..+..+..+.++++...|+-..|..||...+
T Consensus       126 L~~~l~~~~~~s------~~l~~i~k----~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  126 LGISLEAELTES------EYLEILLK----YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HhhHHHHHHHHH------HHHHHHHH----hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            987654322111      11111111    11112111      1122345567889999999999999886443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.69  E-value=0.083  Score=56.00  Aligned_cols=144  Identities=13%  Similarity=0.214  Sum_probs=80.3

Q ss_pred             ceeeeeCceEEEEEEeCCC---CcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.|..|-...+|+....+.   +..|++|.......... .-.+|..+++.+...++. ++++++ ..+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~-~~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVF-GNG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEe-CCc---EeehhhcC
Confidence            3455566778888875432   23788998765543222 225788888888665664 455554 333   58999987


Q ss_pred             CCcchh-------c----------cccccc-ccccccHHHHHHHHHH----------------------HHHHHHHhHh-
Q 040242          437 GSLDKL-------L----------FDNDQQ-KKKILNWDQRYKILIG----------------------VAQALLYLHE-  475 (662)
Q Consensus       437 gsL~~~-------l----------~~~~~~-~~~~l~~~~~~~i~~~----------------------ia~~L~yLH~-  475 (662)
                      ..|..-       +          |..... ....--|....+...+                      +.+-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            766421       1          111100 0011123322222211                      1111222211 


Q ss_pred             ----cCCCCEEeCCcCCCceEeCC-CCCeEEeecccccc
Q 040242          476 ----ECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARA  509 (662)
Q Consensus       476 ----~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~  509 (662)
                          ......+|+|+.+.||++++ ++.++++||..+..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11235899999999999975 57899999998864

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.59  E-value=0.047  Score=53.78  Aligned_cols=31  Identities=39%  Similarity=0.506  Sum_probs=22.2

Q ss_pred             CCEEeCCcCCCceEe-CCCCCeEEeecccccc
Q 040242          479 QRVVHRDVKPSNVLI-DADLNPKLGDFGLARA  509 (662)
Q Consensus       479 ~~ivH~Dlkp~NIll-~~~~~~kL~DfGla~~  509 (662)
                      ..++|+|+.+.||++ +.++.++++||..+..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            468999999999999 8899999999987764

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.43  E-value=0.097  Score=54.81  Aligned_cols=106  Identities=19%  Similarity=0.164  Sum_probs=75.7

Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ...|++|++. +++|...         +...|.+...++++.+..+.-+...  -+.-|||+.-.||+++ +|++.|+||
T Consensus       299 ~y~yl~~kdh-gt~is~i---------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         299 LYLYLHFKDH-GTPISII---------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             eEEEEEEecC-Cceeeee---------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEe
Confidence            3567888876 6666543         3467889999999999988888774  6788999999999999 999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTL  550 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvv  550 (662)
                      -++|+--.+...      .-...-.|-.+. |.-+.+-+||-+--.
T Consensus       366 klsRl~~~q~~i------sy~rldhp~lF~-G~dd~QFeIYrlMr~  404 (488)
T COG5072         366 KLSRLSYSQGII------SYNRLDHPDLFN-GVDDYQFEIYRLMRR  404 (488)
T ss_pred             eeeecccCCcee------eccccCchhhhc-CccceeeeHHHHHHH
Confidence            999953222111      111233455555 445778889875443

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.26  E-value=0.15  Score=53.53  Aligned_cols=32  Identities=22%  Similarity=0.186  Sum_probs=28.4

Q ss_pred             CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       478 ~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ..+++|+|+.++|++++.++.+.+.||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            45799999999999999999999999987763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.18  E-value=0.048  Score=58.51  Aligned_cols=82  Identities=15%  Similarity=0.134  Sum_probs=50.1

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeecc------chhhHHHHHHHHHHhhccc--ccccee-eeeeEeccCeeeEE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN------SRQGMKEFVAEITSMGRLR--HRNLVQ-LHGWCRKQDELLLV  430 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~------~~~~~~~f~~Ei~~l~~l~--H~niv~-l~~~~~~~~~~~lV  430 (662)
                      .+.||.|--..||++.+...+..|+||.-...      -+-..++..-|.+.|+...  .|..|+ ++.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            45789999999999998433567999964221      1223445556666666552  454444 4443  33456789


Q ss_pred             EeccCC-CCcchhc
Q 040242          431 YDYVPN-GSLDKLL  443 (662)
Q Consensus       431 ~E~~~~-gsL~~~l  443 (662)
                      ||+++. ..|++.|
T Consensus       112 MEdL~~~~ilR~~L  125 (409)
T PRK12396        112 MEDLSDHTILRTAL  125 (409)
T ss_pred             HHhCcccHHHHHHH
Confidence            999864 2344443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	662
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-53
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-42
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-36
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-35
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-35
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-33
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-23
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		7e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		7e-22
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		9e-22
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		9e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-21
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-21
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-21
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-21
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-21
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-21
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-21
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-21
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-21
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		9e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-20
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-20
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-20
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-20
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-20
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-20
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-20
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-20
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-20
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-18
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-18
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-18
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-18
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-18
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-18
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		5e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		5e-18
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-18
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		8e-18
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		9e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-17
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-17
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-17
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-17
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-17
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-17
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-17
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-17
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-17
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-17
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		4e-17
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-17
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-17
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		5e-17
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		5e-17
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-17
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-17
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-17
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		5e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		5e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		5e-17
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-17
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		6e-17
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		6e-17
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		7e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		7e-17
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-17
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		8e-17
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-17
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-17
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-16
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-16
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-16
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-16
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-16
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-16
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-16
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-16
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-16
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-16
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-16
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-16
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-16
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-16
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-16
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-16
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-16
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-16
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-16
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-16
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-16
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-16
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-16
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-16
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-16
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-16
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-16
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		5e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		5e-16
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-16
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		6e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-16
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-16
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		6e-16
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		6e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		7e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		7e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-16
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		7e-16
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-16
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		7e-16
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		8e-16
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		8e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-16
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		9e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		9e-16
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		9e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		9e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		1e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-15
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-15
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-15
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-15
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-15
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-15
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
1avb_A	226	Arcelin-1 From Phaseolus Vulgaris L Length = 226		2e-15
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-15
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-15
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		3e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-15
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-15
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		4e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		4e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-15
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		4e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-15
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		6e-15
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-15
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-15
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-15
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-14
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		1e-14
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-14
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-14
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-14
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-14
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-14
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		2e-14
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-14
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-14
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-14
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-14
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-14
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-14
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-14
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		4e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-14
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-14
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		4e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		4e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		4e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		4e-14
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		5e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		5e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-14
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-14
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		6e-14
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-14
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-14
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-14
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-14
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		7e-14
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-14
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		8e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-13
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-13
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-13
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-13
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-13
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-13
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-13
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-13
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-13
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-13
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-13
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-13
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-13
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		5e-13
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-13
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-13
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		6e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		6e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		6e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-13
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-13
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		8e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		8e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-13
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-12
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-12
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-12
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-12
1fat_A	252	Phytohemagglutinin-L Length = 252		2e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-12
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-12
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		2e-12
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-12
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-12
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-12
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-12
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-12
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-12
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-12
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-12
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-12
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-12
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-12
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-12
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-12
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-12
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-12
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-12
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-12
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-12
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-12
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-12
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-12
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-12
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-12
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-12
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-12
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-12
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-12
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-12
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-12
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-12
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-12
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		3e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-12
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		3e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		3e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		3e-12
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-12
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-12
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		3e-12
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		4e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-12
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-12
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		4e-12
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-12
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-12
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		4e-12
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		5e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		5e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		6e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		6e-12
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-12
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-12
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-12
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-12
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		6e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		7e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		7e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		8e-12
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-12
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-12
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		8e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-12
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		8e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		9e-12
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		9e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		9e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-11
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		1e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-11
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-11
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-11
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-11
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		3e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-11
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		3e-11
2eig_A	234	Lotus Tetragonolobus Seed Lectin (Isoform) Length =		3e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-11
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-11
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		3e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-11
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		3e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-11
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-11
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-11
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-11
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-11
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		5e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		5e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-11
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		6e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-11
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-11
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		6e-11
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		7e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-11
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		9e-11
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-11
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-10
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		1e-10
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-10
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		1e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-10
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-10
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-10
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-10
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-10
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-10
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-10
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-10
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-10
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-10
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		3e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-10
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-10
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-10
1ioa_A	240	Arcelin-5, A Lectin-Like Defense Protein From Phase		3e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-10
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-10
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-10
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		4e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-10
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-10
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		4e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		4e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-10
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-10
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		5e-10
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		5e-10
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-10
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-10
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		7e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-10
3soa_A	444	Full-Length Human Camkii Length = 444		8e-10
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-10
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		9e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		9e-10
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-09
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		2e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-09
1qmo_E	133	Structure Of Fril, A Legume Lectin That Delays Hema		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-09
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-09
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-09
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-09
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-09
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-09
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-09
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-09
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-09
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-09
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-09
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-09
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-09
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-09
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-09
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-09
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-09
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-09
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		4e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-09
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		5e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-09
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-09
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		5e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		6e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-09
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		6e-09
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-09
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-09
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-09
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-09
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		9e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		9e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-09
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-08
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-08
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-08
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-08
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-08
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-08
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-08
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-08
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		2e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-08
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		3e-08
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-08
2d3p_A	236	Cratylia Floribunda Seed Lectin Crystallized At Bas		3e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-08
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		3e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		3e-08
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		4e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-08
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		4e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		5e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		5e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		5e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		5e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		6e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		7e-08
3u4x_A	236	Crystal Structure Of A Lectin From Camptosema Pedic		7e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		8e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-08
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		8e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-08
1wuv_A	237	Crystal Structure Of Native Canavalia Gladiata Lect		8e-08
2ctv_A	237	High Resolution Crystallographic Studies Of Native		8e-08
1fny_A	237	Legume Lectin Of The Bark Of Robinia Pseudoacacia.		8e-08
2yz4_A	237	The Neutron Structure Of Concanavalin A At 2.2 Angs		8e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-07
1cn1_A	237	Crystal Structure Of Demetallized Concanavalin A. T		2e-07
2cna_A	237	The Covalent And Three-Dimensional Structure Of Con		2e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  205 bits (522), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 115/305 (37%), Positives = 178/305 (58%), Gaps = 7/305 (2%)
Query: 334 EDWEVEYGAC-RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS 392
           ED EV  G   RF   EL  A+  F  KN++G GGFGKVY+G + + G  VA+KR+    
Sbjct: 16  EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEER 74
Query: 393 RQGMK-EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
            QG + +F  E+  +    HRNL++L G+C    E LLVY Y+ NGS+   L +  + + 
Sbjct: 75  XQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 134
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
             L+W +R +I +G A+ L YLH+ CD +++HRDVK +N+L+D +    +GDFGLA+  D
Sbjct: 135 P-LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 193
Query: 512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM--E 569
           +        + GT+G++APE   TGK++  TDVFG+G ++LE+  G+R  +  R A   +
Sbjct: 194 YKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 253
Query: 570 LVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF 628
           ++L+DWV+ L  + ++   +D  L   +  +E E ++ + LLC    P  RP    VV+ 
Sbjct: 254 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 313
Query: 629 LLRDA 633
           L  D 
Sbjct: 314 LEGDG 318

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  203 bits (517), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 114/305 (37%), Positives = 177/305 (58%), Gaps = 7/305 (2%)
Query: 334 EDWEVEYGAC-RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS 392
           ED EV  G   RF   EL  A+  F  KN++G GGFGKVY+G + + G  VA+KR+    
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEER 66
Query: 393 RQGMK-EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
            QG + +F  E+  +    HRNL++L G+C    E LLVY Y+ NGS+   L +  + + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
             L+W +R +I +G A+ L YLH+ CD +++HRDVK +N+L+D +    +GDFGLA+  D
Sbjct: 127 P-LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
Query: 512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM--E 569
           +        + G +G++APE   TGK++  TDVFG+G ++LE+  G+R  +  R A   +
Sbjct: 186 YKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245
Query: 570 LVLVDWVRELHSQGQITRAIDPTLD-YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF 628
           ++L+DWV+ L  + ++   +D  L   +  +E E ++ + LLC    P  RP    VV+ 
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305
Query: 629 LLRDA 633
           L  D 
Sbjct: 306 LEGDG 310

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  171 bits (432), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 167/300 (55%), Gaps = 9/300 (3%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           D +   + V + + R    +L  AT  F  K L+G G FGKVY+GV+   G +VA+KR  
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRT 72
Query: 390 HNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ 449
             S QG++EF  EI ++   RH +LV L G+C +++E++L+Y Y+ NG+L + L+ +D  
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 450 KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA 509
               ++W+QR +I IG A+ L YLH    + ++HRDVK  N+L+D +  PK+ DFG+++ 
Sbjct: 133 TMS-MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 510 YDHNINPQTTHIV-GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
                      +V GTLGY+ PE    G+ T  +DV+ FG ++ EV C R  I  Q    
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPR 247
Query: 569 ELV-LVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           E+V L +W  E H+ GQ+ + +DP L D   P+         + C     + RPS   V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  170 bits (431), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 108/300 (36%), Positives = 167/300 (55%), Gaps = 9/300 (3%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           D +   + V + + R    +L  AT  F  K L+G G FGKVY+GV+   G +VA+KR  
Sbjct: 14  DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRT 72
Query: 390 HNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ 449
             S QG++EF  EI ++   RH +LV L G+C +++E++L+Y Y+ NG+L + L+ +D  
Sbjct: 73  PESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLP 132
Query: 450 KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA 509
               ++W+QR +I IG A+ L YLH    + ++HRDVK  N+L+D +  PK+ DFG+++ 
Sbjct: 133 TMS-MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK 188
Query: 510 YDHNINPQTTHIV-GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
                      +V GTLGY+ PE    G+ T  +DV+ FG ++ EV C R  I  Q    
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI-VQSLPR 247
Query: 569 ELV-LVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           E+V L +W  E H+ GQ+ + +DP L D   P+         + C     + RPS   V+
Sbjct: 248 EMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  148 bits (374), Expect = 9e-36,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 151/296 (51%), Gaps = 20/296 (6%)
Query: 345 FRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAH----NSRQ 394
           F + EL + T  F E+      N +G GGFG VY+G + +T   VA+K++A      + +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEE 72
Query: 395 GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
             ++F  EI  M + +H NLV+L G+    D+L LVY Y+PNGSL   L   D      L
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--L 130
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           +W  R KI  G A  + +LHE      +HRD+K +N+L+D     K+ DFGLARA +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 515 NP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                + IVGT  Y+APE  R G+ T  +D++ FG ++LE+  G   ++  R   +L+L 
Sbjct: 188 QTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   +  I   ID  ++  D    E + ++   C     + RP  ++V Q L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  147 bits (371), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 150/296 (50%), Gaps = 20/296 (6%)
Query: 345 FRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAH----NSRQ 394
           F + EL + T  F E+      N +G GGFG VY+G + +T   VA+K++A      + +
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEE 72
Query: 395 GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
             ++F  EI  M + +H NLV+L G+    D+L LVY Y+PNGSL   L   D      L
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--L 130
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           +W  R KI  G A  + +LHE      +HRD+K +N+L+D     K+ DFGLARA +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 515 NP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                  IVGT  Y+APE  R G+ T  +D++ FG ++LE+  G   ++  R   +L+L 
Sbjct: 188 QTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 245
Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   +  I   ID  ++  D    E + ++   C     + RP  ++V Q L
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  147 bits (370), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 99/296 (33%), Positives = 150/296 (50%), Gaps = 20/296 (6%)
Query: 345 FRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAH----NSRQ 394
           F + EL + T  F E+      N +G GGFG VY+G + +T   VA+K++A      + +
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEE 66
Query: 395 GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
             ++F  EI  M + +H NLV+L G+    D+L LVY Y+PNGSL   L   D      L
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP--L 124
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           +W  R KI  G A  + +LHE      +HRD+K +N+L+D     K+ DFGLARA +   
Sbjct: 125 SWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 515 NP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                  IVGT  Y+APE  R G+ T  +D++ FG ++LE+  G   ++  R   +L+L 
Sbjct: 182 QXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 239
Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   +  I   ID  ++  D    E + ++   C     + RP  ++V Q L
Sbjct: 240 IKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 98/296 (33%), Positives = 145/296 (48%), Gaps = 20/296 (6%)
Query: 345 FRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAH----NSRQ 394
           F + EL + T  F E+      N  G GGFG VY+G + +T   VA+K++A      + +
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEE 63
Query: 395 GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
             ++F  EI    + +H NLV+L G+    D+L LVY Y PNGSL   L   D      L
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP--L 121
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           +W  R KI  G A  + +LHE      +HRD+K +N+L+D     K+ DFGLARA +   
Sbjct: 122 SWHXRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 515 NP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                + IVGT  Y APE  R G+ T  +D++ FG ++LE+  G   ++  R   +L+L 
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLD 236
Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   +  I   ID   +  D    E   ++   C     + RP  ++V Q L
Sbjct: 237 IKEEIEDEEKTIEDYIDKKXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLL 292

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  106 bits (265), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 110/213 (51%), Gaps = 23/213 (10%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHRNLV 415
           + ++G GGFGKVYR      G EVA+K   H+  + + + +  +    +L    +H N++
Sbjct: 12  EEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L G C K+  L LV ++   G L+++L         ++NW       + +A+ + YLH+
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHD 123
Query: 476 ECDQRVVHRDVKPSNVLI-----DADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGY 527
           E    ++HRD+K SN+LI     + DL+    K+ DFGLAR + H     +    G   +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSA--AGAYAW 180
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +APE+ R    +  +DV+ +G L+ E+  G  P
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 119/212 (56%), Gaps = 21/212 (9%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG----LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRN 413
           + ++G+G FG+VY+G++ ++     + VAIK  +  +  +Q + +F+ E   MG+  H N
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHN 107
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L G   K   ++++ +Y+ NG+LDK L + D +   +    Q   +L G+A  + YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVL----QLVGMLRGIAAGMKYL 163
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG----TLGYLA 529
               +   VHRD+   N+L++++L  K+ DFGL+R  +   +P+ T+        + + A
Sbjct: 164 ---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTA 218
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           PE     K T+++DV+ FG +M EV   G RP
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 71/209 (33%), Positives = 113/209 (54%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G+G FG+V  G +   G   L VAIK  +V +  +Q  ++F+ E + MG+  H N+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNI 85
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           + L G   K   +++V +Y+ NGSLD  L  ND Q   I    Q   +L G++  + YL 
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVI----QLVGMLRGISAGMKYLS 141
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + APE 
Sbjct: 142 ---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEA 198
Query: 533 TRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
               K T+++DV+ +G +M EV   G RP
Sbjct: 199 IAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 68/210 (32%), Positives = 116/210 (55%), Gaps = 16/210 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLV 415
           + ++G+G FG+V  G +   G   + VAIK +    + +  ++F++E + MG+  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L G   K   ++++ +++ NGSLD  L  ND Q   I    Q   +L G+A  + YL  
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL-- 151
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVG---TLGYLAPE 531
             D   VHRD+   N+L++++L  K+ DFGL+R   D   +P  T  +G    + + APE
Sbjct: 152 -ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 532 LTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
             +  K T+++DV+ +G +M EV + G RP
Sbjct: 211 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 118/211 (55%), Gaps = 18/211 (8%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLE---VAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G+G FG+V RG + + G +   VAIK +   +  RQ  +EF++E + MG+  H N+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNI 79
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++L G       ++++ +++ NG+LD  L  ND Q   I    Q   +L G+A  + YL 
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI----QLVGMLRGIASGMRYLA 135
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN-INPQTTHIVG---TLGYLAP 530
           E      VHRD+   N+L++++L  K+ DFGL+R  + N  +P  T  +G    + + AP
Sbjct: 136 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAP 192
Query: 531 ELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           E     K T+++D + +G +M EV + G RP
Sbjct: 193 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 125/217 (57%), Gaps = 13/217 (5%)
Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLR 410
           S++  F++   +G+G +  VY+G+  +TG+ VA+K V  +S +G     + EI+ M  L+
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           H N+V+L+     +++L LV++++ N     +D     N  +  + LN  + ++    + 
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLE-LNLVKYFQW--QLL 118
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           Q L + HE    +++HRD+KP N+LI+     KLGDFGLARA+   +N  ++ +V TL Y
Sbjct: 119 QGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 528 LAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
            AP++    +  +TS D++  G ++ E+  G +P+ P
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFP 210

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 69/211 (32%), Positives = 118/211 (55%), Gaps = 18/211 (8%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLE---VAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G+G FG+V RG + + G +   VAIK +   +  RQ  +EF++E + MG+  H N+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++L G       ++++ +++ NG+LD  L  ND Q   I    Q   +L G+A  + YL 
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVI----QLVGMLRGIASGMRYLA 133
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN-INPQTTHIVG---TLGYLAP 530
           E      VHRD+   N+L++++L  K+ DFGL+R  + N  +P  T  +G    + + AP
Sbjct: 134 E---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAP 190
Query: 531 ELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           E     K T+++D + +G +M EV + G RP
Sbjct: 191 EAIAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGLAR  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 80
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 135
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 136 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 237
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 97
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 152
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 153 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 210
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 211 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 254
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 255 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  100 bits (250), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 138/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 107
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYL-- 161
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 162 -SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 220
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 221 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 264
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 265 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  100 bits (249), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V +Y+ NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 99.0 bits (245), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 115/210 (54%), Gaps = 16/210 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLV 415
           + ++G+G FG+V  G +   G   + VAIK +    + +  ++F++E + MG+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L G   K   ++++ +++ NGSLD  L  ND Q   I    Q   +L G+A  + YL  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI----QLVGMLRGIAAGMKYL-- 125
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVG---TLGYLAPE 531
             D   VHR +   N+L++++L  K+ DFGL+R   D   +P  T  +G    + + APE
Sbjct: 126 -ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 532 LTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
             +  K T+++DV+ +G +M EV + G RP
Sbjct: 185 AIQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 105/201 (52%), Gaps = 4/201 (1%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K  +G+G FG V+R     + + V I        + + EF+ E+  M RLRH N+V   G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              +   L +V +Y+  GSL +LL  +  +++  L+  +R  +   VA+ + YLH   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
            +VHRD+K  N+L+D     K+ DFGL+R         +    GT  ++APE+ R   + 
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRDEPSN 217
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
             +DV+ FG ++ E+A  ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V + + NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 80
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V + + NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 135
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 136 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 193
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 194 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 237
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 105/201 (52%), Gaps = 4/201 (1%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K  +G+G FG V+R     + + V I        + + EF+ E+  M RLRH N+V   G
Sbjct: 42  KEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              +   L +V +Y+  GSL +LL  +  +++  L+  +R  +   VA+ + YLH   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ--LDERRRLSMAYDVAKGMNYLHNR-NP 158
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
            +VHR++K  N+L+D     K+ DFGL+R         +    GT  ++APE+ R   + 
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL-SSKSAAGTPEWMAPEVLRDEPSN 217
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
             +DV+ FG ++ E+A  ++P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 115/209 (55%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G+G FG+V  G +   G   + VAIK  +V +  +Q  ++F+ E + MG+  H N+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPNV 106
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V L G   +   +++V +++ NG+LD  L  +D Q   I    Q   +L G+A  + YL 
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVI----QLVGMLRGIAAGMRYL- 161
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPEL 532
              D   VHRD+   N+L++++L  K+ DFGL+R  + +     T   G +   + APE 
Sbjct: 162 --ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEA 219
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
            +  K T+++DV+ +G +M EV + G RP
Sbjct: 220 IQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 137/278 (49%), Gaps = 33/278 (11%)
Query: 361 NLVGSGGFGKVYRG--VIPSTG-LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            +VG+G FG+V  G   +PS   + VAIK  +V +  +Q  ++F+ E + MG+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G   K   +++V + + NGSLD  L  +D Q   I    Q   +L G+A  + YL  
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI----QLVGMLRGIASGMKYLS- 164
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELT 533
             D   VHRD+   N+LI+++L  K+ DFGL+R  + +     T   G   + + +PE  
Sbjct: 165 --DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 534 RTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              K T+++DV+ +G ++ EV + G RP              W  E+ +Q  + +A+D  
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERPY-------------W--EMSNQ-DVIKAVDEG 266
Query: 593 LDYFDPQEAELVL-TLGLLCCDPHPDFRPSTRRVVQFL 629
                P +    L  L L C     + RP   ++V  L
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 96.7 bits (239), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G G FG+V  G +   G   + VAIK  +  +  +Q  ++F++E + MG+  H N+
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNI 92
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           + L G   K   ++++ +Y+ NGSLD  L  ND +   I    Q   +L G+   + YL 
Sbjct: 93  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS 148
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   N+L++++L  K+ DFG++R  + +     T   G   + + APE 
Sbjct: 149 ---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 205
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K T+++DV+ +G +M EV + G RP
Sbjct: 206 IAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 346 RYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEI 403
           R   L + T G +  K  +G+GGFG V R +   TG +VAIK+     S +  + +  EI
Sbjct: 4   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI 63
Query: 404 TSMGRLRHRNLV---QLHGWCRK---QDELLLVYDYVPNGSLDKLL--FDNDQQKKKILN 455
             M +L H N+V   ++    +K    D  LL  +Y   G L K L  F+N    K+   
Sbjct: 64  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE--- 120
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLARAYDH 512
                 +L  ++ AL YLHE    R++HRD+KP N+++      L  K+ D G A+  D 
Sbjct: 121 -GPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
                 T  VGTL YLAPEL    K T + D + FGTL  E   G RP  P
Sbjct: 177 G--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/231 (35%), Positives = 112/231 (48%), Gaps = 22/231 (9%)
Query: 346 RYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEI 403
           R   L + T G +  K  +G+GGFG V R +   TG +VAIK+     S +  + +  EI
Sbjct: 5   RSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEI 64
Query: 404 TSMGRLRHRNLV---QLHGWCRK---QDELLLVYDYVPNGSLDKLL--FDNDQQKKKILN 455
             M +L H N+V   ++    +K    D  LL  +Y   G L K L  F+N    K+   
Sbjct: 65  QIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKE--- 121
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLARAYDH 512
                 +L  ++ AL YLHE    R++HRD+KP N+++      L  K+ D G A+  D 
Sbjct: 122 -GPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
                 T  VGTL YLAPEL    K T + D + FGTL  E   G RP  P
Sbjct: 178 G--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G G FG+V  G +   G   + VAIK  +  +  +Q  ++F++E + MG+  H N+
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           + L G   K   ++++ +Y+ NGSLD  L  ND +   I    Q   +L G+   + YL 
Sbjct: 78  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS 133
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   N+L++++L  K+ DFG++R  + +     T   G   + + APE 
Sbjct: 134 ---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 190
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K T+++DV+ +G +M EV + G RP
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++G G FG+V  G +   G   + VAIK  +  +  +Q  ++F++E + MG+  H N+
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIMGQFDHPNI 71
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           + L G   K   ++++ +Y+ NGSLD  L  ND +   I    Q   +L G+   + YL 
Sbjct: 72  IHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVI----QLVGMLRGIGSGMKYLS 127
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   N+L++++L  K+ DFG++R  + +     T   G   + + APE 
Sbjct: 128 ---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEA 184
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K T+++DV+ +G +M EV + G RP
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 97/201 (48%), Gaps = 11/201 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G GG   VY        ++VAIK +        + +K F  E+ +  +L H+N+V +  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              + D   LV +Y+   +L + +     +    L+ D        +   + + H   D 
Sbjct: 79  VDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAH---DM 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           R+VHRD+KP N+LID++   K+ DFG+A+A       QT H++GT+ Y +PE  +     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
             TD++  G ++ E+  G  P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++GSG  G+V  G +   G   + VAIK  +  +  RQ  ++F++E + MG+  H N+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNI 112
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++L G   +    ++V +Y+ NGSLD  L  +D Q   +    Q   +L GV   + YL 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM----QLVGMLRGVGAGMRYL- 167
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   NVL+D++L  K+ DFGL+R  + + +   T   G   + + APE 
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEA 225
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
                 ++++DV+ FG +M EV A G RP
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 133/281 (47%), Gaps = 26/281 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK---EFVAEITSMG 407
           Y+    FR +  +G G F +VYR      G+ VA+K+V        K   + + EI  + 
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           +L H N+++ +    + +EL +V +    G L +++  + +++K+++     +K  + + 
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLC 146
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
            AL ++H    +RV+HRD+KP+NV I A    KLGD GL R +        + +VGT  Y
Sbjct: 147 SALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 202
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           ++PE          +D++  G L+ E+A  + P    +             L+S  +   
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-----------NLYSLCKKIE 251
Query: 588 AID-PTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRV 625
             D P L  D++  +  +LV     +C +P P+ RP    V
Sbjct: 252 QCDYPPLPSDHYSEELRQLV----NMCINPDPEKRPDVTYV 288

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/209 (33%), Positives = 112/209 (53%), Gaps = 16/209 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTG---LEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + ++GSG  G+V  G +   G   + VAIK  +  +  RQ  ++F++E + MG+  H N+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNI 112
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++L G   +    ++V +Y+ NGSLD  L  +D Q   +    Q   +L GV   + YL 
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIM----QLVGMLRGVGAGMRYL- 167
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPEL 532
              D   VHRD+   NVL+D++L  K+ DFGL+R  + + +   T   G   + + APE 
Sbjct: 168 --SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEA 225
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
                 ++++DV+ FG +M EV A G RP
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 114/227 (50%), Gaps = 18/227 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVA-EITSMGRLRHRN 413
           F+  NL+G G F  VYR     TGLEVAIK +   +  + GM + V  E+    +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+ +    + + LV +   NG +++ L    + + K  + ++    +  +   +LYL
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYL----KNRVKPFSENEARHFMHQIITGMLYL 128
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH--IVGTLGYLAPE 531
           H      ++HRD+  SN+L+  ++N K+ DFGLA        P   H  + GT  Y++PE
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM---PHEKHYTLCGTPNYISPE 182
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP---QRTAMELVLVDW 575
           +         +DV+  G +   +  GR P +    + T  ++VL D+
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   S     +F+ E   M +L H  LVQL+G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKD-KVAIKTIKEGS-MSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV++++ +G L   L    + ++ +   +    + + V + + YL E C   V+
Sbjct: 93  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 145
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 246
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 247 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 134/297 (45%), Gaps = 49/297 (16%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH----- 411
           F E  ++G G FG+V +          AIK++ H + + +   ++E+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 412 --------RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
                   RN V+     +K+  L +  +Y  NG+L  L+   +  +++    D+ +++ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR----DEYWRLF 122
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-------- 515
             + +AL Y+H    Q ++HRD+KP N+ ID   N K+GDFGLA+    +++        
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 516 -----PQTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
                   T  +GT  Y+A E L  TG      D++  G +  E+      I P  T ME
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM------IYPFSTGME 233
Query: 570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            V +  +++L S   ++    P    FD  + ++   +  L  D  P+ RP  R ++
Sbjct: 234 RVNI--LKKLRS---VSIEFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV      +TG +VA+K +     A +  QG  E   EI+ +  LRH ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +   + +DE+++V +Y  N      LFD   Q+ K+   + R +    +  A+ Y H   
Sbjct: 80  YDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHR-- 131
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             ++VHRD+KP N+L+D  LN K+ DFGL+         +T+   G+  Y APE+  +GK
Sbjct: 132 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGK 187
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    DV+  G ++  + C R P + +
Sbjct: 188 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 216

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV      +TG +VA+K +     A +  QG  E   EI+ +  LRH ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +   + +DE+++V +Y  N      LFD   Q+ K+   + R +    +  A+ Y H   
Sbjct: 70  YDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHR-- 121
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             ++VHRD+KP N+L+D  LN K+ DFGL+         +T+   G+  Y APE+  +GK
Sbjct: 122 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGK 177
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    DV+  G ++  + C R P + +
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 206

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV      +TG +VA+K +     A +  QG  E   EI+ +  LRH ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +   + +DE+++V +Y  N      LFD   Q+ K+   + R +    +  A+ Y H   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHR-- 125
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             ++VHRD+KP N+L+D  LN K+ DFGL+         +T+   G+  Y APE+  +GK
Sbjct: 126 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGK 181
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    DV+  G ++  + C R P + +
Sbjct: 182 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 210

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   +    ++F+ E   M +L H  LVQL+G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKD-KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV++++ +G L   L    + ++ +   +    + + V + + YL E C   V+
Sbjct: 71  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 224
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 225 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 109/209 (52%), Gaps = 21/209 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-----AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV      +TG +VA+K +     A +  QG  E   EI+ +  LRH ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +   + +DE+++V +Y  N      LFD   Q+ K+   + R +    +  A+ Y H   
Sbjct: 79  YDVIKSKDEIIMVIEYAGNE-----LFDYIVQRDKMSEQEAR-RFFQQIISAVEYCHR-- 130
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             ++VHRD+KP N+L+D  LN K+ DFGL+         +T+   G+  Y APE+  +GK
Sbjct: 131 -HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI-SGK 186
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    DV+  G ++  + C R P + +
Sbjct: 187 LYAGPEVDVWSCGVILYVMLCRRLPFDDE 215

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 360 KNLVGSGGFGKVYRG----VIPST-GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K  +G G FGKV+      + P+   + VA+K +   +    K+F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDK----------LLFDND-QQKKKILNWDQRYKIL 463
           V+ +G C   D L++V++Y+ +G L+K          +L D   +Q K  L   Q   I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIV 522
             +A  ++YL     Q  VHRD+   N L+ A+L  K+GDFG++R  Y  +      H +
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
             + ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 90.1 bits (222), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   +    ++F+ E   M +L H  LVQL+G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV++++ +G L   L    + ++ +   +    + + V + + YL E C   V+
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 125
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 226
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 129/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   +    ++F+ E   M +L H  LVQL+G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKD-KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV++++ +G L   L    + ++ +   +    + + V + + YL E C   V+
Sbjct: 76  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 128
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 229
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 230 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 89.7 bits (221), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 13/206 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G +G VY+ +   TG  VAIK+V   S   ++E + EI+ M +    ++V+ +G   
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           K  +L +V +Y   GS+  ++    + + K L  D+   IL    + L YLH     R +
Sbjct: 95  KNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  N+L++ + + KL DFG+A      +  +   ++GT  ++APE+ +        
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXM-AKRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 543 DVFGFGTLMLEVACGRRP---IEPQR 565
           D++  G   +E+A G+ P   I P R
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 76/213 (35%), Positives = 114/213 (53%), Gaps = 26/213 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           VG G +G VY+    S G  VA+KR+  ++  +G+    + EI+ +  L H N+V L   
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDN-----DQQKKKILNWDQRYKILIGVAQALLYLHE 475
              +  L LV++++    L K+L +N     D Q K  L     Y++L GVA        
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYL-----YQLLRGVAH------- 134
Query: 476 ECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LT 533
            C Q R++HRD+KP N+LI++D   KL DFGLARA+   +    TH V TL Y AP+ L 
Sbjct: 135 -CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLM 192
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
            + K +TS D++  G +  E+  G +P+ P  T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 86/300 (28%), Positives = 134/300 (44%), Gaps = 51/300 (17%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGR 408
           + + + +    LVG G +G V +     TG  VAIK+   +    M + +A  EI  + +
Sbjct: 21  FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKL-LFDNDQQKKKILNWDQRYKILIGVA 467
           LRH NLV L   C+K+    LV+++V +  LD L LF N       L++    K L  + 
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG------LDYQVVQKYLFQII 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-------AYDHNINPQTTH 520
             + + H      ++HRD+KP N+L+      KL DFG AR        YD         
Sbjct: 135 NGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE------- 184
Query: 521 IVGTLGYLAPEL----TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV----- 571
            V T  Y APEL     + GKA    DV+  G L+ E+  G  P+ P  + ++ +     
Sbjct: 185 -VATRWYRAPELLVGDVKYGKA---VDVWAIGCLVTEMFMG-EPLFPGDSDIDQLYHIMM 239
Query: 572 ----LVDWVRELHSQGQITRAID-PTLDYFDPQE------AELVLTLGLLCCDPHPDFRP 620
               L+   +EL ++  +   +  P +   +P E      +E+V+ L   C    PD RP
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 76/213 (35%), Positives = 114/213 (53%), Gaps = 26/213 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           VG G +G VY+    S G  VA+KR+  ++  +G+    + EI+ +  L H N+V L   
Sbjct: 29  VGEGTYGVVYKAK-DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDN-----DQQKKKILNWDQRYKILIGVAQALLYLHE 475
              +  L LV++++    L K+L +N     D Q K  L     Y++L GVA        
Sbjct: 88  IHSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQIKIYL-----YQLLRGVAH------- 134
Query: 476 ECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LT 533
            C Q R++HRD+KP N+LI++D   KL DFGLARA+   +    TH V TL Y AP+ L 
Sbjct: 135 -CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR-SYTHEVVTLWYRAPDVLM 192
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT 566
            + K +TS D++  G +  E+  G +P+ P  T
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVT 224

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 15/231 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V       TG +VA+K++    +Q  +    E+  M    H N+V ++    
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V +AL YLH   +Q V+
Sbjct: 113 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIATVCLSVLRALSYLH---NQGVI 163
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+ +D   KL DFG        + P+   +VGT  ++APE+       T  
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV---LVDWVRELHSQGQITRA 588
           D++  G +++E+  G  P   EP   AM  +   L   V++LH    + R 
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSVLRG 273

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V  G       +VA+K +   S     EF  E  +M +L H  LV+ +G C 
Sbjct: 16  LGSGQFGVVKLGKWKGQ-YDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           K+  + +V +Y+ NG L   L    +   K L   Q  ++   V + + +L      + +
Sbjct: 74  KEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+D DL  K+ DFG+ R   + ++ Q    VGT   + + APE+    K +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           + +DV+ FG LM EV + G+ P
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP 205

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K    + +VG G FG V +    +   +VAIK++   S +  K F+ E+  + R+ H N+
Sbjct: 9   KEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESER--KAFIVELRQLSRVNHPNI 64
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ----QKKKILNWDQRYKILIGVAQAL 470
           V+L+G C   + + LV +Y   GSL  +L   +          ++W       +  +Q +
Sbjct: 65  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGV 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            YLH    + ++HRD+KP N+L+ A     K+ DFG A     +I    T+  G+  ++A
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMA 172
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
           PE+      +   DVF +G ++ EV   R+P +          + W         +    
Sbjct: 173 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA--------VHNGT 222
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            P L    P+  E ++T    C    P  RPS   +V+ +
Sbjct: 223 RPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 259

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 52/279 (18%)
Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           ++ ++G G +G VY G   S  + +AIK +     +  +    EI     L+H+N+VQ  
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLF-------DNDQQ----KKKILNWDQRYKILIGVA 467
           G   +   + +  + VP GSL  LL        DN+Q      K+IL             
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL------------- 118
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLG 526
           + L YLH   D ++VHRD+K  NVLI+      K+ DFG ++     INP T    GTL 
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQ 174
Query: 527 YLAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRPI----EPQRTAMELVLVDWVRELH 580
           Y+APE+   G      + D++  G  ++E+A G+ P     EPQ    ++ +        
Sbjct: 175 YMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF------- 227
Query: 581 SQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFR 619
                   + P +      EA+  +   L C +P PD R
Sbjct: 228 -------KVHPEIPESMSAEAKAFI---LKCFEPDPDKR 256

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/276 (28%), Positives = 121/276 (43%), Gaps = 52/276 (18%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           ++G G +G VY G   S  + +AIK +     +  +    EI     L+H+N+VQ  G  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 422 RKQDELLLVYDYVPNGSLDKLLF-------DNDQQ----KKKILNWDQRYKILIGVAQAL 470
            +   + +  + VP GSL  LL        DN+Q      K+IL             + L
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQIL-------------EGL 135
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            YLH   D ++VHRD+K  NVLI+      K+ DFG ++     INP T    GTL Y+A
Sbjct: 136 KYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMA 191
Query: 530 PELTRTGKA--TTSTDVFGFGTLMLEVACGRRPI----EPQRTAMELVLVDWVRELHSQG 583
           PE+   G      + D++  G  ++E+A G+ P     EPQ    ++ +           
Sbjct: 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF---------- 241
Query: 584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFR 619
                + P +      EA+  +   L C +P PD R
Sbjct: 242 ----KVHPEIPESMSAEAKAFI---LKCFEPDPDKR 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   +    ++F+ E   M +L H  LVQL+G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKD-KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV +++ +G L   L    + ++ +   +    + + V + + YL E C   V+
Sbjct: 74  EQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 126
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 227
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 228 RLASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/280 (26%), Positives = 125/280 (44%), Gaps = 34/280 (12%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K    + +VG G FG V +    +   +VAIK++   S +  K F+ E+  + R+ H N+
Sbjct: 8   KEIEVEEVVGRGAFGVVCKAKWRAK--DVAIKQIESESER--KAFIVELRQLSRVNHPNI 63
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ----QKKKILNWDQRYKILIGVAQAL 470
           V+L+G C   + + LV +Y   GSL  +L   +          ++W       +  +Q +
Sbjct: 64  VKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGV 115
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            YLH    + ++HRD+KP N+L+ A     K+ DFG A     +I    T+  G+  ++A
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHMTNNKGSAAWMA 171
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
           PE+      +   DVF +G ++ EV   R+P +          + W         +    
Sbjct: 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD--EIGGPAFRIMWA--------VHNGT 221
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            P L    P+  E ++T    C    P  RPS   +V+ +
Sbjct: 222 RPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIM 258

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/282 (24%), Positives = 116/282 (41%), Gaps = 33/282 (11%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
            ++G G FG+  +     TG  + +K +     +  + F+ E+  M  L H N+++  G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             K   L  + +Y+  G+L  ++   D Q      W QR      +A  + YLH      
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIASGMAYLH---SMN 128
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTH------------IVGTLGY 527
           ++HRD+   N L+  + N  + DFGLAR   D    P+               +VG   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +APE+          DVF FG ++ E+  GR   +P      +        L+ +G + R
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDF-----GLNVRGFLDR 242
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                  Y  P        + + CCD  P+ RPS  ++  +L
Sbjct: 243 -------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 133/297 (44%), Gaps = 49/297 (16%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH----- 411
           F E  ++G G FG+V +          AIK++ H + + +   ++E+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 412 --------RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
                   RN V+     +K+  L +  +Y  N +L  L+   +  +++    D+ +++ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR----DEYWRLF 122
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-------- 515
             + +AL Y+H    Q ++HRD+KP N+ ID   N K+GDFGLA+    +++        
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 516 -----PQTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
                   T  +GT  Y+A E L  TG      D++  G +  E+      I P  T ME
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM------IYPFSTGME 233
Query: 570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            V +  +++L S   ++    P    FD  + ++   +  L  D  P+ RP  R ++
Sbjct: 234 RVNI--LKKLRS---VSIEFPPD---FDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 138
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 197
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 99  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 149
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 208
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 97  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 147
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 206
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 92  VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 142
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 201
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 12/209 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +  VY+G    T   VA+K +     +G     + E++ +  L+H N+V LH   
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             +  L LV++Y     LDK L         I+N       L  + + L Y H    Q+V
Sbjct: 70  HTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR---QKV 121
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKATT 540
           +HRD+KP N+LI+     KL DFGLARA           +V TL Y  P+ L  +   +T
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYST 180
Query: 541 STDVFGFGTLMLEVACGRRPIEPQRTAME 569
             D++G G +  E+A G RP+ P  T  E
Sbjct: 181 QIDMWGVGCIFYEMATG-RPLFPGSTVEE 208

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 131
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 135
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 135
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G FG+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 127
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 188 SIKSDVWAFGVLLWEIA 204

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG V+ G   +   +VAIK +   +    ++F+ E   M +L H  LVQL+G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           +Q  + LV++++ +G L   L    + ++ +   +    + + V + + YL E     V+
Sbjct: 73  EQAPICLVFEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVI 125
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L+  +   K+ DFG+ R     ++ Q T   GT   + + +PE+    + +
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTR---FVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +DV+ FG LM EV + G+ P E +                S  ++   I      + P
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENR----------------SNSEVVEDISTGFRLYKP 226
Query: 599 QEAEL-VLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + A   V  +   C    P+ RP+  R+++ L
Sbjct: 227 RLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 134
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 195 IKSDVWAFGVLLWEIA 210

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 108/208 (51%), Gaps = 11/208 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEP 563
              +  +D++  G  ++E+A GR PI P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPP 205

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 135
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G + K L     QK    +  +    +  +A AL Y H    +
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-----QKLSKFDEQRTATYITELANALSYCH---SK 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 142 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 192
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 251
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 214

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 143
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 204 IKSDVWAFGVLLWEIA 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 131
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 192 IKSDVWAFGVLLWEIA 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 214

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 12/211 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V    + S+G  VA+K++    +Q  +    E+  M   +H N+V+++    
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +++  G+L  ++          +N +Q   + + V QAL  LH    Q V+
Sbjct: 219 VGDELWVVMEFLEGGALTDIVTHTR------MNEEQIAAVCLAVLQALSVLHA---QGVI 269
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG        + P+   +VGT  ++APEL          
Sbjct: 270 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEV 328
Query: 543 DVFGFGTLMLEVACGRRPI--EPQRTAMELV 571
           D++  G +++E+  G  P   EP   AM+++
Sbjct: 329 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 123 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 177
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 127
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKF 187
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 188 SIKSDVWAFGVLLWEIA 204

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 86.3 bits (212), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 135
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 196 IKSDVWAFGVLLWEIA 211

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 193 IKSDVWAFGVLLWEIA 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA+K +     +   +++   E+  M  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +       T    G+  Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   ++P  DY DP+  EL++++G
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 299

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 184
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 185 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 239
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 276

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 80/298 (26%), Positives = 132/298 (44%), Gaps = 33/298 (11%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLE-----VAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K  +G G FGKV+     +   E     VA+K +   S    K+F  E   +  L+H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLL--------FDNDQQKKKILNWDQRYKILIGV 466
           V+ +G C + D L++V++Y+ +G L+K L           +      L   Q   I   +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL 525
           A  ++YL     Q  VHRD+   N L+  +L  K+GDFG++R  Y  +      H +  +
Sbjct: 138 AAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
            ++ PE     K TT +DV+  G ++ E+   G++P   Q +  E++      E  +QG+
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVI------ECITQGR 247
Query: 585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
           + +          PQE   V  L L C    P  R + + +   L   A      LDI
Sbjct: 248 VLQRPRTC-----PQE---VYELMLGCWQREPHMRKNIKGIHTLLQNLAKASPVYLDI 297

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G FGK         G +  IK +  +  S +  +E   E+  +  ++H N+VQ    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 421 CRKQDELLLVYDYVPNGSLDK-------LLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
             +   L +V DY   G L K       +LF  DQ    IL+W       + +  AL ++
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ----ILDW------FVQICLALKHV 141
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H   D++++HRD+K  N+ +  D   +LGDFG+AR  +  +       +GT  YL+PE+ 
Sbjct: 142 H---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE-LARACIGTPYYLSPEIC 197
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIE 562
                   +D++  G ++ E+   +   E
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFE 226

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTELCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 190 SIKSDVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 190 SIKSDVWAFGVLLWEIA 206

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 85.5 bits (210), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 190 SIKSDVWAFGVLLWEIA 206

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 12  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 70  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 122
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA++ +     +   +++   E+  M  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +      +     G+  Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDEFCGSPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   ++P  DY DP+  EL++++G
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 299

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA+K +     +   +++   E+  M  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +      +     G   Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   ++P  DY DP+  EL++++G
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 299

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 134
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 135 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 194
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 195 SIKSDVWAFGVLLWEIA 211

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 149
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 150 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQG 204
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
              +  +D++  G  ++E+A GR PI P   A EL L+
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPP-DAKELELM 241

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 190 SIKSDVWAFGVLLWEIA 206

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 16  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 74  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 126
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 183
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 90  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEETSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA+K +     +   +++   E+  M  L H N+
Sbjct: 9   YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  +   K+K    + R K    +  A+ Y H
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEK----EARAKFR-QIVSAVQYCH 123
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +       T    G+  Y APEL +
Sbjct: 124 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQ 178
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 179 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 238
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   ++P  DY DP+  EL++++G
Sbjct: 239 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 292

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 124/273 (45%), Gaps = 33/273 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 23  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 81  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 133
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 190
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
           + +D++ FG LM E+ + G+ P E                  +  +    I   L  + P
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYER----------------FTNSETAEHIAQGLRLYRP 234
Query: 599 QEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLL 630
             A E V T+   C     D RP+ + ++  +L
Sbjct: 235 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 267

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 75  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 184
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 32  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 90  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 142
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T  VG+   + +  PE+    K +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 199
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHD 185
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA++ +     +   +++   E+  M  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +       T    G+  Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   ++P  DY DP+  EL++++G
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVEPLPDYKDPRRTELMVSMG 299

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 153
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 210
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 144
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 145 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 201
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 202 EKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G +G+VY+ +   T   VAIKR+   H         + E++ +  L+HRN+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           ++L         L L+++Y  N  L K +  N     +++     Y+++ GV     + H
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIK-SFLYQLINGVN----FCH 149
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
               +R +HRD+KP N+L+   DA   P  K+GDFGLARA+   I  Q TH + TL Y  
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRP 205
Query: 530 PELTRTGKA-TTSTDVFGFGTLMLEV 554
           PE+    +  +TS D++    +  E+
Sbjct: 206 PEILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHD 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG-WC 421
           +G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G   
Sbjct: 201 IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 256
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL        
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 310
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGKAT 539
           VHRD+   NVL+  D   K+ DFGL +         +T   G L   + APE  R  K +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 364
Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           T +DV+ FG L+ E+ + GR P
Sbjct: 365 TKSDVWSFGILLWEIYSFGRVP 386

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG-WC 421
           +G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G   
Sbjct: 29  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 84
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL        
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 138
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGKAT 539
           VHRD+   NVL+  D   K+ DFGL +         +T   G L   + APE  R  K +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 192
Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           T +DV+ FG L+ E+ + GR P
Sbjct: 193 TKSDVWSFGILLWEIYSFGRVP 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 75  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 126
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 127 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 183
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 184 EKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 102/202 (50%), Gaps = 20/202 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG-WC 421
           +G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G   
Sbjct: 14  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL        
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 123
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGKAT 539
           VHRD+   NVL+  D   K+ DFGL +         +T   G L   + APE  R  K +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREKKFS 177
Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           T +DV+ FG L+ E+ + GR P
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVP 199

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 127
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 128 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKF 187
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 188 SIKSDVWAFGVLLWEIA 204

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/294 (25%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA+K +     +   +++   E+  M  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD+N K+ DFG +  +       T    G+  Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H   ++   + P  DY DP+  EL++++G
Sbjct: 246 KFLILNPSKRGTLEQIMKDRWMNVGHEDDELKPYVAPLPDYKDPRRTELMVSMG 299

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C  +    +V +Y+P G+ LD L   N ++   ++       +   ++ A+ YL +   
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVV----LLYMATQISSAMEYLEK--- 148
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HRD+   N L+  +   K+ DFGL+R    +           + + APE       
Sbjct: 149 KNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTF 208
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 209 SIKSDVWAFGVLLWEIA 225

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 115/222 (51%), Gaps = 12/222 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 141
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 142 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG 196
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWV 576
              +  +D++  G  ++E+A GR PI     +M +  L+D++
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYI 238

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 131
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 132 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 189 EKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 106/207 (51%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV+++V      K   D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEF-VAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 125
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 126 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 181
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 182 LLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G + K L     QK    +  +    +  +A AL Y H    +
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL-----QKLSKFDEQRTATYITELANALSYCH---SK 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMHD 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 125
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 126 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 181
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 182 LLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 110/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 117
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y AP
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAP 173
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 174
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 175 LLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 174
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMHD 185
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 174
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           EK L G+G FG+V+     +   +VA+K +   S   ++ F+AE   M  L+H  LV+LH
Sbjct: 20  EKKL-GAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH 76
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK---KILNWDQRYKILIGVAQALLYLHE 475
               K+  + ++ +++  GSL   L  ++  K+   K++++  +      +A+ + ++ +
Sbjct: 77  AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ 129
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              +  +HRD++ +N+L+ A L  K+ DFGLAR  + N           + + APE    
Sbjct: 130 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 186
Query: 536 GKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
           G  T  +DV+ FG L++E+   GR P                    S  ++ RA++    
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM----------------SNPEVIRALERGYR 230
Query: 595 YFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
              P+   E +  + + C    P+ RP T   +Q +L D
Sbjct: 231 MPRPENCPEELYNIMMRCWKNRPEERP-TFEYIQSVLDD 268

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEF-VAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI-------- 462
           H N+V+L      +++L LV+++V            DQ  KK ++      I        
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV------------DQDLKKFMDASALTGIPLPLIKSY 111
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L  + Q L + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V
Sbjct: 112 LFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEV 167
Query: 523 GTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
            TL Y APE+    K  +T+ D++  G +  E+   R
Sbjct: 168 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 66
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 122
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 123 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 178
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY          +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 73  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 124
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 125 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 181
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 182 EKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           H N+V+L      +++L LV++++   S+D K   D        L   + Y  L  + Q 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY--LFQLLQG 118
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y A
Sbjct: 119 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRA 174
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           PE+    K  +T+ D++  G +  E+   R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 109/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLSF 118
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 174
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           H N+V+L      +++L LV++++   S+D K   D        L   + Y  L  + Q 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSY--LFQLLQG 116
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y A
Sbjct: 117 LAFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRA 172
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           PE+    K  +T+ D++  G +  E+   R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/196 (27%), Positives = 101/196 (51%), Gaps = 7/196 (3%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C ++    ++ +++  G+L   L + ++Q+   +N      +   ++ A+ YL +   +
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQE---VNAVVLLYMATQISSAMEYLEK---K 376
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HR++   N L+  +   K+ DFGL+R    +           + + APE     K +
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 540 TSTDVFGFGTLMLEVA 555
             +DV+ FG L+ E+A
Sbjct: 437 IKSDVWAFGVLLWEIA 452

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 132
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE        
Sbjct: 133 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXHD 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 190 EKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F   + +G+G  G V +     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 77
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L +  +  ++IL      K+ I V + L YL E
Sbjct: 78  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLRE 132
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y+APE  + 
Sbjct: 133 K--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMAPERLQG 187
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEP 563
              +  +D++  G  ++E+A GR PI P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYPIPP 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 123/294 (41%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVAIK +         +++   E+  M  L H N+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L L+ +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFR-QIVSAVQYCH 131
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           +   +R+VHRD+K  N+L+DAD+N K+ DFG +  +   +  +     G   Y APEL +
Sbjct: 132 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDAFCGAPPYAAPELFQ 186
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H + ++   ++P LD  D +  ++++ +G
Sbjct: 247 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMG 300

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 83.6 bits (205), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 132/279 (47%), Gaps = 35/279 (12%)
Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           EK L G+G FG+V+     +   +VA+K +   S   ++ F+AE   M  L+H  LV+LH
Sbjct: 193 EKKL-GAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH 249
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK---KILNWDQRYKILIGVAQALLYLHE 475
               K+  + ++ +++  GSL   L  ++  K+   K++++  +      +A+ + ++ +
Sbjct: 250 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ 302
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              +  +HRD++ +N+L+ A L  K+ DFGLAR  + N           + + APE    
Sbjct: 303 ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF 359
Query: 536 GKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
           G  T  +DV+ FG L++E+   GR P                    S  ++ RA++    
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGM----------------SNPEVIRALERGYR 403
Query: 595 YFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
              P+   E +  + + C    P+ RP T   +Q +L D
Sbjct: 404 MPRPENCPEELYNIMMRCWKNRPEERP-TFEYIQSVLDD 441

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 107/208 (51%), Gaps = 11/208 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  ++ + + E+  +       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L    +  ++IL      K+ I V + L YL E
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLRE 125
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 126 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTRSYMSPERLQG 180
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEP 563
              +  +D++  G  ++E+A GR P  P
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPP 208

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 122
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 153
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 154 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVAIK +         +++   E+  M  L H N+
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L L+ +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EARSKFR-QIVSAVQYCH 128
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           +   +R+VHRD+K  N+L+DAD+N K+ DFG +  +   +  +     G+  Y APEL +
Sbjct: 129 Q---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLDTFCGSPPYAAPELFQ 183
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 184 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 243
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E ++ D W+   H + ++   ++P LD  D +  ++++ +G
Sbjct: 244 RFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRIDIMVGMG 297

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 127
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 128 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 185 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 126
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 127 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 184 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/197 (27%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           K+ +G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 420 WCRKQDELLLVYDYVPNGS-LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            C ++    ++ +++  G+ LD L   N Q+   ++       +   ++ A+ YL +   
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV----LLYMATQISSAMEYLEK--- 336
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +  +HR++   N L+  +   K+ DFGL+R    +           + + APE     K 
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 539 TTSTDVFGFGTLMLEVA 555
           +  +DV+ FG L+ E+A
Sbjct: 397 SIKSDVWAFGVLLWEIA 413

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 20/202 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG-WC 421
           +G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G   
Sbjct: 20  IGKGEFGDVMLG--DYRGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIV 75
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL        
Sbjct: 76  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNF 129
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELTRTGKAT 539
           VHRD+   NVL+  D   K+ DFGL +         +T   G L   + APE  R    +
Sbjct: 130 VHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREAAFS 183
Query: 540 TSTDVFGFGTLMLEV-ACGRRP 560
           T +DV+ FG L+ E+ + GR P
Sbjct: 184 TKSDVWSFGILLWEIYSFGRVP 205

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 23  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 79
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 133
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 222

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 128
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 129 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 186 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 121
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 122 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 179 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 120
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 121 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 178 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 129
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 130 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 187 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 125
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 129
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 186
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     TG   A K +   S + +++++ EI  +    H  +V+L G   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
              +L ++ ++ P G++D ++ + D+     L   Q   +   + +AL +LH    +R++
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLH---SKRII 131
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--LTRTGKATT 540
           HRD+K  NVL+  + + +L DFG++      +  + + I GT  ++APE  +  T K T 
Sbjct: 132 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTP 190
Query: 541 ---STDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVD 574
                D++  G  ++E+A    P   + P R  +++   D
Sbjct: 191 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 230

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 22  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 78
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 132
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 221

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           H N+V+L      +++L LV++++   S+D K   D        L   + Y  L  + Q 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY--LFQLLQG 118
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y A
Sbjct: 119 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRA 174
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           PE+    K  +T+ D++  G +  E+   R
Sbjct: 175 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 122
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 78  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 129
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ +FG +    H  + + T + GTL YL PE+       
Sbjct: 130 RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 186
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 187 EKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 13/210 (6%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           H N+V+L      +++L LV++++   S+D K   D        L   + Y  L  + Q 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSY--LFQLLQG 117
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y A
Sbjct: 118 LAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRA 173
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           PE+    K  +T+ D++  G +  E+   R
Sbjct: 174 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ +FG +    H  + + T + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 30  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 86
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 140
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 140
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 140
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 141 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 198 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     TG   A K +   S + +++++ EI  +    H  +V+L G   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
              +L ++ ++ P G++D ++ + D+     L   Q   +   + +AL +LH    +R++
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLH---SKRII 139
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--LTRTGKATT 540
           HRD+K  NVL+  + + +L DFG++      +  + + I GT  ++APE  +  T K T 
Sbjct: 140 HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETMKDTP 198
Query: 541 ---STDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVD 574
                D++  G  ++E+A    P   + P R  +++   D
Sbjct: 199 YDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD 238

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 128 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 137
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 153
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 154 RVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMHD 210
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 211 EKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 21  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 29  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 85
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 139
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 228

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 172
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEF-VAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 118
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 119 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 174
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 109/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +++P GSL + L    Q+ K+ ++  +  +    
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL----QKHKERIDHIKLLQYTSQ 125
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 126 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 77  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 128
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHD 185
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 186 EKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 79  YFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 130
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 131 RVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDDLCGTLDYLPPEMIEGRMHD 187
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 188 EKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 130/297 (43%), Gaps = 49/297 (16%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH----- 411
           F E  ++G G FG+V +          AIK++ H + + +   ++E+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYVVR 66
Query: 412 --------RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
                   RN V+     +K+  L +  +Y  N +L  L+   +  +++    D+ +++ 
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR----DEYWRLF 122
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-------- 515
             + +AL Y+H    Q ++HR++KP N+ ID   N K+GDFGLA+    +++        
Sbjct: 123 RQILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 516 -----PQTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
                   T  +GT  Y+A E L  TG      D +  G +  E       I P  T  E
Sbjct: 180 LPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX------IYPFSTGXE 233
Query: 570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            V +  +++L S   ++    P    FD  + ++   +  L  D  P+ RP  R ++
Sbjct: 234 RVNI--LKKLRS---VSIEFPPD---FDDNKXKVEKKIIRLLIDHDPNKRPGARTLL 282

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEF-VAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 118
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 174
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 172
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 117
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 118 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 173
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 172
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 119
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 175
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 118
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 119 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 174
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 26  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 225

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 82.4 bits (202), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V  G       +VAIK +   S     EF+ E   M  L H  LVQL+G C 
Sbjct: 17  LGTGQFGVVKYGKWRGQ-YDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           KQ  + ++ +Y+ NG L   L    ++ +      Q  ++   V +A+ YL     ++ +
Sbjct: 75  KQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFL 127
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPELTRTGKAT 539
           HRD+   N L++     K+ DFGL+R   + ++ + T   G+   + +  PE+    K +
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFS 184
Query: 540 TSTDVFGFGTLMLEV-ACGRRPIE 562
           + +D++ FG LM E+ + G+ P E
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 27  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 83
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 137
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 226

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 120
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 121 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 176
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 117
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 118 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 173
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 119
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 175
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 16  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 72
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 73  SEEPIXIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 126
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 187 DVWSFGILLTELTTKGRVP 205

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 102/204 (50%), Gaps = 9/204 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE--FVAEITSMGRLRHRNLVQLHGW 420
           +G+G +G+  +    S G  +  K + + S    ++   V+E+  +  L+H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 421 C--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              R    L +V +Y   G L  ++    ++++  L+ +   +++  +  AL   H   D
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 479 --QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               V+HRD+KP+NV +D   N KLGDFGLAR  +H+ +   T  VGT  Y++PE     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMNRM 191
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                +D++  G L+ E+ C   P
Sbjct: 192 SYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 31  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 87
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 141
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 230

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY     ++   +A+K +  A   + G++ +   E+     LRH N+++L+G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCH---SK 127
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           +V+HRD+KP N+L+ +    K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 128 KVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHD 184
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G+ P E
Sbjct: 185 EKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++     D    D        L   + Y  L  + Q L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSY--LFQLLQGL 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 117 AFCH---SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 172
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 109/209 (52%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGL 116
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 117 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 172
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+ ++  ++  +G+    + EI+ +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 118
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 119 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 174
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+ ++  ++  +G+    + EI+ +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 117
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +    TH V TL Y APE+
Sbjct: 118 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYTHEVVTLWYRAPEI 173
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 16  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 72
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 126
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 215

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 108/207 (52%), Gaps = 11/207 (5%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLRHR 412
           + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           N+V+L      +++L LV++++ +  L K + D        L   + Y  L  + Q L +
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSY--LFQLLQGLAF 119
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
            H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y APE+
Sbjct: 120 CH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAPEI 175
Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGR 558
               K  +T+ D++  G +  E+   R
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 82.0 bits (201), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 19  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 75
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 76  SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 129
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 190 DVWSFGILLTELTTKGRVP 208

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/281 (23%), Positives = 127/281 (45%), Gaps = 37/281 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-------MKEFVAEITSMGRLRHRNLV 415
           +G GGFG V++G +      VAIK +     +G        +EF  E+  M  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L+G         +V ++VP G L   L D    K   + W  + ++++ +A  + Y+  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 476 ECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           + +  +VHRD++  N+ +     +A +  K+ DFGL++   H++    + ++G   ++AP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLLGNFQWMAP 195
Query: 531 ELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           E     +   T   D + F  ++  +  G  P + + +  ++  ++ +RE          
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMIRE--------EG 246
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + PT+    P     V+    LC    P  RP    +V+ L
Sbjct: 247 LRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 136/283 (48%), Gaps = 34/283 (12%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +   L+  Q   IL  + + L YLH 
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHS 142
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+      KL DFG+A +  D  I   T   VGT  ++APE+ +
Sbjct: 143 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 197
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G    EP  + +  + V ++        I +   PTL+
Sbjct: 198 QSAYDSKADIWSLGITAIELARG----EPPHSELHPMKVLFL--------IPKNNPPTLE 245
Query: 595 --YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDA 633
             Y  P + E V      C +  P FRP+ + ++  +F+LR+A
Sbjct: 246 GNYSKPLK-EFVEA----CLNKEPSFRPTAKELLKHKFILRNA 283

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 96/198 (48%), Gaps = 10/198 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G V       +G +VA+K +    +Q  +    E+  M   +H N+V+++    
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             +EL ++ +++  G+L       D   +  LN +Q   +   V QAL YLH    Q V+
Sbjct: 113 VGEELWVLMEFLQGGAL------TDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVI 163
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  ++L+  D   KL DFG       ++ P+   +VGT  ++APE+       T  
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKXLVGTPYWMAPEVISRSLYATEV 222
Query: 543 DVFGFGTLMLEVACGRRP 560
           D++  G +++E+  G  P
Sbjct: 223 DIWSLGIMVIEMVDGEPP 240

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +      + G++ +   E+     LRH N+++L+G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCH---SK 131
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ ++   K+ DFG +    H  + + T + GTL YL PE+       
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHD 188
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G  P E
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 15  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 71
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 72  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 125
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 186 DVWSFGILLTELTTKGRVP 204

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 106/209 (50%), Gaps = 11/209 (5%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGM-KEFVAEITSMGRLR 410
           + + F++   +G G +G VY+     TG  VA+K++  ++  +G+    + EI+ +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N+V+L      +++L LV++++      K   D        L   + Y  L  + Q L
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSY--LFQLLQGL 119
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            + H     RV+HRD+KP N+LI+ +   KL DFGLARA+   +     H V TL Y AP
Sbjct: 120 AFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-TYXHEVVTLWYRAP 175
Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGR 558
           E+    K  +T+ D++  G +  E+   R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 13/198 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G VY+    + G   A+K++      +G+    + EI+ +  L+H N+V+L+  
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
              +  L+LV++++ +  L KLL   +   + +       ++L G+A    Y H   D+R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCH---DRR 120
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           V+HRD+KP N+LI+ +   K+ DFGLARA+   +  + TH V TL Y AP+ L  + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 540 TSTDVFGFGTLMLEVACG 557
           T+ D++  G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 109/198 (55%), Gaps = 13/198 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G VY+    + G   A+K++      +G+    + EI+ +  L+H N+V+L+  
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
              +  L+LV++++ +  L KLL   +   + +       ++L G+A    Y H   D+R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCH---DRR 120
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           V+HRD+KP N+LI+ +   K+ DFGLARA+   +  + TH V TL Y AP+ L  + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVLMGSKKYS 179
Query: 540 TSTDVFGFGTLMLEVACG 557
           T+ D++  G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 329 GDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK-- 386
           G D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K  
Sbjct: 1   GSDSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKML 43
Query: 387 RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
            V   + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   
Sbjct: 44  NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHII 102
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
           + + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGL
Sbjct: 103 ETKFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL 155
Query: 507 ARAYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
           A      + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 156 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVIEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 109/216 (50%), Gaps = 30/216 (13%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 122
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HRD+   N+L++ +   K+GDFGL +     + PQ        
Sbjct: 123 ICKGMEYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTK-----VLPQDKEFFKVK 174
Query: 525 ------LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
                 + + APE     K + ++DV+ FG ++ E+
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 17  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 74  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 127
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 188 DVWSFGILLTELTTKGRVP 206

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 192 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 249 SEEPIYIVGEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 302
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 363 DVWSFGILLTELTTKGRVP 381

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVCEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL          L+  Q   IL  + + L YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+      KL DFG+A +  D  I   T   VGT  ++APE+ +
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIK 177
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G    EP  + +  + V ++        I +   PTL+
Sbjct: 178 QSAYDSKADIWSLGITAIELARG----EPPHSELHPMKVLFL--------IPKNNPPTLE 225
Query: 595 --YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDAS 634
             Y  P + E V      C +  P FRP+ + ++  +F+LR+A 
Sbjct: 226 GNYSKPLK-EFVEA----CLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 275 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 385
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 446 DVWSFGILLTELTTKGRVP 464

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 329 GDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK-- 386
           G D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K  
Sbjct: 1   GSDSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKML 43
Query: 387 RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
            V   + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   
Sbjct: 44  NVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHII 102
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
           + + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGL
Sbjct: 103 ETKFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGL 155
Query: 507 ARAYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
           A      + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 156 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 213

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 109/198 (55%), Gaps = 13/198 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G VY+    + G   A+K++      +G+    + EI+ +  L+H N+V+L+  
Sbjct: 10  IGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
              +  L+LV++++ +  L KLL   +   + +       ++L G+A    Y H   D+R
Sbjct: 69  IHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA----YCH---DRR 120
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
           V+HRD+KP N+LI+ +   K+ DFGLARA+   +  + TH + TL Y AP+ L  + K +
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 540 TSTDVFGFGTLMLEVACG 557
           T+ D++  G +  E+  G
Sbjct: 180 TTIDIWSVGCIFAEMVNG 197

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 107/212 (50%), Gaps = 14/212 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   +   ++ F+ E   M  L+H  LV+L+    
Sbjct: 21  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +++ + ++ +Y+  GSL   L  ++  K    K++++  +      +A+ + Y+     +
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---K 129
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD++ +NVL+   L  K+ DFGLAR  + N           + + APE    G  T
Sbjct: 130 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 189
Query: 540 TSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
             +DV+ FG L+ E+    +   P RT  +++
Sbjct: 190 IKSDVWSFGILLYEIVTYGKIPYPGRTNADVM 221

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/247 (27%), Positives = 106/247 (42%), Gaps = 36/247 (14%)
Query: 30  QANLSLDGTAFVRKDGILAVS------NDQGRILGHAFYPSPLRFKQLSKYNINNNTISH 83
           Q +L   G A V  +  L ++      N QG  +G A Y +P+R  Q S           
Sbjct: 15  QQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLWQSSSL--------- 65
Query: 84  TALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRIL 143
              +F T F FSI             F+     + PS    + LGL   ++NA     ++
Sbjct: 66  -VASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVV 124
Query: 144 AVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPI 203
           +VEFD   N ++ D N  H+GID++S+ S  +    +                 ++G   
Sbjct: 125 SVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDW-----------------QNGKTA 167
Query: 204 QAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHN 263
            A I YNS    ++V  S    P     ++S+ ++L  V   ++ VGFSA+TG  T  +N
Sbjct: 168 TAHISYNSASKRLSVVSS---YPNSSPVVVSFDVELNNVXPXWVRVGFSATTGQYTQTNN 224
Query: 264 VHGWSFK 270
           +  WSF+
Sbjct: 225 ILAWSFR 231

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 105/211 (49%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L  + ++   I       K+L  
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHI-------KLLQY 122
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
            +Q    +     +R +HRD+   N+L++ +   K+GDFGL +    +         G  
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 183 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1AVB|A Chain A, Arcelin-1 From Phaseolus Vulgaris L Length = 226

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/255 (31%), Positives = 122/255 (47%), Gaps = 45/255 (17%)
Query: 22  SFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGR---ILGHAFYPSPLRFKQLSKYNINN 78
           SF    F + NL L G A V  +G L ++N +G     +G AFY +P++        IN+
Sbjct: 5   SFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQ--------IND 56
Query: 79  NTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKF 138
            TI + A +FSTNF F I  K  +   +GLAF L+     P  L  +YLGL N T+N   
Sbjct: 57  RTIDNLA-SFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFN-TTNYDR 113
Query: 139 STRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLK 198
               +AV FD V          N + ID++S+      P A   ++  N   +N      
Sbjct: 114 DAHTVAVVFDTVS---------NRIEIDVNSI-----RPIA---TESCNFGHNN------ 150
Query: 199 SGDPIQAWIDYNSQEMLINVT-ISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL 257
            G+  +  I Y+S +  + V+ + P    K H   +S  + L   +++++ VGFSA++G 
Sbjct: 151 -GEKAEVRITYDSPKNDLRVSLLYPSSEEKCH---VSATVPLEKEVEDWVSVGFSATSGS 206
Query: 258 ---LTAFHNVHGWSF 269
               T  HNV  WSF
Sbjct: 207 KKETTETHNVLSWSF 221

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G V++     T   VA+KRV   +  +G+    + EI  +  L+H+N+V+LH  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL---NWDQRYKILIGVAQALLYLHEEC 477
                +L LV+++             DQ  KK     N D   +I+      LL     C
Sbjct: 70  LHSDKKLTLVFEFC------------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 478 DQR-VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             R V+HRD+KP N+LI+ +   KL DFGLARA+   +   +  +V TL Y  P++    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 537 KA-TTSTDVFGFGTLMLEVACGRRPIEP 563
           K  +TS D++  G +  E+A   RP+ P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAARPLFP 204

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     T +  A K +   S + +++++ EI  +    H N+V+L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ L ++ ++   G++D ++     + ++ L   Q   +      AL YLH   D +++
Sbjct: 105 YENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT-- 540
           HRD+K  N+L   D + KL DFG++      I  + + I GT  ++APE+     +    
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDRP 216
Query: 541 ---STDVFGFGTLMLEVACGRRP---IEPQRTAMEL 570
                DV+  G  ++E+A    P   + P R  +++
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 79
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL---KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYV 133
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 194 DVWSFGILLTELTTKGRVP 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +  + ++GSG    V          +VAIKR+     +  M E + EI +M +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 416 QLHGWCRKQDELLLVYDYVPNGS-LD--KLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
             +     +DEL LV   +  GS LD  K +    + K  +L+      IL  V + L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG----LARAYDHNINPQTTHIVGTLGYL 528
           LH+      +HRDVK  N+L+  D + ++ DFG    LA   D   N      VGT  ++
Sbjct: 137 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193
Query: 529 APELTRTGKATT-STDVFGFGTLMLEVACGRRP 560
           APE+    +      D++ FG   +E+A G  P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M ++RH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKIRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +  + ++GSG    V          +VAIKR+     +  M E + EI +M +  H N+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 416 QLHGWCRKQDELLLVYDYVPNGS-LD--KLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
             +     +DEL LV   +  GS LD  K +    + K  +L+      IL  V + L Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG----LARAYDHNINPQTTHIVGTLGYL 528
           LH+      +HRDVK  N+L+  D + ++ DFG    LA   D   N      VGT  ++
Sbjct: 132 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 529 APELTRTGKATT-STDVFGFGTLMLEVACGRRP 560
           APE+    +      D++ FG   +E+A G  P
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 221

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 23  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 79
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 80  SEEPIYIVTEYMNKGSLLDFL---KGETGKYLRLPQLVDMSAQIASGMAYVER---MNYV 133
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 194 DVWSFGILLTELTTKGRVP 212

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGL--EVAIKRVA-HNSRQGMKEFVAEITSMGRLRHR-NLV 415
           ++++G G FG+V +  I   GL  + AIKR+  + S+   ++F  E+  + +L H  N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL---LY 472
            L G C  +  L L  +Y P+G+L   L     +K ++L  D  + I    A  L     
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFL-----RKSRVLETDPAFAIANSTASTLSSQQL 134
Query: 473 LHEECD----------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           LH   D          ++ +HRD+   N+L+  +   K+ DFGL+R        Q  ++ 
Sbjct: 135 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVK 187
Query: 523 GTLG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
            T+G     ++A E       TT++DV+ +G L+ E+
Sbjct: 188 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 104/216 (48%), Gaps = 16/216 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     T +  A K +   S + +++++ EI  +    H N+V+L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ L ++ ++   G++D ++     + ++ L   Q   +      AL YLH   D +++
Sbjct: 105 YENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT-- 540
           HRD+K  N+L   D + KL DFG++      I  + + I GT  ++APE+     +    
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMCETSKDRP 216
Query: 541 ---STDVFGFGTLMLEVACGRRP---IEPQRTAMEL 570
                DV+  G  ++E+A    P   + P R  +++
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 105/209 (50%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 17  LGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 127
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HR+++ +N+L+   L+ K+ DFGLAR  + N           + + APE    G  T  +
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 216

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 121/262 (46%), Gaps = 43/262 (16%)
Query: 20  TNSFIYNGFI--QANLSLDGTAFVRKDGILAVSN-DQGRI-----LGHAFYPSPLRFKQL 71
           T+SF ++ F   Q NL   G A V   G L ++  D+  +     LG A Y SP+     
Sbjct: 4   TDSFTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPI----- 58
Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
              NI ++     A +F+T+F F+I          GLAF L     PP   A  +LGL  
Sbjct: 59  ---NIWDSKTGVVA-SFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAG-FLGL-F 112
Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           D++    S + +AVEFD  +N    D  D H+GID++S+ S                   
Sbjct: 113 DSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSI-----------------K 155
Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYVG 250
            +   L +G+  +  I Y+S   L+   ++ L  P      I S  +DL +VL E++ +G
Sbjct: 156 TVKWDLANGEAAKVLITYDSSAKLL---VAALVYPSSKTSFILSDVVDLKSVLPEWVSIG 212
Query: 251 FSASTGLLTAF---HNVHGWSF 269
           FSA+TG  + +   H+V  WSF
Sbjct: 213 FSAATGASSGYIETHDVFSWSF 234

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 108/211 (51%), Gaps = 20/211 (9%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H++ + +++F  EI  + 
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 408 RLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L+H N+V+  G C    +  L L+ +Y+P GSL   L    Q+ K+ ++  +  +    
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQ 123
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           + + + YL     +R +HR++   N+L++ +   K+GDFGL +    +         G  
Sbjct: 124 ICKGMEYL---GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 525 -LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + + APE     K + ++DV+ FG ++ E+
Sbjct: 181 PIFWYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 136/283 (48%), Gaps = 34/283 (12%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +   L+  Q   IL  + + L YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHS 137
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+      KL DFG+A +  D  I  +    VGT  ++APE+ +
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIK 192
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G    EP  + +  + V ++        I +   PTL+
Sbjct: 193 QSAYDSKADIWSLGITAIELARG----EPPHSELHPMKVLFL--------IPKNNPPTLE 240
Query: 595 --YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDA 633
             Y  P + E V      C +  P FRP+ + ++  +F+LR+A
Sbjct: 241 GNYSKPLK-EFVEA----CLNKEPSFRPTAKELLKHKFILRNA 278

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 9/204 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE--FVAEITSMGRLRHRNLVQLHGW 420
           +G+G +G+  +    S G  +  K + + S    ++   V+E+  +  L+H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 421 C--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              R    L +V +Y   G L  ++    ++++  L+ +   +++  +  AL   H   D
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 479 --QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               V+HRD+KP+NV +D   N KLGDFGLAR  +H+ +      VGT  Y++PE     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNRM 191
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                +D++  G L+ E+ C   P
Sbjct: 192 SYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 19/252 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHR 412
           F    L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH 
Sbjct: 10  FEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  L    +  D L  V +Y   G L   L      ++++ + D+       +  AL Y
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDY 123
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAP 530
           LH E  + VV+RD+K  N+++D D + K+ DFGL +     I    T     GT  YLAP
Sbjct: 124 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 178
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRA 588
           E+        + D +G G +M E+ CGR P   Q      EL+L++ +R   + G   ++
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 238
Query: 589 IDPTLDYFDPQE 600
           +   L   DP++
Sbjct: 239 LLSGLLKKDPKQ 250

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 19/252 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHR 412
           F    L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH 
Sbjct: 12  FEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  L    +  D L  V +Y   G L   L      ++++ + D+       +  AL Y
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDY 125
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAP 530
           LH E  + VV+RD+K  N+++D D + K+ DFGL +     I    T     GT  YLAP
Sbjct: 126 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 180
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRA 588
           E+        + D +G G +M E+ CGR P   Q      EL+L++ +R   + G   ++
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 240
Query: 589 IDPTLDYFDPQE 600
           +   L   DP++
Sbjct: 241 LLSGLLKKDPKQ 252

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+  +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGL--EVAIKRVA-HNSRQGMKEFVAEITSMGRLRHR-NLV 415
           ++++G G FG+V +  I   GL  + AIKR+  + S+   ++F  E+  + +L H  N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL---LY 472
            L G C  +  L L  +Y P+G+L   L     +K ++L  D  + I    A  L     
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFL-----RKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 473 LHEECD----------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           LH   D          ++ +HRD+   N+L+  +   K+ DFGL+R        Q  ++ 
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-------QEVYVK 197
Query: 523 GTLG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
            T+G     ++A E       TT++DV+ +G L+ E+
Sbjct: 198 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 74/252 (29%), Positives = 114/252 (45%), Gaps = 19/252 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHR 412
           F    L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH 
Sbjct: 11  FEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  L    +  D L  V +Y   G L   L      ++++ + D+       +  AL Y
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDY 124
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAP 530
           LH E  + VV+RD+K  N+++D D + K+ DFGL +     I    T     GT  YLAP
Sbjct: 125 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 179
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRA 588
           E+        + D +G G +M E+ CGR P   Q      EL+L++ +R   + G   ++
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKS 239
Query: 589 IDPTLDYFDPQE 600
           +   L   DP++
Sbjct: 240 LLSGLLKKDPKQ 251

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 9/204 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE--FVAEITSMGRLRHRNLVQLHGW 420
           +G+G +G+  +    S G  +  K + + S    ++   V+E+  +  L+H N+V+ +  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 421 C--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              R    L +V +Y   G L  ++    ++++  L+ +   +++  +  AL   H   D
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQ-YLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 479 --QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
               V+HRD+KP+NV +D   N KLGDFGLAR  +H+        VGT  Y++PE     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-EDFAKEFVGTPYYMSPEQMNRM 191
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                +D++  G L+ E+ C   P
Sbjct: 192 SYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  G L   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVMEYMSKGCLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 69/295 (23%), Positives = 124/295 (42%), Gaps = 52/295 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRNL 414
           +R +  +G G F KV       TG EVA+K +         +++   E+  M  L H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEK----EARAKFR-QIVSAVQYCH 131
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           +   + +VHRD+K  N+L+D D+N K+ DFG +  +   +  +     G+  Y APEL +
Sbjct: 132 Q---KYIVHRDLKAENLLLDGDMNIKIADFGFSNEF--TVGNKLDTFCGSPPYAAPELFQ 186
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLK 246
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGL 609
                    R ++E ++ D W+   H + ++    +P  D+ D +  ++++T+G 
Sbjct: 247 KLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPDFNDTKRIDIMVTMGF 301

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.1 bits (196), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/284 (27%), Positives = 135/284 (47%), Gaps = 34/284 (11%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL          L+  Q   IL  + + L YLH 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP------LDETQIATILREILKGLDYLHS 122
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+      KL DFG+A +  D  I  +    VGT  ++APE+ +
Sbjct: 123 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIK 177
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G    EP  + +  + V ++        I +   PTL+
Sbjct: 178 QSAYDSKADIWSLGITAIELARG----EPPHSELHPMKVLFL--------IPKNNPPTLE 225
Query: 595 --YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDAS 634
             Y  P + E V      C +  P FRP+ + ++  +F+LR+A 
Sbjct: 226 GNYSKPLK-EFVEA----CLNKEPSFRPTAKELLKHKFILRNAK 264

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 80/262 (30%), Positives = 121/262 (46%), Gaps = 43/262 (16%)
Query: 20  TNSFIYNGFI--QANLSLDGTAFVRKDGILAVSN-DQGRI-----LGHAFYPSPLRFKQL 71
           T+SF ++ F   Q NL   G A V   G L ++  D+  +     LG A Y SP+     
Sbjct: 4   TDSFTFSKFKPNQPNLKKQGDATVTSSGTLQLTKVDKNGVPDPKSLGRALYASPI----- 58
Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
              NI ++     A +F+T+F F+I          GLAF L     PP   A  +LGL  
Sbjct: 59  ---NIWDSKTGVVA-SFATSFRFTIYAPNIATIADGLAFFLAPVSSPPKAGAG-FLGL-F 112
Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           D++    S + +AVEFD  +N    D  D H+GID++S+ S                   
Sbjct: 113 DSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIGIDVNSIKSI-----------------K 155
Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYVG 250
            +   L +G+  +  I Y+S   L+   ++ L  P      I S  +DL +VL E++ +G
Sbjct: 156 TVKWDLANGEAAKVLITYDSSAKLL---VAALVYPSSKTSFILSDVVDLKSVLPEWVSIG 212
Query: 251 FSASTGLLTAF---HNVHGWSF 269
           FSA+TG  + +   H+V  WSF
Sbjct: 213 FSAATGASSGYIETHDVFSWSF 234

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VAIK +   +    + F+ E   M +L+H  LVQL+    
Sbjct: 17  LGNGQFGEVWMGTW-NGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYA-VV 73
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L D + +  K+ N      +   VA  + Y+        +
Sbjct: 74  SEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPN---LVDMAAQVAAGMAYIER---MNYI 127
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 543 DVFGFGTLMLE-VACGRRP 560
           DV+ FG L+ E V  GR P
Sbjct: 188 DVWSFGILLTELVTKGRVP 206

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-------MKEFVAEITSMGRLRHRNLV 415
           +G GGFG V++G +      VAIK +     +G        +EF  E+  M  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L+G         +V ++VP G L   L D    K   + W  + ++++ +A  + Y+  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 476 ECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           + +  +VHRD++  N+ +     +A +  K+ DF L++   H++    + ++G   ++AP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSV----SGLLGNFQWMAP 195
Query: 531 ELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           E     +   T   D + F  ++  +  G  P + + +  ++  ++ +RE          
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMIRE--------EG 246
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + PT+    P     V+    LC    P  RP    +V+ L
Sbjct: 247 LRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           + +G G FGKV  G    TG +VA+K   R    S   + +   EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +       +  +V +YV  G L    FD   +  ++   + R ++   +  A+ Y H   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCHR-- 129
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
              VVHRD+KP NVL+DA +N K+ DFGL+         +T+   G+  Y APE+  +G+
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI-SGR 185
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    D++  G ++  + CG  P + +
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 26  LGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 82
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  G L   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 83  SEEPIYIVTEYMSKGCLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 136
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +
Sbjct: 137 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 196
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 197 DVWSFGILLTELTTKGRVP 215

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 103/216 (47%), Gaps = 16/216 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FGKVY+     T +  A K +   S + +++++ EI  +    H N+V+L     
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ L ++ ++   G++D ++     + ++ L   Q   +      AL YLH   D +++
Sbjct: 105 YENNLWILIEFCAGGAVDAVML----ELERPLTESQIQVVCKQTLDALNYLH---DNKII 157
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT-- 540
           HRD+K  N+L   D + KL DFG++      I  +   I GT  ++APE+     +    
Sbjct: 158 HRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMCETSKDRP 216
Query: 541 ---STDVFGFGTLMLEVACGRRP---IEPQRTAMEL 570
                DV+  G  ++E+A    P   + P R  +++
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/281 (23%), Positives = 126/281 (44%), Gaps = 37/281 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-------MKEFVAEITSMGRLRHRNLV 415
           +G GGFG V++G +      VAIK +     +G        +EF  E+  M  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L+G         +V ++VP G L   L D    K   + W  + ++++ +A  + Y+  
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLD----KAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 476 ECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           + +  +VHRD++  N+ +     +A +  K+ DFG ++   H++    + ++G   ++AP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSV----SGLLGNFQWMAP 195
Query: 531 ELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           E     +   T   D + F  ++  +  G  P + + +  ++  ++ +RE          
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINMIRE--------EG 246
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           + PT+    P     V+    LC    P  RP    +V+ L
Sbjct: 247 LRPTIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKEL 284

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    
Sbjct: 193 LGQGCFGEVWMGTWNGT-TRVAIKTLKPGN-MSPEAFLQEAQVMKKLRHEKLVQLYA-VV 249
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            ++ + +V +Y+  GSL   L     +  K L   Q   +   +A  + Y+        V
Sbjct: 250 SEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYV 303
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+  +L  K+ DFGL R  + N           + + APE    G+ T  +
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 543 DVFGFGTLMLEVAC-GRRP 560
           DV+ FG L+ E+   GR P
Sbjct: 364 DVWSFGILLTELTTKGRVP 382

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG+V+ G   +   +VA+K +   +   ++ F+ E   M  L+H  LV+L+    
Sbjct: 20  LGAGQFGEVWMGYY-NNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALLYLHEECDQ 479
           K++ + ++ +++  GSL   L  ++  K    K++++  +      +A+ + Y+     +
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQ------IAEGMAYIER---K 128
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
             +HRD++ +NVL+   L  K+ DFGLAR  + N           + + APE    G  T
Sbjct: 129 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT 188
Query: 540 TSTDVFGFGTLMLEVACGRRPIEPQRT 566
             ++V+ FG L+ E+    +   P RT
Sbjct: 189 IKSNVWSFGILLYEIVTYGKIPYPGRT 215

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 15/250 (6%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHR 412
           F    L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH 
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  L    +  D L  V +Y   G L   L      ++++ + D+       +  AL Y
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDY 263
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH E  + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+
Sbjct: 264 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEV 320
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRAID 590
                   + D +G G +M E+ CGR P   Q      EL+L++ +R   + G   +++ 
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL 380
Query: 591 PTLDYFDPQE 600
             L   DP++
Sbjct: 381 SGLLKKDPKQ 390

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   +A+K +      + G++ +   E+     LRH N+++L+G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H    +
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL-----QKLSRFDEQRTATYITELANALSYCH---SK 131
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           RV+HRD+KP N+L+ ++   K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 132 RVIHRDIKPENLLLGSNGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHD 188
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G  P E
Sbjct: 189 EKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 79.3 bits (194), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 113/246 (45%), Gaps = 15/246 (6%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHRNLVQ 416
            L+G G FGKV      +TG   A+K +        K+ VA   +  R+    RH  L  
Sbjct: 157 KLLGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 215
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L    +  D L  V +Y   G L   L      ++++ + D+       +  AL YLH E
Sbjct: 216 LKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHSE 270
Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+    
Sbjct: 271 --KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDN 327
Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRAIDPTLD 594
               + D +G G +M E+ CGR P   Q      EL+L++ +R   + G   +++   L 
Sbjct: 328 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLL 387
Query: 595 YFDPQE 600
             DP++
Sbjct: 388 KKDPKQ 393

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 79.0 bits (193), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 31/233 (13%)
Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V   
Sbjct: 3   DDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNVTAP 45
Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + + +
Sbjct: 46  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFE 104
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
            I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA    
Sbjct: 105 MIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 157
Query: 512 H-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
             + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 158 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 210

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 31/233 (13%)
Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V   
Sbjct: 1   DDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + + +
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFE 102
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
            I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA    
Sbjct: 103 MIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 512 H-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
             + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG---MKEFVAEITSMGRLRH 411
           K F +   +G G FG VY          VAIK+++++ +Q     ++ + E+  + +LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N +Q  G   ++    LV +Y    + D L     +  KK L   +   +  G  Q L 
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLA 129
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           YLH      ++HRDVK  N+L+      KLGDFG A     +I       VGT  ++APE
Sbjct: 130 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPE 181
Query: 532 LTRT---GKATTSTDVFGFGTLMLEVACGRRPI 561
           +      G+     DV+  G   +E+A  + P+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGM-KEFVAEITSMGRLRHRNLVQLHGW 420
           +G G +G V++     T   VA+KRV   +  +G+    + EI  +  L+H+N+V+LH  
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL---NWDQRYKILIGVAQALLYLHEEC 477
                +L LV+++             DQ  KK     N D   +I+      LL     C
Sbjct: 70  LHSDKKLTLVFEFC------------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 478 DQR-VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             R V+HRD+KP N+LI+ +   KL +FGLARA+   +   +  +V TL Y  P++    
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGA 176
Query: 537 KA-TTSTDVFGFGTLMLEVACGRRPIEP 563
           K  +TS D++  G +  E+A   RP+ P
Sbjct: 177 KLYSTSIDMWSAGCIFAELANAGRPLFP 204

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG---MKEFVAEITSMGRLRH 411
           K F +   +G G FG VY          VAIK+++++ +Q     ++ + E+  + +LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N +Q  G   ++    LV +Y    + D L     +  KK L   +   +  G  Q L 
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLA 168
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           YLH      ++HRDVK  N+L+      KLGDFG A     +I       VGT  ++APE
Sbjct: 169 YLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPE 220
Query: 532 LTRT---GKATTSTDVFGFGTLMLEVACGRRPI 561
           +      G+     DV+  G   +E+A  + P+
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY      +   VA+K +  +   ++G++ +   EI     L H N+++L+ 
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +   +  + L+ +Y P G L K L     QK    +  +   I+  +A AL+Y H    +
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL-----QKSCTFDEQRTATIMEELADALMYCH---GK 142
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           +V+HRD+KP N+L+      K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWS---VHAPSLRRKTMCGTLDYLPPEMIEGRMHN 199
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E+  G  P E
Sbjct: 200 EKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 125/270 (46%), Gaps = 45/270 (16%)
Query: 18  AETNSFIYNGF--IQANLSLDGTAFVRKDGILAVSN-DQGRI-----LGHAFYPSPLRFK 69
           AE  SF+++ F  ++ NL L G A V   G+L ++N D   +     LG A Y +P+   
Sbjct: 1   AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDSNGVPEPSSLGRATYSAPI--- 57
Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                NI ++     A +F+T+F F+I          GLAF L      P      +LGL
Sbjct: 58  -----NIWDSATGLVA-SFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGL 110
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
             D++    + + +AVEFD  +N    D    H+G D++S IS+I               
Sbjct: 111 -FDSAVGDTTYQTVAVEFDTYENTVFTDPPYTHIGFDVNS-ISSI--------------- 153
Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPI-DLATVLDEYMY 248
              +   L +G+  +  I YNS   L+   ++ L  P      I   I DL++VL E++ 
Sbjct: 154 -KTVKWSLANGEAAKVLITYNSAVKLL---VASLVYPSSKTSFILADIVDLSSVLPEWVR 209
Query: 249 VGFSASTGLLTAF---HNVHGWSF--KIGG 273
           VGFSA+TG    +   H+V  WSF  K+ G
Sbjct: 210 VGFSAATGASKGYIETHDVFSWSFASKLAG 239

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 25  DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 67
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + 
Sbjct: 68  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIET 126
Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
           + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA 
Sbjct: 127 KFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 179
Query: 509 AYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
                + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 180 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 235

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 112/233 (48%), Gaps = 31/233 (13%)
Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V   
Sbjct: 1   DDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + + +
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIETKFE 102
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
            I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA    
Sbjct: 103 MIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKS 155
Query: 512 H-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
             + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 108/229 (47%), Gaps = 27/229 (11%)
Query: 336 WEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG 395
           WE+E        SE+  +T+       +GSG FG VY+G      + V I +V   + + 
Sbjct: 31  WEIEA-------SEVMLSTR-------IGSGSFGTVYKGKWHGD-VAVKILKVVDPTPEQ 75
Query: 396 MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN 455
            + F  E+  + + RH N++   G+  K D L +V  +    SL K L   + + +    
Sbjct: 76  FQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMF-- 132
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NI 514
             Q   I    AQ + YLH    + ++HRD+K +N+ +   L  K+GDFGLA      + 
Sbjct: 133 --QLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187
Query: 515 NPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRP 560
           + Q     G++ ++APE+ R       +  +DV+ +G ++ E+  G  P
Sbjct: 188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 26  DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 68
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + 
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIET 127
Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
           + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA 
Sbjct: 128 KFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 180
Query: 509 AYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
                + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 181 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 18  DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 60
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + 
Sbjct: 61  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIET 119
Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
           + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA 
Sbjct: 120 KFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 172
Query: 509 AYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
                + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 173 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 228

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGL--EVAIKRVA-HNSRQGMKEFVAEITSMGRLRHR-NLV 415
           ++++G G FG+V +  I   GL  + AIKR+  + S+   ++F  E+  + +L H  N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL---LY 472
            L G C  +  L L  +Y P+G+L   L     +K ++L  D  + I    A  L     
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFL-----RKSRVLETDPAFAIANSTASTLSSQQL 141
Query: 473 LHEECD----------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           LH   D          ++ +HR++   N+L+  +   K+ DFGL+R        Q  ++ 
Sbjct: 142 LHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRG-------QEVYVK 194
Query: 523 GTLG-----YLAPELTRTGKATTSTDVFGFGTLMLEV 554
            T+G     ++A E       TT++DV+ +G L+ E+
Sbjct: 195 KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 21/206 (10%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           ++G G FG+V++    +TGL++A K +     +  +E   EI+ M +L H NL+QL+   
Sbjct: 96  ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAF 155
Query: 422 RKQDELLLVYDYVPNGSLDKLLFD---NDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
             +++++LV +YV  G L   + D   N  +   IL   Q       + + + ++H+   
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ-------ICEGIRHMHQ--- 205
Query: 479 QRVVHRDVKPSNVL-IDADLNP-KLGDFGLARAYDHNINPQTTHIV--GTLGYLAPELTR 534
             ++H D+KP N+L ++ D    K+ DFGLAR Y     P+    V  GT  +LAPE+  
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRY----KPREKLKVNFGTPEFLAPEVVN 261
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               +  TD++  G +   +  G  P
Sbjct: 262 YDFVSFPTDMWSVGVIAYMLLSGLSP 287

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 113/236 (47%), Gaps = 31/236 (13%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 26  DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 68
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L   + 
Sbjct: 69  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHIIET 127
Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
           + + I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA 
Sbjct: 128 KFEMIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLAT 180
Query: 509 AYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
                + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 181 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 236

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL       D   +  ++  Q   +     QAL +LH     +V+
Sbjct: 88  VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD+K  N+L+  D + KL DFG         + ++T +VGT  ++APE+          
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 197
Query: 543 DVFGFGTLMLEVACGRRP 560
           D++  G + +E+  G  P
Sbjct: 198 DIWSLGIMAIEMIEGEPP 215

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 235

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 30  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 89
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 142
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 143 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 199
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 200 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 243

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 235

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL  ++ +        ++  Q   +     QAL +LH     +V+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGTLGYLAPELTRTGKAT 539
           HRD+K  N+L+  D + KL DFG        I P+    + +VGT  ++APE+       
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSEMVGTPYWMAPEVVTRKAYG 194
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
              D++  G + +E+  G  P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 78.2 bits (191), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 83
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 237

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 235

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 18/212 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVA-EITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +   H  ++    +V  E   M RL H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 414 LVQLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQAL 470
            V+L+ +C + DE L     Y  NG L K +       +KI ++D+         +  AL
Sbjct: 99  FVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSAL 150
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYLA 529
            YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y++
Sbjct: 151 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVS 207
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 208 PELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 191
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 235

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 101
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 154
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 155 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 211
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 212 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 255

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/224 (29%), Positives = 108/224 (48%), Gaps = 20/224 (8%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 42  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 101
Query: 413 NLVQLHGWCR----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           N++ ++   R    +Q + + +  ++    L KLL      K + L+ D     L  + +
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL------KTQHLSNDHICYFLYQILR 155
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLG 526
            L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T  
Sbjct: 156 GLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 527 YLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
           Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 255

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 127/281 (45%), Gaps = 30/281 (10%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +    +  Q   +L  + + L YLH 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLL------RAGPFDEFQIATMLKEILKGLDYLHS 138
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   + +HRD+K +NVL+    + KL DFG+A +  D  I   T   VGT  ++APE+ +
Sbjct: 139 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQ 193
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                +  D++  G   +E+A G  P         L L+         G  T++    +D
Sbjct: 194 QSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFID 253
Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV--QFLLRDA 633
                           C +  P FRP+ + ++  +F+++++
Sbjct: 254 ---------------ACLNKDPSFRPTAKELLKHKFIVKNS 279

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 139
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 140 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 196
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 240

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 28  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 87
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 140
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 141 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 197
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 198 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 241

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 19  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 78
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 131
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 132 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 188
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 189 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 232

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 239

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 132
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 133 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 233

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLR 410
           AT  +     +G G +G VY+   P +G  VA+K V   N  +G+    V E+  + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 411 ---HRNLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
              H N+V+L   C      ++ ++ LV+++V +  L   L   D+     L  +    +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           +    + L +LH  C   +VHRD+KP N+L+ +    KL DFGLAR Y + +      +V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALAPVV 172
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
            TL Y APE+       T  D++  G +  E+   R+P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL  ++ +        ++  Q   +     QAL +LH     +V+
Sbjct: 89  VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH---IVGTLGYLAPELTRTGKAT 539
           HRD+K  N+L+  D + KL DFG        I P+ +    +VGT  ++APE+       
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 195
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
              D++  G + +E+  G  P
Sbjct: 196 PKVDIWSLGIMAIEMIEGEPP 216

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 22  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 81
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 134
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 135 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATR 191
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 192 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 235

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 28  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL  ++ +        ++  Q   +     QAL +LH     +V+
Sbjct: 88  VGDELWVVMEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVI 138
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH---IVGTLGYLAPELTRTGKAT 539
           HRD+K  N+L+  D + KL DFG        I P+ +    +VGT  ++APE+       
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFC----AQITPEQSKRSXMVGTPYWMAPEVVTRKAYG 194
Query: 540 TSTDVFGFGTLMLEVACGRRP 560
              D++  G + +E+  G  P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPP 215

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 132/282 (46%), Gaps = 51/282 (18%)
Query: 359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           EK L G+G FG+V+     +   +VA+K +   S   ++ F+AE   M  L+H  LV+LH
Sbjct: 187 EKKL-GAGQFGEVWMATY-NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLH 243
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK---KILNWDQRYKILIGVAQALLYLHE 475
               K+  + ++ +++  GSL   L  ++  K+   K++++  +      +A+ + ++ +
Sbjct: 244 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQ------IAEGMAFIEQ 296
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT---LGYLAPEL 532
              +  +HRD++ +N+L+ A L  K+ DFGLAR             VG    + + APE 
Sbjct: 297 ---RNYIHRDLRAANILVSASLVCKIADFGLAR-------------VGAKFPIKWTAPEA 340
Query: 533 TRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
              G  T  +DV+ FG L++E+   GR P                    S  ++ RA++ 
Sbjct: 341 INFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM----------------SNPEVIRALER 384
Query: 592 TLDYFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
                 P+   E +  + + C    P+ RP T   +Q +L D
Sbjct: 385 GYRMPRPENCPEELYNIMMRCWKNRPEERP-TFEYIQSVLDD 425

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 20  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 79
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 132
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 133 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 189
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 190 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 233

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN------SRQGMKEFVAEITSMGRLRHRNLV 415
            +G GGF K +      T    A K V  +       R+ M     EI+    L H+++V
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 80
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLY 472
             HG+    D + +V +     SL +L     +++K +   + RY   +I++G      Y
Sbjct: 81  GFHGFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----Y 132
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH     RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   + T + GT  Y+APE+
Sbjct: 133 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEV 188
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
                 +   DV+  G +M  +  G+ P E
Sbjct: 189 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 16/207 (7%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           + +G G FGKV  G    TG +VA+K   R    S   + +   EI ++   RH ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +       ++ +V +YV  G L   +  N +     L+  +  ++   +   + Y H   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQILSGVDYCHR-- 134
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
              VVHRD+KP NVL+DA +N K+ DFGL+         + +   G+  Y APE+  +G+
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPEVI-SGR 190
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIE 562
             A    D++  G ++  + CG  P +
Sbjct: 191 LYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 16/209 (7%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           + +G G FGKV  G    TG +VA+K   R    S   + +   EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +       +  +V +YV  G L    FD   +  ++   + R ++   +  A+ Y H   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEAR-RLFQQILSAVDYCHR-- 129
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
              VVHRD+KP NVL+DA +N K+ DFGL+         + +   G+  Y APE+  +G+
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPEVI-SGR 185
Query: 538 --ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             A    D++  G ++  + CG  P + +
Sbjct: 186 LYAGPEVDIWSCGVILYALLCGTLPFDDE 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +        ++   EI+    L H+++V  H
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHE 475
           G+    D + +V +     SL +L     +++K +   + RY   +I++G      YLH 
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----YLHR 139
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
               RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   + T + GT  Y+APE+   
Sbjct: 140 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSK 195
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
              +   DV+  G +M  +  G+ P E
Sbjct: 196 KGHSFEVDVWSIGCIMYTLLVGKPPFE 222

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 138/304 (45%), Gaps = 45/304 (14%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 2   DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 44
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L  ++ 
Sbjct: 45  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASET 103
Query: 449 --QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
             + KK+++      I    A+ + YLH +    ++HRD+K +N+ +  D   K+GDFGL
Sbjct: 104 KFEMKKLID------IARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 154
Query: 507 ARAYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRPIE 562
           A      + + Q   + G++ ++APE+ R   +   +  +DV+ FG ++ E+  G+ P  
Sbjct: 155 ATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 214
Query: 563 PQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
                 +++      E+  +G    ++ P L        + +  L   C     D RPS 
Sbjct: 215 NINNRDQII------EMVGRG----SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 264
Query: 623 RRVV 626
            R++
Sbjct: 265 PRIL 268

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +        ++   EI+    L H+++V  H
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHE 475
           G+    D + +V +     SL +L     +++K +   + RY   +I++G      YLH 
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----YLHR 135
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
               RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   + T + GT  Y+APE+   
Sbjct: 136 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSK 191
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
              +   DV+  G +M  +  G+ P E
Sbjct: 192 KGHSFEVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 106/224 (47%), Gaps = 35/224 (15%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F+E  L+GSGGFG+V++      G    I+RV +N+ +  +    E+ ++ +L H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 417 LHG-WC------RKQDELLLVYDYVPNGSLD------KLLFDNDQ--QKKKILNWDQRYK 461
            +G W          D+ L   DY P  S +      K LF   +   K  +  W ++ +
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 462 -----------ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY 510
                      +   + + + Y+H    ++++HRD+KPSN+ +      K+GDFGL  + 
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            +  + + T   GTL Y++PE   +       D++  G ++ E+
Sbjct: 187 KN--DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 239

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A+ S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 239

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 113/233 (48%), Gaps = 39/233 (16%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA---HNSRQGMKEFVAEITSMGRLR-HRNLVQLH 418
           +G G +G V++ +   TG  VA+K++     NS    + F  EI  +  L  H N+V L 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF-REIMILTELSGHENIVNLL 75
Query: 419 GWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
              R  ++  + LV+DY+    L  ++  N      IL    +  ++  + + + YLH  
Sbjct: 76  NVLRADNDRDVYLVFDYMET-DLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLHSG 128
Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY------DHNI--------------NP 516
               ++HRD+KPSN+L++A+ + K+ DFGL+R++       +NI               P
Sbjct: 129 G---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQP 185
Query: 517 QTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
             T  V T  Y APE L  + K T   D++  G ++ E+ CG +PI P  + M
Sbjct: 186 ILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPIFPGSSTM 237

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KCQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 239

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLR 410
           AT  +     +G G +G VY+   P +G  VA+K V   N  +G+    V E+  + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 411 ---HRNLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
              H N+V+L   C      ++ ++ LV+++V +  L   L   D+     L  +    +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           +    + L +LH  C   +VHRD+KP N+L+ +    KL DFGLAR Y + +      +V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALDPVV 172
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
            TL Y APE+       T  D++  G +  E+   R+P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 141
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/294 (24%), Positives = 117/294 (39%), Gaps = 52/294 (17%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNL 414
           +R    +G G F KV       TG EVA+K +     +   +++   E+     L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +  L LV +Y   G +   L  + + K+K    + R K    +  A+ Y H
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEK----EARAKFR-QIVSAVQYCH 130
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           ++    +VHRD+K  N+L+DAD N K+ DFG +  +      +     G   Y APEL +
Sbjct: 131 QKF---IVHRDLKAENLLLDADXNIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPELFQ 185
Query: 535 TGKAT-TSTDVFGFGTLMLEVACGRRPIEPQ----------------------------- 564
             K      DV+  G ++  +  G  P + Q                             
Sbjct: 186 GKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLK 245
Query: 565 ---------RTAMELVLVD-WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
                    R  +E +  D W    H   ++   ++P  DY DP+  EL ++ G
Sbjct: 246 KFLILNPSKRGTLEQIXKDRWXNVGHEDDELKPYVEPLPDYKDPRRTELXVSXG 299

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 141
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 142 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 126
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 127 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 121/261 (46%), Gaps = 36/261 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGW 420
           +G G FG+V++     TG +VA+K+V   N ++G     + EI  +  L+H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 421 CRKQ--------DELLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           CR +          + LV+D+  +   G L  +L              +  +++  +   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK--------FTLSEIKRVMQMLLNG 137
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLG 526
           L Y+H     +++HRD+K +NVLI  D   KL DFGLARA+    N Q       V TL 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 527 YLAPELTRTGKAT-TSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQ 584
           Y  PEL    +      D++G G +M E+   R PI    T   +L L+  +      G 
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL-----CGS 248
Query: 585 ITRAIDPTLDYFDPQEA-ELV 604
           IT  + P +D ++  E  ELV
Sbjct: 249 ITPEVWPNVDNYELYEKLELV 269

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 122/261 (46%), Gaps = 36/261 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGW 420
           +G G FG+V++     TG +VA+K+V   N ++G     + EI  +  L+H N+V L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 421 CRKQ--------DELLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           CR +          + LV+D+  +   G L  +L      + K        +++  +   
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--------RVMQMLLNG 136
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLG 526
           L Y+H     +++HRD+K +NVLI  D   KL DFGLARA+    N Q       V TL 
Sbjct: 137 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 193
Query: 527 YLAPELTRTGKAT-TSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQ 584
           Y  PEL    +      D++G G +M E+   R PI    T   +L L+  +      G 
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL-----CGS 247
Query: 585 ITRAIDPTLDYFDPQEA-ELV 604
           IT  + P +D ++  E  ELV
Sbjct: 248 ITPEVWPNVDNYELYEKLELV 268

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLR 410
           AT  +     +G G +G VY+   P +G  VA+K V   N  +G+    V E+  + RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 411 ---HRNLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
              H N+V+L   C      ++ ++ LV+++V +  L   L   D+     L  +    +
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETIKDL 117
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           +    + L +LH  C   +VHRD+KP N+L+ +    KL DFGLAR Y + +      +V
Sbjct: 118 MRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALFPVV 172
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
            TL Y APE+       T  D++  G +  E+   R+P+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM-FRRKPL 210

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 122/261 (46%), Gaps = 36/261 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGW 420
           +G G FG+V++     TG +VA+K+V   N ++G     + EI  +  L+H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 421 CRKQ--------DELLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           CR +          + LV+D+  +   G L  +L      + K        +++  +   
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--------RVMQMLLNG 137
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLG 526
           L Y+H     +++HRD+K +NVLI  D   KL DFGLARA+    N Q       V TL 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 527 YLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQ 584
           Y  PEL    +      D++G G +M E+   R PI    T   +L L+  +      G 
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL-----CGS 248
Query: 585 ITRAIDPTLDYFDPQEA-ELV 604
           IT  + P +D ++  E  ELV
Sbjct: 249 ITPEVWPNVDNYELYEKLELV 269

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/304 (25%), Positives = 138/304 (45%), Gaps = 45/304 (14%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 14  DSSDDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 56
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+  K  +L +V  +    SL   L  ++ 
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTK-PQLAIVTQWCEGSSLYHHLHASET 115
Query: 449 --QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
             + KK+++      I    A+ + YLH +    ++HRD+K +N+ +  D   K+GDFGL
Sbjct: 116 KFEMKKLID------IARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 507 ARAYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRPIE 562
           A      + + Q   + G++ ++APE+ R   +   +  +DV+ FG ++ E+  G+ P  
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 563 PQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
                 +++      E+  +G    ++ P L        + +  L   C     D RPS 
Sbjct: 227 NINNRDQII------EMVGRG----SLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 276
Query: 623 RRVV 626
            R++
Sbjct: 277 PRIL 280

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 145
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
            + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 181
Query: 538 ATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
              + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAI++++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 239

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 122/261 (46%), Gaps = 36/261 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGW 420
           +G G FG+V++     TG +VA+K+V   N ++G     + EI  +  L+H N+V L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 421 CRKQDE--------LLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           CR +          + LV+D+  +   G L  +L      + K        +++  +   
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK--------RVMQMLLNG 137
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI---VGTLG 526
           L Y+H     +++HRD+K +NVLI  D   KL DFGLARA+    N Q       V TL 
Sbjct: 138 LYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLW 194
Query: 527 YLAPELTRTGKAT-TSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQ 584
           Y  PEL    +      D++G G +M E+   R PI    T   +L L+  +      G 
Sbjct: 195 YRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPIMQGNTEQHQLALISQL-----CGS 248
Query: 585 ITRAIDPTLDYFDPQEA-ELV 604
           IT  + P +D ++  E  ELV
Sbjct: 249 ITPEVWPNVDNYELYEKLELV 269

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 363 VGSGGFGKVY----RGVIPST-GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV+      ++P    + VA+K +   S    ++F  E   +  L+H+++V+ 
Sbjct: 26  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI----------LNWDQRYKILIGVA 467
            G C +   LL+V++Y+ +G L++ L  +    K +          L   Q   +   VA
Sbjct: 86  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             ++YL        VHRD+   N L+   L  K+GDFG++R  Y  +        +  + 
Sbjct: 146 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 125
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
            + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+     
Sbjct: 126 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 184
Query: 538 ATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
              + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 226

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVA-EITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +   H  ++    +V  E   M RL H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
            V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  AL 
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSALE 123
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYLAP 530
           YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y++P
Sbjct: 124 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 180
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           EL     A  S+D++  G ++ ++  G  P 
Sbjct: 181 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVA-EITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +   H  ++    +V  E   M RL H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
            V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  AL 
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSALE 124
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYLAP 530
           YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y++P
Sbjct: 125 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 181
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           EL     A  S+D++  G ++ ++  G  P 
Sbjct: 182 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 145
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 146 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 147
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 148 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 363 VGSGGFGKVY----RGVIPST-GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV+      ++P    + VA+K +   S    ++F  E   +  L+H+++V+ 
Sbjct: 49  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI----------LNWDQRYKILIGVA 467
            G C +   LL+V++Y+ +G L++ L  +    K +          L   Q   +   VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             ++YL        VHRD+   N L+   L  K+GDFG++R  Y  +        +  + 
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 9/209 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G  G+V+ G   +   +VA+K +   S      F+AE   M +L+H+ LV+L+    
Sbjct: 21  LGAGQAGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYA-VV 77
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
            Q+ + ++ +Y+ NGSL   L      K  I   ++   +   +A+ + ++ E   +  +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIKLTI---NKLLDMAAQIAEGMAFIEE---RNYI 131
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HRD++ +N+L+   L+ K+ DFGLAR  +             + + APE    G  T  +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 543 DVFGFGTLMLEVACGRRPIEPQRTAMELV 571
           DV+ FG L+ E+    R   P  T  E++
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVI 220

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVA-EITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +   H  ++    +V  E   M RL H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
            V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  AL 
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSALE 121
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYLAP 530
           YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y++P
Sbjct: 122 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 178
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           EL     A  S+D++  G ++ ++  G  P 
Sbjct: 179 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 16/211 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVA-EITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +   H  ++    +V  E   M RL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
            V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  AL 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSALE 122
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYLAP 530
           YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y++P
Sbjct: 123 YLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSP 179
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           EL     A  S+D++  G ++ ++  G  P 
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 20/215 (9%)
Query: 363 VGSGGFGKVY----RGVIPST-GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV+      ++P    + VA+K +   S    ++F  E   +  L+H+++V+ 
Sbjct: 20  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI----------LNWDQRYKILIGVA 467
            G C +   LL+V++Y+ +G L++ L  +    K +          L   Q   +   VA
Sbjct: 80  FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             ++YL        VHRD+   N L+   L  K+GDFG++R  Y  +        +  + 
Sbjct: 140 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
           ++ PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTRT 535
            + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  YLAPE+   
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
                + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 31/233 (13%)
Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V   
Sbjct: 1   DDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNVTAP 43
Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + Q ++ F  E+  + + RH N++   G+     +L +V  +    SL   L   + + +
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIETKFE 102
Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
            I   D    I    AQ + YLH +    ++HRD+K +N+ +  DL  K+GDFGLA    
Sbjct: 103 MIKLID----IARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155
Query: 512 H-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRP 560
             + + Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP 208

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 80/264 (30%), Positives = 123/264 (46%), Gaps = 43/264 (16%)
Query: 18  AETNSFIYNGF--IQANLSLDGTAFVRKDGILAVSN-DQGRI-----LGHAFYPSPLRFK 69
           AE  SF+++ F  ++ NL L G A V   G+L ++N D+  +     LG A Y +P+   
Sbjct: 1   AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPI--- 57
Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                NI ++     A +F+T+F F+I          GLAF L      P      +LGL
Sbjct: 58  -----NIWDSATGLVA-SFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGL 110
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
             D++ +  + + +AVEFD  +N    D    H+G D++S IS+I               
Sbjct: 111 -FDSAVSGSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNS-ISSI--------------- 153
Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPI-DLATVLDEYMY 248
              +   L +G+  +  I YNS   L+   ++ L  P      I   I DL++VL E++ 
Sbjct: 154 -KTVKWSLANGEAAKVLITYNSAVKLL---VASLVYPSSKTSFILADIVDLSSVLPEWVR 209
Query: 249 VGFSASTGLLTA---FHNVHGWSF 269
           VGFSA+TG        H+V  WSF
Sbjct: 210 VGFSAATGASGGKIETHDVFSWSF 233

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTRT 535
            + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  YLAPE+   
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
                + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY          +A+K +  +   ++G++ +   EI     LRH N+++++ 
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +   +  + L+ ++ P G L K L     QK    +  +    +  +A AL Y HE   +
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEELADALHYCHE---R 133
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           +V+HRD+KP N+L+      K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 190
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G  P +
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTRT 535
            + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  YLAPE+   
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 179
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
                + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 14/222 (6%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
            + VV+RD+K  N+++D D + K+ DFGL +    +     T   GT  YLAPE+     
Sbjct: 123 SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLAPEVLEDND 181
Query: 538 ATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
              + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 223

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 18/224 (8%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQL 417
            L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  L  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
               +  D L  V +Y   G L   L      ++++   ++       +  AL YLH   
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYGAEIVSALEYLHS-- 128
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTLGYLAPELTRT 535
            + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  YLAPE+   
Sbjct: 129 -RDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPEVLED 184
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVR 577
                + D +G G +M E+ CGR P   Q      EL+L++ +R
Sbjct: 185 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIR 228

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F  V      +T  E AIK +    R  +KE        E   M RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 144
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 145 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAE 402
           R++ +E       FR  +++G+G F +V       T   VAIK +A  + +G +     E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 403 ITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           I  + +++H N+V L         L L+   V  G L    FD   +K      D   ++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS-RL 121
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVL---IDADLNPKLGDFGLARAYDHNINPQTT 519
           +  V  A+ YLH   D  +VHRD+KP N+L   +D D    + DFGL++  D      T 
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
              GT GY+APE+      + + D +  G +   + CG  P   +  A
Sbjct: 179 --CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 361 NLVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-----LRHRN 413
            ++G G FGKV+  + +  S   ++   +V   +   +++ V   T M R     + H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR--TKMERDILVEVNHPF 87
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI-LIGVAQALLY 472
           +V+LH   + + +L L+ D++  G L   L       K+++  ++  K  L  +A AL +
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 141
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAPE 531
           LH      +++RD+KP N+L+D + + KL DFGL++ + DH    +     GT+ Y+APE
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 196
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELVL 572
           +      T S D + FG LM E+  G  P +   ++  M ++L
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 114/237 (48%), Gaps = 20/237 (8%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y     +TG +VA+K +   S    + +   EI  +  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 418 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C +   + + L+ +++P+GSL + L  N    K  +N  Q+ K  + + + + YL  
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG- 143
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH--IVGTLGYLAPELT 533
              ++ VHRD+   NVL++++   K+GDFGL +A + +    T        + + APE  
Sbjct: 144 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 201
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
              K   ++DV+ FG  + E+       +   + M L L   +   H Q  +TR ++
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTY---CDSDSSPMALFL-KMIGPTHGQMTVTRLVN 254

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-GMKEFVAEITSMGRLRHRNLVQLH 418
           K  +GSG FG V+     S+GLE  IK +  +  Q  M++  AEI  +  L H N++++ 
Sbjct: 27  KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIF 86
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
                   + +V +    G L + +  + Q + K L+     +++  +  AL Y H    
Sbjct: 87  EVFEDYHNMYIVMETCEGGELLERIV-SAQARGKALSEGYVAELMKQMMNALAYFH---S 142
Query: 479 QRVVHRDVKPSNVLIDADLNP----KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           Q VVH+D+KP N+L   D +P    K+ DFGLA  +    +  +T+  GT  Y+APE+ +
Sbjct: 143 QHVVHKDLKPENILFQ-DTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAPEVFK 199
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               T   D++  G +M  +  G  P
Sbjct: 200 RD-VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 114/237 (48%), Gaps = 20/237 (8%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y     +TG +VA+K +   S    + +   EI  +  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 418 HGWCRKQ--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C +   + + L+ +++P+GSL + L  N    K  +N  Q+ K  + + + + YL  
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLG- 131
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH--IVGTLGYLAPELT 533
              ++ VHRD+   NVL++++   K+GDFGL +A + +    T        + + APE  
Sbjct: 132 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECL 189
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
              K   ++DV+ FG  + E+       +   + M L L   +   H Q  +TR ++
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLTY---CDSDSSPMALFL-KMIGPTHGQMTVTRLVN 242

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 127/273 (46%), Gaps = 28/273 (10%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F + + +G G FG+VY+G+   T   VAIK +    +   +++   EIT + +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +  G   K  +L ++ +Y+  GS   LL     ++  I        IL  + + L YLH 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYIAT------ILREILKGLDYLHS 134
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTTHIVGTLGYLAPELTR 534
           E   R +HRD+K +NVL+    + KL DFG+A +  D  I  +    VGT  ++APE+ +
Sbjct: 135 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNXFVGTPFWMAPEVIK 189
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                   D++  G   +E+A G    EP  + +  + V ++        I +   PTL 
Sbjct: 190 QSAYDFKADIWSLGITAIELAKG----EPPNSDLHPMRVLFL--------IPKNSPPTL- 236
Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             + Q ++        C +  P FRP+ + +++
Sbjct: 237 --EGQHSKPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMK-EFVAEITSMGRLRHRNLVQLHG 419
           +G G FG VY          +A+K +  +   ++G++ +   EI     LRH N+++++ 
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +   +  + L+ ++ P G L K L     QK    +  +    +  +A AL Y HE   +
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKEL-----QKHGRFDEQRSATFMEELADALHYCHE---R 134
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           +V+HRD+KP N+L+      K+ DFG +    H  + +   + GTL YL PE+       
Sbjct: 135 KVIHRDIKPENLLMGYKGELKIADFGWS---VHAPSLRRRXMCGTLDYLPPEMIEGKTHD 191
Query: 540 TSTDVFGFGTLMLEVACGRRPIE 562
              D++  G L  E   G  P +
Sbjct: 192 EKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 363 VGSGGFGKVYRGV-IPSTGLEVAIKRV-AHNSRQGMK----EFVAEITSMGRLRHRNLVQ 416
           +G G +GKV++   + + G  VA+KRV      +GM       VA +  +    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 LHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
           L   C      ++ +L LV+++V       L    D+  +  +  +    ++  + + L 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y   +    T +V TL Y APE
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPE 189
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +       T  D++  G +  E+   R+P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAE 402
           R++ +E       FR  +++G+G F +V       T   VAIK +A  + +G +     E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 403 ITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           I  + +++H N+V L         L L+   V  G L    FD   +K      D   ++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS-RL 121
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVL---IDADLNPKLGDFGLARAYDHNINPQTT 519
           +  V  A+ YLH   D  +VHRD+KP N+L   +D D    + DFGL++  D      T 
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
              GT GY+APE+      + + D +  G +   + CG  P   +  A
Sbjct: 179 --CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 106/235 (45%), Gaps = 49/235 (20%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRN 413
            +  K+L+G G +G VY     +    VAIK+V          K  + EIT + RL+   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 414 LVQLHGWC-----RKQDELLLVYDYVPNGSLDKL----LFDNDQQKKKILNWDQRYKILI 464
           +++LH         K DEL +V + + +  L KL    +F  +Q  K IL     Y +L+
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTIL-----YNLLL 142
Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA--------------- 509
           G      ++HE     ++HRD+KP+N L++ D + K+ DFGLAR                
Sbjct: 143 GEK----FIHE---SGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEE 195
Query: 510 ---------YDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
                    ++ N+  Q T  V T  Y APEL    +  T S D++  G +  E+
Sbjct: 196 KEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V       
Sbjct: 29  IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             DEL +V +Y+  GSL       D   +  ++  Q   +     QAL +LH     +V+
Sbjct: 89  VGDELWVVMEYLAGGSL------TDVVTETCMDEGQIAAVCRECLQALEFLH---SNQVI 139
Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTST 542
           HR++K  N+L+  D + KL DFG         + ++T +VGT  ++APE+          
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKV 198
Query: 543 DVFGFGTLMLEVACGRRP 560
           D++  G + +E+  G  P
Sbjct: 199 DIWSLGIMAIEMIEGEPP 216

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 24/210 (11%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN------SRQGMKEFVAEITSMGRLRHRNLV 415
            +G GGF K +      T    A K V  +       R+ M     EI+    L H+++V
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS---MEISIHRSLAHQHVV 78
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLY 472
             HG+    D + +V +     SL +L     +++K +   + RY   +I++G      Y
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----Y 130
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH     RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   +   + GT  Y+APE+
Sbjct: 131 LHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEV 186
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
                 +   DV+  G +M  +  G+ P E
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 361 NLVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-----LRHRN 413
            ++G G FGKV+  + +  S   ++   +V   +   +++ V   T M R     + H  
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR--TKMERDILVEVNHPF 88
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLY 472
           +V+LH   + + +L L+ D++  G L   L       K+++  ++  K  +  +A AL +
Sbjct: 89  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 142
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAPE 531
           LH      +++RD+KP N+L+D + + KL DFGL++ + DH    +     GT+ Y+APE
Sbjct: 143 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 197
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELVL 572
           +      T S D + FG LM E+  G  P +   ++  M ++L
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 240

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 363 VGSGGFGKVYRGV-IPSTGLEVAIKRV-AHNSRQGMK----EFVAEITSMGRLRHRNLVQ 416
           +G G +GKV++   + + G  VA+KRV      +GM       VA +  +    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 LHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
           L   C      ++ +L LV+++V       L    D+  +  +  +    ++  + + L 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y   +    T +V TL Y APE
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 189
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +       T  D++  G +  E+   R+P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 21/210 (10%)
Query: 363 VGSGGFGKVYRGV-IPSTGLEVAIKRV-AHNSRQGMK----EFVAEITSMGRLRHRNLVQ 416
           +G G +GKV++   + + G  VA+KRV      +GM       VA +  +    H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 417 LHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
           L   C      ++ +L LV+++V       L    D+  +  +  +    ++  + + L 
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYL----DKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y   +    T +V TL Y APE
Sbjct: 135 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPE 189
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +       T  D++  G +  E+   R+P+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMF-RRKPL 218

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 113/223 (50%), Gaps = 24/223 (10%)
Query: 361 NLVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-----LRHRN 413
            ++G G FGKV+  + +  S   ++   +V   +   +++ V   T M R     + H  
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR--TKMERDILVEVNHPF 87
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI-LIGVAQALLY 472
           +V+LH   + + +L L+ D++  G L   L       K+++  ++  K  L  +A AL +
Sbjct: 88  IVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDH 141
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAPE 531
           LH      +++RD+KP N+L+D + + KL DFGL++ + DH    +     GT+ Y+APE
Sbjct: 142 LHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 196
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELVL 572
           +      T S D + FG LM E+  G  P +   ++  M ++L
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMIL 239

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/304 (25%), Positives = 137/304 (45%), Gaps = 45/304 (14%)
Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RV 388
           D  +DWE+  G            T G R    +GSG FG VY+G       +VA+K   V
Sbjct: 14  DAADDWEIPDGQI----------TVGQR----IGSGSFGTVYKGKWHG---DVAVKMLNV 56
Query: 389 AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ 448
              + Q ++ F  E+  + + RH N++   G+     +L +V  +    SL   L  ++ 
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASET 115
Query: 449 --QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
             + KK+++      I    A+ + YLH +    ++HRD+K +N+ +  D   K+GDFGL
Sbjct: 116 KFEMKKLID------IARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 507 ARAYDH-NINPQTTHIVGTLGYLAPELTRTGKA---TTSTDVFGFGTLMLEVACGRRPIE 562
           A      + + Q   + G++ ++APE+ R   +   +  +DV+ FG ++ E+  G+ P  
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 563 PQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
                 +++      E+  +G ++    P L        + +  L   C     D RPS 
Sbjct: 227 NINNRDQII------EMVGRGSLS----PDLSKVRSNCPKRMKRLMAECLKKKRDERPSF 276
Query: 623 RRVV 626
            R++
Sbjct: 277 PRIL 280

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAE 402
           R++ +E       FR  +++G+G F +V       T   VAIK +A  + +G +     E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENE 66
Query: 403 ITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           I  + +++H N+V L         L L+   V  G L    FD   +K      D   ++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS-RL 121
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVL---IDADLNPKLGDFGLARAYDHNINPQTT 519
           +  V  A+ YLH   D  +VHRD+KP N+L   +D D    + DFGL++  D      T 
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
              GT GY+APE+      + + D +  G +   + CG  P   +  A
Sbjct: 179 --CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+        V T 
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 195
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 239

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 106/213 (49%), Gaps = 23/213 (10%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE------FVAEITSMGRLRHRN 413
           +  +G G FGKV       T  +VA+K +   SRQ +K+         EI+ +  LRH +
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFI---SRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+       ++++V +Y         LFD   +KK+ +  D+  +    +  A+ Y 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYAGGE-----LFDYIVEKKR-MTEDEGRRFFQQIICAIEYC 124
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H     ++VHRD+KP N+L+D +LN K+ DFGL+         +T+   G+  Y APE+ 
Sbjct: 125 HR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVI 179
Query: 534 RTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQ 564
             GK  A    DV+  G ++  +  GR P + +
Sbjct: 180 -NGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDE 211

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  + R RH 
Sbjct: 27  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 86
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 139
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+        V T 
Sbjct: 140 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATR 196
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 197 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 240

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +        ++   EI+    L H+++V  H
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHE 475
           G+    D + +V +     SL +L     +++K +   + RY   +I++G      YLH 
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----YLHR 157
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
               RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   +   + GT  Y+APE+   
Sbjct: 158 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 213
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
              +   DV+  G +M  +  G+ P E
Sbjct: 214 KGHSFEVDVWSIGCIMYTLLVGKPPFE 240

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.9 bits (185), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 106 G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 157
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 218 TSASDVWMFGVCMWEI 233

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 98/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +        ++   EI+    L H+++V  H
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHE 475
           G+    D + +V +     SL +L     +++K +   + RY   +I++G      YLH 
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLEL----HKRRKALTEPEARYYLRQIVLGCQ----YLHR 159
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
               RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   +   + GT  Y+APE+   
Sbjct: 160 ---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPEVLSK 215
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
              +   DV+  G +M  +  G+ P E
Sbjct: 216 KGHSFEVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 75  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 187 TSASDVWMFGVCMWEI 202

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 103/228 (45%), Gaps = 16/228 (7%)
Query: 344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAE 402
           R++ +E       FR  +++G+G F +V       T   VAIK +A  + +G +     E
Sbjct: 9   RWKQAEDIRDIYDFR--DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 66
Query: 403 ITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           I  + +++H N+V L         L L+   V  G L    FD   +K      D   ++
Sbjct: 67  IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL----FDRIVEKGFYTERDAS-RL 121
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVL---IDADLNPKLGDFGLARAYDHNINPQTT 519
           +  V  A+ YLH   D  +VHRD+KP N+L   +D D    + DFGL++  D      T 
Sbjct: 122 IFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA 178
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
              GT GY+APE+      + + D +  G +   + CG  P   +  A
Sbjct: 179 --CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 224

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 103/212 (48%), Gaps = 17/212 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGR-LRHRNLVQL 417
           ++G G FGKV      +  +  A+K +   +   ++  K  ++E   + + ++H  LV L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +  D+L  V DY+  G L    F + Q+++  L    R+     +A AL YLH   
Sbjct: 105 HFSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARF-YAAEIASALGYLH--- 156
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLAPELTRT 535
              +V+RD+KP N+L+D+  +  L DFGL +    NI  N  T+   GT  YLAPE+   
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVLHK 213
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
                + D +  G ++ E+  G  P   + TA
Sbjct: 214 QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA 245

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 20/213 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRH 411
           F+   ++G G F         +T  E AIK +    R  +KE        E   M RL H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQA 469
              V+L+   +  ++L     Y  NG L K +       +KI ++D+         +  A
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI-------RKIGSFDETCTRFYTAEIVSA 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD-HNINPQTTHIVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+     +   +    VGT  Y+
Sbjct: 143 LEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           +PEL     A  S+D++  G ++ ++  G  P 
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  +   RH 
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE 83
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFPGKHYLD 237

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     + VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLE---S 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 81  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 132
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 193 TSASDVWMFGVCMWEI 208

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 80  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 131
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 192 TSASDVWMFGVCMWEI 207

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 111/238 (46%), Gaps = 34/238 (14%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNL 414
           +G G FGKV    Y      TG  VA+K +  +     R G K+   EI  +  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 415 VQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++  G C  Q E  L LV +YVP GSL   L  +     ++L + Q+      + + + Y
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 132
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAP 530
           LH    Q  +HR++   NVL+D D   K+GDFGLA+A             G   + + AP
Sbjct: 133 LH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           E  +  K   ++DV+ FG  + E+   C      P +  +EL+ +       +QGQ+T
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGI-------AQGQMT 239

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 363 VGSGGFGKVYRGVI--PSTGLE---VAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQ 416
           +G   FGKVY+G +  P+ G +   VAIK +   +   ++E F  E     RL+H N+V 
Sbjct: 34  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DNDQQKKKILNWDQRYKILIG 465
           L G   K   L +++ Y  +G L + L            D+D+  K  L       ++  
Sbjct: 94  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGT 524
           +A  + YL       VVH+D+   NVL+   LN K+ D GL R  Y  +      + +  
Sbjct: 154 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 210
Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + ++APE    GK +  +D++ +G ++ EV
Sbjct: 211 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 83  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 195 TSASDVWMFGVCMWEI 210

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 21/210 (10%)
Query: 363 VGSGGFGKVYRGVI--PSTGLE---VAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQ 416
           +G   FGKVY+G +  P+ G +   VAIK +   +   ++E F  E     RL+H N+V 
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLF-----------DNDQQKKKILNWDQRYKILIG 465
           L G   K   L +++ Y  +G L + L            D+D+  K  L       ++  
Sbjct: 77  LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGT 524
           +A  + YL       VVH+D+   NVL+   LN K+ D GL R  Y  +      + +  
Sbjct: 137 IAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP 193
Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + ++APE    GK +  +D++ +G ++ EV
Sbjct: 194 IRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V+R    +TG   A K V        +    EI +M  LRH  LV LH    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             +E++++Y+++  G     LF+    +   ++ D+  + +  V + L ++HE      V
Sbjct: 225 DDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYV 277
Query: 483 HRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
           H D+KP N++     +   KL DFGL    D   + + T   GT  + APE+        
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 335
Query: 541 STDVFGFGTLMLEVACGRRPI 561
            TD++  G L   +  G  P 
Sbjct: 336 YTDMWSVGVLSYILLSGLSPF 356

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V+R    +TG   A K V        +    EI +M  LRH  LV LH    
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
             +E++++Y+++  G     LF+    +   ++ D+  + +  V + L ++HE      V
Sbjct: 119 DDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYV 171
Query: 483 HRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
           H D+KP N++     +   KL DFGL    D   + + T   GT  + APE+        
Sbjct: 172 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGY 229
Query: 541 STDVFGFGTLMLEVACGRRPI 561
            TD++  G L   +  G  P 
Sbjct: 230 YTDMWSVGVLSYILLSGLSPF 250

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 103/237 (43%), Gaps = 31/237 (13%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLV 415
           F     +G GGFG V+           AIKR+   +R+  +E V  E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 416 Q-LHGWCRKQDELLL------VYDYVPNGSLDKLLFDNDQQKKKILNWDQR---YKILIG 465
           +  + W  K     L      VY Y+      K    +    +  +   +R     I + 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT------- 518
           +A+A+ +LH    + ++HRD+KPSN+    D   K+GDFGL  A D +   QT       
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 519 ----THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
               T  VGT  Y++PE       +   D+F  G ++ E+      + P  T ME V
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL------LYPFSTQMERV 234

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 72/238 (30%), Positives = 111/238 (46%), Gaps = 34/238 (14%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNL 414
           +G G FGKV    Y      TG  VA+K +  +     R G K+   EI  +  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 415 VQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++  G C  Q E  L LV +YVP GSL   L  +     ++L + Q+      + + + Y
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 132
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAP 530
           LH    Q  +HR++   NVL+D D   K+GDFGLA+A             G   + + AP
Sbjct: 133 LHA---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           E  +  K   ++DV+ FG  + E+   C      P +  +EL+ +       +QGQ+T
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGI-------AQGQMT 239

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV-----AEI 403
           ++ S  K + + + +G G F  VY+    +T   VAIK++    R   K+ +      EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 404 TSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
             +  L H N++ L      +  + LV+D++    L+ ++ DN      +L        +
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSL----VLTPSHIKAYM 118
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
           +   Q L YLH+     ++HRD+KP+N+L+D +   KL DFGLA+++  + N    H V 
Sbjct: 119 LMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVV 174
Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC 556
           T  Y APEL    +      ++G G  M  V C
Sbjct: 175 TRWYRAPELLFGAR------MYGVGVDMWAVGC 201

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F+E  L+GSGGFG+V++      G    IKRV +N+ +  +    E+ ++ +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 417 LHG-W--------------CRKQDELLLV-YDYVPNGSLDKLLFDNDQQK-KKILNWDQR 459
            +G W               R + + L +  ++   G+L++ +     +K  K+L  +  
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT 519
            +I  GV     Y+H    +++++RD+KPSN+ +      K+GDFGL  +  +  + +  
Sbjct: 129 EQITKGVD----YIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRX 179
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              GTL Y++PE   +       D++  G ++ E+
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLR 410
           AT  +     +G G +G VY+   P +G  VA+K  RV +    G    ++ +  +  LR
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 411 ------HRNLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR 459
                 H N+V+L   C      ++ ++ LV+++V +  L   L   D+     L  +  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL---DKAPPPGLPAETI 122
Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT 519
             ++    + L +LH  C   +VHRD+KP N+L+ +    KL DFGLAR Y + +    T
Sbjct: 123 KDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALT 177
Query: 520 HIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            +V TL Y APE+       T  D++  G +  E+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     + VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLE---S 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 27/232 (11%)
Query: 350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGR 408
           +Y+ +  F+ K+L+G G +G V       TG  VAIK++    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 409 LRHRNLVQLHGWCRKQ-----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
            +H N++ +    R       +E+ ++ + +    L +++        ++L+ D     +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI------STQMLSDDHIQYFI 118
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH----NINPQ-- 517
               +A+  LH      V+HRD+KPSN+LI+++ + K+ DFGLAR  D     N  P   
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 518 ---TTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
               T  V T  Y APE+  T  K + + DV+  G ++ E+   RRPI P R
Sbjct: 176 QSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 111/232 (47%), Gaps = 27/232 (11%)
Query: 350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGR 408
           +Y+ +  F+ K+L+G G +G V       TG  VAIK++    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 409 LRHRNLVQLHGWCRKQ-----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
            +H N++ +    R       +E+ ++ + +    L +++        ++L+ D     +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI------STQMLSDDHIQYFI 118
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH----NINPQ-- 517
               +A+  LH      V+HRD+KPSN+LI+++ + K+ DFGLAR  D     N  P   
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 518 ---TTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
               T  V T  Y APE+  T  K + + DV+  G ++ E+   RRPI P R
Sbjct: 176 QSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     + VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 78  G-VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLE---S 129
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ A    KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 190 TSASDVWMFGVCMWEI 205

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 112/226 (49%), Gaps = 30/226 (13%)
Query: 361 NLVGSGGFGKVY--RGVI-PSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLR 410
            ++G G FGKV+  R V  P +G       L+ A  +V    R  M+  +     +  + 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI-----LADVN 88
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQA 469
           H  +V+LH   + + +L L+ D++  G L   L       K+++  ++  K  +  +A  
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALG 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
           L +LH      +++RD+KP N+L+D + + KL DFGL++ A DH    +     GT+ Y+
Sbjct: 143 LDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH--EKKAYSFCGTVEYM 197
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELVL 572
           APE+      + S D + +G LM E+  G  P +   ++  M L+L
Sbjct: 198 APEVVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLIL 243

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 107/225 (47%), Gaps = 22/225 (9%)
Query: 356 GFREKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHR 412
           G R  NL  +G G +G V         + VAIK+++    Q   +  + EI  +   RH 
Sbjct: 24  GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHE 83
Query: 413 NLVQLHGWCR-----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           N++ ++   R     +  ++ +V D +    L KLL      K + L+ D     L  + 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLL------KTQHLSNDHICYFLYQIL 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR    DH+     T  V T 
Sbjct: 137 RGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATR 193
Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
            Y APE+    K  T S D++  G ++ E+    RPI P +  ++
Sbjct: 194 WYRAPEIMLNSKGYTKSIDIWSVGCILAEM-LSNRPIFPGKHYLD 237

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHGWC 421
           +G G +G V           VAIK+++    Q   +  + EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 422 RKQD-----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           R        ++ +V D +    L KLL      K + L+ D     L  + + L Y+H  
Sbjct: 111 RASTLEAMRDVYIVQDLM-ETDLYKLL------KSQQLSNDHICYFLYQILRGLKYIH-- 161
Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD--HNINPQTTHIVGTLGYLAPELTR 534
               V+HRD+KPSN+LI+   + K+ DFGLAR  D  H+     T  V T  Y APE+  
Sbjct: 162 -SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIML 220
Query: 535 TGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
             K  T S D++  G ++ E+    RPI P
Sbjct: 221 NSKGYTKSIDIWSVGCILAEM-LSNRPIFP 249

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 20/212 (9%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGW 420
           LVG+G +G+VY+G    TG   AIK V   +    +E   EI  + +   HRN+   +G 
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 89
Query: 421 CRKQ------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
             K+      D+L LV ++   GS+  L+ +    K   L  +    I   + + L +LH
Sbjct: 90  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLH 146
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           +    +V+HRD+K  NVL+  +   KL DFG++   D  +  + T  +GT  ++APE+  
Sbjct: 147 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAPEVIA 202
Query: 535 TGKATTST-----DVFGFGTLMLEVACGRRPI 561
             +   +T     D++  G   +E+A G  P+
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 38/283 (13%)
Query: 344 RFRYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEF 399
           ++++ E    TK  FR+  ++G GGFG+V    + +TG   A K++     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR 459
           + E   + ++  R +V L      +D L LV   +  G L   ++   Q           
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--------- 282
Query: 460 YKILIGVAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH 512
                  A+A+ Y  E C        +R+V+RD+KP N+L+D   + ++ D GLA    H
Sbjct: 283 ----FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV---H 335
Query: 513 NINPQTTH-IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
               QT    VGT+GY+APE+ +  + T S D +  G L+ E+  G+ P + ++  ++  
Sbjct: 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP 614
            V+ +        +    +   + F PQ   L     LLC DP
Sbjct: 396 EVERL--------VKEVPEEYSERFSPQARSLCSQ--LLCKDP 428

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     + VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ A    KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 570 TSASDVWMFGVCMWEI 585

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 26/210 (12%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSRQGMK---EFVAEITSMGRL 409
            +   ++GSG FG VY+G+    G    + VAIK +  N   G K   EF+ E   M  +
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASM 74
Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVA 467
            H +LV+L G C     + LV   +P+G L + + ++      + +LNW       + +A
Sbjct: 75  DHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIA 127
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY---DHNINPQTTHIVGT 524
           + ++YL E   +R+VHRD+   NVL+ +  + K+ DFGLAR     +   N     +   
Sbjct: 128 KGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM--P 182
Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + ++A E     K T  +DV+ +G  + E+
Sbjct: 183 IKWMALECIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 38/283 (13%)
Query: 344 RFRYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEF 399
           ++++ E    TK  FR+  ++G GGFG+V    + +TG   A K++     +   G    
Sbjct: 172 QWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA 231
Query: 400 VAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR 459
           + E   + ++  R +V L      +D L LV   +  G L   ++   Q           
Sbjct: 232 LNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAG--------- 282
Query: 460 YKILIGVAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH 512
                  A+A+ Y  E C        +R+V+RD+KP N+L+D   + ++ D GLA    H
Sbjct: 283 ----FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV---H 335
Query: 513 NINPQTTH-IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
               QT    VGT+GY+APE+ +  + T S D +  G L+ E+  G+ P + ++  ++  
Sbjct: 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP 614
            V+ +        +    +   + F PQ   L     LLC DP
Sbjct: 396 EVERL--------VKEVPEEYSERFSPQARSLCSQ--LLCKDP 428

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 112/232 (48%), Gaps = 27/232 (11%)
Query: 350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGR 408
           +Y+ +  F+ K+L+G G +G V       TG  VAIK++    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 409 LRHRNLVQLHGWCRKQ-----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
            +H N++ +    R       +E+ ++ + +    L +++        ++L+ D     +
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVI------STQMLSDDHIQYFI 118
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTT-- 519
               +A+  LH      V+HRD+KPSN+LI+++ + K+ DFGLAR  D +   N + T  
Sbjct: 119 YQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 520 -----HIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
                  V T  Y APE+  T  K + + DV+  G ++ E+   RRPI P R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPIFPGR 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 363 VGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQLH 418
           +G G FG V++G+  S     + VAIK   + +   ++E F+ E  +M +  H ++V+L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G    ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     
Sbjct: 458 G-VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 539 TTSTDVFGFGTLMLEV 554
           T+++DV+ FG  M E+
Sbjct: 570 TSASDVWMFGVCMWEI 585

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 105/212 (49%), Gaps = 30/212 (14%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSRQGMK---EFVAEITSMGRL 409
            +   ++GSG FG VY+G+    G    + VAIK +  N   G K   EF+ E   M  +
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASM 97
Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVA 467
            H +LV+L G C     + LV   +P+G L + + ++      + +LNW       + +A
Sbjct: 98  DHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNW------CVQIA 150
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-----AYDHNINPQTTHIV 522
           + ++YL E   +R+VHRD+   NVL+ +  + K+ DFGLAR       ++N +     I 
Sbjct: 151 KGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI- 206
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               ++A E     K T  +DV+ +G  + E+
Sbjct: 207 ---KWMALECIHYRKFTHQSDVWSYGVTIWEL 235

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 113/241 (46%), Gaps = 19/241 (7%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVA-EITSMGRLR 410
           K +     +G GGF K Y  +      EV   +V   S   +   KE ++ EI     L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           + ++V  HG+    D + +V +     SL +L     +++K +   + RY  +    Q +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL----HKRRKAVTEPEARY-FMRQTIQGV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH   + RV+HRD+K  N+ ++ D++ K+GDFGLA   + +   + T + GT  Y+AP
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAP 211
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E+      +   D++  G ++  +  G+ P E        +   ++R   ++  + R I+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-----TSCLKETYIRIKKNEYSVPRHIN 266
Query: 591 P 591
           P
Sbjct: 267 P 267

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 110/238 (46%), Gaps = 34/238 (14%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNL 414
           +G G FGKV    Y      TG  VA+K +  ++    R G K+   EI  +  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHI 95
Query: 415 VQLHGWCRKQD--ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++  G C       L LV +YVP GSL   L  +     ++L + Q+      + + + Y
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ------ICEGMAY 149
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG--TLGYLAP 530
           LH    Q  +HRD+   NVL+D D   K+GDFGLA+A             G   + + AP
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           E  +  K   ++DV+ FG  + E+   C      P +  +EL+ +       +QGQ+T
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGI-------AQGQMT 256

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-------RQGMKEFVAEITSMGRLRHRNL 414
           ++G G FGKV    +  TG   A+K +  +           M E    I S+ R  H  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPFL 86
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
            QL    +  D L  V ++V  G L   +F + Q+ ++      R+     +  AL++LH
Sbjct: 87  TQLFCCFQTPDRLFFVMEFVNGGDL---MF-HIQKSRRFDEARARF-YAAEIISALMFLH 141
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              D+ +++RD+K  NVL+D + + KL DFG+ +    N    T    GT  Y+APE+ +
Sbjct: 142 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-GVTTATFCGTPDYIAPEILQ 197
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
                 + D +  G L+ E+ CG  P E +
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 73.6 bits (179), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 106/228 (46%), Gaps = 46/228 (20%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ--GMKEFVAEITSMGRLRHRNLVQL 417
           K+L+G G +G VY     +T   VAIK+V          K  + EIT + RL+   +++L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 418 HGWC-----RKQDELLLVYDYVPNGSLDKL----LFDNDQQKKKILNWDQRYKILIGVAQ 468
           +         K DEL +V + + +  L KL    +F  ++  K IL     Y +L+G   
Sbjct: 91  YDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTIL-----YNLLLGEN- 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA------------------- 509
              ++HE     ++HRD+KP+N L++ D + K+ DFGLAR                    
Sbjct: 144 ---FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197
Query: 510 --YDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
             ++ N+  Q T  V T  Y APEL    +  T S D++  G +  E+
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 73.2 bits (178), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 15/212 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F  ++ +G G    VYR     T    A+K +     +  K    EI  + RL H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L        E+ LV + V  G L    FD   +K      D    +   + +A+ YLHE 
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVK-QILEAVAYLHE- 166
Query: 477 CDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
               +VHRD+KP N+L      D   K+ DFGL++  +H +  +T  + GT GY APE+ 
Sbjct: 167 --NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYCAPEIL 222
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQR 565
           R        D++  G +   + CG  P   +R
Sbjct: 223 RGCAYGPEVDMWSVGIITYILLCGFEPFYDER 254

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 33/273 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FGKV       T    A+K +       R  ++    E+  M  L H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL-- 80
Query: 420 WCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           W   QDE  + +V D +  G L   L  N   K++ +        +  +  AL YL    
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL-----FICELVMALDYLQ--- 132
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL--TRT 535
           +QR++HRD+KP N+L+D   +  + DF +A         Q T + GT  Y+APE+  +R 
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRK 190
Query: 536 GKATT-STDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
           G   + + D +  G    E+  GRRP               +R   S  +I    + T+ 
Sbjct: 191 GAGYSFAVDWWSLGVTAYELLRGRRPYH-------------IRSSTSSKEIVHTFETTVV 237
Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
            +    ++ +++L     +P+PD R S    VQ
Sbjct: 238 TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQ 270

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/239 (28%), Positives = 110/239 (46%), Gaps = 28/239 (11%)
Query: 337 EVEYGACRFRYSELYSATKGFREKNL---VGSGGFGKVYRGVIPST----GLEVAIKRVA 389
           E E  A   R S   S++ G ++ +L   +G G + KV    +  T     + V  K + 
Sbjct: 31  EEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV 90
Query: 390 HNSRQ----GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFD 445
           ++         ++ V E  S     H  LV LH   + +  L  V +YV  G L   +F 
Sbjct: 91  NDDEDIDWVQTEKHVFEQAS----NHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFH 143
Query: 446 NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG 505
             +Q+K      + Y   I +A  L YLHE   + +++RD+K  NVL+D++ + KL D+G
Sbjct: 144 MQRQRKLPEEHARFYSAEISLA--LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 506 LARAYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           + +     + P   T+   GT  Y+APE+ R      S D +  G LM E+  GR P +
Sbjct: 199 MCK---EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 19/242 (7%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVA-EITSMGRLR 410
           K +     +G GGF K Y  +      EV   +V   S   +   KE ++ EI     L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           + ++V  HG+    D + +V +     SL +L     +++K +   + RY  +    Q +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL----HKRRKAVTEPEARY-FMRQTIQGV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH   + RV+HRD+K  N+ ++ D++ K+GDFGLA   + +   +   + GT  Y+AP
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAP 211
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E+      +   D++  G ++  +  G+ P E        +   ++R   ++  + R I+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-----TSCLKETYIRIKKNEYSVPRHIN 266
Query: 591 PT 592
           P 
Sbjct: 267 PV 268

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 34/240 (14%)
Query: 339 EYGACRFRYSELYSATKGFREKNL---VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG 395
           E  A   R S   S++ G ++ +L   +G G + KV    +  T    A+K V       
Sbjct: 1   EKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVK------ 54
Query: 396 MKEFVAEITSMGRLR-----------HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLF 444
            KE V +   +  ++           H  LV LH   + +  L  V +YV  G L   +F
Sbjct: 55  -KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---MF 110
Query: 445 DNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF 504
              +Q+K      + Y   I +A  L YLHE   + +++RD+K  NVL+D++ + KL D+
Sbjct: 111 HMQRQRKLPEEHARFYSAEISLA--LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 505 GLARAYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           G+ +     + P   T+   GT  Y+APE+ R      S D +  G LM E+  GR P +
Sbjct: 166 GMCK---EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 19/242 (7%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVA-EITSMGRLR 410
           K +     +G GGF K Y  +      EV   +V   S   +   KE ++ EI     L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           + ++V  HG+    D + +V +     SL +L     +++K +   + RY  +    Q +
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL----HKRRKAVTEPEARY-FMRQTIQGV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH   + RV+HRD+K  N+ ++ D++ K+GDFGLA   + +   +   + GT  Y+AP
Sbjct: 156 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYIAP 211
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E+      +   D++  G ++  +  G+ P E        +   ++R   ++  + R I+
Sbjct: 212 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-----TSCLKETYIRIKKNEYSVPRHIN 266
Query: 591 PT 592
           P 
Sbjct: 267 PV 268

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 34/218 (15%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H+     ++F  EI  + 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 408 RLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L    +V+  G  +   + EL LV +Y+P+G L   L              QR++  + 
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL--------------QRHRARLD 109
Query: 466 VAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
            ++ LLY  + C        +R VHRD+   N+L++++ + K+ DFGLA+    + +   
Sbjct: 110 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXV 169
Query: 519 THIVGT--LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               G   + + APE       +  +DV+ FG ++ E+
Sbjct: 170 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 417 LHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALL 471
           L G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + 
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMK 145
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGY 527
           YL     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + +
Sbjct: 146 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKW 201
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R
Sbjct: 202 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--R 253
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 254 LLQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 286

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 112/242 (46%), Gaps = 19/242 (7%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVA-EITSMGRLR 410
           K +     +G GGF K Y  +      EV   +V   S   +   KE ++ EI     L 
Sbjct: 26  KRYMRGRFLGKGGFAKCYE-ITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           + ++V  HG+    D + +V +     SL +L     +++K +   + RY  +    Q +
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLEL----HKRRKAVTEPEARY-FMRQTIQGV 139
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH   + RV+HRD+K  N+ ++ D++ K+GDFGLA   + +   +   + GT  Y+AP
Sbjct: 140 QYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAP 195
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E+      +   D++  G ++  +  G+ P E        +   ++R   ++  + R I+
Sbjct: 196 EVLCKKGHSFEVDIWSLGCILYTLLVGKPPFE-----TSCLKETYIRIKKNEYSVPRHIN 250
Query: 591 PT 592
           P 
Sbjct: 251 PV 252

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 148
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 257
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 258 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 288

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 417 LHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALL 471
           L G C R +   L+V  Y+ +G L   +  N+     +       K LIG    VA+ + 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTV-------KDLIGFGLQVAKGMK 142
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGY 527
           YL     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + +
Sbjct: 143 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKW 198
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R
Sbjct: 199 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--R 250
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 251 LLQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 283

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 39/278 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 56  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 115
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + Y
Sbjct: 116 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKY 167
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGYL 528
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + ++
Sbjct: 168 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWM 223
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R 
Sbjct: 224 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 275
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 276 LQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 307

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 35  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 94
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 95  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 146
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 147 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 203
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 255
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 256 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 286

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 120/278 (43%), Gaps = 37/278 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 96  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 155
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 207
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 208 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 264
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 316
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
            P  +Y      E++L     C  P  + RPS   +V 
Sbjct: 317 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELVS 348

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 20/209 (9%)
Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR 412
            T  F   +L+ S   G+ Y   +    + V +K+V H + + +         +  + H 
Sbjct: 15  GTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL--------MLSIVTHP 66
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            ++++ G  +   ++ ++ DY+  G L  LL    ++ ++  N   ++     V  AL Y
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLL----RKSQRFPNPVAKF-YAAEVCLALEY 121
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH    + +++RD+KP N+L+D + + K+ DFG A+     +   T  + GT  Y+APE+
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY----VPDVTYXLCGTPDYIAPEV 174
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPI 561
             T     S D + FG L+ E+  G  P 
Sbjct: 175 VSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 149
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 206
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 207 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 258
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 259 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 289

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y      TG  VA+K +       ++  +  EI  +  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 418 HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C  Q E  + LV +YVP GSL   L  +                 +G+AQ LL+  +
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH----------------CVGLAQLLLFAQQ 119
Query: 476 ECD-------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LG 526
            C+       Q  +HR +   NVL+D D   K+GDFGLA+A             G   + 
Sbjct: 120 ICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 179
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
           + APE  +  K   ++DV+ FG  + E+   C      P     EL+        H+QGQ
Sbjct: 180 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKFTELI-------GHTQGQ 231
Query: 585 IT 586
           +T
Sbjct: 232 MT 233

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 39/278 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + Y
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKY 147
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGYL 528
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + ++
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWM 203
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R 
Sbjct: 204 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 255
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 256 LQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 287

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 42  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 101
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 102 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 153
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 154 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 210
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 211 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 262
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 263 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 293

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 127/278 (45%), Gaps = 39/278 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   +  N+     +       K LIG    VA+ + Y
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTV-------KDLIGFGLQVAKGMKY 148
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGYL 528
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWM 204
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 256
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 257 LQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 288

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 39/279 (13%)
Query: 361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 417 LHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALL 471
           L G C R +   L+V  Y+ +G L   +  N+     +       K LIG    VA+ + 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTV-------KDLIGFGLQVAKGMK 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGY 527
           YL     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + +
Sbjct: 145 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKW 200
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--R 252
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 253 LLQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 285

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 120/277 (43%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 148
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 205
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 257
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 258 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 288

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 39/278 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 37  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 96
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + Y
Sbjct: 97  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKY 148
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGYL 528
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + ++
Sbjct: 149 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWM 204
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R 
Sbjct: 205 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 256
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 257 LQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 288

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 363 VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQL 417
           +G G FGKV    Y      TG  VA+K +       ++  +  EI  +  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 418 HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G C  Q E  + LV +YVP GSL   L  +                 +G+AQ LL+  +
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRH----------------CVGLAQLLLFAQQ 120
Query: 476 ECD-------QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LG 526
            C+       Q  +HR +   NVL+D D   K+GDFGLA+A             G   + 
Sbjct: 121 ICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 180
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVA--CGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
           + APE  +  K   ++DV+ FG  + E+   C      P     EL+        H+QGQ
Sbjct: 181 WYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQ-SPHTKFTELI-------GHTQGQ 232
Query: 585 IT 586
           +T
Sbjct: 233 MT 234

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 119/277 (42%), Gaps = 37/277 (13%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 36  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 95
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + Y
Sbjct: 96  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKY 147
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD             L   ++A
Sbjct: 148 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMA 204
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
            E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R +
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RLL 256
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            P  +Y      E++L     C  P  + RPS   +V
Sbjct: 257 QP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 287

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 72.4 bits (176), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 126/279 (45%), Gaps = 39/279 (13%)
Query: 361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 417 LHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALL 471
           L G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + 
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMK 139
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGY 527
           YL     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + +
Sbjct: 140 YL---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKW 195
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R
Sbjct: 196 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--R 247
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 248 LLQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 280

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 39/278 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 55  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 114
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + Y
Sbjct: 115 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKY 166
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYD---HNINPQTTHIVGTLGYL 528
           L     ++ VHRD+   N ++D     K+ DFGLAR  YD   ++++ +T   +  + ++
Sbjct: 167 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL-PVKWM 222
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R 
Sbjct: 223 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--RL 274
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 275 LQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 306

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 189
Query: 529 APELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H  LV LH   + +  L  V +YV  G L   +F   +Q+K      + Y   I +A  L
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--L 119
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYL 528
            YLHE   + +++RD+K  NVL+D++ + KL D+G+ +     + P   T+   GT  Y+
Sbjct: 120 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYI 173
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           APE+ R      S D +  G LM E+  GR P +
Sbjct: 174 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 81
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 139
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 140 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 194
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 195 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 252
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 253 REMNPNYTEF 262

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 104
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 162
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 163 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 217
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 218 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 275
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 276 REMNPNYTEF 285

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 89
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 147
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 148 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 202
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 203 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 260
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 261 REMNPNYTEF 270

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 78/154 (50%), Gaps = 13/154 (8%)
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H  LV LH   + +  L  V +YV  G L   +F   +Q+K      + Y   I +A  L
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLA--L 123
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYL 528
            YLHE   + +++RD+K  NVL+D++ + KL D+G+ +     + P   T+   GT  Y+
Sbjct: 124 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYI 177
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           APE+ R      S D +  G LM E+  GR P +
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR  ++ +   +TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG LM E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 103/213 (48%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR  ++ +   +TT+ 
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG LM E+
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/249 (29%), Positives = 123/249 (49%), Gaps = 22/249 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 417 L----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++L
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRSL 214
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y A
Sbjct: 215 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRA 269
Query: 530 PELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQITR 587
           PEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI R
Sbjct: 270 PELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI-R 327
Query: 588 AIDPTLDYF 596
            ++P    F
Sbjct: 328 EMNPNYTEF 336

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 30/214 (14%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA--LLYL 473
            L G C     +L++ +Y   G L   L    ++K ++L  D  + I    A    LL+ 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL----RRKSRVLETDPAFAIANSTASTRDLLHF 169
Query: 474 HEECDQ--------RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG-- 523
             +  Q          +HRDV   NVL+      K+GDFGLAR    +I   + +IV   
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGN 225
Query: 524 ---TLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ +G L+ E+
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 168
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 223
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 281
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 282 REMNPNYTEF 291

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KXQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 114
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 172
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 173 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 227
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 228 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 285
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 286 REMNPNYTEF 295

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 121
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 178
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 112
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 170
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 171 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 225
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 226 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 283
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 284 REMNPNYTEF 293

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KXQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 124/259 (47%), Gaps = 48/259 (18%)
Query: 23  FIYNGFIQANLSLDGTAFVRKDGILAVSNDQG----RI--LGHAFYPSPLRFKQLSKYNI 76
           F +  F + NL L   A V   G L ++N  G    R+  LG AFY +P++        I
Sbjct: 6   FNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQ--------I 57
Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGG--HGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
            +NT + T  +F+T+F F+I  + P   G   GLAF L+     P      +LGL  D S
Sbjct: 58  WDNT-TGTVASFATSFTFNI--QVPNNAGPADGLAFALVPVGSQPKDKGG-FLGLF-DGS 112
Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
           N+ F T  +AVEFD + N +  D  + H+GID++S+ S   +   + F  G N       
Sbjct: 113 NSNFHT--VAVEFDTLYNKDW-DPTERHIGIDVNSIRS--IKTTRWDFVNGENA------ 161
Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYVGFSA 253
                    +  I Y+S     N+ ++ L  P      I S  +DL +VL E++ VGFSA
Sbjct: 162 ---------EVLITYDSS---TNLLVASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSA 209
Query: 254 STGLLTA---FHNVHGWSF 269
           +TG+       ++V  WSF
Sbjct: 210 TTGINKGNVETNDVLSWSF 228

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQAL 470
            L G C     +L++ +Y   G L   L      D D++  + L           VAQ +
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG-----TL 525
            +L     +  +HRDV   NVL+      K+GDFGLAR    +I   + +IV       +
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPV 218
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            ++APE       T  +DV+ +G L+ E+
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR  + NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 121
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTHIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYR 195
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 83/259 (32%), Positives = 124/259 (47%), Gaps = 48/259 (18%)
Query: 23  FIYNGFIQANLSLDGTAFVRKDGILAVSNDQG----RI--LGHAFYPSPLRFKQLSKYNI 76
           F +  F + NL L   A V   G L ++N  G    R+  LG AFY +P++        I
Sbjct: 6   FNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQ--------I 57
Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGG--HGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
            +NT + T  +F+T+F F+I  + P   G   GLAF L+     P      +LGL  D S
Sbjct: 58  WDNT-TGTVASFATSFTFNI--QVPNNAGPADGLAFALVPVGSQPKDKGG-FLGLF-DGS 112
Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
           N+ F T  +AVEFD + N +  D  + H+GID++S+ S   +   + F  G N       
Sbjct: 113 NSNFHT--VAVEFDTLYNKDW-DPTERHIGIDVNSIRS--IKTTRWDFVNGENA------ 161
Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYVGFSA 253
                    +  I Y+S   L+   ++ L  P      I S  +DL +VL E++ VGFSA
Sbjct: 162 ---------EVLITYDSSTNLL---VASLVYPSQKTSFIVSDTVDLKSVLPEWVSVGFSA 209
Query: 254 STGLLTA---FHNVHGWSF 269
           +TG+       ++V  WSF
Sbjct: 210 TTGINKGNVETNDVLSWSF 228

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 131
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT--HIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 132 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 188
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 72  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 125
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTHIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 126 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 78  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 131
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTHIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 132 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG---------- 465
            L G C     +L++ +Y   G L   L    ++K ++L  D  + I             
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFL----RRKSRVLETDPAFAIANSTLSTRDLLHF 169
Query: 466 ---VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
              VAQ + +L     +  +HRDV   NVL+      K+GDFGLAR    +I   + +IV
Sbjct: 170 SSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIV 222
Query: 523 G-----TLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
                  + ++APE       T  +DV+ +G L+ E+
Sbjct: 223 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/244 (25%), Positives = 113/244 (46%), Gaps = 33/244 (13%)
Query: 351 YSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSM 406
           ++A K F +K    +++G G    V R V  +TG E A+K +   + +   E + E+   
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145
Query: 407 GR-----LR----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD 457
            R     LR    H +++ L         + LV+D +  G L    FD   +K  +   +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKE 201
Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP- 516
            R  I+  + +A+ +LH      +VHRD+KP N+L+D ++  +L DFG    +  ++ P 
Sbjct: 202 TR-SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFG----FSCHLEPG 253
Query: 517 -QTTHIVGTLGYLAPELTRTGKATT------STDVFGFGTLMLEVACGRRPIEPQRTAME 569
            +   + GT GYLAPE+ +     T        D++  G ++  +  G  P   +R  + 
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM 313
Query: 570 LVLV 573
           L ++
Sbjct: 314 LRMI 317

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 68  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 121
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTHIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 24/209 (11%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQAL 470
            L G C     +L++ +Y   G L   L      D D++  + L           VAQ +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG-----TL 525
            +L     +  +HRDV   NVL+      K+GDFGLAR    +I   + +IV       +
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNARLPV 226
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            ++APE       T  +DV+ +G L+ E+
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 138
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 191
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 138
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 191
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 18/209 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGV--IPS-TGLEVAIKRVAHN---SRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG    PS   + VA+K +  +     + M +F+ E+ +M  
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L HRNL++L+G       + +V +  P GSL D+L      Q   +L    RY +   VA
Sbjct: 72  LDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAV--QVA 125
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTHIVGTL 525
           + + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H     
Sbjct: 126 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEV 554
            + APE  +T   + ++D + FG  + E+
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +     TG E A K    R   +SR+G+  +E   E+  +  +RH N++ 
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G L   L      +K+ L  D+  + L  +   + YLH  
Sbjct: 80  LHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL-NP--KLGDFGLARAYDHNINP--QTTHIVGTLGYLAP 530
             +R+ H D+KP N+ L+D ++ NP  KL DFG+A    H I    +  +I GT  ++AP
Sbjct: 133 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKIEAGNEFKNIFGTPEFVAP 187
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+          D++  G +   +  G  P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 189
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 141
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 194
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGXVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 133
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 186
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 189
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 138
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 191
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 79
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 80  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 133
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 134 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 186
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 187 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 132
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 185
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 196
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 195
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 141
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 194
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 81
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 82  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 135
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 136 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 188
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 189 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 141
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYR 194
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 146
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 147 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 201
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 259
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 260 REMNPNYTEF 269

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 77
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 135
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 136 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 190
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 248
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 249 REMNPNYTEF 258

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 14/210 (6%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRN 413
           K F  K  +G+G F +V      +TG   A+K +   + +G +  +  EI  + +++H N
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHEN 81
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L       + L LV   V  G L    FD   +K      D    ++  V  A+ YL
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGEL----FDRIVEKGFYTEKDAS-TLIRQVLDAVYYL 136
Query: 474 HEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H      +VHRD+KP N+L    D +    + DFGL++         T    GT GY+AP
Sbjct: 137 HR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTA--CGTPGYVAP 191
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+      + + D +  G +   + CG  P
Sbjct: 192 EVLAQKPYSKAVDCWSIGVIAYILLCGYPP 221

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 124/282 (43%), Gaps = 19/282 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWC 421
           +G G F    + V   +    A+K ++       ++   EIT++     H N+V+LH   
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLHEVF 75
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             Q    LV + +  G L    F+  ++KK     +  Y I+  +  A+ ++H   D  V
Sbjct: 76  HDQLHTFLVMELLNGGEL----FERIKKKKHFSETEASY-IMRKLVSAVSHMH---DVGV 127
Query: 482 VHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           VHRD+KP N+L    + +L  K+ DFG AR    +  P  T    TL Y APEL      
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGY 186
Query: 539 TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDP 598
             S D++  G ++  +  G+ P +    ++       + +   +G  +   +   +    
Sbjct: 187 DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV--S 244
Query: 599 QEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPL 640
           QEA+ ++  GLL  DP+   + S  R  ++L   + L   PL
Sbjct: 245 QEAKDLIQ-GLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL 285

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 80
Query: 414 LVQL---HGWCRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 81  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 134
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 135 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 187
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 188 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 148
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 201
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 148
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 201
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 95
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 153
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 154 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 208
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 266
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 267 REMNPNYTEF 276

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+    TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKNTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQL 417
           K  +G G F  V R V  +TGLE A K +     S +  ++   E     +L+H N+V+L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +++    LV+D V  G     LF++   ++     D  + I   + +++ Y H   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQ-QILESIAYCH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHR++KP N+L+ +       KL DFGL  A + N +       GT GYL+PE+ +
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               +   D++  G ++  +  G  P
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 147
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 200
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 363 VGSGGFGKVYRGVIPSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +G G F K+++GV    G        EV +K +    R   + F    + M +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G C   DE +LV ++V  GSLD  L    ++ K  +N   + ++   +A A+ +L E
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN----PQTTHIVGTLGYLAPE 531
                ++H +V   N+L+  + + K G+    +  D  I+    P+   +   + ++ PE
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWVPPE 187
Query: 532 LTRTGK-ATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
                K    +TD + FGT + E+   G +P+    +  +L   +   +L +        
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA-------- 239
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   P+ AEL   L   C D  PD RPS R +++ L
Sbjct: 240 --------PKAAELA-NLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           ++G G FG+V +     T  E A+K +  A    +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                    +V +    G L    FD   ++K+    D   +I+  V   + Y+H+    
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---H 140
Query: 480 RVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+++   D + K+ DFGL+  +  N   +    +GT  Y+APE+ R G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/251 (27%), Positives = 114/251 (45%), Gaps = 43/251 (17%)
Query: 339 EYGACRFRYSELYSATKGFREKNL-----VGSGGFGKVYRGV---IPSTG--LEVAIKRV 388
           EY    FR  E Y     F  +NL     +GSG FGKV       I  TG  ++VA+K +
Sbjct: 25  EYFYVDFREYE-YDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 83
Query: 389 AHNSRQGMKE-FVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSL------- 439
              +    +E  ++E+  M +L  H N+V L G C     + L+++Y   G L       
Sbjct: 84  KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSK 143
Query: 440 ------DKLLFDN-----DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKP 488
                 D++ ++N     +++   +L ++        VA+ + +L     +  VHRD+  
Sbjct: 144 REKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAA 200
Query: 489 SNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT-----LGYLAPELTRTGKATTSTD 543
            NVL+      K+ DFGLAR    +I   + ++V       + ++APE    G  T  +D
Sbjct: 201 RNVLVTHGKVVKICDFGLAR----DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSD 256
Query: 544 VFGFGTLMLEV 554
           V+ +G L+ E+
Sbjct: 257 VWSYGILLWEI 267

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           ++G G FG+V +     T  E A+K +  A    +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                    +V +    G L    FD   ++K+    D   +I+  V   + Y+H+    
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---H 140
Query: 480 RVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+++   D + K+ DFGL+  +  N   +    +GT  Y+APE+ R G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR  + NI+   +TT+
Sbjct: 150 TYQLARGMEYL---ASQKCIHRDLTARNVLVTENNVMKIADFGLARDIN-NIDYYKKTTN 205
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 239

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 146
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 147 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 201
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 202 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 259
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 260 REMNPNYTEF 269

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 152 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 207
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 241

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 84
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 142
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 143 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 197
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 255
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 256 REMNPNYTEF 265

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           F+     ++ L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           ++G G FG+V +     T  E A+K +  A    +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                    +V +    G L    FD   ++K+    D   +I+  V   + Y+H+    
Sbjct: 89  ILEDSSSFYIVGELYTGGEL----FDEIIKRKRFSEHDAA-RIIKQVFSGITYMHK---H 140
Query: 480 RVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+++   D + K+ DFGL+  +  N   +    +GT  Y+APE+ R G
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR--IGTAYYIAPEVLR-G 197
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 198 TYDEKCDVWSAGVILYILLSGTPP 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 80
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 138
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 139 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 193
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 251
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 252 REMNPNYTEF 261

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHEN 94
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 95  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 148
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 149 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 201
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 202 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 159
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 160 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 212
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 155 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 210
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 244

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 168
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 169 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 223
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 281
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 282 REMNPNYTEF 291

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 93
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 94  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 147
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 148 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYR 200
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 201 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 144
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 145 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 91  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 144
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 145 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 201
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 202 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 38/280 (13%)
Query: 363 VGSGGFGKVYRGVIPSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +G G F K+++GV    G        EV +K +    R   + F    + M +L H++LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G C   DE +LV ++V  GSLD  L    ++ K  +N   + ++   +A A+ +L E
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAWAMHFLEE 131
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN----PQTTHIVGTLGYLAPE 531
                ++H +V   N+L+  + + K G+    +  D  I+    P+   +   + ++ PE
Sbjct: 132 ---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI-LQERIPWVPPE 187
Query: 532 LTRTGK-ATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
                K    +TD + FGT + E+   G +P+    +  +L   +   +L +        
Sbjct: 188 CIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA-------- 239
Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   P+ AEL   L   C D  PD RPS R +++ L
Sbjct: 240 --------PKAAELA-NLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 155
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 208
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQL 417
           K  +G G F  V R V  +TGLE A K +     S +  ++   E     +L+H N+V+L
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +++    LV+D V  G     LF++   ++     D  + I   + +++ Y H   
Sbjct: 70  HDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQ-QILESIAYCH--- 121
Query: 478 DQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHR++KP N+L+ +       KL DFGL  A + N +       GT GYL+PE+ +
Sbjct: 122 SNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               +   D++  G ++  +  G  P
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V     QG      E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 189
Query: 529 APELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 156
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWYR 209
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR  + NI+   +TT+
Sbjct: 209 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDIN-NIDYYKKTTN 264
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 298

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +     TG E A K    R   +SR+G+  +E   E+  +  +RH N++ 
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G L   L      +K+ L  D+  + L  +   + YLH  
Sbjct: 94  LHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLH-- 146
Query: 477 CDQRVVHRDVKPSNV-LIDADL-NP--KLGDFGLARAYDHNINP--QTTHIVGTLGYLAP 530
             +R+ H D+KP N+ L+D ++ NP  KL DFG+A    H I    +  +I GT  ++AP
Sbjct: 147 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKIEAGNEFKNIFGTPEFVAP 201
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+          D++  G +   +  G  P
Sbjct: 202 EIVNYEPLGLEADMWSIGVITYILLSGASP 231

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 24/210 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +     TG E A K    R   +SR+G+  +E   E+  +  +RH N++ 
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G L   L      +K+ L  D+  + L  +   + YLH  
Sbjct: 73  LHDIFENKTDVVLILELVSGGELFDFL-----AEKESLTEDEATQFLKQILDGVHYLH-- 125
Query: 477 CDQRVVHRDVKPSNV-LIDADL-NP--KLGDFGLARAYDHNINP--QTTHIVGTLGYLAP 530
             +R+ H D+KP N+ L+D ++ NP  KL DFG+A    H I    +  +I GT  ++AP
Sbjct: 126 -SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA----HKIEAGNEFKNIFGTPEFVAP 180
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+          D++  G +   +  G  P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQL 417
           K  +G G F  V R V  +TGLE A K +     S +  ++   E     +L+H N+V+L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +++    LV+D V  G     LF++   ++     D  + I   + +++ Y H   
Sbjct: 71  HDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQ-QILESIAYCH--- 122
Query: 478 DQRVVHRDVKPSNVLIDADLN---PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHR++KP N+L+ +       KL DFGL  A + N +       GT GYL+PE+ +
Sbjct: 123 SNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               +   D++  G ++  +  G  P
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 89  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 142
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 143 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 199
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 200 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H+     ++F  EI  + 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 408 RLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L    +V+  G  +   +  L LV +Y+P+G L   L              QR++  + 
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------------QRHRARLD 125
Query: 466 VAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
            ++ LLY  + C        +R VHRD+   N+L++++ + K+ DFGLA+    + +   
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185
Query: 519 THIVGT--LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               G   + + APE       +  +DV+ FG ++ E+
Sbjct: 186 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 122/250 (48%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V     QG      E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L    +    K+DE  L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I     Y 
Sbjct: 135 LAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YR 189
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H+     ++F  EI  + 
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 408 RLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L    +V+  G  +   +  L LV +Y+P+G L   L              QR++  + 
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------------QRHRARLD 112
Query: 466 VAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
            ++ LLY  + C        +R VHRD+   N+L++++ + K+ DFGLA+    + +   
Sbjct: 113 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 172
Query: 519 THIVGT--LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               G   + + APE       +  +DV+ FG ++ E+
Sbjct: 173 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  +GSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 87
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 88  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 141
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 142 GLKYIHS---ADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYR 194
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 195 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 104/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   ++ DFGLAR   +NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 34/243 (13%)
Query: 353 ATKGFRE----KNLVGSGGFGKVYRGVIPSTGLEVAIKRV--------AHNSRQGMKEFV 400
           +T GF E    K ++G G    V R +   T  E A+K +        +    Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE-- 68
Query: 401 AEITSMGRLR----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNW 456
           A +  +  LR    H N++QL           LV+D +  G L    FD   +K  +   
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP 516
           + R KI+  + + +  LH+     +VHRD+KP N+L+D D+N KL DFG +   D     
Sbjct: 125 ETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GE 178
Query: 517 QTTHIVGTLGYLAPELTRTGKATT------STDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
           +   + GT  YLAPE+                D++  G +M  +  G  P   ++  + L
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 571 VLV 573
            ++
Sbjct: 239 RMI 241

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 84
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 85  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 138
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 139 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYR 191
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 192 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 84/302 (27%), Positives = 137/302 (45%), Gaps = 42/302 (13%)
Query: 357 FREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRH 411
            R+  ++GSG FG VY+G+ IP   +  + VAIK +  N S +  KE + E   M  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
             + +L G C     + LV   +P G L   + +N  +   + +LNW       + +A+ 
Sbjct: 79  PYVSRLLGICLTS-TVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNW------CMQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D R+VHRD+   NVL+ +  + K+ DFGLAR  D  I+    H  G    + 
Sbjct: 132 MSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIE--PQRTAMELVLVDWVRELHSQG 583
           ++A E     + T  +DV+ +G  + E+   G +P +  P R          + +L  +G
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---------IPDLLEKG 237
Query: 584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIH 643
           +  R   P +   D      V  + + C     + RP  R +V    R A  PQ  + I 
Sbjct: 238 E--RLPQPPICTID------VYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQ 289
Query: 644 HE 645
           +E
Sbjct: 290 NE 291

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/279 (26%), Positives = 121/279 (43%), Gaps = 41/279 (14%)
Query: 362 LVGSGGFGKVYRGVI---PSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQL 417
           ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++ L
Sbjct: 38  VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 97
Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG----VAQALLY 472
            G C R +   L+V  Y+ +G L   + +           +   K LIG    VA+ + +
Sbjct: 98  LGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--------NPTVKDLIGFGLQVAKGMKF 149
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-----AYDHNINPQTTHIVGTLGY 527
           L     ++ VHRD+   N ++D     K+ DFGLAR      +D   N     +   + +
Sbjct: 150 L---ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKL--PVKW 204
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           +A E  +T K TT +DV+ FG L+ E+     P  P     ++ +         QG+  R
Sbjct: 205 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR--R 256
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
            + P  +Y      E++L     C  P  + RPS   +V
Sbjct: 257 LLQP--EYCPDPLYEVMLK----CWHPKAEMRPSFSELV 289

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 102/218 (46%), Gaps = 34/218 (15%)
Query: 357 FREKNL-----VGSGGFGKV----YRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMG 407
           F E++L     +G G FG V    Y  +  +TG  VA+K++ H+     ++F  EI  + 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 408 RLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
            L    +V+  G  +   +  L LV +Y+P+G L   L              QR++  + 
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--------------QRHRARLD 113
Query: 466 VAQALLYLHEEC-------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
            ++ LLY  + C        +R VHRD+   N+L++++ + K+ DFGLA+    + +   
Sbjct: 114 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 173
Query: 519 THIVGT--LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               G   + + APE       +  +DV+ FG ++ E+
Sbjct: 174 VREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 71  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 124
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 125 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y 
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEM----TGYVATRWYR 195
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++  Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 106/243 (43%), Gaps = 34/243 (13%)
Query: 353 ATKGFRE----KNLVGSGGFGKVYRGVIPSTGLEVAIKRV--------AHNSRQGMKEFV 400
           +T GF E    K ++G G    V R +   T  E A+K +        +    Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE-- 68
Query: 401 AEITSMGRLR----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNW 456
           A +  +  LR    H N++QL           LV+D +  G L    FD   +K  +   
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEK 124
Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP 516
           + R KI+  + + +  LH+     +VHRD+KP N+L+D D+N KL DFG +   D     
Sbjct: 125 ETR-KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GE 178
Query: 517 QTTHIVGTLGYLAPELTRTGKATT------STDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
           +   + GT  YLAPE+                D++  G +M  +  G  P   ++  + L
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML 238
Query: 571 VLV 573
            ++
Sbjct: 239 RMI 241

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 81  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 134
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 135 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 191
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P   + VA+K +  + + + + + V+E+  M  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++  Y   G+L + L           +D ++  ++ + +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN--PQTTH 520
              +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR   +NI+   +TT+
Sbjct: 163 TYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++APE       T  +DV+ FG LM E+
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 69  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 122
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 123 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 179
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 180 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 433 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 486
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 487 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 543
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 544 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 128
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 185
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 75  VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 128
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 129 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPEC 185
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 186 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 69.7 bits (169), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 362 LVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQL 417
           ++G G FG+VY GV  +     + VA+K    +     KE F++E   M  L H ++V+L
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 74
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            G   ++   +++  Y P G L   L + ++   K+L         + + +A+ YL    
Sbjct: 75  IGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 126
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
               VHRD+   N+L+ +    KLGDFGL+R  +     + +     + +++PE     +
Sbjct: 127 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 186
Query: 538 ATTSTDVFGFGTLMLEV-ACGRRP 560
            TT++DV+ F   M E+ + G++P
Sbjct: 187 FTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 357 FREKNLV-----GSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITS 405
           F  KNLV     G G FGKV +         +    VA+K +  N S   +++ ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN------------------- 446
           + ++ H ++++L+G C +   LLL+ +Y   GSL   L ++                   
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
           D   ++ L           ++Q + YL E    ++VHRD+   N+L+      K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 507 AR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE-VACGRRP---I 561
           +R  Y+ +   + +     + ++A E       TT +DV+ FG L+ E V  G  P   I
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 562 EPQR 565
            P+R
Sbjct: 257 PPER 260

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 38/102 (37%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N+LI A    K+ DFG+ARA   + N   QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR   H  +  T + V T  Y 
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYR 196
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR   H  +  T + V T  Y 
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYR 196
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 89
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 90  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR   H  +  T + V T  Y 
Sbjct: 144 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYR 196
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 362 LVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQL 417
           ++G G FG+VY GV  +     + VA+K    +     KE F++E   M  L H ++V+L
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 90
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            G   ++   +++  Y P G L   L + ++   K+L         + + +A+ YL    
Sbjct: 91  IGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 142
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
               VHRD+   N+L+ +    KLGDFGL+R  +     + +     + +++PE     +
Sbjct: 143 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 202
Query: 538 ATTSTDVFGFGTLMLEV-ACGRRP 560
            TT++DV+ F   M E+ + G++P
Sbjct: 203 FTTASDVWMFAVCMWEILSFGKQP 226

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 359 EKNLVGSGGFGKVYRGVIP----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          + V I +   N      E +AE   M +L +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C + +  +LV +    G L+K L  N   K K +      +++  V+  + YL 
Sbjct: 434 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLE 487
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
           E      VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 488 E---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 544
Query: 533 TRTGKATTSTDVFGFGTLMLEV-ACGRRP 560
               K ++ +DV+ FG LM E  + G++P
Sbjct: 545 INYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 34/214 (15%)
Query: 357 FREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRH 411
            R+  ++GSG FG V++GV IP   S  + V IK +   S RQ  +     + ++G L H
Sbjct: 33  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 92
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK------ILNWDQRYKILIG 465
            ++V+L G C     L LV  Y+P GSL     D+ +Q +       +LNW       + 
Sbjct: 93  AHIVRLLGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWG------VQ 141
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           +A+ + YL E     +VHR++   NVL+ +    ++ DFG+A      + P    ++ + 
Sbjct: 142 IAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL----LPPDDKQLLYSE 194
Query: 525 ----LGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
               + ++A E    GK T  +DV+ +G  + E+
Sbjct: 195 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 109/228 (47%), Gaps = 35/228 (15%)
Query: 357 FREKNLVGSGGFGKVYRGV-IP---STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRH 411
            R+  ++GSG FG V++GV IP   S  + V IK +   S RQ  +     + ++G L H
Sbjct: 15  LRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK------ILNWDQRYKILIG 465
            ++V+L G C     L LV  Y+P GSL     D+ +Q +       +LNW       + 
Sbjct: 75  AHIVRLLGLC-PGSSLQLVTQYLPLGSL----LDHVRQHRGALGPQLLLNWG------VQ 123
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT- 524
           +A+ + YL E     +VHR++   NVL+ +    ++ DFG+A      + P    ++ + 
Sbjct: 124 IAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL----LPPDDKQLLYSE 176
Query: 525 ----LGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTA 567
               + ++A E    GK T  +DV+ +G  + E+   G  P    R A
Sbjct: 177 AKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA 224

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KSQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGL R  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 362 LVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLVQL 417
           ++G G FG+VY GV  +     + VA+K    +     KE F++E   M  L H ++V+L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            G   ++   +++  Y P G L   L + ++   K+L         + + +A+ YL    
Sbjct: 79  IGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLT---LVLYSLQICKAMAYLE--- 130
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
               VHRD+   N+L+ +    KLGDFGL+R  +     + +     + +++PE     +
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR 190
Query: 538 ATTSTDVFGFGTLMLEV-ACGRRP 560
            TT++DV+ F   M E+ + G++P
Sbjct: 191 FTTASDVWMFAVCMWEILSFGKQP 214

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ D+GLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQL 417
           K  +G G F  V R V  +TGLE A K +     S +  ++   E     +L+H N+V+L
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +++    LV+D V  G     LF++   ++     D  + I   + +++ Y H   
Sbjct: 94  HDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQ-QILESIAYCH--- 145
Query: 478 DQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHR++KP N+L+ +       KL DFGL  A + N +       GT GYL+PE+ +
Sbjct: 146 SNGIVHRNLKPENLLLASKAKGAAVKLADFGL--AIEVNDSEAWHGFAGTPGYLSPEVLK 203
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
               +   D++  G ++  +  G  P
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 72
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 73  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 121
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 219

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 117/260 (45%), Gaps = 41/260 (15%)
Query: 22  SFIYNGFI--QANLSLDGTAFVRKDGILAVS-----NDQGRILGHAFYPSPLRFKQLSKY 74
           SF  N F+  +A+L   G A V   G+L ++       Q   +G A Y +P+R       
Sbjct: 5   SFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVR------- 57
Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLM-SRKQPPSCLANQYLGLPNDT 133
            I  NT    A +FST+F F +    P +   GLAF L     Q PS   ++YLGL  + 
Sbjct: 58  -IWGNTTGSVA-SFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGL-FNN 114
Query: 134 SNAKFSTRILAVEFDA--VQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           SN+  S +I+AVEFD     + +  D N  H+GID++  I +I      + + G      
Sbjct: 115 SNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNG-IESIKTVQWDWINGGVAF--- 170
Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
                L     + A + Y S +   +V  S               +DL  +L E++ VGF
Sbjct: 171 ATITYLAPNKTLIASLVYPSNQTTFSVAAS---------------VDLKEILPEWVRVGF 215
Query: 252 SASTGLLTAF--HNVHGWSF 269
           SA+TG  T    H+V  WSF
Sbjct: 216 SAATGYPTEVETHDVLSWSF 235

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F+ + + G G FG V  G   STG+ VAIK+V  + R   +E    +  +  L H N+VQ
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQ 83
Query: 417 LHGWC-------RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY----KILIG 465
           L  +        R+   L +V +YVP           D   +   N+ +R      ILI 
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVP-----------DTLHRCCRNYYRRQVAPPPILIK 132
Query: 466 VAQALLYLHEEC----DQRVVHRDVKPSNVLI-DADLNPKLGDFGLARAYDHNINPQTTH 520
           V    L     C       V HRD+KP NVL+ +AD   KL DFG A+    +  P   +
Sbjct: 133 VFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAY 191
Query: 521 IVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACG 557
           I     Y APEL    +  TT+ D++  G +  E+  G
Sbjct: 192 ICSRY-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 221

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 357 FREKNLV-----GSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITS 405
           F  KNLV     G G FGKV +         +    VA+K +  N S   +++ ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN------------------- 446
           + ++ H ++++L+G C +   LLL+ +Y   GSL   L ++                   
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
           D   ++ L           ++Q + YL E    ++VHRD+   N+L+      K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 507 AR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE-VACGRRP---I 561
           +R  Y+ +   + +     + ++A E       TT +DV+ FG L+ E V  G  P   I
Sbjct: 197 SRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 562 EPQR 565
            P+R
Sbjct: 257 PPER 260

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 105
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 106 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 159
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     +    V T  Y 
Sbjct: 160 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGYVATRWYR 212
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 8/216 (3%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRN 413
           F +  ++G GGFG+V+   + +TG   A K++     +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      + +L LV   +  G +   +++ D+         Q  + +   AQ +  L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF----QEPRAIFYTAQIVSGL 302
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + +++RD+KP NVL+D D N ++ D GLA         +T    GT G++APEL 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAPELL 361
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
              +   S D F  G  + E+   R P   +   +E
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 8/216 (3%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRN 413
           F +  ++G GGFG+V+   + +TG   A K++     +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      + +L LV   +  G +   +++ D+         Q  + +   AQ +  L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF----QEPRAIFYTAQIVSGL 302
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + +++RD+KP NVL+D D N ++ D GLA         +T    GT G++APEL 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAPELL 361
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
              +   S D F  G  + E+   R P   +   +E
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 8/216 (3%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRN 413
           F +  ++G GGFG+V+   + +TG   A K++     +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      + +L LV   +  G +   +++ D+         Q  + +   AQ +  L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF----QEPRAIFYTAQIVSGL 302
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + +++RD+KP NVL+D D N ++ D GLA         +T    GT G++APEL 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAPELL 361
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
              +   S D F  G  + E+   R P   +   +E
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 8/216 (3%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ---GMKEFVAEITSMGRLRHRN 413
           F +  ++G GGFG+V+   + +TG   A K++     +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      + +L LV   +  G +   +++ D+         Q  + +   AQ +  L
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGF----QEPRAIFYTAQIVSGL 302
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + +++RD+KP NVL+D D N ++ D GLA         +T    GT G++APEL 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-QTKTKGYAGTPGFMAPELL 361
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
              +   S D F  G  + E+   R P   +   +E
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 76/251 (30%), Positives = 126/251 (50%), Gaps = 24/251 (9%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V     QG      E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QGKAFKNRELQIMRKLDHCNIV 76
Query: 416 QL----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKI-LNWDQRYKILIGVAQ 468
           +L    +    K+DE  L LV DYVP  ++ ++     + K+ + + + + Y  +  + +
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVP-ATVYRVARHYSRAKQTLPVIYVKLY--MYQLFR 133
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGY 527
           +L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-Y 188
Query: 528 LAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQI 585
            APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI 247
Query: 586 TRAIDPTLDYF 596
            R ++P    F
Sbjct: 248 -REMNPNYTEF 257

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT
Sbjct: 120 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 286

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 37/102 (36%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QT 518
           +++    QAL + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT
Sbjct: 137 EVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             ++GT  YL+PE  R       +DV+  G ++ EV  G  P
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 20/208 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVAEITSMGRLRHRNLVQ 416
           +GSG F  V +    STGLE A K    R +  SR+G+  +E   E++ + ++ H N++ 
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + +++L+ + V  G     LFD   QK+  L+ ++    +  +   + YLH  
Sbjct: 80  LHDVYENRTDVVLILELVSGGE----LFDFLAQKES-LSEEEATSFIKQILDGVNYLH-- 132
Query: 477 CDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             +++ H D+KP N+ L+D ++   + KL DFGLA   +  +  +  +I GT  ++APE+
Sbjct: 133 -TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
                     D++  G +   +  G  P
Sbjct: 190 VNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 103/237 (43%), Gaps = 30/237 (12%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--------AHNSRQGMKEFVAEITSM 406
           + +  K ++G G    V R +   T  E A+K +        +    Q ++E  A +  +
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELRE--ATLKEV 61
Query: 407 GRLR----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
             LR    H N++QL           LV+D +  G L    FD   +K  +   + R KI
Sbjct: 62  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETR-KI 116
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           +  + + +  LH+     +VHRD+KP N+L+D D+N KL DFG +   D     +   + 
Sbjct: 117 MRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVC 171
Query: 523 GTLGYLAPELTRTGKATT------STDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
           GT  YLAPE+                D++  G +M  +  G  P   ++  + L ++
Sbjct: 172 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI 228

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 41/263 (15%)
Query: 16  AHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQ 70
           A A   SF +  F + NL L   A V    +      +  +     LG AFY +P++   
Sbjct: 22  ASANLISFTFKKFNETNLILQRDATVSSGKLRITKAAENGVPTAGSLGRAFYSTPIQ--- 78
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                I +NT + T  +++T+F F++          GLAF L+     P      +LGL 
Sbjct: 79  -----IWDNT-TGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPKDKGG-FLGLF 131
Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
            D+ N   S + +AVEFD   N    D  + H+GID++S+ S   +  ++ F+ G N   
Sbjct: 132 -DSKNYASSNQTVAVEFDTFYNGGW-DPTERHIGIDVNSIKS--IKTTSWDFANGENA-- 185
Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYV 249
                        +  I Y+S     N+ ++ L  P      I S  +DL +VL E++ V
Sbjct: 186 -------------EVLITYDSS---TNLLVASLVHPSQKTSFIVSERVDLTSVLPEWVSV 229
Query: 250 GFSASTGLLTAF---HNVHGWSF 269
           GFSA+TGL   +   + V  WSF
Sbjct: 230 GFSATTGLSKGYVETNEVLSWSF 252

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 363 VGSGGFGKVYRGV--IPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FG V +GV  +    ++VAIK +   + +   +E + E   M +L +  +V+L G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C + + L+LV +    G L K L      K++ +      ++L  V+  + YL E   +
Sbjct: 78  VC-QAEALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---K 129
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELTRTGK 537
             VHRD+   NVL+      K+ DFGL++A   + +  T    G   L + APE     K
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 538 ATTSTDVFGFGTLMLE-VACGRRPIEPQR 565
            ++ +DV+ +G  M E ++ G++P +  +
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKPYKKMK 218

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRN 413
           +G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKI 462
           ++ L G C +   L ++ +Y   G+L + L           ++     ++ L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH-NINPQTTHI 521
              VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H +   +TT+ 
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              + ++APE       T  +DV+ FG L+ E+
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 74
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 75  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 123
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELP 207

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRHRN 413
           ++ + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+ +   +    LV +    G L    FD    +K+    D   +I+  V   + Y+
Sbjct: 94  IMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGITYM 148
Query: 474 HEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+    ++VHRD+KP N+L+++   D N ++ DFGL+  ++   + +    +GT  Y+AP
Sbjct: 149 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAP 203
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      DV+  G ++  +  G  P
Sbjct: 204 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 232

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 119/250 (47%), Gaps = 22/250 (8%)
Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            + +  ++G+G FG VY+  +  +G  VAIK+V  + R   +    E+  M +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 416 QLHGWCRKQDE------LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L  +     E      L LV DYVP          +  ++   + + + Y  +  + ++
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  + I     Y 
Sbjct: 135 LAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YR 189
Query: 529 APELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQIT 586
           APEL       T+S DV+  G ++ E+  G +PI P  + + +LV +  V    ++ QI 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLVEIIKVLGTPTREQI- 247
Query: 587 RAIDPTLDYF 596
           R ++P    F
Sbjct: 248 REMNPNYTEF 257

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 17/204 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 DV+  G ++  +  G  P
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELP 206

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +GSG +G+V       TG E AIK +  +S          + E+  + +L H N+++L+ 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 88
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +   +    LV +    G L    FD    ++K    D    I+  V     YLH+    
Sbjct: 89  FFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAV-IMKQVLSGTTYLHK---H 140
Query: 480 RVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+++   D   K+ DFGL+  ++  +  +    +GT  Y+APE+ R  
Sbjct: 141 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLRK- 197
Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           K     DV+  G ++  + CG  P   Q
Sbjct: 198 KYDEKCDVWSCGVILYILLCGYPPFGGQ 225

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 88
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 89  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 143 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYR 195
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 38/244 (15%)
Query: 357 FREKNLV-----GSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITS 405
           F  KNLV     G G FGKV +         +    VA+K +  N S   +++ ++E   
Sbjct: 20  FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNV 79
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN------------------- 446
           + ++ H ++++L+G C +   LLL+ +Y   GSL   L ++                   
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
           D   ++ L           ++Q + YL E     +VHRD+   N+L+      K+ DFGL
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAARNILVAEGRKMKISDFGL 196
Query: 507 AR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLE-VACGRRP---I 561
           +R  Y+ +   + +     + ++A E       TT +DV+ FG L+ E V  G  P   I
Sbjct: 197 SRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 256
Query: 562 EPQR 565
            P+R
Sbjct: 257 PPER 260

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 92
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 93  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 146
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 147 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 199
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 200 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRHRN 413
           ++ + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+ +   +    LV +    G L    FD    +K+    D   +I+  V   + Y+
Sbjct: 88  IMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGITYM 142
Query: 474 HEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+    ++VHRD+KP N+L+++   D N ++ DFGL+  ++   + +    +GT  Y+AP
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAP 197
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      DV+  G ++  +  G  P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 132
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 185
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 117
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 118 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 172
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 3   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 117
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 118 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 172
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 109/234 (46%), Gaps = 23/234 (9%)
Query: 340 YGACRFRYSE---LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM 396
           YG  +  Y+E    Y A K   +K L+   GF +              I+      R  +
Sbjct: 26  YGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQ-----PRGPI 80
Query: 397 KEFVAEITSMGRLRHRNLVQLHGWCR--KQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL 454
           ++   EI  + +L H N+V+L        +D L +V++ V  G + ++         K L
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEV------PTLKPL 134
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
           + DQ       + + + YLH    Q+++HRD+KPSN+L+  D + K+ DFG++  +  + 
Sbjct: 135 SEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS- 190
Query: 515 NPQTTHIVGTLGYLAPE-LTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQR 565
           +   ++ VGT  ++APE L+ T K  +  + DV+  G  +     G+ P   +R
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 16/210 (7%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K F    ++GSG F +V+      TG   A+K +  +          EI  + +++H N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           V L           LV   V  G L D++L      ++ +        ++  V  A+ YL
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRIL------ERGVYTEKDASLVIQQVLSAVKYL 122
Query: 474 HEECDQRVVHRDVKPSNVL-IDADLNPK--LGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           HE     +VHRD+KP N+L +  + N K  + DFGL++   + I    +   GT GY+AP
Sbjct: 123 HE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVAP 176
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+      + + D +  G +   + CG  P
Sbjct: 177 EVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 101
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 102 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 155
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 156 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 208
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 209 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+  FGLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 156
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 209
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 17/208 (8%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +GSG +G+V       TG E AIK +  +S          + E+  + +L H N+++L+ 
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
           +   +    LV +    G L    FD    ++K    D    I+  V     YLH+    
Sbjct: 72  FFEDKRNYYLVMEVYRGGEL----FDEIILRQKFSEVDAAV-IMKQVLSGTTYLHK---H 123
Query: 480 RVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+++   D   K+ DFGL+  ++  +  +    +GT  Y+APE+ R  
Sbjct: 124 NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE--VGGKMKERLGTAYYIAPEVLRK- 180
Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           K     DV+  G ++  + CG  P   Q
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQ 208

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           VGSG +G V   +   +G +VAIK+++    S    K    E+  +  ++H N++ L   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
                 L   YD+     L       D QK   L + +  KI   V Q L  L       
Sbjct: 92  FTPASSLRNFYDFY----LVMPFMQTDLQKIMGLKFSEE-KIQYLVYQMLKGLKYIHSAG 146
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
           VVHRD+KP N+ ++ D   K+ DFGLAR  D     + T  V T  Y APE+  +     
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 541 ST-DVFGFGTLMLEVACGR 558
            T D++  G +M E+  G+
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRHRN 413
           ++ + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+ +   +    LV +    G L    FD    +K+    D   +I+  V   + Y+
Sbjct: 111 IMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGITYM 165
Query: 474 HEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+    ++VHRD+KP N+L+++   D N ++ DFGL+  ++   + +    +GT  Y+AP
Sbjct: 166 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAP 220
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      DV+  G ++  +  G  P
Sbjct: 221 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 249

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 363 VGSGGFGKVYR----GVIPSTGLE-VAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQ 416
           +G G FG+V++    G++P      VA+K +   +   M+ +F  E   M    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLL------------FDNDQQKKKI-------LNWD 457
           L G C     + L+++Y+  G L++ L              +   + ++       L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINP 516
           ++  I   VA  + YL E   ++ VHRD+   N L+  ++  K+ DFGL+R  Y  +   
Sbjct: 175 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
              +    + ++ PE     + TT +DV+ +G ++ E+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 14/194 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHR-NLVQLHG 419
           +G G F  V + +  STG E A K +    R      E + EI  +   +    ++ LH 
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                 E++L+ +Y   G +  L      +  ++++ +   +++  + + + YLH+    
Sbjct: 97  VYENTSEIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---N 150
Query: 480 RVVHRDVKPSNVLIDADL---NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VH D+KP N+L+ +     + K+ DFG++R   H    +   I+GT  YLAPE+    
Sbjct: 151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYD 208
Query: 537 KATTSTDVFGFGTL 550
             TT+TD++  G +
Sbjct: 209 PITTATDMWNIGII 222

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ D GLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 17/210 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRHRN 413
           ++ + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+ +   +    LV +    G L    FD    +K+    D   +I+  V   + Y+
Sbjct: 112 IMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGITYM 166
Query: 474 HEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+    ++VHRD+KP N+L+++   D N ++ DFGL+  ++   + +    +GT  Y+AP
Sbjct: 167 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYIAP 221
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      DV+  G ++  +  G  P
Sbjct: 222 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 250

>pdb|2EIG|A Chain A, Lotus Tetragonolobus Seed Lectin (Isoform) Length = 234

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 117/257 (45%), Gaps = 44/257 (17%)
Query: 22  SFIYNGFIQ-ANLSLDGTAFVRKDGILAVSNDQ--GRILGHAFYPSPLRFKQLSKYNINN 78
           SF Y  F    +L   G A +  DG LA+  D    R   HA Y +P+     +  N+  
Sbjct: 2   SFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIWDSATGNV-- 59
Query: 79  NTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKF 138
                 +   S +F+ S V +YP   G          + PP+     YLG+  D+SN++ 
Sbjct: 60  -----ASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGG-YLGI-TDSSNSQ- 111
Query: 139 STRILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVL 197
             + +AVEFD+  N+ + + +  +H+GID++S++S           K  N N        
Sbjct: 112 -NQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMS----------LKAVNWN-------R 153
Query: 198 KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHR----PLISYPIDLATVLDEYMYVGFSA 253
            SG   +A I Y+S   ++ V ++       H+      IS  IDL TVL E + VGFSA
Sbjct: 154 VSGSLEKATIIYDSDTKILTVVMT-------HQNGQITTISQEIDLKTVLPEKVSVGFSA 206
Query: 254 ST-GLLTAFHNVHGWSF 269
           +T       H+++ WSF
Sbjct: 207 TTWNPERERHDIYSWSF 223

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 414 LVQL---HGWCRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K   L  D    ++  + +
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCAKLTDDHVQFLIYQILR 132
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     + T  V T  Y 
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYR 185
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNL 414
           +R+   VGSG +G V   V   TG +VAIK++     S    K    E+  +  +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 415 VQLHGWC---RKQDELLLVYDYVP--NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           + L          D+    Y  +P     L KL+      K + L  D+   ++  + + 
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM------KHEKLGEDRIQFLVYQMLKG 140
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D  +       V T  Y A
Sbjct: 141 LRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEM----XGXVVTRWYRA 193
Query: 530 PELTRTG-KATTSTDVFGFGTLMLEVACGR 558
           PE+     + T + D++  G +M E+  G+
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 26/207 (12%)
Query: 366 GGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD 425
           G FG V++  + +  + V I  +  + +    E+  E+ S+  ++H N++Q  G  ++  
Sbjct: 35  GRFGCVWKAQLLNEYVAVKIFPI-QDKQSWQNEY--EVYSLPGMKHENILQFIGAEKRGT 91
Query: 426 ----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC---- 477
               +L L+  +   GSL   L      K  +++W++   I   +A+ L YLHE+     
Sbjct: 92  SVDVDLWLITAFHEKGSLSDFL------KANVVSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 478 ---DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPELT 533
                 + HRD+K  NVL+  +L   + DFGLA  ++   +   TH  VGT  Y+APE+ 
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVL 205
Query: 534 RTG-----KATTSTDVFGFGTLMLEVA 555
                    A    D++  G ++ E+A
Sbjct: 206 EGAINFQRDAFLRIDMYAMGLVLWELA 232

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 11/212 (5%)
Query: 350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMG 407
           ++   + ++  + VGSG +G V       +GL++A+K+++    S    K    E+  + 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
            ++H N++ L         L    D      L     +N  + +K+ + D    ++  + 
Sbjct: 106 HMKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-DHVQFLIYQIL 164
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           + L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  +    T  V T  Y
Sbjct: 165 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----TGYVATRWY 217
Query: 528 LAPELTRTGKATTST-DVFGFGTLMLEVACGR 558
            APE+         T D++  G +M E+  GR
Sbjct: 218 RAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ D GLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 89
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 150 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 206
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 100/220 (45%), Gaps = 20/220 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G  G+V   V   T   VA+K V         E +  EI     L H N+V+ +G  
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD-QRY--KILIGVAQALLYLHEECD 478
           R+ +   L  +Y   G L    FD  +    +   D QR+  +++ GV    +YLH    
Sbjct: 74  REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGV----VYLH---G 122
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ-TTHIVGTLGYLAPE-LTRTG 536
             + HRD+KP N+L+D   N K+ DFGLA  + +N   +    + GTL Y+APE L R  
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI-EPQRTAMELVLVDW 575
                 DV+  G ++  +  G  P  +P  +  E    DW
Sbjct: 183 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDW 220

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 46/301 (15%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ + + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV- 245
Query: 591 PTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF 646
             +D  Y D  +   E V  L  +C   +P  RP+   +V  LL+D        D+H  F
Sbjct: 246 --MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLKD--------DLHPSF 294
Query: 647 P 647
           P
Sbjct: 295 P 295

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           VGSG +G V   +   +G +VAIK+++    S    K    E+  +  ++H N++ L   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
                 L   YD+     L       D QK   + + +  KI   V Q L  L       
Sbjct: 110 FTPASSLRNFYDFY----LVMPFMQTDLQKIMGMEFSEE-KIQYLVYQMLKGLKYIHSAG 164
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
           VVHRD+KP N+ ++ D   K+ DFGLAR  D  +    T  V T  Y APE+  +     
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEM----TGYVVTRWYRAPEVILSWMHYN 220
Query: 541 ST-DVFGFGTLMLEVACGR 558
            T D++  G +M E+  G+
Sbjct: 221 QTVDIWSVGCIMAEMLTGK 239

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 9/193 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+ G + +    VA+K         +K +F+ E   + +  H N+V+L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  + +V + V  G  D L F   +  +  L      +++   A  + YL  +C    
Sbjct: 182 TQKQPIYIVMELVQGG--DFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT-LGYLAPELTRTGKATT 540
           +HRD+   N L+      K+ DFG++R     +   +  +    + + APE    G+ ++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 541 STDVFGFGTLMLE 553
            +DV+ FG L+ E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 143 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 83
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 144 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 200
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 201 MSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 111
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 112 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 171
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 172 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 228
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 229 MSPESLKDGVFTTYSDVWSFGVVLWEIA 256

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 76
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 137 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIA 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 27/207 (13%)
Query: 366 GGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-- 423
           G FG V++  + +    VA+K      +Q  +    EI S   ++H NL+Q     ++  
Sbjct: 26  GRFGCVWKAQLMNDF--VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGS 82
Query: 424 --QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC---- 477
             + EL L+  +   GSL       D  K  I+ W++   +   +++ L YLHE+     
Sbjct: 83  NLEVELWLITAFHDKGSL------TDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 478 ----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPEL 532
                  + HRD K  NVL+ +DL   L DFGLA  ++    P  TH  VGT  Y+APE+
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV 196
Query: 533 TRTG-----KATTSTDVFGFGTLMLEV 554
                     A    D++  G ++ E+
Sbjct: 197 LEGAINFQRDAFLRIDMYAMGLVLWEL 223

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 143 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 199
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 200 MSPESLKDGVFTTYSDVWSFGVVLWEIA 227

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 357 FREKNL---------VGSGGFGKVYRGVIPSTGLEVAIK----RVAHNSRQGM--KEFVA 401
           FR++N+         +GSG F  V +    STGL+ A K    R   +SR+G+  ++   
Sbjct: 4   FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E++ +  ++H N++ LH     + +++L+ + V  G L   L      +K+ L  ++  +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL-----AEKESLTEEEATE 118
Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNV-LIDADL---NPKLGDFGLARAYDHNINPQ 517
            L  +   + YLH     ++ H D+KP N+ L+D ++     K+ DFGLA   D     +
Sbjct: 119 FLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNE 173
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +I GT  ++APE+          D++  G +   +  G  P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 80
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 81  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 140
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 141 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 197
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 198 MSPESLKDGVFTTYSDVWSFGVVLWEIA 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 107/218 (49%), Gaps = 14/218 (6%)
Query: 363 VGSGGFGKVYRGV--IPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHG 419
           +G G FG V +GV  +    ++VAIK +   + +   +E + E   M +L +  +V+L G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
            C + + L+LV +    G L K L      K++ +      ++L  V+  + YL E   +
Sbjct: 404 VC-QAEALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---K 455
Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT--LGYLAPELTRTGK 537
             VHR++   NVL+      K+ DFGL++A   + +  T    G   L + APE     K
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 538 ATTSTDVFGFGTLMLE-VACGRRPIEPQRTAMELVLVD 574
            ++ +DV+ +G  M E ++ G++P +  +    +  ++
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     +    V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     +    V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 101/222 (45%), Gaps = 22/222 (9%)
Query: 348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITS 405
           SE+Y   K       +GSG +G+V       T +E AIK  R    S     + + E+  
Sbjct: 36  SEMYQRVKK------LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAV 89
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
           +  L H N+++L+ +   +    LV +    G L    FD    + K    D    I+  
Sbjct: 90  LKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRMKFNEVDAAV-IIKQ 144
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIV 522
           V   + YLH+     +VHRD+KP N+L+++   D   K+ DFGL+  +++    +    +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERL 199
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           GT  Y+APE+ R  K     DV+  G ++  +  G  P   Q
Sbjct: 200 GTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQ 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 78
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 79  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 132
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     +    V T  Y 
Sbjct: 133 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYR 185
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ D GLAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 9/193 (4%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK-EFVAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+ G + +    VA+K         +K +F+ E   + +  H N+V+L G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++  + +V + V  G  D L F   +  +  L      +++   A  + YL  +C    
Sbjct: 182 TQKQPIYIVMELVQGG--DFLTFLRTEGAR--LRVKTLLQMVGDAAAGMEYLESKC---C 234
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT-LGYLAPELTRTGKATT 540
           +HRD+   N L+      K+ DFG++R     +   +  +    + + APE    G+ ++
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 541 STDVFGFGTLMLE 553
            +DV+ FG L+ E
Sbjct: 295 ESDVWSFGILLWE 307

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 93/205 (45%), Gaps = 14/205 (6%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +N +G G +G+V   V   T +  A K++     + +  F  EI  M  L H N+++L+ 
Sbjct: 31  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 90
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                 ++ LV +    G L + +       K++       +I+  V  A+ Y H+    
Sbjct: 91  TFEDNTDIYLVMELCTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK---L 142
Query: 480 RVVHRDVKPSNVLI--DADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            V HRD+KP N L   D+  +P KL DFGLA  +      +T   VGT  Y++P++   G
Sbjct: 143 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-G 199
Query: 537 KATTSTDVFGFGTLMLEVACGRRPI 561
                 D +  G +M  + CG  P 
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 129/301 (42%), Gaps = 46/301 (15%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 143
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + ++AP
Sbjct: 144 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ + + 
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV- 244
Query: 591 PTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF 646
             +D  Y D  +   E V  L  +C   +P  RP+   +V  LL+D        D+H  F
Sbjct: 245 --MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLKD--------DLHPSF 293
Query: 647 P 647
           P
Sbjct: 294 P 294

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +N +G G +G+V   V   T +  A K++     + +  F  EI  M  L H N+++L+ 
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73
Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                 ++ LV +    G L + +       K++       +I+  V  A+ Y H+    
Sbjct: 74  TFEDNTDIYLVMELCTGGELFERVV-----HKRVFRESDAARIMKDVLSAVAYCHK---L 125
Query: 480 RVVHRDVKPSNVLI--DADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            V HRD+KP N L   D+  +P KL DFGLA  +      +T   VGT  Y++P++   G
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTK--VGTPYYVSPQVLE-G 182
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D +  G +M  + CG  P
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPP 206

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 30/215 (13%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILI 464
            L G C     +L++ +Y   G L   L           ++     ++ L+         
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG- 523
            VAQ + +L     +  +HRDV   NVL+      K+GDFGLAR    +I   + +IV  
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKG 226
Query: 524 ----TLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
                + ++APE       T  +DV+ +G L+ E+
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 62/232 (26%), Positives = 99/232 (42%), Gaps = 27/232 (11%)
Query: 346 RYSELYSATKGFREK-------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQG 395
           RY ++    +G + K        ++G G FG+V      ++    A+K ++      R  
Sbjct: 59  RYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSD 118
Query: 396 MKEFVAEITSMGRLRHRNLVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKI 453
              F  E   M       +VQL  +C  QD+  L +V +Y+P G L  L+ + D  +K  
Sbjct: 119 SAFFWEERDIMAFANSPWVVQL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK-- 174
Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
             W + Y      A+ +L L       ++HRDVKP N+L+D   + KL DFG     D  
Sbjct: 175 --WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET 227
Query: 514 INPQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPI 561
                   VGT  Y++PE+ ++    G      D +  G  + E+  G  P 
Sbjct: 228 GMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 11  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 145
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL+    ++ VHR++   N ++  D   K+GDFG+ R  Y+ +   +    +  + ++AP
Sbjct: 146 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ + + 
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV- 246
Query: 591 PTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF 646
             +D  Y D  +   E V  L  +C   +P+ RP+   +V  LL+D        D+H  F
Sbjct: 247 --MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLKD--------DLHPSF 295
Query: 647 P 647
           P
Sbjct: 296 P 296

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 50  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 112/243 (46%), Gaps = 30/243 (12%)
Query: 357 FREKNLVGSGGFGKVY--RGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHR 412
           F    ++G+G +GKV+  R +      ++   +V   +    K    E T   R  L H 
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 413 N----LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
                LV LH   + + +L L+ DY+  G L    F +  Q+++       +++ I V +
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGEL----FTHLSQRERF----TEHEVQIYVGE 167
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            +L L       +++RD+K  N+L+D++ +  L DFGL++ +  +   +     GT+ Y+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 529 APELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           AP++ R G +    + D +  G LM E+  G  P            VD   E +SQ +I+
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF----------TVDG--EKNSQAEIS 275
Query: 587 RAI 589
           R I
Sbjct: 276 RRI 278

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 12  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 121
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 128/301 (42%), Gaps = 46/301 (15%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R  Y+     +    +  + ++AP
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ + + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV- 245
Query: 591 PTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF 646
             +D  Y D  +   E V  L  +C   +P  RP+   +V  LL+D        D+H  F
Sbjct: 246 --MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLKD--------DLHPSF 294
Query: 647 P 647
           P
Sbjct: 295 P 295

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 130/301 (43%), Gaps = 46/301 (15%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL+    ++ VHR++   N ++  D   K+GDFG+ R  Y+ +   +    +  + ++AP
Sbjct: 145 YLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ + + 
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVLKFV- 245
Query: 591 PTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEF 646
             +D  Y D  +   E V  L  +C   +P+ RP+   +V  LL+D        D+H  F
Sbjct: 246 --MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLKD--------DLHPSF 294
Query: 647 P 647
           P
Sbjct: 295 P 295

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 14  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 123
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 23/210 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRH-RNLVQLHGW 420
           +G G +G V + V   +G  +A+KR+      +  K+ + ++  + R      +VQ +G 
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 421 CRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             ++ +  +  + + + S DK         +D   ++IL      KI +   +AL +L E
Sbjct: 90  LFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKE 143
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE---- 531
             + +++HRD+KPSN+L+D   N KL DFG++     +I    T   G   Y+APE    
Sbjct: 144 --NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERIDP 199
Query: 532 -LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +R G    S DV+  G  + E+A GR P
Sbjct: 200 SASRQGYDVRS-DVWSLGITLYELATGRFP 228

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 17  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 126
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 102
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 103 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 156
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D     +    V T  Y 
Sbjct: 157 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGXVATRWYR 209
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 210 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 17/210 (8%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH---NSRQGMKEFVAEITSMGRLRHRN 413
           ++ + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           + +L+ +   +    LV +    G L    FD    +K+    D   +I+  V   + Y 
Sbjct: 88  IXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSEVDAA-RIIRQVLSGITYX 142
Query: 474 HEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+    ++VHRD+KP N+L+++   D N ++ DFGL+  ++   + +    +GT  Y+AP
Sbjct: 143 HK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKXKDKIGTAYYIAP 197
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      DV+  G ++  +  G  P
Sbjct: 198 EVLH-GTYDEKCDVWSTGVILYILLSGCPP 226

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+RG     G EVA+K    +SR+    F  AEI     LRH N++      
Sbjct: 37  IGKGRFGEVWRG--KWRGEEVAVK--IFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 422 RKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            K +    +L LV DY  +GSL       D   +  +  +   K+ +  A  L +LH E 
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSL------FDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 146
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---NINPQTTHIVGTLGYLA 529
                   + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y+A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 530 PEL------TRTGKATTSTDVFGFGTLMLEVA 555
           PE+       +  ++    D++  G +  E+A
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 124/280 (44%), Gaps = 37/280 (13%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 76
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N  +  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 137 GMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 193
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           ++PE  + G  TT +DV+ FG ++ E+A    +P   Q  + E VL         +G + 
Sbjct: 194 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLL 246
Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
              D   D        ++L L  +C   +P  RPS   ++
Sbjct: 247 DKPDNCPD--------MLLELMRMCWQYNPKMRPSFLEII 278

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 14/214 (6%)
Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL 409
           S T  ++    +G G F  V R V   TG E A K +     S +  ++   E      L
Sbjct: 1   SMTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +H N+V+LH    ++    LV+D V  G     LF++   ++     D  + I   + +A
Sbjct: 61  KHSNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCIQ-QILEA 115
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLG 526
           +L+ H+     VVHRD+KP N+L+ +       KL DFGLA     +         GT G
Sbjct: 116 VLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFG-FAGTPG 171
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           YL+PE+ R        D++  G ++  +  G  P
Sbjct: 172 YLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/265 (24%), Positives = 106/265 (40%), Gaps = 70/265 (26%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLV 415
           F     +G GGFG V+           AIKR+   +R+  +E V  E+ ++ +L H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67
Query: 416 QL---------HGWCRKQDELLLVYDYV------------PNGSLDKL------------ 442
           +            W  + DE+ L  +              P+  + ++            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 443 --------LFDNDQ--QKKKILNWDQR------------YKILIGVAQALLYLHEECDQR 480
                   L+   Q  +K+ + +W  R              I I +A+A+ +LH    + 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKG 184
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---------THI--VGTLGYLA 529
           ++HRD+KPSN+    D   K+GDFGL  A D +   QT         TH   VGT  Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 530 PELTRTGKATTSTDVFGFGTLMLEV 554
           PE       +   D+F  G ++ E+
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFEL 269

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 128/305 (41%), Gaps = 54/305 (17%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG----- 526
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R    +I        G  G     
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           ++APE  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 587 RAIDPTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
           + +   +D  Y D  +   E V  L  +C   +P+ RP+   +V  LL+D        D+
Sbjct: 243 KFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEIVN-LLKD--------DL 290
Query: 643 HHEFP 647
           H  FP
Sbjct: 291 HPSFP 295

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/263 (29%), Positives = 125/263 (47%), Gaps = 46/263 (17%)
Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVS--NDQG----RILGHAFYPSPLRFK 69
           AET SF +N F+  Q N+ L G A V   G L ++  ++ G      LG A Y +P+   
Sbjct: 1   AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHI- 59
Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
               ++    +++  A +F  NF F   P   +L   GLAF L      P   A  YLGL
Sbjct: 60  ----WDKETGSVASFAASF--NFTF-YAPDTKRLA-DGLAFFLAPIDTKPQTHAG-YLGL 110
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+  +     +++AVEFD  +N    D  + H+GI+++S+ S          +   ++ 
Sbjct: 111 FNENESGD---QVVAVEFDTFRNS--WDPPNPHIGINVNSIRS--------IKTTSWDLA 157
Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRP-LISYPIDLATVLDEYMY 248
           ++ ++ VL         I Y++   L+   ++ L  P      ++S  +DL T L E++ 
Sbjct: 158 NNKVAKVL---------ITYDASTSLL---VASLVYPSQRTSNILSDVVDLKTSLPEWVR 205
Query: 249 VGFSASTGLLT--AFHNVHGWSF 269
           +GFSA+TGL      H+V  WSF
Sbjct: 206 IGFSAATGLDIPGESHDVLSWSF 228

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 27/218 (12%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH-------------NSRQGMKEFVAEITSMGRL 409
           +GSG +G+V      +   E AIK +               N  +  +E   EI+ +  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
            H N+++L      +    LV ++   G L    F+    + K    D    I+  +   
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FEQIINRHKFDECDAA-NIMKQILSG 158
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
           + YLH+     +VHRD+KP N+L++     LN K+ DFGL+  +  +   +    +GT  
Sbjct: 159 ICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR--LGTAY 213
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           Y+APE+ +  K     DV+  G +M  + CG  P   Q
Sbjct: 214 YIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ 250

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 108/262 (41%), Gaps = 45/262 (17%)
Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNI 76
           ET SF+   F   Q NL   G  +  K+  L ++      +G A Y SP+        N+
Sbjct: 2   ETTSFLITKFSPDQQNLIFQGDGYTTKEK-LTLTKAVKNTVGRALYSSPIHIWDRETGNV 60
Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA 136
            N         F T+F F I          G  F +      P      YLG+ N     
Sbjct: 61  AN---------FVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQT-GGGYLGVFNSAEYD 110
Query: 137 KFSTRILAVEFDAVQNLELQDIN-DNHVGIDISSLISNISEPAAYYFSKGSNINDDNISV 195
           K +T+ +AVEFD   N      N D H+GID++S+ S               +N    S 
Sbjct: 111 K-TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKS---------------VNTK--SW 152
Query: 196 VLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPL--------ISYPIDLATVLDEYM 247
            L++G+     I +N+   ++ V+++      P+  L        +S  + L  V+ E++
Sbjct: 153 KLQNGEEANVVIAFNAATNVLTVSLT-----YPNNSLEEEVTSYTLSDVVSLKDVVPEWV 207
Query: 248 YVGFSASTGLLTAFHNVHGWSF 269
            +GFSA+TG   A H V  WSF
Sbjct: 208 RIGFSATTGAEYAAHEVLSWSF 229

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 23/211 (10%)
Query: 358 REKNL--VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRN 413
           R +NL  VGSG +G V       TG  VA+K+++    S    K    E+  +  ++H N
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHEN 82
Query: 414 LVQLHGW---CRKQDELLLVY--DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           ++ L       R  +E   VY   ++    L+ ++      K + L  D    ++  + +
Sbjct: 83  VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIV------KCQKLTDDHVQFLIYQILR 136
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            L Y+H      ++HRD+KPSN+ ++ D   K+ DF LAR  D     + T  V T  Y 
Sbjct: 137 GLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD----EMTGYVATRWYR 189
Query: 529 APELTRTGKATTST-DVFGFGTLMLEVACGR 558
           APE+         T D++  G +M E+  GR
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 25/219 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAI-----KRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           +G G F  VY+G+   T +EVA      +++  + RQ  KE   E   +  L+H N+V+ 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVRF 90
Query: 418 H-GW---CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKIL-NWDQRYKILIGVAQALLY 472
           +  W    + +  ++LV +   +G+L   L      K K+L +W ++      + + L +
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQF 144
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           LH      ++HRD+K  N+ I       K+GD GLA     +       ++GT  + APE
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFXAPE 200
Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
                K   S DV+ FG   LE A    P    + A ++
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQI 238

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTG--------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           ++G GG+GKV++ V   TG        ++V  K +   + +      AE   +  ++H  
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L    +   +L L+ +Y+  G L   L     +++ I   D     L  ++ AL +L
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQL-----EREGIFMEDTACFYLAEISMALGHL 137
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H+   + +++RD+KP N++++   + KL DFGL +   H+    T    GT+ Y+APE+ 
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHXFCGTIEYMAPEIL 193
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
                  + D +  G LM ++  G  P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 99/207 (47%), Gaps = 18/207 (8%)
Query: 362 LVGSGGFGKVYRGVIPSTG--------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           ++G GG+GKV++ V   TG        ++V  K +   + +      AE   +  ++H  
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L    +   +L L+ +Y+  G L   L     +++ I   D     L  ++ AL +L
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQL-----EREGIFMEDTACFYLAEISMALGHL 137
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H+   + +++RD+KP N++++   + KL DFGL +   H+    T    GT+ Y+APE+ 
Sbjct: 138 HQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD-GTVTHTFCGTIEYMAPEIL 193
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
                  + D +  G LM ++  G  P
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPP 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 23/209 (11%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHR 412
           +G G FG VY GV        P T   VAIK V  N    M+E   F+ E + M      
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTV--NEAASMRERIEFLNEASVMKEFNCH 88
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVA 467
           ++V+L G   +    L++ + +  G L   L           +L   +  +  ++   +A
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLG 526
             + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + 
Sbjct: 149 DGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVA 555
           +++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 206 WMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +KE    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL-- 471
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 472 -YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH      +++RD+KP N++ID     K+ DFGLA+     +  +T  + GT  YLAP
Sbjct: 155 EYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAP 207
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           E+  +     + D +  G L+ E+A G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y+P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y+P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 54/305 (17%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 144
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG----- 526
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R    +I        G  G     
Sbjct: 145 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 197
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           ++APE  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ 
Sbjct: 198 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 242
Query: 587 RAIDPTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
           + +   +D  Y D  +   E V  L  +C   +P  RP+   +V  LL+D        D+
Sbjct: 243 KFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLKD--------DL 290
Query: 643 HHEFP 647
           H  FP
Sbjct: 291 HPSFP 295

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +    F + ++  +      R+      AQ +L  
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 147
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 203
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 37/222 (16%)
Query: 363 VGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL-RHRNLV 415
           +G+G FGKV        G     L+VA+K +   +    KE  ++E+  M  L +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDN------------------DQQKKKILNWD 457
            L G C     +L++ +Y   G L   L                     D++  + L   
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ 517
                   VAQ + +L     +  +HRDV   NVL+      K+GDFGLAR    +I   
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMND 211
Query: 518 TTHIVG-----TLGYLAPELTRTGKATTSTDVFGFGTLMLEV 554
           + +IV       + ++APE       T  +DV+ +G L+ E+
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 15/207 (7%)
Query: 361 NLVGSGGFGKVYRGVIPS---TGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
            ++G G FG V  G +     T L+VA+K  ++ ++S++ ++EF++E   M    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 416 QLHGWCRKQD-----ELLLVYDYVPNGSLDK-LLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +L G C +       + +++  ++  G L   LL+   +   K +      K ++ +A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTLGYL 528
           + YL    ++  +HRD+   N ++  D+   + DFGL++  Y  +   Q       + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVA 555
           A E       T+ +DV+ FG  M E+A
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIA 243

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 79
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L           +L   +  +  ++   +A 
Sbjct: 80  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 139
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGY 527
            + YL+     + VHRD+   N ++  D   K+GDFG+ R  Y+ +   +    +  + +
Sbjct: 140 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 196
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVA 555
           ++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 197 MSPESLKDGVFTTYSDVWSFGVVLWEIA 224

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 83
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG-- 526
            + YL+     + VHRD+   N ++  D   K+GDFG+ R    +I        G  G  
Sbjct: 144 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLL 196
Query: 527 ---YLAPELTRTGKATTSTDVFGFGTLMLEVA 555
              +++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 228

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 343 CRFRYSEL--YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV 400
           C+++  EL  +     F    ++G GGFG+VY      TG   A+K      R  MK+  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ-- 231
Query: 401 AEITSMGRLRHRNLVQLHGWC----------RKQDELLLVYDYVPNGSLDKLLFDNDQQK 450
            E  ++      +LV   G C             D+L  + D +  G L   L     Q 
Sbjct: 232 GETLALNERIMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQH 286
Query: 451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY 510
                 D R+      A+ +L L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +
Sbjct: 287 GVFSEADMRFY----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
                P  +  VGT GY+APE+ + G A  +S D F  G ++ ++  G  P    +T
Sbjct: 343 SKK-KPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 343 CRFRYSEL--YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV 400
           C+++  EL  +     F    ++G GGFG+VY      TG   A+K      R  MK+  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ-- 231
Query: 401 AEITSMGRLRHRNLVQLHGWC----------RKQDELLLVYDYVPNGSLDKLLFDNDQQK 450
            E  ++      +LV   G C             D+L  + D +  G L   L     Q 
Sbjct: 232 GETLALNERIMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQH 286
Query: 451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY 510
                 D R+      A+ +L L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +
Sbjct: 287 GVFSEADMRFY----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
                P  +  VGT GY+APE+ + G A  +S D F  G ++ ++  G  P    +T
Sbjct: 343 SKK-KPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 14/205 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEI-TSMGRLRHRNLVQLHGW 420
           +G G +G V +     +G  +A+KR+ A  + Q  K  + ++  SM  +     V  +G 
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             ++ ++ +  + + + SLDK  +     K + +  D   KI + + +AL +LH +    
Sbjct: 119 LFREGDVWICMELM-DTSLDKF-YKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 174
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA-----PELTRT 535
           V+HRDVKPSNVLI+A    K+ DFG++     ++    T   G   Y+A     PEL + 
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSV--AKTIDAGCKPYMAPERINPELNQK 232
Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
           G +  S D++  G  M+E+A  R P
Sbjct: 233 GYSVKS-DIWSLGITMIELAILRFP 256

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 343 CRFRYSEL--YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV 400
           C+++  EL  +     F    ++G GGFG+VY      TG   A+K      R  MK+  
Sbjct: 174 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ-- 230
Query: 401 AEITSMGRLRHRNLVQLHGWC----------RKQDELLLVYDYVPNGSLDKLLFDNDQQK 450
            E  ++      +LV   G C             D+L  + D +  G L   L     Q 
Sbjct: 231 GETLALNERIMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQH 285
Query: 451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY 510
                 D R+      A+ +L L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +
Sbjct: 286 GVFSEADMRFY----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 341
Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
                P  +  VGT GY+APE+ + G A  +S D F  G ++ ++  G  P    +T
Sbjct: 342 SKK-KPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 395

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 28/237 (11%)
Query: 343 CRFRYSEL--YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV 400
           C+++  EL  +     F    ++G GGFG+VY      TG   A+K      R  MK+  
Sbjct: 175 CQWKNVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQ-- 231
Query: 401 AEITSMGRLRHRNLVQLHGWC----------RKQDELLLVYDYVPNGSLDKLLFDNDQQK 450
            E  ++      +LV   G C             D+L  + D +  G L   L     Q 
Sbjct: 232 GETLALNERIMLSLVST-GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQH 286
Query: 451 KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY 510
                 D R+      A+ +L L    ++ VV+RD+KP+N+L+D   + ++ D GLA  +
Sbjct: 287 GVFSEADMRFY----AAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342
Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
                P  +  VGT GY+APE+ + G A  +S D F  G ++ ++  G  P    +T
Sbjct: 343 SKK-KPHAS--VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 396

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 54/305 (17%)
Query: 363 VGSGGFGKVYRG-----VIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG VY G     +       VA+K V  + S +   EF+ E + M      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFD-----NDQQKKKILNWDQRYKILIGVAQALL 471
           L G   K    L+V + + +G L   L        +   +      +  ++   +A  + 
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 141
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG----- 526
           YL+    ++ VHRD+   N ++  D   K+GDFG+ R    +I        G  G     
Sbjct: 142 YLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPVR 194
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           ++APE  + G  TTS+D++ FG ++ E+                 L +   +  S  Q+ 
Sbjct: 195 WMAPESLKDGVFTTSSDMWSFGVVLWEITS---------------LAEQPYQGLSNEQVL 239
Query: 587 RAIDPTLD--YFDPQE--AELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
           + +   +D  Y D  +   E V  L  +C   +P  RP+   +V  LL+D        D+
Sbjct: 240 KFV---MDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVN-LLKD--------DL 287
Query: 643 HHEFP 647
           H  FP
Sbjct: 288 HPSFP 292

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K +++   +GSG  G V        G+ VA+K+++    ++   K    E+  +  
Sbjct: 18  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 77
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL----LYQM 133
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    N     T  V
Sbjct: 134 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNF--MMTPYV 184
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 185 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 33/220 (15%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G +G V++     TG  VAIK+   +    + + +A  EI  + +L+H NLV L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 421 CRKQDELLLVYDYVPNG---SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            R++  L LV++Y  +     LD+      +   K + W           QA+ + H+  
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAVNFCHK-- 120
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-------YDHNINPQTTHIVGTLGYLAP 530
               +HRDVKP N+LI      KL DFG AR        YD          V T  Y +P
Sbjct: 121 -HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE--------VATRWYRSP 171
Query: 531 E-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
           E L    +     DV+  G +  E+  G  P+ P ++ ++
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKSDVD 210

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 147
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 203
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 204 LSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)
Query: 363 VGSGGFGKVYRGVI-------PSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRN 413
           +G G FG VY GV        P T   VAIK V  A + R+ + EF+ E + M      +
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPET--RVAIKTVNEAASMRERI-EFLNEASVMKEFNCHH 74
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKIL---NWDQRYKILIGVAQ 468
           +V+L G   +    L++ + +  G L   L     + +   +L   +  +  ++   +A 
Sbjct: 75  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 134
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG-- 526
            + YL+     + VHRD+   N ++  D   K+GDFG+ R    +I        G  G  
Sbjct: 135 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDXXRKGGKGLL 187
Query: 527 ---YLAPELTRTGKATTSTDVFGFGTLMLEVA 555
              +++PE  + G  TT +DV+ FG ++ E+A
Sbjct: 188 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 219

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           + G+  K  +G G + +  R V  +T +E A+K V   S++   E +  +   G+  H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVK-VIDKSKRDPSEEIEILLRYGQ--HPN 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++ L         + LV + +  G L DK+L      ++K  +  +   +L  + + + Y
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKTVEY 136
Query: 473 LHEECDQRVVHRDVKPSNVL-IDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           LH    Q VVHRD+KPSN+L +D   NP   ++ DFG A+      N        T  ++
Sbjct: 137 LH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-NGLLMTPCYTANFV 192
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELV 571
           APE+ +        D++  G L+  +  G  P    P  T  E++
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 185
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/262 (29%), Positives = 114/262 (43%), Gaps = 48/262 (18%)
Query: 22  SFIYNGFIQANLSLDGTAFVRKDGILA----------VSNDQGRILGHAFYPSPLRFKQL 71
           SFI     + NL   G A   ++ IL           V +  GRIL  A         Q+
Sbjct: 15  SFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSA---------QV 65
Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQP-PSCLANQYLGLP 130
             +  + N +++    FS  F  S     P     G+AF +       PS  A   LGL 
Sbjct: 66  RLWEKSTNRVANLQTQFS--FFLSSPLSNP---ADGIAFFIAPPDTTIPSGSAGGLLGLF 120
Query: 131 N-DTSNAKFSTRILAVEFDA--VQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSN 187
           N  T+  + + ++LAVEFD    QN    D N  H+GID++S+ S  S+   +   +G  
Sbjct: 121 NPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRS--SKVVRWERREGKT 178
Query: 188 INDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYM 247
           +N      VL         + YN     I+V  +    P   R  +S+ +DL T+L E++
Sbjct: 179 LN------VL---------VTYNPSTRTIDVVAT---YPDGQRYQLSHVVDLTTILPEWV 220
Query: 248 YVGFSASTGLLTAFHNVHGWSF 269
            VGFSA++G     HN+  WSF
Sbjct: 221 RVGFSAASGEQFQTHNLESWSF 242

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 97/215 (45%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K +++   +GSG  G V        G+ VA+K+++    ++   K    E+  +  
Sbjct: 20  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    N     T  V
Sbjct: 136 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 102/224 (45%), Gaps = 26/224 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +GSG FG V+R V  +TG     K +  N+   + ++    EI+ M +L H  L+ LH  
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 421 CRKQDELLLVYDYVPNGSL-DKLLF-DNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
              + E++L+ +++  G L D++   D    + +++N+      +    + L ++HE   
Sbjct: 117 FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINY------MRQACEGLKHMHE--- 167
Query: 479 QRVVHRDVKPSNVLIDADL--NPKLGDFGLARAYDHNINPQTTHIV--GTLGYLAPELTR 534
             +VH D+KP N++ +     + K+ DFGLA      +NP     V   T  + APE+  
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLAT----KLNPDEIVKVTTATAEFAAPEIVD 223
Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQ---RTAMELVLVDW 575
                  TD++  G L   +  G  P   +    T   +   DW
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1IOA|A Chain A, Arcelin-5, A Lectin-Like Defense Protein From Phaseolus Vulgaris Length = 240

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 48/246 (19%)
Query: 33  LSLDGTAFVRKDGILAV----SNDQGRI--LGHAFYPSPLRFKQLSKYNINNNTISHTAL 86
           L L G A +   G L +    SN+  R+  LG AFY  P++ K            S+   
Sbjct: 17  LILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD-----------SNNVA 65
Query: 87  TFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVE 146
           +F+TNF F I  K   +  +GLAF L+    PP     ++LG+ N T+N + + R +AV 
Sbjct: 66  SFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFN-TNNPEPNARTVAVV 123
Query: 147 FDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAW 206
           F+  +         N +  D + +   ++E   ++   G      ++ +   S +     
Sbjct: 124 FNTFK---------NRIDFDKNFIKPYVNENCDFHKYNGEKT---DVQITYDSSN----- 166
Query: 207 IDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL---LTAFHN 263
              N   + ++ T+S +      +  +S  + L   +DE++ VGFS ++GL    T  H+
Sbjct: 167 ---NDLRVFLHFTVSQV------KCSVSATVHLEKEVDEWVSVGFSPTSGLTEDTTETHD 217
Query: 264 VHGWSF 269
           V  WSF
Sbjct: 218 VLSWSF 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 80  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 188
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 71  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 178
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G F  V R V    G E A K +     S +  ++   E      L+H N+V+LH  
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             ++    L++D V  G     LF++   ++     D  + I   + +A+L+ H+     
Sbjct: 90  ISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASHCIQ-QILEAVLHCHQ---MG 141
Query: 481 VVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
           VVHRD+KP N+L+ + L     KL DFGLA   +           GT GYL+PE+ R   
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLRKDP 200
Query: 538 ATTSTDVFGFGTLMLEVACGRRP 560
                D++  G ++  +  G  P
Sbjct: 201 YGKPVDLWACGVILYILLVGYPP 223

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 78  PHVCRLLGICLTST-VQLIMQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 130
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 185
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 20/225 (8%)
Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           T G+  K  +G G +    R +  +T +E A+K +  + R   +E +  +   G+  H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-IEILLRYGQ--HPN 77
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++ L         + +V + +  G L DK+L      ++K  +  +   +L  + + + Y
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKIL------RQKFFSEREASAVLFTITKTVEY 131
Query: 473 LHEECDQRVVHRDVKPSNVL-IDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           LH    Q VVHRD+KPSN+L +D   NP   ++ DFG A+      N        T  ++
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANFV 187
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELV 571
           APE+        + D++  G L+  +  G  P    P  T  E++
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 74  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 181
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 102 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 154
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 155 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 209
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/231 (24%), Positives = 106/231 (45%), Gaps = 28/231 (12%)
Query: 346 RYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITS 405
           ++ ++Y  T       L+G G + KV   V    G E A+K +   +         E+ +
Sbjct: 9   KFEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET 63
Query: 406 MGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
           + + + ++N+++L  +        LV++ +  GS+   +     QK+K  N  +  +++ 
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI-----QKQKHFNEREASRVVR 118
Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDA--DLNP-KLGDFGLARAYDHN------IN 515
            VA AL +LH    + + HRD+KP N+L ++   ++P K+ DF L      N        
Sbjct: 119 DVAAALDFLH---TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITT 175
Query: 516 PQTTHIVGTLGYLAPELTR--TGKAT---TSTDVFGFGTLMLEVACGRRPI 561
           P+ T   G+  Y+APE+    T +AT      D++  G ++  +  G  P 
Sbjct: 176 PELTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 102/205 (49%), Gaps = 14/205 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEI-TSMGRLRHRNLVQLHGW 420
           +G G +G V +     +G  +A+KR+ A  + Q  K  + ++  SM  +     V  +G 
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             ++ ++ +  + + + SLDK  +     K + +  D   KI + + +AL +LH +    
Sbjct: 75  LFREGDVWICMELM-DTSLDKF-YKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 130
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA-----PELTRT 535
           V+HRDVKPSNVLI+A    K+ DFG++     ++        G   Y+A     PEL + 
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERINPELNQK 188
Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
           G +  S D++  G  M+E+A  R P
Sbjct: 189 GYSVKS-DIWSLGITMIELAILRFP 212

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G+G +G V       TG +VAIK++  A +     K  + E+  +   +H N++ +   
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 421 CRKQDELLLVYDYVPNGSLDKL-----LFDNDQQK----KKILNWDQRYKILIGVAQALL 471
            R           VP G    +     L ++D  +     + L  +     L  + + L 
Sbjct: 122 LRPT---------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-----DHNINPQTTHIVGTLG 526
           Y+H     +V+HRD+KPSN+L++ +   K+GDFG+AR       +H      T  V T  
Sbjct: 173 YMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF--MTEYVATRW 227
Query: 527 YLAPELTRT-GKATTSTDVFGFGTLMLEVACGRR 559
           Y APEL  +  + T + D++  G +  E+   R+
Sbjct: 228 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 83  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 135
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 190
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +    F + ++  +      R+      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +    F + ++  +      R+      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 87  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 139
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 194
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 175
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 231
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 232 LSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +    F + ++  +      R+      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 21/216 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHR 412
           F    ++G G FGKV+      T    AIK +  +      +    +     L     H 
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIGVAQAL 470
            L  +    + ++ L  V +Y+  G L   ++      K  L+    Y  +I++G    L
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILG----L 132
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYL 528
            +LH    + +V+RD+K  N+L+D D + K+ DFG+ +    N+  + +T    GT  Y+
Sbjct: 133 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTPDYI 186
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           APE+    K   S D + FG L+ E+  G+ P   Q
Sbjct: 187 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 21/211 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +KE    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL-- 471
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 472 -YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH      +++RD+KP N++ID     ++ DFGLA+     +  +T  + GT  YLAP
Sbjct: 155 EYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAP 207
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           E+  +     + D +  G L+ E+A G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           + G+  K  +G G + +  R V  +T +E A+K V   S++   E +  +   G+  H N
Sbjct: 26  SDGYVVKETIGVGSYSECKRCVHKATNMEYAVK-VIDKSKRDPSEEIEILLRYGQ--HPN 82
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++ L         + LV + +  G L DK+L      ++K  +  +   +L  + + + Y
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKIL------RQKFFSEREASFVLHTIGKTVEY 136
Query: 473 LHEECDQRVVHRDVKPSNVL-IDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           LH    Q VVHRD+KPSN+L +D   NP   ++ DFG A+      N        T  ++
Sbjct: 137 LH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-NGLLMTPCYTANFV 192
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELV 571
           APE+ +        D++  G L+  +  G  P    P  T  E++
Sbjct: 193 APEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEIL 237

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGXLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 63.5 bits (153), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 80  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 132
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G+G +G V       TG +VAIK++  A +     K  + E+  +   +H N++ +   
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 421 CRKQDELLLVYDYVPNGSLDKL-----LFDNDQQK----KKILNWDQRYKILIGVAQALL 471
            R           VP G    +     L ++D  +     + L  +     L  + + L 
Sbjct: 123 LRPT---------VPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-----DHNINPQTTHIVGTLG 526
           Y+H     +V+HRD+KPSN+L++ +   K+GDFG+AR       +H      T  V T  
Sbjct: 174 YMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF--MTEYVATRW 228
Query: 527 YLAPELTRT-GKATTSTDVFGFGTLMLEVACGRR 559
           Y APEL  +  + T + D++  G +  E+   R+
Sbjct: 229 YRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 140
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEII 196
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 197 LSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YVP G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 21/212 (9%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL----RHRNLVQ 416
            ++G G FGKV+      T    AIK +  +      +    +     L     H  L  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIGVAQALLYLH 474
           +    + ++ L  V +Y+  G L   ++      K  L+    Y  +I++G    L +LH
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDL---MYHIQSCHKFDLSRATFYAAEIILG----LQFLH 135
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLAPEL 532
               + +V+RD+K  N+L+D D + K+ DFG+ +    N+  + +T    GT  Y+APE+
Sbjct: 136 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFCGTPDYIAPEI 189
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
               K   S D + FG L+ E+  G+ P   Q
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y P G +    F + ++  +      R+      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG----- 395
            A R   +EL++    +  +  + SG +G V  GV  S G+ VAIKRV +    G     
Sbjct: 8   AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 396 ------MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ 449
                  K  + EI  +    H N++ L            ++ +    ++ KL    +  
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRD----------IFVHFEEPAMHKLYLVTELM 116
Query: 450 KKKILNWDQRYKILIG-------VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG 502
           +  +       +I+I        +   LL LH   +  VVHRD+ P N+L+  + +  + 
Sbjct: 117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176
Query: 503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS-TDVFGFGTLMLEV 554
           DF LAR  +   +   TH V    Y APEL    K  T   D++  G +M E+
Sbjct: 177 DFNLAR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 102/223 (45%), Gaps = 26/223 (11%)
Query: 346 RYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVA-----IKRVAHNSRQGMKEFV 400
           R++E Y     F E   +G G F  V R V    G E A      K+++    Q + E  
Sbjct: 8   RFTEEYQL---FEE---LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-ERE 60
Query: 401 AEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY 460
           A I  +  L+H N+V+LH    ++    L++D V  G     LF++   ++     D  +
Sbjct: 61  ARICRL--LKHPNIVRLHDSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADASH 114
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQ 517
            I   + +A+L+ H+     VVHR++KP N+L+ + L     KL DFGLA   +      
Sbjct: 115 CIQ-QILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170
Query: 518 TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
                GT GYL+PE+ R        D++  G ++  +  G  P
Sbjct: 171 FG-FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 111/264 (42%), Gaps = 46/264 (17%)
Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQL 71
           E+ SF +  F   Q NL L   A V   G L ++           LG A Y +P+     
Sbjct: 2   ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPI----- 56
Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
              +I++NT   T  +F+T+F F +          GLAF L      P      +LGL  
Sbjct: 57  ---HIHDNT---TLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQARGG-FLGLFA 109
Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           D ++   S + +AVEFD   N    D N  H+GID + + S  + P    + + +NI   
Sbjct: 110 DRAHDA-SYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIESKKTTPFDMVYGEKANI--- 163
Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPL-ISYPIDLATVLDEYMYVG 250
                          I Y +    +  +   L  P       +S  +DL  +L EY+ VG
Sbjct: 164 --------------VITYQASTKALAAS---LVFPVSQTSYAVSARVDLRDILPEYVRVG 206
Query: 251 FSASTGL---LTAFHNVHGWSFKI 271
           FSA+TGL   +   H++  WSF +
Sbjct: 207 FSATTGLNAGVVETHDIVSWSFAV 230

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 97/233 (41%), Gaps = 32/233 (13%)
Query: 341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG----- 395
            A R   +EL++    +  +  + SG +G V  GV  S G+ VAIKRV +    G     
Sbjct: 8   AAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGV-DSEGIPVAIKRVFNTVSDGRTVNI 66
Query: 396 ------MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ 449
                  K  + EI  +    H N++ L            ++ +    ++ KL    +  
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLRD----------IFVHFEEPAMHKLYLVTELM 116
Query: 450 KKKILNWDQRYKILIG-------VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG 502
           +  +       +I+I        +   LL LH   +  VVHRD+ P N+L+  + +  + 
Sbjct: 117 RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176
Query: 503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS-TDVFGFGTLMLEV 554
           DF LAR  +   +   TH V    Y APEL    K  T   D++  G +M E+
Sbjct: 177 DFNLAR--EDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEM 227

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 117/266 (43%), Gaps = 51/266 (19%)
Query: 18  AETNSFIYNGFIQANLSLDGTAFV----------RKDGILAVSNDQGRILGHAFYPSPLR 67
           A+  SF +  F  ++  L G A V          + +G+  +S+     LG AFY SP++
Sbjct: 1   ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSS-----LGRAFYSSPIQ 55
Query: 68  FKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYL 127
                 Y+ +   ++  A +F+ N    I          G+AF L+     P   +  +L
Sbjct: 56  I-----YDKSTGAVASWATSFTAN----IFAPNKSSSADGIAFALVPVGSEPKSNSG-FL 105
Query: 128 GLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSN 187
           G+  D+     S + +AVEFD   N +  D    H+GID++S+ S     A++  + G N
Sbjct: 106 GV-FDSDVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKS--IRTASWGLANGQN 161
Query: 188 INDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRP-LISYPIDLATVLDEY 246
                           +  I YN+   L+   ++ L  P      ++S  +D+   L EY
Sbjct: 162 A---------------EILITYNAATSLL---VASLVHPSRRTSYIVSERVDITNELPEY 203
Query: 247 MYVGFSASTGL---LTAFHNVHGWSF 269
           + +GFSA+TGL    T  H+V  WSF
Sbjct: 204 VSIGFSATTGLSEGYTETHDVLSWSF 229

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 123
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H   +  V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 124 RHCH---NXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 177
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 221
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 222 ------FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-----KEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+    G +V I       R+       KE + E   M  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 111 PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 163
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 218
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 92/220 (41%), Gaps = 38/220 (17%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAE--ITSMGRLRHRNLVQL-- 417
           L+G G +G VY+G +      VA+K  +  +RQ    F+ E  I  +  + H N+ +   
Sbjct: 20  LIGRGRYGAVYKGSLDER--PVAVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFIV 74
Query: 418 ---HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
                    + E LLV +Y PNGSL K L           +W    ++   V + L YLH
Sbjct: 75  GDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSSCRLAHSVTRGLAYLH 128
Query: 475 EECDQ------RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN--INP-----QTTHI 521
            E  +       + HRD+   NVL+  D    + DFGL+     N  + P          
Sbjct: 129 TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISE 188
Query: 522 VGTLGYLAPE-------LTRTGKATTSTDVFGFGTLMLEV 554
           VGT+ Y+APE       L     A    D++  G +  E+
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 128
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 129 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 182
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 226
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 227 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 276

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +      +  N   
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LVKLEFSFKDNSNLYMVLEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N+LID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 71
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 72  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 127
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 128 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 181
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 225
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 226 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 275

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 70
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 71  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 126
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 127 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 180
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 224
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 225 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 274

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 114
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 115 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 170
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 171 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 224
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 268
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 269 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 318

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 123
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 124 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 177
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 221
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++ SG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 84  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 128
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 129 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 182
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 226
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 227 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 276

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 81  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 133
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 188
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 73  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 128
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 129 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 182
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 183 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 226
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 227 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 276

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++ SG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 156 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 209
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 253
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 254 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 303

>pdb|1QMO|E Chain E, Structure Of Fril, A Legume Lectin That Delays Hematopoietic Progenitor Maturation Length = 133

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Composition-based stats.
 Identities = 45/130 (34%), Positives = 65/130 (50%), Gaps = 20/130 (15%)
Query: 140 TRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
           + ++AVEFD   N +  D N  H+GID++S+ S ++    +                 ++
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDW-----------------QN 43
Query: 200 GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLT 259
           G    A I YNS    ++VT    G  KP    +SY I+L TVL E++ VG SASTG   
Sbjct: 44  GKIATAHISYNSVSKRLSVTSYYAG-SKP--ATLSYDIELHTVLPEWVRVGLSASTGQDK 100
Query: 260 AFHNVHGWSF 269
             + VH WSF
Sbjct: 101 ERNTVHSWSF 110

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 79  PHVCRLLGICLTST-VQLIMQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 86
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 87  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 142
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 143 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 196
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 240
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 241 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 290

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 77  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 129
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 184
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 20/225 (8%)
Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           T G+  K  +G G +    R +  +T  E A+K +  + R   +E +  +   G+  H N
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEE-IEILLRYGQ--HPN 77
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++ L         + +V +    G L DK+L      ++K  +  +   +L  + + + Y
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKIL------RQKFFSEREASAVLFTITKTVEY 131
Query: 473 LHEECDQRVVHRDVKPSNVL-IDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           LH    Q VVHRD+KPSN+L +D   NP   ++ DFG A+      N        T  ++
Sbjct: 132 LHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLXTPCYTANFV 187
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRPIE--PQRTAMELV 571
           APE+        + D++  G L+     G  P    P  T  E++
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL 232

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 114
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 115 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 170
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 171 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 224
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 225 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 86
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 87  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 142
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 143 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 196
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 197 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++ SG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFGLA+        +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 143
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 144 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 197
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 156
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 157 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 210
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 346 RYSELYSATKGFREK-------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQG 395
           RY +  +  +  R K        ++G G FG+V      ST    A+K ++      R  
Sbjct: 58  RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 117
Query: 396 MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN 455
              F  E   M       +VQL    +    L +V +Y+P G L  L+ + D  +K    
Sbjct: 118 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---- 173
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN 515
           W + Y      A+ +L L        +HRDVKP N+L+D   + KL DFG     +    
Sbjct: 174 WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 516 PQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPI 561
            +    VGT  Y++PE+ ++    G      D +  G  + E+  G  P 
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/221 (27%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH---- 418
           +G GG G V+  V       VAIK++     Q +K  + EI  + RL H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 419 ----------GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR---YKILIG 465
                     G   + + + +V +Y+           N  ++  +L    R   Y++L G
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYMETD------LANVLEQGPLLEEHARLFMYQLLRG 132
Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNINPQTTHI--- 521
               L Y+H      V+HRD+KP+N+ I+  DL  K+GDFGLAR  D    P  +H    
Sbjct: 133 ----LKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD----PHYSHKGHL 181
Query: 522 ---VGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGR 558
              + T  Y +P L  +    T + D++  G +  E+  G+
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 156
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 157 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 210
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 156 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 209
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 143
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 144 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 197
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     ++ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 210
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 156
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 157 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 210
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 93/230 (40%), Gaps = 23/230 (10%)
Query: 346 RYSELYSATKGFREK-------NLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQG 395
           RY +  +  +  R K        ++G G FG+V      ST    A+K   +     R  
Sbjct: 53  RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 112
Query: 396 MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN 455
              F  E   M       +VQL    +    L +V +Y+P G L  L+ + D  +K    
Sbjct: 113 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---- 168
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN 515
           W + Y      A+ +L L        +HRDVKP N+L+D   + KL DFG     +    
Sbjct: 169 WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 223
Query: 516 PQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPI 561
            +    VGT  Y++PE+ ++    G      D +  G  + E+  G  P 
Sbjct: 224 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           L +L    +    L +V +Y P G +    F + ++  +      R+      AQ +L  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFXEPHARFY----AAQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 156 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 209
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 100 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 155
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 156 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 209
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 210 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 101 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 156
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 157 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 210
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 211 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 79  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 131
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 186
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 68  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 123
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 124 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 177
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 88  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 143
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 144 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 197
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 198 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 241
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 242 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 291

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 346 RYSELYSATKGFREK-------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQG 395
           RY +  +  +  R K        ++G G FG+V      ST    A+K ++      R  
Sbjct: 58  RYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSD 117
Query: 396 MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN 455
              F  E   M       +VQL    +    L +V +Y+P G L  L+ + D  +K    
Sbjct: 118 SAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK---- 173
Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN 515
           W + Y      A+ +L L        +HRDVKP N+L+D   + KL DFG     +    
Sbjct: 174 WARFY-----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM 228
Query: 516 PQTTHIVGTLGYLAPELTRT----GKATTSTDVFGFGTLMLEVACGRRPI 561
            +    VGT  Y++PE+ ++    G      D +  G  + E+  G  P 
Sbjct: 229 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 119/296 (40%), Gaps = 49/296 (16%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 38  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 94
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 95  FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 150
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 151 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 204
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA 588
           PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+   
Sbjct: 205 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV--- 248
Query: 589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                 +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 249 ------FFRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 298

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 15/206 (7%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQL 417
           ++G G FGKV       T    AIK +  +       ++  + E   +  L +   L QL
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H   +  D L  V +YV  G L   ++   Q  K      Q       ++  L +LH+  
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGK--FKEPQAVFYAAEISIGLFFLHK-- 138
Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT-HIVGTLGYLAPELTRTG 536
            + +++RD+K  NV++D++ + K+ DFG+ +  +H ++  TT    GT  Y+APE+    
Sbjct: 139 -RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIAYQ 195
Query: 537 KATTSTDVFGFGTLMLEVACGRRPIE 562
               S D + +G L+ E+  G+ P +
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 106
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++  +     R      V +A+
Sbjct: 107 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELAR-SFFWQVLEAV 162
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 163 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 216
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 217 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 23/215 (10%)
Query: 357 FREKNLVGSGGFGKVYRGV-IPS---TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+ IP      + VAIK +    S +  KE + E   M  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQA 469
            ++ +L G C     + L+   +P G L   + ++      + +LNW       + +A+ 
Sbjct: 84  PHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 136
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG---TLG 526
           + YL    D+R+VHRD+   NVL+    + K+ DFG  RA       +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFG--RAKLLGAEEKEYHAEGGKVPIK 191
Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           ++A E       T  +DV+ +G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           L +L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 26/214 (12%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 119
Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+
Sbjct: 120 FSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAV 175
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y  
Sbjct: 176 RHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSP 229
Query: 530 PELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIE 562
           PE  R  +    S  V+  G L+ ++ CG  P E
Sbjct: 230 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/297 (24%), Positives = 119/297 (40%), Gaps = 51/297 (17%)
Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----------SRQGMKEFVAEITSMGRLR 410
           L+GSGGFG VY G+  S  L VAIK V  +           +R  M+  + +  S G   
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 71
Query: 411 HRNLVQLHGWCRKQDELLLVYDYV-PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
              +++L  W  + D  +L+ + + P   L   + +    ++++            V +A
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELAR-----SFFWQVLEA 126
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           + + H  C   V+HRD+K  N+LID +    KL DFG        +    T   GT  Y 
Sbjct: 127 VRHCH-NCG--VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYS 180
Query: 529 APELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
            PE  R  +    S  V+  G L+ ++ CG  P E     +             +GQ+  
Sbjct: 181 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEII-------------RGQV-- 225
Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
                  +F  + +     L   C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 226 -------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 275

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 89/208 (42%), Gaps = 15/208 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           L +L    +    L +V +Y P G +   L       ++I  + + +      AQ +L  
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 155
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                  +++RD+KP N++ID     K+ DFG A+     +  +T  + GT  YLAPE+ 
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPEII 211
Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPI 561
            +     + D +  G L+ E+A G  P 
Sbjct: 212 LSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 113/282 (40%), Gaps = 44/282 (15%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR------ 410
           +R   L+G GGFG V+ G   +  L+VAIK +  N   G       +T    +       
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 411 ----HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGV 466
               H  +++L  W   Q+  +LV +  P  + D  LFD   +K  +     R      V
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRC-FFGQV 148
Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLN-PKLGDFGLARAYDHNINPQTTHIVGTL 525
             A+ + H    + VVHRD+K  N+LID      KL DFG + A  H  +   T   GT 
Sbjct: 149 VAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFG-SGALLH--DEPYTDFDGTR 202
Query: 526 GYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
            Y  PE ++R         V+  G L+ ++ CG  P E  +  +E        ELH    
Sbjct: 203 VYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILE-------AELHFPAH 255
Query: 585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVV 626
           ++           P    L+      C  P P  RPS   ++
Sbjct: 256 VS-----------PDCCALIRR----CLAPKPSSRPSLEEIL 282

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 131
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
            ++  +      R+      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 132 LRRIGRFXEPHARFY----AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 45  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 96
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 152
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
            ++  +      R+      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 153 LRRIGRFXEPHARFY----AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 208
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 209 AK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 361 NLVGSGGFGKVYRGVI---PSTGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G         ++ AIK ++     Q ++ F+ E   M  L H N++ 
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 417 LHGWCRKQDEL-LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           L G     + L  ++  Y+ +G  D L F    Q+   +         + VA+ + YL E
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHG--DLLQFIRSPQRNPTVK--DLISFGLQVARGMEYLAE 142
Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY---DHNINPQTTHIVGTLGYLAPEL 532
              Q+ VHRD+   N ++D     K+ DFGLAR     ++    Q  H    + + A E 
Sbjct: 143 ---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199
Query: 533 TRTGKATTSTDVFGFGTLMLEV 554
            +T + TT +DV+ FG L+ E+
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWEL 221

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 131
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
            ++  +      R+      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 132 LRRIGRFXEPHARFY----AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 131
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
            ++  +      R+      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 132 LRRIGRFXEPHARFY----AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 131
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
            ++  +      R+      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 132 LRRIGRFAEPHARFY----AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 19  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 70
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +    F +
Sbjct: 71  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSH 126
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
            ++  +      R+      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 127 LRRIGRFXEPHARFY----AAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 182
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 183 AK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 51/233 (21%)
Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           ++L+G+G +G V           VAIK++          K  + EI  + RL H ++V++
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 418 HGWC-----RKQDELLLVYDYVPNGSLDKL----LFDNDQQKKKILNWDQRYKILIGVAQ 468
                     K DEL +V + + +    KL    ++  +   K +L     Y +L+GV  
Sbjct: 118 LDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLL-----YNLLVGVK- 170
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---------------- 512
              Y+H      ++HRD+KP+N L++ D + K+ DFGLAR  D+                
Sbjct: 171 ---YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDD 224
Query: 513 ----------NINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEV 554
                     N+  Q T  V T  Y APEL    +  T + DV+  G +  E+
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 11  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 62
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 63  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 119
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 120 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGF 174
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 175 AK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 98/225 (43%), Gaps = 38/225 (16%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
            L+G G FG+VY G       EVAI+   +  ++   +K F  E+ +  + RH N+V   
Sbjct: 39  ELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G C     L ++       +L  ++ D     K +L+ ++  +I   + + + YLH +  
Sbjct: 96  GACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKG- 150
Query: 479 QRVVHRDVKPSNVLIDADLNPK--LGDFGL--------ARAYDHNINPQTTHIVGTLGYL 528
             ++H+D+K  NV  D   N K  + DFGL        A   +  +  Q     G L +L
Sbjct: 151 --ILHKDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQN----GWLCHL 201
Query: 529 APELTRTGKATTS---------TDVFGFGTLMLEVACGRRPIEPQ 564
           APE+ R     T          +DVF  GT+  E+     P + Q
Sbjct: 202 APEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ 246

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 39/222 (17%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHGW- 420
           VG G +G+V+RG+    G  VA+K  +    Q   +E   EI +   LRH N++      
Sbjct: 16  VGKGRYGEVWRGLW--HGESVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIASD 71
Query: 421 ---CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
                   +L L+  Y  +GSL   L      +++ L      ++ +  A  L +LH E 
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYDFL------QRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-------DHNINPQTTHIVGTL 525
                   + HRD K  NVL+ ++L   + D GLA  +       D   NP+    VGT 
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR----VGTK 181
Query: 526 GYLAPEL------TRTGKATTSTDVFGFGTLMLEVACGRRPI 561
            Y+APE+      T   ++   TD++ FG ++ E+A  RR I
Sbjct: 182 RYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTI 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 188 AK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +L H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 171
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAE-ITSMG 407
           E++ AT   R    +G G FG+V+R     TG + A+K+V       ++ F AE + +  
Sbjct: 91  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACA 140
Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
            L    +V L+G  R+   + +  + +  GSL +L+     +++  L  D+    L    
Sbjct: 141 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQAL 195
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQT----THIV 522
           + L YLH    +R++H DVK  NVL+ +D  +  L DFG A     +   ++     +I 
Sbjct: 196 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           GT  ++APE+          DV+    +ML +  G  P
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 188 AK----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 21/211 (9%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--- 413
           F     +G+G FG+V       TG   A+K +       +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL-- 471
           LV+L    +    L +V +YV  G +   L       ++I  + + +      AQ +L  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-------RRIGRFSEPHARFYA-AQIVLTF 154
Query: 472 -YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YLH      +++RD+KP N+LID     ++ DFG A+     +  +T  + GT  YLAP
Sbjct: 155 EYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           E+  +     + D +  G L+ E+A G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 92/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +L H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 157
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 25  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 76
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 77  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 133
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 134 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 185
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 186 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 17/210 (8%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGM--KEFVAEITSMGRLRHRNLV 415
            ++G G F  V R +   TG + A+K V      S  G+  ++   E +    L+H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK--ILIGVAQALLYL 473
           +L         L +V++++    L    F+  ++      + +      +  + +AL Y 
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADL---CFEIVKRADAGFVYSEAVASHYMRQILEALRYC 146
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H   D  ++HRDVKP NVL+ +  N    KLGDFG+A     +        VGT  ++AP
Sbjct: 147 H---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-GLVAGGRVGTPHFMAP 202
Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+ +        DV+G G ++  +  G  P
Sbjct: 203 EVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
           L QLH   +  D L  V +YV  G L   +       +++  + + + +     +A  L 
Sbjct: 83  LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFKEPHAVFYAAEIAIGLF 135
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLA 529
           +L     + +++RD+K  NV++D++ + K+ DFG+ +    NI     T    GT  Y+A
Sbjct: 136 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIA 189
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           PE+        S D + FG L+ E+  G+ P E
Sbjct: 190 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 102/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/117 (33%), Positives = 61/117 (52%), Gaps = 11/117 (9%)
Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA-RAYDHNINPQTT 519
           K+ + + +AL YL E+    V+HRDVKPSN+L+D     KL DFG++ R  D     ++ 
Sbjct: 128 KMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS- 184
Query: 520 HIVGTLGYLAPELTRTGKATT-----STDVFGFGTLMLEVACGRRPIEPQRTAMELV 571
              G   Y+APE       T        DV+  G  ++E+A G+ P +  +T  E++
Sbjct: 185 --AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL 239

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 188 AK----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 76/264 (28%), Positives = 116/264 (43%), Gaps = 45/264 (17%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G A + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNNDLTLQGAAIITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P+     YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGV 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + LAVEFD   N         H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLKSGDPIQAWIDYN-SQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY 248
                VV+K          Y+ S ++L+ V + P          I+  +D+  VL E++ 
Sbjct: 168 -----VVIK----------YDASSKILLAVLVYP---SSGAIYTIAEIVDVKQVLPEWVD 209
Query: 249 VGFSASTGL---LTAFHNVHGWSF 269
           VG S +TG        H+V+ WSF
Sbjct: 210 VGLSGATGAQRDAAETHDVYSWSF 233

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 130
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 131 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 185
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
            APE+        + D++  G +M E+ C +
Sbjct: 186 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 59.3 bits (142), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 17/153 (11%)
Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG--VAQALL 471
           L QLH   +  D L  V +YV  G L   +       +++  + + + +     +A  L 
Sbjct: 404 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-------QQVGRFKEPHAVFYAAEIAIGLF 456
Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI--NPQTTHIVGTLGYLA 529
           +L     + +++RD+K  NV++D++ + K+ DFG+ +    NI     T    GT  Y+A
Sbjct: 457 FLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGTPDYIA 510
Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE 562
           PE+        S D + FG L+ E+  G+ P E
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 25  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 84
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 141
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 142 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 196
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
            APE+        + D++  G +M E+ C +
Sbjct: 197 RAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           VG G FG+V+R     TG + A+K+V       ++ F V E+ +   L    +V L+G  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 135
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
           R+   + +  + +  GSL +L+     ++   L  D+    L    + L YLH    +R+
Sbjct: 136 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLH---TRRI 187
Query: 482 VHRDVKPSNVLIDADLN-PKLGDFGLARAYDHNINPQTT----HIVGTLGYLAPELTRTG 536
           +H DVK  NVL+ +D +   L DFG A     +   ++     +I GT  ++APE+    
Sbjct: 188 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 247
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D++    +ML +  G  P
Sbjct: 248 PCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/235 (24%), Positives = 98/235 (41%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 45  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 96
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 97  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 153
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 154 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 208
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +   T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 209 AK----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 148
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 149 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 113/261 (43%), Gaps = 41/261 (15%)
Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQLS 72
           A   SF +  F   +  L G A V    +      +  I     LG AFY SP++     
Sbjct: 1   ANIQSFSFKNFNSPSFILQGDATVSSGKLQLTKVKENGIPTPSSLGRAFYSSPIQI---- 56
Query: 73  KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPND 132
            Y+ +   ++    +++T+F   I          G+AF L+     P      YLG+  D
Sbjct: 57  -YDKSTGAVA----SWATSFTVKISAPSKASFADGIAFALVPVGSEPRRNGG-YLGV-FD 109
Query: 133 TSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDN 192
           +     S + +AVEFD + N    D +  H+GID++S+ S  +                 
Sbjct: 110 SDVYNNSAQTVAVEFDTLSN-SGWDPSMKHIGIDVNSIKSIAT----------------- 151
Query: 193 ISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRP-LISYPIDLATVLDEYMYVGF 251
           +S  L +G+  +  I YN+   L+   ++ L  P      ++S  +D+   L EY+ VGF
Sbjct: 152 VSWDLANGENAEILITYNAATSLL---VASLVHPSRRTSYILSERVDITNELPEYVSVGF 208
Query: 252 SASTGLLTAF---HNVHGWSF 269
           SA+TGL   +   H+V  WSF
Sbjct: 209 SATTGLSEGYIETHDVLSWSF 229

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 95/202 (47%), Gaps = 16/202 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G FG V+R V  S+      K V     +G  + +   EI+ +   RHRN++ LH  
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
               +EL+++++++    LD  +F+        LN  +    +  V +AL +LH      
Sbjct: 70  FESMEELVMIFEFI--SGLD--IFERINTSAFELNEREIVSYVHQVCEALQFLH---SHN 122
Query: 481 VVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           + H D++P N++     +   K+ +FG AR      N +   +     Y APE+ +    
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEVHQHDVV 180
Query: 539 TTSTDVFGFGTLMLEVACGRRP 560
           +T+TD++  GTL+  +  G  P
Sbjct: 181 STATDMWSLGTLVYVLLSGINP 202

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAE-ITSMG 407
           E++ AT   R    +G G FG+V+R     TG + A+K+V       ++ F AE + +  
Sbjct: 72  EVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVR------LEVFRAEELMACA 121
Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
            L    +V L+G  R+   + +  + +  GSL +L+     +++  L  D+    L    
Sbjct: 122 GLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLV-----KEQGCLPEDRALYYLGQAL 176
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQ----TTHIV 522
           + L YLH    +R++H DVK  NVL+ +D  +  L DFG A     +   +      +I 
Sbjct: 177 EGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           GT  ++APE+          DV+    +ML +  G  P
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 171
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           VG G FG+V+R     TG + A+K+V       ++ F V E+ +   L    +V L+G  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 119
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
           R+   + +  + +  GSL +L+     ++   L  D+    L    + L YLH    +R+
Sbjct: 120 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLH---TRRI 171
Query: 482 VHRDVKPSNVLIDADLN-PKLGDFGLARAYDHNINPQTT----HIVGTLGYLAPELTRTG 536
           +H DVK  NVL+ +D +   L DFG A     +   ++     +I GT  ++APE+    
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D++    +ML +  G  P
Sbjct: 232 PCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 156
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 157 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 163
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 164 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 156
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 157 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ ++A G  P 
Sbjct: 188 AK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N++ID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 188 AK----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 157
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 173
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 174 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 113/267 (42%), Gaps = 49/267 (18%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G + + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P      YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGGGYLGI 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + L VEFD   N +       H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLGVEFDTFSN-QWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLK---SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY 246
                VV+K   S   + A + Y S   +                 I+  +D+  VL E+
Sbjct: 168 -----VVIKYDASSKILHAVLVYPSSGAIYT---------------IAEIVDVKQVLPEW 207
Query: 247 MYVGFSASTGL---LTAFHNVHGWSFK 270
           + VG S +TG        H+V+ WSF+
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN--INPQTTHIVGTL 525
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +  + P+    V T 
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE----VVTR 189
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
            Y APE+        + D++  G +M E+ C +
Sbjct: 190 YYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 171
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 172 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 43/277 (15%)
Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
            ++G+G FG V++  +  +  EVAIK+V  + R   +E    +  M  ++H N+V L  +
Sbjct: 46  KVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAF 100
Query: 421 C----RKQDELLL--VYDYVPNG--SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
                 K+DE+ L  V +YVP       +      Q    +L     Y++L    ++L Y
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAY 156
Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           +H      + HRD+KP N+L+D      KL DFG A+       P  + I     Y APE
Sbjct: 157 IH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSXICSRY-YRAPE 211
Query: 532 LT-RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQITRAI 589
           L       TT+ D++  G +M E+  G +P+ P  + + +LV +  V    S+ QI + +
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQG-QPLFPGESGIDQLVEIIKVLGTPSREQI-KTM 269
Query: 590 DPT-LDYFDPQEAELVLTLGLLCCDPHP---DFRPST 622
           +P  +++  PQ              PHP    FRP T
Sbjct: 270 NPNYMEHKFPQ------------IRPHPFSKVFRPRT 294

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 197
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y      +    +  + ++
Sbjct: 198 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 183
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y  +   +    +  + ++
Sbjct: 184 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 19/223 (8%)
Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITS 405
           E+    + F    ++G G FG+V    + +T    A+K   +     R     F  E   
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 127
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI--L 463
           +     + +  LH   + ++ L LV DY   G L  LL    + + K+     R+ I  +
Sbjct: 128 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 184
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
           +    ++  LH       VHRD+KP NVL+D + + +L DFG     + +   Q++  VG
Sbjct: 185 VLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 238
Query: 524 TLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPI 561
           T  Y++PE+ +      GK     D +  G  M E+  G  P 
Sbjct: 239 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 90/206 (43%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 174
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+AR  Y      +    +  + ++
Sbjct: 175 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 100/230 (43%), Gaps = 27/230 (11%)
Query: 336 WEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSR 393
           + VE G   F      +  K ++    +GSG  G V           VAIK+++    ++
Sbjct: 11  YSVEIGDSTF------TVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQ 64
Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDND 447
              K    E+  M  + H+N++ L      Q  L    D Y+    +D  L      + D
Sbjct: 65  THAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELD 124
Query: 448 QQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA 507
            ++   L     Y++L+G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLA
Sbjct: 125 HERMSYL----LYQMLVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLA 173
Query: 508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
           R    +     T  V T  Y APE+        + D++  G +M E+  G
Sbjct: 174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 19/223 (8%)
Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITS 405
           E+    + F    ++G G FG+V    + +T    A+K   +     R     F  E   
Sbjct: 84  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDV 143
Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI--L 463
           +     + +  LH   + ++ L LV DY   G L  LL    + + K+     R+ I  +
Sbjct: 144 LVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL---SKFEDKLPEDMARFYIGEM 200
Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
           +    ++  LH       VHRD+KP NVL+D + + +L DFG     + +   Q++  VG
Sbjct: 201 VLAIDSIHQLH------YVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVG 254
Query: 524 TLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPI 561
           T  Y++PE+ +      GK     D +  G  M E+  G  P 
Sbjct: 255 TPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF-VAEITSMGRLRHRNLVQLHGWC 421
           +G G FG+V+R     TG + A+K+V       ++ F V E+ +   L    +V L+G  
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAV 133
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
           R+   + +  + +  GSL +L+     ++   L  D+    L    + L YLH    +R+
Sbjct: 134 REGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLH---TRRI 185
Query: 482 VHRDVKPSNVLIDADLN-PKLGDFGLARAYDHNINPQTT----HIVGTLGYLAPELTRTG 536
           +H DVK  NVL+ +D +   L DFG A     +   ++     +I GT  ++APE+    
Sbjct: 186 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 245
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D++    +ML +  G  P
Sbjct: 246 PCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 113/267 (42%), Gaps = 49/267 (18%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G A + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P+     YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGI 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + L VEFD   N         H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLGVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLK---SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY 246
                VV+K   S   + A + Y S   +                 I+  +D+  VL E+
Sbjct: 168 -----VVIKYDASSKILHAVLVYPSSGAIYT---------------IAEIVDVKQVLPEW 207
Query: 247 MYVGFSASTGL---LTAFHNVHGWSFK 270
           + VG S +TG        H+V+ WSF+
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 129
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 130 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 180
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 129
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 130 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 180
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 128
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 129 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 179
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 13/165 (7%)
Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLV 415
            R + ++  GGF  VY      +G E A+KR+  N  +  +  + E+  M +L  H N+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 416 QLHGWCR--------KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           Q               Q E LL+ +    G L + L     + +  L+ D   KI     
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELC-KGQLVEFL--KKMESRGPLSCDTVLKIFYQTC 146
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH 512
           +A+ ++H +    ++HRD+K  N+L+      KL DFG A    H
Sbjct: 147 RAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH 190

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 58  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 173
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 174 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 224
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 115/265 (43%), Gaps = 45/265 (16%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G + + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P+     YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGI 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + L VEFD   N +       H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLGVEFDTFSN-QWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPL-ISYPIDLATVLDEYMY 248
                VV+K          Y++   L++     L  P       I+  +D+  VL E++ 
Sbjct: 168 -----VVIK----------YDASSKLLHAV---LVYPSSGAIYTIAEIVDVKQVLPEWVD 209
Query: 249 VGFSASTGL---LTAFHNVHGWSFK 270
           VG S +TG        H+V+ WSF+
Sbjct: 210 VGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/235 (23%), Positives = 98/235 (41%), Gaps = 23/235 (9%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL 506
               ++I  + + +      AQ +L         +++RD+KP N+LID     ++ DFG 
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           A+     +  +T  + GT  YLAP +  +     + D +  G L+ E+A G  P 
Sbjct: 188 AK----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L+G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 97/213 (45%), Gaps = 15/213 (7%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN--INPQTTHIVGTL 525
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +  + P+    V T 
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPE----VVTR 189
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
            Y APE+        + D++  G +M E+ C +
Sbjct: 190 YYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 136
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 137 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 187
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 58  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 117
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 173
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 174 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 224
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 136
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 137 LCGIK----HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 187
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 19  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 78
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 134
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 135 LCGIK----HLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 185
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2D3P|A Chain A, Cratylia Floribunda Seed Lectin Crystallized At Basic Ph Length = 236

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 68/155 (43%), Gaps = 26/155 (16%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D N  H+GI+I S+ S  +           N+ D  +        
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKSIRSKATTRW--------NVQDGKVGT------ 49
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS    ++  +S    P      +SY +DL  +L E++ VG SASTGL    
Sbjct: 50  ---AHISYNSVAKRLSAIVS---YPGGSSATVSYDVDLNNILPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF----KIGGT--ARELDVTMLPFHARPK 290
           + +  WSF    K   T  A+ L  T   F   PK
Sbjct: 104 NTILSWSFTSKLKTNSTADAQSLHFTFNQFSQNPK 138

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 41/178 (23%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 398 EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL---DKLLFDNDQQKKKIL 454
           +F  E+  +  +++   +   G     DE+ ++Y+Y+ N S+   D+  F  D+     +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 455 NWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI 514
                  I+  V  +  Y+H E  + + HRDVKPSN+L+D +   KL DFG +   ++ +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGES---EYMV 203
Query: 515 NPQTTHIVGTLGYLAPEL--TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
           + +     GT  ++ PE     +       D++  G  +  +     P   + + +EL
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L+G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LVGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 74/267 (27%), Positives = 112/267 (41%), Gaps = 49/267 (18%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G A + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P      YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGI 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + L VEFD   N         H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLGVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLK---SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY 246
                VV+K   S   + A + Y S   +                 I+  +D+  VL E+
Sbjct: 168 -----VVIKYDASSKILHAVLVYPSSGAIYT---------------IAEIVDVKQVLPEW 207
Query: 247 MYVGFSASTGL---LTAFHNVHGWSFK 270
           + VG S +TG        H+V+ WSF+
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKX 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 57.0 bits (136), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 115/265 (43%), Gaps = 45/265 (16%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G A + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW- 60
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
                   ++ + T  +F T F FSI   Y + L   GL F +   K  P      YLG+
Sbjct: 61  --------DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGV 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + LAVEFD   N         H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNN-SKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPL-ISYPIDLATVLDEYMY 248
                VV+K          Y++   +++V    L  P       I+  +D+  VL +++ 
Sbjct: 168 -----VVIK----------YDAPSKILHVV---LVYPSSGAIYTIAEIVDVKQVLPDWVD 209
Query: 249 VGFSASTGL---LTAFHNVHGWSFK 270
           VG S +TG        H+V+ WSF+
Sbjct: 210 VGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G F  V R V  +   E A K +     S +  ++   E      L+H N+V+LH  
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             ++    LV+D V  G L    F++   ++     D  + I   + +++ ++H+     
Sbjct: 99  ISEEGFHYLVFDLVTGGEL----FEDIVAREYYSEADASHCIH-QILESVNHIHQ---HD 150
Query: 481 VVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTH-----IVGTLGYLAPEL 532
           +VHRD+KP N+L+ +       KL DFGLA      I  Q          GT GYL+PE+
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLA------IEVQGEQQAWFGFAGTPGYLSPEV 204
Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
            R        D++  G ++  +  G  P
Sbjct: 205 LRKDPYGKPVDIWACGVILYILLVGYPP 232

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 363 VGSGGFGKVYRGVIPS-----TGLEVAIKRVAH-NSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +G G FG+VY G +       + L+VA+K +    S Q   +F+ E   + +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQALLYL 473
             G   +     ++ + +  G L   L +      Q   +   D  + +   +A    YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH-VARDIACGCQYL 157
Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLAR-AYDHNINPQTTHIVGTLGYL 528
            E      +HRD+   N L+     P    K+GDFG+A+  Y  +   +    +  + ++
Sbjct: 158 EE---NHFIHRDIAARNCLLTCP-GPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 529 APELTRTGKATTSTDVFGFGTLMLEV 554
            PE    G  T+ TD + FG L+ E+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 72
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL----LYQM 128
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 129 LXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF--MMTPYV 179
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 191
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            APE+        + D++  G +M E+  G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 56.6 bits (135), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 115
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W +R      + +A+
Sbjct: 116 ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPW-ERKSYWKNMLEAV 168
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 220
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 272
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 273 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 304

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 16/215 (7%)
Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL 409
           S T  ++    +G G F  V R +   TG E A K +     S +  ++   E      L
Sbjct: 1   SMTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +H N+V+LH    ++    LV+D V  G     LF++   ++     D  + I     Q 
Sbjct: 61  KHPNIVRLHDSISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCI-----QQ 111
Query: 470 LLYLHEECD-QRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTL 525
           +L     C    +VHRD+KP N+L+ +       KL DFGLA     +         GT 
Sbjct: 112 ILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTP 170
Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           GYL+PE+ R        D++  G ++  +  G  P
Sbjct: 171 GYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPP 205

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 191
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            APE+        + D++  G +M E+  G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 101/238 (42%), Gaps = 29/238 (12%)
Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA 389
           +D L+ WE          S+  +    F     +G+G FG+V       +G   A+K + 
Sbjct: 24  EDFLKKWETP--------SQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILD 75
Query: 390 HNSRQGMKEFVAEITSMGRLRHRN---LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN 446
                 +K+    +     L+  N   LV+L    +    L +V +YV  G +   L   
Sbjct: 76  KQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL--- 132
Query: 447 DQQKKKILNWDQRYKILIGVAQALL---YLHEECDQRVVHRDVKPSNVLIDADLNPKLGD 503
               ++I  + + +      AQ +L   YLH      +++RD+KP N+LID     ++ D
Sbjct: 133 ----RRIGRFSEPHARFYA-AQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           FG A+     +  +T  + GT   LAPE+  +     + D +  G L+ E+A G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 137
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYVVTRYY 192
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            APE+        + D++  G +M E+  G
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDEL------LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L       LV + +       +  + D ++   L     Y++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LXGIK----HLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVA 555
            T  Y APE+        + D++  G +M E+ 
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 36  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 87
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W +R      + +A+
Sbjct: 88  ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPW-ERKSYWKNMLEAV 140
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 141 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 192
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 193 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 244
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 245 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 276

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 17  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 68
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W+ R      + +A+
Sbjct: 69  ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWE-RKSYWKNMLEAV 121
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 122 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 173
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 225
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 226 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 257

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 88/204 (43%), Gaps = 16/204 (7%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +G G F  V R +   TG E A K +     S +  ++   E      L+H N+V+LH  
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD-Q 479
             ++    LV+D V  G     LF++   ++     D  + I     Q +L     C   
Sbjct: 72  ISEEGFHYLVFDLVTGGE----LFEDIVAREYYSEADASHCI-----QQILESVNHCHLN 122
Query: 480 RVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +VHRD+KP N+L+ +       KL DFGLA     +         GT GYL+PE+ R  
Sbjct: 123 GIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSPEVLRKD 181
Query: 537 KATTSTDVFGFGTLMLEVACGRRP 560
                 D++  G ++  +  G  P
Sbjct: 182 PYGKPVDMWACGVILYILLVGYPP 205

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 115
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W +R      + +A+
Sbjct: 116 ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPW-ERKSYWKNMLEAV 168
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 220
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 272
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 273 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 304

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 20  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 71
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W +R      + +A+
Sbjct: 72  ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPW-ERKSYWKNMLEAV 124
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 125 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 176
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 177 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 228
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 229 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 260

>pdb|3U4X|A Chain A, Crystal Structure Of A Lectin From Camptosema Pedicellatum Seeds In Complex With 5-Bromo-4-Chloro-3-Indolyl-Alpha-D-Mannose Length = 236

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 68/155 (43%), Gaps = 26/155 (16%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D N  H+GI+I S+ S  +           N+ D  +        
Sbjct: 4   IVAVELDTYPNTDIGDPNYQHIGINIKSIRSKATTRW--------NVQDGKVGT------ 49
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS    ++  +S    P      +SY +DL  +L E++ VG SASTG+    
Sbjct: 50  ---AHISYNSVAKRLSAIVS---YPGGSSATVSYDVDLNNILPEWVRVGLSASTGVYKET 103
Query: 262 HNVHGWSF----KIGGT--ARELDVTMLPFHARPK 290
           + +  WSF    K   T  A+ L  T   F   PK
Sbjct: 104 NTILSWSFTSKLKTNSTADAQSLHFTFNQFSQSPK 138

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAIK ++       ++R+         EI  + +L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 78  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 131
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAIK ++       ++R+         EI  + +L H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 77  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 130
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 131 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 185
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 186 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 227

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 94/210 (44%), Gaps = 11/210 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 136
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V T  Y
Sbjct: 137 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMTPEVVTRYY 191
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            APE+        + D++  G +M E+  G
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAIK ++       ++R+         EI  + +L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 78  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 131
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 112/267 (41%), Gaps = 49/267 (18%)
Query: 19  ETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVS--NDQGR----ILGHAFYPSPLRFKQ 70
           ET SF ++ F   N  L+L G + + + G+L ++  N  G       G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGASLITQSGVLQLTKINQNGMPAWDSTGRTLYAKPVHIWD 61
Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
           ++         + T  +F T F FSI   Y + L   GL F +   K  P+     YLG+
Sbjct: 62  MT---------TGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLGI 111
Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N  S    S + L VEFD   N         H+GID++S+ S  ++P  +    G   N
Sbjct: 112 FNQ-SKQDNSYQTLGVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQP--FQLDNGQVAN 167
Query: 190 DDNISVVLK---SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY 246
                VV+K   S   + A + Y S   +                 I+  +D+  VL E+
Sbjct: 168 -----VVIKYDASSKLLHAVLVYPSSGAIYT---------------IAEIVDVKQVLPEW 207
Query: 247 MYVGFSASTGL---LTAFHNVHGWSFK 270
           + VG S +TG        H+V+ WSF+
Sbjct: 208 VDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAIK ++       ++R+         EI  + +L H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 84  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 137
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 138 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 192
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 193 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 234

>pdb|1WUV|A Chain A, Crystal Structure Of Native Canavalia Gladiata Lectin (Cgl): A Tetrameric Cona-Like Lectin Length = 237

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 61/128 (47%), Gaps = 20/128 (15%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D N  H+GIDI S+ S           K +  N       +++G 
Sbjct: 4   IVAVELDTYPNTDIGDPNYPHIGIDIKSVRSK----------KTAKWN-------MQNGK 46
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS    ++  +S    P      +SY +DL  VL E++ VG SASTGL    
Sbjct: 47  VGTAHIIYNSVGKRLSAVVS---YPNGDSATVSYDVDLDNVLPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF 269
           + +  WSF
Sbjct: 104 NTILSWSF 111

>pdb|2CTV|A Chain A, High Resolution Crystallographic Studies Of Native Concanavalin A Using Rapid Laue Data Collection Methods And The Introduction Of A Monochromatic Large-Angle Oscillation Technique (Lot) Length = 237

Iteration: 1
 Score = 55.8 bits (133), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 62/128 (48%), Gaps = 20/128 (15%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D +  H+GIDI S+ S           K +  N       +++G 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSK----------KTAKWN-------MQNGK 46
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL    
Sbjct: 47  VGTAHIIYNSVDKRLSAVVS---YPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF 269
           + +  WSF
Sbjct: 104 NTILSWSF 111

>pdb|1FNY|A Chain A, Legume Lectin Of The Bark Of Robinia Pseudoacacia. Length = 237

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 102/242 (42%), Gaps = 39/242 (16%)
Query: 37  GTAFVRKDGILAVSN-----DQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN 91
           G A V   G+L ++N        + LG A Y +P +    +  N+          +F T+
Sbjct: 22  GDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIWDSTTGNV---------ASFVTS 72
Query: 92  FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQ 151
           F F I    P     GLAF L      P  L    LG+  D    K S +I+AVEFD   
Sbjct: 73  FTFIIQAPNPATTADGLAFFLAPVDTQPLDLGGM-LGIFKDGYFNK-SNQIVAVEFDTFS 130
Query: 152 NLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNS 211
           N +  D    H+GI+++S+ S  + P  +                  +G+    +I Y +
Sbjct: 131 NGDW-DPKGRHLGINVNSIESIKTVPWNW-----------------TNGEVANVFISYEA 172
Query: 212 QEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF---HNVHGWS 268
               +  ++    +      +I   +D+  VL E++  GFSA+TG+   +   ++V  WS
Sbjct: 173 STKSLTASLVYPSLETSF--IIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTNDVLSWS 230
Query: 269 FK 270
           F+
Sbjct: 231 FE 232

>pdb|2YZ4|A Chain A, The Neutron Structure Of Concanavalin A At 2.2 Angstroms Length = 237

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 62/128 (48%), Gaps = 20/128 (15%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D +  H+GIDI S+ S           K +  N       +++G 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSK----------KTAKWN-------MQNGK 46
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL    
Sbjct: 47  VGTAHIIYNSVDKRLSAVVS---YPNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF 269
           + +  WSF
Sbjct: 104 NTILSWSF 111

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAIK ++       ++R+         EI  + +L H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 78  IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 131
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 132 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 228

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 16  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 67
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W+ R      + +A+
Sbjct: 68  ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPWE-RKSYWKNMLEAV 120
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VGT+
Sbjct: 121 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGTV 172
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 173 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 224
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 225 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 256

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 21/215 (9%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLL-----FDNDQQKKKILNWDQRYKI 462
           + H+N++ L      Q  L    D Y+    +D  L      + D ++   L     Y++
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYL----LYQM 135
Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L G+     +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +     T  V
Sbjct: 136 LCGIK----HLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSF--MMTPYV 186
Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            T  Y APE+        + D++  G +M E+  G
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 14/205 (6%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNL-VQLHGW 420
           +G G +G V +     +G   A+KR+ A  + Q  K  + ++    R       V  +G 
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
             ++ ++ +  + + + SLDK  +     K + +  D   KI + + +AL +LH +    
Sbjct: 102 LFREGDVWICXE-LXDTSLDKF-YKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS-- 157
Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA-----PELTRT 535
           V+HRDVKPSNVLI+A    K  DFG++     ++        G   Y A     PEL + 
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDID--AGCKPYXAPERINPELNQK 215
Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
           G +  S D++  G   +E+A  R P
Sbjct: 216 GYSVKS-DIWSLGITXIELAILRFP 239

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQL--- 417
           VGSG +G V          +VA+K+++    S    +    E+  +  L+H N++ L   
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 418 ---HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
                      E+ LV   +    L+ ++      K + L+ +    ++  + + L Y+H
Sbjct: 88  FTPATSIEDFSEVYLVTTLM-GADLNNIV------KCQALSDEHVQFLVYQLLRGLKYIH 140
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 ++HRD+KPSNV ++ D   ++ DFGLAR  D  +    T  V T  Y APE+  
Sbjct: 141 SAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEM----TGYVATRWYRAPEIML 193
Query: 535 TGKATTST-DVFGFGTLMLEVACGR 558
                  T D++  G +M E+  G+
Sbjct: 194 NWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-----QL 417
           +G G +G+V+ G     G +VA+K V   + +       EI     +RH N++      +
Sbjct: 45  IGKGRYGEVWMG--KWRGEKVAVK-VFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101
Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            G      +L L+ DY  NGSL       D  K   L+     K+       L +LH E 
Sbjct: 102 KG-TGSWTQLYLITDYHENGSL------YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 478 -----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN----PQTTHIVGTLGYL 528
                   + HRD+K  N+L+  +    + D GLA  +  + N    P  T  VGT  Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYM 213
Query: 529 APELTRTG------KATTSTDVFGFGTLMLEVA 555
            PE+          ++    D++ FG ++ EVA
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQL--- 417
           VGSG +G V          +VA+K+++    S    +    E+  +  L+H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 418 ---HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
                      E+ LV   +    L+ ++      K + L+ +    ++  + + L Y+H
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIV------KSQALSDEHVQFLVYQLLRGLKYIH 148
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 ++HRD+KPSNV ++ D   ++ DFGLAR  D  +    T  V T  Y APE+  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIML 201
Query: 535 TGKATTST-DVFGFGTLMLEVACGR 558
                  T D++  G +M E+  G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAI+ ++       ++R+         EI  + +L H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 217 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 270
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 271 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 325
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 326 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 367

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH------NSRQG--MKEFVAEITSMGRLRHRNL 414
           +GSG  G+V       T  +VAI+ ++       ++R+         EI  + +L H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           +++  +   +D   +V + +  G L   +  N + K+        Y++L+ V     YLH
Sbjct: 203 IKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKL-YFYQMLLAVQ----YLH 256
Query: 475 EECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           E     ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 257 E---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 311
Query: 532 -LTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            L   G A    + D +  G ++     G  P    RT + L
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL 353

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 11/210 (5%)
Query: 351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGR 408
           ++  K ++    +GSG  G V           VAIK+++    ++   K    E+  M  
Sbjct: 22  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 81
Query: 409 LRHRNLVQLHGWCRKQDELLLVYD-YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           + H+N++ L      Q  L    D Y+    +D  L    Q +   L+ ++   +L  + 
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQML 138
Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR    +        V T  Y
Sbjct: 139 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF--MMVPFVVTRYY 193
Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACG 557
            APE+        + D++  G +M E+  G
Sbjct: 194 RAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 33/220 (15%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G GGF  V        G   A+KR+  + +Q  +E   E        H N+++L  +C 
Sbjct: 37  LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 423 KQ----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           ++     E  L+  +   G+L   + +  + K   L  DQ   +L+G+ + L  +H    
Sbjct: 97  RERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG--------------- 523
           +   HRD+KP+N+L+  +  P L D G       ++N    H+ G               
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLG-------SMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 524 TLGYLAPELTRTGKATT---STDVFGFGTLMLEVACGRRP 560
           T+ Y APEL            TDV+  G ++  +  G  P
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 19/217 (8%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRH 411
           + F    ++G G FG+V    + +     A+K   +     R     F  E   +     
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL--FDNDQQKKKILNWDQRYKILIGVAQA 469
           + +  LH   +  + L LV DY   G L  LL  F++   ++    +     I I     
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L Y         VHRD+KP N+L+D + + +L DFG       +   Q++  VGT  Y++
Sbjct: 194 LHY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYIS 244
Query: 530 PELTRT-----GKATTSTDVFGFGTLMLEVACGRRPI 561
           PE+ +      G+     D +  G  M E+  G  P 
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 20/208 (9%)
Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           + F+  + +G G +G+V++      G   A+KR     R G K+   ++  +G   H  +
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVG--SHEKV 113
Query: 415 VQLHGWCRKQDE------LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
            Q H  C + ++      +L +   +   SL +    + +     L   Q +  L     
Sbjct: 114 GQ-HPCCVRLEQAWEEGGILYLQTELCGPSLQQ----HCEAWGASLPEAQVWGYLRDTLL 168
Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
           AL +LH    Q +VH DVKP+N+ +      KLGDFGL          +     G   Y+
Sbjct: 169 ALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE--GDPRYM 223
Query: 529 APELTRTGKATTSTDVFGFGTLMLEVAC 556
           APEL + G   T+ DVF  G  +LEVAC
Sbjct: 224 APELLQ-GSYGTAADVFSLGLTILEVAC 250

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +GSG FG         +   VA+K +    +  + E V  EI +   LRH N+V+     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEK--IDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHEECD 478
                L +V +Y   G L    F+      +    + R+   +++ GV+    Y H    
Sbjct: 84  LTPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVS----YCHA--- 132
Query: 479 QRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRT 535
            +V HRD+K  N L+D    P  K+ DFG +++   +  P++T  VGT  Y+APE L + 
Sbjct: 133 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKK 190
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
                  DV+  G  +  +  G  P E
Sbjct: 191 EYDGKVADVWSCGVTLYVMLVGAYPFE 217

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 22/207 (10%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +GSG FG         T   VA+K +   +   + E V  EI +   LRH N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGA--AIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHEECD 478
                L ++ +Y   G L    ++      +    + R+   ++L GV+    Y H    
Sbjct: 86  LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCHS--- 134
Query: 479 QRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRT 535
            ++ HRD+K  N L+D    P  K+ DFG +++   +  P++T  VGT  Y+APE L R 
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQ 192
Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIE 562
                  DV+  G  +  +  G  P E
Sbjct: 193 EYDGKIADVWSCGVTLYVMLVGAYPFE 219

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/81 (38%), Positives = 40/81 (49%)
Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
            HRDVKP N+L+ AD    L DFG+A A       Q  + VGTL Y APE      AT  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 542 TDVFGFGTLMLEVACGRRPIE 562
            D++    ++ E   G  P +
Sbjct: 216 ADIYALTCVLYECLTGSPPYQ 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 88/206 (42%), Gaps = 20/206 (9%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +GSG FG         +   VA+K +    +        EI +   LRH N+V+      
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAAN-VKREIINHRSLRHPNIVRFKEVIL 85
Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY---KILIGVAQALLYLHEECDQ 479
               L +V +Y   G L    F+      +    + R+   +++ GV+    Y H     
Sbjct: 86  TPTHLAIVMEYASGGEL----FERICNAGRFSEDEARFFFQQLISGVS----YCHA---M 134
Query: 480 RVVHRDVKPSNVLIDADLNPKLG--DFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTG 536
           +V HRD+K  N L+D    P+L   DFG +++   +  P++T  VGT  Y+APE L +  
Sbjct: 135 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKE 192
Query: 537 KATTSTDVFGFGTLMLEVACGRRPIE 562
                 DV+  G  +  +  G  P E
Sbjct: 193 YDGKVADVWSCGVTLYVMLVGAYPFE 218

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 118/278 (42%), Gaps = 65/278 (23%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  +       
Sbjct: 64  IGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS------- 115
Query: 421 CRKQDELLLVYDY----------VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
               D+++ +YDY          +  G++D  L    ++KK I  W +R      + +A+
Sbjct: 116 ----DKIIRLYDYEITDQYIYMVMECGNID--LNSWLKKKKSIDPW-ERKSYWKNMLEAV 168
Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-----VGTL 525
             +H+     +VH D+KP+N LI  D   KL DFG+A    + + P TT +     VG +
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLI-VDGMLKLIDFGIA----NQMQPDTTSVVKDSQVGAV 220
Query: 526 GYLAPELTRTGKATTST-----------DVFGFGTLMLEVACGRRPIEPQRTAMELVLVD 574
            Y+ PE  +   ++              DV+  G ++  +  G+ P +         +++
Sbjct: 221 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IIN 272
Query: 575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCC 612
            + +LH+       IDP  +   P   E  L   L CC
Sbjct: 273 QISKLHA------IIDPNHEIEFPDIPEKDLQDVLKCC 304

>pdb|1CN1|A Chain A, Crystal Structure Of Demetallized Concanavalin A. The Metal- Binding Region Length = 237

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 61/128 (47%), Gaps = 20/128 (15%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D +  H+GIDI S+ S           K +  N       ++ G 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSK----------KTAKWN-------MQDGK 46
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL    
Sbjct: 47  VGTAHIIYNSVDKRLSAVVS---YPNADATSVSYDVDLNDVLPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF 269
           + +  WSF
Sbjct: 104 NTILSWSF 111

>pdb|2CNA|A Chain A, The Covalent And Three-Dimensional Structure Of Concanavalin A, Iv.Atomic Coordinates,Hydrogen Bonding,And Quaternary Structure Length = 237

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/128 (32%), Positives = 61/128 (47%), Gaps = 20/128 (15%)
Query: 142 ILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGD 201
           I+AVE D   N ++ D +  H+GIDI S+ S           K +  N       ++ G 
Sbjct: 4   IVAVELDTYPNTDIGDPSYPHIGIDIKSVRSK----------KTAKWN-------MQDGK 46
Query: 202 PIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAF 261
              A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL    
Sbjct: 47  VGTAHIIYNSVDKRLSAVVS---YPNADATSVSYDVDLNDVLPEWVRVGLSASTGLYKET 103
Query: 262 HNVHGWSF 269
           + +  WSF
Sbjct: 104 NTILSWSF 111

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 23/205 (11%)
Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNLVQL--- 417
           VGSG +G V          +VA+K+++    S    +    E+  +  L+H N++ L   
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 418 ---HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
                      E+ LV   +    L+ ++      K + L+ +    ++  + + L Y+H
Sbjct: 96  FTPATSIEDFSEVYLVTTLM-GADLNNIV------KCQALSDEHVQFLVYQLLRGLKYIH 148
Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 ++HRD+KPSNV ++ D   ++ DFGLAR  D  +    T  V T  Y APE+  
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEM----TGYVATRWYRAPEIML 201
Query: 535 TGKATTST-DVFGFGTLMLEVACGR 558
                  T D++  G +M E+  G+
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	662
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-126
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-117
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-114
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-73
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-58
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-58
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	1e-57
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	2e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-56
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	6e-56
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	6e-56
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-54
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-54
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	2e-54
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	7e-54
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	8e-54
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	9e-54
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	1e-53
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	1e-53
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	2e-53
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	3e-53
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-53
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	5e-53
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-53
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	5e-53
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	2e-52
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	8e-52
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	8e-52
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	5e-51
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-50
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	1e-50
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	5e-50
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	6e-50
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-49
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	8e-49
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	8e-49
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	1e-47
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-47
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-47
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-47
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-42
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-41
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-40
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	4e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-39
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-39
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-38
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-38
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-36
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	9e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-35
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-35
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-35
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-35
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-35
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	6e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-34
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-34
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-34
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-34
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-34
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-34
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-34
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	7e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-34
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-34
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-33
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-33
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-33
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-33
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-33
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-33
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-33
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-33
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-32
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-32
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-32
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-32
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-32
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	3e-32
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-32
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	4e-32
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-32
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	8e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	8e-32
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-31
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-31
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-31
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-31
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-31
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-31
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-31
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-30
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	3e-30
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-30
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-30
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-30
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-30
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	7e-30
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	6e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-30
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-29
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-29
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	8e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-28
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-28
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-28
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-28
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-28
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-28
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-28
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-28
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	4e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-28
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-27
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-27
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-27
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-27
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-27
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-27
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-27
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-27
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	8e-27
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-26
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-26
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-26
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-26
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-26
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-26
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-26
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-26
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	7e-26
3bhy_A	283	Death-associated protein kinase 3; death associate	9e-26
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-25
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-25
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-25
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-25
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-25
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-25
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-25
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	8e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-25
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-24
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-24
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-24
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-23
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	6e-23
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-22
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-22
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-22
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-22
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-22
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	5e-22
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	7e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-21
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-20
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-19
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-19
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-19
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-19
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	4e-19
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-18
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	4e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-17
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	7e-17
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-16
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	7e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	2e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-15
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-15
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-14
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	3e-12
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-11
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-10
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-09
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-09
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	3e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-08
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	5e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-07
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	7e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-06
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  374 bits (962), Expect = e-126
 Identities = 116/307 (37%), Positives = 179/307 (58%), Gaps = 7/307 (2%)

Query: 334 EDWEVEYGACR-FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS 392
           ED EV  G  + F   EL  A+  F  KN++G GGFGKVY+G +   G  VA+KR+    
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLAD-GTLVAVKRLKEER 66

Query: 393 RQGMK-EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
            QG + +F  E+  +    HRNL++L G+C    E LLVY Y+ NGS+   L +  + + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
             L+W +R +I +G A+ L YLH+ CD +++HRDVK +N+L+D +    +GDFGLA+  D
Sbjct: 127 P-LDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185

Query: 512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-- 569
           +     TT + GT+G++APE   TGK++  TDVFG+G ++LE+  G+R  +  R A +  
Sbjct: 186 YKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD 245

Query: 570 LVLVDWVRELHSQGQITRAIDPTLDY-FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF 628
           ++L+DWV+ L  + ++   +D  L   +  +E E ++ + LLC    P  RP    VV+ 
Sbjct: 246 VMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRM 305

Query: 629 LLRDASL 635
           L  D   
Sbjct: 306 LEGDGLA 312

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  353 bits (908), Expect = e-117
 Identities = 105/298 (35%), Positives = 163/298 (54%), Gaps = 7/298 (2%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR 393
             + V + + R    +L  AT  F  K L+G G FGKVY+GV+   G +VA+KR    S 
Sbjct: 18  SSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRD-GAKVALKRRTPESS 76

Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI 453
           QG++EF  EI ++   RH +LV L G+C +++E++L+Y Y+ NG+L + L+ +D      
Sbjct: 77  QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS- 135

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           ++W+QR +I IG A+ L YLH      ++HRDVK  N+L+D +  PK+ DFG+++     
Sbjct: 136 MSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTEL 192

Query: 514 INPQ-TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL 572
                +T + GTLGY+ PE    G+ T  +DV+ FG ++ EV C R  I        + L
Sbjct: 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

Query: 573 VDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            +W  E H+ GQ+ + +DP L D   P+         + C     + RPS   V+  L
Sbjct: 253 AEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  344 bits (884), Expect = e-114
 Identities = 99/298 (33%), Positives = 150/298 (50%), Gaps = 22/298 (7%)

Query: 344 RFRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKR----VAHNSR 393
            F + EL + T  F E+      N +G GGFG VY+G +      VA+K+    V   + 
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN--NTTVAVKKLAAMVDITTE 71

Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI 453
           +  ++F  EI  M + +H NLV+L G+    D+L LVY Y+PNGSL   L   D      
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPP 129

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           L+W  R KI  G A  + +LHE      +HRD+K +N+L+D     K+ DFGLARA +  
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186

Query: 514 INP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL 572
                T+ IVGT  Y+APE    G+ T  +D++ FG ++LE+  G   ++  R     +L
Sbjct: 187 AQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLL 243

Query: 573 VDWVRELHS-QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           +D   E+   +  I   ID  ++  D    E + ++   C     + RP  ++V Q L
Sbjct: 244 LDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLL 301

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  238 bits (609), Expect = 3e-73
 Identities = 66/309 (21%), Positives = 121/309 (39%), Gaps = 33/309 (10%)

Query: 345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEIT 404
                LY  +   +   +   G FG V++  +      VA+K      +Q   +   E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSW-QNEYEVY 70

Query: 405 SMGRLRHRNLVQLHGWCRK----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY 460
           S+  ++H N++Q  G  ++      +L L+  +   GSL   L      K  +++W++  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL------KANVVSWNELC 124

Query: 461 KILIGVAQALLYLHEE-------CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
            I   +A+ L YLHE+           + HRD+K  NVL+  +L   + DFGLA  ++  
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 514 INP-QTTHIVGTLGYLAPELTRTG-----KATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
            +   T   VGT  Y+APE+          A    D++  G ++ E+A      +     
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 568 MELVLVDWVRELHSQGQITRAI-----DPTL--DYFDPQEAELVLTLGLLCCDPHPDFRP 620
             L   + + +  S   +   +      P L   +       ++      C D   + R 
Sbjct: 245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 621 STRRVVQFL 629
           S   V + +
Sbjct: 305 SAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  199 bits (507), Expect = 2e-58
 Identities = 68/320 (21%), Positives = 115/320 (35%), Gaps = 44/320 (13%)

Query: 345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEIT 404
              SE        +   L+G G +G VY+G +      VA+K  +  +RQ        I 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK-NIY 59

Query: 405 SMGRLRHRNLVQLHGWCRK-----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR 459
            +  + H N+ +      +     + E LLV +Y PNGSL K L           +W   
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL------SLHTSDWVSS 113

Query: 460 YKILIGVAQALLYLHEECDQR------VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
            ++   V + L YLH E  +       + HRD+   NVL+  D    + DFGL+     N
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 514 -------INPQTTHIVGTLGYLAPE-------LTRTGKATTSTDVFGFGTLMLEVACGRR 559
                   +      VGT+ Y+APE       L     A    D++  G +  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 560 PIEPQRTA--MELVLVDWVRELHSQGQITRAID-----PTLDYFDPQEAELVLTLGLL-- 610
            + P  +    ++     V    +   +   +      P       + +  V +L     
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 611 -CCDPHPDFRPSTRRVVQFL 629
            C D   + R + +   + +
Sbjct: 294 DCWDQDAEARLTAQXAEERM 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 3e-58
 Identities = 79/312 (25%), Positives = 140/312 (44%), Gaps = 46/312 (14%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +D ++ +        +L         K  +G+G FG V+R      G +VA+K       
Sbjct: 30  DDMDIPW-------CDL-------NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF 73

Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
             + + EF+ E+  M RLRH N+V   G   +   L +V +Y+  GSL +LL  +  +++
Sbjct: 74  HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ 133

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
             L+  +R  +   VA+ + YLH   +  +VHR++K  N+L+D     K+ DFGL+R   
Sbjct: 134 --LDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190

Query: 512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAM 568
                 +    GT  ++APE+ R   +   +DV+ FG ++ E+A  ++P   + P +  +
Sbjct: 191 ST-FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ-VV 248

Query: 569 ELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             V     R               +    +PQ A ++      C    P  RPS   ++ 
Sbjct: 249 AAVGFKCKR-------------LEIPRNLNPQVAAII----EGCWTNEPWKRPSFATIMD 291

Query: 628 FL--LRDASLPQ 637
            L  L  +++P 
Sbjct: 292 LLRPLIKSAVPP 303

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  193 bits (492), Expect = 1e-57
 Identities = 69/270 (25%), Positives = 111/270 (41%), Gaps = 38/270 (14%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGIL------AVSNDQGRILGHAFYPSPLRFK 69
           A +  F +  F   Q +L   G A V  +  L      +  N QG  +G A Y +P+R  
Sbjct: 1   ANSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW 60

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
           Q           S    +F T F FSI             F+     + PS    + LGL
Sbjct: 61  Q----------SSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGL 110

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
              ++NA     +++VEFD   N ++ D N  H+GID++S+ S  +    +         
Sbjct: 111 FGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQ-------- 162

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                    +G    A I YNS    ++V       P     ++S+ ++L  V  +++ V
Sbjct: 163 ---------NGKTATAHISYNSASKRLSVV---SSYPNSSPVVVSFDVELNNVBPBWVRV 210

Query: 250 GFSASTGLLTAFHNVHGWSFKIGGTARELD 279
           GFSA+TG  T  +N+  WSF+      + +
Sbjct: 211 GFSATTGQYTQTNNILAWSFRSSLMGYQAN 240

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  191 bits (485), Expect = 2e-56
 Identities = 69/273 (25%), Positives = 115/273 (42%), Gaps = 41/273 (15%)

Query: 18  AETNSFIYNGF--IQANLSLDGTAFVRKDGILAVSND------QGRILGHAFYPSPLRFK 69
           AE  SF+++ F  ++ NL L G A V   G+L ++N       +   LG A Y +P+   
Sbjct: 1   AEETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW 60

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                    ++ +    +F+T+F F+I          GLAF L      P      +LGL
Sbjct: 61  ---------DSATGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGL 110

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            +   +   + + +AVEFD  +N    D    H+G D++S+ S  +              
Sbjct: 111 FDSAVSGS-TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVK------------ 157

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                  L +G+  +  I YNS   L+  ++           +++  +DL++VL E++ V
Sbjct: 158 -----WSLANGEAAKVLITYNSAVKLLVASLVYPS--SKTSFILADIVDLSSVLPEWVRV 210

Query: 250 GFSASTGLLTAF---HNVHGWSFKIGGTARELD 279
           GFSA+TG        H+V  WSF          
Sbjct: 211 GFSAATGASGGKIETHDVFSWSFASKLAGXXTK 243

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  192 bits (491), Expect = 2e-56
 Identities = 73/330 (22%), Positives = 120/330 (36%), Gaps = 53/330 (16%)

Query: 333 LEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS 392
           +           FR S+L        E   +G G FG+  +     TG  + +K +    
Sbjct: 2   MPHRI-------FRPSDLI-----HGEV--LGKGCFGQAIKVTHRETGEVMVMKELIRFD 47

Query: 393 RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKK 452
            +  + F+ E+  M  L H N+++  G   K   L  + +Y+  G+L  ++   D Q   
Sbjct: 48  EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ--- 104

Query: 453 ILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH 512
              W QR      +A  + YLH      ++HRD+   N L+  + N  + DFGLAR    
Sbjct: 105 -YPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160

Query: 513 N-------------INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR 559
                            +   +VG   ++APE+          DVF FG ++ E+     
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220

Query: 560 PIEP--QRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPD 617
                  RT    + V    + +          P+              + + CCD  P+
Sbjct: 221 ADPDYLPRTMDFGLNVRGFLDRY----CPPNCPPSF-----------FPITVRCCDLDPE 265

Query: 618 FRPSTRRVVQFL--LRDASLPQAPLDIHHE 645
            RPS  ++  +L  LR       PL    E
Sbjct: 266 KRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  189 bits (480), Expect = 6e-56
 Identities = 58/256 (22%), Positives = 98/256 (38%), Gaps = 35/256 (13%)

Query: 18  AETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVSND-QGRILGHAFYPSPLRFKQLSKY 74
           AET SF +N F + N  ++  G   V  +G + ++N  +   +G   Y  P+R       
Sbjct: 1   AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW----- 55

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               ++ +    +F T+F F +          G+ F +          +     L    +
Sbjct: 56  ----SSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT 111

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
               +   + VEFD   N E  D   +HVGID++S+ S  + P                 
Sbjct: 112 KG--AGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWN--------------- 154

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               SG  ++  + Y+S    ++V ++           I+  +DL   L E +  GFSAS
Sbjct: 155 --SVSGAVVKVTVIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSAS 209

Query: 255 TGLL-TAFHNVHGWSF 269
             L     H +  WSF
Sbjct: 210 GSLGGRQIHLIRSWSF 225

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  190 bits (482), Expect = 6e-56
 Identities = 65/272 (23%), Positives = 104/272 (38%), Gaps = 40/272 (14%)

Query: 10  LLLLGFAHAETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG------RILGHAF 61
           +LL      ++ SF +  F   + NL   G A   ++ IL ++            +G   
Sbjct: 1   MLLNRANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRIL 60

Query: 62  YPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSC 121
           + + +R              ++      T F F +             F+       PS 
Sbjct: 61  HSAQVRLW---------EKSTNRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSG 111

Query: 122 LANQYLGLPNDTSNAKFST-RILAVEFDAV--QNLELQDINDNHVGIDISSLISNISEPA 178
            A   LGL N  +    S  ++LAVEFD    QN    D N  H+GID++S+ S+     
Sbjct: 112 SAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKV--- 168

Query: 179 AYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPID 238
                         +    + G  +   + YN     I+V       P   R  +S+ +D
Sbjct: 169 --------------VRWERREGKTLNVLVTYNPSTRTIDVV---ATYPDGQRYQLSHVVD 211

Query: 239 LATVLDEYMYVGFSASTGLLTAFHNVHGWSFK 270
           L T+L E++ VGFSA++G     HN+  WSF 
Sbjct: 212 LTTILPEWVRVGFSAASGEQFQTHNLESWSFT 243

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  187 bits (477), Expect = 1e-54
 Identities = 66/314 (21%), Positives = 126/314 (40%), Gaps = 53/314 (16%)

Query: 331 DILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH 390
                  +         +E+         +  +G GGFG V++G +      VAIK +  
Sbjct: 9   PKSRLPTLAD-------NEI-------EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLIL 54

Query: 391 NSRQG-------MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL 443
              +G        +EF  E+  M  L H N+V+L+G         +V ++VP G L   L
Sbjct: 55  GDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRL 112

Query: 444 FDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-----ADLN 498
                 K   + W  + ++++ +A  + Y+    +  +VHRD++  N+ +      A + 
Sbjct: 113 ----LDKAHPIKWSVKLRLMLDIALGIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVC 167

Query: 499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL--TRTGKATTSTDVFGFGTLMLEVAC 556
            K+ DFGL++   H+     + ++G   ++APE         T   D + F  ++  +  
Sbjct: 168 AKVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223

Query: 557 GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPH 615
           G  P +          + ++  +  +G   R   PT+ +   P+   ++     LC    
Sbjct: 224 GEGPFD----EYSYGKIKFINMIREEGL--R---PTIPEDCPPRLRNVI----ELCWSGD 270

Query: 616 PDFRPSTRRVVQFL 629
           P  RP    +V+ L
Sbjct: 271 PKKRPHFSYIVKEL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  187 bits (478), Expect = 1e-54
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 35/305 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
              + +VG G FG V +        +VAIK++   S    K F+ E+  + R+ H N+V+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW--RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVK 65

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L+G C     + LV +Y   GSL  +L  +  +              +  +Q + YLH  
Sbjct: 66  LYGACLN--PVCLVMEYAEGGSLYNVL--HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 477 CDQRVVHRDVKPSNVLIDADLN-PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
             + ++HRD+KP N+L+ A     K+ DFG A     +I    T+  G+  ++APE+   
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPEVFEG 177

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              +   DVF +G ++ EV   R+P   I      +   + +  R             P 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR-------------PP 224

Query: 593 L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR-DASLPQAPLDIHHEFPRAI 650
           L          L+      C    P  RPS   +V+ +       P A   + +    ++
Sbjct: 225 LIKNLPKPIESLM----TRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSL 280

Query: 651 PEFSE 655
           P   +
Sbjct: 281 PPGED 285

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  185 bits (470), Expect = 2e-54
 Identities = 64/264 (24%), Positives = 106/264 (40%), Gaps = 41/264 (15%)

Query: 22  SFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQLSKY 74
           SF +  F   Q  L   G A V   G+L ++N        + LG A Y +P +       
Sbjct: 5   SFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW----- 59

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               ++ +    +F T+F F I    P     GLAF L      P       LG+  D  
Sbjct: 60  ----DSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKDGY 114

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
             K + +I+AVEFD   N +  D    H+GI+++S+ S  + P  +              
Sbjct: 115 FNKSN-QIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWT------------- 159

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               +G+    +I Y +    +  ++           +I   +D+  VL E++  GFSA+
Sbjct: 160 ----NGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSAT 213

Query: 255 TGLLTAF---HNVHGWSFKIGGTA 275
           TG+   +   ++V  WSF+     
Sbjct: 214 TGIDKGYVQTNDVLSWSFESNLPG 237

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  183 bits (465), Expect = 7e-54
 Identities = 67/259 (25%), Positives = 110/259 (42%), Gaps = 43/259 (16%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI---LGHAFYPSPLRFKQLSKY 74
           +   SF    F + NL L G A V  +G L ++N +G     +G AFY +P++       
Sbjct: 1   SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN----- 55

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               +       +FSTNF F I  K  +   +GLAF L+     P  L  +YLGL N T+
Sbjct: 56  ----DRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTTN 110

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
             +     +AV FD            N + ID++S+    +E   +              
Sbjct: 111 YDR-DAHTVAVVFD---------TVSNRIEIDVNSIRPIATESCNFG------------- 147

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               +G+  +  I Y+S +  + V++         +  +S  + L   +++++ VGFSA+
Sbjct: 148 --HNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSAT 203

Query: 255 TGLLTAF---HNVHGWSFK 270
           +G        HNV  WSF 
Sbjct: 204 SGSKKETTETHNVLSWSFS 222

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  184 bits (467), Expect = 8e-54
 Identities = 69/277 (24%), Positives = 115/277 (41%), Gaps = 44/277 (15%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSND------QGRILGHAFYPSPLRFK 69
           AET SF +N F+  Q N+ L G A V   G L ++        +   LG A Y +P+   
Sbjct: 1   AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                       + +  +F+ +F F+      +    GLAF L      P      YLGL
Sbjct: 61  DKE---------TGSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQ-THAGYLGL 110

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+  +     +++AVEFD  +N    D  + H+GI+++S+ S  +              
Sbjct: 111 FNENES---GDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS------------ 153

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                  L +    +  I Y++   L+  ++      +    ++S  +DL T L E++ +
Sbjct: 154 -----WDLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRI 206

Query: 250 GFSASTGLLTAF--HNVHGWSFKIGGTARELDVTMLP 284
           GFSA+TGL      H+V  WSF         ++  L 
Sbjct: 207 GFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPLD 243

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  183 bits (466), Expect = 9e-54
 Identities = 64/262 (24%), Positives = 101/262 (38%), Gaps = 37/262 (14%)

Query: 18  AETNSFIYNGFIQ--ANLSLDGTAFVRKDGIL----AVSNDQGRILGHAFYPSPLRFKQL 71
           ++  SF +  F Q   +LS  G A V + G+L      +N      G A Y +P+     
Sbjct: 1   SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW-- 58

Query: 72  SKYNINNNTISHTALTFSTNFVFSIV-PKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                  N  +    +F T+F F +     P+    GL F L     P    A  Y GL 
Sbjct: 59  -------NCNTGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLR-RAGGYFGLF 110

Query: 131 NDTSNAKFSTRILAVEFDAVQNL-ELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
           NDT     S + +AVEFD + +     D    H+GID++ + S  +E     +       
Sbjct: 111 NDT-KCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYG------ 163

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                      +     I Y +    +  +++           ++  +DL  +L E++ V
Sbjct: 164 ---------LNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSV 212

Query: 250 GFSASTGL-LTAFHNVHGWSFK 270
           GFS ST +   A H V  W F 
Sbjct: 213 GFSGSTYIGRQATHEVLNWYFT 234

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  183 bits (466), Expect = 1e-53
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 38/277 (13%)

Query: 18  AETNSFIYNGF---IQANLSLDGTAFVRKDGI-LAVSNDQGRIL----GHAFYPSPLRFK 69
           +++ SF +  F   ++ ++   G A      + L  +N  G  L    G A Y  P++  
Sbjct: 2   SDSVSFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW 61

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                    +  + +  +F T F F +          GLAF L          A +YLGL
Sbjct: 62  ---------DNKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKD-AGEYLGL 110

Query: 130 PNDTSNAKFST-RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNI 188
            N ++  + S  +++AVEFD   N    + +  H+GI+++S++S  ++            
Sbjct: 111 FNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSD------ 164

Query: 189 NDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY 248
                   + SG    A I Y+    ++ V +S    P     ++S+ +D+   L E + 
Sbjct: 165 --------IFSGKIATARISYDGSAEILTVVLSY---PDGSDYILSHSVDMRQNLPESVR 213

Query: 249 VGFSASTGLLTAF-HNVHGWSFKIGGTARELDVTMLP 284
           VG SASTG        +  W F     +  +   M P
Sbjct: 214 VGISASTGNNQFLTVYILSWRFSSNLQSTSVKAAMEP 250

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  183 bits (464), Expect = 1e-53
 Identities = 67/262 (25%), Positives = 109/262 (41%), Gaps = 38/262 (14%)

Query: 22  SFIYNGFI-QANLSLDGTAFVRKDGILAVSND--QGRILGHAFYPSPLRFKQLSKYNINN 78
           SF Y  F    +L   G A +  DG LA+  D    R   HA Y +P+            
Sbjct: 2   SFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIW--------- 52

Query: 79  NTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRK-QPPSCLANQYLGLPNDTSNAK 137
           ++ +    +F T+F F +          G+ F L     + P      YLG+ + +++  
Sbjct: 53  DSATGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSSNS-- 110

Query: 138 FSTRILAVEFDAVQN-LELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVV 196
              + +AVEFD+  N  + + +  +H+GID++S++S  +                     
Sbjct: 111 -QNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVN-----------------WN 152

Query: 197 LKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST- 255
             SG   +A I Y+S   ++ V ++           IS  IDL TVL E + VGFSA+T 
Sbjct: 153 RVSGSLEKATIIYDSDTKILTVVMTH---QNGQITTISQEIDLKTVLPEKVSVGFSATTW 209

Query: 256 GLLTAFHNVHGWSFKIGGTARE 277
                 H+++ WSF       E
Sbjct: 210 NPERERHDIYSWSFTSTLKEPE 231

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  183 bits (464), Expect = 2e-53
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 46/279 (16%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI------LGHAFYPSPLRFKQL 71
           +    F +  F + NL L   A V   G L ++N  G        LG AFY +P++    
Sbjct: 1   SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW-- 58

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
                  +  + T  +F+T+F F+I          GLAF L     P         G   
Sbjct: 59  -------DNTTGTVASFATSFTFNIQVPNNAGPADGLAFAL----VPVGSQPKDKGGFLG 107

Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
               +  +   +AVEFD + N +  D  + H+GID++S+ S  +    +           
Sbjct: 108 LFDGSNSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV---------- 156

Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
                  +G+  +  I Y+S   L+  ++      +    ++S  +DL +VL E++ VGF
Sbjct: 157 -------NGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGF 207

Query: 252 SASTGLLTAF---HNVHGWSFK----IGGTARELDVTML 283
           SA+TG+       ++V  WSF        T+  L++  L
Sbjct: 208 SATTGINKGNVETNDVLSWSFASKLSDETTSEGLNLANL 246

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  181 bits (461), Expect = 3e-53
 Identities = 64/258 (24%), Positives = 102/258 (39%), Gaps = 35/258 (13%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNI 76
           ET SF+   F   Q NL   G  +      L ++      +G A Y SP+          
Sbjct: 2   ETTSFLITKFSPDQQNLIFQGDGYTT-KEKLTLTKAVKNTVGRALYSSPIHIW------- 53

Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA 136
             +  +     F T+F F I          G  F +      P      YLG+ N     
Sbjct: 54  --DRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYD 110

Query: 137 KFSTRILAVEFDAVQNLELQDIN-DNHVGIDISSLISNISEPAAYYFSKGSNINDDNISV 195
           K +T+ +AVEFD   N      N D H+GID++S+ S  ++                   
Sbjct: 111 K-TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSW----------------- 152

Query: 196 VLKSGDPIQAWIDYNSQEMLINVTISPLG---IPKPHRPLISYPIDLATVLDEYMYVGFS 252
            L++G+     I +N+   ++ V+++        +     +S  + L  V+ E++ +GFS
Sbjct: 153 KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFS 212

Query: 253 ASTGLLTAFHNVHGWSFK 270
           A+TG   A H V  WSF 
Sbjct: 213 ATTGAEYAAHEVLSWSFH 230

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  183 bits (466), Expect = 3e-53
 Identities = 77/310 (24%), Positives = 129/310 (41%), Gaps = 59/310 (19%)

Query: 336 WEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV----AHN 391
            E+++       +EL         + ++G GGFGKVYR      G EVA+K        +
Sbjct: 2   LEIDF-------AEL-------TLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDED 45

Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
             Q ++    E      L+H N++ L G C K+  L LV ++   G L+++L        
Sbjct: 46  ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL------SG 99

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP--------KLGD 503
           K +  D      + +A+ + YLH+E    ++HRD+K SN+LI   +          K+ D
Sbjct: 100 KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159

Query: 504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP--- 560
           FGLAR +            G   ++APE+ R    +  +DV+ +G L+ E+  G  P   
Sbjct: 160 FGLAREWHRT---TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

Query: 561 IEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFR 619
           I+        V ++ +                +        A+L+      C +P P  R
Sbjct: 217 IDGLA-VAYGVAMNKLA-------------LPIPSTCPEPFAKLMED----CWNPDPHSR 258

Query: 620 PSTRRVVQFL 629
           PS   ++  L
Sbjct: 259 PSFTNILDQL 268

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  181 bits (460), Expect = 5e-53
 Identities = 64/274 (23%), Positives = 101/274 (36%), Gaps = 50/274 (18%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQL 71
           +T SF +N F   +  L L   A +  + +L ++            G A Y  P++    
Sbjct: 2   KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVWDS 61

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYP-QLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
           +         +    +F T F FSI   +P      GL F +             Y G+ 
Sbjct: 62  T---------TGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFGIY 111

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           N  S        +AVEFD  +N    D    H+GID++S+IS  + P             
Sbjct: 112 NPLS----PYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVP------------- 152

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
                 L +G      I Y++   +++V +            I+  +DL  VL E + VG
Sbjct: 153 ----FTLDNGGIANVVIKYDASTKILHVVLVFP--SLGTIYTIADIVDLKQVLPESVNVG 206

Query: 251 FSASTGLLTAF-------HNVHGWSFKIGGTARE 277
           FSA+TG  +         H++  WSF        
Sbjct: 207 FSAATGDPSGKQRNATETHDILSWSFSASLPGTN 240

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  181 bits (460), Expect = 5e-53
 Identities = 71/265 (26%), Positives = 113/265 (42%), Gaps = 41/265 (15%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQ 70
           ++  SF  N F+  +A+L   G A V   G+L ++  +        +G A Y +P+R   
Sbjct: 1   SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW- 59

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLM-SRKQPPSCLANQYLGL 129
                      + +  +FST+F F +    P +   GLAF L     Q PS   ++YLGL
Sbjct: 60  --------GNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGL 111

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQ--DINDNHVGIDISSLISNISEPAAYYFSKGSN 187
            N++ N+  S +I+AVEFD          D N  H+GID++ + S  +    +     + 
Sbjct: 112 FNNS-NSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI----NG 166

Query: 188 INDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYM 247
                    L     + A + Y S                     ++  +DL  +L E++
Sbjct: 167 GVAFATITYLAPNKTLIASLVYPS---------------NQTTFSVAASVDLKEILPEWV 211

Query: 248 YVGFSASTGLLTAF--HNVHGWSFK 270
            VGFSA+TG  T    H+V  WSF 
Sbjct: 212 RVGFSAATGYPTEVETHDVLSWSFT 236

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  179 bits (456), Expect = 2e-52
 Identities = 68/262 (25%), Positives = 101/262 (38%), Gaps = 44/262 (16%)

Query: 19  ETNSFIYNGF--IQANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQL 71
           E+ SF +  F   Q NL L   A V   G L ++           LG A Y +P+     
Sbjct: 2   ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHDN 61

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
           +           T  +F+T+F F +          GLAF L      P      +LGL  
Sbjct: 62  T-----------TLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFA 109

Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           D ++   S + +AVEFD   N    D N  H+GID + + S  + P              
Sbjct: 110 DRAHDA-SYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTP-------------- 152

Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
                +  G+     I Y +    +  ++            +S  +DL  +L EY+ VGF
Sbjct: 153 ---FDMVYGEKANIVITYQASTKALAASLVFPV--SQTSYAVSARVDLRDILPEYVRVGF 207

Query: 252 SASTGLLTAF---HNVHGWSFK 270
           SA+TGL       H++  WSF 
Sbjct: 208 SATTGLNAGVVETHDIVSWSFA 229

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  179 bits (457), Expect = 8e-52
 Identities = 69/315 (21%), Positives = 127/315 (40%), Gaps = 47/315 (14%)

Query: 324 RRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEV 383
                  D  +DWE+          ++            +GSG FG VY+G       +V
Sbjct: 7   HHHHGSRDAADDWEIPD-------GQI-------TVGQRIGSGSFGTVYKGKWHG---DV 49

Query: 384 AIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK 441
           A+K   V   + Q ++ F  E+  + + RH N++   G+     +L +V  +    SL  
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYH 108

Query: 442 LLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL 501
            L       +      +   I    A+ + YLH    + ++HRD+K +N+ +  D   K+
Sbjct: 109 HL----HASETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKI 161

Query: 502 GDFGLARAYDHNINPQT-THIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACG 557
           GDFGLA              + G++ ++APE+ R   +   +  +DV+ FG ++ E+  G
Sbjct: 162 GDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

Query: 558 RRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP 614
           + P   I  +   +E+V          +G ++  +         +   L+      C   
Sbjct: 222 QLPYSNINNRDQIIEMV---------GRGSLSPDLSKVRSNCPKRMKRLMAE----CLKK 268

Query: 615 HPDFRPSTRRVVQFL 629
             D RPS  R++  +
Sbjct: 269 KRDERPSFPRILAEI 283

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  178 bits (453), Expect = 8e-52
 Identities = 65/275 (23%), Positives = 111/275 (40%), Gaps = 43/275 (15%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQLS 72
           A+  SF +  F  ++  L G A V    +         +     LG AFY SP++     
Sbjct: 1   ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY--- 57

Query: 73  KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPND 132
                 +  +    +++T+F  +I          G+AF L+     P    + +LG+ + 
Sbjct: 58  ------DKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGVFDS 110

Query: 133 TSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDN 192
                 S + +AVEFD   N +  D    H+GID++S+ S  +                 
Sbjct: 111 DVYDN-SAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWG------------- 155

Query: 193 ISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS 252
               L +G   +  I YN+   L+  ++      +    ++S  +D+   L EY+ +GFS
Sbjct: 156 ----LANGQNAEILITYNAATSLLVASLV--HPSRRTSYIVSERVDITNELPEYVSIGFS 209

Query: 253 ASTGLLTAF---HNVHGWSFK----IGGTARELDV 280
           A+TGL   +   H+V  WSF        T   LD+
Sbjct: 210 ATTGLSEGYTETHDVLSWSFASKLPDDSTTEPLDI 244

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  176 bits (446), Expect = 5e-51
 Identities = 67/268 (25%), Positives = 113/268 (42%), Gaps = 40/268 (14%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSND---QGRILGHAFYPSPLRFKQLS 72
           ++  SF ++ F+  Q N+   G A V   G+L V+         +G A Y +P++     
Sbjct: 3   SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW--- 59

Query: 73  KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLM-SRKQPPSCLANQYLGLPN 131
                 ++I+    +F+T+F F +       G  GLAF L  +  Q PS  +    GL +
Sbjct: 60  ------DSITGKVASFATSFSFVVKADKSD-GVDGLAFFLAPANSQIPSGSSAGMFGLFS 112

Query: 132 DTSNAKFSTRILAVEFDAVQNLEL--QDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            + ++K S +I+AVEFD          D +  H+GID++S+ S  +    +         
Sbjct: 113 SS-DSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWR-------- 163

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                    +G+     I Y +    + V +S          +I+  +DL  +L E++ V
Sbjct: 164 ---------NGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSV 212

Query: 250 GFSASTGLLTAF--HNVHGWSFKIGGTA 275
           GFS   G    F  H+V  W F     A
Sbjct: 213 GFSGGVGNAAEFETHDVLSWYFTSNLEA 240

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  177 bits (452), Expect = 1e-50
 Identities = 64/321 (19%), Positives = 125/321 (38%), Gaps = 54/321 (16%)

Query: 324 RRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEV 383
           R+       L++W++ +        +L           L+G G FG+VY G       EV
Sbjct: 16  RKASQTSIFLQEWDIPF-------EQL-------EIGELIGKGRFGQVYHGRWHG---EV 58

Query: 384 AIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDK 441
           AI+   +  ++   +K F  E+ +  + RH N+V   G C     L ++       +L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 442 LLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL 501
           ++    +  K +L+ ++  +I   + + + YLH    + ++H+D+K  NV  D +    +
Sbjct: 119 VV----RDAKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVI 170

Query: 502 GDFGLAR----AYDHNINPQTTHIVGTLGYLAPELTRTGKA---------TTSTDVFGFG 548
            DFGL              +     G L +LAPE+ R             +  +DVF  G
Sbjct: 171 TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALG 230

Query: 549 TLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLG 608
           T+  E+     P + Q     +  +         G   +     +     + ++++L   
Sbjct: 231 TIWYELHAREWPFKTQPAEAIIWQM---------GTGMKPNLSQIG-MGKEISDILLF-- 278

Query: 609 LLCCDPHPDFRPSTRRVVQFL 629
             C     + RP+  +++  L
Sbjct: 279 --CWAFEQEERPTFTKLMDML 297

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  174 bits (443), Expect = 1e-50
 Identities = 67/264 (25%), Positives = 109/264 (41%), Gaps = 43/264 (16%)

Query: 19  ETNSFIYNGFIQA--NLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQ 70
           ET SF ++ F     NL+L G A + + G+L ++             G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW- 60

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYP-QLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                   ++ + T  +F T F FSI   Y   L   GL F +   K  P+     YLG+
Sbjct: 61  --------DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGV 111

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N++     S + LAVEFD   N         H+GID++S+ S  ++P            
Sbjct: 112 FNNSKQDN-SYQTLAVEFDTFSNPW-DPPQVPHIGIDVNSIRSIKTQP------------ 157

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                  L +G      I Y++   +++V +            I+  +D+  VL +++ V
Sbjct: 158 -----FQLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDV 210

Query: 250 GFSASTGLLTAF---HNVHGWSFK 270
           G S +TG        H+V+ WSF+
Sbjct: 211 GLSGATGAQRDAAETHDVYSWSFQ 234

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  174 bits (443), Expect = 5e-50
 Identities = 52/306 (16%), Positives = 117/306 (38%), Gaps = 53/306 (17%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +   +++        +L      F  K  +     G++++G     G ++ +K  +V   
Sbjct: 3   KHSGIDF-------KQLN-----FLTK--LNENHSGELWKGRW--QGNDIVVKVLKVRDW 46

Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQ 449
           S +  ++F  E   +    H N++ + G C+        L+  ++P GSL  +L +    
Sbjct: 47  STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG--- 103

Query: 450 KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA 509
              +++  Q  K  + +A+ + +LH   +  +    +   +V+ID D+  ++    +  +
Sbjct: 104 TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162

Query: 510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTST---DVFGFGTLMLEVACGRRP---IEP 563
           +      Q+   +    ++APE  +     T+    D++ F  L+ E+     P   +  
Sbjct: 163 F------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216

Query: 564 QRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR 623
               M       V     +  I   I P +       ++L+     +C +  P  RP   
Sbjct: 217 MEIGM------KVALEGLRPTIPPGISPHV-------SKLM----KICMNEDPAKRPKFD 259

Query: 624 RVVQFL 629
            +V  L
Sbjct: 260 MIVPIL 265

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  173 bits (439), Expect = 6e-50
 Identities = 57/261 (21%), Positives = 92/261 (35%), Gaps = 42/261 (16%)

Query: 22  SFIYNGFI------QANLSLDGTAFVRKDGI-----LAVSNDQGRILGHAFYPSPLRFKQ 70
           +F Y  F          ++  G A      +      A  N      G A Y  P+    
Sbjct: 5   NFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD 64

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
            +    +          F T+F F +   Y      GLAF L             +LGL 
Sbjct: 65  STGKAAS----------FYTSFTFLLKN-YGAPTADGLAFFLAPVDSSVKD-YGGFLGLF 112

Query: 131 NDTSNAKFST-RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
              + A  S  +++AVEFD   N +  D    H+GID++S++S  +              
Sbjct: 113 RHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDD------- 165

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                          A I Y+++  ++ V +S          ++S+ +DLA VL + + +
Sbjct: 166 -------AYGSSIATAHITYDARSKILTVLLSY---EHGRDYILSHVVDLAKVLPQKVRI 215

Query: 250 GFSASTGLLTAFHNVHGWSFK 270
           GFSA  G       +  W F 
Sbjct: 216 GFSAGVG-YDEVTYILSWHFF 235

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  172 bits (438), Expect = 7e-49
 Identities = 69/300 (23%), Positives = 112/300 (37%), Gaps = 47/300 (15%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAE--ITSMGRLRHRNLVQLH 418
             VG G +G+V+RG     G  VA+K     S +  K +  E  + +   LRH N++   
Sbjct: 14  ECVGKGRYGEVWRGSW--QGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 419 GWCRKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
                      +L L+  Y   GSL   L      +   L+     +I++ +A  L +LH
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYL------QLTTLDTVSCLRIVLSIASGLAHLH 122

Query: 475 EECDQR-----VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ---TTHIVGTLG 526
            E         + HRD+K  N+L+  +    + D GLA  +  + N         VGT  
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR 182

Query: 527 YLAPEL------TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
           Y+APE+           +    D++ FG ++ EVA             +    D V    
Sbjct: 183 YMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE-DYKPPFYDVVPNDP 241

Query: 581 SQGQITRAID-----PTLDYFDPQEAELVLTLGLL------CCDPHPDFRPSTRRVVQFL 629
           S   + + +      P +    P       TL  L      C   +P  R +  R+ + L
Sbjct: 242 SFEDMRKVVCVDQQRPNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  170 bits (431), Expect = 8e-49
 Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 49/273 (17%)

Query: 18  AETNSFIYNGFIQ-ANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQ 70
           A   SF +  F     L L G A +   G L ++            LG AFY  P++ K 
Sbjct: 1   ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                      S+   +F+TNF F I  K   +  +GLAF L+    PP     ++LG+ 
Sbjct: 61  -----------SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIF 108

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           N   N + + R +AV F+  +N    D + N +   ++                      
Sbjct: 109 NTN-NPEPNARTVAVVFNTFKNRI--DFDKNFIKPYVN---------------------- 143

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
           +N      +G+     I Y+S    + V +         +  +S  + L   +DE++ VG
Sbjct: 144 ENCDFHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVG 201

Query: 251 FSASTGLLTAF---HNVHGWSFKIGGTARELDV 280
           FS ++GL       H+V  WSF      +  ++
Sbjct: 202 FSPTSGLTEDTTETHDVLSWSFSSKFRNKLSNI 234

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  169 bits (430), Expect = 8e-49
 Identities = 61/266 (22%), Positives = 102/266 (38%), Gaps = 49/266 (18%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQ 70
           ET SF ++ F      L+L   A ++ +G+L ++          +  G A Y  P++   
Sbjct: 1   ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIW- 59

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
                   ++ +    +F T F F+I   Y       GL F ++    P        LG+
Sbjct: 60  --------DSTTGNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQG-EDGGNLGV 110

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
                         AVEFD  QN    D    H+GID++S++S+ +              
Sbjct: 111 FKPPEG----DNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKT-------------- 150

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVL--DEYM 247
              +   L++G      I Y+S   ++NV ++           +S  +DL       E++
Sbjct: 151 ---LHFQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWV 205

Query: 248 YVGFSASTGLLTAF---HNVHGWSFK 270
            VG SA+TG        H +  WSF 
Sbjct: 206 NVGLSATTGYQKNAVETHEIISWSFT 231

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score =  166 bits (420), Expect = 1e-47
 Identities = 57/256 (22%), Positives = 99/256 (38%), Gaps = 58/256 (22%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNIN 77
           A   SFI + F + NL L G A V  +G L +S +    +  AFY +P++ +        
Sbjct: 1   ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR-------- 52

Query: 78  NNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAK 137
            ++ +    +F TNF  +I          GL FVL+                       +
Sbjct: 53  -DSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVP-------------------VQPE 92

Query: 138 FSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVL 197
                + VEFD            + + ID+++             S   +++D +     
Sbjct: 93  SKGDTVTVEFDTFL---------SRISIDVNNNDIK---------SVPWDVHDYD----- 129

Query: 198 KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL 257
             G   +  I YNS   + +V++S     K     +S  ++L   + +++ VGFSA++G 
Sbjct: 130 --GQNAEVRITYNSSTKVFSVSLSNPSTGKS--NNVSTTVELEKEVYDWVSVGFSATSGA 185

Query: 258 LTAF---HNVHGWSFK 270
                  H+V  WSF 
Sbjct: 186 YQWSYETHDVLSWSFS 201

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  169 bits (430), Expect = 2e-47
 Identities = 67/296 (22%), Positives = 107/296 (36%), Gaps = 39/296 (13%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFV--AEITSMGRLRHRNLVQLH 418
             +G G +G+V+ G     G +VA+K            +    EI     +RH N++   
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 419 GWCRK----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
               K      +L L+ DY  NGSL   L      K   L+     K+       L +LH
Sbjct: 98  AADIKGTGSWTQLYLITDYHENGSLYDYL------KSTTLDAKSMLKLAYSSVSGLCHLH 151

Query: 475 EECDQR-----VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ---TTHIVGTLG 526
            E         + HRD+K  N+L+  +    + D GLA  +  + N         VGT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211

Query: 527 YLAPEL------TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
           Y+ PE+          ++    D++ FG ++ EVA             +L   D V    
Sbjct: 212 YMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEE-YQLPYHDLVPSDP 270

Query: 581 SQGQITRAID-----PTLDYFDPQEAELVLTLGLL--CCDPHPDFRPSTRRVVQFL 629
           S   +   +      P+       +  L     L+  C   +P  R +  RV + L
Sbjct: 271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  168 bits (427), Expect = 5e-47
 Identities = 69/297 (23%), Positives = 115/297 (38%), Gaps = 41/297 (13%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAE--ITSMGRLRHRNLVQLH 418
             +G G FG+V+RG     G EVA+K     S +  + +  E  I     LRH N++   
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 419 GWCRKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
               K +    +L LV DY  +GSL   L       +  +  +   K+ +  A  L +LH
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLH 156

Query: 475 EECDQR-----VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGTLG 526
            E         + HRD+K  N+L+  +    + D GLA  +D   +       H VGT  
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 216

Query: 527 YLAPEL------TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
           Y+APE+       +  ++    D++  G +  E+A  R  I       +L   D V    
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSDP 275

Query: 581 SQGQITRAID--------PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           S  ++ + +         P           +   +   C   +   R +  R+ + L
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR-ECWYANGAARLTALRIKKTL 331

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  154 bits (390), Expect = 3e-42
 Identities = 76/294 (25%), Positives = 137/294 (46%), Gaps = 26/294 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRN 413
           FR +  +G G F +VYR      G+ VA+K+V        K     + EI  + +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++ +    + +EL +V +    G L +++  + +++K+++     +K  + +  AL ++
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMI-KHFKKQKRLIPERTVWKYFVQLCSALEHM 152

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H    +RV+HRD+KP+NV I A    KLGD GL R +        + +VGT  Y++PE  
Sbjct: 153 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERI 208

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQITRAIDPT 592
                   +D++  G L+ E+A  + P    +  +  L             +I +   P 
Sbjct: 209 HENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-----------KIEQCDYPP 257

Query: 593 L--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHH 644
           L  D++  +  +LV     +C +P P+ RP    V     R  +   + L+ HH
Sbjct: 258 LPSDHYSEELRQLV----NMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  153 bits (389), Expect = 1e-41
 Identities = 71/310 (22%), Positives = 125/310 (40%), Gaps = 28/310 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           +     +G G FGK         G +  IK +  +  S +  +E   E+  +  ++H N+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           VQ      +   L +V DY   G L K +   + QK  +   DQ     + +  AL ++H
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              D++++HRD+K  N+ +  D   +LGDFG+AR  +  +       +GT  YL+PE+  
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICE 198

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA-IDPTL 593
                  +D++  G ++ E+   +   E   +   LVL           +I      P  
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVL-----------KIISGSFPPVS 246

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPLDIHHEFPRAIP 651
            ++      LV    L   +P    RPS   +++  F+ +      +P  I  EF     
Sbjct: 247 LHYSYDLRSLV--SQLFKRNPR--DRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTF 302

Query: 652 EFSEDDSDPS 661
                   P+
Sbjct: 303 SKFGSQPIPA 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  148 bits (376), Expect = 2e-40
 Identities = 63/286 (22%), Positives = 114/286 (39%), Gaps = 40/286 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
            +    +G G F  VY+G+   T +EVA   +     ++   + F  E   +  L+H N+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 415 VQLHG----WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           V+ +       + +  ++LV + + +G+L   L     ++ K++           + + L
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGL 142

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            +LH      ++HRD+K  N+ I     + K+GD GLA     +       ++GT  ++A
Sbjct: 143 QFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMA 198

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHSQGQIT 586
           PE+        S DV+ FG  MLE+A    P    +        V         + G   
Sbjct: 199 PEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRV---------TSGVKP 248

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD 632
            + D       P+  E++      C   + D R S +     LL  
Sbjct: 249 ASFD---KVAIPEVKEII----EGCIRQNKDERYSIKD----LLNH 283

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  144 bits (364), Expect = 4e-40
 Identities = 48/206 (23%), Positives = 78/206 (37%), Gaps = 32/206 (15%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNI 76
           ET SF+   F   Q NL   G  +      L ++      +G A Y SP+          
Sbjct: 2   ETTSFLITKFSPDQQNLIFQGDGYTT-KEKLTLTKAVKNTVGRALYSSPIHIW------- 53

Query: 77  NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA 136
             +  +     F T+F F I          G  F +      P      YLG+ N     
Sbjct: 54  --DRETGNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAEYD 110

Query: 137 KFSTRILAVEFDAVQNLELQDIN-DNHVGIDISSLISNISEPAAYYFSKGSNINDDNISV 195
           K +T+ +AVEFD   N      N D H+GID++S+ S  ++                   
Sbjct: 111 K-TTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKS-----------------W 152

Query: 196 VLKSGDPIQAWIDYNSQEMLINVTIS 221
            L++G+     I +N+   ++ V+++
Sbjct: 153 KLQNGEEANVVIAFNAATNVLTVSLT 178

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  146 bits (371), Expect = 2e-39
 Identities = 60/286 (20%), Positives = 107/286 (37%), Gaps = 32/286 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G GGF  V        G   A+KR+  + +Q  +E   E        H N+++
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 417 LHGWCRKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           L  +C ++     E  L+  +   G+L   + +  + K   L  DQ   +L+G+ + L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEI-ERLKDKGNFLTEDQILWLLLGICRGLEA 149

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI--------VGT 524
           +H    +   HRD+KP+N+L+  +  P L D G       ++      +          T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 525 LGYLAPEL---TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS 581
           + Y APEL            TDV+  G ++  +  G  P +      + V       L  
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA------LAV 260

Query: 582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           Q Q++    P          +L+ +         P  RP    ++ 
Sbjct: 261 QNQLS---IPQSPRHSSALWQLLNS----MMTVDPHQRPHIPLLLS 299

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (375), Expect = 2e-39
 Identities = 48/203 (23%), Positives = 84/203 (41%), Gaps = 16/203 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           G G FG+V+ G + +    VA+K            +F+ E   + +  H N+V+L G C 
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT 182

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++  + +V + V  G     L    + +   L      +++   A  + YL     +  +
Sbjct: 183 QKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCI 235

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY----LAPELTRTGKA 538
           HRD+   N L+      K+ DFG++R     +        G         APE    G+ 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGV---YAASGGLRQVPVKWTAPEALNYGRY 292

Query: 539 TTSTDVFGFGTLMLEVA-CGRRP 560
           ++ +DV+ FG L+ E    G  P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  145 bits (369), Expect = 3e-39
 Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 14/207 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRL-RHRN 413
           F+  + +G G +G+V++      G   A+KR        +     +AE+ S  ++ +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
            V+L     +   L L  +     SL +      +     L   Q +  L     AL +L
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHC----EAWGASLPEAQVWGYLRDTLLALAHL 173

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H    Q +VH DVKP+N+ +      KLGDFGL          +     G   Y+APEL 
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELL 228

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
           + G   T+ DVF  G  +LEVAC    
Sbjct: 229 Q-GSYGTAADVFSLGLTILEVACNMEL 254

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  144 bits (366), Expect = 5e-39
 Identities = 64/288 (22%), Positives = 127/288 (44%), Gaps = 50/288 (17%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F+E  L+GSGGFG+V++      G    IKRV +N+ +  +E    + ++ +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKALAKLDHVNIVH 68

Query: 417 LHG----------------WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY 460
            +G                   K   L +  ++   G+L++ +   ++++ + L+     
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDKVLAL 125

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH 520
           ++   + + + Y+H    +++++RD+KPSN+ +      K+GDFGL  +  ++     + 
Sbjct: 126 ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS- 181

Query: 521 IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
             GTL Y++PE   +       D++  G ++ E+           TA E           
Sbjct: 182 -KGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH------VCDTAFET---------- 224

Query: 581 SQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
                T   D  + D FD +E  L+           P+ RP+T  +++
Sbjct: 225 -SKFFTDLRDGIISDIFDKKEKTLL----QKLLSKKPEDRPNTSEILR 267

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  142 bits (361), Expect = 2e-38
 Identities = 65/282 (23%), Positives = 121/282 (42%), Gaps = 23/282 (8%)

Query: 352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRL 409
           S  + +     +G+G +G+  +    S G  +  K +     +    +  V+E+  +  L
Sbjct: 3   SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62

Query: 410 RHRNLVQLHGW--CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           +H N+V+ +     R    L +V +Y   G L  ++     ++++ L+ +   +++  + 
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-TKGTKERQYLDEEFVLRVMTQLT 121

Query: 468 QALLYLHE--ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
            AL   H   +    V+HRD+KP+NV +D   N KLGDFGLAR  +H+ +   T  VGT 
Sbjct: 122 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTP 180

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI 585
            Y++PE          +D++  G L+ E+     P     +  EL             +I
Sbjct: 181 YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAG-----------KI 228

Query: 586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
                  + Y    E   ++T  +L        RPS   +++
Sbjct: 229 REGKFRRIPYRYSDELNEIIT-RMLNLK--DYHRPSVEEILE 267

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  142 bits (359), Expect = 5e-38
 Identities = 67/212 (31%), Positives = 103/212 (48%), Gaps = 21/212 (9%)

Query: 358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
            ++ ++G G +G VY G   S  + +AIK +     +  +    EI     L+H+N+VQ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD----QRY--KILIGVAQALL 471
            G   +   + +  + VP GSL  LL    + K   L  +      Y  +IL G    L 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEG----LK 136

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           YLH   D ++VHRD+K  NVLI+      K+ DFG ++     INP T    GTL Y+AP
Sbjct: 137 YLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLA-GINPCTETFTGTLQYMAP 192

Query: 531 ELTRTGK--ATTSTDVFGFGTLMLEVACGRRP 560
           E+   G      + D++  G  ++E+A G+ P
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  140 bits (355), Expect = 2e-37
 Identities = 68/309 (22%), Positives = 118/309 (38%), Gaps = 47/309 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLV 415
           F     +G GGFG V+           AIKR+   +R+  +E  + E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 416 QLHG---------WCRKQDELLLVY---DYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
           +              +     + +Y         +L   +  N +   +         I 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM--NGRCTIEERERSVCLHIF 124

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI-- 521
           + +A+A+ +LH    + ++HRD+KPSN+    D   K+GDFGL  A D +   QT     
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 522 ---------VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL 572
                    VGT  Y++PE       +   D+F  G ++ E+        P  T ME V 
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVR 235

Query: 573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLR 631
              + ++ +         P      P E  +V    +L     P  RP    +++  +  
Sbjct: 236 T--LTDVRNL-----KFPPLFTQKYPCEYVMVQD--MLSPS--PMERPEAINIIENAVFE 284

Query: 632 DASLPQAPL 640
           D   P   +
Sbjct: 285 DLDFPGKTV 293

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  138 bits (349), Expect = 1e-36
 Identities = 72/298 (24%), Positives = 129/298 (43%), Gaps = 49/298 (16%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F E  ++G G FG+V +          AIK++ H   + +   ++E+  +  L H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 417 LHG-------------WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
            +                +K+  L +  +Y  NG+L    +D    +      D+ +++ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYWRLF 122

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT----- 518
             + +AL Y+H    Q ++HRD+KP N+ ID   N K+GDFGLA+    +++        
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 519 --------THIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME 569
                   T  +GT  Y+A E L  TG      D++  G +  E+        P  T ME
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGME 233

Query: 570 LVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
            V +  +++L     I     P  D    +  + ++ L L+  D  P+ RP  R ++ 
Sbjct: 234 RVNI--LKKL-RSVSIE--FPPDFDDNKMKVEKKIIRL-LIDHD--PNKRPGARTLLN 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  139 bits (351), Expect = 1e-36
 Identities = 66/331 (19%), Positives = 111/331 (33%), Gaps = 55/331 (16%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLV 415
            R + ++  GGF  VY      +G E A+KR+  N  +  +  + E+  M +L  H N+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 416 QLHGWC--------RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           Q               Q E LL+ +      ++ L      + +  L+ D   KI     
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL---KKMESRGPLSCDTVLKIFYQTC 146

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI------ 521
           +A+ ++H      ++HRD+K  N+L+      KL DFG A    H  +   +        
Sbjct: 147 RAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 522 -----VGTLGYLAPEL---TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                  T  Y  PE+             D++  G ++  +   + P E           
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED---------- 255

Query: 574 DWVRELHSQGQITRAI--DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR 631
                  ++ +I       P  D        L+          +P+ R S   VV  L  
Sbjct: 256 ------GAKLRIVNGKYSIPPHDTQYTVFHSLIRA----MLQVNPEERLSIAEVVHQLQE 305

Query: 632 DASLPQAPLDIHHEFPRAIPEFSEDDSDPSS 662
            A+               I E  E +    S
Sbjct: 306 IAAARNVNP------KSPITELLEQNGGYGS 330

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  144 bits (365), Expect = 2e-36
 Identities = 72/217 (33%), Positives = 96/217 (44%), Gaps = 17/217 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLH---- 418
           G+GGFG V R +   TG +VAIK+         +E    EI  M +L H N+V       
Sbjct: 23  GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82

Query: 419 --GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                   D  LL  +Y   G L K L  N  +    L       +L  ++ AL YLHE 
Sbjct: 83  GLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 477 CDQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
              R++HRD+KP N+++         K+ D G A+  D          VGTL YLAPEL 
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPELL 195

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
              K T + D + FGTL  E   G RP  P    ++ 
Sbjct: 196 EQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  137 bits (347), Expect = 2e-36
 Identities = 54/203 (26%), Positives = 96/203 (47%), Gaps = 13/203 (6%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA----EITSMGRLRHRNLVQL 417
            +G GG   VY        ++VAIK       +  +E +     E+ +  +L H+N+V +
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
                + D   LV +Y+   +L + +     +    L+ D        +   + + H+  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYI-----ESHGPLSVDTAINFTNQILDGIKHAHD-- 129

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             R+VHRD+KP N+LID++   K+ DFG+A+A       QT H++GT+ Y +PE  +   
Sbjct: 130 -MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 538 ATTSTDVFGFGTLMLEVACGRRP 560
               TD++  G ++ E+  G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  140 bits (355), Expect = 6e-36
 Identities = 52/198 (26%), Positives = 99/198 (50%), Gaps = 8/198 (4%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           G G +G+VY GV     L VA+K +  ++ + ++EF+ E   M  ++H NLVQL G C +
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTR 287

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
           +    ++ +++  G+L   L + +   ++ ++      +   ++ A+ YL +   +  +H
Sbjct: 288 EPPFYIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTD 543
           R++   N L+  +   K+ DFGL+R    +           + + APE     K +  +D
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401

Query: 544 VFGFGTLMLEVA-CGRRP 560
           V+ FG L+ E+A  G  P
Sbjct: 402 VWAFGVLLWEIATYGMSP 419

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  136 bits (345), Expect = 9e-36
 Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 20/210 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVAEITSMGRLRHRNLV 415
              +  VG G FG+V+R     TG + A+K+V     R        E+ +   L    +V
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV------EELVACAGLSSPRIV 113

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L+G  R+   + +  + +  GSL +L+     ++   L  D+    L    + L YLH 
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQALEGLEYLHT 168

Query: 476 ECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTH----IVGTLGYLAP 530
              +R++H DVK  NVL+ +D +   L DFG A     +   ++      I GT  ++AP
Sbjct: 169 ---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAP 225

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+          D++    +ML +  G  P
Sbjct: 226 EVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  135 bits (342), Expect = 1e-35
 Identities = 57/203 (28%), Positives = 85/203 (41%), Gaps = 13/203 (6%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA----EITSMGRLRHRNLVQL 417
           LVG GG G VY          VA+K +   +      F      E  + GRL+  ++V +
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H +     +L +    +    L  +L     +++  L   +   I+  +  AL   H   
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML-----RRQGPLAPPRAVAIVRQIGSALDAAHA-- 152

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
                HRDVKP N+L+ AD    L DFG+A A       Q  + VGTL Y+APE      
Sbjct: 153 -AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 538 ATTSTDVFGFGTLMLEVACGRRP 560
           AT   D++    ++ E   G  P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  137 bits (345), Expect = 2e-35
 Identities = 44/335 (13%), Positives = 83/335 (24%), Gaps = 63/335 (18%)

Query: 348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEIT 404
           S L    +  +    +  G    V+         + A+K     A NSR  ++       
Sbjct: 55  SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATF 114

Query: 405 SMGRLRHRNLVQLHGWCR--------------------------KQDELLLVYDYVPNGS 438
           +  RL   +  +     R                               LL+     +  
Sbjct: 115 AAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA-ASVD 173

Query: 439 LDKL--LFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
           L+ L    D     +        + +   + +    L     + +VH    P N+ I  D
Sbjct: 174 LELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPD 230

Query: 497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA--TTSTDVFGFGTLMLEV 554
               LGD          +  +       + Y   E      A  T + + +  G  +  V
Sbjct: 231 GRLMLGDVSALWK----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286

Query: 555 ACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP 614
            C   P       ++         +     +       L    P   + ++    L  D 
Sbjct: 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPL----PDFVKTLIG-RFLNFDR 341

Query: 615 -----------HPDFRPSTRRVVQFLLRDASLPQA 638
                       P+F      +       +SL   
Sbjct: 342 RRRLLPLEAMETPEFLQLQNEI------SSSLSTG 370

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  135 bits (341), Expect = 2e-35
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKE-FVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +   +   +E    EI+    L H+++V  H
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G+    D + +V +     SL     +  +++K +   + RY  L  +     YLH    
Sbjct: 82  GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR--- 133

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
            RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   +   + GT  Y+APE+      
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 192

Query: 539 TTSTDVFGFGTLMLEVACGRRPIE 562
           +   DV+  G +M  +  G+ P E
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  134 bits (339), Expect = 2e-35
 Identities = 55/202 (27%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
           G G F  VYR     TGLEVAIK +   +  + GM + V  E+    +L+H ++++L+ +
Sbjct: 20  GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNY 79

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
               + + LV +   NG +        + + K  + ++    +  +   +LYLH      
Sbjct: 80  FEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLHS---HG 132

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATT 540
           ++HRD+  SN+L+  ++N K+ DFGLA           T + GT  Y++PE+        
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGL 191

Query: 541 STDVFGFGTLMLEVACGRRPIE 562
            +DV+  G +   +  GR P +
Sbjct: 192 ESDVWSLGCMFYTLLIGRPPFD 213

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  135 bits (342), Expect = 2e-35
 Identities = 57/204 (27%), Positives = 95/204 (46%), Gaps = 12/204 (5%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKE-FVAEITSMGRLRHRNLVQLH 418
            +G GGF K +      T    A K V  +   +   +E    EI+    L H+++V  H
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G+    D + +V +     SL     +  +++K +   + RY  L  +     YLH    
Sbjct: 108 GFFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEARY-YLRQIVLGCQYLHR--- 159

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
            RV+HRD+K  N+ ++ DL  K+GDFGLA   +++   +   + GT  Y+APE+      
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGH 218

Query: 539 TTSTDVFGFGTLMLEVACGRRPIE 562
           +   DV+  G +M  +  G+ P E
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFE 242

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  133 bits (337), Expect = 6e-35
 Identities = 53/222 (23%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--QGMKEFVAEITSMGRLRHR 412
           + +     +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  
Sbjct: 28  RIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 86

Query: 413 NL--VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           +   ++L+ +      + +V +   N  L+  L     +KKK ++  +R      + +A+
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAV 140

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-DHNINPQTTHIVGTLGYLA 529
             +H      +VH D+KP+N LI  D   KL DFG+A        +      VGT+ Y+ 
Sbjct: 141 HTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 530 PEL-----------TRTGKATTSTDVFGFGTLMLEVACGRRP 560
           PE                K +  +DV+  G ++  +  G+ P
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  134 bits (339), Expect = 6e-35
 Identities = 52/222 (23%), Positives = 94/222 (42%), Gaps = 27/222 (12%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHR 412
           + +     +GSGG  KV++  +       AIK V       Q +  +  EI  + +L+  
Sbjct: 9   RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 67

Query: 413 NL--VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           +   ++L+ +      + +V +   N  L+  L     +KKK ++  +R      + +A+
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAV 121

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-DHNINPQTTHIVGTLGYLA 529
             +H      +VH D+KP+N LI  D   KL DFG+A        +      VGT+ Y+ 
Sbjct: 122 HTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 530 PEL-----------TRTGKATTSTDVFGFGTLMLEVACGRRP 560
           PE                K +  +DV+  G ++  +  G+ P
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (336), Expect = 1e-34
 Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 14/204 (6%)

Query: 364 GSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           GSG  G+V  G +   G   + VAIK + A  + +  ++F++E + MG+  H N+++L G
Sbjct: 58  GSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEG 117

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              +    ++V +Y+ NGSLD  L  +D Q        Q   +L GV   + YL +    
Sbjct: 118 VVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSD---L 170

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL--APELTRTGK 537
             VHRD+   NVL+D++L  K+ DFGL+R  + + +   T   G +     APE      
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230

Query: 538 ATTSTDVFGFGTLMLEVA-CGRRP 560
            ++++DV+ FG +M EV   G RP
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  134 bits (338), Expect = 2e-34
 Identities = 52/222 (23%), Positives = 95/222 (42%), Gaps = 27/222 (12%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHR 412
           + +     +GSGG  KV++ V+       AIK V       Q +  +  EI  + +L+  
Sbjct: 56  RIYSILKQIGSGGSSKVFQ-VLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQH 114

Query: 413 NL--VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           +   ++L+ +      + +V +   N  L+  L     +KKK ++  +R      + +A+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL-----KKKKSIDPWERKSYWKNMLEAV 168

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY-DHNINPQTTHIVGTLGYLA 529
             +H+     +VH D+KP+N LI  D   KL DFG+A        +      VG + Y+ 
Sbjct: 169 HTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 530 PEL-----------TRTGKATTSTDVFGFGTLMLEVACGRRP 560
           PE                K +  +DV+  G ++  +  G+ P
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  132 bits (333), Expect = 3e-34
 Identities = 60/290 (20%), Positives = 98/290 (33%), Gaps = 41/290 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLV 415
           +   +++G G    V+RG    TG   AIK   + S     +    E   + +L H+N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 416 QLHG--WCRKQDELLLVYDYVPNGSLDKLLFD--NDQQKKKILNWDQRYKILIGVAQALL 471
           +L            +L+ ++ P GS    L+    +      L   +   +L  V   + 
Sbjct: 71  KLFAIEEETTTRHKVLIMEFCPCGS----LYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 472 YLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           +L E     +VHR++KP N++     D     KL DFG AR  + +    +  + GT  Y
Sbjct: 127 HLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEY 181

Query: 528 LAPELTRTGKATTST--------DVFGFGTLMLEVACGRRPIEPQRTA------MELVLV 573
           L P++                  D++  G      A G  P  P          M  ++ 
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT 241

Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTL---------GLLCCDP 614
                  S  Q             P    L   L          +L  D 
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ 291

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  131 bits (331), Expect = 3e-34
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           G G +G+VY GV     L VA+K  +      +   EF+ E   M  ++H NLVQL G C
Sbjct: 22  GGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLLGVC 78

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            ++    ++ +++  G+L   L + ++Q+   ++      +   ++ A+ YL +   +  
Sbjct: 79  TREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEK---KNF 132

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APELTRTG 536
           +HRD+   N L+  +   K+ DFGL+R    +     T+             APE     
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGD-----TYTAHAGAKFPIKWTAPESLAYN 187

Query: 537 KATTSTDVFGFGTLMLEVA-CGRRP 560
           K +  +DV+ FG L+ E+A  G  P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSP 212

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  131 bits (331), Expect = 3e-34
 Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 17/211 (8%)

Query: 357 FREKNLVGSGGFGKVYRGV--IPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHR 412
             +K L GSG FG V +G   +      VA+K  +   N      E +AE   M +L + 
Sbjct: 20  LEDKEL-GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNP 78

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            +V++ G C  +   +LV +    G L+K L     Q+ + +      +++  V+  + Y
Sbjct: 79  YIVRMIGICEAE-SWMLVMEMAELGPLNKYL-----QQNRHVKDKNIIELVHQVSMGMKY 132

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAP 530
           L EE     VHRD+   NVL+      K+ DFGL++A   + N       G     + AP
Sbjct: 133 L-EE--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAP 189

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           E     K ++ +DV+ FG LM E    G++P
Sbjct: 190 ECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  131 bits (333), Expect = 4e-34
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)

Query: 364 GSGGFGKVYRGVIPSTG----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           GSG FG VY+G+    G    + VAIK +    S +  KE + E   M  + + ++ +L 
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEE 476
           G C     + L+   +P G L   + ++      + +LNW       + +A+ + YL + 
Sbjct: 84  GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED- 135

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APE 531
             +R+VHRD+   NVL+    + K+ DFGLA+     +  +        G +     A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKEYHAEGGKVPIKWMALE 189

Query: 532 LTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
                  T  +DV+ +G  + E+   G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  130 bits (329), Expect = 4e-34
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 14/205 (6%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFV-AEITSMGRLRHRNLVQL 417
             +G G FG VY      +   +A+K +  A   + G++  +  E+     LRH N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +G+      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y H   
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYCHS-- 127

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
            +RV+HRD+KP N+L+ +    K+ DFG +    H  + + T + GTL YL PE+     
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRM 183

Query: 538 ATTSTDVFGFGTLMLEVACGRRPIE 562
                D++  G L  E   G+ P E
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (330), Expect = 6e-34
 Identities = 54/209 (25%), Positives = 93/209 (44%), Gaps = 19/209 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA----EITSMGRLRHRNLVQL 417
           ++G GG  +V+         +VA+K V          F      E  +   L H  +V +
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 418 HGWCRKQDELL----LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +     +        +V +YV   +L  ++       +  +   +  +++    QAL + 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQALNFS 132

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYLAPE 531
           H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT  ++GT  YL+PE
Sbjct: 133 HQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             R       +DV+  G ++ EV  G  P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  130 bits (329), Expect = 6e-34
 Identities = 55/202 (27%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 364 GSGGFGKVYRGV----IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG V          +TG  VA+K++ H++ + +++F  EI  +  L+H N+V+  G
Sbjct: 19  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 78

Query: 420 WCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            C       L L+ +Y+P GSL   L    Q+ K+ ++  +  +    + + + YL    
Sbjct: 79  VCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APEL 532
            +R +HRD+   N+L++ +   K+GDFGL +    +   +    V   G       APE 
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKEPGESPIFWYAPES 188

Query: 533 TRTGKATTSTDVFGFGTLMLEV 554
               K + ++DV+ FG ++ E+
Sbjct: 189 LTESKFSVASDVWSFGVVLYEL 210

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  130 bits (328), Expect = 7e-34
 Identities = 54/220 (24%), Positives = 92/220 (41%), Gaps = 41/220 (18%)

Query: 364 GSGGFGKVYRGVIPSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           G G F K+++GV    G        EV +K +    R   + F    + M +L H++LV 
Sbjct: 17  GQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVL 76

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            +G C   DE +LV ++V  GSLD  L  N       +N   + ++   +A A+ +L E 
Sbjct: 77  NYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQLAAAMHFLEE- 131

Query: 477 CDQRVVHRDVKPSNVLIDADLNP--------KLGDFGLARAYDHNINPQTTHIVGTLGY- 527
               ++H +V   N+L+  + +         KL D G++             ++      
Sbjct: 132 --NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDILQ 178

Query: 528 -----LAPELTRTGKA-TTSTDVFGFGTLMLEVA-CGRRP 560
                + PE     K    +TD + FGT + E+   G +P
Sbjct: 179 ERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (334), Expect = 7e-34
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 14/204 (6%)

Query: 364 GSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G+G FG+V  G +       + VAIK +    + +  ++F+ E + MG+  H N+++L G
Sbjct: 54  GAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEG 113

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              K   +++V +Y+ NGSLD  L  +D Q        Q   +L G+A  + YL +    
Sbjct: 114 VVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSD---M 166

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL--APELTRTGK 537
             VHRD+   N+LI+++L  K+ DFGL R  + +     T   G +     +PE     K
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226

Query: 538 ATTSTDVFGFGTLMLEVA-CGRRP 560
            T+++DV+ +G ++ EV   G RP
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERP 250

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  130 bits (328), Expect = 7e-34
 Identities = 63/295 (21%), Positives = 106/295 (35%), Gaps = 52/295 (17%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRL-RHRN 413
           F E   +GSG FG V++ V    G   AIKR           +  + E+ +   L +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V+      + D +L+  +Y   GSL   + +N  +        +   +L+ V + L Y+
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP-------------------KLGDFGLARAYDHNI 514
           H      +VH D+KPSN+ I     P                   K+GD G         
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185

Query: 515 NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
           +PQ     G   +LA E+ +         D+F     ++  A                  
Sbjct: 186 SPQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP------------ 231

Query: 574 DWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
              R      +I +   P +      +  EL+     +   P P+ RPS   +V+
Sbjct: 232 ---RNGDQWHEIRQGRLPRIPQVLSQEFTELL----KVMIHPDPERRPSAMALVK 279

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  130 bits (330), Expect = 7e-34
 Identities = 81/298 (27%), Positives = 121/298 (40%), Gaps = 42/298 (14%)

Query: 364 GSGGFGKVYRGVI----PSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FGKV           TG  VA+K + A    Q    +  EI  +  L H ++++  
Sbjct: 40  GEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYK 99

Query: 419 GWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           G C       L LV +YVP GSL   L  +     ++L +         + + + YLH  
Sbjct: 100 GCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLF------AQQICEGMAYLHA- 152

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APE 531
             Q  +HRD+   NVL+D D   K+GDFGLA+A          + V   G       APE
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG---HEYYRVREDGDSPVFWYAPE 207

Query: 532 LTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELVLVDW-------VRELHSQG 583
             +  K   ++DV+ FG  + E+         P    +EL+ +         + EL  +G
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267

Query: 584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL--LRDASLPQAP 639
           +  R   P      P E   V  L   C +    FRP+   ++  L  + +    QAP
Sbjct: 268 E--RLPRPDK---CPAE---VYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  129 bits (327), Expect = 1e-33
 Identities = 57/208 (27%), Positives = 96/208 (46%), Gaps = 14/208 (6%)

Query: 359 EKNLVGSGGFGKVYRGVIPSTG--LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
               +G G FG V +GV       ++VAIK +     +   +E + E   M +L +  +V
Sbjct: 14  ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 73

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +L G C + + L+LV +    G L K L    ++    +      ++L  V+  + YL E
Sbjct: 74  RLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE 128

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL--GYLAPELT 533
              +  VHRD+   NVL+      K+ DFGL++A   + +  T    G     + APE  
Sbjct: 129 ---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 185

Query: 534 RTGKATTSTDVFGFGTLMLEVA-CGRRP 560
              K ++ +DV+ +G  M E    G++P
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKP 213

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (328), Expect = 2e-33
 Identities = 65/205 (31%), Positives = 111/205 (54%), Gaps = 15/205 (7%)

Query: 364 GSGGFGKVYRGVIPSTG----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G+G FG+VY+G++ ++     + VAIK + A  + +   +F+ E   MG+  H N+++L 
Sbjct: 53  GAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLE 112

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           G   K   ++++ +Y+ NG+LDK L + D +     +  Q   +L G+A  + YL     
Sbjct: 113 GVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN--- 165

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRTG 536
              VHRD+   N+L++++L  K+ DFGL+R  + +     T   G +     APE     
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225

Query: 537 KATTSTDVFGFGTLMLEVA-CGRRP 560
           K T+++DV+ FG +M EV   G RP
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGERP 250

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  129 bits (327), Expect = 2e-33
 Identities = 52/222 (23%), Positives = 97/222 (43%), Gaps = 26/222 (11%)

Query: 364 GSGGFGKVYRGVI----PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG V          +TG  VA+K++ H+     ++F  EI  +  L    +V+  G
Sbjct: 32  GKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRG 91

Query: 420 WCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHE 475
                    L LV +Y+P+G L   L  +  +    ++L +         + + + YL  
Sbjct: 92  VSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY------SSQICKGMEYLGS 145

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----AP 530
              +R VHRD+   N+L++++ + K+ DFGLA+    + +    ++V   G       AP
Sbjct: 146 ---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWYAP 199

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELV 571
           E       +  +DV+ FG ++ E+     +   P    + ++
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM 241

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  127 bits (322), Expect = 3e-33
 Identities = 58/202 (28%), Positives = 93/202 (46%), Gaps = 18/202 (8%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           GSG FG V+ G   +   +VAIK  R    S +   +F+ E   M +L H  LVQL+G C
Sbjct: 17  GSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            +Q  + LV +++ +G L   L             +    + + V + + YL E     V
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEE---ACV 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRTGKAT 539
           +HRD+   N L+  +   K+ DFG+ R    +    T+           +PE+    + +
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYS 183

Query: 540 TSTDVFGFGTLMLEVA-CGRRP 560
           + +DV+ FG LM EV   G+ P
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIP 205

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  131 bits (332), Expect = 4e-33
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 10/198 (5%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    +
Sbjct: 193 GQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 250

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
           +  + +V +Y+  GSL   L     +    L   Q   +   +A  + Y+        VH
Sbjct: 251 E-PIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVER---MNYVH 303

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTD 543
           RD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 544 VFGFGTLMLEVA-CGRRP 560
           V+ FG L+ E+   GR P
Sbjct: 364 VWSFGILLTELTTKGRVP 381

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  127 bits (321), Expect = 5e-33
 Identities = 64/203 (31%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           GSG FG V  G       +VA+K  +    S     EF  E  +M +L H  LV+ +G C
Sbjct: 17  GSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            K+  + +V +Y+ NG L   L    +   K L   Q  ++   V + + +L      + 
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQF 125

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL---GYLAPELTRTGKA 538
           +HRD+   N L+D DL  K+ DFG+ R    +   Q    VGT     + APE+    K 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD---QYVSSVGTKFPVKWSAPEVFHYFKY 182

Query: 539 TTSTDVFGFGTLMLEVA-CGRRP 560
           ++ +DV+ FG LM EV   G+ P
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKMP 205

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  128 bits (324), Expect = 5e-33
 Identities = 53/202 (26%), Positives = 99/202 (49%), Gaps = 21/202 (10%)

Query: 364 GSGGFGKVYRGV----IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG V          +TG  VA+K++ H++ + +++F  EI  +  L+H N+V+  G
Sbjct: 50  GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKG 109

Query: 420 WCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
            C       L L+ +Y+P GSL   L  + ++    ++  +  +    + + + YL    
Sbjct: 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLGT-- 163

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APEL 532
            +R +HRD+   N+L++ +   K+GDFGL +    +   +  + V   G       APE 
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKEPGESPIFWYAPES 219

Query: 533 TRTGKATTSTDVFGFGTLMLEV 554
               K + ++DV+ FG ++ E+
Sbjct: 220 LTESKFSVASDVWSFGVVLYEL 241

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  129 bits (327), Expect = 7e-33
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 22/222 (9%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLH 418
            +++G G    V+RG    TG   AIK   + S     +    E   + +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 419 GW--CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                      +L+ ++ P GSL  +L   +      L   +   +L  V   + +L E 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLRDVVGGMNHLRE- 130

Query: 477 CDQRVVHRDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
               +VHR++KP N++     D     KL DFG AR  + +    +  + GT  YL P++
Sbjct: 131 --NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186

Query: 533 TRTGKATTST--------DVFGFGTLMLEVACGRRPIEPQRT 566
                             D++  G      A G  P  P   
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG 228

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  131 bits (332), Expect = 9e-33
 Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 10/198 (5%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           G G FG+V+ G    T   VAIK +   +    + F+ E   M +LRH  LVQL+    +
Sbjct: 276 GQGCFGEVWMGTWNGTT-RVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE 333

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
           +  + +V +Y+  GSL   L     +    L   Q   +   +A  + Y+        VH
Sbjct: 334 EP-IYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVER---MNYVH 386

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTD 543
           RD++ +N+L+  +L  K+ DFGLAR  + N           + + APE    G+ T  +D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 544 VFGFGTLMLEVA-CGRRP 560
           V+ FG L+ E+   GR P
Sbjct: 447 VWSFGILLTELTTKGRVP 464

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (319), Expect = 1e-32
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)

Query: 364 GSGGFGKVYRGV---IPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FG V RG         + VA+K +     +  + M +F+ E+ +M  L HRNL++L
Sbjct: 27  GDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRL 86

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           +G       + +V +  P GSL   L  +              +  + VA+ + YL    
Sbjct: 87  YGVVLTP-PMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAEGMGYLES-- 139

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRT 535
            +R +HRD+   N+L+      K+GDFGL RA   N +         + +   APE  +T
Sbjct: 140 -KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 198

Query: 536 GKATTSTDVFGFGTLMLEVA-CGRRP 560
              + ++D + FG  + E+   G+ P
Sbjct: 199 RTFSHASDTWMFGVTLWEMFTYGQEP 224

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  126 bits (318), Expect = 2e-32
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           G+G FG V  G       +VAIK  +    S     EF+ E   M  L H  LVQL+G C
Sbjct: 33  GTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
            KQ  + ++ +Y+ NG L   L +   +        Q  ++   V +A+ YL     ++ 
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLES---KQF 141

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL---GYLAPELTRTGKA 538
           +HRD+   N L++     K+ DFGL+R    +   + T  VG+     +  PE+    K 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD---EYTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 539 TTSTDVFGFGTLMLEVA-CGRRP 560
           ++ +D++ FG LM E+   G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  126 bits (319), Expect = 2e-32
 Identities = 56/221 (25%), Positives = 103/221 (46%), Gaps = 23/221 (10%)

Query: 364 GSGGFGKVYRGV----IPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FGKV          +TG +VA+K +   +    + +   EI  +  L H N+V+  
Sbjct: 30  GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYK 89

Query: 419 GWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           G C +     + L+ +++P+GSL + L  N  +    +N  Q+ K  + + + + YL   
Sbjct: 90  GICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYLGS- 144

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APE 531
             ++ VHRD+   NVL++++   K+GDFGL +A + +   +  + V           APE
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDRDSPVFWYAPE 199

Query: 532 LTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELV 571
                K   ++DV+ FG  + E+         P    ++++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMI 240

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  129 bits (327), Expect = 2e-32
 Identities = 68/201 (33%), Positives = 98/201 (48%), Gaps = 20/201 (9%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC-R 422
           G G FG V  G     G +VA+K + +++    + F+AE + M +LRH NLVQL G    
Sbjct: 202 GKGEFGDVMLGDY--RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 257

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
           ++  L +V +Y+  GSL   L       + +L  D   K  + V +A+ YL        V
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFV 311

Query: 483 HRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRTGKATT 540
           HRD+   NVL+  D   K+ DFGL +         +T   G L     APE  R  K +T
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFST 365

Query: 541 STDVFGFGTLMLEVA-CGRRP 560
            +DV+ FG L+ E+   GR P
Sbjct: 366 KSDVWSFGILLWEIYSFGRVP 386

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  132 bits (333), Expect = 2e-32
 Identities = 66/332 (19%), Positives = 112/332 (33%), Gaps = 52/332 (15%)

Query: 342 ACRFRYSELYSATKG------FREKNLVGSGGFGKVYRGV-IPSTGLEVAIKRVAHNSRQ 394
            C   YS L     G      +  K  +  GG G +Y  +     G  V +K + H+   
Sbjct: 61  YCGSPYSFLPQLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDA 120

Query: 395 GMKE-FVAEITSMGRLRHRNLVQLH--GWCRKQDELLLVY---DYVPNGSLDKLLFDNDQ 448
             +   +AE   +  + H ++VQ+        +    + Y   +YV   SL +       
Sbjct: 121 EAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK----- 175

Query: 449 QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR 508
              + L   +    L+ +  AL YLH      +V+ D+KP N+++  +   KL D G   
Sbjct: 176 --GQKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229

Query: 509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM 568
             +        ++ GT G+ APE+ R    T +TD++  G  +  +         +    
Sbjct: 230 RIN-----SFGYLYGTPGFQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGR---- 279

Query: 569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF 628
               VD + E     +   +              L+        DP P  R +T   +  
Sbjct: 280 ---YVDGLPEDDPVLKTYDSYG-----------RLLRR----AIDPDPRQRFTTAEEMSA 321

Query: 629 LLRDASLPQAPLDIHHEFPRAIPEFSEDDSDP 660
            L          D     P     FS   S  
Sbjct: 322 QLTGVLREVVAQDTGVPRPGLSTIFSPSRSTF 353

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  125 bits (316), Expect = 3e-32
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 14/204 (6%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVA-EITSMGRLRHRNLVQLH 418
            +G G FG VY          +A+K +  +   ++G++  +  EI     LRH N+++++
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
            +   +  + L+ ++ P G L    +   Q+  +         +   +A AL Y HE   
Sbjct: 81  NYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFME-ELADALHYCHE--- 132

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
           ++V+HRD+KP N+L+      K+ DFG +  +  ++  +T    GTL YL PE+      
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTM--CGTLDYLPPEMIEGKTH 189

Query: 539 TTSTDVFGFGTLMLEVACGRRPIE 562
               D++  G L  E   G  P +
Sbjct: 190 DEKVDLWCAGVLCYEFLVGMPPFD 213

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (319), Expect = 3e-32
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 27/210 (12%)

Query: 364 GSGGFGKVYRGVIPSTG----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           GSG FG V++GV    G    + V IK +   + RQ  +     + ++G L H ++V+L 
Sbjct: 22  GSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEE 476
           G C     L LV  Y+P GSL   +  +      + +LNW       + +A+ + YL E 
Sbjct: 82  GLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLEE- 133

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APE 531
               +VHR++   NVL+ +    ++ DFG+A      + P    ++ +         A E
Sbjct: 134 --HGMVHRNLAARNVLLKSPSQVQVADFGVADL----LPPDDKQLLYSEAKTPIKWMALE 187

Query: 532 LTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
               GK T  +DV+ +G  + E+   G  P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  120 bits (302), Expect = 3e-32
 Identities = 42/131 (32%), Positives = 61/131 (46%), Gaps = 20/131 (15%)

Query: 140 TRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKS 199
           + ++AVEFD   N +  D N  H+GID++S+ S ++    +                  +
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQ-----------------N 43

Query: 200 GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLT 259
           G    A I YNS    ++VT             +SY I+L TVL E++ VG SASTG   
Sbjct: 44  GKIATAHISYNSVSKRLSVTSYY---AGSKPATLSYDIELHTVLPEWVRVGLSASTGQDK 100

Query: 260 AFHNVHGWSFK 270
             + VH WSF 
Sbjct: 101 ERNTVHSWSFT 111

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  126 bits (318), Expect = 3e-32
 Identities = 55/210 (26%), Positives = 95/210 (45%), Gaps = 27/210 (12%)

Query: 364 GSGGFGKVYRGVIPSTG----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           GSG FG VY+G+    G    + VAIK +    S +  KE + E   M  + + ++ +L 
Sbjct: 24  GSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLL 83

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEE 476
           G C     + L+   +P G L   + ++      + +LNW       + +A+ + YL + 
Sbjct: 84  GIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLED- 135

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APE 531
             +R+VHRD+   NVL+    + K+ DFGLA+     +  +        G +     A E
Sbjct: 136 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGAEEKEYHAEGGKVPIKWMALE 189

Query: 532 LTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
                  T  +DV+ +G  + E+   G +P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  125 bits (315), Expect = 4e-32
 Identities = 68/207 (32%), Positives = 97/207 (46%), Gaps = 24/207 (11%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM--KEFVAEITSMGRLRHRNLVQL 417
              +G G FG V  G     G +VA+K +    +     + F+AE + M +LRH NLVQL
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCI----KNDATAQAFLAEASVMTQLRHSNLVQL 79

Query: 418 HGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            G    ++  L +V +Y+  GSL   L       + +L  D   K  + V +A+ YL   
Sbjct: 80  LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG- 135

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTR 534
                VHRD+   NVL+  D   K+ DFGL +         +T   G L     APE  R
Sbjct: 136 --NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALR 187

Query: 535 TGKATTSTDVFGFGTLMLEVA-CGRRP 560
             K +T +DV+ FG L+ E+   GR P
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVP 214

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  129 bits (325), Expect = 4e-32
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 16/201 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           G+G FG+V+         +VA+K +   S   ++ F+AE   M  L+H  LV+LH    K
Sbjct: 197 GAGQFGEVWMATYNKHT-KVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK 254

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
            + + ++ +++  GSL   L  ++          +       +A+ + ++ +   +  +H
Sbjct: 255 -EPIYIITEFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIH 307

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG---YLAPELTRTGKATT 540
           RD++ +N+L+ A L  K+ DFGLAR  + N   + T   G      + APE    G  T 
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDN---EYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 541 STDVFGFGTLMLEVA-CGRRP 560
            +DV+ FG L++E+   GR P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  124 bits (313), Expect = 6e-32
 Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 18/202 (8%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           G+G FG+V+ G       +VA+K  +    S      F+AE   M +L+H+ LV+L+   
Sbjct: 22  GAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYAVV 77

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             Q+ + ++ +Y+ NGSL   L      K   L  ++   +   +A+ + ++ E   +  
Sbjct: 78  -TQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEE---RNY 130

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRTGKAT 539
           +HRD++ +N+L+   L+ K+ DFGLAR  + N    T            APE    G  T
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFT 188

Query: 540 TSTDVFGFGTLMLEVA-CGRRP 560
             +DV+ FG L+ E+   GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  124 bits (313), Expect = 8e-32
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)

Query: 364 GSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG V++G+  S     L VAIK      S    ++F+ E  +M +  H ++V+L G
Sbjct: 24  GEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 83

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              +   + ++ +    G L   L          L+          ++ AL YL     +
Sbjct: 84  VITENP-VWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLES---K 135

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL---GYLAPELTRTG 536
           R VHRD+   NVL+ ++   KLGDFGL+R  + +                ++APE     
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS---TYYKASKGKLPIKWMAPESINFR 192

Query: 537 KATTSTDVFGFGTLMLEVA-CGRRP 560
           + T+++DV+ FG  M E+   G +P
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  124 bits (313), Expect = 8e-32
 Identities = 54/205 (26%), Positives = 90/205 (43%), Gaps = 19/205 (9%)

Query: 364 GSGGFGKVYRGV---IPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG+VY GV        + VA+K      +    ++F++E   M  L H ++V+L G
Sbjct: 21  GEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG 80

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              ++    ++ +  P G L   L  N       L         + + +A+ YL      
Sbjct: 81  IIEEE-PTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQICKAMAYLES---I 132

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL---GYLAPELTRTG 536
             VHRD+   N+L+ +    KLGDFGL+R  +            T     +++PE     
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDE---DYYKASVTRLPIKWMSPESINFR 189

Query: 537 KATTSTDVFGFGTLMLEVA-CGRRP 560
           + TT++DV+ F   M E+   G++P
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQP 214

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  129 bits (326), Expect = 1e-31
 Identities = 56/203 (27%), Positives = 95/203 (46%), Gaps = 14/203 (6%)

Query: 364 GSGGFGKVYRGV--IPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGW 420
           G G FG V +GV  +    ++VAIK +     +   +E + E   M +L +  +V+L G 
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 404

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
           C + + L+LV +    G L K L    ++    +      ++L  V+  + YL E   + 
Sbjct: 405 C-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEE---KN 456

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY--LAPELTRTGKA 538
            VHR++   NVL+      K+ DFGL++A   + +  T    G       APE     K 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 539 TTSTDVFGFGTLMLEVA-CGRRP 560
           ++ +DV+ +G  M E    G++P
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKP 539

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  126 bits (318), Expect = 1e-31
 Identities = 42/355 (11%), Positives = 82/355 (23%), Gaps = 75/355 (21%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEITSMGRLRH-- 411
                ++G              TG    +             +K+   E+  +  LR   
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 412 --------------RNLVQLHGWCRKQDE-------------LLLVYDYVPNGSLDKLLF 444
                          +LV+     +                  L         +  ++L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 445 DNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF 504
            +    K  L    R ++ + V + L  LH      +VH  ++P ++++D      L  F
Sbjct: 200 SHSSTHKS-LVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGF 255

Query: 505 GLARAYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRR 559
                   +               A  +           T + D +  G  +  + C   
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315

Query: 560 P--IEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDP--- 614
           P   +      E +                          PQ    +L  G L       
Sbjct: 316 PNTDDAALGGSEWIFRSCKNI-------------------PQPVRALLE-GFLRYPKEDR 355

Query: 615 --------HPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSEDDSDPS 661
                    P++    R  +   L        P       P    +  E  +  +
Sbjct: 356 LLPLQAMETPEYE-QLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEA 409

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  123 bits (311), Expect = 2e-31
 Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 16/209 (7%)

Query: 361 NLVGSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +        + +F+ E   M    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 417 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           L G C + +   L+V  Y+ +G L   + +                  + VA+ + YL  
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLAS 146

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-YDHNINPQTTHIVGTL--GYLAPEL 532
              ++ VHRD+   N ++D     K+ DFGLAR  YD             L   ++A E 
Sbjct: 147 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 533 TRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
            +T K TT +DV+ FG L+ E+   G  P
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  123 bits (311), Expect = 2e-31
 Identities = 80/309 (25%), Positives = 138/309 (44%), Gaps = 36/309 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLV 415
           F +   +G G FG+V++G+   T   VAIK +     +  +++   EIT + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G   K  +L ++ +Y+  GS   LL      +   L+  Q   IL  + + L YLH 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL------EPGPLDETQIATILREILKGLDYLHS 137

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
              ++ +HRD+K +NVL+      KL DFG+A         + T  VGT  ++APE+ + 
Sbjct: 138 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
               +  D++  G   +E+A G  P   + P +  + L              I +   PT
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSELHPMK-VLFL--------------IPKNNPPT 238

Query: 593 L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPLDIHHEFPRA 649
           L   +     E V      C +  P FRP+ + +++  F+LR+A       ++   + R 
Sbjct: 239 LEGNYSKPLKEFV----EACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRW 294

Query: 650 IPEFSEDDS 658
             E S DDS
Sbjct: 295 KAEQSHDDS 303

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  123 bits (310), Expect = 2e-31
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 16/212 (7%)

Query: 358 REKNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRN 413
               ++G G FG VY G         ++ AIK ++     Q ++ F+ E   M  L H N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 414 LVQLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++ L G     +    ++  Y+ +G L + +    +  ++           + VA+ + Y
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQFI----RSPQRNPTVKDLISFGLQVARGMEY 139

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLA 529
           L E   Q+ VHRD+   N ++D     K+ DFGLAR   D        H    L   + A
Sbjct: 140 LAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA 196

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
            E  +T + TT +DV+ FG L+ E+   G  P
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  123 bits (311), Expect = 3e-31
 Identities = 59/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FGKV+     +       + VA+K +   S    ++F  E   +  L+H+++V+  
Sbjct: 50  GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFF 109

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLL----------FDNDQQKKKILNWDQRYKILIGVAQ 468
           G C +   LL+V++Y+ +G L++ L             +      L   Q   +   VA 
Sbjct: 110 GVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAA 169

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            ++YL        VHRD+   N L+   L  K+GDFG++R    +I     + VG    L
Sbjct: 170 GMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTML 222

Query: 529 -----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
                 PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  122 bits (309), Expect = 3e-31
 Identities = 63/219 (28%), Positives = 103/219 (47%), Gaps = 29/219 (13%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G FGKV+     +       + VA+K +   +    K+F  E   +  L+H ++V+ +
Sbjct: 24  GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFY 83

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILIGVA 467
           G C   D L++V++Y+ +G L+K L               +Q K  L   Q   I   +A
Sbjct: 84  GVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 143

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             ++YL     Q  VHRD+   N L+ A+L  K+GDFG++R    ++     + VG    
Sbjct: 144 SGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVGGHTM 196

Query: 528 L-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           L      PE     K TT +DV+ FG ++ E+   G++P
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  123 bits (310), Expect = 4e-31
 Identities = 60/222 (27%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLE--VAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLV 415
           ++++G G FG+V +  I   GL    AIKR+    S+   ++F  E+  + +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILI 464
            L G C  +  L L  +Y P+G+L   L           F         L+  Q      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
            VA+ + YL +   ++ +HRD+   N+L+  +   K+ DFGL+R  +        ++  T
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199

Query: 525 LGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           +G L     A E       TT++DV+ +G L+ E+   G  P
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  121 bits (307), Expect = 5e-31
 Identities = 60/220 (27%), Positives = 92/220 (41%), Gaps = 30/220 (13%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G   FGKVY+G +           VAIK +         +EF  E     RL+H N+V L
Sbjct: 18  GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCL 77

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYKILIGV 466
            G   K   L +++ Y  +G L + L            D+D+  K  L       ++  +
Sbjct: 78  LGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQI 137

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
           A  + YL       VVH+D+   NVL+   LN K+ D GL R     +     + +    
Sbjct: 138 AAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGNS 190

Query: 527 YL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
            L     APE    GK +  +D++ +G ++ EV   G +P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  123 bits (310), Expect = 8e-31
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 16/209 (7%)

Query: 361 NLVGSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
            ++G G FG VY G +       +  A+K +        + +F+ E   M    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 417 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           L G C + +   L+V  Y+ +G L   + +                  + VA+ + +L  
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLAS 210

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTL--GYLAPEL 532
              ++ VHRD+   N ++D     K+ DFGLAR  YD   +         L   ++A E 
Sbjct: 211 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 533 TRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
            +T K TT +DV+ FG L+ E+   G  P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  122 bits (308), Expect = 1e-30
 Identities = 59/237 (24%), Positives = 109/237 (45%), Gaps = 11/237 (4%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +          + + E+  +       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L     +K   +      K+ I V + L YL E
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++      I+      VGT  Y++PE  + 
Sbjct: 150 K--HKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFVGTRSYMSPERLQG 204

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
              +  +D++  G  ++E+A GR PI P       ++     E  +     R   P 
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  126 bits (319), Expect = 1e-30
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 364 GSGGFGKVYRGVIPSTG---LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           G G FG V++G+  S     + VAIK      S    ++F+ E  +M +  H ++V+L G
Sbjct: 399 GEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIG 458

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
               ++ + ++ +    G L   L    Q +K  L+          ++ AL YL     +
Sbjct: 459 VI-TENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLES---K 510

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE     + T
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 570

Query: 540 TSTDVFGFGTLMLEVA-CGRRP 560
           +++DV+ FG  M E+   G +P
Sbjct: 571 SASDVWMFGVCMWEILMHGVKP 592

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  120 bits (304), Expect = 2e-30
 Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 41/312 (13%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FG VY GV            VAIK V    S +   EF+ E + M      ++V+L
Sbjct: 34  GQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 93

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLL-----FDNDQQKKKILNWDQRYKILIGVAQALLY 472
            G   +    L++ + +  G L   L        +       +  +  ++   +A  + Y
Sbjct: 94  LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL---- 528
           L+     + VHRD+   N ++  D   K+GDFG+ R    +I     +  G  G L    
Sbjct: 154 LNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRW 206

Query: 529 -APELTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
            +PE  + G  TT +DV+ FG ++ E+A    +P     +  +      V     +G + 
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQ------VLRFVMEGGL- 258

Query: 587 RAIDPTLDYFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHE 645
                 LD   P    +++  L  +C   +P  RPS   ++  +  +       +  ++ 
Sbjct: 259 ------LDK--PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYS 310

Query: 646 FPRAIPEFSEDD 657
               +PE  E D
Sbjct: 311 EENKLPEPEELD 322

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  122 bits (309), Expect = 3e-30
 Identities = 43/215 (20%), Positives = 84/215 (39%), Gaps = 23/215 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLV 415
           F  K+++G G  G +    +     +VA+KR+     +       E+  +     H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRI---LPECFSFADREVQLLRESDEHPNVI 81

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           +     + +    +  +     +L + +    +QK       +   +L      L +LH 
Sbjct: 82  RYFCTEKDRQFQYIAIELCA-ATLQEYV----EQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 476 ECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYL 528
                +VHRD+KP N+LI        +   + DFGL +      +   + + + GT G++
Sbjct: 137 ---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193

Query: 529 APEL---TRTGKATTSTDVFGFGTLMLEVACGRRP 560
           APE+         T + D+F  G +   V      
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  119 bits (301), Expect = 3e-30
 Identities = 64/276 (23%), Positives = 113/276 (40%), Gaps = 29/276 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEIT-SMGRLRHRNL 414
                 +G G +G V +     +G  +A+KR+      Q  K  + ++  SM  +     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V  +G   ++ ++ +  + + + SLDK        K + +  D   KI + + +AL +LH
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFY-KQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--- 531
            +    V+HRDVKPSNVLI+A    K+ DFG++     ++        G   Y+APE   
Sbjct: 127 SK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV--AKDIDAGCKPYMAPERIN 182

Query: 532 -LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
                   +  +D++  G  M+E+A  R P +   T  + +            Q+     
Sbjct: 183 PELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLK-----------QVVEEPS 231

Query: 591 PTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRR 624
           P L  D F  +  +        C   +   RP+   
Sbjct: 232 PQLPADKFSAEFVDFTSQ----CLKKNSKERPTYPE 263

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (303), Expect = 6e-30
 Identities = 46/229 (20%), Positives = 86/229 (37%), Gaps = 29/229 (12%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK----------------RVAHNSRQGMKEFVA-EITSM 406
             G F K+            A+K                     S +   +    E+  +
Sbjct: 40  NQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 407 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKIL 463
             +++   +   G     DE+ ++Y+Y+ N S+ K        D+     +       I+
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             V  +  Y+H E  + + HRDVKPSN+L+D +   KL DFG +  Y  +   + +   G
Sbjct: 158 KSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGS--RG 212

Query: 524 TLGYLAPEL--TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
           T  ++ PE     +       D++  G  +  +     P   + + +EL
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  119 bits (300), Expect = 7e-30
 Identities = 52/218 (23%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 360 KNLVGSGGFGKVYRGV---IPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
             ++G G FG V  G       T L+VA+K  ++ ++S++ ++EF++E   M    H N+
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 415 VQLHGWCRKQD-----ELLLVYDYVPNGSLDKLLFDN-DQQKKKILNWDQRYKILIGVAQ 468
           ++L G C +       + +++  ++  G L   L  +  +   K +      K ++ +A 
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            + YL     +  +HRD+   N ++  D+   + DFGL++     I     +  G +  +
Sbjct: 159 GMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAKM 211

Query: 529 -----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
                A E       T+ +DV+ FG  M E+A  G  P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  117 bits (293), Expect = 7e-30
 Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 20/132 (15%)

Query: 139 STRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLK 198
           +  I+AVE D   N ++ D +  H+GIDI S+ S  +                     ++
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWN-----------------MQ 43

Query: 199 SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLL 258
           +G    A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL 
Sbjct: 44  NGKVGTAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLY 100

Query: 259 TAFHNVHGWSFK 270
              + +  WSF 
Sbjct: 101 KETNTILSWSFT 112

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 59.1 bits (142), Expect = 6e-10
 Identities = 27/124 (21%), Positives = 39/124 (31%), Gaps = 18/124 (14%)

Query: 17  HAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRIL------GHAFYPSPLRFKQ 70
           +A    F      Q +L L G A    DG L ++             G A + +P+    
Sbjct: 124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW- 182

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRK-QPPSCLANQYLGL 129
                 +    S     F   F F I          G+AF + +     PS    + LGL
Sbjct: 183 ----ESSAVVAS-----FEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGL 232

Query: 130 PNDT 133
             D 
Sbjct: 233 FPDA 236

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  119 bits (301), Expect = 7e-30
 Identities = 61/202 (30%), Positives = 93/202 (46%), Gaps = 14/202 (6%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLH 418
            LVG G +G V +     TG  VAIK+   +    M + +A  EI  + +LRH NLV L 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
             C+K+    LV+++V + ++   L    +     L++    K L  +   + + H    
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDL----ELFPNGLDYQVVQKYLFQIINGIGFCH---S 142

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIVGTLGYLAPE-LTRTG 536
             ++HRD+KP N+L+      KL DFG AR        +     V T  Y APE L    
Sbjct: 143 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--AAPGEVYDDEVATRWYRAPELLVGDV 200

Query: 537 KATTSTDVFGFGTLMLEVACGR 558
           K   + DV+  G L+ E+  G 
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGE 222

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  119 bits (300), Expect = 7e-30
 Identities = 62/212 (29%), Positives = 107/212 (50%), Gaps = 13/212 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           F     +G G +G VY+ +   TG  VAIK+V       ++E + EI+ M +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVK 88

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
            +G   K  +L +V +Y   GS+  ++    + + K L  D+   IL    + L YLH  
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDII----RLRNKTLTEDEIATILQSTLKGLEYLHF- 143

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
              R +HRD+K  N+L++ + + KL DFG+A      +  + T ++GT  ++APE+ +  
Sbjct: 144 --MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEI 200

Query: 537 KATTSTDVFGFGTLMLEVACGRRP---IEPQR 565
                 D++  G   +E+A G+ P   I P R
Sbjct: 201 GYNCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  118 bits (298), Expect = 9e-30
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 13/212 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                   DEL +V +Y+  GSL  ++       +  ++  Q   +     QAL +LH  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHS- 134

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
              +V+HRD+K  N+L+  D + KL DFG         + ++T +VGT  ++APE+    
Sbjct: 135 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 191

Query: 537 KATTSTDVFGFGTLMLEVACGRRP---IEPQR 565
                 D++  G + +E+  G  P     P R
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  119 bits (299), Expect = 9e-30
 Identities = 54/212 (25%), Positives = 99/212 (46%), Gaps = 13/212 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
                 +G G  G V       +G +VA+K +    +Q  +    E+  M   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           ++      +EL ++ +++  G+L  ++       +  LN +Q   +   V QAL YLH  
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV------SQVRLNEEQIATVCEAVLQALAYLHA- 159

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             Q V+HRD+K  ++L+  D   KL DFG       ++  + + +VGT  ++APE+    
Sbjct: 160 --QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPEVISRS 216

Query: 537 KATTSTDVFGFGTLMLEVACGRRP---IEPQR 565
              T  D++  G +++E+  G  P     P +
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ 248

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  118 bits (297), Expect = 2e-29
 Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G G +G V++     TG  VAIK+   +    + + +A  EI  + +L+H NLV L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR 480
            R++  L LV++Y  + ++   L     + ++ +       I     QA+ + H+     
Sbjct: 71  FRRKRRLHLVFEYCDH-TVLHEL----DRYQRGVPEHLVKSITWQTLQAVNFCHK---HN 122

Query: 481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKAT 539
            +HRDVKP N+LI      KL DFG AR      +      V T  Y +PE L    +  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY-YDDEVATRWYRSPELLVGDTQYG 181

Query: 540 TSTDVFGFGTLMLEVACGR 558
              DV+  G +  E+  G 
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (296), Expect = 2e-29
 Identities = 52/217 (23%), Positives = 104/217 (47%), Gaps = 16/217 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G G FGKVY+     TG   A K +   S + +++++ EI  +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L G      +L ++ ++ P G++D ++     +  + L   Q   +   + +AL +LH  
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALNFLHS- 135

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             +R++HRD+K  NVL+  + + +L DFG++      +  + +  +GT  ++APE+    
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCE 192

Query: 537 KATTST-----DVFGFGTLMLEVACGRRP---IEPQR 565
               +      D++  G  ++E+A    P   + P R
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 229

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  118 bits (298), Expect = 2e-29
 Identities = 53/220 (24%), Positives = 99/220 (45%), Gaps = 11/220 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEI-TSMGRLRHRNL 414
            ++   +G G +G V + V   +G  +A+KR+ +    +  K+ + ++   M       +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           VQ +G   ++ +  +  + + + S DK           ++  +   KI +   +AL +L 
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE--- 531
           E    +++HRD+KPSN+L+D   N KL DFG++     +I    T   G   Y+APE   
Sbjct: 143 EN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI--AKTRDAGCRPYMAPERID 198

Query: 532 -LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
                      +DV+  G  + E+A GR P     +  + 
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  118 bits (297), Expect = 2e-29
 Identities = 71/315 (22%), Positives = 121/315 (38%), Gaps = 49/315 (15%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FG+VY G +         L+VA+K +    S Q   +F+ E   + +  H+N+V+ 
Sbjct: 39  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 98

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G   +     ++ + +  G L   L +      +   L       +   +A    YL E
Sbjct: 99  IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158

Query: 476 ECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL---- 528
                 +HRD+   N L+         K+GDFG+AR    +I   + +  G    L    
Sbjct: 159 ---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVKW 211

Query: 529 -APELTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
             PE    G  T+ TD + FG L+ E+   G  P  P ++  E      V E  + G   
Sbjct: 212 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQE------VLEFVTSGGR- 263

Query: 587 RAIDPTLDYFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVV---QFLLRDASLPQAPLDI 642
                 +D   P+     V  +   C    P+ RP+   ++   ++  +D  +    L I
Sbjct: 264 ------MDP--PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPI 315

Query: 643 HHEFPRAIPEFSEDD 657
            +      P   E++
Sbjct: 316 EYG-----PLVEEEE 325

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  118 bits (298), Expect = 3e-29
 Identities = 36/222 (16%), Positives = 69/222 (31%), Gaps = 22/222 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVAEITSMGRLR---H 411
               +L+G G F +VY             ++            EF      M RL+    
Sbjct: 67  VYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQ 126

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
              ++ +     Q+  +LV +    G+L   +       +K++         + +   + 
Sbjct: 127 HMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIE 186

Query: 472 YLHEECDQRVVHRDVKPSNVLI-----------DADLNPKLGDFGLARAYDHNINPQT-T 519
            +H+     ++H D+KP N ++           D      L D G +            T
Sbjct: 187 QVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243

Query: 520 HIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRP 560
               T G+   E+  + K      D FG    +  +  G   
Sbjct: 244 AKCETSGFQCVEM-LSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  116 bits (293), Expect = 4e-29
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 12/213 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVAEITSMGRLRHRNLV 415
           +  + ++GSG    V          +VAIKR+     +  M E + EI +M +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLD---KLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
             +     +DEL LV   +  GS+    K +    + K  +L+      IL  V + L Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG----LARAYDHNINPQTTHIVGTLGYL 528
           LH+      +HRDVK  N+L+  D + ++ DFG    LA   D   N      VGT  ++
Sbjct: 137 LHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 529 APELTRTGKA-TTSTDVFGFGTLMLEVACGRRP 560
           APE+    +      D++ FG   +E+A G  P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  116 bits (293), Expect = 7e-29
 Identities = 49/250 (19%), Positives = 93/250 (37%), Gaps = 47/250 (18%)

Query: 333 LEDWEVEYGACRFRYSELYSATKGFREK----NLVGSGGFGKVYRGVIPSTG---LEVAI 385
           LED  +                    ++     ++G G FG V    +       ++VA+
Sbjct: 15  LEDVLIP------------------EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAV 56

Query: 386 K--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------ELLLVYDYVPNG 437
           K  +    +   ++EF+ E   M    H ++ +L G   +          +++  ++ +G
Sbjct: 57  KMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116

Query: 438 SLDKLLFDN-DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
            L   L  +   +    L      + ++ +A  + YL     +  +HRD+   N ++  D
Sbjct: 117 DLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAED 173

Query: 497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYL-----APELTRTGKATTSTDVFGFGTLM 551
           +   + DFGL+R     I     +  G    L     A E       T  +DV+ FG  M
Sbjct: 174 MTVCVADFGLSR----KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTM 229

Query: 552 LEVA-CGRRP 560
            E+   G+ P
Sbjct: 230 WEIMTRGQTP 239

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  117 bits (295), Expect = 8e-29
 Identities = 38/255 (14%), Positives = 71/255 (27%), Gaps = 50/255 (19%)

Query: 348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVAEIT 404
           SEL    +      ++G              TG    +             +K+   E+ 
Sbjct: 66  SELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVL 125

Query: 405 SMGRLR-------------------------HRNLVQLHGWCRKQDELLLVYDY-VPNGS 438
            +  LR                          + ++++    R    L   + Y     +
Sbjct: 126 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185

Query: 439 LDKLL--FDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD 496
           L        +     K L    R ++ + V + L  LH      +VH  ++P ++++D  
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQR 242

Query: 497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT-----------RTGKATTSTDVF 545
               L  F                   + G+  PEL            R    T S D +
Sbjct: 243 GGVFLTGFEHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAW 297

Query: 546 GFGTLMLEVACGRRP 560
             G ++  + C   P
Sbjct: 298 ALGLVIYWIWCADLP 312

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  115 bits (291), Expect = 9e-29
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVA--EITSMGRLRHRNLVQLHG 419
           +G G +G V++     T   VA+KRV   +  +G+    A  EI  +  L+H+N+V+LH 
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGV-PSSALREICLLKELKHKNIVRLHD 68

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQ-----QKKKILNWDQRYKILIGVAQALLYLH 474
                 +L LV+++     L K     +        K  L     +++L G+     + H
Sbjct: 69  VLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFL-----FQLLKGLG----FCH 118

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               + V+HRD+KP N+LI+ +   KL +FGLARA+   +    +  V TL Y  P++  
Sbjct: 119 ---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC-YSAEVVTLWYRPPDVLF 174

Query: 535 TGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
             K  +TS D++  G +  E+A   RP+ P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFP 204

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  117 bits (295), Expect = 1e-28
 Identities = 53/190 (27%), Positives = 95/190 (50%), Gaps = 11/190 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
             +  ++G G FG+V++    +TGL++A K +     +  +E   EI+ M +L H NL+Q
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L+     +++++LV +YV  G     LFD    +   L        +  + + + ++H+ 
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ- 205

Query: 477 CDQRVVHRDVKPSNVL-IDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               ++H D+KP N+L ++ D    K+ DFGLAR Y      +     GT  +LAPE+  
Sbjct: 206 --MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVN 261

Query: 535 TGKATTSTDV 544
               +  TD+
Sbjct: 262 YDFVSFPTDM 271

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  116 bits (293), Expect = 1e-28
 Identities = 70/223 (31%), Positives = 108/223 (48%), Gaps = 33/223 (14%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVA--EITSMGRLRHRNLVQLHG 419
           +G G FG+V++     TG +VA+K+V   N ++G     A  EI  +  L+H N+V L  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83

Query: 420 --------WCRKQDELLLVYDYVPN---GSLDKLLFD-NDQQKKKILNWDQRYKILIGVA 467
                   + R +  + LV+D+  +   G L  +L      + K+++       +L G+ 
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVM-----QMLLNGLY 138

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT---THIVGT 524
               Y+H     +++HRD+K +NVLI  D   KL DFGLARA+    N Q    T+ V T
Sbjct: 139 ----YIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191

Query: 525 LGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRT 566
           L Y  PEL    +      D++G G +M E+   R PI    T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNT 233

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  117 bits (294), Expect = 1e-28
 Identities = 56/225 (24%), Positives = 92/225 (40%), Gaps = 25/225 (11%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FG+VY G +         L+VA+K +    S Q   +F+ E   + +  H+N+V+ 
Sbjct: 80  GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRC 139

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKILIGVAQALLYLHE 475
            G   +     ++ + +  G L   L +      +   L       +   +A    YL E
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199

Query: 476 ECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL---- 528
                 +HRD+   N L+         K+GDFG+AR    +I     +  G    L    
Sbjct: 200 ---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVKW 252

Query: 529 -APELTRTGKATTSTDVFGFGTLMLEVA-CGRRPIEPQRTAMELV 571
             PE    G  T+ TD + FG L+ E+   G  P  P ++  E++
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEVL 296

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  115 bits (290), Expect = 2e-28
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 25/221 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEF----VAEITSMGRLR- 410
           +     +G G +G VY+   P +G  VA+K V   N   G        V E+  + RL  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 411 --HRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKIL 463
             H N+V+L          ++ ++ LV+++V    L   L   D+     L  +    ++
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAETIKDLM 126

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIV 522
               + L +LH      +VHRD+KP N+L+ +    KL DFGLAR Y +       T +V
Sbjct: 127 RQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY---QMALTPVV 180

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
            TL Y APE+       T  D++  G +  E+   R+P+  
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPLFC 220

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  117 bits (294), Expect = 2e-28
 Identities = 46/185 (24%), Positives = 80/185 (43%), Gaps = 15/185 (8%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK 423
           GSG FG V+R V  +TG     K +             EI+ M +L H  L+ LH     
Sbjct: 60  GSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED 119

Query: 424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH 483
           + E++L+ +++  G     LFD    +   ++  +    +    + L ++HE     +VH
Sbjct: 120 KYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 172

Query: 484 RDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
            D+KP N++      + +  K+ DFGLA   + +   +      T  + APE+       
Sbjct: 173 LDIKPENIMCETKKASSV--KIIDFGLATKLNPDEIVKV--TTATAEFAAPEIVDREPVG 228

Query: 540 TSTDV 544
             TD+
Sbjct: 229 FYTDM 233

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (289), Expect = 2e-28
 Identities = 59/278 (21%), Positives = 111/278 (39%), Gaps = 34/278 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEI-TSMGRLRHRNL 414
                 +GSG  G+V++     TG  +A+K++  +  ++  K  + ++   +       +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           VQ  G      ++ +  + +     +KL     ++ +  +      K+ + + +AL YL 
Sbjct: 87  VQCFGTFITNTDVFIAMELM-GTCAEKL----KKRMQGPIPERILGKMTVAIVKALYYLK 141

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           E+    V+HRDVKPSN+L+D     KL DFG++     +     +   G   Y+APE   
Sbjct: 142 EK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRS--AGCAAYMAPERID 197

Query: 535 TGKATTST-----DVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
               T        DV+  G  ++E+A G+ P +  +T  E++            ++ +  
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT-----------KVLQEE 246

Query: 590 DPTL---DYFDPQEAELVLTLGLLCCDPHPDFRPSTRR 624
            P L     F       V      C       RP   +
Sbjct: 247 PPLLPGHMGFSGDFQSFVKD----CLTKDHRKRPKYNK 280

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  116 bits (292), Expect = 3e-28
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 27/212 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH---- 418
           +G+G FG V++  +  +  EVAIK+V     Q  +    E+  M  ++H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESD-EVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102

Query: 419 --GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR---YKILIGVAQALLYL 473
             G  + +  L LV +YVP  ++ +      + K+ +     +   Y++L    ++L Y+
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL----RSLAYI 157

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           H      + HRD+KP N+L+D      KL DFG A+       P  ++I  +  Y APEL
Sbjct: 158 HS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYIC-SRYYRAPEL 212

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
                  TT+ D++  G +M E+    +P+ P
Sbjct: 213 IFGATNYTTNIDIWSTGCVMAEL-MQGQPLFP 243

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  114 bits (287), Expect = 4e-28
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 13/205 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNL 414
           + + + +G G +  VY+G    T   VA+K +     +G     A  E++ +  L+H N+
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANI 62

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V LH     +  L LV++Y+    L + L         I+N       L  + + L Y H
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLRGLAYCH 117

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               Q+V+HRD+KP N+LI+     KL DFGLARA          + V TL Y  P++  
Sbjct: 118 R---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT-YDNEVVTLWYRPPDILL 173

Query: 535 TGKA-TTSTDVFGFGTLMLEVACGR 558
                +T  D++G G +  E+A GR
Sbjct: 174 GSTDYSTQIDMWGVGCIFYEMATGR 198

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  116 bits (292), Expect = 4e-28
 Identities = 66/218 (30%), Positives = 109/218 (50%), Gaps = 26/218 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           + +  ++G+G FG VY+  +  +G  VAIK+V     Q  +    E+  M +L H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111

Query: 417 L----HGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR---YKILIGVA 467
           L    +    K+DE  L LV DYVP  ++ ++     + K+ +     +   Y++     
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLF---- 166

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLG 526
           ++L Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I  +  
Sbjct: 167 RSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYIC-SRY 221

Query: 527 YLAPELT-RTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           Y APEL       T+S DV+  G ++ E+    +PI P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAEL-LLGQPIFP 258

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  114 bits (286), Expect = 6e-28
 Identities = 66/336 (19%), Positives = 108/336 (32%), Gaps = 83/336 (24%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLV 415
           F     +G GGFG V+           AIKR+   +R+  +E V  E+ ++ +L H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG---------- 465
           +      +        +       D+           +     + + +            
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 466 ---VAQALLYLH-EECD--------------------------------------QRVVH 483
                +  LY+  + C                                       + ++H
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH 187

Query: 484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-----------THIVGTLGYLAPEL 532
           RD+KPSN+    D   K+GDFGL  A D +   QT           T  VGT  Y++PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV-LVDWVRELHSQGQITRAIDP 591
                 +   D+F  G ++ E+           T ME V ++  VR L            
Sbjct: 248 IHGNNYSHKVDIFSLGLILFELLY------SFSTQMERVRIITDVRNLK--------FPL 293

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
                 PQE  +V         P P  RP    +++
Sbjct: 294 LFTQKYPQEHMMV----QDMLSPSPTERPEATDIIE 325

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  117 bits (295), Expect = 7e-28
 Identities = 56/209 (26%), Positives = 88/209 (42%), Gaps = 29/209 (13%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G+G FG V+R    +TG   A K V        +    EI +M  LRH  LV LH    
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLYLHEE 476
             +E++++Y+++  G     LF+      K+ +   +       + +  V + L ++HE 
Sbjct: 225 DDNEMVMIYEFMSGGE----LFE------KVADEHNKMSEDEAVEYMRQVCKGLCHMHE- 273

Query: 477 CDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                VH D+KP N++     +   KL DFGL    D           GT  + APE+  
Sbjct: 274 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP--KQSVKVTTGTAEFAAPEVAE 329

Query: 535 TGKATTSTDVFGFGTL---MLEVACGRRP 560
                  TD++  G L   +L    G  P
Sbjct: 330 GKPVGYYTDMWSVGVLSYILL---SGLSP 355

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  113 bits (284), Expect = 9e-28
 Identities = 49/181 (27%), Positives = 78/181 (43%), Gaps = 15/181 (8%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
             ++GSG F +V+      TG   A+K +  +          EI  + +++H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
                    LV   V  G     LFD   ++      D    ++  V  A+ YLH   + 
Sbjct: 74  IYESTTHYYLVMQLVSGGE----LFDRILERGVYTEKDAS-LVIQQVLSAVKYLH---EN 125

Query: 480 RVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRT 535
            +VHRD+KP N+L    + +    + DFGL++      N   +   GT GY+APE L + 
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ---NGIMSTACGTPGYVAPEVLAQK 182

Query: 536 G 536
            
Sbjct: 183 P 183

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  111 bits (281), Expect = 1e-27
 Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 16/176 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
            +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEEC 477
            R+ +   L  +Y   G L    FD  +    +   D +     ++ GV     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG-- 123

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPEL 532
              + HRD+KP N+L+D   N K+ DFGLA  + +N   +  + + GTL Y+APEL
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  112 bits (282), Expect = 2e-27
 Identities = 63/200 (31%), Positives = 110/200 (55%), Gaps = 10/200 (5%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA--EITSMGRLRHRNLVQLHGW 420
           +G+G +  VY+G+  +TG+ VA+K V  +S +G     A  EI+ M  L+H N+V+L+  
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENIVRLYDV 71

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFD-NDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
              +++L LV++++ N  L K +         + L  +        + Q L + H   + 
Sbjct: 72  IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---EN 127

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA- 538
           +++HRD+KP N+LI+     KLGDFGLARA+   +N   +  V TL Y AP++    +  
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT-FSSEVVTLWYRAPDVLMGSRTY 186

Query: 539 TTSTDVFGFGTLMLEVACGR 558
           +TS D++  G ++ E+  G+
Sbjct: 187 STSIDIWSCGCILAEMITGK 206

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  112 bits (283), Expect = 2e-27
 Identities = 55/217 (25%), Positives = 97/217 (44%), Gaps = 32/217 (14%)

Query: 364 GSGGFGKVYRGVI-------PSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRL-RHRNL 414
           G G FG+V            P   + VA+K +    + + + + V+E+  M  + +H+N+
Sbjct: 44  GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 103

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDNDQQKKKILNWDQRYKIL 463
           + L G C +   L ++ +Y   G+L            +  +D ++  ++ + +       
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR    +IN    +   
Sbjct: 164 YQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKT 216

Query: 524 TLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA 555
           T G L     APE       T  +DV+ FG LM E+ 
Sbjct: 217 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  113 bits (284), Expect = 3e-27
 Identities = 57/223 (25%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 364 GSGGFGKVYRGVI-------PSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRL-RHRNL 414
           G G FG+V            P   + VA+K +    + + + + V+E+  M  + +H+N+
Sbjct: 90  GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 149

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDNDQQKKKILNWDQRYKIL 463
           + L G C +   L ++ +Y   G+L            +  +D ++  ++ + +       
Sbjct: 150 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 209

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             +A+ + YL     Q+ +HRD+   NVL+  +   K+ DFGLAR    +IN    +   
Sbjct: 210 YQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYYKKT 262

Query: 524 TLGYL-----APELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
           T G L     APE       T  +DV+ FG LM E+   G  P
Sbjct: 263 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (285), Expect = 4e-27
 Identities = 53/228 (23%), Positives = 90/228 (39%), Gaps = 34/228 (14%)

Query: 324 RRIRNGDDILEDWEVEYGACRFRYSELYSA-----TKGFREK----NLVGSGGFGKVYRG 374
           R + N  +I            F + +L         K  R++      +GSG  G+V   
Sbjct: 98  RPLNNNSEIALSLSRNK---VFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLA 154

Query: 375 VIPSTGLEVAIKRVA--------HNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE 426
               T  +VAI+ ++                    EI  + +L H  ++++  +   +D 
Sbjct: 155 FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 213

Query: 427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV 486
             +V + +  G     LFD     K+ L           +  A+ YLH   +  ++HRD+
Sbjct: 214 YYIVLELMEGGE----LFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH---ENGIIHRDL 265

Query: 487 KPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
           KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 266 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 311

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  111 bits (280), Expect = 4e-27
 Identities = 55/176 (31%), Positives = 82/176 (46%), Gaps = 16/176 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
            +G G +G+V   V   T   VA+K V         E +  EI     L H N+V+ +G 
Sbjct: 14  TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEEC 477
            R+ +   L  +Y   G L    FD  +    +   D +     ++ GV     YLH   
Sbjct: 74  RREGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG-- 123

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPEL 532
              + HRD+KP N+L+D   N K+ DFGLA  + +N   +  + + GTL Y+APEL
Sbjct: 124 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 178

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  111 bits (280), Expect = 6e-27
 Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 26/212 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-----EITSMGRLRHRNLVQL 417
           +G G F  VY+    +T   VAIK++    R   K+ +      EI  +  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ-----QKKKILNWDQRYKILIGVAQALLY 472
                 +  + LV+D++    L+ ++ DN         K  +        L G+     Y
Sbjct: 78  LDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYM-----LMTLQGLE----Y 127

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH      ++HRD+KP+N+L+D +   KL DFGLA+++        TH V T  Y APEL
Sbjct: 128 LH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-YTHQVVTRWYRAPEL 183

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
               +      D++  G ++ E+   R P  P
Sbjct: 184 LFGARMYGVGVDMWAVGCILAEL-LLRVPFLP 214

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  111 bits (279), Expect = 6e-27
 Identities = 77/322 (23%), Positives = 131/322 (40%), Gaps = 46/322 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLV 415
           F    LVG+G +G+VY+G    TG   AIK +        +E   EI  + +   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 416 QLHG------WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
             +G           D+L LV ++   GS+  L+      K   L  +    I   + + 
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI---KNTKGNTLKEEWIAYICREILRG 141

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
           L +LH+    +V+HRD+K  NVL+  +   KL DFG++   D  +  + T  +GT  ++A
Sbjct: 142 LSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMA 197

Query: 530 PELTRTGKATTST-----DVFGFGTLMLEVACGRRP---IEPQRTAMELVLVDWVRELHS 581
           PE+    +   +T     D++  G   +E+A G  P   + P R      L         
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-----ALF-------- 244

Query: 582 QGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQ 637
              I R   P L    +  +    +      C   +   RP+T ++++  F+    +  Q
Sbjct: 245 --LIPRNPAPRLKSKKWSKKFQSFI----ESCLVKNHSQRPATEQLMKHPFIRDQPNERQ 298

Query: 638 APLDIHHEFPRAIPEFSEDDSD 659
             + +     R   +  E D  
Sbjct: 299 VRIQLKDHIDRTKKKRGEKDET 320

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  111 bits (279), Expect = 6e-27
 Identities = 57/219 (26%), Positives = 87/219 (39%), Gaps = 29/219 (13%)

Query: 364 GSGGFGKVYRGVIP-----STGLEVAIKRV-AHNSRQGMKEFVAEITSMGRL-RHRNLVQ 416
           G+G FGKV              L+VA+K + +       +  ++E+  M  L +H N+V 
Sbjct: 55  GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVN 114

Query: 417 LHGWCRKQDELLLVYDYVPNGSL---------DKLLFDNDQQKKKILNWDQRYKILIGVA 467
           L G C     +L++ +Y   G L                        +          VA
Sbjct: 115 LLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVA 174

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           Q + +L     +  +HRDV   NVL+      K+GDFGLAR    +I   + +IV     
Sbjct: 175 QGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVKGNAR 227

Query: 528 L-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           L     APE       T  +DV+ +G L+ E+   G  P
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (281), Expect = 6e-27
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 33/223 (14%)

Query: 364 GSGGFGKVYRGVI-------PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNL 414
           G G FG+V            P+   +VA+K +  + + + + + ++E+  M  + +H+N+
Sbjct: 78  GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNI 137

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSL-----------DKLLFDNDQQKKKILNWDQRYKIL 463
           + L G C +   L ++ +Y   G+L            +  ++     ++ L+        
Sbjct: 138 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 197

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR    +I+    +   
Sbjct: 198 YQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKKT 250

Query: 524 TLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           T G L     APE       T  +DV+ FG L+ E+   G  P
Sbjct: 251 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (281), Expect = 7e-27
 Identities = 48/207 (23%), Positives = 76/207 (36%), Gaps = 16/207 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           G      V       TG  V ++R+     S + +     E+       H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
              +EL +V  ++  GS   L+          +N      IL GV +AL Y+H       
Sbjct: 96  IADNELWVVTSFMAYGSAKDLI---CTHFMDGMNELAIAYILQGVLKALDYIHH---MGY 149

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTT------HIVGTLGYLAPELTRT 535
           VHR VK S++LI  D    L       +   +   Q        + V  L +L+PE+ + 
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 536 GKA--TTSTDVFGFGTLMLEVACGRRP 560
                   +D++  G    E+A G  P
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVP 236

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  112 bits (283), Expect = 8e-27
 Identities = 48/231 (20%), Positives = 88/231 (38%), Gaps = 35/231 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLV 415
              + ++G G  G V        G  VA+KR+           + EI  +     H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNVI 72

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILIGVAQALLYL 473
           + +        L +  +   N +L  L+   +   + +    +     +L  +A  + +L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 474 HEECDQRVVHRDVKPSNVLID-------------ADLNPKLGDFGLARAYD---HNINPQ 517
           H     +++HRD+KP N+L+               +L   + DFGL +  D    +    
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 518 TTHIVGTLGYLAPEL-------TRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
             +  GT G+ APEL           + T S D+F  G +   +   G+ P
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  110 bits (276), Expect = 1e-26
 Identities = 51/223 (22%), Positives = 87/223 (39%), Gaps = 33/223 (14%)

Query: 364 GSGGFGKVYRGVIP-----STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQ 416
           G+G FGKV              + VA+K +  +      +  ++E+  +  L  H N+V 
Sbjct: 32  GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVN 91

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLL-------------FDNDQQKKKILNWDQRYKIL 463
           L G C      L++ +Y   G L   L                 +  +  L+ +      
Sbjct: 92  LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
             VA+ + +L     +  +HRD+   N+L+      K+ DFGLAR    +I   + ++V 
Sbjct: 152 YQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSNYVVK 204

Query: 524 TLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
               L     APE       T  +DV+ +G  + E+   G  P
Sbjct: 205 GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  109 bits (274), Expect = 1e-26
 Identities = 57/201 (28%), Positives = 87/201 (43%), Gaps = 14/201 (6%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR 422
           +G G +G+V   V   T +  A K++     + +  F  EI  M  L H N+++L+    
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVV 482
              ++ LV +    G     LF+    K+     D   +I+  V  A+ Y H      V 
Sbjct: 77  DNTDIYLVMELCTGGE----LFERVVHKRVFRESDAA-RIMKDVLSAVAYCH---KLNVA 128

Query: 483 HRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKAT 539
           HRD+KP N L      D   KL DFGLA  +      +T   VGT  Y++P++   G   
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSPQVLE-GLYG 185

Query: 540 TSTDVFGFGTLMLEVACGRRP 560
              D +  G +M  + CG  P
Sbjct: 186 PECDEWSAGVMMYVLLCGYPP 206

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  110 bits (277), Expect = 1e-26
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 25/220 (11%)

Query: 357 FREKNLVGSGGFGKVYRGV-IPSTGLEVAIKRVA-HNSRQGMKEFVA--EITSMGRLR-- 410
           +     +G G +GKV++   + + G  VA+KRV      +GM       E+  +  L   
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGM-PLSTIREVAVLRHLETF 71

Query: 411 -HRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
            H N+V+L          ++ +L LV+++V    L   L   D+  +  +  +    ++ 
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETIKDMMF 127

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT-THIVG 523
            + + L +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y         T +V 
Sbjct: 128 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 181

Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           TL Y APE+       T  D++  G +  E+   R+P+  
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPLFR 220

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  110 bits (276), Expect = 1e-26
 Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 32/222 (14%)

Query: 364 GSGGFGKVYRGVIP-----STGLEVAIKRV-AHNSRQGMKEFVAEITSMGRL-RHRNLVQ 416
           G G FG+V           +T   VA+K +    +    +  ++E+  +  +  H N+V 
Sbjct: 36  GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95

Query: 417 LHGWCRKQDE-LLLVYDYVPNGSL-----------DKLLFDNDQQKKKILNWDQRYKILI 464
           L G C K    L+++ ++   G+L                  +   K  L  +       
Sbjct: 96  LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
            VA+ + +L     ++ +HRD+   N+L+      K+ DFGLAR    +I     ++   
Sbjct: 156 QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKG 208

Query: 525 LGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
              L     APE       T  +DV+ FG L+ E+   G  P
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  110 bits (276), Expect = 1e-26
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 26/208 (12%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVA--EITSMGRLRHRNLVQLHG 419
           +G G +G+VY+ +   T   VAIKR+   +  +G+    A  E++ +  L+HRN+++L  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGV-PGTAIREVSLLKELQHRNIIELKS 100

Query: 420 WCRKQDELLLVYDYVPN---GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                  L L+++Y  N     +DK    + +  K  L     Y+++ GV     + H  
Sbjct: 101 VIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFL-----YQLINGVN----FCH-- 149

Query: 477 CDQRVVHRDVKPSNVLIDADLNP-----KLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
             +R +HRD+KP N+L+           K+GDFGLARA+   I    TH + TL Y  PE
Sbjct: 150 -SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ-FTHEIITLWYRPPE 207

Query: 532 LTRTGKA-TTSTDVFGFGTLMLEVACGR 558
           +    +  +TS D++    +  E+    
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  109 bits (275), Expect = 1e-26
 Identities = 66/206 (32%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVA--EITSMGRLRHRN 413
           +++   VG G +G VY+    S G  VA+KR+      +G+    A  EI+ +  L H N
Sbjct: 23  YQKLEKVGEGTYGVVYKA-KDSQGRIVALKRIRLDAEDEGI-PSTAIREISLLKELHHPN 80

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V L      +  L LV++++    L K+L     + K  L   Q    L  + + + + 
Sbjct: 81  IVSLIDVIHSERCLTLVFEFMEK-DLKKVL----DENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H     R++HRD+KP N+LI++D   KL DFGLARA+   +    TH V TL Y AP++ 
Sbjct: 136 H---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS-YTHEVVTLWYRAPDVL 191

Query: 534 RTGKA-TTSTDVFGFGTLMLEVACGR 558
              K  +TS D++  G +  E+  G+
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  109 bits (274), Expect = 2e-26
 Identities = 53/228 (23%), Positives = 99/228 (43%), Gaps = 38/228 (16%)

Query: 364 GSGGFGKVYRGVIP-----STGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FGKV +         +    VA+K +  + S   +++ ++E   + ++ H ++++L
Sbjct: 32  GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKL 91

Query: 418 HGWCRKQDELLLVYDYVPNGSL-------------------DKLLFDNDQQKKKILNWDQ 458
           +G C +   LLL+ +Y   GSL                    +     D   ++ L    
Sbjct: 92  YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151

Query: 459 RYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
                  ++Q + YL E    ++VHRD+   N+L+      K+ DFGL+R    ++  + 
Sbjct: 152 LISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYEED 204

Query: 519 THIVGTLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
           +++  + G +     A E       TT +DV+ FG L+ E+   G  P
Sbjct: 205 SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  109 bits (275), Expect = 2e-26
 Identities = 57/248 (22%), Positives = 91/248 (36%), Gaps = 50/248 (20%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           K  +G G +G V   +   T    AIK     ++   + + ++    E+  M +L H N+
Sbjct: 31  KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI 90

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSL-DKLLFDNDQQKKKILNWDQRY------------- 460
            +L+     +  + LV +    G L DKL    D    K      +              
Sbjct: 91  ARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAI 150

Query: 461 ---------------------KILIGVAQALLYLHEECDQRVVHRDVKPSNVLI--DADL 497
                                 I+  +  AL YLH    Q + HRD+KP N L   +   
Sbjct: 151 NGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSF 207

Query: 498 NPKLGDFGLARAYDHNINPQTTH---IVGTLGYLAPE-LTRTGKA-TTSTDVFGFGTLML 552
             KL DFGL++ +    N +        GT  ++APE L  T ++     D +  G L+ 
Sbjct: 208 EIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267

Query: 553 EVACGRRP 560
            +  G  P
Sbjct: 268 LLLMGAVP 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  108 bits (272), Expect = 2e-26
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +GSG FG V+     S+GLE  IK +  +  Q   E +  EI  +  L H N++++    
Sbjct: 30  LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF 89

Query: 422 RKQDELLLVYDYVPNGSLDKLLFD---NDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
                + +V +    G     L +   + Q + K L+     +++  +  AL Y H    
Sbjct: 90  EDYHNMYIVMETCEGGE----LLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS--- 142

Query: 479 QRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           Q VVH+D+KP N+L          K+ DFGLA  +  + +       GT  Y+APE+ + 
Sbjct: 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN--AAGTALYMAPEVFK- 199

Query: 536 GKATTSTDVFGFGTLMLEVACGRRP 560
              T   D++  G +M  +  G  P
Sbjct: 200 RDVTFKCDIWSAGVVMYFLLTGCLP 224

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  109 bits (274), Expect = 2e-26
 Identities = 51/212 (24%), Positives = 92/212 (43%), Gaps = 36/212 (16%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWC 421
           +G G FG V+R V  S+      K V    +   +  V  EI+ +   RHRN++ LH   
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLYLHE 475
              +EL+++++++        +F+      +I               +  V +AL +LH 
Sbjct: 71  ESMEELVMIFEFISGLD----IFE------RINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 476 ECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
                + H D++P N++      + +  K+ +FG AR      N +   +     Y APE
Sbjct: 121 ---HNIGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL--LFTAPEYYAPE 173

Query: 532 LTRTGKATTSTDVFGFGTL---MLEVACGRRP 560
           + +    +T+TD++  GTL   +L    G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLL---SGINP 202

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  108 bits (272), Expect = 3e-26
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 15/200 (7%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVA-HNSRQGMKEFVA--EITSMGRLRHRNLVQLHG 419
           +G G +G VY+    + G   A+K++      +G+       EI+ +  L+H N+V+L+ 
Sbjct: 10  IGEGTYGVVYKA-QNNYGETFALKKIRLEKEDEGI-PSTTIREISILKELKHSNIVKLYD 67

Query: 420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ 479
               +  L+LV++++    L KLL       +  L        L+ +   + Y H   D+
Sbjct: 68  VIHTKKRLVLVFEHLDQ-DLKKLL----DVCEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA- 538
           RV+HRD+KP N+LI+ +   K+ DFGLARA+   +    TH + TL Y AP++    K  
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK-YTHEIVTLWYRAPDVLMGSKKY 178

Query: 539 TTSTDVFGFGTLMLEVACGR 558
           +T+ D++  G +  E+  G 
Sbjct: 179 STTIDIWSVGCIFAEMVNGT 198

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  109 bits (275), Expect = 3e-26
 Identities = 60/218 (27%), Positives = 93/218 (42%), Gaps = 22/218 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRN 413
           F +   +G G FG VY          VAIK++      S +  ++ + E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
            +Q  G   ++    LV +Y    + D L     +  KK L   +   +  G  Q L YL
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLL-----EVHKKPLQEVEIAAVTHGALQGLAYL 170

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H      ++HRDVK  N+L+      KLGDFG A      + P  +  VGT  ++APE+ 
Sbjct: 171 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS-FVGTPYWMAPEVI 222

Query: 534 RTGKATT---STDVFGFGTLMLEVACGRRP---IEPQR 565
                       DV+  G   +E+A  + P   +    
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 260

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  109 bits (274), Expect = 3e-26
 Identities = 54/228 (23%), Positives = 92/228 (40%), Gaps = 38/228 (16%)

Query: 364 GSGGFGKVYRGVIPSTG-----LEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
           G G FG+V++   P          VA+K +    S     +F  E   M    + N+V+L
Sbjct: 56  GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKL 115

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLL-------------------FDNDQQKKKILNWDQ 458
            G C     + L+++Y+  G L++ L                             L+  +
Sbjct: 116 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 175

Query: 459 RYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
           +  I   VA  + YL E   ++ VHRD+   N L+  ++  K+ DFGL+R    NI    
Sbjct: 176 QLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSAD 228

Query: 519 THIVGTLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
            +       +      PE     + TT +DV+ +G ++ E+   G +P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  108 bits (273), Expect = 3e-26
 Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 20/209 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVA-EITSMGRLRHR--N 413
           L+GSGGFG VY G+  S  L VAIK     R++          V  E+  + ++      
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L  W  + D  +L+ +  P    D  LFD   ++   L  +        V +A+ + 
Sbjct: 110 VIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGA-LQEELARSFFWQVLEAVRHC 165

Query: 474 HEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           H   +  V+HRD+K  N+LID +    KL DFG   A   +         GT  Y  PE 
Sbjct: 166 H---NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDF--DGTRVYSPPEW 219

Query: 533 TRTGK-ATTSTDVFGFGTLMLEVACGRRP 560
            R  +    S  V+  G L+ ++ CG  P
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  108 bits (271), Expect = 3e-26
 Identities = 56/193 (29%), Positives = 87/193 (45%), Gaps = 24/193 (12%)

Query: 353 ATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIK--------RVAHNSRQGMKEFV 400
           +T GF E      ++G G    V R +   T  E A+K          +    Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 401 A-EITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ 458
             E+  + ++  H N++QL           LV+D +  G L    FD   +K  +   + 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKET 126

Query: 459 RYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
           R KI+  + + +  LH      +VHRD+KP N+L+D D+N KL DFG +   D     + 
Sbjct: 127 R-KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182

Query: 519 THIVGTLGYLAPE 531
             + GT  YLAPE
Sbjct: 183 --VCGTPSYLAPE 193

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  111 bits (279), Expect = 4e-26
 Identities = 52/207 (25%), Positives = 99/207 (47%), Gaps = 17/207 (8%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVA---HNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           + ++G G FG+V       TG E A+K ++      +   +  + E+  + +L H N+++
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L+ +   +    LV +    G     LFD +   +K  +     +I+  V   + Y+H+ 
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGE----LFD-EIISRKRFSEVDAARIIRQVLSGITYMHK- 144

Query: 477 CDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
              ++VHRD+KP N+L+     D N ++ DFGL+  ++   + +    +GT  Y+APE+ 
Sbjct: 145 --NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA--SKKMKDKIGTAYYIAPEVL 200

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
             G      DV+  G ++  +  G  P
Sbjct: 201 H-GTYDEKCDVWSTGVILYILLSGCPP 226

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  108 bits (273), Expect = 5e-26
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 35/205 (17%)

Query: 348 SELYSATKGFRE----KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEI 403
            +L+  +  F +    K  +G G +    R +  +T +E A+K +  + R   +    EI
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE----EI 66

Query: 404 TSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY-- 460
             + R  +H N++ L         + +V + +  G     L D   ++K        +  
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE----LLDKILRQKF-------FSE 115

Query: 461 ----KILIGVAQALLYLHEECDQRVVHRDVKPSNVL-IDADLNP---KLGDFGLARAYDH 512
                +L  + + + YLH    Q VVHRD+KPSN+L +D   NP   ++ DFG A+    
Sbjct: 116 REASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172

Query: 513 NINPQTTHIVGTLGYLAPE-LTRTG 536
                 T    T  ++APE L R G
Sbjct: 173 ENGLLMT-PCYTANFVAPEVLERQG 196

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  108 bits (272), Expect = 7e-26
 Identities = 49/191 (25%), Positives = 88/191 (46%), Gaps = 20/191 (10%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFV-AEITSMGRLRHRNLVQL 417
           GSG F  V +    STGLE A K     +   + R   +E +  E++ + ++ H N++ L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITL 80

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H     + +++L+ + V  G     LFD   QK+ +   +     +  +   + YLH   
Sbjct: 81  HDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQILDGVNYLHT-- 133

Query: 478 DQRVVHRDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
            +++ H D+KP N+++        + KL DFGLA   +     +  +I GT  ++APE+ 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIV 190

Query: 534 RTGKATTSTDV 544
                    D+
Sbjct: 191 NYEPLGLEADM 201

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  108 bits (272), Expect = 7e-26
 Identities = 53/194 (27%), Positives = 94/194 (48%), Gaps = 23/194 (11%)

Query: 351 YSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIK-------RVAHNSRQGMKEF 399
           ++A K F +K    +++G G    V R V  +TG E A+K       R++    + ++E 
Sbjct: 86  WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREA 145

Query: 400 VA-EITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD 457
              E   + ++  H +++ L         + LV+D +  G L    FD   +K  +   +
Sbjct: 146 TRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKE 201

Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ 517
            R  I+  + +A+ +LH      +VHRD+KP N+L+D ++  +L DFG +   +     +
Sbjct: 202 TR-SIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR 257

Query: 518 TTHIVGTLGYLAPE 531
              + GT GYLAPE
Sbjct: 258 E--LCGTPGYLAPE 269

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (267), Expect = 9e-26
 Identities = 48/199 (24%), Positives = 85/199 (42%), Gaps = 36/199 (18%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVA-EITSMGRLRHRNLVQL 417
           GSG F  V +     TG E A K     R++ + R   +E +  E+  +  +RH N++ L
Sbjct: 14  GSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL 73

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALL 471
           H     + +++L+ + V  G     LFD       +    +        + L  +   + 
Sbjct: 74  HDIFENKTDVVLILELVSGGE----LFD------FLAE-KESLTEDEATQFLKQILDGVH 122

Query: 472 YLHEECDQRVVHRDVKPSNVLI------DADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           YLH    +R+ H D+KP N+++      +  +  KL DFG+A   +     +   I GT 
Sbjct: 123 YLHS---KRIAHFDLKPENIMLLDKNVPNPRI--KLIDFGIAHKIEAGNEFKN--IFGTP 175

Query: 526 GYLAPELTRTGKATTSTDV 544
            ++APE+          D+
Sbjct: 176 EFVAPEIVNYEPLGLEADM 194

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  106 bits (267), Expect = 1e-25
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 20/193 (10%)

Query: 354 TKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVAEITSMG 407
           +  F +       +G G F  V R V  +TGLE A K +     S +  ++   E     
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           +L+H N+V+LH   +++    LV+D V  G     LF++   ++     D     +  + 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-HCIQQIL 115

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
           +++ Y H      +VHR++KP N+L+         KL DFGLA   +   +       GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAWHGFAGT 170

Query: 525 LGYLAPE-LTRTG 536
            GYL+PE L +  
Sbjct: 171 PGYLSPEVLKKDP 183

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  110 bits (276), Expect = 1e-25
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQL 417
              +GSG +G+V       T +E AIK +     S     + + E+  +  L H N+++L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           + +   +    LV +    G     LFD +   +   N      I+  V   + YLH+  
Sbjct: 102 YDFFEDKRNYYLVMECYKGGE----LFD-EIIHRMKFNEVDAAVIIKQVLSGVTYLHK-- 154

Query: 478 DQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHRD+KP N+L+   + D   K+ DFGL+  +++    +    +GT  Y+APE+ R
Sbjct: 155 -HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLR 211

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
             K     DV+  G ++  +  G  P
Sbjct: 212 -KKYDEKCDVWSIGVILFILLAGYPP 236

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  107 bits (270), Expect = 1e-25
 Identities = 56/203 (27%), Positives = 81/203 (39%), Gaps = 20/203 (9%)

Query: 342 ACRFRYSELYSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMK 397
           +    Y    S      +     + +G G    VYR     T    A+K +        K
Sbjct: 36  SLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKK 93

Query: 398 EFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWD 457
               EI  + RL H N+++L        E+ LV + V  G     LFD   +K      D
Sbjct: 94  IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGE----LFDRIVEKGYYSERD 149

Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNI 514
                +  + +A+ YLHE     +VHRD+KP N+L      D   K+ DFGL++  +H  
Sbjct: 150 AA-DAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH-- 203

Query: 515 NPQTTHIVGTLGYLAPE-LTRTG 536
                 + GT GY APE L    
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCA 226

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  108 bits (272), Expect = 1e-25
 Identities = 59/265 (22%), Positives = 104/265 (39%), Gaps = 29/265 (10%)

Query: 330 DDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVI--PSTGLEVAIKR 387
           D +  D++V+  + R R  +L+       E   VG G +G VY+          + A+K+
Sbjct: 1   DKMDYDFKVKLSSERERVEDLFE-----YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQ 55

Query: 388 VAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC--RKQDELLLVYDYVPN---GSLDKL 442
           +             EI  +  L+H N++ L          ++ L++DY  +     +   
Sbjct: 56  IEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFH 113

Query: 443 LFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP--- 499
                 +K   L       +L  +   + YLH      V+HRD+KP+N+L+  +      
Sbjct: 114 RASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGR 170

Query: 500 -KLGDFGLARAYDHNINPQT--THIVGTLGYLAPEL---TRTGKATTSTDVFGFGTLMLE 553
            K+ D G AR ++  + P      +V T  Y APEL    R    T + D++  G +  E
Sbjct: 171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARH--YTKAIDIWAIGCIFAE 228

Query: 554 VACGRRPIEPQRTAMELVLVDWVRE 578
           +     PI   R         +  +
Sbjct: 229 L-LTSEPIFHCRQEDIKTSNPYHHD 252

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  106 bits (268), Expect = 1e-25
 Identities = 50/191 (26%), Positives = 88/191 (46%), Gaps = 20/191 (10%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVA-EITSMGRLRHRNLVQL 417
           GSG F  V +    STGLE A K     +   + R   +E +  E++ + ++ H N++ L
Sbjct: 21  GSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITL 80

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
           H     + +++L+ + V  G     LFD   QK+ +   +     +  +   + YLH   
Sbjct: 81  HDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEAT-SFIKQILDGVNYLHT-- 133

Query: 478 DQRVVHRDVKPSNVLIDADLNP----KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
            +++ H D+KP N+++     P    KL DFGLA   +     +  +I GT  ++APE+ 
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED--GVEFKNIFGTPEFVAPEIV 190

Query: 534 RTGKATTSTDV 544
                    D+
Sbjct: 191 NYEPLGLEADM 201

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  106 bits (268), Expect = 1e-25
 Identities = 58/212 (27%), Positives = 96/212 (45%), Gaps = 20/212 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFV-AEITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK     H  ++    +V  E   M RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR-YKILIGVAQ---A 469
            V+L+   +  ++L     Y  NG L K +    ++         R Y      A+   A
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFY-----TAEIVSA 142

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYL 528
           L YLH    + ++HRD+KP N+L++ D++ ++ DFG A+           +  VGT  Y+
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 199

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +PEL     A  S+D++  G ++ ++  G  P
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (267), Expect = 1e-25
 Identities = 48/188 (25%), Positives = 80/188 (42%), Gaps = 24/188 (12%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEFVA-EITSMGRLRHRNLVQL 417
           L+G G +GKV   +   T    A+K   +         +  V  EI  + RLRH+N++QL
Sbjct: 12  LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71

Query: 418 H---GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ--RY--KILIGVAQAL 470
                   KQ  + +V +Y   G  +  + D+  +K+      Q   Y  +++ G+    
Sbjct: 72  VDVLYNEEKQK-MYMVMEYCVCGMQE--MLDSVPEKR--FPVCQAHGYFCQLIDGLE--- 123

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV-GTLGYLA 529
            YLH    Q +VH+D+KP N+L+      K+   G+A A        T     G+  +  
Sbjct: 124 -YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179

Query: 530 PELTRTGK 537
           PE+     
Sbjct: 180 PEIANGLD 187

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  105 bits (265), Expect = 2e-25
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 20/216 (9%)

Query: 354 TKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMG 407
              F E+     ++G G FG+V +     T  E A+K +  A    +     + E+  + 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLK 76

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           +L H N+++L           +V +    G     LFD   ++K+    D   +I+  V 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-RIIKQVF 131

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
             + Y+H      +VHRD+KP N+L+   + D + K+ DFGL+  +  N   +    +GT
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGT 186

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             Y+APE+ R G      DV+  G ++  +  G  P
Sbjct: 187 AYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPP 221

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  106 bits (266), Expect = 2e-25
 Identities = 59/211 (27%), Positives = 86/211 (40%), Gaps = 22/211 (10%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVA-EITSMGRLR----H 411
           L+G GGFG V+ G   +  L+VAIK     RV   S          E+  + ++     H
Sbjct: 38  LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
             +++L  W   Q+  +LV +        + LFD   +K   L           V  A+ 
Sbjct: 98  PGVIRLLDWFETQEGFMLVLERPLPA---QDLFDYITEKGP-LGEGPSRCFFGQVVAAIQ 153

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           + H    + VVHRD+K  N+LID      KL DFG   A  H+         GT  Y  P
Sbjct: 154 HCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDF--DGTRVYSPP 207

Query: 531 ELTRTGK-ATTSTDVFGFGTLMLEVACGRRP 560
           E     +       V+  G L+ ++ CG  P
Sbjct: 208 EWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  106 bits (267), Expect = 2e-25
 Identities = 56/228 (24%), Positives = 93/228 (40%), Gaps = 38/228 (16%)

Query: 364 GSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQ 416
           GSG FGKV              ++VA+K +         +  ++E+  M +L  H N+V 
Sbjct: 54  GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVN 113

Query: 417 LHGWCRKQDELLLVYDYVPNGSL------------------DKLLFDNDQQKKKILNWDQ 458
           L G C     + L+++Y   G L                  +      +++   +L ++ 
Sbjct: 114 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 173

Query: 459 RYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
                  VA+ + +L     +  VHRD+   NVL+      K+ DFGLAR    +I   +
Sbjct: 174 LLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDS 226

Query: 519 THIVGTLGYL-----APELTRTGKATTSTDVFGFGTLMLEVA-CGRRP 560
            ++V     L     APE    G  T  +DV+ +G L+ E+   G  P
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  106 bits (268), Expect = 3e-25
 Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 24/223 (10%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
              F+ + + G G FG V  G   STG+ VAIK+V  + R   +E +  +  +  L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80

Query: 414 LVQLH-----GWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ----RYKI 462
           +VQL         R + +  L +V +YVP+ +L +    N  +++            +++
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-RNYYRRQVAPPPILIKVFLFQL 138

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNPKLGDFGLARAYDHNINPQTTHI 521
           +    +++  LH      V HRD+KP NVL++ AD   KL DFG A+    +  P   +I
Sbjct: 139 I----RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS-EPNVAYI 192

Query: 522 VGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
             +  Y APEL    +  TT+ D++  G +  E+     PI  
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPIFR 233

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  106 bits (267), Expect = 3e-25
 Identities = 49/175 (28%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGWCR 422
           GSG FG         T   VA+K +       + E V  EI +   LRH N+V+      
Sbjct: 29  GSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKEVIL 86

Query: 423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEECDQ 479
               L ++ +Y   G L    ++      +    + R+    +L GV+    Y H     
Sbjct: 87  TPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCHS---M 135

Query: 480 RVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           ++ HRD+K  N L+D    P  K+ DFG +++   +  P++T  VGT  Y+APE+
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEV 188

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  106 bits (266), Expect = 4e-25
 Identities = 43/188 (22%), Positives = 75/188 (39%), Gaps = 26/188 (13%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G F  V R +   TG + A+K     +   +     ++   E +    L+H ++V+L 
Sbjct: 33  GKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELL 92

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLY 472
                   L +V++++        L     ++         Y        +  + +AL Y
Sbjct: 93  ETYSSDGMLYMVFEFMDGAD----LCFEIVKRADA---GFVYSEAVASHYMRQILEALRY 145

Query: 473 LHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            H+     ++HRDVKP  VL+   +     KLG FG+A     +        VGT  ++A
Sbjct: 146 CHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFMA 201

Query: 530 PE-LTRTG 536
           PE + R  
Sbjct: 202 PEVVKREP 209

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  105 bits (265), Expect = 7e-25
 Identities = 54/199 (27%), Positives = 90/199 (45%), Gaps = 20/199 (10%)

Query: 348 SELYSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVA 401
             + +A+  F +       +G G F  V R V  +TGLE A K +     S +  ++   
Sbjct: 18  EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77

Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E     +L+H N+V+LH   +++    LV+D V  G     LF++   ++     D    
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADAS-H 132

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQT 518
            +  + +++ Y H      +VHR++KP N+L+         KL DFGLA   +   +   
Sbjct: 133 CIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--SEAW 187

Query: 519 THIVGTLGYLAPE-LTRTG 536
               GT GYL+PE L +  
Sbjct: 188 HGFAGTPGYLSPEVLKKDP 206

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  104 bits (262), Expect = 7e-25
 Identities = 41/188 (21%), Positives = 81/188 (43%), Gaps = 30/188 (15%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLH 418
           ++++G G   +V   +   T  E A+K +             E+  + + + HRN+++L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLY 472
            +  ++D   LV++ +  GS    +  +  +++        +       ++  VA AL +
Sbjct: 78  EFFEEEDRFYLVFEKMRGGS----ILSHIHKRRH-------FNELEASVVVQDVASALDF 126

Query: 473 LHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHN------INPQTTHIVG 523
           LH   ++ + HRD+KP N+L    +     K+ DF L      N        P+     G
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 524 TLGYLAPE 531
           +  Y+APE
Sbjct: 184 SAEYMAPE 191

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  107 bits (270), Expect = 7e-25
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 31/219 (14%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVA-------------HNSRQGMKEFVAEITSM 406
              +GSG +G+V      +   E AIK +               N  +  +E   EI+ +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 407 GRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY--KILI 464
             L H N+++L      +    LV ++   G     LF+    + K    D+     I+ 
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKF---DECDAANIMK 153

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHI 521
            +   + YLH+     +VHRD+KP N+L+   ++ LN K+ DFGL+  +  +   +    
Sbjct: 154 QILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--R 208

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +GT  Y+APE+ +  K     DV+  G +M  + CG  P
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  107 bits (268), Expect = 8e-25
 Identities = 50/182 (27%), Positives = 79/182 (43%), Gaps = 21/182 (11%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH 418
           G G F  V R V    G E A       +++    Q ++    E      L+H N+V+LH
Sbjct: 20  GKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLKHPNIVRLH 76

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
               ++    L++D V  G     LF++   ++     D     +  + +A+L+ H+   
Sbjct: 77  DSISEEGHHYLIFDLVTGGE----LFEDIVAREYYSEADAS-HCIQQILEAVLHCHQ--- 128

Query: 479 QRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTR 534
             VVHR++KP N+L+         KL DFGLA   +           GT GYL+PE L +
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG-FAGTPGYLSPEVLRK 187

Query: 535 TG 536
             
Sbjct: 188 DP 189

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  104 bits (262), Expect = 8e-25
 Identities = 54/192 (28%), Positives = 85/192 (44%), Gaps = 30/192 (15%)

Query: 356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNL 414
             ++K L G G F    + V   +    A+K ++       ++   EIT++     H N+
Sbjct: 13  DLKDKPL-GEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNI 68

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQ 468
           V+LH     Q    LV + +  G L    F+  ++KK        +       I+  +  
Sbjct: 69  VKLHEVFHDQLHTFLVMELLNGGEL----FERIKKKKH-------FSETEASYIMRKLVS 117

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           A+ ++H   D  VVHRD+KP N+L    + +L  K+ DFG AR    +  P  T    TL
Sbjct: 118 AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTL 173

Query: 526 GYLAPE-LTRTG 536
            Y APE L + G
Sbjct: 174 HYAAPELLNQNG 185

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  104 bits (261), Expect = 1e-24
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 32/197 (16%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVA-EITSMGRLRHRNLVQL 417
           GSG F  V +    STGL+ A K     R   + R   +E +  E++ +  ++H N++ L
Sbjct: 20  GSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITL 79

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALL 471
           H     + +++L+ + V  G     LFD       +    +        + L  +   + 
Sbjct: 80  HEVYENKTDVILILELVAGGE----LFD------FLAE-KESLTEEEATEFLKQILNGVY 128

Query: 472 YLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           YLH     ++ H D+KP N+++          K+ DFGLA   D     +   I GT  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183

Query: 528 LAPELTRTGKATTSTDV 544
           +APE+          D+
Sbjct: 184 VAPEIVNYEPLGLEADM 200

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  103 bits (260), Expect = 2e-24
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 15/201 (7%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC 421
           G G F KV       TG EVAIK +     +   +++   E+  M  L H N+V+L    
Sbjct: 24  GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83

Query: 422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRV 481
             +  L L+ +Y   G +    FD      + +   +       +  A+ Y H+   +R+
Sbjct: 84  ETEKTLYLIMEYASGGEV----FDYLVAHGR-MKEKEARSKFRQIVSAVQYCHQ---KRI 135

Query: 482 VHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK--AT 539
           VHRD+K  N+L+DAD+N K+ DFG +  +            G   Y APEL + GK    
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKKYDG 192

Query: 540 TSTDVFGFGTLMLEVACGRRP 560
              DV+  G ++  +  G  P
Sbjct: 193 PEVDVWSLGVILYTLVSGSLP 213

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  105 bits (265), Expect = 3e-24
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 16/206 (7%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNSRQGMKEFVAEITSMGRLRHRNLVQL 417
             ++G G FG+V +     T  E A+K +       +     + E+  + +L H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 418 HGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC 477
                      +V +    G     LFD +  K+K  +     +I+  V   + Y+H+  
Sbjct: 87  FEILEDSSSFYIVGELYTGGE----LFD-EIIKRKRFSEHDAARIIKQVFSGITYMHK-- 139

Query: 478 DQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
              +VHRD+KP N+L+   + D + K+ DFGL+  +    N +    +GT  Y+APE+ R
Sbjct: 140 -HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ--NTKMKDRIGTAYYIAPEVLR 196

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP 560
            G      DV+  G ++  +  G  P
Sbjct: 197 -GTYDEKCDVWSAGVILYILLSGTPP 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  101 bits (255), Expect = 3e-24
 Identities = 54/175 (30%), Positives = 82/175 (46%), Gaps = 19/175 (10%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
           G G FGKV  G    TG +VA+K +         +   +  EI ++   RH ++++L+  
Sbjct: 20  GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQV 79

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEEC 477
                +  +V +YV  G L    FD   +  ++   + R     IL  V     Y H   
Sbjct: 80  ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD----YCHR-- 129

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
              VVHRD+KP NVL+DA +N K+ DFGL+         +T+   G+  Y APE+
Sbjct: 130 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 181

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (257), Expect = 4e-24
 Identities = 52/215 (24%), Positives = 87/215 (40%), Gaps = 34/215 (15%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLH 418
           K ++G G  GKV       TG + A+K +        ++   E+    +     ++V + 
Sbjct: 34  KQVLGLGVNGKVLECFHRRTGQKCALKLL--YDSPKARQ---EVDHHWQASGGPHIVCIL 88

Query: 419 GWC----RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQ 468
                    +  LL++ + +  G L    F   Q++      DQ +      +I+  +  
Sbjct: 89  DVYENMHHGKRCLLIIMECMEGGEL----FSRIQERG-----DQAFTEREAAEIMRDIGT 139

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           A+ +LH      + HRDVKP N+L    + D   KL DFG A+               T 
Sbjct: 140 AIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNALQTPCYTP 193

Query: 526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            Y+APE+    K   S D++  G +M  + CG  P
Sbjct: 194 YYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  101 bits (253), Expect = 5e-24
 Identities = 34/285 (11%), Positives = 80/285 (28%), Gaps = 56/285 (19%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLH 418
             G     + ++ +  +   +VA+  V          ++E ++    + R+    + ++ 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
                +   L+V +++  GSL ++   +        +     + +  +A A    H    
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR--- 147

Query: 479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA 538
             V      PS V +  D +  L                          +         A
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPD-------A 179

Query: 539 TTSTDVFGFGTLMLEVACGRRPIEPQ--RTAMELVLVDWVRELHSQGQITRAIDPTLDYF 596
               D+ G G  +  +   R P+     R+ +     D   +      I R I   +   
Sbjct: 180 NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS-- 237

Query: 597 DPQEAELVLTLGLLCCDPHPDFRPST--RRVVQFLLRDASLPQAP 639
                   +    +        R ++    ++Q     A   +  
Sbjct: 238 -------AVAARSV--QGDGGIRSASTLLNLMQQATAVADRTEVL 273

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  101 bits (254), Expect = 1e-23
 Identities = 49/194 (25%), Positives = 84/194 (43%), Gaps = 28/194 (14%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHR-NLVQLHGW 420
           G G F  V + +  STG E A K  +     +    E + EI  +   +    ++ LH  
Sbjct: 38  GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV 97

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN-WDQRY------KILIGVAQALLYL 473
                E++L+ +Y   G     +F         L    +        +++  + + + YL
Sbjct: 98  YENTSEIILILEYAAGGE----IFS------LCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 474 HEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
           H+     +VH D+KP N+L+       + K+ DFG++R   H    +   I+GT  YLAP
Sbjct: 148 HQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAP 202

Query: 531 ELTRTGKATTSTDV 544
           E+      TT+TD+
Sbjct: 203 EILNYDPITTATDM 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  102 bits (257), Expect = 1e-23
 Identities = 60/253 (23%), Positives = 96/253 (37%), Gaps = 36/253 (14%)

Query: 323 LRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLE 382
           LR+ +N D+ L  ++        +  +L    + +    ++G G FG+V      ST   
Sbjct: 41  LRKNKNIDNFLSRYKDTIN----KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96

Query: 383 VAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSL 439
            A+K ++        +   F  E   M       +VQL    +    L +V +Y+P G L
Sbjct: 97  YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL 156

Query: 440 DKLLFDNDQQKKKILNWDQRYKILIGVAQ--------ALLYLHEECDQRVVHRDVKPSNV 491
             L+                Y +    A+        AL  +H       +HRDVKP N+
Sbjct: 157 VNLM--------------SNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNM 199

Query: 492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKA---TTSTDVFGF 547
           L+D   + KL DFG     +     +    VGT  Y++PE L   G         D +  
Sbjct: 200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 259

Query: 548 GTLMLEVACGRRP 560
           G  + E+  G  P
Sbjct: 260 GVFLYEMLVGDTP 272

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  101 bits (253), Expect = 1e-23
 Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 17/177 (9%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK--------RVAHNSRQGMKEFVAEITSMGRLRHRNLV 415
           GSG FG V+  V      EV +K                 + +   EI  + R+ H N++
Sbjct: 33  GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           ++      Q    LV +   +G LD  LF    +  + L+      I   +  A+ YL  
Sbjct: 93  KVLDIFENQGFFQLVMEKHGSG-LD--LFAFIDRHPR-LDEPLASYIFRQLVSAVGYLRL 148

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
              + ++HRD+K  N++I  D   KL DFG A   +      T    GT+ Y APE+
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPEV 200

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  100 bits (252), Expect = 2e-23
 Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 22/179 (12%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVA--------HNSRQGMKEFVAEITSMGRLRHRNLV 415
           GSG  G+V       T  +VAIK ++                    EI  + +L H  ++
Sbjct: 19  GSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCII 78

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           ++  +    ++  +V + +  G     LFD     K+ L           +  A+ YLH 
Sbjct: 79  KIKNFF-DAEDYYIVLELMEGGE----LFDKVVGNKR-LKEATCKLYFYQMLLAVQYLH- 131

Query: 476 ECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
             +  ++HRD+KP NVL+   + D   K+ DFG ++        +T  + GT  YLAPE
Sbjct: 132 --ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPE 186

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (257), Expect = 4e-23
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 16/224 (7%)

Query: 343 CRFRYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKE 398
            ++++ E    TK  FR+  ++G GGFG+V    + +TG   A K++       R+G   
Sbjct: 171 LQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAM 230

Query: 399 FVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ 458
            + E   + ++  R +V L      +D L LV   +  G L      +     +    + 
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEA 286

Query: 459 RYKILIG-VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQ 517
           R       +   L  LH    +R+V+RD+KP N+L+D   + ++ D GLA    H    Q
Sbjct: 287 RAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQ 340

Query: 518 TTH-IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           T    VGT+GY+APE+ +  + T S D +  G L+ E+  G+ P
Sbjct: 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (257), Expect = 6e-23
 Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 24/214 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAE---ITSMGR 408
           F    ++G GGFG+VY      TG   A+K     R+    +QG    + E   ++ +  
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK--MKQGETLALNERIMLSLVST 248

Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VA 467
                +V +       D+L  + D +  G L   L      +  + + +   +     + 
Sbjct: 249 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFS-EADMRFYAAEII 302

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
             L ++H    + VV+RD+KP+N+L+D   + ++ D GLA         +    VGT GY
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGY 356

Query: 528 LAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRP 560
           +APE+ + G A  +S D F  G ++ ++  G  P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  101 bits (253), Expect = 1e-22
 Identities = 57/225 (25%), Positives = 103/225 (45%), Gaps = 15/225 (6%)

Query: 343 CRFRYSELYSATKG-FREKNLVGSGGFGKVYRGVIPSTGLEVAIK-----RVAHNSRQGM 396
            ++++ E     +  F +  ++G GGFG+V+   + +TG   A K     R+    R+G 
Sbjct: 172 LQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLK--KRKGY 229

Query: 397 KEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNW 456
           +  + E   + ++  R +V L      + +L LV   +  G +   +++ D+        
Sbjct: 230 QGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-- 287

Query: 457 DQRYKILIG-VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN 515
           + R       +   L +LH+   + +++RD+KP NVL+D D N ++ D GLA        
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAG-Q 343

Query: 516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            +T    GT G++APEL    +   S D F  G  + E+   R P
Sbjct: 344 TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  100 bits (251), Expect = 1e-22
 Identities = 55/175 (31%), Positives = 84/175 (48%), Gaps = 19/175 (10%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
           G G FGKV  G    TG +VA+K +         +   +  EI ++   RH ++++L+  
Sbjct: 25  GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQV 84

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEEC 477
                ++ +V +YV  G L    FD   +  ++   + R     IL GV     Y H   
Sbjct: 85  ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD----YCHR-- 134

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
              VVHRD+KP NVL+DA +N K+ DFGL+         +T+   G+  Y APE+
Sbjct: 135 -HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEV 186

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 98.1 bits (245), Expect = 2e-22
 Identities = 49/207 (23%), Positives = 88/207 (42%), Gaps = 23/207 (11%)

Query: 363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWC 421
           +G G + +V+  +  +   +V +K +    +   K+   EI  +  LR   N++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 422 RKQDE--LLLVYDYVPNGSLDKLLFD-NDQQKKKILNWDQRYKILIGVAQALLYLHEECD 478
           +        LV+++V N    +L     D   +  +     Y+IL    +AL Y H    
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYM-----YEIL----KALDYCHS--- 148

Query: 479 QRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
             ++HRDVKP NV+ID +    +L D+GLA  Y      +    V +  +  PEL    +
Sbjct: 149 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPELLVDYQ 206

Query: 538 A-TTSTDVFGFGTLMLEVACGRRPIEP 563
               S D++  G ++  +   + P   
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFH 233

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 98.6 bits (246), Expect = 2e-22
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 43/216 (19%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWC- 421
           G G  GKV +     T  + A+K +        +    E+    R  +  ++V++     
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHIVRIVDVYE 125

Query: 422 ---RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLY 472
                +  LL+V + +  G L    F   Q +      DQ +      +I+  + +A+ Y
Sbjct: 126 NLYAGRKCLLIVMECLDGGEL----FSRIQDRG-----DQAFTEREASEIMKSIGEAIQY 176

Query: 473 LHEECDQRVVHRDVKPSNVLI-----DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           LH      + HRDVKP N+L      +A L  KL DFG A+    + N  TT    T  Y
Sbjct: 177 LH---SINIAHRDVKPENLLYTSKRPNAIL--KLTDFGFAKETTSH-NSLTT-PCYTPYY 229

Query: 528 LAPELTRTGKATTSTDVFGFGTL---MLEVACGRRP 560
           +APE+    K   S D++  G +   +L   CG  P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILL---CGYPP 262

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.6 bits (246), Expect = 4e-22
 Identities = 62/259 (23%), Positives = 96/259 (37%), Gaps = 43/259 (16%)

Query: 323 LRRIRNGDDILEDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLE 382
           L + +   D L+  E        R  E+      F    ++G G F +V    +  TG  
Sbjct: 33  LAQDKYVADFLQWAEPIVV----RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88

Query: 383 VAIK-----------RVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE--LLL 429
            A+K            V+         F  E   +     R + QLH     QDE  L L
Sbjct: 89  YAMKIMNKWDMLKRGEVSC--------FREERDVLVNGDRRWITQLH--FAFQDENYLYL 138

Query: 430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLYLHEECDQRVVHRDVKP 488
           V +Y   G L  LL     +  + +   +  +  +  +  A+  +H       VHRD+KP
Sbjct: 139 VMEYYVGGDLLTLL----SKFGERIP-AEMARFYLAEIVMAIDSVHR---LGYVHRDIKP 190

Query: 489 SNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKA------TTS 541
            N+L+D   + +L DFG       +   ++   VGT  YL+PE L   G           
Sbjct: 191 DNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPE 250

Query: 542 TDVFGFGTLMLEVACGRRP 560
            D +  G    E+  G+ P
Sbjct: 251 CDWWALGVFAYEMFYGQTP 269

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 48/202 (23%), Positives = 84/202 (41%), Gaps = 38/202 (18%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIK-------------------------RVAHNSRQGMKE 398
           G G +G V      +     A+K                                +G  E
Sbjct: 22  GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81

Query: 399 FVA-EITSMGRLRHRNLVQLHG--WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILN 455
            V  EI  + +L H N+V+L        +D L +V++ V  G +     +    K   L+
Sbjct: 82  QVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPTLKP--LS 135

Query: 456 WDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN 515
            DQ       + + + YLH    Q+++HRD+KPSN+L+  D + K+ DFG++  +  + +
Sbjct: 136 EDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS-D 191

Query: 516 PQTTHIVGTLGYLAPELTRTGK 537
              ++ VGT  ++APE     +
Sbjct: 192 ALLSNTVGTPAFMAPESLSETR 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 96.2 bits (240), Expect = 7e-22
 Identities = 52/175 (29%), Positives = 87/175 (49%), Gaps = 20/175 (11%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVA-EITSMGRLRHRNLVQLHGW 420
           G G FGKV       T  +VA+K ++     +  M   V  EI+ +  LRH ++++L+  
Sbjct: 18  GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV 77

Query: 421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK---ILIGVAQALLYLHEEC 477
                ++++V +Y   G L    FD   +KK++   + R     I+  +     Y H   
Sbjct: 78  ITTPTDIVMVIEYA-GGEL----FDYIVEKKRMTEDEGRRFFQQIICAIE----YCHR-- 126

Query: 478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
             ++VHRD+KP N+L+D +LN K+ DFGL+         +T+   G+  Y APE+
Sbjct: 127 -HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEV 178

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 97.5 bits (243), Expect = 1e-21
 Identities = 60/254 (23%), Positives = 99/254 (38%), Gaps = 35/254 (13%)

Query: 323 LRRIRNGDDILEDWEVEYGACRFRYSELYSATKG-------FREKNLVGSGGFGKVYRGV 375
           LRR +N  + LE                 S  K        F    ++G G FG+V    
Sbjct: 46  LRREKNILEYLE-----------WAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVK 94

Query: 376 IPSTGLEVAIKRVAHNSRQGMKE---FVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD 432
           + +     A+K +         E   F  E   +     + +  LH   +  + L LV D
Sbjct: 95  LKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMD 154

Query: 433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLYLHEECDQRVVHRDVKPSNV 491
           Y   G L  LL     + +  L  ++  +  +  +  A+  +H+      VHRD+KP N+
Sbjct: 155 YYVGGDLLTLL----SKFEDRLP-EEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNI 206

Query: 492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL-----TRTGKATTSTDVFG 546
           L+D + + +L DFG       +   Q++  VGT  Y++PE+        G+     D + 
Sbjct: 207 LMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS 266

Query: 547 FGTLMLEVACGRRP 560
            G  M E+  G  P
Sbjct: 267 LGVCMYEMLYGETP 280

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 96.2 bits (240), Expect = 1e-21
 Identities = 63/213 (29%), Positives = 90/213 (42%), Gaps = 22/213 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFV-AEITSMGRLRHRN 413
           F     +G G FGKV       T    A+K         +     V  E+  M  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 414 LVQLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQAL 470
           LV L  W   QDE  + +V D +  G L   L     Q+      ++  K+ I  +  AL
Sbjct: 77  LVNL--WYSFQDEEDMFMVVDLLLGGDLRYHL-----QQNVHFK-EETVKLFICELVMAL 128

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            YL     QR++HRD+KP N+L+D   +  + DF +A          TT + GT  Y+AP
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITT-MAGTKPYMAP 183

Query: 531 E-LTRTGKA--TTSTDVFGFGTLMLEVACGRRP 560
           E  +    A  + + D +  G    E+  GRRP
Sbjct: 184 EMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 93.1 bits (232), Expect = 1e-20
 Identities = 49/208 (23%), Positives = 86/208 (41%), Gaps = 17/208 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF---VAEITSMGRLRHRN 413
           F     +G+G FG+V       +G   A+K +       +K+    + E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLY 472
           LV+L    +    L +V +YV  G +   L     ++    + +   +     +     Y
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHL-----RRIGRFS-EPHARFYAAQIVLTFEY 156

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH      +++RD+KP N+LID     ++ DFG A+         T  + GT   LAPE+
Sbjct: 157 LHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEI 209

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRP 560
             +     + D +  G L+ E+A G  P
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 90.8 bits (226), Expect = 7e-20
 Identities = 56/221 (25%), Positives = 99/221 (44%), Gaps = 29/221 (13%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRH 411
            K +     VGSG +G V   +   +G +VAIK+++    S    K    E+  +  ++H
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82

Query: 412 RNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKIL 463
            N++ L          R   +  LV  ++    L K++     +++ + ++     Y++L
Sbjct: 83  ENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLV-----YQML 136

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
               + L Y+H      VVHRD+KP N+ ++ D   K+ DFGLAR  D     + T  V 
Sbjct: 137 ----KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVV 185

Query: 524 TLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           T  Y APE +        + D++  G +M E+    + +  
Sbjct: 186 TRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTLFK 225

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 91.8 bits (228), Expect = 8e-20
 Identities = 51/220 (23%), Positives = 97/220 (44%), Gaps = 26/220 (11%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRH 411
            K ++    +GSG  G V           VAIK+++    ++   K    E+  M  + H
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120

Query: 412 RNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKIL 463
           +N++ L           +  ++ LV + +   +L +++      ++   +L     Y++L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLL-----YQML 174

Query: 464 IGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVG 523
                 + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR      +   T  V 
Sbjct: 175 ----CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVV 225

Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           T  Y APE+        + D++  G +M E+    + + P
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKILFP 264

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 1e-19
 Identities = 52/254 (20%), Positives = 99/254 (38%), Gaps = 60/254 (23%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           +K +     +G+G FG V       +G   A+K+V  + R   +E    +  M  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 414 LVQL------------------------------------HGWCRKQDE--LLLVYDYVP 435
           +++L                                               L ++ +YVP
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 436 NGSLDKLLFDNDQQKKKILNWDQ----RYKILIGVAQALLYLHEECDQRVVHRDVKPSNV 491
           + +L K+L  +  +  + +  +      Y++     +A+ ++H      + HRD+KP N+
Sbjct: 122 D-TLHKVL-KSFIRSGRSIPMNLISIYIYQLF----RAVGFIHS---LGICHRDIKPQNL 172

Query: 492 LIDADLNP-KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGT 549
           L+++  N  KL DFG A+      +  +   + +  Y APEL       T S D++  G 
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIP--SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGC 230

Query: 550 LMLEVACGRRPIEP 563
           +  E+    +P+  
Sbjct: 231 VFGEL-ILGKPLFS 243

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 56/228 (24%), Positives = 103/228 (45%), Gaps = 35/228 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           + +   +G GG G V+  V       VAIK++     Q +K  + EI  + RL H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 417 LH--------------GWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQR 459
           +               G   + + + +V +Y+    L  +L      ++  +  +     
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFM----- 126

Query: 460 YKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNINPQT 518
           Y++L    + L Y+H      V+HRD+KP+N+ I+  DL  K+GDFGLAR  D + + + 
Sbjct: 127 YQLL----RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179

Query: 519 --THIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
             +  + T  Y +P L  +    T + D++  G +  E+    + +  
Sbjct: 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTLFA 226

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.7 bits (223), Expect = 2e-19
 Identities = 50/217 (23%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRHRNL 414
           ++    +GSG  G V           VAIK+++    ++   K    E+  M  + H+N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86

Query: 415 VQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDN--DQQKKKILNWDQRYKILIGV 466
           + L           +  ++ +V + +   +L +++      ++   +L     Y++L G 
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLL-----YQMLCG- 139

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
              + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR      +   T  V T  
Sbjct: 140 ---IKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRY 191

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           Y APE+        + D++  G +M E+      + P
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVLFP 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 89.3 bits (222), Expect = 2e-19
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 26/219 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +   + +G G +G V         + VAIK++     +   +  + EI  + R RH N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 416 QLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVA 467
            ++         +  ++ +V D +    L KLL      +      L     Y+IL    
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQHLSNDHICYFL-----YQIL---- 138

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR  D + +     T  V T 
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 526 GYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
            Y APE+    K  T S D++  G ++ E+    RPI P
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPIFP 233

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 88.5 bits (220), Expect = 4e-19
 Identities = 58/239 (24%), Positives = 96/239 (40%), Gaps = 39/239 (16%)

Query: 347 YSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA----- 401
            +EL++    +  +  + SG +G V    + S G+ VAIKRV +    G    +      
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCA-GVDSEGIPVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 402 ------EITSMGRLRHRNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDN---- 446
                 EI  +    H N++ L             +L LV + +    L +++ D     
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI 131

Query: 447 -DQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG 505
             Q  +  +     Y IL      L  LH   +  VVHRD+ P N+L+  + +  + DF 
Sbjct: 132 SPQHIQYFM-----YHIL----LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFN 179

Query: 506 LARAYDHNINPQTTHIVGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           LAR      +   TH V    Y APE + +    T   D++  G +M E+   R+ +  
Sbjct: 180 LAREDTA--DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKALFR 235

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 82.2 bits (203), Expect = 4e-19
 Identities = 29/124 (23%), Positives = 42/124 (33%), Gaps = 20/124 (16%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRI------LGHAFYPSPLRFK 69
           A++ SF +  F   Q +L   G A    + +L V+             G   Y +PLR  
Sbjct: 1   AQSLSFSFTKFDPNQEDLIFQGHATST-NNVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW 59

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
           +           S    +F T   F I   Y      GLAF +       S     +LGL
Sbjct: 60  E----------DSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGL 108

Query: 130 PNDT 133
             + 
Sbjct: 109 FPNA 112

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 88.3 bits (219), Expect = 1e-18
 Identities = 54/216 (25%), Positives = 85/216 (39%), Gaps = 56/216 (25%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA-----EITSMGRLRH 411
           +  ++L+G+G +G V           VAIK++                  EI  + RL H
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNRLNH 111

Query: 412 RNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDN----DQQKKKILNWDQRYKI 462
            ++V++          K DEL +V +   +    KL        +   K +L     Y +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLL-----YNL 165

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH---------- 512
           L      + Y+H      ++HRD+KP+N L++ D + K+ DFGLAR  D+          
Sbjct: 166 L----VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPI 218

Query: 513 ----------------NINPQTTHIVGTLGYLAPEL 532
                           N+  Q T  V T  Y APEL
Sbjct: 219 SPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL 254

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 87.0 bits (216), Expect = 2e-18
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 32/223 (14%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRH 411
              +R+   VGSG +G V   V   TG +VAIK++     S    K    E+  +  +RH
Sbjct: 24  RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83

Query: 412 RNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR----YK 461
            N++ L              +  LV  ++    L KL+      K + L  D+     Y+
Sbjct: 84  ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM------KHEKLGEDRIQFLVYQ 136

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI 521
           +L    + L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D     + T  
Sbjct: 137 ML----KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD----SEMTGY 185

Query: 522 VGTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
           V T  Y APE +    + T + D++  G +M E+    + +  
Sbjct: 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTLFK 227

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 87.1 bits (216), Expect = 3e-18
 Identities = 63/216 (29%), Positives = 91/216 (42%), Gaps = 29/216 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKEFVAEITS 405
           F    L+G G FGKV      +TG   A+K            VAH         + E   
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRV 201

Query: 406 MGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG 465
           +   RH  L  L    +  D L  V +Y   G L    F +  +++     + R +    
Sbjct: 202 LQNSRHPFLTALKYSFQTHDRLCFVMEYANGGEL----FFHLSRERVFS--EDRARFYGA 255

Query: 466 -VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGT 524
            +  AL YLH E +  VV+RD+K  N+++D D + K+ DFGL +              GT
Sbjct: 256 EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGT 312

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
             YLAPE+        + D +G G +M E+ CGR P
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 86.2 bits (214), Expect = 3e-18
 Identities = 56/222 (25%), Positives = 100/222 (45%), Gaps = 30/222 (13%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLRH 411
            + ++  + VGSG +G V       TGL VA+K+++    S    K    E+  +  ++H
Sbjct: 28  PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87

Query: 412 RNLVQLH------GWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKI 462
            N++ L           + +++ LV   +    L+ ++      D   + ++     Y+I
Sbjct: 88  ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLI-----YQI 141

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L    + L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR        + T  V
Sbjct: 142 L----RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTA----DEMTGYV 190

Query: 523 GTLGYLAPE-LTRTGKATTSTDVFGFGTLMLEVACGRRPIEP 563
            T  Y APE +        + D++  G +M E+    R + P
Sbjct: 191 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTLFP 231

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 84.9 bits (211), Expect = 4e-18
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 19/209 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEF---VAEITSMGRLRHRN 413
           F+    +G+G FG+V+       G   A+K +       +K+      E   +  + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLY 472
           ++++ G  +   ++ ++ DY+  G L  LL     +K +    +   K     V  AL Y
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLL-----RKSQRFP-NPVAKFYAAEVCLALEY 121

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPE 531
           LH    + +++RD+KP N+L+D + + K+ DFG A+       P  T+ + GT  Y+APE
Sbjct: 122 LHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPE 173

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           +  T     S D + FG L+ E+  G  P
Sbjct: 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.8 bits (208), Expect = 1e-17
 Identities = 59/229 (25%), Positives = 104/229 (45%), Gaps = 33/229 (14%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHR 412
           +  F+ K+L+G G +G V       TG  VAIK++   +        + EI  +   +H 
Sbjct: 10  SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHE 69

Query: 413 NLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILI 464
           N++ +            +E+ ++ + +    L +++      D   +  +     Y+ L 
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFI-----YQTL- 122

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT------ 518
              +A+  LH      V+HRD+KPSN+LI+++ + K+ DFGLAR  D +    +      
Sbjct: 123 ---RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176

Query: 519 ---THIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
                 V T  Y APE+  T    + + DV+  G ++ E+   RRPI P
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRPIFP 224

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 41/167 (24%), Positives = 66/167 (39%), Gaps = 36/167 (21%)

Query: 364 GSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWC- 421
           G G  GKV +     T  + A+K +        +    E+    R  +  ++V++     
Sbjct: 27  GLGINGKVLQIFNKRTQEKFALKML--QDCPKARR---EVELHWRASQCPHIVRIVDVYE 81

Query: 422 ---RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRY------KILIGVAQALLY 472
                +  LL+V + +  G L    F   Q +      DQ +      +I+  + +A+ Y
Sbjct: 82  NLYAGRKCLLIVMECLDGGEL----FSRIQDRG-----DQAFTEREASEIMKSIGEAIQY 132

Query: 473 LHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLA-----RAYD 511
           LH      + HRDVKP N+L      +   KL DFG A       YD
Sbjct: 133 LH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYD 176

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 81.5 bits (202), Expect = 7e-17
 Identities = 64/213 (30%), Positives = 93/213 (43%), Gaps = 34/213 (15%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKEFVAEITSMGRLR 410
           L+G G FGKV      +TG   A+K            VAH         V E   +   R
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNTR 63

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQA 469
           H  L  L    +  D L  V +Y   G L    F +  +++     ++R +     +  A
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL----FFHLSRERVFT--EERARFYGAEIVSA 117

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLGY 527
           L YLH    + VV+RD+K  N+++D D + K+ DFGL +     I+   T     GT  Y
Sbjct: 118 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE---GISDGATMKTFCGTPEY 171

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           LAPE+        + D +G G +M E+ CGR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 80.7 bits (200), Expect = 9e-17
 Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 20/207 (9%)

Query: 362 LVGSGGFGKVY---RGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           ++G G FGKV+   +          A+K  + A    +       E   +  + H  +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLYLHE 475
           LH   + + +L L+ D++  G L    F    ++      ++  K  +  +A AL +LH 
Sbjct: 91  LHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFT--EEDVKFYLAELALALDHLHS 144

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLGYLAPELT 533
                +++RD+KP N+L+D + + KL DFGL++    +I+  +  +   GT+ Y+APE+ 
Sbjct: 145 ---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAPEVV 198

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
                T S D + FG LM E+  G  P
Sbjct: 199 NRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 82.8 bits (204), Expect = 1e-16
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 35/219 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEIT 404
           F    ++G G FGKV       T    A+K            V       M E  V  + 
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT----MVEKRVLALP 398

Query: 405 SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
                +   L QLH   +  D L  V +YV  G L      + QQ  +    +       
Sbjct: 399 G----KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFK--EPHAVFYA 448

Query: 465 G-VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHI 521
             +A  L +L     + +++RD+K  NV++D++ + K+ DFG+ +    NI     T   
Sbjct: 449 AEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTF 502

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            GT  Y+APE+        S D + FG L+ E+  G+ P
Sbjct: 503 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 53/210 (25%), Positives = 101/210 (48%), Gaps = 24/210 (11%)

Query: 362 LVGSGGFGKVY---RGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAEITSMGRLRHRN 413
           ++G GG+GKV+   +    +TG   A+K      +  N++       AE   +  ++H  
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKHPF 82

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQALLY 472
           +V L    +   +L L+ +Y+  G L   L     +++ I   +      +  ++ AL +
Sbjct: 83  IVDLIYAFQTGGKLYLILEYLSGGELFMQL-----EREGIFM-EDTACFYLAEISMALGH 136

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLGYLAP 530
           LH+   + +++RD+KP N++++   + KL DFGL +    +I+    TH   GT+ Y+AP
Sbjct: 137 LHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE---SIHDGTVTHTFCGTIEYMAP 190

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           E+        + D +  G LM ++  G  P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 80.0 bits (198), Expect = 2e-16
 Identities = 56/216 (25%), Positives = 102/216 (47%), Gaps = 32/216 (14%)

Query: 362 LVGSGGFGKVY---RGVIPSTGLEVAIK-----RVAHNSRQGMKEFVAEITSMGR--LRH 411
           ++G+G +GKV+   +     TG   A+K      +   ++        E T   R  L H
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKT------TEHTRTERQVLEH 114

Query: 412 RN----LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-V 466
                 LV LH   + + +L L+ DY+  G L   L      +++    +   +I +G +
Sbjct: 115 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFT-EHEVQIYVGEI 168

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
             AL +LH+     +++RD+K  N+L+D++ +  L DFGL++ +  +   +     GT+ 
Sbjct: 169 VLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225

Query: 527 YLAPELTRTGKA--TTSTDVFGFGTLMLEVACGRRP 560
           Y+AP++ R G +    + D +  G LM E+  G  P
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.4 bits (196), Expect = 7e-16
 Identities = 54/198 (27%), Positives = 88/198 (44%), Gaps = 24/198 (12%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRH 411
              +  K+L+G G +G VY     +T   VAIK+V          K  + EIT + RL+ 
Sbjct: 25  PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84

Query: 412 RNLVQLH-----GWCRKQDELLLVYDYVPNGSLDKLLFDN----DQQKKKILNWDQRYKI 462
             +++L+         K DEL +V +   +  L KL        ++  K IL     Y +
Sbjct: 85  DYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPIFLTEEHIKTIL-----YNL 138

Query: 463 LIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIV 522
           L+G      ++HE     ++HRD+KP+N L++ D + K+ DFGLAR  +   +    + +
Sbjct: 139 LLG----ENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191

Query: 523 GTLGYLAPELTRTGKATT 540
                  P      K  T
Sbjct: 192 EENEEPGPHNKNLKKQLT 209

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 57/214 (26%), Positives = 88/214 (41%), Gaps = 35/214 (16%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEITSMGRL 409
           ++G G FGKV       T    A+K            V       M E  V  +      
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT----MVEKRVLALPG---- 78

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQ 468
           +   L QLH   +  D L  V +YV  G L      + QQ  +    +         +A 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFK--EPHAVFYAAEIAI 132

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLG 526
            L +L     + +++RD+K  NV++D++ + K+ DFG+ +    NI    TT    GT  
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE---NIWDGVTTKTFCGTPD 186

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           Y+APE+        S D + FG L+ E+  G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 2e-15
 Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 35/214 (16%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEITSMGRL 409
           ++G G FGKV    +  TG   A+K            V       M E  +  +      
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT----MTEKRILSLAR---- 81

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQ 468
            H  L QL    +  D L  V ++V  G L      + Q+ ++    + R +     +  
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFD--EARARFYAAEIIS 135

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLG 526
           AL++LH+   + +++RD+K  NVL+D + + KL DFG+ +     I    TT    GT  
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE---GICNGVTTATFCGTPD 189

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           Y+APE+ +      + D +  G L+ E+ CG  P
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 60/214 (28%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEITSMGRL 409
           ++G G + KV    +  T    A+K            +         E  V E  S    
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV----QTEKHVFEQAS---- 67

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQ 468
            H  LV LH   + +  L  V +YV  G L      + Q+++K+   ++  +     ++ 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLP--EEHARFYSAEISL 121

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLG 526
           AL YLHE   + +++RD+K  NVL+D++ + KL D+G+ +     + P  TT    GT  
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 175

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           Y+APE+ R      S D +  G LM E+  GR P
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 77.4 bits (191), Expect = 3e-15
 Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 35/214 (16%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEITSMGRL 409
           ++G G + KV    +  T    A++            +         E  V E  S    
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV----QTEKHVFEQAS---- 110

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQ 468
            H  LV LH   + +  L  V +YV  G L      + Q+++K+   ++  +     ++ 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLP--EEHARFYSAEISL 164

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLG 526
           AL YLHE   + +++RD+K  NVL+D++ + KL D+G+ +     + P  TT    GT  
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE---GLRPGDTTSTFCGTPN 218

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           Y+APE+ R      S D +  G LM E+  GR P
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 76.9 bits (190), Expect = 3e-15
 Identities = 57/219 (26%), Positives = 88/219 (40%), Gaps = 35/219 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK-----------RVAHNSRQGMKE-FVAEIT 404
           F    ++G G FGKV+      T    AIK            V       M E  V  + 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT----MVEKRVLSLA 74

Query: 405 SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
                 H  L  +    + ++ L  V +Y+  G L      + Q   K      R     
Sbjct: 75  W----EHPFLTHMFCTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFD--LSRATFYA 124

Query: 465 G-VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-I 521
             +   L +LH    + +V+RD+K  N+L+D D + K+ DFG+ +    N+     T+  
Sbjct: 125 AEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTF 178

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            GT  Y+APE+    K   S D + FG L+ E+  G+ P
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 75.4 bits (186), Expect = 9e-15
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 33/213 (15%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVA---EITSM--------GRLR 410
           ++G G FGKV      +  +  A+K +        K+ +    E   +          ++
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVK 97

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIG-VAQA 469
           H  LV LH   +  D+L  V DY+  G L    F + Q+++  L  + R +     +A A
Sbjct: 98  HPFLVGLHFSFQTADKLYFVLDYINGGEL----FYHLQRERCFL--EPRARFYAAEIASA 151

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTH-IVGTLGY 527
           L YLH      +V+RD+KP N+L+D+  +  L DFGL +    NI    TT    GT  Y
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPEY 205

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           LAPE+        + D +  G ++ E+  G  P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 73.2 bits (180), Expect = 5e-14
 Identities = 58/236 (24%), Positives = 106/236 (44%), Gaps = 43/236 (18%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAH--NSRQGMKEFVAEITSMGRLR-HRN 413
           +     +G G +G V++ +   TG  VA+K++     +    +    EI  +  L  H N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70

Query: 414 LVQLHGWCRKQD--ELLLVYDYVPNGSLDKLLFDN---DQQKKKILNWDQRYKILIGVAQ 468
           +V L    R  +  ++ LV+DY+    L  ++  N      K+ ++     Y+++    +
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANILEPVHKQYVV-----YQLI----K 120

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI-------------- 514
            + YLH      ++HRD+KPSN+L++A+ + K+ DFGL+R++ +                
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 515 ------NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEP 563
                  P  T  V T  Y APE+       T   D++  G ++ E+    +PI P
Sbjct: 178 ENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPIFP 232

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 72.6 bits (177), Expect = 5e-14
 Identities = 47/226 (20%), Positives = 75/226 (33%), Gaps = 48/226 (21%)

Query: 353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEIT 404
            T+  +    +G G FG+V++ +   T   VAIK +A           ++  +E + EI 
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHT--PVAIKIIAIEGPDLVNGSHQKTFEEILPEII 75

Query: 405 SMGRL---------RHRNLVQLHGWCRKQD----ELLLVYDY----------VPNGSLDK 441
               L         R    + L+     Q      LL  +D+           P+   D 
Sbjct: 76  ISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDD 135

Query: 442 LLF----------DNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV 491
            LF          D +Q + K+ +      IL  +  +L         R  HRD+   NV
Sbjct: 136 QLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASL--RFEHRDLHWGNV 193

Query: 492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK 537
           L+      KL      ++      P     V  + Y    L R G 
Sbjct: 194 LLKKTSLKKLHYTLNGKSSTI---PSCGLQVSIIDYTLSRLERDGI 236

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 60.6 bits (147), Expect = 3e-12
 Identities = 16/37 (43%), Positives = 23/37 (62%)

Query: 233 ISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSF 269
           +S  + L  V+ E++ +GFSA+TG   A H V  WSF
Sbjct: 6   LSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 42

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 44/217 (20%), Positives = 81/217 (37%), Gaps = 30/217 (13%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIK---RVAHNSRQGMKEF-------VAEITSMGRLRH 411
            +G G F  V+          VA+K        +     E         A+ T    +  
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGA 85

Query: 412 RNLVQLHGW----CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
            ++++L             +++V++ V   +L  L+   + +    +      +I   + 
Sbjct: 86  NHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRG---IPLIYVKQISKQLL 141

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNP------KLGDFGLARAYDHNINPQTTHI 521
             L Y+H  C   ++H D+KP NVL++   +P      K+ D G A  YD +    T  I
Sbjct: 142 LGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY---TNSI 196

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR 558
             T  Y +PE+          D++    L+ E+  G 
Sbjct: 197 Q-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 64.5 bits (156), Expect = 1e-11
 Identities = 31/238 (13%), Positives = 67/238 (28%), Gaps = 39/238 (16%)

Query: 32  NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN 91
             +  G A    D I    + + +  G  +  +   F+                  +   
Sbjct: 50  FWAHAGNAIPSADQIRIAPSLKSQR-GSVWTKTKAAFEN-----------------WEVE 91

Query: 92  FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQ 151
             F +  +  ++G  GLA      +     +     G  +           + + FD+  
Sbjct: 92  VTFRVTGR-GRIGADGLAIWYTENQGLDGPV----FGSAD-------MWNGVGIFFDSFD 139

Query: 152 NLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNS 211
           N   ++     V  +   +  +     A         +  N         P++A I Y  
Sbjct: 140 NDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRN------KPYPVRAKITYYQ 193

Query: 212 QEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSF 269
           + + + +          +            V+    + G SA+TG L   H+V  +  
Sbjct: 194 KTLTVMINNGFTPDKNDYEFCAKVE---NMVIPTQGHFGISAATGGLADDHDVLSFLT 248

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 29/101 (28%), Positives = 46/101 (45%), Gaps = 13/101 (12%)

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTL 525
           VA+ + +L     ++ +HRD+   N+L+      K+ DFGLAR    +I     ++    
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGD 254

Query: 526 GYL-----APELTRTGKATTSTDVFGFGTLMLEVAC-GRRP 560
             L     APE       T  +DV+ FG L+ E+   G  P
Sbjct: 255 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 53.8 bits (129), Expect = 8e-08
 Identities = 22/99 (22%), Positives = 43/99 (43%), Gaps = 12/99 (12%)

Query: 357 FREK----NLVGSGGFGKVYRGVI-----PSTGLEVAIKRV-AHNSRQGMKEFVAEITSM 406
            R++      +G G FG+V           +T   VA+K +    +    +  ++E+  +
Sbjct: 20  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 79

Query: 407 GRL-RHRNLVQLHGWCRKQDE-LLLVYDYVPNGSLDKLL 443
             +  H N+V L G C K    L+++ ++   G+L   L
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 49/176 (27%), Positives = 74/176 (42%), Gaps = 28/176 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLV 415
           FR    +G G FG++  G    T   VAIK     SR        E     +L     + 
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIP 68

Query: 416 QLHGWCRKQDELLLVYDYVPNG-SLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALL 471
           Q++ +        +V + +  G SL+ L FD   +    K +L       I I +   + 
Sbjct: 69  QVYYFGPCGKYNAMVLELL--GPSLEDL-FDLCDRTFSLKTVLM------IAIQLISRME 119

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPK-----LGDFGLARAYDHNINPQT-THI 521
           Y+H +    +++RDVKP N LI    N       + DF LA+ Y   I+P+T  HI
Sbjct: 120 YVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY---IDPETKKHI 169

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 4e-10
 Identities = 66/369 (17%), Positives = 118/369 (31%), Gaps = 105/369 (28%)

Query: 325 RIRNGDDILEDWEVEYGACRFR-YSELYSATKGFR-EKNLV--GSGGFGKVYRGVIPSTG 380
           R+ N + +   + V     R + Y +L  A    R  KN++  G  G GK       +  
Sbjct: 118 RLYNDNQVFAKYNV----SRLQPYLKLRQALLELRPAKNVLIDGVLGSGK-------TW- 165

Query: 381 LEVAIKRVAHNSRQGMKEFVAEI--TSMGRLRHRNLVQLHGWCRKQDELL-----LVYDY 433
             VA+        Q   +F  +I   ++              C   + +L     L+Y  
Sbjct: 166 --VALDVCLSYKVQCKMDF--KIFWLNLKN------------CNSPETVLEMLQKLLYQI 209

Query: 434 VPNGS--LD-----KLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV 486
            PN +   D     KL   + Q + + L   + Y+        LL L           +V
Sbjct: 210 DPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYE------NCLLVL----------LNV 253

Query: 487 KPSNVLIDA-DLNPKL----GDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTS 541
           + +    +A +L+ K+        +    D      TTHI  +L + +  LT     +  
Sbjct: 254 QNAKA-WNAFNLSCKILLTTRFKQVT---DFLSAATTTHI--SLDHHSMTLTPDEVKSLL 307

Query: 542 TDVFGFGTLML-EVACGRRPIEPQRTAM--ELVLVD---WVRELHSQG-QITRAIDPTLD 594
                     L           P+R ++  E +      W    H    ++T  I+ +L+
Sbjct: 308 LKYLDCRPQDLPREVLT---TNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLN 364

Query: 595 YFDPQEA-----ELVL----------TLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAP 639
             +P E       L +           L L+  D           VV  L + + + + P
Sbjct: 365 VLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKS---DVMVVVNKLHKYSLVEKQP 421

Query: 640 LD----IHH 644
            +    I  
Sbjct: 422 KESTISIPS 430

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 35/176 (19%), Positives = 61/176 (34%), Gaps = 30/176 (17%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGL--------EVAIKRVAHNS----------RQGMKE 398
           ++ K+       G +Y     ST          + ++K  A +           R     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 399 FVAEITSMGRLRHRNLVQLHGWCRKQDEL-LLVYDYVPNG-SLDKLLFDNDQQKKKILNW 456
            V +   +       +    G+   QD+   LV   +  G SL   L   D   K +L+ 
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL---DVSPKHVLSE 158

Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK--LGDFGLARAY 510
               ++   +  AL +LHE      VH +V   N+ +D +   +  L  +G A  Y
Sbjct: 159 RSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 40/176 (22%), Positives = 70/176 (39%), Gaps = 28/176 (15%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLV 415
           ++    +G G FG ++ G       +VAIK     S         E  +   L     + 
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIP 69

Query: 416 QLHGWCRKQDELLLVYDYVPNG-SLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALL 471
            ++ + ++    +LV D +  G SL+ L  D   +K   K +            +   + 
Sbjct: 70  NVYYFGQEGLHNVLVIDLL--GPSLEDL-LDLCGRKFSVKTVAM------AAKQMLARVQ 120

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPK-----LGDFGLARAYDHNINPQT-THI 521
            +HE   + +V+RD+KP N LI    +       + DFG+ + Y    +P T  HI
Sbjct: 121 SIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY---RDPVTKQHI 170

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 42/173 (24%), Positives = 72/173 (41%), Gaps = 24/173 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLV 415
           +R    +GSG FG +Y G   + G EVAIK     ++        E      ++    + 
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIP 68

Query: 416 QLHGWCRKQDELLLVYDYVPNG-SLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLY 472
            +     + D  ++V + +  G SL+ L     ++   K +L       +   +   + Y
Sbjct: 69  TIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKTVLL------LADQMISRIEY 120

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPK---LGDFGLARAYDHNINPQT-THI 521
           +H    +  +HRDVKP N L+          + DFGLA+ Y    + +T  HI
Sbjct: 121 IHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY---RDARTHQHI 167

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 38/205 (18%), Positives = 75/205 (36%), Gaps = 48/205 (23%)

Query: 357 FREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSRQ-----------GMKEFV 400
           ++    +G GGFG +Y   + S     +     +K    ++                E +
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 401 AEITSMGRLRHRNLVQLH--GWCRKQDEL--LLVYDYVPNG-SLDKLLFDNDQQ--KKKI 453
            +     +L++  + +    G   K  +    ++ D    G  L K+   N ++  +K +
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIYEANAKRFSRKTV 154

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK--LGDFGLARAYD 511
           L      ++ + +   L Y+HE      VH D+K SN+L++     +  L D+GLA  Y 
Sbjct: 155 L------QLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRY- 204

Query: 512 HNINPQT-THI--------VGTLGY 527
                               GT+ +
Sbjct: 205 --CPEGVHKAYAADPKRCHDGTIEF 227

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 46/174 (26%), Positives = 75/174 (43%), Gaps = 26/174 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV- 415
           FR    +GSG FG++Y G    T  EVAIK     ++     +  E      L+    + 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIP 66

Query: 416 QLHGWCRKQDELLLVYDYVPNG-SLDKLLFDNDQQK---KKILNWDQRYKILIGVAQALL 471
            +  +  + D  +LV D +  G SL+ L F+   +K   K +L       +   +   + 
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDL-FNFCSRKLSLKTVLM------LADQMINRVE 117

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPK---LGDFGLARAYDHNINPQT-THI 521
           ++H +     +HRD+KP N L+          + DFGLA+ Y    +  T  HI
Sbjct: 118 FVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTSTHQHI 165

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 53.8 bits (128), Expect = 5e-08
 Identities = 31/241 (12%), Positives = 66/241 (27%), Gaps = 44/241 (18%)

Query: 32  NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN 91
                G+  +    +    +++ +  G  +   P   K                  +  +
Sbjct: 26  LWDFQGSTILTSQYVRLTPDERSKE-GSIWNHQPCFLKD-----------------WEMH 67

Query: 92  FVFSIV-PKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAV 150
             F +       L G G+A            +     G  +       +   LA+  D  
Sbjct: 68  VHFKVHGTGKKNLHGDGIALWY----TRDRLVPGPVFGSKD-------NFHGLAIFLDTY 116

Query: 151 QNLELQDINDNHVGIDIS--SLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWID 208
            N E  +    ++ + ++  SL  + S+   +    G   +  N              + 
Sbjct: 117 PNDETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRN------RDHDTFLAVR 170

Query: 209 YNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWS 268
           Y+     + V        +    +    +     L    Y G SA TG L+  H++    
Sbjct: 171 YSRGR--LTVMTDLEDKNEWKNCIDITGV----RLPTGYYFGASAGTGDLSDNHDIISMK 224

Query: 269 F 269
            
Sbjct: 225 L 225

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 41/207 (19%), Positives = 83/207 (40%), Gaps = 24/207 (11%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKE--FVAEITSMGRLRHRNLVQ 416
           ++G G FG+V +         VA+K V +  R   Q  +E   +  +    +    N++ 
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK-KILNWDQRYKILIGVAQALLYLHE 475
           +      ++ + + ++      L   L++  ++ K +  +     K    + Q L  LH 
Sbjct: 164 MLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH- 217

Query: 476 ECDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINP--QTTHIVGTLGYLAPE 531
               R++H D+KP N+L+        K+ DFG +      +    Q+        Y APE
Sbjct: 218 --KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRF------YRAPE 269

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGR 558
           +    +     D++  G ++ E+  G 
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 50.9 bits (122), Expect = 7e-07
 Identities = 44/208 (21%), Positives = 82/208 (39%), Gaps = 22/208 (10%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKE--FVAEITSMGRLRHRNLV 415
           +L+G G FG+V +         VAIK + +      Q   E   +  +          +V
Sbjct: 60  SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIV 119

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDN-DQQKKKILNWDQRYKILIGVAQALLYLH 474
            L      ++ L LV++      L   L+D       + ++ +   K    +  ALL+L 
Sbjct: 120 HLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLA 174

Query: 475 EECDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINP--QTTHIVGTLGYLAP 530
              +  ++H D+KP N+L+        K+ DFG +      I    Q+        Y +P
Sbjct: 175 TP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF------YRSP 227

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGR 558
           E+        + D++  G +++E+  G 
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 50.3 bits (120), Expect = 1e-06
 Identities = 32/153 (20%), Positives = 48/153 (31%), Gaps = 55/153 (35%)

Query: 461 KILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD------------------------ 496
           KI+  V Q L YLH +C  R++H D+KP N+L+  +                        
Sbjct: 150 KIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207

Query: 497 -------------------------LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE 531
                                    L  K+ D G A           T  + T  Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK----HFTEDIQTRQYRSLE 263

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ 564
           +       T  D++    +  E+A G    EP 
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPH 296

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 36/202 (17%), Positives = 67/202 (33%), Gaps = 45/202 (22%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVA---IKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
           +     +GSGGFG +Y     +   + A   +K     +     E         +   + 
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 414 LVQLHG----------WC-----RKQDELLLVYDYVPNG-SLDKLLFDNDQQKKK-ILNW 456
            ++                    + +    +V + +  G  L K+   N   KK  +L  
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVL-- 154

Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK--LGDFGLARAYDHNI 514
               ++ I +   L Y+HE      VH D+K +N+L+      +  L D+GL+  Y    
Sbjct: 155 ----QLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY---C 204

Query: 515 NPQT-THI--------VGTLGY 527
                            GT+ +
Sbjct: 205 PNGNHKQYQENPRKGHNGTIEF 226

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 28/141 (19%), Positives = 55/141 (39%), Gaps = 21/141 (14%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHR-----N 413
            +G G FG+V            A+K V +  +           E   + ++++      N
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI----EADILKKIQNDDINNNN 97

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI-LNWDQRYKILIGVAQALLY 472
           +V+ HG     D + L+++      L   L++   +      + +      I + +AL Y
Sbjct: 98  IVKYHGKFMYYDHMCLIFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 473 LHEECDQRVVHRDVKPSNVLI 493
           L       + H D+KP N+L+
Sbjct: 153 LR---KMSLTHTDLKPENILL 170

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	662
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.98
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.95
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.91
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	99.77
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.76
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	99.57
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.44
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.23
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.07
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.98
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.85
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.33
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.3
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.04
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.8
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.72
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.52
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.43
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.24
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.0
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.93
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.91
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.85
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.64
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.61
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.59
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.43
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.86
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.68
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.37
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.39
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	85.61
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	85.31
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	83.97
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	81.96
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	80.77

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=1.6e-63  Score=499.42  Aligned_cols=237  Identities=30%  Similarity=0.475  Sum_probs=202.8

Q ss_pred             HHHHHHHHHhh-ccCCCceeEEeCCCCCCCeeEecceeeeCCCeEEecCCCCC------eeEEEEcCCceeecccccccc
Q 040242            4 FSLLLHLLLLG-FAHAETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGR------ILGHAFYPSPLRFKQLSKYNI   76 (662)
Q Consensus         4 ~~~~~~~l~~~-~~~~~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~~~------~~Gr~~y~~pv~l~~~~~~~~   76 (662)
                      ++++++++|+. +.++..++|+|++|.++||+|+|||++. +|.|+||++..+      ++|||+|++||+||       
T Consensus         9 ~~~~~fl~l~~~~~sa~~~sF~f~~F~~~nL~l~GdA~i~-~g~L~LT~~~~~~~p~~~s~Gra~Y~~Pi~l~-------   80 (281)
T 3ujo_A            9 KRIVLFLILLTKAASANLISFTFKKFNETNLILQRDATVS-SGKLRITKAAENGVPTAGSLGRAFYSTPIQIW-------   80 (281)
T ss_dssp             ---------------CEEEEEEESSCCSTTEEECSSCCCB-TTBEECSCCCSSCCCCSSCEEEEEESSCEECB-------
T ss_pred             HHHHHHHHHHcccCcCCcceEEcCCCCccCEEEecceEEe-CCEEEeCCCCCCCcccCCceEEEEECCCEEcc-------
Confidence            44444555443 4567889999999999999999999998 999999998765      89999999999999       


Q ss_pred             cCCCCCceeeeeEEEEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCC
Q 040242           77 NNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQ  156 (662)
Q Consensus        77 ~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~  156 (662)
                        +.++++++||+|+|+|+|.+++...+||||||||+|....|. ++||||||+|.+++ ++.||+|||||||++|.+| 
T Consensus        81 --d~~tg~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~N~e~-  155 (281)
T 3ujo_A           81 --DNTTGTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDTFYNGGW-  155 (281)
T ss_dssp             --CSSSCCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECCSCCCSS-
T ss_pred             --cCCCCCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEeccccccC-
Confidence              666677888999999999988778899999999999876554 68999999998766 7789999999999999887 


Q ss_pred             CCCCCeeEEecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeee
Q 040242          157 DINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYP  236 (662)
Q Consensus       157 d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~  236 (662)
                      ||++|||||||||+.|..+++|.                 +.+|+.++|||+||+.+++|+|++++.+.  ++.|+|++.
T Consensus       156 Dp~~nHVGIDvNSi~S~~t~~~~-----------------l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~~~lS~~  216 (281)
T 3ujo_A          156 DPTERHIGIDVNSIKSIKTTSWD-----------------FANGENAEVLITYDSSTNLLVASLVHPSQ--KTSFIVSER  216 (281)
T ss_dssp             CCSSSEEEEEESSSCCSCEEECC-----------------CCSSCCEEEEEEECTTTCEEEEEEECTTT--CCCEEEEEE
T ss_pred             CCCCCeEEEEcCCCCcccccccc-----------------ccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCCceEEEE
Confidence            99999999999999998887653                 56999999999999999999999997654  457899999


Q ss_pred             cccccccccceEEeeeccCCc---ccceeEEecceeeec
Q 040242          237 IDLATVLDEYMYVGFSASTGL---LTAFHNVHGWSFKIG  272 (662)
Q Consensus       237 vdL~~~l~~~~~vGFsastG~---~~~~~~i~sW~f~~~  272 (662)
                      |||+++|||+||||||||||.   ..|.|+|++|+|++.
T Consensus       217 vDL~~~L~e~v~VGFSAsTG~~~~~~e~H~IlsWSFss~  255 (281)
T 3ujo_A          217 VDLTSVLPEWVSVGFSATTGLSKGYVETNEVLSWSFASK  255 (281)
T ss_dssp             CCSTTTSCSEEEEEEEEEECSSTTSCCCCEEEEEEEEEE
T ss_pred             echHHhccCcEEEEEEeecCCCCcccceeEEEEEEEEEE
Confidence            999999999999999999996   689999999999865

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=4.5e-62  Score=485.36  Aligned_cols=228  Identities=27%  Similarity=0.413  Sum_probs=203.6

Q ss_pred             hccCCCceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCcee
Q 040242           14 GFAHAETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTA   85 (662)
Q Consensus        14 ~~~~~~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~   85 (662)
                      -+.++..++|+|++|.  ..||+|+|+|++.++|.|+||+...      +++|||+|++||+||         +.+++++
T Consensus         5 ~~~sa~~~sF~f~~F~~~~~~l~l~GdA~i~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pv~l~---------d~~tg~v   75 (261)
T 3zyr_A            5 RANSTDSLSFSFINFDRDERNLIFQGDAHTSRNNILQLTRTDSNGAPVRSTVGRILHSAQVRLW---------EKSTNRV   75 (261)
T ss_dssp             ---CCEEEEEEESSCCSCCTTEEEEETCEECTTSCEECSCBCTTSCBCSSEEEEEEESSCEECB---------CTTTCCB
T ss_pred             ccCcCcccEEEcCCCCCCCCCeEEeccEEecCCCeEEeCCCCCCCccccCCEEEEEECCCEEee---------cCCCCCc
Confidence            3567788999999998  6799999999997799999998764      799999999999999         6666778


Q ss_pred             eeeEEEEEEEEecCCCCCCCCceeEEEccCCCC-CCCCcccccCCCCCCCCCC-CCCcEEEEEeecc---CCCCCCCCCC
Q 040242           86 LTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQP-PSCLANQYLGLPNDTSNAK-FSTRILAVEFDAV---QNLELQDIND  160 (662)
Q Consensus        86 ~sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~-~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~---~n~~~~d~~~  160 (662)
                      +||+|+|+|.|.++ ...+||||||||+|.... |.+++||||||+|.+++++ ..||+|||||||+   +|.+| ||++
T Consensus        76 aSFsT~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEFDT~~~~~n~~~-Dp~~  153 (261)
T 3zyr_A           76 ANLQTQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQNSNTW-DPNY  153 (261)
T ss_dssp             EEEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEEECCCCTTTCTT-SCSS
T ss_pred             eeEEEEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEEeccccccCcCC-CCCC
Confidence            88999999999987 677899999999998764 7889999999999887743 5789999999999   99887 9999


Q ss_pred             CeeEEecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccc
Q 040242          161 NHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLA  240 (662)
Q Consensus       161 ~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~  240 (662)
                      |||||||||+.|..+++|.                 +.+|+.++|||+||+.+++|+|++++.+.   ..|+|++.+||+
T Consensus       154 nHVGIdvNsi~S~~s~~~~-----------------l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~  213 (261)
T 3zyr_A          154 QHIGIDVNSIRSSKVVRWE-----------------RREGKTLNVLVTYNPSTRTIDVVATYPDG---QRYQLSHVVDLT  213 (261)
T ss_dssp             CEEEEEESSSSCSEEEECC-----------------CCTTCCEEEEEEEETTTTEEEEEEECTTC---CEEEEEEECCGG
T ss_pred             CeEEEEcCCCCcccccccc-----------------ccCCceEEEEEEEcCCCCEEEEEEEcCCC---CCeEEEEEechH
Confidence            9999999999999887663                 56899999999999999999999997552   378999999999


Q ss_pred             cccccceEEeeeccCCcccceeEEecceeeec
Q 040242          241 TVLDEYMYVGFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       241 ~~l~~~~~vGFsastG~~~~~~~i~sW~f~~~  272 (662)
                      ++|||+|||||||+||...|.|+|++|+|++.
T Consensus       214 ~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~  245 (261)
T 3zyr_A          214 TILPEWVRVGFSAASGEQFQTHNLESWSFTST  245 (261)
T ss_dssp             GTSCSEEEEEEEEEESSSCCEEEEEEEEEEEE
T ss_pred             HhCcCcEEEEEEecCCCccceEEEEEEEEEEE
Confidence            99999999999999999999999999999865

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=2.5e-62  Score=485.87  Aligned_cols=224  Identities=30%  Similarity=0.475  Sum_probs=202.8

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCCC------eeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGR------ILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~~------~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +.++|+|++|.  +.||+|+|+|++.++|.|+||+...+      ++|||+|++||+||         +.++++++||+|
T Consensus         2 ~~~sF~f~~F~~~~~nl~l~GdA~v~~~g~L~LT~~~~~~~~~~~s~Gra~Y~~Pi~l~---------d~~tg~vaSFsT   72 (251)
T 3ipv_A            2 EETSFVFSKFKPLEPNLILQGDALVTVAGVLQLTNVDKNGVPEPSSLGRATYSAPINIW---------DSATGLVASFAT   72 (251)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             cceEEEeCCCCCCCCCeEEeccEEecCCCeEEcCCCCCCCcccCCcEEEEEECCCEEee---------cCCCCceeeEEE
Confidence            46899999998  68999999999977999999998755      89999999999999         566677788999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      +|+|.|.+++...+||||||||+|....|. ..||||||+|.+++ +..||+|||||||++|.+|+||++|||||||||+
T Consensus        73 ~F~F~I~~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNsi  150 (251)
T 3ipv_A           73 SFRFTIYAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDTYENTVFTDPPYTHIGFDVNSI  150 (251)
T ss_dssp             EEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEECSCCGGGTCCSSCEEEEEESSS
T ss_pred             EEEEEEeCCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEecccccccCCCCCCeEEEEcCCC
Confidence            999999988778899999999999876555 57999999998766 6789999999999999888899999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEe
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG  250 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vG  250 (662)
                      .|..+++|                 .+.+|+.++|||+||+.+++|+|+|++.+.  +..|+|++.|||+++|+|+||||
T Consensus       151 ~S~~t~~~-----------------~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VG  211 (251)
T 3ipv_A          151 SSIKTVKW-----------------SLANGEAAKVLITYNSAVKLLVASLVYPSS--KTSFILADIVDLSSVLPEWVRVG  211 (251)
T ss_dssp             SCSEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEEE
T ss_pred             ccccccee-----------------EecCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCcEEEE
Confidence            99887765                 367999999999999999999999997654  45789999999999999999999


Q ss_pred             eeccCCcc---cceeEEecceeeec
Q 040242          251 FSASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       251 FsastG~~---~~~~~i~sW~f~~~  272 (662)
                      |||+||..   .|.|+|++|+|++.
T Consensus       212 FSAsTG~~~~~~e~h~IlsWsF~s~  236 (251)
T 3ipv_A          212 FSAATGASGGKIETHDVFSWSFASK  236 (251)
T ss_dssp             EEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEEecCCCccccceeEEEEEEEEEE
Confidence            99999998   89999999999865

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=1.9e-60  Score=472.05  Aligned_cols=223  Identities=30%  Similarity=0.458  Sum_probs=201.4

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ..++|+|++|.  ..||+|+|+|++.++|.|+||++.     .+++|||+|++||+||         +.++++++||+|+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---------~~~tg~vaSFsT~   72 (239)
T 1dbn_A            2 DELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW---------GNTTGSVASFSTS   72 (239)
T ss_dssp             CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEecCCCcEEeCCCCCCCcccCceEEEEeCCCEecc---------cCCCCCccceEEE
Confidence            56899999998  679999999999878999999876     6799999999999999         5666777889999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCC-CCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCC---CCCCCCCCCeeEEec
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQ-PPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQN---LELQDINDNHVGIDI  167 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n---~~~~d~~~~Hvgid~  167 (662)
                      |+|+|.+++...+||||||||+|... .|.++.|+||||+|.++ +++.+|+|||||||++|   .+ +||++||||||+
T Consensus        73 F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~~~~-~Dp~~nHVGIdv  150 (239)
T 1dbn_A           73 FTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDP-WDPNYRHIGIDV  150 (239)
T ss_dssp             EEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCT-TSCSSCEEEEEE
T ss_pred             EEEEEeCCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEeccccCcccc-cCCCCCcEEEec
Confidence            99999988777899999999999875 57788999999998764 46789999999999999   77 599999999999


Q ss_pred             CCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccce
Q 040242          168 SSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYM  247 (662)
Q Consensus       168 ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~  247 (662)
                      ||+.|..+++|                 +|.+|+.++|||+||+.+++|+|+|++.+.  +..|+|++.+||+++|+|+|
T Consensus       151 Ns~~S~~~~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v  211 (239)
T 1dbn_A          151 NGIESIKTVQW-----------------DWINGGVAFATITYLAPNKTLIASLVYPSN--QTTFSVAASVDLKEILPEWV  211 (239)
T ss_dssp             SSSSCSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEE
T ss_pred             CCccccceEcc-----------------cccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCcceEEEEechHHhCCccE
Confidence            99999887764                 377999999999999999999999987653  45689999999999999999


Q ss_pred             EEeeeccCCcc--cceeEEecceeee
Q 040242          248 YVGFSASTGLL--TAFHNVHGWSFKI  271 (662)
Q Consensus       248 ~vGFsastG~~--~~~~~i~sW~f~~  271 (662)
                      ||||||+||..  .|.|+|++|+|+.
T Consensus       212 ~VGFSAsTG~~~~~~~h~IlsWsF~s  237 (239)
T 1dbn_A          212 RVGFSAATGYPTEVETHDVLSWSFTS  237 (239)
T ss_dssp             EEEEEEEECSGGGCCCCEEEEEEEEE
T ss_pred             EEEEEeccCCCccceeeEEEEEEeEe
Confidence            99999999999  9999999999985

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=2.4e-60  Score=470.12  Aligned_cols=223  Identities=29%  Similarity=0.456  Sum_probs=198.5

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ..++|+|++|.  ..||+|+|+|.+.++|.|+||++.     .+++|||+|++||+||         +.++++++||+|+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---------d~~tg~vaSFsT~   72 (237)
T 1fny_A            2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW---------DSTTGNVASFVTS   72 (237)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEeccCCeEEecCCcCCCcccCceEEEEeCCCEecc---------cCCCCCccceEEE
Confidence            35789999998  679999999999878999999876     6799999999999999         5666777889999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCc
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLI  171 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~  171 (662)
                      |+|+|.+++...+||||||||+|....| ++.|+||||+|.++ +++.+|+|||||||++|.+ +||++|||||||||+.
T Consensus        73 F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~~-~Dp~~nHVGIdvNsi~  149 (237)
T 1fny_A           73 FTFIIQAPNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGD-WDPKGRHLGINVNSIE  149 (237)
T ss_dssp             EEEECCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEECSCCTT-TCCSSSEEEEEESSSS
T ss_pred             EEEEEeCCCCCCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeecccCcc-cCCCCCceEEecCCcc
Confidence            9999998877789999999999987554 48899999998764 4778999999999999988 5999999999999999


Q ss_pred             ccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEee
Q 040242          172 SNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       172 s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      |..+++|                 +|.+|+.++|||+||+.+++|+|+|++.+.  |..|+|++.+||+++||++|||||
T Consensus       150 S~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGF  210 (237)
T 1fny_A          150 SIKTVPW-----------------NWTNGEVANVFISYEASTKSLTASLVYPSL--ETSFIIDAIVDVKIVLPEWVRFGF  210 (237)
T ss_dssp             CSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             ccccccc-----------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCcEEEEE
Confidence            9887765                 377999999999999999999999987653  557899999999999999999999


Q ss_pred             eccCCcc---cceeEEecceeeec
Q 040242          252 SASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       252 sastG~~---~~~~~i~sW~f~~~  272 (662)
                      ||+||..   .|.|+|++|+|+..
T Consensus       211 SAsTG~~~~~~~~h~IlsWsF~s~  234 (237)
T 1fny_A          211 SATTGIDKGYVQTNDVLSWSFESN  234 (237)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEeeCCCCcccceeEEEEEEEEEe
Confidence            9999998   99999999999864

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=1e-59  Score=471.23  Aligned_cols=241  Identities=25%  Similarity=0.365  Sum_probs=201.2

Q ss_pred             CceeEEeCCCC---CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeE
Q 040242           19 ETNSFIYNGFI---QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFS   89 (662)
Q Consensus        19 ~~~~f~~~~f~---~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~   89 (662)
                      ..++|+|++|.   ..||+|+|+|.+. +|.|+||++.      .++.|||||++||+||         +.++++++||+
T Consensus         3 ~~~~F~f~~F~~~~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~tg~vasFs   72 (257)
T 1hql_A            3 DSVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW---------DNKTESVASFY   72 (257)
T ss_dssp             -CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECC---------CSTTCCCCEEE
T ss_pred             cceEEEcCCCCCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEecc---------cCCCCCeeceE
Confidence            46799999998   5799999999998 8999999875      5789999999999999         55666778899


Q ss_pred             EEEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCC-CCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecC
Q 040242           90 TNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS-NAKFSTRILAVEFDAVQNLELQDINDNHVGIDIS  168 (662)
Q Consensus        90 t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~n  168 (662)
                      |+|+|+|.++ ...+||||||||+|....| ++.|+||||++.++ ++++.+++|||||||++|.+|+||++||||||+|
T Consensus        73 T~F~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHVGIdvN  150 (257)
T 1hql_A           73 TEFTFFLKIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVN  150 (257)
T ss_dssp             EEEEEEEEEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEES
T ss_pred             EEEEEEEecC-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEecccccccccCCCCCceeeeeC
Confidence            9999999987 6778999999999987544 58899999998765 3678899999999999999988999999999999


Q ss_pred             CCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceE
Q 040242          169 SLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY  248 (662)
Q Consensus       169 s~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~  248 (662)
                      |+.|..+++|..              ..|.+|+.++|||+||+.+++|+|+|++.+.   ..|+|++.+||+.+||++||
T Consensus       151 s~~S~~s~~~~~--------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~e~~~  213 (257)
T 1hql_A          151 SIVSVATKRWED--------------SDIFSGKIATARISYDGSAEILTVVLSYPDG---SDYILSHSVDMRQNLPESVR  213 (257)
T ss_dssp             SSSCSEEEECCH--------------HHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EEEEEEEECCGGGTSCSEEE
T ss_pred             CccccceeccCc--------------ccccCCceEEEEEEEeCCCCEEEEEEecCCC---CceeeEEeechHHhcCCceE
Confidence            999988877631              1255799999999999999999999987654   46899999999999999999


Q ss_pred             EeeeccCC-cccceeEEecceeeecCcCCCCCccCCCCCCC
Q 040242          249 VGFSASTG-LLTAFHNVHGWSFKIGGTARELDVTMLPFHAR  288 (662)
Q Consensus       249 vGFsastG-~~~~~~~i~sW~f~~~~~~~~l~~~~lP~~~~  288 (662)
                      |||||||| ...+.|+|++|+|+.....+..+.+.+|..|+
T Consensus       214 vGFSAsTG~~~~~~H~IlsWsF~s~~~~~~~~~~~~p~~~~  254 (257)
T 1hql_A          214 VGISASTGNNQFLTVYILSWRFSSNLQSTSVKAAMEPEITR  254 (257)
T ss_dssp             EEEEEECCSCCCEEEEEEEEEEEEEC---------------
T ss_pred             EEEEeccCCCccceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence            99999999 99999999999999988877777777776543

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=1.4e-59  Score=466.04  Aligned_cols=223  Identities=29%  Similarity=0.388  Sum_probs=200.6

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC---CCeeEE-EEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ---GRILGH-AFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~---~~~~Gr-~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      .+++|+|++|.  ..||+|+|+|++.++|.|+||++.   .+++|| |+|++||+||         +.++++++||+|+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gr~a~y~~Pv~l~---------~~~tg~vaSFsT~F   72 (242)
T 1fx5_A            2 DDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW---------NCNTGELASFITSF   72 (242)
T ss_dssp             CEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECE---------ETTTTEECEEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEeccCCcEEecCCCCcccCCccCEEEeCCCEEee---------cCCCCCccceEEEE
Confidence            56899999998  679999999999878999999886   689999 9999999999         56677788899999


Q ss_pred             EEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCC-CCCCCCeeEEecCCC
Q 040242           93 VFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLEL-QDINDNHVGIDISSL  170 (662)
Q Consensus        93 ~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~-~d~~~~Hvgid~ns~  170 (662)
                      +|+|.++ +...+||||||||+|....| ++.|+||||+|.++ +++.+|+|||||||++|.++ +||++||||||+||+
T Consensus        73 ~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~~~~Dp~~nHVGIdvNs~  150 (242)
T 1fx5_A           73 SFFMETSANPKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCV  150 (242)
T ss_dssp             EEEEEESSCGGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESSS
T ss_pred             EEEEecCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEeccccCcccccCCCCCeEEEecCCc
Confidence            9999987 56778999999999987544 48899999998764 57789999999999999987 799999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCC--CcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceE
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSG--DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY  248 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g--~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~  248 (662)
                      .|..+++|                 +|.+|  +.++|||+||+.+++|+|+|++.+.  |..|+|++.+||+++||++||
T Consensus       151 ~S~~~~~~-----------------~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~  211 (242)
T 1fx5_A          151 KSINAERW-----------------NKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTSISVTSIVDLKEILPEWVS  211 (242)
T ss_dssp             SCSEEEEC-----------------CCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCGGGTSCSEEE
T ss_pred             cccceecc-----------------cccCCCceeEEEEEEEeCCCCEEEEEEecCCC--CccceeeEEechHHhCCccEE
Confidence            99887754                 36789  9999999999999999999987653  456899999999999999999


Q ss_pred             EeeeccC--CcccceeEEecceeeec
Q 040242          249 VGFSAST--GLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       249 vGFsast--G~~~~~~~i~sW~f~~~  272 (662)
                      |||||+|  |.. |.|+|++|+|+..
T Consensus       212 VGFSAsT~~G~~-~~h~IlsWsF~s~  236 (242)
T 1fx5_A          212 VGFSGSTYIGRQ-ATHEVLNWYFTST  236 (242)
T ss_dssp             EEEEEEEETTSC-EEEEEEEEEEEEE
T ss_pred             EEEEecccCCCc-ceeEEEEEEeEee
Confidence            9999999  998 9999999999875

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=9.9e-60  Score=464.26  Aligned_cols=220  Identities=26%  Similarity=0.402  Sum_probs=199.8

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCC-CCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSND-QGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFS   95 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~-~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~   95 (662)
                      .+++|+|++|.  ..||+|+|+|++.++|.|+||++ ..+++|||+|++||+||         +.++++++||+|+|+|+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~Gra~y~~Pi~l~---------~~~tg~vaSFsT~F~F~   72 (232)
T 1v6i_A            2 ETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW---------SSATGNVASFLTSFSFE   72 (232)
T ss_dssp             EEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECB---------CTTTCCBCEEEEEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEEccCCcEEeCCCCCCCceEEEEeCCCEEee---------cCCCCCccceEEEEEEE
Confidence            45799999998  67999999999987899999998 88999999999999999         56667778899999999


Q ss_pred             EecCCCCCCCCceeEEEccCCC-CCCCC-cccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccc
Q 040242           96 IVPKYPQLGGHGLAFVLMSRKQ-PPSCL-ANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISN  173 (662)
Q Consensus        96 i~~~~~~~~gdGlaF~l~~~~~-~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~  173 (662)
                      |.+++...+||||||||+|... .|.++ +|+||||+|.    ++.+|+|||||||++|.+++||++||||||+||+.|.
T Consensus        73 I~~~~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEFDT~~n~~~~Dp~~nHVGIdvns~~S~  148 (232)
T 1v6i_A           73 MKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSV  148 (232)
T ss_dssp             EECCSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCS
T ss_pred             EecCCCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEeecccccccCCCCCCeEEEEcCCcccc
Confidence            9988777789999999999874 57777 8999999986    5678999999999999998999999999999999998


Q ss_pred             ccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeec
Q 040242          174 ISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA  253 (662)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsa  253 (662)
                      .+++|                 +|.+|+.++|||+||+.+++|+|+|++ +  +|..|+|++.+||+++||++|||||| 
T Consensus       149 ~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFS-  207 (232)
T 1v6i_A          149 KTVPW-----------------NSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDITTIAQVVDLKAKLPERVKFGFS-  207 (232)
T ss_dssp             EEEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCEEEEEEECCHHHHSCSEEEEEEE-
T ss_pred             ccccc-----------------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEEEEechHHhCCccEEEEEE-
Confidence            87764                 377999999999999999999999997 4  46679999999999999999999999 


Q ss_pred             cCCc--ccceeEEecceeeec
Q 040242          254 STGL--LTAFHNVHGWSFKIG  272 (662)
Q Consensus       254 stG~--~~~~~~i~sW~f~~~  272 (662)
                      |||.  ..|.|+|++|+|+..
T Consensus       208 sTG~~~~~~~h~IlsWsF~s~  228 (232)
T 1v6i_A          208 ASGSLGGRQIHLIRSWSFTST  228 (232)
T ss_dssp             EECCSSBCCEEEEEEEEEEEE
T ss_pred             ecCCCccccEEEEEEEEEEee
Confidence            9998  599999999999865

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=1.6e-59  Score=465.31  Aligned_cols=223  Identities=30%  Similarity=0.487  Sum_probs=198.6

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      .+++|+|++|.  ..||+|+|+|++.++|.|+||++.      .+++|||+|++||+||         +.++++++||+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pi~l~---------~~~tg~vaSFsT   72 (239)
T 1gzc_A            2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW---------DSTTGTVASFET   72 (239)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             eeEEEEeCCCCCCCCCeEEcccEEEcCCCcEEeCCCCcCCcccCCceEEEEeCCCEecc---------cCCCCCccceEE
Confidence            35789999998  679999999999878999999876      5789999999999999         566677788999


Q ss_pred             EEEEEEecCC-CCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           91 NFVFSIVPKY-PQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        91 ~F~f~i~~~~-~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      +|+|+|.+++ ...+||||||||+|....| ++.|+||||+|.++ +++.+|+|||||||++|. |.||++||||||+||
T Consensus        73 ~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~n~-~dDp~~nHVGIdvns  149 (239)
T 1gzc_A           73 RFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFDTFSNP-WDPPQVPHIGIDVNS  149 (239)
T ss_dssp             EEEEECCCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEECSCCT-TSCSSSSEEEEEESS
T ss_pred             EEEEEEeCCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEeccccc-CCCCCCCeEEEecCC
Confidence            9999999876 6778999999999987554 48899999998764 577899999999999998 777999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+++|                 +|.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+++||++|||
T Consensus       150 ~~S~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~V  210 (239)
T 1gzc_A          150 IRSIKTQPF-----------------QLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAIYTIAEIVDVKQVLPDWVDV  210 (239)
T ss_dssp             SSCSEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCHHHHSCSEEEE
T ss_pred             ccccccccc-----------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceEEEEechHHhCCCceEE
Confidence            999887654                 377999999999999999999999987543  5578999999999999999999


Q ss_pred             eeeccCCcc---cceeEEecceeeec
Q 040242          250 GFSASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG~~---~~~~~i~sW~f~~~  272 (662)
                      ||||+||..   .|.|+|++|+|+..
T Consensus       211 GFSAsTG~~~~~~~~h~IlsWsF~s~  236 (239)
T 1gzc_A          211 GLSGATGAQRDAAETHDVYSWSFQAS  236 (239)
T ss_dssp             EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEEeccCCCccccceEEEEEEEeEEe
Confidence            999999974   89999999999864

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=7.2e-59  Score=461.00  Aligned_cols=224  Identities=29%  Similarity=0.458  Sum_probs=201.4

Q ss_pred             CCCceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC---CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           17 HAETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ---GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        17 ~~~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ++..++|+|++|.  ..||+|+|+|.+.++|.|+||++.   .+++|||+|++||+||         +.++++++||+|+
T Consensus         2 s~~~~~F~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~---------~~~tg~vasFsT~   72 (242)
T 1qnw_A            2 LSDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW---------DSITGKVASFATS   72 (242)
T ss_dssp             -CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             CccceEEEcCCCCCCCCCeEEccceEEccCCcEEecCCCCcccCCeEEEEeCCCEeee---------cCCCCCcccEEEE
Confidence            3567899999998  679999999999878999999986   7899999999999999         5666777889999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCC-CCCCCcccccCCCCCCCCCCCCCcEEEEEeecc----CCCCCCCCCCCeeEEe
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQ-PPSCLANQYLGLPNDTSNAKFSTRILAVEFDAV----QNLELQDINDNHVGID  166 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~----~n~~~~d~~~~Hvgid  166 (662)
                      |+|+|.++ ...+||||||||+|... .|.++.|+||||++.++ +++.+|+|||||||+    +|.  +||++||||||
T Consensus        73 F~F~I~~~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~~~~~N~--~Dp~~nHVGId  148 (242)
T 1qnw_A           73 FSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNP--WDPDFKHIGID  148 (242)
T ss_dssp             EEEECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCT--TSCSSCEEEEE
T ss_pred             EEEEEecC-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEeecccccccCC--CCCCCCcEEEe
Confidence            99999887 67789999999999874 57788999999998764 477899999999999    997  69999999999


Q ss_pred             cCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccc
Q 040242          167 ISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY  246 (662)
Q Consensus       167 ~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~  246 (662)
                      +||+.|..+++|                 +|.+|+.++|||+||+.+++|+|+|++.+.  |..|+|++.+||+++||++
T Consensus       149 vNs~~S~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~  209 (242)
T 1qnw_A          149 VNSIKSIKTVKW-----------------DWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTSNIITASVDLKAILPEW  209 (242)
T ss_dssp             ESSSSCSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCEEEEEEECCHHHHSCSE
T ss_pred             cCCccccceecc-----------------cccCCCEEEEEEEEeCCCcEEEEEEecCCC--CcceeEEEeechHHhcCCc
Confidence            999999887654                 377999999999999999999999987543  5578999999999999999


Q ss_pred             eEEeeeccCCcc--cceeEEecceeeec
Q 040242          247 MYVGFSASTGLL--TAFHNVHGWSFKIG  272 (662)
Q Consensus       247 ~~vGFsastG~~--~~~~~i~sW~f~~~  272 (662)
                      |||||||+||..  .|.|+|++|+|+..
T Consensus       210 v~VGFSAsTG~~~~~~~h~IlsWsF~s~  237 (242)
T 1qnw_A          210 VSVGFSGGVGNAAEFETHDVLSWYFTSN  237 (242)
T ss_dssp             EEEEEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred             eEEEEEeccCCCccceEEEEEEEEeEee
Confidence            999999999999  99999999999875

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=9.1e-59  Score=457.40  Aligned_cols=218  Identities=31%  Similarity=0.435  Sum_probs=198.0

Q ss_pred             eeEEeCCCC-CCCeeEecceeeeCCCeEEecCC--CCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEe
Q 040242           21 NSFIYNGFI-QANLSLDGTAFVRKDGILAVSND--QGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIV   97 (662)
Q Consensus        21 ~~f~~~~f~-~~~~~l~G~a~~~~~~~~~Lt~~--~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~   97 (662)
                      ++|+|++|. ..||+|+|+|.+.++|.|+||++  ..+++|||+|++||+||         +.++++++||+|+|+|+|.
T Consensus         1 ~sF~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~Gra~y~~Pv~l~---------~~~tg~vaSFsT~F~F~I~   71 (234)
T 2eig_A            1 VSFNYTRFKDDGSLIFQGDAKIWTDGRLAMPTDPLVNRTTSHALYATPVPIW---------DSATGNVASFITSFSFIVS   71 (234)
T ss_dssp             CEEEESSCCSSSSEEEEETCEEEGGGEEESSSCGGGSSEEEEEEESSCEECB---------CTTTCCBCEEEEEEEEEEE
T ss_pred             CeEEcCCCCCCCCeEEcccEEEcCCCCeeeCCCCCccCceEEEEeCCCEEee---------cCCCCCccceEEEEEEEEe
Confidence            479999998 88999999999987899999998  77899999999999999         5666777889999999999


Q ss_pred             cCCCCCCCCceeEEEccCCC-CCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCC---CeeEEecCCCccc
Q 040242           98 PKYPQLGGHGLAFVLMSRKQ-PPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDIND---NHVGIDISSLISN  173 (662)
Q Consensus        98 ~~~~~~~gdGlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~---~Hvgid~ns~~s~  173 (662)
                      +++...+||||||||+|... .|.++.|+||||+|.+   ++.+|+|||||||++|.  +||++   ||||||+||+.|.
T Consensus        72 ~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~--~Dp~~~~~nHVGIdvNsi~S~  146 (234)
T 2eig_A           72 NVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFDSHPNV--WDPKSLRSSHIGIDVNSIMSL  146 (234)
T ss_dssp             ECTTSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEECSCCT--TSCTTTCSSEEEEEESSSSCS
T ss_pred             CCCCCCCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEeccccCc--cCCCCCCCCceEEecCCcccc
Confidence            88777899999999999874 5777899999999875   56789999999999997  69999   9999999999998


Q ss_pred             ccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeec
Q 040242          174 ISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA  253 (662)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsa  253 (662)
                      .+++|                 +|.+|+.++|||+||+.+++|+|+|++ +  .|..|+|++.+||+++||++|||||||
T Consensus       147 ~~~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~~~ls~~vdL~~~l~e~v~VGFSA  206 (234)
T 2eig_A          147 KAVNW-----------------NRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQITTISQEIDLKTVLPEKVSVGFSA  206 (234)
T ss_dssp             EEEEC-----------------CCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCEEEEEEECCHHHHSCSEEEEEEEE
T ss_pred             ceecc-----------------cccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCcceEeEeechHHhcCCceEEEEEe
Confidence            87654                 377999999999999999999999998 4  466789999999999999999999999


Q ss_pred             cC--CcccceeEEecceeeecC
Q 040242          254 ST--GLLTAFHNVHGWSFKIGG  273 (662)
Q Consensus       254 st--G~~~~~~~i~sW~f~~~~  273 (662)
                      +|  |.. |.|+|++|+|+...
T Consensus       207 sT~~G~~-~~h~IlsWsF~s~l  227 (234)
T 2eig_A          207 TTWNPER-ERHDIYSWSFTSTL  227 (234)
T ss_dssp             EECSSCC-EEEEEEEEEEEEEC
T ss_pred             eecCCCc-ceeEEEEEEEEecC
Confidence            99  988 99999999998753

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=2e-58  Score=458.87  Aligned_cols=223  Identities=29%  Similarity=0.461  Sum_probs=199.6

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      .+++|+|++|.  ..||+|+|+|.+.++|.|+||++..      ++.|||+|++||+||         +. +++++||+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~G~a~y~~Pv~l~---------~~-~g~~~sFst   71 (240)
T 2fmd_A            2 NSVCFTFTDFESGQQDLIFQGDASVGSNKALQLTKVDSKGNPQGGSVGRALYTAPIRLW---------QS-SSLVASFET   71 (240)
T ss_dssp             CEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCSSCEEEEEESSCEECC---------CT-TCSEEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEccceEEcCCCCEEeCCCCcCCcccCCCeEEEEECCCEEee---------CC-CCCcCcEEE
Confidence            56899999998  6799999999998789999999875      799999999999999         55 677889999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCC-CcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSC-LANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      +|+|+|.++ ...+||||||+|+|....|.+ +.|+||||++.+++++..+++|||||||++|.+++||++||||||+|+
T Consensus        72 ~F~F~I~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfDT~~N~~~~Dp~~nHvgIdvns  150 (240)
T 2fmd_A           72 TFTFSISQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDIGDPNYRHIGIDVNS  150 (240)
T ss_dssp             EEEEECCBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEECSCCGGGTCCSSCEEEEEESS
T ss_pred             EEEEEEecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEeccccccccCCCCCCceeecccc
Confidence            999999987 677899999999998766655 889999999987767789999999999999998889999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+.+|                 ++.+|+.++|||+||+.+++|+|++++.+.   ..|+|++.+||+.+||++|||
T Consensus       151 ~~S~~s~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~l~~~~yv  210 (240)
T 2fmd_A          151 IRSKAASKW-----------------DWQNGKTATAHISYNSASKRLSVVSSYPNS---SPVVVSFDVELNNVBPBWVRV  210 (240)
T ss_dssp             SSCSEEEEC-----------------CCCSSCEEEEEEEEETTTTEEEEEEECTTS---CCEEEEEECCGGGTSCSEEEE
T ss_pred             ccccceeEE-----------------EeeCCCEEEEEEEEeCCCCEEEEEEecCCC---CceEEEEEechHHhCCCceEE
Confidence            999877654                 367899999999999999999999987654   478999999999999999999


Q ss_pred             eeeccCCcccceeEEecceeeec
Q 040242          250 GFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG~~~~~~~i~sW~f~~~  272 (662)
                      ||||+||...+.|+|++|+|++.
T Consensus       211 GFSAsTG~~~~~H~IlsWsF~s~  233 (240)
T 2fmd_A          211 GFSATTGQYTQTNNILAWSFRSS  233 (240)
T ss_dssp             EEEEECCSSCBCCEEEEEEEEEE
T ss_pred             EEEeccCCccccEEEEEEEeEec
Confidence            99999999999999999999875

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=1.8e-58  Score=460.67  Aligned_cols=220  Identities=30%  Similarity=0.477  Sum_probs=198.0

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      ..++|+|++|.  ..||+|+|+|.+.++|.|+||++.      .+++|||+|++||+||         +.++++++||+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~GdA~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~tg~vaSFsT   72 (253)
T 1sbf_A            2 ETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW---------DKETGSVASFAA   72 (253)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCBCTTSCBCTTCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEcccEEEcCCCeEEeCCCccCCcccCCCeEEEEECCCEecc---------cCCCCcccceEE
Confidence            45799999998  679999999999878999999876      5789999999999999         566677788999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      +|+|+|.+++...+||||||||+|....| ++.|+||||+|.+   ++.+|+|||||||++|.  +||++||||||+||+
T Consensus        73 ~F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~  146 (253)
T 1sbf_A           73 SFNFTFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNSI  146 (253)
T ss_dssp             EEEEEEECSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEECSCCT--TCCSSSEEEEEESSS
T ss_pred             EEEEEEeCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEeccccCC--CCCCCCcEEEEcCCc
Confidence            99999998877789999999999987554 5889999999875   66899999999999997  699999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEe
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG  250 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vG  250 (662)
                      .|..+.+|                 ++.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+.+||++||||
T Consensus       147 ~S~~t~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VG  207 (253)
T 1sbf_A          147 RSIKTTSW-----------------DLANNKVAKVLITYDASTSLLVASLVYPSQ--RTSNILSDVVDLKTSLPEWVRIG  207 (253)
T ss_dssp             SCSEEEEC-----------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEE
T ss_pred             cccceecc-----------------cccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCcceEEEEechHHhCCCceEEE
Confidence            99887654                 377899999999999999999999987653  45689999999999999999999


Q ss_pred             eeccCCcc--cceeEEecceeeec
Q 040242          251 FSASTGLL--TAFHNVHGWSFKIG  272 (662)
Q Consensus       251 FsastG~~--~~~~~i~sW~f~~~  272 (662)
                      |||+||..  .|.|+|++|+|+..
T Consensus       208 FSAsTG~~~~~~~H~IlsWsF~s~  231 (253)
T 1sbf_A          208 FSAATGLDIPGESHDVLSWSFASN  231 (253)
T ss_dssp             EEEEECSSSCCCEEEEEEEEEEEE
T ss_pred             EEeccCCCccceeeEEEEEEeEee
Confidence            99999999  99999999999875

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=2.5e-58  Score=456.95  Aligned_cols=224  Identities=28%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSI   96 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i   96 (662)
                      .+++|+|++|.  ..||+|+|+|. .++|.|+||++.+++.|||||++||+||         +..+++++||+|+|+|+|
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~G~a~y~~Pv~l~---------~~~~~~~~sFst~F~F~I   71 (234)
T 2bqp_A            2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIW---------DRETGNVANFVTSFTFVI   71 (234)
T ss_dssp             EEEEEEESSBCTTCTTEEEEETCE-EETBEEEEECSCTTCEEEEEESSCEECB---------CTTTCCBCEEEEEEEEEE
T ss_pred             cceEEEcCCCCCCCCCEEEeecee-cCCCEEEeCCCCCCCEEEEEECCCEEcc---------cCCCCceeeEEEEEEEEE
Confidence            46799999998  67999999999 5689999999999999999999999999         566677788999999999


Q ss_pred             ecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCC--CCeeEEecCCCcccc
Q 040242           97 VPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDIN--DNHVGIDISSLISNI  174 (662)
Q Consensus        97 ~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~  174 (662)
                      .+++...+||||||+|+|....|. +.|++|||++.++ ++..+++|||||||++|.+ +||+  +||||||+|++.|..
T Consensus        72 ~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT~~N~~-~Dp~~~~nHVgIdvns~~S~~  148 (234)
T 2bqp_A           72 NAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVN  148 (234)
T ss_dssp             ECSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSE
T ss_pred             eCCCCCCCCCcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEecccCcc-cCCCCCCCceeEeeCCccccc
Confidence            988777899999999999876655 8899999999764 5778999999999999988 5999  999999999999987


Q ss_pred             cccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCC---CCCCCeeeeecccccccccceEEee
Q 040242          175 SEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIP---KPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~---~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      +.+|                 ++.+|+.++|||+||+.+++|+|++++.+.+   +|..|+|++.+||+.+||++|||||
T Consensus       149 s~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~~~ls~~vdL~~~l~~~~yvGF  211 (234)
T 2bqp_A          149 TKSW-----------------KLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGF  211 (234)
T ss_dssp             EEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEEECC------CEEEEEEEECCGGGTSCSEEEEEE
T ss_pred             eEee-----------------EEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCcceEEEEechHHhCCCceEEEE
Confidence            7654                 3678999999999999999999999987665   6678999999999999999999999


Q ss_pred             eccCCcccceeEEecceeeec
Q 040242          252 SASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       252 sastG~~~~~~~i~sW~f~~~  272 (662)
                      ||+||...+.|+|++|+|+..
T Consensus       212 SAsTG~~~~~H~IlsWsF~s~  232 (234)
T 2bqp_A          212 SATTGAEYAAHEVLSWSFHSE  232 (234)
T ss_dssp             EEECSSSCCEEEEEEEEEEEE
T ss_pred             EeccCCCcccEEEEEEEEEee
Confidence            999999999999999999864

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=1.5e-58  Score=461.79  Aligned_cols=222  Identities=28%  Similarity=0.455  Sum_probs=199.7

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      .+++|+|++|.+.||+|+|+|.+. +|.|+||++.      .+++|||+|++||+||         +.++++++||+|+|
T Consensus         2 ~~~~F~f~~F~~~~l~l~GdA~v~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~tg~vaSFsT~F   71 (253)
T 1g7y_A            2 DIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY---------DKSTGAVASWATSF   71 (253)
T ss_dssp             EEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECB---------CTTTCCBCEEEEEE
T ss_pred             cceEEEcCCCCcCCEEEecceEEe-CCEEEeCCCCCCCccccCCeEEEEECCCEEee---------cCCCCCccceEEEE
Confidence            467999999999999999999998 8999999876      5799999999999999         56667778899999


Q ss_pred             EEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcc
Q 040242           93 VFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLIS  172 (662)
Q Consensus        93 ~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s  172 (662)
                      +|+|.+++...+||||||||+|....| ++.|+||||++.++ ++..+|+|||||||++|.+ +||++||||||+||+.|
T Consensus        72 ~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT~~N~~-~Dp~~nHVGIdvns~~S  148 (253)
T 1g7y_A           72 TANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDTFSNTD-WDPTSRHIGIDVNSIKS  148 (253)
T ss_dssp             EEECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEECSCCTT-TCCSSCEEEEEESSSSC
T ss_pred             EEEEecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecceeccC-cCCCCCcEeeccCCccc
Confidence            999998766778999999999987554 58899999998764 4678999999999999988 59999999999999999


Q ss_pred             cccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeee
Q 040242          173 NISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS  252 (662)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFs  252 (662)
                      ..+.+|                 ++.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+.+||++||||||
T Consensus       149 ~~t~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFS  209 (253)
T 1g7y_A          149 IRTASW-----------------GLANGQNAEILITYNAATSLLVASLVHPSR--RTSYIVSERVDITNELPEYVSIGFS  209 (253)
T ss_dssp             SEEEEC-----------------CCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             cceecc-----------------ccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEE
Confidence            887764                 367899999999999999999999987653  4568999999999999999999999


Q ss_pred             ccCCcc---cceeEEecceeeec
Q 040242          253 ASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       253 astG~~---~~~~~i~sW~f~~~  272 (662)
                      |+||..   .+.|+|++|+|+..
T Consensus       210 AsTG~~~~~~~~H~IlsWsF~s~  232 (253)
T 1g7y_A          210 ATTGLSEGYTETHDVLSWSFASK  232 (253)
T ss_dssp             EECCSSSSCCCCCEEEEEEEEEE
T ss_pred             eCcCCCCcccceeEEEEEEEEee
Confidence            999999   99999999999875

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=1.4e-58  Score=461.61  Aligned_cols=221  Identities=30%  Similarity=0.445  Sum_probs=199.6

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      ..++|+|++|.+.||+|+|+|.+.++|.|+||++.      .++.|||+|++||+||         +.++++++||+|+|
T Consensus         2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~tg~vaSFsT~F   72 (252)
T 1fat_A            2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW---------DNTTGTVASFATSF   72 (252)
T ss_dssp             CCEEEEESSCCGGGEEEEETCEECTTSCEECSCCC-CCCCCTTCEEEEEEEEEEECE---------ETTTTEEEEEEEEE
T ss_pred             cceEEEcCCCCcCCEEEeccEEECCCCEEEeCCCCCCCccccCCEEEEEECCCEecc---------cCCCCcccceEEEE
Confidence            56899999999889999999999878999999876      5799999999999999         56677788999999


Q ss_pred             EEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcc
Q 040242           93 VFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLIS  172 (662)
Q Consensus        93 ~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s  172 (662)
                      +|+|.+++...+||||||||+|....| ++.|+||||+|.+   ++.+|+|||||||++|.+ +||++||||||+||+.|
T Consensus        73 ~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT~~N~~-~Dp~~nHVGIdvNs~~S  147 (252)
T 1fat_A           73 TFNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKD-WDPTERHIGIDVNSIRS  147 (252)
T ss_dssp             EEECCCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEECSCCTT-TCCSSCEEEEEESSSSC
T ss_pred             EEEEeCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeecccCCC-CCCCCCeEEEecCCccc
Confidence            999998776778999999999987554 5889999999875   568999999999999988 69999999999999999


Q ss_pred             cccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeee
Q 040242          173 NISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS  252 (662)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFs  252 (662)
                      ..+.+|                 ++.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+.+||++||||||
T Consensus       148 ~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~~~VGFS  208 (252)
T 1fat_A          148 IKTTRW-----------------DFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTSFIVSDTVDLKSVLPEWVSVGFS  208 (252)
T ss_dssp             SEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             cceecc-----------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCcceEEEEechHHhCCCceEEEEE
Confidence            887654                 367899999999999999999999987653  4568999999999999999999999


Q ss_pred             ccCCcc---cceeEEecceeeec
Q 040242          253 ASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       253 astG~~---~~~~~i~sW~f~~~  272 (662)
                      |+||..   .|.|+|++|+|+..
T Consensus       209 AsTG~~~~~~~~H~IlsWsF~s~  231 (252)
T 1fat_A          209 ATTGINKGNVETNDVLSWSFASK  231 (252)
T ss_dssp             EEECSSTTBCCCCEEEEEEEEEE
T ss_pred             eccCCCCcccceEEEEEEEEEee
Confidence            999999   99999999999875

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=3.8e-58  Score=456.69  Aligned_cols=220  Identities=25%  Similarity=0.363  Sum_probs=197.6

Q ss_pred             CceeEEeCCC----C--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceee
Q 040242           19 ETNSFIYNGF----I--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTAL   86 (662)
Q Consensus        19 ~~~~f~~~~f----~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~   86 (662)
                      ++++|+|++|    .  ..||+|+|+|.+. +|.|+||++.      .+++|||+|++||+||         + ++++++
T Consensus         2 ~~~~F~f~~F~~~~~~~~~~l~l~GdA~i~-~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------~-~tg~va   70 (243)
T 1gsl_A            2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLW---------D-STGKAA   70 (243)
T ss_dssp             CCCEEEESCCCCTTCCTTSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECB---------C-TTSCBC
T ss_pred             cceEEEcCCCccccCCCCCCEEEccceEec-CCcEEecCCccCCcccCCCeEEEEECCCEEcc---------C-CCCCcC
Confidence            4679999999    6  5799999999998 8999999876      5799999999999999         6 667778


Q ss_pred             eeEEEEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCC-CCCCCcEEEEEeeccCCCCCCCCCCCeeEE
Q 040242           87 TFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSN-AKFSTRILAVEFDAVQNLELQDINDNHVGI  165 (662)
Q Consensus        87 sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgi  165 (662)
                      ||+|+|+|+|.++ ...+||||||||+|....| ++.|+||||++.+++ +++.|++|||||||++|.+|+||++|||||
T Consensus        71 sFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFDT~~N~~~~Dp~~nHvGI  148 (243)
T 1gsl_A           71 SFYTSFTFLLKNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGI  148 (243)
T ss_dssp             EEEEEEEEEEEES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEE
T ss_pred             ceEEEEEEEEecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEeccccccccCCCCCCceee
Confidence            8999999999987 6778999999999987544 488999999988754 678899999999999999888999999999


Q ss_pred             ecCCCcccccccccccccCCCCCCCCCcceeecC---CCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccc
Q 040242          166 DISSLISNISEPAAYYFSKGSNINDDNISVVLKS---GDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATV  242 (662)
Q Consensus       166 d~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~---g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~  242 (662)
                      |+||+.|..+.+|                 ++.+   |+.++|||+||+.+++|+|+|++.+.   ..|+|++.+||+.+
T Consensus       149 dvns~~S~~~~~~-----------------~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~~~ls~~vdL~~~  208 (243)
T 1gsl_A          149 DVNSIVSVATTRW-----------------ENDDAYGSSIATAHITYDARSKILTVLLSYEHG---RDYILSHVVDLAKV  208 (243)
T ss_dssp             EESSSSCSEEEEC-----------------CHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CEEEEEEECCHHHH
T ss_pred             ccCCccccceeee-----------------EEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---CceeEEEEechHHh
Confidence            9999999887765                 2556   99999999999999999999987654   46899999999999


Q ss_pred             cccceEEeeeccCCcccceeEEecceeeec
Q 040242          243 LDEYMYVGFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       243 l~~~~~vGFsastG~~~~~~~i~sW~f~~~  272 (662)
                      ||++|||||||+|| ..|.|+|++|+|++.
T Consensus       209 l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~  237 (243)
T 1gsl_A          209 LPQKVRIGFSAGVG-YDEVTYILSWHFFST  237 (243)
T ss_dssp             SCSEEEEEEEEEEC-BSEEEEEEEEEEEEE
T ss_pred             CCCceEEEEEeccC-CcceeEEEEEEEEee
Confidence            99999999999999 999999999999875

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=3.8e-58  Score=454.37  Aligned_cols=220  Identities=30%  Similarity=0.481  Sum_probs=197.0

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      .+++|+|++|.  +.||+|+|+|.+.++|.|+||++.     .++.|||+|++||+||         +.++  ++||+|+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pi~l~---------d~~~--~~sFsT~   70 (233)
T 1n47_A            2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH---------DNTT--LASFTTS   70 (233)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECB---------CSSC--BCEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEccceEEccCCcEEeccCcCCCccCCCeEEEEECCCEecc---------CCCC--cCCEEEE
Confidence            46799999998  679999999999878999999876     4799999999999999         4444  7899999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCc
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLI  171 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~  171 (662)
                      |+|+|.+++...+||||||||+|....|. +.|+||||++.+ +++..+|+|||||||++|.  +||++||||||+||+.
T Consensus        71 F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~n~~vAVEFDT~~N~--~Dp~~nHvGIdvns~~  146 (233)
T 1n47_A           71 FSFVMAAPAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADR-AHDASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIE  146 (233)
T ss_dssp             EEEECCCSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSS-SCCGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSS
T ss_pred             EEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCccCceEEEEeccccCC--CCCCCCcEEEccCCcc
Confidence            99999988767789999999999876654 889999999976 4577899999999999997  6999999999999999


Q ss_pred             ccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEee
Q 040242          172 SNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       172 s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      |..+.+|                 ++.+|+.++|||+||+.+++|+|++++.+.+  ..|+|++.+||+.+||++|||||
T Consensus       147 S~~~~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~~~~~vGF  207 (233)
T 1n47_A          147 SKKTTPF-----------------DMVYGEKANIVITYQASTKALAASLVFPVSQ--TSYAVSARVDLRDILPEYVRVGF  207 (233)
T ss_dssp             CSEEEEC-----------------CCCTTSCEEEEEEEETTTTEEEEEEEETTTT--EEEEEEEECCGGGTSCSEEEEEE
T ss_pred             ccccccc-----------------cccCCCEEEEEEEEeCCCCEEEEEEecCCCC--CcceEEEEechHHhCCCceEEEE
Confidence            9877654                 3678999999999999999999999876533  46899999999999999999999


Q ss_pred             eccCCcc---cceeEEecceeeec
Q 040242          252 SASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       252 sastG~~---~~~~~i~sW~f~~~  272 (662)
                      ||+||..   .|.|+|++|+|+..
T Consensus       208 SAsTG~~~~~~~~h~IlsWsF~s~  231 (233)
T 1n47_A          208 SATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EeccCCCccccceeEEEEEEEEee
Confidence            9999998   99999999999864

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=8e-58  Score=453.51  Aligned_cols=219  Identities=29%  Similarity=0.431  Sum_probs=196.2

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      +.++|+|++|.  ..||+|+|+|.+.++|.|+||++.     .+++|||+|++||+||         +.++++++||+|+
T Consensus         2 ~~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~tg~vaSFsT~   72 (242)
T 1wbf_A            2 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW---------DSTTGNVASFETR   72 (242)
T ss_dssp             CEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEccceEEccCCcEEecCcccCCcccCCeEEEEECCCEecc---------cCCCCCeeeEEEE
Confidence            46799999998  689999999999878999999876     6799999999999999         5566777889999


Q ss_pred             EEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           92 FVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        92 F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      |+|+|.++ +...+||||||||+|....| ++.|+||||+|.+    +.+|+|||||||++|.  +||++||||||+||+
T Consensus        73 F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFDT~~N~--~Dp~~nHVGIdvNs~  145 (242)
T 1wbf_A           73 FSFSIRQPFPRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSV  145 (242)
T ss_dssp             EEEECCCSCCSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSS
T ss_pred             EEEEEeCCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEeccccCC--CCCCCCeEEEECCCc
Confidence            99999887 56778999999999987544 4789999999864    6789999999999997  699999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEe
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG  250 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vG  250 (662)
                      .|..+.+|                 +|.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+.+||++||||
T Consensus       146 ~S~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VG  206 (242)
T 1wbf_A          146 ISTKTVPF-----------------TLDNGGIANVVIKYDASTKILHVVLVFPSL--GTIYTIADIVDLKQVLPESVNVG  206 (242)
T ss_dssp             SCSEEEEC-----------------CCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSCSEEEEE
T ss_pred             cccceeee-----------------EecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCcceEEEEechHHhcCCceEEE
Confidence            99877654                 377999999999999999999999987653  45689999999999999999999


Q ss_pred             eeccC----Ccc---cceeEEecceeeec
Q 040242          251 FSAST----GLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       251 Fsast----G~~---~~~~~i~sW~f~~~  272 (662)
                      |||||    |..   .|.|+|++|+|+..
T Consensus       207 FSAsTg~~~G~~~~~~~~h~IlsWsF~s~  235 (242)
T 1wbf_A          207 FSAATGDPSGKQRNATETHDILSWSFSAS  235 (242)
T ss_dssp             EEEEECCGGGCCTTCCCCCEEEEEEEEEE
T ss_pred             EEEeecCcCCccccccceEEEEEEEeEec
Confidence            99999    888   89999999999875

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=1.5e-57  Score=451.41  Aligned_cols=218  Identities=27%  Similarity=0.435  Sum_probs=195.9

Q ss_pred             ceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           20 TNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        20 ~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      .++|+|++|.  ..||+|+|+|.+.++|.|+||++.      .++.|||+|++||+||         +.++++++||+|+
T Consensus         2 ~~~F~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------d~~~g~vasFsT~   72 (238)
T 1f9k_A            2 TQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIW---------DSTTGNVASFETR   72 (238)
T ss_dssp             EEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             CeEEEcCCCCCCCCCeEEccceEECcCCcEEecCccccCccccCCEEEEEECCCEEee---------cCCCCCeeeEEEE
Confidence            5789999998  679999999999878999999876      5799999999999999         5666777889999


Q ss_pred             EEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           92 FVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        92 F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      |+|+|.++ +...+||||||||+|....| ++.|+||||+|.+   ++ +++|||||||++|.  +||++||||||+|++
T Consensus        73 F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFDT~~N~--~Dp~~nHVgIdvns~  145 (238)
T 1f9k_A           73 FSFNITQPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFDTFQNT--WDPQVPHIGIDVNSI  145 (238)
T ss_dssp             EEEEEECCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEECSCCT--TCCSSSEEEEEESSS
T ss_pred             EEEEEecCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEecccCC--CCCCCCeEEEecCCc
Confidence            99999987 66778999999999987544 5889999999875   45 89999999999997  699999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeeccccccccc--ceE
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDE--YMY  248 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~--~~~  248 (662)
                      .|..+.+|                 +|.+|+.++|||+||+.+++|+|++++.+.  |..|+|++.+||+.+||+  +||
T Consensus       146 ~S~~s~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~~~~~~~  206 (238)
T 1f9k_A          146 VSSKTLHF-----------------QLENGGVANVVIKYDSPTKILNVVLAFHSV--GTVYTLSNIVDLKQEFPNSEWVN  206 (238)
T ss_dssp             SCSEEEEC-----------------CCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEEEEEEEECCHHHHSTTCSEEE
T ss_pred             cccceEee-----------------cccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCceeEEEEechHHhCCCCceEE
Confidence            99877654                 377999999999999999999999987653  456899999999999999  999


Q ss_pred             EeeeccCCcc---cceeEEecceeeec
Q 040242          249 VGFSASTGLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       249 vGFsastG~~---~~~~~i~sW~f~~~  272 (662)
                      ||||||||..   .|.|+|++|+|+..
T Consensus       207 vGFSAsTG~~~~~~~~h~IlsWsF~s~  233 (238)
T 1f9k_A          207 VGLSATTGYQKNAVETHEIISWSFTSS  233 (238)
T ss_dssp             EEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred             EEEEeCcCCCCcccceEEEEEeEeEee
Confidence            9999999999   99999999999875

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=9.3e-58  Score=448.93  Aligned_cols=217  Identities=32%  Similarity=0.489  Sum_probs=194.5

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCC---CCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSND---QGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFS   95 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~   95 (662)
                      ..++|+|++|.++||+|+|+|.+.++|.|+||++   ..+++|||+|++||+||         +.++++++||+|+|+|+
T Consensus         2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~Gra~y~~Pv~l~---------~~~~g~vaSFsT~F~F~   72 (226)
T 1avb_A            2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN---------DRTIDNLASFSTNFTFR   72 (226)
T ss_dssp             EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECE---------EGGGTEEEEEEEEEEEE
T ss_pred             cceEEEcCCCCccCEEEeccEEECCCCEEEeCCCCCCccCCeEEEEeCCCEEee---------cCCCCCcccEEEEEEEE
Confidence            4578999999989999999999987899999998   77899999999999999         55566778899999999


Q ss_pred             EecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccc
Q 040242           96 IVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNIS  175 (662)
Q Consensus        96 i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~  175 (662)
                      |.+++...+||||||||+|....|. +.|+||||+|.+ +++..+|+|||||||+         +||||||+||+.|..+
T Consensus        73 I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~S~~t  141 (226)
T 1avb_A           73 INAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDTV---------SNRIEIDVNSIRPIAT  141 (226)
T ss_dssp             EEESSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSSCSEE
T ss_pred             EeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecCc---------CCccceeecCcccCcc
Confidence            9988777899999999999876665 889999999975 4567899999999998         6999999999999988


Q ss_pred             ccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccC
Q 040242          176 EPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST  255 (662)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast  255 (662)
                      ++|.               ..|.+|+.++|||+||+.+++|+|++++.+.+  +.|+|++.+||+++||++|||||||+|
T Consensus       142 ~~~~---------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~~~ls~~vdL~~~l~e~~~VGFSAsT  204 (226)
T 1avb_A          142 ESCN---------------FGHNNGEKAEVRITYDSPKNDLRVSLLYPSSE--EKCHVSATVPLEKEVEDWVSVGFSATS  204 (226)
T ss_dssp             EECC---------------SGGGTTCEEEEEEEEEGGGTEEEEEEEETTTT--EEEEEEEECCHHHHSCSEEEEEEEEEE
T ss_pred             ccCC---------------ccccCCCeEEEEEEEeCCCcEEEEEEeecCCC--ccceEEEEechHHhCCCceEEEEEecc
Confidence            7653               35679999999999999999999999876543  378999999999999999999999999


Q ss_pred             Ccc---cceeEEecceeeec
Q 040242          256 GLL---TAFHNVHGWSFKIG  272 (662)
Q Consensus       256 G~~---~~~~~i~sW~f~~~  272 (662)
                      |..   .|.|+|++|+|+..
T Consensus       205 G~~~~~~~~h~IlsWsF~s~  224 (226)
T 1avb_A          205 GSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             CSSGGGCEEEEEEEEEEEEE
T ss_pred             CCCCcccceeEEEEEEEEee
Confidence            999   99999999999853

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=1e-56  Score=445.03  Aligned_cols=216  Identities=29%  Similarity=0.471  Sum_probs=193.7

Q ss_pred             CceeEEeCCCCCCC-eeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFIQAN-LSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~~~~-~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ..++|+|++|.+.| |+|+|+|.+.++|.|+||++..      ++.|||+|++||+||         +.+  +++||+|+
T Consensus         2 ~~~~F~f~~F~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~s~Gra~y~~Pi~l~---------d~~--~vaSFsT~   70 (240)
T 1ioa_A            2 TETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK---------DSN--NVASFNTN   70 (240)
T ss_dssp             CCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECB---------CSS--CBEEEEEE
T ss_pred             cceEEEcCCCCCCCcEEEccceEECCCCeEEeCCCCCCCccccCceEEEEECCCEEcc---------CCC--ccccEEEE
Confidence            46799999999999 9999999998789999998775      799999999999999         444  78899999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCc
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLI  171 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~  171 (662)
                      |+|+|.+++...+||||||||+|....|. +.|+||||+|.+ ++++.+|+|||||||+         +||||||+||+.
T Consensus        71 F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT~---------~nHVGIdvNs~~  139 (240)
T 1ioa_A           71 FTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNTF---------KNRIDFDKNFIK  139 (240)
T ss_dssp             EEEECCBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEETT---------TTEEEEEESSSS
T ss_pred             EEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecCc---------CCceeeeeCCcc
Confidence            99999988777899999999999876665 889999999875 4567899999999998         599999999999


Q ss_pred             ccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEee
Q 040242          172 SNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       172 s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      |..+++|.               ..|.+|+.++|||+||+.+++|+|++++.+.  ++.|+|++.+||+++||++|||||
T Consensus       140 S~~t~~~~---------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdL~~~l~e~v~VGF  202 (240)
T 1ioa_A          140 PYVNENCD---------------FHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVKCSVSATVHLEKEVDEWVSVGF  202 (240)
T ss_dssp             CSEEEECC---------------HHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCEEEEEEECCGGGTSCSEEEEEE
T ss_pred             ccccccCC---------------ccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CccceeEEEechHHhCCCceEEEE
Confidence            99887663               4567999999999999999999999987654  347899999999999999999999


Q ss_pred             eccCCcc---cceeEEecceeeecC
Q 040242          252 SASTGLL---TAFHNVHGWSFKIGG  273 (662)
Q Consensus       252 sastG~~---~~~~~i~sW~f~~~~  273 (662)
                      ||+||..   .|.|+|++|+|+...
T Consensus       203 SAsTG~~~~~~~~H~IlsWsF~s~~  227 (240)
T 1ioa_A          203 SPTSGLTEDTTETHDVLSWSFSSKF  227 (240)
T ss_dssp             EEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred             EeccCCCCcccceeEEEEEEEEeeC
Confidence            9999999   999999999998753

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=7.2e-53  Score=411.80  Aligned_cols=200  Identities=28%  Similarity=0.438  Sum_probs=173.9

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEec
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVP   98 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~   98 (662)
                      ..++|+|++|.++||+|+|+|.+.++|.|+||++..++.|||+|++||+||         +.++++++||+|+|+|+|.+
T Consensus         2 ~~~~F~f~~F~~~~l~l~G~A~v~~~g~l~LT~~~~~~~Gra~y~~Pi~l~---------~~~~g~vaSFsT~F~F~I~~   72 (223)
T 1dhk_B            2 TETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR---------DSTTGNVASFDTNFTMNIRT   72 (223)
T ss_dssp             CCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESE---------ETTTTEECEEEEEEEEEEEC
T ss_pred             cceEEEcCCCCcCCEEEeccEEECCCCEEEcCCCCCCCEEEEEECCCEEee---------cCCCCCccceEEEEEEEEeC
Confidence            467999999998999999999998789999999988999999999999999         56677788899999999998


Q ss_pred             CCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccc
Q 040242           99 KYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPA  178 (662)
Q Consensus        99 ~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~  178 (662)
                      ++...+||||||||+|....|.                   +++|||||||+         +||||||+||+ |..+++|
T Consensus        73 ~~~~~~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT~---------~nHVGIdvNsi-S~~~~~~  123 (223)
T 1dhk_B           73 HRQANSAVGLDFVLVPVQPESK-------------------GDTVTVEFDTF---------LSRISIDVNNN-DIKSVPW  123 (223)
T ss_dssp             CC---CCSEEEEEEEEC-------------------------CCEEEEEETT---------TTEEEEEETTE-EEEEEEC
T ss_pred             CCCCCCCCceEEEEecCCCCCC-------------------ccEEEEEecCC---------CCcccccCCcc-ccccccC
Confidence            8777899999999999764321                   24799999998         59999999999 9887765


Q ss_pred             cccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccCCcc
Q 040242          179 AYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLL  258 (662)
Q Consensus       179 ~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~  258 (662)
                      .               ..|.+|+.++|||+||+.+++|+|++++.+.  ++.|+|++.+||+++||++|||||||+||..
T Consensus       124 ~---------------~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~  186 (223)
T 1dhk_B          124 D---------------VHDYDGQNAEVRITYNSSTKVFSVSLSNPST--GKSNNVSTTVELEKEVYDWVSVGFSATSGAY  186 (223)
T ss_dssp             C---------------GGGTTTSCEEEEEEEETTTTEEEEEEECTTT--CCEEEEEEECCCCSGGGSEEEEEEEEEECSG
T ss_pred             C---------------ccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CccceEEEEechHHhCCCceEEEEEeccCCC
Confidence            2               3567999999999999999999999987653  3478999999999999999999999999999


Q ss_pred             ---cceeEEecceeeecC
Q 040242          259 ---TAFHNVHGWSFKIGG  273 (662)
Q Consensus       259 ---~~~~~i~sW~f~~~~  273 (662)
                         .|.|+|++|+|+...
T Consensus       187 ~~~~~~H~IlsWsF~s~~  204 (223)
T 1dhk_B          187 QWSYETHDVLSWSFSSKF  204 (223)
T ss_dssp             GGSCCEEEEEEEEEEEEC
T ss_pred             ccccceEEEEEEEEEecc
Confidence               999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-53  Score=445.97  Aligned_cols=264  Identities=26%  Similarity=0.399  Sum_probs=211.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...++||+|+||+||+|++.     .++..||||++........++|.+|+++|++++|||||+++|+|.+.+.++|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45667789999999999999874     3578899999988777778899999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhccccccc----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          430 VYDYVPNGSLDKLLFDNDQQ----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      |||||++|+|.++|+.....          ....++|.+++.++.|||+||+|||+   .+|+||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcE
Confidence            99999999999999764321          23569999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       500 kL~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.||......   .+...+.
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~  274 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT---EAIDCIT  274 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH---HHHHHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH---HHHHHHH
Confidence            999999999764432 223344679999999999999999999999999999999999 89999865432   1222221


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                          ++.     .+   ..+...+..+.+|+.+||+.||++||||.||+++|+...+.|
T Consensus       275 ----~g~-----~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          275 ----QGR-----EL---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             ----HTC-----CC---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             ----cCC-----CC---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence                121     11   122334567889999999999999999999999998765544

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.4e-53  Score=439.60  Aligned_cols=260  Identities=26%  Similarity=0.427  Sum_probs=214.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...+.||+|+||+||+|++.     .++..||||+++.......++|.+|+++|++++|||||+++|+|.+++.+++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            46777899999999999999874     3578899999988777778899999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc--------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          430 VYDYVPNGSLDKLLFDNDQ--------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      |||||++|+|.++|+....        .....++|.++++++.|||+||.|||+   ++|+||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEE
Confidence            9999999999999975421        123569999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       502 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||......   .+...+.  
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~---~~~~~i~--  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EVIECIT--  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH---HHHHHHH--
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH--
Confidence            999999876443221 2223568999999999999999999999999999999999 89999865432   1222221  


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .+..        ...+...+..+.+|+.+||+.||++||||+||++.|++.
T Consensus       245 --~~~~--------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          245 --QGRV--------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             --HTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              1211        112334456788999999999999999999999999764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-52  Score=433.08  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=208.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +++...++||+|+||+||+|++.+   .||||+++..  ..+..++|.+|+.++++++|||||+++|+|.+ +.++||||
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE  111 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ  111 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence            456778999999999999999843   5999998643  44566889999999999999999999999865 56899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++|+|.++|+..    ...++|.+++.++.|||+||+|||+   ++|+||||||+||||++++.+||+|||+|+....
T Consensus       112 y~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  184 (307)
T 3omv_A          112 WCEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR  184 (307)
T ss_dssp             CCSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred             cCCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence            99999999999654    3569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CC-CCcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          513 NI-NPQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       513 ~~-~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .. ........||+.|||||++.+   +.++.++|||||||+||||+||+.||.........      ......    ..
T Consensus       185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~------~~~~~~----~~  254 (307)
T 3omv_A          185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGR----GY  254 (307)
T ss_dssp             ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHT----TC
T ss_pred             CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH------HHHHhc----CC
Confidence            32 223445689999999999853   46899999999999999999999999765432211      111111    12


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC-CCCCC
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD-ASLPQ  637 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~-~~~p~  637 (662)
                      ..|.+.......+..+.+|+.+||+.||++||||.||+++|+.. .++|.
T Consensus       255 ~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          255 ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence            23333344445667788999999999999999999999998753 34444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.3e-52  Score=437.15  Aligned_cols=260  Identities=26%  Similarity=0.371  Sum_probs=212.5

Q ss_pred             CCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++..+.||+|+||+||+|.+.     .+++.||||++.... ....++|.+|+.++++++|||||+++|+|.+.+.+++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l  106 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM  106 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence            3555788999999999999974     356789999997543 3446789999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          430 VYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      |||||++|+|.++|.....           .....++|.++++++.|||+||+|||+   .+|+||||||+||||++++.
T Consensus       107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGC
T ss_pred             EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCC
Confidence            9999999999999965321           123569999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~  576 (662)
                      +||+|||+++...... ........||+.|||||++.++.++.++|||||||+||||+| |+.||......   .+...+
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~~~~~i  260 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---DVVEMI  260 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---HHHHHH
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---HHHHHH
Confidence            9999999998764432 223345679999999999999999999999999999999998 89999865432   122222


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                          ..+..        ...+...+..+.+|+.+||+.||++||||.||+++|+.-.
T Consensus       261 ----~~~~~--------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          261 ----RNRQV--------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             ----HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ----HcCCC--------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                12211        1123345567889999999999999999999999998643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.1e-51  Score=432.63  Aligned_cols=252  Identities=23%  Similarity=0.397  Sum_probs=206.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|++..+|+.||||++...  .....+.|.+|+.++++++|||||++++++.+++.+|+|||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6799999999999999999999999999999999764  34456789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++|+|.++|....   ...+++.+.+.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++....
T Consensus       104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            999999999996442   4557889999999999999999999   8999999999999999999999999999997643


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .. ......+||+.|||||++.+..++.++|||||||+||||+||+.||.......   +   +.... .+..     +.
T Consensus       178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i~-~~~~-----~~  244 (350)
T 4b9d_A          178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---L---VLKII-SGSF-----PP  244 (350)
T ss_dssp             HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHH-HTCC-----CC
T ss_pred             Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHHHH-cCCC-----CC
Confidence            21 12234679999999999999999999999999999999999999998654321   1   11111 1111     11


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         .+......+.+|+.+||+.||++|||+.|++++
T Consensus       245 ---~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          245 ---VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             ---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               122334568889999999999999999999874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-50  Score=426.08  Aligned_cols=256  Identities=24%  Similarity=0.359  Sum_probs=215.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +.|+..++||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++..++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            45888899999999999999999999999999997765555667899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++..      ..+++.+...++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++.+....
T Consensus       154 ~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          154 EGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             TTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            99999999842      458999999999999999999999   899999999999999999999999999999775442


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       ......+||+.|||||++.+..++.++|||||||++|||++|+.||.......   +...+.         +...+.+.
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~---------~~~~~~~~  291 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR---------DNLPPRLK  291 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH---------HSSCCCCS
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH---------cCCCCCCC
Confidence             23345689999999999999999999999999999999999999998654321   111111         11122221


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDA  633 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~  633 (662)
                       ........+.+|+.+||+.||++|||+.|++++  +.+..
T Consensus       292 -~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          292 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             -CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence             122345678889999999999999999999984  55443

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.5e-50  Score=420.69  Aligned_cols=251  Identities=25%  Similarity=0.277  Sum_probs=206.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +.|...++||+|+||+||+|+++.+|+.||||+++....     ..+|+.++++++|||||++++++.+++.+|||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  132 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL  132 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence            567788899999999999999999999999999976432     246999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccccccCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAYDHN  513 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~~~~  513 (662)
                      ++|+|.++|.+     ...+++.+...++.||++||.|||+   .+|+||||||+||||+.++ .+||+|||+++.....
T Consensus       133 ~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          133 EGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             TTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             CCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            99999999953     3569999999999999999999999   8999999999999999988 5999999999977543


Q ss_pred             CCC----cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          514 INP----QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       514 ~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ...    .....+||+.|||||++.+..++.++|||||||++|||+||+.||.........   ..+.   ..       
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~---~~i~---~~-------  271 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC---LKIA---SE-------  271 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH---HHHH---HS-------
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHH---cC-------
Confidence            221    122357999999999999999999999999999999999999999765432111   1111   11       


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .+.+...++.....+.+++.+||+.||.+|||+.|++++|..
T Consensus       272 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          272 PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            111112333455678889999999999999999999998854

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.4e-50  Score=411.14  Aligned_cols=246  Identities=26%  Similarity=0.398  Sum_probs=199.9

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec----cCeeeEEE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELLLVY  431 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV~  431 (662)
                      +..+.||+|+||+||+|.+..++..||||++...  .....+.|.+|+.++++++|||||++++++..    ++.+++||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5567899999999999999999999999999654  34456789999999999999999999999865    34689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeC-CCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLID-ADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfGla~  508 (662)
                      |||++|+|.++|.+     ...+++..+..++.||++||+|||+   .+  |+||||||+||||+ .++.+||+|||+|+
T Consensus       109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            99999999999953     3569999999999999999999998   55  99999999999998 47999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ....   ......+||+.|||||++.+ .++.++|||||||+||||+||+.||........  +.    .....+.    
T Consensus       181 ~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~~----~~i~~~~----  246 (290)
T 3fpq_A          181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY----RRVTSGV----  246 (290)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH----HHHTTTC----
T ss_pred             eCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--HH----HHHHcCC----
Confidence            6433   23445689999999998865 699999999999999999999999975433221  11    1111111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .+.  ..+......+.+|+.+||+.||++|||+.|++++
T Consensus       247 -~~~--~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          247 -KPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -CCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCC--CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111  1111223457889999999999999999999874

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3e-50  Score=419.53  Aligned_cols=265  Identities=25%  Similarity=0.328  Sum_probs=202.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC----eeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----ELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~lV  430 (662)
                      ++|...++||+|+||+||+|++  +|+.||||++...... ...+..|+..+.+++|||||+++++|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4567789999999999999998  5889999999654332 223456777778899999999999998764    57999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC-----CCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC-----DQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ||||++|+|.++|+.      ..++|..+++++.|+++||+|||+.+     .++|+||||||+||||+.++++||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             ecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence            999999999999953      45899999999999999999999842     2489999999999999999999999999


Q ss_pred             ccccccCCCCC---cceecccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHcCCCCCCcccchhh----H--
Q 040242          506 LARAYDHNINP---QTTHIVGTLGYLAPELTRTG------KATTSTDVFGFGTLMLEVACGRRPIEPQRTAME----L--  570 (662)
Q Consensus       506 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----~--  570 (662)
                      +++........   ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+........    .  
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99877554322   22345799999999998654      367899999999999999999887653221100    0  


Q ss_pred             --HHHHHHHHHhhcCccccccCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          571 --VLVDWVRELHSQGQITRAIDPTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       571 --~l~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .....+....    ..+.++|.+.  ....+..+.+.+|+.+||+.||++||||.||++.|++.
T Consensus       234 ~~~~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          234 SDPSVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence              0011111111    1223344442  12345677899999999999999999999999999754

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-50  Score=415.88  Aligned_cols=260  Identities=22%  Similarity=0.307  Sum_probs=215.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||+||+|+.+.+|+.||||++.+.   .....+.+.+|++++++++|||||++++++++++.+|+||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4688999999999999999999999999999999764   2344678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|.++|.+     ...+++.+...++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.+.
T Consensus       112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            99999999999953     3569999999999999999999999   899999999999999999999999999999875


Q ss_pred             CCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... .......+||+.|||||++.+..++.++||||+||+||||+||+.||......   .+...+.    .+.      
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~----~~~------  250 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKII----KLE------  250 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HTC------
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH----cCC------
Confidence            432 23345578999999999999989999999999999999999999999865422   1111111    111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQA  638 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~  638 (662)
                      ..+   +......+.+|+.+||+.||++|||++|++.+  |.++..+...
T Consensus       251 ~~~---p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i  297 (311)
T 4aw0_A          251 YDF---PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  297 (311)
T ss_dssp             CCC---CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCC---CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence            111   22234567889999999999999999997532  4444444333

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-49  Score=427.32  Aligned_cols=255  Identities=24%  Similarity=0.360  Sum_probs=215.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +.|+..+.||+|+||+||+|+++.+|+.||||++........+.+.+|+.+|++++|||||++++++...+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56899999999999999999999999999999998765555667899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++.      ...+++.+...++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++.+....
T Consensus       231 ~gG~L~~~i~------~~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          231 EGGALTDIVT------HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             TTEEHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCcHHHHHh------ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            9999999984      3458999999999999999999999   899999999999999999999999999999775542


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       ......+||+.|||||++.+..++.++|||||||++|||++|+.||.......   +...+.         +...+.+.
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~---------~~~~~~~~  368 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR---------DNLPPRLK  368 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH---------HSCCCCCS
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH---------cCCCCCCc
Confidence             23345689999999999999999999999999999999999999997654321   111111         11122221


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRD  632 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  632 (662)
                       ........+.+|+.+||+.||++|||+.|++++  |.+.
T Consensus       369 -~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          369 -NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             -CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             -ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence             112334567889999999999999999999984  5544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=8.3e-50  Score=423.27  Aligned_cols=264  Identities=22%  Similarity=0.339  Sum_probs=213.5

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCC-----CcEEEEEEeeccc-hhhHHHHHHHHHHhhcccc-ccceeeeeeEecc
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPST-----GLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQ  424 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~-----g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~  424 (662)
                      ...++|+..+.||+|+||+||+|.+...     ++.||||++.... ....++|.+|+.+|.+++| ||||+++|+|.+.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~  140 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP  140 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence            3457889999999999999999997543     3679999997653 3446789999999999965 8999999999764


Q ss_pred             -CeeeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceE
Q 040242          425 -DELLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       425 -~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  492 (662)
                       +.+++|||||++|+|.++|+.....           ....|+|.+++.++.|||+||+|||+   ++|+||||||+|||
T Consensus       141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL  217 (353)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCcccee
Confidence             5789999999999999999754321           13459999999999999999999999   89999999999999


Q ss_pred             eCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhH
Q 040242          493 IDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMEL  570 (662)
Q Consensus       493 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~  570 (662)
                      |++++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||........ 
T Consensus       218 l~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~-  296 (353)
T 4ase_A          218 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-  296 (353)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH-
T ss_pred             eCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence            999999999999999976544322 2334679999999999999999999999999999999998 9999976543211 


Q ss_pred             HHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       571 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       +.    ....++.     .+.   .+......+.+++.+||+.||++|||+.||+++|+..
T Consensus       297 -~~----~~i~~g~-----~~~---~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          297 -FC----RRLKEGT-----RMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             -HH----HHHHHTC-----CCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HH----HHHHcCC-----CCC---CCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence             11    1112221     111   1223345688899999999999999999999998753

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=1.4e-48  Score=368.74  Aligned_cols=174  Identities=27%  Similarity=0.447  Sum_probs=156.7

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSI   96 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i   96 (662)
                      .+++|+|++|.  +.||+|+|+|. .++|.|+||+...+++|||+|++||+||         +.++++++||+|+|+|.|
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~-~~~g~l~LT~~~~~~~Gra~y~~Pv~l~---------d~~tg~vaSFsT~F~F~I   71 (181)
T 2ltn_A            2 ETTSFLITKFSPDQQNLIFQGDGY-TTKEKLTLTKAVKNTVGRALYSSPIHIW---------DRETGNVANFVTSFTFVI   71 (181)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCE-ECSSSEEEECSCSSCEEEEEESSCEECB---------CTTTCCBCEEEEEEEEEE
T ss_pred             cceEEEcCCCCCCCCCEEEecccc-CCCCCeEcCCCCCCCEEEEEECCCEEee---------cCCCCCccceEEEEEEEE
Confidence            46799999998  68999999999 6789999999988999999999999999         556677788999999999


Q ss_pred             ecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCC--CCeeEEecCCCcccc
Q 040242           97 VPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDIN--DNHVGIDISSLISNI  174 (662)
Q Consensus        97 ~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~--~~Hvgid~ns~~s~~  174 (662)
                      .+++...+||||||||+|....|. +.|+||||+|.+ ++++.+|+|||||||++|.+ +||+  +|||||||||+.|..
T Consensus        72 ~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT~~n~~-~Dp~~~~nHVGIdvNs~~S~~  148 (181)
T 2ltn_A           72 NAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDTFYNAA-WDPSNRDRHIGIDVNSIKSVN  148 (181)
T ss_dssp             ECSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCTTSCCEEEEEECSCCTT-TSCTTCCCEEEEEESSSSCSE
T ss_pred             ecCCCCCCCCceEEEEecCCCCCC-CCCccccccccC-CCCccccEEEEEeccccccc-cCCCCCCCEEEEEcCCccccc
Confidence            988777899999999999876665 889999999876 45778999999999999988 6999  999999999999988


Q ss_pred             cccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEcc
Q 040242          175 SEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISP  222 (662)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~  222 (662)
                      +++|                 ++.+|+.++|||+||+.+++|+|+|++
T Consensus       149 t~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~  179 (181)
T 2ltn_A          149 TKSW-----------------KLQNGEEANVVIAFNAATNVLTVSLTY  179 (181)
T ss_dssp             EEEC-----------------CCCTTCCEEEEEEEETTTTEEEEEEEE
T ss_pred             eecc-----------------ccCCCCEEEEEEEEECCCCEEEEEEec
Confidence            8765                 367999999999999999999999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3.5e-49  Score=403.42  Aligned_cols=247  Identities=26%  Similarity=0.387  Sum_probs=193.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|+...+|+.||||++.+..   ....+.+.+|+.++++++|||||++++++...+.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999997642   334567999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||| +|+|.+++.+     ...+++.+...++.||+.||+|||+   ++|+||||||+|||++.++++||+|||+++...
T Consensus        93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            999 7899998853     3469999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...  .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||......   .+...+    ..+.      
T Consensus       164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i----~~~~------  228 (275)
T 3hyh_A          164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNI----SNGV------  228 (275)
T ss_dssp             -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHTC------
T ss_pred             CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HcCC------
Confidence            432  2334689999999999988765 58999999999999999999999764321   111111    1111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+   +......+.+|+.+||+.||++|||++|++++
T Consensus       229 ~~~---p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          229 YTL---PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             CCC---CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             CCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            111   22234567889999999999999999999984

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.2e-49  Score=407.08  Aligned_cols=248  Identities=23%  Similarity=0.320  Sum_probs=197.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|+||+||+|+..   .+++.||||++.+..  ......+.+|+.++++++|||||++++++..++.+|+
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            56899999999999999999873   457899999996542  2233468889999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |||||++|+|.++|.+     ...+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            9999999999999953     3569999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ..... ......+||+.|||||++.+..++.++||||+||++|||+||+.||.......   +...+.    ++.     
T Consensus       176 ~~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~----~~~-----  242 (304)
T 3ubd_A          176 SIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMIL----KAK-----  242 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCC-----
T ss_pred             ccCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHH----cCC-----
Confidence            54332 22334689999999999999999999999999999999999999998654321   111111    111     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQ  627 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  627 (662)
                       ..   ++......+.+|+.+||+.||++|||     ++|+++
T Consensus       243 -~~---~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          243 -LG---MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -CC---CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -CC---CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence             11   12233456788999999999999998     567765

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.8e-48  Score=402.17  Aligned_cols=252  Identities=22%  Similarity=0.358  Sum_probs=192.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccC--------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--------  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--------  425 (662)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.++++++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            35888999999999999999999999999999997643 344567999999999999999999999987544        


Q ss_pred             ----eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          426 ----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       426 ----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                          .+++|||||++|+|.+++.....  ....++...+.++.||++||+|||+   .+|+||||||+||||+.++.+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEE
Confidence                36999999999999999965432  3345677788999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCC-----------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH
Q 040242          502 GDFGLARAYDHNINP-----------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL  570 (662)
Q Consensus       502 ~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  570 (662)
                      +|||+++........           ..+..+||+.|||||++.+..++.++|||||||++|||++   ||......  .
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~--~  234 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER--V  234 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--H
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH--H
Confidence            999999977543221           1233579999999999999999999999999999999997   77532211  1


Q ss_pred             HHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       571 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   +.. ....        ............+..|+.+||+.||.+|||+.|++++
T Consensus       235 ~~---~~~-~~~~--------~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          235 RT---LTD-VRNL--------KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HH---HHH-HHTT--------CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HH---HHH-HhcC--------CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            10   111 0111        1111112233456789999999999999999999974

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.5e-45  Score=385.80  Aligned_cols=287  Identities=36%  Similarity=0.653  Sum_probs=247.8

Q ss_pred             cccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          343 CRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       343 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      .++.+.++..++++|+..+.||+|+||+||+|.+. ++..||||++........+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            34566677778999999999999999999999974 68899999998776677788999999999999999999999999


Q ss_pred             ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       423 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ..+..++||||+++|+|.+++..... ....++|.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEEC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEe
Confidence            99999999999999999999975432 13469999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          503 DFGLARAYDHNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       503 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      |||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|+.||.............|......
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  261 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN  261 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc
Confidence            999998654322 2223345689999999999888899999999999999999999999986655555556677777777


Q ss_pred             cCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          582 QGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       582 ~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      .+.+.+.+++.+ .....+....+.+++.+||+.||++||++.||+++|+....
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            777888888877 56778889999999999999999999999999999986543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.2e-45  Score=388.72  Aligned_cols=296  Identities=37%  Similarity=0.695  Sum_probs=251.5

Q ss_pred             CccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeee
Q 040242          341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHG  419 (662)
Q Consensus       341 ~~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~  419 (662)
                      ...+|++.++..++++|+..+.||+|+||.||+|... +++.||||++..... .....+.+|+.++++++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3567899999999999999999999999999999874 688999999976532 22336899999999999999999999


Q ss_pred             eEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       420 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      +|...+..++||||+++|+|.+++..... ....++|..++.++.|+++||.|||+.+..+|+||||||+|||++.++.+
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            99999999999999999999999976532 24569999999999999999999999433399999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCccc--chhhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQR--TAMELVLVDWVR  577 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~--~~~~~~l~~~~~  577 (662)
                      ||+|||+++..............||+.|+|||.+.+..++.++|||||||++|||++|+.||....  ......+.+|+.
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            999999999876554444455679999999999988889999999999999999999999996322  122334667877


Q ss_pred             HHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 040242          578 ELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQA  638 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~  638 (662)
                      .......+....+..+ ..+.......+.+++.+||+.||.+|||+.||+++|++.......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~~~  315 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAERW  315 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSSSC
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhhhh
Confidence            7777777777777777 567888999999999999999999999999999999987555443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-45  Score=395.02  Aligned_cols=262  Identities=23%  Similarity=0.359  Sum_probs=204.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec------cCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK------QDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~------~~~  426 (662)
                      ++|+..+.||+|+||+||+|++..+|+.||||++...  .....+.+.+|+.+|++++|||||++++++..      .+.
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999654  23445678999999999999999999998754      357


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      +|+|||||+ |+|.+++..     ...+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecce
Confidence            899999995 789999854     3469999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCC---CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          507 ARAYDHNI---NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       507 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      ++.+....   .......+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.........   +......
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~---I~~~~g~  281 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL---IMMVLGT  281 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH---HHHhcCC
Confidence            98764321   2233456899999999988765 569999999999999999999999987654332221   1111100


Q ss_pred             C--ccc------------cccCCCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 G--QIT------------RAIDPTLD----YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~--~~~------------~~id~~l~----~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .  ...            ..+.+...    ...+.....+.+|+.+||+.||.+|||+.|++++
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0  000            00000000    0001123567889999999999999999999984

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.9e-44  Score=403.53  Aligned_cols=253  Identities=24%  Similarity=0.331  Sum_probs=212.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||+|..+.+|+.||||++........+.+.+|+.+|++++|||||++++++...+.+++|||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999999999999999998776666778899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC--CCeEEeeccccccccC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD--LNPKLGDFGLARAYDH  512 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfGla~~~~~  512 (662)
                      ++|+|.++|...    ...+++.+...++.||++||.|||+   .+|+||||||+|||++.+  +.+||+|||+++.+..
T Consensus       237 ~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~  309 (573)
T 3uto_A          237 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  309 (573)
T ss_dssp             CCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred             CCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence            999999998543    3568999999999999999999999   899999999999999854  8899999999998754


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .  ......+||+.|||||++.+..++.++||||+||++|||++|+.||.........   ..+    .....  .+.+.
T Consensus       310 ~--~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~---~~i----~~~~~--~~~~~  378 (573)
T 3uto_A          310 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL---RNV----KSCDW--NMDDS  378 (573)
T ss_dssp             T--SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHH----HTTCC--CCCSG
T ss_pred             C--CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH---HHH----HhCCC--CCCcc
Confidence            3  2334568999999999999999999999999999999999999999865432211   111    11100  01111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         ........+.+|+.+||+.||.+|||+.|++++
T Consensus       379 ---~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          379 ---AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ---GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               111234567789999999999999999999985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.5e-44  Score=380.74  Aligned_cols=201  Identities=26%  Similarity=0.413  Sum_probs=171.9

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ...++|+..++||+|+||+||+|+.+   .+++.||||++....  ...++.+|+++|.++ +||||+++++++...+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999874   357889999986543  235678999999998 699999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeeccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGL  506 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGl  506 (662)
                      ++|||||++|+|.+++.        .+++.+...++.||++||+|||+   .+|+||||||+|||++.+ +.+||+|||+
T Consensus        96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            99999999999999982        38889999999999999999999   899999999999999877 7899999999


Q ss_pred             cccccCCCC---------------------------CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCC
Q 040242          507 ARAYDHNIN---------------------------PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGR  558 (662)
Q Consensus       507 a~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~  558 (662)
                      |+.......                           ......+||+.|+|||++.+. .++.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            986543211                           112335799999999998765 5899999999999999999999


Q ss_pred             CCCCccc
Q 040242          559 RPIEPQR  565 (662)
Q Consensus       559 ~p~~~~~  565 (662)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9996544

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2.1e-43  Score=396.81  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=203.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHH---HHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMK---EFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~---~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..++||+|+||+||+|+.+.+|+.||||++.+..   .....   ....++.+++.++|||||++++++...+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999999999999999996542   12222   2344567778889999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +|||||+||+|.++|..     ...+++.....++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+|+
T Consensus       269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~  340 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  340 (689)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence            99999999999999953     3568999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .+...   .....+||+.|||||++.. ..++.++||||+||+||||++|+.||..........+...+.   . .    
T Consensus       341 ~~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~---~-~----  409 (689)
T 3v5w_A          341 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-M----  409 (689)
T ss_dssp             ECSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH---H-C----
T ss_pred             ecCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc---C-C----
Confidence            76543   2334689999999999965 468999999999999999999999998654332222111111   0 0    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  627 (662)
                        ...   ++......+.+|+.+||+.||.+|++     +.||++
T Consensus       410 --~~~---~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 --AVE---LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             --CCC---CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             --CCC---CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence              111   22234456788999999999999998     688876

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-43  Score=365.04  Aligned_cols=255  Identities=23%  Similarity=0.400  Sum_probs=212.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...++||+|+||+||+|.+..++..||+|++........+.|.+|+.++++++||||+++++++...+..++||||+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~   89 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI   89 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence            56888999999999999999999899999999997777777889999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus        90 ~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           90 KGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             TTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             CCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999653    3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCc-------------ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH---HHHHHHHH
Q 040242          515 NPQ-------------TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL---VLVDWVRE  578 (662)
Q Consensus       515 ~~~-------------~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~---~l~~~~~~  578 (662)
                      ...             .....||+.|+|||.+.+..++.++|||||||++|||++|..|+.........   ....... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~-  241 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD-  241 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH-
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc-
Confidence            211             11457999999999999999999999999999999999999998653321110   0111110 


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                                  ..   .+......+.+++.+||+.||++||++.++++.|+..
T Consensus       242 ------------~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          242 ------------RY---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ------------HT---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------cc---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                        00   1122234578899999999999999999999988754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-42  Score=362.71  Aligned_cols=267  Identities=27%  Similarity=0.410  Sum_probs=205.9

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ...++|+..+.||+|+||+||+|..  .+..||||++....  ....+++.+|+.++++++||||+++++++...+..++
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence            3456788999999999999999988  57899999986653  4456789999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ||||+++|+|.+++.....  ...+++..++.++.|+++||.|||+   .+  |+||||||+||+++.++.+||+|||++
T Consensus       112 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  186 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS  186 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred             EEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence            9999999999999975432  3459999999999999999999999   77  999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      +...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ..+..   ..    
T Consensus       187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~---~~~~~---~~----  255 (309)
T 3p86_A          187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV---AAVGF---KC----  255 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH---HHHHH---SC----
T ss_pred             ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---cC----
Confidence            8654332 2233457999999999999999999999999999999999999999865432111   11110   00    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPL  640 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~  640 (662)
                          .....+......+.+|+.+||+.||.+||++.++++.|+.......+|+
T Consensus       256 ----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p~~  304 (309)
T 3p86_A          256 ----KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVPPP  304 (309)
T ss_dssp             ----CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC------
T ss_pred             ----CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCCCC
Confidence                0011223344568899999999999999999999999987654444443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-41  Score=355.30  Aligned_cols=281  Identities=35%  Similarity=0.600  Sum_probs=234.0

Q ss_pred             ccccchHHHHHhccCCccc------ceeeeeCceEEEEEEeCCCCcEEEEEEeecc----chhhHHHHHHHHHHhhcccc
Q 040242          342 ACRFRYSELYSATKGFREK------NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN----SRQGMKEFVAEITSMGRLRH  411 (662)
Q Consensus       342 ~~~~~~~el~~at~~f~~~------~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l~H  411 (662)
                      ...|++.++..++++|...      +.||+|+||.||+|..  ++..||||++...    .....+.+.+|+.++++++|
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            4678999999999999988      8999999999999997  5789999998653    23446789999999999999


Q ss_pred             ccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       412 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      |||+++++++...+..++||||+++++|.+++.....  ...+++..++.++.|+++||.|||+   .+++||||||+||
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Ni  164 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANI  164 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHE
Confidence            9999999999999999999999999999999965421  4569999999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH
Q 040242          492 LIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL  570 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  570 (662)
                      +++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........ 
T Consensus       165 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-  242 (307)
T 2nru_A          165 LLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL-  242 (307)
T ss_dssp             EECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB-
T ss_pred             EEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH-
Confidence            9999999999999999876543222 2233578999999998864 578999999999999999999999986543221 


Q ss_pred             HHHHHHHHHhh-cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          571 VLVDWVRELHS-QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       571 ~l~~~~~~~~~-~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       +..+...... ...+.+.+++.+..........+.+++.+||+.||.+||++.+|+++|++.
T Consensus       243 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 -LLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             -TTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -HHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence             1122222222 223445566666667788889999999999999999999999999999764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.4e-42  Score=359.19  Aligned_cols=252  Identities=25%  Similarity=0.392  Sum_probs=212.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||+||+|.+..+++.||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            36799999999999999999999889999999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|+|.+++..      ..+++.++..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus        99 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           99 LAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            999999999843      358899999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .. ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........      .....+      .+.+
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~~~------~~~~  236 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNG------TPEL  236 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHC------SCCC
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCC------CCCC
Confidence            32 2334579999999999999899999999999999999999999997654322111      111111      1111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ..+......+.+++.+||+.||.+|||+.|++++
T Consensus       237 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          237 -QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             -SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -CCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             1123345668899999999999999999999984

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-42  Score=361.47  Aligned_cols=264  Identities=22%  Similarity=0.341  Sum_probs=220.0

Q ss_pred             ccccchHHHHHhccC----------CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc
Q 040242          342 ACRFRYSELYSATKG----------FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH  411 (662)
Q Consensus       342 ~~~~~~~el~~at~~----------f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H  411 (662)
                      +..++++++..+++.          |+..+.||+|+||.||+|....+|+.||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345888898888875          6777899999999999999988899999999987766667889999999999999


Q ss_pred             ccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       412 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      |||+++++++...+..++||||+++++|.+++..      ..+++..+..++.|+++||.|||+   .+|+||||||+||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI  172 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI  172 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence            9999999999999999999999999999999843      358999999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH
Q 040242          492 LIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV  571 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  571 (662)
                      +++.++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---  248 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---  248 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred             EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence            999999999999999987654322 2334579999999999998899999999999999999999999997553321   


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....+..         ...+.+. ........+.+++.+||+.||++||++.|++++
T Consensus       249 ~~~~~~~---------~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          249 AMKRLRD---------SPPPKLK-NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHH---------SSCCCCT-TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhc---------CCCCCcC-ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111111         1111111 122334568889999999999999999999985

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-42  Score=379.93  Aligned_cols=269  Identities=21%  Similarity=0.239  Sum_probs=217.2

Q ss_pred             ccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch---hhHHHHHHHHHHhhccccccceeee
Q 040242          342 ACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR---QGMKEFVAEITSMGRLRHRNLVQLH  418 (662)
Q Consensus       342 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~---~~~~~f~~Ei~~l~~l~H~niv~l~  418 (662)
                      +..+.+.++...+++|+..++||+|+||+||+|++..+++.||||++.+...   .....+.+|+.++.+++||||++++
T Consensus        61 ~~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  140 (437)
T 4aw2_A           61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH  140 (437)
T ss_dssp             HHHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             cccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEE
Confidence            3345677788888999999999999999999999998999999999976422   2233488999999999999999999


Q ss_pred             eeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       419 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      ++|...+.+++|||||++|+|.+++...    ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.
T Consensus       141 ~~~~~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~  213 (437)
T 4aw2_A          141 YAFQDDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGH  213 (437)
T ss_dssp             EEEECSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSC
T ss_pred             EEEeeCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCC
Confidence            9999999999999999999999999653    3568999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV  573 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~  573 (662)
                      +||+|||+++..............||+.|+|||++.     .+.++.++|||||||++|||++|+.||..........  
T Consensus       214 vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~--  291 (437)
T 4aw2_A          214 IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG--  291 (437)
T ss_dssp             EEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--
T ss_pred             EEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH--
Confidence            999999999876554333344468999999999986     5678999999999999999999999998654322111  


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQF  628 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  628 (662)
                       .+.....     ..--|..   .......+.+|+.+||+.+|++  ||+++|++++
T Consensus       292 -~i~~~~~-----~~~~p~~---~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          292 -KIMNHKE-----RFQFPTQ---VTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             -HHHTHHH-----HCCCCSS---CCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             -hhhhccc-----cccCCcc---cccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence             1100000     0001111   1123456778888999888888  9999999985

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-41  Score=353.88  Aligned_cols=260  Identities=23%  Similarity=0.378  Sum_probs=209.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|.+..++..||+|++...   .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            6788999999999999999999889999999998543   3445678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        91 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  162 (294)
T 4eqm_A           91 EYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS  162 (294)
T ss_dssp             ECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred             eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence            99999999999953     3468999999999999999999999   899999999999999999999999999998776


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ...........||+.|+|||.+.+..++.++||||||+++|||++|+.||........      ....... .    . +
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~-~----~-~  230 (294)
T 4eqm_A          163 ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQD-S----V-P  230 (294)
T ss_dssp             ------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSS-C----C-C
T ss_pred             cccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhc-c----C-C
Confidence            5443444456799999999999998999999999999999999999999986543211      1111111 0    0 1


Q ss_pred             CC-CCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCC
Q 040242          592 TL-DYFDPQEAELVLTLGLLCCDPHPDFRP-STRRVVQFLLRDAS  634 (662)
Q Consensus       592 ~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~~~~  634 (662)
                      .. .......+..+.+++.+||+.||.+|| +++++.+.|.....
T Consensus       231 ~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          231 NVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            11 112233456788999999999999999 89999999987644

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=3.6e-42  Score=362.68  Aligned_cols=258  Identities=28%  Similarity=0.419  Sum_probs=209.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC---cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||+||+|.+..++   ..||||++... .....+.|.+|+.++++++||||+++++++...+..++|
T Consensus        49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  128 (325)
T 3kul_A           49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV  128 (325)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred             hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence            56788899999999999999997544   45999999765 444567899999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       129 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          129 TEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             EECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             eeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            9999999999999544    3468999999999999999999999   89999999999999999999999999999977


Q ss_pred             cCCCCCc--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINPQ--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .......  .....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...+    ..+    
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~----  270 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSV----EEG----  270 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHH----HTT----
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcC----
Confidence            5542222  222346778999999988889999999999999999999 999997654321   11111    111    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                       ..   ...+......+.+|+.+||+.||.+||++.+|++.|+....
T Consensus       271 -~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          271 -YR---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             -CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CC---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence             00   11222345678899999999999999999999999987643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=7.2e-42  Score=360.80  Aligned_cols=249  Identities=25%  Similarity=0.376  Sum_probs=209.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999999889999999999764  3445677899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++.+...++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        94 e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  165 (328)
T 3fe3_A           94 EYASGGEVFDYLVA-----HGRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT  165 (328)
T ss_dssp             CCCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred             ECCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence            99999999999853     3458999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCC-cchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKAT-TSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..  .......||+.|+|||.+.+..+. .++||||+||++|||++|+.||.......   +..   .. ..+.      
T Consensus       166 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~---~i-~~~~------  230 (328)
T 3fe3_A          166 VG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE---RV-LRGK------  230 (328)
T ss_dssp             SS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HH-HHCC------
T ss_pred             CC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH---HH-HhCC------
Confidence            43  233446799999999999877764 89999999999999999999998654321   111   11 1111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   .+......+.+|+.+||+.||.+|||++|++++
T Consensus       231 ~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          231 YR---IPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CC---CCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CC---CCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11   112234567789999999999999999999985

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-42  Score=360.11  Aligned_cols=263  Identities=23%  Similarity=0.363  Sum_probs=208.3

Q ss_pred             cCCcccceeeeeCceEEEEEE----eCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc--Ceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGV----IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~----~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  428 (662)
                      ++|+..+.||+|+||+||+|+    ...+++.||||++........+.+.+|+.++++++||||+++++++...  ...+
T Consensus        10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (295)
T 3ugc_A           10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK   89 (295)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred             HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence            678889999999999999998    4567899999999887777778899999999999999999999998654  4689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++|+|.+++...    ...+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        90 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~  162 (295)
T 3ugc_A           90 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  162 (295)
T ss_dssp             EEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred             EEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence            999999999999999654    3458999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh---------HHHHHHHH
Q 040242          509 AYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME---------LVLVDWVR  577 (662)
Q Consensus       509 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~~  577 (662)
                      .......  .......++..|+|||.+.+..++.++||||||+++|||++|..|+........         ......+.
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (295)
T 3ugc_A          163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  242 (295)
T ss_dssp             -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence            7654322  122334577889999999988999999999999999999999999864321100         00011111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .....+.        ....+......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       243 ~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          243 ELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111111        1112334456788999999999999999999999998754

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-42  Score=360.21  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=207.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC----eeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----ELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~l  429 (662)
                      .++|+..++||+|+||+||+|++.  ++.||||++..... ....+..|+.++++++||||+++++++....    .+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            467899999999999999999984  78999999966543 3345567999999999999999999998754    4799


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC----------CEEeCCcCCCceEeCCCCCe
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ----------RVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivH~Dlkp~NIll~~~~~~  499 (662)
                      ||||+++|+|.+++..      ..++|..++.++.|+++||.|||+   .          +|+||||||+|||++.++.+
T Consensus       100 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            9999999999999943      348999999999999999999998   6          99999999999999999999


Q ss_pred             EEeeccccccccCCCCC-cceecccCCcccCcccccCC-----CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH-
Q 040242          500 KLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTG-----KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL-  572 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-  572 (662)
                      ||+|||+++........ ......||+.|+|||.+.+.     .++.++|||||||++|||++|+.||........... 
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            99999999876554322 23335799999999998763     456788999999999999999999975432211111 


Q ss_pred             ---------HHHHHHHhhcCccccccCCCCCC--CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 ---------VDWVRELHSQGQITRAIDPTLDY--FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ---------~~~~~~~~~~~~~~~~id~~l~~--~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                               .++... ..    .....+.+..  ........+.+|+.+||+.||++|||+.||++.|++.
T Consensus       251 ~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          251 EEIGQHPSLEDMQEV-VV----HKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             HHHCSSCCHHHHHHH-HT----TSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhhccCCchhhhhhh-hh----cccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                     111111 11    1112222211  1234567799999999999999999999999999753

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-41  Score=365.05  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=212.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeC-------CCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP-------STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~-------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++|...+.||+|+||+||+|.+.       .++..||||++... .....+++.+|+.+++++ +||||++++++|...+
T Consensus        81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  160 (370)
T 2psq_A           81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG  160 (370)
T ss_dssp             GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSS
T ss_pred             HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCC
Confidence            57888999999999999999864       24567999999765 344567899999999999 8999999999999999


Q ss_pred             eeeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      .+++||||+++|+|.+++......           ....+++.+++.++.||++||.|||+   .+|+||||||+|||++
T Consensus       161 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~  237 (370)
T 2psq_A          161 PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVT  237 (370)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEC
T ss_pred             CEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEEC
Confidence            999999999999999999754310           12458999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~---~  314 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---L  314 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H
Confidence            999999999999987654322 22233467889999999998899999999999999999999 999997654321   1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ...+    ..+.        ....+......+.+++.+||+.||.+||++.|+++.|++.
T Consensus       315 ~~~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          315 FKLL----KEGH--------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             HHHH----HTTC--------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH----hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111    1111        0112233456788999999999999999999999999764

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=7.3e-42  Score=367.28  Aligned_cols=256  Identities=27%  Similarity=0.443  Sum_probs=199.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|++.   ..+..||||++... .....++|.+|+.++++++||||++++++|...+..++|
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  124 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV  124 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence            57888999999999999999986   45678999999765 344567899999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...    ...+++.+++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          125 TEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             EECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            9999999999999654    3468999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCc--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINPQ--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .......  .....++..|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...+    ..+.   
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----~~~~---  267 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----DEGY---  267 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----HTTE---
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC---
Confidence            5432211  122345778999999998899999999999999999998 999997553321   11111    1110   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .   ...+......+.+++.+||+.||.+||++.+|++.|++.
T Consensus       268 --~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          268 --R---LPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --E---CCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --C---CCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence              0   111223456788999999999999999999999998754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3e-41  Score=344.87  Aligned_cols=257  Identities=27%  Similarity=0.408  Sum_probs=211.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|... ++..||+|++..... ..+++.+|+.++.+++||||+++++++...+..++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence            367888999999999999999885 577899999976532 346789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           85 ISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             cCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            9999999999543    3469999999999999999999999   89999999999999999999999999999876554


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........      ... ..+.  ..    
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~-~~~~--~~----  224 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKV-SQGH--RL----  224 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHH-HTTC--CC----
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHH-HcCC--CC----
Confidence            3323333456778999999988889999999999999999999 99999755432111      111 1110  00    


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                        ..+......+.+++.+||+.||.+|||+.|++++|+....
T Consensus       225 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          225 --YRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             --CCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             --CCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence              1111234568899999999999999999999999987643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.8e-41  Score=355.07  Aligned_cols=249  Identities=27%  Similarity=0.356  Sum_probs=208.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||++....+|+.||||++.+.   .......+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            5788999999999999999999989999999999764   2334567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|..++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999999999853     3468999999999999999999999   899999999999999999999999999998643


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+   .. +.      .
T Consensus       157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i---~~-~~------~  222 (337)
T 1o6l_A          157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI---LM-EE------I  222 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---HH-CC------C
T ss_pred             cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHH---Hc-CC------C
Confidence            322 23344679999999999998899999999999999999999999997653221   11111   11 11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||     ++.||+++
T Consensus       223 ~---~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C---CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            1   1223345678899999999999999     89999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=5.2e-42  Score=368.99  Aligned_cols=257  Identities=22%  Similarity=0.340  Sum_probs=210.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|...+.||+|+||.||+|.+..+++.||||++.... ....++|.+|+.++++++||||++++++|...+..++|||
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  192 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME  192 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence            357888999999999999999998889999999987542 3345678999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       193 ~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          193 LVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             cCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            99999999999643    3468999999999999999999999   8999999999999999999999999999986543


Q ss_pred             CCCCc-ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          513 NINPQ-TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       513 ~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..... .....++..|+|||.+..+.++.++|||||||++|||++ |+.||.......   ..+.    ...+..     
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~-----  333 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TREF----VEKGGR-----  333 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HHHH----HHTTCC-----
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC-----
Confidence            21111 111235778999999988889999999999999999998 999997654321   1111    111110     


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         ...+...+..+.+|+.+||+.||++|||+.+|++.|+..
T Consensus       334 ---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          334 ---LPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence               011223446688899999999999999999999999753

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.9e-41  Score=346.64  Aligned_cols=254  Identities=27%  Similarity=0.432  Sum_probs=209.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||+|.+. ++..||+|++..... ..+++.+|+.++++++||||+++++++...+..++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            56888999999999999999995 577899999976532 3467899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        88 ~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           88 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999654    3568999999999999999999999   899999999999999999999999999998765432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........+|+.|+|||.+.+..++.++||||+|+++|||++ |+.||.......   ..   ... ..+     ..+  
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~---~~~-~~~-----~~~--  226 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---EDI-STG-----FRL--  226 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHH-HTT-----CCC--
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HHH-hcC-----ccC--
Confidence            222333456788999999988899999999999999999999 999997654321   11   111 111     011  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       ..+......+.+++.+||+.||.+||++.+++++|+..
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          227 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence             11222345688999999999999999999999999753

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=348.21  Aligned_cols=273  Identities=22%  Similarity=0.278  Sum_probs=216.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccC--eeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--ELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV~  431 (662)
                      ++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++....  ..++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (319)
T 4euu_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (319)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence            57888999999999999999999889999999997643 344677889999999999999999999987665  789999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe----CCCCCeEEeecccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLA  507 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla  507 (662)
                      ||+++++|.+++.....  ...+++.+++.++.|+++||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             ECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             eCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            99999999999975432  3349999999999999999999999   899999999999999    78888999999999


Q ss_pred             ccccCCCCCcceecccCCcccCccccc--------CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh--HHHHHHHH
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTR--------TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME--LVLVDWVR  577 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~  577 (662)
                      +......  ......||+.|+|||.+.        +..++.++|||||||++|||++|+.||........  ..+.....
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             eecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            8765432  223457999999999875        56789999999999999999999999974332211  11111111


Q ss_pred             HHhhcCccccc---------cCCCC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 040242          578 ELHSQGQITRA---------IDPTL---DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL  635 (662)
Q Consensus       578 ~~~~~~~~~~~---------id~~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~  635 (662)
                      .. ........         ..+.+   ..........+..++.+||+.||++|||+.|++++...++-.
T Consensus       242 ~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          242 GK-PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             HC-CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CC-CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            11 11100000         00111   245577888899999999999999999999999998765443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=356.14  Aligned_cols=246  Identities=26%  Similarity=0.357  Sum_probs=197.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||+||+|.+..+++.||||++...  ......++..|+..+.++ +||||++++++|...+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            6799999999999999999999889999999998653  233344566677666665 8999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+ +++|.+++...    ...++|..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       137 e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             ECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999 77999988543    3569999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.....        |  .....+....    
T Consensus       209 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~--------~--~~~~~~~~~~----  271 (311)
T 3p1a_A          209 TAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG--------W--QQLRQGYLPP----  271 (311)
T ss_dssp             --------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH--------H--HHHTTTCCCH----
T ss_pred             cCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH--------H--HHHhccCCCc----
Confidence            432  2334569999999998875 789999999999999999999877654321        1  1111111110    


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         .........+.+++.+||+.||++|||+.|++++
T Consensus       272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence               0111234668899999999999999999999974

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=9.4e-42  Score=359.70  Aligned_cols=256  Identities=24%  Similarity=0.371  Sum_probs=202.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcE----EEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLE----VAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~----vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..++||+|+||+||+|++..++..    ||+|.+... .....++|.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~   93 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence            5688899999999999999998766654    588877543 3345678999999999999999999999998754 789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |+||+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            99999999999999654    3568999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||........   ...+    ..+.   
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~~----~~~~---  236 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGE---  236 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC---
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHH---HHHH----HcCC---
Confidence            7544322 2233456889999999999999999999999999999999 9999976543221   1111    1111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                           ....+......+..++.+||+.||.+||++.|++++|+...
T Consensus       237 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~  277 (327)
T 3poz_A          237 -----RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -----CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                 01122334557889999999999999999999999987643

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.9e-41  Score=361.49  Aligned_cols=271  Identities=23%  Similarity=0.344  Sum_probs=215.3

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEE-----eCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceee
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGV-----IPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQL  417 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~-----~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l  417 (662)
                      +...+.....++|+..+.||+|+||.||+|.     ...+++.||||++... .....+.+.+|+.++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            3444555567889999999999999999998     4456789999999764 334457899999999999 79999999


Q ss_pred             eeeEeccC-eeeEEEeccCCCCcchhcccccccc----------------------------------------------
Q 040242          418 HGWCRKQD-ELLLVYDYVPNGSLDKLLFDNDQQK----------------------------------------------  450 (662)
Q Consensus       418 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~----------------------------------------------  450 (662)
                      +++|...+ ..++||||+++|+|.+++.......                                              
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99998765 4899999999999999997643210                                              


Q ss_pred             ---------------cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          451 ---------------KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       451 ---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                                     ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                           1228999999999999999999999   8999999999999999999999999999986644322


Q ss_pred             -CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          516 -PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       516 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                       .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||.........  ...    ...+.     ... 
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~----~~~~~-----~~~-  316 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRR----LKEGT-----RMR-  316 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHH----HHHTC-----CCC-
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HHH----HHcCC-----CCC-
Confidence             22334568899999999988899999999999999999998 99999765432211  111    11111     111 


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .+......+.+++.+||+.||.+||++.||+++|+..
T Consensus       317 --~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          317 --APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             --CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence              1122345688899999999999999999999999753

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=9.1e-41  Score=346.40  Aligned_cols=261  Identities=17%  Similarity=0.210  Sum_probs=211.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||+|....+++.||||++.....  .+.+.+|+.++.++ +|+|++++++++......++||||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~   87 (298)
T 1csn_A           10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   87 (298)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEe
Confidence            578999999999999999999988999999999865432  24577899999999 799999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC-----eEEeeccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN-----PKLGDFGLAR  508 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DfGla~  508 (662)
                      + +++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.     +||+|||+++
T Consensus        88 ~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           88 L-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             c-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9 99999999643    3458999999999999999999999   89999999999999987776     9999999998


Q ss_pred             cccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          509 AYDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       509 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      ........      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            77654321      234457999999999999989999999999999999999999999865432222222222111111


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ....+        .....+..+.+++.+||+.||++||++.+|++.|+...
T Consensus       240 ~~~~~--------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          240 TPLRE--------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             SCHHH--------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             ccHHH--------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            10000        01123467889999999999999999999999987653

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-41  Score=348.93  Aligned_cols=253  Identities=27%  Similarity=0.457  Sum_probs=198.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|..  .++.||||++...  ...+.|.+|+.++++++||||+++++++.+  ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcC
Confidence            5688899999999999999998  4788999998654  345788999999999999999999998873  489999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC-eEEeeccccccccCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN-PKLGDFGLARAYDHN  513 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-~kL~DfGla~~~~~~  513 (662)
                      ++|+|.+++.....  ...+++..++.++.|+++||.|||+....+|+||||||+||+++.++. +||+|||++......
T Consensus        82 ~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH  159 (307)
T ss_dssp             TTCBHHHHHHCSSS--EECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred             CCCCHHHHHhccCC--CCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence            99999999975431  345788999999999999999999854468999999999999998887 799999999865432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                          .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.........    ..+.... +.     .+.+
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~-~~-----~~~~  225 (307)
T 2eva_A          160 ----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMWAVHN-GT-----RPPL  225 (307)
T ss_dssp             ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHHHHHT-TC-----CCCC
T ss_pred             ----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHHHHhc-CC-----CCCc
Confidence                22346899999999999889999999999999999999999999754332111    1111111 11     1111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         .......+.+++.+||+.||.+||++.+++++|+..
T Consensus       226 ---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          226 ---IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             ---BTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---ccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence               122345678899999999999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-41  Score=378.89  Aligned_cols=259  Identities=24%  Similarity=0.376  Sum_probs=215.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|.+..++..||||++.... ...++|.+|+.++++++||||++++++|...+..++||||
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~  297 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF  297 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEc
Confidence            356888999999999999999998889999999997653 3467899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      |++|+|.+++....   ...+++..++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       298 ~~~g~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          298 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             cCCCCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            99999999996543   3568999999999999999999999   89999999999999999999999999999976543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .........++..|+|||.+....++.++|||||||++|||++ |+.||.......   +.+.+    ..+.       +
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~-------~  437 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDY-------R  437 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTC-------C
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCC-------C
Confidence            2222223456789999999988889999999999999999999 999997654321   11111    1110       0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                       ...+......+.+|+.+||+.||.+||++.+|++.|+....
T Consensus       438 -~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          438 -MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -CCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence             11223345678899999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-41  Score=353.43  Aligned_cols=253  Identities=21%  Similarity=0.288  Sum_probs=209.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|...+.||+|+||.||+|....++..||+|.+.... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467889999999999999999999999999999987543 3446788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC--CCCeEEeecccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA--DLNPKLGDFGLARAYD  511 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~  511 (662)
                      +++|+|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.  ++.+||+|||+++...
T Consensus        83 ~~g~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           83 ISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            9999999999543    3468999999999999999999999   89999999999999987  7899999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   ..   ..... +...  .++
T Consensus       156 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~-~~~~--~~~  224 (321)
T 1tki_A          156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMN-AEYT--FDE  224 (321)
T ss_dssp             TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHH-TCCC--CCH
T ss_pred             CC--CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HH---HHHHc-CCCC--CCh
Confidence            43  23344679999999999988888999999999999999999999997654321   11   11111 1000  000


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .   ........+.+++.+||+.||.+|||+.|++++
T Consensus       225 ~---~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          225 E---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             H---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h---hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            0   001234568899999999999999999999984

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.7e-41  Score=356.63  Aligned_cols=253  Identities=22%  Similarity=0.345  Sum_probs=208.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh------hHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ------GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      .+.|+..+.||+|+||.||++....+|..||+|.+......      ..+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            36788999999999999999999989999999999765322      356789999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEee
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGD  503 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~D  503 (662)
                      ++||||+++|+|.+++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            999999999999999954     3468999999999999999999999   8999999999999998877    799999


Q ss_pred             ccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      ||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........   ..   .. ..+
T Consensus       163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~---~~---~i-~~~  233 (361)
T 2yab_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA---NI-TAV  233 (361)
T ss_dssp             CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HH---HH-HTT
T ss_pred             cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HH-Hhc
Confidence            99998765432  23345799999999999988999999999999999999999999976533211   11   11 111


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..  ..++.   ........+.+++.+||+.||.+|||+.|++++
T Consensus       234 ~~--~~~~~---~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          234 SY--DFDEE---FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CC--CCCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CC--CCCch---hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00  00000   001224567889999999999999999999863

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-42  Score=367.48  Aligned_cols=261  Identities=23%  Similarity=0.364  Sum_probs=209.3

Q ss_pred             cCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||+||+|.+     ..++..||||++... ......++.+|+.++++++||||+++++++...+..+
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  150 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF  150 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence            5688899999999999999995     345678999999654 3455667899999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccc--cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC---CeEEee
Q 040242          429 LVYDYVPNGSLDKLLFDNDQ--QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL---NPKLGD  503 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~D  503 (662)
                      +||||+++|+|.+++.....  .....+++.+++.++.||++||.|||+   .+|+||||||+|||++.++   .+||+|
T Consensus       151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~D  227 (367)
T 3l9p_A          151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGD  227 (367)
T ss_dssp             EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECC
Confidence            99999999999999965421  113468999999999999999999999   8999999999999999555   599999


Q ss_pred             ccccccccCC-CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhh
Q 040242          504 FGLARAYDHN-INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       504 fGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      ||+++..... .........||+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...+    .
T Consensus       228 FG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i----~  300 (367)
T 3l9p_A          228 FGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV----T  300 (367)
T ss_dssp             CHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----H
T ss_pred             CccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----H
Confidence            9999865332 1223334568999999999988899999999999999999998 999997654321   11111    1


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      .+.        ....+......+.+|+.+||+.||.+||++.+|+++|+...
T Consensus       301 ~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          301 SGG--------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cCC--------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            111        01112233456889999999999999999999999996543

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-41  Score=355.39  Aligned_cols=264  Identities=24%  Similarity=0.367  Sum_probs=214.0

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      ..++|+..+.||+|+||.||+|.+..     ++..||||++... .....+.+.+|+.++++++||||+++++++...+.
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  124 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP  124 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCc
Confidence            45788999999999999999999863     4588999999765 34446789999999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhccccccc-------------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ-------------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK  487 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  487 (662)
                      .++||||+++|+|.+++......                   ....+++.+++.++.||++||.|||+   .+|+|||||
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlk  201 (343)
T 1luf_A          125 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA  201 (343)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCS
T ss_pred             eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            99999999999999999753211                   02569999999999999999999999   899999999


Q ss_pred             CCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccc
Q 040242          488 PSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQR  565 (662)
Q Consensus       488 p~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~  565 (662)
                      |+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999986543321 22234567899999999988889999999999999999999 999997653


Q ss_pred             chhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          566 TAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       566 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      ...   +..    ....+..        ...+......+.+++.+||+.||++||++.+|+++|++...
T Consensus       282 ~~~---~~~----~~~~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          282 HEE---VIY----YVRDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             HHH---HHH----HHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hHH---HHH----HHhCCCc--------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            321   111    1111111        11222344678899999999999999999999999987644

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.4e-40  Score=350.26  Aligned_cols=253  Identities=24%  Similarity=0.322  Sum_probs=205.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||+||+|.+..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   86 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence            678999999999999999999988999999999865432 3346688999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|+|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        87 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~  158 (323)
T 3tki_A           87 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (323)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             CCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence            999999999953     3458999999999999999999999   89999999999999999999999999999866432


Q ss_pred             C-CCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          514 I-NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       514 ~-~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . ........||+.|+|||.+.+..+ +.++|||||||++|||++|+.||........ ....|...    .   ..   
T Consensus       159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~----~---~~---  227 (323)
T 3tki_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK----K---TY---  227 (323)
T ss_dssp             TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT----C---TT---
T ss_pred             CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc----c---cc---
Confidence            2 122334579999999999977665 7899999999999999999999976543221 11122110    0   00   


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       228 --~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 --LNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              01112334567889999999999999999999985

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-40  Score=357.80  Aligned_cols=254  Identities=20%  Similarity=0.266  Sum_probs=211.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|....+++.||+|++..........+.+|+.++++++||||+++++++...+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            36789999999999999999999989999999999877666667899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC--CCCeEEeecccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA--DLNPKLGDFGLARAYD  511 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~  511 (662)
                      +++|+|.+++...    ...+++.+++.++.||++||.|||+   .+|+||||||+|||++.  ++.+||+|||+++...
T Consensus       130 ~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          130 LSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             CCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             CCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            9999999998643    3468999999999999999999999   89999999999999974  4779999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.   . ..  ...++
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~---~-~~--~~~~~  271 (387)
T 1kob_A          203 PDE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK---R-CD--WEFDE  271 (387)
T ss_dssp             TTS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH---H-CC--CCCCS
T ss_pred             CCc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHH---h-CC--CCCCc
Confidence            432  2334579999999999998889999999999999999999999998654321   111111   1 10  01111


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   .......+.+++.+||+.||.+|||+.|++++
T Consensus       272 ~~---~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DA---FSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ST---TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            11   12334568899999999999999999999985

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.9e-41  Score=346.84  Aligned_cols=254  Identities=27%  Similarity=0.405  Sum_probs=206.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||++... ++..||||++..... ..+++.+|+.++.+++||||+++++++...+..++||||
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  100 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY  100 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence            467888999999999999999985 577899999976532 346789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus       101 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  173 (283)
T 3gen_A          101 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  173 (283)
T ss_dssp             CTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred             cCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence            9999999999653    3468999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.........   .   . ...+     ....
T Consensus       174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~---~---~-~~~~-----~~~~  241 (283)
T 3gen_A          174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---E---H-IAQG-----LRLY  241 (283)
T ss_dssp             HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH---H---H-HHTT-----CCCC
T ss_pred             ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH---H---H-Hhcc-----cCCC
Confidence            2222233456788999999998889999999999999999998 99999765432111   1   1 1111     1111


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         .+......+.+++.+||+.||.+||++.+++++|..
T Consensus       242 ---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          242 ---RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             ---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence               112224568899999999999999999999999865

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=1e-40  Score=346.56  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=201.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhc--cccccceeeeeeEecc----Cee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHRNLVQLHGWCRKQ----DEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~~~~~~~----~~~  427 (662)
                      .++|+..+.||+|+||+||+|..  +++.||||++....   .+.+..|.+++..  ++||||+++++++...    ...
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            46789999999999999999998  68899999986543   3445556666555  7999999999987543    468


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhH--------hcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH--------EECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--------~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      ++||||+++|+|.+++.      ...+++..++.++.|+++||.|||        +   .+|+||||||+|||++.++.+
T Consensus        82 ~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~  152 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQ------LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQC  152 (301)
T ss_dssp             EEEECCCTTCBHHHHHT------TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCE
T ss_pred             EEehhhccCCCHHHHHh------hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCE
Confidence            99999999999999994      345899999999999999999999        6   899999999999999999999


Q ss_pred             EEeeccccccccCCCCC---cceecccCCcccCcccccCC------CCCcchhHHHHHHHHHHHHcC----------CCC
Q 040242          500 KLGDFGLARAYDHNINP---QTTHIVGTLGYLAPELTRTG------KATTSTDVFGFGTLMLEVACG----------RRP  560 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~t~ksDV~S~Gvvl~elltG----------~~p  560 (662)
                      ||+|||+++........   ......||+.|+|||.+.+.      .+++++|||||||++|||++|          +.|
T Consensus       153 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~p  232 (301)
T 3q4u_A          153 CIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPP  232 (301)
T ss_dssp             EECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccc
Confidence            99999999876543222   12234799999999999776      445799999999999999999          888


Q ss_pred             CCcccchhhHHHHHHHHHHhhcCccccccCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          561 IEPQRTAMELVLVDWVRELHSQGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       561 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      |.......... .. +......    ....+.+  ..........+.+|+.+||+.||.+|||+.||++.|++
T Consensus       233 f~~~~~~~~~~-~~-~~~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          233 FYDVVPNDPSF-ED-MRKVVCV----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTTSCSSCCH-HH-HHHHHTT----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccccCCCCcch-hh-hhHHHhc----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            86432221111 11 1111111    1112222  12234577889999999999999999999999999975

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.6e-40  Score=358.78  Aligned_cols=267  Identities=21%  Similarity=0.272  Sum_probs=207.1

Q ss_pred             ccCCcccceeeee--CceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSG--GFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G--~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..++||+|  +||+||+|+...+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            3678999999999  99999999999899999999997653  4455778899999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |||||++|+|.+++....   ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||++..
T Consensus       104 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            999999999999996542   3558999999999999999999999   8999999999999999999999999998865


Q ss_pred             ccCCC------CCcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          510 YDHNI------NPQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       510 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      .....      ........||+.|+|||.+.+  ..++.++|||||||++|||++|+.||..........  ..+.....
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~  255 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVP  255 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCC
Confidence            43211      111122478999999999987  578999999999999999999999997644322111  00000000


Q ss_pred             ----------------------cCcccccc---CC-------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 ----------------------QGQITRAI---DP-------TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ----------------------~~~~~~~i---d~-------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                            .....+.+   .+       ............+.+|+.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                  00000000   00       0001222334668899999999999999999999975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=344.60  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=199.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--------------------------hhHHHHHHHHHHhhc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--------------------------QGMKEFVAEITSMGR  408 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--------------------------~~~~~f~~Ei~~l~~  408 (662)
                      ++|+..+.||+|+||.||+|++..+++.||||++.....                          ...+.+.+|+.++++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            678899999999999999999988999999999865431                          123568899999999


Q ss_pred             cccccceeeeeeEec--cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCc
Q 040242          409 LRHRNLVQLHGWCRK--QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDV  486 (662)
Q Consensus       409 l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dl  486 (662)
                      ++||||+++++++..  .+..++||||+++++|.+++.      ...+++.+++.++.|+++||.|||+   .+|+||||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl  163 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT------LKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI  163 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC------SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence            999999999999986  568999999999999998763      3468999999999999999999999   89999999


Q ss_pred             CCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCc
Q 040242          487 KPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK---ATTSTDVFGFGTLMLEVACGRRPIEP  563 (662)
Q Consensus       487 kp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~  563 (662)
                      ||+|||++.++.+||+|||+++...... .......||+.|+|||.+.+..   .+.++|||||||++|||++|+.||..
T Consensus       164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          164 KPSNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence            9999999999999999999998765432 2233457999999999987655   37889999999999999999999975


Q ss_pred             ccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          564 QRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       564 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....   .+   .... ......   .+.    .......+.+++.+||+.||++||++.|++++
T Consensus       243 ~~~~---~~---~~~~-~~~~~~---~~~----~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          243 ERIM---CL---HSKI-KSQALE---FPD----QPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SSHH---HH---HHHH-HHCCCC---CCS----SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             ccHH---HH---HHHH-hcccCC---CCC----ccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            4321   11   1111 111100   011    11234568889999999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.2e-41  Score=355.25  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=204.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcE----EEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLE----VAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~----vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..++||+|+||+||+|.+..++..    ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            5688899999999999999998777664    7788775432 233456788999999999999999999986 567899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            99999999999999654    3568999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......+|..|+|||.+.+..++.++|||||||++|||++ |+.||........   .+.+    ..+..  
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~--  235 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDLL----EKGER--  235 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHHH----HTTCB--
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHHH----HcCCC--
Confidence            7544322 2344567889999999998899999999999999999999 9999986543221   1111    11110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      .      ..+......+.+++.+||+.||.+||++.+++++|.+..
T Consensus       236 ~------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          236 L------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             C------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             C------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            0      011112334678999999999999999999999997543

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=4.7e-41  Score=347.19  Aligned_cols=259  Identities=25%  Similarity=0.365  Sum_probs=206.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-------cEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-------LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-------~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      ++|...+.||+|+||+||+|.+..++       ..||+|++........+.+.+|+.++++++||||+++++++...+..
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   87 (289)
T 4fvq_A            8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN   87 (289)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred             hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence            57888999999999999999987665       47999999877777778899999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC--------e
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN--------P  499 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--------~  499 (662)
                      ++||||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.        +
T Consensus        88 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           88 ILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999654    3458999999999999999999999   89999999999999998887        9


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||++.....     .....||+.|+|||.+.+ ..++.++|||||||++|||++|..|+.........  ...   
T Consensus       161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~---  230 (289)
T 4fvq_A          161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQF---  230 (289)
T ss_dssp             EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH---
T ss_pred             eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HHH---
Confidence            9999999875432     223468899999999887 67899999999999999999966554433222111  011   


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLD  641 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~~  641 (662)
                       ...       .+.+   +......+.+++.+||+.||.+|||+.+++++|+........+..
T Consensus       231 -~~~-------~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~~~~  282 (289)
T 4fvq_A          231 -YED-------RHQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG  282 (289)
T ss_dssp             -HHT-------TCCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--------
T ss_pred             -hhc-------cCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCCCCC
Confidence             110       0011   111123477899999999999999999999999988776555544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-41  Score=371.18  Aligned_cols=258  Identities=23%  Similarity=0.409  Sum_probs=211.2

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ...++|+..+.||+|+||+||+|.+. .+..||||++.... ...++|.+|+.++++++||||+++++++. .+..++||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEE
Confidence            34567888999999999999999995 57789999997653 34678999999999999999999999986 56789999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++....   ...+++..++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       262 e~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  335 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE  335 (454)
T ss_dssp             CCCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred             eecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence            9999999999996542   3468899999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...........++..|+|||.+..+.++.++|||||||++|||++ |+.||.......   +...+.    .+.      
T Consensus       336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~----~~~------  402 (454)
T 1qcf_A          336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALE----RGY------  402 (454)
T ss_dssp             CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHH----HTC------
T ss_pred             CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC------
Confidence            322112223456789999999998899999999999999999999 999997643321   111111    110      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                       .+ ..+...+..+.+|+.+||+.||++|||+++|++.|+...
T Consensus       403 -~~-~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          403 -RM-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -CC-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CC-CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             00 112234567889999999999999999999999998764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=8.2e-41  Score=353.66  Aligned_cols=247  Identities=23%  Similarity=0.348  Sum_probs=206.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||+||+|.+..+++.||||++....   ......+.+|+.++++++||||+++++++...+..++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            67889999999999999999998899999999997542   222457889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+ +|+|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++....
T Consensus        89 E~~-~g~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           89 EYA-GGELFDYIVE-----KKRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             CCC-CEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             ECC-CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            999 7899888853     3468999999999999999999999   799999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...  ......||+.|+|||.+.+..+ ++++|||||||++|||++|+.||......                .+.+.+.
T Consensus       160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~----------------~~~~~i~  221 (336)
T 3h4j_B          160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP----------------NLFKKVN  221 (336)
T ss_dssp             TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST----------------TCBCCCC
T ss_pred             CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH----------------HHHHHHH
Confidence            432  2234579999999999987765 78999999999999999999999754321                1122222


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ......+......+.+|+.+||+.||.+|||+.|++++
T Consensus       222 ~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            22222333345668899999999999999999999984

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.7e-41  Score=353.04  Aligned_cols=252  Identities=22%  Similarity=0.344  Sum_probs=201.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccC--------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--------  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--------  425 (662)
                      ++|+..+.||+|+||.||+|++..+|+.||||++.... ....+.+.+|+.++++++||||+++++++.+..        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56888999999999999999998899999999997543 345678999999999999999999999986543        


Q ss_pred             -------------------------------------------------eeeEEEeccCCCCcchhcccccccccccccH
Q 040242          426 -------------------------------------------------ELLLVYDYVPNGSLDKLLFDNDQQKKKILNW  456 (662)
Q Consensus       426 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~  456 (662)
                                                                       ..++||||+++++|.+++.....  ....++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~  163 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDREH  163 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSCH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchhh
Confidence                                                             27999999999999999976532  345677


Q ss_pred             HHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-----------CcceecccCC
Q 040242          457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-----------PQTTHIVGTL  525 (662)
Q Consensus       457 ~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-----------~~~~~~~gt~  525 (662)
                      ..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.......           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            7899999999999999999   8999999999999999999999999999987765421           1223356999


Q ss_pred             cccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 040242          526 GYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVL  605 (662)
Q Consensus       526 ~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~  605 (662)
                      .|+|||.+.+..++.++|||||||++|||++|..|+....     ..   ... ...        .............+.
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~-----~~---~~~-~~~--------~~~~~~~~~~~~~~~  303 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV-----RI---ITD-VRN--------LKFPLLFTQKYPQEH  303 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH-----HH---HHH-HHT--------TCCCHHHHHHCHHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH-----HH---HHH-hhc--------cCCCcccccCChhHH
Confidence            9999999998899999999999999999999877643111     10   000 011        111111223445678


Q ss_pred             HHHHHccCCCCCCCCCHHHHHHH
Q 040242          606 TLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       606 ~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +++.+||+.||.+||++.|++++
T Consensus       304 ~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          304 MMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHccCCCCcCCCHHHHhhc
Confidence            89999999999999999999974

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=351.62  Aligned_cols=251  Identities=22%  Similarity=0.343  Sum_probs=207.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh------hHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ------GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|...+.||+|+||.||++....+|..||+|++......      ..+.+.+|+.++++++||||+++++++...+..+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            5688899999999999999999989999999999764321      3577899999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Df  504 (662)
                      +||||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            99999999999999954     3468999999999999999999999   8999999999999999887    7999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ..+..    . 
T Consensus       163 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~----~-  232 (326)
T 2y0a_A          163 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSA----V-  232 (326)
T ss_dssp             TTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHH----T-
T ss_pred             CCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHh----c-
Confidence            9998765432  223457999999999999889999999999999999999999999765332111   11110    0 


Q ss_pred             cccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           .... ..........+.+++.+||+.||.+|||+.|++++
T Consensus       233 -----~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          233 -----NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             -----CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 0000 00001224567889999999999999999999984

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=358.48  Aligned_cols=248  Identities=24%  Similarity=0.333  Sum_probs=201.1

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      ..++||+|+||.||+|....+|..||+|++........+++.+|+.++++++||||+++++++...+..++||||+++++
T Consensus        93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             cceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            35789999999999999988999999999988766667889999999999999999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe--CCCCCeEEeeccccccccCCCCC
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI--DADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll--~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |.+++...    ...+++..++.++.||++||.|||+   .+|+||||||+|||+  +.++.+||+|||+++......  
T Consensus       173 L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--  243 (373)
T 2x4f_A          173 LFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--  243 (373)
T ss_dssp             EHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--
Confidence            99988643    3568999999999999999999999   899999999999999  667889999999999765432  


Q ss_pred             cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCC
Q 040242          517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF  596 (662)
Q Consensus       517 ~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~  596 (662)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +.    .......  . ..+.   .
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~----~i~~~~~--~-~~~~---~  311 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LN----NILACRW--D-LEDE---E  311 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HH----HHHHTCC--C-SCSG---G
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhccC--C-CChh---h
Confidence            22334699999999999988899999999999999999999999986543211  11    1111100  0 0000   0


Q ss_pred             CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          597 DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       597 ~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .......+.+|+.+||+.||.+||++.|+++
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1123456888999999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5e-41  Score=364.39  Aligned_cols=262  Identities=21%  Similarity=0.239  Sum_probs=212.1

Q ss_pred             chHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          346 RYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       346 ~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      .+.++....++|+..++||+|+||+||+|+...+++.||+|++.+..   ....+.+.+|+.+++.++||||+++++++.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            45566667889999999999999999999999999999999996532   122345789999999999999999999999


Q ss_pred             ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       423 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ..+.+++||||+++|+|.+++..      ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~  210 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLA  210 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEe
Confidence            99999999999999999999843      348899999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCCC----CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGK----ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      |||+++..............||+.|+|||++.+..    ++.++|||||||++|||++|+.||.........  ...+..
T Consensus       211 DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~--~~i~~~  288 (410)
T 3v8s_A          211 DFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY--SKIMNH  288 (410)
T ss_dssp             CCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH--HHHHTH
T ss_pred             ccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHH--HHHHhc
Confidence            99999876544322334568999999999987654    788999999999999999999999865432111  111100


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDF--RPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~--RPt~~eVl~~  628 (662)
                      .      ....-|..    ......+..|+.+||+.+|.+  ||+++||+++
T Consensus       289 ~------~~~~~p~~----~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          289 K------NSLTFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             H------HHCCCCTT----CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             c------ccccCCCc----ccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            0      00001111    123456778889999999998  9999999985

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=6e-41  Score=361.35  Aligned_cols=261  Identities=24%  Similarity=0.378  Sum_probs=212.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-------CCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++|...+.||+|+||+||+|++..       .+..||||++... .....+++.+|+++++++ +||||++++++|...+
T Consensus        69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~  148 (382)
T 3tt0_A           69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG  148 (382)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCC
Confidence            678889999999999999999743       3357999999765 344567899999999999 9999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..++||||+++|+|.+++.....           .....+++.+++.++.|+++||.|||+   .+|+||||||+|||++
T Consensus       149 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          149 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  225 (382)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEC
T ss_pred             ceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEc
Confidence            99999999999999999965431           112459999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~---~  302 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---L  302 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H
Confidence            999999999999987654322 22333467889999999999999999999999999999999 999997553221   1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ...+    ..+.     ..   ..+......+.+|+.+||+.||++||++.||+++|++..
T Consensus       303 ~~~~----~~~~-----~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          303 FKLL----KEGH-----RM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             HHHH----HTTC-----CC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHH----HcCC-----CC---CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1111    1111     11   112234456889999999999999999999999997664

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.6e-40  Score=350.90  Aligned_cols=246  Identities=21%  Similarity=0.280  Sum_probs=207.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+++...+|+.||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            57888999999999999999999899999999997642   234567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       121 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~  192 (350)
T 1rdq_E          121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence            99999999999953     2458999999999999999999999   899999999999999999999999999998764


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +.   ... ..+.      .
T Consensus       193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~---~~i-~~~~------~  255 (350)
T 1rdq_E          193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY---EKI-VSGK------V  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHH-HHCC------C
T ss_pred             CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HH---HHH-HcCC------C
Confidence            32    234579999999999998899999999999999999999999998653221   11   111 1111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||+     ++||+++
T Consensus       256 ~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 R---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             C---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C---CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence            1   12233456889999999999999998     8998863

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.6e-41  Score=350.45  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=215.2

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ..++|+..+.||+|+||.||+|.+..++..||+|++.... ...+++.+|+.++++++||||+++++++...+..++|||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   89 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   89 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence            4577889999999999999999998889999999997543 345788999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++....   ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           90 FMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             CCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             cCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            999999999996543   4568999999999999999999999   8999999999999999999999999999987765


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||........   ...+    ...     .. 
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~~~----~~~-----~~-  230 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKD-----YR-  230 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH----HTT-----CC-
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----hcc-----CC-
Confidence            44333334567889999999988899999999999999999999 9999976543221   1111    110     01 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ...+......+.+++.+||+.||.+||++.++++.|+.
T Consensus       231 --~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          231 --MERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence              11122344678899999999999999999999998864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.5e-40  Score=341.61  Aligned_cols=263  Identities=27%  Similarity=0.359  Sum_probs=205.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57889999999999999999999899999999997543  3345778999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++ +|.+.+...    ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9975 555555332    3568999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---c---c
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---Q---I  585 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~  585 (662)
                      .. .......||+.|+|||.+.+.. ++.++|||||||++|||++|+.|+........ .+ ..+.......   .   .
T Consensus       154 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~-~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          154 PV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QL-KRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HH-HHHHHHHCCCCTTTCTTG
T ss_pred             cc-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HH-HHHHHHhCCCChhhhhhh
Confidence            32 2233457899999999987765 79999999999999999999988654433221 11 1111111110   0   0


Q ss_pred             cccc----------CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAI----------DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~i----------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+..          ...+..........+.+|+.+||+.||++|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            0000          001112223445678899999999999999999999974

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.8e-40  Score=350.25  Aligned_cols=257  Identities=19%  Similarity=0.195  Sum_probs=208.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||+||+|....+++.||||++.....  .+++..|+.+++++ +||||+++++++...+..++||||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            678899999999999999999988999999999875532  24578999999999 999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC-----eEEeeccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN-----PKLGDFGLAR  508 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~-----~kL~DfGla~  508 (662)
                      + +++|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.     +||+|||+++
T Consensus        87 ~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           87 L-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             C-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            9 99999999643    3569999999999999999999999   89999999999999999887     9999999999


Q ss_pred             cccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          509 AYDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       509 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      .+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76543221      123567999999999999999999999999999999999999999865433222221111111100


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      .. .+..    .   ...+ .+.+++..||+.||.+||++.+|++.|.
T Consensus       239 ~~-~~~~----~---~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          239 TP-IEVL----C---ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             SC-HHHH----T---TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             CC-HHHH----h---ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            00 0000    0   0122 7889999999999999999999999885

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2e-40  Score=351.59  Aligned_cols=265  Identities=24%  Similarity=0.273  Sum_probs=207.9

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-----chhhHHHHHHHHHHhhccccccceeeeeeEec
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-----SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK  423 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-----~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~  423 (662)
                      ++....++|+..+.||+|+||.||+|....++..||+|++...     .....+.+.+|+.++++++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            3556678899999999999999999999999999999998654     23456789999999999999999999999999


Q ss_pred             cCeeeEEEeccCCCCcchhcccccc-----------------------------------cccccccHHHHHHHHHHHHH
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQ-----------------------------------QKKKILNWDQRYKILIGVAQ  468 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~-----------------------------------~~~~~l~~~~~~~i~~~ia~  468 (662)
                      .+..++||||+++|+|.+++.....                                   .....+++..++.++.|+++
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            9999999999999999999852110                                   01233567788899999999


Q ss_pred             HHHHhHhcCCCCEEeCCcCCCceEeCCCC--CeEEeeccccccccCCCC---CcceecccCCcccCcccccC--CCCCcc
Q 040242          469 ALLYLHEECDQRVVHRDVKPSNVLIDADL--NPKLGDFGLARAYDHNIN---PQTTHIVGTLGYLAPELTRT--GKATTS  541 (662)
Q Consensus       469 ~L~yLH~~~~~~ivH~Dlkp~NIll~~~~--~~kL~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~t~k  541 (662)
                      ||.|||+   .+|+||||||+||+++.++  .+||+|||+++.+.....   .......||+.|+|||.+.+  ..++.+
T Consensus       180 ~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            9999999   8999999999999998776  899999999987644222   12344579999999999865  678999


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 040242          542 TDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS  621 (662)
Q Consensus       542 sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt  621 (662)
                      +|||||||++|||++|+.||........      .........  ....+    ........+.+|+.+||+.||.+||+
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~--~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps  324 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKL--CFENP----NYNVLSPLARDLLSNLLNRNVDERFD  324 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC--CTTSG----GGGGSCHHHHHHHHHHSCSCTTTSCC
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccc--ccCCc----ccccCCHHHHHHHHHHcCCChhHCCC
Confidence            9999999999999999999976543211      111111100  00001    11123466889999999999999999


Q ss_pred             HHHHHHH
Q 040242          622 TRRVVQF  628 (662)
Q Consensus       622 ~~eVl~~  628 (662)
                      +.|++++
T Consensus       325 ~~~~l~h  331 (345)
T 3hko_A          325 AMRALQH  331 (345)
T ss_dssp             HHHHHHS
T ss_pred             HHHHhcC
Confidence            9999984

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.4e-41  Score=343.95  Aligned_cols=255  Identities=25%  Similarity=0.386  Sum_probs=196.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..+.||+|+||.||+|.+..+   +..||+|++... .....+.+.+|+.++++++||||+++++++. .+..++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l   92 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   92 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence            36788899999999999999998543   457999998764 3445677999999999999999999999984 467899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        93 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  165 (281)
T 1mp8_A           93 IMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  165 (281)
T ss_dssp             EEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccc
Confidence            99999999999999543    3468999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .............+++.|+|||.+....++.++|||||||++|||++ |+.||........   ...+    ..+.    
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i----~~~~----  234 (281)
T 1mp8_A          166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI----ENGE----  234 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC----
T ss_pred             cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH----HcCC----
Confidence            75543333334567889999999988889999999999999999997 9999976543221   1111    1111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          ....+......+.+++.+||+.||.+||++.|+++.|+.
T Consensus       235 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          235 ----RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                011223345678899999999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=8.2e-41  Score=351.36  Aligned_cols=266  Identities=22%  Similarity=0.339  Sum_probs=197.2

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCc---EEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGL---EVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK  423 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~---~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~  423 (662)
                      ++....++|+..+.||+|+||+||+|.+..++.   .||||++...  .....+++.+|+.++++++||||+++++++..
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            344455789999999999999999999876654   7999999764  34456789999999999999999999999987


Q ss_pred             cCee------eEEEeccCCCCcchhccccccc-ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          424 QDEL------LLVYDYVPNGSLDKLLFDNDQQ-KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       424 ~~~~------~lV~E~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      .+..      ++||||+++|+|.+++...... ....+++.+++.++.|+++||.|||+   .+|+||||||+||+++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCC
Confidence            7655      9999999999999999644321 12358999999999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHH
Q 040242          497 LNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVD  574 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  574 (662)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.........   .
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H
Confidence            9999999999987644322 22233456889999999998899999999999999999999 89999765433211   1


Q ss_pred             HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       575 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+    ..+.        ....+......+.+++.+||+.||.+||++.++++.|+..
T Consensus       251 ~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          251 YL----IGGN--------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             HH----HTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----hcCC--------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11    1111        1112233446788999999999999999999999988755

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.9e-40  Score=351.88  Aligned_cols=256  Identities=22%  Similarity=0.313  Sum_probs=206.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-----hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-----QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-----~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..+.||+|+||+||+|....+++.||||++.....     ...+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            568889999999999999999998999999999865321     235778999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEeeccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLGDFGL  506 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGl  506 (662)
                      ||||+++++|.+++..... ....+++..+..++.||++||.|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus       104 v~e~~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988854321 13458999999999999999999999   89999999999999987655   99999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ++...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......    +...+    ..+...
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~i----~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEGI----IKGKYK  250 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHHH----HHTCCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHHH----HcCCCC
Confidence            98765432 2233457999999999999888999999999999999999999999864321    11111    111100


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ..+..   .......+.+|+.+||+.||++||++.|++++
T Consensus       251 --~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          251 --MNPRQ---WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --CCHHH---HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --CCccc---cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              00000   01224568889999999999999999999873

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=4.6e-41  Score=358.14  Aligned_cols=249  Identities=23%  Similarity=0.363  Sum_probs=203.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..++||+|+||+||+|+...+++.||||++.+.   .....+.+..|..++.++ +||||+++++++...+.+++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            36799999999999999999999989999999999764   233456788999999988 69999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       102 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQK-----SRRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence            9999999999999853     3468999999999999999999999   8999999999999999999999999999985


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .... +.     
T Consensus       174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~~-----  240 (353)
T 3txo_A          174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE---AILN-DE-----  240 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC-----
T ss_pred             cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH---HHHc-CC-----
Confidence            4322 223344679999999999988889999999999999999999999998654321   111   1111 11     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST------RRVVQ  627 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~eVl~  627 (662)
                       .   .++......+..++.+||+.||.+||++      .|+++
T Consensus       241 -~---~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          241 -V---VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -C---CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence             0   1122234567889999999999999998      77776

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2.3e-40  Score=354.15  Aligned_cols=253  Identities=24%  Similarity=0.361  Sum_probs=208.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46789999999999999999999989999999999764  3345577899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC---CeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL---NPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~  508 (662)
                      ||+++|+|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++   .+||+|||+++
T Consensus       108 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~  179 (362)
T 2bdw_A          108 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  179 (362)
T ss_dssp             CCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCB
T ss_pred             ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcce
Confidence            99999999998854     3458999999999999999999999   8999999999999998654   59999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+    ..+... .
T Consensus       180 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~~i----~~~~~~-~  249 (362)
T 2bdw_A          180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYAQI----KAGAYD-Y  249 (362)
T ss_dssp             CCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHTCCC-C
T ss_pred             EecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH----HhCCCC-C
Confidence            765432  233457999999999999889999999999999999999999999765332   111111    111110 0


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        +  ..........+.+|+.+||+.||.+||++.|++++
T Consensus       250 --~--~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          250 --P--SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             --C--TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             --C--cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0  00112334668899999999999999999999875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2e-40  Score=339.19  Aligned_cols=249  Identities=29%  Similarity=0.491  Sum_probs=195.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch----hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR----QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~----~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|.+  .+..||||++.....    ...+.+.+|+.++++++||||+++++++...+..++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            5788899999999999999998  478999999865432    3356789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC---EEeCCcCCCceEeCC--------CCCe
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR---VVHRDVKPSNVLIDA--------DLNP  499 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivH~Dlkp~NIll~~--------~~~~  499 (662)
                      |||+++++|.+++.      ...+++..++.++.|+++||.|||+   .+   |+||||||+||+++.        ++.+
T Consensus        85 ~e~~~~~~L~~~~~------~~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           85 MEFARGGPLNRVLS------GKRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EECCTTEEHHHHHT------SSCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEcCCCCCHHHHhh------cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence            99999999999984      3458999999999999999999999   56   999999999999986        6789


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      ||+|||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      ...
T Consensus       156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~  226 (271)
T 3dtc_A          156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGV  226 (271)
T ss_dssp             EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHH
T ss_pred             EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhh
Confidence            999999998655432   22357899999999998888999999999999999999999999865432111      111


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .. ..    ..   ...+......+.+++.+||+.||.+||++.|++++|++
T Consensus       227 ~~-~~----~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          227 AM-NK----LA---LPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             HT-SC----CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             hc-CC----CC---CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence            11 11    11   11223345678899999999999999999999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-40  Score=344.93  Aligned_cols=246  Identities=25%  Similarity=0.336  Sum_probs=207.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+++...+|+.||+|++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            57889999999999999999999899999999997642   234567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            99999999999954     3458899999999999999999999   899999999999999999999999999998754


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ...... +.      .
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~~i~~-~~------~  220 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILN-AE------L  220 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHH-CC------C
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CC------C
Confidence            32    2345799999999999988999999999999999999999999976533211      111111 11      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||     ++++++++
T Consensus       221 ~---~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 R---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C---CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            1   1223345678899999999999999     89999863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.4e-41  Score=364.36  Aligned_cols=268  Identities=24%  Similarity=0.264  Sum_probs=215.3

Q ss_pred             ccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeee
Q 040242          342 ACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLH  418 (662)
Q Consensus       342 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~  418 (662)
                      +..++++++....++|+..++||+|+||+||+++.+.+|+.||||++.+..   ....+.+.+|..++.+++||||++++
T Consensus        48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            445667777778899999999999999999999999899999999997642   22334578999999999999999999


Q ss_pred             eeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       419 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      +++...+.+++||||+++|+|.+++...    ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~  200 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGH  200 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSC
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCC
Confidence            9999999999999999999999999543    2468999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCccccc-------CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR-------TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV  571 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  571 (662)
                      +||+|||+++..............||+.|+|||++.       ...++.++|||||||++|||++|+.||..........
T Consensus       201 vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~  280 (412)
T 2vd5_A          201 IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG  280 (412)
T ss_dssp             EEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999876554333333468999999999986       3568999999999999999999999998654322111


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFR---PSTRRVVQF  628 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R---Pt~~eVl~~  628 (662)
                        ..+.. ..     ...-|.   ........+.+|+.+||+ +|.+|   |+++|++++
T Consensus       281 --~i~~~-~~-----~~~~p~---~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          281 --KIVHY-KE-----HLSLPL---VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --HHHTH-HH-----HCCCC-------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --HHHhc-cc-----CcCCCc---cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence              11100 00     000111   112234567889999999 99998   699999874

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.3e-40  Score=347.89  Aligned_cols=261  Identities=25%  Similarity=0.376  Sum_probs=212.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      .++|...+.||+|+||.||+|...     .++..||||++... .....+.+.+|+.++++++||||+++++++...+..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  101 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL  101 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence            467888999999999999999873     45588999999764 344567899999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhccccccc-------------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCC
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQ-------------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKP  488 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp  488 (662)
                      ++||||+++++|.+++......                   ....+++.+++.++.|+++||.|||+   .+|+||||||
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp  178 (314)
T 2ivs_A          102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA  178 (314)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSG
T ss_pred             EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccch
Confidence            9999999999999999754310                   12458999999999999999999999   8999999999


Q ss_pred             CceEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 040242          489 SNVLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRT  566 (662)
Q Consensus       489 ~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~  566 (662)
                      +||+++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999876543221 2233457889999999988889999999999999999999 9999976543


Q ss_pred             hhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          567 AMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       567 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ...   ...+    ..+.     .   ...+......+.+++.+||+.||.+||++.+++++|++.
T Consensus       259 ~~~---~~~~----~~~~-----~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          259 ERL---FNLL----KTGH-----R---MERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             GGH---HHHH----HTTC-----C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH---HHHh----hcCC-----c---CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            221   1111    1111     0   112223456788999999999999999999999998753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-40  Score=361.81  Aligned_cols=254  Identities=23%  Similarity=0.313  Sum_probs=207.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|....+|+.+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            467899999999999999999999999999999997643  344567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC---CCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~  508 (662)
                      ||+++|+|.+.+..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++   .++.+||+|||+++
T Consensus        90 E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           90 DLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             CCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999998854     3458999999999999999999999   8999999999999998   56789999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ...... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......   +...+    ..+.. ..
T Consensus       162 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~~~i----~~~~~-~~  232 (444)
T 3soa_A          162 EVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LYQQI----KAGAY-DF  232 (444)
T ss_dssp             CCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HHTCC-CC
T ss_pred             EecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HHHHH----HhCCC-CC
Confidence            765432 22334679999999999998899999999999999999999999997654321   11111    11111 11


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      -.+..    ......+.+|+.+||+.||.+|||+.|++++
T Consensus       233 ~~~~~----~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 PSPEW----DTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             CTTTT----TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             Ccccc----ccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            11111    1234567889999999999999999999984

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.1e-40  Score=367.34  Aligned_cols=257  Identities=28%  Similarity=0.422  Sum_probs=204.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+.++++++||||+++++++.. +..++||||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~  259 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY  259 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehh
Confidence            4678889999999999999999954 5679999997653 235689999999999999999999999976 678999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|+|.+++....   ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       260 ~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  333 (452)
T 1fmk_A          260 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN  333 (452)
T ss_dssp             CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred             hcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCC
Confidence            99999999996432   3458999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .........++..|+|||.+..+.++.++|||||||++|||++ |+.||.......   +...    ...+.       +
T Consensus       334 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~----i~~~~-------~  399 (452)
T 1fmk_A          334 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQ----VERGY-------R  399 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTTC-------C
T ss_pred             ceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCC-------C
Confidence            3233334457889999999988899999999999999999999 999997543321   1111    11111       0


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                       ...+...+..+.+|+.+||+.||++|||+.++++.|+....
T Consensus       400 -~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          400 -MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence             11223445678899999999999999999999999987643

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.1e-41  Score=353.84  Aligned_cols=270  Identities=23%  Similarity=0.320  Sum_probs=213.2

Q ss_pred             cCCcccceeeeeCceEEEEEE----eCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe--ccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGV----IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR--KQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~----~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~  428 (662)
                      ++|+..+.||+|+||.||++.    ...++..||||++........+.+.+|+.++++++||||+++++++.  ..+..+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            578889999999999999999    45678999999998877777788999999999999999999999886  455689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus       103 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  175 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRH----RARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAK  175 (327)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred             EEEeecCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccce
Confidence            999999999999999643    3469999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          509 AYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       509 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ........  ......||..|+|||.+.+..++.++|||||||++|||++|+.||.......... ..+.........+.
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~  254 (327)
T 3lxl_A          176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-MGCERDVPALSRLL  254 (327)
T ss_dssp             ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-CC----CCHHHHHH
T ss_pred             ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-cccccccccHHHHH
Confidence            76543221  2233467888999999988889999999999999999999999986433211000 00000000000001


Q ss_pred             cccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          587 RAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       587 ~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +.+.... ...+......+.+|+.+||+.||.+||++.|++++|+..
T Consensus       255 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  301 (327)
T 3lxl_A          255 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML  301 (327)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC
T ss_pred             HHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111111 122334556788999999999999999999999999865

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=5.6e-40  Score=338.90  Aligned_cols=253  Identities=25%  Similarity=0.483  Sum_probs=205.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-------hHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-------GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-------~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      .++|+..+.||+|+||+||+|.+..+++.||||++......       ..+.+.+|+.++++++||||+++++++.... 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            36788899999999999999999889999999998654321       1267899999999999999999999997655 


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeCCCCC-----e
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLIDADLN-----P  499 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~-----~  499 (662)
                       ++||||+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+  |+||||||+||+++.++.     +
T Consensus        97 -~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             -eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence             7999999999999988654    4569999999999999999999999   77  999999999999988776     9


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCccccc--CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR--TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ||+|||+++....    ......||+.|+|||.+.  ...++.++|||||||++|||++|+.||......... ....+.
T Consensus       169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~  243 (287)
T 4f0f_A          169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK-FINMIR  243 (287)
T ss_dssp             EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH-HHHHHH
T ss_pred             EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH-HHHHHh
Confidence            9999999985432    234467899999999983  455789999999999999999999999765433211 111111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         ..     ...+.   .+......+.+++.+||+.||.+||++.|+++.|++
T Consensus       244 ---~~-----~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 ---EE-----GLRPT---IPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             ---HS-----CCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---cc-----CCCCC---CCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence               11     11111   223345678899999999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-40  Score=344.44  Aligned_cols=262  Identities=27%  Similarity=0.353  Sum_probs=202.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||+||+|.+. +++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            367899999999999999999995 58999999996542  233567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||++ ++|.+++...    ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        99 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           99 EFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             ECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             cCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            9997 5888877543    3458999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc------
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ------  584 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~------  584 (662)
                      ... .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........   .+........      
T Consensus       171 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~  246 (311)
T 3niz_A          171 IPV-RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQ  246 (311)
T ss_dssp             SCC-C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGG
T ss_pred             CCc-ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhh
Confidence            432 22334578999999998876 568999999999999999999999998654433221   1111111000      


Q ss_pred             ----------cccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ----------ITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ----------~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                ..+..+... ....+.....+.+|+.+||+.||.+|||++|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                      000000000 00111233567899999999999999999999974

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2.5e-40  Score=364.24  Aligned_cols=249  Identities=29%  Similarity=0.403  Sum_probs=205.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC-eeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD-ELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  432 (662)
                      .++|+..+.||+|+||.||+|.+.  ++.||||++....  ..+.|.+|+.++++++||||++++++|...+ ..++|||
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            467888999999999999999984  7799999997653  4568999999999999999999999987665 7999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.+++....   ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       268 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  341 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  341 (450)
T ss_dssp             CCTTCBHHHHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence            999999999996542   3457899999999999999999999   8999999999999999999999999999985433


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .    .....++..|+|||.+.+..++.++|||||||++|||++ |+.||........   ...    ...+.     . 
T Consensus       342 ~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~----i~~~~-----~-  404 (450)
T 1k9a_A          342 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPR----VEKGY-----K-  404 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHH----HHTTC-----C-
T ss_pred             c----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCC-----C-
Confidence            2    122357889999999999999999999999999999998 9999976543211   111    11111     0 


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ...+...+..+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       405 --~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          405 --MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              11223345678899999999999999999999999875

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.9e-39  Score=348.89  Aligned_cols=250  Identities=26%  Similarity=0.365  Sum_probs=207.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||++....+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999999999999999997642   334577899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|..++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            99999999999954     3458999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..  .......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+......          
T Consensus       167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~----------  234 (384)
T 4fr4_A          167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFET----------  234 (384)
T ss_dssp             TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHH----------
T ss_pred             CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhh----------
Confidence            43  23345679999999999864   4588999999999999999999999975433222222111111          


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-TRRVVQ  627 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~  627 (662)
                         ....++......+..|+.+||+.||.+||+ +.+|.+
T Consensus       235 ---~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          235 ---TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               011122334567889999999999999998 777775

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=348.14  Aligned_cols=269  Identities=23%  Similarity=0.285  Sum_probs=211.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe----ccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR----KQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~----~~~~~~l  429 (662)
                      .++|+..+.||+|+||.||++....+++.||||++........+.+.+|+.++++++||||+++++++.    .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            367899999999999999999998899999999997776677788999999999999999999999987    3447899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++..... ....+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus       108 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            9999999999999965321 14568999999999999999999999   8999999999999999999999999999876


Q ss_pred             ccCCCCC--------cceecccCCcccCcccccCCC---CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          510 YDHNINP--------QTTHIVGTLGYLAPELTRTGK---ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       510 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      .......        ......||+.|+|||.+....   ++.++|||||||++|||++|+.||.......... ...+  
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-~~~~--  260 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV-ALAV--  260 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH-HHHH--
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh-hHHh--
Confidence            5321111        012245799999999987543   6889999999999999999999986421111110 0000  


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAP  639 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p  639 (662)
                        .. .    .  .. .........+.+++.+||+.||.+||++.+++++|+...+.++.+
T Consensus       261 --~~-~----~--~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  311 (317)
T 2buj_A          261 --QN-Q----L--SI-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQ  311 (317)
T ss_dssp             --HC-C--------C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC-
T ss_pred             --hc-c----C--CC-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCCC
Confidence              00 0    0  00 111233456889999999999999999999999999876554443

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.9e-40  Score=351.65  Aligned_cols=253  Identities=25%  Similarity=0.346  Sum_probs=192.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++....  ..+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            3467888999999999999999998889999999997653  34568899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~  509 (662)
                      |+++++|.+++...     ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.   ++.+||+|||+++.
T Consensus       129 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~  200 (349)
T 2w4o_A          129 LVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI  200 (349)
T ss_dssp             CCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred             eCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence            99999999998543     458999999999999999999999   89999999999999975   88999999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +.   ... ..... ...
T Consensus       201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~---~~i-~~~~~-~~~  271 (349)
T 2w4o_A          201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--MF---RRI-LNCEY-YFI  271 (349)
T ss_dssp             --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--HH---HHH-HTTCC-CCC
T ss_pred             cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--HH---HHH-HhCCC-ccC
Confidence            65432  22345789999999999988999999999999999999999999975543211  11   111 11110 011


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ..........+.+|+.+||+.||++||++.|++++
T Consensus       272 ----~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          272 ----SPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ----TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----CchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                11122345668899999999999999999999984

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=5.8e-41  Score=348.75  Aligned_cols=261  Identities=25%  Similarity=0.388  Sum_probs=206.7

Q ss_pred             cCCcccceeeeeCceEEEEEE----eCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc--Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGV----IPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~----~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  427 (662)
                      +.|+..+.||+|+||.||+|.    ...+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ...
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            457889999999999999999    45678999999997543 34457889999999999999999999999876  568


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccc
Confidence            9999999999999999543    3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch---------hhHHHHHHH
Q 040242          508 RAYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA---------MELVLVDWV  576 (662)
Q Consensus       508 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~---------~~~~l~~~~  576 (662)
                      +.......  .......||..|+|||.+.+..++.++||||||+++|||++|+.|+......         .........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            87765432  1223356788899999998888999999999999999999999986432110         000111111


Q ss_pred             HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       577 ~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       .....+.        ....+......+.+|+.+||+.||.+|||+.++++.|+.
T Consensus       254 -~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          254 -NTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             -HHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             -HHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence             1111111        111233445678899999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-40  Score=338.17  Aligned_cols=249  Identities=24%  Similarity=0.415  Sum_probs=186.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|+...+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            57888999999999999999998889999999996542   223467899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        91 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             ECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            999999999999643    3568999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........               ......
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------------~~~~~~  227 (278)
T 3cok_A          164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------------NKVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------------HHHhhc
Confidence            3322 223357899999999998888999999999999999999999999754322110               000001


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .. ..+......+.+++.+||+.||++||++.++++
T Consensus       228 ~~-~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          228 DY-EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CC-CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc-CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11 112233456789999999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-40  Score=357.33  Aligned_cols=256  Identities=23%  Similarity=0.307  Sum_probs=204.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..++||+|+||+||+++.+.+++.||||++.+..   ....+.+..|..++.++ +||||+++++++...+.+++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            357899999999999999999999999999999997653   22334578899999887 89999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|..++..     ...+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       131 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEcCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            9999999999999853     3468999999999999999999999   8999999999999999999999999999985


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh--HHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME--LVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~  587 (662)
                      .... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||........  ....+++.+......   
T Consensus       203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~---  278 (396)
T 4dc2_A          203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ---  278 (396)
T ss_dssp             CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC---
T ss_pred             cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc---
Confidence            3322 2234456899999999999999999999999999999999999999964321110  000111111111111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST------RRVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~eVl~  627 (662)
                         .   .++......+.+|+.+||+.||.+||++      .||++
T Consensus       279 ---~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 ---I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             ---C---CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             ---c---CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence               1   1222344567889999999999999985      67765

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.5e-40  Score=337.51  Aligned_cols=254  Identities=27%  Similarity=0.418  Sum_probs=208.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||.||++... ++..||+|++..... ..+++.+|+.++++++||||+++++++...+..++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            56888999999999999999995 678899999976533 3467899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        86 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           86 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             TTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            999999999543    3468999999999999999999999   899999999999999999999999999998764322


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........++..|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..   ... ..+.     .+  
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~i-~~~~-----~~--  224 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---EDI-STGF-----RL--  224 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHH-HTTC-----CC--
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH---HHH-hcCC-----cC--
Confidence            122223456789999999988889999999999999999999 899987543221   11   111 1110     01  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       ..+......+.+++.+||+.||.+||++.+++++|+..
T Consensus       225 -~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          225 -YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             11122345688899999999999999999999999753

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.2e-40  Score=336.12  Aligned_cols=250  Identities=19%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|++  .+..||||++...  .....+.|.+|+.++++++||||+++++++...  +..++|
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            5688899999999999999999  4789999999764  344567899999999999999999999999887  788999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      |||+++|+|.+++....   ...+++.+++.++.|+++||.|||+   .+  ++||||||+||+++.++.++|+|||+..
T Consensus        88 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             ecccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999996543   3468999999999999999999998   67  9999999999999999999999998876


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCc---chhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATT---STDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~---ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      .....      ...||+.|+|||.+.+...+.   ++|||||||++|||++|+.||........      .......   
T Consensus       162 ~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~---  226 (271)
T 3kmu_A          162 SFQSP------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVALE---  226 (271)
T ss_dssp             TTSCT------TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHHS---
T ss_pred             eeccc------CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHhc---
Confidence            53322      246799999999987655443   79999999999999999999976543211      1111111   


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        ...+.   .+......+.+++.+||+.||.+|||+.++++.|+..
T Consensus       227 --~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          227 --GLRPT---IPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             --CCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              11111   2223455688999999999999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-40  Score=350.39  Aligned_cols=285  Identities=25%  Similarity=0.343  Sum_probs=207.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh-HHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~-~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|...+.||+|+||+||+|....+++.||||++....... ...+.+|+.++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57888999999999999999998899999999996543222 22456799999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      ++ |+|.+++...    ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.....
T Consensus        82 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            96 6898888544    3468999999999999999999999   89999999999999999999999999999865433


Q ss_pred             CCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---cccccc
Q 040242          514 INPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---QITRAI  589 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~i  589 (662)
                      . .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   ..+.......   ......
T Consensus       154 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          154 T-KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             ----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGG
T ss_pred             c-cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhh
Confidence            2 22233568999999998876 56899999999999999999999999865443222   1222211100   000000


Q ss_pred             ---------CCCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC-CCCCCCCCCCCCCCCCCCC
Q 040242          590 ---------DPTLDY-----FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRD-ASLPQAPLDIHHEFPRAIP  651 (662)
Q Consensus       590 ---------d~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~-~~~p~~p~~~~~~~~~~~~  651 (662)
                               .+....     ........+.+|+.+||+.||.+|||++|++++  +.+. ......|............
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~~~  308 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQ  308 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSSSCTTSCGGGSTTCC
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccccccCCCCCcHhHHHHHH
Confidence                     000000     011234567899999999999999999999983  3332 3333444444333333333

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1e-40  Score=354.15  Aligned_cols=251  Identities=24%  Similarity=0.340  Sum_probs=207.1

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ...++|...+.||+|+||+||+|+.+.+|+.||||++....   ....+.+..|..++.++ +||||+++++++...+..
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            34578999999999999999999999899999999997642   33456678899999887 899999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++|+|.+++..     ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        94 ~lv~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            999999999999999853     3468999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      +...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +...+.    .+    
T Consensus       166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~----~~----  233 (345)
T 1xjd_A          166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR----MD----  233 (345)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HC----
T ss_pred             hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHH----hC----
Confidence            8643221 23345689999999999998899999999999999999999999998654321   111111    11    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR-RVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl~  627 (662)
                        .+.+   +......+.+++.+||+.||.+||++. +|++
T Consensus       234 --~~~~---p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          234 --NPFY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             --CCCC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCCC---CcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence              1111   222345678899999999999999997 7764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-40  Score=354.60  Aligned_cols=274  Identities=22%  Similarity=0.297  Sum_probs=214.7

Q ss_pred             ccccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-----ccccee
Q 040242          342 ACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-----HRNLVQ  416 (662)
Q Consensus       342 ~~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----H~niv~  416 (662)
                      ...+++.+.....++|...++||+|+||+||+|++..+++.||||++... ....+.+..|+.++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            44566667667788999999999999999999999889999999999653 334566778999999886     999999


Q ss_pred             eeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-
Q 040242          417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-  495 (662)
Q Consensus       417 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-  495 (662)
                      +++++...+..++||||+ +++|.+++....   ...+++..+..++.||+.||.|||+   .+|+||||||+|||++. 
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~  173 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDP  173 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCT
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccc
Confidence            999999999999999999 999999996543   3458999999999999999999999   89999999999999975 


Q ss_pred             ------------------------CCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHH
Q 040242          496 ------------------------DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLM  551 (662)
Q Consensus       496 ------------------------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl  551 (662)
                                              ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  249 (360)
T 3llt_A          174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL  249 (360)
T ss_dssp             TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHH
T ss_pred             cccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHH
Confidence                                    788999999999865432    2345789999999999999999999999999999


Q ss_pred             HHHHcCCCCCCcccchhhHHHHHHH---------HHHhhcCccccccCC-CC----C-C-C---------------CHHH
Q 040242          552 LEVACGRRPIEPQRTAMELVLVDWV---------RELHSQGQITRAIDP-TL----D-Y-F---------------DPQE  600 (662)
Q Consensus       552 ~elltG~~p~~~~~~~~~~~l~~~~---------~~~~~~~~~~~~id~-~l----~-~-~---------------~~~~  600 (662)
                      |||++|+.||...............         ...... .....++. .+    . . .               ....
T Consensus       250 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (360)
T 3llt_A          250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT-NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIK  328 (360)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTS-GGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCC
T ss_pred             HHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhc-cCccccCcccceecCcccccchhhhhhhhhcccccccch
Confidence            9999999999865433222111110         000000 00000000 00    0 0 0               0011


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          601 AELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       601 ~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...+.+|+.+||+.||.+|||+.|++++
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            2567799999999999999999999864

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=6.1e-40  Score=339.39  Aligned_cols=259  Identities=25%  Similarity=0.443  Sum_probs=199.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..++||+|+||+||+|++..   .||||++...  .....+.|.+|+.++++++||||+++++++ ..+..++||
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~   98 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVT   98 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEE
Confidence            3678999999999999999998743   5999998654  345567899999999999999999999976 455689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        99 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           99 QWCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccc
Confidence            999999999999654    4568999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCC-CCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          512 HNI-NPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       512 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ... ........||+.|+|||.+.   ...++.++||||||+++|||++|+.||........  +...    ...+.   
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~----~~~~~---  242 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEM----VGRGS---  242 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHH----HHHTS---
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHH----hcccc---
Confidence            321 22233457899999999886   56788899999999999999999999976543321  1111    11221   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                       ..+.+..........+.+++.+||+.||.+||++.++++.|+...
T Consensus       243 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          243 -LSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             -CCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -cCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence             122222233345577889999999999999999999999998754

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.9e-40  Score=347.24  Aligned_cols=256  Identities=23%  Similarity=0.306  Sum_probs=206.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+++.+.+++.||||++.+.   .....+.+..|..++.++ +||||+++++++...+..++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            5688899999999999999999989999999999764   234456788999999988 899999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        89 ~e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             ECCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            999999999999853     3468999999999999999999999   89999999999999999999999999999864


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh--HHHHHHHHHHhhcCccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME--LVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~--~~l~~~~~~~~~~~~~~~~  588 (662)
                      .... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........  ......+.+......    
T Consensus       161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~----  235 (345)
T 3a8x_A          161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ----  235 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC----
T ss_pred             cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC----
Confidence            3221 233446899999999999988999999999999999999999999974321110  000111111111111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST------RRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~------~eVl~~  628 (662)
                        .   .++......+.+|+.+||+.||.+||++      .|++++
T Consensus       236 --~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          236 --I---RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             --C---CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             --C---CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence              1   1122344567889999999999999995      677753

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.1e-40  Score=350.13  Aligned_cols=271  Identities=23%  Similarity=0.370  Sum_probs=216.9

Q ss_pred             chHHHHHhccCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeee
Q 040242          346 RYSELYSATKGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHG  419 (662)
Q Consensus       346 ~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~  419 (662)
                      ..++.....++|+..+.||+|+||.||+|.+.     ..+..||||++.... ......+.+|+.++++++||||+++++
T Consensus        16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            33444556688999999999999999999875     346789999997543 344567899999999999999999999


Q ss_pred             eEeccCeeeEEEeccCCCCcchhccccccc-----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQ-----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       420 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ++...+..++||||+++|+|.+++......     ....+++..++.++.|+++||.|||+   .+|+||||||+||+++
T Consensus        96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~  172 (322)
T 1p4o_A           96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVA  172 (322)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEEC
T ss_pred             EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEc
Confidence            999999999999999999999999653211     01457899999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +
T Consensus       173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  249 (322)
T 1p4o_A          173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---V  249 (322)
T ss_dssp             TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---H
T ss_pred             CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---H
Confidence            999999999999986543321 12223456889999999988889999999999999999999 888987543221   1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      ...    ...+.        ....+......+.+++.+||+.||.+||++.|++++|+....
T Consensus       250 ~~~----~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          250 LRF----VMEGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHH----HHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHH----HHcCC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111    11111        111222345668899999999999999999999999987644

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=4.9e-40  Score=339.95  Aligned_cols=261  Identities=25%  Similarity=0.379  Sum_probs=202.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            4788899999999999999999 578899999986543  2234678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++ +|.+++...    ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        81 ~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (288)
T ss_dssp             CCSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             ecCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence            9975 998888543    3568899999999999999999999   8999999999999999999999999999987653


Q ss_pred             CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC--------
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG--------  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--------  583 (662)
                      .. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........  . .+.......        
T Consensus       153 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~-~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          153 PV-RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--M-RIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--H-HHHHHHCCCCTTTSTTG
T ss_pred             cc-cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--H-HHHHHHCCCChhhchhh
Confidence            32 122335789999999998654 5899999999999999999999999865432211  1 111111100        


Q ss_pred             ccccccCCCCC--------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLD--------YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~--------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ......++...        .........+.+|+.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00011111111        1112345677899999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.4e-40  Score=348.10  Aligned_cols=255  Identities=23%  Similarity=0.342  Sum_probs=198.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCe----
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE----  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~----  426 (662)
                      .++|+..+.||+|+||.||++.+..+++.||||++...   .......+.+|+.++++++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            36789999999999999999999889999999999764   23445678999999999999999999999876653    


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence            4999999999999999953     3468999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++.......  .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........      .........
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~  236 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP  236 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC
Confidence            987654322  223345789999999999998999999999999999999999999976543211      111111110


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..    +  ..........+.+++.+||+.||.+||+..+++++
T Consensus       237 ~~----~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          237 IP----P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             CC----H--HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CC----c--ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence            00    0  00011234568899999999999999977766653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.7e-41  Score=353.28  Aligned_cols=259  Identities=24%  Similarity=0.366  Sum_probs=203.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcE----EEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLE----VAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~----vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|+..++||+|+||+||+|.+..+++.    |++|.+... .....+++.+|+.++++++||||++++++|.... .++
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   93 (327)
T 3lzb_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL   93 (327)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred             hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence            6788999999999999999998777664    577776543 3445678999999999999999999999998754 789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |+||+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            99999999999999654    3568999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........   ...+    ..+.   
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~~~----~~~~---  236 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSIL----EKGE---  236 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH----HTTC---
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHH----HcCC---
Confidence            6543221 2223456889999999998899999999999999999999 9999986543321   1111    1111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                           ....+......+.+++.+||+.||.+||++.|+++.|++....|
T Consensus       237 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          237 -----RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -----CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -----CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence                 01112234456888999999999999999999999998765443

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-40  Score=341.95  Aligned_cols=264  Identities=22%  Similarity=0.361  Sum_probs=211.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEe--ccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCR--KQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~l  429 (662)
                      .++|+..+.||+|+||.||++....+++.||+|++...  .....+.+.+|+.++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            36788999999999999999999889999999999754  3445678999999999999999999999874  4568999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC-----EEeCCcCCCceEeCCCCCeEEeec
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR-----VVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ||||+++++|.+++..... ....+++..++.++.|+++||.|||+   .+     ++||||||+||+++.++.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999965421 13458999999999999999999999   56     999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+++...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||......   .+...+    ..+.
T Consensus       161 g~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~i----~~~~  232 (279)
T 2w5a_A          161 GLARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI----REGK  232 (279)
T ss_dssp             CHHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH----HHTC
T ss_pred             chheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHHHH----hhcc
Confidence            9998764432 1122346899999999999888999999999999999999999999865322   111111    1111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQ  637 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~  637 (662)
                      .        ...+......+.+++.+||+.||.+||++.||++++....+.+.
T Consensus       233 ~--------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  277 (279)
T 2w5a_A          233 F--------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHH  277 (279)
T ss_dssp             C--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGSC
T ss_pred             c--------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhccc
Confidence            1        11122344678899999999999999999999998876655443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.8e-40  Score=344.46  Aligned_cols=267  Identities=25%  Similarity=0.413  Sum_probs=194.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|+..+.||+|+||+||+|....+|+.||+|++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4678899999999999999999988999999999976532 334678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhccccccc-ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQ-KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |++ ++|.+++...... ....+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 6999988643211 12458999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--Ccc---
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--GQI---  585 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~~~---  585 (662)
                      .... ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.........   ..+......  ...   
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhh
Confidence            4322 2233578999999999876 46899999999999999999999999865443221   111111110  000   


Q ss_pred             ---ccccCCCCCC-------------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 ---TRAIDPTLDY-------------FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ---~~~id~~l~~-------------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         .....+.+..             ........+.+++.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence               0000111100             011234568899999999999999999999874

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3e-40  Score=353.51  Aligned_cols=267  Identities=18%  Similarity=0.211  Sum_probs=206.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCC-----CcEEEEEEeeccchhhH-----------HHHHHHHHHhhcccccccee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPST-----GLEVAIKRVAHNSRQGM-----------KEFVAEITSMGRLRHRNLVQ  416 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~-----g~~vavK~~~~~~~~~~-----------~~f~~Ei~~l~~l~H~niv~  416 (662)
                      ..++|+..++||+|+||.||+|.+..+     ++.||||++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            346899999999999999999998654     47899999876542211           23455677788889999999


Q ss_pred             eeeeEecc----CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceE
Q 040242          417 LHGWCRKQ----DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVL  492 (662)
Q Consensus       417 l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIl  492 (662)
                      +++++...    ...++||||+ +++|.+++...    ...+++.+++.++.||+.||.|||+   .+|+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEE
Confidence            99998765    4589999999 99999999643    3569999999999999999999999   89999999999999


Q ss_pred             eC--CCCCeEEeeccccccccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcc
Q 040242          493 ID--ADLNPKLGDFGLARAYDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQ  564 (662)
Q Consensus       493 l~--~~~~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~  564 (662)
                      ++  .++.+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            99  8899999999999876543211      113345999999999999989999999999999999999999999854


Q ss_pred             cchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          565 RTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       565 ~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .....  ...+....+.. .+.+.+++.+.  ....+..+.+++..||+.+|.+||++.+|++.|...
T Consensus       265 ~~~~~--~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          265 LKDPK--YVRDSKIRYRE-NIASLMDKCFP--AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             TTCHH--HHHHHHHHHHH-CHHHHHHHHSC--TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCHH--HHHHHHHHhhh-hHHHHHHHhcc--cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            32211  11122211111 12222222221  112345688899999999999999999999988644

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.5e-39  Score=335.01  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=208.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46899999999999999999999989999999999654  3445577889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGla~  508 (662)
                      ||+++++|.+.+..     ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++.
T Consensus        85 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           85 DLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            99999999888843     3458999999999999999999999   89999999999999987665   9999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........   ...+    ..+.. ..
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~---~~~~----~~~~~-~~  226 (284)
T 3kk8_A          157 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---YAQI----KAGAY-DY  226 (284)
T ss_dssp             ECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTCC-CC
T ss_pred             EcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH---HHHH----Hhccc-cC
Confidence            765432  22345789999999999998999999999999999999999999976543211   1111    11111 11


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+.    .......+.+++.+||+.||++||++.|++++
T Consensus       227 ~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 PSPE----WDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             CTTT----TTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             Cchh----hcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1111    11234567889999999999999999999984

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=5.5e-40  Score=337.15  Aligned_cols=248  Identities=24%  Similarity=0.363  Sum_probs=208.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|....++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            35788899999999999999999989999999999877666678899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~  510 (662)
                      +++++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||++   +.++.+||+|||++...
T Consensus        88 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           88 CTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             cCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            999999998853     3458999999999999999999999   899999999999999   88899999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........      .. ...+..     
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~-~~~~~~-----  224 (277)
T 3f3z_A          160 KPGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVM------LK-IREGTF-----  224 (277)
T ss_dssp             CTTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HH-HHHCCC-----
T ss_pred             cCcc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHH------HH-HHhCCC-----
Confidence            5432  2334578999999998865 4899999999999999999999999765432111      11 111110     


Q ss_pred             CCCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDP----QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          ..+.    .....+.+++.+||+.||.+||++.+++++
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          225 ----TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                0111    234568899999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.1e-40  Score=338.63  Aligned_cols=249  Identities=26%  Similarity=0.422  Sum_probs=204.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      +.++|+..+.||+|+||.||+|....++..||||++....   ......+.+|+.++++++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            3467889999999999999999999999999999996542   2235678999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++..     ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            9999999999999843     3458999999999999999999999   8999999999999999999999999999865


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ....   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........   ..+    ..      .
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~----~~------~  222 (279)
T 3fdn_A          159 APSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY---KRI----SR------V  222 (279)
T ss_dssp             C-----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHH----HH------T
T ss_pred             CCcc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH---HHH----Hh------C
Confidence            4332   223457899999999999889999999999999999999999999865432111   111    11      0


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...   .+......+.+|+.+||+.||.+||+++|++++
T Consensus       223 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 EFT---FPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCC---CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCC---CCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111   122234567889999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-40  Score=348.78  Aligned_cols=264  Identities=24%  Similarity=0.371  Sum_probs=210.4

Q ss_pred             hccCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ..++|...+.||+|+||.||+|.+     ..++..||||++.... ....+.+.+|+.++.++ +||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457889999999999999999997     2456789999997542 33456789999999999 8999999999999999


Q ss_pred             eeeEEEeccCCCCcchhccccccc------------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQ------------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK  487 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  487 (662)
                      ..++||||+++|+|.+++......                  ....+++..++.++.||++||.|||+   .+|+|||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik  199 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA  199 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence            999999999999999999754310                  01348999999999999999999999   899999999


Q ss_pred             CCceEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCccc
Q 040242          488 PSNVLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQR  565 (662)
Q Consensus       488 p~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~  565 (662)
                      |+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||....
T Consensus       200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999999999999999999876543322 2223467889999999988899999999999999999998 999997654


Q ss_pred             chhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          566 TAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       566 ~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ....  +...+    ..+     ..+   ..+......+..|+.+||+.||.+||++.+++++|....
T Consensus       280 ~~~~--~~~~~----~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          280 VDAN--FYKLI----QNG-----FKM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             CSHH--HHHHH----HTT-----CCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cHHH--HHHHH----hcC-----CCC---CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            3221  11111    111     111   112233566888999999999999999999999997653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-40  Score=344.19  Aligned_cols=262  Identities=22%  Similarity=0.373  Sum_probs=212.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~  426 (662)
                      .++|+..+.||+|+||.||+|.+     ..++..||||++.... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~  101 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence            36788899999999999999985     3467899999997653 34457899999999999 99999999999999999


Q ss_pred             eeEEEeccCCCCcchhccccccc-------------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ-------------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI  493 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  493 (662)
                      .++||||+++|+|.+++......             ....+++.+++.++.|+++||.|||+   .+|+||||||+||++
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~  178 (313)
T 1t46_A          102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (313)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEE
Confidence            99999999999999999754310             12358999999999999999999999   899999999999999


Q ss_pred             CCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHH
Q 040242          494 DADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELV  571 (662)
Q Consensus       494 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  571 (662)
                      +.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........  
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--  256 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH--
Confidence            99999999999999876554322 1223457889999999988899999999999999999999 9999976543221  


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +...+.    .+     ..+.   .+......+.+++.+||+.||.+||++.|++++|++.
T Consensus       257 ~~~~~~----~~-----~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 FYKMIK----EG-----FRML---SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HHHHHH----HT-----CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhc----cC-----CCCC---CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            111111    11     1111   1123346688999999999999999999999999754

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.6e-40  Score=339.92  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=207.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|... ++..||||++.... ...+.+.+|++++++++||||+++++++. .+..++||||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   88 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY   88 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEec
Confidence            367888999999999999999985 56789999996543 33567899999999999999999999986 4568999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        89 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  162 (279)
T 1qpc_A           89 MENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (279)
T ss_dssp             CTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             CCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence            99999999996432   3468999999999999999999999   89999999999999999999999999999876544


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .........++..|+|||.+.++.++.++||||||+++|||++ |+.||.......   +...+    ..+     ... 
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~-----~~~-  229 (279)
T 1qpc_A          163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNL----ERG-----YRM-  229 (279)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTT-----CCC-
T ss_pred             ccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHH----hcc-----cCC-
Confidence            3222333456789999999988889999999999999999999 899997543321   11111    111     011 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        ..+......+.+++.+|++.||++||++.++++.|+..
T Consensus       230 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          230 --VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence              11223346788999999999999999999999988753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.1e-40  Score=342.03  Aligned_cols=263  Identities=24%  Similarity=0.289  Sum_probs=203.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      -++|+..+.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367999999999999999999998889999999997542   33357789999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            999999999999953     3458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ............|++.|+|||.+.+..++.++||||||+++|||++|+.||......   .+    ........      
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~~~~~~------  251 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM----GAHINQAI------  251 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH----HHHHHSCC------
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH----HHHhccCC------
Confidence            554333334457899999999999889999999999999999999999999865322   11    11111110      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCCCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRP-STRRVVQFLLRDASLPQ  637 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~~~~~p~  637 (662)
                      +............+.+++.+||+.||.+|| +++++++.|+....-+.
T Consensus       252 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          252 PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            011111223345688899999999999999 99999999987654443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.2e-40  Score=344.82  Aligned_cols=270  Identities=27%  Similarity=0.452  Sum_probs=204.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|....+|..||||++...   .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            5688899999999999999999888999999999753   3445678899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..... ....+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++...
T Consensus       112 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             ECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             ecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            99999999999864321 14568999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ .+   ... ......     +
T Consensus       188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~---~~~-~~~~~~-----~  256 (310)
T 2wqm_A          188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SL---CKK-IEQCDY-----P  256 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HH---HHH-HHTTCS-----C
T ss_pred             CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HH---HHH-hhcccC-----C
Confidence            432 122335689999999999988999999999999999999999999975432211 11   111 111111     1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLD  641 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~~  641 (662)
                      .+  ........+.+++.+||+.||.+||++.+|+++|++..+....|++
T Consensus       257 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          257 PL--PSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             CC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             CC--cccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            11  1122345688999999999999999999999999887655555544

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-39  Score=337.33  Aligned_cols=265  Identities=26%  Similarity=0.325  Sum_probs=204.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|.+..+|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57889999999999999999998889999999986543  3345678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++..     ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus        83 ~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            9999999998743     3458999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH--------HHHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV--------RELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~--------~~~~~~~  583 (662)
                      ... ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||...............        ...+...
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            322 2234578999999998875 56899999999999999999999999866543322211110        1111111


Q ss_pred             ccccccC-CCCCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAID-PTLDYF------DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id-~~l~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....... +.....      .......+.+++.+||+.||.+|||++|++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1111100 111000      01234568899999999999999999999975

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.3e-40  Score=352.63  Aligned_cols=277  Identities=17%  Similarity=0.162  Sum_probs=213.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC--------CCcEEEEEEeeccchhhHHHHHHHHHHhhcccccccee----------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS--------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ----------  416 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~--------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~----------  416 (662)
                      ++|...+.||+|+||.||+|++..        .++.||||++...     +.+.+|+.++++++||||++          
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  116 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL  116 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence            678899999999999999999976        4789999998754     35788999999999999988          


Q ss_pred             -----eeeeEec-cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCc
Q 040242          417 -----LHGWCRK-QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN  490 (662)
Q Consensus       417 -----l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  490 (662)
                           +++++.. .+..++||||+ +++|.+++....   ...+++.+++.++.||++||.|||+   .+|+||||||+|
T Consensus       117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~N  189 (352)
T 2jii_A          117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAEN  189 (352)
T ss_dssp             CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGG
T ss_pred             cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHH
Confidence                 6677765 67899999999 999999996542   3579999999999999999999999   899999999999


Q ss_pred             eEeCCCC--CeEEeeccccccccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 040242          491 VLIDADL--NPKLGDFGLARAYDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       491 Ill~~~~--~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      |+++.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876543211      1233579999999999999899999999999999999999999998


Q ss_pred             cccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCC
Q 040242          563 PQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI  642 (662)
Q Consensus       563 ~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~~~  642 (662)
                      ....... .+.........  ......+....  .......+.+++.+||+.||.+||++.+|++.|+....-...+...
T Consensus       270 ~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~  344 (352)
T 2jii_A          270 NCLPNTE-DIMKQKQKFVD--KPGPFVGPCGH--WIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD  344 (352)
T ss_dssp             GGTTCHH-HHHHHHHHHHH--SCCCEECTTSC--EECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred             cCCcCHH-HHHHHHHhccC--Chhhhhhhccc--cCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence            6542221 12222221111  11111111110  1122466888999999999999999999999997765444444455


Q ss_pred             CCCCCC
Q 040242          643 HHEFPR  648 (662)
Q Consensus       643 ~~~~~~  648 (662)
                      +..|..
T Consensus       345 ~~dw~~  350 (352)
T 2jii_A          345 PIGLPM  350 (352)
T ss_dssp             CCCCCC
T ss_pred             cccCcC
Confidence            555544

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.2e-39  Score=337.67  Aligned_cols=275  Identities=19%  Similarity=0.261  Sum_probs=214.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeE-eccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC-RKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~lV~E  432 (662)
                      .++|+..+.||+|+||.||+|.+..+++.||||++.....  .+++.+|+.++++++|++++..+.++ ...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            4689999999999999999999988999999999866533  24688999999999998877776666 55667899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~  509 (662)
                      |+ +++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||++   +.++.+||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            99 99999999643    3468999999999999999999999   899999999999999   4889999999999987


Q ss_pred             ccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH-HHHhhc
Q 040242          510 YDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV-RELHSQ  582 (662)
Q Consensus       510 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~-~~~~~~  582 (662)
                      .......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+ ......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            6654321      123457999999999999989999999999999999999999999864322211111111 111110


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCCCCCC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFP  647 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~p~~~~~~~~  647 (662)
                       . ...+       ....+..+.+++.+||+.||.+||++.+|++.|+....-...+...+..|.
T Consensus       238 -~-~~~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~  293 (296)
T 3uzp_A          238 -P-IEVL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWN  293 (296)
T ss_dssp             -C-HHHH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGG
T ss_pred             -c-hHHH-------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCccccccccc
Confidence             0 0000       112235688999999999999999999999999765444444444444443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.4e-40  Score=350.48  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=207.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..+.||+|+||+||+++...+++.||||++....   ....+.+..|..++..+ +||||+++++++...+..++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   98 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF   98 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence            367999999999999999999998889999999997652   23456788999999988 89999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        99 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           99 VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            9999999999999953     3458999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   .... +.     
T Consensus       171 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~---~i~~-~~-----  237 (353)
T 2i0e_A          171 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---SIME-HN-----  237 (353)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHH-CC-----
T ss_pred             cccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHH---HHHh-CC-----
Confidence            43221 23344679999999999998899999999999999999999999998653321   111   1111 11     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                       .   .++......+.+|+.+||+.||.+||+     +++++++
T Consensus       238 -~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 -V---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             -C---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             -C---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence             1   112234566888999999999999995     5788764

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-39  Score=343.99  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=208.9

Q ss_pred             chHHHHHhccCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccc-cccceeeeeeE
Q 040242          346 RYSELYSATKGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLR-HRNLVQLHGWC  421 (662)
Q Consensus       346 ~~~el~~at~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~  421 (662)
                      .+.....-.++|... +.||+|+||.||+|....+++.||||++....  .....++.+|+.++.+++ ||||+++++++
T Consensus        19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~   98 (327)
T 3lm5_A           19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY   98 (327)
T ss_dssp             CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            334444455667776 89999999999999999899999999997643  234678899999999994 69999999999


Q ss_pred             eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCC
Q 040242          422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLN  498 (662)
Q Consensus       422 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~  498 (662)
                      ...+..++||||+++|+|.+++....   ...+++.+++.++.|++.||.|||+   .+|+||||||+||+++.   ++.
T Consensus        99 ~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~  172 (327)
T 3lm5_A           99 ENTSEIILILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGD  172 (327)
T ss_dssp             ECSSEEEEEEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCC
T ss_pred             EeCCeEEEEEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCc
Confidence            99999999999999999999986542   4568999999999999999999999   89999999999999998   789


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      +||+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........   .+..
T Consensus       173 ~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~  247 (327)
T 3lm5_A          173 IKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NISQ  247 (327)
T ss_dssp             EEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHH
T ss_pred             EEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHHh
Confidence            9999999998765432  2234579999999999999999999999999999999999999997654322111   0110


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          .. ...    ...........+.+++.+||+.||.+|||+.+++++
T Consensus       248 ----~~-~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          248 ----VN-VDY----SEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             ----TC-CCC----CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             ----cc-ccc----CchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                00 000    011122344668889999999999999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6.6e-40  Score=337.49  Aligned_cols=257  Identities=25%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC---CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ..++|...+.||+|+||+||+|.+..   .+..||+|.+... .....+.+.+|+.++++++||||+++++++.. +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            34678889999999999999998643   3346999999765 34456789999999999999999999999865 4578


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  161 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR  161 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred             EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence            999999999999999543    3458999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ..............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.........   ..+.    .+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~----~~~~--  232 (281)
T 3cc6_A          162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLE----KGDR--  232 (281)
T ss_dssp             CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHH----HTCC--
T ss_pred             ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHh----cCCC--
Confidence            765543333344567889999999988889999999999999999998 99999754432211   1111    1110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         ..   .+......+.+++.+||+.||.+||++.|++++|+..
T Consensus       233 ---~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 ---LP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             ---CC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CC---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence               01   1122345688999999999999999999999999753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3e-40  Score=347.97  Aligned_cols=263  Identities=22%  Similarity=0.273  Sum_probs=187.9

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEeccCCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .+.||+|+||+||+|.+..+++.||||++...   ....+.+|+.++.+++ ||||+++++++...+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999999989999999999654   3456778999999997 9999999999999999999999999999


Q ss_pred             cchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC---CeEEeeccccccccCCCC
Q 040242          439 LDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL---NPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       439 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---~~kL~DfGla~~~~~~~~  515 (662)
                      |.+++..     ...+++.++..++.|+++||.|||+   .+|+||||||+|||++.++   .+||+|||+++...... 
T Consensus        93 L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-  163 (325)
T 3kn6_A           93 LFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-  163 (325)
T ss_dssp             HHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred             HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-
Confidence            9999954     3468999999999999999999999   8999999999999997765   79999999998665432 


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC-C
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-D  594 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~  594 (662)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......+..      .. .
T Consensus       164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~  237 (325)
T 3kn6_A          164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEG  237 (325)
T ss_dssp             --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCS
T ss_pred             CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCc
Confidence            2233456899999999999989999999999999999999999999754322110000111111111110      01 0


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPL  640 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~  640 (662)
                      .........+.+|+.+||+.||.+|||++|++++  +....+.+..|.
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~~~~~~  285 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPL  285 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCCCCSCC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccCCCCCC
Confidence            0011235678899999999999999999999964  455555544443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=6.9e-40  Score=338.42  Aligned_cols=254  Identities=26%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|...+.||+|+||.||++....++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56888999999999999999998899999999997653 33467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~  510 (662)
                      +++|+|.+++..... ....+++..++.++.|+++||.|||+   .+|+||||||+||++   +.++.+||+|||+++..
T Consensus       102 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            999999999865421 13569999999999999999999999   899999999999999   55678999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ....  ......||+.|+|||.+. +.++.++||||||+++|||++|+.||.........   ....   . .      .
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~---~~~~---~-~------~  241 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQ---QKAT---Y-K------E  241 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH---H-C------C
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHH---hhhc---c-C------C
Confidence            5432  233457899999999886 56899999999999999999999999865432111   1110   0 0      1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +............+.+++.+||+.||++||++.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          242 PNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             cccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            11110011124567789999999999999999999863

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.2e-40  Score=363.10  Aligned_cols=250  Identities=27%  Similarity=0.356  Sum_probs=198.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||.||+|....+|+.||||++...   .......+.+|+.++++++||||+++++++...+..++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            5788999999999999999999999999999999764   2334567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++..+..++.||++||.|||+.  .+|+||||||+||||+.++.+||+|||+++...
T Consensus       228 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          228 EYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             CCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             eeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            99999999999843     34689999999999999999999963  689999999999999999999999999998643


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+.   . ..      .
T Consensus       301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~---~-~~------~  366 (446)
T 4ejn_A          301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL---M-EE------I  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH---H-CC------C
T ss_pred             CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHH---h-CC------C
Confidence            322 22334679999999999999999999999999999999999999997654321   111111   1 10      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      .   ++......+.+|+.+||+.||.+||     +++|++++
T Consensus       367 ~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 R---FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C---CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            1   1223345688999999999999999     99999873

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4.7e-40  Score=349.82  Aligned_cols=248  Identities=28%  Similarity=0.414  Sum_probs=204.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +.|+..+.||+|+||+||+|....+++.||||++...   .....+++.+|+.++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588889999999999999999889999999999754   2344567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||++ |+|.+++...    ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       134 e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9996 6888877433    3568999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..     ....||+.|+|||.+.   .+.++.++|||||||++|||++|+.||........      +...... .    
T Consensus       206 ~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~-~----  269 (348)
T 1u5q_A          206 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN-E----  269 (348)
T ss_dssp             SB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS-C----
T ss_pred             CC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc-C----
Confidence            32     2357899999999884   56789999999999999999999999975533211      1111111 1    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       .+.+  ........+.+++.+||+.||++|||+.+++++.
T Consensus       270 -~~~~--~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          270 -SPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             -CCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             -CCCC--CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence             1111  1122345678899999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=6.2e-40  Score=342.41  Aligned_cols=264  Identities=28%  Similarity=0.356  Sum_probs=202.7

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-----hhHHHHHHHHHHhhccc---cccceeeeeeEecc
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-----QGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQ  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-----~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~  424 (662)
                      .+++|+..+.||+|+||+||+|.+..+++.||||++.....     .....+.+|+.++++++   ||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            35789999999999999999999988999999999864321     11245567777776664   99999999999775


Q ss_pred             C-----eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          425 D-----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       425 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      .     ..++||||+. ++|.+++....   ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCE
Confidence            5     5799999996 69999996543   3449999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      ||+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ..+...
T Consensus       160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~  234 (308)
T 3g33_A          160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDL  234 (308)
T ss_dssp             EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHH
T ss_pred             EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHH
Confidence            999999998765432  234467899999999999889999999999999999999999999865433221   111111


Q ss_pred             hhc---Ccccc-------ccCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQ---GQITR-------AIDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~---~~~~~-------~id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...   .....       ...+..    ....++....+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            110   00000       000000    00112334678899999999999999999999974

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.7e-40  Score=343.22  Aligned_cols=252  Identities=21%  Similarity=0.340  Sum_probs=207.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh------hHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ------GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||.||+|....+|..||||++......      ..+++.+|+.++++++||||+++++++...+..+
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            5688899999999999999999889999999999764321      3577999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Df  504 (662)
                      +||||+++++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++    .+||+||
T Consensus        92 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            99999999999999954     3458999999999999999999999   8999999999999999888    7999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||........      .... ....
T Consensus       164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i-~~~~  234 (321)
T 2a2a_A          164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANI-TSVS  234 (321)
T ss_dssp             TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHH-HTTC
T ss_pred             ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHHH-Hhcc
Confidence            9998765432  22345789999999999988999999999999999999999999976533211      1111 1100


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ...++..   .......+.+++.+||+.||.+|||+.|++++
T Consensus       235 --~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          235 --YDFDEEF---FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --CCCCHHH---HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --cccChhh---hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000   01223568899999999999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-40  Score=346.21  Aligned_cols=257  Identities=27%  Similarity=0.454  Sum_probs=201.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC----cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ++|...++||+|+||+||+|....++    ..||||++... .......+.+|+.++++++||||+++++++...+..++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            45677899999999999999986443    45999999765 33445678999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus       124 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence            99999999999999643    3568999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          510 YDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       510 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      .......  ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...    ...+.  
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~~----~~~~~--  267 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMKA----INDGF--  267 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHTTC--
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHHH----HHCCC--
Confidence            6543221  1222346789999999998899999999999999999999 999997543221   1111    11111  


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                         ..   ..+......+.+++.+||+.||.+||++.+++++|++..
T Consensus       268 ---~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  308 (333)
T 1mqb_A          268 ---RL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI  308 (333)
T ss_dssp             ---CC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ---cC---CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               00   112234566889999999999999999999999997653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-39  Score=336.25  Aligned_cols=256  Identities=25%  Similarity=0.352  Sum_probs=203.9

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCc---EEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCee-eEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGL---EVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL-LLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~-~lV  430 (662)
                      .|...++||+|+||+||+|.+..++.   .||+|.+... .....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            35556899999999999999754443   7999998754 334567899999999999999999999999876655 999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+.+++|.+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            9999999999999653    3568999999999999999999999   89999999999999999999999999999865


Q ss_pred             cCCC---CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNI---NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....   ........+++.|+|||.+.+..++.++||||||+++|||++|+.|+........  +...+.    .+.   
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~----~~~---  245 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD--LTHFLA----QGR---  245 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG--HHHHHH----TTC---
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH--HHHHhh----cCC---
Confidence            4321   1223345678999999999999999999999999999999996666543322211  111111    111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .   ...+......+.+++.+||+.||.+|||++++++.|++.
T Consensus       246 --~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          246 --R---LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             --C---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --C---CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              0   111222345688999999999999999999999998754

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=7.9e-40  Score=338.78  Aligned_cols=264  Identities=20%  Similarity=0.271  Sum_probs=204.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeE-eccCeeeEEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWC-RKQDELLLVY  431 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~lV~  431 (662)
                      ..++|+..+.||+|+||+||+|.+..+++.||||++......  +++..|+.++++++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999999889999999987554322  3578899999999998888777766 5566789999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~  508 (662)
                      ||+ +++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+|||+   +.++.+||+|||+++
T Consensus        85 e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             ECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             Ecc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            999 99999998643    3458999999999999999999999   899999999999999   788999999999998


Q ss_pred             cccCCCC------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          509 AYDHNIN------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       509 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      .......      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            7655432      1223457899999999999999999999999999999999999999764332211111111111000


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      .. ...+       ....+..+.+++.+||+.||++||++.+|++.|+....
T Consensus       237 ~~-~~~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          237 TP-IEVL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             SC-HHHH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ch-hhhh-------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            00 0000       01124568899999999999999999999999876533

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-39  Score=344.96  Aligned_cols=249  Identities=24%  Similarity=0.382  Sum_probs=208.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  120 (335)
T 2owb_A           41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL  120 (335)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            5688899999999999999999989999999998764   2345677899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus       121 e~~~~~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  192 (335)
T 2owb_A          121 ELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  192 (335)
T ss_dssp             CCCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence            99999999998843     3468999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||.........      ... ..+.      .
T Consensus       193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~-~~~~------~  258 (335)
T 2owb_A          193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRI-KKNE------Y  258 (335)
T ss_dssp             STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH-HHTC------C
T ss_pred             cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHH-hcCC------C
Confidence            3322 233457899999999998888999999999999999999999999765322111      111 1111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+   +......+.+|+.+||+.||++||++.|++++
T Consensus       259 ~~---~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 SI---PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CC---CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11   11233567889999999999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.2e-39  Score=357.80  Aligned_cols=254  Identities=24%  Similarity=0.414  Sum_probs=210.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||.||+|.+..+|+.||||++....   ....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            56888999999999999999998899999999997643   233567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~  167 (476)
T 2y94_A           96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  167 (476)
T ss_dssp             ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence            99999999999954     3458999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||.......   +.   ... ..+.      
T Consensus       168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~---~~i-~~~~------  232 (476)
T 2y94_A          168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LF---KKI-CDGI------  232 (476)
T ss_dssp             TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HH---HHH-HTTC------
T ss_pred             ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HH---HHH-hcCC------
Confidence            432  2334579999999999987764 789999999999999999999998654321   11   111 1111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDAS  634 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~  634 (662)
                        . ..+......+.+|+.+||+.||.+|||+.|+++  .+.+..+
T Consensus       233 --~-~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  275 (476)
T 2y94_A          233 --F-YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLP  275 (476)
T ss_dssp             --C-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCC
T ss_pred             --c-CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCc
Confidence              0 111223356788999999999999999999998  4555443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.4e-39  Score=334.98  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=202.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      +++|+..+.||+|+||+||+|....+++.||||++...  ......++.+|+..+.++ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            36788999999999999999999889999999999764  334456788999999999 999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC--------------
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD--------------  496 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--------------  496 (662)
                      |||+++++|.+++..... ....+++.+++.++.||++||.|||+   .+|+||||||+||+++.+              
T Consensus        90 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EECCTTCBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC----------------
T ss_pred             EEecCCCcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            999999999999965421 12568999999999999999999999   899999999999999844              


Q ss_pred             -----CCeEEeeccccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH
Q 040242          497 -----LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL  570 (662)
Q Consensus       497 -----~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  570 (662)
                           ..+||+|||++.......     ...||+.|+|||.+.+. .+++++|||||||++|||++|+.++......   
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~---  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW---  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence                 479999999998765432     23589999999998765 5668999999999999999999876543210   


Q ss_pred             HHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       571 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                             .....+.        +...+......+.+++.+||+.||.+||++.|++++
T Consensus       238 -------~~~~~~~--------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          238 -------HEIRQGR--------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -------HHHHTTC--------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -------HHHHcCC--------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence                   1111111        111222334668889999999999999999999874

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.2e-39  Score=335.79  Aligned_cols=249  Identities=24%  Similarity=0.376  Sum_probs=208.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||.||++.+..+++.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   94 (294)
T 2rku_A           15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL   94 (294)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence            6788899999999999999999989999999998664   2345677899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        95 e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~  166 (294)
T 2rku_A           95 ELCRRRSLLELHKR-----RKALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE  166 (294)
T ss_dssp             ECCTTCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence            99999999998843     3468999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... .......||+.|+|||.+.+..++.++||||||+++|||++|+.||........      .... ....      .
T Consensus       167 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~-~~~~------~  232 (294)
T 2rku_A          167 YDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRI-KKNE------Y  232 (294)
T ss_dssp             STT-CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH-HTTC------C
T ss_pred             cCc-cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-hhcc------C
Confidence            332 223345789999999999988899999999999999999999999976542211      1111 1111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .   .+......+.+++.+||+.||++||++.|++++
T Consensus       233 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 S---IPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C---CccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1   112234567889999999999999999999984

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7e-40  Score=342.68  Aligned_cols=271  Identities=23%  Similarity=0.344  Sum_probs=214.6

Q ss_pred             cchHHHHHhccCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceee
Q 040242          345 FRYSELYSATKGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQL  417 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l  417 (662)
                      +...+.....++|+..+.||+|+||+||+|.+     ..+++.||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            34444555668899999999999999999985     3467899999997653 34456789999999999 79999999


Q ss_pred             eeeEeccC-eeeEEEeccCCCCcchhcccccccc-----------cccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCC
Q 040242          418 HGWCRKQD-ELLLVYDYVPNGSLDKLLFDNDQQK-----------KKILNWDQRYKILIGVAQALLYLHEECDQRVVHRD  485 (662)
Q Consensus       418 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~D  485 (662)
                      ++++...+ ..++||||+++++|.+++.......           ...+++..++.++.|+++||.|||+   .+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            99987755 5899999999999999997653210           1238999999999999999999999   8999999


Q ss_pred             cCCCceEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCc
Q 040242          486 VKPSNVLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEP  563 (662)
Q Consensus       486 lkp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~  563 (662)
                      |||+||+++.++.+||+|||+++........ ......||+.|+|||.+.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876543222 2233567889999999988899999999999999999998 9999976


Q ss_pred             ccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          564 QRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       564 ~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ......  +..    ....+.     ....   +......+.+++.+||+.||.+||++.|++++|+..
T Consensus       254 ~~~~~~--~~~----~~~~~~-----~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEE--FCR----RLKEGT-----RMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHH--HHH----HHHHTC-----CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHH--HHH----HhccCc-----cCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            543221  111    111111     0111   122345688899999999999999999999999753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=8.4e-40  Score=345.64  Aligned_cols=262  Identities=24%  Similarity=0.389  Sum_probs=210.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeC-------CCCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEecc
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIP-------STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ  424 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~-------~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~  424 (662)
                      .++|...+.||+|+||.||+|.+.       .++..||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            367888999999999999999975       35678999999765 344567899999999999 899999999999999


Q ss_pred             CeeeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI  493 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  493 (662)
                      +..++||||+++|+|.+++......           ....+++.+++.++.||++||.|||+   .+|+||||||+||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll  190 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLV  190 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEE
Confidence            9999999999999999999754311           12358999999999999999999999   899999999999999


Q ss_pred             CCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHH
Q 040242          494 DADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELV  571 (662)
Q Consensus       494 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~  571 (662)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   
T Consensus       191 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---  267 (334)
T 2pvf_A          191 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---  267 (334)
T ss_dssp             CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---
T ss_pred             cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH---
Confidence            9999999999999987654321 12223456889999999988889999999999999999999 999997553221   


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      +...+.    .+.     .+   ..+......+.+++.+||+.||.+||++.|+++.|++..
T Consensus       268 ~~~~~~----~~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 LFKLLK----EGH-----RM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             HHHHHH----HTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHh----cCC-----CC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            111111    111     01   112233456888999999999999999999999997653

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-40  Score=339.22  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=207.2

Q ss_pred             cCCcccc-eeeeeCceEEEEEEeC--CCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKN-LVGSGGFGKVYRGVIP--STGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~-~LG~G~~g~Vy~~~~~--~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...+ .||+|+||.||+|.+.  .++..||||++... .....+++.+|+.++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555555 8999999999999863  46788999999765 344567899999999999999999999999 55678999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++..
T Consensus        88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999643    4568999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ......  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +...+    ..+.   
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i----~~~~---  230 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGK---  230 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTC---
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----hcCC---
Confidence            543221  1223356889999999988889999999999999999998 999997654321   11111    1111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .   ...+......+.+++.+||+.||.+||++.+++++|...
T Consensus       231 --~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          231 --R---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             --C---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --c---CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0   112234456788999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=8.6e-40  Score=344.77  Aligned_cols=249  Identities=23%  Similarity=0.331  Sum_probs=195.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      ++|+..+.||+|+||.||+++..   .+++.||+|++....    ......+.+|+.++++++||||+++++++...+..
T Consensus        17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   96 (327)
T 3a62_A           17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL   96 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred             HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence            67889999999999999999984   578999999997642    23345678999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           97 YLILEYLSGGELFMQLER-----EGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             EEEEECCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             EEEEeCCCCCcHHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999853     3458899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      +...... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||........      ...... ..   
T Consensus       169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~-~~---  237 (327)
T 3a62_A          169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT------IDKILK-CK---  237 (327)
T ss_dssp             -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH-TC---
T ss_pred             cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHh-CC---
Confidence            8643321 122345799999999999988899999999999999999999999986543211      111111 10   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                         ..   .+......+.+++.+||+.||.+||     ++.|++++
T Consensus       238 ---~~---~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ---LN---LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ---CC---CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ---CC---CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence               11   1223345688899999999999999     78898874

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.6e-40  Score=345.97  Aligned_cols=264  Identities=24%  Similarity=0.383  Sum_probs=212.0

Q ss_pred             HHhccCCcccceeeeeCceEEEEEEeCCCCc-----EEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEec
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGL-----EVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK  423 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~-----~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~  423 (662)
                      ....++|+..+.||+|+||.||+|.....+.     .||+|.+.... ....+.+.+|+.+++++ +||||+++++++..
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  121 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH  121 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec
Confidence            3345789999999999999999999865553     79999997653 34567789999999999 89999999999999


Q ss_pred             cCeeeEEEeccCCCCcchhccccccc---------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQ---------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      .+..++||||+++|+|.+++......         ....+++..++.++.|+++||.|||+   .+|+||||||+||+++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~  198 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLT  198 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEEC
Confidence            99999999999999999999654210         02357999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||........  +
T Consensus       199 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~  276 (333)
T 2i1m_A          199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--F  276 (333)
T ss_dssp             GGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--H
T ss_pred             CCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--H
Confidence            9999999999999876543222 2223457889999999988889999999999999999999 9999976543221  1


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ...+..    +     ....   .+......+.+++.+||+.||.+||++.||+++|+.
T Consensus       277 ~~~~~~----~-----~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          277 YKLVKD----G-----YQMA---QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             HHHHHH----T-----CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhc----C-----CCCC---CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence            111111    1     0111   112234568889999999999999999999999965

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=348.92  Aligned_cols=263  Identities=23%  Similarity=0.364  Sum_probs=209.6

Q ss_pred             cCCcccceeeeeCceEEEEEEe----CCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC--eee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--ELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~----~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~  428 (662)
                      ++|+..+.||+|+||.||++..    ..+++.||||++........+.+.+|+.++++++||||+++++++...+  ..+
T Consensus        41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  120 (326)
T 2w1i_A           41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK  120 (326)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred             HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence            5688899999999999999984    5678999999998777777788999999999999999999999987654  789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus       121 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~  193 (326)
T 2w1i_A          121 LIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTK  193 (326)
T ss_dssp             EEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence            999999999999999644    3458999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh---------HHHHHHHH
Q 040242          509 AYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME---------LVLVDWVR  577 (662)
Q Consensus       509 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~---------~~l~~~~~  577 (662)
                      ........  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+........         ......+.
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred             hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence            76544221  12234567889999999888889999999999999999999998764311100         00111111


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +....+.       . ...+......+.+++.+||+.||++||++.||++.|+..
T Consensus       274 ~~~~~~~-------~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          274 ELLKNNG-------R-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHTTC-------C-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhhcCC-------C-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111111       0 111233456788999999999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=3.3e-39  Score=345.50  Aligned_cols=255  Identities=16%  Similarity=0.149  Sum_probs=203.2

Q ss_pred             HHhccCCcccceeeeeCceEEEEEE-----eCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc---cccceeeeeeEe
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGV-----IPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR---HRNLVQLHGWCR  422 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~-----~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~  422 (662)
                      ....++|...++||+|+||+||+|.     ...+++.||||++.....   .++..|+.++.+++   |+||+++++++.
T Consensus        61 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~  137 (365)
T 3e7e_A           61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHL  137 (365)
T ss_dssp             ECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred             EECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence            3445789999999999999999994     556788999999976543   35566666666665   999999999999


Q ss_pred             ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-------
Q 040242          423 KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-------  495 (662)
Q Consensus       423 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-------  495 (662)
                      ..+..++||||+++|+|.+++..........+++..++.++.||++||.|||+   .+|+||||||+|||++.       
T Consensus       138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~  214 (365)
T 3e7e_A          138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDD  214 (365)
T ss_dssp             CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC--
T ss_pred             cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccc
Confidence            99999999999999999999975432234679999999999999999999999   89999999999999998       


Q ss_pred             ----CCCeEEeeccccccccCC-CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH
Q 040242          496 ----DLNPKLGDFGLARAYDHN-INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL  570 (662)
Q Consensus       496 ----~~~~kL~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~  570 (662)
                          ++.+||+|||+++.+... .........||+.|+|||++.+..++.++|||||||++|||++|+.||......   
T Consensus       215 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~---  291 (365)
T 3e7e_A          215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG---  291 (365)
T ss_dssp             ----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT---
T ss_pred             cccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC---
Confidence                899999999999765422 222334467999999999999989999999999999999999999998644321   


Q ss_pred             HHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhc
Q 040242          571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFR-PSTRRVVQFLLR  631 (662)
Q Consensus       571 ~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~R-Pt~~eVl~~L~~  631 (662)
                                     ...+...+..+.  ..+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       292 ---------------~~~~~~~~~~~~--~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          292 ---------------ECKPEGLFRRLP--HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             ---------------EEEECSCCTTCS--SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ---------------ceeechhccccC--cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                           011122222111  24566788889999999999 578877777654

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.7e-40  Score=354.49  Aligned_cols=246  Identities=15%  Similarity=0.166  Sum_probs=194.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHH---HHhhccccccceeee-------e
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEI---TSMGRLRHRNLVQLH-------G  419 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei---~~l~~l~H~niv~l~-------~  419 (662)
                      ..++|...+.||+|+||+||+|.+..+|+.||||++...   .....+.+.+|+   +.+++++||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            356788899999999999999999888999999999743   344567889999   556666899999998       5


Q ss_pred             eEeccC-----------------eeeEEEeccCCCCcchhccccccc--ccccccHHHHHHHHHHHHHHHHHhHhcCCCC
Q 040242          420 WCRKQD-----------------ELLLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEECDQR  480 (662)
Q Consensus       420 ~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  480 (662)
                      ++...+                 ..++||||+ +|+|.+++......  ....+++..++.++.||++||.|||+   .+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YG  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TT
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence            555443                 278999999 78999999653211  12456679999999999999999999   89


Q ss_pred             EEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCC-----------CCCcchhHHHHHH
Q 040242          481 VVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-----------KATTSTDVFGFGT  549 (662)
Q Consensus       481 ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~t~ksDV~S~Gv  549 (662)
                      |+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999986332    3344567 999999999877           7999999999999


Q ss_pred             HHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          550 LMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       550 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ++|||++|+.||.......                ..+.+.....    .....+.+|+.+||+.||.+||++.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~----------------~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG----------------GSEWIFRSCK----NIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------C----------------CSGGGGSSCC----CCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCccccccc----------------chhhhhhhcc----CCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999997543211                1111111111    22356788999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7e-40  Score=337.11  Aligned_cols=252  Identities=23%  Similarity=0.400  Sum_probs=205.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec-----------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-----------  423 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-----------  423 (662)
                      ++|+..+.||+|+||.||+|.+..+++.||+|++.....    .+.+|++++++++||||+++++++..           
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B           11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-------
T ss_pred             cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccc
Confidence            568889999999999999999988899999999976542    45689999999999999999998854           


Q ss_pred             -----cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          424 -----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       424 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                           ....++||||+++++|.+++....   ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTE
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCC
Confidence                 445899999999999999996542   3568999999999999999999999   89999999999999999999


Q ss_pred             eEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          499 PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      +||+|||++.......  ......|++.|+|||.+.+..++.++||||||+++|||++|..|+....        .+.. 
T Consensus       161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~~~-  229 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KFFT-  229 (284)
T ss_dssp             EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HHHH-
T ss_pred             EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HHHH-
Confidence            9999999998765432  2233568999999999998889999999999999999999998864221        1111 


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQA  638 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p~~  638 (662)
                      ....+.        +   +......+.+++.+||+.||.+||++.|++++|.....-+..
T Consensus       230 ~~~~~~--------~---~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          230 DLRDGI--------I---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             HHHTTC--------C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             Hhhccc--------c---cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            111111        1   112234577899999999999999999999999876555443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-39  Score=359.04  Aligned_cols=262  Identities=23%  Similarity=0.273  Sum_probs=199.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------C
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------D  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~  425 (662)
                      .++|+..+.||+|+||+||+|.+..+++.||||++...  .....+++.+|+.++++++||||+++++++...      .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            47899999999999999999999999999999999764  344567889999999999999999999999654      3


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||+++ +|.+.+       ...+++.++..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~-~l~~~~-------~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHH-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHH-------hhcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence            57999999965 566665       2348899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH-HH---------
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV-DW---------  575 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~---------  575 (662)
                      +++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......... ..         
T Consensus       210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~  287 (464)
T 3ttj_A          210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  287 (464)
T ss_dssp             CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            99876543  2334468999999999999999999999999999999999999999865533222110 00         


Q ss_pred             ------HHHHhhcCc------cccccCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 ------VRELHSQGQ------ITRAIDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ------~~~~~~~~~------~~~~id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            ++.......      ........+    ..........+.+|+.+||+.||++|||+.|++++
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          288 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  000000000      000000000    00011225678999999999999999999999985

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-39  Score=337.79  Aligned_cols=265  Identities=24%  Similarity=0.352  Sum_probs=200.2

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhc--cccccceeeeeeEecc----C
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHRNLVQLHGWCRKQ----D  425 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~~~~~~~----~  425 (662)
                      ...++|+..++||+|+||.||+|+..  ++.||||++.....   ..+..|.+++..  ++||||+++++++...    .
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~  108 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWT  108 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGC
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCC
Confidence            34478999999999999999999984  88999999865432   334445555544  5999999999999877    6


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC-----CCCEEeCCcCCCceEeCCCCCeE
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC-----DQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                      ..++||||+++|+|.+++.      ...+++..++.++.|++.||.|||+.+     ..+|+||||||+|||++.++.+|
T Consensus       109 ~~~lv~e~~~~g~L~~~l~------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k  182 (337)
T 3mdy_A          109 QLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC  182 (337)
T ss_dssp             EEEEEECCCTTCBHHHHHH------HCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred             ceEEEEeccCCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence            8899999999999999994      335899999999999999999999821     12999999999999999999999


Q ss_pred             EeeccccccccCCCCCc---ceecccCCcccCcccccCCCCCcc------hhHHHHHHHHHHHHcC----------CCCC
Q 040242          501 LGDFGLARAYDHNINPQ---TTHIVGTLGYLAPELTRTGKATTS------TDVFGFGTLMLEVACG----------RRPI  561 (662)
Q Consensus       501 L~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~t~k------sDV~S~Gvvl~elltG----------~~p~  561 (662)
                      |+|||+++.........   .....||+.|+|||.+.+...+.+      +|||||||++|||++|          +.||
T Consensus       183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~  262 (337)
T 3mdy_A          183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY  262 (337)
T ss_dssp             ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence            99999998765432221   123579999999999987766655      9999999999999999          6666


Q ss_pred             CcccchhhHHHHHHHHHHhhcCccccccCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          562 EPQRTAMELVLVDWVRELHSQGQITRAIDPTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       562 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ..........  ........    .....+.+.  .........+.+|+.+||+.||.+||++.||+++|++..
T Consensus       263 ~~~~~~~~~~--~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          263 HDLVPSDPSY--EDMREIVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTSCSSCCH--HHHHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hhhcCCCCch--hhhHHHHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            5332211110  11111111    111222221  112367788999999999999999999999999997643

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=7.8e-40  Score=349.95  Aligned_cols=254  Identities=21%  Similarity=0.267  Sum_probs=195.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||+||++....+++.||||++..... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            4679999999999999999999998999999999976432 235678999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC--eEEeecccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN--PKLGDFGLARAYD  511 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~~~  511 (662)
                      +++|+|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.  +||+|||+++...
T Consensus        98 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           98 ASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            999999999843     3458999999999999999999999   89999999999999987765  9999999998543


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcc-hhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTS-TDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k-sDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ..  .......||+.|+|||.+.+..++.+ +|||||||++|||++|+.||.........  ...+...... .      
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~-~------  238 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSV-K------  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTT-C------
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcC-C------
Confidence            22  22234579999999999987777655 89999999999999999999864332111  1111111110 0      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+. ........+.+|+.+||+.||.+|||+.|++++
T Consensus       239 ~~~~-~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 YSIP-DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCC-TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCC-CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0110 011234567889999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.2e-39  Score=330.89  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=207.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            57888999999999999999998889999999997543 34457789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..     ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        87 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  158 (276)
T 2yex_A           87 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  158 (276)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence            999999999853     3458999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CC-CcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          514 IN-PQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       514 ~~-~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      .. .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|..     ..  ..   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----~~--~~---  227 (276)
T 2yex_A          159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----KK--TY---  227 (276)
T ss_dssp             TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-----TC--TT---
T ss_pred             cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-----cc--cc---
Confidence            21 12334578999999999987664 7899999999999999999999976543221 1122211     00  00   


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       . .........+.+++.+||+.||.+|||+.|++++
T Consensus       228 -~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          228 -L-NPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             -S-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             -c-CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence             0 0112334567889999999999999999999864

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=5.7e-40  Score=346.16  Aligned_cols=256  Identities=25%  Similarity=0.328  Sum_probs=191.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEe--------cc
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCR--------KQ  424 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~--------~~  424 (662)
                      ..+|+..++||+|+||.||+|.+..+++.||||++........+.+.+|+.++.+++ ||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            357888999999999999999998899999999997777777788999999999996 999999999984        33


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeCCCCCeEEe
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                      ...++||||+. |+|.+++.....  ...+++.+++.++.||++||.|||+   .+  |+||||||+|||++.++.+||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEe
Confidence            45899999995 799998864321  3569999999999999999999999   67  9999999999999999999999


Q ss_pred             eccccccccCCCCC-----------cceecccCCcccCcccc---cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh
Q 040242          503 DFGLARAYDHNINP-----------QTTHIVGTLGYLAPELT---RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM  568 (662)
Q Consensus       503 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  568 (662)
                      |||+++........           ......||+.|+|||.+   .+..++.++|||||||++|||++|+.||.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  260 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR  260 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence            99999876543221           11134589999999998   56678999999999999999999999997532210


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                            .+.         ......   ........+.+|+.+||+.||.+||++.|++++|....
T Consensus       261 ------~~~---------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          261 ------IVN---------GKYSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------------------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------hhc---------CcccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                  000         000000   01112234778999999999999999999999997553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=343.11  Aligned_cols=265  Identities=18%  Similarity=0.217  Sum_probs=201.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC---CCcEEEEEEeeccchh-----------hHHHHHHHHHHhhccccccceeeeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQ-----------GMKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~~~~-----------~~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      ++|...+.||+|+||.||+|.+..   .+..+|||++......           ....+.+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            578889999999999999999976   6788999998765321           12346788899999999999999999


Q ss_pred             Eec----cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          421 CRK----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       421 ~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      +..    ....++||||+ +++|.+++...     ..+++.+++.++.||++||.|||+   .+|+||||||+|||++.+
T Consensus       117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESS
T ss_pred             cccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccC
Confidence            987    67899999999 99999999543     368999999999999999999999   899999999999999988


Q ss_pred             C--CeEEeeccccccccCCCC------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh
Q 040242          497 L--NPKLGDFGLARAYDHNIN------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM  568 (662)
Q Consensus       497 ~--~~kL~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  568 (662)
                      +  .+||+|||+++.+.....      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  999999999987643221      11234579999999999998899999999999999999999999996432221


Q ss_pred             hHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          569 ELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      .. ..........  .+...+.....  .......+.+++.+||+.||++||++.+|++.|+...
T Consensus       268 ~~-~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          268 VA-VQTAKTNLLD--ELPQSVLKWAP--SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HH-HHHHHHHHHH--TTTHHHHHHSC--TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HH-HHHHHHhhcc--cccHHHHhhcc--ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            11 1111111111  00010000000  0123456889999999999999999999999998753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=333.63  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=203.1

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccC
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      +|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            35556799999999999999988999999999987766667889999999999999999999999999999999999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-CCCeEEeeccccccccCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-~~~~kL~DfGla~~~~~~~  514 (662)
                      +++|.+++.....  ...+++..+..++.|+++||.|||+   .+++||||||+||+++. ++.+||+|||+++......
T Consensus       103 ~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          103 GGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             EEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            9999999965421  3356788899999999999999999   89999999999999987 8999999999998764321


Q ss_pred             CCcceecccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                       .......|++.|+|||.+.+..  ++.++||||||+++|||++|+.||..........   +....       ....+.
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~-------~~~~~~  246 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGM-------FKVHPE  246 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHH-------HCCCCC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhcc-------cccccc
Confidence             2233457899999999986543  7899999999999999999999997543321111   00000       011122


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +   +......+.+++.+||+.||++||++.+++++
T Consensus       247 ~---~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          247 I---PESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             C---CTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             c---cccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            2   22344667889999999999999999999973

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.4e-39  Score=337.38  Aligned_cols=258  Identities=22%  Similarity=0.376  Sum_probs=208.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|...+.||+|+||+||++....+|+.||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            35788899999999999999999889999999999876555556789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~~  510 (662)
                      +++++|.+++..     ...+++..++.++.|++.||.|||+   .+++||||||+||++   +.++.+||+|||+++..
T Consensus        88 ~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~  159 (304)
T 2jam_A           88 VSGGELFDRILE-----RGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKME  159 (304)
T ss_dssp             CCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred             CCCccHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence            999999998843     3458999999999999999999999   899999999999999   78899999999999864


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.......   +...+    .++.. . ..
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~i----~~~~~-~-~~  227 (304)
T 2jam_A          160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFEKI----KEGYY-E-FE  227 (304)
T ss_dssp             CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HHCCC-C-CC
T ss_pred             CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCC-C-CC
Confidence            432   2233568999999999998899999999999999999999999997643221   11111    11110 0 01


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDAS  634 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~  634 (662)
                         ..........+.+++.+||+.||.+||++.|+++  .+.+..+
T Consensus       228 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (304)
T 2jam_A          228 ---SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA  270 (304)
T ss_dssp             ---TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred             ---ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence               1112234466889999999999999999999997  4555443

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.5e-40  Score=369.81  Aligned_cols=258  Identities=28%  Similarity=0.424  Sum_probs=209.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ..++|+..+.||+|+||.||+|.+.. +..||||++.... ...++|.+|+.++++++|+||+++++++.. +..++|||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence            34678889999999999999999954 5679999997654 235689999999999999999999999976 67899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++|+|.++|....   ...+++.+++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  415 (535)
T 2h8h_A          342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED  415 (535)
T ss_dssp             CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred             hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence            999999999996432   3458999999999999999999999   8999999999999999999999999999987643


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..........++..|+|||.+..+.++.++|||||||+||||++ |+.||.......   +...+    ..+..      
T Consensus       416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~~------  482 (535)
T 2h8h_A          416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQV----ERGYR------  482 (535)
T ss_dssp             HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHH----HTTCC------
T ss_pred             CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCC------
Confidence            21112223456789999999988899999999999999999999 999997643321   11111    11110      


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                        ...+......+.+|+.+||+.||++||++.+|+++|+....
T Consensus       483 --~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 --MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence              11122345678899999999999999999999999987643

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5e-40  Score=352.59  Aligned_cols=245  Identities=26%  Similarity=0.344  Sum_probs=194.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHH-hhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITS-MGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..++||+|+||+||+++.+.++..||||++.+..   ......+..|..+ ++.++||||+++++++...+.+++|
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv  117 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV  117 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEE
Confidence            56888999999999999999999999999999997653   2334556777776 5778999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++..     ...+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       118 ~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~  189 (373)
T 2r5t_A          118 LDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKEN  189 (373)
T ss_dssp             EECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred             EeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence            999999999999853     3458889999999999999999999   89999999999999999999999999999864


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... ........||+.|+|||++.+..++.++|||||||++|||++|+.||........   .   ..... ..      
T Consensus       190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~---~---~~i~~-~~------  255 (373)
T 2r5t_A          190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---Y---DNILN-KP------  255 (373)
T ss_dssp             BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH---H---HHHHH-SC------
T ss_pred             ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H---HHHHh-cc------
Confidence            332 2233446899999999999998999999999999999999999999976543211   1   11111 11      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRR  624 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  624 (662)
                        + .++......+.+|+.+||+.||.+||++.+
T Consensus       256 --~-~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          256 --L-QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --C-CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --c-CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              1 112223456788999999999999999853

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.1e-40  Score=344.96  Aligned_cols=266  Identities=26%  Similarity=0.351  Sum_probs=205.5

Q ss_pred             CcccceeeeeCceEEEEEEe----CCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc--CeeeE
Q 040242          357 FREKNLVGSGGFGKVYRGVI----PSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ--DELLL  429 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~----~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l  429 (662)
                      |+..+.||+|+||+||++..    ..+++.||||++.... ....+.+.+|+.++++++||||+++++++...  ...++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48899999999999988764    3468899999997653 34567799999999999999999999999874  57899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++..      ..+++.+++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus       113 v~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            9999999999999953      348999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.||........ ....+.........+.+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  262 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVLRLTE  262 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHHHHHH
Confidence            7553221  22334678889999999888899999999999999999999999874322100 00000000000000111


Q ss_pred             ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+.... ...+......+.+|+.+||+.||.+||++.|+++.|+..
T Consensus       263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111111 122334456788999999999999999999999998753

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.4e-39  Score=336.11  Aligned_cols=256  Identities=25%  Similarity=0.366  Sum_probs=201.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEe-ccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCR-KQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~l  429 (662)
                      .+|+..++||+|+||+||+|.+..+   ...||+|.+... .....+.+.+|+.++++++||||++++++|. .++..++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            4577889999999999999997543   335899998764 3445678999999999999999999999865 4557899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++...    ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus       105 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~  177 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD  177 (298)
T ss_dssp             EEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCC
T ss_pred             EEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccc
Confidence            99999999999999653    3568899999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCC---CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcC-CCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          510 YDHNIN---PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACG-RRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       510 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG-~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ......   .......+|+.|+|||.+.+..++.++||||||+++|||++| .+||........   ...+    ..+. 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~~~~----~~~~-  249 (298)
T 3f66_A          178 MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGR-  249 (298)
T ss_dssp             CSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---HHHH----HTTC-
T ss_pred             ccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---HHHH----hcCC-
Confidence            644321   122335678899999999888999999999999999999995 455544332211   1111    1110 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                             ....+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus       250 -------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          250 -------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             -------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   0011122345688999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1e-39  Score=365.90  Aligned_cols=254  Identities=25%  Similarity=0.370  Sum_probs=210.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      .++|+..++||+|+||.||+|....+|+.||||++....   ......+.+|+.++++++||||+++++++...+.+++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999999899999999997642   23456788999999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++....   ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       263 mEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~  336 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV  336 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence            99999999999996543   3458999999999999999999999   89999999999999999999999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh-HHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..+...+..    .      
T Consensus       337 ~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~----~------  404 (576)
T 2acx_A          337 PEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE----V------  404 (576)
T ss_dssp             CTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH----C------
T ss_pred             ccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc----c------
Confidence            5432  23345899999999999988899999999999999999999999986533211 111111111    0      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      ..   .++......+..|+.+||+.||.+||     ++.||+++
T Consensus       405 ~~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 PE---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cc---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            11   12223446688899999999999999     78999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=7.2e-39  Score=333.41  Aligned_cols=257  Identities=22%  Similarity=0.309  Sum_probs=203.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc----hhhHHHHHHHHHHhhccccccceeeeeeEe--ccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS----RQGMKEFVAEITSMGRLRHRNLVQLHGWCR--KQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~--~~~~~  427 (662)
                      .++|...+.||+|+||.||++....++..||+|++....    ....+.+.+|+.++++++||||+++++++.  ..+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367999999999999999999998899999999997643    234578999999999999999999999984  45578


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||++++ |.+++....   ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccc
Confidence            9999999876 777765432   4568999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC-CcceecccCCcccCcccccCCC--CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          508 RAYDHNIN-PQTTHIVGTLGYLAPELTRTGK--ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       508 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ........ .......||+.|+|||.+.+..  .+.++||||||+++|||++|+.||.......   +   .. ....+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~-~i~~~~  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---L---FE-NIGKGS  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HH-HHHHCC
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---H---HH-HHhcCC
Confidence            87654322 2223456899999999987644  3789999999999999999999998643221   1   11 111111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCC
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDA  633 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~  633 (662)
                            ..   .+......+.+++.+||+.||.+||++.|++++  +.+..
T Consensus       230 ------~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          230 ------YA---IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             ------CC---CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred             ------CC---CCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence                  11   122334567889999999999999999999975  44443

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.5e-39  Score=340.14  Aligned_cols=267  Identities=22%  Similarity=0.348  Sum_probs=202.8

Q ss_pred             HHHHHhccCCcccceeeeeCceEEEEEEeCC---CCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          348 SELYSATKGFREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       348 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      .++....++|...+.||+|+||.||+|....   ++..||||++...  .....+.+.+|+.++++++||||+++++++.
T Consensus        27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~  106 (313)
T 3brb_A           27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI  106 (313)
T ss_dssp             TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence            3444456788999999999999999998754   4558999998654  3445678999999999999999999999997


Q ss_pred             ccC-----eeeEEEeccCCCCcchhcccccc-cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          423 KQD-----ELLLVYDYVPNGSLDKLLFDNDQ-QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       423 ~~~-----~~~lV~E~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      ..+     ..++||||+++++|.+++..... .....+++..++.++.|+++||.|||+   .+|+||||||+||+++.+
T Consensus       107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~  183 (313)
T 3brb_A          107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDD  183 (313)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTT
T ss_pred             eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCC
Confidence            765     35999999999999999854321 124569999999999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHH
Q 040242          497 LNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVD  574 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~  574 (662)
                      +.+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   ..
T Consensus       184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~  260 (313)
T 3brb_A          184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---YD  260 (313)
T ss_dssp             SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH
T ss_pred             CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---HH
Confidence            9999999999987654321 22233467889999999998899999999999999999999 8888875543221   11


Q ss_pred             HHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          575 WVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       575 ~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .+    ..+.        ....+......+.+++.+||+.||.+||++.+++++|+..
T Consensus       261 ~~----~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          261 YL----LHGH--------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HH----HTTC--------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HcCC--------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11    1111        0111223446788999999999999999999999999764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.3e-39  Score=343.07  Aligned_cols=258  Identities=27%  Similarity=0.433  Sum_probs=206.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEE--EEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEV--AIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~v--avK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|....++..+  |+|++... .....+.+.+|+.++.++ +||||+++++++...+..++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67888999999999999999998778755  99998754 334456789999999999 899999999999999999999


Q ss_pred             EeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          431 YDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      |||+++++|.+++.....           .....+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeE
Confidence            999999999999975431           113468999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||+++......  ......+++.|+|||.+.+..++.++|||||||++|||++ |+.||.......      .. .
T Consensus       182 kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~-~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-E  252 (327)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH-H
T ss_pred             EEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH-H
Confidence            999999998543221  2223457889999999988888999999999999999998 999997654321      11 1


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ....+     ...   ..+......+.+|+.+||+.||.+||++.++++.|...
T Consensus       253 ~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          253 KLPQG-----YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             HGGGT-----CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhhcC-----CCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111     111   11223446688999999999999999999999988653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.5e-39  Score=331.79  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=206.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|....++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            57888999999999999999998889999999996542   223567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..     ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        94 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~  165 (284)
T 2vgo_A           94 EFAPRGELYKELQK-----HGRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP  165 (284)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred             EeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence            99999999999853     2458999999999999999999999   899999999999999999999999999997654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..   ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........      .... ...      +.
T Consensus       166 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~-~~~------~~  229 (284)
T 2vgo_A          166 SL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRI-VNV------DL  229 (284)
T ss_dssp             SS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHH-HTT------CC
T ss_pred             cc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHH-hcc------cc
Confidence            32   22345789999999999988899999999999999999999999976533211      1111 111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||++.+++++
T Consensus       230 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          230 K---FPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             C---CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             C---CCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence            1   122334567889999999999999999999973

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=345.32  Aligned_cols=251  Identities=24%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhcccc--ccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRH--RNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..+.||+|+||.||++... ++..||||++...  .....+.+.+|+.++.+++|  +||+++++++...+..++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence            356889999999999999999984 6889999998754  34456789999999999986  999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||| +.+++|.+++..     ...+++.++..++.|+++||.|||+   .+|+||||||+|||++ ++.+||+|||+++.
T Consensus        87 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           87 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEC-CCSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEe-CCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            999 458899999954     3468999999999999999999999   8999999999999997 57899999999987


Q ss_pred             ccCCCCC-cceecccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ....... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.........     ..
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----~~  231 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK-----LH  231 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH-----HH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH-----HH
Confidence            6543222 2334579999999999854           67899999999999999999999999754322110     11


Q ss_pred             HHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          578 ELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                               ..+++.. ..++......+.+|+.+||+.||.+|||+.|++++-
T Consensus       232 ---------~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          232 ---------AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ---------HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ---------HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                     1112211 122222345678899999999999999999999863

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6.3e-40  Score=354.07  Aligned_cols=262  Identities=25%  Similarity=0.394  Sum_probs=195.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccc-cccceeeeeeEeccC--eee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQD--ELL  428 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~--~~~  428 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++.+++ ||||+++++++...+  ..+
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~   87 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY   87 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence            46899999999999999999999999999999998643  3445667889999999997 999999999997544  789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +|||||+ ++|..++.      ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        88 lv~e~~~-~~L~~~~~------~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           88 LVFDYME-TDLHAVIR------ANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEECCS-EEHHHHHH------HTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEecccC-cCHHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            9999996 68988884      2458899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCC--------------------CCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccch
Q 040242          509 AYDHNI--------------------NPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTA  567 (662)
Q Consensus       509 ~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  567 (662)
                      .+....                    ........||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            754311                    112234579999999998876 67899999999999999999999999865543


Q ss_pred             hhHHHHHHHHHHhhcCc---c---------------cccc---CCCCCCCC-------------HHHHHHHHHHHHHccC
Q 040242          568 MELVLVDWVRELHSQGQ---I---------------TRAI---DPTLDYFD-------------PQEAELVLTLGLLCCD  613 (662)
Q Consensus       568 ~~~~l~~~~~~~~~~~~---~---------------~~~i---d~~l~~~~-------------~~~~~~l~~l~~~Cl~  613 (662)
                      ......  + .......   +               ....   .......-             ......+.+|+.+||+
T Consensus       238 ~~~~~i--~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          238 NQLERI--I-GVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHHH--H-HHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHHH--H-HhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            222111  0 1000000   0               0000   00000000             0224568899999999


Q ss_pred             CCCCCCCCHHHHHHH
Q 040242          614 PHPDFRPSTRRVVQF  628 (662)
Q Consensus       614 ~dP~~RPt~~eVl~~  628 (662)
                      .||.+|||+.|++++
T Consensus       315 ~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          315 FNPNKRISANDALKH  329 (388)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             cCcccCCCHHHHhCC
Confidence            999999999999986

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-39  Score=331.94  Aligned_cols=248  Identities=25%  Similarity=0.385  Sum_probs=201.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec----cCeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~l  429 (662)
                      .|...+.||+|+||+||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            467788999999999999999999999999998754  34456789999999999999999999998865    346899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeC-CCCCeEEeeccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLID-ADLNPKLGDFGL  506 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfGl  506 (662)
                      ||||+++++|.+++..     ...+++..++.++.|+++||.|||+   .+  |+||||||+||+++ .++.+||+|||+
T Consensus       107 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEecCCCCHHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            9999999999999953     3568999999999999999999999   67  99999999999998 789999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      +......   ......||+.|+|||.+. +.++.++|||||||++|||++|+.||.........     ... ...+...
T Consensus       179 ~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~~-~~~~~~~  248 (290)
T 1t4h_A          179 ATLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YRR-VTSGVKP  248 (290)
T ss_dssp             GGGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HHH-HTTTCCC
T ss_pred             ccccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HHH-HhccCCc
Confidence            9764432   334457999999999886 45899999999999999999999999764432211     111 1111111


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .       ..+......+.+++.+||+.||.+||++.|++++
T Consensus       249 ~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          249 A-------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             G-------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             c-------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            1       1111223568899999999999999999999974

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.4e-39  Score=333.32  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch------hhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR------QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||.||++....+++.||+|.+.....      ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            568889999999999999999988899999999876421      13578899999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Df  504 (662)
                      +||||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.++    .+||+||
T Consensus        85 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            99999999999999843     3468999999999999999999999   8999999999999998877    8999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |++.......  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........  +    ... ....
T Consensus       157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~-~~~~  227 (283)
T 3bhy_A          157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--L----TNI-SAVN  227 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--H----HHH-HTTC
T ss_pred             ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--H----HHh-Hhcc
Confidence            9998765432  22345689999999999988999999999999999999999999976543211  1    110 1100


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .  ..++.   ........+.+++.+||+.||.+||++.|++++
T Consensus       228 ~--~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          228 Y--DFDEE---YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             C--CCCHH---HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             c--CCcch---hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            0  00000   001224568899999999999999999999973

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=341.32  Aligned_cols=268  Identities=24%  Similarity=0.334  Sum_probs=196.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec-----cCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-----QDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-----~~~~~l  429 (662)
                      ++|+..+.||+|+||.||+|+.  +++.||||++....... .....|+..+..++||||+++++++..     ....++
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~l   89 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLL   89 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEE
T ss_pred             HHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCceEEE
Confidence            6788999999999999999987  68899999997543322 112344445566899999999986532     236789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC------CCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC------DQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      ||||+++|+|.+++..      ..+++..++.++.|+++||.|||+.+      ..+|+||||||+|||++.++.+||+|
T Consensus        90 v~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           90 VMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            9999999999999943      34588999999999999999999821      11999999999999999999999999


Q ss_pred             ccccccccCCCC-------CcceecccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh
Q 040242          504 FGLARAYDHNIN-------PQTTHIVGTLGYLAPELTRT-------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME  569 (662)
Q Consensus       504 fGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~  569 (662)
                      ||+++.+.....       .......||+.|+|||.+.+       ..++.++|||||||++|||++|+.|+........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987654321       12223569999999999876       3466789999999999999999877653322110


Q ss_pred             H--H---------HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          570 L--V---------LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       570 ~--~---------l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .  .         .................+... ..........+.+|+.+||+.||.+|||+.|+++.|+..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEA-WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT-CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccccCCCCCcc-cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            0  0         000111111111111111111 122345677899999999999999999999999998754

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=345.42  Aligned_cols=243  Identities=21%  Similarity=0.309  Sum_probs=204.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--------hhHHHHHHHHHHhhccccccceeeeeeEeccC
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--------QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--------~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~  425 (662)
                      .++|+..+.||+|+||+||+|.+..+++.||||++.....        ...+.+.+|+.++++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4678999999999999999999999999999999976521        13345778999999999999999999999999


Q ss_pred             eeeEEEeccCCC-CcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          426 ELLLVYDYVPNG-SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       426 ~~~lV~E~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      ..++||||+.+| +|.+++...     ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeec
Confidence            999999999777 999998543     458999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      |+++......  ......||+.|+|||.+.+..+ +.++|||||||++|||++|+.||......                
T Consensus       175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            9998765432  2334579999999999987776 88999999999999999999999753211                


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ..... ..+......+.+|+.+||+.||.+||++.+++++
T Consensus       237 -----~~~~~-~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          237 -----VEAAI-HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -----TTTCC-CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -----Hhhcc-CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                 00011 0111234568889999999999999999999985

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.7e-39  Score=333.83  Aligned_cols=249  Identities=30%  Similarity=0.406  Sum_probs=197.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc-CeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-DELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||+||++..  .|+.||||++....  ..+.+.+|+.++++++||||+++++++... +..++||||
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           21 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            6788899999999999999998  47899999997543  456789999999999999999999997654 478999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++....   ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  170 (278)
T 1byg_A           97 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  170 (278)
T ss_dssp             CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             CCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence            99999999996432   3458999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                          .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||........   ..    ....+     ..+ 
T Consensus       171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~----~~~~~-----~~~-  233 (278)
T 1byg_A          171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKG-----YKM-  233 (278)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH----HHTTT-----CCC-
T ss_pred             ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHhcC-----CCC-
Confidence                122357889999999988889999999999999999998 9999976533211   11    11111     111 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        ..+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus       234 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          234 --DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             --CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence              12223456788999999999999999999999998753

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.7e-39  Score=348.60  Aligned_cols=264  Identities=23%  Similarity=0.323  Sum_probs=198.8

Q ss_pred             cCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhc-cccccceeeeeeEec----cCeee
Q 040242          355 KGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR-LRHRNLVQLHGWCRK----QDELL  428 (662)
Q Consensus       355 ~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~-l~H~niv~l~~~~~~----~~~~~  428 (662)
                      ++|... ++||+|+||+||++.+..+++.||||++...     ..+.+|+.++.+ .+||||+++++++..    .+.++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            455555 6899999999999999989999999999643     345678887744 589999999998865    56789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeecc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFG  505 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfG  505 (662)
                      +|||||++|+|.+++....   ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus       136 lv~E~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG  209 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  209 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEeCCCCcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecc
Confidence            9999999999999996542   3469999999999999999999999   89999999999999998   7889999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh-HHHHHHHHHHhhcCc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME-LVLVDWVRELHSQGQ  584 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~-~~l~~~~~~~~~~~~  584 (662)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ......+    ..+.
T Consensus       210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i----~~~~  283 (400)
T 1nxk_A          210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI----RMGQ  283 (400)
T ss_dssp             TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHH----HHTC
T ss_pred             cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHH----HcCc
Confidence            998654322  23345789999999999989999999999999999999999999975432210 0011111    1111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPL  640 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~  640 (662)
                      .. .-.+.    .......+.+|+.+||+.||.+|||+.|++++  +......+..|.
T Consensus       284 ~~-~~~~~----~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~  336 (400)
T 1nxk_A          284 YE-FPNPE----WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  336 (400)
T ss_dssp             CC-CCTTT----TTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTSCCCBC
T ss_pred             cc-CCCcc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCCCCCcc
Confidence            10 00011    12234568899999999999999999999985  455444444443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.7e-40  Score=342.29  Aligned_cols=257  Identities=21%  Similarity=0.300  Sum_probs=200.1

Q ss_pred             cCCcc-cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFRE-KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~-~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      +.|+. .++||+|+||+||+|....+++.||||++........+.+.+|+.++.++ +||||+++++++...+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45666 37899999999999999889999999999877666677899999999885 79999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~DfGla~~  509 (662)
                      |+++++|.+++..     ...+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.   +||+|||+++.
T Consensus        92 ~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           92 KMRGGSILSHIHK-----RRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             cCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            9999999999954     3458999999999999999999999   89999999999999998876   99999999986


Q ss_pred             ccCCCC------CcceecccCCcccCcccccC-----CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhH--------
Q 040242          510 YDHNIN------PQTTHIVGTLGYLAPELTRT-----GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL--------  570 (662)
Q Consensus       510 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~--------  570 (662)
                      ......      .......||+.|+|||.+..     ..++.++|||||||++|||++|+.||.........        
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  243 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP  243 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence            543211      11223469999999999864     45788999999999999999999999754321100        


Q ss_pred             HHHHHHHHHhhcCccccccCCCCCCCCH----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          571 VLVDWVRELHSQGQITRAIDPTLDYFDP----QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       571 ~l~~~~~~~~~~~~~~~~id~~l~~~~~----~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....-+.+....+..         ..+.    .....+.+|+.+||+.||.+|||+.|++++
T Consensus       244 ~~~~~~~~~i~~~~~---------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          244 ACQNMLFESIQEGKY---------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHHHCCC---------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHHhccCc---------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            000001111111110         1111    124568899999999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=348.14  Aligned_cols=269  Identities=22%  Similarity=0.282  Sum_probs=213.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccC--eeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD--ELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV~  431 (662)
                      ++|...++||+|+||+||+|.+..+++.||||++.... ....+.+.+|++++++++||||+++++++...+  ..++||
T Consensus         9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~   88 (396)
T 4eut_A            9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM   88 (396)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence            57888999999999999999999889999999997643 334577889999999999999999999998665  789999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe----CCCCCeEEeecccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI----DADLNPKLGDFGLA  507 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~DfGla  507 (662)
                      ||+++|+|.+++.....  ...+++..++.++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        89 e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           89 EFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             CCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             ecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            99999999999965432  2349999999999999999999999   899999999999999    77788999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccC--------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRT--------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      +......  ......||+.|+|||.+..        ..++.++|||||||++|||++|+.||..........  +.+...
T Consensus       164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~--~~~~~~  239 (396)
T 4eut_A          164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK--EVMYKI  239 (396)
T ss_dssp             EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCH--HHHHHH
T ss_pred             eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchH--HHHHHH
Confidence            8765432  2234579999999998764        456789999999999999999999997433221110  111111


Q ss_pred             hhcC---ccccc---c--------C-CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          580 HSQG---QITRA---I--------D-PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       580 ~~~~---~~~~~---i--------d-~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ....   .....   .        + +............+..++.+||+.||++||++.|+++.+...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            1110   00000   0        0 111234577888899999999999999999999999888654

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.4e-39  Score=335.00  Aligned_cols=249  Identities=26%  Similarity=0.433  Sum_probs=208.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +.|+..+.||+|+||.||+|....+++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  101 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY  101 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence            56888999999999999999998889999999997653 34567899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..      ..+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus       102 ~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  172 (303)
T 3a7i_A          102 LGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT  172 (303)
T ss_dssp             CTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence            999999999843      458999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      . .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.......   ....+.    .+.     .+.+
T Consensus       173 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~----~~~-----~~~~  239 (303)
T 3a7i_A          173 Q-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLIP----KNN-----PPTL  239 (303)
T ss_dssp             B-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HSC-----CCCC
T ss_pred             c-cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHhh----cCC-----CCCC
Confidence            2 22234578999999999998899999999999999999999999997543321   111111    111     1111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         .......+.+++.+||+.||.+||++.+++++
T Consensus       240 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          240 ---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence               12234568899999999999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-39  Score=349.31  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=194.5

Q ss_pred             CCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec-cCeeeEE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDELLLV  430 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV  430 (662)
                      .|+..++||+|+||+||+|.+..+   +..||||.+... .....++|.+|+.++++++||||++++++|.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            456678999999999999997533   246899998654 34556789999999999999999999998754 4578999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...    ...+++.+++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       170 ~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             EECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccc
Confidence            9999999999999644    3568899999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCC---CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          511 DHNIN---PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       511 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      .....   .......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........   ...+    ..+.. 
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~----~~~~~-  314 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGRR-  314 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH----HTTCC-
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH----HcCCC-
Confidence            43321   12233467889999999998899999999999999999999 6667765433211   1111    11110 


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                             ...+......+.+++.+||+.||.+||++.|+++.|+..
T Consensus       315 -------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          315 -------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             -------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                   011223345688999999999999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-39  Score=342.80  Aligned_cols=267  Identities=24%  Similarity=0.331  Sum_probs=197.5

Q ss_pred             HHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       350 l~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      -....++|+..++||+|+||+||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (329)
T 3gbz_A           29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL  108 (329)
T ss_dssp             ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred             cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence            3445578999999999999999999998899999999996543  22345678999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-----CCCCeEEe
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-----ADLNPKLG  502 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-----~~~~~kL~  502 (662)
                      ++||||++ |+|.+++...     ..+++..++.++.||++||.|||+   .+|+||||||+|||++     .++.+||+
T Consensus       109 ~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          109 HLIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             EEEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             EEEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEEC
Confidence            99999997 5999998543     358999999999999999999999   8999999999999994     45559999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      |||+++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........  .......-.
T Consensus       180 Dfg~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~  256 (329)
T 3gbz_A          180 DFGLARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGL  256 (329)
T ss_dssp             CTTHHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCC
T ss_pred             cCCCccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCC
Confidence            999998765432 223345789999999998764 4899999999999999999999999865433221  111111000


Q ss_pred             --cCcccc--------ccCCCCCCC------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 --QGQITR--------AIDPTLDYF------DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 --~~~~~~--------~id~~l~~~------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ......        ...+.....      .......+.+|+.+||+.||.+|||+.|++++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence              000000        000000000      01134667899999999999999999999973

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.8e-39  Score=349.21  Aligned_cols=249  Identities=23%  Similarity=0.352  Sum_probs=197.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccc--cccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLR--HRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||++.... ++.||||++...  .....+.+.+|+.++.+++  ||||+++++++...+..++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            458899999999999999999864 889999998654  3455678999999999996  59999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      || +.+++|.+++...     ..+++.++..++.||++||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+
T Consensus       135 ~E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EE-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             Ee-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            99 5689999999543     468888999999999999999999   8999999999999995 589999999999876


Q ss_pred             cCCCCC-cceecccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          511 DHNINP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       511 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||........     .+..
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~~~~  279 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA  279 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----HHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----HHHH
Confidence            543221 2334579999999999864           3688999999999999999999999975432211     1111


Q ss_pred             HhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                               .+++.. ..++......+.+|+.+||+.||.+||++.|++++
T Consensus       280 ---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 ---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---------HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                     111111 11122224567889999999999999999999975

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-39  Score=337.85  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=203.9

Q ss_pred             ccCCcccc-eeeeeCceEEEEEEe--CCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          354 TKGFREKN-LVGSGGFGKVYRGVI--PSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       354 t~~f~~~~-~LG~G~~g~Vy~~~~--~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      .++|...+ .||+|+||+||+|.+  ...+..||||++....  ....+++.+|+.++++++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999954  4567899999997653  33467899999999999999999999999 566789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...     ..+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        94 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  165 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK  165 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence            999999999999999543     458899999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCc--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          509 AYDHNINPQ--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       509 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      .........  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.......   +...    ...+. 
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----~~~~~-  237 (291)
T 1xbb_A          166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM----LEKGE-  237 (291)
T ss_dssp             ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH----HHTTC-
T ss_pred             eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHcCC-
Confidence            765433211  122346789999999988888999999999999999999 999998654321   1111    11111 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          .   ...+......+.+++.+||+.||.+||++.+|++.|+.
T Consensus       238 ----~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          238 ----R---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             ----C---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ----C---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                0   11223345678899999999999999999999999864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.9e-39  Score=343.27  Aligned_cols=264  Identities=22%  Similarity=0.322  Sum_probs=206.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||+||++.+..++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  112 (360)
T 3eqc_A           33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH  112 (360)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence            5788999999999999999999889999999999765 344467889999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++..     ...+++..+..++.|++.||.|||+.  .+|+||||||+||+++.++.+||+|||++......
T Consensus       113 ~~~~~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          113 MDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            999999999953     34589999999999999999999982  28999999999999999999999999999765332


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH---------HHHHhhc--
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW---------VRELHSQ--  582 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~---------~~~~~~~--  582 (662)
                         ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..............         .......  
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  262 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence               12335789999999999998999999999999999999999999975443211110000         0000000  


Q ss_pred             ------------Ccccc----ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 ------------GQITR----AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ------------~~~~~----~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                  ....+    ...... ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                        00000    000000 01111234568899999999999999999999974

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=7.3e-39  Score=357.93  Aligned_cols=255  Identities=22%  Similarity=0.339  Sum_probs=209.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...++||+|+||.||+++.+.+|+.||||++.+..   ....+.+..|+.++++++||||+++++++...+.+++||
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm  264 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM  264 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence            67888999999999999999998899999999997643   234567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++..... ....+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       265 E~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          265 TIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             CCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999865431 13468999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh-hHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM-ELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~-~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+.   ..... ..      
T Consensus       341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~---~~i~~-~~------  409 (543)
T 3c4z_A          341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK---QRVLE-QA------  409 (543)
T ss_dssp             TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH---HHHHH-CC------
T ss_pred             CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH---HHHhh-cc------
Confidence            432 22334589999999999999899999999999999999999999997643211 11111   11111 10      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPST-----RRVVQ  627 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~  627 (662)
                         ..++......+..|+.+||+.||.+||++     .+|++
T Consensus       410 ---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 ---VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ---cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence               11223345677889999999999999975     67765

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.7e-39  Score=339.79  Aligned_cols=264  Identities=23%  Similarity=0.347  Sum_probs=206.6

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhc--cccccceeeeeeEeccC----
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGR--LRHRNLVQLHGWCRKQD----  425 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~--l~H~niv~l~~~~~~~~----  425 (662)
                      ...++|...+.||+|+||.||+|+.  +++.||||++...   ....+..|++++..  ++||||+++++++....    
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~  113 (342)
T 1b6c_B           39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT  113 (342)
T ss_dssp             HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred             cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence            3457899999999999999999998  5889999999654   33567788888877  79999999999998776    


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC-----CCCEEeCCcCCCceEeCCCCCeE
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC-----DQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                      ..++||||+++|+|.+++..      ..+++.+++.++.|+++||.|||...     ..+|+||||||+||+++.++.+|
T Consensus       114 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~k  187 (342)
T 1b6c_B          114 QLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC  187 (342)
T ss_dssp             CEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEE
T ss_pred             eeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEE
Confidence            78999999999999999943      35899999999999999999999210     18999999999999999999999


Q ss_pred             EeeccccccccCCCCC---cceecccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcC----------CCCC
Q 040242          501 LGDFGLARAYDHNINP---QTTHIVGTLGYLAPELTRTGK------ATTSTDVFGFGTLMLEVACG----------RRPI  561 (662)
Q Consensus       501 L~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG----------~~p~  561 (662)
                      |+|||+++........   ......||+.|+|||.+.+..      ++.++|||||||++|||++|          +.||
T Consensus       188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~  267 (342)
T 1b6c_B          188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY  267 (342)
T ss_dssp             ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence            9999999876544321   223457899999999987652      33689999999999999999          6787


Q ss_pred             CcccchhhHHHHHHHHHHhhcCccccccCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          562 EPQRTAMELVLVDWVRELHSQGQITRAIDPTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       562 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ........ ....+... ..    .....+.+.  ....+....+.+|+.+||+.||++||++.+|+++|+..
T Consensus       268 ~~~~~~~~-~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          268 YDLVPSDP-SVEEMRKV-VC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTTSCSSC-CHHHHHHH-HT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccCcCcc-cHHHHHHH-HH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            64422111 11111111 11    112223321  12346778899999999999999999999999999754

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.2e-39  Score=331.15  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=200.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            57888999999999999999998889999999996643   234567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++..     ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++....
T Consensus        91 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  162 (276)
T 2h6d_A           91 EYVSGGELFDYICK-----HGRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS  162 (276)
T ss_dssp             ECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred             eccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence            99999999999953     2458899999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ...  ......|++.|+|||.+.+... +.++||||||+++|||++|+.||.......   +...+    ..+.      
T Consensus       163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~~----~~~~------  227 (276)
T 2h6d_A          163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LFKKI----RGGV------  227 (276)
T ss_dssp             C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------
T ss_pred             CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HHHHh----hcCc------
Confidence            432  2233468999999999987665 689999999999999999999997543221   11111    1111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRD  632 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  632 (662)
                      .   ..+......+.+++.+||+.||.+||++.|++++  +.+.
T Consensus       228 ~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          228 F---YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             C---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             c---cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            0   1122234567889999999999999999999985  4443

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-39  Score=339.65  Aligned_cols=266  Identities=24%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh-----hHHHHHHHHHHhhccccccceeeeeeEeccCe
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ-----GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~-----~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~  426 (662)
                      ...++|+..+.||+|+||.||+|.+..+|+.||||++......     ..+.+.+|+.++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3457899999999999999999999888999999998654221     12467899999999999999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+++ +|.+++...    ...+++.++..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             eEEEEEcCCC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            9999999975 888888543    3468899999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC--
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG--  583 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~--  583 (662)
                      ++...... .......||+.|+|||.+.+. .++.++|||||||++|||++|..||........  +.. +.......  
T Consensus       159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~~~-i~~~~~~~~~  234 (346)
T 1ua2_A          159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTR-IFETLGTPTE  234 (346)
T ss_dssp             GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH-HHHHHCCCCT
T ss_pred             ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHH-HHHHcCCCCh
Confidence            98765432 223345789999999998654 588999999999999999999999876543221  111 11111100  


Q ss_pred             -ccc------cccCC-CCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          584 -QIT------RAIDP-TLDYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       584 -~~~------~~id~-~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       ...      +.+.. .....+     ......+.+|+.+||+.||.+|||+.|++++-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence             000      00000 000011     22346788999999999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-39  Score=369.30  Aligned_cols=253  Identities=25%  Similarity=0.389  Sum_probs=202.0

Q ss_pred             CCcccc-eeeeeCceEEEEEEeC--CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          356 GFREKN-LVGSGGFGKVYRGVIP--STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       356 ~f~~~~-~LG~G~~g~Vy~~~~~--~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++...+ .||+|+||.||+|.+.  .++..||||++.... ....++|.+|+.++++++||||++++++|.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            333344 7999999999999875  345679999997653 3456789999999999999999999999976 5699999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++|+|.+++...    ...+++..++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       415 E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~  487 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALG  487 (613)
T ss_dssp             ECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred             EeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence            999999999999644    4568999999999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCc--ceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 HNINPQ--TTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......  .....+++.|+|||++.++.++.++|||||||++|||++ |+.||.......   +...+    ..+..   
T Consensus       488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i----~~~~~---  557 (613)
T 2ozo_A          488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGKR---  557 (613)
T ss_dssp             --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHHHH----HTTCC---
T ss_pred             CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCC---
Confidence            432211  122345689999999998899999999999999999998 999998654332   11111    12211   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                           ...+......+.+|+.+||+.||.+||++.+|++.|+.
T Consensus       558 -----~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          558 -----MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             -----CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                 11233455678899999999999999999999998864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-39  Score=355.98  Aligned_cols=265  Identities=24%  Similarity=0.295  Sum_probs=188.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Cee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~  427 (662)
                      ++|+..++||+|+||+||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++...     ..+
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~  132 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL  132 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence            6789999999999999999999889999999999653  344567899999999999999999999998433     578


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+ +++|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+||||+.++.+||+|||++
T Consensus       133 ~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla  203 (458)
T 3rp9_A          133 YVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLA  203 (458)
T ss_dssp             EEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccc
Confidence            9999998 6789998853     3458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCC--------------------------CcceecccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHc----
Q 040242          508 RAYDHNIN--------------------------PQTTHIVGTLGYLAPELT-RTGKATTSTDVFGFGTLMLEVAC----  556 (662)
Q Consensus       508 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~ellt----  556 (662)
                      +.......                          ......+||+.|+|||++ ....++.++|||||||++|||++    
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~  283 (458)
T 3rp9_A          204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKE  283 (458)
T ss_dssp             BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTT
T ss_pred             hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccc
Confidence            87653221                          123345789999999975 56679999999999999999999    


Q ss_pred             -------CCCCCCcccch-----------------hhHHHHHHHHHHhhcC--------------cccccc----CCCCC
Q 040242          557 -------GRRPIEPQRTA-----------------MELVLVDWVRELHSQG--------------QITRAI----DPTLD  594 (662)
Q Consensus       557 -------G~~p~~~~~~~-----------------~~~~l~~~~~~~~~~~--------------~~~~~i----d~~l~  594 (662)
                             |+++|.+....                 ........+.......              .....+    ...+.
T Consensus       284 ~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  363 (458)
T 3rp9_A          284 NVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLA  363 (458)
T ss_dssp             TCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGG
T ss_pred             cccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHH
Confidence                   55555433210                 0000001111110000              000000    00011


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...+.....+.+|+.+||+.||.+|||+.|++++
T Consensus       364 ~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          364 ERFPASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             GGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHCCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1112235668899999999999999999999985

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-39  Score=342.35  Aligned_cols=253  Identities=21%  Similarity=0.345  Sum_probs=203.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|+..+.||+|+||.||++..+.+++.||||++......    ..+|++++.++ +||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            35788899999999999999999989999999999765432    34688888887 79999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-C---CeEEeeccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-L---NPKLGDFGLAR  508 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~---~~kL~DfGla~  508 (662)
                      |+++|+|.+++...     ..+++.++..++.||++||.|||+   .+|+||||||+|||+..+ +   .+||+|||+++
T Consensus        97 ~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~  168 (342)
T 2qr7_A           97 LMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAK  168 (342)
T ss_dssp             CCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCE
T ss_pred             CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcc
Confidence            99999999998543     458999999999999999999999   899999999999998543 3   49999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ....... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........+...+    ..+...  
T Consensus       169 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i----~~~~~~--  241 (342)
T 2qr7_A          169 QLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI----GSGKFS--  241 (342)
T ss_dssp             ECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH----HHCCCC--
T ss_pred             cCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH----ccCCcc--
Confidence            7654322 233457899999999998777889999999999999999999999854322222222111    111111  


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   ..+.......+.+|+.+||+.||++||++.+++++
T Consensus       242 ~~---~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 LS---GGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CC---STTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             cC---ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            00   11222345668889999999999999999999974

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-39  Score=343.72  Aligned_cols=262  Identities=23%  Similarity=0.366  Sum_probs=205.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEe-----CCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVI-----PSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~-----~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~  427 (662)
                      .++|+..+.||+|+||.||+|.+     ..++..||||++... ......++.+|+.++++++||||+++++++...+..
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  108 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  108 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence            36789999999999999999994     456788999999654 345567899999999999999999999999999999


Q ss_pred             eEEEeccCCCCcchhccccccc--ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEe
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQ--KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLG  502 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~  502 (662)
                      ++||||+++++|.+++......  ....+++.+++.++.|+++||.|||+   .+|+||||||+||+++.   +..+||+
T Consensus       109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999754321  12458999999999999999999999   89999999999999984   4569999


Q ss_pred             eccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHh
Q 040242          503 DFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       503 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      |||+++....... .......||+.|+|||.+.+..++.++|||||||++|||++ |+.||......   .+...+    
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~----  258 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---EVLEFV----  258 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HHHHHH----
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---HHHHHH----
Confidence            9999986543322 22233567899999999988889999999999999999998 99998754322   111111    


Q ss_pred             hcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          581 SQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       581 ~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ..+..        ..........+.+++.+||+.||.+||++.+++++|....
T Consensus       259 ~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          259 TSGGR--------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcCCC--------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence            11110        1112233456889999999999999999999999987543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.6e-39  Score=334.06  Aligned_cols=254  Identities=24%  Similarity=0.327  Sum_probs=190.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||+||++....+++.||||++....  ....+.+.++...++.++||||+++++++...+..++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            467889999999999999999998899999999997642  223334455556688899999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||++ |+|.+++..... ....+++..++.++.|++.||.|||+   . +|+||||||+||+++.++.+||+|||+++..
T Consensus        86 e~~~-~~l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             ECCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             ehhc-cchHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            9996 588888754321 24579999999999999999999999   6 9999999999999999999999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELT----RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT  586 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~  586 (662)
                      ....  ......||+.|+|||.+    .+..++.++|||||||++|||++|+.||........ .+    .......   
T Consensus       161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~---  230 (290)
T 3fme_A          161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL----KQVVEEP---  230 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH----HHHHHSC---
T ss_pred             cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH----HHHhccC---
Confidence            5432  22234689999999996    556789999999999999999999999975433211 11    1111111   


Q ss_pred             cccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       587 ~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                         .+..  ........+.+++.+||+.||.+|||+.|+++
T Consensus       231 ---~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ---SPQL--PADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ---CCCC--CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ---CCCc--ccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence               1111  11223456889999999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-39  Score=339.73  Aligned_cols=263  Identities=26%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             ccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEe
Q 040242          344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCR  422 (662)
Q Consensus       344 ~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~  422 (662)
                      .+.+.++....++|+..+.||+|+||.||+|.+..+++.||||++.... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            3455566667889999999999999999999998899999999986543 2346788999999999 8999999999997


Q ss_pred             c------cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC
Q 040242          423 K------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD  496 (662)
Q Consensus       423 ~------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~  496 (662)
                      .      .+..++||||+++++|.+++....   ...+++..++.++.||+.||.|||+   .+|+||||||+||+++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~  165 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTEN  165 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTT
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCC
Confidence            6      467899999999999999996543   3568999999999999999999999   899999999999999999


Q ss_pred             CCeEEeeccccccccCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH
Q 040242          497 LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV  571 (662)
Q Consensus       497 ~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~  571 (662)
                      +.+||+|||++........ ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||..........
T Consensus       166 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  244 (326)
T 2x7f_A          166 AEVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF  244 (326)
T ss_dssp             CCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             CCEEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence            9999999999987654321 223357899999999986     5678999999999999999999999997544321111


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            .... ..     .+.+  ........+.+++.+||+.||.+||++.+++++
T Consensus       245 ------~~~~-~~-----~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          245 ------LIPR-NP-----APRL--KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ------HHHH-SC-----CCCC--SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ------Hhhc-Cc-----cccC--CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                  1111 11     1111  112234568889999999999999999999983

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.4e-40  Score=348.89  Aligned_cols=255  Identities=23%  Similarity=0.350  Sum_probs=205.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeC---CCCcEEEEEEeeccc----hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIP---STGLEVAIKRVAHNS----RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~---~~g~~vavK~~~~~~----~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~  426 (662)
                      ++|+..+.||+|+||.||+++..   .+++.||||++....    ....+.+.+|+.++.++ +||||+++++++...+.
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            57888999999999999999984   478999999986532    22345677899999999 69999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+++++|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       134 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQ-----RERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             EEEEeecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            9999999999999999953     3468999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++.+............||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........  ..........  
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~--  281 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS--  281 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHC--
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhcc--
Confidence            987654333334456799999999998753  4789999999999999999999999754322111  1111111111  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQFL  629 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~L  629 (662)
                           .+   .++......+.+|+.+||+.||.+||     ++.|++++.
T Consensus       282 -----~~---~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 -----EP---PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -----CC---CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -----CC---CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                 11   12233445678899999999999999     999999865

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.2e-39  Score=348.90  Aligned_cols=254  Identities=23%  Similarity=0.351  Sum_probs=194.6

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhccccccceeeeeeEecc
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~  424 (662)
                      ..++|...+.||+|+||+||+|....+++.||||++....        ......+.+|+.++++++||||+++++++. .
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c
Confidence            3478999999999999999999999999999999997542        112235789999999999999999999985 4


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEE
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKL  501 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL  501 (662)
                      +..++||||+++|+|.+++...     ..+++.++..++.|+++||.|||+   .+|+||||||+|||++.+   ..+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEE
Confidence            5689999999999999988543     458999999999999999999999   899999999999999754   45999


Q ss_pred             eeccccccccCCCCCcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          502 GDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       502 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      +|||+++.....  .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........  +.+.+  
T Consensus       284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i--  357 (419)
T 3i6u_A          284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI--  357 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH--
T ss_pred             eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH--
Confidence            999999876543  22334679999999998853   5678899999999999999999999975433211  11111  


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ..+...     ............+.+++.+||+.||.+||++.|++++
T Consensus       358 --~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          358 --TSGKYN-----FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             --HTTCCC-----CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --hcCCCC-----CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence              111100     0000001234568899999999999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2e-39  Score=337.13  Aligned_cols=254  Identities=22%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|.+..++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   97 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF   97 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence            46788999999999999999999888999999999877666778899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus        98 ~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (302)
T 2j7t_A           98 CPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT  170 (302)
T ss_dssp             CTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred             CCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence            9999999998543    3458999999999999999999999   89999999999999999999999999987643221


Q ss_pred             CCCcceecccCCcccCcccc-----cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          514 INPQTTHIVGTLGYLAPELT-----RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~-----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      . .......||+.|+|||.+     ....++.++||||||+++|||++|+.||........      ...... ..    
T Consensus       171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~----  238 (302)
T 2j7t_A          171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAK-SD----  238 (302)
T ss_dssp             H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHH-SC----
T ss_pred             c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhc-cC----
Confidence            1 112234689999999988     466789999999999999999999999976543211      111111 11    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .+. ...+......+.+++.+||+.||.+|||+.+++++
T Consensus       239 -~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          239 -PPT-LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -CCC-CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -Ccc-cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             011 11123345668899999999999999999999863

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-39  Score=342.54  Aligned_cols=265  Identities=28%  Similarity=0.408  Sum_probs=204.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  104 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE  104 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence            57888999999999999999998889999999986543  3345678899999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+++++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++....
T Consensus       105 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  176 (331)
T 4aaa_A          105 FVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  176 (331)
T ss_dssp             CCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             cCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence            9999999988643     3458999999999999999999999   8999999999999999999999999999986654


Q ss_pred             CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHH--------HHHHHhhcC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVD--------WVRELHSQG  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~--------~~~~~~~~~  583 (662)
                      .. .......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.............        .....+...
T Consensus       177 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (331)
T 4aaa_A          177 PG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN  255 (331)
T ss_dssp             --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHC
T ss_pred             Cc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhc
Confidence            32 222345789999999998765 68999999999999999999999998654332211100        001111111


Q ss_pred             cc-ccccCCCCC-CC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QI-TRAIDPTLD-YF-----DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~-~~~id~~l~-~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .. .....+.+. ..     .+.....+.+|+.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            11 111112211 11     11335678999999999999999999999873

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.5e-38  Score=343.20  Aligned_cols=263  Identities=21%  Similarity=0.258  Sum_probs=205.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc--------cccceeeeeeEe---
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR--------HRNLVQLHGWCR---  422 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~--------H~niv~l~~~~~---  422 (662)
                      .++|+..++||+|+||+||+|+...+++.||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            36799999999999999999999889999999999754 344567889999999986        788999999987   


Q ss_pred             -ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeCCCC---
Q 040242          423 -KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLIDADL---  497 (662)
Q Consensus       423 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~---  497 (662)
                       .....++||||+ +++|.+++....   ...+++..++.++.||++||.|||+   . +|+||||||+|||++.++   
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~  187 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYI  187 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhh
Confidence             556899999999 666666664332   3568999999999999999999999   7 999999999999999775   


Q ss_pred             ----------------------------------------------CeEEeeccccccccCCCCCcceecccCCcccCcc
Q 040242          498 ----------------------------------------------NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE  531 (662)
Q Consensus       498 ----------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE  531 (662)
                                                                    .+||+|||+++.....    .....||+.|+|||
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE  263 (397)
T 1wak_A          188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE  263 (397)
T ss_dssp             HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred             hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence                                                          8999999999876533    23347899999999


Q ss_pred             cccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh---hHHHHHHHHHHhh--------cCccc-cccCC--------
Q 040242          532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM---ELVLVDWVRELHS--------QGQIT-RAIDP--------  591 (662)
Q Consensus       532 ~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~---~~~l~~~~~~~~~--------~~~~~-~~id~--------  591 (662)
                      ++.+..++.++|||||||++|||++|+.||.......   .......+.+...        .+... .....        
T Consensus       264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            9998889999999999999999999999997543221   1111111111110        00000 00000        


Q ss_pred             C------------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          592 T------------LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       592 ~------------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .            ...........+.+|+.+||+.||.+|||+.|++++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            0            012356677889999999999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.4e-38  Score=337.62  Aligned_cols=262  Identities=23%  Similarity=0.268  Sum_probs=196.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~------  425 (662)
                      .++|+..+.||+|+||.||+|....+++.||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            36899999999999999999999889999999999753  3344577899999999999999999999997654      


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||++ ++|.+++       ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCS-EEHHHHH-------HSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCC-CCHHHHH-------hhccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence            7899999996 5788877       3458899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH---------H--
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV---------D--  574 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~--  574 (662)
                      +++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||............         +  
T Consensus       173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  250 (371)
T 2xrw_A          173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFM  250 (371)
T ss_dssp             C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHH
T ss_pred             ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            998654321  233457899999999999888999999999999999999999999865432211100         0  


Q ss_pred             -----HHHHHhhcCc------cccccC----CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 -----WVRELHSQGQ------ITRAID----PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 -----~~~~~~~~~~------~~~~id----~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           .+........      ..+...    +............+.+|+.+||+.||.+|||++|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          251 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                 0000000000      000000    00000112235678999999999999999999999984

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-39  Score=343.72  Aligned_cols=258  Identities=24%  Similarity=0.342  Sum_probs=199.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~------  425 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46788999999999999999999989999999998553  3344577899999999999999999999997653      


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||+ +++|.+++..      ..+++..+..++.||++||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence            469999999 8899999843      458899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--  582 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  582 (662)
                      +++.....    .....+|+.|+|||.+.+ ..++.++||||+||+++||++|+.||...........   +......  
T Consensus       174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~~~  246 (367)
T 1cm8_A          174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE---IMKVTGTPP  246 (367)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCC
T ss_pred             cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCC
Confidence            99875432    234578999999998876 6789999999999999999999999986543322111   0000000  


Q ss_pred             ---------C-------ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 ---------G-------QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ---------~-------~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                               .       .+...-...+..........+.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                     0       000000111111222345668899999999999999999999985

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.1e-38  Score=336.01  Aligned_cols=257  Identities=20%  Similarity=0.265  Sum_probs=202.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEec--cCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRK--QDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~--~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|.+..+++.||||++....   .+.+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            67889999999999999999998899999999996543   467889999999997 9999999999987  56789999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAY  510 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~  510 (662)
                      ||+++++|.+++.        .+++.++..++.|+++||.|||+   .+|+||||||+|||++.++ .+||+|||+++..
T Consensus       113 e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~  181 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  181 (330)
T ss_dssp             ECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             eccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence            9999999999872        37888999999999999999999   8999999999999999777 7999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH--------HHhh
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR--------ELHS  581 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~--------~~~~  581 (662)
                      ....  ......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... +.....        ....
T Consensus       182 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~~  258 (330)
T 3nsz_A          182 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYID  258 (330)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHHH
T ss_pred             CCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHHH
Confidence            5432  2233578999999999876 67899999999999999999999999644322111 111100        0000


Q ss_pred             cCcc------ccc--------cCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 QGQI------TRA--------IDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~------~~~--------id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....      .+.        ..... ..........+.+|+.+||+.||.+|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0000      000        00000 11112245678899999999999999999999974

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=6.2e-39  Score=341.30  Aligned_cols=263  Identities=26%  Similarity=0.369  Sum_probs=202.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEec--------c
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--------Q  424 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--------~  424 (662)
                      ++|+..+.||+|+||+||+|....+|+.||||++....  ......+.+|+.++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            67899999999999999999998899999999986543  2234577899999999999999999999876        4


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      +..++||||++ ++|.+.+...    ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred             ceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence            46899999996 4777777543    3458999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCC---CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh
Q 040242          505 GLARAYDHNIN---PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       505 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      |+++.+.....   .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........   +....
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~  245 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLC  245 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHh
Confidence            99987653221   22334578999999998875 4579999999999999999999999986544322221   11111


Q ss_pred             hc---C--------ccccccCCCCC-CCC-HH------HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQ---G--------QITRAIDPTLD-YFD-PQ------EAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~---~--------~~~~~id~~l~-~~~-~~------~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   .        ...+.+..... ... ..      ....+.+|+.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            10   0        00000000000 000 01      12457899999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.9e-39  Score=337.14  Aligned_cols=265  Identities=24%  Similarity=0.361  Sum_probs=189.0

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ..++|+..+.||+|+||.||+|....+++.||||++.... ....+++.+|+.++++++||||+++++++...+..++||
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   92 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM   92 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence            3478999999999999999999998889999999986543 334567889999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccc---cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQ---QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      ||+++++|.+++.....   .....+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||++.
T Consensus        93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~  169 (303)
T 2vwi_A           93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSA  169 (303)
T ss_dssp             ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred             hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence            99999999999864211   113568999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC----CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          509 AYDHNIN----PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       509 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      .......    .......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||..........      .... .
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~-~  242 (303)
T 2vwi_A          170 FLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM------LTLQ-N  242 (303)
T ss_dssp             HCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH------HHHT-S
T ss_pred             eeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH------HHhc-c
Confidence            6643321    12233578999999998865 468999999999999999999999998654332111      1111 1


Q ss_pred             ccccccCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ... ......  ..........+.+++.+||+.||.+||++.+++++
T Consensus       243 ~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          243 DPP-SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             SCC-CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCC-ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            100 010000  11112234567889999999999999999999873

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=332.95  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=204.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||.||+|....+|+.||||++....  ..+++.+|+.++.+++||||+++++++...+..++||||
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  105 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEY  105 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeec
Confidence            467899999999999999999998889999999997643  346788999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++++|.+++...    ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++......
T Consensus       106 ~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          106 CGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             CTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             CCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            9999999998532    4568999999999999999999999   89999999999999999999999999999876543


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      . .......|++.|+|||.+.+..++.++||||||+++|||++|+.||.........      ... ....     .+..
T Consensus       179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~~-----~~~~  245 (314)
T 3com_A          179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMI-PTNP-----PPTF  245 (314)
T ss_dssp             B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHH-HHSC-----CCCC
T ss_pred             c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHH-hcCC-----Cccc
Confidence            2 2223457899999999999888999999999999999999999999754432111      111 1110     1111


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .........+.+++.+||+.||.+||++.+++++
T Consensus       246 -~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          246 -RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             -SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence             1122335678899999999999999999999973

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2e-39  Score=347.99  Aligned_cols=254  Identities=13%  Similarity=0.072  Sum_probs=186.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcc--ccccceeee-------eeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRL--RHRNLVQLH-------GWC  421 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l--~H~niv~l~-------~~~  421 (662)
                      ...|...+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            455888999999999999999998899999999998753   23456677885544444  699988755       343


Q ss_pred             ecc-----------------CeeeEEEeccCCCCcchhcccccccccccccHHHH------HHHHHHHHHHHHHhHhcCC
Q 040242          422 RKQ-----------------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQR------YKILIGVAQALLYLHEECD  478 (662)
Q Consensus       422 ~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~  478 (662)
                      ...                 ...++||||++ |+|.+++...    ...+.+..+      +.++.||++||.|||+   
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~----~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---  212 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL----DFVYVFRGDEGILALHILTAQLIRLAANLQS---  212 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH----HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh----ccccchhhhhhhhhHHHHHHHHHHHHHHHHH---
Confidence            322                 34799999998 8999999654    234566667      8888999999999999   


Q ss_pred             CCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHc
Q 040242          479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVAC  556 (662)
Q Consensus       479 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~ellt  556 (662)
                      .+|+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||.+.+  ..++.++|||||||++|||++
T Consensus       213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence            89999999999999999999999999999865422    224567799999999987  678999999999999999999


Q ss_pred             CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          557 GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       557 G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      |+.||..........        +............. ..........+.+|+.+||+.||++|||+.++++
T Consensus       289 g~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          289 LFLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SSCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            999998653321100        00000011111111 1111244567889999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.1e-38  Score=328.85  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---------hhhHHHHHHHHHHhhccc-cccceeeeeeEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---------RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRK  423 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~  423 (662)
                      .++|+..+.||+|+||.||+|....+++.||||++....         ....+.+.+|+.++++++ ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            468999999999999999999999899999999996542         233467889999999996 9999999999999


Q ss_pred             cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      .+..++||||+++++|.+++..     ...+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~d  167 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD  167 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEec
Confidence            9999999999999999999953     3468999999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCCcceecccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          504 FGLARAYDHNINPQTTHIVGTLGYLAPELTR------TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       504 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ||++.......  ......|++.|+|||.+.      ...++.++||||||+++|||++|+.||.......   ...   
T Consensus       168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~---  239 (298)
T 1phk_A          168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLR---  239 (298)
T ss_dssp             CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---
T ss_pred             ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHH---
Confidence            99998765432  233457899999999874      4568899999999999999999999997543221   111   


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .. ..+... ..    ..........+.+++.+||+.||.+||++.|+++
T Consensus       240 ~~-~~~~~~-~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          240 MI-MSGNYQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HH-HHTCCC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HH-hcCCcc-cC----cccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            11 111110 00    1111234567889999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.4e-38  Score=330.00  Aligned_cols=252  Identities=25%  Similarity=0.470  Sum_probs=197.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec----------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----------  423 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----------  423 (662)
                      .++|+..+.||+|+||.||+|....+++.||||++... ....+.+.+|+.++++++||||+++++++..          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35788999999999999999999889999999999653 3456788999999999999999999998854          


Q ss_pred             ---cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeE
Q 040242          424 ---QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       424 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                         .+..++||||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEE
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEE
Confidence               45789999999999999999643    3467889999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCC-------------CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          501 LGDFGLARAYDHNI-------------NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       501 L~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      |+|||+++......             ........||+.|+|||.+.+. .++.++|||||||++|||++   |+.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998764321             1122345689999999998754 68999999999999999998   5543211


Q ss_pred             hhhHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          567 AMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       567 ~~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .  .   ...... ..      ....+ ..+.......+.+++.+||+.||.+|||+.+++++
T Consensus       234 ~--~---~~~~~~-~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 R--V---NILKKL-RS------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             H--H---HHHHHH-HS------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             H--H---HHHHhc-cc------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            1  1   111111 11      11111 22344455678899999999999999999999974

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.8e-38  Score=339.82  Aligned_cols=256  Identities=24%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             HHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhcc-ccccceeeeeeE
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRL-RHRNLVQLHGWC  421 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~  421 (662)
                      ....++|+..+.||+|+||.||+|.+..+|+.||||++....        ....+.+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            344567999999999999999999998889999999986543        12245688999999999 799999999999


Q ss_pred             eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEE
Q 040242          422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKL  501 (662)
Q Consensus       422 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL  501 (662)
                      ...+..++||||+++++|.+++..     ...+++..+..++.||+.||.|||+   .+++||||||+||+++.++.+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999853     3468999999999999999999999   89999999999999999999999


Q ss_pred             eeccccccccCCCCCcceecccCCcccCcccccC------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHH
Q 040242          502 GDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW  575 (662)
Q Consensus       502 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~  575 (662)
                      +|||++.......  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.......   ....
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~  316 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRM  316 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHH
Confidence            9999998765432  2334679999999998853      357889999999999999999999997643221   1111


Q ss_pred             HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.    .+... ...+...    .....+.+++.+||+.||.+||++.|++++
T Consensus       317 i~----~~~~~-~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          317 IM----EGQYQ-FSSPEWD----DRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HH----HTCCC-CCHHHHS----SSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HH----hCCCC-CCCcccc----cCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11    11100 0000000    123568889999999999999999999974

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3e-38  Score=345.89  Aligned_cols=199  Identities=31%  Similarity=0.426  Sum_probs=169.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Ce
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  426 (662)
                      .++|...+.||+|+||.||+|.+..+++.||||++...  .....+.+.+|+.++++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999999753  344567899999999999999999999999766     57


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||++ ++|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            899999995 699999853     3458999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC---------------------CcceecccCCcccCcccc-cCCCCCcchhHHHHHHHHHHHHcCCCCC
Q 040242          507 ARAYDHNIN---------------------PQTTHIVGTLGYLAPELT-RTGKATTSTDVFGFGTLMLEVACGRRPI  561 (662)
Q Consensus       507 a~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~t~ksDV~S~Gvvl~elltG~~p~  561 (662)
                      ++.......                     .......||+.|+|||.+ ....++.++||||+||++|||++|..|+
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            997654321                     123456899999999985 5667999999999999999999865444

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.6e-39  Score=368.03  Aligned_cols=247  Identities=26%  Similarity=0.378  Sum_probs=199.0

Q ss_pred             ceeeeeCceEEEEEEe--CCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVI--PSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~--~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      +.||+|+||.||+|.+  ...++.||||++....  ....+++.+|+.++++++||||++++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            5799999999999965  4456889999997643  3446789999999999999999999999964 568999999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC-
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-  515 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-  515 (662)
                      |+|.+++..     ...+++.+++.++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++.+..... 
T Consensus       454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999953     3468999999999999999999999   8999999999999999999999999999987654322 


Q ss_pred             -CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          516 -PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       516 -~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                       .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +.    .....+..        
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~----~~i~~~~~--------  590 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGER--------  590 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTCC--------
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCC--------
Confidence             12233456889999999998899999999999999999998 999998654321   11    11111111        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ...+......+.+|+.+||+.||++||++.+|++.|+.
T Consensus       591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11223445678899999999999999999999999874

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-38  Score=350.03  Aligned_cols=260  Identities=20%  Similarity=0.261  Sum_probs=206.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc-ccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|+..++||+|+||.||+|++..+++.||||++......  .++..|+++++.++| +++..+..++...+..++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            36799999999999999999999889999999988654332  357889999999987 555566666777788999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~~  509 (662)
                      |+ +++|.+++...    ...+++.+++.++.||+.||.|||+   .+|+||||||+||||   +.++.+||+|||+++.
T Consensus        84 ~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             CC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             CC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            99 99999999643    3469999999999999999999999   899999999999999   6889999999999987


Q ss_pred             ccCCCCC------cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          510 YDHNINP------QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       510 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      +......      ......||+.|+|||.+.+..++.++|||||||+||||++|+.||..............+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            7654321      1224679999999999999999999999999999999999999998654432222222221111110


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      .+.. +       .......+.+|+.+||+.+|++||++.+|++.|+.
T Consensus       236 ~~~~-l-------~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          236 SIEA-L-------CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             CHHH-H-------HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cHHH-H-------hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            0000 0       01224568899999999999999999999998754

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=1.4e-38  Score=354.60  Aligned_cols=251  Identities=24%  Similarity=0.370  Sum_probs=200.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|....++..||||++....  ......+.+|+.++++++||||++++++|...+..++|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            56888999999999999999999899999999997653  3345678999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~~  509 (662)
                      ||++|+|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++..   +.+||+|||+++.
T Consensus       117 ~~~~g~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          117 CYKGGELFDEIIH-----RMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            9999999988843     3468999999999999999999999   899999999999999764   4599999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .....  ......||+.|+|||++. +.++.++||||+||++|||++|+.||.......   +...+    ..+... ..
T Consensus       189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i----~~~~~~-~~  257 (494)
T 3lij_A          189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRKV----EKGKYT-FD  257 (494)
T ss_dssp             CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCCC-CC
T ss_pred             CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCCC-CC
Confidence            65432  233457999999999886 568999999999999999999999998654321   11111    111110 00


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+...    .....+.+|+.+||+.||.+|||+.|++++
T Consensus       258 ~~~~~----~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          258 SPEWK----NVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             SGGGT----TSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             chhcc----cCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            01111    234567889999999999999999999964

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.2e-38  Score=340.32  Aligned_cols=271  Identities=25%  Similarity=0.324  Sum_probs=203.2

Q ss_pred             ccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-----------hhhHHHHHHHHHHhhccccc
Q 040242          344 RFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-----------RQGMKEFVAEITSMGRLRHR  412 (662)
Q Consensus       344 ~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-----------~~~~~~f~~Ei~~l~~l~H~  412 (662)
                      +....++....++|...+.||+|+||.||+|.+. .|..||||++....           ....+.+.+|+.++++++||
T Consensus        11 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   89 (362)
T 3pg1_A           11 RDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP   89 (362)
T ss_dssp             HHHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCT
T ss_pred             HHHHHHHHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCc
Confidence            3456788899999999999999999999999985 48999999985532           12247899999999999999


Q ss_pred             cceeeeeeEec-----cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC
Q 040242          413 NLVQLHGWCRK-----QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK  487 (662)
Q Consensus       413 niv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  487 (662)
                      ||+++++++..     ....++||||++ |+|.+++...    ...+++..+..++.||++||.|||+   .+|+|||||
T Consensus        90 ~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlk  161 (362)
T 3pg1_A           90 NILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLH  161 (362)
T ss_dssp             TBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCC
T ss_pred             CccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCC
Confidence            99999999843     336899999997 6888888643    3568999999999999999999999   899999999


Q ss_pred             CCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          488 PSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       488 p~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      |+||+++.++.+||+|||+++.....  .......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  239 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF  239 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             hHHEEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99999999999999999999854432  22334578999999998876 6789999999999999999999999986543


Q ss_pred             hhhHHHHHHHHHHhhcC-----------ccccccCCCC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          567 AMELVLVDWVRELHSQG-----------QITRAIDPTL--------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       567 ~~~~~l~~~~~~~~~~~-----------~~~~~id~~l--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .....   .+.......           ...+.+...+        ..........+.+|+.+||+.||.+|||+.|+++
T Consensus       240 ~~~~~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          240 YNQLN---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHHH---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHH---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            22111   111100000           0001111111        0111223456889999999999999999999998


Q ss_pred             H
Q 040242          628 F  628 (662)
Q Consensus       628 ~  628 (662)
                      +
T Consensus       317 h  317 (362)
T 3pg1_A          317 H  317 (362)
T ss_dssp             S
T ss_pred             C
Confidence            5

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.8e-38  Score=332.27  Aligned_cols=262  Identities=21%  Similarity=0.325  Sum_probs=206.5

Q ss_pred             cCCcccceeeeeCceEEEEEEe-CCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc------ceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI-PSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN------LVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~-~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------iv~l~~~~~~~~~~  427 (662)
                      ++|+..+.||+|+||+||+|.+ ..+++.||||++.... ...+.+.+|+.++++++|++      ++++++++...+..
T Consensus        14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~   92 (339)
T 1z57_A           14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHI   92 (339)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEE
T ss_pred             CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcE
Confidence            5789999999999999999998 5578999999996543 44567889999999998765      99999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC------------
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA------------  495 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~------------  495 (662)
                      ++||||+ +++|.+++....   ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.            
T Consensus        93 ~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           93 CIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             EEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999 899999986542   3468899999999999999999999   89999999999999987            


Q ss_pred             -------CCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh
Q 040242          496 -------DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM  568 (662)
Q Consensus       496 -------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~  568 (662)
                             ++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  241 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE  241 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH
T ss_pred             cccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH
Confidence                   678999999999865432    233578999999999998899999999999999999999999998654432


Q ss_pred             hHHHHHHHHH-----HhhcCcccc---------------------ccCCC--CCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          569 ELVLVDWVRE-----LHSQGQITR---------------------AIDPT--LDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       569 ~~~l~~~~~~-----~~~~~~~~~---------------------~id~~--l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                      ..........     .........                     ...+.  ...........+.+|+.+||+.||.+||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            2211111100     000000000                     00000  0112345677899999999999999999


Q ss_pred             CHHHHHHH
Q 040242          621 STRRVVQF  628 (662)
Q Consensus       621 t~~eVl~~  628 (662)
                      |+.|++++
T Consensus       322 t~~ell~h  329 (339)
T 1z57_A          322 TLREALKH  329 (339)
T ss_dssp             CHHHHTTS
T ss_pred             CHHHHhcC
Confidence            99999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.9e-38  Score=352.81  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=204.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..++||+|+||+||+|....+++.||||++....  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            57889999999999999999998899999999996542  2345778999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC---CCCCeEEeecccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLARA  509 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~  509 (662)
                      |+++|+|.+++..     ...+++..+..++.||++||.|||+   .+|+||||||+|||++   .++.+||+|||+++.
T Consensus       102 ~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          102 LYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999998853     3468999999999999999999999   8999999999999995   456799999999987


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      .....  ......||+.|+|||++.+ .++.++||||+||++|||++|+.||.......   +...+    ..+...   
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i----~~~~~~---  240 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKRV----ETGKYA---  240 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHTCCC---
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCCC---
Confidence            65432  2334579999999999875 58999999999999999999999997654321   11111    111110   


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       ... .........+.+++.+||+.||.+|||+.|++++
T Consensus       241 -~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -FDL-PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -SCS-GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCC-cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             000 0112234568899999999999999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=5.3e-39  Score=331.95  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=198.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-CC--cEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-TG--LEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-~g--~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||+||+|.+.. ++  ..||||++...   .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~   96 (291)
T 1u46_A           18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK   96 (291)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred             hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence            578889999999999999998643 23  36899998654   3345678999999999999999999999998755 89


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++++|.+++...    ...+++..++.++.|+++||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        97 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccc
Confidence            999999999999999643    3568999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          509 AYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       509 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ........  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.||.......      .+......+. 
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~~~~~~~-  242 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------ILHKIDKEGE-  242 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHHHHTSCC-
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------HHHHHHccCC-
Confidence            76543221  1223457889999999988888999999999999999999 999997654321      1111111110 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                            . ..........+.+++.+||+.||.+||++.+++++|.+..+
T Consensus       243 ------~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          243 ------R-LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             ------C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             ------C-CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence                  0 01122345678899999999999999999999999987543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.1e-38  Score=354.55  Aligned_cols=251  Identities=24%  Similarity=0.375  Sum_probs=207.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..++||+|+||.||+|....+++.||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            56888999999999999999999899999999996542   345678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe---CCCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll---~~~~~~kL~DfGla~  508 (662)
                      ||+++|+|.+++...     ..+++..+..++.||++||.|||+   .+|+||||||+|||+   +.++.+||+|||+++
T Consensus       106 e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  177 (484)
T 3nyv_A          106 EVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST  177 (484)
T ss_dssp             CCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred             ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence            999999999988543     458999999999999999999999   899999999999999   567899999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .+....  ......||+.|+|||.+.+ .++.++||||+||++|||++|+.||.......   +...+    ..+...  
T Consensus       178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i----~~~~~~--  245 (484)
T 3nyv_A          178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKKV----EKGKYT--  245 (484)
T ss_dssp             HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCCCC--
T ss_pred             Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHHH----HcCCCC--
Confidence            765432  2334579999999999865 68999999999999999999999998654321   11111    111110  


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        ... .........+.+|+.+||+.||.+|||+.|++++
T Consensus       246 --~~~-~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          246 --FEL-PQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             --CCS-GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --CCC-cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence              000 0112334668899999999999999999999974

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=5.9e-38  Score=343.14  Aligned_cols=201  Identities=20%  Similarity=0.300  Sum_probs=175.0

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc------ccccceeeeeeEeccCee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL------RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l------~H~niv~l~~~~~~~~~~  427 (662)
                      ..+|+..++||+|+||+||+|.+..+++.||||++.... ...+++.+|+.+++.+      +|+||+++++++...+..
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            356888999999999999999999899999999997643 3345677888888777      567999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC--eEEeecc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN--PKLGDFG  505 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~--~kL~DfG  505 (662)
                      ++||||+. ++|.+++....   ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.  +||+|||
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             EEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecc
Confidence            99999995 69999886543   3458999999999999999999999   79999999999999999987  9999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      +++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            99764432    2335789999999999988999999999999999999999999986544

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=2.5e-38  Score=353.48  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=203.5

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-------------hhHHHHHHHHHHhhccccccceeeeee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-------------QGMKEFVAEITSMGRLRHRNLVQLHGW  420 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-------------~~~~~f~~Ei~~l~~l~H~niv~l~~~  420 (662)
                      .++|...++||+|+||+||+|....++..||||++.....             ...+.+.+|+.++++++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            4678899999999999999999998999999999875421             235678999999999999999999999


Q ss_pred             EeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC---
Q 040242          421 CRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL---  497 (662)
Q Consensus       421 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~---  497 (662)
                      +...+..++|||||++|+|.+++..     ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIIN-----RHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCc
Confidence            9999999999999999999998853     3468999999999999999999999   8999999999999998776   


Q ss_pred             CeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          498 NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       498 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      .+||+|||+++......  ......||+.|+|||.+. +.++.++||||+||++|+|++|+.||.......   +...+ 
T Consensus       187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i-  259 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIKKV-  259 (504)
T ss_dssp             SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-
T ss_pred             cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH-
Confidence            69999999998765432  233457999999999987 468999999999999999999999998654321   11111 


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         ..+....  +..   ........+.+|+.+||+.||.+|||+.|++++
T Consensus       260 ---~~~~~~~--~~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          260 ---EKGKYYF--DFN---DWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ---HHCCCCC--CHH---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HcCCCCC--Ccc---ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               1111100  000   001124568899999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-38  Score=343.39  Aligned_cols=265  Identities=23%  Similarity=0.323  Sum_probs=200.6

Q ss_pred             HHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc------
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------  424 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------  424 (662)
                      ....++|+..+.||+|+||+||+|.+..+|+.||||++......    ..+|+.++++++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999999999999999998655322    23699999999999999999998443      


Q ss_pred             --------------------------------CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHH
Q 040242          425 --------------------------------DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY  472 (662)
Q Consensus       425 --------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~y  472 (662)
                                                      ...++||||++ ++|.+.+..... ....+++..+..++.||++||.|
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            34889999997 688888754321 24569999999999999999999


Q ss_pred             hHhcCCCCEEeCCcCCCceEeC-CCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHH
Q 040242          473 LHEECDQRVVHRDVKPSNVLID-ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTL  550 (662)
Q Consensus       473 LH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvv  550 (662)
                      ||+   .+|+||||||+|||++ .++.+||+|||+++......  ......||+.|+|||.+.+. .++.++||||+||+
T Consensus       157 LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  231 (383)
T 3eb0_A          157 IHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV  231 (383)
T ss_dssp             HHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence            999   8999999999999997 68899999999998764432  22345689999999988764 48999999999999


Q ss_pred             HHHHHcCCCCCCcccchhhHHHHHHHHHHh--------h-cCccccccCCCCCC------CCHHHHHHHHHHHHHccCCC
Q 040242          551 MLEVACGRRPIEPQRTAMELVLVDWVRELH--------S-QGQITRAIDPTLDY------FDPQEAELVLTLGLLCCDPH  615 (662)
Q Consensus       551 l~elltG~~p~~~~~~~~~~~l~~~~~~~~--------~-~~~~~~~id~~l~~------~~~~~~~~l~~l~~~Cl~~d  615 (662)
                      +|||++|+.||..........  ..+...-        . .....+..-+.+..      .+......+.+|+.+||+.|
T Consensus       232 l~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          232 FGELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            999999999998654332211  1111000        0 00001111111110      22234566889999999999


Q ss_pred             CCCCCCHHHHHHH
Q 040242          616 PDFRPSTRRVVQF  628 (662)
Q Consensus       616 P~~RPt~~eVl~~  628 (662)
                      |.+|||+.|++++
T Consensus       310 P~~R~t~~e~l~h  322 (383)
T 3eb0_A          310 PDLRINPYEAMAH  322 (383)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999963

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.4e-38  Score=335.98  Aligned_cols=259  Identities=20%  Similarity=0.309  Sum_probs=205.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh-----------------HHHHHHHHHHhhcccccccee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-----------------MKEFVAEITSMGRLRHRNLVQ  416 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~-----------------~~~f~~Ei~~l~~l~H~niv~  416 (662)
                      .++|...+.||+|+||.||+|..  +++.||||++.......                 .+.+.+|+.++++++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            36799999999999999999999  78999999997543221                 278999999999999999999


Q ss_pred             eeeeEeccCeeeEEEeccCCCCcchh------cccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCc
Q 040242          417 LHGWCRKQDELLLVYDYVPNGSLDKL------LFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSN  490 (662)
Q Consensus       417 l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~N  490 (662)
                      +++++...+..++||||+++++|.++      +....   ...+++..++.++.|+++||.|||+.  .+++||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~--~~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY---TCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS---CCCCCHHHHHHHHHHHHHHHHHHHHT--SCEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc---ccCCCHHHHHHHHHHHHHHHHHHhcc--CCEeecCCChHh
Confidence            99999999999999999999999999      53321   46799999999999999999999972  699999999999


Q ss_pred             eEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCC-CCCc-chhHHHHHHHHHHHHcCCCCCCcccchh
Q 040242          491 VLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATT-STDVFGFGTLMLEVACGRRPIEPQRTAM  568 (662)
Q Consensus       491 Ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~-ksDV~S~Gvvl~elltG~~p~~~~~~~~  568 (662)
                      |+++.++.+||+|||++......   ......|+..|+|||.+.+. .++. ++|||||||++|||++|+.||.......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999876443   33345789999999999877 5555 9999999999999999999998654321


Q ss_pred             hHHHHHHHHHHhhcCccccccC------CCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          569 ELVLVDWVRELHSQGQITRAID------PTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       569 ~~~l~~~~~~~~~~~~~~~~id------~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .  +...    ...+......+      +..    ..........+.+|+.+||+.||.+||++.|++++
T Consensus       260 ~--~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 E--LFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             H--HHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             H--HHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1  1111    11111110000      000    00113345678899999999999999999999974

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.2e-38  Score=335.67  Aligned_cols=262  Identities=24%  Similarity=0.350  Sum_probs=202.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Cee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DEL  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~  427 (662)
                      .++|+..+.||+|+||.||+|....+|+.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46899999999999999999999888999999999654 334456788999999999999999999988654     678


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||++ ++|.+++..      ..+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            99999996 689988842      458999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCC---------cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          508 RAYDHNINP---------QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       508 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      +........         ......||+.|+|||.+.. ..++.++|||||||++|||++|+.||..........   .+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~  236 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIF  236 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHH
Confidence            876542211         1223478999999998754 678999999999999999999999998654322211   111


Q ss_pred             HHhhcCc---ccccc----------------CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          578 ELHSQGQ---ITRAI----------------DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       578 ~~~~~~~---~~~~i----------------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .......   ....+                ...+..........+.+|+.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            1111000   00000                000000011334567899999999999999999999984

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.8e-38  Score=334.22  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=183.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHH-HhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEIT-SMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||.||+|....+|+.||||++.... .....++..|+. +++.++||||+++++++...+..++|||
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e  101 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME  101 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence            67888999999999999999998899999999997653 334455666666 7788899999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |++ ++|.+++..........+++..+..++.|+++||.|||+   . +|+||||||+||+++.++.+||+|||+++...
T Consensus       102 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A          102 LMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             CCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             ecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            997 488887753222224568999999999999999999999   6 99999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccc----cCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELT----RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ...  ......||+.|+|||.+    .+..++.++|||||||++|||++|+.||........     .+      .....
T Consensus       178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~------~~~~~  244 (327)
T 3aln_A          178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QL------TQVVK  244 (327)
T ss_dssp             ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCC
T ss_pred             ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HH------HHHhc
Confidence            432  22234689999999998    456789999999999999999999999975422100     00      01111


Q ss_pred             ccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          588 AIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       588 ~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ...+.+ ..........+.+|+.+||+.||.+||++.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            111122 1112234567889999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=5.9e-39  Score=343.81  Aligned_cols=257  Identities=24%  Similarity=0.352  Sum_probs=187.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc------C
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------D  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~  425 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999999899999999999653  334567889999999999999999999998654      5


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++|+|++ +++|.+++..      ..+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence            679999999 7899999843      458999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC-
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG-  583 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  583 (662)
                      +++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........   +....... 
T Consensus       178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~  250 (367)
T 2fst_X          178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPG  250 (367)
T ss_dssp             -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCSCC
T ss_pred             cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCC
Confidence            99865432    334578999999999876 6789999999999999999999999986554322211   11110000 


Q ss_pred             -------------ccccccCCCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 -------------QITRAIDPTLDYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 -------------~~~~~id~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                   ...+.+ +......     ......+.+|+.+||+.||.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          251 AELLKKISSESARNYIQSL-TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTS-CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhhhHHHHHHHhcc-CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                         000000 0000001     1224567899999999999999999999985

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2e-37  Score=333.73  Aligned_cols=209  Identities=20%  Similarity=0.296  Sum_probs=177.0

Q ss_pred             HHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cc-----cceeeeeeE
Q 040242          348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HR-----NLVQLHGWC  421 (662)
Q Consensus       348 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~-----niv~l~~~~  421 (662)
                      .+-....++|+..+.||+|+||+||+|.+..+++.||||++... .....++..|+.+++.++ |+     +|+++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            33344568899999999999999999999889999999999754 334566778888888775 44     499999999


Q ss_pred             eccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC--CCCCe
Q 040242          422 RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID--ADLNP  499 (662)
Q Consensus       422 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~  499 (662)
                      ...+..++||||++ ++|.+++....   ...+++..+..++.|++.||.|||+. ..+|+||||||+|||++  .++.+
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999995 59999986543   34589999999999999999999942 27899999999999995  47789


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      ||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876432    2345789999999999998999999999999999999999999986543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.2e-39  Score=334.39  Aligned_cols=262  Identities=24%  Similarity=0.335  Sum_probs=197.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe------------
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR------------  422 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~------------  422 (662)
                      ++|+..+.||+|+||.||+|....+++.||||++........+++.+|+.++++++||||+++++++.            
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            67888999999999999999998889999999998777777788999999999999999999999873            


Q ss_pred             --ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-CCCCe
Q 040242          423 --KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNP  499 (662)
Q Consensus       423 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~  499 (662)
                        .....++||||++ |+|.+++..      ..+++..++.++.|+++||.|||+   .+|+||||||+||+++ +++.+
T Consensus        91 ~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~  160 (320)
T 2i6l_A           91 LTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVL  160 (320)
T ss_dssp             CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEE
T ss_pred             ccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeE
Confidence              3467899999997 699999843      458899999999999999999999   8999999999999997 56789


Q ss_pred             EEeeccccccccCCCC--CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH
Q 040242          500 KLGDFGLARAYDHNIN--PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       500 kL~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  576 (662)
                      ||+|||+++.......  .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||..........  ..+
T Consensus       161 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~~~  238 (320)
T 2i6l_A          161 KIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--LIL  238 (320)
T ss_dssp             EECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHH
T ss_pred             EEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHH
Confidence            9999999987653221  12233567999999998765 678999999999999999999999998654322111  111


Q ss_pred             HH-----------HhhcCc--ccc-ccCCCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 RE-----------LHSQGQ--ITR-AIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 ~~-----------~~~~~~--~~~-~id~~l--~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..           ....-.  ... ...+..  ..........+.+++.+||+.||.+||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            00           000000  000 000000  00112235678899999999999999999999984

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=3.1e-38  Score=331.79  Aligned_cols=265  Identities=26%  Similarity=0.378  Sum_probs=204.3

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeC-CCCcEEEEEEeeccch--hhHHHHHHHHHHhhcc---ccccceeeeeeEe---
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIP-STGLEVAIKRVAHNSR--QGMKEFVAEITSMGRL---RHRNLVQLHGWCR---  422 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~-~~g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~---  422 (662)
                      .+.++|+..+.||+|+||.||+|.+. .+++.||+|++.....  .....+.+|+.+++++   +||||+++++++.   
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            45678999999999999999999985 5788999999865432  1223456677766666   8999999999987   


Q ss_pred             --ccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeE
Q 040242          423 --KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPK  500 (662)
Q Consensus       423 --~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~k  500 (662)
                        .....++||||++ |+|.+++....   ...+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~k  160 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIK  160 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEE
Confidence              5567899999997 69999986543   3458999999999999999999999   8999999999999999999999


Q ss_pred             EeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHh
Q 040242          501 LGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH  580 (662)
Q Consensus       501 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~  580 (662)
                      |+|||+++......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.........   ..+....
T Consensus       161 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~  235 (326)
T 1blx_A          161 LADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVI  235 (326)
T ss_dssp             ECSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred             EecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHc
Confidence            99999998654321  233457899999999999889999999999999999999999999865432211   1111111


Q ss_pred             hcC---ccc-------ccc----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          581 SQG---QIT-------RAI----DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       581 ~~~---~~~-------~~i----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...   ...       ...    ...+..........+.+|+.+||+.||.+||++.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          236 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            100   000       000    001111223345678899999999999999999999964

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.2e-38  Score=338.99  Aligned_cols=264  Identities=24%  Similarity=0.338  Sum_probs=205.3

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEecc-----C
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----D  425 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~  425 (662)
                      ...++|+..+.||+|+||.||+|.+..++..||||++.... ....+.+.+|++++.+++||||+++++++...     .
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            34568999999999999999999998899999999997543 34457889999999999999999999998654     3


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ..++||||++ ++|.+++.      ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       104 ~~~iv~e~~~-~~L~~~l~------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEcccC-cCHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCc
Confidence            6899999996 69999884      3458999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCC--cceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          506 LARAYDHNINP--QTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       506 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      +++........  ......||+.|+|||.+.+ ..++.++|||||||++|||++|+.||...........   +......
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~~~  250 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILGS  250 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH---HHHHHCS
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH---HHHHhCC
Confidence            99876543221  2234579999999998654 4589999999999999999999999986544332211   1110000


Q ss_pred             Cc---c--------cccc--CCCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 GQ---I--------TRAI--DPTLDY-----FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~~---~--------~~~i--d~~l~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   +        ....  .+....     ........+.+|+.+||+.||.+|||+.|++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00   0        0000  000000     111234568899999999999999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=6.2e-38  Score=333.90  Aligned_cols=257  Identities=23%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCe-----
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE-----  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~-----  426 (662)
                      .++|...+.||+|+||.||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36788899999999999999999889999999999654  33445778999999999999999999999987654     


Q ss_pred             -eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          427 -LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       427 -~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                       .++||||++ ++|.+++       ...+++.++..++.||++||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIM-------GLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCEEEEECCS-EEGGGTT-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEecccc-CCHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence             499999996 6998887       3348999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--  582 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--  582 (662)
                      +++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........  ..+ .....  
T Consensus       172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~-~~~~~~~  244 (353)
T 3coi_A          172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QIL-KVTGVPG  244 (353)
T ss_dssp             CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHH-HHHCBCC
T ss_pred             cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCCC
Confidence            99865432    234578999999998876 678999999999999999999999998654322111  111 00000  


Q ss_pred             ----------------CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 ----------------GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ----------------~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                      ..+.....+.+..........+.+|+.+||+.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                            0000011111222233456778899999999999999999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-38  Score=365.04  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=208.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  429 (662)
                      .++|+..++||+|+||+||+|+...+++.||||++.+.   .....+.+..|..++..+ +||||+++++++...+.+++
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l  419 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF  419 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence            46799999999999999999999999999999999764   233456788899999988 79999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++|+|.+++..     ...+++..++.++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       420 V~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          420 VMEYVNGGDLMYHIQQ-----VGRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEeCcCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            9999999999999953     3468999999999999999999999   8999999999999999999999999999986


Q ss_pred             ccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          510 YDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       510 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ..... .......||+.|+|||++.+..++.++|||||||+||||++|+.||.......   +   ...... +      
T Consensus       492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~-~------  557 (674)
T 3pfq_A          492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---L---FQSIME-H------  557 (674)
T ss_dssp             CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHS-S------
T ss_pred             cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---H---HHHHHh-C------
Confidence            43322 23445689999999999999999999999999999999999999998654321   1   111111 1      


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST-----RRVVQ  627 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~-----~eVl~  627 (662)
                        . ..++......+.+|+.+||+.||.+||++     +||++
T Consensus       558 --~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          558 --N-VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --C-CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --C-CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              1 11223345678899999999999999997     78775

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.3e-38  Score=334.60  Aligned_cols=252  Identities=24%  Similarity=0.366  Sum_probs=198.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhccccccceeeeeeEeccC
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~  425 (662)
                      .++|...+.||+|+||.||+|.+..+++.||||++....        ......+.+|+.++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357889999999999999999999899999999986542        122345889999999999999999999987655


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEe
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLG  502 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~  502 (662)
                       .++||||+++++|.+++..     ...+++..++.++.||++||.|||+   .+|+||||||+||+++.++.   +||+
T Consensus        89 -~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             -EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             -eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEc
Confidence             8999999999999998854     3468999999999999999999999   89999999999999987664   9999


Q ss_pred             eccccccccCCCCCcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      |||+++.....  .......||+.|+|||.+.   ...++.++|||||||++|||++|+.||........  +...+.  
T Consensus       160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~--  233 (322)
T 2ycf_A          160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT--  233 (322)
T ss_dssp             CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH--
T ss_pred             cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH--
Confidence            99999876432  1223356899999999863   56789999999999999999999999975433211  111111  


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                        .+...  ..+.   ........+.+++.+||+.||.+||++.++++
T Consensus       234 --~~~~~--~~~~---~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 --SGKYN--FIPE---VWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             --HTCCC--CCHH---HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --hCccc--cCch---hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence              11100  0000   00123456889999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=4e-38  Score=337.95  Aligned_cols=257  Identities=24%  Similarity=0.337  Sum_probs=200.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCee----
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDEL----  427 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~----  427 (662)
                      .++|...+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+.++++++||||+++++++...+..    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46788899999999999999999999999999999764  334467889999999999999999999999877654    


Q ss_pred             --eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          428 --LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       428 --~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                        ++||||++ ++|.+++       ...+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       121 ~~~lv~e~~~-~~l~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIM-------GMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCEEEEECCC-EEHHHHT-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEEcccc-ccHHHHh-------hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecC
Confidence              99999996 6888887       3448999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC-
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG-  583 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  583 (662)
                      +++.....    .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..........  ..+. ..... 
T Consensus       190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~-~~~~~~  262 (371)
T 4exu_A          190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILK-VTGVPG  262 (371)
T ss_dssp             CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHH-HHCCCC
T ss_pred             cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHH-HhCCCc
Confidence            99865432    234578999999998876 678999999999999999999999998654322111  1110 00000 


Q ss_pred             -------------ccccccCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 -------------QITRAIDPTL----DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 -------------~~~~~id~~l----~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                                   ...+.+....    ..........+.+|+.+||+.||++|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                         0000000000    00112235678899999999999999999999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.3e-37  Score=333.31  Aligned_cols=266  Identities=20%  Similarity=0.262  Sum_probs=204.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-----------cccceeeeeeEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-----------HRNLVQLHGWCRK  423 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~niv~l~~~~~~  423 (662)
                      ++|...+.||+|+||+||+|++..+++.||||++.... ...+.+.+|+.++++++           |+||+++++++..
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~   97 (373)
T 1q8y_A           19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   97 (373)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence            57899999999999999999998899999999997543 34567788999998886           8999999999876


Q ss_pred             cC----eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeC----
Q 040242          424 QD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLID----  494 (662)
Q Consensus       424 ~~----~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~----  494 (662)
                      .+    ..++||||+ +++|.+++....   ...+++..+..++.||+.||.|||+   . +|+||||||+|||++    
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           98 KGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEET
T ss_pred             cCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCC
Confidence            54    789999999 999999996543   3458999999999999999999999   7 999999999999994    


Q ss_pred             --CCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchh----
Q 040242          495 --ADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAM----  568 (662)
Q Consensus       495 --~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~----  568 (662)
                        ..+.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||.......    
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              4457999999999876543    233478999999999998899999999999999999999999998543211    


Q ss_pred             hHHHHHHHHH-----------------HhhcCccccccCC-----------CCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 040242          569 ELVLVDWVRE-----------------LHSQGQITRAIDP-----------TLDYFDPQEAELVLTLGLLCCDPHPDFRP  620 (662)
Q Consensus       569 ~~~l~~~~~~-----------------~~~~~~~~~~id~-----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP  620 (662)
                      ...+...+..                 .+........+..           ....++......+.+|+.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            1111111100                 0000000000000           00124567788899999999999999999


Q ss_pred             CHHHHHHH--HhcC
Q 040242          621 STRRVVQF--LLRD  632 (662)
Q Consensus       621 t~~eVl~~--L~~~  632 (662)
                      |+.|++++  +...
T Consensus       327 t~~ell~hp~f~~~  340 (373)
T 1q8y_A          327 DAGGLVNHPWLKDT  340 (373)
T ss_dssp             CHHHHHTCGGGTTC
T ss_pred             CHHHHhhChhhhcc
Confidence            99999984  4443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=5.4e-38  Score=334.83  Aligned_cols=271  Identities=25%  Similarity=0.320  Sum_probs=195.2

Q ss_pred             HHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCe-
Q 040242          348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE-  426 (662)
Q Consensus       348 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~-  426 (662)
                      .+.....++|+..+.||+|+||+||+|.+..++..||||++..... ....+.+|+..+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            4456667899999999999999999999988999999999865432 23456788888999999999999999966443 


Q ss_pred             ------eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhH--hcCCCCEEeCCcCCCceEeCC-CC
Q 040242          427 ------LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH--EECDQRVVHRDVKPSNVLIDA-DL  497 (662)
Q Consensus       427 ------~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivH~Dlkp~NIll~~-~~  497 (662)
                            .++||||+++ +|...+.... .....+++..+..++.|++.||.|||  +   .+|+||||||+|||++. ++
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTT
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCC
Confidence                  7899999975 5554443211 12456889999999999999999999  7   89999999999999997 89


Q ss_pred             CeEEeeccccccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHH
Q 040242          498 NPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV  576 (662)
Q Consensus       498 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~  576 (662)
                      .+||+|||+++......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||.........  ...+
T Consensus       170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~  245 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIV  245 (360)
T ss_dssp             EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHH
T ss_pred             cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHH
Confidence            99999999998765432  22345789999999988654 4899999999999999999999999865433221  1111


Q ss_pred             HH-----------HhhcCccccccCCC-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          577 RE-----------LHSQGQITRAIDPT-------LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       577 ~~-----------~~~~~~~~~~id~~-------l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..           ...........+..       +..........+.+|+.+||+.||.+|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          246 RVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            11           00000000000000       011222346778999999999999999999999985

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.8e-37  Score=338.39  Aligned_cols=261  Identities=26%  Similarity=0.367  Sum_probs=197.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc------Ceee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------DELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~~~~  428 (662)
                      .+|+..++||+|+||.||+|++..+|+.||||++.....    .+.+|++++++++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            457888999999999999999988899999999865432    234699999999999999999998542      2367


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeecccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLA  507 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~DfGla  507 (662)
                      +||||+++ +|.+.+.... .....+++..+..++.||++||.|||+   .+|+||||||+||||+.+ +.+||+|||++
T Consensus       130 lv~e~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a  204 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSA  204 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             eehhcccc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhh
Confidence            99999975 6666654321 124569999999999999999999999   899999999999999965 56899999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH-------
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL-------  579 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------  579 (662)
                      +......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........  +...+..+       
T Consensus       205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~--l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQ  280 (420)
T ss_dssp             EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCSCCHHH
T ss_pred             hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHHH
Confidence            8765432  22335789999999998664 789999999999999999999999986543322  22222110       


Q ss_pred             hh--cCccccccCCCCCC------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HS--QGQITRAIDPTLDY------FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~--~~~~~~~id~~l~~------~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.  .....+...+.+..      +.......+.+|+.+||+.||.+||++.|++++
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            00  01111111122211      122335678899999999999999999999974

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2e-37  Score=329.16  Aligned_cols=263  Identities=19%  Similarity=0.286  Sum_probs=204.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCC-cEEEEEEeeccchhhHHHHHHHHHHhhcccccc------ceeeeeeEeccCe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTG-LEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN------LVQLHGWCRKQDE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g-~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n------iv~l~~~~~~~~~  426 (662)
                      .++|+..+.||+|+||+||+|....++ ..||+|++.... ...+.+..|+.++++++|++      ++.+++++...+.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            368999999999999999999997666 789999997543 34567888999999998877      8999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe-------------
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI-------------  493 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll-------------  493 (662)
                      .++||||+ +++|.+++....   ...+++.+++.++.||++||.|||+   .+|+||||||+|||+             
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             EEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccc
Confidence            99999999 667777765432   3468999999999999999999999   899999999999999             


Q ss_pred             ------CCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccch
Q 040242          494 ------DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA  567 (662)
Q Consensus       494 ------~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~  567 (662)
                            +.++.+||+|||+++.....    .....||+.|+|||.+.+..++.++|||||||++|||++|+.||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  56789999999999864432    23357899999999999889999999999999999999999999865433


Q ss_pred             hhHHHHHHHHH-----HhhcCccccc-cC-------------------CC---CCCCCHHHHHHHHHHHHHccCCCCCCC
Q 040242          568 MELVLVDWVRE-----LHSQGQITRA-ID-------------------PT---LDYFDPQEAELVLTLGLLCCDPHPDFR  619 (662)
Q Consensus       568 ~~~~l~~~~~~-----~~~~~~~~~~-id-------------------~~---l~~~~~~~~~~l~~l~~~Cl~~dP~~R  619 (662)
                      ...........     .......... ..                   +.   .......+...+.+|+.+||+.||++|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            22211111100     0000000000 00                   00   011223456688999999999999999


Q ss_pred             CCHHHHHHH
Q 040242          620 PSTRRVVQF  628 (662)
Q Consensus       620 Pt~~eVl~~  628 (662)
                      ||+.|++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999863

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-37  Score=321.71  Aligned_cols=252  Identities=22%  Similarity=0.382  Sum_probs=204.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|....+++.||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            367999999999999999999998889999999986543  334678899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC---CCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD---LNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~---~~~kL~DfGla~  508 (662)
                      ||+++++|.+++..     ...+++.+++.++.|+++||.|||+   .+++||||||+||+++.+   +.+||+|||++.
T Consensus       101 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          101 ELYTGGELFDEIIK-----RKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             CCCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999998853     3458999999999999999999999   899999999999999764   469999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ......  ......|++.|+|||.+.+ .++.++||||||+++|||++|+.||.......   +..    ....+.....
T Consensus       173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~~  242 (287)
T 2wei_A          173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK----RVETGKYAFD  242 (287)
T ss_dssp             TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCCC
T ss_pred             eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCCCCC
Confidence            765432  2233468999999998865 58999999999999999999999997654321   111    1111111100


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      . +..    ......+.+++.+||+.||++||++.|++++
T Consensus       243 ~-~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          243 L-PQW----RTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             S-GGG----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             c-hhh----hhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            0 000    1234568889999999999999999999983

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.1e-38  Score=332.13  Aligned_cols=259  Identities=24%  Similarity=0.399  Sum_probs=200.2

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ..++|+..+.||+|+||.||+|....   .+|+|++....  ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv  107 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAII  107 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEE
Confidence            34778899999999999999999843   49999986542  23345678899999999999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++++|.+++...    ...+++.+++.++.|+++||.|||+   .+++||||||+||+++ ++.+||+|||+++..
T Consensus       108 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~  179 (319)
T 2y4i_B          108 TSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSIS  179 (319)
T ss_dssp             CBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC--
T ss_pred             eecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccc
Confidence            9999999999999654    3468999999999999999999999   8999999999999998 679999999998765


Q ss_pred             cCCC----CCcceecccCCcccCcccccC---------CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHH
Q 040242          511 DHNI----NPQTTHIVGTLGYLAPELTRT---------GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVR  577 (662)
Q Consensus       511 ~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~  577 (662)
                      ....    ........|++.|+|||.+..         ..++.++|||||||++|||++|+.||........      .+
T Consensus       180 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~  253 (319)
T 2y4i_B          180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI------IW  253 (319)
T ss_dssp             --------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH------HH
T ss_pred             ccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HH
Confidence            3211    122233468999999998864         3578899999999999999999999976543211      11


Q ss_pred             HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          578 ELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       578 ~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                      .. ..+     ..+.+.  .......+.+++.+||+.||.+||++.+++++|+......
T Consensus       254 ~~-~~~-----~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          254 QM-GTG-----MKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HH-HTT-----CCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             Hh-ccC-----CCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            11 111     111111  1112345788999999999999999999999998765443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.3e-37  Score=329.39  Aligned_cols=266  Identities=22%  Similarity=0.297  Sum_probs=181.2

Q ss_pred             ccCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec----cCeee
Q 040242          354 TKGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELL  428 (662)
Q Consensus       354 t~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~  428 (662)
                      .++|... ++||+|+||+||+|.+..+++.||||++..... ..+   .....+..++||||+++++++..    ....+
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~---e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  102 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQ---EVDHHWQASGGPHIVCILDVYENMHHGKRCLL  102 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHH---HHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHH---HHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence            4678874 469999999999999998999999999965422 112   22234566799999999999876    44689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeecc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFG  505 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfG  505 (662)
                      +||||+++|+|.+++....   ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.   ++.+||+|||
T Consensus       103 lv~e~~~gg~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          103 IIMECMEGGELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEeccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            9999999999999996543   3469999999999999999999999   89999999999999986   4559999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +++.....   ......||+.|+|||.+.+..++.++|||||||++|||++|+.||..........   ........+  
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~--  248 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLG--  248 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcc--
Confidence            99865432   2234568999999999988889999999999999999999999997543221100   000000000  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcCCCCCCCCC
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPL  640 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~~~~p~~p~  640 (662)
                       ....+  ..........+.+|+.+||+.||.+|||+.|+++  .+......|..|.
T Consensus       249 -~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~  302 (336)
T 3fhr_A          249 -QYGFP--NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL  302 (336)
T ss_dssp             ---CCC--TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCBC
T ss_pred             -ccccC--chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCcc
Confidence             00000  1111234566888999999999999999999998  4555555554443

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.2e-38  Score=359.94  Aligned_cols=257  Identities=25%  Similarity=0.381  Sum_probs=205.1

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCC---CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~---~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ..++|+..+.||+|+||.||+|.+..   .+..||||++... .....+.|.+|+.++++++||||+++++++. .+..+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~  466 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW  466 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceE
Confidence            34678889999999999999999854   3467999998764 3444578999999999999999999999985 45689


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++|+|.+++...    ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus       467 lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~  539 (656)
T 2j0j_A          467 IIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR  539 (656)
T ss_dssp             EEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred             EEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCe
Confidence            999999999999999543    3468999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ..............+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.......   +...+.    .+..  
T Consensus       540 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~----~~~~--  610 (656)
T 2j0j_A          540 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIE----NGER--  610 (656)
T ss_dssp             SCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----HTCC--
T ss_pred             ecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHH----cCCC--
Confidence            775543333344567889999999988899999999999999999997 999997654321   111111    1110  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         +   ..+......+.+++.+||+.||.+||++.++++.|+..
T Consensus       611 ---~---~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 ---L---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ---C---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---C---CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               1   11223456788999999999999999999999998753

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.1e-38  Score=328.08  Aligned_cols=261  Identities=22%  Similarity=0.341  Sum_probs=200.6

Q ss_pred             cccchHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccc--cccceeee
Q 040242          343 CRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLR--HRNLVQLH  418 (662)
Q Consensus       343 ~~~~~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~--H~niv~l~  418 (662)
                      ..+.+..+....++|+..+.||+|+||.||++... +++.||||++...  .....+.+.+|+.++.+++  |+||++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   94 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   94 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEE
Confidence            34445555556678999999999999999999985 5889999998654  3445678999999999997  49999999


Q ss_pred             eeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC
Q 040242          419 GWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN  498 (662)
Q Consensus       419 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~  498 (662)
                      +++...+..++||| +.+++|.+++..     ...+++.+++.++.|+++||.|||+   .+|+||||||+||++++ +.
T Consensus        95 ~~~~~~~~~~lv~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           95 DYEITDQYIYMVME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             EEEECSSEEEEEEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TE
T ss_pred             EEeecCCEEEEEEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-Ce
Confidence            99999999999999 568999999954     3468899999999999999999999   89999999999999964 88


Q ss_pred             eEEeeccccccccCCCCC-cceecccCCcccCcccccC-----------CCCCcchhHHHHHHHHHHHHcCCCCCCcccc
Q 040242          499 PKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRT-----------GKATTSTDVFGFGTLMLEVACGRRPIEPQRT  566 (662)
Q Consensus       499 ~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~  566 (662)
                      +||+|||+++........ ......|++.|+|||.+.+           ..++.++|||||||++|||++|+.||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            999999999876543221 2234578999999999865           4688899999999999999999999975432


Q ss_pred             hhhHHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          567 AMELVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       567 ~~~~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...     .+...         +++.. ...+......+.+++.+||+.||.+||++.|++++
T Consensus       245 ~~~-----~~~~~---------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          245 QIS-----KLHAI---------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HHH-----HHHHH---------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH-----HHHHH---------HhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            211     11111         11111 11122224568889999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=6.5e-38  Score=339.05  Aligned_cols=260  Identities=24%  Similarity=0.338  Sum_probs=194.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCe------ee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE------LL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~------~~  428 (662)
                      .+|...++||+|+||+||+|++..++ .||+|++......    ..+|+.++++++||||+++++++...+.      .+
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~-~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTE-EEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCC-eEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            46888999999999999999997655 4999988654322    2369999999999999999999965443      78


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-CCCCeEEeecccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNPKLGDFGLA  507 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~DfGla  507 (662)
                      +||||++++.+........  ....+++..+..++.||++||.|||+   .+|+||||||+|||++ .++.+||+|||++
T Consensus       115 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEeeccCccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            9999997654443332111  14568999999999999999999999   8999999999999999 7999999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH-------
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL-------  579 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~-------  579 (662)
                      +......  ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||..........  ..+...       
T Consensus       190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~~  265 (394)
T 4e7w_A          190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSREQ  265 (394)
T ss_dssp             EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHH
T ss_pred             ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHH
Confidence            8764432  22345789999999988654 58999999999999999999999998654332221  111110       


Q ss_pred             hh--cCccccccCCCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HS--QGQITRAIDPTLD------YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~--~~~~~~~id~~l~------~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      +.  .....+..-+...      .+.......+.+|+.+||+.||.+|||+.|++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00  0000111111111      1122244678899999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=337.32  Aligned_cols=266  Identities=21%  Similarity=0.293  Sum_probs=183.1

Q ss_pred             Ccc-cceeeeeCceEEEEEEeC--CCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEe--ccCeeeEEE
Q 040242          357 FRE-KNLVGSGGFGKVYRGVIP--STGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCR--KQDELLLVY  431 (662)
Q Consensus       357 f~~-~~~LG~G~~g~Vy~~~~~--~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~lV~  431 (662)
                      |.. .++||+|+||+||+|...  .++..||||++.....  ...+.+|+.++++++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            444 468999999999999975  4678899999965432  246789999999999999999999995  467899999


Q ss_pred             eccCCCCcchhccccccc----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe----CCCCCeEEee
Q 040242          432 DYVPNGSLDKLLFDNDQQ----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI----DADLNPKLGD  503 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll----~~~~~~kL~D  503 (662)
                      ||++ ++|.+++......    ....+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9995 5888877533211    12359999999999999999999999   899999999999999    7788999999


Q ss_pred             ccccccccCCCC--CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchh------hHHHHH
Q 040242          504 FGLARAYDHNIN--PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAM------ELVLVD  574 (662)
Q Consensus       504 fGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~------~~~l~~  574 (662)
                      ||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......      ......
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~  255 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLD  255 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHH
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHH
Confidence            999987654322  223446789999999998774 58999999999999999999999997543210      001111


Q ss_pred             HHHHHhhcC--cccccc-------------C-CCCCCC---------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          575 WVRELHSQG--QITRAI-------------D-PTLDYF---------DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       575 ~~~~~~~~~--~~~~~i-------------d-~~l~~~---------~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.......  .....+             . ......         .......+.+|+.+||+.||.+|||+.|++++
T Consensus       256 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          256 RIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            111111000  000000             0 000000         00113457889999999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-38  Score=328.06  Aligned_cols=244  Identities=27%  Similarity=0.399  Sum_probs=194.5

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh------hHHHHHHHHHHhhcc----ccccceeeeeeEe
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ------GMKEFVAEITSMGRL----RHRNLVQLHGWCR  422 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l----~H~niv~l~~~~~  422 (662)
                      ..++|+..+.||+|+||.||+|.+..+++.||||++......      ....+..|+.++.++    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            347799999999999999999999889999999999665321      223456789999888    8999999999999


Q ss_pred             ccCeeeEEEec-cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-CCCCeE
Q 040242          423 KQDELLLVYDY-VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNPK  500 (662)
Q Consensus       423 ~~~~~~lV~E~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~k  500 (662)
                      ..+..++|||| +++++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+||+++ .++.+|
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITE-----KGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999 789999999954     3458999999999999999999999   8999999999999999 889999


Q ss_pred             EeeccccccccCCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          501 LGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       501 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      |+|||+++.....   ......|+..|+|||.+.+..+ +.++|||||||++|||++|+.||......        .   
T Consensus       181 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------~---  246 (312)
T 2iwi_A          181 LIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------L---  246 (312)
T ss_dssp             ECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H---
T ss_pred             EEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH--------h---
Confidence            9999999876543   2234568999999998876665 45899999999999999999999753210        0   


Q ss_pred             hhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 040242          580 HSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL  629 (662)
Q Consensus       580 ~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L  629 (662)
                       . ..      .   .........+.+++.+||+.||++||++.|++++-
T Consensus       247 -~-~~------~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          247 -E-AE------L---HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             -H-TC------C---CCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             -h-hc------c---CCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence             0 00      0   11223345678899999999999999999999853

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-37  Score=321.85  Aligned_cols=253  Identities=22%  Similarity=0.326  Sum_probs=182.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-hh-HHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-QG-MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-~~-~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .++|+..+.||+|+||.||+|.+..+|+.||||++..... .. .+.+.++..+++.++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            3678889999999999999999988899999999976532 22 333445556788889999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCC-CEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQ-RVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||+ ++.+..+....    ...+++..++.++.|+++||.|||+   . +++||||||+||+++.++.+||+|||++...
T Consensus       104 e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          104 ELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             CCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             ecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999 55555544321    3568999999999999999999998   5 8999999999999999999999999999865


Q ss_pred             cCCCCCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ....  ......|++.|+|||.+.     ...++.++|||||||++|||++|+.||........ .    +.......  
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~----~~~~~~~~--  246 (318)
T 2dyl_A          176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-V----LTKVLQEE--  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-H----HHHHHHSC--
T ss_pred             cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-H----HHHHhccC--
Confidence            4432  223356899999999984     45688999999999999999999999975432211 1    11111110  


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                          .+.+. ........+.+++.+||+.||.+||++.+++++
T Consensus       247 ----~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          247 ----PPLLP-GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ----CCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ----CCCCC-ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                11111 011234567889999999999999999999873

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.4e-36  Score=332.82  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=187.5

Q ss_pred             CcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEeccC
Q 040242          357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       357 f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      |...++||+|+||+||.+.. .+|+.||||++....   .+.+.+|+.++.++ +||||+++++++...+..++|||||.
T Consensus        17 ~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~   92 (434)
T 2rio_A           17 VVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN   92 (434)
T ss_dssp             EEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred             eeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence            44568899999999976544 468999999986543   34678899999887 89999999999999999999999995


Q ss_pred             CCCcchhccccccccc--ccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-------------CCeE
Q 040242          436 NGSLDKLLFDNDQQKK--KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-------------LNPK  500 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-------------~~~k  500 (662)
                       |+|.+++........  ...++..++.++.||++||.|||+   .+|+||||||+|||++.+             +.+|
T Consensus        93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k  168 (434)
T 2rio_A           93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL  168 (434)
T ss_dssp             -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred             -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence             799999975432111  112455678899999999999999   899999999999999754             4799


Q ss_pred             EeeccccccccCCCCC---cceecccCCcccCcccccC-------CCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhh
Q 040242          501 LGDFGLARAYDHNINP---QTTHIVGTLGYLAPELTRT-------GKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAME  569 (662)
Q Consensus       501 L~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~  569 (662)
                      |+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||........
T Consensus       169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~  248 (434)
T 2rio_A          169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES  248 (434)
T ss_dssp             ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHHH
T ss_pred             EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhHH
Confidence            9999999977553221   2234579999999999865       568999999999999999999 9999975432211


Q ss_pred             HHHHHHHHHHhhcCccccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          570 LVLVDWVRELHSQGQITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       570 ~~l~~~~~~~~~~~~~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                          ..+.     +..  .. +.+ ..........+.+|+.+||+.||.+||++.+|++
T Consensus       249 ----~i~~-----~~~--~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          249 ----NIIR-----GIF--SL-DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HHHH-----TCC--CC-CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHhc-----CCC--Cc-ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                1111     100  00 111 1224566788999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.5e-38  Score=328.04  Aligned_cols=243  Identities=26%  Similarity=0.433  Sum_probs=200.9

Q ss_pred             hccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchh------hHHHHHHHHHHhhccc--cccceeeeeeEecc
Q 040242          353 ATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQ------GMKEFVAEITSMGRLR--HRNLVQLHGWCRKQ  424 (662)
Q Consensus       353 at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~------~~~~f~~Ei~~l~~l~--H~niv~l~~~~~~~  424 (662)
                      ..++|+..+.||+|+||.||+|....+++.||||++......      ..+.+..|+.++++++  |+||+++++++...
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~  120 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP  120 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC
Confidence            346789999999999999999999889999999999765321      2245678999999996  59999999999999


Q ss_pred             CeeeEEEeccCC-CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC-CCCCeEEe
Q 040242          425 DELLLVYDYVPN-GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID-ADLNPKLG  502 (662)
Q Consensus       425 ~~~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~-~~~~~kL~  502 (662)
                      +..++|||++.+ ++|.+++..     ...+++..++.++.|+++||.|||+   .+|+||||||+|||++ .++.+||+
T Consensus       121 ~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          121 DSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             CcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999976 899999853     3468999999999999999999999   8999999999999999 78899999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      |||+++.....   ......||+.|+|||.+.+... +.++|||||||++|||++|+.||......        .    .
T Consensus       193 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~--------~----~  257 (320)
T 3a99_A          193 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI--------I----R  257 (320)
T ss_dssp             CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------H----H
T ss_pred             eCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------h----c
Confidence            99999876543   2233568999999998876665 68899999999999999999999753210        0    0


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       +..         .........+.+++.+||+.||.+||++.|++++
T Consensus       258 -~~~---------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          258 -GQV---------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             -CCC---------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -ccc---------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             000         0111234567889999999999999999999984

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-36  Score=330.39  Aligned_cols=249  Identities=21%  Similarity=0.295  Sum_probs=186.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ..+|+..++||+|+||+||.... .+++.||||++......   .+.+|+.+++++ +||||+++++++...+..++|||
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            35688889999999999654333 46889999999654322   346799999999 89999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-----CCCeEEeecccc
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-----DLNPKLGDFGLA  507 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DfGla  507 (662)
                      ||+ |+|.+++....    ..+.+..++.++.||++||.|||+   .+|+||||||+|||++.     ...+||+|||++
T Consensus        99 ~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             CCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             CCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            995 69999996542    335556678999999999999999   89999999999999953     346889999999


Q ss_pred             ccccCCCC--CcceecccCCcccCccccc---CCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhh
Q 040242          508 RAYDHNIN--PQTTHIVGTLGYLAPELTR---TGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       508 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      +.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||.........       ....
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-------~~~~  243 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-------ILLG  243 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-------HHTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-------HHhc
Confidence            87654321  2234467999999999987   4567889999999999999999 88898644321110       0000


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                            ................+.+|+.+||+.||.+||++.||++
T Consensus       244 ------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 ------ACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             ------CCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------cCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence                  0011111112345566789999999999999999999995

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=1.7e-36  Score=269.32  Aligned_cols=113  Identities=39%  Similarity=0.533  Sum_probs=104.5

Q ss_pred             CcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEE
Q 040242          140 TRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVT  219 (662)
Q Consensus       140 ~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~  219 (662)
                      ||+|||||||++|.+++||++||||||+||+.|..+++|                 ++.+|+.++|||+||+.+++|+|+
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~-----------------~l~sG~~~~v~I~Yd~~~~~L~V~   63 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKW-----------------DWQNGKIATAHISYNSVSKRLSVT   63 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----------------CCCTTSCEEEEEEEETTTTEEEEE
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeee-----------------EEcCCCEEEEEEEEeCCCcEEEEE
Confidence            579999999999999889999999999999999887765                 367999999999999999999999


Q ss_pred             EccCCCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEEecceeeec
Q 040242          220 ISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       220 ~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW~f~~~  272 (662)
                      +++.+. +  .|+|++.+||+++|+++||||||||||...|.|+|++|+|+..
T Consensus        64 l~~~~~-~--~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~  113 (133)
T 1qmo_E           64 SYYAGS-K--PATLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSS  113 (133)
T ss_dssp             EECSSS-C--CEEEEEECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred             EccCCC-c--cceEEEeechHHhccccEEEEEEeccCCCcceeEEEEEEEEee
Confidence            987654 2  7999999999999999999999999999999999999999875

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.2e-35  Score=306.78  Aligned_cols=240  Identities=23%  Similarity=0.327  Sum_probs=187.2

Q ss_pred             cCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHh-hccccccceeeeeeEec----cCeee
Q 040242          355 KGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSM-GRLRHRNLVQLHGWCRK----QDELL  428 (662)
Q Consensus       355 ~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l-~~l~H~niv~l~~~~~~----~~~~~  428 (662)
                      ++|... ++||+|+||.||++....+++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7899999999999999889999999999643     3456788887 55699999999999876    67789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeecc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFG  505 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfG  505 (662)
                      +||||+++|+|.+++....   ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.   ++.+||+|||
T Consensus        92 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg  165 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  165 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEeecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence            9999999999999996542   3469999999999999999999999   89999999999999998   7889999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ++....                       +..++.++|||||||++|||++|+.||........            ....
T Consensus       166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~------------~~~~  210 (299)
T 3m2w_A          166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SPGM  210 (299)
T ss_dssp             TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------CCS
T ss_pred             cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh------------hHHH
Confidence            987532                       13457899999999999999999999975432110            0011


Q ss_pred             ccccCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 040242          586 TRAIDPTLDYFD----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPL  640 (662)
Q Consensus       586 ~~~id~~l~~~~----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~  640 (662)
                      ...+.......+    ......+.+++.+||+.||.+||++.|++++  +.+....|..|.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~  271 (299)
T 3m2w_A          211 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  271 (299)
T ss_dssp             CCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred             HHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence            111111111112    1235678899999999999999999999984  555555555444

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=3.4e-36  Score=311.18  Aligned_cols=227  Identities=14%  Similarity=0.143  Sum_probs=184.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||.||+|.+..+++.||||++....   ....+.+.+|+..+.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            56888999999999999999998889999999997652   344578999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+++++|.+++...       ....+..+++.|+++||.|||+   .+|+||||||+|||++.++.+||++++      
T Consensus       111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999432       2445678899999999999999   899999999999999999999998443      


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                                     |++|       ++.++|||||||++|||++|+.||..........            ...+.+..
T Consensus       175 ---------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~------------~~~~~~~~  220 (286)
T 3uqc_A          175 ---------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA------------PAERDTAG  220 (286)
T ss_dssp             ---------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE------------ECCBCTTS
T ss_pred             ---------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH------------HHHHHhcc
Confidence                           3333       6889999999999999999999998654321000            00000110


Q ss_pred             CC---CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TL---DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l---~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..   ..........+.+++.+||+.||.+| |+.|+++.|...
T Consensus       221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          221 QPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             CBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            00   01122345668899999999999999 999999999754

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=7.2e-37  Score=346.29  Aligned_cols=258  Identities=31%  Similarity=0.439  Sum_probs=203.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec------cCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK------QDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~------~~~~  427 (662)
                      ++|+..+.||+|+||+||+|.+..+|..||||++... .....+.+.+|+.++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6799999999999999999999888999999998764 44556789999999999999999999999765      6678


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---eEEeec
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---PKLGDF  504 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---~kL~Df  504 (662)
                      ++||||+++|+|.+++.....  ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.   +||+||
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccc
Confidence            999999999999999975432  3468999999999999999999999   89999999999999997765   999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC-
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG-  583 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~-  583 (662)
                      |++.......  ......||+.|+|||.+.+..++.++|||||||++|||++|+.||......     ..|........ 
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~  241 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSN  241 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC----
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccc
Confidence            9998765432  223457899999999999999999999999999999999999999754321     11211110000 


Q ss_pred             ---ccccccC---------CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 040242          584 ---QITRAID---------PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRR  624 (662)
Q Consensus       584 ---~~~~~id---------~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~e  624 (662)
                         ...+...         +............+.+++.+||+.||.+|||+.+
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence               0000010         1112345567888999999999999999999966

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-35  Score=343.97  Aligned_cols=237  Identities=24%  Similarity=0.338  Sum_probs=192.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCe-----e
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDE-----L  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~-----~  427 (662)
                      ++|+..++||+|+||.||+|.+.. +++.||||++... .......+.+|+.++++++||||+++++++...+.     .
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~  159 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG  159 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence            689999999999999999999965 6899999998654 34456678999999999999999999999987765     7


Q ss_pred             eEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccc
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLA  507 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla  507 (662)
                      ++||||+++++|.+++.       ..++|.+++.++.||++||.|||+   .+|+||||||+|||++.+ .+||+|||++
T Consensus       160 ~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a  228 (681)
T 2pzi_A          160 YIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAV  228 (681)
T ss_dssp             EEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccc
Confidence            99999999999999873       368999999999999999999999   899999999999999986 9999999999


Q ss_pred             ccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          508 RAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       508 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      +.....     ....||+.|+|||++.++. +.++|||||||++|||++|..|+......                    
T Consensus       229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------------  282 (681)
T 2pzi_A          229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------------  282 (681)
T ss_dssp             EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------------
T ss_pred             hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------------
Confidence            876432     3457999999999987654 89999999999999999998887642110                    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHHh
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-TRRVVQFLL  630 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-~~eVl~~L~  630 (662)
                      .+..  ..........+.+|+.+||+.||.+||+ ++++.+.|.
T Consensus       283 ~~~~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          283 GLPE--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             SCCT--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             cccc--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            0000  0001123356889999999999999995 555555443

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=100.00  E-value=1.4e-35  Score=298.32  Aligned_cols=201  Identities=17%  Similarity=0.154  Sum_probs=148.7

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCC-CCCCCcee
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYP-QLGGHGLA  109 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~-~~~gdGla  109 (662)
                      .++.++|+|.+. +|.|+||++.+++.||+||+.|+++.                 ||+|+|+|+|.+++. ..+|||||
T Consensus        25 ~~~~l~G~a~i~-~g~l~LT~~~~~~~G~~w~~~pi~~~-----------------sF~t~F~F~I~~~~~~~~~gdGlA   86 (253)
T 2dur_A           25 PLWDFQGSTILT-SQYVRLTPDERSKEGSIWNHQPCFLK-----------------DWEMHVHFKVHGTGKKNLHGDGIA   86 (253)
T ss_dssp             CSEEEEETCEEC-SSCEEEECSSSSEEEEEEESSCBCCS-----------------SEEEEEEEEEECCCCTTCCCCEEE
T ss_pred             CCEEEccceEEE-CCEEEECCCCCCCEEEEEeCCCCccC-----------------cEEEEEEEEEecCCCCCcCCCcEE
Confidence            599999999995 89999999999999999999999965                 599999999998765 57899999


Q ss_pred             EEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCC
Q 040242          110 FVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN  189 (662)
Q Consensus       110 F~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~  189 (662)
                      |+|+|...    ..|++||+.+       .++.|||||||++|.++.|    |+++|||++.+..+..+....|.+...-
T Consensus        87 F~l~~~~~----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~----~~~~~I~~~~n~gs~~~d~~~dg~~~~~  151 (253)
T 2dur_A           87 LWYTRDRL----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTE----RVFPYISVMVNNGSLSYDHSKDGRWTEL  151 (253)
T ss_dssp             EEEESCCS----CEETBTEECS-------SCEEEEEEEECSCCCTTCC----SCSSEEEEEEEESCCCCCGGGTTGGGCC
T ss_pred             EEEECCCC----CCCcccCcCC-------CCCEEEEEEECCCCCCCCC----CCCcEEEEEecCCceeeeccCCCccccc
Confidence            99999753    3578999733       2577999999999975433    5555555555554443221111100000


Q ss_pred             CCCcceee-cCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEEecce
Q 040242          190 DDNISVVL-KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWS  268 (662)
Q Consensus       190 ~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW~  268 (662)
                      .. -...+ +.|..++|||+|++.  +|+|.+++.+.. +..+++  .++ ...||++|||||||+||...+.|+|++|+
T Consensus       152 ~~-c~~~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~~~~--~~~-~v~Lp~~~yvGfSAaTG~~~~~h~Ilsws  224 (253)
T 2dur_A          152 AG-CTADFRNRDHDTFLAVRYSRG--RLTVMTDLEDKN-EWKNCI--DIT-GVRLPTGYYFGASAGTGDLSDNHDIISMK  224 (253)
T ss_dssp             EE-EECCCBTCSSCEEEEEEEETT--EEEEEEECSSSS-CCEEEE--EEC-CEECCSSBEEEEEEEESSSCCEEEEEEEE
T ss_pred             cc-ccHhhccCCCCeEEEEEEECC--EEEEEEeCCCCC-CceEEE--EeC-CcccCCCcEEEEEeccCCCcceEEEEEEE
Confidence            00 01123 348899999999965  899999865432 333343  344 34589999999999999999999999999


Q ss_pred             eee
Q 040242          269 FKI  271 (662)
Q Consensus       269 f~~  271 (662)
                      |..
T Consensus       225 f~s  227 (253)
T 2dur_A          225 LFQ  227 (253)
T ss_dssp             EEE
T ss_pred             EEe
Confidence            974

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-35  Score=322.85  Aligned_cols=247  Identities=15%  Similarity=0.130  Sum_probs=185.6

Q ss_pred             HhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhcccc-ccceee---------e
Q 040242          352 SATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRH-RNLVQL---------H  418 (662)
Q Consensus       352 ~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H-~niv~l---------~  418 (662)
                      ..+..|...++||+|+||.||+|.+..+|+.||||++....   ....+.|.+|+.+++.++| +|...+         .
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            34456778899999999999999998899999999987432   2335778999999999977 322111         1


Q ss_pred             ee------------Eec-----cCeeeEEEeccCCCCcchhccccc--ccccccccHHHHHHHHHHHHHHHHHhHhcCCC
Q 040242          419 GW------------CRK-----QDELLLVYDYVPNGSLDKLLFDND--QQKKKILNWDQRYKILIGVAQALLYLHEECDQ  479 (662)
Q Consensus       419 ~~------------~~~-----~~~~~lV~E~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  479 (662)
                      ..            +..     ....+++|+++ +++|.+++....  ......+++..++.++.|+++||.|||+   .
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  230 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y  230 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence            11            111     12457777776 789999884211  1124568999999999999999999999   8


Q ss_pred             CEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccc----------cCCCCCcchhHHHHHH
Q 040242          480 RVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT----------RTGKATTSTDVFGFGT  549 (662)
Q Consensus       480 ~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~t~ksDV~S~Gv  549 (662)
                      +|+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence            9999999999999999999999999999865433    334567 999999998          5556888999999999


Q ss_pred             HHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          550 LMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       550 vl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ++|||++|+.||........               ....+. ....    .+..+.+|+.+||+.||.+||++.++++
T Consensus       306 il~elltg~~Pf~~~~~~~~---------------~~~~~~-~~~~----~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGG---------------SEWIFR-SCKN----IPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSC---------------SGGGGS-SCCC----CCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHCCCCCCCcchhhh---------------HHHHHh-hccc----CCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            99999999999975432211               011111 1112    2366889999999999999999777654

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=100.00  E-value=8.2e-35  Score=293.45  Aligned_cols=204  Identities=17%  Similarity=0.206  Sum_probs=153.8

Q ss_pred             ceeEEeCCCCC-----CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEE
Q 040242           20 TNSFIYNGFIQ-----ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVF   94 (662)
Q Consensus        20 ~~~f~~~~f~~-----~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f   94 (662)
                      ..||+-+.+..     .++.++|+|.+ +++.|+||++.+++.||+||+.|+++-                 ||+|+|+|
T Consensus        33 ~~Sf~~P~~~~~~~~i~~w~~~G~a~i-~~~~IrLT~~~~~~~G~~w~~~p~~~~-----------------sF~t~F~F   94 (260)
T 1gv9_A           33 KYSFKGPHLVQSDGTVPFWAHAGNAIP-SADQIRIAPSLKSQRGSVWTKTKAAFE-----------------NWEVEVTF   94 (260)
T ss_dssp             GGCEECSSCSCTTSCBTTEEEEETCEE-CSSCEEEECSSTTCEEEEEESSCBCCS-----------------SEEEEEEE
T ss_pred             ceeEcCccccCCCCccCCeEEcccEEe-eCCEEEeCCCCCCCEEEEEECCCcccc-----------------CEEEEEEE
Confidence            45676555432     58999999988 489999999999999999999999743                 59999999


Q ss_pred             EEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCC-CC------CCCeeEEec
Q 040242           95 SIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQ-DI------NDNHVGIDI  167 (662)
Q Consensus        95 ~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~-d~------~~~Hvgid~  167 (662)
                      +|.+++ ..+||||||+|+|...    ..|++||+.+       .++.||||||||.|.++. +|      |++|+|||+
T Consensus        95 ~I~~~~-~~~gdGlAF~l~~~~~----~~g~~~G~~~-------~~~gvaVefDT~~N~~~~~~p~I~~~indg~~~~d~  162 (260)
T 1gv9_A           95 RVTGRG-RIGADGLAIWYTENQG----LDGPVFGSAD-------MWNGVGIFFDSFDNDGKKNNPAIVVVGNNGQINYDH  162 (260)
T ss_dssp             EEECSS-SCCCCEEEEEEESSCC----CEEEETTECS-------CCEEEEEEEECCCC-----CCEEEEEEEESCCCCCH
T ss_pred             EEecCC-CCCCCeEEEEEecCCC----CCCCccCCCC-------CCCEEEEEEECCCCCCCCCCCceEEEeCCCceEeec
Confidence            998864 4689999999999753    3678999832       346799999999996431 22      456777776


Q ss_pred             CC-CcccccccccccccCCCCCCCCCcceee-cCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeeccccccccc
Q 040242          168 SS-LISNISEPAAYYFSKGSNINDDNISVVL-KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDE  245 (662)
Q Consensus       168 ns-~~s~~~~~~~~~~~~~~~~~~~~~~~~l-~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~  245 (662)
                      |+ +.|.....+.               ..+ ++|..++|||+|++.  +|+|.+++...+......++..+| ...||+
T Consensus       163 ~~d~~s~~~~~c~---------------~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~~~~~~~vd-~~~LP~  224 (260)
T 1gv9_A          163 QNDGATQALASCQ---------------RDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKNDYEFCAKVE-NMVIPT  224 (260)
T ss_dssp             HHHHHHHCSEEEC---------------CCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTCCEEEEEET-TCCCCS
T ss_pred             CCCcccceeeccC---------------hhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCcceEEEEEc-ccccCC
Confidence            64 4333222111               122 358999999999986  899999863212222346788888 677999


Q ss_pred             ceEEeeeccCCcccceeEEecceeee
Q 040242          246 YMYVGFSASTGLLTAFHNVHGWSFKI  271 (662)
Q Consensus       246 ~~~vGFsastG~~~~~~~i~sW~f~~  271 (662)
                      ++||||||+||...+.|+|++|+|..
T Consensus       225 ~~~vGfSAaTG~~~e~hdIlsw~~~~  250 (260)
T 1gv9_A          225 QGHFGISAATGGLADDHDVLSFLTFQ  250 (260)
T ss_dssp             SBEEEEEEECCSSCCEEEEEEEEEEE
T ss_pred             CcEEEEEEeCCCCcceEEEEEEEEEE
Confidence            99999999999999999999999963

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.1e-35  Score=309.20  Aligned_cols=241  Identities=18%  Similarity=0.203  Sum_probs=184.1

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhccc---------ccccee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRLR---------HRNLVQ  416 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~---------H~niv~  416 (662)
                      .++|+..+.||+|+||+||+|++  +|+.||||++....        ....+.+.+|+.++++++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35688899999999999999998  67999999997652        223467888999888886         666655


Q ss_pred             eeee-----------------Eec-------------cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHH
Q 040242          417 LHGW-----------------CRK-------------QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGV  466 (662)
Q Consensus       417 l~~~-----------------~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i  466 (662)
                      +.+.                 +..             .+..++||||+++|++.+.+.      ...+++.++..++.||
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~------~~~~~~~~~~~i~~qi  170 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR------TKLSSLATAKSILHQL  170 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT------TTCCCHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH------hcCCCHHHHHHHHHHH
Confidence            5554                 333             678999999999997766663      2458899999999999


Q ss_pred             HHHHHHhH-hcCCCCEEeCCcCCCceEeCCCC--------------------CeEEeeccccccccCCCCCcceecccCC
Q 040242          467 AQALLYLH-EECDQRVVHRDVKPSNVLIDADL--------------------NPKLGDFGLARAYDHNINPQTTHIVGTL  525 (662)
Q Consensus       467 a~~L~yLH-~~~~~~ivH~Dlkp~NIll~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~  525 (662)
                      +.||.||| +   .+|+||||||+|||++.++                    .+||+|||+++.....      ...||+
T Consensus       171 ~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~  241 (336)
T 2vuw_A          171 TASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCD  241 (336)
T ss_dssp             HHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCC
T ss_pred             HHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEee
Confidence            99999999 8   8999999999999999887                    8999999999976532      347999


Q ss_pred             cccCcccccCCCCCcchhHHHHHHH-HHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc--cCCC-CCCCCHHHH
Q 040242          526 GYLAPELTRTGKATTSTDVFGFGTL-MLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA--IDPT-LDYFDPQEA  601 (662)
Q Consensus       526 ~y~aPE~~~~~~~t~ksDV~S~Gvv-l~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~--id~~-l~~~~~~~~  601 (662)
                      .|+|||.+.+.. +.++||||++++ .+++++|..||...         .|.......  +.+.  .... .........
T Consensus       242 ~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~s  309 (336)
T 2vuw_A          242 VSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTDK--MLKQMTFKTKCNTPAMKQIK  309 (336)
T ss_dssp             CTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHHH--HHHTCCCSSCCCSHHHHHHH
T ss_pred             cccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHHh--hhhhhccCcccchhhhhhcC
Confidence            999999998665 899999998777 77888899987431         121111100  0100  0111 112234567


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHH-HH
Q 040242          602 ELVLTLGLLCCDPHPDFRPSTRRVV-QF  628 (662)
Q Consensus       602 ~~l~~l~~~Cl~~dP~~RPt~~eVl-~~  628 (662)
                      ..+.+|+.+||+.|     |+.|++ ++
T Consensus       310 ~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          310 RKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             HHHHHHHHHHhccC-----CHHHHHhcC
Confidence            88999999999976     999988 53

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.98  E-value=1.1e-32  Score=271.37  Aligned_cols=115  Identities=34%  Similarity=0.477  Sum_probs=105.9

Q ss_pred             CCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEE
Q 040242          139 STRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINV  218 (662)
Q Consensus       139 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V  218 (662)
                      .||+|||||||++|.+|+||++|||||||||+.|..+++|                 ++.+|+.++|||+||+.+++|+|
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~-----------------~l~~g~~~~v~I~Yd~~~~~L~V   63 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----------------NMQNGKVGTAHIIYNSVDKRLSA   63 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEE
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccc-----------------cccCCCEEEEEEEEeCCCCEEEE
Confidence            3789999999999999999999999999999999888765                 36799999999999999999999


Q ss_pred             EEccCCCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEEecceeeecC
Q 040242          219 TISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGG  273 (662)
Q Consensus       219 ~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW~f~~~~  273 (662)
                      ++++.+.   ..|+|++.+||+++|+|+||||||||||...|.|+|++|+|+...
T Consensus        64 ~l~~~~~---~~~~ls~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~  115 (237)
T 1nls_A           64 VVSYPNA---DSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL  115 (237)
T ss_dssp             EEECTTS---CCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred             EEecCCC---CcceEEEeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence            9987543   578999999999999999999999999999999999999998764

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.95  E-value=4.1e-28  Score=210.54  Aligned_cols=103  Identities=27%  Similarity=0.415  Sum_probs=92.2

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      .+++|+|++|.  ..||+|+|+|++.+ |.|+||++..      +++|||+|++||+||         +. +++++||+|
T Consensus         2 ~~~~F~f~~F~~~~~nl~l~G~A~v~~-g~l~LT~~~~~g~~~~~s~Gra~Y~~Pv~l~---------d~-tg~vaSFsT   70 (113)
T 1qmo_A            2 QSLSFSFTKFDPNQEDLIFQGHATSTN-NVLQVTKLDSAGNPVSSSAGRVLYSAPLRLW---------ED-SAVLTSFDT   70 (113)
T ss_dssp             EEEEEEESSCCSSCTTEEEEETCEEET-TEEECSCBCTTSCBCSSCEEEEEESSCEECC---------CT-TEEEEEEEE
T ss_pred             cceEEEcCCCCCCCCCeEEecceEcCC-CceEeCCCCCCCcccCCcEEEEEeCCCEEee---------CC-CCCEEeeEE
Confidence            46799999998  67999999999986 9999998764      789999999999999         66 778899999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT  133 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~  133 (662)
                      +|+|.|.+++...+||||||||+|....|. +.|+||||+|.+
T Consensus        71 ~F~F~I~~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           71 IINFEISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA  112 (113)
T ss_dssp             EEEEEEECSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred             EEEEEEecCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence            999999988777899999999999876676 899999999864

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=9.6e-29  Score=278.71  Aligned_cols=184  Identities=19%  Similarity=0.135  Sum_probs=130.2

Q ss_pred             eeeeCceEEEEEEeCCCCcEEEEEEeecc----------chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEEE
Q 040242          363 VGSGGFGKVYRGVIPSTGLEVAIKRVAHN----------SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       363 LG~G~~g~Vy~~~~~~~g~~vavK~~~~~----------~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      .+.|+.|....+.....|+.++||++...          .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            55566666655554456788999999654          123456799999999999 7999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||++|++|.++|.+.     ..++..   +|+.||++||+|||+   ++|+||||||+||||+.++++||+|||+++...
T Consensus       322 Eyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             ECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             ecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999643     334443   588999999999999   899999999999999999999999999999765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR  559 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~  559 (662)
                      .... .....+||++|+|||++.+ ....++|+|++|++++++.++..
T Consensus       391 ~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          391 QDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             ---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred             CCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence            4432 2344689999999999865 56778999999999888766543

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.93  E-value=1.2e-25  Score=225.35  Aligned_cols=184  Identities=15%  Similarity=0.204  Sum_probs=141.5

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.++|+|.+. ++.|+||++ .++.|++|.+.|+++.                .+|+|+|+|+|.+.. ..+||||||
T Consensus        31 ~~w~~~G~a~v~-~~~IrLTp~-~~s~G~iW~~~p~~~~----------------~~f~~~f~FrI~g~~-~~~gdGlAf   91 (256)
T 2a6y_A           31 NNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK----------------DSFTMEWTFRSVGYS-GQTDGGISF   91 (256)
T ss_dssp             TTEEEEETCEEE-TBEEECCCS-TTCEEEEEESSCEEES----------------SCEEEEEEEEEESCC-SCCSCEEEE
T ss_pred             CCeEEccceEEe-CCEEEECCC-CCceEEEeeCCCCccc----------------CCEEEEEEEEEecCC-CCCCCeEEE
Confidence            689999999995 899999998 6779998888888754                359999999998764 348999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCC------CCeeEEecCCCcccccccccccccC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDIN------DNHVGIDISSLISNISEPAAYYFSK  184 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~------~~Hvgid~ns~~s~~~~~~~~~~~~  184 (662)
                      ++++....|  ..|+.+|..+.       -+-+||||||+.|.   .|.      +.|+++|.+++.+.....+.     
T Consensus        92 wlt~~~~~~--~~g~~~G~~~~-------f~GlaV~fDT~~n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~-----  154 (256)
T 2a6y_A           92 WFVQDSNIP--RDKQLYNGPVN-------YDGLQLLVDNNGPL---GPTLRGQLNDGQKPVDKTKIYDQSFASCL-----  154 (256)
T ss_dssp             EEEECSSSC--CCCTBTTBCTT-------CEEEEEEEESCSTT---CSEEEEEEEESSSCCCGGGHHHHCSEEEE-----
T ss_pred             EEeCCCCcc--cCCcccCcCCC-------CCEEEEEEECCCCC---CceEEEEECCCceecccCCCcccceecce-----
Confidence            999976432  56788888642       23489999999873   343      56777776653332222111     


Q ss_pred             CCCCCCCCcceee-cCCCcEEEEEEEe-CCCcEEEEEEccCCCCCCCCCeeeeecccccc-cccce-EEeeeccCC---c
Q 040242          185 GSNINDDNISVVL-KSGDPIQAWIDYN-SQEMLINVTISPLGIPKPHRPLISYPIDLATV-LDEYM-YVGFSASTG---L  257 (662)
Q Consensus       185 ~~~~~~~~~~~~l-~~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~-l~~~~-~vGFsastG---~  257 (662)
                                ... ++|...++||+|+ +..+.|+|.+..           ...+++..+ ||+++ ||||||+||   .
T Consensus       155 ----------~~~rn~~~~~~v~I~Y~~~~~~~L~V~i~~-----------~~c~~~~~v~LP~~~~~~GfSAaTG~~~~  213 (256)
T 2a6y_A          155 ----------MGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-----------KVCFQTRKVRFPSGSYRIGVTAQNGAVNN  213 (256)
T ss_dssp             ----------CCCTTCSSCEEEEEEEEGGGTSEEEEEETT-----------EEEEEESCEECCSEEEEEEEEEECCSGGG
T ss_pred             ----------eecccCCCcEEEEEEEecCCCcEEEEEEcC-----------EEEEEECcEEeCCCCeEEEEEEeCCCCCC
Confidence                      011 4788999999999 888999999964           134555655 79997 699999999   8


Q ss_pred             ccceeEEecceeee
Q 040242          258 LTAFHNVHGWSFKI  271 (662)
Q Consensus       258 ~~~~~~i~sW~f~~  271 (662)
                      ..+.|+|++|+|..
T Consensus       214 ~~d~hdIls~~~~~  227 (256)
T 2a6y_A          214 NAESFEIFKMQFFN  227 (256)
T ss_dssp             CCCEEEEEEEEEEE
T ss_pred             CcceEEEEEEEEEe
Confidence            89999999999986

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.91  E-value=1.7e-25  Score=250.84  Aligned_cols=185  Identities=15%  Similarity=0.182  Sum_probs=146.2

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--------hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ...++||+|+||+||+|..  .+..+++|+.....        ....+.+.+|++++++++||||+++..++...+..++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4467899999999999965  57789999864321        1124568999999999999999977777777788899


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ||||+++++|.+++..             +..++.|+++||.|||+   .+|+||||||+|||++.  .+||+|||+++.
T Consensus       417 VmE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~  478 (540)
T 3en9_A          417 MMSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKI  478 (540)
T ss_dssp             EEECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEE
T ss_pred             EEECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEE
Confidence            9999999999999943             45799999999999999   89999999999999999  999999999998


Q ss_pred             ccCCCCCc------ceecccCCcccCcccccC--CCCCcchhHHHHHHHHHHHHcCCCCCC
Q 040242          510 YDHNINPQ------TTHIVGTLGYLAPELTRT--GKATTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       510 ~~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      ........      .....||+.|+|||++..  ..++..+|+|+..+-.++.+.++.+|.
T Consensus       479 ~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          479 SNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            75432111      134679999999999876  457788899999999888888877663

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.90  E-value=5.1e-24  Score=209.67  Aligned_cols=104  Identities=26%  Similarity=0.432  Sum_probs=91.4

Q ss_pred             CceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +.++|+|++|..  +||+|+|+|++.++|.|+||++..      +++|||+|++||+||         +. ++.++||+|
T Consensus       124 ~~~~F~~~~F~~~~~nl~l~G~A~v~~~g~l~LT~~~~n~~~~~~~~Gra~Y~~Pv~lw---------d~-~~~vaSFsT  193 (237)
T 1nls_A          124 NALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW---------ES-SAVVASFEA  193 (237)
T ss_dssp             EEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECC---------CT-TEEEEEEEE
T ss_pred             ccchhhhccccccCCCeEEccceEecCCCceEecCCccCCccccCceEEEEeCCCEEee---------cC-CCCEeeeEE
Confidence            557999999984  699999999998789999998763      689999999999999         54 567899999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCC-CCCCCCcccccCCCCCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRK-QPPSCLANQYLGLPNDT  133 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~-~~~~~~~g~~lGl~~~~  133 (662)
                      +|+|.|.+.. ..+||||||||+|.. ..|.+++||||||+|.+
T Consensus       194 ~F~F~I~~~~-~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          194 TFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             EEEEECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             EEEEEEecCC-CCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence            9999998863 568999999999987 46888999999999874

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=2.7e-22  Score=206.27  Aligned_cols=153  Identities=14%  Similarity=0.096  Sum_probs=123.9

Q ss_pred             hHHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch------------------hhHHHHHHHHHHhhc
Q 040242          347 YSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR------------------QGMKEFVAEITSMGR  408 (662)
Q Consensus       347 ~~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~------------------~~~~~f~~Ei~~l~~  408 (662)
                      +..+......|...+.||+|+||.||+|.+ .+|+.||||.+.....                  .....+.+|+.++++
T Consensus        82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~  160 (282)
T 1zar_A           82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK  160 (282)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh
Confidence            344555566777789999999999999999 7899999999964321                  235678999999999


Q ss_pred             cccccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCC
Q 040242          409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKP  488 (662)
Q Consensus       409 l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp  488 (662)
                      ++  | +++.+++.. +..++||||+++++|.+ +..           .....++.|+++||.|||+   .+|+||||||
T Consensus       161 l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp  221 (282)
T 1zar_A          161 LQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQ  221 (282)
T ss_dssp             TT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCST
T ss_pred             cc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCH
Confidence            99  5 667775543 56799999999999998 421           2244699999999999999   8999999999


Q ss_pred             CceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCccccc
Q 040242          489 SNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR  534 (662)
Q Consensus       489 ~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  534 (662)
                      +|||++ ++.+||+|||+++.              +..+.|||++.
T Consensus       222 ~NILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          222 YNVLVS-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             TSEEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             HHEEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            999999 99999999999974              33468899874

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=99.77  E-value=3.5e-18  Score=167.46  Aligned_cols=188  Identities=14%  Similarity=0.193  Sum_probs=128.8

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++ .++.|.+|.+.|+++.         +       +|+++|+|+|..+. ..+||||||
T Consensus        24 ~~W~~~G~a~i~-~~~IrLTp~-~~~~G~iWs~~p~~~~---------~-------~weie~~Fri~g~~-~~~gdGlA~   84 (222)
T 2a6z_A           24 NNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK---------D-------SFTMEWTFRSVGYS-GQTDGGISF   84 (222)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC---------S-------CEEEEEEEEEESCC-SCCSCEEEE
T ss_pred             CCcEEcccEEEc-CCEEEECCC-CCCeEEEEeCCCCCCC---------C-------CEEEEEEEEEeCCC-CCCCCEEEE
Confidence            589999999986 789999999 4678999999999865         2       49999999998764 347999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccC-CCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSK-GSNIN  189 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~-~~~~~  189 (662)
                      ++++.+..+  ..|..+|..+.-       .=+||+|||+.|.      .++|.+.+|.-.-    ...  .+. +...-
T Consensus        85 W~t~~~~~~--~~g~~~G~~~~f-------~GL~I~~Dt~~n~------~p~i~~~~ndG~~----~yd--~~~~~~~~~  143 (222)
T 2a6z_A           85 WFVQDSNIP--RDKQLYNGPVNY-------DGLQLLVDNNGPL------GPTLRGQLNDGQK----PVD--KTKIYDQSF  143 (222)
T ss_dssp             EEEECSSSC--CCCTBTTBCTTC-------EEEEEEEESCSTT------SSEEEEEEEESSS----CCC--GGGHHHHCS
T ss_pred             EEECCCccc--CCCcccCCCCCC-------CEEEEEEECCCCC------CceEEEEECCCCe----eec--cCCCccccc
Confidence            999875311  345556653321       1279999999873      3567766543211    000  000 00000


Q ss_pred             CCCcceee-cCCCcEEEEEEEe-CCCcEEEEEEccCCCCCCCCCeee-eecccccccccc-eEEeeeccCC---ccccee
Q 040242          190 DDNISVVL-KSGDPIQAWIDYN-SQEMLINVTISPLGIPKPHRPLIS-YPIDLATVLDEY-MYVGFSASTG---LLTAFH  262 (662)
Q Consensus       190 ~~~~~~~l-~~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~~~~~~ls-~~vdL~~~l~~~-~~vGFsastG---~~~~~~  262 (662)
                      ..+ .... +.+.+.++||+|+ ...+.|+|.++.       +.++. ..|+    ||+. .|+||||+||   +..+.|
T Consensus       144 ~~C-~~~~rn~~~~~~~rI~Y~~~~~~~l~v~id~-------~~C~~~~~v~----LP~~~~y~G~SA~TG~l~~~~d~h  211 (222)
T 2a6z_A          144 ASC-LMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQTRKVR----FPSGSYRIGVTAQNGAVNNNAESF  211 (222)
T ss_dssp             EEE-ECCCTTEEEEEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----CCSSEEEEEEEEECCSGGGCCCEE
T ss_pred             ccc-ceeccCCCCcEEEEEEEEcCCCcEEEEEEcC-------eEEEEeCCee----cCCCCcEEEEEEcCCCCCCCCccE
Confidence            000 0111 3567889999999 667889999864       12332 2233    4555 4799999999   888999


Q ss_pred             EEecceee
Q 040242          263 NVHGWSFK  270 (662)
Q Consensus       263 ~i~sW~f~  270 (662)
                      .|++|++.
T Consensus       212 dil~~~~~  219 (222)
T 2a6z_A          212 EIFKMQFF  219 (222)
T ss_dssp             EEEEEEEE
T ss_pred             EEEEEEEE
Confidence            99999885

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.76  E-value=1.3e-18  Score=176.39  Aligned_cols=145  Identities=17%  Similarity=0.115  Sum_probs=110.2

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCCCCcE--EEEEEeeccch------------------------hhHHHHHHH
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLE--VAIKRVAHNSR------------------------QGMKEFVAE  402 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~--vavK~~~~~~~------------------------~~~~~f~~E  402 (662)
                      ++.....-|+..+.||+|+||.||+|....+|+.  ||||++.....                        .....+.+|
T Consensus        41 ~~~~~~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E  120 (258)
T 1zth_A           41 KLSAKGYITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKE  120 (258)
T ss_dssp             HHHHTTSEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHH
T ss_pred             HHHhCCCchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHH
Confidence            3333333466788999999999999998667888  99998754311                        112367899


Q ss_pred             HHHhhccccccc--eeeeeeEeccCeeeEEEeccCC-C----CcchhcccccccccccccHHHHHHHHHHHHHHHHHhH-
Q 040242          403 ITSMGRLRHRNL--VQLHGWCRKQDELLLVYDYVPN-G----SLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH-  474 (662)
Q Consensus       403 i~~l~~l~H~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH-  474 (662)
                      +.++.+++|+++  ..++.+    +..+|||||+.+ |    +|.++..        ..++.....++.|++++|.||| 
T Consensus       121 ~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~--------~~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          121 FRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR--------ELKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG--------GGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh--------ccChHHHHHHHHHHHHHHHHHHH
Confidence            999999998864  334432    356899999942 5    4444431        1335677889999999999999 


Q ss_pred             hcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       475 ~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      +   .+|+||||||.|||++.  .++|+|||++...
T Consensus       189 ~---~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 E---AELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             T---SCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             H---CCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            7   89999999999999998  9999999999864

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=1.5e-15  Score=160.70  Aligned_cols=145  Identities=13%  Similarity=0.141  Sum_probs=99.9

Q ss_pred             HHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch--------------hhHHHH--------HHHHHHhh
Q 040242          350 LYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR--------------QGMKEF--------VAEITSMG  407 (662)
Q Consensus       350 l~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~--------------~~~~~f--------~~Ei~~l~  407 (662)
                      +...-.-|.+.++||+|++|.||+|... +|+.||||+++....              ......        ..|...|.
T Consensus        90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~  168 (397)
T 4gyi_A           90 HAARKDVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK  168 (397)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHCCCEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence            3333334888999999999999999985 689999998753210              011112        23444555


Q ss_pred             ccccccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcC
Q 040242          408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVK  487 (662)
Q Consensus       408 ~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlk  487 (662)
                      ++.+.++.-..-+..  ...+|||||+++++|.++...           .....++.|++.+|.|||+   .+|||||||
T Consensus       169 rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~---~gIVHrDLK  232 (397)
T 4gyi_A          169 ALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK---HGLIHGDFN  232 (397)
T ss_dssp             HHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCS
T ss_pred             HHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH---CCCcCCCCC
Confidence            554333221111111  123799999999888776521           1234678999999999999   899999999


Q ss_pred             CCceEeCCCCC----------eEEeecccccccc
Q 040242          488 PSNVLIDADLN----------PKLGDFGLARAYD  511 (662)
Q Consensus       488 p~NIll~~~~~----------~kL~DfGla~~~~  511 (662)
                      |.|||+++++.          +.|+||+-+....
T Consensus       233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             TTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             HHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence            99999988773          8899999766443

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=99.57  E-value=7.9e-14  Score=135.92  Aligned_cols=187  Identities=13%  Similarity=0.112  Sum_probs=120.6

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++ +++.|.+|-+.|+.+-                .+|+.+|+|+|..... .+||||||
T Consensus        27 ~~W~~~G~t~v~-~~~IrLTp~-~s~~G~lWs~~p~~~~----------------~~weiev~Fri~G~~~-~~gdGlA~   87 (226)
T 2a6v_A           27 SQWTLGDKVKLE-EGRFVLTPG-KNTKGSLWLKPEYSIK----------------DAMTIEWTFRSFGFRG-STKGGLAF   87 (226)
T ss_dssp             TTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCBCCS----------------SCEEEEEEEEEESCCS-CCSCEEEE
T ss_pred             CCcEEcCCeEEe-CCEEEECCC-CCceEEEeeCCCCCCC----------------CCeEEEEEEEEecCCC-CCCCEEEE
Confidence            489999999987 678999999 9999999999999962                1399999999998743 37999999


Q ss_pred             EEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCC
Q 040242          111 VLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND  190 (662)
Q Consensus       111 ~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~  190 (662)
                      .++..+..   ..|..+|-....=      .=+||.|||+.|.      ...|-+-+|.-    +....  .+. ...-.
T Consensus        88 Wyt~~~~~---~~g~vfGg~~d~f------~GlgI~~Dt~~n~------~p~i~~~~NDG----t~~yd--~~~-~~~~g  145 (226)
T 2a6v_A           88 WLKQGNEG---DSTELFGGSSKKF------NGLMILLRLDDKL------GESVTAYLNDG----TKDLD--IES-SPYFA  145 (226)
T ss_dssp             EEECSCCC---CCCTBTTTBCSSC------EEEEEEEEEETTT------EEEEEEEEEES----SSCCC--TTT-SCCSE
T ss_pred             EEECCCCC---CCcccccccCCCc------cEEEEEEECCCCC------CceEEEEECCC----CcccC--CCC-Ccccc
Confidence            99976531   2333332101000      1179999999762      12233322211    11100  000 00000


Q ss_pred             CCcceeecCCCcEEEEEEEe-CCCcEEEEEEccCCCCCCCCCeeeeeccccc-ccccce--EEeeeccCCcccceeEEec
Q 040242          191 DNISVVLKSGDPIQAWIDYN-SQEMLINVTISPLGIPKPHRPLISYPIDLAT-VLDEYM--YVGFSASTGLLTAFHNVHG  266 (662)
Q Consensus       191 ~~~~~~l~~g~~~~~~I~Y~-~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~-~l~~~~--~vGFsastG~~~~~~~i~s  266 (662)
                      .+..--.+.+.+.+++|.|. ...+.|+|.++.       +.++.    ... .||..-  |+||||+||...+.|+|++
T Consensus       146 ~C~~~~rn~~~~t~~ri~Y~~~~~~~l~v~id~-------~~Cf~----~~~v~LP~g~~~yfGiSAaTg~~~D~hdils  214 (226)
T 2a6v_A          146 SCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQ----TRKVKFMGSSPFRIGTSAINDASKESFEILK  214 (226)
T ss_dssp             EEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEE----ESCCCGGGTSCBEEEEEEECCTTCCEEEEEE
T ss_pred             eEeEeccCCCCCEEEEEEEEccCCCEEEEEEcC-------CeeEE----ECCeecCCCCccEEEEEEcCCCCcccEEEEE
Confidence            11000124567889999997 457899999863       12333    222 234444  9999999999999999998


Q ss_pred             cee
Q 040242          267 WSF  269 (662)
Q Consensus       267 W~f  269 (662)
                      -.+
T Consensus       215 ~~~  217 (226)
T 2a6v_A          215 MKL  217 (226)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            665

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.44  E-value=4.1e-14  Score=103.47  Aligned_cols=44  Identities=36%  Similarity=0.508  Sum_probs=41.3

Q ss_pred             CCeeeeecccccccccceEEeeeccCCcccceeEEecceeeecC
Q 040242          230 RPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGG  273 (662)
Q Consensus       230 ~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW~f~~~~  273 (662)
                      +|+|++.+||+++|+|+|||||||+||...+.|+|++|+|+...
T Consensus         3 ~p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~   46 (52)
T 2ltn_B            3 SYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL   46 (52)
T ss_dssp             EEEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred             eeeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence            47899999999999999999999999999999999999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.23  E-value=3.2e-11  Score=121.81  Aligned_cols=146  Identities=14%  Similarity=0.051  Sum_probs=113.3

Q ss_pred             HHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeE
Q 040242          351 YSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       351 ~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~l  429 (662)
                      .....+|.....++.|+.+.||+...  .+..+++|+...........+.+|+.+++.+. +..+.++++++...+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            33445788788888899999999986  36789999987532222345788999999884 6778889999988889999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC--------------------------------
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC--------------------------------  477 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--------------------------------  477 (662)
                      ||||++|.+|.+.+.          +......++.+++++|..||+..                                
T Consensus        88 v~e~i~G~~l~~~~~----------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE----------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEECCSSEEHHHHCC----------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEecCCeehhhccC----------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            999999999887641          11234478889999999999810                                


Q ss_pred             ------------------------CCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          478 ------------------------DQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       478 ------------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                                              ...++|+|++|.||+++++..+.|.||+.+.
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    1459999999999999876556799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.07  E-value=2.6e-10  Score=114.43  Aligned_cols=138  Identities=16%  Similarity=0.092  Sum_probs=98.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc--eeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL--VQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~l~~~~~~~~~~~lV~E  432 (662)
                      .++....+.+.|..+.||+... .+|..+++|.....   ....+..|+.+++.+++.++  .++++++...+..++|||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e   95 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG   95 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence            3444433334555699999976 45678999987654   22456789999988865554  458888888788999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC-----------------------------------
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC-----------------------------------  477 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----------------------------------  477 (662)
                      |++|.+|.  ....           ....++.++++.|..||+..                                   
T Consensus        96 ~i~G~~l~--~~~~-----------~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           96 EVPGQDLL--SSHL-----------APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             CCSSEETT--TSCC-----------CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             ecCCcccC--cCcC-----------CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            99998885  2110           12256677777788877631                                   


Q ss_pred             --------------------CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          478 --------------------DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       478 --------------------~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                                          ...++|+|++|.||+++++..+.|.||+.+..
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                12399999999999998776677999998763

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.98  E-value=2e-09  Score=113.91  Aligned_cols=142  Identities=13%  Similarity=0.184  Sum_probs=107.3

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEee--ccc-hhhHHHHHHHHHHhhccc--cccceeeeeeEecc---CeeeEE
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVA--HNS-RQGMKEFVAEITSMGRLR--HRNLVQLHGWCRKQ---DELLLV  430 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~--~~~-~~~~~~f~~Ei~~l~~l~--H~niv~l~~~~~~~---~~~~lV  430 (662)
                      ..+.|+.|.++.||+....  +..+++|+..  ... ......+.+|+.+++.++  +..+.+++.++...   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            3567899999999998873  4578889876  332 122346778999999886  45578899988776   458999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC---------------------------------
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC---------------------------------  477 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------  477 (662)
                      |||++|..+.+..       ...++..++..++.++++.|..||+..                                 
T Consensus       120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            9999998886532       234677888899999999999999731                                 


Q ss_pred             ----------------------CCCEEeCCcCCCceEeCCCCC--eEEeecccccc
Q 040242          478 ----------------------DQRVVHRDVKPSNVLIDADLN--PKLGDFGLARA  509 (662)
Q Consensus       478 ----------------------~~~ivH~Dlkp~NIll~~~~~--~kL~DfGla~~  509 (662)
                                            ...++|+|+++.||+++.++.  +.|.||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  257999999999999998754  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.85  E-value=1.9e-09  Score=111.39  Aligned_cols=187  Identities=16%  Similarity=0.157  Sum_probs=122.0

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-ccc--ceeeeeeEeccC---eeeEEEec
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRN--LVQLHGWCRKQD---ELLLVYDY  433 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~E~  433 (662)
                      .+.++.|....||+..     ..+++|+....  .....+.+|..+++.+. +..  +.+++..+...+   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4568999999999853     45888986433  34567889999998883 333  334555543333   35899999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhc-------------------------------------
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE-------------------------------------  476 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------  476 (662)
                      ++|.+|....       ...++..++..++.++++.|..||+.                                     
T Consensus        98 i~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (304)
T 3sg8_A           98 IKGVPLTPLL-------LNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQM  170 (304)
T ss_dssp             CCCEECCHHH-------HHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHH
T ss_pred             cCCeECCccc-------cccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccH
Confidence            9999987643       23466677778888888888888851                                     


Q ss_pred             ------------------CCCCEEeCCcCCCceEeCC--CCCeEEeeccccccccCCCCCcce-------------eccc
Q 040242          477 ------------------CDQRVVHRDVKPSNVLIDA--DLNPKLGDFGLARAYDHNINPQTT-------------HIVG  523 (662)
Q Consensus       477 ------------------~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~~~~~~~~~-------------~~~g  523 (662)
                                        ....++|+|++|.||++++  ...+.|.||+.+..-....+....             ....
T Consensus       171 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~  250 (304)
T 3sg8_A          171 KKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHH
Confidence                              1145899999999999998  456789999988753321000000             0000


Q ss_pred             CCcccC-cccccCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 040242          524 TLGYLA-PELTRTGKATTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       524 t~~y~a-PE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      ..+... |+....  .....+.|+++.++|++.+|..++.
T Consensus       251 ~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            011112 222111  1123689999999999999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=3.3e-06  Score=87.06  Aligned_cols=136  Identities=19%  Similarity=0.172  Sum_probs=91.5

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccc---cceeeeeeEe-ccCeeeEEEeccC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR---NLVQLHGWCR-KQDELLLVYDYVP  435 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~---niv~l~~~~~-~~~~~~lV~E~~~  435 (662)
                      .+.++.|....||+.     +..+++|+...  ......+..|..+|+.+.+.   .+.+++.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456888888899987     45688887532  23456788999999999653   2556666664 4556789999999


Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhc---------------------------------------
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE---------------------------------------  476 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------  476 (662)
                      |..|.+...       ..++..++..++.++++.|..||+.                                       
T Consensus        97 G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~  169 (306)
T 3tdw_A           97 GQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR  169 (306)
T ss_dssp             SEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred             CeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence            988876321       1122333333444444444444421                                       


Q ss_pred             ------------------CCCCEEeCCcCCCceEeCC---CCC-eEEeecccccc
Q 040242          477 ------------------CDQRVVHRDVKPSNVLIDA---DLN-PKLGDFGLARA  509 (662)
Q Consensus       477 ------------------~~~~ivH~Dlkp~NIll~~---~~~-~kL~DfGla~~  509 (662)
                                        ....++|+|+++.||+++.   ++. +.|.||+.+..
T Consensus       170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                              2246799999999999997   455 47999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.33  E-value=3e-06  Score=85.34  Aligned_cols=136  Identities=21%  Similarity=0.188  Sum_probs=97.3

Q ss_pred             eeeeeCce-EEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCeeeEEEeccCCCCc
Q 040242          362 LVGSGGFG-KVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSL  439 (662)
Q Consensus       362 ~LG~G~~g-~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL  439 (662)
                      .+..|..+ .||+......+..+.+|+-...   ...++..|...|+.+. +--+-++++++...+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 6999887667778999987543   3456778888888774 33366788999888999999999999887


Q ss_pred             chhcccccccccccccHHHHHHHHHHHHHHHHHhHhc-------------------------------------------
Q 040242          440 DKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE-------------------------------------------  476 (662)
Q Consensus       440 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-------------------------------------------  476 (662)
                      .+.....         ......+..++++.|.-||+.                                           
T Consensus       108 ~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          108 FQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             cccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            7654211         122344556666666666631                                           


Q ss_pred             ------------CCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          477 ------------CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       477 ------------~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                                  ....++|+|+++.|||++.++.+-|.||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                        012389999999999999877677999987763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.04  E-value=9.8e-06  Score=85.19  Aligned_cols=82  Identities=6%  Similarity=-0.036  Sum_probs=56.3

Q ss_pred             ccee-eeeCceEEEEEEeC--C----CCcEEEEEEeeccc---hhhHHHHHHHHHHhhcccc---ccceeeeeeEecc--
Q 040242          360 KNLV-GSGGFGKVYRGVIP--S----TGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRH---RNLVQLHGWCRKQ--  424 (662)
Q Consensus       360 ~~~L-G~G~~g~Vy~~~~~--~----~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H---~niv~l~~~~~~~--  424 (662)
                      .+.| +.|....+|+....  .    ++..+++|+.....   ......+..|+.+++.+..   -.+.+++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4567 78888999988763  0    15678888765432   1012356778888888853   2466788887655  


Q ss_pred             -CeeeEEEeccCCCCcch
Q 040242          425 -DELLLVYDYVPNGSLDK  441 (662)
Q Consensus       425 -~~~~lV~E~~~~gsL~~  441 (662)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35789999999988765

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.80  E-value=2.9e-05  Score=82.95  Aligned_cols=76  Identities=13%  Similarity=0.109  Sum_probs=49.0

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccch-------hhHHHHHHHHHHhhcccc--ccce-eeeeeEeccCeeeE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR-------QGMKEFVAEITSMGRLRH--RNLV-QLHGWCRKQDELLL  429 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~-------~~~~~f~~Ei~~l~~l~H--~niv-~l~~~~~~~~~~~l  429 (662)
                      .+.||.|..+.||++.....+..++||.......       .....+..|.++++.+..  +..+ +++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            4679999999999997755677899998643221       122456778888887742  3433 555443  345689


Q ss_pred             EEeccCCC
Q 040242          430 VYDYVPNG  437 (662)
Q Consensus       430 V~E~~~~g  437 (662)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.72  E-value=0.00025  Score=73.56  Aligned_cols=142  Identities=15%  Similarity=0.232  Sum_probs=79.4

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccc--cceeeee------eEeccCeeeEEEe
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR--NLVQLHG------WCRKQDELLLVYD  432 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~--niv~l~~------~~~~~~~~~lV~E  432 (662)
                      +.|+.|..+.||+....  +..+++|+.....    .+...|..++..|...  .+.+++.      +....+..+++||
T Consensus        38 ~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTD--SGAVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EECC----CEEEEEEET--TEEEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeccccccCcEEEEEeC--CCCEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            45666778899998873  3358999987532    2233445555544321  2233332      1234567899999


Q ss_pred             ccCCCCcch--------------hcccccccc---------cccccHHHHH-----------------------------
Q 040242          433 YVPNGSLDK--------------LLFDNDQQK---------KKILNWDQRY-----------------------------  460 (662)
Q Consensus       433 ~~~~gsL~~--------------~l~~~~~~~---------~~~l~~~~~~-----------------------------  460 (662)
                      |++|..+..              .+|......         ...-.|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999876641              111110000         0011232111                             


Q ss_pred             --HHHHHHHHHHHHhHh----------cCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          461 --KILIGVAQALLYLHE----------ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       461 --~i~~~ia~~L~yLH~----------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                        .+...+.+++.+|++          .....++|+|+++.||+++.++.+.|.||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111123345666653          124789999999999999888899999999765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.52  E-value=0.00044  Score=70.19  Aligned_cols=80  Identities=18%  Similarity=0.219  Sum_probs=57.3

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc---ccceeeeeeEeccCeeeEEEe
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH---RNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H---~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .....+.+|.|..+.||+... .+|+.|.+|+...........|..|+..|+.|.-   --+.+++++.    ..++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            345567899999999999998 5688999998765544434567889888887742   1244455543    3478999


Q ss_pred             ccCCCCcc
Q 040242          433 YVPNGSLD  440 (662)
Q Consensus       433 ~~~~gsL~  440 (662)
                      |++.+...
T Consensus        91 ~l~~~~~~   98 (288)
T 3f7w_A           91 WVDERPPT   98 (288)
T ss_dssp             CCCCCCCC
T ss_pred             eecccCCC
Confidence            99887654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.43  E-value=0.0019  Score=66.37  Aligned_cols=141  Identities=16%  Similarity=0.106  Sum_probs=92.8

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc---cccceeeeeeEeccCeeeEEEeccC
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR---HRNLVQLHGWCRKQDELLLVYDYVP  435 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~~  435 (662)
                      ..+.|+.|....+|+...  ++..+++|+....   ....+..|...|+.|.   ...+.+++.++...+..++||||++
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            356789999999999886  4667889987543   3456788988888884   2567788998888888999999999


Q ss_pred             CCCcch-----------hcccccc-cc----------------cccccHHHHH---HHHH----------------HHHH
Q 040242          436 NGSLDK-----------LLFDNDQ-QK----------------KKILNWDQRY---KILI----------------GVAQ  468 (662)
Q Consensus       436 ~gsL~~-----------~l~~~~~-~~----------------~~~l~~~~~~---~i~~----------------~ia~  468 (662)
                      +..+..           .||.... .+                .-.-+|...+   ++..                .+.+
T Consensus       115 G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~  194 (312)
T 3jr1_A          115 KSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQ  194 (312)
T ss_dssp             CCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHH
T ss_pred             CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHH
Confidence            987642           1222111 00                0012454322   1111                1111


Q ss_pred             H-HHHhHh-cCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          469 A-LLYLHE-ECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       469 ~-L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      . ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       195 ~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          195 IVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            1 123321 1247799999999999999887 8888873

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.24  E-value=0.0008  Score=72.27  Aligned_cols=80  Identities=13%  Similarity=0.053  Sum_probs=48.9

Q ss_pred             CCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCC---CCCcchhHHHHHHHHHHH
Q 040242          478 DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG---KATTSTDVFGFGTLMLEV  554 (662)
Q Consensus       478 ~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDV~S~Gvvl~el  554 (662)
                      ...++|+|+++.|||++.++ ++|.||+.+..-....+....-..-...|++|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            37899999999999998876 99999998875322111000000011346666654311   112235666888888887


Q ss_pred             HcCC
Q 040242          555 ACGR  558 (662)
Q Consensus       555 ltG~  558 (662)
                      ++++
T Consensus       310 y~~~  313 (420)
T 2pyw_A          310 FNKR  313 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.00  E-value=0.0029  Score=68.13  Aligned_cols=75  Identities=17%  Similarity=0.189  Sum_probs=51.2

Q ss_pred             cceeeeeCceEEEEEEeCC-------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc-eeeeeeEeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL-VQLHGWCRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  431 (662)
                      .+.|+.|....+|+.....       .+..+++|+.....  ....+..|..++..+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888889999998753       25689999884421  11345578888888854444 456665542    3899


Q ss_pred             eccCCCCcc
Q 040242          432 DYVPNGSLD  440 (662)
Q Consensus       432 E~~~~gsL~  440 (662)
                      ||+++.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999876664

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.93  E-value=0.0042  Score=63.72  Aligned_cols=160  Identities=13%  Similarity=0.080  Sum_probs=86.1

Q ss_pred             cchHHHHHhccCCcc-----cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc--eee
Q 040242          345 FRYSELYSATKGFRE-----KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL--VQL  417 (662)
Q Consensus       345 ~~~~el~~at~~f~~-----~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni--v~l  417 (662)
                      ++.+++...-..|..     .+.|+.|....+|+.... +| .+++|......  ...++..|+.++..+...++  .++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            344444444444543     345667888899998873 34 58899886521  11234456666666643222  233


Q ss_pred             eee------EeccCeeeEEEeccCCCCcchh--------------ccccc----ccc---cccccHHHHHHH--------
Q 040242          418 HGW------CRKQDELLLVYDYVPNGSLDKL--------------LFDND----QQK---KKILNWDQRYKI--------  462 (662)
Q Consensus       418 ~~~------~~~~~~~~lV~E~~~~gsL~~~--------------l~~~~----~~~---~~~l~~~~~~~i--------  462 (662)
                      +..      ....+..+++|+|++|..+...              +|...    ...   .....|...+.-        
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            321      1223567899999998765321              11100    000   011123331110        


Q ss_pred             ----HHHHHHHHHHhHhc----CCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          463 ----LIGVAQALLYLHEE----CDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       463 ----~~~ia~~L~yLH~~----~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                          ...+.+.+..|++.    ....++|+|+++.||+++.+..+.|.||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                11244455555532    13579999999999999987656899998665

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.91  E-value=0.0036  Score=63.77  Aligned_cols=72  Identities=8%  Similarity=0.039  Sum_probs=45.4

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEEecc-CCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVYDYV-PNG  437 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~-~~g  437 (662)
                      .+.|+.|....+|+.      ..+++|+........ .....|+.+++.+...++. ++++++  .+.-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence            677999999999998      348888876542211 1224577777777543443 455543  33357899999 666


Q ss_pred             Ccc
Q 040242          438 SLD  440 (662)
Q Consensus       438 sL~  440 (662)
                      +|.
T Consensus        94 ~l~   96 (301)
T 3dxq_A           94 TMS   96 (301)
T ss_dssp             ECC
T ss_pred             cCC
Confidence            664

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.85  E-value=0.0064  Score=62.50  Aligned_cols=144  Identities=13%  Similarity=0.141  Sum_probs=79.9

Q ss_pred             ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeee-----EeccCeeeEEEec
Q 040242          361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGW-----CRKQDELLLVYDY  433 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~E~  433 (662)
                      ..++ |....||+... .+|+.+++|...... .....+..|..++..+....  +.+++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4566 78889998766 346679999986331 12345566777777764322  3334432     1224566889999


Q ss_pred             cCCCCcch----h----------cccccc----cccccccHHHH----HHH---------------HHHHHHHHHHhHhc
Q 040242          434 VPNGSLDK----L----------LFDNDQ----QKKKILNWDQR----YKI---------------LIGVAQALLYLHEE  476 (662)
Q Consensus       434 ~~~gsL~~----~----------l~~~~~----~~~~~l~~~~~----~~i---------------~~~ia~~L~yLH~~  476 (662)
                      ++|..+..    .          +|....    .....+++...    ..+               ...+.+.+..+...
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98866542    0          111000    00111222110    000               11111223333221


Q ss_pred             ----CCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          477 ----CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       477 ----~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                          ....++|+|+++.||+++ + .+.|.||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                235689999999999999 4 899999987763

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.64  E-value=0.0097  Score=64.48  Aligned_cols=76  Identities=9%  Similarity=0.025  Sum_probs=49.0

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc-eeeeeeEeccCeeeEEEeccCCCC
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL-VQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .+.|+.|-...+|+......+..+++|+......... .-..|..++..|...++ .++++.+. +   .+||||+++..
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT-N---GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET-T---EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC-C---eEEEEeeCCcc
Confidence            4568888889999998854357888998754322111 11478888888865555 45676663 2   25999999866


Q ss_pred             cc
Q 040242          439 LD  440 (662)
Q Consensus       439 L~  440 (662)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.61  E-value=0.0072  Score=63.79  Aligned_cols=145  Identities=21%  Similarity=0.238  Sum_probs=83.6

Q ss_pred             cceeeeeCceEEEEEEeCC-------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc-eeeeeeEeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL-VQLHGWCRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  431 (662)
                      .+.|..|-...+|+.....       ++..+++|+..... .......+|..+++.|.-.++ .++++++..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3567778888899988742       35789999864322 234555689888888853333 456666543    2999


Q ss_pred             eccCCCCcchh-c----------------cccccc-ccccc-cHHHHHHHHHHHHH-------------------HHHHh
Q 040242          432 DYVPNGSLDKL-L----------------FDNDQQ-KKKIL-NWDQRYKILIGVAQ-------------------ALLYL  473 (662)
Q Consensus       432 E~~~~gsL~~~-l----------------~~~~~~-~~~~l-~~~~~~~i~~~ia~-------------------~L~yL  473 (662)
                      ||++|..|..- +                |..... .+... -|.+..++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998777531 1                111000 01111 23444444433321                   22333


Q ss_pred             Hh-----cCCCCEEeCCcCCCceEeCCC----CCeEEeecccccc
Q 040242          474 HE-----ECDQRVVHRDVKPSNVLIDAD----LNPKLGDFGLARA  509 (662)
Q Consensus       474 H~-----~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~  509 (662)
                      .+     .....++|+|+.+.||+++.+    +.+.|.||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            22     123569999999999999876    7899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.59  E-value=0.0099  Score=56.97  Aligned_cols=170  Identities=12%  Similarity=0.069  Sum_probs=90.5

Q ss_pred             CCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCC
Q 040242          436 NGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN  515 (662)
Q Consensus       436 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~  515 (662)
                      .-+|.++|...    ..+|++++.|.++.|.+++|.-+-... .+ ..+=+.|..|+|..+|++.+.+ ..+.       
T Consensus        32 ~vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------   97 (229)
T 2yle_A           32 ALSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-------   97 (229)
T ss_dssp             EEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C----------
T ss_pred             cccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc-------
Confidence            34788888543    678999999999999999987762211 11 1333457999999999988864 1110       


Q ss_pred             CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCCC
Q 040242          516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY  595 (662)
Q Consensus       516 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~  595 (662)
                            .....+.+||... ...+.+.=|||+|+++|.-+-=..|-.... .....|...+..+.....-....|..+..
T Consensus        98 ------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~eE~-eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~  169 (229)
T 2yle_A           98 ------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENEER-ELSPPLEQLIDHMANTVEADGSNDEGYEA  169 (229)
T ss_dssp             ---------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTEEE-CCCHHHHHHHHHHTTCCC-----------
T ss_pred             ------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCcccch-hhCHHHHHHHHHHHhcccccccccccccc
Confidence                  1123466888764 355789999999999999887444432211 11112222222221110000122333210


Q ss_pred             CC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          596 FD--PQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       596 ~~--~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                      .+  .++.+.         ...+..|++.++|++.-..+.+-|
T Consensus       170 ~~eg~~d~~~---------~~~~~~~~sl~~Vi~~C~~hl~~p  203 (229)
T 2yle_A          170 AEEGLGDEDE---------KRKISAIRSYRDVMKLCAAHLPTE  203 (229)
T ss_dssp             ---------C---------CSCCCCCCSHHHHHHHHHTTSSSG
T ss_pred             cccccccccc---------cccccCcCCHHHHHHHHHhhccCc
Confidence            00  000010         246778889999998877776644

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.56  E-value=0.012  Score=60.69  Aligned_cols=144  Identities=15%  Similarity=0.133  Sum_probs=71.8

Q ss_pred             cceeeeeCceE-EEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeeeEeccCeeeEEEeccCC
Q 040242          360 KNLVGSGGFGK-VYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       360 ~~~LG~G~~g~-Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      .+.|+.|.... +|+... .++..+++|.......   .++..|+.++..+....  +.+++.++...+  +++||++.+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~   96 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD   96 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence            34566665554 566654 2256677776543321   22345666666664323  455666654443  789999977


Q ss_pred             CCcchhccccccc---------------------ccccccHHHH----------H----------HHHHHHHHHHHHhHh
Q 040242          437 GSLDKLLFDNDQQ---------------------KKKILNWDQR----------Y----------KILIGVAQALLYLHE  475 (662)
Q Consensus       437 gsL~~~l~~~~~~---------------------~~~~l~~~~~----------~----------~i~~~ia~~L~yLH~  475 (662)
                      ..+.+++......                     ....++....          +          .....+.+.+..|.+
T Consensus        97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~  176 (333)
T 3csv_A           97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS  176 (333)
T ss_dssp             CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred             cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence            6665444211100                     0000110000          0          000111122222211


Q ss_pred             ---cCCCCEEeCCcCCCceEeCCC----CCeEEeecccccc
Q 040242          476 ---ECDQRVVHRDVKPSNVLIDAD----LNPKLGDFGLARA  509 (662)
Q Consensus       476 ---~~~~~ivH~Dlkp~NIll~~~----~~~kL~DfGla~~  509 (662)
                         .....++|+|+.+.|||++.+    ..+.|.||+.+..
T Consensus       177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence               123679999999999999875    6789999998874

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.43  E-value=0.01  Score=62.20  Aligned_cols=75  Identities=9%  Similarity=0.051  Sum_probs=45.0

Q ss_pred             cceeeeeCceEEEEEEeCC--------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEE
Q 040242          360 KNLVGSGGFGKVYRGVIPS--------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLV  430 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~--------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV  430 (662)
                      .+.|+.|....+|+.....        .+..+++|+........ .+...|..+++.+...+++ ++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            3567788888999988742        12578888875543221 1235677778777544443 566543  2  3689


Q ss_pred             EeccCCCCc
Q 040242          431 YDYVPNGSL  439 (662)
Q Consensus       431 ~E~~~~gsL  439 (662)
                      |||++|..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999988665

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.68  E-value=0.063  Score=55.58  Aligned_cols=31  Identities=19%  Similarity=0.265  Sum_probs=27.8

Q ss_pred             CCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          479 QRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       479 ~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ..++|+|+.+.||+++.++.+.|.||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            5799999999999999888899999987764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.37  E-value=0.24  Score=52.83  Aligned_cols=144  Identities=13%  Similarity=0.109  Sum_probs=83.7

Q ss_pred             cceeeeeCceEEEEEEeCCC-------CcEEEEEEeeccchhhHHHHHHHHHHhhccccccc-eeeeeeEeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPST-------GLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL-VQLHGWCRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~-------g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  431 (662)
                      .+.|..|-...+|+......       +..+++|+......... +-.+|..+++.+.-.++ .++++.+.    -++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            45677788889999887421       57799998755432211 12467777777753344 34554332    27899


Q ss_pred             eccCCCCcchh-c----------------ccccc------c--ccccccHHHHHHHHHHH-------------------H
Q 040242          432 DYVPNGSLDKL-L----------------FDNDQ------Q--KKKILNWDQRYKILIGV-------------------A  467 (662)
Q Consensus       432 E~~~~gsL~~~-l----------------~~~~~------~--~~~~l~~~~~~~i~~~i-------------------a  467 (662)
                      ||++|..|..- +                |....      .  ...+.-|.+..++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998776421 1                11100      0  01111244433333222                   1


Q ss_pred             HHHHHhHh---------------------cCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          468 QALLYLHE---------------------ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       468 ~~L~yLH~---------------------~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      +.+.+|.+                     .....++|+|+.+.||+ +.++.+.|.||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     11246899999999999 7888999999988864

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.39  E-value=0.69  Score=48.81  Aligned_cols=30  Identities=23%  Similarity=0.332  Sum_probs=25.2

Q ss_pred             CEEeCCcCCCceEe------CCCCCeEEeecccccc
Q 040242          480 RVVHRDVKPSNVLI------DADLNPKLGDFGLARA  509 (662)
Q Consensus       480 ~ivH~Dlkp~NIll------~~~~~~kL~DfGla~~  509 (662)
                      .++|+|+.+.|||+      +++..+++.||.++..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567799999988764

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=85.61  E-value=0.3  Score=33.77  Aligned_cols=13  Identities=31%  Similarity=0.388  Sum_probs=5.4

Q ss_pred             HHHhhhhhhhhcc
Q 040242          315 VIIAAILVLRRIR  327 (662)
Q Consensus       315 ~~~~~~~~~r~~~  327 (662)
                      +++.+++++||++
T Consensus        27 i~~~~~~~~RRr~   39 (44)
T 2ks1_B           27 VALGIGLFMRRRH   39 (44)
T ss_dssp             HHHHHHHHHHTTT
T ss_pred             HHHHHHHHhhhhH
Confidence            3333444444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=85.31  E-value=3.5  Score=39.17  Aligned_cols=116  Identities=11%  Similarity=0.132  Sum_probs=80.0

Q ss_pred             ccccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCC
Q 040242          410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPS  489 (662)
Q Consensus       410 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  489 (662)
                      .||++++. .+-...+.+.+.|+.-+.  ...+-.      -..++...+++++.+|+....+++.     -+|--|.|+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~--~~~f~~------ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~  108 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDN--HTPFDN------IKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD  108 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTT--SEEGGG------GGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcc--cCCHHH------HHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence            58888876 456666677666665442  222221      2346778899999999988866654     378899999


Q ss_pred             ceEeCCCCCeEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCC
Q 040242          490 NVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIE  562 (662)
Q Consensus       490 NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~  562 (662)
                      ||+++.++.+++.-.|+-..+                  +|.     ..++..=.-.+=|++..+++++..|+
T Consensus       109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999876654322                  221     22333334567788889999988875

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=83.97  E-value=0.3  Score=33.70  Aligned_cols=23  Identities=13%  Similarity=0.306  Sum_probs=9.1

Q ss_pred             ehHHHHHHHHHHHhhhhhhhhcc
Q 040242          305 TLASAILVIFVIIAAILVLRRIR  327 (662)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~r~~~  327 (662)
                      +++.+++++++++..++++||++
T Consensus        16 VVgGv~~v~ii~~~~~~~~RRRr   38 (44)
T 2l2t_A           16 VIGGLFILVIVGLTFAVYVRRKS   38 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             ehHHHHHHHHHHHHHHHHhhhhh
Confidence            33333333333344444444443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=81.96  E-value=0.36  Score=32.27  Aligned_cols=28  Identities=14%  Similarity=0.176  Sum_probs=15.9

Q ss_pred             cceEEeeehHHHHHHHHHHHhhhhhhhh
Q 040242          298 KGFAVGITLASAILVIFVIIAAILVLRR  325 (662)
Q Consensus       298 ~~~~i~~~~~~~~~~~~~~~~~~~~~r~  325 (662)
                      .+.++++++++++.+++++.++++++||
T Consensus        10 ~GaIAGiVvG~v~gv~li~~l~~~~~rr   37 (38)
T 2k1k_A           10 GGEIVAVIFGLLLGAALLLGILVFRSRR   37 (38)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred             CCceeeeehHHHHHHHHHHHHHHHHeec
Confidence            4556667777666555555555554444

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=80.77  E-value=0.16  Score=54.85  Aligned_cols=61  Identities=13%  Similarity=0.141  Sum_probs=17.8

Q ss_pred             ccceeeeeCceEEEEEEeCCCCcEEEE------EEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          359 EKNLVGSGGFGKVYRGVIPSTGLEVAI------KRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       359 ~~~~LG~G~~g~Vy~~~~~~~g~~vav------K~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      ..+.||   ||.||+|.+.....+|||      |.....  .++....|.+|..+++.++|+|+++.+++..
T Consensus       146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            345676   999999999655567888      766543  2334467888999999999999999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	662
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-65
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	6e-63
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-60
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-59
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	6e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-58
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	9e-58
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-58
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	1e-57
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-57
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	2e-56
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-56
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	8e-56
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-55
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	2e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-55
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	5e-55
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	5e-55
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-54
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-54
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	6e-54
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	1e-53
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-53
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-53
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	3e-53
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	5e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-52
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	1e-52
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	2e-52
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	4e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-52
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	1e-51
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	3e-51
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-51
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-51
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	1e-50
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	2e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-50
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	1e-49
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-49
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-47
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-46
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	1e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-45
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-45
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	9e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	3e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	9e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-42
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-41
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-40
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-39
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-38
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-37
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-36
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	4e-36
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	3e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-22
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	1e-21
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	6e-04
d2a6za1	221	b.29.1.13 (A:7-227) Emp47p N-terminal domain {Bake	8e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (547), Expect = 2e-65
 Identities = 74/312 (23%), Positives = 127/312 (40%), Gaps = 44/312 (14%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHN 391
           +DWE+  G                     +GSG FG VY+G        VA+K   V   
Sbjct: 1   DDWEIPDGQ--------------ITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAP 43

Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + Q ++ F  E+  + + RH N++   G+     +L +V  +    SL   L       +
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHL----HIIE 98

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
                 +   I    AQ + YLH    + ++HRD+K +N+ +  DL  K+GDFGLA    
Sbjct: 99  TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155

Query: 512 HNINP-QTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
                 Q   + G++ ++APE+ R       +  +DV+ FG ++ E+  G+ P       
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS----- 210

Query: 568 MELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             +   D +  +  +G     + P L        + +  L   C     D RP   +++ 
Sbjct: 211 -NINNRDQIIFMVGRGY----LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILA 265

Query: 628 FL--LRDASLPQ 637
            +  L   SLP+
Sbjct: 266 SIELLA-RSLPK 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (529), Expect = 6e-63
 Identities = 71/296 (23%), Positives = 125/296 (42%), Gaps = 37/296 (12%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR 393
           ++WEV                +  +    +G+G FG+V+ G       +VA+K +     
Sbjct: 6   DEWEVPR--------------ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSL-KQGS 49

Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI 453
                F+AE   M +L+H+ LV+L+     Q+ + ++ +Y+ NGSL   L      K   
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIK--- 105

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           L  ++   +   +A+ + ++ E      +HRD++ +N+L+   L+ K+ DFGLAR  + N
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162

Query: 514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                      + + APE    G  T  +DV+ FG L+ E+    R   P  T  E++  
Sbjct: 163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ- 221

Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                      + R          P+E   +  L  LC    P+ RP+   +   L
Sbjct: 222 ----------NLERGYRMVRPDNCPEE---LYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 8e-63
 Identities = 58/236 (24%), Positives = 110/236 (46%), Gaps = 11/236 (4%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLRHRNLV 415
           F + + +G+G  G V++     +GL +A K +    +  +  + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
             +G      E+ +  +++  GSLD++L     +K   +      K+ I V + L YL E
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLRE 122

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
           +   +++HRDVKPSN+L+++    KL DFG++     +        VGT  Y++PE  + 
Sbjct: 123 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---MANSFVGTRSYMSPERLQG 177

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
              +  +D++  G  ++E+A GR PI P       ++     E  +     R   P
Sbjct: 178 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 6e-61
 Identities = 75/296 (25%), Positives = 121/296 (40%), Gaps = 37/296 (12%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR 393
           + WE+                +  R +  +G G FG+V+ G    T   VAIK +     
Sbjct: 10  DAWEIPR--------------ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGT 53

Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI 453
              + F+ E   M +LRH  LVQL+     ++ + +V +Y+  GSL   L     +  K 
Sbjct: 54  MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKG---ETGKY 109

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           L   Q   +   +A  + Y+        VHRD++ +N+L+  +L  K+ DFGLAR  + N
Sbjct: 110 LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166

Query: 514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                      + + APE    G+ T  +DV+ FG L+ E+    R   P     E++  
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-- 224

Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                     Q+ R          P+  E +  L   C    P+ RP+   +  FL
Sbjct: 225 ---------DQVERGYRMP---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL 268

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-60
 Identities = 63/274 (22%), Positives = 117/274 (42%), Gaps = 25/274 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
                 +GSG FG V+ G       +VAIK +        ++F+ E   M +L H  LVQ
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L+G C +Q  + LV++++ +G L        + ++ +   +    + + V + +      
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDY----LRTQRGLFAAETLLGMCLDVCEGM---AYL 117

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
            +  V+HRD+   N L+  +   K+ DFG+ R    +    +T     + + +PE+    
Sbjct: 118 EEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF 596
           + ++ +DV+ FG LM EV    +     R+  E+V                 I      +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---------------EDISTGFRLY 222

Query: 597 DPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            P+ A   V  +   C    P+ RP+  R+++ L
Sbjct: 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 4e-60
 Identities = 69/294 (23%), Positives = 119/294 (40%), Gaps = 33/294 (11%)

Query: 360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHG 419
           +  +G G FG+V+RG     G EVA+K  +    +      AEI     LRH N++    
Sbjct: 8   QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 420 WCRKQD----ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
              K +    +L LV DY  +GSL   L       +  +  +   K+ +  A  L +LH 
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYL------NRYTVTVEGMIKLALSTASGLAHLHM 118

Query: 476 EC-----DQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD---HNINPQTTHIVGTLGY 527
           E         + HRD+K  N+L+  +    + D GLA  +D     I+    H VGT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178

Query: 528 LAPEL------TRTGKATTSTDVFGFGTLMLEVACGRRPI----EPQRTAMELVLVDWVR 577
           +APE+       +  ++    D++  G +  E+A          + Q    +LV  D   
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 238

Query: 578 ELHSQGQITRAIDPTL--DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           E   +    + + P +   +   +   ++  +   C   +   R +  R+ + L
Sbjct: 239 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  200 bits (510), Expect = 1e-59
 Identities = 79/319 (24%), Positives = 127/319 (39%), Gaps = 39/319 (12%)

Query: 348 SELYSA---TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG---MKEFVA 401
           +EL+      K F +   +G G FG VY          VAIK+++++ +Q     ++ + 
Sbjct: 5   AELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK 64

Query: 402 EITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYK 461
           E+  + +LRH N +Q  G   ++    LV +Y    + D L        KK L   +   
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAA 119

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI 521
           +  G  Q L YLH      ++HRDVK  N+L+      KLGDFG A              
Sbjct: 120 VTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSF 171

Query: 522 VGTLGYLAPEL---TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE 578
           VGT  ++APE+      G+     DV+  G   +E+A  + P+        L        
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------- 224

Query: 579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLP 636
                 I +   P L       +E        C    P  RP++  +++  F+LR+   P
Sbjct: 225 -----HIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP-P 276

Query: 637 QAPLDIHHEFPRAIPEFSE 655
              +D+      A+ E   
Sbjct: 277 TVIMDLIQRTKDAVRELDN 295

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 3e-59
 Identities = 68/275 (24%), Positives = 113/275 (41%), Gaps = 25/275 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
                 +G+G FG V  G       +VAIK +         EF+ E   M  L H  LVQ
Sbjct: 6   LTFLKELGTGQFGVVKYGKWR-GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L+G C KQ  + ++ +Y+ NG L   L     + +      Q  ++   V +A+ YL   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLE-- 117

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTG 536
             ++ +HRD+   N L++     K+ DFGL+R    +    +      + +  PE+    
Sbjct: 118 -SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 176

Query: 537 KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYF 596
           K ++ +D++ FG LM E+    +    + T  E                   I   L  +
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---------------EHIAQGLRLY 221

Query: 597 DPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFLL 630
            P  A E V T+   C     D RP+ + ++  +L
Sbjct: 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  198 bits (503), Expect = 6e-59
 Identities = 68/307 (22%), Positives = 129/307 (42%), Gaps = 40/307 (13%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR 393
           + WE+E                    K+ +G G +G+VY GV     L VA+K +  ++ 
Sbjct: 10  DKWEMER--------------TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 55

Query: 394 QGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKI 453
           + ++EF+ E   M  ++H NLVQL G C ++    ++ +++  G+L   L + ++Q+   
Sbjct: 56  E-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE--- 111

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           ++      +   ++ A+ YL +   +  +HRD+   N L+  +   K+ DFGL+R    +
Sbjct: 112 VSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168

Query: 514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                      + + APE     K +  +DV+ FG L+ E+A       P     ++   
Sbjct: 169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-- 226

Query: 574 DWVRELHSQGQITRAIDPTLDYFDPQE-AELVLTLGLLCCDPHPDFRPSTRRVVQFL--- 629
                          ++       P+   E V  L   C   +P  RPS   + Q     
Sbjct: 227 -------------ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

Query: 630 LRDASLP 636
            +++S+ 
Sbjct: 274 FQESSIS 280

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (501), Expect = 1e-58
 Identities = 71/303 (23%), Positives = 135/303 (44%), Gaps = 40/303 (13%)

Query: 345 FRYSELYSATKGFREK---------NLVGSGGFGKVYRGVIPSTG---LEVAIKRV-AHN 391
           F + +   A + F ++          ++G+G FG+V  G +   G   + VAIK + +  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 392 SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKK 451
           + +  ++F++E + MG+  H N++ L G   K   ++++ +++ NGSLD       +Q  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF----LRQND 122

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
                 Q   +L G+A  + YL +      VHRD+   N+L++++L  K+ DFGL+R  +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 512 HNINPQTTH----IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTA 567
            + +  T          + + APE  +  K T+++DV+ +G +M EV           T 
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239

Query: 568 MELVLVDWVRELHSQGQITRAIDPTLDYFDPQE-AELVLTLGLLCCDPHPDFRPSTRRVV 626
            +++                AI+       P +    +  L L C     + RP   ++V
Sbjct: 240 QDVI---------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 627 QFL 629
             L
Sbjct: 285 NTL 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 2e-58
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 23/277 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           +     +G+G +G+  +    S G  +  K +     +    +  V+E+  +  L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 415 VQLHGWC--RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           V+ +     R    L +V +Y   G L  ++     ++++ L+ +   +++  +  AL  
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG-TKERQYLDEEFVLRVMTQLTLALKE 124

Query: 473 LHE--ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            H   +    V+HRD+KP+NV +D   N KLGDFGLAR  +H+        VGT  Y++P
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSP 183

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E          +D++  G L+ E+     P     +  EL            G+I     
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPF-TAFSQKELA-----------GKIREGKF 231

Query: 591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             + Y    E   ++       +     RPS   +++
Sbjct: 232 RRIPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (495), Expect = 9e-58
 Identities = 67/293 (22%), Positives = 131/293 (44%), Gaps = 32/293 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G G FGKVY+     T +  A K +   S + +++++ EI  +    H N+V+
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           L      ++ L ++ ++   G++D ++ +     ++ L   Q   +      AL YLH+ 
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLE----LERPLTESQIQVVCKQTLDALNYLHD- 128

Query: 477 CDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL---- 532
              +++HRD+K  N+L   D + KL DFG++      I  +    +GT  ++APE+    
Sbjct: 129 --NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRDSFIGTPYWMAPEVVMCE 185

Query: 533 -TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
            ++        DV+  G  ++E+A    P   +   M ++L           +I ++  P
Sbjct: 186 TSKDRPYDYKADVWSLGITLIEMAEIEPPH-HELNPMRVLL-----------KIAKSEPP 233

Query: 592 TLDYFD--PQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPL 640
           TL          +  L     C + + D R +T +++Q  F+  D++ P   L
Sbjct: 234 TLAQPSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 9e-58
 Identities = 67/283 (23%), Positives = 116/283 (40%), Gaps = 32/283 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRN 413
           F     +G G FG VY      +   +A+K +            +   E+     LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +++L+G+      + L+ +Y P G++ + L     QK    +  +    +  +A AL Y 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYREL-----QKLSKFDEQRTATYITELANALSYC 122

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H    +RV+HRD+KP N+L+ +    K+ DFG +     +   + T + GTL YL PE+ 
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---RRTTLCGTLDYLPPEMI 176

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
                    D++  G L  E   G+ P     T  E              +I+R      
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPF-EANTYQETYK-----------RISRVEFTFP 224

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDAS 634
           D+      +L+          +P  RP  R V++  ++  ++S
Sbjct: 225 DFVTEGARDLI----SRLLKHNPSQRPMLREVLEHPWITANSS 263

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  193 bits (490), Expect = 1e-57
 Identities = 65/276 (23%), Positives = 113/276 (40%), Gaps = 44/276 (15%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSND------QGRILGHAFYPSPLRFK 69
           AET SF +N F+  Q N+ L G A V   G L ++        +   LG A Y +P+   
Sbjct: 1   AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW 60

Query: 70  QLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGL 129
                    +  + +  +F+ +F F+      +    GLAF L     P       + G 
Sbjct: 61  ---------DKETGSVASFAASFNFTFYAPDTKRLADGLAFFL----APIDTKPQTHAGY 107

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
               +  +   +++AVEFD  +N    D  + H+GI+++S+ S  +              
Sbjct: 108 LGLFNENESGDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTS------------ 153

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                  L +    +  I Y++   L+  ++      +    ++S  +DL T L E++ +
Sbjct: 154 -----WDLANNKVAKVLITYDASTSLLVASLVYPS--QRTSNILSDVVDLKTSLPEWVRI 206

Query: 250 GFSASTGLLTAF--HNVHGWSFKIGGTARELDVTML 283
           GFSA+TGL      H+V  WSF         ++  L
Sbjct: 207 GFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPL 242

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 2e-57
 Identities = 72/321 (22%), Positives = 131/321 (40%), Gaps = 39/321 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGL--EVAIKRV-AHNSRQGMKEFVAEITSMGRL-RHR 412
            + ++++G G FG+V +  I   GL  + AIKR+  + S+   ++F  E+  + +L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNWDQRYK 461
           N++ L G C  +  L L  +Y P+G+L   L           F         L+  Q   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 462 ILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHI 521
               VA+ + YL +   ++ +HRD+   N+L+  +   K+ DFGL+R  +  +  + T  
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMG 186

Query: 522 VGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS 581
              + ++A E       TT++DV+ +G L+ E+           T  EL           
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE--------- 237

Query: 582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLD 641
             ++ +            E   V  L   C    P  RPS  +++  L R     +  ++
Sbjct: 238 --KLPQGYRLEKPLNCDDE---VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVN 292

Query: 642 IHHEFPRAIPEFSEDDSDPSS 662
                     +F+    D S+
Sbjct: 293 -----TTLYEKFTYAGIDCSA 308

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 8e-57
 Identities = 72/274 (26%), Positives = 115/274 (41%), Gaps = 29/274 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
            +    +G G FG V  G     G +VA+K +   +    + F+AE + M +LRH NLVQ
Sbjct: 9   LKLLQTIGKGEFGDVMLGDY--RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQ 64

Query: 417 LHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           L G   ++   L +V +Y+  GSL   L     + + +L  D   K  + V +A+ YL  
Sbjct: 65  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS---RGRSVLGGDCLLKFSLDVCEAMEYLEG 121

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRT 535
                 VHRD+   NVL+  D   K+ DFGL +      +         + + APE  R 
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALRE 174

Query: 536 GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLDY 595
            K +T +DV+ FG L+ E+    R   P+    ++V            ++ +        
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------RVEKGYKMDAPD 223

Query: 596 FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
             P     V  +   C       RPS  ++ + L
Sbjct: 224 GCPPA---VYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-56
 Identities = 63/278 (22%), Positives = 117/278 (42%), Gaps = 30/278 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
            +    +G G F  VY+G+   T +EVA   +     ++   + F  E   +  L+H N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 415 VQLHGWC----RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           V+ +       + +  ++LV + + +G+L   L     ++ K++           + + L
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGL 125

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            +LH      ++HRD+K  N+ I     + K+GD GLA     +       ++GT  ++A
Sbjct: 126 QFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS---FAKAVIGTPEFMA 181

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
           PE+    K   S DV+ FG  MLE+A    P    + A ++             ++T  +
Sbjct: 182 PEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR-----------RVTSGV 229

Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
            P    FD      V  +   C   + D R S + ++ 
Sbjct: 230 KPAS--FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  189 bits (480), Expect = 2e-56
 Identities = 63/262 (24%), Positives = 109/262 (41%), Gaps = 38/262 (14%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILA---VSNDQGRILGHAFYPSPLRFKQLS 72
           ++  SF ++ F+  Q N+   G A V   G+L    VS      +G A Y +P++     
Sbjct: 1   SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW--- 57

Query: 73  KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPND 132
                 ++I+    +F+T+F F +             F+  +  Q PS  +    GL + 
Sbjct: 58  ------DSITGKVASFATSFSFVVKADKSDGVDGLAFFLAPANSQIPSGSSAGMFGLFS- 110

Query: 133 TSNAKFSTRILAVEFDAVQNLELQ--DINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           +S++K S +I+AVEFD          D +  H+GID++S+ S  +    +          
Sbjct: 111 SSDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWR--------- 161

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
                   +G+     I Y +    + V +S          +I+  +DL  +L E++ VG
Sbjct: 162 --------NGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSVG 211

Query: 251 FSASTGLLTAF--HNVHGWSFK 270
           FS   G    F  H+V  W F 
Sbjct: 212 FSGGVGNAAEFETHDVLSWYFT 233

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (484), Expect = 4e-56
 Identities = 62/299 (20%), Positives = 109/299 (36%), Gaps = 43/299 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNSRQGM-KEFVAEITSMGRLR 410
                 +G G FG+V++   P          VA+K +   +   M  +F  E   M    
Sbjct: 15  IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQK-------------------K 451
           + N+V+L G C     + L+++Y+  G L++ L                           
Sbjct: 75  NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGP 134

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA-Y 510
             L+  ++  I   VA  + YL E   ++ VHRD+   N L+  ++  K+ DFGL+R  Y
Sbjct: 135 PPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
             +      +    + ++ PE     + TT +DV+ +G ++ E+              E+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                         I    D  +          +  L  LC    P  RPS   + + L
Sbjct: 252 --------------IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRIL 296

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  187 bits (477), Expect = 8e-56
 Identities = 68/264 (25%), Positives = 110/264 (41%), Gaps = 43/264 (16%)

Query: 19  ETNSFIYNGFIQA--NLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQ 70
           ET SF ++ F     NL+L G A + + G+L ++             G   Y  P+    
Sbjct: 2   ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW- 60

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQ-LGGHGLAFVLMSRKQPPSCLANQYLGL 129
                   ++ + T  +F T F FSI   Y + L   GL F +   K  P+     YLG+
Sbjct: 61  --------DSTTGTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPA-QGYGYLGV 111

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
            N+ S    S + LAVEFD   N         H+GID++S+ S  ++P            
Sbjct: 112 FNN-SKQDNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNSIRSIKTQPFQ---------- 159

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                  L +G      I Y++   +++V +            I+  +D+  VL +++ V
Sbjct: 160 -------LDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDV 210

Query: 250 GFSASTGLLTAF---HNVHGWSFK 270
           G S +TG        H+V+ WSF+
Sbjct: 211 GLSGATGAQRDAAETHDVYSWSFQ 234

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  186 bits (474), Expect = 1e-55
 Identities = 67/259 (25%), Positives = 109/259 (42%), Gaps = 43/259 (16%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI---LGHAFYPSPLRFKQLSKY 74
           +   SF    F + NL L G A V  +G L ++N +G     +G AFY +P++       
Sbjct: 1   SNDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN----- 55

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               +       +FSTNF F I  K  +   +GLAF L+     P  L  +YLGL N T 
Sbjct: 56  ----DRTIDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT- 109

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
                      + DA     + D   N + ID++S+    +E   +              
Sbjct: 110 ---------NYDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFG------------- 147

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               +G+  +  I Y+S +  + V++         +  +S  + L   +++++ VGFSA+
Sbjct: 148 --HNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSAT 203

Query: 255 TGLL---TAFHNVHGWSFK 270
           +G     T  HNV  WSF 
Sbjct: 204 SGSKKETTETHNVLSWSFS 222

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 62/265 (23%), Positives = 100/265 (37%), Gaps = 49/265 (18%)

Query: 19  ETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSND------QGRILGHAFYPSPLRFKQ 70
           ET SF ++ F +    L+L   A ++ +G+L ++          +  G A Y  P++   
Sbjct: 1   ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKI-- 58

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQL-GGHGLAFVLMSRKQPPSCLANQYLGL 129
                   ++ +    +F T F F+I   Y       GL F        P        G 
Sbjct: 59  -------WDSTTGNVASFETRFSFNITQPYAYPEPADGLTFF-----MVPPNSPQGEDGG 106

Query: 130 PNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
                         AVEFD  QN    D    H+GID++S++S          SK  +  
Sbjct: 107 NLGVFKPPEGDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVS----------SKTLHFQ 154

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVL--DEYM 247
                  L++G      I Y+S   ++NV ++   +       +S  +DL       E++
Sbjct: 155 -------LENGGVANVVIKYDSPTKILNVVLAFHSVGTV--YTLSNIVDLKQEFPNSEWV 205

Query: 248 YVGFSASTGL---LTAFHNVHGWSF 269
            VG SA+TG        H +  WSF
Sbjct: 206 NVGLSATTGYQKNAVETHEIISWSF 230

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 3e-55
 Identities = 68/302 (22%), Positives = 120/302 (39%), Gaps = 28/302 (9%)

Query: 349 ELYSATKGFREKNLV-GSGGFGKVYRGVIPST--GLEVAIKRVAHNSRQG-MKEFVAEIT 404
           +L+         ++  G G FG V +GV       ++VAIK +   + +   +E + E  
Sbjct: 2   KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 405 SMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILI 464
            M +L +  +V+L G C+ +  L+LV +    G L K L      K++ +      ++L 
Sbjct: 62  IMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVG----KREEIPVSNVAELLH 116

Query: 465 GVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIV 522
            V+  + YL    ++  VHRD+   NVL+      K+ DFGL++A   D +     +   
Sbjct: 117 QVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 523 GTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ 582
             L + APE     K ++ +DV+ +G  M E     +    +    E++           
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM----------- 222

Query: 583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDI 642
             I +          P E      L   C     + RP    V Q +        + ++ 
Sbjct: 223 AFIEQGKRMECPPECPPELY---ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEG 279

Query: 643 HH 644
           HH
Sbjct: 280 HH 281

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 5e-55
 Identities = 63/274 (22%), Positives = 113/274 (41%), Gaps = 23/274 (8%)

Query: 354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN 413
            K +     +G G  G VY  +  +TG EVAI+++    +   +  + EI  M   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           +V         DEL +V +Y+  GSL  ++       +  ++  Q   +     QAL +L
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFL 132

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H     +V+HRD+K  N+L+  D + KL DFG           + + +VGT  ++APE+ 
Sbjct: 133 HS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QSKRSTMVGTPYWMAPEVV 188

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
                    D++  G + +E+  G  P   +     L        L +        +P  
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-------YLIATNGTPELQNP-- 239

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           +       + +      C D   + R S + ++Q
Sbjct: 240 EKLSAIFRDFL----NRCLDMDVEKRGSAKELLQ 269

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  185 bits (471), Expect = 5e-55
 Identities = 61/256 (23%), Positives = 100/256 (39%), Gaps = 35/256 (13%)

Query: 18  AETNSFIYNGFIQAN--LSLDGTAFVRKDGILAVSND-QGRILGHAFYPSPLRFKQLSKY 74
           AET SF +N F + N  ++  G   V  +G + ++N  +   +G   Y  P+R       
Sbjct: 1   AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW----- 55

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               ++ +    +F T+F F +          G+ F +          A    G     S
Sbjct: 56  ----SSATGNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIP--AGSIGGGTLGVS 109

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
           + K +   + VEFD   N E  D   +HVGID++S+ S  + P                 
Sbjct: 110 DTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPW---------------- 153

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               SG  ++  + Y+S    ++V ++           I+  +DL   L E +  GFSAS
Sbjct: 154 -NSVSGAVVKVTVIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSAS 209

Query: 255 TGLL-TAFHNVHGWSF 269
             L     H +  WSF
Sbjct: 210 GSLGGRQIHLIRSWSF 225

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 5e-55
 Identities = 67/311 (21%), Positives = 122/311 (39%), Gaps = 28/311 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAH-NSRQGMKEFVAEITSMGRLRH 411
           F++  ++GSG FG VY+G+    G    + VAIK +    S +  KE + E   M  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            ++ +L G C     + L+   +P G L     D  ++ K  +         + +A+ + 
Sbjct: 71  PHVCRLLGICL-TSTVQLITQLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMN 125

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINPQTTHIVGTLGYLAP 530
           YL    D+R+VHRD+   NVL+    + K+ DFGLA+                 + ++A 
Sbjct: 126 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182

Query: 531 ELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID 590
           E       T  +DV+ +G  + E+            A E+              + +   
Sbjct: 183 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------SILEKGER 231

Query: 591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLPQAPLDIHHEFPRAI 650
                    +   V  + + C     D RP  R ++    + A  PQ  L I  +    +
Sbjct: 232 LPQPPICTID---VYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHL 288

Query: 651 PEFSEDDSDPS 661
           P  ++ +   +
Sbjct: 289 PSPTDSNFYRA 299

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 5e-55
 Identities = 69/288 (23%), Positives = 130/288 (45%), Gaps = 30/288 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHNSRQGMK-EFVAEITSMGRLRH 411
              + ++G+G FG+VY+G++ ++     + VAIK +     +  + +F+ E   MG+  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALL 471
            N+++L G   K   ++++ +Y+ NG+LDK      ++K    +  Q   +L G+A  + 
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKF----LREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 472 YLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGYLA 529
           YL        VHRD+   N+L++++L  K+ DFGL+R  + +      T+     + + A
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
           PE     K T+++DV+ FG +M EV         + +  E++               +AI
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM---------------KAI 226

Query: 590 DPTLDY-FDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP 636
           +              +  L + C       RP    +V  L +    P
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  184 bits (468), Expect = 1e-54
 Identities = 67/261 (25%), Positives = 116/261 (44%), Gaps = 42/261 (16%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI------LGHAFYPSPLRFKQL 71
           +    F +  F + NL L   A V   G L ++N  G        LG AFY +P++    
Sbjct: 1   SNDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW-- 58

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
                  +  + T  +F+T+F F+I          GLAF L+     P      +LGL +
Sbjct: 59  -------DNTTGTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGLFD 110

Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
            +++   +   +AVEFD + N +  D  + H+GID++S+ S  +    +           
Sbjct: 111 GSNS---NFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFV---------- 156

Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
                  +G+  +  I Y+S   L+  ++      +    ++S  +DL +VL E++ VGF
Sbjct: 157 -------NGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGF 207

Query: 252 SASTGLLTAF---HNVHGWSF 269
           SA+TG+       ++V  WSF
Sbjct: 208 SATTGINKGNVETNDVLSWSF 228

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 2e-54
 Identities = 60/274 (21%), Positives = 105/274 (38%), Gaps = 24/274 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV-AHNSRQGMKEFVAEITSMGRLRHRNLV 415
           +     +G G +G+V   V   T   VA+K V    +    +    EI     L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
           + +G  R+ +   L  +Y   G L   +     +    +      +    +   ++YLH 
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH-IVGTLGYLAPELTR 534
                + HRD+KP N+L+D   N K+ DFGLA  + +N   +  + + GTL Y+APEL +
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178

Query: 535 TGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
             +      DV+  G ++  +  G      Q +       DW  +        +      
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAG-ELPWDQPSDSCQEYSDWKEK--------KTYLNPW 229

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
              D     L+          +P  R +   + +
Sbjct: 230 KKIDSAPLALLHK----ILVENPSARITIPDIKK 259

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 4e-54
 Identities = 66/277 (23%), Positives = 108/277 (38%), Gaps = 29/277 (10%)

Query: 359 EKNLVGSGGFGKVYRGVIP--STGLEVAIKRVAHNSRQG--MKEFVAEITSMGRLRHRNL 414
           E   +GSG FG V +G          VA+K + + +       E +AE   M +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V++ G C   +  +LV +    G L+K L      + + +      +++  V+  + YL 
Sbjct: 71  VRMIGICE-AESWMLVMEMAELGPLNKYLQ-----QNRHVKDKNIIELVHQVSMGMKYLE 124

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY--DHNINPQTTHIVGTLGYLAPEL 532
              +   VHRD+   NVL+      K+ DFGL++A   D N     TH    + + APE 
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
               K ++ +DV+ FG LM E     +         E+              + +     
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA-----------MLEKGERMG 230

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                P+E      L  LC     + RP    V   L
Sbjct: 231 CPAGCPREM---YDLMNLCWTYDVENRPGFAAVELRL 264

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  181 bits (461), Expect = 1e-53
 Identities = 56/258 (21%), Positives = 96/258 (37%), Gaps = 36/258 (13%)

Query: 22  SFIYNGF---IQANLSLDGTAFVRKDGI-LAVSNDQGRIL----GHAFYPSPLRFKQLSK 73
           SF +  F   ++ ++   G A      + L  +N  G  L    G A Y  P++      
Sbjct: 3   SFTFPNFWSDVEDSIIFQGDANTTAGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW---- 58

Query: 74  YNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDT 133
                +  + +  +F T F F +          GLAF L                    T
Sbjct: 59  -----DNKTESVASFYTEFTFFLKI-TGNGPADGLAFFLAPPDSDVKDAGEYLGLFNKST 112

Query: 134 SNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNI 193
           +      +++AVEFD   N    + +  H+GI+++S++S  ++             D + 
Sbjct: 113 ATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRW----------EDSD- 161

Query: 194 SVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSA 253
              + SG    A I Y+    ++ V    L  P     ++S+ +D+   L E + VG SA
Sbjct: 162 ---IFSGKIATARISYDGSAEILTVV---LSYPDGSDYILSHSVDMRQNLPESVRVGISA 215

Query: 254 STGLLTAF-HNVHGWSFK 270
           STG        +  W F 
Sbjct: 216 STGNNQFLTVYILSWRFS 233

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 2e-53
 Identities = 62/278 (22%), Positives = 110/278 (39%), Gaps = 29/278 (10%)

Query: 360 KNLVGSGGFGKVYRGVIPS---TGLEVAIKRVAHNSRQG-MKEFVAEITSMGRLRHRNLV 415
             ++G G FG VY G +       +  A+K +   +  G + +F+ E   M    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 416 QLHGWC-RKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
            L G C R +   L+V  Y+ +G L        + +             + VA+ +    
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNF----IRNETHNPTVKDLIGFGLQVAKGM---K 144

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY---DHNINPQTTHIVGTLGYLAPE 531
               ++ VHRD+   N ++D     K+ DFGLAR     + +     T     + ++A E
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 204

Query: 532 LTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP 591
             +T K TT +DV+ FG L+ E+     P  P     ++ +            + +    
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----------YLLQGRRL 253

Query: 592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
               + P     +  + L C  P  + RPS   +V  +
Sbjct: 254 LQPEYCPDP---LYEVMLKCWHPKAEMRPSFSELVSRI 288

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (465), Expect = 3e-53
 Identities = 59/295 (20%), Positives = 109/295 (36%), Gaps = 39/295 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQGMKE-FVAEITSMGRL- 409
                 +G+G FGKV              + VA+K +  ++    +E  ++E+  +  L 
Sbjct: 25  LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDN-------------DQQKKKILNW 456
            H N+V L G C      L++ +Y   G L   L                 +  +  L+ 
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNIN- 515
           +        VA+ + +L     +  +HRD+   N+L+      K+ DFGLAR   ++ N 
Sbjct: 145 EDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 516 PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW 575
               +    + ++APE       T  +DV+ +G  + E+        P            
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS------ 255

Query: 576 VRELHSQGQITRAIDPTLDYFDPQEA-ELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                   +  + I        P+ A   +  +   C D  P  RP+ +++VQ +
Sbjct: 256 --------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  181 bits (459), Expect = 3e-53
 Identities = 63/261 (24%), Positives = 101/261 (38%), Gaps = 37/261 (14%)

Query: 18  AETNSFIYNGFIQ--ANLSLDGTAFVRKDGIL----AVSNDQGRILGHAFYPSPLRFKQL 71
           ++  SF +  F Q   +LS  G A V + G+L      +N      G A Y +P+     
Sbjct: 1   SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIWNC 60

Query: 72  SKYNINNNTISHTALTFSTNFVF-SIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
           +         +    +F T+F F       P+    GL F L     P    A  Y GL 
Sbjct: 61  N---------TGELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPLR-RAGGYFGLF 110

Query: 131 NDTSNAKFSTRILAVEFDAVQN-LELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN 189
           NDT     S + +AVEFD + + +   D    H+GID++ + S  +E     +       
Sbjct: 111 NDT-KCDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYG------ 163

Query: 190 DDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV 249
                      +     I Y +    +  +++           ++  +DL  +L E++ V
Sbjct: 164 ---------LNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSV 212

Query: 250 GFSASTGL-LTAFHNVHGWSF 269
           GFS ST +   A H V  W F
Sbjct: 213 GFSGSTYIGRQATHEVLNWYF 233

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  180 bits (457), Expect = 5e-53
 Identities = 60/266 (22%), Positives = 102/266 (38%), Gaps = 48/266 (18%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQL 71
           +T SF +N F   +  L L   A +  + +L ++            G A Y  P++    
Sbjct: 1   KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW-- 58

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
                  ++ +    +F T F FSI   +P+          ++     +     Y G+ N
Sbjct: 59  -------DSTTGNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGIYN 111

Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
             S        +AVEFD  +N    D    H+GID++S+IS                   
Sbjct: 112 PLSP----YPFVAVEFDTFRNTW--DPQIPHIGIDVNSVIST-----------------K 148

Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
            +   L +G      I Y++   +++V +    +       I+  +DL  VL E + VGF
Sbjct: 149 TVPFTLDNGGIANVVIKYDASTKILHVVLVFPSLGTI--YTIADIVDLKQVLPESVNVGF 206

Query: 252 SASTGLLTAF-------HNVHGWSFK 270
           SA+TG  +         H++  WSF 
Sbjct: 207 SAATGDPSGKQRNATETHDILSWSFS 232

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-52
 Identities = 63/299 (21%), Positives = 109/299 (36%), Gaps = 42/299 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTG-----LEVAIKRVAHNSRQGMKE-FVAEITSMGRL- 409
                ++GSG FGKV              ++VA+K +   +    +E  ++E+  M +L 
Sbjct: 39  LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 98

Query: 410 RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQ------------------QKK 451
            H N+V L G C     + L+++Y   G L   L    +                  +  
Sbjct: 99  SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 158

Query: 452 KILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD 511
            +L ++        VA+ + +L     +  VHRD+   NVL+      K+ DFGLAR   
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 512 HNINPQT-THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
            + N     +    + ++APE    G  T  +DV+ +G L+ E+        P       
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275

Query: 571 VLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                         I         ++  +E  +++     C       RPS   +  FL
Sbjct: 276 F----------YKLIQNGFKMDQPFYATEEIYIIM---QSCWAFDSRKRPSFPNLTSFL 321

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (458), Expect = 1e-52
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 29/285 (10%)

Query: 355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRV---AHNSRQGMKEFVAEITSMGR 408
           K  R    +G G FG V RG   +     + VA+K +     +  + M +F+ E+ +M  
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 409 LRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           L HRNL++L+G       + +V +  P GSL     D  ++ +         +  + VA+
Sbjct: 68  LDHRNLIRLYGVVL-TPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLG 526
            + YL     +R +HRD+   N+L+      K+GDFGL RA   N +      H      
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           + APE  +T   + ++D + FG  + E+    +         +++          +    
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKEGER 233

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR 631
                          + +  + + C    P+ RP+   +  FLL 
Sbjct: 234 LPRPEDCP-------QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 68/262 (25%), Positives = 101/262 (38%), Gaps = 44/262 (16%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQL 71
           E+ SF +  F   Q NL L   A V   G L ++           LG A Y +P+     
Sbjct: 2   ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIHD- 60

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
                     + T  +F+T+F F +          GLAF L      P      +LGL  
Sbjct: 61  ----------NTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFA 109

Query: 132 DTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDD 191
           D ++   S + +AVEFD   N    D N  H+GID + + S  + P              
Sbjct: 110 DRAH-DASYQTVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTP-------------- 152

Query: 192 NISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF 251
                +  G+     I Y +    +  ++            +S  +DL  +L EY+ VGF
Sbjct: 153 ---FDMVYGEKANIVITYQASTKALAASLV--FPVSQTSYAVSARVDLRDILPEYVRVGF 207

Query: 252 SASTGLLTAF---HNVHGWSFK 270
           SA+TGL       H++  WSF 
Sbjct: 208 SATTGLNAGVVETHDIVSWSFA 229

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  179 bits (455), Expect = 2e-52
 Identities = 66/275 (24%), Positives = 111/275 (40%), Gaps = 43/275 (15%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI-----LGHAFYPSPLRFKQLS 72
           A+  SF +  F  ++  L G A V    +         +     LG AFY SP++     
Sbjct: 1   ADIQSFSFKNFNSSSFILQGDATVSSSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY--- 57

Query: 73  KYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPND 132
                 +  +    +++T+F  +I          G+AF L+     P    + +LG+ + 
Sbjct: 58  ------DKSTGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPK-SNSGFLGVFDS 110

Query: 133 TSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDN 192
                 S + +AVEFD   N +  D    H+GID++S+ S                    
Sbjct: 111 -DVYDNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSI-----------------RT 151

Query: 193 ISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS 252
            S  L +G   +  I YN+   L+  ++      +    ++S  +D+   L EY+ +GFS
Sbjct: 152 ASWGLANGQNAEILITYNAATSLLVASLV--HPSRRTSYIVSERVDITNELPEYVSIGFS 209

Query: 253 ASTGLLTAF---HNVHGWSFK----IGGTARELDV 280
           A+TGL   +   H+V  WSF        T   LD+
Sbjct: 210 ATTGLSEGYTETHDVLSWSFASKLPDDSTTEPLDI 244

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  178 bits (451), Expect = 4e-52
 Identities = 63/264 (23%), Positives = 103/264 (39%), Gaps = 39/264 (14%)

Query: 18  AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQ 70
           ++  SF  N F+  +A+L   G A V   G+L ++  +        +G A Y +P+R   
Sbjct: 1   SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW- 59

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                      + +  +FST+F F +    P +   GLAF L          +       
Sbjct: 60  --------GNTTGSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGL 111

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQ--DINDNHVGIDISSLISNISEPAAYYFSKGSNI 188
            + SN+  S +I+AVEFD          D N  H+GID++ + S  +    +     +  
Sbjct: 112 FNNSNSDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWI----NGG 167

Query: 189 NDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY 248
                   L     + A + Y                       ++  +DL  +L E++ 
Sbjct: 168 VAFATITYLAPNKTLIASLVYP---------------SNQTTFSVAASVDLKEILPEWVR 212

Query: 249 VGFSASTGLLTAF--HNVHGWSFK 270
           VGFSA+TG  T    H+V  WSF 
Sbjct: 213 VGFSAATGYPTEVETHDVLSWSFT 236

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (460), Expect = 4e-52
 Identities = 65/316 (20%), Positives = 118/316 (37%), Gaps = 31/316 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G+G FG V+R    +TG   A K V        +    EI +M  LRH  LV 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH      +E++++Y+++  G L + + D    +   ++ D+  + +  V + L ++HE 
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVAD----EHNKMSEDEAVEYMRQVCKGLCHMHE- 142

Query: 477 CDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                VH D+KP N++     +   KL DFGL    D   + + T   GT  + APE+  
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                  TD++  G L   +  G  P        E +                  D    
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPF-GGENDDETL------RNVKSCDWNM-DDSAFS 250

Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FL------LRDASLPQAPLDIHHEF 646
                  + +           P+ R +  + ++  +L       RD+ +P +      + 
Sbjct: 251 GISEDGKDFI----RKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDS 306

Query: 647 PRAIPEFSEDDSDPSS 662
            +   +   +   P  
Sbjct: 307 IKTKYDAWPEPLPPLG 322

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  176 bits (448), Expect = 1e-51
 Identities = 64/259 (24%), Positives = 105/259 (40%), Gaps = 41/259 (15%)

Query: 22  SFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQLSKY 74
           SF +  F   Q  L   G A V   G+L ++N        + LG A Y +P +       
Sbjct: 5   SFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW----- 59

Query: 75  NINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTS 134
               ++ +    +F T+F F I    P     GLAF L      P       LG+  D  
Sbjct: 60  ----DSTTGNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGIFKD-G 113

Query: 135 NAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNIS 194
               S +I+AVEFD   N +  D    H+GI+++S+ S  + P  +              
Sbjct: 114 YFNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWT------------- 159

Query: 195 VVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS 254
               +G+    +I Y +    +  ++           +I   +D+  VL E++  GFSA+
Sbjct: 160 ----NGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGFSAT 213

Query: 255 TGLLTAF---HNVHGWSFK 270
           TG+   +   ++V  WSF+
Sbjct: 214 TGIDKGYVQTNDVLSWSFE 232

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  175 bits (445), Expect = 3e-51
 Identities = 53/259 (20%), Positives = 90/259 (34%), Gaps = 40/259 (15%)

Query: 22  SFIYNGFI------QANLSLDGTAFVRKDGI-----LAVSNDQGRILGHAFYPSPLRFKQ 70
           +F Y  F          ++  G A      +      A  N      G A Y  P+    
Sbjct: 5   NFTYPDFWSYSLKNGTEITFLGDATRIPGALQLTKTDANGNPVRSSAGQASYSEPVFLWD 64

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
            +    +          F T+F F ++  Y      GLAF L                  
Sbjct: 65  STGKAAS----------FYTSFTF-LLKNYGAPTADGLAFFLAPVDSSVKDYGGFLGLFR 113

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           ++T+      +++AVEFD   N +  D    H+GID++S++S  +               
Sbjct: 114 HETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDD-------- 165

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
                         A I Y+++  ++ V +S          ++S+ +DLA VL + + +G
Sbjct: 166 ------AYGSSIATAHITYDARSKILTVLLSY---EHGRDYILSHVVDLAKVLPQKVRIG 216

Query: 251 FSASTGLLTAFHNVHGWSF 269
           FSA  G       +  W F
Sbjct: 217 FSAGVGYDEV-TYILSWHF 234

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (448), Expect = 3e-51
 Identities = 62/277 (22%), Positives = 112/277 (40%), Gaps = 26/277 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHR 412
                 +G G FG V++G+  S     L VAIK   + +   ++E F+ E  +M +  H 
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
           ++V+L G    ++ + ++ +    G L   L          L+          ++ AL Y
Sbjct: 69  HIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAY 123

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           L     +R VHRD+   NVL+ ++   KLGDFGL+R  + +   + +     + ++APE 
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 180

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
               + T+++DV+ FG  M E+              +++           G+I       
Sbjct: 181 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-----------GRIENGERLP 229

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           +    P     ++     C    P  RP    +   L
Sbjct: 230 MPPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQL 263

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  176 bits (447), Expect = 9e-51
 Identities = 65/336 (19%), Positives = 126/336 (37%), Gaps = 52/336 (15%)

Query: 334 EDWEVEYGACRFRYSELYSATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRV 388
           ++WEV                +       +G G FG VY GV            VAIK V
Sbjct: 13  DEWEVAR--------------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV 58

Query: 389 -AHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDND 447
               S +   EF+ E + M      ++V+L G   +    L++ + +  G L   L    
Sbjct: 59  NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLR 118

Query: 448 QQKKKI-----LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG 502
                       +  +  ++   +A  + YL+     + VHRD+   N ++  D   K+G
Sbjct: 119 PAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIG 175

Query: 503 DFGLAR-AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPI 561
           DFG+ R  Y+ +   +    +  + +++PE  + G  TT +DV+ FG ++ E+A      
Sbjct: 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235

Query: 562 EPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS 621
               +  ++              +   ++  L        +++  L  +C   +P  RPS
Sbjct: 236 YQGLSNEQV--------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPS 281

Query: 622 TRRVVQFLLRDASLPQAPLDIHHEFPRAIPEFSEDD 657
              ++  +           ++   F      +SE++
Sbjct: 282 FLEIISSIKE---------EMEPGFREVSFYYSEEN 308

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  173 bits (439), Expect = 2e-50
 Identities = 54/262 (20%), Positives = 96/262 (36%), Gaps = 39/262 (14%)

Query: 19  ETNSFIYNGFI--QANLSLDGTAFVRKDGI-----LAVSNDQGRILGHAFYPSPLRFKQL 71
           ++ SF +  F   Q NL   G A ++ + +      +  N     +G   + + +     
Sbjct: 2   DSLSFGFPTFPSDQKNLIFQGDAQIKNNAVQLTKTDSNGNPVASTVGRILFSAQVHLW-- 59

Query: 72  SKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPN 131
                     S     F + F FS+             F+       PS      LGL  
Sbjct: 60  -------EKSSSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGLFA 112

Query: 132 D-TSNAKFSTRILAVEFDAVQNLELQDI--NDNHVGIDISSLISNISEPAAYYFSKGSNI 188
             T+    + +++AVEFD     +      N  H+GID++S+ S                
Sbjct: 113 PGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSV--------------- 157

Query: 189 NDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMY 248
               +    + G  +   + +N     ++V  +        R  +SY +D+ +VL E++ 
Sbjct: 158 --KTVKWDRRDGQSLNVLVTFNPSTRNLDVVATY---SDGTRYEVSYEVDVRSVLPEWVR 212

Query: 249 VGFSASTGLLTAFHNVHGWSFK 270
           VGFSA++G     H +  WSF 
Sbjct: 213 VGFSAASGEQYQTHTLESWSFT 234

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  176 bits (446), Expect = 4e-50
 Identities = 60/312 (19%), Positives = 114/312 (36%), Gaps = 27/312 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +GSG FG V+R V  +TG     K +             EI+ M +L H  L+ 
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH     + E++L+ +++  G L   +      +   ++  +    +    + L ++HE 
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHE- 145

Query: 477 CDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               +VH D+KP N++ +       K+ DFGLA   +   +        T  + APE+  
Sbjct: 146 --HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVD 201

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
                  TD++  G L   +  G  P       +E +      +   +       +    
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETL------QNVKRCDWEF-DEDAFS 253

Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDAS--LPQAPLDIHHEFPRAI 650
              P+  + +           P  R +    ++  +L  D S    + P   +++  + I
Sbjct: 254 SVSPEAKDFIKN----LLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKI 309

Query: 651 PEFSEDDSDPSS 662
            E   D   P  
Sbjct: 310 KEKYADWPAPQP 321

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  171 bits (433), Expect = 1e-49
 Identities = 64/262 (24%), Positives = 102/262 (38%), Gaps = 49/262 (18%)

Query: 18  AETNSFIYNGFIQ-ANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQ 70
           A   SF +  F     L L G A +   G L ++            LG AFY  P++ K 
Sbjct: 1   ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIKD 60

Query: 71  LSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLP 130
                      S+   +F+TNF F I  K   +  +GLAF L+    PP     ++LG+ 
Sbjct: 61  -----------SNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIF 108

Query: 131 NDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIND 190
           N   N + + R +AV F+  +N    D + N +   ++                      
Sbjct: 109 NTN-NPEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNE--------------------- 144

Query: 191 DNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG 250
            N      +G+     I Y+S    + V +         +  +S  + L   +DE++ VG
Sbjct: 145 -NCDFHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVG 201

Query: 251 FSASTGLLTAF---HNVHGWSF 269
           FS ++GL       H+V  WSF
Sbjct: 202 FSPTSGLTEDTTETHDVLSWSF 223

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 2e-49
 Identities = 57/269 (21%), Positives = 100/269 (37%), Gaps = 28/269 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRN 413
           F+   ++G G F  V      +T  E AIK +          +     E   M RL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
            V+L+   +  ++L     Y  NG L K +      K    +           A+ +  L
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR-----KIGSFDETC---TRFYTAEIVSAL 121

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI-NPQTTHIVGTLGYLAPEL 532
                + ++HRD+KP N+L++ D++ ++ DFG A+         +    VGT  Y++PEL
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
                A  S+D++  G ++ ++  G  P         +             +I +     
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPF-RAGNEYLIFQ-----------KIIKLEYDF 229

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPS 621
            + F P+  +LV              R  
Sbjct: 230 PEKFFPKARDLVEK----LLVLDATKRLG 254

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 4e-48
 Identities = 63/300 (21%), Positives = 116/300 (38%), Gaps = 38/300 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPST-------GLEVAIKRV-AHNSRQGMKEFVAEITSMGR 408
                 +G G FG+V                 +VA+K + +  + + + + ++E+  M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 409 L-RHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLL-----------FDNDQQKKKILNW 456
           + +H+N++ L G C +   L ++ +Y   G+L + L           ++     ++ L+ 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 457 DQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP 516
                    VA+ + YL     ++ +HRD+   NVL+  D   K+ DFGLAR   H    
Sbjct: 135 KDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 517 QTTH-IVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDW 575
           + T      + ++APE       T  +DV+ FG L+ E+        P     EL     
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 247

Query: 576 VRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASL 635
                    +              E      +   C    P  RP+ +++V+ L R  +L
Sbjct: 248 -------KLLKEGHRMDKPSNCTNEL---YMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  167 bits (425), Expect = 1e-47
 Identities = 67/303 (22%), Positives = 121/303 (39%), Gaps = 31/303 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-FVAEITSMGRLRHRNLV 415
           +  ++++G+G F +V       T   VAIK +A  + +G +     EI  + +++H N+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L         L L+   V  G L   +      +K         +++  V  A+ YLH+
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAVKYLHD 125

Query: 476 ECDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
                +VHRD+KP N+L    D D    + DFGL++  D       +   GT GY+APE+
Sbjct: 126 LG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP--GSVLSTACGTPGYVAPEV 180

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
                 + + D +  G +   + CG  P        +L       E   + +      P 
Sbjct: 181 LAQKPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLF------EQILKAEYEFDS-PY 232

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPLDIHHEFPRAI 650
            D       + +        +  P+ R +  + +Q  ++  D +L +   +IH      I
Sbjct: 233 WDDISDSAKDFIRH----LMEKDPEKRFTCEQALQHPWIAGDTALDK---NIHQSVSEQI 285

Query: 651 PEF 653
            + 
Sbjct: 286 KKN 288

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  165 bits (418), Expect = 4e-47
 Identities = 65/287 (22%), Positives = 112/287 (39%), Gaps = 38/287 (13%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---------AHNSRQGMKEFVAEITSMG 407
           +  K ++G G    V R +   T  E A+K +         A   ++  +  + E+  + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 408 RLR-HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGV 466
           ++  H N++QL           LV+D +  G L   L      +K  L+  +  KI+  +
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMRAL 119

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLG 526
            + +  LH+     +VHRD+KP N+L+D D+N KL DFG +   D     +   + GT  
Sbjct: 120 LEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPS 174

Query: 527 YLAPELTRTGKA------TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
           YLAPE+                D++  G +M  +  G  P    R  M ++       + 
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF-WHRKQMLML------RMI 227

Query: 581 SQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
             G   +   P  D +     +LV           P  R +    + 
Sbjct: 228 MSGNY-QFGSPEWDDYSDTVKDLVSR----FLVVQPQKRYTAEEALA 269

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  163 bits (414), Expect = 2e-46
 Identities = 60/275 (21%), Positives = 111/275 (40%), Gaps = 29/275 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRN 413
           +    ++G GG  +V+         +VA+K +             F  E  +   L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 414 LVQLHGWCRKQDE----LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQA 469
           +V ++     +        +V +YV   +L  ++       +  +   +  +++    QA
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV-----HTEGPMTPKRAIEVIADACQA 123

Query: 470 LLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP--QTTHIVGTLGY 527
           L + H+     ++HRDVKP+N++I A    K+ DFG+ARA   + N   QT  ++GT  Y
Sbjct: 124 LNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQY 180

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
           L+PE  R       +DV+  G ++ EV  G  P     + + +      + +        
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF-TGDSPVSVAY----QHVREDPIPPS 235

Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
           A    L      + + V+   L     +P+ R  T
Sbjct: 236 ARHEGL----SADLDAVV---LKALAKNPENRYQT 263

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 3e-46
 Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 33/289 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G G FG V+R V  S+      K V             EI+ +   RHRN++ 
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILH 65

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
           LH      +EL+++++++    + + +          LN  +    +  V +AL +LH  
Sbjct: 66  LHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVCEALQFLHS- 120

Query: 477 CDQRVVHRDVKPSNVLIDADLNP--KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               + H D++P N++     +   K+ +FG AR      N +         Y APE+ +
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQ 176

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
               +T+TD++  GTL+  +  G  P     T  +++      E     + T   +    
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPF-LAETNQQII------ENIMNAEYTF-DEEAFK 228

Query: 595 YFDPQEAELVLTLGLLCCDP-----------HPDFRPSTRRVVQFLLRD 632
               +  + V    LL  +            HP  +    RV   ++R 
Sbjct: 229 EISIEAMDFV--DRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRT 275

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  159 bits (402), Expect = 1e-45
 Identities = 57/255 (22%), Positives = 93/255 (36%), Gaps = 58/255 (22%)

Query: 18  AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNIN 77
           A   SFI + F + NL L G A V  +G L +S +    +  AFY +P++ +        
Sbjct: 1   ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR-------- 52

Query: 78  NNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAK 137
            ++ +    +F TNF  +I          GL FVL+  +                     
Sbjct: 53  -DSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPES------------------ 93

Query: 138 FSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVL 197
                + VEFD   +    D+N+N                          I      V  
Sbjct: 94  -KGDTVTVEFDTFLSRISIDVNNND-------------------------IKSVPWDVHD 127

Query: 198 KSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL 257
             G   +  I YNS   + +V++S           +S  ++L   + +++ VGFSA++G 
Sbjct: 128 YDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGA 185

Query: 258 LTA---FHNVHGWSF 269
                  H+V  WSF
Sbjct: 186 YQWSYETHDVLSWSF 200

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 2e-45
 Identities = 64/311 (20%), Positives = 117/311 (37%), Gaps = 31/311 (9%)

Query: 362 LVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGW 420
           ++G G  GKV +     T  + A+K +     Q   +   E+    R  +  ++V++   
Sbjct: 19  VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73

Query: 421 CR----KQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
                  +  LL+V + +  G L   + D   Q        +  +I+  + +A+ YLH  
Sbjct: 74  YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA---FTEREASEIMKSIGEAIQYLHS- 129

Query: 477 CDQRVVHRDVKPSNVLIDADLNP---KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
               + HRDVKP N+L  +       KL DFG A+    + +  T     T  Y+APE+ 
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVL 185

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
              K   S D++  G +M  + CG  P         L +   ++     GQ     +P  
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH---GLAISPGMKTRIRMGQY-EFPNPEW 241

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRDASLPQAPLDIHHEFPRAIP 651
                +   L+           P  R +    +   ++++   +PQ PL           
Sbjct: 242 SEVSEEVKMLIRN----LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297

Query: 652 EFSEDDSDPSS 662
            + +   + +S
Sbjct: 298 RWEDVKEEMTS 308

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 3e-45
 Identities = 69/324 (21%), Positives = 124/324 (38%), Gaps = 31/324 (9%)

Query: 349 ELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGM-KEFVAEITSMG 407
           +++     +   + +G G +G V         + VAIK+++    Q   +  + EI  + 
Sbjct: 2   QVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILL 61

Query: 408 RLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVA 467
           R RH N++ ++   R      +   Y+    +   L+     K + L+ D     L  + 
Sbjct: 62  RFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK--LLKTQHLSNDHICYFLYQIL 119

Query: 468 QALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT--THIVGTL 525
           + L Y+H      V+HRD+KPSN+L++   + K+ DFGLAR  D + +     T  V T 
Sbjct: 120 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 526 GYLAPELTRTGKATT-STDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
            Y APE+    K  T S D++  G ++ E+   R     +    +L  +  +    SQ  
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 585 ITRAIDPTLDYFD---------------PQEAELVLTLGLLCCDPHPDFRPSTRRVVQ-- 627
           +   I+     +                P      L L       +P  R    + +   
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP 296

Query: 628 -----FLLRDASLPQAPLDIHHEF 646
                +   D  + +AP     E 
Sbjct: 297 YLEQYYDPSDEPIAEAPFKFDMEL 320

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (403), Expect = 9e-45
 Identities = 60/293 (20%), Positives = 104/293 (35%), Gaps = 36/293 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNSRQG-MKEFVAEITSMGR-L 409
            +    +G G FG+V           +T   VA+K +   +     +  ++E+  +    
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 410 RHRNLVQLHGWCRKQDE-LLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWD 457
            H N+V L G C K    L+++ ++   G+L   L     +            K  L  +
Sbjct: 75  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 134

Query: 458 QRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR-AYDHNINP 516
                   VA+ + +L     ++ +HRD+   N+L+      K+ DFGLAR  Y      
Sbjct: 135 HLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191

Query: 517 QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV 576
           +       L ++APE       T  +DV+ FG L+ E+        P     E       
Sbjct: 192 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---- 247

Query: 577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
                  ++          +   E        L C    P  RP+   +V+ L
Sbjct: 248 ------RRLKEGTRMRAPDYTTPEM---YQTMLDCWHGEPSQRPTFSELVEHL 291

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 3e-44
 Identities = 61/271 (22%), Positives = 107/271 (39%), Gaps = 29/271 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGR-LRHR 412
           F    ++G G FGKV+      T    AIK +  +       ++  + E   +     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 413 NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLY 472
            L  +    + ++ L  V +Y+  G L   +     Q     +  +       +   L +
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-----QSCHKFDLSRATFYAAEIILGLQF 118

Query: 473 LHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           LH    + +V+RD+K  N+L+D D + K+ DFG+ +      + +T    GT  Y+APE+
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNTFCGTPDYIAPEI 174

Query: 533 TRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT 592
               K   S D + FG L+ E+  G+ P    +   EL                R  +P 
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEELF------------HSIRMDNPF 221

Query: 593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTR 623
              +  +EA+ +L   +      P+ R   R
Sbjct: 222 YPRWLEKEAKDLL---VKLFVREPEKRLGVR 249

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  158 bits (401), Expect = 9e-44
 Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 31/275 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFVAEITSMGRLR 410
           F    ++G GGFG+VY      TG   A+K +                    ++ +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
              +V +       D+L  + D +  G L   L      +  + +          +   L
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-----SQHGVFSEADMRFYAAEIILGL 120

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAP 530
            ++H    + VV+RD+KP+N+L+D   + ++ D GLA  +      +    VGT GY+AP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAP 174

Query: 531 ELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI 589
           E+ + G A  +S D F  G ++ ++  G  P    +T  +  +      +          
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV-------- 226

Query: 590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRR 624
               D F P+   L+   GLL  D   + R     
Sbjct: 227 -ELPDSFSPELRSLL--EGLLQRD--VNRRLGCLG 256

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 1e-42
 Identities = 68/298 (22%), Positives = 106/298 (35%), Gaps = 43/298 (14%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFVAEITSMGRLR 410
           ++   L+GSGGFG VY G+  S  L VAIK V                   E+  + ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 411 --HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
                +++L  W  + D  +L+ +                 ++  L  +        V +
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI----TERGALQEELARSFFWQVLE 121

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGY 527
           A+ + H      V+HRD+K  N+LID +    KL DFG             T   GT  Y
Sbjct: 122 AVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVY 175

Query: 528 LAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
             PE  R  +    S  V+  G L+ ++ CG  P E                     +I 
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------------EII 217

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLDIH 643
           R           +   L+      C    P  RP+   +     ++D  LPQ   +IH
Sbjct: 218 RGQVFFRQRVSSECQHLI----RWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 271

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  154 bits (390), Expect = 1e-42
 Identities = 54/271 (19%), Positives = 102/271 (37%), Gaps = 31/271 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           F+    +G+G FG+V+       G   A+K +        + ++    E   +  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           ++++ G  +   ++ ++ DY+  G L  LL  +                    A+  L L
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKFYAAEVCLAL 117

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + +++RD+KP N+L+D + + K+ DFG A+            + GT  Y+APE+ 
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPEVV 173

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
            T     S D + FG L+ E+  G  P       M+              +I  A     
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPF-YDSNTMKTYE-----------KILNAELRFP 221

Query: 594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRR 624
            +F+    +L+              R    +
Sbjct: 222 PFFNEDVKDLL----SRLITRDLSQRLGNLQ 248

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 3e-42
 Identities = 66/307 (21%), Positives = 117/307 (38%), Gaps = 32/307 (10%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKE-----FVAEITSMGRLRHRNLV 415
           + +G G F  VY+    +T   VAIK++    R   K+      + EI  +  L H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            L      +  + LV+D++       +     +    +L        ++   Q L YLH+
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVII-----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 476 ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPE-LTR 534
                ++HRD+KP+N+L+D +   KL DFGLA+++        TH V T  Y APE L  
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV----------DWVRELHSQGQ 584
                   D++  G ++ E+      +       +L  +           W         
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 585 ITRAIDP--TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLD 641
           +T    P   L +      + +L L       +P  R +  + ++     +   P     
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG-- 292

Query: 642 IHHEFPR 648
              + PR
Sbjct: 293 --CQLPR 297

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 5e-42
 Identities = 62/286 (21%), Positives = 107/286 (37%), Gaps = 22/286 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIK--RVAHNSRQGMKEFVAEITSMGRLRHRNL 414
           F++   +G G +G VY+     TG  VA+K  R+   +       + EI+ +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L      +++L LV++++       +    D      +        L  + Q L + H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFM----DASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
                 V+HRD+KP N+LI+ +   KL DFGLARA+   +   T  +V         L  
Sbjct: 120 SHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRP-------------IEPQRTAMELVLVDWVRELHS 581
               +T+ D++  G +  E+   R                    T  E+V          
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236

Query: 582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
           +    +          P   E   +L        P+ R S +  + 
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-41
 Identities = 52/281 (18%), Positives = 105/281 (37%), Gaps = 32/281 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV------AHNSRQGMKEFVAEITSMGRLR 410
           +     +GSG F  V +    STGL+ A K +      +       ++   E++ +  ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           H N++ LH     + +++L+ + V  G L      +   +K+ L  ++  + L  +    
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGEL-----FDFLAEKESLTEEEATEFLKQILNG- 125

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNP----KLGDFGLARAYDHNINPQTTHIVGTLG 526
             ++     ++ H D+KP N+++     P    K+ DFGLA   D     +  +I GT  
Sbjct: 126 --VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GNEFKNIFGTPE 181

Query: 527 YLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           ++APE+          D++  G +   +  G  P         L              ++
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------------ANVS 229

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
                  D +    + L            P  R + +  +Q
Sbjct: 230 AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-40
 Identities = 72/305 (23%), Positives = 116/305 (38%), Gaps = 31/305 (10%)

Query: 341 GACRFRYSELYSATKGFREKNLVGSGGFGKVYRGV-IPSTGLEVAIKRV-----AHNSRQ 394
           G CR          + +     +G G +GKV++   + + G  VA+KRV           
Sbjct: 1   GLCRA--------DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL 52

Query: 395 GMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLD-KLLFDNDQQKKKI 453
                VA +  +    H N+V+L   C            +    +D  L    D+  +  
Sbjct: 53  STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG 112

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           +  +    ++  + + L +LH     RVVHRD+KP N+L+ +    KL DFGLAR Y   
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF- 168

Query: 514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV 573
                T +V TL Y APE+       T  D++  G +  E+   +          +L  +
Sbjct: 169 -QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI 227

Query: 574 ----------DWVRELHSQGQITRAIDPT-LDYFDPQEAELVLTLGLLCCDPHPDFRPST 622
                     DW R++    Q   +     ++ F     EL   L L C   +P  R S 
Sbjct: 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 287

Query: 623 RRVVQ 627
              + 
Sbjct: 288 YSALS 292

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 2e-40
 Identities = 75/328 (22%), Positives = 120/328 (36%), Gaps = 37/328 (11%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           + +  ++G+G FG VY+  +  +G  VAIK+V     Q  +    E+  M +L H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 77

Query: 417 LHGWCRKQDE------LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
           L  +     E      L LV DYVP          +  + K+ L        +  + ++L
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSL 135

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLA 529
            Y+H      + HRD+KP N+L+D D    KL DFG A+       P  ++I        
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAP 191

Query: 530 PELTRTGKATTSTDVFGFGTLMLEVACGRRP-------------IEPQRTAMELVLVDWV 576
             +      T+S DV+  G ++ E+  G+               I+   T     + +  
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 577 RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FL--LRD 632
                         P    F P+     + L     +  P  R +        F   LRD
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311

Query: 633 --ASLPQAPLDIHHEFPRAIPEFSEDDS 658
               LP    D    F     E S +  
Sbjct: 312 PNVKLPNGR-DTPALFNFTTQELSSNPP 338

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (372), Expect = 2e-40
 Identities = 53/282 (18%), Positives = 102/282 (36%), Gaps = 26/282 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +R    +GSG FG +Y G   + G EVAIK      +    +   E      ++    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVGIP 66

Query: 417 LHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE 476
              WC  + +  ++   +   SL+    D      +  +      +   +   + Y+H  
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLE----DLFNFCSRKFSLKTVLLLADQMISRIEYIHS- 121

Query: 477 CDQRVVHRDVKPSNVLI---DADLNPKLGDFGLARAYD------HNINPQTTHIVGTLGY 527
             +  +HRDVKP N L+          + DFGLA+ Y       H    +  ++ GT  Y
Sbjct: 122 --KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179

Query: 528 LAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR 587
            +       + +   D+   G +++    G  P +  + A +        E  S+ +++ 
Sbjct: 180 ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ERISEKKMST 235

Query: 588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
            I+     +  + A  +      C     D +P    + Q  
Sbjct: 236 PIEVLCKGYPSEFATYL----NFCRSLRFDDKPDYSYLRQLF 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-40
 Identities = 56/207 (27%), Positives = 89/207 (42%), Gaps = 12/207 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV---AHNSRQGMKEFVAEITSMGRLRHRN 413
           F    L+G G FGKV      +TG   A+K +      ++  +   V E   +   RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           L  L    +  D L  V +Y   G L   L      ++++   ++        A+ +  L
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERARFYG---AEIVSAL 118

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
                + VV+RD+K  N+++D D + K+ DFGL +    +         GT  YLAPE+ 
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFCGTPEYLAPEVL 177

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRP 560
                  + D +G G +M E+ CGR P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  146 bits (368), Expect = 5e-40
 Identities = 59/286 (20%), Positives = 112/286 (39%), Gaps = 24/286 (8%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           +     +G G +G VY+      G   A+K++             + EI+ +  L+H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+L+     +  L+LV++++       L        +  L        L+ +   + Y H
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLD-----VCEGGLESVTAKSFLLQLLNGIAYCH 117

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
           +   +RV+HRD+KP N+LI+ +   K+ DFGLARA+   +   T  IV         L  
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV-------------DWVRELHS 581
           + K +T+ D++  G +  E+  G         A +L+ +             +       
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234

Query: 582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ 627
               T       + F     E  + L        P+ R + ++ ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 6e-40
 Identities = 63/277 (22%), Positives = 111/277 (40%), Gaps = 14/277 (5%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           + +   +G G +G V++     T   VA+KRV    +        + EI  +  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 415 VQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLH 474
           V+LH       +L LV+++                    L+ +     L    Q L  L 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKK-----YFDSCNGDLDPEIVKSFL---FQLLKGLG 115

Query: 475 EECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTR 534
               + V+HRD+KP N+LI+ +   KL +FGLARA+   +   +  +V         L  
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175

Query: 535 TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD 594
               +TS D++  G +  E+A   RP+ P     + +     R     G  T    P++ 
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL----KRIFRLLGTPTEEQWPSMT 231

Query: 595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR 631
                +   +        +  P    + R ++Q LL+
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLK 268

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  144 bits (363), Expect = 3e-39
 Identities = 46/285 (16%), Positives = 94/285 (32%), Gaps = 30/285 (10%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN-LV 415
           ++    +G G FG ++ G       +VAIK      R    +   E  +   L     + 
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIP 64

Query: 416 QLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHE 475
            ++ + ++    +LV D +     D L         +  +          +   +  +HE
Sbjct: 65  NVYYFGQEGLHNVLVIDLLGPSLEDLL-----DLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 476 ECDQRVVHRDVKPSNVLIDADLNP-----KLGDFGLARAYD------HNINPQTTHIVGT 524
              + +V+RD+KP N LI    +       + DFG+ + Y       H    +  ++ GT
Sbjct: 120 ---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176

Query: 525 LGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ 584
             Y++       + +   D+   G + +    G  P +  + A      + + E      
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236

Query: 585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFL 629
           +       L    P+E    +       +   D  P    +    
Sbjct: 237 L-----RELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLF 273

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 3e-38
 Identities = 65/301 (21%), Positives = 114/301 (37%), Gaps = 38/301 (12%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           + +   +G G FG+V++     TG +VA+K+V   +         + EI  +  L+H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 415 VQLHGWCRKQDE--------LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGV 466
           V L   CR +          + LV+D+  +                     +  +++   
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL-----LSNVLVKFTLSEIKRVM--- 123

Query: 467 AQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTH---IVG 523
              L  L+     +++HRD+K +NVLI  D   KL DFGLARA+    N Q       V 
Sbjct: 124 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183

Query: 524 TLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWV------ 576
           TL Y  PEL    +      D++G G +M E+      ++      +L L+  +      
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243

Query: 577 --------RELHSQGQITRAIDPTLDYFDPQEAELVLTLGLL--CCDPHPDFRPSTRRVV 626
                    EL+ + ++ +     +             L L+       P  R  +   +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303

Query: 627 Q 627
            
Sbjct: 304 N 304

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 6e-37
 Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 13/222 (5%)

Query: 345 FRYSELYSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKE 398
           F   E+       R        VGSG +G V   V   TG +VAIK++     S    K 
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 399 FVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQ 458
              E+  +  +RH N++ L       + L    D+                K + L  D+
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLG-KLMKHEKLGEDR 122

Query: 459 RYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQT 518
              ++  + + L Y+H      ++HRD+KP N+ ++ D   K+ DFGLAR  D   +  T
Sbjct: 123 IQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMT 176

Query: 519 THIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
            ++V         +    + T + D++  G +M E+  G+  
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  138 bits (347), Expect = 2e-36
 Identities = 53/269 (19%), Positives = 97/269 (36%), Gaps = 19/269 (7%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRN 413
           F     +G+G FG+V       +G   A+K +        + ++  + E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 414 LVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
           LV+L    +    L +V +YV  G +   L      +    +          +     YL
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR-----RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 474 HEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELT 533
           H      +++RD+KP N+LID     ++ DFG A+            + GT   LAPE+ 
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT----WTLCGTPEALAPEII 210

Query: 534 RTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL 593
            +     + D +  G L+ E+A G  P       +++       ++      +  +   L
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPF-FADQPIQIYEKIVSGKVRFPSHFSSDLKDLL 269

Query: 594 DYF---DPQEAELVLTLGLLCCDPHPDFR 619
                 D  +    L  G+     H  F 
Sbjct: 270 RNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  133 bits (337), Expect = 4e-36
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 20/131 (15%)

Query: 139 STRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLK 198
           +  I+AVE D   N ++ D +  H+GIDI S+ S  +                     ++
Sbjct: 1   ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWN-----------------MQ 43

Query: 199 SGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLL 258
           +G    A I YNS +  ++  +S    P      +SY +DL  VL E++ VG SASTGL 
Sbjct: 44  NGKVGTAHIIYNSVDKRLSAVVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLY 100

Query: 259 TAFHNVHGWSF 269
              + +  WSF
Sbjct: 101 KETNTILSWSF 111

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 82.3 bits (203), Expect = 3e-18
 Identities = 26/119 (21%), Positives = 39/119 (32%), Gaps = 18/119 (15%)

Query: 22  SFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRI------LGHAFYPSPLRFKQLSKYN 75
            F      Q +L L G A    DG L ++            +G A + +P+   + S   
Sbjct: 129 MFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIWESSA-- 186

Query: 76  INNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMS-RKQPPSCLANQYLGLPNDT 133
                      +F   F F I          G+AF + +     PS    + LGL  D 
Sbjct: 187 --------VVASFEATFTFLIKSPDSH-PADGIAFFISNIDSSIPSGSTGRLLGLFPDA 236

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  130 bits (328), Expect = 4e-34
 Identities = 46/219 (21%), Positives = 87/219 (39%), Gaps = 21/219 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLV 415
           ++    +G G + +V+  +  +   +V +K +        K+   EI  +  LR   N++
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNII 93

Query: 416 QLHGWCRKQDE--LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYL 473
            L    +        LV+++V N    +L         + L        +  + +AL Y 
Sbjct: 94  TLADIVKDPVSRTPALVFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYC 145

Query: 474 HEECDQRVVHRDVKPSNVLIDAD-LNPKLGDFGLARAYDHNINPQTTHIVGTLGYLAPEL 532
           H      ++HRDVKP NV+ID +    +L D+GLA  Y      +    V +  +  PEL
Sbjct: 146 HS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP--GQEYNVRVASRYFKGPEL 200

Query: 533 TRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMEL 570
               +    S D++  G ++  +   + P        + 
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 6e-34
 Identities = 62/278 (22%), Positives = 113/278 (40%), Gaps = 30/278 (10%)

Query: 357 FREKNLVGSGGFGKVYRG---VIPSTGLEVAIKRV----AHNSRQGMKEFVAEITSMGRL 409
           F    ++G+G +GKV+         TG   A+K +         +  +    E   +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 410 RHR-NLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           R    LV LH   + + +L L+ DY+  G L   L      +++     +     I V +
Sbjct: 86  RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-----SQRERFTEHEVQ---IYVGE 137

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            +L L       +++RD+K  N+L+D++ +  L DFGL++ +  +   +     GT+ Y+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197

Query: 529 APELTRTGKA--TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQIT 586
           AP++ R G +    + D +  G LM E+  G  P                 E +SQ +I+
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD------------GEKNSQAEIS 245

Query: 587 RAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRR 624
           R I  +   +  + + L   L        P  R     
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP 283

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (321), Expect = 5e-33
 Identities = 48/212 (22%), Positives = 88/212 (41%), Gaps = 21/212 (9%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKEFVAEITSMGRLRHRNL 414
           ++    +GSG  G V           VAIK++     ++   K    E+  M  + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 415 VQLHGWCRKQD------ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQ 468
           + L      Q       ++ LV + +       +  + D         ++   +L  +  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD--------HERMSYLLYQMLC 130

Query: 469 ALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINPQTTHIVGTLGYL 528
            + +LH      ++HRD+KPSN+++ +D   K+ DFGLAR      +   T  V T  Y 
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYR 185

Query: 529 APELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
           APE+        + D++  G +M E+   +  
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 3e-31
 Identities = 53/227 (23%), Positives = 92/227 (40%), Gaps = 23/227 (10%)

Query: 345 FRYSELYSATKGFREK----NLVGSGGFGKVYRGVIPSTGLEVAIKRV--AHNSRQGMKE 398
           F   EL        E+    + VGSG +G V       TGL VA+K++     S    K 
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 399 FVAEITSMGRLRHRNLVQLHGWCRKQDEL-----LLVYDYVPNGSLDKLLFDNDQQKKKI 453
              E+  +  ++H N++ L         L     + +  ++    L+ +       K + 
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI------VKCQK 117

Query: 454 LNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
           L  D    ++  + + L Y+H      ++HRD+KPSN+ ++ D   K+ DFGLAR  D  
Sbjct: 118 LTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD- 173

Query: 514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP 560
               T ++          +        + D++  G +M E+  GR  
Sbjct: 174 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  112 bits (281), Expect = 1e-27
 Identities = 43/237 (18%), Positives = 81/237 (34%), Gaps = 16/237 (6%)

Query: 357 FREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQ 416
           +     +G G F  V+          VA+K V    +   +    EI  + R+   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 417 LHGWCRKQDELLLVY--DYVPNGSLDKL---------LFDNDQQKKKILNWDQRYKILIG 465
                      LL +     PNG    +         L    + + + +      +I   
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 466 VAQALLYLHEECDQRVVHRDVKPSNVLIDA-DLNPKLGDFGLARAYDHN-INPQTTHIVG 523
           +   L Y+H      ++H D+KP NVL++  D    L    +A   +    +   T+ + 
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 524 TLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELH 580
           T  Y +PE+          D++    L+ E+  G    EP          D + ++ 
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.9 bits (230), Expect = 2e-22
 Identities = 29/163 (17%), Positives = 54/163 (33%), Gaps = 23/163 (14%)

Query: 361 NLVGSGGFGKVYRGVIPSTGLEVAIK----------RVAHNSRQGMKEFVAEITSMGRLR 410
            L+G G    V+         E  +K          +V      G   F        R  
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 411 HRNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQAL 470
            R L +L G    +      Y +  N  L +L+   +  + ++ N D+   +L  + + +
Sbjct: 65  FRALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE---VLDMILEEV 116

Query: 471 LYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN 513
              +      +VH D+   NVL+  +    + DF  +      
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEE 155

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 92.1 bits (228), Expect = 1e-21
 Identities = 32/238 (13%), Positives = 65/238 (27%), Gaps = 39/238 (16%)

Query: 32  NLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN 91
             +  G A    D I  ++       G  +  +   F+                  +   
Sbjct: 25  FWAHAGNAIPSADQIR-IAPSLKSQRGSVWTKTKAAFEN-----------------WEVE 66

Query: 92  FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQ 151
             F +  +  ++G  GLA            L     G  +           + + FD+  
Sbjct: 67  VTFRVTGRG-RIGADGLAIWY----TENQGLDGPVFGSAD-------MWNGVGIFFDSFD 114

Query: 152 NLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNS 211
           N      N+  + +  ++   N            ++   D          P++A I Y  
Sbjct: 115 NDG--KKNNPAIVVVGNNGQINYDHQNDGATQALASCQRD----FRNKPYPVRAKITYYQ 168

Query: 212 QEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSF 269
           + + + +                       V+    + G SA+TG L   H+V  +  
Sbjct: 169 KTLTVMINNGFT---PDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 39.2 bits (91), Expect = 6e-04
 Identities = 24/249 (9%), Positives = 53/249 (21%), Gaps = 50/249 (20%)

Query: 22  SFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTI 81
                    +  +L     + +   +       +  G  +       K            
Sbjct: 13  EVTDQQKELSQWTLGDKVKLEEGRFVLTPGKNTK--GSLWLKPEYSIKDA---------- 60

Query: 82  SHTALTFSTNFVFSIVPKYPQLGGHGLAFVLMS-RKQPPSCLANQYLGLPNDTSNAKFST 140
                  +  + F            GLAF L    +   + L        N         
Sbjct: 61  ------MTIEWTFRSFGFR-GSTKGGLAFWLKQGNEGDSTELFGGSSKKFNG-------- 105

Query: 141 RILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSG 200
             L +                 V   ++    ++   ++ YF+        +      S 
Sbjct: 106 --LMILLRLDDK------LGESVTAYLNDGTKDLDIESSPYFA-SCLFQYQD------SM 150

Query: 201 DPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTA 260
            P    + YN  +  +      L +   +R        +  +      +G SA       
Sbjct: 151 VPSTLRLTYNPLDNHL------LKLQMDNRVCFQTR-KVKFMGSSPFRIGTSAINDASKE 203

Query: 261 FHNVHGWSF 269
              +     
Sbjct: 204 SFEILKMKL 212

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 221

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 39.2 bits (91), Expect = 8e-04
 Identities = 26/238 (10%), Positives = 57/238 (23%), Gaps = 49/238 (20%)

Query: 29  IQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTF 88
           +  N      A + +  I+  SN   +  G  +       K                 +F
Sbjct: 21  VPNNWQTGEQASLEEGRIVLTSNQNSK--GSLWLKQGFDLKD----------------SF 62

Query: 89  STNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFD 148
           +  + F  V         G++F  +  +        Q    P       +    L +  D
Sbjct: 63  TMEWTFRSVGYS-GQTDGGISFWFV--QDSNIPRDKQLYNGPV-----NYDG--LQLLVD 112

Query: 149 AVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWID 208
               L        + G           +  A        +   +      S  P    + 
Sbjct: 113 NNGPLGPTLRGQLNDGQKPVDKTKIYDQSFASC-----LMGYQD------SSVPSTIRVT 161

Query: 209 YNSQEMLI-NVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVH 265
           Y+ ++  +  V +             +  +   +       +G +A  G +       
Sbjct: 162 YDLEDDNLLKVQV------DNKVCFQTRKVRFPS---GSYRIGVTAQNGAVNNNAESF 210

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	662
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.96
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.95
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.85
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.84
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.41
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.67
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.12
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.16
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.36

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=2.2e-55  Score=434.54  Aligned_cols=224  Identities=25%  Similarity=0.385  Sum_probs=195.3

Q ss_pred             ceeEEeCCCCC---CCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           20 TNSFIYNGFIQ---ANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        20 ~~~f~~~~f~~---~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +++|+|++|.+   .+|+|+|||.+. +|.|+||+..      ..++|||+|++||+||         +.+++.++||+|
T Consensus         1 ~~sF~f~~F~~~~~~~l~l~G~A~~~-~~~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---------~~~t~~~asFsT   70 (236)
T d1hqla_           1 SVSFTFPNFWSDVEDSIIFQGDANTT-AGTLQLCKTNQYGTPLQWSAGRALYSDPVQLW---------DNKTESVASFYT   70 (236)
T ss_dssp             CCEEEESCSCSCGGGTEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECC---------CSTTCCCCEEEE
T ss_pred             CEEEEeCCCCCCCcCCEEEeccEEec-CCEEEEecCCCCCcccccceEEEEECCCEEee---------cCCCCceeEEEE
Confidence            57999999974   589999999986 8999999753      4578999999999999         666777788999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCC-CCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNA-KFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      +|+|.|.+. ...+||||||||+|... +.+..|++||+++..+.+ ...+++|||||||++|.+++||++||||||+|+
T Consensus        71 ~F~F~i~~~-~~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~D~~~nHIgIdvns  148 (236)
T d1hqla_          71 EFTFFLKIT-GNGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNS  148 (236)
T ss_dssp             EEEEEEEEC-SSCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEECSCCSSSCCCSSCEEEEEESS
T ss_pred             EEEEEEeCC-CCCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEeeCccCCCCCCCCCCEEEEEcCC
Confidence            999999875 45689999999999764 445789999999886654 457899999999999999999999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+.++.              ..++.+|+.++|||+||+.+++|+|+|++.   ++..|+|++.|||+++|+++|||
T Consensus       149 ~~s~~~~~~~--------------~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~~~ls~~vdL~~~l~~~v~v  211 (236)
T d1hqla_         149 IVSVATKRWE--------------DSDIFSGKIATARISYDGSAEILTVVLSYP---DGSDYILSHSVDMRQNLPESVRV  211 (236)
T ss_dssp             SSCSEEEECC--------------HHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEEEEEEEECCGGGTSCSEEEE
T ss_pred             cccccccccc--------------cccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCCeeEEEEeCHHHhCCCcEEE
Confidence            9998776553              356889999999999999999999999853   46678999999999999999999


Q ss_pred             eeeccCCc-ccceeEEecceeeec
Q 040242          250 GFSASTGL-LTAFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG~-~~~~~~i~sW~f~~~  272 (662)
                      |||||||. ..+.|+|++|+|+++
T Consensus       212 GFSasTG~~~~~~h~I~sWsF~s~  235 (236)
T d1hqla_         212 GISASTGNNQFLTVYILSWRFSSN  235 (236)
T ss_dssp             EEEEECCSCCCEEEEEEEEEEEEE
T ss_pred             EEEeECCCCCceEEEEEEeEeEec
Confidence            99999997 467899999999863

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=1.2e-54  Score=430.70  Aligned_cols=223  Identities=26%  Similarity=0.365  Sum_probs=194.9

Q ss_pred             CceeEEeCCCC------CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceee
Q 040242           19 ETNSFIYNGFI------QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTAL   86 (662)
Q Consensus        19 ~~~~f~~~~f~------~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~   86 (662)
                      ++++|+|++|.      ..||+|+|+|++. +|.|+||+..      .+++|||+|++||+||         +. ++.++
T Consensus         2 ~s~sF~f~~F~~~~~~~~~~l~l~G~A~~~-~g~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---------~~-t~~~a   70 (243)
T d1leda_           2 NTVNFTYPDFWSYSLKNGTEITFLGDATRI-PGALQLTKTDANGNPVRSSAGQASYSEPVFLW---------DS-TGKAA   70 (243)
T ss_dssp             CCCEEEESCBCCTTSCTTTSEEEEETCEEE-TBEEECSCBCTTSCBCSSEEEEEEESSCEECB---------CT-TSCBC
T ss_pred             CceEEEcCCCCCCCCCCCCcEEEeeeeEEc-CCEEEeccCCCCCCccccceEEEEeCCCeEec---------CC-CCcEe
Confidence            57999999995      3689999999997 7999999643      3589999999999999         43 56788


Q ss_pred             eeEEEEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCC-CCCcEEEEEeeccCCCCCCCCCCCeeEE
Q 040242           87 TFSTNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAK-FSTRILAVEFDAVQNLELQDINDNHVGI  165 (662)
Q Consensus        87 sF~t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEFDt~~n~~~~d~~~~Hvgi  165 (662)
                      ||+|+|+|.|.+.. ..+||||||||+|... +.+..|++||+++..+.++ ..+++|||||||++|.+++||++|||||
T Consensus        71 sFsT~F~f~i~~~~-~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFDT~~n~~~~d~~~nHVgI  148 (243)
T d1leda_          71 SFYTSFTFLLKNYG-APTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFDTWINKDWNDPPYPHIGI  148 (243)
T ss_dssp             EEEEEEEEEEEESS-SSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEECSCCGGGTCCSSCEEEE
T ss_pred             eEEEEEEEEcCCCC-CCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEeCccccccCCCCCCceEE
Confidence            99999999997663 5689999999999764 4457899999998766544 5789999999999999999999999999


Q ss_pred             ecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeeccccccccc
Q 040242          166 DISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDE  245 (662)
Q Consensus       166 d~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~  245 (662)
                      |+|++.|..+.++.              ..++.+|+.++|||+||+.+++|+|++++   .++..|+|++.|||+++|++
T Consensus       149 dvns~~s~~~~~~~--------------~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~---~~~~~p~ls~~idL~~~l~~  211 (243)
T d1leda_         149 DVNSIVSVATTRWE--------------NDDAYGSSIATAHITYDARSKILTVLLSY---EHGRDYILSHVVDLAKVLPQ  211 (243)
T ss_dssp             EESSSSCSEEEECC--------------HHHHTSCCEEEEEEEEETTTTEEEEEEEE---TTSCEEEEEEECCHHHHSCS
T ss_pred             EecCcccccccccc--------------cCCcccCceeEEEEEEECCCCEEEEEEee---CCCCCceEEEecCHHHhcCC
Confidence            99999998877654              34688999999999999999999999985   35667899999999999999


Q ss_pred             ceEEeeeccCCcccceeEEecceeeec
Q 040242          246 YMYVGFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       246 ~~~vGFsastG~~~~~~~i~sW~f~~~  272 (662)
                      +||||||||||. .|.|+|++|+|++.
T Consensus       212 ~vyvGFSAsTG~-~~~h~I~sWsF~s~  237 (243)
T d1leda_         212 KVRIGFSAGVGY-DEVTYILSWHFFST  237 (243)
T ss_dssp             EEEEEEEEEECB-SEEEEEEEEEEEEE
T ss_pred             cEEEEEEcccCC-cceeeEEEEEEEee
Confidence            999999999995 69999999999864

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=1.5e-53  Score=423.99  Aligned_cols=227  Identities=28%  Similarity=0.384  Sum_probs=196.9

Q ss_pred             CCceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           18 AETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        18 ~~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ++++||+|++|..  +||+|+|+|++.++|.|+||+..    .++.|||+|++||+||         +.+++.++||+|+
T Consensus         1 ~~~~sF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~G~a~y~~Pv~l~---------~~~t~~~~sF~t~   71 (240)
T d1fx5a_           1 SDDLSFKFKNFSQNGKDLSFQGNASVIETGVLQLNKVGNNLPDETGGIARYIAPIHIW---------NCNTGELASFITS   71 (240)
T ss_dssp             CCEEEEEESSCCTTCSSEEEEETCEECTTSCEESCCCSSSSCSEEEEEEEESSCEECE---------ETTTTEECEEEEE
T ss_pred             CCceEEECCCCCCCCCCEEEeeeeEecCCCEEEccCCCCCCccceeEEEecCCCceee---------cCCCCceeeeEEE
Confidence            3678999999974  68999999999888999999765    3478999999999999         6667777889999


Q ss_pred             EEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCC-CCCCCCCCeeEEecCC
Q 040242           92 FVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNL-ELQDINDNHVGIDISS  169 (662)
Q Consensus        92 F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~-~~~d~~~~Hvgid~ns  169 (662)
                      |+|.|... ++..+||||||+|+|.. .+.+.+|++|||++..+ +++.+++|||||||++|. +++||++||||||+||
T Consensus        72 F~f~i~~~~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFDT~~n~~~~~D~~~nHIgid~ns  149 (240)
T d1fx5a_          72 FSFFMETSANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNC  149 (240)
T ss_dssp             EEEEEEESSCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEECCCTTTSTTSCSSCEEEEEESS
T ss_pred             EEEEEeCCCCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEeeccccccccCCCCCCceEEccCC
Confidence            99999654 44568999999999975 46778999999998754 456789999999999984 7789999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.+..+.++.               ..+.+|+.++|||+||+.+++|.|++.+.+  +|..|.+++.|||+.+|+++|||
T Consensus       150 ~~s~~~~~~~---------------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdLs~~l~~~v~v  212 (240)
T d1fx5a_         150 VKSINAERWN---------------KRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTSISVTSIVDLKEILPEWVSV  212 (240)
T ss_dssp             SSCSEEEECC---------------CCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCGGGTSCSEEEE
T ss_pred             cccccccccc---------------cccCCCCeEEEEEEEcCCCCEEEEEEecCC--CceeeEEeEEEchHHhCCCcEEE
Confidence            9987766553               346789999999999999999999998644  66688999999999999999999


Q ss_pred             eeeccCCc-ccceeEEecceeeec
Q 040242          250 GFSASTGL-LTAFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG~-~~~~~~i~sW~f~~~  272 (662)
                      |||||||. ..|.|+|++|+|++.
T Consensus       213 GFSasTG~~~~~~H~I~sWsFsst  236 (240)
T d1fx5a_         213 GFSGSTYIGRQATHEVLNWYFTST  236 (240)
T ss_dssp             EEEEEEETTSCEEEEEEEEEEEEE
T ss_pred             EEEeECCCCCCceEEEEEEEeEEe
Confidence            99999995 678999999999864

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=6.1e-53  Score=419.11  Aligned_cols=225  Identities=28%  Similarity=0.465  Sum_probs=195.8

Q ss_pred             CCceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC---CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           18 AETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ---GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        18 ~~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~---~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      ++++||+|++|.+  .||+|+|||++.++|.|+||+..   .+++|||+|++||+||         +.+++.++||+|+|
T Consensus         1 s~~lsF~f~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~G~a~y~~Pi~l~---------~~~~~~~~sF~t~F   71 (237)
T d1qnwa_           1 SDDLSFNFDKFVPNQKNIIFQGDASVSTTGVLQVTKVSKPTTTSIGRALYAAPIQIW---------DSITGKVASFATSF   71 (237)
T ss_dssp             CCSEEEEESSCCTTCTTEEEEETCEECTTSCEESSCCC--CCCEEEEEEESSCEECB---------CTTTCCBCEEEEEE
T ss_pred             CCcEEEEcCCCCCCCCCEEEeeceEEcCCCeEEeccCCCCccccEEEEEECCCEEec---------CCCCcceeeEEEEE
Confidence            3679999999964  68999999999888999999864   4689999999999999         66777778899999


Q ss_pred             EEEEecCCCCCCCCceeEEEccCCCC-CCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCC--CCCCCeeEEecCC
Q 040242           93 VFSIVPKYPQLGGHGLAFVLMSRKQP-PSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQ--DINDNHVGIDISS  169 (662)
Q Consensus        93 ~f~i~~~~~~~~gdGlaF~l~~~~~~-~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~--d~~~~Hvgid~ns  169 (662)
                      +|.|.++. ..+||||||+|+|.... +.++.++++|+.+..+ +.+.+++|||||||++|.+++  ||+++|||||+|+
T Consensus        72 ~f~i~~~~-~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~-~~~~~~~vAVEFDT~~n~~~~~~d~~~nHvgid~ns  149 (237)
T d1qnwa_          72 SFVVKADK-SDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNS  149 (237)
T ss_dssp             EEECCBSS-SCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEESS
T ss_pred             EEEEecCC-CCCcceeEEEEeCCCCCCCCCCccccccccCCCC-CCCcccEEEEEeeceecCCcCCCCCCCCeEEEECCC
Confidence            99997764 56899999999998744 6778888999987643 467889999999999997655  6999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+.++                 .+.+|+.++|||+||+.+++|+|++++..  +|..|+|++.|||+++|+++|||
T Consensus       150 ~~s~~~~~~-----------------~~~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~p~ls~~vDLs~~l~~~vyv  210 (237)
T d1qnwa_         150 IKSIKTVKW-----------------DWRNGEVADVVITYRAPTKSLTVCLSYPS--DGTSNIITASVDLKAILPEWVSV  210 (237)
T ss_dssp             SSCSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEE
T ss_pred             CCccccccc-----------------ccCCCcEEEEEEEEcCCCcEEEEEEecCC--CCccceEEEEEChHHhCCCcEEE
Confidence            998765543                 46789999999999999999999998644  77789999999999999999999


Q ss_pred             eeeccCCccc--ceeEEecceeeec
Q 040242          250 GFSASTGLLT--AFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG~~~--~~~~i~sW~f~~~  272 (662)
                      |||||||...  |.|+|++|+|+++
T Consensus       211 GFSasTG~~~~~q~h~I~sWsF~s~  235 (237)
T d1qnwa_         211 GFSGGVGNAAEFETHDVLSWYFTSN  235 (237)
T ss_dssp             EEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred             EEEeECCCCCCccEeEEEEeEeEEe
Confidence            9999999864  8899999999864

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=8.4e-53  Score=418.31  Aligned_cols=223  Identities=29%  Similarity=0.469  Sum_probs=194.3

Q ss_pred             CceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +++||+|++|++  +||+|+|+|.+.++|.|+||+..+      +++|||+|++||+||         +.+++.++||+|
T Consensus         2 ~~~sF~f~~F~~~~~nl~l~G~A~i~~~g~l~LT~~~~~~~~~~~~~Gr~~y~~Pv~l~---------~~~~~~~~sFst   72 (239)
T d1gzca_           2 ETISFSFSEFEPGNDNLTLQGAALITQSGVLQLTKINQNGMPAWDSTGRTLYTKPVHMW---------DSTTGTVASFET   72 (239)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBCTTSCBCSSCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             eeEEEEeCCCCCCCCCeEEeeeeEECCCCeEEccCCCCCCcccccceEEEEeCCCeEec---------CCCCCceeeEEE
Confidence            578999999974  689999999998889999998653      478999999999999         677778888999


Q ss_pred             EEEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           91 NFVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        91 ~F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      +|+|.|... ....+||||||+|+|.... .+..+++||+++.... ...++.|||||||++| +++||+++|||||+|+
T Consensus        73 ~F~f~i~~~~~~~~g~dG~aF~l~p~~~~-~~~~~g~lg~~~~~~~-~~~~~~vaVEFDT~~n-~~~d~~~~HvgI~vn~  149 (239)
T d1gzca_          73 RFSFSIEQPYTRPLPADGLVFFMGPTKSK-PAQGYGYLGVFNNSKQ-DNSYQTLAVEFDTFSN-PWDPPQVPHIGIDVNS  149 (239)
T ss_dssp             EEEEECCCCCSSSCCCEEEEEEEECSSCC-CCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCC-TTSCSSSSEEEEEESS
T ss_pred             EEEEEEecCCCCCCCCCeEEEEECCCCCC-CCCCcccccccccCCC-CCccceEEEEEEcccc-CCCCCCCCEEEEEECC
Confidence            999999754 3456899999999998753 4567889999877554 3467889999999999 5789999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+.++                 ++.+|+.++|||+||+.+++|+|++++..  +|..|.|++.|||+++|+++|||
T Consensus       150 ~~s~~t~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyv  210 (239)
T d1gzca_         150 IRSIKTQPF-----------------QLDNGQVANVVIKYDAPSKILHVVLVYPS--SGAIYTIAEIVDVKQVLPDWVDV  210 (239)
T ss_dssp             SSCSEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCHHHHSCSEEEE
T ss_pred             ccccccCCc-----------------cccCCCEEEEEEEEeCCCcEEEEEEecCC--CCcceeeeeEechHHhcCCcEEE
Confidence            998766543                 57899999999999999999999998643  77789999999999999999999


Q ss_pred             eeeccCC---cccceeEEecceeeec
Q 040242          250 GFSASTG---LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       250 GFsastG---~~~~~~~i~sW~f~~~  272 (662)
                      ||||+||   +..|.|+|++|+|+++
T Consensus       211 GFSAsTG~~~~~~~~H~V~sWsF~s~  236 (239)
T d1gzca_         211 GLSGATGAQRDAAETHDVYSWSFQAS  236 (239)
T ss_dssp             EEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEEEEcCCCCCCceeeEEEEEEeEee
Confidence            9999999   4678999999999975

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=1.5e-52  Score=415.47  Aligned_cols=219  Identities=29%  Similarity=0.427  Sum_probs=190.4

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      +++||+|++|.  .+||+|+|||++.++|.|+||++.     .+++|||+|++||+||         +.++++++||+|+
T Consensus         1 ~t~sF~f~~F~~~~~~l~l~G~A~i~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~---------~~~~~~~~sF~t~   71 (237)
T d2d3sa1           1 KTISFNFNQFHQNEEQLKLQRDARISSNSVLELTKVVNGVPTWNSTGRALYAKPVQVW---------DSTTGNVASFETR   71 (237)
T ss_dssp             CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             CeEEEEeCCCCCCCCCEEEeeeeEeCCCCeEEcCCCCCCCcccccEEEEEeCCCEEee---------cCCCCceeeEEEE
Confidence            47899999995  368999999999878899999864     4689999999999999         6677778889999


Q ss_pred             EEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           92 FVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        92 F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      |+|.|... ....+||||||+|+|... +.+..|++||+++..    ..+++|||||||++|.  +||++||||||+|++
T Consensus        72 F~f~i~~~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFDT~~n~--~d~~~nHvgI~vns~  144 (237)
T d2d3sa1          72 FSFSIRQPFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFDTFRNT--WDPQIPHIGIDVNSV  144 (237)
T ss_dssp             EEEECCCSCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEECSCCT--TCCSSSEEEEEESSS
T ss_pred             EEEEeecCCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEEeecCC--CCCCCCcEEEEcCCC
Confidence            99999654 335678999999999764 456789999998763    4578899999999997  699999999999999


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEe
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG  250 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vG  250 (662)
                      .|..+.+                 ..+.+|+.++|||+||+.+++|+|++++.+  +|..|++++.+||+.+|+++||||
T Consensus       145 ~s~~~~~-----------------~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvG  205 (237)
T d2d3sa1         145 ISTKTVP-----------------FTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTIYTIADIVDLKQVLPESVNVG  205 (237)
T ss_dssp             SCSEEEE-----------------CCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEE
T ss_pred             ccccccc-----------------eeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcccceeeEechHHhCCCcEEEE
Confidence            9875543                 357899999999999999999999998754  566789999999999999999999


Q ss_pred             eeccCCc-------ccceeEEecceeeec
Q 040242          251 FSASTGL-------LTAFHNVHGWSFKIG  272 (662)
Q Consensus       251 FsastG~-------~~~~~~i~sW~f~~~  272 (662)
                      ||||||.       ..|.|+|++|+|+++
T Consensus       206 FSasTG~~~~~~~~~~e~h~I~sWsFss~  234 (237)
T d2d3sa1         206 FSAATGDPSGKQRNATETHDILSWSFSAS  234 (237)
T ss_dssp             EEEEECCGGGCCTTCCCCCEEEEEEEEEE
T ss_pred             EEeECCCCccCccccceeeEEEEeEeEee
Confidence            9999995       568999999999875

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=7.4e-52  Score=414.51  Aligned_cols=228  Identities=29%  Similarity=0.448  Sum_probs=190.5

Q ss_pred             CCceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeE
Q 040242           18 AETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFS   89 (662)
Q Consensus        18 ~~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~   89 (662)
                      +.++||+|++|..  .||+|+|+|++.++|.|+||++.      ..++|||+|++||+||         +..++.++||+
T Consensus         1 a~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------~~~~~~~~sf~   71 (251)
T d1g9fa_           1 AETVSFSWNKFVPKQPNMILQGDAIVTSSGKLQLNKVDENGTPKPSSLGRALYSTPIHIW---------DKETGSVASFA   71 (251)
T ss_dssp             CEEEEEEESSCCC-CTTEEEEETCBCCTTC-CBCSCBC---CBCTTCEEEEEESSCEECB---------CC-CCCBCEEE
T ss_pred             CceEEEEeCCCCCCCCCEEEeeeEEECCCCEEEecCCcCCCcccCceEEEEEeCCCEEcc---------CCCCccceeeE
Confidence            3579999999974  58999999999888999999754      3589999999999999         66677778899


Q ss_pred             EEEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           90 TNFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        90 t~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      |+|+|.|.......+||||||+|+|.... .+..+|+||+++..   ...+++|||||||++|.  +||+++|||||+|+
T Consensus        72 t~f~F~i~~~~~~~~gDGlAFvl~p~~~~-~~~~~g~lG~~~~~---~~~~~~vaVEFDT~~n~--~D~~~~Hvgi~~n~  145 (251)
T d1g9fa_          72 ASFNFTFYAPDTKRLADGLAFFLAPIDTK-PQTHAGYLGLFNEN---ESGDQVVAVEFDTFRNS--WDPPNPHIGINVNS  145 (251)
T ss_dssp             EEEEEEEECSCC--CCEEEEEEEEETTCC-CCCCGGGTTTCCTT---SCCCSCEEEEEECC-CT--TSCSSSEEEEEESS
T ss_pred             EEEEEEEecCCCCCCCCceEEEEecCCCC-CCCccCccCccccc---CCCcceEEEEEecccCC--CCCCCCcEeEEecC
Confidence            99999999887888999999999998754 45778999998764   44578899999999997  69999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEE
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYV  249 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~v  249 (662)
                      +.|..+..                 +++.+|+.++|||+||+.+++|+|++...  .+|..|++++.+||+.+|+++|||
T Consensus       146 ~~s~~~~~-----------------~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~l~~~vdL~~~l~~~~yv  206 (251)
T d1g9fa_         146 IRSIKTTS-----------------WDLANNKVAKVLITYDASTSLLVASLVYP--SQRTSNILSDVVDLKTSLPEWVRI  206 (251)
T ss_dssp             SSCSEEEE-----------------CCCCTTCCEEEEEEEETTTTEEEEEEEEG--GGTEEEEEEEECCC-CCSCSEEEE
T ss_pred             cccccccc-----------------eEecCCCEEEEEEEEECCccEEEEEEecC--CCCcceeEEEEecchhhCCCcEEE
Confidence            98876543                 35789999999999999999999999753  367788999999999999999999


Q ss_pred             eeeccCCccc--ceeEEecceeeecCcCCCCC
Q 040242          250 GFSASTGLLT--AFHNVHGWSFKIGGTARELD  279 (662)
Q Consensus       250 GFsastG~~~--~~~~i~sW~f~~~~~~~~l~  279 (662)
                      |||||||...  |.|+|++|+|+++.+++..+
T Consensus       207 GFSAsTG~~~~~~~h~I~sWsF~s~~~~~~~~  238 (251)
T d1g9fa_         207 GFSAATGLDIPGESHDVLSWSFASNLPHASSN  238 (251)
T ss_dssp             EEEEEECSSSCCCEEEEEEEEEEEEECC----
T ss_pred             EEEeecCCCCCCceeEEEEeEeECCCCCCCcc
Confidence            9999999765  88999999999876554433

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=2.2e-51  Score=406.77  Aligned_cols=219  Identities=27%  Similarity=0.440  Sum_probs=188.2

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +++||+|++|.  .+||+|+|+|++.++|.|+||+..      .+++|||+|++||+||         +.+++.++||+|
T Consensus         1 ~~~SF~f~~F~~~~~~l~l~G~A~~~~~g~l~LT~~~~~~~~~~~~~Gra~y~~Pv~l~---------~~~~~~~~sFsT   71 (234)
T d1f9ka_           1 ETQSFNFDHFEENSKELNLQRQASIKSNGVLELTKLTKNGVPVWKSTGRALYAEPIKIW---------DSTTGNVASFET   71 (234)
T ss_dssp             CEEEEEESSCCSSCTTEEEEETCEECTTSCEECSCSEETTEECCSCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             CceEEEeCCCCCCCCCEEEeeeEEEcCCCEEEeecCCCCCCcccceeEEEEeCCCEEee---------CCCCCcCcceEE
Confidence            46899999996  468999999999888999999864      3578999999999999         666677788999


Q ss_pred             EEEEEEecC-CCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCC
Q 040242           91 NFVFSIVPK-YPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISS  169 (662)
Q Consensus        91 ~F~f~i~~~-~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns  169 (662)
                      +|+|+|.+. ....+||||||+|+|... +.+..|+++|+++.    ...++.|||||||++|.  +||++||||||+|+
T Consensus        72 ~F~f~i~~~~~~~~g~dG~aF~i~p~~~-~~~~~g~~~g~~~~----~~~~~~vaVEFDT~~n~--~Dp~~nHvgi~~ns  144 (234)
T d1f9ka_          72 RFSFNITQPYAYPEPADGLTFFMVPPNS-PQGEDGGNLGVFKP----PEGDNAFAVEFDTFQNT--WDPQVPHIGIDVNS  144 (234)
T ss_dssp             EEEEEEECCCSSSCCCEEEEEEEECTTC-CCCCSGGGTTTCCS----SCCSCCEEEEEECSCCT--TCCSSSEEEEEESS
T ss_pred             EEEEEEECCCCCCCccceEEEEECCCCC-CcccccccccccCC----CCccceEEEEEeccccC--CCCCCCcEeEecCC
Confidence            999999765 334678999999999764 56678899999776    34567899999999996  79999999999999


Q ss_pred             CcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccc--cce
Q 040242          170 LISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLD--EYM  247 (662)
Q Consensus       170 ~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~--~~~  247 (662)
                      +.|..+.+                 +++.+|+.++|||+||+.+++|+|+++...  ++..|.|++.|||+.+|+  ++|
T Consensus       145 ~~s~~~~~-----------------~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~idL~~~l~~~~~v  205 (234)
T d1f9ka_         145 IVSSKTLH-----------------FQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTVYTLSNIVDLKQEFPNSEWV  205 (234)
T ss_dssp             SSCSEEEE-----------------CCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSTTCSEE
T ss_pred             cccccccc-----------------ccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCccceEEEEEcHHHhcCCCCEE
Confidence            98875543                 358899999999999999999999998754  556789999999999996  679


Q ss_pred             EEeeeccCCc---ccceeEEecceeeec
Q 040242          248 YVGFSASTGL---LTAFHNVHGWSFKIG  272 (662)
Q Consensus       248 ~vGFsastG~---~~~~~~i~sW~f~~~  272 (662)
                      |||||||||.   ..|.|+|++|+|+++
T Consensus       206 ~vGFSasTG~~~~~~~~h~I~sWsF~s~  233 (234)
T d1f9ka_         206 NVGLSATTGYQKNAVETHEIISWSFTSS  233 (234)
T ss_dssp             EEEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred             EEEEEeecCCCCCceeeeEEEEEEeEEe
Confidence            9999999994   578999999999863

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=4.1e-51  Score=404.87  Aligned_cols=221  Identities=29%  Similarity=0.442  Sum_probs=194.1

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      ++++|+|++|.++||+|+|||++.++|.|+||+..      .+++|||+|++||+||         +..+..++||+|+|
T Consensus         2 ~~~sF~f~~F~~~nl~l~GdA~i~~~g~l~LT~~~~~~~~~~~~~G~~~y~~Pi~l~---------~~~~~~~~sF~t~f   72 (233)
T d1g8wa_           2 NDIYFNFQRFNETNLILQRDASVSSSGQLRLTNLNGNGEPRVGSLGRAFYSAPIQIW---------DNTTGTVASFATSF   72 (233)
T ss_dssp             EEEEEEESSCCGGGEEEEETCEECTTSCEECSCCCSTTCCCTTCEEEEEESSCEECB---------CTTTCCBEEEEEEE
T ss_pred             CceEEECCCCCcCcEEEeccEEECCCCEEEecCCCCCCCcccceeEEEEcCCCeEee---------cCCCCceeeEEEEE
Confidence            57899999999999999999999888999999753      3489999999999999         67777788999999


Q ss_pred             EEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcc
Q 040242           93 VFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLIS  172 (662)
Q Consensus        93 ~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s  172 (662)
                      +|+|.+.+...+||||||+|+|... +.+..|++||+++..   +..++.|||||||++|.++ ||+++||||++|++.|
T Consensus        73 ~f~i~~~~~~~~gDGlAF~l~~~~~-~~g~~g~~lG~~~g~---~~~~~~vaVEFDT~~N~~~-d~~~~Hvgi~~n~~~s  147 (233)
T d1g8wa_          73 TFNIQVPNNAGPADGLAFALVPVGS-QPKDKGGFLGLFDGS---NSNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRS  147 (233)
T ss_dssp             EEECCCCSSCBCCEEEEEEEEETTC-CCCCCGGGTTTCCSS---CCCCCCEEEEEECSCCTTT-CCSSCEEEEEESSSSC
T ss_pred             EEEEecCCCCCCCCeEEEEEecCCC-CCCcccccCCccccC---CCcccEEEEEeecccCCCC-CCCCCeEEEECCCcce
Confidence            9999988777899999999999875 446789999998764   3457889999999999875 9999999999999988


Q ss_pred             cccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeee
Q 040242          173 NISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS  252 (662)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFs  252 (662)
                      ..+.+.                 ++.+|+.++|||+||+.+++|.|++.+.+  ++..|++++.+||+.+||++||||||
T Consensus       148 ~~~~~~-----------------~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFS  208 (233)
T d1g8wa_         148 IKTTRW-----------------DFVNGENAEVLITYDSSTNLLVASLVYPS--QKTSFIVSDTVDLKSVLPEWVSVGFS  208 (233)
T ss_dssp             SEEEEC-----------------CCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             eeeccc-----------------cccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCcEEEEEEechhHcCCCcEEEEEE
Confidence            655433                 46799999999999999999999998644  66678999999999999999999999


Q ss_pred             ccCCc---ccceeEEecceeeec
Q 040242          253 ASTGL---LTAFHNVHGWSFKIG  272 (662)
Q Consensus       253 astG~---~~~~~~i~sW~f~~~  272 (662)
                      |+||.   ..|.|+|++|+|++.
T Consensus       209 AsTG~~~~~~~~h~I~sWsFss~  231 (233)
T d1g8wa_         209 ATTGINKGNVETNDVLSWSFASK  231 (233)
T ss_dssp             EEECSSTTBCCCCEEEEEEEEEE
T ss_pred             EEcCCCCCCceeeEEEEEEEEEE
Confidence            99994   557799999999863

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=6.1e-51  Score=409.26  Aligned_cols=222  Identities=28%  Similarity=0.474  Sum_probs=194.9

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNF   92 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F   92 (662)
                      ..+||+|++|+++||+|+|||.+. ++.|+||++..      .++|||+|++||+||         +..++.++||+|+|
T Consensus         2 ~~~sF~f~~F~~~~l~l~GdA~~~-~~~l~LT~~~~~~~~~~~~~G~a~y~~pv~l~---------~~~~~~~~sF~t~F   71 (253)
T d1g7ya_           2 DIQSFSFKNFNSSSFILQGDATVS-SSKLRLTKVKGNGLPTLSSLGRAFYSSPIQIY---------DKSTGAVASWATSF   71 (253)
T ss_dssp             EEEEEEESSCCSSCEEEEETCEEE-TTEEECSCBCTTSCBCSSCEEEEEESSCEECB---------CTTTCCBCEEEEEE
T ss_pred             cccEEecCCCCcccEEEEeeeEEc-CCEEEeCCCCCCCCcccceeEEEEeCCCeEee---------cCCCCceeeEEEEE
Confidence            468999999999999999999996 78899997543      488999999999999         66777788899999


Q ss_pred             EEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcc
Q 040242           93 VFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLIS  172 (662)
Q Consensus        93 ~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s  172 (662)
                      +|+|.+.....+||||||+|+|....+ +..+|++|+++..+. ...++.|||||||++|.++ ||+++|||||+|++.|
T Consensus        72 ~F~i~~~~~~~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT~~n~~~-d~~~~Hvgi~~ns~~s  148 (253)
T d1g7ya_          72 TANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKS  148 (253)
T ss_dssp             EEECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEECSCCTTT-CCSSCEEEEEESSSSC
T ss_pred             EEEEecCCCCCCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEeceecCCC-CCCCCcEEEeeCCccc
Confidence            999988877779999999999987544 467889999987554 3467889999999999875 9999999999999998


Q ss_pred             cccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeee
Q 040242          173 NISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFS  252 (662)
Q Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFs  252 (662)
                      ..++++                 .+.+|+.++|||+||+.+++|+|+++..  .+|..|++++.+||+.+|+++||||||
T Consensus       149 ~~~~~~-----------------~~~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~~~ls~~vdL~~~l~~~~yvGFS  209 (253)
T d1g7ya_         149 IRTASW-----------------GLANGQNAEILITYNAATSLLVASLVHP--SRRTSYIVSERVDITNELPEYVSIGFS  209 (253)
T ss_dssp             SEEEEC-----------------CCCTTSEEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCHHHHSCSEEEEEEE
T ss_pred             ccccCC-----------------CccCCCEEEEEEEEeCCcEEEEEEEecC--CCCCceEEEEEechhhcCCCcEEEEEE
Confidence            766543                 4789999999999999999999999763  477788999999999999999999999


Q ss_pred             ccCC---cccceeEEecceeeec
Q 040242          253 ASTG---LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       253 astG---~~~~~~~i~sW~f~~~  272 (662)
                      |+||   .+.+.|+|++|+|++.
T Consensus       210 AsTG~~~~~~~~H~IlsWsF~s~  232 (253)
T d1g7ya_         210 ATTGLSEGYTETHDVLSWSFASK  232 (253)
T ss_dssp             EECCSSSSCCCCCEEEEEEEEEE
T ss_pred             eEcCCCCCcccccEEEEEEeEEe
Confidence            9999   5679999999999864

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=1.6e-50  Score=403.83  Aligned_cols=226  Identities=30%  Similarity=0.461  Sum_probs=196.1

Q ss_pred             CCceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           18 AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        18 ~~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      ++++||+|++|.  ..||+|+|+|++.++|.||||++.     .+++|||+|++||+||         +..++.++||+|
T Consensus         1 ~~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~l~LT~~~~~~~~~~~~G~a~y~~pi~l~---------~~~~~~~~sFst   71 (239)
T d1dbna_           1 SDELSFTINNFVPNEADLLFQGEASVSSTGVLQLTKVENGQPQKYSVGRALYAAPVRIW---------GNTTGSVASFST   71 (239)
T ss_dssp             CCEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEE
T ss_pred             CCceEEEeCCCCCCCCCEEEeeeeEECCCCEEEccCCCCCCcccceeEEEeecCCEEcc---------CCCCccceEEEE
Confidence            467999999996  468999999999888999999763     4578999999999999         677778888999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCC-CCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCC--CCCCCCeeEEec
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQ-PPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLEL--QDINDNHVGIDI  167 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid~  167 (662)
                      +|+|+|.+.....+||||||+|+|... .+.+..|++||+++..+ +++.++.+||||||++|.++  +||+++|||||+
T Consensus        72 ~F~F~i~~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfDT~~n~~~~~~d~~~~hvgid~  150 (239)
T d1dbna_          72 SFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDV  150 (239)
T ss_dssp             EEEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEECCCCTTTCTTSCSSCEEEEEE
T ss_pred             EEEEEEECCCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEeeeecCCCCCCCCCCceeeEEc
Confidence            999999888777899999999999774 46678899999988654 45678999999999999765  388999999999


Q ss_pred             CCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccce
Q 040242          168 SSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYM  247 (662)
Q Consensus       168 ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~  247 (662)
                      |++.|..+...                 .+.+|+.+.|||+|++.++.|.|++....  ++..|.+++.+||+++|+++|
T Consensus       151 n~~~s~~~~~~-----------------~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~~~ls~~vdL~~~l~~~v  211 (239)
T d1dbna_         151 NGIESIKTVQW-----------------DWINGGVAFATITYLAPNKTLIASLVYPS--NQTTFSVAASVDLKEILPEWV  211 (239)
T ss_dssp             SSSSCSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEE
T ss_pred             CCccccccccc-----------------eEeCCceeEEEEEEcCCCCEEEEEEEecC--CCccEEEEEecchHHhcCCcE
Confidence            99988765543                 35689999999999999999999998643  666789999999999999999


Q ss_pred             EEeeeccCCcc--cceeEEecceeeec
Q 040242          248 YVGFSASTGLL--TAFHNVHGWSFKIG  272 (662)
Q Consensus       248 ~vGFsastG~~--~~~~~i~sW~f~~~  272 (662)
                      |||||||||..  .|.|+|++|+|+++
T Consensus       212 yvGFSAsTG~~~~~~~H~I~sWsFss~  238 (239)
T d1dbna_         212 RVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             EEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             EEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence            99999999965  47899999999863

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=2e-50  Score=400.55  Aligned_cols=224  Identities=26%  Similarity=0.376  Sum_probs=188.8

Q ss_pred             CCceeEEeCCCCCC--CeeEecceeeeCCCeEEecCC-CCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEE
Q 040242           18 AETNSFIYNGFIQA--NLSLDGTAFVRKDGILAVSND-QGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVF   94 (662)
Q Consensus        18 ~~~~~f~~~~f~~~--~~~l~G~a~~~~~~~~~Lt~~-~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f   94 (662)
                      ++++||+|++|.+.  +|+|+|||.+.++|.|+||++ ..+++|||+|++||+||         ++.+..++||+|+|+|
T Consensus         1 a~~~sF~~~~F~~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~G~a~y~~Pi~l~---------~~~~~~~~sf~t~f~f   71 (232)
T d1v6ia_           1 AETVSFNFNSFSEGNPAINFQGDVTVLSNGNIQLTNLNKVNSVGRVLYAMPVRIW---------SSATGNVASFLTSFSF   71 (232)
T ss_dssp             CEEEEEEESSCCTTCTTEEEEESCEECTTSCEECSCTTSTTCEEEEEESSCEECB---------CTTTCCBCEEEEEEEE
T ss_pred             CccEEEECCCCCCCCCCEEEeeeeEEcCCCEEEeCCCCCCCceEEEEcCCCEEcc---------CCCCCccceeEEEEEE
Confidence            35799999999864  599999999988899999986 45899999999999999         6777778889999999


Q ss_pred             EEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccc
Q 040242           95 SIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNI  174 (662)
Q Consensus        95 ~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~  174 (662)
                      .|.+.+...+||||||+|+|......+  ++..|+.......+..++.|||||||++|.+++||+++|||||+|++.+..
T Consensus        72 ~i~~~~~~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT~~n~~~~d~~~~Higid~n~~~s~~  149 (232)
T d1v6ia_          72 EMKDIKDYDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVK  149 (232)
T ss_dssp             EEECCSSSBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEECSCCGGGTCCSSCEEEEEEEESSCSE
T ss_pred             EeccCCCCCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEeEecCCCCCCCCccEeEeeCCccccc
Confidence            999888788999999999998744322  222222222223356778999999999999889999999999999988865


Q ss_pred             cccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeecc
Q 040242          175 SEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS  254 (662)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsas  254 (662)
                      ...                 .++.+|+.++|||+||+.+++|+|+++.   .++..|.+++.+||+.+|+++||||||||
T Consensus       150 ~~~-----------------~~~~~g~~~~v~I~Yd~~~~~L~V~~~~---~~~~~~~l~~~vdL~~~l~~~vyvGFSAs  209 (232)
T d1v6ia_         150 TVP-----------------WNSVSGAVVKVTVIYDSSTKTLSVAVTN---DNGDITTIAQVVDLKAKLPERVKFGFSAS  209 (232)
T ss_dssp             EEE-----------------CCCCTTCEEEEEEEEETTTTEEEEEEEC---TTSCEEEEEEECCHHHHSCSEEEEEEEEE
T ss_pred             ccc-----------------cccCCCCEEEEEEEEeCCceEEEEEEec---CCCCcceEEEEEchhhccCCcEEEEEEEE
Confidence            442                 3577999999999999999999999985   34567889999999999999999999999


Q ss_pred             CCcc-cceeEEecceeeec
Q 040242          255 TGLL-TAFHNVHGWSFKIG  272 (662)
Q Consensus       255 tG~~-~~~~~i~sW~f~~~  272 (662)
                      ||.. .|.|+|++|+|+++
T Consensus       210 TG~~~~~~H~I~sWsFss~  228 (232)
T d1v6ia_         210 GSLGGRQIHLIRSWSFTST  228 (232)
T ss_dssp             CCSSBCCEEEEEEEEEEEE
T ss_pred             CCCCCCcccEEEEeEeEEe
Confidence            9975 58999999999864

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=8.7e-51  Score=420.37  Aligned_cols=266  Identities=27%  Similarity=0.447  Sum_probs=205.1

Q ss_pred             cchHHHHHhccC---------CcccceeeeeCceEEEEEEeCCCCc---EEEEEEeecc-chhhHHHHHHHHHHhhcccc
Q 040242          345 FRYSELYSATKG---------FREKNLVGSGGFGKVYRGVIPSTGL---EVAIKRVAHN-SRQGMKEFVAEITSMGRLRH  411 (662)
Q Consensus       345 ~~~~el~~at~~---------f~~~~~LG~G~~g~Vy~~~~~~~g~---~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H  411 (662)
                      ++|+++..|+++         |+..++||+|+||+||+|.+..++.   .||||++... .....++|.+|+++|++++|
T Consensus         7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H   86 (299)
T d1jpaa_           7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH   86 (299)
T ss_dssp             GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred             CCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCC
Confidence            456666666544         4556899999999999999876553   5899998654 44556789999999999999


Q ss_pred             ccceeeeeeEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCce
Q 040242          412 RNLVQLHGWCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNV  491 (662)
Q Consensus       412 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NI  491 (662)
                      ||||+++|+|...+..++|||||++|+|.+++...    ...++|.+++.++.|||+||.|||+   .+|+||||||+||
T Consensus        87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NI  159 (299)
T d1jpaa_          87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNI  159 (299)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGE
T ss_pred             CCCccEEEEEeeCCEEEEEEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceE
Confidence            99999999999999999999999999999988654    3569999999999999999999999   8999999999999


Q ss_pred             EeCCCCCeEEeeccccccccCCCCC----cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccc
Q 040242          492 LIDADLNPKLGDFGLARAYDHNINP----QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRT  566 (662)
Q Consensus       492 ll~~~~~~kL~DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~  566 (662)
                      ||+.++.+||+|||+++........    ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.....
T Consensus       160 Ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~  239 (299)
T d1jpaa_         160 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN  239 (299)
T ss_dssp             EECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999976543222    1222467999999999999999999999999999999998 8999976543


Q ss_pred             hhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          567 AMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       567 ~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .   .+...+.    .+.       ++ ..+...+..+.+|+.+||+.||++||||.||++.|++.
T Consensus       240 ~---~~~~~i~----~~~-------~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         240 Q---DVINAIE----QDY-------RL-PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             H---HHHHHHH----TTC-------CC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             H---HHHHHHH----cCC-------CC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            2   1222221    111       11 12234456788999999999999999999999999764

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-50  Score=410.56  Aligned_cols=255  Identities=26%  Similarity=0.397  Sum_probs=199.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|.+. ++..||||++.... ...++|.+|++++++++|||||+++|+|..++..++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            56888999999999999999985 57789999997643 34578999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++...    ...++|..++.++.|+|+||.|||+   .+|+||||||+|||+++++.+||+|||+++......
T Consensus        83 ~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  155 (263)
T d1sm2a_          83 EHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  155 (263)
T ss_dssp             TTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred             CCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCC
Confidence            999999998654    4568999999999999999999999   899999999999999999999999999998776554


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ........||+.|+|||++.+..++.++|||||||++|||+|+..|+.......  .+...+..    +.  ..      
T Consensus       156 ~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i~~----~~--~~------  221 (263)
T d1sm2a_         156 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDIST----GF--RL------  221 (263)
T ss_dssp             ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHHHH----TC--CC------
T ss_pred             ceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHHHh----cC--CC------
Confidence            444445678999999999999999999999999999999999655443332221  11122211    10  01      


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..+......+.+|+.+||+.||++||||+||+++|++.
T Consensus       222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            11223345688999999999999999999999999753

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=1.3e-49  Score=394.96  Aligned_cols=220  Identities=30%  Similarity=0.480  Sum_probs=191.5

Q ss_pred             CceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCCC-----CeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQG-----RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~~-----~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      ++++|+|++|.  .+||+|+|||.+.++|.|+||++..     +++|||||++||+||         +.  ..++||+|+
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~i~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pv~l~---------~~--~~~~sF~t~   70 (233)
T d1n47a_           2 ESTSFSFTNFNPNQNNLILQEDALVNSAGTLELTAVAAGAPVPDSLGRALYAAPIHIH---------DN--TTLASFTTS   70 (233)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEESSCBSSSSBCTTCEEEEEESSCEECB---------CS--SCBCEEEEE
T ss_pred             CceEEEeCCCCCCCCCeEEecceEECCCCEEEecCCCCCCcCCCceEEEEeCCCEEcc---------CC--CeeeeEEEE
Confidence            57899999996  3799999999998889999998653     589999999999999         43  246899999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCc
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLI  171 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~  171 (662)
                      |+|.|.+.....+||||||+|+|... +.+..|++|||++.... +..++.|||||||++|.  +||++||||||+|++.
T Consensus        71 f~f~i~~~~~~~~gDGlAF~l~~~~~-~~~~~gg~lGl~~~~~~-~~~~~~~aVefDT~~n~--~d~~~~higi~~n~~~  146 (233)
T d1n47a_          71 FSFVMAAPAAAAVADGLAFFLAPPDT-QPQARGGFLGLFADRAH-DASYQTVAVEFDTYSNA--WDPNYTHIGIDTNGIE  146 (233)
T ss_dssp             EEEECCCSSTTSCCEEEEEEEECTTC-CCCCCGGGTTTCSSSSC-CGGGCCEEEEEECSCCT--TSCSSCEEEEEESSSS
T ss_pred             EEEEEeCCCCCCCCCceEEEECCCCC-CCCCCCCccccccccCC-CCcCceEEEEEEeeecC--CCCCCCceeEccCCcc
Confidence            99999888778899999999999765 34567899999976554 45678899999999997  6999999999999998


Q ss_pred             ccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEee
Q 040242          172 SNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       172 s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      |..+.+                 ..+.+|+.++|||+||+.+++|.|++...  .++..|.++..+||+.+|+++|||||
T Consensus       147 s~~~~~-----------------~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~--~~~~~~~ls~~vdL~~~l~~~vyvGF  207 (233)
T d1n47a_         147 SKKTTP-----------------FDMVYGEKANIVITYQASTKALAASLVFP--VSQTSYAVSARVDLRDILPEYVRVGF  207 (233)
T ss_dssp             CSEEEE-----------------CCCCTTSCEEEEEEEETTTTEEEEEEEET--TTTEEEEEEEECCGGGTSCSEEEEEE
T ss_pred             cccccc-----------------ceecCCCEEEEEEEEcCCCeEEEEEEEeC--CCCccEEEEEEechHHhcCCcEEEEE
Confidence            876554                 35779999999999999999999999864  36777899999999999999999999


Q ss_pred             eccCC---cccceeEEecceeeec
Q 040242          252 SASTG---LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       252 sastG---~~~~~~~i~sW~f~~~  272 (662)
                      ||+||   ...|.|+|++|+|+++
T Consensus       208 SAsTG~~~~~~~~H~I~sWsFss~  231 (233)
T d1n47a_         208 SATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEecCCCCCcccccEEEEEEeEEE
Confidence            99999   5678999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.5e-51  Score=418.83  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=216.3

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      .++|+..+.||+|+||+||+|++..+++.||||++.... ...++|.+|+.++++++|||||+++++|.+.+..++||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeec
Confidence            467888999999999999999998889999999997653 3457899999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      |++|+|.+++....   ...++|..++.++.||++||+|||+   ++|+||||||+||||++++.+||+|||+++.....
T Consensus        95 ~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~  168 (287)
T d1opja_          95 MTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  168 (287)
T ss_dssp             CTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred             ccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCC
Confidence            99999999996543   4679999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      .........|++.|+|||++.++.++.++|||||||++|||++|+.|+........  +.+.+    ..+     ..+  
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~i----~~~-----~~~--  235 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYELL----EKD-----YRM--  235 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHHH----HTT-----CCC--
T ss_pred             CceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHHH----hcC-----CCC--
Confidence            44344445689999999999999999999999999999999998777654433221  11111    111     111  


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                       ..+...+..+.+|+.+||+.||++||||.||++.|+..
T Consensus       236 -~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         236 -ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             12233456788999999999999999999999999765

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=1.2e-49  Score=397.23  Aligned_cols=223  Identities=28%  Similarity=0.432  Sum_probs=194.0

Q ss_pred             CceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC-----CCeeEEEEcCCceeecccccccccCCCCCceeeeeEEE
Q 040242           19 ETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ-----GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTN   91 (662)
Q Consensus        19 ~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~-----~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~   91 (662)
                      .++||+|++|.+  +|++|+|||.+.++|.||||++.     .+++|||+|++||+||         +..++.++||+|+
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~v~~~g~i~LT~~~~~~~~~~~~G~~~y~~Pi~l~---------~~~~~~~~sF~t~   72 (237)
T d1fnya_           2 GSLSFSFPKFAPNQPYLINQGDALVTSTGVLQLTNVVNGVPSSKSLGRALYAAPFQIW---------DSTTGNVASFVTS   72 (237)
T ss_dssp             EEEEEEESSCCTTCTTEEEEETCEECTTSCEECSCEETTEECSSCEEEEEESSCEECB---------CTTTCCBCEEEEE
T ss_pred             ceEEEEeCCCCCCCCCeEEcccEEEcCCCEEECCCCCCCCcccccEEEEEeCCCeEcc---------cCCCCcceeeEEE
Confidence            478999999964  69999999999888999999863     4689999999999999         7777788889999


Q ss_pred             EEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCc
Q 040242           92 FVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLI  171 (662)
Q Consensus        92 F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~  171 (662)
                      |+|+|.+.+...+||||||+|+|.... .+..+|+||+++... .+..++.+||||||++|.++ ||+++|||||+|++.
T Consensus        73 F~F~i~~~~~~~~gDG~AF~l~~~~~~-~~~~gg~lg~~~~~~-~~~~~~~~aVefDT~~n~~~-d~~~~Higi~~n~~~  149 (237)
T d1fnya_          73 FTFIIQAPNPATTADGLAFFLAPVDTQ-PLDLGGMLGIFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIE  149 (237)
T ss_dssp             EEEECCCSSTTSCCEEEEEEEEETTCC-CCCCGGGTTTCC----CCTTSCCEEEEEECSCCTTT-CCSSSEEEEEESSSS
T ss_pred             EEEEEecCCCCCCCCeeEEEEcCCCCC-cccccCcccccCCCC-ccCccceEEEEeccccccCC-CCCCceEEEecCCCc
Confidence            999998887788999999999998754 456788999987543 34678899999999999875 999999999999998


Q ss_pred             ccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEee
Q 040242          172 SNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGF  251 (662)
Q Consensus       172 s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGF  251 (662)
                      |..+.+.                 .+.+|+.++|||+||+.+++|.|++.+.+  ++..|+++..+||+.+|+++|||||
T Consensus       150 s~~~~~~-----------------~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGF  210 (237)
T d1fnya_         150 SIKTVPW-----------------NWTNGEVANVFISYEASTKSLTASLVYPS--LETSFIIDAIVDVKIVLPEWVRFGF  210 (237)
T ss_dssp             CSEEEEC-----------------CCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEE
T ss_pred             ccccccc-----------------cccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcceeEEEEechhhcCCCcEEEEE
Confidence            8765433                 46789999999999999999999998754  5667899999999999999999999


Q ss_pred             eccCC---cccceeEEecceeeec
Q 040242          252 SASTG---LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       252 sastG---~~~~~~~i~sW~f~~~  272 (662)
                      ||+||   ...|.|+|++|+|+++
T Consensus       211 SAsTG~~s~~~e~H~I~sWsF~s~  234 (237)
T d1fnya_         211 SATTGIDKGYVQTNDVLSWSFESN  234 (237)
T ss_dssp             EEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             EEECCCCCCcccccEEEEeEeEEe
Confidence            99999   5668999999999975

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-50  Score=408.52  Aligned_cols=257  Identities=25%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..++||+|+||+||+|+..   ..||||++...  .....+.|.+|+.++++++|||||++++++.. +.+++|||
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            56888999999999999999873   35999998654  45567889999999999999999999999864 56899999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++|+|.+++...    ...++|.+++.++.|||+||+|||+   ++|+||||||+||||+.++.+||+|||+++....
T Consensus        84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            99999999999654    3469999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCC-CcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          513 NIN-PQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       513 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ... .......||+.|+|||++.+   +.++.++|||||||+||||+||+.||.........  ...+.    .+    .
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~----~~----~  226 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVG----RG----Y  226 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----HT----S
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHh----cC----C
Confidence            322 23345679999999999864   35799999999999999999999999865433221  11111    11    1


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      ..|.+.......++.+.+|+.+||+.||++|||++||+++|+..
T Consensus       227 ~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         227 LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             CCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            22222233344556788999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=407.74  Aligned_cols=254  Identities=26%  Similarity=0.412  Sum_probs=207.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|.++ ++..||||++.... ...++|.+|+.++++++|||||+++|+|.+ +..++||||+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~   89 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM   89 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred             HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence            56888899999999999999985 57889999997643 345789999999999999999999998865 5679999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++....   ...++|.++++++.||++||+|||+   .+|+||||||+||||++++.+||+|||+++......
T Consensus        90 ~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          90 ENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             TTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             CCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCc
Confidence            9999999886543   4469999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ........||+.|+|||++.++.++.++|||||||++|||+||..|+.......+  +...+    ..+     ..+.  
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~~~i----~~~-----~~~~--  230 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VIQNL----ERG-----YRMV--  230 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHH----HTT-----CCCC--
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HHHHH----Hhc-----CCCC--
Confidence            3344456789999999999988999999999999999999997666543332211  11111    111     1111  


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                       .+...++.+.+|+.+||+.||++||||.||++.|+.
T Consensus       231 -~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 -RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence             122344568899999999999999999999998863

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=405.53  Aligned_cols=252  Identities=24%  Similarity=0.335  Sum_probs=205.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..++||+|+||+||+|+++.+|+.||||++.... .+..+++.+|++++++++||||+++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            56888999999999999999999999999999997653 33456789999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      |++|+|.++|..     ...+++.++..++.||++||+|||+   .+|+||||||+|||+++++.+||+|||+++.....
T Consensus        85 ~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          85 CSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             cCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            999999999953     3469999999999999999999999   89999999999999999999999999999976543


Q ss_pred             C-CCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          514 I-NPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       514 ~-~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      . .......+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.......... ..+     ....       
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-~~~-----~~~~-------  223 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-SDW-----KEKK-------  223 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-HHH-----HTTC-------
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-HHH-----hcCC-------
Confidence            2 223345689999999999987765 678999999999999999999997654322111 111     0000       


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      ............+.+|+.+||+.||++|||++|+++
T Consensus       224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            001111223456778999999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-50  Score=407.40  Aligned_cols=257  Identities=22%  Similarity=0.379  Sum_probs=198.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec--cCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--QDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV  430 (662)
                      ++|+..+.||+|+||+||+|+.+.+|+.||||++...  .....+.+.+|++++++++|||||++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999999999999999998765  34446778999999999999999999999864  4568999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC--CCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC--DQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      ||||++|+|.+++..... ....+++..++.++.|+++||+|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        84 mEy~~~g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            999999999999865432 1457999999999999999999999842  2359999999999999999999999999999


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......   .+...+    ..+..   
T Consensus       163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~i----~~~~~---  231 (269)
T d2java1         163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGKI----REGKF---  231 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHH----HHTCC---
T ss_pred             ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHHH----HcCCC---
Confidence            8754322 233468999999999999999999999999999999999999999764332   111111    11111   


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                           ...+....+.+.+|+.+||+.||.+|||+.|++++
T Consensus       232 -----~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         232 -----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 11122334568889999999999999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-49  Score=406.62  Aligned_cols=251  Identities=25%  Similarity=0.387  Sum_probs=212.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|.+..+|+.||||++........+.+.+|+.++++++||||+++++++...+.+++|||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999999999999999998766666778999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++.      ...+++.++..++.||+.||+|||+   .+|+||||||+|||++.++++||+|||+++.+....
T Consensus       100 ~gg~L~~~~~------~~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1         100 AGGSLTDVVT------ETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             TTCBHHHHHH------HSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             CCCcHHHHhh------ccCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999874      3458999999999999999999999   899999999999999999999999999999775432


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ....    ..+      .+.+ 
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~--~~~~----~~~------~~~~-  236 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA----TNG------TPEL-  236 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH--HHHH----HHC------SCCC-
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHH--HHHH----hCC------CCCC-
Confidence             2334467999999999999999999999999999999999999999765432211  1111    111      1111 


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..+......+.+|+.+||+.||.+|||+.|++++
T Consensus       237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1223345678899999999999999999999873

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=402.39  Aligned_cols=246  Identities=26%  Similarity=0.402  Sum_probs=208.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+..   ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46888999999999999999999999999999997542   334577899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|.+++..     ...+++.++..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            99999999999953     3569999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +..   . ...+      ..
T Consensus       158 ~~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~---~-i~~~------~~  221 (263)
T d2j4za1         158 SS---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYK---R-ISRV------EF  221 (263)
T ss_dssp             CC---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHTT------CC
T ss_pred             CC---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHH---H-HHcC------CC
Confidence            32   3345689999999999999899999999999999999999999997643221   111   1 1111      11


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .+   +....+.+.+|+.+||+.||++|||++|+++
T Consensus       222 ~~---p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TF---PDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CC---CccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            11   2223456788999999999999999999997

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=405.82  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC----cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG----LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      ..|+..++||+|+||+||+|.+..++    ..||||++... ......+|.+|+.++++++|||||+++|+|...+..++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            46788999999999999999986544    47999999654 33445679999999999999999999999999999999


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      |||||++++|.+++...    ...++|.++++++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus        87 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          87 ITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhc
Confidence            99999999999987544    4569999999999999999999999   8999999999999999999999999999987


Q ss_pred             ccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .......  ......||+.|+|||++.++.++.++|||||||++|||++|+.|+.......+  +...+    ..+    
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~--~~~~i----~~~----  229 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE--VMKAI----NDG----  229 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HHHHH----HTT----
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH--HHHHH----hcc----
Confidence            6543221  22335689999999999999999999999999999999997766654332211  11111    111    


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDASLP  636 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~~p  636 (662)
                       ..   ...+...+..+.+|+.+||+.||++||||.||+++|++....|
T Consensus       230 -~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         230 -FR---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -CC---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -CC---CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence             11   1222334567889999999999999999999999998754433

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=397.46  Aligned_cols=253  Identities=28%  Similarity=0.409  Sum_probs=213.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..++||+|+||+||+|+++ ++..||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            57888999999999999999984 678999999976543 3578999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|..++...    ...+++..+++++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~  154 (258)
T d1k2pa_          82 ANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  154 (258)
T ss_dssp             TTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred             CCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence            999999998554    4568999999999999999999999   899999999999999999999999999998776554


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                      ........||+.|+|||.+.+..++.++|||||||++|||+| |+.||.......   +..    ...++.     .   
T Consensus       155 ~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~----~i~~~~-----~---  219 (258)
T d1k2pa_         155 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE----HIAQGL-----R---  219 (258)
T ss_dssp             CCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHH----HHHTTC-----C---
T ss_pred             ceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHH----HHHhCC-----C---
Confidence            444445679999999999999999999999999999999998 899997654321   111    111111     0   


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ...+......+.+|+.+||+.||++|||++||+++|..
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            11122334678899999999999999999999999853

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-49  Score=404.63  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=210.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      +.|+..+.||+|+||+||+|++..++..||||++........+.|.+|++++++++|||||++++++...+..++|||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            45788999999999999999999999999999998776667788999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++.+.    ...+++.++..++.||++||.|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus        92 ~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~  164 (288)
T d2jfla1          92 AGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  164 (288)
T ss_dssp             TTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH
T ss_pred             CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc
Confidence            999999988543    3569999999999999999999999   899999999999999999999999999997653321


Q ss_pred             CCcceecccCCcccCccccc-----CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          515 NPQTTHIVGTLGYLAPELTR-----TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                       .......||+.|+|||++.     ...++.++|||||||++|||++|+.||........  +....    . +.     
T Consensus       165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~--~~~i~----~-~~-----  231 (288)
T d2jfla1         165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV--LLKIA----K-SE-----  231 (288)
T ss_dssp             -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--HHHHH----H-SC-----
T ss_pred             -ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH--HHHHH----c-CC-----
Confidence             1223457999999999883     44578999999999999999999999976543221  11111    1 11     


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+.+ ..+......+.+|+.+||+.||.+|||+.|++++
T Consensus       232 ~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         232 PPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             CCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111 1223445678899999999999999999999873

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=1.1e-47  Score=383.68  Aligned_cols=223  Identities=25%  Similarity=0.423  Sum_probs=192.7

Q ss_pred             CceeEEeCCCCC--CCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           19 ETNSFIYNGFIQ--ANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        19 ~~~~f~~~~f~~--~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +++||+|++|.+  +||+|+|+|.+. ++.|+||++.      .+++|||+|++||+||         +..++.++||+|
T Consensus         2 ~~~sF~f~~F~~~~~~l~l~G~A~i~-~~~i~LT~~~~~~~~~~~~~G~~~y~~Pi~l~---------~~~~~~~~sF~t   71 (241)
T d1ukga_           2 DSLSFGFPTFPSDQKNLIFQGDAQIK-NNAVQLTKTDSNGNPVASTVGRILFSAQVHLW---------EKSSSRVANFQS   71 (241)
T ss_dssp             CEEEEEESSCCSCCSSEEEEETCEEE-TTEEECSCBCTTSCBCSSEEEEEEESSCEECE---------ETTTTEEEEEEE
T ss_pred             ccEEEEeCCCCCCCCCEEEeeeEEEe-CCEEEeCCCCCCCCccccceEEEEeCCCeecc---------cCCCCceeeeEE
Confidence            679999999964  689999999997 7899999854      4689999999999999         677788899999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCC-CCCCCCcccccCCCCCCC-CCCCCCcEEEEEeeccCCCCC--CCCCCCeeEEe
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRK-QPPSCLANQYLGLPNDTS-NAKFSTRILAVEFDAVQNLEL--QDINDNHVGID  166 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~-~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEFDt~~n~~~--~d~~~~Hvgid  166 (662)
                      +|+|+|.... ..+|||||||++|.. ..+.+.+|+++|+++... .+...++.|||||||++|.+.  +||+++|||||
T Consensus        72 ~F~f~i~~~~-~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEfDt~~n~~~~~~~~~~~Higid  150 (241)
T d1ukga_          72 QFSFSLKSPL-SNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGID  150 (241)
T ss_dssp             EEEEEEECSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEEECCCCTTTCTTSCSSCEEEEE
T ss_pred             EEEEEEecCC-CCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceeccCEecCccCCCCCCCccEeee
Confidence            9999997764 567999999999866 346777888899887644 345688999999999998654  45899999999


Q ss_pred             cCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccc
Q 040242          167 ISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEY  246 (662)
Q Consensus       167 ~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~  246 (662)
                      +|++.|....+                 ..+.+|..++|||+||+.+++|+|+++..   ++..|.+++.+||+.+|+++
T Consensus       151 ~n~~~s~~~~~-----------------~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~~~l~~~vdL~~~l~~~  210 (241)
T d1ukga_         151 VNSIRSVKTVK-----------------WDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTRYEVSYEVDVRSVLPEW  210 (241)
T ss_dssp             ESSSSCSEEEE-----------------CCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCEEEEEEECCGGGTSCSE
T ss_pred             cCCcccccccc-----------------cccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCceEEEEEEehHHhCCCc
Confidence            99999875543                 35789999999999999999999999763   56678999999999999999


Q ss_pred             eEEeeeccCCcccceeEEecceeeec
Q 040242          247 MYVGFSASTGLLTAFHNVHGWSFKIG  272 (662)
Q Consensus       247 ~~vGFsastG~~~~~~~i~sW~f~~~  272 (662)
                      ||||||||||...|.|+|++|+|+++
T Consensus       211 ~yvGFSAsTG~~~~~H~IlsWsFss~  236 (241)
T d1ukga_         211 VRVGFSAASGEQYQTHTLESWSFTST  236 (241)
T ss_dssp             EEEEEEEEESSSCCEEEEEEEEEEEE
T ss_pred             EEEEEEEecCCCCceeEEEEeEEEEE
Confidence            99999999999999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=401.28  Aligned_cols=254  Identities=26%  Similarity=0.395  Sum_probs=206.6

Q ss_pred             cCCcccce-eeeeCceEEEEEEeCC--CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNL-VGSGGFGKVYRGVIPS--TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~-LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...+. ||+|+||+||+|.++.  ++..||||++... .....++|.+|++++++++|||||+++|+|.. +.+++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            45556664 9999999999998753  4557999999765 34456789999999999999999999999965 568999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||||++|+|.+++...    +..+++.++.+++.||++||+|||+   ++|+||||||+||||+.++.+||+|||+++..
T Consensus        87 mE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          87 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999998544    3569999999999999999999999   89999999999999999999999999999977


Q ss_pred             cCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          511 DHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       511 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .....  .......||+.|+|||++.++.++.++|||||||++|||+| |+.||.......   +...    ...+..  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~----i~~~~~--  230 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAF----IEQGKR--  230 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHH----HHTTCC--
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHH----HHcCCC--
Confidence            54322  12233468999999999998899999999999999999998 899998654321   1111    122211  


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         +   ..+...+..+.+|+.+||+.||++||||.+|++.|+.
T Consensus       231 ---~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 ---M---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ---C---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---C---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               1   1223345678899999999999999999999998863

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=397.46  Aligned_cols=256  Identities=29%  Similarity=0.420  Sum_probs=203.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|++.. +..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~-~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECC-CCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            568889999999999999999964 5679999996543 345789999999999999999999999954 5689999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|..++....   ...++|.+++.++.||++||+|||+   .+|+||||||+||||+.++++||+|||+++......
T Consensus        94 ~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          94 SKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             TTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             CCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999986543   4569999999999999999999999   899999999999999999999999999999876554


Q ss_pred             CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCCC
Q 040242          515 NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTLD  594 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~  594 (662)
                      ........||+.|+|||++..+.++.++|||||||++|||+||..|+.......+  +..++..    +     ..+   
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~~~~i~~----~-----~~~---  233 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VLDQVER----G-----YRM---  233 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HHHHHHT----T-----CCC---
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH--HHHHHHh----c-----CCC---
Confidence            4444556799999999999999999999999999999999997777654433211  1222211    1     011   


Q ss_pred             CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          595 YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       595 ~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ..+....+.+.+++.+||+.||++||+|.+|+++|+...
T Consensus       234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            122334567889999999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=392.33  Aligned_cols=246  Identities=26%  Similarity=0.399  Sum_probs=199.2

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec----cCeeeEEE
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK----QDELLLVY  431 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV~  431 (662)
                      +..+.||+|+||+||+|.+..++..||+|++...  .....+.|.+|++++++++|||||++++++..    ...+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            4566899999999999999989999999998764  34456789999999999999999999999865    34689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCC--EEeCCcCCCceEeC-CCCCeEEeeccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQR--VVHRDVKPSNVLID-ADLNPKLGDFGLAR  508 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivH~Dlkp~NIll~-~~~~~kL~DfGla~  508 (662)
                      ||+++|+|.+++.+     ...+++..++.++.||++||+|||+   .+  |+||||||+|||++ +++.+||+|||+++
T Consensus        92 E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          92 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            99999999999953     3568999999999999999999998   56  99999999999996 57899999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      .....   ......||+.|+|||++.+ .++.++|||||||++|||++|+.||.........  .    .....+.    
T Consensus       164 ~~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~----~~i~~~~----  229 (270)
T d1t4ha_         164 LKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--Y----RRVTSGV----  229 (270)
T ss_dssp             GCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--H----HHHTTTC----
T ss_pred             eccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--H----HHHHcCC----
Confidence            64332   3345689999999999875 5999999999999999999999999754432211  1    1111111    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                       .+.  ..+......+.+|+.+||+.||++|||+.|++++
T Consensus       230 -~~~--~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         230 -KPA--SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -CCG--GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -CCc--ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             111  1112223457889999999999999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=406.34  Aligned_cols=263  Identities=24%  Similarity=0.337  Sum_probs=207.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      .++|+..++||+|+||+||+|++..+|+.||+|++.... ....+++.+|+.+|++++|||||+++++|...+.+++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            478999999999999999999999999999999997653 3445678999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ||++|+|.+++.+     ...+++..+..++.|+++||.|||+.  .+|+||||||+|||++.++.+||+|||+|+....
T Consensus        85 y~~gg~L~~~l~~-----~~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  157 (322)
T d1s9ja_          85 HMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  157 (322)
T ss_dssp             CCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred             cCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence            9999999999953     34689999999999999999999972  4899999999999999999999999999997643


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHH-HHHHHHHhhc--------C
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVL-VDWVRELHSQ--------G  583 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l-~~~~~~~~~~--------~  583 (662)
                      .   .....+||+.|+|||++.+..++.++||||+||++|||++|+.||........... ..........        +
T Consensus       158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (322)
T d1s9ja_         158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG  234 (322)
T ss_dssp             H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred             C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence            2   22346899999999999999999999999999999999999999976543211110 0000000000        0


Q ss_pred             c--------------ccc-------ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 Q--------------ITR-------AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~--------------~~~-------~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .              ..+       ...+.+  ........+.+|+.+||+.||.+|||++|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKL--PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -----------CCCCHHHHHHHHHTSCCCCC--CBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhHHHHHhhhhccCCccC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0              000       000001  001123567889999999999999999999984

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=397.42  Aligned_cols=246  Identities=26%  Similarity=0.373  Sum_probs=198.8

Q ss_pred             ceeeeeCceEEEEEEeCC--CCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEeccCC
Q 040242          361 NLVGSGGFGKVYRGVIPS--TGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYVPN  436 (662)
Q Consensus       361 ~~LG~G~~g~Vy~~~~~~--~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  436 (662)
                      ++||+|+||+||+|.+..  .++.||||++...  .....++|.+|+.++++++|||||+++++|.. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            579999999999998643  4578999999654  33345789999999999999999999999965 467899999999


Q ss_pred             CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCCCC
Q 040242          437 GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNINP  516 (662)
Q Consensus       437 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~~  516 (662)
                      |+|.+++..     ...++|.+++.++.||++||+|||+   .+|+||||||+||||+.++.+||+|||+++........
T Consensus        92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999854     3469999999999999999999999   89999999999999999999999999999876544322


Q ss_pred             --cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCCC
Q 040242          517 --QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPTL  593 (662)
Q Consensus       517 --~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l  593 (662)
                        ......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......   .+...+    ..+..        
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i----~~~~~--------  228 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAML----EKGER--------  228 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHH----HTTCC--------
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHH----HcCCC--------
Confidence              2233578999999999998899999999999999999998 89999864322   111111    12211        


Q ss_pred             CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          594 DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       594 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ...+...+..+.+|+.+||+.||++|||+++|+++|+
T Consensus       229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            1122334567889999999999999999999998875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=399.80  Aligned_cols=250  Identities=22%  Similarity=0.319  Sum_probs=206.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            56889999999999999999999899999999997542   334577999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|.+++..     ...+++.....++.|++.||+|||+   .+|+||||||+|||+++++.+||+|||+++.+.
T Consensus        88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence            99999999998843     3569999999999999999999999   899999999999999999999999999999775


Q ss_pred             CCC-CCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          512 HNI-NPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       512 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ... ........||+.|+|||++.+..++.++||||+||++|||++|+.||.......   +..    ....+.      
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~----~i~~~~------  226 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQ----KIIKLE------  226 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHTTC------
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHH----HHHcCC------
Confidence            432 223344679999999999999999999999999999999999999998653221   111    111111      


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   ++......+.+|+.+||+.||.+|||++|++++
T Consensus       227 ~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         227 YD---FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CC---CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             CC---CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            11   122334567889999999999999999997643

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-48  Score=405.12  Aligned_cols=259  Identities=24%  Similarity=0.371  Sum_probs=208.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-----cEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-----LEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDEL  427 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-----~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  427 (662)
                      ++|+..++||+|+||+||+|++...+     ..||||.+... .......+.+|+.++.++ +|||||+++++|...+..
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~  116 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI  116 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeE
Confidence            57888999999999999999986543     36999998654 334456789999999998 899999999999999999


Q ss_pred             eEEEeccCCCCcchhcccccc------------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCC
Q 040242          428 LLVYDYVPNGSLDKLLFDNDQ------------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPS  489 (662)
Q Consensus       428 ~lV~E~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~  489 (662)
                      ++|||||++|+|.++|+....                  .....++|..++.++.||++||+|||+   .+|+||||||+
T Consensus       117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~  193 (325)
T d1rjba_         117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAAR  193 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGG
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchh
Confidence            999999999999999975431                  112468999999999999999999999   89999999999


Q ss_pred             ceEeCCCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccch
Q 040242          490 NVLIDADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTA  567 (662)
Q Consensus       490 NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~  567 (662)
                      |||++.++.+||+|||+++........ ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876554332 2234568999999999999999999999999999999998 89999765432


Q ss_pred             hhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 040242          568 MELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLL  630 (662)
Q Consensus       568 ~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~  630 (662)
                      ..  +...+    ..+.     .+   ..+...++.+.+|+.+||+.||++|||++||+++|.
T Consensus       274 ~~--~~~~~----~~~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 AN--FYKLI----QNGF-----KM---DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HH--HHHHH----HTTC-----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH--HHHHH----hcCC-----CC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21  11111    1111     11   122334567889999999999999999999999995

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.8e-47  Score=403.39  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=212.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|++..+|+.||||++........+.+.+|+.++++++|||||++++++.+.+.+++|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC--CCCeEEeeccccccccC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA--DLNPKLGDFGLARAYDH  512 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~--~~~~kL~DfGla~~~~~  512 (662)
                      ++|+|.+++...    ...+++.++..++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||+++....
T Consensus       106 ~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~  178 (350)
T d1koaa2         106 SGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP  178 (350)
T ss_dssp             CSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred             CCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence            999999998543    3469999999999999999999999   89999999999999964  67899999999997654


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........      +..... ...  ..++ 
T Consensus       179 ~--~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~-~~~--~~~~-  246 (350)
T d1koaa2         179 K--QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKS-CDW--NMDD-  246 (350)
T ss_dssp             T--SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH-TCC--CSCC-
T ss_pred             c--cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCC--CCCc-
Confidence            3  233446899999999999999999999999999999999999999975533211      111111 110  0011 


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                        .......+.+.+|+.+||+.||++|||+.|++++
T Consensus       247 --~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 --SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             --GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             --ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence              1112234567889999999999999999999985

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-48  Score=398.89  Aligned_cols=251  Identities=28%  Similarity=0.435  Sum_probs=206.9

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      +.|+..+.||+|+||+||+|++..+|+.||||++....   ....+.+.+|+.++++++|||||++++++...+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45888999999999999999999999999999997643   344567999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|..++..     ...+++.+++.++.||++||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus        95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            99999999776632     3569999999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccC---CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccc
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRT---GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRA  588 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~  588 (662)
                      ..     ....||+.|+|||++.+   +.++.++|||||||++|||++|+.||.........      ..... +.    
T Consensus       167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~------~~i~~-~~----  230 (309)
T d1u5ra_         167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-NE----  230 (309)
T ss_dssp             SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHH-SC----
T ss_pred             CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-CC----
Confidence            32     33579999999999853   46899999999999999999999999755332111      11111 11    


Q ss_pred             cCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH--HHhcC
Q 040242          589 IDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ--FLLRD  632 (662)
Q Consensus       589 id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~--~L~~~  632 (662)
                       .+.+.  +....+.+.+|+.+||+.||.+|||+.|+++  .+.+.
T Consensus       231 -~~~~~--~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         231 -SPALQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             -CCCCS--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             -CCCCC--CCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence             11111  1223456888999999999999999999997  35544

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.1e-47  Score=397.75  Aligned_cols=267  Identities=24%  Similarity=0.359  Sum_probs=214.1

Q ss_pred             HHHHhccCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEe
Q 040242          349 ELYSATKGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCR  422 (662)
Q Consensus       349 el~~at~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~  422 (662)
                      +++-..++|+..+.||+|+||+||+|+.+.     +++.||||++.... .+..++|.+|+.++++++||||++++++|.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            344456789999999999999999999753     45789999997653 344678999999999999999999999999


Q ss_pred             ccCeeeEEEeccCCCCcchhcccccc-------------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEe
Q 040242          423 KQDELLLVYDYVPNGSLDKLLFDNDQ-------------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVH  483 (662)
Q Consensus       423 ~~~~~~lV~E~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  483 (662)
                      ..+..++||||+++|+|.++|.....                   .....++|.+++.++.|++.||+|||+   .+|+|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence            99999999999999999999964321                   113458999999999999999999999   89999


Q ss_pred             CCcCCCceEeCCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCC
Q 040242          484 RDVKPSNVLIDADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR-RPI  561 (662)
Q Consensus       484 ~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~  561 (662)
                      |||||+||||+.++.+||+|||+++....... ...+...||+.|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999986644322 2333467899999999999999999999999999999999996 466


Q ss_pred             CcccchhhHHHHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 040242          562 EPQRTAMELVLVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDA  633 (662)
Q Consensus       562 ~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~  633 (662)
                      ......+   +...+    .++..        ...+...+..+..|+.+||+.||++||||.||+++|++..
T Consensus       244 ~~~~~~e---~~~~v----~~~~~--------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEE---VIYYV----RDGNI--------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHH---HHHHH----HTTCC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHH---HHHHH----HcCCC--------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            5443221   11111    12211        1122334457889999999999999999999999998753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.9e-47  Score=399.77  Aligned_cols=252  Identities=20%  Similarity=0.266  Sum_probs=212.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|+..+.||+|+||+||+|....+|+.||||++........+.+.+|+.++++++|||||++++++..++.+++|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            56899999999999999999998899999999998776666678899999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC--CCCCeEEeeccccccccC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID--ADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~--~~~~~kL~DfGla~~~~~  512 (662)
                      ++|+|.+++...    ...+++.+.+.++.||++||+|||+   .+|+||||||+||||+  .++.+||+|||+++....
T Consensus       109 ~gg~L~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~  181 (352)
T d1koba_         109 SGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  181 (352)
T ss_dssp             CCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCChHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCC
Confidence            999999887543    3469999999999999999999999   8999999999999998  678999999999998764


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .  .......||+.|+|||++.+..++.++||||+||++|||+||+.||........   ...+.    .+.      ..
T Consensus       182 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~~~i~----~~~------~~  246 (352)
T d1koba_         182 D--EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET---LQNVK----RCD------WE  246 (352)
T ss_dssp             T--SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH----HCC------CC
T ss_pred             C--CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHH----hCC------CC
Confidence            3  234456799999999999999999999999999999999999999986543211   11111    111      11


Q ss_pred             C-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      . ..........+.+|+.+||+.||.+|||+.|++++
T Consensus       247 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         247 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1 11122344567889999999999999999999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.6e-47  Score=396.83  Aligned_cols=256  Identities=23%  Similarity=0.374  Sum_probs=195.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      +.|+..+.||+|+||+||+|+++.+|+.||||++.... ....+.+.+|+.++++++||||+++++++..++.+++||||
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~   88 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL   88 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            56888999999999999999999899999999997653 23345688999999999999999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC---CCCCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID---ADLNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~---~~~~~kL~DfGla~~~  510 (662)
                      |++|+|.++|..     ...+++.+...++.||+.||+|||+   .+|+||||||+|||+.   +++.+||+|||+++..
T Consensus        89 ~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~  160 (307)
T d1a06a_          89 VSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME  160 (307)
T ss_dssp             CCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred             cCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence            999999999954     3469999999999999999999999   8999999999999994   5789999999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      ....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+    ..+..  ...
T Consensus       161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i----~~~~~--~~~  229 (307)
T d1a06a_         161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI----LKAEY--EFD  229 (307)
T ss_dssp             --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HTTCC--CCC
T ss_pred             cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH----hccCC--CCC
Confidence            5432  2334679999999999999999999999999999999999999998654321   11111    11110  011


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcC
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRD  632 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~  632 (662)
                         ..........+.+|+.+||+.||++|||+.|++++  +.+.
T Consensus       230 ---~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         230 ---SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             ---TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ---CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence               11122344668899999999999999999999985  5443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=388.78  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=207.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc------hhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS------RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~------~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++.+..      ....+.|.+|+.++++++|||||++++++.+.+.++
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            57899999999999999999999899999999996542      123578999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC----CeEEeec
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL----NPKLGDF  504 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~----~~kL~Df  504 (662)
                      +|||||++|+|.+++..     ...+++..++.++.|+++||+|||+   .+|+||||||+|||++.++    .+||+||
T Consensus        90 iv~E~~~gg~L~~~i~~-----~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhcc-----ccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecch
Confidence            99999999999999953     3469999999999999999999999   8999999999999998876    4999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      |+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........      ... ..+.
T Consensus       162 G~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i-~~~~  232 (293)
T d1jksa_         162 GLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANV-SAVN  232 (293)
T ss_dssp             TTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HTTC
T ss_pred             hhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHH------HHH-HhcC
Confidence            9998765432  233457899999999999989999999999999999999999999865432111      111 1111


Q ss_pred             cccccCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          585 ITRAIDPTL-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       585 ~~~~id~~l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            ... ..........+.+|+.+||+.||++|||++|++++
T Consensus       233 ------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         233 ------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             ------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                  011 00011234567889999999999999999999873

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-47  Score=385.99  Aligned_cols=248  Identities=30%  Similarity=0.430  Sum_probs=197.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEec-cCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||.||+|.+  .|..||||+++...  ..++|.+|++++++++||||++++|+|.+ .+.+++||||
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            4577789999999999999999  47889999996543  34679999999999999999999999865 4568999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCC
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHN  513 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~  513 (662)
                      +++|+|.++|....   ...++|..+++++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  156 (262)
T ss_dssp             CTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             cCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC
Confidence            99999999996542   4569999999999999999999999   89999999999999999999999999999865432


Q ss_pred             CCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          514 INPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       514 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                          .....+|..|+|||++.++.+++++|||||||++|||+| |+.|+......   .+..++.    .+     ..+.
T Consensus       157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~----~~-----~~~~  220 (262)
T d1byga_         157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVE----KG-----YKMD  220 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHT----TT-----CCCC
T ss_pred             ----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----cC-----CCCC
Confidence                223467899999999998999999999999999999998 67777654322   1222221    11     1112


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                         .+......+.+|+.+||+.||.+||||.+++++|++
T Consensus       221 ---~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         221 ---APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence               223344678899999999999999999999999975

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-46  Score=391.47  Aligned_cols=246  Identities=25%  Similarity=0.338  Sum_probs=207.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++.+.   .....+.+.+|+.++++++||||+++++++...+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5688999999999999999999989999999999754   2334678999999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|..++..     ...+++.....++.||+.||+|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus        84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            99999999998854     3457888889999999999999999   899999999999999999999999999998765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....||+.|+|||++.+..++.++||||+||++|||++|+.||........      ..... .+.      .
T Consensus       156 ~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~-~~~------~  218 (316)
T d1fota_         156 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKIL-NAE------L  218 (316)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH-HCC------C
T ss_pred             cc----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH------HHHHH-cCC------C
Confidence            43    2346899999999999998999999999999999999999999986543211      11111 111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~~  628 (662)
                      .   ++......+.+++.+||+.||.+||     |+++++++
T Consensus       219 ~---~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 R---FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C---CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            1   1222345678899999999999996     89999864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-47  Score=387.41  Aligned_cols=254  Identities=26%  Similarity=0.392  Sum_probs=197.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..+.||+|+||.||+|++..+   +..||||.+... .....+.|.+|+.++++++||||++++++|. .+..++|
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv   85 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWII   85 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEE
Confidence            5688899999999999999998543   356899998654 3444678999999999999999999999996 4678999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      |||+++|+|.+++...    ...+++.+++.++.||++||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        86 ~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          86 MELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999987543    4568999999999999999999999   89999999999999999999999999999977


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccccc
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITRAI  589 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~i  589 (662)
                      ............||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......   +...+    ..+..    
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~~----  227 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER----  227 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC----
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCC----
Confidence            6554445555678999999999999999999999999999999998 888887654322   11111    11111    


Q ss_pred             CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          590 DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       590 d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          ...+...+..+.+|+.+||+.||++|||+.||+++|+.
T Consensus       228 ----~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         228 ----LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11223345678899999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-47  Score=395.60  Aligned_cols=255  Identities=24%  Similarity=0.387  Sum_probs=203.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc----EEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL----EVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~----~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  429 (662)
                      .+|+..++||+|+||+||+|.+..+|+    +||+|++... ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            358889999999999999999877665    5899988654 345577899999999999999999999999864 5678


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+.+|+|.+++...    ...+++..+++++.|||+||.|||+   ++|+||||||+||||+.++.+||+|||+++.
T Consensus        88 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~  160 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKL  160 (317)
T ss_dssp             EEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHH
T ss_pred             EEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeecccccee
Confidence            89999999999988654    4679999999999999999999999   8999999999999999999999999999997


Q ss_pred             ccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          510 YDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       510 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      ....... ......||+.|+|||.+.++.++.++|||||||++|||+| |+.||.......   +...+.    .+.   
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i~----~~~---  230 (317)
T d1xkka_         161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE----KGE---  230 (317)
T ss_dssp             TTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHHH----HTC---
T ss_pred             cccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH----cCC---
Confidence            7554332 2333568999999999999999999999999999999998 788887543321   111111    111   


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                          ++ ..+......+.+|+.+||+.||.+|||+.||+++|.+.
T Consensus       231 ----~~-~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         231 ----RL-PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ----CC-CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CC-CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                11 12233456788999999999999999999999988654

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=100.00  E-value=6.5e-47  Score=374.81  Aligned_cols=216  Identities=28%  Similarity=0.450  Sum_probs=184.5

Q ss_pred             CCceeEEeCCCCC-CCeeEecceeeeCCCeEEecCCCC------CeeEEEEcCCceeecccccccccCCCCCceeeeeEE
Q 040242           18 AETNSFIYNGFIQ-ANLSLDGTAFVRKDGILAVSNDQG------RILGHAFYPSPLRFKQLSKYNINNNTISHTALTFST   90 (662)
Q Consensus        18 ~~~~~f~~~~f~~-~~~~l~G~a~~~~~~~~~Lt~~~~------~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t   90 (662)
                      +..++|+|++|+. .+|+|+|||++.++|.|+||++.+      .++|||+|++||+||         +  +++++||+|
T Consensus         1 a~~~sF~f~~F~~~~~l~l~GdA~i~~~g~l~LT~~~~~~~~~~~s~G~a~y~~Pv~l~---------~--~~~~~sFst   69 (228)
T d1ioaa_           1 ATETSFNFPNFHTDDKLILQGNATISSKGQLQLTGVGSNELPRVDSLGRAFYSDPIQIK---------D--SNNVASFNT   69 (228)
T ss_dssp             CCCCEEEESSCCTTSSEEEEETCEECTTSCEETTCBCTTSSBCSSCBEEEEESSCEECB---------C--SSCBEEEEE
T ss_pred             CccceEEcCCCCCCCcEEEeeeeEEcCCCEEEecCCCCCCccccceeEEEEECCceEec---------C--CCceeeEEE
Confidence            3568999999976 469999999998889999998654      478999999999999         3  356789999


Q ss_pred             EEEEEEecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCC
Q 040242           91 NFVFSIVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSL  170 (662)
Q Consensus        91 ~F~f~i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~  170 (662)
                      +|+|+|.+.+...+||||||+|+|.+. +.+..|++||+++... ++..++.|||||||++|.  .|++.+|+++++++.
T Consensus        70 ~F~f~i~~~~~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~~-~~~~~~~vave~dt~~n~--~~~~~~~~~~~~~~~  145 (228)
T d1ioaa_          70 NFTFIIRAKNQSISAYGLAFALVPVNS-PPQKKQEFLGIFNTNN-PEPNARTVAVVFNTFKNR--IDFDKNFIKPYVNEN  145 (228)
T ss_dssp             EEEEECCBSCTTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCSS-CCGGGCCEEEEEETTTTE--EEEEESSSSCSEEEE
T ss_pred             EEEEEEecCCCCCCCCEEEEEEeCCCC-CCCCCccccccccccC-CCCcceeEEEEecCcccc--ccCCCCccceecccc
Confidence            999999988778899999999999875 4456889999988643 456788999999999985  588888888887643


Q ss_pred             cccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEe
Q 040242          171 ISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVG  250 (662)
Q Consensus       171 ~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vG  250 (662)
                      .+                      ..+.+|+.++|||+||+.+++|+|++++..  ++..|.+++.+||+++|+++||||
T Consensus       146 ~~----------------------~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~~~ls~~vdL~~~l~~~vyvG  201 (228)
T d1ioaa_         146 CD----------------------FHKYNGEKTDVQITYDSSNNDLRVFLHFTV--SQVKCSVSATVHLEKEVDEWVSVG  201 (228)
T ss_dssp             CC----------------------HHHHCSSCEEEEEEEETTTTEEEEEEEETT--TCCEEEEEEECCGGGTSCSEEEEE
T ss_pred             cc----------------------cccccCcEEEEEEEEcCCCCEEEEEEEeCC--CCceeeEEEEEchHHcCCCcEEEE
Confidence            22                      356789999999999999999999998743  677899999999999999999999


Q ss_pred             eeccCC---cccceeEEecceeeec
Q 040242          251 FSASTG---LLTAFHNVHGWSFKIG  272 (662)
Q Consensus       251 FsastG---~~~~~~~i~sW~f~~~  272 (662)
                      ||||||   +..|.|+|++|+|++.
T Consensus       202 FSAsTG~~~~~~~~h~I~sWsFss~  226 (228)
T d1ioaa_         202 FSPTSGLTEDTTETHDVLSWSFSSK  226 (228)
T ss_dssp             EEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred             EEeecCCCCCCceEEEEEEEEeEEe
Confidence            999999   5668899999999863

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=5e-47  Score=375.31  Aligned_cols=217  Identities=29%  Similarity=0.438  Sum_probs=190.8

Q ss_pred             CceeEEeCCCCCCCeeEecceeeeCCCeEEecCC---CCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEE
Q 040242           19 ETNSFIYNGFIQANLSLDGTAFVRKDGILAVSND---QGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFS   95 (662)
Q Consensus        19 ~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~---~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~   95 (662)
                      +++||+|++|...||+|+|||++.++|.|+||+.   ..+++|||+|++||+||         +..+..++||+|+|+|+
T Consensus         2 ~~~sf~f~~F~~~nl~l~GdA~v~~~g~i~LT~~~~~~~~~~G~~~y~~Pv~l~---------~~~~~~~~sF~t~f~f~   72 (226)
T d1avba_           2 NDASFNVETFNKTNLILQGDATVSSEGHLLLTNVKGNEEDSMGRAFYSAPIQIN---------DRTIDNLASFSTNFTFR   72 (226)
T ss_dssp             EEEEEEESSCCGGGEEEEETCEECTTSCEECSCSSSCCTTCEEEEEESSCEECE---------EGGGTEEEEEEEEEEEE
T ss_pred             CceEEECCCCCccceeEecceEECCCCeEEccCCCCCCccceEEEEeCCCeEcc---------cCCCCcccceEEEEEEE
Confidence            5789999999999999999999987889999964   45789999999999999         66677788899999999


Q ss_pred             EecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccc
Q 040242           96 IVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNIS  175 (662)
Q Consensus        96 i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~  175 (662)
                      |.+.....+||||||+|+|.... .+..++++|+++.          ++|||||+.|...+|+++||||||+|+..+..+
T Consensus        73 i~~~~~~~~gDG~aF~i~~~~~~-~g~~gg~~gl~~~----------~~v~fdt~~~~~~~d~~~nhi~i~~n~~~s~~~  141 (226)
T d1avba_          73 INAKNIENSAYGLAFALVPVGSR-PKLKGRYLGLFNT----------TNYDRDAHTVAVVFDTVSNRIEIDVNSIRPIAT  141 (226)
T ss_dssp             EEESSTTSCCEEEEEEEEETTCC-CCCCGGGTTTCSC----------SSCCGGGCCEEEEEETTTTEEEEEESSSSCSEE
T ss_pred             EecCCCCCCCceEEEEEccCCCC-CCCccccCCcccc----------ccccccceeccccccCCCCEEEEeCCCCccccc
Confidence            99988788999999999998754 4567889999764          479999999976679999999999999988766


Q ss_pred             ccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccC
Q 040242          176 EPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST  255 (662)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast  255 (662)
                      .+..               ..+.+|+.+.|||+||+.+++|+|+++..+  ++..|.++..+||+.+||++|||||||+|
T Consensus       142 ~~~~---------------~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~~~~~vdL~~~l~~~~y~GFSAaT  204 (226)
T d1avba_         142 ESCN---------------FGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEKCHVSATVPLEKEVEDWVSVGFSATS  204 (226)
T ss_dssp             EECC---------------SGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEEEEEEEECCHHHHSCSEEEEEEEEEE
T ss_pred             cccc---------------cccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCccEEEEEEecHHHccCCcEEEEEEEEc
Confidence            6543               357799999999999999999999998754  66778899999999999999999999999


Q ss_pred             Cc---ccceeEEecceeeec
Q 040242          256 GL---LTAFHNVHGWSFKIG  272 (662)
Q Consensus       256 G~---~~~~~~i~sW~f~~~  272 (662)
                      |.   ..|.|+|++|+|+++
T Consensus       205 G~~s~~~~~H~IlsWsF~s~  224 (226)
T d1avba_         205 GSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             CSSGGGCEEEEEEEEEEEEE
T ss_pred             CCCCCCeeeeEEEEEEeEEe
Confidence            95   567899999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=390.89  Aligned_cols=249  Identities=27%  Similarity=0.356  Sum_probs=209.6

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|+.+.+|+.||||++.+.   .....+.+.+|+.+|++++||||+++++++.+.+.+++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5689999999999999999999999999999999764   2334678899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      |||++|+|.+++..     ...+++.....++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~  156 (337)
T d1o6la_          85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence            99999999999853     3568889999999999999999999   899999999999999999999999999998654


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ... ......+||+.|+|||++.+..++.++||||+||++|||++|+.||.......   +...+    ..+.      .
T Consensus       157 ~~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i----~~~~------~  222 (337)
T d1o6la_         157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI----LMEE------I  222 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------C
T ss_pred             cCC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHH----hcCC------C
Confidence            332 23345689999999999999999999999999999999999999998654321   11111    1111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQF  628 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~~  628 (662)
                      .   ++......+.+|+.+||+.||.+||+     ++|++++
T Consensus       223 ~---~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             C---CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            1   12233456788999999999999995     8888874

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-46  Score=386.83  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=203.2

Q ss_pred             cceeeeeCceEEEEEEeCCCC---cEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEec-cCeeeEEEecc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTG---LEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK-QDELLLVYDYV  434 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g---~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~  434 (662)
                      .++||+|+||+||+|.+..++   ..||||++... .....++|.+|++++++++||||++++|+|.. ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            468999999999999986543   36999999753 55567889999999999999999999999875 46899999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      ++|+|.+++...    ...+++..+++++.|+++||.|||+   .+|+||||||+||||++++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            999999998654    4567889999999999999999999   899999999999999999999999999999765432


Q ss_pred             CC---cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          515 NP---QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       515 ~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..   ......||+.|+|||.+.++.++.++||||||+++|||+||+.|+.......  .+..++    ..+..     +
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i----~~g~~-----~  253 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYL----LQGRR-----L  253 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH----HTTCC-----C
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HcCCC-----C
Confidence            22   2233578999999999999999999999999999999999888876543221  111111    11111     1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         ..+....+.+.+|+.+||+.||++||+|.||+++|++.
T Consensus       254 ---~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 ---LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             ---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence               11122345688999999999999999999999999765

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=388.93  Aligned_cols=258  Identities=27%  Similarity=0.426  Sum_probs=206.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCc--EEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGL--EVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~--~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|+..++||+|+||+||+|+++.+|.  .||||++... .....++|.+|+++++++ +|||||+++++|..++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            568888999999999999999987776  4778887654 344566899999999999 799999999999999999999


Q ss_pred             EeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          431 YDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      |||+++|+|.++|+....           .....++|.++++++.|||+||.|||+   .+|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            999999999999975421           124679999999999999999999999   899999999999999999999


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCC-CCCcccchhhHHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRR-PIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~-p~~~~~~~~~~~l~~~~~~  578 (662)
                      ||+|||+++.......  .....||..|+|||.+..+.++.++|||||||++|||++|.. ||......   .+.+.+  
T Consensus       167 kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~~~i--  239 (309)
T d1fvra_         167 KIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKL--  239 (309)
T ss_dssp             EECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHG--
T ss_pred             EEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HHHHHH--
Confidence            9999999986544322  223468999999999999999999999999999999999765 55433221   111111  


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                        .++     ..+   ..+......+.+|+.+||+.||++||||+||+++|++.
T Consensus       240 --~~~-----~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         240 --PQG-----YRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             --GGT-----CCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --Hhc-----CCC---CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence              111     111   12233456788999999999999999999999998765

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-46  Score=381.63  Aligned_cols=255  Identities=26%  Similarity=0.412  Sum_probs=198.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCC---CcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPST---GLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~---g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..+.||+|+||+||+|+....   ...||||++...   ..+..++|.+|+.++++++||||++++|+|.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            5688899999999999999986432   246899998654   34456789999999999999999999999975 4678


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +||||+++|+|.+++...    ...+++..++.++.|||+||.|||+   ++|+||||||+||+|+.++.+||+|||+++
T Consensus        87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence            999999999999988543    4569999999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCC--cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          509 AYDHNINP--QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       509 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      ........  ......|+..|+|||.+.+..++.++|||||||++|||+| |+.||.......   ...++   ...+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i---~~~~~-  232 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI---DKEGE-  232 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTSCC-
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH---HhCCC-
Confidence            87554322  2233567889999999999999999999999999999998 899997543321   11222   11111 


Q ss_pred             ccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          586 TRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       586 ~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                          .+   ..+...+..+.+|+.+||+.||.+||||.||+++|.+
T Consensus       233 ----~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         233 ----RL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ----CC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                11   1122334568899999999999999999999999865

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=9.6e-46  Score=378.59  Aligned_cols=258  Identities=23%  Similarity=0.341  Sum_probs=203.6

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc---chhhHHHHHHHHHHhhccccccceeeeeeEeccC----e
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN---SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----E  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~---~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----~  426 (662)
                      .++|+..+.||+|+||+||+|++..+|+.||||++...   .....+.|.+|+.++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999999889999999999754   2344567999999999999999999999987654    3


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .++||||+++++|.+++..     ...+++.+.+.++.||++||.|||+   .+|+||||||+|||++.++..+|+|||.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence            7999999999999998843     3569999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCC--CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNIN--PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++.......  .......||+.|+|||++.+..+++++|||||||++|||+||+.||........      .........
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~  231 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP  231 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC
Confidence            876543322  233446799999999999998999999999999999999999999986543211      111111111


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-STRRVVQFLLR  631 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-t~~eVl~~L~~  631 (662)
                      .    .+  .......+..+.+++.+||+.||.+|| |++++++.|.+
T Consensus       232 ~----~~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         232 I----PP--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             C----CG--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             C----CC--chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            1    00  111223346688899999999999999 89999888765

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.2e-45  Score=386.33  Aligned_cols=245  Identities=21%  Similarity=0.277  Sum_probs=207.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  431 (662)
                      ++|+..+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999999899999999997542   234567899999999999999999999999999999999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYD  511 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~  511 (662)
                      ||+.+|+|..++..     ...+++.+...++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++...
T Consensus       121 e~~~~g~l~~~l~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRR-----IGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccchhhhHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            99999999999853     3468999999999999999999999   899999999999999999999999999999765


Q ss_pred             CCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCC
Q 040242          512 HNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDP  591 (662)
Q Consensus       512 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~  591 (662)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||+||+.||......   .+...+.    .+.      +
T Consensus       193 ~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~~i~----~~~------~  255 (350)
T d1rdqe_         193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI---QIYEKIV----SGK------V  255 (350)
T ss_dssp             SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH----HCC------C
T ss_pred             cc----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH---HHHHHHh----cCC------C
Confidence            32    23467999999999999999999999999999999999999999765322   1111111    111      1


Q ss_pred             CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040242          592 TLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQ  627 (662)
Q Consensus       592 ~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  627 (662)
                      .   .+......+.+++.+||+.||.+|+     |++++++
T Consensus       256 ~---~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 R---FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C---CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C---CCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1   1222345678899999999999994     8999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-46  Score=383.63  Aligned_cols=261  Identities=23%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeecc-chhhHHHHHHHHHHhhcc-ccccceeeeeeEecc-Ce
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQ-DE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~-~~  426 (662)
                      ++|+..++||+|+||.||+|.+..     +++.||||++... .....+.+..|...+.++ +|+||+++++++... ..
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~   92 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP   92 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSC
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCe
Confidence            578889999999999999999743     3468999999754 344456788888888887 689999999998765 46


Q ss_pred             eeEEEeccCCCCcchhccccccc-----------ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQ-----------KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA  495 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~  495 (662)
                      +++|||||++|+|.++|+.....           ....++|.+++.++.||++||+|||+   ++|+||||||+||||+.
T Consensus        93 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~  169 (299)
T d1ywna1          93 LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSE  169 (299)
T ss_dssp             CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECG
T ss_pred             EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECC
Confidence            89999999999999999754321           13458999999999999999999999   89999999999999999


Q ss_pred             CCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCcccchhhHHHH
Q 040242          496 DLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR-RPIEPQRTAMELVLV  573 (662)
Q Consensus       496 ~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~  573 (662)
                      ++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+||. .||........  + 
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~--~-  246 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F-  246 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH--H-
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH--H-
Confidence            99999999999987654332 2334467999999999999999999999999999999999975 56764433211  1 


Q ss_pred             HHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          574 DWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       574 ~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                         .....++.     .+..   +......+.+++.+||+.||++|||+.||+++|++.
T Consensus       247 ---~~~~~~~~-----~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         247 ---CRRLKEGT-----RMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             ---HHHHHHTC-----CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHHHhcCC-----CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence               11112221     1111   223345688999999999999999999999999753

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-45  Score=388.11  Aligned_cols=249  Identities=22%  Similarity=0.308  Sum_probs=202.0

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHH---HHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEF---VAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f---~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..++||+|+||.||+|+...+|+.||||++....   ......+   ..|+.+++.++|||||++++++...+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57899999999999999999999999999999986532   1222333   34577788889999999999999999999


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      +|||||++|+|.++|..     ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~  155 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC  155 (364)
T ss_dssp             EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred             EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence            99999999999999953     3568889999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcccc
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITR  587 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~  587 (662)
                      .....   ......||+.|+|||++.. ..++.++|||||||+||||+||+.||..........+.    ...      .
T Consensus       156 ~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~------~  222 (364)
T d1omwa3         156 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------L  222 (364)
T ss_dssp             ECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHS------S
T ss_pred             ecCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhc------c
Confidence            76543   2334579999999999875 46899999999999999999999999865433221111    000      0


Q ss_pred             ccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 040242          588 AIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPS-----TRRVVQ  627 (662)
Q Consensus       588 ~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt-----~~eVl~  627 (662)
                      ...+   ..+......+.+|+.+||+.||.+|||     ++|+++
T Consensus       223 ~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         223 TMAV---ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             SCCC---CCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             cCCC---CCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            0011   112234456888999999999999999     688876

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=2.5e-45  Score=374.75  Aligned_cols=252  Identities=24%  Similarity=0.353  Sum_probs=207.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---------hhhHHHHHHHHHHhhccc-cccceeeeeeEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---------RQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQ  424 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---------~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~  424 (662)
                      ++|+..+.||+|+||+||+|+...+|+.||||++....         ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            57889999999999999999998899999999996642         122356889999999997 99999999999999


Q ss_pred             CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeec
Q 040242          425 DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDF  504 (662)
Q Consensus       425 ~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  504 (662)
                      +..++|||||++|+|.++|..     ...+++.++..++.||++||+|||+   .+|+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccc
Confidence            999999999999999999953     3569999999999999999999999   89999999999999999999999999


Q ss_pred             cccccccCCCCCcceecccCCcccCccccc------CCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTR------TGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE  578 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~  578 (662)
                      |+++......  ......||+.|+|||.+.      ...++.++||||+||++|||++|+.||.........       .
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~-------~  225 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-------R  225 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------H
T ss_pred             hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHH-------H
Confidence            9999876533  234467999999999875      335688999999999999999999999865432111       1


Q ss_pred             HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ....+... ..    ........+.+.+|+.+||+.||++|||+.||+++
T Consensus       226 ~i~~~~~~-~~----~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         226 MIMSGNYQ-FG----SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             HHHHTCCC-CC----TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             HHHhCCCC-CC----CcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            11111110 00    11122344678889999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-46  Score=384.52  Aligned_cols=262  Identities=23%  Similarity=0.375  Sum_probs=212.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCC-----CCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccCeee
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPS-----TGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELL  428 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  428 (662)
                      ++|+..++||+|+||+||+|.+..     .+..||||++... ..+....|.+|+.++++++||||++++++|...+..+
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~   99 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTL   99 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCcee
Confidence            567888999999999999998742     3578999999754 3445567999999999999999999999999999999


Q ss_pred             EEEeccCCCCcchhccccccc-----ccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQ-----KKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      +|||||++|+|.+++......     ....+++..+.+++.|+|+||.|||+   .+|+||||||+|||+++++++||+|
T Consensus       100 lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_         100 VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECC
T ss_pred             EEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEee
Confidence            999999999999998754211     12457899999999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCC-CCCCcccchhhHHHHHHHHHHhh
Q 040242          504 FGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGR-RPIEPQRTAMELVLVDWVRELHS  581 (662)
Q Consensus       504 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~-~p~~~~~~~~~~~l~~~~~~~~~  581 (662)
                      ||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+||+ .|+.......      +.... .
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~~~i-~  249 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFV-M  249 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHHHH-H
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HHHHH-H
Confidence            9999876543222 233346899999999999999999999999999999999986 5665432211      11111 1


Q ss_pred             cCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 040242          582 QGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRDAS  634 (662)
Q Consensus       582 ~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~~~  634 (662)
                      ++.        ....+......+.+|+.+||+.||++||||++|+++|++...
T Consensus       250 ~~~--------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         250 EGG--------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             TTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             hCC--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            111        111222344678999999999999999999999999988744

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-45  Score=379.68  Aligned_cols=270  Identities=23%  Similarity=0.290  Sum_probs=205.6

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhh-----HHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQG-----MKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~-----~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      .++||+|+||+||+|+++.+|+.||||++.......     .+.+.+|+.++++++|||||++++++..++..++||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            578999999999999999999999999986543221     246889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccCCC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDHNI  514 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~~~  514 (662)
                      +++++..++..     ...+++.++..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 ~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          83 ETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             SEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             cchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            88887766632     3568899999999999999999999   899999999999999999999999999998765543


Q ss_pred             CCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---ccccc--
Q 040242          515 NPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---QITRA--  588 (662)
Q Consensus       515 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~~~~~--  588 (662)
                      . ......||+.|+|||.+... .++.++|||||||++|||++|+.||......+...   .+.+.....   .....  
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTS
T ss_pred             c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhc
Confidence            2 22335799999999988654 57999999999999999999999997654332211   111111100   00000  


Q ss_pred             ----cC-CCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH-HhcCCCCCCCCCC
Q 040242          589 ----ID-PTLDYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF-LLRDASLPQAPLD  641 (662)
Q Consensus       589 ----id-~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~-L~~~~~~p~~p~~  641 (662)
                          .. ......+     ....+.+.+|+.+||+.||++|||++|++++ .-+..+.|.++..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~  294 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ  294 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCC
Confidence                00 0001111     1234568899999999999999999999985 2345555655544

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-46  Score=383.84  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=201.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccC----eeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----ELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~lV  430 (662)
                      +.|...+.||+|+||.||+|++  +|+.||||++...... ...+..|+..+.+++||||++++++|...+    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4566788999999999999998  5889999999654322 222345666677889999999999998654    57999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcC-----CCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEEC-----DQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      ||||++|+|.++|++      ..++|.++++++.|+|.||.|||+..     .++|+||||||+||||+.++.+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred             EecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence            999999999999953      35899999999999999999999731     3699999999999999999999999999


Q ss_pred             ccccccCCCCC---cceecccCCcccCcccccCCC------CCcchhHHHHHHHHHHHHcCCCCCCcccchh----hH--
Q 040242          506 LARAYDHNINP---QTTHIVGTLGYLAPELTRTGK------ATTSTDVFGFGTLMLEVACGRRPIEPQRTAM----EL--  570 (662)
Q Consensus       506 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~----~~--  570 (662)
                      +++........   ......||+.|+|||++....      ++.++|||||||+||||+||..|+.......    ..  
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~  233 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence            99977554322   233467999999999986542      5778999999999999999998875322110    00  


Q ss_pred             --HHHHHHHHHhhcCccccccCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          571 --VLVDWVRELHSQGQITRAIDPTLD--YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       571 --~l~~~~~~~~~~~~~~~~id~~l~--~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                        ...........    .+..+|.+.  ....+....+.+|+.+||+.||++|||+.||+++|++
T Consensus       234 ~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         234 SDPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             SSCCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence              00111222211    222334431  1233466779999999999999999999999999864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-46  Score=382.79  Aligned_cols=260  Identities=25%  Similarity=0.381  Sum_probs=206.8

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCC-------cEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccC
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTG-------LEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQD  425 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g-------~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~  425 (662)
                      ++|+..+.||+|+||.||+|+....+       ..||||+++... .....++.+|...+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            56888899999999999999875443       479999997754 34567899999999888 8999999999999999


Q ss_pred             eeeEEEeccCCCCcchhcccccc-----------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeC
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQ-----------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLID  494 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~  494 (662)
                      ..++|||||++|+|.++|.....           .....+++.+++.++.||+.||+|||+   .+|+||||||+|||++
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~  169 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVT  169 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEC
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeec
Confidence            99999999999999999965431           123569999999999999999999999   8999999999999999


Q ss_pred             CCCCeEEeeccccccccCCCCC-cceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHc-CCCCCCcccchhhHHH
Q 040242          495 ADLNPKLGDFGLARAYDHNINP-QTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVAC-GRRPIEPQRTAMELVL  572 (662)
Q Consensus       495 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~ellt-G~~p~~~~~~~~~~~l  572 (662)
                      .++.+||+|||+++........ ......||+.|+|||.+.++.+++++|||||||++|||++ |..||......   .+
T Consensus       170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~---~~  246 (299)
T d1fgka_         170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE---EL  246 (299)
T ss_dssp             TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---HH
T ss_pred             CCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH---HH
Confidence            9999999999999977654332 3344578999999999999999999999999999999998 67787654321   11


Q ss_pred             HHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          573 VDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       573 ~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      .    .....+.     .+   ..+......+.+|+.+||+.||.+|||+.||++.|++.
T Consensus       247 ~----~~i~~~~-----~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         247 F----KLLKEGH-----RM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             H----HHHHTTC-----CC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHHHcCC-----CC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            1    1112211     11   11223345688999999999999999999999999764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-45  Score=382.79  Aligned_cols=264  Identities=23%  Similarity=0.298  Sum_probs=207.1

Q ss_pred             cCCccc-ceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcc-ccccceeeeeeEec----cCeee
Q 040242          355 KGFREK-NLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRL-RHRNLVQLHGWCRK----QDELL  428 (662)
Q Consensus       355 ~~f~~~-~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~----~~~~~  428 (662)
                      ++|.+. ++||+|+||+||+|++..+++.||||++...     +.+.+|+.++.++ +|||||++++++..    ...++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            568776 4699999999999999889999999999653     3466799887655 89999999999865    45789


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeecc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFG  505 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfG  505 (662)
                      +|||||++|+|.++|....   ...+++.+...++.||++||+|||+   .+|+||||||+|||++.   ++.+||+|||
T Consensus        86 ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccc
Confidence            9999999999999996542   3469999999999999999999999   89999999999999986   4579999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCcc
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQI  585 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~  585 (662)
                      +++......  ......||+.|+|||++.+..++.++|||||||++|||+||+.||..........   .+..   .   
T Consensus       160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~---~---  228 (335)
T d2ozaa1         160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKT---R---  228 (335)
T ss_dssp             TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C---
T ss_pred             eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHH---H---
Confidence            998765432  2344679999999999998899999999999999999999999997543321110   0000   0   


Q ss_pred             ccccCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCCCCC
Q 040242          586 TRAIDPTLD-YFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASLPQAPL  640 (662)
Q Consensus       586 ~~~id~~l~-~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~p~~p~  640 (662)
                      .......+. .........+.+|+.+||+.||++|||+.|++++  +.+....|..|.
T Consensus       229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~  286 (335)
T d2ozaa1         229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL  286 (335)
T ss_dssp             CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCCCEE
T ss_pred             HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCCCCc
Confidence            000000111 1112345678899999999999999999999985  666666665554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-45  Score=381.57  Aligned_cols=262  Identities=21%  Similarity=0.347  Sum_probs=210.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeC-----CCCcEEEEEEeeccc-hhhHHHHHHHHHHhhcc-ccccceeeeeeEeccCe
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIP-----STGLEVAIKRVAHNS-RQGMKEFVAEITSMGRL-RHRNLVQLHGWCRKQDE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~-----~~g~~vavK~~~~~~-~~~~~~f~~Ei~~l~~l-~H~niv~l~~~~~~~~~  426 (662)
                      .++|+..++||+|+||.||+|++.     .+++.||||+++... .....+|.+|+.+++++ +|||||+++++|...+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            367888999999999999999863     456789999997653 34456799999999999 69999999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccc-------------cccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEe
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQ-------------QKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLI  493 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll  493 (662)
                      .++|||||++|+|.++|+....             .....+++..+..++.||++||+|||+   ++++||||||+||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~  178 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILL  178 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccc
Confidence            9999999999999999975431             123469999999999999999999999   899999999999999


Q ss_pred             CCCCCeEEeeccccccccCCCC-CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCC-CCcccchhhHH
Q 040242          494 DADLNPKLGDFGLARAYDHNIN-PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRP-IEPQRTAMELV  571 (662)
Q Consensus       494 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p-~~~~~~~~~~~  571 (662)
                      +.++.+||+|||+++....... .......||+.|+|||.+.++.++.++|||||||++|||+|++.| +........  
T Consensus       179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~--  256 (311)
T d1t46a_         179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--  256 (311)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH--
T ss_pred             cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH--
Confidence            9999999999999997765432 223346789999999999999999999999999999999995544 544332211  


Q ss_pred             HHHHHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 040242          572 LVDWVRELHSQGQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLRD  632 (662)
Q Consensus       572 l~~~~~~~~~~~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~~  632 (662)
                      +...+..    +.     .+   ..+......+.+|+.+||+.||.+||||.||+++|++.
T Consensus       257 ~~~~i~~----~~-----~~---~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         257 FYKMIKE----GF-----RM---LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             HHHHHHH----TC-----CC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhc----CC-----CC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            1122211    11     11   11223456788999999999999999999999999753

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-45  Score=380.90  Aligned_cols=252  Identities=20%  Similarity=0.289  Sum_probs=207.3

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEecc
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYDYV  434 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  434 (662)
                      ++|...+.||+|+||+||+|.++.+++.||||.+...... ...+.+|+++|++++|||||++++++.+.+.+++|||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            6788999999999999999999999999999999765433 456889999999999999999999999999999999999


Q ss_pred             CCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC--CCeEEeeccccccccC
Q 040242          435 PNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD--LNPKLGDFGLARAYDH  512 (662)
Q Consensus       435 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~--~~~kL~DfGla~~~~~  512 (662)
                      ++|+|.+++...    ...+++.+...++.||++||.|||+   .+|+||||||+|||++.+  ..+||+|||+++....
T Consensus        84 ~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~  156 (321)
T d1tkia_          84 SGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP  156 (321)
T ss_dssp             CCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred             CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhcccc
Confidence            999999999644    3468999999999999999999999   899999999999999854  5799999999987644


Q ss_pred             CCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccCCC
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAIDPT  592 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id~~  592 (662)
                      .  .......+|+.|+|||.+.+..++.++||||+||++|||++|+.||.......   +.   ..... +..  ..+..
T Consensus       157 ~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~---~~i~~-~~~--~~~~~  225 (321)
T d1tkia_         157 G--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---II---ENIMN-AEY--TFDEE  225 (321)
T ss_dssp             T--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHHH-TCC--CCCHH
T ss_pred             C--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHh-CCC--CCChh
Confidence            3  23344678999999999999999999999999999999999999998654321   11   11111 100  00000


Q ss_pred             CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          593 LDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       593 l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                         ........+.+|+.+||+.||.+|||+.|++++
T Consensus       226 ---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         226 ---AFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             ---HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ---hccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               001124557889999999999999999999984

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-44  Score=374.41  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=202.4

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..++||+|+||+||+|++..+|+.||||++....  ....+++.+|++++++++||||+++++++..++..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            57899999999999999999999899999999996543  2335678999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+.++ +.+++....   ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~~-~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQD-LKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSEE-HHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCCc-hhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence            99654 444443221   4569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhh--cCcccc--
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHS--QGQITR--  587 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~--~~~~~~--  587 (662)
                      .. .......||+.|+|||.+.... .+.++||||+||++|||++|+.||..........  .-......  +.....  
T Consensus       155 ~~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~  231 (298)
T d1gz8a_         155 PV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGVT  231 (298)
T ss_dssp             CS-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred             Cc-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhccccc
Confidence            32 2233457999999999876654 5889999999999999999999998654322211  11111000  000000  


Q ss_pred             cc---CCCC---CCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          588 AI---DPTL---DYF-----DPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       588 ~i---d~~l---~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ..   ....   ...     .......+.+|+.+||+.||++|||+.|++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00   0000   000     01223567889999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-45  Score=383.24  Aligned_cols=248  Identities=23%  Similarity=0.339  Sum_probs=205.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc---hhhHHHHHHHHHHhh-ccccccceeeeeeEeccCeeeEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS---RQGMKEFVAEITSMG-RLRHRNLVQLHGWCRKQDELLLV  430 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~---~~~~~~f~~Ei~~l~-~l~H~niv~l~~~~~~~~~~~lV  430 (662)
                      ++|...+.||+|+||+||+|+++.+|+.||||++.+..   ....+.+..|..++. .++||||+++++++.+++..++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57889999999999999999999999999999997542   334556777777665 68999999999999999999999


Q ss_pred             EeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccc
Q 040242          431 YDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAY  510 (662)
Q Consensus       431 ~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~  510 (662)
                      ||||++|+|.+++..     ...+++.+...++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence            999999999999953     3458889999999999999999999   89999999999999999999999999999866


Q ss_pred             cCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCccccccC
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQITRAID  590 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~~~~~id  590 (662)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.....   +..    ....+      .
T Consensus       154 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~----~i~~~------~  219 (320)
T d1xjda_         154 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFH----SIRMD------N  219 (320)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHC------C
T ss_pred             cccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHH----HHHcC------C
Confidence            5432 23344689999999999999999999999999999999999999998654321   111    11111      1


Q ss_pred             CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 040242          591 PTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR-RVVQ  627 (662)
Q Consensus       591 ~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~-eVl~  627 (662)
                      +.+   +......+.+|+.+||+.||.+||++. ++++
T Consensus       220 ~~~---p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         220 PFY---PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             CCC---CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             CCC---CccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            111   222345688999999999999999996 6764

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.5e-44  Score=351.22  Aligned_cols=199  Identities=28%  Similarity=0.456  Sum_probs=164.0

Q ss_pred             CCceeEEeCCCCCCCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEe
Q 040242           18 AETNSFIYNGFIQANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIV   97 (662)
Q Consensus        18 ~~~~~f~~~~f~~~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~   97 (662)
                      +..++|+|++|+.+||+|+|||++.++|.||||++.++++|||+|++||+||         +..+++++||+|+|+|+|.
T Consensus         1 a~~~sF~~~~F~~~~l~l~GdA~v~~~g~i~LT~~~~~~~G~~~y~~Pi~l~---------~~~~~~~~sF~t~F~f~i~   71 (204)
T d1dhkb_           1 ATETSFIIDAFNKTNLILQGDATVSSNGNLQLSYNSYDSMSRAFYSAPIQIR---------DSTTGNVASFDTNFTMNIR   71 (204)
T ss_dssp             CCCCEEEESSCCGGGEEEESSEEECTTSCEEESSSCSSEEEEEEESSCEESE---------ETTTTEECEEEEEEEEEEE
T ss_pred             CccceEECCCCCccCeeEecceEEcCCCeEEeCCCCCCCEEEEEeCCCEecc---------CCCCcccccEEEEEEEEEe
Confidence            3568999999999999999999998889999999999999999999999999         6677788889999999999


Q ss_pred             cCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccccc
Q 040242           98 PKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEP  177 (662)
Q Consensus        98 ~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~  177 (662)
                      +.+...+||||||+++|...                   ...++.|||||||+.|         |+++|+++...... .
T Consensus        72 ~~~~~~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt~~n---------~~~~d~~~~~~~~~-~  122 (204)
T d1dhkb_          72 THRQANSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDTFLS---------RISIDVNNNDIKSV-P  122 (204)
T ss_dssp             CCC---CCSEEEEEEEEC-------------------------CCEEEEEETTTT---------EEEEEETTEEEEEE-E
T ss_pred             cCCCCCCCceEEEEecCCCC-------------------CCCCcEeeEeeEcccc---------cccCcccccccccc-c
Confidence            88777889999999998642                   1234679999999875         55555555332111 1


Q ss_pred             ccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccCCc
Q 040242          178 AAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGL  257 (662)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~  257 (662)
                                     ..+.+.+|+.++|||+||+.+++|+|+++..+  ++..+.|++.+||+.+||++|||||||+||.
T Consensus       123 ---------------~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~~~l~~~vdL~~~l~~~~yvGFSAaTG~  185 (204)
T d1dhkb_         123 ---------------WDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKSNNVSTTVELEKEVYDWVSVGFSATSGA  185 (204)
T ss_dssp             ---------------CCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCEEEEEEECCCCSGGGSEEEEEEEEEECS
T ss_pred             ---------------cccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCceeEEEEecchhccCCcEEEEEEeecCC
Confidence                           12456789999999999999999999998755  5557889999999999999999999999996


Q ss_pred             c---cceeEEecceeee
Q 040242          258 L---TAFHNVHGWSFKI  271 (662)
Q Consensus       258 ~---~~~~~i~sW~f~~  271 (662)
                      .   .|.|+|++|+|++
T Consensus       186 ~~~~~e~H~IlsWsFss  202 (204)
T d1dhkb_         186 YQWSYETHDVLSWSFSS  202 (204)
T ss_dssp             GGGSCCEEEEEEEEEEE
T ss_pred             CCCCceeeEEEEEEEEe
Confidence            4   5789999999985

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-44  Score=368.98  Aligned_cols=241  Identities=27%  Similarity=0.418  Sum_probs=197.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccch------hhHHHHHHHHHHhhccc--cccceeeeeeEeccCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSR------QGMKEFVAEITSMGRLR--HRNLVQLHGWCRKQDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~------~~~~~f~~Ei~~l~~l~--H~niv~l~~~~~~~~~  426 (662)
                      ++|+..++||+|+||+||+|+...+|+.||||++.....      ....++.+|+.++++++  |||||++++++...+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            578999999999999999999999999999999865421      12234678999999996  8999999999999999


Q ss_pred             eeEEEeccCC-CCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCC-CCeEEeec
Q 040242          427 LLLVYDYVPN-GSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDAD-LNPKLGDF  504 (662)
Q Consensus       427 ~~lV~E~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~-~~~kL~Df  504 (662)
                      .++||||+.+ +++.+++..     ...+++.++..++.||++||+|||+   .+|+||||||+|||++.+ +.+||+||
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             EEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECcc
Confidence            9999999976 567777632     4569999999999999999999999   899999999999999855 78999999


Q ss_pred             cccccccCCCCCcceecccCCcccCcccccCCCC-CcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC
Q 040242          505 GLARAYDHNINPQTTHIVGTLGYLAPELTRTGKA-TTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG  583 (662)
Q Consensus       505 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~  583 (662)
                      |+++.....   ......||+.|+|||++.+..+ +.++||||+||++|||++|+.||......         .    .+
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i---------~----~~  219 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI---------I----RG  219 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------H----HC
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchHH---------h----hc
Confidence            999875433   2334679999999999876654 67789999999999999999999753210         0    01


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .      ..   ++......+.+|+.+||+.||++|||++|++++
T Consensus       220 ~------~~---~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 Q------VF---FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             C------CC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             c------cC---CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1      01   111233567889999999999999999999874

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-43  Score=368.12  Aligned_cols=264  Identities=27%  Similarity=0.360  Sum_probs=199.8

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCC-CcEEEEEEeeccch--hhHHHHHHHHHHhhcc---ccccceeeeeeEec----
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPST-GLEVAIKRVAHNSR--QGMKEFVAEITSMGRL---RHRNLVQLHGWCRK----  423 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~-g~~vavK~~~~~~~--~~~~~f~~Ei~~l~~l---~H~niv~l~~~~~~----  423 (662)
                      .++|+..+.||+|+||+||+|++..+ ++.||||++.....  .....+.+|+.+++.|   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47899999999999999999998654 67799999865422  2223456677766665   79999999999853    


Q ss_pred             -cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEe
Q 040242          424 -QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLG  502 (662)
Q Consensus       424 -~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~  502 (662)
                       ....+++|||++++.+.......    ...+++.....++.|+++||+|||+   .+|+||||||+|||++.++.+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence             34689999999888776554332    4568999999999999999999999   899999999999999999999999


Q ss_pred             eccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          503 DFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       503 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      |||+++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...........  ........
T Consensus       159 dfg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~--i~~~~~~~  234 (305)
T d1blxa_         159 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGK--ILDVIGLP  234 (305)
T ss_dssp             SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCC
T ss_pred             chhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHH--HHHhhCCC
Confidence            99999865432  233456799999999999999999999999999999999999999986543322211  11110000


Q ss_pred             C--------cccc-cc----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          583 G--------QITR-AI----DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       583 ~--------~~~~-~i----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .        .... ..    ...+........+.+.+|+.+||+.||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0        0000 00    000111222334567889999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3e-43  Score=361.70  Aligned_cols=262  Identities=25%  Similarity=0.381  Sum_probs=201.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc--hhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS--RQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~--~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..++||+|+||+||+|+++ +|+.||||++....  ....+.+.+|+.++++++||||+++++++...+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            57889999999999999999995 78999999996643  3335789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      |+.++.+..+...     ...+++..+..++.||++||+|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~  152 (286)
T d1ob3a_          81 HLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGI  152 (286)
T ss_dssp             CCSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred             eehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceeccc
Confidence            9987777666532     3569999999999999999999999   8999999999999999999999999999987654


Q ss_pred             CCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc--C---ccc
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ--G---QIT  586 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~--~---~~~  586 (662)
                      ... ......+++.|+|||.+.+. .++.++||||+||++|||++|+.||..........  ...+.....  .   ...
T Consensus       153 ~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         153 PVR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred             Ccc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH--HHHHhhCCCChhhccchh
Confidence            322 23334689999999988654 56899999999999999999999997654322211  111110000  0   000


Q ss_pred             c--ccCCCC--------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          587 R--AIDPTL--------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       587 ~--~id~~l--------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .  ..+...        ..........+.+++.+||+.||++|||++|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0  000000        01112234568899999999999999999999863

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-42  Score=358.16  Aligned_cols=267  Identities=24%  Similarity=0.320  Sum_probs=198.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec--------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK--------  423 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~--------  423 (662)
                      .++|+..+.||+|+||+||+|++..+|+.||||++...  .....+++.+|+++|++++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36899999999999999999999889999999998554  23345678999999999999999999998855        


Q ss_pred             cCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEee
Q 040242          424 QDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGD  503 (662)
Q Consensus       424 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~D  503 (662)
                      .+..++||||++++.+..+...     ...++......++.|+++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeee
Confidence            3468999999988777655432     3457888899999999999999999   8999999999999999999999999


Q ss_pred             ccccccccCCCC---CcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHH
Q 040242          504 FGLARAYDHNIN---PQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVREL  579 (662)
Q Consensus       504 fGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~  579 (662)
                      ||+++.......   .......||+.|+|||.+.+. .+++++||||+||++|||++|+.||..................
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~  240 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS  240 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            999987654321   122235799999999988755 6899999999999999999999999865433222211111100


Q ss_pred             hhcCccccc--------cCCCC-CCCCH-------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          580 HSQGQITRA--------IDPTL-DYFDP-------QEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       580 ~~~~~~~~~--------id~~l-~~~~~-------~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .........        +.... .....       .....+.+|+.+||+.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         241 ITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             CCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            000000000        00000 00001       112346789999999999999999999975

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-42  Score=363.92  Aligned_cols=268  Identities=24%  Similarity=0.311  Sum_probs=200.2

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccC------
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD------  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~------  425 (662)
                      .++|+..+.||+|+||+||+|.+..+|+.||||++...  .....+.+.+|+.+|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            36799999999999999999999889999999999753  3344678899999999999999999999997655      


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      .+++||||+ +.+|..++.      ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~------~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK------HEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHH------hccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccc
Confidence            579999999 667777663      3469999999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHH-----H
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRE-----L  579 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~-----~  579 (662)
                      +++.....    .+...||+.|+|||.+.+ ..++.++||||+||++|||++|+.||.................     .
T Consensus       167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            99876543    334578999999998865 4578999999999999999999999986543322111110000     0


Q ss_pred             hhcC----------ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCC
Q 040242          580 HSQG----------QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASL  635 (662)
Q Consensus       580 ~~~~----------~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~  635 (662)
                      ....          .+.+.-...+..........+.+|+.+||+.||++|||+.|++++  +....+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            0000          000000011111112234567789999999999999999999985  6554433

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=363.33  Aligned_cols=273  Identities=24%  Similarity=0.284  Sum_probs=203.4

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc-chhhHHHHHHHHHHhhccccccceeeeeeEeccC----eee
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN-SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQD----ELL  428 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~-~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~  428 (662)
                      +.+|+..+.||+|+||+||+|++..+|+.||||++... .....+++.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            46799999999999999999999889999999999754 3445678899999999999999999999986653    234


Q ss_pred             EEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          429 LVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       429 lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      ++++|+.+|+|.+++.      ...+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        87 ~l~~~~~~g~L~~~l~------~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          87 YLVTHLMGADLYKLLK------TQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEECCCEEHHHHHH------HCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEeecCCchhhhhh------cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            5556677999999994      2358999999999999999999999   899999999999999999999999999998


Q ss_pred             cccCCCC--CcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc-
Q 040242          509 AYDHNIN--PQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ-  584 (662)
Q Consensus       509 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  584 (662)
                      .......  .......||+.|+|||.+.. ..++.++||||+||++|||++|+.||....................... 
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            7644321  22344679999999998854 4678899999999999999999999976543322221111100000000 


Q ss_pred             ---------cccccCCCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCC
Q 040242          585 ---------ITRAIDPTLDYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDASL  635 (662)
Q Consensus       585 ---------~~~~id~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~~  635 (662)
                               ......+.....+     ......+.+|+.+||+.||.+|||+.|++++  |......
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                     0000001111111     1122467889999999999999999999985  5544333

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-42  Score=365.13  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=196.4

Q ss_pred             CCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeeeeeEecc------CeeeE
Q 040242          356 GFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ------DELLL  429 (662)
Q Consensus       356 ~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~------~~~~l  429 (662)
                      +|+..++||+|+||+||+|++..+|+.||||++......    ..+|+.+|++++||||+++++++...      ..+++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577889999999999999999999999999999765432    24699999999999999999998543      24789


Q ss_pred             EEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccc
Q 040242          430 VYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLAR  508 (662)
Q Consensus       430 V~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~  508 (662)
                      |||||+++.+..+....  .....+++.++..++.||++||+|||+   .+|+||||||+|||++.++ .+||+|||+++
T Consensus        97 v~Ey~~~~~~~~l~~~~--~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYS--RAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             EEECCSEEHHHHHHHHH--HTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             EEeccCCccHHHHHhhh--hccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchh
Confidence            99999766544443211  124569999999999999999999999   8999999999999999775 89999999998


Q ss_pred             cccCCCCCcceecccCCcccCcccccC-CCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHH---------HHHH
Q 040242          509 AYDHNINPQTTHIVGTLGYLAPELTRT-GKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVD---------WVRE  578 (662)
Q Consensus       509 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~---------~~~~  578 (662)
                      ......  ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||.............         +...
T Consensus       172 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~  249 (350)
T d1q5ka_         172 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE  249 (350)
T ss_dssp             ECCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             hccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhh
Confidence            765432  2233579999999998764 568999999999999999999999998654332221110         1111


Q ss_pred             HhhcCccccccCCCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          579 LHSQGQITRAIDPTL------DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       579 ~~~~~~~~~~id~~l------~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      ...  ...+..-+..      ..........+.+|+.+||+.||++|||+.|++++
T Consensus       250 ~~~--~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         250 MNP--NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HCC-----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcc--chhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            000  0000000111      11122345568889999999999999999999974

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=348.35  Aligned_cols=263  Identities=25%  Similarity=0.335  Sum_probs=207.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEeccCeeeEEEe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQDELLLVYD  432 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  432 (662)
                      ++|+..+.||+|+||+||+|++..+++.||||+++..  .....+++.+|+.++++++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5789999999999999999999999999999998654  23446789999999999999999999999999999999999


Q ss_pred             ccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccccccccC
Q 040242          433 YVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGLARAYDH  512 (662)
Q Consensus       433 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~~~~  512 (662)
                      ++.+++|..++..     ...+++..+..++.|+++||+|||+   .+|+||||||+|||++.++.+||+|||.++....
T Consensus        82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            9999998887743     3567899999999999999999999   8999999999999999999999999999997755


Q ss_pred             CCCCcceecccCCcccCcccccCCC-CCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcC---c---c
Q 040242          513 NINPQTTHIVGTLGYLAPELTRTGK-ATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQG---Q---I  585 (662)
Q Consensus       513 ~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~---~---~  585 (662)
                      ... ......++..|+|||.+.... ++.++||||+||++|||++|+.||.......+..  .-+.......   .   .
T Consensus       154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL--KRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH--HHHHHHHCCCCTTTCTTG
T ss_pred             CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH--HHHHhhcCCCChhhhhhh
Confidence            432 223345788999999887654 6899999999999999999999976543322211  1111111100   0   0


Q ss_pred             cccc----------CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          586 TRAI----------DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       586 ~~~i----------d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                      .+..          ..............+.+|+.+||+.||.+|||++|++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0000          001111223344567889999999999999999999874

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-41  Score=349.44  Aligned_cols=259  Identities=17%  Similarity=0.214  Sum_probs=205.7

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccc-ccceeeeeeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~  433 (662)
                      ++|+..+.||+|+||+||+|++..+|+.||||++.....  ..++.+|++.++.++| +|++.+++++..+...++||||
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            578999999999999999999998999999998865432  2346778888888865 8999999999999999999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC-----CCCeEEeeccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA-----DLNPKLGDFGLAR  508 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~-----~~~~kL~DfGla~  508 (662)
                      + +++|.+++...    ...+++.++..++.|++.||+|||+   .+|+||||||+|||++.     ++.+||+|||+++
T Consensus        83 ~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          83 L-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             c-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeE
Confidence            9 78999988544    3468999999999999999999999   89999999999999974     5679999999999


Q ss_pred             cccCCCC------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhc
Q 040242          509 AYDHNIN------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQ  582 (662)
Q Consensus       509 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~  582 (662)
                      .+.....      .......||+.|+|||.+.+..+++++|||||||++|||++|+.||..............+......
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            7654322      1233467999999999999999999999999999999999999999865443322222222111111


Q ss_pred             CccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          583 GQITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       583 ~~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      ....+ +       ....++.+.+++..|+..+|++||+++.+.+.|..
T Consensus       235 ~~~~~-l-------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         235 TPLRE-L-------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             SCHHH-H-------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             CChHH-h-------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            10000 1       11123567888899999999999999888877654

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-41  Score=349.81  Aligned_cols=258  Identities=19%  Similarity=0.231  Sum_probs=197.5

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccceeee-eeEeccCeeeEEEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLVQLH-GWCRKQDELLLVYDY  433 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv~l~-~~~~~~~~~~lV~E~  433 (662)
                      ++|+..++||+|+||+||+|++..+|+.||||++.....  .+++..|++++++++|+|++..+ ++....+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            468999999999999999999988999999999876533  24578899999999877766554 555677788999999


Q ss_pred             cCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCC---CCCeEEeeccccccc
Q 040242          434 VPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDA---DLNPKLGDFGLARAY  510 (662)
Q Consensus       434 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~---~~~~kL~DfGla~~~  510 (662)
                      + +++|...+...    ...+++..+..++.|++.||+|||+   ++|+||||||+|||++.   +..+||+|||+++.+
T Consensus        85 ~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          85 L-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             C-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             c-CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            9 66776666433    4568999999999999999999999   89999999999999864   557999999999987


Q ss_pred             cCCCC------CcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH-HHHHHHhhcC
Q 040242          511 DHNIN------PQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV-DWVRELHSQG  583 (662)
Q Consensus       511 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~-~~~~~~~~~~  583 (662)
                      .....      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||............ .+...... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~-~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS-T  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHH-S
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCC-C
Confidence            54322      1233467999999999999989999999999999999999999999765433222111 11111000 0


Q ss_pred             ccccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 040242          584 QITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQFLLR  631 (662)
Q Consensus       584 ~~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~L~~  631 (662)
                      . ...       .....+..+.+++.+|++.+|++||++.++.+.|+.
T Consensus       236 ~-~~~-------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         236 P-IEV-------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             C-HHH-------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             C-hhH-------hccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            0 000       011234567889999999999999999988877653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-42  Score=359.34  Aligned_cols=253  Identities=23%  Similarity=0.355  Sum_probs=202.8

Q ss_pred             cCCcccceeeeeCceEEEEEEe---CCCCcEEEEEEeecc----chhhHHHHHHHHHHhhcccc-ccceeeeeeEeccCe
Q 040242          355 KGFREKNLVGSGGFGKVYRGVI---PSTGLEVAIKRVAHN----SRQGMKEFVAEITSMGRLRH-RNLVQLHGWCRKQDE  426 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~---~~~g~~vavK~~~~~----~~~~~~~f~~Ei~~l~~l~H-~niv~l~~~~~~~~~  426 (662)
                      ++|+..+.||+|+||+||+|+.   +.+|+.||||++...    .....+.+.+|++++++++| |||+++++++.....
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   346889999998653    22334568899999999977 899999999999999


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .+++|||+.+|+|.+++...     ..++......++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence            99999999999999998543     456778889999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCC--CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTG--KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ  584 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~  584 (662)
                      ++.+............|++.|+|||.+.+.  .++.++|||||||+||||++|+.||..........  .........  
T Consensus       176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~~~~--  251 (322)
T d1vzoa_         176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS--  251 (322)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC--
T ss_pred             hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcccC--
Confidence            987655444444556899999999988654  46889999999999999999999997654322111  111111110  


Q ss_pred             cccccCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 040242          585 ITRAIDPTLDYFDPQEAELVLTLGLLCCDPHPDFRP-----STRRVVQ  627 (662)
Q Consensus       585 ~~~~id~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----t~~eVl~  627 (662)
                           .+.   ++......+.+++.+||+.||.+||     |++|+++
T Consensus       252 -----~~~---~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         252 -----EPP---YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -----CCC---CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -----CCC---CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                 111   2223456788899999999999999     4889886

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.4e-40  Score=348.57  Aligned_cols=257  Identities=19%  Similarity=0.277  Sum_probs=199.1

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEec--cCeeeEEE
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRK--QDELLLVY  431 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~--~~~~~lV~  431 (662)
                      ++|+..++||+|+||+||+|++..+|+.||||++....   .+++.+|+.+|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999999999999999996543   457889999999995 9999999999874  35689999


Q ss_pred             eccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCC-CeEEeeccccccc
Q 040242          432 DYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADL-NPKLGDFGLARAY  510 (662)
Q Consensus       432 E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~-~~kL~DfGla~~~  510 (662)
                      |||++++|..+.        ..+++.++..++.||+.||.|||+   .+|+||||||+|||++.++ .+||+|||+++..
T Consensus       112 e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         112 EHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             ECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             eecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceec
Confidence            999999998764        348899999999999999999999   8999999999999998765 5899999999876


Q ss_pred             cCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHH--H---------HHHHHH
Q 040242          511 DHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELV--L---------VDWVRE  578 (662)
Q Consensus       511 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~--l---------~~~~~~  578 (662)
                      ....  ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||..........  +         ..|...
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5432  23345789999999987765 47999999999999999999999997554322111  0         111111


Q ss_pred             HhhcC--ccccccCC--C------C-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 040242          579 LHSQG--QITRAIDP--T------L-DYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQ  627 (662)
Q Consensus       579 ~~~~~--~~~~~id~--~------l-~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~  627 (662)
                      .....  ........  .      . ..........+.+|+.+||+.||.+|||++|+++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000  00000000  0      0 0111223456788999999999999999999986

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-40  Score=352.95  Aligned_cols=262  Identities=22%  Similarity=0.268  Sum_probs=193.9

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEec------cC
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRK------QD  425 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~------~~  425 (662)
                      .++|+..++||+|+||+||+|++..+|+.||||++...  .....+++.+|+.++++++||||+++++++..      ..
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            36799999999999999999999989999999999754  34445678999999999999999999999854      35


Q ss_pred             eeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeecc
Q 040242          426 ELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFG  505 (662)
Q Consensus       426 ~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfG  505 (662)
                      .+|+|||||.++.+. .+       ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+|++|||
T Consensus        96 ~~~iv~Ey~~~~l~~-~~-------~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          96 DVYLVMELMDANLCQ-VI-------QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             EEEEEEECCSEEHHH-HH-------TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             eeEEEEeccchHHHH-hh-------hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechh
Confidence            789999999665544 44       2357899999999999999999999   899999999999999999999999999


Q ss_pred             ccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHH---------HH-
Q 040242          506 LARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLV---------DW-  575 (662)
Q Consensus       506 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~---------~~-  575 (662)
                      +++......  ......+|+.|+|||.+.+..+++++||||+||+++||++|+.||............         ++ 
T Consensus       165 ~~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            998765432  334457899999999999999999999999999999999999999755432211100         00 


Q ss_pred             ------HHHHhhcCc------ccccc----CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 040242          576 ------VRELHSQGQ------ITRAI----DPTLDYFDPQEAELVLTLGLLCCDPHPDFRPSTRRVVQF  628 (662)
Q Consensus       576 ------~~~~~~~~~------~~~~i----d~~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~  628 (662)
                            .........      .....    .+............+.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  000001000      00000    011111123456678999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-41  Score=353.21  Aligned_cols=265  Identities=23%  Similarity=0.314  Sum_probs=200.7

Q ss_pred             ccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeecc--chhhHHHHHHHHHHhhccccccceeeeeeEecc-----Ce
Q 040242          354 TKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHN--SRQGMKEFVAEITSMGRLRHRNLVQLHGWCRKQ-----DE  426 (662)
Q Consensus       354 t~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~--~~~~~~~f~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  426 (662)
                      +++|+..++||+|+||+||+|++..+|+.||||++...  .....+++.+|+.+|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999999989999999999754  334456789999999999999999999998643     34


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCeEEeeccc
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNPKLGDFGL  506 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGl  506 (662)
                      .+++++|+.+|+|.+++..      ..+++.++..++.||+.||+|||+   .+|+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccch
Confidence            5777788889999999843      358999999999999999999999   8999999999999999999999999999


Q ss_pred             cccccCCCCCcceecccCCcccCcccccCC-CCCcchhHHHHHHHHHHHHcCCCCCCcccchhhHHHHHHHHHHhhcCc-
Q 040242          507 ARAYDHNINPQTTHIVGTLGYLAPELTRTG-KATTSTDVFGFGTLMLEVACGRRPIEPQRTAMELVLVDWVRELHSQGQ-  584 (662)
Q Consensus       507 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~~~l~~~~~~~~~~~~-  584 (662)
                      +.....    ......|++.|+|||...+. .++.++||||+||++|||++|+.||...........   +........ 
T Consensus       168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~  240 (348)
T d2gfsa1         168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGA  240 (348)
T ss_dssp             --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCH
T ss_pred             hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCCh
Confidence            976543    23345789999999986654 568999999999999999999999986543222111   111000000 


Q ss_pred             ----------cccccC--CCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCC
Q 040242          585 ----------ITRAID--PTLDYFD-----PQEAELVLTLGLLCCDPHPDFRPSTRRVVQF--LLRDAS  634 (662)
Q Consensus       585 ----------~~~~id--~~l~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPt~~eVl~~--L~~~~~  634 (662)
                                ......  +......     ......+.+|+.+||+.||.+|||+.|++++  +.+...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~  309 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD  309 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCC
Confidence                      000000  0011111     1223557889999999999999999999984  554433

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.9e-36  Score=315.54  Aligned_cols=265  Identities=20%  Similarity=0.216  Sum_probs=193.2

Q ss_pred             cCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-----------cccceeeeeeEec
Q 040242          355 KGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-----------HRNLVQLHGWCRK  423 (662)
Q Consensus       355 ~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-----------H~niv~l~~~~~~  423 (662)
                      .+|+..++||+|+||+||+|++..+|+.||||++..... ..+.+.+|+.++++++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            358899999999999999999998999999999976532 3456778888888775           5789999998865


Q ss_pred             c--CeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCC---
Q 040242          424 Q--DELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLN---  498 (662)
Q Consensus       424 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~---  498 (662)
                      .  ...+++++++..+.........  .....+++..+..++.||++||.|||+.  .+|+||||||+|||++.++.   
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~--~~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRR--CGIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHT--TCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhh--cCcccccCChhHeeeeccCcccc
Confidence            4  4566777776555443332211  1246688889999999999999999974  68999999999999987654   


Q ss_pred             ---eEEeeccccccccCCCCCcceecccCCcccCcccccCCCCCcchhHHHHHHHHHHHHcCCCCCCcccchhh----HH
Q 040242          499 ---PKLGDFGLARAYDHNINPQTTHIVGTLGYLAPELTRTGKATTSTDVFGFGTLMLEVACGRRPIEPQRTAME----LV  571 (662)
Q Consensus       499 ---~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDV~S~Gvvl~elltG~~p~~~~~~~~~----~~  571 (662)
                         ++++|||.+......    .....||+.|+|||.+....++.++||||+||+++||++|+.||........    ..
T Consensus       168 ~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence               999999999865432    2345799999999999988999999999999999999999999975432111    11


Q ss_pred             HHHHHHHH-------hhc----------CccccccCC-----------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 040242          572 LVDWVREL-------HSQ----------GQITRAIDP-----------TLDYFDPQEAELVLTLGLLCCDPHPDFRPSTR  623 (662)
Q Consensus       572 l~~~~~~~-------~~~----------~~~~~~id~-----------~l~~~~~~~~~~l~~l~~~Cl~~dP~~RPt~~  623 (662)
                      +...++.+       ...          ......+..           ............+.+|+.+||+.||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            11111110       000          000000000           01123456778899999999999999999999


Q ss_pred             HHHHH
Q 040242          624 RVVQF  628 (662)
Q Consensus       624 eVl~~  628 (662)
                      |++++
T Consensus       324 e~L~H  328 (362)
T d1q8ya_         324 GLVNH  328 (362)
T ss_dssp             HHHTC
T ss_pred             HHhcC
Confidence            99975

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.96  E-value=1.3e-30  Score=253.95  Aligned_cols=115  Identities=35%  Similarity=0.509  Sum_probs=104.9

Q ss_pred             CCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEE
Q 040242          139 STRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINV  218 (662)
Q Consensus       139 ~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V  218 (662)
                      .|++|||||||++|.+++||++||||||+|++.|..+.++                 ++.+|+.++|||+||+.+++|+|
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~-----------------~l~~G~~~~v~I~Yd~~~~~L~V   63 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKW-----------------NMQNGKVGTAHIIYNSVDKRLSA   63 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEEC-----------------CCCTTCEEEEEEEEETTTTEEEE
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecc-----------------cccCCCEEEEEEEEecCCcEEEE
Confidence            3789999999999998899999999999999998766543                 57899999999999999999999


Q ss_pred             EEccCCCCCCCCCeeeeecccccccccceEEeeeccCCcccceeEEecceeeecC
Q 040242          219 TISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGWSFKIGG  273 (662)
Q Consensus       219 ~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW~f~~~~  273 (662)
                      ++..   .++..|++++.+||+++|+++||||||||||...|.|+|++|+|++.-
T Consensus        64 ~~~~---~~~~~~~ls~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~~  115 (237)
T d1nlsa_          64 VVSY---PNADSATVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL  115 (237)
T ss_dssp             EEEC---TTSCCEEEEEECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred             EEec---CCCCCeEEEEEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEeec
Confidence            9974   456678999999999999999999999999999999999999998753

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.95  E-value=1.8e-27  Score=234.87  Aligned_cols=210  Identities=17%  Similarity=0.149  Sum_probs=142.2

Q ss_pred             eeEEeCCCCC-----CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEE
Q 040242           21 NSFIYNGFIQ-----ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFS   95 (662)
Q Consensus        21 ~~f~~~~f~~-----~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~   95 (662)
                      .||+.+.+.+     .++.+.|+|.+. ++.|+||++.++++|+|||+.|+++.                 +|+|+|+|.
T Consensus         9 ~sf~~P~~~~~~~~~~~w~~~G~a~i~-~~~i~LT~~~~~~~G~v~~~~p~~~~-----------------~F~~~f~f~   70 (228)
T d1gv9a_           9 YSFKGPHLVQSDGTVPFWAHAGNAIPS-ADQIRIAPSLKSQRGSVWTKTKAAFE-----------------NWEVEVTFR   70 (228)
T ss_dssp             GCEECSSCSCTTSCBTTEEEEETCEEC-SSCEEEECSSTTCEEEEEESSCBCCS-----------------SEEEEEEEE
T ss_pred             eccCCCcccCCCCCccceEEeeeEEEE-CCEEEECCCCCCCEEEEEeCCCcccc-----------------CcEEEEEEe
Confidence            3566665543     367999999886 78999999999999999999999976                 399999999


Q ss_pred             EecCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccc
Q 040242           96 IVPKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNIS  175 (662)
Q Consensus        96 i~~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~  175 (662)
                      +.... ..+||||||+|++..    +..|+.+|..       ...+-+||||||+.|.  +|++.+|+.++.|.......
T Consensus        71 ~~~~~-~~ggdG~aF~i~~~~----~~~g~~~G~~-------~~~~glaVefDt~~n~--~~~~~~~~~~~~n~~~~~~~  136 (228)
T d1gv9a_          71 VTGRG-RIGADGLAIWYTENQ----GLDGPVFGSA-------DMWNGVGIFFDSFDND--GKKNNPAIVVVGNNGQINYD  136 (228)
T ss_dssp             EECSS-SCCCCEEEEEEESSC----CCEEEETTEC-------SCCEEEEEEEECCCC-------CCEEEEEEEESCCCCC
T ss_pred             ccCCC-CCCCCEEEEEEecCC----CCCCCccCcC-------CCCceEEEEEEccccc--CCCCCCcEEEEecCCcceee
Confidence            98643 568999999999864    3456666662       2235689999999996  57888888888765432111


Q ss_pred             ccc-cccccCCCCCCCCCcceeecCCCcEEEEEEEeCCCcEEEEEEccCCCCCCCCCeeeeecccccccccceEEeeecc
Q 040242          176 EPA-AYYFSKGSNINDDNISVVLKSGDPIQAWIDYNSQEMLINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAS  254 (662)
Q Consensus       176 ~~~-~~~~~~~~~~~~~~~~~~l~~g~~~~~~I~Y~~~~~~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsas  254 (662)
                      ... .+.....     .........+..+++||+|+  .+.|+|++..........+.....++ ...+++++|||||||
T Consensus       137 ~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~~~--~~~l~v~i~~~~~~~~~~~~~~~~~~-~~~l~~~~y~GFTAs  208 (228)
T d1gv9a_         137 HQNDGATQALA-----SCQRDFRNKPYPVRAKITYY--QKTLTVMINNGFTPDKNDYEFCAKVE-NMVIPTQGHFGISAA  208 (228)
T ss_dssp             HHHHHHHHCSE-----EECCCCBSCSSCEEEEEEEE--TTEEEEEEECSSCCCTTCCEEEEEET-TCCCCSSBEEEEEEE
T ss_pred             ecCCCcccccc-----ceeeeecCCceEEEEEEEec--CCEEEEEEeccccCCCcceeEEEEec-ccccCCCEEEEEEEe
Confidence            100 0000000     00000112344556666665  68888988765444444444444333 456799999999999


Q ss_pred             CCcccceeEEecceee
Q 040242          255 TGLLTAFHNVHGWSFK  270 (662)
Q Consensus       255 tG~~~~~~~i~sW~f~  270 (662)
                      ||...+.|+|++|.+.
T Consensus       209 TG~~~~~H~I~s~~~~  224 (228)
T d1gv9a_         209 TGGLADDHDVLSFLTF  224 (228)
T ss_dssp             CCSSCCEEEEEEEEEE
T ss_pred             CCCCcCeEEEEEEEEE
Confidence            9999999999999874

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.90  E-value=4.8e-24  Score=207.25  Aligned_cols=105  Identities=28%  Similarity=0.454  Sum_probs=91.5

Q ss_pred             CCceeEEeCCCC--CCCeeEecceeeeCCCeEEecCCC------CCeeEEEEcCCceeecccccccccCCCCCceeeeeE
Q 040242           18 AETNSFIYNGFI--QANLSLDGTAFVRKDGILAVSNDQ------GRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFS   89 (662)
Q Consensus        18 ~~~~~f~~~~f~--~~~~~l~G~a~~~~~~~~~Lt~~~------~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~   89 (662)
                      +++++|+|++|.  ++||+|+|+|++.++|.||||+..      ..++|||+|++|||||         +. +++++||+
T Consensus       123 sn~~~F~f~~F~~~~~nl~l~G~A~i~~~G~l~LT~~~~~~~~~~~s~Gra~y~~Pv~l~---------d~-t~~~~SFs  192 (237)
T d1nlsa_         123 TNALHFMFNQFSKDQKDLILQGDATTGTDGNLELTRVSSNGSPQGSSVGRALFYAPVHIW---------ES-SAVVASFE  192 (237)
T ss_dssp             EEEEEEEESCCCTTCTTEEEEETCEEEETTEEESSCBCTTSCBCSSCEEEEEESSCEECC---------CT-TEEEEEEE
T ss_pred             cccceEEeeecCCCCCCEEEeeeeEecCCCcEEecCCCCCCcccCcceEEEEeCCCEEEE---------CC-CCcEeeEE
Confidence            467999999997  479999999999889999999753      4579999999999999         53 67789999


Q ss_pred             EEEEEEEecCCCCCCCCceeEEEccCC-CCCCCCcccccCCCCCC
Q 040242           90 TNFVFSIVPKYPQLGGHGLAFVLMSRK-QPPSCLANQYLGLPNDT  133 (662)
Q Consensus        90 t~F~f~i~~~~~~~~gdGlaF~l~~~~-~~~~~~~g~~lGl~~~~  133 (662)
                      |+|+|.|.+.+ ..+||||||||+|.. ..|.++.|+||||+|.+
T Consensus       193 T~F~F~I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~  236 (237)
T d1nlsa_         193 ATFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             EEEEEECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             EEEEEEEecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCC
Confidence            99999998765 568999999999975 45888999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=1.4e-21  Score=186.71  Aligned_cols=163  Identities=13%  Similarity=0.125  Sum_probs=119.5

Q ss_pred             cccceeeeeCceEEEEEEeCCCCcEEEEEEeeccc------------------hhhHHHHHHHHHHhhccccccceeeee
Q 040242          358 REKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS------------------RQGMKEFVAEITSMGRLRHRNLVQLHG  419 (662)
Q Consensus       358 ~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~------------------~~~~~~f~~Ei~~l~~l~H~niv~l~~  419 (662)
                      ...++||+|+||+||+|++. +|+.||||+++...                  .........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            34689999999999999984 68999999875321                  011234567888999999999998876


Q ss_pred             eEeccCeeeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhcCCCCEEeCCcCCCceEeCCCCCe
Q 040242          420 WCRKQDELLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEECDQRVVHRDVKPSNVLIDADLNP  499 (662)
Q Consensus       420 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH~Dlkp~NIll~~~~~~  499 (662)
                      +..    .+++|||+++..+.+            ++......++.|++++|.|||+   .+|+||||||+|||++++ .+
T Consensus        82 ~~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~  141 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GI  141 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EE
T ss_pred             ecC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CE
Confidence            542    379999998765433            3344556799999999999999   899999999999999965 48


Q ss_pred             EEeeccccccccCCCCCcceecccCCcccC------cccccCCCCCcchhHHHHHHHH
Q 040242          500 KLGDFGLARAYDHNINPQTTHIVGTLGYLA------PELTRTGKATTSTDVFGFGTLM  551 (662)
Q Consensus       500 kL~DfGla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~t~ksDV~S~Gvvl  551 (662)
                      +|+|||++....+....         .|..      .|.+ .+.++.++|+||..--+
T Consensus       142 ~liDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         142 WIIDFPQSVEVGEEGWR---------EILERDVRNIITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EECCCTTCEETTSTTHH---------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             EEEECCCcccCCCCCcH---------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence            99999999876543211         1111      1111 24567889999975433

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.85  E-value=1.4e-20  Score=183.42  Aligned_cols=196  Identities=12%  Similarity=0.134  Sum_probs=127.1

Q ss_pred             EEeCCCCC-----CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEe
Q 040242           23 FIYNGFIQ-----ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIV   97 (662)
Q Consensus        23 f~~~~f~~-----~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~   97 (662)
                      |+++.+..     .++.+.|+|.+. ++.|+||++ .++.|.+|++.|++++         +       +|+++|+|+|.
T Consensus        10 ~s~p~~~~~~~~~~~W~~~g~a~~~-~~~i~LTp~-~~~~G~~w~~~~i~~~---------~-------~f~~~~~F~i~   71 (221)
T d2a6za1          10 YSLPDLINTRKVPNNWQTGEQASLE-EGRIVLTSN-QNSKGSLWLKQGFDLK---------D-------SFTMEWTFRSV   71 (221)
T ss_dssp             GCBCCCTTCCSCCTTEEEEETCEEE-TTEEESCCS-TTCEEEEEESSCEECC---------S-------CEEEEEEEEEE
T ss_pred             ccCCCccccccCCCccEEcceeEEE-CCEEEECCC-CCCceEEEECCccccC---------C-------CeEEEEEEEEe
Confidence            67766632     589999999987 789999997 5788999999999998         2       39999999998


Q ss_pred             cCCCCCCCCceeEEEccCCCCCCCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCccccccc
Q 040242           98 PKYPQLGGHGLAFVLMSRKQPPSCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEP  177 (662)
Q Consensus        98 ~~~~~~~gdGlaF~l~~~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~  177 (662)
                      ... ..+||||||++++...  .+..|+.+|....       ..-+||||||+.|.    ....|+.++.++..-..+..
T Consensus        72 g~~-~~ggdG~af~~~~~~~--~~~~g~~~G~~~~-------~~GlaV~fDt~~n~----~~~~~~~~ndgt~~~~~~~~  137 (221)
T d2a6za1          72 GYS-GQTDGGISFWFVQDSN--IPRDKQLYNGPVN-------YDGLQLLVDNNGPL----GPTLRGQLNDGQKPVDKTKI  137 (221)
T ss_dssp             SCC-SCCSCEEEEEEEECSS--SCCCCTBTTBCTT-------CEEEEEEEESCSTT----SSEEEEEEEESSSCCCGGGH
T ss_pred             CCC-CCCCCcEEEEEEcCCC--ccccccccccCCC-------CceEEEEEECCCCC----CCceEEEecCCCccccccCC
Confidence            653 5689999999997642  2234555555222       23489999999873    22234444433322111110


Q ss_pred             ccccccCCCCCCCCCccee-ecCCCcEEEEEEEeCCCc-EEEEEEccCCCCCCCCCeeeeecccccccccceEEeeeccC
Q 040242          178 AAYYFSKGSNINDDNISVV-LKSGDPIQAWIDYNSQEM-LINVTISPLGIPKPHRPLISYPIDLATVLDEYMYVGFSAST  255 (662)
Q Consensus       178 ~~~~~~~~~~~~~~~~~~~-l~~g~~~~~~I~Y~~~~~-~l~V~~~~~~~~~~~~~~ls~~vdL~~~l~~~~~vGFsast  255 (662)
                            .+. .... ..+. ..++...+++|+|++.++ .|.|.+..       +.++.  ++--.+.++.+|+||||+|
T Consensus       138 ------~~~-~~~~-~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~-------~~c~~--~~~v~lp~~~~~fG~SA~T  200 (221)
T d2a6za1         138 ------YDQ-SFAS-CLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQ--TRKVRFPSGSYRIGVTAQN  200 (221)
T ss_dssp             ------HHH-CSEE-EECCCTTEEEEEEEEEEEEGGGTSEEEEEETT-------EEEEE--ESCCCCCSSEEEEEEEEEC
T ss_pred             ------ccc-ccce-eeecccCCCCCEEEEEEEecCccceEEEEecC-------cEeEE--ECCeecCCCCEEEEEEEcc
Confidence                  000 0000 0111 235677899999987664 47888752       11221  1211222567899999999


Q ss_pred             CcccceeEEecc
Q 040242          256 GLLTAFHNVHGW  267 (662)
Q Consensus       256 G~~~~~~~i~sW  267 (662)
                      |...+.|++..+
T Consensus       201 G~~~~~hd~~~i  212 (221)
T d2a6za1         201 GAVNNNAESFEI  212 (221)
T ss_dssp             CSGGGCCCEEEE
T ss_pred             CCccCCCceEEE
Confidence            999998886543

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.84  E-value=2.1e-20  Score=181.46  Aligned_cols=189  Identities=13%  Similarity=0.116  Sum_probs=130.0

Q ss_pred             CCeeEecceeeeCCCeEEecCCCCCeeEEEEcCCceeecccccccccCCCCCceeeeeEEEEEEEEecCCCCCCCCceeE
Q 040242           31 ANLSLDGTAFVRKDGILAVSNDQGRILGHAFYPSPLRFKQLSKYNINNNTISHTALTFSTNFVFSIVPKYPQLGGHGLAF  110 (662)
Q Consensus        31 ~~~~l~G~a~~~~~~~~~Lt~~~~~~~Gr~~y~~pv~l~~~~~~~~~~~~~~~~~~sF~t~F~f~i~~~~~~~~gdGlaF  110 (662)
                      .++.+.|+|.+. ++.|+||++. ++.|++|++.|+.++         +       +|+++|+|+|.... ..+||||||
T Consensus        22 ~~W~~~G~~~~~-~~~i~LTp~~-~~~G~~w~~~~i~~~---------~-------~f~i~~~F~i~g~~-~~~~dG~af   82 (218)
T d2a6va1          22 SQWTLGDKVKLE-EGRFVLTPGK-NTKGSLWLKPEYSIK---------D-------AMTIEWTFRSFGFR-GSTKGGLAF   82 (218)
T ss_dssp             TTEEEEETCEEE-TTEEESCCST-TCEEEEEESSCBCCS---------S-------CEEEEEEEEEESCC-SCCSCEEEE
T ss_pred             CccEECCCEEEE-CCEEEECCCC-CCeeEEEeCCccccc---------c-------cceEEEEEEEeCCC-CCCCCcEEE
Confidence            689999999987 7899999984 678999999999988         3       39999999998653 568999999


Q ss_pred             EEccCCCCC-CCCcccccCCCCCCCCCCCCCcEEEEEeeccCCCCCCCCCCCeeEEecCCCcccccccccccccCCCCCC
Q 040242          111 VLMSRKQPP-SCLANQYLGLPNDTSNAKFSTRILAVEFDAVQNLELQDINDNHVGIDISSLISNISEPAAYYFSKGSNIN  189 (662)
Q Consensus       111 ~l~~~~~~~-~~~~g~~lGl~~~~~~~~~~~~~vaVEFDt~~n~~~~d~~~~Hvgid~ns~~s~~~~~~~~~~~~~~~~~  189 (662)
                      ++++..... .+..+|..+.++.          +||||||+.|.      .+||.+.+|.-.    .++....|  . .-
T Consensus        83 w~~~~~~~~~~~~~~G~~~~f~G----------laV~fDt~~n~------~~~i~~~~ndGs----~~~~~~~d--~-~~  139 (218)
T d2a6va1          83 WLKQGNEGDSTELFGGSSKKFNG----------LMILLRLDDKL------GESVTAYLNDGT----KDLDIESS--P-YF  139 (218)
T ss_dssp             EEECSCCCCCCTBTTTBCSSCEE----------EEEEEEEETTT------EEEEEEEEEESS----SCCCTTTS--C-CS
T ss_pred             EEEcCCcccCCCcccccCCCcce----------EEEEEECCCCC------CCeEEEEeCCCC----ccccccCC--c-cc
Confidence            999865321 1122233333332          89999999874      368887766321    11111111  0 00


Q ss_pred             CCCcceeecCCCcEEEEEEEeCCCc-EEEEEEccCCCCCCCCCee-eeecccccccccceEEeeeccCCcccceeEEecc
Q 040242          190 DDNISVVLKSGDPIQAWIDYNSQEM-LINVTISPLGIPKPHRPLI-SYPIDLATVLDEYMYVGFSASTGLLTAFHNVHGW  267 (662)
Q Consensus       190 ~~~~~~~l~~g~~~~~~I~Y~~~~~-~l~V~~~~~~~~~~~~~~l-s~~vdL~~~l~~~~~vGFsastG~~~~~~~i~sW  267 (662)
                      ....--...++...+++|.|++.+. .+.|.+..       +.++ ...|+|  ..++++|+||||+||...+.|+|++|
T Consensus       140 g~c~~~~~~~~~~~~~~i~Y~~~~~~~l~v~id~-------~~c~~t~~i~l--p~~~~~yfG~SA~Tg~~~d~~dIls~  210 (218)
T d2a6va1         140 ASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVKF--MGSSPFRIGTSAINDASKESFEILKM  210 (218)
T ss_dssp             EEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCCG--GGTSCBEEEEEEECCTTCCEEEEEEE
T ss_pred             ceEEecccCCCCcEEEEEEEECcccceEEEEeCC-------cEEEEECCeec--CCCCcEEEEEEECCCCCcCcEEEEEE
Confidence            0000011346788999999997664 47888752       1232 223333  34577999999999999999999999


Q ss_pred             eee
Q 040242          268 SFK  270 (662)
Q Consensus       268 ~f~  270 (662)
                      ++-
T Consensus       211 ~~~  213 (218)
T d2a6va1         211 KLY  213 (218)
T ss_dssp             EEE
T ss_pred             EEE
Confidence            985

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.41  E-value=4.6e-07  Score=88.50  Aligned_cols=150  Identities=16%  Similarity=0.084  Sum_probs=100.5

Q ss_pred             HHHHHhccCCcccceeeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccc-cccceeeeeeEeccCe
Q 040242          348 SELYSATKGFREKNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLR-HRNLVQLHGWCRKQDE  426 (662)
Q Consensus       348 ~el~~at~~f~~~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~-H~niv~l~~~~~~~~~  426 (662)
                      .|+.+.-+.|+..+..+.+..+.||+...  ++..+.+|+...........+.+|...+..+. +--+-+++.++..++.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~   84 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW   84 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCc
Confidence            35555556776665544445578998765  56678899887665544455677888877663 3335667888888888


Q ss_pred             eeEEEeccCCCCcchhcccccccccccccHHHHHHHHHHHHHHHHHhHhc------------------------------
Q 040242          427 LLLVYDYVPNGSLDKLLFDNDQQKKKILNWDQRYKILIGVAQALLYLHEE------------------------------  476 (662)
Q Consensus       427 ~~lV~E~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------  476 (662)
                      .++||+++++.++.+.....          .....++.++++.|..||+.                              
T Consensus        85 ~~lv~~~l~G~~~~~~~~~~----------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (263)
T d1j7la_          85 SNLLMSEADGVLCSEEYEDE----------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVD  154 (263)
T ss_dssp             EEEEEECCSSEEHHHHTTTC----------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCC
T ss_pred             eEEEEEeccccccccccccc----------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhh
Confidence            99999999998876544211          11223344455555555521                              


Q ss_pred             -----------------------C---CCCEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          477 -----------------------C---DQRVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       477 -----------------------~---~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                                             .   ...++|+|+.|.||+++++..+-|.||+.+..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         155 CENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   0   12389999999999999876677999987763

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.67  E-value=7.6e-05  Score=71.72  Aligned_cols=76  Identities=14%  Similarity=0.075  Sum_probs=52.3

Q ss_pred             eeeeeCc-eEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhcccccc--ceeeeeeEeccCeeeEEEeccCCCC
Q 040242          362 LVGSGGF-GKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRN--LVQLHGWCRKQDELLLVYDYVPNGS  438 (662)
Q Consensus       362 ~LG~G~~-g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gs  438 (662)
                      .+..|.. +.||+... ..+..+.+|........   .+..|...++.+....  +.+++.++...+..++|||++++.+
T Consensus        17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3444543 67899887 45666888976554332   3556777776664323  5567888888888999999999877


Q ss_pred             cch
Q 040242          439 LDK  441 (662)
Q Consensus       439 L~~  441 (662)
                      +.+
T Consensus        93 ~~~   95 (255)
T d1nd4a_          93 LLS   95 (255)
T ss_dssp             TTT
T ss_pred             ccc
Confidence            754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.12  E-value=0.0008  Score=69.05  Aligned_cols=78  Identities=12%  Similarity=0.084  Sum_probs=47.5

Q ss_pred             cceeeeeCceEEEEEEeCCCCcEEEEEEeeccc-------hhhHHHHHHHHHHhhccc-c--ccceeeeeeEeccCeeeE
Q 040242          360 KNLVGSGGFGKVYRGVIPSTGLEVAIKRVAHNS-------RQGMKEFVAEITSMGRLR-H--RNLVQLHGWCRKQDELLL  429 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~-------~~~~~~f~~Ei~~l~~l~-H--~niv~l~~~~~~~~~~~l  429 (662)
                      .+.||.|....||+.....+++.++||.-....       .....+...|.+.|+.+. +  ..+.+++.++  .+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            346899999999999987778889999653211       111223445777776552 2  3455565544  445689


Q ss_pred             EEeccCCCCc
Q 040242          430 VYDYVPNGSL  439 (662)
Q Consensus       430 V~E~~~~gsL  439 (662)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.21  E-value=0.0057  Score=60.64  Aligned_cols=138  Identities=14%  Similarity=0.116  Sum_probs=77.6

Q ss_pred             ceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccccc-----eeee--eeEeccCeeeEEEeccCCCCcc
Q 040242          368 FGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNL-----VQLH--GWCRKQDELLLVYDYVPNGSLD  440 (662)
Q Consensus       368 ~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~ni-----v~l~--~~~~~~~~~~lV~E~~~~gsL~  440 (662)
                      --.||+... .+|..+++|..+.. ....+++..|...+..|...++     +..-  ......+..+.++++++|..+.
T Consensus        35 EN~vy~v~~-~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQD-EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECC-TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEc-CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            358999988 46888999988654 2344667778887777653222     1111  1234456788999999876553


Q ss_pred             hhc--------------cc----ccccccccccH-------------------HHHHHHHHHHHHHHHHhHh----cCCC
Q 040242          441 KLL--------------FD----NDQQKKKILNW-------------------DQRYKILIGVAQALLYLHE----ECDQ  479 (662)
Q Consensus       441 ~~l--------------~~----~~~~~~~~l~~-------------------~~~~~i~~~ia~~L~yLH~----~~~~  479 (662)
                      ..-              |.    .....+..+++                   ..+-.+...+.+.+..+..    ....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            210              00    00000111111                   1111122222233333322    2245


Q ss_pred             CEEeCCcCCCceEeCCCCCeEEeecccccc
Q 040242          480 RVVHRDVKPSNVLIDADLNPKLGDFGLARA  509 (662)
Q Consensus       480 ~ivH~Dlkp~NIll~~~~~~kL~DfGla~~  509 (662)
                      ++||+|+.+.|||++++  ..+.||+-+..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            78999999999999754  46889997763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.16  E-value=0.011  Score=60.24  Aligned_cols=75  Identities=17%  Similarity=0.193  Sum_probs=50.0

Q ss_pred             cceeeeeCceEEEEEEeCC-------CCcEEEEEEeeccchhhHHHHHHHHHHhhccccccce-eeeeeEeccCeeeEEE
Q 040242          360 KNLVGSGGFGKVYRGVIPS-------TGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHRNLV-QLHGWCRKQDELLLVY  431 (662)
Q Consensus       360 ~~~LG~G~~g~Vy~~~~~~-------~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~  431 (662)
                      .+.|+.|-.-.+|+.....       ....|.+++... ... .-...+|..+++.+.-.++. ++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            4568888888999988742       235677776653 222 23345788888888544554 67777643    6899


Q ss_pred             eccCCCCcc
Q 040242          432 DYVPNGSLD  440 (662)
Q Consensus       432 E~~~~gsL~  440 (662)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876664

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.36  E-value=0.056  Score=52.59  Aligned_cols=160  Identities=12%  Similarity=0.017  Sum_probs=83.2

Q ss_pred             cchHHHHHhccCCcccce-----eeeeCceEEEEEEeCCCCcEEEEEEeeccchhhHHHHHHHHHHhhccccc-----cc
Q 040242          345 FRYSELYSATKGFREKNL-----VGSGGFGKVYRGVIPSTGLEVAIKRVAHNSRQGMKEFVAEITSMGRLRHR-----NL  414 (662)
Q Consensus       345 ~~~~el~~at~~f~~~~~-----LG~G~~g~Vy~~~~~~~g~~vavK~~~~~~~~~~~~f~~Ei~~l~~l~H~-----ni  414 (662)
                      ++-+|+....++|...++     |..|---+.|+.+.. +| .+++|++.....  .++...|+..+..|...     ..
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~p   78 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLP   78 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEEC-CC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccc
Confidence            455677777777866444     345556788998874 34 589998865321  12334456666665432     22


Q ss_pred             eeeee---eEeccCeeeEEEeccCCCCcchhcccc--------------------ccc----------------cccccc
Q 040242          415 VQLHG---WCRKQDELLLVYDYVPNGSLDKLLFDN--------------------DQQ----------------KKKILN  455 (662)
Q Consensus       415 v~l~~---~~~~~~~~~lV~E~~~~gsL~~~l~~~--------------------~~~----------------~~~~l~  455 (662)
                      +...+   +.........++.+..+......-...                    ...                ......
T Consensus        79 i~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (316)
T d2ppqa1          79 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  158 (316)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             ceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhc
Confidence            22111   122344567777777665443211100                    000                000001


Q ss_pred             HHHHHHHHHHHHHHHHHhHh-cCCCCEEeCCcCCCceEeCCCCCeEEeeccccc
Q 040242          456 WDQRYKILIGVAQALLYLHE-ECDQRVVHRDVKPSNVLIDADLNPKLGDFGLAR  508 (662)
Q Consensus       456 ~~~~~~i~~~ia~~L~yLH~-~~~~~ivH~Dlkp~NIll~~~~~~kL~DfGla~  508 (662)
                      .......+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+.
T Consensus       159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             chhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            11112222222222222221 234679999999999999988777899999776